PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cheng, XB; Sato, N; Kohi, S; Yamaguchi, K				Cheng, Xiao-Bo; Sato, Norihiro; Kohi, Shiro; Yamaguchi, Koji			Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							PROSTATE-CANCER; TUMOR MICROENVIRONMENT; BREAST-CANCER; EXPRESSION; BIOMARKERS; CELLS; HYAL1; CARCINOMAS; PROGRESSION; SYNTHASES	Background: Although pancreatic ductal adenocarcinoma is characterized by an abundant stroma enriched with hyaluronan (HA), the prognostic impact of HA and its regulators remains unknown. Methods: Using immunohistochemistry, expression patterns of HA and its regulators, including a synthesizing enzyme (HAS2), and a degrading enzyme (HYAL1) were investigated in patients who received surgical resection. The prognostic significance of these markers and other clinicopathological variables was determined using univariate and multivariate analyses. The HA levels were determined quantitatively by enzyme-linked immunosorbent assay (ELISA). Results: We found that strong expressions of HA (P=0.008) and HAS2 (P=0.022) were significantly associated with shorter survival time after surgery. By contrast, weak expression of HYAL1 was significantly associated with poor survival (P=0.001). In multivariate analysis, tumor stage (hazard ratio (HR)=2.76, 95% confidence interval (CI): 1.14-6.66 P=0.024), strong HA expression (HR=6.04, 95% CI: 1.42-25.69 P=0.015), and weak HYAL1 expression (HR=3.16, 95% CI: 1.19-8.40 P=0.021) were independent factors predicting poor survival. ELISA revealed higher concentration of HA in pancreatic cancer tissues than in normal pancreatic tissues (P=0.001). Conclusion: These findings suggest, for the first time, that HA and its regulators may have prognostic impact in patients with pancreatic cancer.	[Cheng, Xiao-Bo; Sato, Norihiro; Kohi, Shiro; Yamaguchi, Koji] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 807, Japan; [Cheng, Xiao-Bo] China Med Univ, Affiliated Hosp 4, Dept Breast Surg, Shenyang, Peoples R China	University of Occupational & Environmental Health - Japan; China Medical University	Sato, N (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 807, Japan.	norisato@med.uoeh-u.ac.jp			Pancreas Research Foundation of Japan	Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan)	The study was supported by a grant from the Pancreas Research Foundation of Japan (http://www.jprf.or.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2011, BRIT J SURG, V98, P1041, DOI 10.1002/bjs.7574; Assmann V, 1996, CLIN CANCER RES, V2, P1607; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Csoka TB, 1998, GENOMICS, V48, P63, DOI 10.1006/geno.1997.5158; Erkan M., 2010, Experimental Oncology, V32, P128; FRIES H, 1994, VIRCHOWS ARCH, V424, P7; Frost GI, 2000, ONCOGENE, V19, P870, DOI 10.1038/sj.onc.1203317; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Jimeno A, 2006, MOL CANCER THER, V5, P787, DOI 10.1158/1535-7163.MCT-06-0005; Kramer MW, 2011, CANCER-AM CANCER SOC, V117, P1197, DOI 10.1002/cncr.25565; Kramer MW, 2010, EUR UROL, V57, P86, DOI 10.1016/j.eururo.2009.03.057; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; MAHLBACHER V, 1992, EUR J CELL BIOL, V58, P28; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Nykopp TK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-143; Posey JT, 2003, CANCER RES, V63, P2638; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Ropponen K, 1998, CANCER RES, V58, P342; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Setala LP, 1997, BRIT J CANCER, V79, P1133; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Tan JX, 2011, INT J CANCER, V128, P1303, DOI 10.1002/ijc.25460; Theocharis AD, 2000, BBA-MOL BASIS DIS, V1502, P201, DOI 10.1016/S0925-4439(00)00051-X; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Winter JM, 2013, J SURG ONCOL, V107, P15, DOI 10.1002/jso.23192	31	84	87	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80765	10.1371/journal.pone.0080765	http://dx.doi.org/10.1371/journal.pone.0080765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244714	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600216
J	McDonald, AJ; Dibble, JP; Evans, EGB; Millhauser, GL				McDonald, Alex J.; Dibble, Jessie P.; Evans, Eric G. B.; Millhauser, Glenn L.			A New Paradigm for Enzymatic Control of alpha-Cleavage and beta-Cleavage of the Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; COPPER-BINDING; IN-VIVO; TERMINAL FRAGMENT; OXIDATIVE STRESS; AMINO-TERMINUS; SCRAPIE PRION; ZINC; DOMAIN; BRAIN	The cellular form of the prion protein (PrPC) is found in both full-length and several different cleaved forms in vivo. Although the precise functions of the PrPC proteolytic products are not known, cleavage between the unstructured N-terminal domain and the structured C-terminal domain at Lys-109 down arrow His-110 (mouse sequence), termed alpha-cleavage, has been shown to produce the anti-apoptotic N1 and the scrapie-resistant C1 peptide fragments. beta-Cleavage, residing adjacent to the octarepeat domain and N-terminal to the alpha-cleavage site, is thought to arise from the action of reactive oxygen species produced from redox cycling of coordinated copper. We sought to elucidate the role of key members of the ADAM (a disintegrin and metalloproteinase) enzyme family, as well as Cu2+ redox cycling, in recombinant mouse PrP (MoPrP) cleavage through LC/MS analysis. Our findings show that although Cu2+ redox-generated reactive oxygen species do produce fragmentation corresponding to beta-cleavage, ADAM8 also cleaves MoPrP in the octarepeat domain in a Cu2+- and Zn2+-dependent manner. Additional cleavage by ADAM8 was observed at the previously proposed location of alpha-cleavage, Lys-109 down arrow His-110 (MoPrP sequencing); however, upon addition of Cu2+, the location of alpha-cleavage shifted by several amino acids toward the C terminus. ADAM10 and ADAM17 have also been implicated in alpha-cleavage at Lys109 down arrow His-110; however, we observed that they instead cleaved MoPrP at a novel location, Ala-119 down arrow Val-120, with additional cleavage by ADAM10 at Gly-227 down arrow Arg-228 near the C terminus. Together, our results show that MoPrP cleavage is far more complex than previously thought and suggest a mechanism by which PrPC fragmentation responds to Cu2+ and Zn2+.	[McDonald, Alex J.; Dibble, Jessie P.; Evans, Eric G. B.; Millhauser, Glenn L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Millhauser, GL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	glennm@ucsc.edu			National Institutes of Health [GM065790]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065790.	Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Budimir A, 2011, ACTA PHARMACEUT, V61, P1, DOI 10.2478/v10007-011-0006-6; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Campbell L, 2013, BBA-MOL BASIS DIS, V1832, P826, DOI 10.1016/j.bbadis.2013.02.020; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; Faller P, 2012, FREE RADICAL BIO MED, V52, P747, DOI 10.1016/j.freeradbiomed.2011.11.005; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kenche VB, 2011, BRIT J PHARMACOL, V163, P211, DOI 10.1111/j.1476-5381.2011.01221.x; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Liang JJ, 2012, J BIOL CHEM, V287, P16510, DOI 10.1074/jbc.M112.360891; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Oliveira-Martins JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009107; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Walter ED, 2006, BIOCHEMISTRY-US, V45, P13083, DOI 10.1021/bi060948r; Walter ED, 2009, CURR PROTEIN PEPT SC, V10, P529, DOI 10.2174/138920309789352056; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Watt NT, 2003, TRENDS BIOCHEM SCI, V28, P406, DOI 10.1016/S0968-0004(03)00166-X; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Wik L, 2012, PRION, V6, DOI 10.4161/pri.22588; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	41	80	80	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					803	813		10.1074/jbc.M113.502351	http://dx.doi.org/10.1074/jbc.M113.502351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24247244	hybrid, Green Published			2022-12-25	WOS:000330541200018
J	Lyle, AN; Remus, EW; Fan, AE; Lassegue, B; Walter, GA; Kiyosue, A; Griendling, KK; Taylor, WR				Lyle, Alicia N.; Remus, Ebony W.; Fan, Aaron E.; Lassegue, Bernard; Walter, Grant A.; Kiyosue, Arihiro; Griendling, Kathy K.; Taylor, W. Robert			Hydrogen Peroxide Regulates Osteopontin Expression through Activation of Transcriptional and Translational Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogen Peroxide; Osteopontin; Reactive Oxygen Species (ROS); Transcription; Translation	SMOOTH-MUSCLE-CELLS; DEFICIENT MICE; ESSENTIAL-HYPERTENSION; DEPENDENT TRANSLATION; PROTEIN-SYNTHESIS; RECEPTOR; INITIATION; ATHEROSCLEROSIS; PHOSPHORYLATION	Recent in vivo studies establish that osteopontin (OPN) expression is hydrogen peroxide (H2O2)-dependent. However, the mechanisms by which H2O2 increases OPN expression remain poorly defined. OPN protein expression increased in an unusual biphasic pattern in response to H2O2. To investigate whether these increases were mediated through transcriptional and/or translational regulation of OPN, smooth muscle cells stimulated with 50 m H2O2 were used as an in vitro cell system. Early protein increases at 6 h were not preceded by increased mRNA, whereas later increases (18 h) were, suggesting multiple mechanisms of regulation by H2O2. Polyribosomal fractionation assays established that early increases (6 h) in OPN expression were due to increased translation. This increase in translation occurred through phosphorylation of 4E-BP1 at the reactive oxygen species-sensitive Ser-65, which allowed for release and activation of eukaryotic initiation factor eIF4E and subsequent OPN translation. This early increase (6 h) in OPN was blunted in cells expressing a phospho-deficient 4E-BP1 mutant. H2O2 stimulation increased rat OPN promoter activity at 8 and 18 h, and promoter truncation studies established that promoter region -2284 to -795 is crucial for H2O2-dependent OPN transcription. ChIP studies determined that H2O2-dependent transcription is mediated by the reactive oxygen species-sensitive transcription factors NF-B and AP-1. In conclusion, H2O2 stimulates OPN expression in a unique biphasic pattern, where early increases are translational and late increases are transcriptional.	[Lyle, Alicia N.; Remus, Ebony W.; Fan, Aaron E.; Lassegue, Bernard; Walter, Grant A.; Griendling, Kathy K.; Taylor, W. Robert] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Taylor, W. Robert] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Taylor, W. Robert] Atlanta Vet Affairs Med Ctr, Decatur, GA 30233 USA; [Kiyosue, Arihiro] Tokyo Univ Hosp, Dept Cardiovasc Med, Bungkyo Ku, Tokyo 1138655, Japan	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Tokyo	Taylor, WR (corresponding author), Emory Univ, Sch Med, Div Cardiol, 1639 Pierce Dr,Suite 319 WMB, Atlanta, GA 30322 USA.	wtaylor@emory.edu		Lassegue, Bernard/0000-0003-4924-6506; Lyle, Alicia/0000-0001-7527-9200; Griendling, Kathy/0000-0002-9456-8582	National Institutes of Health [P01 HL095070, R01 HL090584, R01HL062820]; American Heart Association [11POST7570026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092150, R01HL090584, P01HL095070, R01HL062820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL095070, R01 HL090584, and R01HL062820 (to W. R. T.). This work was also supported by American Heart Association Post-doctoral Grant 11POST7570026 (to A. N. L.).	Abe K, 2008, HYPERTENS RES, V31, P987, DOI 10.1291/hypres.31.987; Bidder M, 2002, J BIOL CHEM, V277, P44485, DOI 10.1074/jbc.M206235200; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Collins AR, 2004, J AM COLL CARDIOL, V43, P1698, DOI 10.1016/j.jacc.2003.11.058; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Duvall CL, 2008, ARTERIOSCL THROM VAS, V28, P290, DOI 10.1161/ATVBAHA.107.158485; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Gauer S, 2008, J CELL BIOCHEM, V103, P615, DOI 10.1002/jcb.21433; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Grant CM, 2011, ANTIOXID REDOX SIGN, V15, P191, DOI 10.1089/ars.2010.3699; GRIENDLING KK, 1991, J BIOL CHEM, V266, P15498; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Heesom KJ, 1999, FEBS LETT, V457, P489, DOI 10.1016/S0014-5793(99)01094-7; Hu T, 2009, CLIN EXP PHARMACOL P, V36, P626, DOI 10.1111/j.1440-1681.2008.05124.x; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kurata M, 2011, J HUM HYPERTENS, V25, P334, DOI 10.1038/jhh.2010.73; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lorenzen JM, 2010, ATHEROSCLEROSIS, V209, P184, DOI 10.1016/j.atherosclerosis.2009.09.009; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Matsui Y, 2003, ARTERIOSCL THROM VAS, V23, P1029, DOI 10.1161/01.ATV.0000074878.29805.D0; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; REDPATH NT, 1989, BIOCHEM J, V262, P69, DOI 10.1042/bj2620069; Rocic P, 2003, J BIOL CHEM, V278, P36973, DOI 10.1074/jbc.M302099200; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Strom A, 2004, J VASC RES, V41, P314, DOI 10.1159/000079205; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Umekawa T, 2009, BJU INT, V104, P115, DOI 10.1111/j.1464-410X.2009.08374.x; Williams ES, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/496540; Zhao W, 2011, J IMMUNOL, V186, P3173, DOI 10.4049/jimmunol.1003626	37	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					275	285		10.1074/jbc.M113.489641	http://dx.doi.org/10.1074/jbc.M113.489641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24247243	Green Published, hybrid			2022-12-25	WOS:000329370900024
J	Skorek, K; Raczkowska, A; Dudek, B; Mietka, K; Guz-Regner, K; Pawlak, A; Klausa, E; Bugla-Ploskonska, G; Brzostek, K				Skorek, Karolina; Raczkowska, Adrianna; Dudek, Bartlomiej; Mietka, Katarzyna; Guz-Regner, Katarzyna; Pawlak, Aleksandra; Klausa, Elzbieta; Bugla-Ploskonska, Gabriela; Brzostek, Katarzyna			Regulatory Protein OmpR Influences the Serum Resistance of Yersinia enterocolitica O:9 by Modifying the Structure of the Outer Membrane	PLOS ONE			English	Article							ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; ANTIBIOTIC-RESISTANCE; COMPLEMENT RESISTANCE; VIRULENCE PLASMID; GENOME SEQUENCE; AIL PROTEIN; FACTOR-H; LIPOPOLYSACCHARIDE; YADA	The EnvZ/OmpR two-component system constitutes a regulatory pathway involved in bacterial adaptive responses to environmental cues. Our previous findings indicated that the OmpR regulator in Yersinia enterocolitica O:9 positively regulates the expression of FlhDC, the master flagellar activator, which influences adhesion/ invasion properties and biofilm formation. Here we show that a strain lacking OmpR grown at 37(omicron)C exhibits extremely high resistance to the bactericidal activity of normal human serum (NHS) compared with the wild-type strain. Analysis of OMP expression in the ompR mutant revealed that OmpR reciprocally regulates Ail and OmpX, two homologous OMPs of Y. enterocolitica, without causing significant changes in the level of YadA, the major serum resistance factor. Analysis of mutants in individual genes belonging to the OmpR regulon (ail, ompX, ompC and flhDC) and strains lacking plasmid pYV, expressing YadA, demonstrated the contribution of the respective proteins to serum resistance. We show that Ail and OmpC act in an opposite way to the OmpX protein to confer serum resistance to the wild-type strain, but are not responsible for the high resistance of the ompR mutant. The serum resistance phenotype of ompR seems to be multifactorial and mainly attributable to alterations that potentiate the function of YadA. Our results indicate that a decreased level of FlhDC in the ompR mutant cells is partly responsible for the serum resistance and this effect can be suppressed by overexpression of flhDC in trans. The observation that the loss of FlhDC enhances the survival of wild-type cells in NHS supports the involvement of FlhDC regulator in this phenotype. In addition, the ompR mutant exhibited a lower level of LPS, but this was not correlated with changes in the level of FlhDC. We propose that OmpR might alter the susceptibility of Y. enterocolitica O:9 to complement-mediated killing through remodeling of the outer membrane.	[Skorek, Karolina; Raczkowska, Adrianna; Brzostek, Katarzyna] Univ Warsaw, Fac Biol, Dept Appl Microbiol, Warsaw, Poland; [Dudek, Bartlomiej; Mietka, Katarzyna; Guz-Regner, Katarzyna; Pawlak, Aleksandra; Bugla-Ploskonska, Gabriela] Univ Wroclaw, Fac Biol Sci, Dept Microbiol, PL-50138 Wroclaw, Poland; [Klausa, Elzbieta] Reg Ctr Transfus Med & Blood Bank, Wroclaw, Poland	University of Warsaw; University of Wroclaw	Brzostek, K (corresponding author), Univ Warsaw, Fac Biol, Dept Appl Microbiol, Warsaw, Poland.	kbrzostek@biol.uw.edu.pl	Morka, Katarzyna/AAU-8766-2020; Raczkowska, Adrianna/AAJ-2244-2020; Helena, Gabriela/D-2336-2017; Raczkowska, Adrianna/ABD-8025-2020	Helena, Gabriela/0000-0002-1222-201X; Raczkowska, Adrianna/0000-0002-4311-1689; Brzostek, Katarzyna/0000-0002-7464-1228; Guz-Regner, Katarzyna/0000-0001-5160-3985; Dudek, Bartlomiej/0000-0002-6181-3772	National Science Center, Poland [2011/01/B/NZ6/01845]	National Science Center, Poland(National Science Centre, Poland)	This research was supported in part by a grant from the National Science Center, Poland (grant 2011/01/B/NZ6/01845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BALLIGAND G, 1985, INFECT IMMUN, V48, P782, DOI 10.1128/IAI.48.3.782-786.1985; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; Baumler AJ, 1996, GENE, V183, P207, DOI 10.1016/S0378-1119(96)00560-4; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bengoechea JA, 2004, MOL MICROBIOL, V52, P451, DOI 10.1111/j.1365-2958.2004.03987.x; Bialas N, 2012, ARCH IMMUNOL THER EX, V60, P199, DOI 10.1007/s00005-012-0168-z; Biedzka-Sarek M, 2005, INFECT IMMUN, V73, P2232, DOI 10.1128/IAI.73.4.2232-2244.2005; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P5016, DOI 10.1128/IAI.00314-08; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P4100, DOI 10.1128/IAI.00313-08; BLISKA JB, 1992, P NATL ACAD SCI USA, V89, P3561, DOI 10.1073/pnas.89.8.3561; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; BRZOSTEK K, 1988, J GEN MICROBIOL, V134, P1535; Brzostek K, 2007, FOLIA MICROBIOL, V52, P73, DOI 10.1007/BF02932142; Brzostek K, 2003, FEMS MICROBIOL LETT, V228, P265, DOI 10.1016/S0378-1097(03)00779-1; BRZOSTEK K, 1990, FEMS MICROBIOL LETT, V70, P275, DOI 10.1016/S0378-1097(05)80007-2; BRZOSTEK K, 1989, RES MICROBIOL, V140, P599, DOI 10.1016/0923-2508(89)90192-7; Brzostek K, 2007, MICROBIOL-SGM, V153, P2416, DOI 10.1099/mic.0.2006/003202-0; Brzostek K, 2012, ADV EXP MED BIOL, V954, P325, DOI 10.1007/978-1-4614-3561-7_40; Bugla-Ploskonska G, 2010, MICROB ECOL, V59, P601, DOI 10.1007/s00248-009-9600-2; CAROFF M, 1984, EUR J BIOCHEM, V139, P195, DOI 10.1111/j.1432-1033.1984.tb07994.x; CHINA B, 1993, INFECT IMMUN, V61, P3129, DOI 10.1128/IAI.61.8.3129-3136.1993; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DEROUVROIT CL, 1992, MOL MICROBIOL, V6, P395, DOI 10.1111/j.1365-2958.1992.tb01483.x; Dorrell N, 1998, FEMS MICROBIOL LETT, V165, P145, DOI 10.1016/S0378-1097(98)00267-5; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Fauconnier A, 1997, MICROBIOL-SGM, V143, P3461, DOI 10.1099/00221287-143-11-3461; Gao H, 2011, BMC MICROBIOL, V23, P11; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; HEFFERNAN EJ, 1992, J BACTERIOL, V174, P84, DOI 10.1128/jb.174.1.84-91.1992; HEFFERNAN EJ, 1994, INFECT IMMUN, V62, P5183, DOI 10.1128/IAI.62.11.5183-5186.1994; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Horne SM, 2006, ARCH MICROBIOL, V185, P115, DOI 10.1007/s00203-005-0077-1; Kapatral V, 1996, MOL MICROBIOL, V19, P1061, DOI 10.1046/j.1365-2958.1996.452978.x; KAPATRAL V, 1995, MOL MICROBIOL, V17, P49, DOI 10.1111/j.1365-2958.1995.mmi_17010049.x; Kirjavainen V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000140; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Kolodziejek AM, 2010, INFECT IMMUN, V78, P5233, DOI 10.1128/IAI.00783-10; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YF, 2012, INFECT IMMUN, V80, P1815, DOI 10.1128/IAI.06395-11; MACK D, 1994, MED MICROBIOL IMMUN, V183, P217; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; MECSAS J, 1995, J BACTERIOL, V177, P799, DOI 10.1128/jb.177.3.799-804.1995; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MILLER VL, 1990, J BACTERIOL, V172, P1062, DOI 10.1128/jb.172.2.1062-1069.1990; Miller VL, 2001, MOL MICROBIOL, V41, P1053, DOI 10.1046/j.1365-2958.2001.02575.x; Muller-Loennies S, 1999, EUR J BIOCHEM, V261, P19, DOI 10.1046/j.1432-1327.1999.00243.x; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; PEPE JC, 1994, MOL MICROBIOL, V11, P123, DOI 10.1111/j.1365-2958.1994.tb00295.x; PIERSON DE, 1994, J BACTERIOL, V176, P4043, DOI 10.1128/JB.176.13.4043-4051.1994; PIERSON DE, 1993, INFECT IMMUN, V61, P1846, DOI 10.1128/IAI.61.5.1846-1852.1993; PILZ D, 1992, INFECT IMMUN, V60, P189, DOI 10.1128/IAI.60.1.189-195.1992; Raczkowska A, 2011, FEMS MICROBIOL LETT, V321, P43, DOI 10.1111/j.1574-6968.2011.02308.x; Raczkowska A, 2011, ANTON LEEUW INT J G, V99, P381, DOI 10.1007/s10482-010-9503-8; Ren Y, 2010, J BACTERIOL, V192, P2463, DOI 10.1128/JB.00067-10; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rosner BM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-337; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; Sambrook J, 2001, MOL CLONING LAB MANU; Schindler MKH, 2012, J IMMUNOL, V189, P4900, DOI 10.4049/jimmunol.1201383; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Skurnik M, 2003, CARBOHYDR RES, V14, p[338, 2521]; Skurnik M., 2004, YERSINIA MOL CELLULA, P215; Skurnik M, 2007, J BACTERIOL, V189, P7244, DOI 10.1128/JB.00605-07; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; STRALEY SC, 1995, TRENDS MICROBIOL, V3, P310, DOI 10.1016/S0966-842X(00)88960-X; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Uliczka F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002117; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; Wang Shu-rong, 2011, Journal of Fungal Research, V9, P3, DOI 10.1007/s11768-011-0236-7; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Yang YX, 1996, INFECT IMMUN, V64, P2483, DOI 10.1128/IAI.64.7.2483-2489.1996; Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	78	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79525	10.1371/journal.pone.0079525	http://dx.doi.org/10.1371/journal.pone.0079525			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260242	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900027
J	Dahlin, JL; Sinville, R; Solberg, J; Zhou, H; Han, JH; Francis, S; Strasser, JM; John, K; Hook, DJ; Walters, MA; Zhang, ZG				Dahlin, Jayme L.; Sinville, Rondedrick; Solberg, Jonathan; Zhou, Hui; Han, Junhong; Francis, Subhashree; Strasser, Jessica M.; John, Kristen; Hook, Derek J.; Walters, Michael A.; Zhang, Zhiguo			A Cell-Free Fluorometric High-Throughput Screen for Inhibitors of Rtt109-Catalyzed Histone Acetylation	PLOS ONE			English	Article							LYSINE 56 ACETYLATION; FALSE POSITIVES; ACETYLTRANSFERASE ASSAY; DRUG-DISCOVERY; MECHANISM; RTT109; CHROMATIN; H3; IDENTIFICATION; FLUORESCENT	The lysine acetyltransferase (KAT) Rtt109 forms a complex with Vps75 and catalyzes the acetylation of histone H3 lysine 56 (H3K56ac) in the Asf1-H3-H4 complex. Rtt109 and H3K56ac are vital for replication-coupled nucleosome assembly and genotoxic resistance in yeast and pathogenic fungal species such as Candida albicans. Remarkably, sequence homologs of Rtt109 are absent in humans. Therefore, inhibitors of Rtt109 are hypothesized as potential and minimally toxic antifungal agents. Herein, we report the development and optimization of a cell-free fluorometric high-throughput screen (HTS) for small-molecule inhibitors of Rtt109-catalyzed histone acetylation. The KAT component of the assay consists of the yeast Rtt109-Vps75 complex, while the histone substrate complex consists of full-length Drosophila histone H3-H4 bound to yeast Asf1. Duplicated assay runs of the LOPAC demonstrated day-to-day and plate-to-plate reproducibility. Approximately 225,000 compounds were assayed in a 384-well plate format with an average Z' factor of 0.71. Based on a 3 sigma cut-off criterion, 1,587 actives (0.7%) were identified in the primary screen. The assay method is capable of identifying previously reported KAT inhibitors such as garcinol. We also observed several prominent active classes of pan-assay interference compounds such as Mannich bases, catechols and p-hydroxyarylsulfonamides. The majority of the primary active compounds showed assay signal interference, though most assay artifacts can be efficiently removed by a series of straightforward counter-screens and orthogonal assays. Post-HTS triage demonstrated a comparatively small number of confirmed actives with IC50 values in the low micromolar range. This assay, which utilizes five label-free proteins involved in H3K56 acetylation in vivo, can in principle identify compounds that inhibit Rtt109-catalyzed H3K56 acetylation via different mechanisms. Compounds discovered via this assay or adaptations thereof could serve as chemical probes or leads for a new class of antifungals targeting an epigenetic enzyme.	[Dahlin, Jayme L.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Dahlin, Jayme L.] Mayo Clin, Coll Med, Med Scientist Training Program, Rochester, MN USA; [Sinville, Rondedrick; Solberg, Jonathan; Francis, Subhashree; Strasser, Jessica M.; John, Kristen; Hook, Derek J.; Walters, Michael A.] Univ Minnesota, Inst Therapeut Discovery & Dev, Minneapolis, MN USA; [Zhou, Hui; Han, Junhong; Zhang, Zhiguo] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu	Dahlin, Jayme/AAM-2306-2021	Walters, Michael/0000-0001-5650-9277; Dahlin, Jayme/0000-0003-4151-9944; Han, Junhong/0000-0002-3371-8698	Minnesota Partnership for Biotechnology and Medical Genomics [73-01]; National Institutes of Health (NIH) [GM72719, GM81838]; Mayo Foundation for Medical Education and Research; Minnesota Supercomputing Institute; NIH Medical Scientist Training Program [T32 GM065841]; NIH Predoctoral Fellowship [F30 DK092026-01]; Pharmaceutical Research and Manufacturers of America Foundation predoctoral pharmacology/toxicology fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841, R01GM081838, R01GM072719] Funding Source: NIH RePORTER	Minnesota Partnership for Biotechnology and Medical Genomics; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation for Medical Education and Research; Minnesota Supercomputing Institute; NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research and Manufacturers of America Foundation predoctoral pharmacology/toxicology fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Minnesota Partnership for Biotechnology and Medical Genomics (# 73-01), the National Institutes of Health (NIH GM72719 and GM81838), the Mayo Foundation for Medical Education and Research and the Minnesota Supercomputing Institute. JLD was supported by the NIH Medical Scientist Training Program (T32 GM065841), an NIH Predoctoral Fellowship (F30 DK092026-01) and a Pharmaceutical Research and Manufacturers of America Foundation predoctoral pharmacology/toxicology fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshiru N, 2013, J PROTEOMICS, V81, P80, DOI 10.1016/j.jprot.2012.09.026; Aherne GW, 2002, METHODS, V26, P245, DOI 10.1016/S1046-2023(02)00028-2; Ait-Si-Ali S, 1998, NUCLEIC ACIDS RES, V26, P3869, DOI 10.1093/nar/26.16.3869; Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Arif M, 2009, J MED CHEM, V52, P267, DOI 10.1021/jm800657z; Baell JB, 2010, FUTURE MED CHEM, V2, P1529, DOI [10.4155/fmc.10.237, 10.4155/FMC.10.237]; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Bova MP, 2004, ARCH BIOCHEM BIOPHYS, V429, P30, DOI 10.1016/j.abb.2004.05.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Bulfer SL, 2011, ANAL BIOCHEM, V410, P133, DOI 10.1016/j.ab.2010.11.004; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Canny SA, 2012, BIOINFORMATICS, V28, P140, DOI 10.1093/bioinformatics/btr622; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chung CC, 2008, ASSAY DRUG DEV TECHN, V6, P361, DOI 10.1089/adt.2007.105; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Collette JR, 2011, CURR OPIN MICROBIOL, V14, P668, DOI 10.1016/j.mib.2011.09.007; Copeland RA, 2003, ANAL BIOCHEM, V320, P1, DOI 10.1016/S0003-2697(03)00346-4; Cornely OA, 2003, BLOOD, V101, P3365, DOI 10.1182/blood-2002-05-1356; Cottier F, 2012, IMMUNOL RES, V53, P127, DOI 10.1007/s12026-012-8265-y; da Rosa JL, 2013, BIOORG MED CHEM LETT, V23, P2853, DOI 10.1016/j.bmcl.2013.03.112; da Rosa JL, 2010, P NATL ACAD SCI USA, V107, P1594, DOI 10.1073/pnas.0912427107; Darcy S, 2011, ASPEC TOUR, P21; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Davis BJ, 2013, BIOORG MED IN PRESS; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Einsele H, 2008, CLIN MICROBIOL INFEC, V14, P37, DOI 10.1111/j.1469-0691.2008.01980.x; Falk H, 2011, J BIOMOL SCREEN, V16, P1196, DOI 10.1177/1087057111421631; Fanslau C, 2010, ANAL BIOCHEM, V402, P65, DOI 10.1016/j.ab.2010.03.025; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Gao T, 2012, ANAL BIOANAL CHEM, V421, P1; Gubler H., 2006, HIGH THROUGHPUT SCRE; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hermann JC, 2013, ACS MED CHEM LETT, V4, P197, DOI 10.1021/ml3003296; Huang Zeqi, 2011, Drug Metab Lett, V5, P156; Huth JR, 2005, J AM CHEM SOC, V127, P217, DOI 10.1021/ja0455547; Inglese J, 2007, NAT CHEM BIOL, V3, P438, DOI 10.1038/nchembio0807-438; Jadhav A, 2010, J MED CHEM, V53, P37, DOI 10.1021/jm901070c; Jaki BU, 2008, J NAT PROD, V71, P1742, DOI 10.1021/np800329j; Johnston PA, 2011, CURR OPIN CHEM BIOL, V15, P174, DOI 10.1016/j.cbpa.2010.10.022; Jones BL, 2003, CURR OPIN INFECT DIS, V16, P521, DOI 10.1097/00001432-200312000-00002; Kevorkov D, 2005, J BIOMOL SCREEN, V10, P557, DOI 10.1177/1087057105276989; Kim Y, 2000, ANAL BIOCHEM, V280, P308, DOI 10.1006/abio.2000.4546; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; Kottom TJ, 2011, AM J RESP CELL MOL, V44, P768, DOI 10.1165/rcmb.2009-0443OC; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Linsky T, 2011, J BIOMOL SCREEN, V16, P1089, DOI 10.1177/1087057111417712; Lor LA, 2007, J BIOMOL SCREEN, V12, P881, DOI 10.1177/1087057107304113; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; McDonald PR, 2011, FUTURE MED CHEM, V3, P1101, DOI [10.4155/FMC.11.84, 10.4155/fmc.11.84]; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Metz JT, 2007, J COMPUT AID MOL DES, V21, P139, DOI 10.1007/s10822-007-9109-z; MIKI T, 1985, ANAL BIOCHEM, V146, P28, DOI 10.1016/0003-2697(85)90390-2; Mirkovic B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027197; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Pupaibool J, 2013, INFECT IMMUN, V81, P2268, DOI 10.1128/IAI.01173-12; Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896; Sang SM, 2002, TETRAHEDRON, V58, P10095, DOI 10.1016/S0040-4020(02)01411-4; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; Sink R, 2010, CURR MED CHEM, V17, P4231, DOI 10.2174/092986710793348545; SIPPEL TO, 1981, J HISTOCHEM CYTOCHEM, V29, P314, DOI 10.1177/29.2.7019305; Sleno L, 2007, RAPID COMMUN MASS SP, V21, P2301, DOI 10.1002/rcm.3092; Soares KM, 2010, ASSAY DRUG DEV TECHN, V8, P152, DOI 10.1089/adt.2009.0247; Stavropoulos P, 2008, P NATL ACAD SCI USA, V105, P12236, DOI 10.1073/pnas.0805813105; Su D, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C111.220715; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tang Y, 2011, STRUCTURE, V19, P221, DOI 10.1016/j.str.2010.12.012; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Turlais F, 2001, ANAL BIOCHEM, V298, P62, DOI 10.1006/abio.2001.5340; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wang R, 2011, MOL BIOSYST, V7, P2970, DOI 10.1039/c1mb05230f; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wurtele H, 2010, NAT MED, V16, P774, DOI 10.1038/nm.2175; Yang JS, 2009, J BIOMOL SCREEN, V14, P111, DOI 10.1177/1087057108328763; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhen Z, 2012, ANAL CHEM, V84, P3614, DOI 10.1021/ac203385v	98	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e78877	10.1371/journal.pone.0078877	http://dx.doi.org/10.1371/journal.pone.0078877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260132	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500012
J	Reeves, MK; Medley, KA; Pinkney, AE; Holyoak, M; Johnson, PTJ; Lannoo, MJ				Reeves, Mari K.; Medley, Kimberly A.; Pinkney, Alfred E.; Holyoak, Marcel; Johnson, Pieter T. J.; Lannoo, Michael J.			Localized Hotspots Drive Continental Geography of Abnormal Amphibians on USWildlife Refuges	PLOS ONE			English	Article							DEFORMED FROGS; TREMATODE INFECTION; LIMB MALFORMATIONS; MALFORMED FROGS; DEFORMITIES; VERMONT; RISK; MINNESOTA; STRESSORS; RADIATION	Amphibians with missing, misshapen, and extra limbs have garnered public and scientific attention for two decades, yet the extent of the phenomenon remains poorly understood. Despite progress in identifying the causes of abnormalities in some regions, a lack of knowledge about their broader spatial distribution and temporal dynamics has hindered efforts to understand their implications for amphibian population declines and environmental quality. To address this data gap, we conducted a nationwide, 10-year assessment of 62,947 amphibians on U. S. National Wildlife Refuges. Analysis of a core dataset of 48,081 individuals revealed that consistent with expected background frequencies, an average of 2% were abnormal, but abnormalities exhibited marked spatial variation with a maximum prevalence of 40%. Variance partitioning analysis demonstrated that factors associated with space (rather than species or year sampled) captured 97% of the variation in abnormalities, and the amount of partitioned variance decreased with increasing spatial scale (from site to refuge to region). Consistent with this, abnormalities occurred in local to regional hotspots, clustering at scales of tens to hundreds of kilometers. We detected such hotspot clusters of high-abnormality sites in the Mississippi River Valley, California, and Alaska. Abnormality frequency was more variable within than outside of hotspot clusters. This is consistent with dynamic phenomena such as disturbance or natural enemies (pathogens or predators), whereas similarity of abnormality frequencies at scales of tens to hundreds of kilometers suggests involvement of factors that are spatially consistent at a regional scale. Our characterization of the spatial and temporal variation inherent in continent-wide amphibian abnormalities demonstrates the disproportionate contribution of local factors in predicting hotspots, and the episodic nature of their occurrence.	[Reeves, Mari K.] US Fish & Wildlife Serv, Anchorage Field Off, Anchorage, AK USA; [Medley, Kimberly A.; Johnson, Pieter T. J.] Univ Colorado, Boulder, CO 80309 USA; [Pinkney, Alfred E.] US Fish & Wildlife Serv, Chesapeake Bay Field Off, Annapolis, MD USA; [Holyoak, Marcel] Univ Calif Davis, Davis, CA 95616 USA; [Lannoo, Michael J.] Indiana Univ Sch Med, Terre Haute, IN USA	United States Department of the Interior; US Fish & Wildlife Service; University of Colorado System; University of Colorado Boulder; United States Department of the Interior; US Fish & Wildlife Service; University of California System; University of California Davis; Indiana University System	Reeves, MK (corresponding author), US Fish & Wildlife Serv, Anchorage Field Off, Anchorage, AK USA.	mari_reeves@fws.gov	Holyoak, Marcel/C-3475-2009	Holyoak, Marcel/0000-0001-9727-3627; JOHNSON, PIETER/0000-0002-7997-5390	USFWS Division of Environmental Quality; National Wildlife Refuge System; National Science Foundation [DEB-0841758, DEB-1149308]; David and Lucile Packard Foundation	USFWS Division of Environmental Quality(US Fish & Wildlife Service); National Wildlife Refuge System; National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	Funding was provided by the USFWS Division of Environmental Quality and the National Wildlife Refuge System. PTJJ was supported by grants from the National Science Foundation (DEB-0841758, DEB-1149308) and a fellowship from the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Ankley GT, 2004, ECOTOX ENVIRON SAFE, V58, P7, DOI 10.1016/j.ecoenv.2004.01.004; Ankley GT, 2002, ENVIRON SCI TECHNOL, V36, P2853, DOI 10.1021/es011195t; ASIH, 2004, GUID US AMPH REPT; Auchincloss AH, 2012, ANNU REV PUBL HEALTH, V33, P107, DOI 10.1146/annurev-publhealth-031811-124655; Bacon JP, 2013, J EXP ZOOL PART B, V320B, P218, DOI 10.1002/jez.b.22496; Ballengee B, 2009, J EXP ZOOL PART B, V312B, P770, DOI 10.1002/jez.b.21296; Bilski P, 2003, AQUAT TOXICOL, V65, P229, DOI 10.1016/S0166-445X(03)00138-3; Blaustein AR, 1997, P NATL ACAD SCI USA, V94, P13735, DOI 10.1073/pnas.94.25.13735; Bowerman J, 2010, ECOLOGY, V91, P242, DOI 10.1890/08-1687.1; Burkhart JG, 2000, ENVIRON HEALTH PERSP, V108, P83, DOI 10.2307/3454299; Crother BI, 2012, SCI STANDARD ENGLISH; ESRI, 2011, ARCGIS DESKT REL 10; Fort DJ, 1999, ENVIRON TOXICOL CHEM, V18, P2305, DOI 10.1002/etc.5620181027; Fort Douglas J., 2006, Applied Herpetology, V3, P143, DOI 10.1163/157075406776984239; GAO, 2003, NAT WILDL REF OPP IM; Gardiner D, 2003, PURE APPL CHEM, V75, P2263, DOI 10.1351/pac200375112263; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Goodman BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020193; Gosner K. L., 1960, Herpetologica, V16, P183; Gottwald TR, 2007, PHYTOPATHOLOGY, V97, P674, DOI 10.1094/PHYTO-97-6-0674; Hatch AC, 1998, ENVIRON TOXICOL CHEM, V17, P1777; Helgen Judy C., 2000, Journal of the Iowa Academy of Science, V107, P96; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hopkins WA, 2000, ENVIRON TOXICOL CHEM, V19, P862, DOI 10.1002/etc.5620190412; Hopkins WA, 1998, ARCH ENVIRON CON TOX, V35, P325, DOI 10.1007/s002449900383; Hoppe DM, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P103; Hoppe David M., 2000, Journal of the Iowa Academy of Science, V107, P86; Johnson PTJ, 2013, J APPL ECOL, V50, P34, DOI 10.1111/1365-2664.12022; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Johnson PTJ, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P511, DOI 10.1201/EBK1420064162-c16; Johnson PTJ, 2010, J EXP ZOOL PART B, V314B, P515, DOI 10.1002/jez.b.21369; Johnson PTJ, 2009, J ANIM ECOL, V78, P191, DOI 10.1111/j.1365-2656.2008.01455.x; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2003, CONSERV BIOL, V17, P1724, DOI 10.1111/j.1523-1739.2003.00217.x; Johnson PTJ, 2003, TRENDS PARASITOL, V19, P332, DOI 10.1016/S1471-4922(03)00148-X; Johnson PTJ, 2002, ECOL MONOGR, V72, P151, DOI 10.1890/0012-9615(2002)072[0151:PROILT]2.0.CO;2; Johnson PTJ, 2001, HERPETOLOGICA, V57, P336; Kaiser J, 1997, SCIENCE, V278, P2051, DOI 10.1126/science.278.5346.2051; Kerby JL, 2010, ECOL LETT, V13, P60, DOI 10.1111/j.1461-0248.2009.01399.x; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; La Clair JJ, 1998, ENVIRON SCI TECHNOL, V32, P1453, DOI 10.1021/es971024h; Lannoo M, 2008, MALFORMED FROGS: THE COLLAPSE OF AQUATIC ECOSYSTEMS, P1; Legendre P., 1998, DEV ENV MODELING, V2nd; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Linzey DW, 2003, INT J ENVIRON HEAL R, V13, P125, DOI 10.1080/0960312031000098053; McCallum ML, 2003, J WILDLIFE DIS, V39, P522, DOI 10.7589/0090-3558-39.3.522; Meteyer CU, 2000, TERATOLOGY, V62, P151, DOI 10.1002/1096-9926(200009)62:3<151::AID-TERA3>3.0.CO;2-2; Ouellet M, 2000, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, P617; Palen WJ, 2010, P NATL ACAD SCI USA, V107, P9701, DOI 10.1073/pnas.0912970107; R Core Development Team, 2008, R LANG ENV STAT COMP; Reeves MK, 2008, ENVIRON HEALTH PERSP, V116, P1009, DOI 10.1289/ehp.10963; Reeves MK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00046.1; Reeves MK, 2010, ECOL MONOGR, V80, P423, DOI 10.1890/09-0879.1; Rohr JR, 2008, NATURE, V455, P1235, DOI 10.1038/nature07281; Rowe CL, 1998, COPEIA, P244, DOI 10.2307/1447729; SESSIONS SK, 1990, J EXP ZOOL, V254, P38, DOI 10.1002/jez.1402540107; Sessions SK, 2010, J EXP ZOOL PART B, V314B, P341, DOI 10.1002/jez.b.21351; Skelly DK, 2007, ECOHEALTH, V4, P156, DOI 10.1007/s10393-007-0103-7; Skelly DK, 2010, J EXP ZOOL PART B, V314B, P179, DOI 10.1002/jez.b.21330; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Taylor B, 2005, ENVIRON HEALTH PERSP, V113, P1497, DOI 10.1289/ehp.7585; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; USEPA, 2009, NAT ASS IMP WAT NEAR; USFWS, 1999, STAND OP PROC ABN AM; Wu XQ, 2012, P NATL ACAD SCI USA, V109, P9477, DOI 10.1073/pnas.1200062109	67	23	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e77467	10.1371/journal.pone.0077467	http://dx.doi.org/10.1371/journal.pone.0077467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260103	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500006
J	Bouskila, J; Javadi, P; Casanova, C; Ptito, M; Bouchard, JF				Bouskila, Joseph; Javadi, Pasha; Casanova, Christian; Ptito, Maurice; Bouchard, Jean-Francois			Rod Photoreceptors Express GPR55 in the Adult Vervet Monkey Retina	PLOS ONE			English	Article							SENSITIVE RECEPTOR GPR55; ACID AMIDE HYDROLASE; CANNABINOID RECEPTOR; LYSOPHOSPHATIDYLINOSITOL RECEPTOR; POSTNATAL-DEVELOPMENT; GLUTAMINE-SYNTHETASE; MACAQUE RETINA; GANGLION-CELLS; MULLER CELLS; RAT RETINA	Cannabinoids exert their actions mainly through two receptors, the cannabinoid CB1 receptor (CB1R) and cannabinoid CB2 receptor (CB2R). In recent years, the G-protein coupled receptor 55 (GPR55) was suggested as a cannabinoid receptor based on its activation by anandamide and tetrahydrocannabinol. Yet, its formal classification is still a matter of debate. CB1R and CB2R expression patterns are well described for rodent and monkey retinas. In the monkey retina, CB1R has been localized in its neural (cone photoreceptor, horizontal, bipolar, amacrine and ganglion cells) and CB2R in glial components (Muller cells). The aim of this study was to determine the expression pattern of GPR55 in the monkey retina by using confocal microscopy. Our results show that GPR55 is strictly localized in the photoreceptor layer of the extrafoveal portion of the retina. Co-immunolabeling of GPR55 with rhodopsin, the photosensitive pigment in rods, revealed a clear overlap of expression throughout the rod structure with most prominent staining in the inner segments. Additionally, double-label of GPR55 with calbindin, a specific marker for cone photoreceptors in the primate retina, allowed us to exclude expression of GPR55 in cones. The labeling of GPR55 in rods was further assessed with a 3D visualization in the XZ and YZ planes thus confirming its exclusive expression in rods. These results provide data on the distribution of GPR55 in the monkey retina, different than CB1R and CB2R. The presence of GPR55 in rods suggests a function of this receptor in scotopic vision that needs to be demonstrated.	[Bouskila, Joseph; Javadi, Pasha; Casanova, Christian; Ptito, Maurice; Bouchard, Jean-Francois] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Bouskila, Joseph] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Ptito, Maurice] Univ Copenhagen, Dept Neurosci & Pharmacol, BRAINlab, Copenhagen, Denmark	Universite de Montreal; Universite de Montreal; University of Copenhagen	Bouchard, JF (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	jean-francois.bouchard@umontreal.ca	Ptito, Maurice/G-3422-2013	Ptito, Maurice/0000-0002-5173-5862	Natural Science and Engineering Research Council of Canada [311892-2010, 6362-2012, 194670-2009]; Canadian Institutes of Health Research [MOP-86495]; CIHR; FRQS	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS	The Natural Science and Engineering Research Council of Canada (311892-2010, JFB; 6362-2012, MP; 194670-2009, CC) and the Canadian Institutes of Health Research (MOP-86495, JFB) supported this work. JB received support from a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from CIHR. MP is Harland Sanders Chair professor in Visual Science. JFB was supported by a "Chercheur-Boursier Junior 2'' from FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.003; Ashton John C., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P233; Balenga NAB, 2011, ADV PHARMACOL, V62, P251, DOI 10.1016/B978-0-12-385952-5.00004-X; Begg M, 2005, PHARMACOL THERAPEUT, V106, P133, DOI 10.1016/j.pharmthera.2004.11.005; Bordt AS, 2006, J COMP NEUROL, V498, P46, DOI 10.1002/cne.21040; Bouskila J, 2012, NEUROSCIENCE, V202, P117, DOI 10.1016/j.neuroscience.2011.11.041; Bouskila J, 2013, J COMP NEUROL, V521, P2399, DOI 10.1002/cne.23333; Brown AJ, 2011, J PHARMACOL EXP THER, V337, P236, DOI 10.1124/jpet.110.172650; Burke M, 2009, J VIS EXP; Chang ML, 2007, J ANAT, V210, P54, DOI 10.1111/j.1469-7580.2006.00671.x; Chiquet C, 2002, NEUROSCIENCE, V115, P1323, DOI 10.1016/S0306-4522(02)00327-5; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; Cuenca N, 2005, J COMP NEUROL, V493, P261, DOI 10.1002/cne.20761; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; El-Remessy AB, 2010, MOL VIS, V16, P1487; Elbegdorj O, 2013, J MOL GRAPH MODEL, V39, P50, DOI 10.1016/j.jmgm.2012.10.005; Ellert-Miklaszewska A, 2007, BRAIN RES, V1137, P161, DOI 10.1016/j.brainres.2006.12.060; Fischer AJ, 2001, INVEST OPHTH VIS SCI, V42, P3256; Gasperi V, 2013, CURR MED CHEM, V20, P64; Henstridge CM, 2012, PHARMACOLOGY, V89, P179, DOI 10.1159/000336872; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Kargl J, 2012, J BIOL CHEM, V287, P44234, DOI 10.1074/jbc.M112.364109; Kolb H, 2002, J COMP NEUROL, V453, P168, DOI 10.1002/cne.10405; Kumar A, 2012, INVEST OPHTH VIS SCI, V53, P4416, DOI 10.1167/iovs.11-9294; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Martinez-Navarrete GC, 2008, J COMP NEUROL, V511, P557, DOI 10.1002/cne.21860; Martinez-Navarrete GC, 2007, MOL VIS, V13, P949; Mills SL, 1999, J COMP NEUROL, V411, P19; Nishikawa S, 2001, CURR EYE RES, V22, P34, DOI 10.1076/ceyr.22.1.34.6979; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Qi HX, 2011, J COMP NEUROL, V519, P738, DOI 10.1002/cne.22545; RIEPE RE, 1977, NATURE, V268, P654, DOI 10.1038/268654a0; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sharir H, 2012, J NEUROIMMUNE PHARM, V7, P856, DOI 10.1007/s11481-012-9351-6; Straiker A, 1999, P NATL ACAD SCI USA, V96, P14565, DOI 10.1073/pnas.96.25.14565; Sylantyev S, 2013, P NATL ACAD SCI USA, V110, P5193, DOI 10.1073/pnas.1211204110; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Wassle H, 2000, VISUAL NEUROSCI, V17, P591, DOI 10.1017/S0952523800174097; Wu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060314; Yazulla S, 2008, PROG RETIN EYE RES, V27, P501, DOI 10.1016/j.preteyeres.2008.07.002; Zabouri N, 2011, NEUROSCIENCE, V195, P145, DOI 10.1016/j.neuroscience.2011.08.008; Zabouri N, 2011, J COMP NEUROL, V519, P1258, DOI 10.1002/cne.22534; Zhao PW, 2013, LIFE SCI, V92, P453, DOI 10.1016/j.lfs.2012.06.039; Zurolo E, 2010, NEUROSCIENCE, V170, P28, DOI 10.1016/j.neuroscience.2010.07.004	48	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81080	10.1371/journal.pone.0081080	http://dx.doi.org/10.1371/journal.pone.0081080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244730	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800175
J	Winther, TN; Heiberg, IL; Bang-Berthelsen, CH; Pociot, F; Hogh, B				Winther, Thilde Nordmann; Heiberg, Ida Louise; Bang-Berthelsen, Claus Heiner; Pociot, Flemming; Hogh, Birthe			Hepatitis B Surface Antigen Quantity Positively Correlates with Plasma Levels of microRNAs Differentially Expressed in Immunological Phases of Chronic Hepatitis B in Children	PLOS ONE			English	Article							VIRUS INFECTION; NATURAL-HISTORY; SERUM; CELLS; REPLICATION; BIOMARKERS	Background and Aim: Children with chronic hepatitis B (CHB) are at high risk of progressive liver disease. It is suggested that a newly-identified panel of 16 microRNAs is important in the pathogenesis of CHB in children. Subviral hepatitis B surface antigen (HBsAg) particles are produced in large excess over infectious virions. Interestingly, circulating HBsAg particles have been shown to carry microRNAs. A thorough characterisation of the identified microRNAs and HBsAg over time in plasma from children with CHB may provide useful information about the natural course of childhood CHB. Patients and Methods: A cohort of 42 children with CHB was followed over time. Three to five blood samples were obtained from each child at minimum intervals of half a year; in total 180 blood samples. Plasma levels of the 16 microRNAs previously identified were analysed by quantitative real-time polymerase-chain-reaction. Plasma HBsAg was quantified using ARCHITECT (R) HBsAg assay. Results: The presence of 14/16 plasma microRNAs in children with CHB was confirmed. All 14 microRNAs were significantly differentially expressed in different immunological phases of the disease. MicroRNA plasma levels were highest in immune-tolerant children, lower in immune-active children, and reached the lowest values in immune-inactive children, p<0.001. Plasma levels of four microRNAs decreased significantly over time in immune-tolerant and immune-active children whereas the microRNA plasma levels were stable in immune-inactive children, p<0.004. HBsAg quantity was positively correlated with plasma levels of 11/14 microRNAs, p<0.004. Conclusion: This is the first study to characterise plasma microRNAs and HBsAg over time in children with CHB. Our data suggest that plasma levels of selected microRNAs and HBsAg are inversely correlated with immunological control of CHB in children. Further studies are, however, needed to advance the understanding of microRNAs and HBsAg in the pathogenesis of CHB in children.	[Winther, Thilde Nordmann; Heiberg, Ida Louise; Hogh, Birthe] Univ Copenhagen, Hvidovre Hosp, Dept Paediat, Copenhagen, Denmark; [Winther, Thilde Nordmann; Bang-Berthelsen, Claus Heiner; Pociot, Flemming] Univ Copenhagen, Glostrup Hosp, Glostrup Res Inst, Diagnost Unit, Glostrup, Denmark; [Winther, Thilde Nordmann; Bang-Berthelsen, Claus Heiner; Pociot, Flemming] Univ Copenhagen, Glostrup Hosp, Glostrup Res Inst, Ctr Noncoding RNA Technol & Hlth, Glostrup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Winther, TN (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Paediat, Copenhagen, Denmark.	thildewinther@gmail.com		Pociot, Flemming/0000-0003-3274-5448; /0000-0003-4541-2538	Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Danish Council for Strategic Research [09-067036/DSF]	Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	TNW was the recipient of a PhD scholarship from the Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. CHBB and FP were supported by the Danish Council for Strategic Research (09-067036/DSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Carey I, 2011, J VIROL, V85, P2416, DOI 10.1128/JVI.01449-10; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Deguchi M, 2004, J VIROL METHODS, V115, P217, DOI 10.1016/j.jviromet.2003.10.002; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; GANEM D, 1991, CURR TOP MICROBIOL, V168, P61; Haber BA, 2009, PEDIATRICS, V124, pE1007, DOI 10.1542/peds.2009-0567; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Krarup HB, 2008, SCAND J GASTROENTERO, V43, P334, DOI 10.1080/00365520701712198; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Liu WH, 2011, BBA-GENE REGUL MECH, V1809, P678, DOI 10.1016/j.bbagrm.2011.04.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lok ASF, 2004, HEPATOLOGY, V39, P857, DOI 10.1002/hep.20110; Marcellin P, 1997, HEPATOLOGY, V26, pS133, DOI 10.1002/hep.510260723; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Mukaide M, 2003, J GASTROEN HEPATOL, V18, P1264, DOI 10.1046/j.1440-1746.2003.03204.x; Novellino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031952; Paganelli M, 2012, J HEPATOL, V57, P885, DOI 10.1016/j.jhep.2012.03.036; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; SSI Statens Serum Institut Copenhagen Denmark, MAND NOT SYST; Tuaillon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032143; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Winther TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058236; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6	36	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80384	10.1371/journal.pone.0080384	http://dx.doi.org/10.1371/journal.pone.0080384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244683	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600208
J	Wong, SCC; He, CW; Chan, CML; Chan, AKC; Wong, HT; Cheung, MT; Luk, LLY; Au, TCC; Chiu, MK; Ma, BBY; Chan, ATC				Wong, Sze Chuen Cesar; He, Catherine Wan; Chan, Charles Ming Lok; Chan, Amanda Kit Ching; Wong, Heong Ting; Cheung, Moon Tong; Luk, Lewis Lai Yin; Au, Thomas Chi Chuen; Chiu, Man Kin; Ma, Brigette Buig Yue; Chan, Anthony Tak Cheung			Clinical Significance of Frizzled Homolog 3 Protein in Colorectal Cancer Patients	PLOS ONE			English	Article							NEURAL CREST DEVELOPMENT; MOLECULAR-CLONING; TUMOR-CELLS; EXPRESSION; IDENTIFICATION; PATHWAY	Frizzled homolog 3 receptor was up-regulated in several gastrointestinal cancers such as esophageal and gastric cancers. Moreover, frizzled homolog 3 has recently reported to be expressed in colorectal adenoma specimens. In the present study, we investigated the clinical significance of frizzled homolog 3 protein in colorectal cancer patients. Using immunocytochemical staining, frizzled homolog 3 expression was examined in 186 colorectal cancer specimens, 79 colorectal adenoma specimens, 133 colorectal polyp specimens, 127 colorectal cancer specimens with lymph node and/or distant metastasis, 310 specimens of various non-colorectal cancer metastatic carcinomas and 40 specimens with simultaneous occurrence of colorectal cancer, colorectal adenoma and colorectal polyp. Statistical analysis was used to correlate frizzled homolog 3 protein expression to the clinicohistopathological factors, recurrence/metastasis and survival after follow-up for 42 months in colorectal cancer patients. Frizzled homolog 3 protein was expressed in 100% colorectal cancer specimens, 89% colorectal adenoma specimens, 75% colorectal polyp specimens and 69% normal colorectal epithelial tissues. Moreover, frizzled homolog 3 immunocytochemical scores were highly correlated with colorectal cancer progression. Furthermore, frizzled homolog 3 was expressed in a comparatively lower percentage of metastatic hepatocellular carcinoma and metastatic renal clear cell carcinoma with focal and very weak staining than other metastatic tumor types. On the other hand, the frizzled homolog 3 immunocytochemical scores of colorectal adenomas with synchronous colorectal carcinomas were significantly higher than those of pure colorectal adenomas. Statistical analysis showed that frizzled homolog 3 immunocytochemical scores were associated with Dukes stage and lymph node status. Finally, stratified groups of colorectal cancer patients had significant differences in their recurrence/metastasis and survival. In conclusion, the present large-scale study has clearly showed that frizzled homolog 3 protein can generate clinically important information for colorectal cancer patients.	[Wong, Sze Chuen Cesar] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Wong, Sze Chuen Cesar; He, Catherine Wan; Chan, Charles Ming Lok; Au, Thomas Chi Chuen; Ma, Brigette Buig Yue; Chan, Anthony Tak Cheung] Chinese Univ Hong Kong, State Key Lab Oncol South China, Sir Y K Pao Ctr Canc, Dept Clin Oncol,Hong Kong Canc Inst, Hong Kong, Hong Kong, Peoples R China; [Wong, Sze Chuen Cesar; He, Catherine Wan; Chan, Charles Ming Lok; Au, Thomas Chi Chuen; Ma, Brigette Buig Yue; Chan, Anthony Tak Cheung] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Chan, Amanda Kit Ching; Chiu, Man Kin] Queen Elizabeth Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Wong, Heong Ting] Kiang Wu Hosp, Dept Pathol, Peninsula, Macau Special A, Peoples R China; [Cheung, Moon Tong; Luk, Lewis Lai Yin] Queen Elizabeth Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong; Prince of Wales Hospital	Wong, SCC (corresponding author), Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.	cesar.wong@polyu.edu.hk	B.Y., Brigette/H-4681-2017; Chan, Anthony Tak Cheung/R-3940-2018	B.Y., Brigette/0000-0003-4802-1102; Chan, Anthony Tak Cheung/0000-0002-6912-8091; WONG, Sze Chuen Cesar/0000-0003-0058-140X; he, wan/0000-0003-1137-3833	Chinese University of Hong Kong [2041412]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Chinese University of Hong Kong(Chinese University of Hong Kong); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Direct Grant from The Chinese University of Hong Kong (Project Code: 2041412) and a private donation. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Caldwell GM, 2008, BRIT J CANCER, V98, P1437, DOI 10.1038/sj.bjc.6604327; Caldwell GM, 2010, BRIT J CANCER, V103, P910, DOI 10.1038/sj.bjc.6605790; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; Edge S.B., 2010, AJCC CANC STAGING MA, V14; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Hung BS, 2001, J INVEST DERMATOL, V116, P940, DOI 10.1046/j.1523-1747.2001.01336.x; Katoh M, 2005, ONCOL REP, V14, P1583; Khan NI, 2007, BRIT J HAEMATOL, V138, P338, DOI 10.1111/j.1365-2141.2007.06667.x; Kirikoshi H, 2001, INT J ONCOL, V19, P767; Kirikoshi H, 2000, BIOCHEM BIOPH RES CO, V271, P8, DOI 10.1006/bbrc.2000.2578; Lee EHL, 2008, CLIN MED INSIGHTS-ON, V2, P169; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; Qiang YW, 2003, ONCOGENE, V22, P1536, DOI 10.1038/sj.onc.1206239; Sala CF, 2000, BIOCHEM BIOPH RES CO, V273, P27, DOI 10.1006/bbrc.2000.2882; Schoen RE, 2002, NAT REV CANCER, V2, P65, DOI 10.1038/nrc705; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Tan C, 2001, DEVELOPMENT, V128, P3665; Tanaka S, 1998, P NATL ACAD SCI USA, V95, P10164, DOI 10.1073/pnas.95.17.10164; Tokuhara M, 1998, BIOCHEM BIOPH RES CO, V243, P622, DOI 10.1006/bbrc.1998.8143; Traverso G, 2002, LANCET, V359, P403, DOI 10.1016/S0140-6736(02)07591-8; Wang YS, 2002, J NEUROSCI, V22, P8563; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wong SCC, 2004, CLIN CANCER RES, V10, P1613, DOI 10.1158/1078-0432.CCR-1168-3; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035; Wong SCC, 2009, CLIN CANCER RES, V15, P1005, DOI 10.1158/1078-0432.CCR-08-1515	31	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79481	10.1371/journal.pone.0079481	http://dx.doi.org/10.1371/journal.pone.0079481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255701	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200066
J	Portelli, MA; Siedlinski, M; Stewart, CE; Postma, DS; Nieuwenhuis, MA; Vonk, JM; Nurnberg, P; Altmuller, J; Moffatt, MF; Wardlaw, AJ; Parker, SG; Connolly, MJ; Koppelman, GH; Sayers, I				Portelli, Michael A.; Siedlinski, Mateusz; Stewart, Ceri E.; Postma, Dirkje S.; Nieuwenhuis, Maartje A.; Vonk, Judith M.; Nurnberg, Peter; Altmuller, Janine; Moffatt, Miriam F.; Wardlaw, Andrew J.; Parker, Stuart G.; Connolly, Martin J.; Koppelman, Gerard H.; Sayers, Ian			Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels	FASEB JOURNAL			English	Article						GWAS; proteolysis; respiratory disease; HBECs; cellular proliferation and wound repair	PLASMINOGEN-ACTIVATOR RECEPTOR; UROKINASE RECEPTOR; PLAUR POLYMORPHISMS; NEUTROPHIL ELASTASE; CELL-PROLIFERATION; LUNG-FUNCTION; ASSOCIATION; SYSTEM; AIRWAY; MEMBRANE	The soluble cleaved urokinase plasminogen activator receptor (scuPAR) is a circulating protein detected in multiple diseases, including various cancers, cardiovascular disease, and kidney disease, where elevated levels of scuPAR have been associated with worsening prognosis and increased disease aggressiveness. We aimed to identify novel genetic and biomolecular mechanisms regulating scuPAR levels. Elevated serum scuPAR levels were identified in asthma (n=514) and chronic obstructive pulmonary disease (COPD; n=219) cohorts when compared to controls (n=96). In these cohorts, a genome-wide association study of serum scuPAR levels identified a human plasma kallikrein gene (KLKB1) promoter polymorphism (rs4253238) associated with serum scuPAR levels in a control/asthma population (P=1.17x10(-7)), which was also observed in a COPD population (combined P=5.04x10(-12)). Using a fluorescent assay, we demonstrated that serum KLKB1 enzymatic activity was driven by rs4253238 and is inverse to scuPAR levels. Biochemical analysis identified that KLKB1 cleaves scuPAR and negates scuPAR's effects on primary human bronchial epithelial cells (HBECs) in vitro. Chymotrypsin was used as a proproteolytic control, while basal HBECs were used as a control to define scuPAR-driven effects. In summary, we reveal a novel post-translational regulatory mechanism for scuPAR using a hypothesis-free approach with implications for multiple human diseases.Portelli, M. A., Siedlinski, M., Stewart, C. E., Postma, D. S., Nieuwenhuis, M. A., Vonk, J. M., Nurnberg, P., Altmuller, J., Moffatt, M. F., Wardlaw, A. J., Parker, S. G., Connolly, M. J., Koppelman, G. H., Sayers, I. Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels.	[Portelli, Michael A.; Stewart, Ceri E.; Sayers, Ian] Univ Nottingham, Queens Med Ctr, Div Resp Med, Nottingham NG7 2UH, England; [Siedlinski, Mateusz; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen Res Inst Asthma & COPD GRIAC,Dept Epide, Groningen, Netherlands; [Postma, Dirkje S.; Nieuwenhuis, Maartje A.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen Res Inst Asthma & COPD GRIAC,Dept Pulmo, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen Res Inst Asthma & COPD GRIAC,Dept Paedi, Groningen, Netherlands; [Nurnberg, Peter; Altmuller, Janine] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Wardlaw, Andrew J.] Univ Leicester, Inst Lung Hlth Immun & Inflammat, Leicester, Leics, England; [Parker, Stuart G.] Univ Sheffield, Sheffield, S Yorkshire, England; [Connolly, Martin J.] Univ Auckland, Freemasons Dept Geriatr Med, Auckland 1, New Zealand	University of Nottingham; University of Groningen; University of Groningen; University of Groningen; University of Cologne; Imperial College London; University of Leicester; University of Sheffield; University of Auckland	Portelli, MA (corresponding author), Univ Nottingham, Queens Med Ctr, Div Resp Med, Nottingham NG7 2UH, England.	michael.portelli@nottingham.ac.uk	Vonk, Judith/K-8477-2019; Portelli, Michael/U-7671-2019; Vonk, Judith M/ABA-3009-2020; Koppelman, Gerard/AAG-9187-2020; Siedlinski, Mateusz/ABF-4244-2021	Vonk, Judith/0000-0001-7531-4547; Portelli, Michael/0000-0003-0821-4575; Vonk, Judith M/0000-0001-7531-4547; Siedlinski, Mateusz/0000-0001-7682-6122; Altmuller, Janine/0000-0003-4372-1521; Sayers, Ian/0000-0001-5601-5410; Wardlaw, Andrew/0000-0001-6583-0791; Stewart, Ceri/0000-0002-6214-2237; Parker, Stuart/0000-0002-8675-6276; Koppelman, Gerard/0000-0001-8567-3252	STEPS (Malta) scholarship; European Union; University Medical Center Groningen; Netherlands Asthma Foundation [AF 95.09, AF 98.48, AF 3.2.02.51, AF 3.2.07.015]; Asthma UK [08/01]; National Institute for Health Research [NF-SI-0512-10030] Funding Source: researchfish; Asthma UK [08/017] Funding Source: researchfish	STEPS (Malta) scholarship; European Union(European Commission); University Medical Center Groningen; Netherlands Asthma Foundation; Asthma UK; National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	The authors thank all participants who contributed to this study and acknowledge Dr. Charlotte Ruse (Sheffield Institute for Studies on Aging, University of Sheffield) for her help in setting up the COPD cohort utilized in this study. The authors also thank Benjamin Willson (Centre for Biomolecular Science, University of Nottingham) for his modification of the CellProfiler pipeline. Support came from the STEPS (Malta) scholarship, financed in part by the European Union, European Social Fund (ESF), under Operational Programme II, Cohesion Policy 2007-2013, Empowering People for More Jobs and a Better Quality of Life; the University Medical Center Groningen; the Netherlands Asthma Foundation, grants AF 95.09, AF 98.48, AF 3.2.02.51, and AF 3.2.07.015; and Asthma UK, grant 08/01.	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; Andolfo A, 2002, THROMB HAEMOSTASIS, V88, P298; Barnes PJ, 2000, CHEST, V117, P10; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton SJ, 2009, J ALLERGY CLIN IMMUN, V123, P1391, DOI 10.1016/j.jaci.2009.03.014; Beaufort N, 2006, BIOL CHEM, V387, P217, DOI 10.1515/BC.2006.029; Beaufort N, 2004, J IMMUNOL, V172, P540, DOI 10.4049/jimmunol.172.1.540; BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blasi F, 2011, CURR PHARM DESIGN, V17, P1911, DOI 10.2174/138161211796718206; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Bruneau N, 2011, CURR PHARM DESIGN, V17, P1914, DOI 10.2174/138161211796718198; Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Fink E, 2007, BIOL CHEM, V388, P957, DOI 10.1515/BC.2007.104; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Gutova M, 2008, STEM CELLS, V26, P1406, DOI 10.1634/stemcells.2008-0141; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Haupt TH, 2012, CRIT CARE, V16, DOI 10.1186/cc11434; HoyerHansen G, 1997, EUR J BIOCHEM, V243, P21, DOI 10.1111/j.1432-1033.1997.0021a.x; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Koolwijk P, 2001, BLOOD, V97, P3123, DOI 10.1182/blood.V97.10.3123; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; Lilla JN, 2009, J BIOL CHEM, V284, P13792, DOI 10.1074/jbc.M900508200; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Marceau F, 2004, NAT REV DRUG DISCOV, V3, P845, DOI 10.1038/nrd1522; Mazzieri R, 2005, THROMB HAEMOSTASIS, V93, P641, DOI 10.1160/TH05-01-0021; MILES LA, 1983, THROMB RES, V29, P407, DOI 10.1016/0049-3848(83)90244-X; Motta G, 1998, BLOOD, V91, P516, DOI 10.1182/blood.V91.2.516.516_516_528; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; PLESNER T, 1994, BLOOD, V83, P808; PLOUG M, 1991, SEMIN THROMB HEMOST, V17, P183, DOI 10.1055/s-2007-1002608; Ploug M, 2003, CURR PHARM DESIGN, V9, P1499, DOI 10.2174/1381612033454630; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; Savva A, 2011, J INFECTION, V63, P344, DOI 10.1016/j.jinf.2011.07.016; Schmaier AH, 1999, THROMB HAEMOSTASIS, V82, P226; Sidenius N, 2000, BLOOD, V96, P4091; Stewart CE, 2013, LUNG, V191, P215, DOI 10.1007/s00408-013-9450-z; Stewart CE, 2012, THORAX, V67, P477, DOI 10.1136/thoraxjnl-2011-200508; Stewart CE, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-112; Stewart CE, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-75; Tan XD, 2006, INT J ONCOL, V28, P369; Team RC, 2012, R LANG ENV STAT COMP; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Verweij N, 2013, HYPERTENSION, V61, P602, DOI 10.1161/HYPERTENSIONAHA.111.203117; WACHTFOGEL YT, 1983, J CLIN INVEST, V72, P1672, DOI 10.1172/JCI111126; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200; Wilcox-Adelman SA, 2000, CELL ADHES COMMUN, V7, P477, DOI 10.3109/15419060009040305; Wilhelm OG, 1999, J CELL PHYSIOL, V180, P225, DOI 10.1002/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2; Xiao W, 2005, CHEST, V128, P2316, DOI 10.1378/chest.128.4.2316; Xu J, 2010, CLIN SCI, V119, P353, DOI 10.1042/CS20100151	63	30	30	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					923	934		10.1096/fj.13-240879	http://dx.doi.org/10.1096/fj.13-240879			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24249636	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000331072200037
J	Lai, WS; Perera, L; Hicks, SN; Blackshear, PJ				Lai, Wi S.; Perera, Lalith; Hicks, Stephanie N.; Blackshear, Perry J.			Mutational and Structural Analysis of the Tandem Zinc Finger Domain of Tristetraprolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Inflammation; RNA-binding Protein; RNA Turnover; RNA-Protein Interaction; Tumor Necrosis Factor (TNF); AU-rich Elements	AU-RICH ELEMENT; CONTAINING MESSENGER-RNAS; PRIMARY RESPONSE GENE; GENOME-WIDE ANALYSIS; FORCE-FIELD; C-ELEGANS; PROTEINS; FAMILY; SEQUENCE; BINDING	Tristetraprolin (TTP), the best known member of a class of tandem (R/K)YKTELCX8CX5CX3H zinc finger proteins, can destabilize target mRNAs by first binding to AU-rich elements (AREs) in their 3-untranslated regions (UTRs) and subsequently promoting deadenylation and ultimate destruction of those mRNAs. This study sought to determine the roles of selected amino acids in the RNA binding domain, known as the tandem zinc finger (TZF) domain, in the ability of the full-length protein to bind to AREs within the tumor necrosis factor (TNF) mRNA 3-UTR. Within the CX8C region of the TZF domain, mutation of some of the residues specific to TTP, not found in other members of the TTP protein family, resulted in decreased binding to RNA as well as inhibited mRNA deadenylation and decay. Evaluation of simulation solution models revealed a distinct structure in the second zinc finger of TTP that was induced by the presence of these TTP-specific residues. In addition, mutations within the lead-in sequences preceding the first C of highly conserved residues within the CX5C or CX3H regions or within the linker region between the two fingers also perturbed both RNA binding and the simulation model of the TZF domain in complex with RNA. We conclude that, although the majority of conserved residues within the TZF domain of TTP are required for productive binding, not all residues at sequence-equivalent positions in the two zinc fingers of the TZF domain of TTP are functionally equivalent.	[Lai, Wi S.; Hicks, Stephanie N.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Perera, Lalith] NIEHS, Lab Struct Biol, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, F1-13 Bldg 101,111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019; Perera, Lalith/ABB-9995-2021; perera, Lalith/B-6879-2012	Blackshear, Perry J./0000-0002-9561-8529; perera, Lalith/0000-0003-0823-1631	National Institutes of Health, NIEHS, Division of Intramural Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS, Division of Intramural Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health, NIEHS, Division of Intramural Research.	Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Case D.A., 2010, AMBER VERSION 11; Cuthbertson BJ, 2008, J BIOL CHEM, V283, P2586, DOI 10.1074/jbc.M707154200; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Farley BM, 2008, RNA, V14, P2685, DOI 10.1261/rna.1256708; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; GOMPERTS M, 1990, ONCOGENE, V5, P1081; HEXIMER SP, 1993, DNA CELL BIOL, V12, P73, DOI 10.1089/dna.1993.12.73; Horner TJ, 2009, MOL CELL BIOL, V29, P1999, DOI 10.1128/MCB.00982-08; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jadhav S, 2008, DEVELOPMENT, V135, P1803, DOI 10.1242/dev.013656; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; MA QF, 1991, ONCOGENE, V6, P1277; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Shimada M, 2002, GENES CELLS, V7, P933, DOI 10.1046/j.1365-2443.2002.00570.x; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Tabara H, 1999, DEVELOPMENT, V126, P1; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44	48	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					565	580		10.1074/jbc.M113.466326	http://dx.doi.org/10.1074/jbc.M113.466326			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24253039	Green Published, hybrid			2022-12-25	WOS:000329370900048
J	Baker, R; Wilkerson, EM; Sumita, K; Isom, DG; Sasaki, AT; Dohlman, HG; Campbell, SL				Baker, Rachael; Wilkerson, Emily M.; Sumita, Kazutaka; Isom, Daniel G.; Sasaki, Atsuo T.; Dohlman, Henrik G.; Campbell, Sharon L.			Differences in the Regulation of K-Ras and H-Ras Isoforms by Monoubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Oncogene; Post-translational Modification; Protein Chemical Modification; Ras; Signal Transduction; Ubiquitination; Monoubiquitination	SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; KRAS MUTATIONS; PROTEINS; BINDING; TRAFFICKING; EFFECTORS; SURFACE; GAPS; GEFS	Ras GTPases are signaling switches that control critical cellular processes including gene expression, differentiation, and apoptosis. The major Ras isoforms (K, H, and N) contain a conserved core GTPase domain, but have distinct biological functions. Among the three Ras isoforms there are clear differences in post-translational regulation, which contribute to differences in localization and signaling output. Modification by ubiquitination was recently reported to activate Ras signaling in cells, but the mechanisms of activation are not well understood. Here, we show that H-Ras is activated by monoubiquitination and that ubiquitination at Lys-117 accelerates intrinsic nucleotide exchange, thereby promoting GTP loading. This mechanism of Ras activation is distinct from K-Ras monoubiquitination at Lys-147, which leads to impaired regulator-mediated GTP hydrolysis. These findings reveal that different Ras isoforms are monoubiquitinated at distinct sites, with distinct mechanisms of action, but with a common ability to chronically activate the protein in the absence of a receptor signal or oncogenic mutation.	[Baker, Rachael; Isom, Daniel G.; Dohlman, Henrik G.; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Dohlman, Henrik G.; Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wilkerson, Emily M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Sumita, Kazutaka; Sasaki, Atsuo T.] Univ Cincinnati, Brain Tumor Ctr, Neurosci Inst, Div Hematol & Oncol,Dept Internal Med, Cincinnati, OH 45267 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; University of Cincinnati	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Genet Med Bldg,Ste 3010, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu; campbesl@med.unc.edu	Sumita, Kazutaka/AAI-1553-2019	Dohlman, Henrik/0000-0003-2443-0729; campbell, sharon/0000-0003-0311-409X	National Institutes of Health [R01-GM106227A, R01-GM101560]; University Cancer Research Fund (UCRF); University of Cincinnati DNS/MERF; American Association of Neurological Surgeons fellowship; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073180, R01GM101560, R01GM106227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund (UCRF); University of Cincinnati DNS/MERF; American Association of Neurological Surgeons fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM106227A (to S. L. C.) and R01-GM101560 (to H. G. D.). This work was also supported by University Cancer Research Fund (UCRF) innovative grants (to S. L. C.) and by the University of Cincinnati DNS/MERF (to A. T. S.).; Partially supported by an American Association of Neurological Surgeons fellowship.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Colicelli J, 2010, CURR BIOL, V20, pR630, DOI 10.1016/j.cub.2010.06.019; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Denayer E, 2008, HUM MUTAT, V29, P232, DOI 10.1002/humu.20616; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Isom DG, 2013, MOL CELL, V51, P531, DOI 10.1016/j.molcel.2013.07.012; Isom DG, 2011, PROTEINS, V79, P1034, DOI 10.1002/prot.22932; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Omerovic J, 2009, FEBS J, V276, P1817, DOI 10.1111/j.1742-4658.2009.06928.x; Pfleger CM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001874; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Schmidt G, 1996, ONCOGENE, V12, P87; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Sprang S, 2001, TRENDS BIOCHEM SCI, V26, P266, DOI 10.1016/S0968-0004(01)01818-7; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wolfman A., 2001, SCI STKE, V2001, ppe2; Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109; Zhang J, 1998, BIOCHEMISTRY-US, V37, P14881, DOI 10.1021/bi9811157	43	48	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36856	36862		10.1074/jbc.C113.525691	http://dx.doi.org/10.1074/jbc.C113.525691			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24247240	Green Published, hybrid			2022-12-25	WOS:000329189700009
J	Luo, H; Zhu, BJ; Gong, L; Yang, JX; Jiang, YY; Zhou, XD				Luo, Hu; Zhu, Bingjing; Gong, Liang; Yang, Jingxiang; Jiang, Yongyuan; Zhou, Xiangdong			The Value of Serum Prealbumin in the Diagnosis and Therapeutic Response of Tuberculosis: A Retrospective Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ACUTE KIDNEY INJURY; PULMONARY TUBERCULOSIS; DIFFERENTIAL-DIAGNOSIS; LIVER-CIRRHOSIS; MORTALITY; DISEASE; ALBUMIN; PREDICT; CANCER	Objective: The aim of this study was to examine serum prealbumin (PA) levels in patients with tuberculosis and lung cancer, and to evaluate the correlations of serum PA levels with clinicopathological characteristics. Method: Total 760 patients were included in the study: 320 patients with tuberculosis, 320 patients with lung cancer, and 120 healthy subjects. Serum PA was detected using a biochemical analyzer to determine the value of serum PA in the diagnosis and therapeutic response of tuberculosis. Results: Compared to lung cancer and healthy individuals, TB patients were more frequent in suffering from low serum PA (75.0% vs. 30.9% vs. 6.7%, P < 0.01), and the serum PA levels of TB patients were significantly reduced (137.5 +/- 42.4 mg/L vs. 183.5 +/- 49.1 mg/L vs. 240.0 +/- 43.9 mg/L, P < 0.01). Among various clinical characteristics, type (with pleuritis), age (>= 60), ESR (> 20 mm/h) and smoking status (>= 20 pack x years) were associated with low serum PA levels of TB patients, while ECOG performance status (>= 2) was associated with low serum PA levels of lung cancer patients. The change of serum PA levels was in accordance with the therapeutic effects of anti-TB drugs, which might present a valuable and objective indicator for monitoring the therapeutic effects of TB drugs on TB patients. Conclusion: Low serum prealbumin levels are very common in TB patients and can be served as a potential indicator for differential diagnosis of lung cancer and monitoring the therapeutic effects of TB drugs.	[Luo, Hu; Zhu, Bingjing; Gong, Liang; Yang, Jingxiang; Jiang, Yongyuan; Zhou, Xiangdong] Third Mil Med Univ, Affiliated Hosp 1, Dept Resp Med, Chongqing, Peoples R China	Army Medical University	Zhou, XD (corresponding author), Third Mil Med Univ, Affiliated Hosp 1, Dept Resp Med, Chongqing, Peoples R China.	xiangdongzhou@126.com						Aliyazicioglu Y, 2007, TURKISH J PEDIATR, V49, P52; Bae HJ, 2011, J GASTROINTEST SURG, V15, P2136, DOI 10.1007/s11605-011-1719-z; Boyaci H, 2013, BRAZ J INFECT DIS; Caccialanza R, 2013, NUTRITION, V29, P580, DOI 10.1016/j.nut.2012.08.007; Cavallin F, 2013, WORLD J SURG; Chang Sheng, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P391; Chang WT, 2008, HEPATO-GASTROENTEROL, V55, P1681; Chrysostomou S, 2010, J RENAL NUTR, V20, P44, DOI 10.1053/j.jrn.2009.04.001; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Davis CJ, 2012, JPEN-PARENTER ENTER, V36, P197, DOI 10.1177/0148607111413896; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Fujii T, 2012, NUTR CANCER, V64, P1169, DOI 10.1080/01635581.2012.718034; Gao C, 2011, CLIN EXP MED, V11, P49, DOI 10.1007/s10238-010-0103-8; Gray JM, 2013, SEMIN RESP CRIT CARE, V34, P32, DOI 10.1055/s-0032-1333469; Guerra LT, 2009, NUTR HOSP, V24, P241; Gupta KB, 2009, LUNG INDIA, V26, P9, DOI 10.4103/0970-2113.45198; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Huang L, 2012, WORLD J GASTROENTERO, V18, P7021, DOI 10.3748/wjg.v18.i47.7021; Jarvis Miles, 2010, Nurs Times, V106, P22; Jolobe O, 2011, THORAX, V66, P731, DOI 10.1136/thx.2010.145730; Jolobe OMP, 2012, EUR RESPIR J, V40, P279, DOI 10.1183/09031936.00004312; Kuszajewski Michele L, 2005, Nursing, V35, P70; Leung CC, 2009, J INFECT DIS, V199, P287, DOI 10.1086/595794; Li YL, 2011, ANN NUCL MED, V25, P804, DOI 10.1007/s12149-011-0530-y; Lin MYC, 2011, AM SURGEON, V77, P1286; Liu F, 2010, J DIGEST DIS, V11, P352, DOI 10.1111/j.1751-2980.2010.00465.x; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Moghazy AM, 2010, BURNS, V36, P495, DOI 10.1016/j.burns.2009.05.014; Mupere E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1050; Murray PT, 2008, NAT CLIN PRACT NEPHR, V4, P528, DOI 10.1038/ncpneph0930; Pontali E, 2013, CURR OPIN PULM MED; Rambod M, 2008, AM J CLIN NUTR, V88, P1485, DOI 10.3945/ajcn.2008.25906; Revannasiddaiah S, 2011, BMJ CASE REP, V2011; Rocha JC, 2010, ANN NUTR METAB, V56, P207, DOI 10.1159/000276641; Saito M, 2012, J GASTROENTEROL, V47, P704, DOI 10.1007/s00535-012-0535-x; Salina T Iu, 2009, Tuberk Biolezni Legkih, P7; Torre-Cisneros J, 2004, TRANSPLANTATION, V77, P1376, DOI 10.1097/01.TP.0000116870.10012.5D; Watts G, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7051; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Xie QH, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-30; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105	42	30	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79940	10.1371/journal.pone.0079940	http://dx.doi.org/10.1371/journal.pone.0079940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260323	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900053
J	Nebendahl, C; Kruger, R; Gors, S; Albrecht, E; Martens, K; Hennig, S; Storm, N; Hoppner, W; Pfuhl, R; Metzler-Zebeli, BU; Hammon, HM; Metges, CC				Nebendahl, Constance; Krueger, Ricarda; Goers, Solvig; Albrecht, Elke; Martens, Karen; Hennig, Steffen; Storm, Niels; Hoeppner, Wolfgang; Pfuhl, Ralf; Metzler-Zebeli, Barbara U.; Hammon, Harald M.; Metges, Cornelia C.			Effects on Transcriptional Regulation and Lipid Droplet Characteristics in the Liver of Female Juvenile Pigs after Early Postnatal Feed Restriction and Refeeding Are Dependent on Birth Weight	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; POLYUNSATURATED FATTY-ACIDS; ADIPOSE-TISSUE LIPOLYSIS; ENDOGENOUS NITRIC-OXIDE; DIET-INDUCED OBESITY; DUTCH HUNGER WINTER; INSULIN-RESISTANCE; CALORIC RESTRICTION; HEPATIC LIPOGENESIS; OXIDATIVE STRESS	Epidemiological and experimental data indicate that caloric restriction in early postnatal life may improve liver lipid metabolism in low birth weight individuals. The present study investigated transcriptional and metabolic responses to low (U) and normal (N) birth weight (d 75, T1) and postnatal feed restriction (R, 60% of controls, d 98, T2) followed by subsequent refeeding until d 131 of age (T3). Liver tissue studies were performed with a total of 42 female pigs which were born by multiparous German landrace sows. Overall, 194 genes were differentially expressed in the liver of U vs. N (T1) animals with roles in lipid metabolism. The total mean area and number of lipid droplets (LD) was about 4.6 and 3.7 times higher in U compared to N. In U, the mean LD size (mm 2) was 24.9% higher. 3-week feed restriction reduced total mean area of LDs by 58.3 and 72.7% in U and N, respectively. A functional role of the affected genes in amino acid metabolism was additionally indicated. This was reflected by a 17.0% higher arginine concentration in the liver of UR animals (vs. NR). To evaluate persistency of effects, analyses were also done after refeeding period at T3. Overall, 4 and 22 genes show persistent regulation in U and N animals after 5 weeks of refeeding, respectively. These genes are involved in e. g. processes of lipid and protein metabolism and glucose homeostasis. Moreover, the recovery of total mean LD area in U and N animals back to the previous T1 level was observed. However, when compared to controls, the mean LD size was still reduced by 23.3% in UR, whereas it was increased in NR (+ 24.7%). The present results suggest that short-term postnatal feed restriction period programmed juvenile U animals for an increased rate of hepatic lipolysis in later life.	[Nebendahl, Constance; Krueger, Ricarda; Goers, Solvig; Martens, Karen; Metzler-Zebeli, Barbara U.; Hammon, Harald M.; Metges, Cornelia C.] Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Albrecht, Elke; Pfuhl, Ralf] Leibniz Inst Farm Anim Biol FBN, Inst Muscle Biol & Growth, Dummerstorf, Germany; [Hennig, Steffen] ImaGenes GmbH, D-13125 Berlin, Germany; [Storm, Niels; Hoeppner, Wolfgang] Bioglobe GmbH, D-22529 Hamburg, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Metges, CC (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany.	metges@fbn-dummerstorf.de	Hammon, Harald/AAD-9990-2020; Albrecht, Elke/ABB-6155-2021	Albrecht, Elke/0000-0001-5974-1514; Pfuhl, Ralf/0000-0001-5008-479X	German Federal Ministry of Education and Research in the program Biomedizinische Ernahrungsforschung [0315397B.]	German Federal Ministry of Education and Research in the program Biomedizinische Ernahrungsforschung	The work was supported by a grant of the German Federal Ministry of Education and Research in the program Biomedizinische Ernahrungsforschung (Project VISION EPIFOOD, 0315397B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviram M, 2005, HANDB EXP PHARM, V170, P263; Aviram M, 1999, FREE RADICAL BIO MED, V26, P892, DOI 10.1016/S0891-5849(98)00272-X; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; Biri A, 2007, GYNECOL OBSTET INVES, V64, P187, DOI 10.1159/000106488; BLAKE WL, 1990, J NUTR, V120, P1727, DOI 10.1093/jn/120.12.1727; Bowman TA, 2010, ENDOCRINOLOGY, V151, P5157, DOI 10.1210/en.2010-0176; Bozhkov A I, 2009, Adv Gerontol, V22, P440; Chen LL, 2011, METABOLISM, V60, P569, DOI 10.1016/j.metabol.2010.05.014; Chen YY, 2012, J GASTROEN HEPATOL, V27, P974, DOI 10.1111/j.1440-1746.2011.06986.x; Cho SJ, 2012, BRIT J NUTR, V108, P2166, DOI 10.1017/S0007114512000347; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Coelho R, 2007, HORM RES, V68, P91, DOI 10.1159/000100974; Dai Y, 2012, ENDOCRINOLOGY, V153, P4216, DOI 10.1210/en.2012-1206; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; Deakin S, 2002, J BIOL CHEM, V277, P4301, DOI 10.1074/jbc.M107440200; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Duarte FO, 2012, EXP PHYSIOL, V97, P882, DOI 10.1113/expphysiol.2011.064121; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Dufour S, 2011, J CLIN ENDOCR METAB, V96, P3873, DOI 10.1210/jc.2011-1747; Eriksson J, 2002, HORM METAB RES, V34, P72, DOI 10.1055/s-2002-20518; ERNST LM, 1993, PEDIATR PATHOL, V13, P763, DOI 10.3109/15513819309048263; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Fruhbeck G, 2001, CELL SIGNAL, V13, P827, DOI 10.1016/S0898-6568(01)00211-X; Fu WJJ, 2005, J NUTR, V135, P714, DOI 10.1093/jn/135.4.714; Garg M, 2012, DIABETES, V61, P1391, DOI 10.2337/db11-1347; Gaudiot N, 1998, J BIOL CHEM, V273, P13475, DOI 10.1074/jbc.273.22.13475; Gaudiot N, 2000, AM J PHYSIOL-CELL PH, V279, pC1603, DOI 10.1152/ajpcell.2000.279.5.C1603; Glimcher LH, 2009, ANN NY ACAD SCI, V1173, pE2, DOI 10.1111/j.1749-6632.2009.04956.x; Godfrey KM, 2011, SEMIN REPROD MED, V29, P257, DOI 10.1055/s-0031-1275518; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; HOFFER LJ, 1990, AM J PHYSIOL, V258, pE832, DOI 10.1152/ajpendo.1990.258.5.E832; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Ibanez L, 2006, HORM RES, V65, P112, DOI 10.1159/000091515; Ibanez L, 2006, MOL CELL ENDOCRINOL, V254, P22, DOI 10.1016/j.mce.2006.04.010; Ishida M, 2013, MOL ASPECTS MED, V34, P826, DOI 10.1016/j.mam.2012.06.009; Ito J, 2011, BBA-MOL CELL BIOL L, V1811, P1062, DOI 10.1016/j.bbalip.2011.08.016; Ji C, 2011, HEPATOLOGY, V54, P229, DOI 10.1002/hep.24368; Jimenez-Chillaron JC, 2012, BIOCHIMIE, V94, P2242, DOI 10.1016/j.biochi.2012.06.012; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; John RM, 2011, DIFFERENTIATION, V81, P270, DOI 10.1016/j.diff.2011.01.007; JUMP DB, 1994, J LIPID RES, V35, P1076; Karowicz-Bilinska A, 2007, FREE RADICAL RES, V41, P870, DOI 10.1080/10715760701291647; Kensara OA, 2005, AM J CLIN NUTR, V82, P980; Khatchadourian A, 2012, BBA-MOL CELL BIOL L, V1821, P607, DOI 10.1016/j.bbalip.2012.01.007; Khedara A, 1999, BIOSCI BIOTECH BIOCH, V63, P698, DOI 10.1271/bbb.63.698; KLAIN GJ, 1977, J NUTR, V107, P426, DOI 10.1093/jn/107.3.426; KNAPIK J, 1991, J APPL PHYSIOL, V70, P43, DOI 10.1152/jappl.1991.70.1.43; Kromer JO, 2005, ANAL BIOCHEM, V340, P171, DOI 10.1016/j.ab.2005.01.027; Lambertini L, 2011, REPROD SCI, V18, P1111, DOI 10.1177/1933719111404611; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, AM J TRANSL RES, V4, P102; Li TG, 2011, HEPATOLOGY, V53, P996, DOI 10.1002/hep.24107; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Liu JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034835; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; Lumey LH, 1997, AM J EPIDEMIOL, V146, P810, DOI 10.1093/oxfordjournals.aje.a009198; MacKay DS, 2012, J NUTR BIOCHEM, V23, P1121, DOI 10.1016/j.jnutbio.2011.06.005; MAFFEIS C, 1994, INT J OBESITY, V18, P301; MAGEE TR, 2008, AM J OBSTET GYNECOL, V199; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Meas T, 2010, DIABETOLOGIA, V53, P907, DOI 10.1007/s00125-009-1650-y; Milagro FI, 2013, MOL ASPECTS MED, V34, P782, DOI 10.1016/j.mam.2012.06.010; Myrie SB, 2011, NEONATOLOGY, V100, P380, DOI 10.1159/000326341; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; OGATA ES, 1990, PEDIATR RES, V27, P56, DOI 10.1203/00006450-199001000-00017; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Okumura T, 2011, J PHYSIOL BIOCHEM, V67, P629, DOI 10.1007/s13105-011-0110-6; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Pankevich DE, 2010, J NEUROSCI, V30, P16399, DOI 10.1523/JNEUROSCI.1955-10.2010; Pohle T, 2004, CANCER RES, V64, P3900, DOI 10.1158/0008-5472.CAN-03-3149; Poore KR, 2004, DIABETOLOGIA, V47, P340, DOI 10.1007/s00125-003-1305-3; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Rosenblat M, 2010, ATHEROSCLEROSIS, V210, P414, DOI 10.1016/j.atherosclerosis.2009.11.044; Rosenblat M, 2009, BIOFACTORS, V35, P98, DOI 10.1002/biof.16; Rozenberg O, 2005, ATHEROSCLEROSIS, V181, P9, DOI 10.1016/j.atherosclerosis.2004.12.030; Rozenberg O, 2003, FREE RADICAL BIO MED, V34, P774, DOI 10.1016/S0891-5849(02)01429-6; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006; Schulz LC, 2010, P NATL ACAD SCI USA, V107, P16757, DOI 10.1073/pnas.1012911107; Shinkyo R, 2011, J BIOL CHEM, V286, P33021, DOI 10.1074/jbc.M111.282434; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sjogren P, 2008, DIABETOLOGIA, V51, P328, DOI 10.1007/s00125-007-0876-9; Sohi G, 2011, MOL ENDOCRINOL, V25, P785, DOI 10.1210/me.2010-0395; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; STEIN TP, 1991, METABOLISM, V40, P478, DOI 10.1016/0026-0495(91)90228-O; Stringer DM, 2010, BBA-MOL CELL BIOL L, V1801, P1375, DOI 10.1016/j.bbalip.2010.08.011; Takemori K, 2011, LIFE SCI, V88, P1088, DOI 10.1016/j.lfs.2011.04.002; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Tost J, 2010, MOL BIOTECHNOL, V44, P71, DOI 10.1007/s12033-009-9216-2; Tsutsumi A, 2011, BIOCHEM BIOPH RES CO, V404, P339, DOI 10.1016/j.bbrc.2010.11.120; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Wollmann HA, 1998, HORM RES, V49, P1, DOI 10.1159/000053079; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Yamada M, 2011, CONGENIT ANOM, V51, P167, DOI 10.1111/j.1741-4520.2011.00336.x; YANG RD, 1986, AM J PHYSIOL, V250, pE39, DOI 10.1152/ajpendo.1986.250.1.E39; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhang X, 2012, BIOCH RES INT, P247	108	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e76705	10.1371/journal.pone.0076705	http://dx.doi.org/10.1371/journal.pone.0076705			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260100	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900003
J	Uchiyama, K; Iwata, H; Moriguchi, Y; Ujino-Ihara, T; Ueno, S; Taguchi, Y; Tsubomura, M; Mishima, K; Iki, T; Watanabe, A; Futamura, N; Shinohara, K; Tsumura, Y				Uchiyama, Kentaro; Iwata, Hiroyoshi; Moriguchi, Yoshinari; Ujino-Ihara, Tokuko; Ueno, Saneyoshi; Taguchi, Yuriko; Tsubomura, Miyoko; Mishima, Kentaro; Iki, Taiichi; Watanabe, Atsushi; Futamura, Norihiro; Shinohara, Kenji; Tsumura, Yoshihiko			Demonstration of Genome-Wide Association Studies for Identifying Markers for Wood Property and Male Strobili Traits in Cryptomeria japonica	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FALSE DISCOVERY RATE; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; COMPLEX TRAITS; GENETIC-STRUCTURE; PHENOTYPIC ASSOCIATIONS; HAPLOTYPE DIVERSITY; NATURAL-POPULATIONS; DEMOGRAPHIC HISTORY	Genome-wide association studies (GWAS) are an alternative to bi-parental QTL mapping in long-lived perennials. In the present study, we examined the potential of GWAS in conifers using 367 unrelated plus trees of Cryptomeria japonica D. Don, which is the most widely planted and commercially important tree species in Japan, and tried to detect significant associations between wood property traits and quantity of male strobili on the one hand, and 1,032 single nucleotide polymorphisms (SNPs) assigned to 1,032 genes on the other. Association analysis was performed with the mixed linear model taking into account kinship relationships and subpopulation structure. In total, 6 SNPs were found to have significant associations with the variations in phenotype. These SNPs were not associated with the positions of known genes and QTLs that have been reported to date, thus they may identify novel QTLs. These 6 SNPs were all found in sequences showing similarities with known genes, although further analysis is required to dissect the ways in which they affect wood property traits and abundance of male strobili. These presumptive QTL loci provide opportunities for improvement of C. japonica, based on a marker approach. The results suggest that GWAS has potential for use in future breeding programs in C. japonica.	[Uchiyama, Kentaro; Ujino-Ihara, Tokuko; Ueno, Saneyoshi; Taguchi, Yuriko; Tsumura, Yoshihiko] Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 305, Japan; [Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Lab Biometry & Bioinformat,Bunkyo Ku, Tokyo, Japan; [Moriguchi, Yoshinari] Niigata Univ, Grad Sch Sci & Technol, Niigata 9518510, Japan; [Tsubomura, Miyoko; Mishima, Kentaro; Iki, Taiichi] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Hitachi, Ibaraki, Japan; [Watanabe, Atsushi] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Futamura, Norihiro] Forestry & Forest Prod Res Inst, Dept Mol & Cell Biol, Tsukuba, Ibaraki 305, Japan; [Shinohara, Kenji] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan	Forestry & Forest Products Research Institute - Japan; University of Tokyo; Niigata University; Forestry & Forest Products Research Institute - Japan; Kyushu University; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan	Tsumura, Y (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 305, Japan.	ytsumu@ffpri.affrc.go.jp	Shinohara, Kenji/N-5405-2015; TSUBOMURA, Miyoko/AAJ-7123-2020	Shinohara, Kenji/0000-0002-8867-7440; Watanabe, Atsushi/0000-0003-0570-8895	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry of Japan	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry of Japan	This research was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry of Japan (http:// www.naro.affrc.go.jp/brain/shien/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov I. Y., 2008, INT J PLANT GENOMICS, V574927; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Al-Rabab'ah MA, 2002, FOREST ECOL MANAG, V163, P263, DOI 10.1016/S0378-1127(01)00584-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Beaulieu J, 2011, GENETICS, V188, P197, DOI 10.1534/genetics.110.125781; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett M.D., 2004, GYMNOSPERM DNA C VAL; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brown GR, 2004, P NATL ACAD SCI USA, V101, P15255, DOI 10.1073/pnas.0404231101; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Buntjer JB, 2005, TRENDS PLANT SCI, V10, P466, DOI 10.1016/j.tplants.2005.08.007; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Chauhan SS, 2006, FOREST ECOL MANAG, V229, P388, DOI 10.1016/j.foreco.2006.04.019; Chuang ST, 2001, J WOOD SCI, V47, P245, DOI 10.1007/BF00766709; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; Cumbie WP, 2011, HEREDITY, V107, P105, DOI 10.1038/hdy.2010.168; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dillon SK, 2010, GENETICS, V185, P1477, DOI 10.1534/genetics.110.116582; Downes GM, 2002, IAWA J, V23, P253, DOI 10.1163/22941932-90000302; Dvornyk V, 2002, MOL BIOL EVOL, V19, P179, DOI 10.1093/oxfordjournals.molbev.a004070; Eckert AJ, 2010, MOL ECOL; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fujisawa Y, 2004, KYUSHU J FOR RES, V57, P210; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Garris AJ, 2003, GENETICS, V165, P759; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; Ghavami F, 2011, G3-GENES GENOM GENET, V1, P209, DOI 10.1534/g3.111.000489; Gonzalez-Martinez SC, 2008, HEREDITY, V101, P19, DOI 10.1038/hdy.2008.21; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hayashi Y., 1960, TAXONOMICAL PHYTOGEO; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang C-L, 2005, US Patent, Patent No. [6871545, 6,871,545]; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ikeda K, 2000, MOKUZAI GAKKAISHI, V46, P602; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Iwata H, 2007, THEOR APPL GENET, V114, P1437, DOI 10.1007/s00122-007-0529-x; Iwata H, 2011, TREE GENET GENOMES, V7, P747, DOI 10.1007/s11295-011-0371-9; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Le Corre V, 2005, MOL ECOL, V14, P4181, DOI 10.1111/j.1365-294X.2005.02722.x; Lynch M., 1998, GENETICS ANAL QUANTI; Mamidi S, 2011, PLANT GENOME-US, V4, P154, DOI 10.3835/plantgenome2011.04.0011; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meuwissen THE, 2001, GENETICS, V157, P1819; Mishima K, 2011, MOKUZAI GAKKAISHI, V57, P256, DOI 10.2488/jwrs.57.256; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; Moriguchi Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-95; Moritsuka E, 2012, GENETICS, V190, P1145, DOI 10.1534/genetics.111.136697; Murai S., 1947, KOKUDO SAIKEN ZOURIN, P131; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nakae K., 2010, Clinical and Experimental Allergy Reviews, V10, P2; Neale DB, 2008, CURR OPIN PLANT BIOL, V11, P149, DOI 10.1016/j.pbi.2007.12.004; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; OHRI D, 1986, PLANT SYST EVOL, V153, P119, DOI 10.1007/BF00989421; Oliphant A, 2002, BIOTECHNIQUES, P56; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; Pigliucci M, 2003, ECOLOGY, V84, P1700, DOI 10.1890/0012-9658(2003)084[1700:SIAMSE]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; Pyhajarvi T, 2007, GENETICS, V177, P1713, DOI 10.1534/genetics.107.077099; Pyhajarvi T, 2011, TREE GENET GENOMES, V7, P385, DOI 10.1007/s11295-010-0340-8; R Development Core Team, 2007, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Robledo-Arnuncio JJ, 2005, J BIOGEOGR, V32, P595, DOI 10.1111/j.1365-2699.2004.01196.x; Savolainen O, 2007, CURR OPIN PLANT BIOL, V10, P162, DOI 10.1016/j.pbi.2007.01.011; Shehzad T, 2009, BREEDING SCI, V59, P217, DOI 10.1270/jsbbs.59.217; Staiger CJ, 2000, ANNU REV PLANT PHYS, V51, P257, DOI 10.1146/annurev.arplant.51.1.257; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; STRAUSS SH, 1992, CAN J FOREST RES, V22, P1050, DOI 10.1139/x92-140; Takahara H, 1998, VEGETATION HIST JAPA; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Tree Breeding Society, 2004, TREE BREED PROJ, P129; Tsubomura M., 2013, Journal of the Japanese Forest Society, V95, P156; Tsubomura M, 2012, ANN FOREST SCI, V69, P867, DOI 10.1007/s13595-012-0223-2; Tsumura Y, 1995, THEOR APPL GENET, V91, P1222, DOI 10.1007/BF00220933; Tsumura Y, 2012, HEREDITY, V109, P349, DOI 10.1038/hdy.2012.50; Tsumura Y, 2011, CRYPTOMERIA WILD CRO, P49; Tsumura Y, 2007, GENETICS, V176, P2393, DOI 10.1534/genetics.107.072652; Uchiyama K, 2012, TREE GENET GENOMES, V8, P1213, DOI 10.1007/s11295-012-0508-5; Yasue M., 1987, Journal of the Japanese Forestry Society, V69, P152; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zobel B, 1984, APPL FOREST TREE IMP	114	32	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79866	10.1371/journal.pone.0079866	http://dx.doi.org/10.1371/journal.pone.0079866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260312	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900049
J	Satoh, SK; Tsuchi, A; Satoh, R; Miyoshi, H; Hamaguchi, MS; Hamaguchi, Y				Satoh, Setsuko K.; Tsuchi, Akifumi; Satoh, Ryohei; Miyoshi, Hiromi; Hamaguchi, Miyako S.; Hamaguchi, Yukihisa			The Tension at the Top of the Animal Pole Decreases during Meiotic Cell Division	PLOS ONE			English	Article							BODY FORMATION; CORTICAL DIFFERENTIATION; MECHANICAL-PROPERTIES; MATURATION DIVISION; TUBIFEX ANNELIDA; FERTILIZED-EGGS; SURFACE; OOCYTES; OLIGOCHAETA; ELASTICITY	Meiotic maturation is essential for the reproduction procedure of many animals. During this process an oocyte produces a large egg cell and tiny polar bodies by highly asymmetric division. In this study, to fully understand the sophisticated spatiotemporal regulation of accurate oocyte meiotic division, we focused on the global and local changes in the tension at the surface of the starfish (Asterina pectinifera) oocyte in relation to the surface actin remodeling. Before the onset of the bulge formation, the tension at the animal pole globally decreased, and started to increase after the onset of the bulge formation. Locally, at the onset of the bulge formation, tension at the top of the animal pole began to decrease, whereas that at the base of the bulge remarkably increased. As the bulge grew, the tension at the base of the bulge additionally increased. Such a change in the tension at the surface was similar to the changing pattern of actin distribution. Therefore, meiotic cell division was initiated by the bulging of the cortex, which had been weakened by actin reduction, and was followed by contraction at the base of the bulge, which had been reinforced by actin accumulation. The force generation system is assumed to allow the meiotic apparatus to move just under the membrane in the small polar body. Furthermore, a detailed comparison of the tension at the surface and the cortical actin distribution indicated another sophisticated feature, namely that the contraction at the base of the bulge was more vigorous than was presumed based on the actin distribution. These features of the force generation system will ensure the precise chromosome segregation necessary to produce a normal ovum with high accuracy in the meiotic maturation.	[Satoh, Setsuko K.; Miyoshi, Hiromi; Hamaguchi, Miyako S.; Hamaguchi, Yukihisa] Tokyo Inst Technol, Dept Bioengn, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan; [Tsuchi, Akifumi] Surugadai Univ, Fac Econ & Management, Hanno, Saitama, Japan; [Satoh, Ryohei] Kitasato Univ, Sch Med, Dept Physiol, Sagamihara, Kanagawa 228, Japan; [Miyoshi, Hiromi] RIKEN, Ctr Adv Photon, Ultrahigh Precis Opt Technol Team, Wako, Saitama, Japan	Tokyo Institute of Technology; Kitasato University; RIKEN	Hamaguchi, Y (corresponding author), Tokyo Inst Technol, Dept Bioengn, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan.	yhamaguc@bio.titech.ac.jp	Miyoshi, Hiromi/Z-2935-2019; Miyoshi, Hiromi/O-4923-2014	Miyoshi, Hiromi/0000-0003-2314-2119; Miyoshi, Hiromi/0000-0003-2314-2119	Tokyo Institute of Technology	Tokyo Institute of Technology	Research was financially supported by Tokyo Institute of Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoury J, 2011, DEVELOPMENT, V138, P2903, DOI 10.1242/dev.060269; Effler JC, 2007, CELL CYCLE, V6, P30, DOI 10.4161/cc.6.1.3674; FREEMAN G, 1988, ROUX ARCH DEV BIOL, V197, P197, DOI 10.1007/BF02439427; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; HAMAGUCHI MS, 1978, EXP CELL RES, V112, P55, DOI 10.1016/0014-4827(78)90524-4; Hamaguchi Y, 2007, CELL STRUCT FUNCT, V32, P29, DOI 10.1247/csf.06034; Hinner B, 1998, PHYS REV LETT, V81, P2614, DOI 10.1103/PhysRevLett.81.2614; Hiramoto Y., 1968, P311; HIRAMOTO Y, 1976, DEV GROWTH DIFFER, V18, P377; Hiramoto Y., 1981, MITOSIS CYTOKINESIS, P397; ICHIDA K, 1976, COMPUTING, V16, P329, DOI 10.1007/BF02252081; IKEDA M, 1976, DEV GROWTH DIFFER, V18, P221; Koyama H, 2012, PLOS ONE, V7; Larson SM, 2010, MOL BIOL CELL, V21, P3182, DOI 10.1091/mbc.E10-01-0066; LONGO FJ, 1987, J EXP ZOOL, V243, P299, DOI 10.1002/jez.1402430215; Miyoshi H, 2006, CELL MOTIL CYTOSKEL, V63, P208, DOI 10.1002/cm.20118; Miyoshi H, 2012, INTEGR BIOL-UK, V4, P875, DOI 10.1039/c2ib20013a; Mohan K, 2012, EXP CELL RES, V318, P1428, DOI 10.1016/j.yexcr.2012.03.028; NAKAMURA S, 1978, DEV GROWTH DIFFER, V20, P317; Pielak RM, 2005, BIOL BULL-US, V209, P21, DOI 10.2307/3593139; Pielak RM, 2004, DEV BIOL, V269, P421, DOI 10.1016/j.ydbio.2004.01.033; Rappaport R., 1996, CYTOKINESIS ANIMAL C; SATOH SK, 1994, DEV GROWTH DIFFER, V36, P557; SHIMIZU T, 1981, DEV BIOL, V85, P65, DOI 10.1016/0012-1606(81)90236-0; SHIMIZU T, 1981, DEV BIOL, V85, P77, DOI 10.1016/0012-1606(81)90237-2; SHIMIZU T, 1990, ANN NY ACAD SCI, V582, P260; Timoshenko S.P., 1959, THEORY PLATES SHELLS; Uyeda TQP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026200	29	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79389	10.1371/journal.pone.0079389	http://dx.doi.org/10.1371/journal.pone.0079389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260212	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500057
J	Korkotian, E; Bombela, T; Odegova, T; Zubov, P; Segal, M				Korkotian, Eduard; Bombela, Tatyana; Odegova, Tatiana; Zubov, Petr; Segal, Menahem			Ethanol Affects Network Activity in Cultured Rat Hippocampus: Mediation by Potassium Channels	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; GABA(A) RECEPTORS; ALCOHOL; PLASTICITY; NEUROTRANSMISSION; POTENTIATION; INHIBITION; NEURONS	The effects of ethanol on neuronal network activity were studied in dissociated cultures of rat hippocampus. Exposure to low (0.25-0.5%) ethanol concentrations caused an increase in synchronized network spikes, and a decrease in the duration of individual spikes. Ethanol also caused an increase in rate of miniature spontaneous excitatory postsynaptic currents. Higher concentrations of ethanol eliminated network spikes. These effects were reversible upon wash. The effects of the high, but not the low ethanol were blocked by the GABA antagonist bicuculline. The enhancing action of low ethanol was blocked by apamin, an SK potassium channel antagonist, and mimicked by 1-EBIO, an SK channel opener. It is proposed that in cultured hippocampal networks low concentration of ethanol is associated with SK channel activity, rather than the GABAergic receptor.	[Korkotian, Eduard; Segal, Menahem] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Bombela, Tatyana] Perm State Pharmaceut Acad, Dept Pharmacognosy, Perm, Russia; [Odegova, Tatiana; Zubov, Petr] Perm State Pharmaceut Acad, Dept Microbiol, Perm, Russia	Weizmann Institute of Science	Korkotian, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	eduardkorkotian@gmail.com	Korkotian, Eduard/P-4559-2019; SEGAL, MENAHEM/K-1577-2012; Korkotian, Eduard/K-1744-2012	Korkotian, Eduard/0000-0001-5515-3387	Ministry of Education and Science of Perm Krai, Russian Federation [Wezimann711458]	Ministry of Education and Science of Perm Krai, Russian Federation	1/2012; Wezimann711458, Grant of The Ministry of Education and Science of Perm Krai, Russian Federation entitled "International Research Groups of Scientists (IRG)" URL: http://minobr.permkrai.ru/activity/wu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariwodola OJ, 2004, J NEUROSCI, V24, P10679, DOI 10.1523/JNEUROSCI.1768-04.2004; Basavarajappa BS, 2008, J NEUROCHEM, V107, P1001, DOI 10.1111/j.1471-4159.2008.05685.x; Brodie MS, 2007, ALCOHOL CLIN EXP RES, V31, P1625, DOI 10.1111/j.1530-0277.2007.00469.x; Brodie MS, 1999, J PHARMACOL EXP THER, V290, P325; Carta M, 2003, P NATL ACAD SCI USA, V100, P6813, DOI 10.1073/pnas.1137276100; CHIN JH, 1977, MOL PHARMACOL, V13, P435; Cohen E, 2008, BRAIN RES, V1235, P21, DOI 10.1016/j.brainres.2008.06.022; Fleming RL, 2009, ALCOHOL, V43, P603, DOI 10.1016/j.alcohol.2009.10.006; Hopf FW, 2010, NEURON, V65, P682, DOI 10.1016/j.neuron.2010.02.015; Mameli M, 2005, J NEUROSCI, V25, P8027, DOI 10.1523/JNEUROSCI.2434-05.2005; Moriguchi S, 2007, ALCOHOL CLIN EXP RES, V31, P89, DOI 10.1111/j.1530-0277.2006.00266.x; Mulholland PJ, 2011, BIOL PSYCHIAT, V69, P625, DOI 10.1016/j.biopsych.2010.09.025; Mulholland PJ, 2009, ALCOHOL CLIN EXP RES, V33, P1125, DOI 10.1111/j.1530-0277.2009.00936.x; Puglia MP, 2010, ALCOHOL CLIN EXP RES, V34, P594, DOI 10.1111/j.1530-0277.2009.01128.x; Sanna E, 2004, J NEUROSCI, V24, P6521, DOI 10.1523/JNEUROSCI.0075-04.2004; Santhakumar V, 2007, ALCOHOL, V41, P211, DOI 10.1016/j.alcohol.2007.04.011; Tu Y, 2007, J NEUROSCI, V27, P4765, DOI 10.1523/JNEUROSCI.5378-06.2007; VanDeMark KL, 2009, ALCOHOL CLIN EXP RES, V33, P1945, DOI 10.1111/j.1530-0277.2009.01032.x; Vlachos A, 2009, J NEUROSCI, V29, P1017, DOI 10.1523/JNEUROSCI.5528-08.2009; Wakita M, 2012, J PHARMACOL EXP THER, V341, P809, DOI 10.1124/jpet.111.189126; Widmer H, 1998, J NEUROENDOCRINOL, V10, P399; Xiao C, 2009, NEUROPSYCHOPHARMACOL, V34, P307, DOI 10.1038/npp.2008.99; Zucca S, 2010, J NEUROSCI, V30, P6776, DOI 10.1523/JNEUROSCI.5405-09.2010	23	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e75988	10.1371/journal.pone.0075988	http://dx.doi.org/10.1371/journal.pone.0075988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260098	Green Published, gold			2022-12-25	WOS:000327258600002
J	Shih, CH; Chen, CJ; Chen, LY				Shih, Chien-Hung; Chen, Chien-Jen; Chen, Linyi			New Function of the Adaptor Protein SH2B1 in Brain-Derived Neurotrophic Factor-Induced Neurite Outgrowth	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; DENDRITIC GROWTH; TRK RECEPTORS; NEURONAL DIFFERENTIATION; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; AXON GROWTH; SH2-B; SYSTEM	Neurite outgrowth is an essential process for the establishment of the nervous system. Brain-derived neurotrophic factor (BDNF) binds to its receptor TrkB and regulates axonal and dendritic morphology of neurons through signal transduction and gene expression. SH2B1 is a signaling adaptor protein that regulates cellular signaling in various physiological processes. The purpose of this study is to investigate the role of SH2B1 in the development of the central nervous system. In this study, we show that knocking down SH2B1 reduces neurite formation of cortical neurons whereas overexpression of SH2B1 beta promotes the development of hippocampal neurons. We further demonstrate that SH2B1 beta promotes BDNF-induced neurite outgrowth and signaling using the established PC12 cells stably expressing TrkB, SH2B1 beta or SH2B1 beta mutants. Our data indicate that overexpressing SH2B1 beta enhances BDNF-induced MEK-ERK1/2, and PI3K-AKT signaling pathways. Inhibition of MEK-ERK1/2 and PI3K-AKT pathways by specific inhibitors suggest that these two pathways are required for SH2B1 beta-promoted BDNF-induced neurite outgrowth. Moreover, SH2B1 beta enhances BDNF-stimulated phosphorylation of signal transducer and activator of transcription 3 at serine 727. Finally, our data indicate that the SH2 domain and tyrosine phosphorylation of SH2B1 beta contribute to BDNF-induced signaling pathways and neurite outgrowth. Taken together, these findings demonstrate that SH2B1 beta promotes BDNF-induced neurite outgrowth through enhancing pathways involved MEK-ERK1/2 and PI3K-AKT.	[Shih, Chien-Hung; Chen, Chien-Jen; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Chen, Linyi] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Chen, LY (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan.	lchen@life.nthu.edu.tw	Chen, Linyi/AAV-2632-2020	Chen, Linyi/0000-0001-7258-8817	National Science Council of Taiwan [NSC101-2311-B-007-012-MY3]; National Health Research Institutes [NHRI-EX102-10206NI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan)	This study was supported by grants from the National Science Council of Taiwan (NSC101-2311-B-007-012-MY3), and National Health Research Institutes (NHRI-EX102-10206NI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2003, BIOCHEM J, V371, P405, DOI 10.1042/BJ20021589; Ahmed Z, 2001, BIOCHEM SOC T, V29, P529, DOI 10.1042/BST0290529; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bosco A, 1999, J NEUROSCI RES, V57, P759, DOI 10.1002/(SICI)1097-4547(19990915)57:6<759::AID-JNR1>3.3.CO;2-P; Chen LY, 2004, MOL CELL BIOL, V24, P3633, DOI 10.1128/MCB.24.9.3633-3647.2004; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; Han X, 2013, PLOS ONE, V8; Horch HW, 1999, NEURON, V23, P353; Hristova M, 2006, MED HYPOTHESES, V66, P545, DOI 10.1016/j.mehy.2005.08.055; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Kong M, 2002, J BIOL CHEM, V277, P15962, DOI 10.1074/jbc.M102777200; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Lu Wan-Chen, 2010, J Mol Signal, V5, P17, DOI 10.1186/1750-2187-5-17; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Morris DL, 2010, ENDOCRINOLOGY, V151, P3643, DOI 10.1210/en.2010-0254; Ng YP, 2006, J BIOL CHEM, V281, P15636, DOI 10.1074/jbc.M601863200; Niblock MM, 2000, J NEUROSCI, V20, P4165; O'Brien KB, 2003, J BIOL CHEM, V278, P11970, DOI 10.1074/jbc.M210765200; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Prudente S, 2011, ATHEROSCLEROSIS, V219, P667, DOI 10.1016/j.atherosclerosis.2011.08.019; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Rabacchi SA, 1999, J NEUROBIOL, V40, P254, DOI 10.1002/(SICI)1097-4695(199908)40:2<254::AID-NEU11>3.0.CO;2-4; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Rui LY, 1999, J BIOL CHEM, V274, P26485, DOI 10.1074/jbc.274.37.26485; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Sandholt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023531; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Tonra JR, 1999, DIABETES, V48, P588, DOI 10.2337/diabetes.48.3.588; Volckmar AL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-65; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yousaf N, 2001, J BIOL CHEM, V276, P40940, DOI 10.1074/jbc.M104191200; Zhang Y, 2006, J CELL SCI, V119, P1666, DOI 10.1242/jcs.02845; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200	48	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79619	10.1371/journal.pone.0079619	http://dx.doi.org/10.1371/journal.pone.0079619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260264	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600040
J	Yue, L; Guo, SJ; Zhang, Y; Liu, LD; Wang, QL; Wang, X; Shen, D; Wang, LC; Sun, L; Wang, JJ; Liao, Y; Li, QH				Yue, Lei; Guo, Sujie; Zhang, Ying; Liu, Longding; Wang, Qingling; Wang, Xi; Shen, Dong; Wang, Lichun; Sun, Le; Wang, Jingjing; Liao, Yun; Li, Qihan			The Modulation of Phosphatase Expression Impacts the Proliferation Efficiency of HSV-1 in Infected Astrocytes	PLOS ONE			English	Article							SIMPLEX-VIRUS INFECTION; PROTEIN; IDENTIFICATION; CULTURE; KINASE	Herpes Simplex Virus 1 (HSV-1) is a major pathogen that causes human neurological diseases, including herpes simplex encephalitis (HSE). Previous studies have shown that astrocytes are involved in HSV-1 systemic pathogenesis in the central nervous system (CNS), although the mechanism remains unclear. In this study, a high-throughput RNAi library screening method was used to analyze the effect of host phosphatase gene regulation on HSV-1 replication using Macaca mulatta primary astrocytes in an in vitro culture system. The results showed that the downregulation of five phosphatase genes (PNKP, SNAP23, PTPRU, LOC714621 and PPM1M) significantly inhibited HSV-1 infection, suggesting that these phosphatases were needed in HSV-1 replication in rhesus astrocytes. Although statistically significant, the effect of downregulation of these phosphatases on HSV-1 replication in a human astrocytoma cell line appears to be more limited. Our results suggest that the phosphatase genes in astrocytes may regulate the immunological and pathological reactions caused by HSV-1 CNS infection through the regulation of HSV-1 replication or of multiple signal transduction pathways.	[Li, Qihan] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; Peking Union Med Coll, Kunming, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, QH (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China.	imbcams.lq@gmail.com			National Basic Research Program [2012CB518901]; National Natural Sciences Foundation of China [31100127]; Yunnan Natural Science Foundation [2013FZ135, 2013FZ128, 2013FZ134]	National Basic Research Program(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province)	This work was supported by the National Basic Research Program (2012CB518901), National Natural Sciences Foundation of China (31100127), the Yunnan Natural Science Foundation (2013FZ135, 2013FZ128, 2013FZ134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baringer JR, 2008, NEUROL CLIN, V26, P657, DOI 10.1016/j.ncl.2008.03.005; Ben Mkaddem S, 2009, J BIOL CHEM, V284, P12541, DOI 10.1074/jbc.M808376200; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013; FRANGAKIS MV, 1984, NEUROCHEM RES, V9, P1689, DOI 10.1007/BF00968079; Frank SPC, 2011, MOL IMMUNOL, V49, P353, DOI 10.1016/j.molimm.2011.09.011; Gorska P, 2000, Med Sci Monit, V6, P171; Guo L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045749; Hayasaka D, 2011, PATHOGENESIS ENCEPHA; Henderson G, 2009, J NEUROVIROL, V15, P439, DOI 10.3109/13550280903296353; Henning MS, 2011, VIROLOGY, V415, P114, DOI 10.1016/j.virol.2011.04.006; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; Jones C, 1999, ADV VIRUS RES, V51, P81; KENNEDY PGE, 1983, BRAIN, V106, P101, DOI 10.1093/brain/106.1.101; Kennedy PGE, 2002, J NEUROL NEUROSUR PS, V73, P237, DOI 10.1136/jnnp.73.3.237; Kimberlin David W, 2007, Herpes, V14, P11; LEVISON SW, 1991, J NEUROCHEM, V57, P782, DOI 10.1111/j.1471-4159.1991.tb08220.x; Li JL, 2011, GLIA, V59, P58, DOI 10.1002/glia.21076; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Mack AF, 2013, NEUROSCIENTIST, V19, P195, DOI 10.1177/1073858412447981; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; NAHMIAS AJ, 1973, NEW ENGL J MED, V289, P781, DOI 10.1056/NEJM197310112891505; NORTON WT, 1988, GLIA, V1, P403, DOI 10.1002/glia.440010608; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; SELMAJ KW, 1990, J IMMUNOL, V144, P129; Tabernero A, 1996, NEUROSCI RES, V24, P131, DOI 10.1016/0168-0102(95)00981-7; Thomas SK, 1999, J VIROL, V73, P6618, DOI 10.1128/JVI.73.8.6618-6625.1999; Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045; Yu JJ, 2013, J BIOL CHEM, V288, P79, DOI 10.1074/jbc.M112.413856; Zolner AE, 2011, NUCLEIC ACIDS RES, V39, P9224, DOI 10.1093/nar/gkr647	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79648	10.1371/journal.pone.0079648	http://dx.doi.org/10.1371/journal.pone.0079648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260274	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600043
J	Li, YL; Yang, FF; Ou, YX; Zhang, DQ; Liu, JX; Chu, GW; Zhang, YR; Otieno, D; Zhou, GY				Li, Yuelin; Yang, Fangfang; Ou, Yangxu; Zhang, Deqiang; Liu, Juxiu; Chu, Guowei; Zhang, Yaru; Otieno, Dennis; Zhou, Guoyi			Changes in Forest Soil Properties in Different Successional Stages in Lower Tropical China	PLOS ONE			English	Article							MICROBIAL BIOMASS; ORGANIC-MATTER; WET FOREST; LONG-TERM; LAND-USE; CARBON; NITROGEN; SECONDARY; VEGETATION; NUTRIENTS	Background: Natural forest succession often affects soil physical and chemical properties. Selected physical and chemical soil properties were studied in an old-growth forest across a forest successional series in Dinghushan Nature Reserve, Southern China. Methodology/Principal Findings: The aim was to assess the effects of forest succession change on soil properties. Soil samples (0-20 cm depth) were collected from three forest types at different succession stages, namely pine (Pinus massoniana) forest (PMF), mixed pine and broadleaf forest (PBMF) and monsoon evergreen broadleaf forest (MEBF), representing early, middle and advanced successional stages respectively. The soil samples were analyzed for soil water storage (SWS), soil organic matter (SOM), soil microbial biomass carbon (SMBC), pH, NH4+-N, available potassium (K), available phosphorus (P) and microelements (available copper (Cu), available zinc (Zn), available iron (Fe) and available boron (B)) between 1999 and 2009. The results showed that SWS, SOM, SMBC, Cu, Zn, Fe and B concentrations were higher in the advanced successional stage (MEBF stage). Conversely, P and pH were lower in the MEBF but higher in the PMF (early successional stage). pH, NH4+-N, P and K declined while SOM, Zn, Cu, Fe and B increased with increasing forest age. Soil pH was lower than 4.5 in the three forest types, indicating that the surface soil was acidic, a stable trend in Dinghushan. Conclusion/Significance: These findings demonstrated significant impacts of natural succession in an old-growth forest on the surface soil nutrient properties and organic matter. Changes in soil properties along the forest succession gradient may be a useful index for evaluating the successional stages of the subtropical forests. We caution that our inferences are drawn from a pseudo-replicated chronosequence, as true replicates were difficult to find. Further studies are needed to draw rigorous conclusions regarding on nutrient dynamics in different successional stages of forest.	[Li, Yuelin; Yang, Fangfang; Ou, Yangxu; Zhang, Deqiang; Liu, Juxiu; Chu, Guowei; Zhang, Yaru; Otieno, Dennis; Zhou, Guoyi] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Ou, Yangxu; Zhang, Yaru] Univ Chinese Acad Sci, Beijing, Peoples R China; [Otieno, Dennis] Univ Bayreuth, Dept Plant Ecol, Bayreuth, Germany	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Bayreuth	Zhou, GY (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	gyzhou@scib.ac.cn	Liu, Juxiu/B-3400-2009		Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-GJ01, KSCX2-EW-J-28]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05050302]; National Science Foundation of China [31170375]; Natural Science Foundation of Guangdong Province, China [9151008901000130]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was funded by the Knowledge Innovation Program of the Chinese Academy of Sciences (Grants No. KZCX2-YW-GJ01 & KSCX2-EW-J-28), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA05050302), the National Science Foundation of China (Grant No. 31170375) and the Natural Science Foundation of Guangdong Province, China (Grant No. 9151008901000130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauhus J, 1998, SOIL BIOL BIOCHEM, V30, P1077, DOI 10.1016/S0038-0717(97)00213-7; Berendse F, 1998, BIOGEOCHEMISTRY, V42, P73, DOI 10.1023/A:1005935823525; Blake G. R., 1986, SSSA BOOK SER, V9, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; BROWN S, 1990, PLANT SOIL, V124, P53, DOI 10.1007/BF00010931; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Carter MR, 1997, DEV SOIL SCI, V25, P1; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Desjardins T, 2004, AGR ECOSYST ENVIRON, V103, P365, DOI 10.1016/j.agee.2003.12.008; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; Fang YT, 2009, FOREST ECOL MANAG, V257, P332, DOI 10.1016/j.foreco.2008.09.004; FERNANDES DN, 1995, CONSERV BIOL, V9, P915, DOI 10.1046/j.1523-1739.1995.09040915.x; GOUDIE A, 1989, NATURE ENV; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Huang D, 2007, J ARID ENVIRON, V70, P120, DOI 10.1016/j.jaridenv.2006.12.009; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P167, DOI 10.1016/0038-0717(76)90001-8; Jia GM, 2005, FOREST ECOL MANAG, V217, P117, DOI 10.1016/j.foreco.2005.05.055; JOERGENSEN RG, 1990, SOIL BIOL BIOCHEM, V22, P1023, DOI 10.1016/0038-0717(90)90027-W; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; KELLNER O, 1995, ECOL B, V44, P227; Litton CM, 2003, GLOBAL CHANGE BIOL, V9, P680, DOI 10.1046/j.1365-2486.2003.00626.x; Liu G, 1996, STANDARD METHODS OBS, V24, P266; Liu JX, 2001, SOIL ENVIRON SCI, V10, P39; MAO DM, 1992, SOIL BIOL BIOCHEM, V24, P865, DOI 10.1016/0038-0717(92)90007-K; Moran EF, 2000, FOREST ECOL MANAG, V139, P93, DOI 10.1016/S0378-1127(99)00337-0; Nave LE, 2010, FOREST ECOL MANAG, V259, P857, DOI 10.1016/j.foreco.2009.12.009; NIHLGARD B, 1971, OIKOS, V22, P302, DOI 10.2307/3543854; Ouyang Xue-jun, 2007, Yingyong Shengtai Xuebao, V18, P1688; Pan CM, 2000, SOIL ENV SCI, V9, P114; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; REINERS WA, 1994, ECOL APPL, V4, P363, DOI 10.2307/1941940; Ren R., 2000, J BEIJING POLYTECHNI, V26, P90; [方运霆 Fang Yunting], 2004, [生态学报, Acta Ecologica Sinica], V24, P135; Toriyama J, 2007, FOREST ENVIRONMENTS IN THE MEKONG RIVER BASIN, P241, DOI 10.1007/978-4-431-46503-4_22; VIERECK L A, 1970, Arctic and Alpine Research, V2, P1, DOI 10.2307/1550138; VITOUSEK PM, 1989, PLANT SOIL, V115, P229, DOI 10.1007/BF02202591; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; Vitousek PM, 1987, COLONIZATION SUCCESS, P207; Wang QK, 2007, GEODERMA, V142, P349, DOI 10.1016/j.geoderma.2007.09.006; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; WERNER P, 1984, BIOTROPICA, V16, P43, DOI 10.2307/2387893; Wu XH, 1985, TROPICAL SUBTROPICAL, V3, P11; Yan ER, 2006, PLANT SOIL, V289, P187, DOI 10.1007/s11104-006-9128-x; Yan Junhua, 2001, Yingyong Shengtai Xuebao, V12, P509; Zhang BG, 1994, WATER HOT RESOURCE I, P24; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168; Zhou GY, 2006, SCI CHINA SER D, V49, P311, DOI 10.1007/s11430-006-0311-y	47	13	19	5	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81359	10.1371/journal.pone.0081359	http://dx.doi.org/10.1371/journal.pone.0081359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244738	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800179
J	Liu, H; Yin, FX; Bai, CL; Shen, QY; Wei, ZY; Li, XX; Liang, H; Bou, S; Li, GP				Liu, Hui; Yin, Feng-Xia; Bai, Chun-Ling; Shen, Qi-Yuan; Wei, Zhu-Ying; Li, Xin-Xin; Liang, Hao; Bou, Shorgan; Li, Guang-Peng			TFIIB Co-Localizes and Interacts with a-Tubulin during Oocyte Meiosis in the Mouse and Depletion of TFIIB Causes Arrest of Subsequent Embryo Development	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR; NUCLEAR; MATURATION; ACTIVATION; DYNAMICS	TFIIB (transcription factor IIB) is a transcription factor that provides a bridge between promoter-bound TFIID and RNA polymerase II, and it is a target of various transcriptional activator proteins that stimulate the pre-initiation complex assembly. The localization and/or attachment matrix of TFIIB in the cytoplast is not well understood. This study focuses on the function of TFIIB and its interrelationship with alpha-tubulins in a mouse model. During oocyte maturation TFIIB distributes throughout the entire nucleus of the germinal vesicle (GV). After progression to GV breakdown (GVBD), TFIIB and alpha-tubulin co-localize and accumulate in the vicinity of the condensed chromosomes. During the MII stage, the TFIIB signals are more concentrated at the equatorial plate and the kinetochores. Colcemid treatment of oocytes disrupts the microtubule (MT) system, although the TFIIB signals are still present with the altered MT state. Injection of oocytes with TFIIB antibodies and siRNAs causes abnormal spindle formation and irregular chromosome alignment. These findings suggest that TFIIB dissociates from the condensed chromatids and then tightly binds to microtubules from GVBD to the MII phase. The assembly and disassembly of TFIIB may very well be associated with and driven by microtubules. TFIIB maintains its contact with the a-tubulins and its colocalization forms a unique distribution pattern. Depletion of Tf2b in oocytes results in a significant decrease in TFIIB expression, although polar body extrusion does not appear to be affected. Knockdown of Tf2b dramatically affects subsequent embryo development with more than 85% of the embryos arrested at the 2-cell stage. These arrested embryos still maintain apparently normal morphology for at least 96h without any obvious degeneration. Analysis of the effects of TFIIB in somatic cells by co-transfection of BiFC plasmids pHA-Tf2b and pFlag-Tuba1 alpha further confirms a direct interaction between TFIIB and a-tubulins.	[Liu, Hui; Yin, Feng-Xia; Bai, Chun-Ling; Shen, Qi-Yuan; Wei, Zhu-Ying; Li, Xin-Xin; Liang, Hao; Bou, Shorgan; Li, Guang-Peng] Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Peoples R China	Inner Mongolia University	Bou, S (corresponding author), Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Peoples R China.	xurg@imu.edu.cn; gpengli@imu.edu.cn						ALMOUZNI G, 1995, EMBO J, V14, P1752, DOI 10.1002/j.1460-2075.1995.tb07164.x; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Bellier S, 1997, EMBO J, V16, P6250, DOI 10.1093/emboj/16.20.6250; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; BouniolBaly C, 1997, EXP CELL RES, V236, P201, DOI 10.1006/excr.1997.3708; De La Fuente R, 2006, DEV BIOL, V292, P1, DOI 10.1016/j.ydbio.2006.01.008; Deng W, 2006, BIOCHEM SOC T, V34, P1051, DOI 10.1042/BST0341051; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175; Gao TL, 2007, CELL RES, V17, P135, DOI 10.1038/cr.2007.2; Green MR, 2005, MOL CELL, V18, P399, DOI 10.1016/j.molcel.2005.04.017; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Li GP, 2005, THERIOGENOLOGY, V63, P2434, DOI 10.1016/j.theriogenology.2004.09.056; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matoba S, 2010, REPROD FERT DEVELOP, V22, P839, DOI 10.1071/RD09277; MESSING SM, 1992, J CELL SCI, V100, P67; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pangas SA, 2006, HUM REPROD UPDATE, V12, P65, DOI 10.1093/humupd/dmi033; Parfenov VN, 2003, J CELL BIOCHEM, V89, P720, DOI 10.1002/jcb.10545; Schatten H, 2011, MOL REPROD DEV, V78, P757, DOI 10.1002/mrd.21380; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Sun F, 2007, CELL RES, V17, P117, DOI 10.1038/cr.2007.1; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; SUSAN LB, 2007, BIOL REPROD, V76, P949, DOI DOI 10.1095/BI0LREPR0D.106.057141.PUBMED:17287496; Torres-Padilla ME, 2006, J CELL BIOL, V174, P329, DOI 10.1083/jcb.200603146; Weinzierl ROJ, 2011, TRANSCR-AUSTIN, V2, P254, DOI 10.4161/trns.2.6.18076; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011	29	2	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80039	10.1371/journal.pone.0080039	http://dx.doi.org/10.1371/journal.pone.0080039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244602	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800111
J	Cedraschi, C; Delezay, S; Marty, M; Berenbaum, F; Bouhassira, D; Henrotin, Y; Laroche, F; Perrot, S				Cedraschi, Christine; Delezay, Sylvie; Marty, Marc; Berenbaum, Francis; Bouhassira, Didier; Henrotin, Yves; Laroche, Francoise; Perrot, Serge			"Let's Talk about OA Pain": A Qualitative Analysis of the Perceptions of People Suffering from OA. Towards the Development of a Specific Pain OA-Related Questionnaire, the Osteoarthritis Symptom Inventory Scale (OASIS)	PLOS ONE			English	Article							NEUROPATHIC PAIN; MCGILL PAIN; HEALTH-CARE; KNEE PAIN; OF-LIFE; HIP; REPLACEMENT; SATURATION; ABNORMALITIES; VALIDATION	Introduction: Pain is the primary outcome measurement in osteoarthritis, and its assessment is mostly based on its intensity. The management of this difficult chronic condition could be improved by using pain descriptors to improve analyses of painful sensations. This should help to define subgroups of patients based on pain phenotype, for more adapted treatment. This study draws upon patients' descriptions of their pain, to identify and understand their perception of osteoarthritis pain and to categorize pain dimensions. Methods: This qualitative study was conducted with representative types of patients suffering from osteoarthritis. Two focus groups were conducted with a sample of 14 participants, with either recent or chronic OA, at one or multiple sites. Focus groups were semi-structured and used open-ended questions addressing personal experiences to explore the experiences of patients with OA pain and the meanings they attributed to these pains. Results: Two main points emerged from content analyses: -A major difficulty in getting patients to describe their osteoarthritis pain: perception that nobody wants to hear about it; necessity to preserve one's self and social image; notion of self-imposed stoicism; and perception of osteoarthritis as a complex, changing, illogical disease associated with aging. -Osteoarthritis pains were numerous and differed in intensity, duration, depth, type of occurrence, impact and rhythm, but also in painful sensations and associated symptoms. Based on analyses of the verbatim interviews, seven dimensions of OA pain emerged: pain sensory description, OA-related symptoms, pain variability profile, pain-triggering factors, pain and physical activity, mood and image, general physical symptoms. Summary: In osteoarthritis, pain analysis should not be restricted to intensity. Our qualitative study identified pain descriptors and defined seven dimensions of osteoarthritis pain. Based on these dimensions, we aim to develop a specific questionnaire on osteoarthritis pain quality for osteoarthritis pain phenotyping: the OsteoArthritis Symptom Inventory Scale (OASIS).	[Cedraschi, Christine] Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Ctr Multidisciplinary Pain, Geneva, Switzerland; [Cedraschi, Christine] Univ Hosp Geneva, Div Gen Med Rehabil, Geneva, Switzerland; [Cedraschi, Christine] Univ Geneva, Geneva, Switzerland; [Delezay, Sylvie] Thelaine, Fontenay Sous Bois, France; [Marty, Marc] Hop Henri Mondor, Dept Rheumatol, F-94010 Creteil, France; [Berenbaum, Francis] Hop St Antoine, Dept Rheumatol, F-75571 Paris, France; [Bouhassira, Didier; Perrot, Serge] INSERM, U987, Pain Ctr, Boulogne, France; [Henrotin, Yves] Univ Liege, Inst Pathol, CHU, Bone & Cartilage Res Unit, Liege, Belgium; [Henrotin, Yves] Princess Paola Hosp, Vivalia, Phys Therapy & Rehabil Dept, Marche En Famenne, Belgium; [Laroche, Francoise] Hop St Antoine, Pain Ctr, F-75571 Paris, France; [Perrot, Serge] Univ Paris 05, Hotel Dieu, Pain Ctr, Serv Med Interne & Therapeut, Paris, France	University of Geneva; University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Perrot, S (corresponding author), INSERM, U987, Pain Ctr, Boulogne, France.	serge.perrot@htd.aphp.fr	Bouhassira, Didier/Y-8403-2018; Berenbaum, Francis/AAO-5690-2020	Bouhassira, Didier/0000-0001-6446-8719; Berenbaum, Francis/0000-0001-8252-7815; Henrotin, Yves/0000-0003-1073-449X	Caisse Nationale de Prevoyance (CNP) insurance company foundation; APICIL insurance company foundation	Caisse Nationale de Prevoyance (CNP) insurance company foundation; APICIL insurance company foundation	The authors received a grant from the Caisse Nationale de Prevoyance (CNP) and APICIL insurance company foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour RS, 2003, J EVAL CLIN PRACT, V9, P179, DOI 10.1046/j.1365-2753.2003.00371.x; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Baron R, 2012, LANCET NEUROL, V11, P999, DOI 10.1016/S1474-4422(12)70189-8; Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; BURCKHARDT CS, 1984, PAIN, V19, P305, DOI 10.1016/0304-3959(84)90007-1; Cheraghi-Sohi S, 2013, ARTHRIT CARE RES, V65, P920, DOI 10.1002/acr.21897; Courvoisier DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023138; Croft P, 2005, ARTHRITIS RHEUM-US, V52, P2350, DOI 10.1002/art.21218; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; Dekker J, 2009, CURR OPIN RHEUMATOL, V21, P520, DOI 10.1097/BOR.0b013e32832e6eaa; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Dwamena F, 2012, COCHRANE DB SYST REV, V12; Dworkin RH, 2012, PAIN, V153, P1148, DOI 10.1016/j.pain.2012.03.003; Edwards RR, 2011, NAT REV RHEUMATOL, V7, P216, DOI 10.1038/nrrheum.2011.2; Fernandez E, 2011, J PAIN, V12, P444, DOI 10.1016/j.jpain.2010.10.011; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Gaskell G., 2000, QUALITATIVE RES TEXT, P38, DOI DOI 10.4135/9781849209731; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hawker GA, 2008, OSTEOARTHR CARTILAGE, V16, P409, DOI 10.1016/j.joca.2007.12.015; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hochman JR, 2013, OSTEOARTHR CARTILAGE, V21, P1236, DOI 10.1016/j.joca.2013.06.023; Hochman JR, 2011, OSTEOARTHR CARTILAGE, V19, P647, DOI 10.1016/j.joca.2011.03.007; Jeffery AE, 2011, ARTHRIT CARE RES, V63, P286, DOI 10.1002/acr.20360; Jinks C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-148; Judge A, 2012, RHEUMATOLOGY, V51, P1804, DOI 10.1093/rheumatology/kes075; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; KUZEL AJ, 1992, RES METH PR, V3, P31; LEQUESNE MG, 1987, SCAND J RHEUMATOL, P85; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mays N, 2000, BRIT MED J, V320, P320, DOI DOI 10.1136/BMJ.320.7226.50.PUBMED:10617534; McHugh GA, 2012, DISABIL REHABIL, V34, P1351, DOI 10.3109/09638288.2011.644022; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Morse J. M., 2008, INT J QUAL METHODS, V1, P13; National Collaborating Centre for Chronic Conditions (UK), 2008, OSTEOARTHRITIS NATL; O'Brien T, 2012, J PAIN, V3, P23; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Perrot S, 2009, CLIN J PAIN, V25, P767, DOI 10.1097/AJP.0b013e3181b43d4f; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rosemann T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-6; RUTA DA, 1994, MED CARE, V32, P1109, DOI 10.1097/00005650-199411000-00004; SPENCER J, 1994, ANAL QUALITATIVE DAT; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Williams ACD, 2000, PAIN, V85, P457, DOI 10.1016/S0304-3959(99)00299-7; Wilson D, 2009, PHYSIOTHER RES INT, V14, P56, DOI 10.1002/pri.424; Woolhead G, 2010, ARTHRIT CARE RES, V62, P944, DOI 10.1002/acr.20164; Wylde V, 2012, RHEUMATOLOGY, V51, P535, DOI 10.1093/rheumatology/ker343	52	28	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79988	10.1371/journal.pone.0079988	http://dx.doi.org/10.1371/journal.pone.0079988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244589	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600167
J	He, Q; Yu, WB; Wu, JJ; Chen, C; Lou, ZY; Zhang, Q; Zhao, J; Wang, J; Xiao, BG				He, Qing; Yu, Wenbo; Wu, Jianjun; Chen, Chan; Lou, Zhiyin; Zhang, Qiong; Zhao, Jian; Wang, Jian; Xiao, Baoguo			Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins	PLOS ONE			English	Article							ANIMAL-MODELS; DISEASE; BRAIN; NEURODEGENERATION; NEUROTOXICITY; INFLAMMATION; MICROGLIA; MECHANISMS; ENDOTOXIN; MICE	Accumulating evidence implicates the relationship between neuroinflammation and pathogenesis in idiopathic Parkinson's disease (iPD). The nose has recently been considered a gate way to the brain which facilitates entry of environmental neurotoxin into the brain. Our study aims to build a PD model by a natural exposure route. In this report, we establish a new endotoxin-based PD model in mice by unilateral intranasal (i.n.) instillation of the lipopolysaccharides (LPS) every other day for 5 months. These mice display a progressive hypokinesia, selective loss of dopaminergic neurons, and reduction in striatal dopamine (DA) content, as well as a-synuclein aggregation in the SN, without systemic inflammatory and immune responses. This new PD model provides a tool for studying the inflammation-mediated chronic pathogenesis and searching for therapeutic intervention in glia-neuron pathway that will slow or halt neurodegeneration in PD.	[He, Qing; Yu, Wenbo; Wu, Jianjun; Chen, Chan; Zhang, Qiong; Zhao, Jian; Wang, Jian; Xiao, Baoguo] Fudan Univ, Inst Brain Sci, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China; [He, Qing; Yu, Wenbo; Wu, Jianjun; Chen, Chan; Zhang, Qiong; Zhao, Jian; Wang, Jian; Xiao, Baoguo] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [He, Qing] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Neurol, Shanghai 200030, Peoples R China; [Yu, Wenbo] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Phys Test, Nanjing, Jiangsu, Peoples R China; [Wu, Jianjun; Chen, Chan; Zhang, Qiong; Zhao, Jian; Wang, Jian] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Lou, Zhiyin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Neurol, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Nanjing Medical University; Fudan University; Shanghai Jiao Tong University	Wang, J (corresponding author), Fudan Univ, Inst Brain Sci, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China.	wangjian336@hotmail.com; bgxiao@shmu.edu.cn	Yu, Wen-Bo/M-8673-2017; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Yu, Wen-Bo/0000-0001-9483-3027; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Foundation; National Foundation of Natural Science of China [30972715, 81070956, 30600663, 81071018, 81371413]	National Foundation(National Science Foundation (NSF)); National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Foundation of This work was supported by grants from the National Foundation of Natural Science of China (No. 30972715, No. 81070956, No. 30972715, No. 81070956, No. 30600663, No. 81071018 and No. 81371413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; CLAPP WD, 1993, CHEST, V104, P825, DOI 10.1378/chest.104.3.825; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Delayre-Orthez C, 2005, INT ARCH ALLERGY IMM, V138, P298, DOI 10.1159/000088867; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Dutta G, 2008, FUND CLIN PHARMACOL, V22, P453, DOI 10.1111/j.1472-8206.2008.00616.x; Friedman JH, 2008, NEUROLOGY, V70, P487, DOI 10.1212/01.wnl.0000279380.25130.ce; Funabe S, 2012, NEUROPATHOLOGY; Genc S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/782462; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Graff CL, 2005, J PHARM SCI-US, V94, P1187, DOI 10.1002/jps.20318; Hong ZY, 2005, ACTA PHARMACOL SIN, V26, P155, DOI 10.1111/j.1745-7254.2005.00523.x; Izuta S, 2012, BIOTECHNOL LETT, V34, P2175, DOI 10.1007/s10529-012-1022-4; Jung BD, 2010, NEUROCHEM INT, V56, P229, DOI 10.1016/j.neuint.2009.10.005; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Krueger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070242; Kurniati NF, 2012, NEPHROL DIAL TRANSPL; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lim KL, 2009, BBA-MOL BASIS DIS, V1792, P604, DOI 10.1016/j.bbadis.2008.10.005; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; Lunardi G, 2009, PARKINSONISM RELAT D, V15, P383, DOI 10.1016/j.parkreldis.2008.10.001; Moore JP, 2013, J IMMUNOL METHODS; Ouchi Y, 2009, PARKINSONISM RELAT D, V15, pS200, DOI 10.1016/S1353-8020(09)70814-4; PEREZOTANO I, 1994, NEUROSCI LETT, V175, P121, DOI 10.1016/0304-3940(94)91094-4; Pignatelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056571; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STERN MB, 1994, NEUROLOGY, V44, P266, DOI 10.1212/WNL.44.2.266; Sultan S, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00052; Tonelli Leonardo H, 2010, Front Biosci (Schol Ed), V2, P135; Wang YQ, 2012, J NEUROCHEM, V120, P314, DOI 10.1111/j.1471-4159.2011.07558.x	37	39	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78418	10.1371/journal.pone.0078418	http://dx.doi.org/10.1371/journal.pone.0078418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250796	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200026
J	Jules, J; Maiguel, D; Hudson, BI				Jules, Joel; Maiguel, Dony; Hudson, Barry I.			Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; DIABETIC-NEPHROPATHY; NEURITE OUTGROWTH; SURFACE RECEPTOR; TUMOR-GROWTH; EXPRESSION; CANCER; ACTIVATION; AMPHOTERIN; PROTEIN	The Receptor for Advanced Glycation End-products (RAGE) is a multi-ligand receptor present on most cell types. Upregulation of RAGE is seen in a number of pathological states including, inflammatory and vascular disease, dementia, diabetes and various cancers. We previously demonstrated that alternative splicing of the RAGE gene is an important mechanism which regulates RAGE signaling through the production of soluble ligand decoy isoforms. However, no studies have identified any alternative splice variants within the intracellular region of RAGE, a region critical for RAGE signaling. Herein, we have cloned and characterized a novel splice variant of RAGE that has a truncated intracellular domain (RAGE Delta ICD). RAGE Delta ICD is prevalent in both human and mouse tissues including lung, brain, heart and kidney. Expression of RAGE Delta ICD in C6 glioma cells impaired RAGE-ligand induced signaling through various MAP kinase pathways including ERK1/2, p38 and SAPK/JNK. Moreover, RAGE Delta ICD significantly affected tumor cell properties through altering cell migration, invasion, adhesion and viability in C6 glioma cells. Furthermore, C6 glioma cells expressing RAGE Delta ICD exhibited drastic inhibition on tumorigenesis in soft agar assays. Taken together, these data indicate that RAGE Delta ICD represents a novel endogenous mechanism to regulate RAGE signaling. Significantly, RAGE Delta ICD could play an important role in RAGE related disease states through down regulation of RAGE signaling.	[Jules, Joel; Hudson, Barry I.] Univ Miami, Leonard M Miller Sch Med, Div Endocrinol Diabet & Metab, Miami, FL 33152 USA; [Maiguel, Dony] Univ Miami, Leonard M Miller Sch Med, Div Nephrol & Hypertens, Miami, FL USA	University of Miami; University of Miami	Hudson, BI (corresponding author), Univ Miami, Leonard M Miller Sch Med, Div Endocrinol Diabet & Metab, Miami, FL 33152 USA.	bhudson@med.miami.edu	Hudson, Barry/B-3122-2009	Hudson, Barry/0000-0001-7647-8121	University of Miami	University of Miami	The work presented here is funded by lab startup funds from the University of Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Albini A, 2010, CURR OPIN CELL BIOL, V22, P677, DOI 10.1016/j.ceb.2010.08.017; Arumugam T, 2012, CLIN CANCER RES, V18, P4356, DOI 10.1158/1078-0432.CCR-12-0221; Bhawal UK, 2005, ONCOLOGY-BASEL, V69, P246, DOI 10.1159/000087910; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hsieh HL, 2003, BIOCHEM BIOPH RES CO, V307, P375, DOI 10.1016/S0006-291X(03)01190-2; Huang JS, 2001, J CELL BIOCHEM, V81, P102, DOI 10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Ishiguro H, 2005, PROSTATE, V64, P92, DOI 10.1002/pros.20219; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jackel A, 1999, HAUTARZT, V50, P250, DOI 10.1007/s001050050897; Kalea AZ, 2010, CANCER RES, V70, P5628, DOI 10.1158/0008-5472.CAN-10-0595; Kalea AZ, 2009, FASEB J, V23, P1766, DOI 10.1096/fj.08-117739; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Kalea AZ, 2012, FRONT BIOSCI, V17, P2756; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Ke N, 2004, BIOTECHNIQUES, V36, P826, DOI 10.2144/04365ST07; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kuniyasu H, 2003, ONCOL REP, V10, P445; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Ma WC, 2007, INVEST OPHTH VIS SCI, V48, P1355, DOI 10.1167/iovs.06-0738; Ma WC, 2012, CELL IMMUNOL, V274, P72, DOI 10.1016/j.cellimm.2012.02.001; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Pietzsch J, 2009, AMINO ACIDS, V36, P381, DOI 10.1007/s00726-008-0097-7; Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Sasahira T, 2005, VIRCHOWS ARCH, V446, P411, DOI 10.1007/s00428-005-1210-x; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Sterenczak KA, 2009, GENE, V434, P35, DOI 10.1016/j.gene.2008.10.027; Su PC, 2012, J BIOL CHEM, V287, P31515, DOI 10.1074/jbc.M112.396895; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Wei W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050736; Wendt T, 2003, J AM SOC NEPHROL, V14, P1383, DOI 10.1097/01.ASN.0000065100.17349.CA; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Xiong F, 2011, J BIOL CHEM, V286, P35061, DOI 10.1074/jbc.M111.261073; Yamagishi S, 2006, METABOLISM, V55, P1227, DOI 10.1016/j.metabol.2006.05.007; Yamamoto KI, 2013, ONCOL REP, V29, P1073, DOI 10.3892/or.2012.2191; YAN HC, 1995, J BIOL CHEM, V270, P23672, DOI 10.1074/jbc.270.40.23672; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zen K, 2007, J IMMUNOL, V178, P2483, DOI 10.4049/jimmunol.178.4.2483; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	57	38	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78267	10.1371/journal.pone.0078267	http://dx.doi.org/10.1371/journal.pone.0078267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260107	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200017
J	Gegenbauer, K; Nagy, Z; Smolenski, A				Gegenbauer, Kristina; Nagy, Zoltan; Smolenski, Albert			Cyclic Nucleotide Dependent Dephosphorylation of Regulator of G-Protein Signaling 18 in Human Platelets	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; IN-VITRO; PHOSPHORYLATION; BINDING; SPINOPHILIN; MEGAKARYOPOIESIS; PHOSPHATASES; RAP1GAP2; CLONING; GEFI	Regulator of G-protein signaling 18 (RGS18) is a GTPase-activating protein that turns off Gq signaling in platelets. RGS18 is regulated by binding to the adaptor protein 14-3-3 via phosphorylated serine residues S49 and S218 on RGS18. In this study we confirm that thrombin, thromboxane A2, or ADP stimulate the interaction of RGS18 and 14-3-3 by increasing the phosphorylation of S49. Cyclic AMP-and cyclic GMP-dependent kinases (PKA, PKG) inhibit the interaction of RGS18 and 14-3-3 by phosphorylating S216. To understand the effect of S216 phosphorylation we studied the phosphorylation kinetics of S49, S216, and S218 using Phos-tag gels and phosphorylation site-specific antibodies in transfected cells and in platelets. Cyclic nucleotide-induced detachment of 14-3-3 from RGS18 coincides initially with double phosphorylation of S216 and S218. This is followed by dephosphorylation of S49 and S218. Dephosphorylation of S49 and S218 might be mediated by protein phosphatase 1 (PP1) which is linked to RGS18 by the regulatory subunit PPP1R9B (spinophilin). We conclude that PKA and PKG induced S216 phosphorylation triggers the dephosphorylation of the 14-3-3 binding sites of RGS18 in platelets.	[Gegenbauer, Kristina; Nagy, Zoltan; Smolenski, Albert] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Gegenbauer, Kristina; Nagy, Zoltan; Smolenski, Albert] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Gegenbauer, Kristina] Natl Childrens Res Ctr, Dublin, Ireland; [Gegenbauer, Kristina] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland	University College Dublin; University College Dublin; National Children's Research Centre (NCRC); Trinity College Dublin; Trinity College Dublin	Smolenski, A (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 2, Ireland.	albert.smolenski@ucd.ie	Nagy, Zoltan/ABE-3429-2020	Nagy, Zoltan/0000-0001-6517-2071; Smolenski, Albert/0000-0001-9210-9406	Science Foundation Ireland [08/IN.1/B1855]; UCD School of Medicine and Medical Science, University College Dublin	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); UCD School of Medicine and Medical Science, University College Dublin	This work was supported by Science Foundation Ireland, http://www.sfi.ie/, grant number 08/IN.1/B1855, and by UCD School of Medicine and Medical Science, University College Dublin, http://www.ucd.ie/medicine/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Antl M, 2007, BLOOD, V109, P552, DOI 10.1182/blood-2005-10-026294; Astuti P, 2010, J BIOL CHEM, V285, P34364, DOI 10.1074/jbc.M110.138412; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Burkhart JM, 2012, BLOOD; BUTT E, 1994, J BIOL CHEM, V269, P14509; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Cohen PTW, 2002, J CELL SCI, V115, P241; Danielewski O, 2005, THROMB HAEMOSTASIS, V93, P319, DOI 10.1160/TH04-09-0582; Gagnon AW, 2002, CELL SIGNAL, V14, P595, DOI 10.1016/S0898-6568(02)00012-8; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Guidetti GF, 2013, BIOCHEM J, V453, P115, DOI 10.1042/BJ20130131; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hoffmeister M, 2008, J BIOL CHEM, V283, P2297, DOI 10.1074/jbc.M706825200; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Louwette S, 2012, J THROMB HAEMOST, V10, P2215, DOI 10.1111/j.1538-7836.2012.04903.x; Louwette S, 2012, J THROMBOSIS HAEMOST; Louwette S, 2012, FASEB J, V26, P2125, DOI 10.1096/fj.11-198739; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Parks IK, 2001, J BIOL CHEM, V276, P915, DOI 10.1074/jbc.M005947200; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Schwarz UR, 2001, BIOCHEM PHARMACOL, V62, P1153, DOI 10.1016/S0006-2952(01)00760-2; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Subramanian H, 2013, J THROMB HAEMOST, V11, P1574, DOI 10.1111/jth.12271; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	38	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80251	10.1371/journal.pone.0080251	http://dx.doi.org/10.1371/journal.pone.0080251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244663	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900072
J	Sacks-Davis, R; Aitken, CK; Higgs, P; Spelman, T; Pedrana, AE; Bowden, S; Bharadwaj, M; Nivarthi, UK; Suppiah, V; George, J; Grebely, J; Drummer, HE; Hellard, M				Sacks-Davis, Rachel; Aitken, Campbell K.; Higgs, Peter; Spelman, Tim; Pedrana, Alisa E.; Bowden, Scott; Bharadwaj, Mandvi; Nivarthi, Usha K.; Suppiah, Vijayaprakash; George, Jacob; Grebely, Jason; Drummer, Heidi E.; Hellard, Margaret			High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GLOBAL EPIDEMIOLOGY; INFECTION; USERS; SEROCONVERSION; VACCINATION; PERSISTENCE; GENOTYPES; INSIGHTS; IMPACT	Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible reinfections were identified (confirmed reinfections were those genetically distinct from the previous infection and possible reinfections were used to define instances where genetic differences between infections could not be assessed due to lack of availability of hepatitis C virus sequence data). The incidence of confirmed reinfection was 28.8 per 100 person-years (PY), 95% CI: 15.0-55.4; the combined incidence of confirmed and possible reinfection was 24.6 per 100 PY (95% CI: 16.8-36.1). The hazard of hepatitis C reinfection was approximately double that of primary hepatitis C infection; it did not reach statistical significance in confirmed reinfections alone (hazard ratio [HR]: 2.45, 95% CI: 0.87-6.86, p=0.089), but did in confirmed and possible hepatitis C reinfections combined (HR: 1.93, 95% CI: 1.01-3.69, p=0.047) and after adjustment for the number of recent injecting partners and duration of injecting. In multivariable analysis, shorter duration of injection (HR: 0.91; 95% CI: 0.83-0.98; p=0.019) and multiple recent injecting partners (HR: 3.12; 95% CI: 1.08-9.00, p=0.035) were independent predictors of possible and confirmed reinfection. Time to spontaneous clearance was shorter in confirmed reinfection (HR: 5.34, 95% CI: 1.67-17.03, p=0.005) and confirmed and possible reinfection (HR: 3.10, 95% CI: 1.10-8.76, p-value=0.033) than primary infection. Nonetheless, 50% of confirmed reinfections and 41% of confirmed or possible reinfections did not spontaneously clear. Conclusions: Hepatitis C reinfection and spontaneous clearance of hepatitis C reinfection were observed at high rates, suggesting partial acquired natural immunity to hepatitis C virus. Public health campaigns about the risks of hepatitis C reinfection are required.	[Sacks-Davis, Rachel; Aitken, Campbell K.; Higgs, Peter; Spelman, Tim; Pedrana, Alisa E.; Hellard, Margaret] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Aitken, Campbell K.; Spelman, Tim; Hellard, Margaret] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Sacks-Davis, Rachel; Aitken, Campbell K.; Hellard, Margaret] Burnet Inst, Ctr Excellence Injecting Drug Use, Melbourne, Vic, Australia; [Higgs, Peter] Curtin Univ, Natl Drug Res Inst, Melbourne, Vic, Australia; [Bowden, Scott] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Bharadwaj, Mandvi; Nivarthi, Usha K.; Drummer, Heidi E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Suppiah, Vijayaprakash; George, Jacob] Univ Sydney, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW 2006, Australia; [Suppiah, Vijayaprakash; George, Jacob] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia; [Suppiah, Vijayaprakash] Univ S Australia, Sch Pharm, Adelaide, SA 5001, Australia; [Grebely, Jason] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Drummer, Heidi E.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Drummer, Heidi E.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia	Burnet Institute; Monash University; Burnet Institute; Curtin University; Victorian Infectious Diseases Reference Laboratory; University of Melbourne; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of South Australia; University of New South Wales Sydney; Kirby Institute; Burnet Institute; Monash University	Sacks-Davis, R (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.	rachelsd@burnet.edu.au	Bharadwaj, Mandvi/C-4446-2014; Higgs, Peter/P-7816-2019; Sacks-Davis, Rachel/H-3277-2019; George, jacob/P-1496-2014; Suppiah, Vijay/D-4174-2011	Higgs, Peter/0000-0002-5587-5379; Suppiah, Vijay/0000-0001-5496-935X; Pedrana, Alisa/0000-0002-1998-5722; Sacks-Davis, Rachel/0000-0003-0860-2762; Drummer, Heidi/0000-0002-0042-6277; Aitken, Campbell/0000-0002-0923-4837	Australia's National Health and Medical Research Council [331312, 1041897, 1020175, 1006759]; Victorian Department of Human Services; Australian Centre for HIV and Hepatitis Virology Research (ACH2); Victorian Operational Infrastructure Support Program; Burnet Institute; Centre for Research Excellence into Injecting Drug Use; Robert W. Storr Bequest	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Department of Human Services; Australian Centre for HIV and Hepatitis Virology Research (ACH2); Victorian Operational Infrastructure Support Program; Burnet Institute; Centre for Research Excellence into Injecting Drug Use; Robert W. Storr Bequest	This work was supported by Australia's National Health and Medical Research Council [project grant 331312, postgraduate scholarship to RSD, training fellowship to PH, RD Wright Career Development Award to HED, senior research fellowship 1041897 to HED, Career Development Fellowship to JGr, project grant 1020175 to HED, project grant 1006759 to JGe, Senior Research Fellowship to MH]; the Victorian Department of Human Services [public health research grant, 2008-09]; the Australian Centre for HIV and Hepatitis Virology Research (ACH2); the Victorian Operational Infrastructure Support Program; the Burnet Institute; the Centre for Research Excellence into Injecting Drug Use; and the Robert W. Storr Bequest to the Medical Foundation of the University of Sydney [to JGe]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Backmund M, 2004, CLIN INFECT DIS, V39, P1540, DOI 10.1086/425361; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Corson S, 2011, INT J DRUG POLICY, V22, P102, DOI 10.1016/j.drugpo.2010.10.007; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; Craine N, 2009, EPIDEMIOL INFECT, V137, P1255, DOI 10.1017/S095026880900212X; Currie SL, 2008, DRUG ALCOHOL DEPEN, V93, P148, DOI 10.1016/j.drugalcdep.2007.09.011; Dalgard O, 2002, EUR ADDICT RES, V8, P45, DOI 10.1159/000049487; Dev AT, 2002, HEPATOLOGY, V36, P1259, DOI 10.1053/jhep.2002.36781; Doyle JS, 2013, BRIT J CLIN PHARMACO, V75, P931, DOI 10.1111/j.1365-2125.2012.04419.x; Grady BPX, 2012, EUR J GASTROEN HEPAT, V24, P1302, DOI 10.1097/MEG.0b013e32835702a8; Grebely J, 2006, HEPATOLOGY, V44, P1139, DOI 10.1002/hep.21376; Grebely J, 2012, LANCET INFECT DIS, V12, P408, DOI 10.1016/S1473-3099(12)70010-5; Grebely J, 2012, HEPATOLOGY, V55, P1058, DOI 10.1002/hep.24754; Grebely J, 2010, J GASTROEN HEPATOL, V25, P1281, DOI 10.1111/j.1440-1746.2010.06238.x; Gyarmathy VA, 2010, AIDS BEHAV, V14, P141, DOI 10.1007/s10461-008-9518-6; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Hahn JA, 2001, HEPATOLOGY, V34, P180, DOI 10.1053/jhep.2001.25759; Halliday J, 2011, EXPERT REV VACCINES, V10, P659, DOI [10.1586/erv.11.55, 10.1586/ERV.11.55]; Judd A, 2005, J VIRAL HEPATITIS, V12, P655, DOI 10.1111/j.1365-2893.2005.00643.x; Kelly PJ, 2000, STAT MED, V19, P13, DOI 10.1002/(SICI)1097-0258(20000115)19:1&lt;13::AID-SIM279&gt;3.0.CO;2-5; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Marufu M, 2012, J MED VIROL, V84, P1737, DOI 10.1002/jmv.23389; McCaw R, 1997, J VIRAL HEPATITIS, V4, P351, DOI 10.1046/j.1365-2893.1997.00060.x; McDonald SA, 2012, INT J DRUG POLICY, V23, P353, DOI 10.1016/j.drugpo.2012.02.003; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Micallef JM, 2007, J VIRAL HEPATITIS, V14, P413, DOI 10.1111/j.1365-2893.2006.00812.x; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Miller ER, 2009, J INFECTION, V58, P375, DOI 10.1016/j.jinf.2009.02.014; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Pham ST, 2010, HEPATOLOGY, V52, P1564, DOI 10.1002/hep.23885; Pouget ER, 2012, ADDICTION, V107, P1057, DOI 10.1111/j.1360-0443.2011.03765.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stoove MA, 2005, DRUG ALCOHOL DEPEN, V77, P81, DOI 10.1016/j.drugalcdep.2004.07.002; Torresi J, 2011, J HEPATOL, V54, P1273, DOI 10.1016/j.jhep.2010.09.040; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; Vickerman P, 2012, J INFECT DIS, V205, P1342, DOI 10.1093/infdis/jis213	43	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80216	10.1371/journal.pone.0080216	http://dx.doi.org/10.1371/journal.pone.0080216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244654	gold, Green Published, Green Accepted			2022-12-25	WOS:000327162900068
J	Toju, H; Yamamoto, S; Sato, H; Tanabe, AS				Toju, Hirokazu; Yamamoto, Satoshi; Sato, Hirotoshi; Tanabe, Akifumi S.			Sharing of Diverse Mycorrhizal and Root-Endophytic Fungi among Plant Species in an Oak-Dominated Cool-Temperate Forest	PLOS ONE			English	Article							ECTOMYCORRHIZAL GENUS STROBILOMYCES; ARBUSCULAR MYCORRHIZAL; COMMUNITY STRUCTURE; COEVOLUTIONARY NETWORKS; SEEDLING ESTABLISHMENT; MUTUALISTIC NETWORKS; HOST-SPECIFICITY; ARCHITECTURE; SOIL; SPECIALIZATION	Most terrestrial plants interact with diverse clades of mycorrhizal and root-endophytic fungi in their roots. Through belowground plant-fungal interactions, dominant plants can benefit by interacting with host-specific mutualistic fungi and proliferate in a community based on positive plant-mutualistic fungal feedback. On the other hand, subordinate plant species may persist in the community by sharing other sets (functional groups) of fungal symbionts with each other. Therefore, revealing how diverse clades of root-associated fungi are differentially hosted by dominant and subordinate plant species is essential for understanding plant community structure and dynamics. Based on 454-pyrosequencing, we determined the community composition of root-associated fungi on 36 co-occurring plant species in an oak-dominated forest in northern Japan and statistically evaluated the host preference phenotypes of diverse mycorrhizal and root-endophytic fungi. An analysis of 278 fungal taxa indicated that an ectomycorrhizal basidiomycete fungus in the genus Lactarius and a possibly endophytic ascomycete fungus in the order Helotiales significantly favored the dominant oak (Quercus) species. In contrast, arbuscular mycorrhizal fungi were generally shared among subordinate plant species. Although fungi with host preferences contributed to the compartmentalization of belowground plant-fungal associations, diverse clades of ectomycorrhizal fungi and possible root endophytes were associated not only with the dominant Quercus but also with the remaining plant species. Our findings suggest that dominant-ectomycorrhizal and subordinate plant species can host different subsets of root-associated fungi, and diverse clades of generalist fungi can counterbalance the compartmentalization of plant-fungal associations. Such insights into the overall structure of belowground plant-fungal associations will help us understand the mechanisms that facilitate the coexistence of plant species in natural communities.	[Toju, Hirokazu; Yamamoto, Satoshi; Sato, Hirotoshi; Tanabe, Akifumi S.] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan; [Toju, Hirokazu; Yamamoto, Satoshi; Sato, Hirotoshi] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan; [Tanabe, Akifumi S.] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa, Japan	Kyoto University; Kyoto University; Japan Fisheries Research & Education Agency (FRA)	Toju, H (corresponding author), Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan.	toju.hirokazu.4c@kyoto-u.ac.jp	Toju, Hirokazu/S-7307-2017; Toju, Hirokazu/T-7355-2019; Sato, Hirotoshi/A-2429-2015; Tanabe, Akifumi/P-9381-2015	Toju, Hirokazu/0000-0002-3362-3285; Tanabe, Akifumi/0000-0003-1017-6504	Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government [GS014]	Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government	This work was supported by the Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government (to H. T.; GS014; http://www.jsps.go.jp/english/e-jisedai/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bever JD, 2001, BIOSCIENCE, V51, P923, DOI 10.1641/0006-3568(2001)051[0923:AMFMDT]2.0.CO;2; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Booth MG, 2004, ECOL LETT, V7, P538, DOI 10.1111/j.1461-0248.2004.00605.x; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Bruns TD, 2002, INTEGR COMP BIOL, V42, P352, DOI 10.1093/icb/42.2.352; Bueno RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056252; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caruso T, 2012, NEW PHYTOL, V194, P891, DOI 10.1111/j.1469-8137.2012.04163.x; Chazdon RL, 2011, ECOLOGY, V92, P1332, DOI 10.1890/10-1345.1; Collier FA, 2009, J ECOL, V97, P950, DOI 10.1111/j.1365-2745.2009.01544.x; CONNELL JH, 1989, AM NAT, V134, P88, DOI 10.1086/284967; Dickie IA, 2001, NEW PHYTOL, V151, P257, DOI 10.1046/j.1469-8137.2001.00148.x; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Dormann C. F., 2009, OPEN ECOL J, V2, P7, DOI DOI 10.2174/1874213000902010007; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Entry JA, 2002, ADV ENVIRON RES, V7, P123, DOI 10.1016/S1093-0191(01)00109-5; FINLAY RD, 1986, NEW PHYTOL, V103, P157, DOI 10.1111/j.1469-8137.1986.tb00604.x; Gehring CA, 1998, ECOLOGY, V79, P1562, DOI 10.1890/0012-9658(1998)079[1562:EFCSOP]2.0.CO;2; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Heleno RH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2112; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Kiers ET, 2006, ECOLOGY, V87, P1627, DOI 10.1890/0012-9658(2006)87[1627:MSITAM]2.0.CO;2; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Klironomos JN, 2000, HOST SPECIFICITY FUN, P845; Kudo G, 2008, ECOLOGY, V89, P321, DOI 10.1890/06-2131.1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Mandyam K, 2012, MYCORRHIZA, V22, P109, DOI 10.1007/s00572-011-0386-y; McGuire KL, 2007, ECOLOGY, V88, P567, DOI 10.1890/05-1173; Montesinos-Navarro A, 2012, NEW PHYTOL, V194, P536, DOI 10.1111/j.1469-8137.2011.04045.x; Murata H, 2013, MYCORRHIZA, V23, P235, DOI 10.1007/s00572-012-0466-7; Nakamura M, 2010, OIKOS, V119, P1445, DOI 10.1111/j.1600-0706.2010.18255.x; Nara K, 2006, NEW PHYTOL, V169, P169, DOI 10.1111/j.1469-8137.2005.01545.x; Nara K, 2004, ECOLOGY, V85, P1700, DOI 10.1890/03-0373; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Newsham KK, 2009, FUNGAL ECOL, V2, P10, DOI 10.1016/j.funeco.2008.10.005; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Sato H, 2008, MOL PHYLOGENET EVOL, V48, P326, DOI 10.1016/j.ympev.2008.01.033; Sato H, 2007, AM J BOT, V94, P1630, DOI 10.3732/ajb.94.10.1630; Sato H, 2012, MOL ECOL, V21, P5599, DOI 10.1111/mec.12053; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Tanabe AS, PLOS ONE IN PRESS; Tanabe AS, 2013, ASSAMS V0 1 2013 01; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tedersoo L, 2009, ENVIRON MICROBIOL, V11, P3166, DOI 10.1111/j.1462-2920.2009.02020.x; THEODOROU C, 1991, NEW PHYTOL, V118, P279, DOI 10.1111/j.1469-8137.1991.tb00978.x; Thompson JN, 2006, SCIENCE, V312, P372, DOI 10.1126/science.1126904; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Upson R, 2009, MYCORRHIZA, V20, P1, DOI 10.1007/s00572-009-0260-3; van der Heijden MGA, 2009, J ECOL, V97, P1139, DOI 10.1111/j.1365-2745.2009.01570.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Wagg C, 2008, MYCORRHIZA, V18, P103, DOI 10.1007/s00572-007-0157-y; Walker JF, 2011, NEW PHYTOL, V191, P515, DOI 10.1111/j.1469-8137.2011.03703.x; Yang HS, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-50	75	49	50	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78248	10.1371/journal.pone.0078248	http://dx.doi.org/10.1371/journal.pone.0078248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24250752	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600086
J	Petris, G; Casini, A; Sasset, L; Cesaratto, F; Bestagno, M; Cereseto, A; Burrone, OR				Petris, Gianluca; Casini, Antonio; Sasset, Linda; Cesaratto, Francesca; Bestagno, Marco; Cereseto, Anna; Burrone, Oscar R.			CD4 and BST-2/Tetherin Proteins Retro-translocate from Endoplasmic Reticulum to Cytosol as Partially Folded and Multimeric Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biotin; Disulfide; ER-associated Degradation; ERAD; Oxidation-Reduction; BST-2; CD4; Biotinylation; Retro-translocation; Tetherin	MEMBRANE-PROTEIN; DISULFIDE REDUCTASE; MISFOLDED PROTEINS; SECRETORY PATHWAY; STRUCTURAL BASIS; CHOLERA-TOXIN; ERAD PATHWAY; BETA-TRCP; DEGRADATION; DISLOCATION	CD4 and BST-2/Tetherin are cellular membrane proteins targeted to degradation by the HIV-1 protein Vpu. In both cases proteasomal degradation following recruitment into the ERAD pathway has been described. CD4 is a type I transmembrane glycoprotein, with four extracellular immunoglobulin-like domains containing three intrachain disulfide bridges. BST-2/Tetherin is an atypical type II transmembrane glycoprotein with an N-terminal transmembrane domain and a C-terminal glycophosphatidylinositol anchor, which dimerizes through three interchain bridges. We investigated spontaneous and Vpu-induced retro-translocation of CD4 and BST-2/Tetherin using our novel biotinylation technique in living cells to determine ER-to-cytosol retro-translocation of proteins. We found that CD4 retro-translocates with oxidized intrachain disulfide bridges, and only upon proteasomal inhibition does it accumulate in the cytosol as already reduced and deglycosylated molecules. Similarly, BST-2/Tetherin is first exposed to the cytosol as a dimeric oxidized complex and then becomes deglycosylated and reduced to monomers. These results raise questions on the required features of the putative retro-translocon, suggesting alternative retro-translocation mechanisms for membrane proteins in which complete cysteine reduction and unfolding are not always strictly required before ER to cytosol dislocation.	[Petris, Gianluca; Sasset, Linda; Cesaratto, Francesca; Bestagno, Marco; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Casini, Antonio; Cereseto, Anna] Univ Trento, Ctr Integrat Biol CIBIO, I-38123 Mattarello, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trento	Burrone, OR (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, Padriciano 99, I-34149 Trieste, Italy.	burrone@icgeb.org	Petris, Gianluca/N-9754-2018; Sasset, Linda/AAC-3131-2020	Petris, Gianluca/0000-0002-2420-6359; Sasset, Linda/0000-0001-5298-2374; Cereseto, Anna/0000-0003-4453-2597; Casini, Antonio/0000-0001-7709-4955	International Centre for Genetic Engineering and Biotechnology predoctoral fellowships	International Centre for Genetic Engineering and Biotechnology predoctoral fellowships	Supported by International Centre for Genetic Engineering and Biotechnology predoctoral fellowships.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Brady RL, 1996, CURR TOP MICROBIOL, V205, P1; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Li SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043328; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; LIU CC, 1995, IMMUNOL TODAY, V16, P194, DOI 10.1016/0167-5699(95)80121-9; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ng CL, 2010, EXP CELL RES, V316, P2113, DOI 10.1016/j.yexcr.2010.04.010; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Olzmann JA, 2011, J BIOL CHEM, V286, P27872, DOI 10.1074/jbc.C111.266452; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Praper T, 2011, J BIOL CHEM, V286, P2946, DOI 10.1074/jbc.M110.169417; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Sokolowska I, 2011, BIOCHEM J, V436, P371, DOI 10.1042/BJ20101493; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vecchi L, 2012, J BIOL CHEM, V287, P20007, DOI 10.1074/jbc.M112.355107; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang XL, 2013, J BIOL CHEM, V288, P23295, DOI 10.1074/jbc.M113.482018; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILLEY RL, 1992, J VIROL, V66, P226, DOI 10.1128/JVI.66.1.226-234.1992; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278	69	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					1	12		10.1074/jbc.M113.512368	http://dx.doi.org/10.1074/jbc.M113.512368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257748	Green Published, hybrid			2022-12-25	WOS:000329370900001
J	Ioannou, S; Ebisch, S; Aureli, T; Bafunno, D; Ioannides, HA; Cardone, D; Manini, B; Romani, GL; Gallese, V; Merla, A				Ioannou, Stephanos; Ebisch, Sjoerd; Aureli, Tiziana; Bafunno, Daniela; Ioannides, Helene Alexi; Cardone, Daniela; Manini, Barbara; Romani, Gian Luca; Gallese, Vittorio; Merla, Arcangelo			The Autonomic Signature of Guilt in Children: A Thermal Infrared Imaging Study	PLOS ONE			English	Article							YOUNG-CHILDREN; EMOTION; TEMPERATURE; RESPONSES; STRESS; SHAME; DETERMINANTS; HEMORRHAGE; COGNITION; STIMULI	So far inferences on early moral development and higher order self conscious emotions have mostly been based on behavioral data. Emotions though, as far as arguments support, are multidimensional notions. Not only do they involve behavioral actions upon perception of an event, but they also carry autonomic physiological markers. The current study aimed to examine and characterise physiological signs that underlie self-conscious emotions in early childhood, while grounding them on behavioral analyses. For this purpose, the "mishap paradigm'' was used as the most reliable method for evoking feelings of "guilt'' in children and autonomic facial temperature variation were detected by functional Infrared Imaging (fIRI). Fifteen children (age: 39-42 months) participated in the study. They were asked to play with a toy, falsely informed that it was the experimenter's "favourite'', while being unaware that it was pre-planned to break. Mishap of the toy during engagement caused sympathetic arousal as shown by peripheral nasal vasoconstriction leading to a marked temperature drop, compared to baseline. Soothing after the mishap phase induced an increase in nose temperature, associated with parasympathetic activity suggesting that the child's distress was neutralized, or even overcompensated. Behavioral analyses reported signs of distress evoked by the paradigm, backing up the thermal observation. The results suggest that the integration of physiological elements should be crucial in research concerning socio-emotional development. fIRI is a non invasive and non contact method providing a powerful tool for inferring early moral emotional signs based on physiological observations of peripheral vasoconstriction, while preserving an ecological and natural context.	[Ioannou, Stephanos; Gallese, Vittorio] Univ Parma, Sect Human Physiol, Dept Neurosci, I-43100 Parma, Italy; [Ioannou, Stephanos; Ebisch, Sjoerd; Bafunno, Daniela; Cardone, Daniela; Manini, Barbara; Romani, Gian Luca; Merla, Arcangelo] G dAnnunzio Fdn, Inst Adv Biomed Technol ITAB, Chieti, Italy; [Ioannou, Stephanos; Ebisch, Sjoerd; Aureli, Tiziana; Ioannides, Helene Alexi; Cardone, Daniela; Manini, Barbara; Romani, Gian Luca; Merla, Arcangelo] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy	University of Parma; G d'Annunzio University of Chieti-Pescara	Ioannou, S (corresponding author), Univ Parma, Sect Human Physiol, Dept Neurosci, I-43100 Parma, Italy.	stephanosioannou@gmail.com	Gallese, Vittorio/ABD-5097-2021; Cardone, Daniela/AAJ-2288-2021; Bafunno, Daniela/AAD-3868-2020	Gallese, Vittorio/0000-0003-4815-3607; Cardone, Daniela/0000-0002-1506-1995; Ioannou, Stephanos/0000-0003-4707-5993	Marie-Curie Initial Training Network, TESIS: Towards an Embodied Science of Inter-Subjectivity [264828]	Marie-Curie Initial Training Network, TESIS: Towards an Embodied Science of Inter-Subjectivity	This work was supported by the Marie-Curie Initial Training Network, TESIS: Towards an Embodied Science of Inter-Subjectivity (FP7-PEOPLE-2010-ITN, 264828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbar M, 2002, ANN NY ACAD SCI, V972, P111, DOI 10.1111/j.1749-6632.2002.tb04560.x; Baker E, 2012, DEV PSYCHOPATHOL, V24, P833, DOI 10.1017/S0954579412000399; Bard KA, 2009, CURR BIOL, V19, pR941, DOI 10.1016/j.cub.2009.09.037; Barrett K. C., 1998, GUILT CHILDREN, P75, DOI [10.1016/B978-012148610-5/50004-7, DOI 10.1016/B978-012148610-5/50004-7]; BARRETT KC, 1993, COGNITION EMOTION, V7, P481, DOI 10.1080/02699939308409201; BERGERSEN TK, 1993, ACTA PHYSIOL SCAND, V147, P195, DOI 10.1111/j.1748-1716.1993.tb09489.x; BLAIR RJR, 1995, PERS INDIV DIFFER, V19, P431, DOI 10.1016/0191-8869(95)00080-P; BUENO L, 1989, ENDOCRINOLOGY, V124, P1788, DOI 10.1210/endo-124-4-1788; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; CHIEN S, 1967, PHYSIOL REV, V47, P214, DOI 10.1152/physrev.1967.47.2.214; Cobos P, 2004, COGNITION EMOTION, V18, P281, DOI 10.1080/02699930244000471; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; COLE PM, 1992, CHILD DEV, V63, P314, DOI 10.1111/j.1467-8624.1992.tb01629.x; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; de Waal FBM, 2010, TRENDS COGN SCI, V14, P201, DOI 10.1016/j.tics.2010.03.003; DUTTON DG, 1974, J PERS SOC PSYCHOL, V30, P510, DOI 10.1037/h0037031; Ebisch SJ, 2012, BIOL PSYCHOL, V89, P123, DOI 10.1016/j.biopsycho.2011.09.018; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garbey M, 2007, IEEE T BIO-MED ENG, V54, P1418, DOI 10.1109/TBME.2007.891930; Gleeson M, 1998, INT J SPORTS MED, V19, pS96, DOI 10.1055/s-2007-971967; HADDY FJ, 1968, ANNU REV MED, V19, P167, DOI 10.1146/annurev.me.19.020168.001123; Hahn AC, 2012, BIOL LETTERS, V8, P864, DOI 10.1098/rsbl.2012.0338; Heims HC, 2004, NEUROPSYCHOLOGIA, V42, P1979, DOI 10.1016/j.neuropsychologia.2004.06.001; Hoffman M.L., 1983, SOCIAL COGNITION SOC, P236; Kamei T, 1998, ANAL CHIM ACTA, V365, P319, DOI 10.1016/S0003-2670(97)00642-9; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Kistler A, 1998, INT J PSYCHOPHYSIOL, V29, P35, DOI 10.1016/S0167-8760(97)00087-1; KOCHANSKA G, 1993, CHILD DEV, V64, P325, DOI 10.2307/1131254; KOCHANSKA G, 1994, DEV PSYCHOL, V30, P20, DOI 10.1037/0012-1649.30.1.20; Kochanska G, 1995, CHILD DEV, V66, P1752, DOI 10.1111/j.1467-8624.1995.tb00963.x; Kochanska G, 2002, CHILD DEV, V73, P461, DOI 10.1111/1467-8624.00418; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; Levenson R. W., 1988, SOCIAL PSYCHOPHYSIOL, P17; Lewis, 1992, SHAME EXPOSED SELF; Lewis M, 2002, CHILD DEV, V73, P1034, DOI 10.1111/1467-8624.00455; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Merla A, 2007, P ANN INT IEEE EMBS, P247, DOI 10.1109/IEMBS.2007.4352270; Miceli M, 2003, NEW IDEAS PSYCHOL, V21, P247, DOI 10.1016/j.newideapsych.2003.09.001; Mills RSL, 2008, DEV PSYCHOL, V44, P1369, DOI 10.1037/a0013150; NAEMURA A, 1993, JPN J PSYCHOL, V64, P51, DOI 10.4992/jjpsy.64.51; Nakanishi R, 2008, INFANT BEHAV DEV, V31, P137, DOI 10.1016/j.infbeh.2007.09.001; Nakayama K, 2005, PHYSIOL BEHAV, V84, P783, DOI 10.1016/j.physbeh.2005.03.009; Nhan BR, 2010, IEEE T BIO-MED ENG, V57, P979, DOI 10.1109/TBME.2009.2035926; Or Calvin K. L., 2007, Occupational Ergonomics, V7, P83; Pavlidis I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00305; PEARCE WJ, 1980, STROKE, V11, P190, DOI 10.1161/01.STR.11.2.190; PORGES SW, 1992, PEDIATRICS, V90, P498; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Radke-Yarrow M., 1984, DEV MAINTENANCE PROS, P81, DOI 10.1007/978-1-4613-2645-8; Radke-Yarrow M., 1982, DEV PROSOCIAL BEHAV, P109; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Shastri D, 2009, IEEE T BIO-MED ENG, V56, P477, DOI 10.1109/TBME.2008.2003265; Tangney JP, 1998, J PERS SOC PSYCHOL, V75, P256, DOI 10.1037/0022-3514.75.1.256; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; van Reekum CM, 2004, COGNITION EMOTION, V18, P663, DOI 10.1080/02699930341000167; VATNER SF, 1974, J CLIN INVEST, V54, P225, DOI 10.1172/JCI107757; ZAHNWAXLER C, 1979, CHILD DEV, V50, P319, DOI 10.1111/j.1467-8624.1979.tb04112.x	64	64	65	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79440	10.1371/journal.pone.0079440	http://dx.doi.org/10.1371/journal.pone.0079440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LO	24260220	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900022
J	Klein, CC; Alves, JMP; Serrano, MG; Buck, GA; Vasconcelos, ATR; Sagot, MF; Teixeira, MMG; Camargo, EP; Motta, MCM				Klein, Cecilia C.; Alves, Joao M. P.; Serrano, Myrna G.; Buck, Gregory A.; Vasconcelos, Ana Tereza R.; Sagot, Marie-France; Teixeira, Marta M. G.; Camargo, Erney P.; Motta, Maria Cristina M.			Biosynthesis of Vitamins and Cofactors in Bacterium-Harbouring Trypanosomatids Depends on the Symbiotic Association as Revealed by Genomic Analyses	PLOS ONE			English	Article							CRITHIDIA STRIGOMONAS ONCOPELTI; BLASTOCRITHIDIA-CULICIS; DIHYDRONEOPTERIN TRIPHOSPHATE; NUTRITIONAL-REQUIREMENTS; METABOLIC PATHWAYS; GROWTH; ENDOSYMBIONTS; SEQUENCE; EVOLUTION; PROTOZOA	Some non-pathogenic trypanosomatids maintain a mutualistic relationship with a betaproteobacterium of the Alcaligenaceae family. Intensive nutritional exchanges have been reported between the two partners, indicating that these protozoa are excellent biological models to study metabolic co-evolution. We previously sequenced and herein investigate the entire genomes of five trypanosomatids which harbor a symbiotic bacterium (SHTs for Symbiont-Haboring Trypanosomatids) and the respective bacteria (TPEs for Trypanosomatid Proteobacterial Endosymbiont), as well as two trypanosomatids without symbionts (RTs for Regular Trypanosomatids), for the presence of genes of the classical pathways for vitamin biosynthesis. Our data show that genes for the biosynthetic pathways of thiamine, biotin, and nicotinic acid are absent from all trypanosomatid genomes. This is in agreement with the absolute growth requirement for these vitamins in all protozoa of the family. Also absent from the genomes of RTs are the genes for the synthesis of pantothenic acid, folic acid, riboflavin, and vitamin B-6. This is also in agreement with the available data showing that RTs are auxotrophic for these essential vitamins. On the other hand, SHTs are autotrophic for such vitamins. Indeed, all the genes of the corresponding biosynthetic pathways were identified, most of them in the symbiont genomes, while a few genes, mostly of eukaryotic origin, were found in the host genomes. The only exceptions to the latter are: the gene coding for the enzyme ketopantoate reductase (EC:1.1.1.169) which is related instead to the Firmicutes bacteria; and two other genes, one involved in the salvage pathway of pantothenic acid and the other in the synthesis of ubiquinone, that are related to Gammaproteobacteria. Their presence in trypanosomatids may result from lateral gene transfer. Taken together, our results reinforce the idea that the low nutritional requirement of SHTs is associated with the presence of the symbiotic bacterium, which contains most genes for vitamin production.	[Klein, Cecilia C.; Sagot, Marie-France] INRIA Grenoble Rhone Alpes, BAMBOO Team, Villeurbanne, France; [Klein, Cecilia C.; Sagot, Marie-France] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR5558, F-69622 Villeurbanne, France; [Klein, Cecilia C.; Vasconcelos, Ana Tereza R.] Lab Nacl Comp Cientif, Petropolis, RJ, Brazil; [Alves, Joao M. P.; Teixeira, Marta M. G.; Camargo, Erney P.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [Serrano, Myrna G.; Buck, Gregory A.] Virginia Commonwealth Univ, Richmond, VA USA; [Motta, Maria Cristina M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Laboratorio Nacional de Computacao Cientifica (LNCC); Universidade de Sao Paulo; Virginia Commonwealth University; Universidade Federal do Rio de Janeiro	Klein, CC (corresponding author), INRIA Grenoble Rhone Alpes, BAMBOO Team, Villeurbanne, France.	cecilia.coimbra-klein@univ-lyon1.fr; motta@biof.ufrj.br	Motta, Maria Cristina M/I-3140-2014; Teixeira, Marta M G/B-1115-2009; Vasconcelos, Ana Tereza R/I-1011-2012; Camargo, Erney/A-6765-2009; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Klein, Cecilia C/H-7019-2015; Alves, Joao M.P./G-8927-2011	Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Camargo, Erney/0000-0003-0011-5871; Klein, Cecilia C/0000-0001-9736-5994; Alves, Joao M.P./0000-0001-5914-2087; /0000-0002-5933-9960; Motta, Maria Cristina/0000-0002-0947-4830	European Research Council under the European Community/ERC [[247073]10]; French project ANR MIRI [BLAN08-1335497]; FAPERJ; FAPERJ-INRIA project RAMPA; Laboratoire International Associe (LIA) LIRIO; Marie-France Sagot (LBBE, UCBL-CNRS-INRIA, France); National Science Foundation[USA] [NSF DEB-0830056]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)	European Research Council under the European Community/ERC(European Research Council (ERC)); French project ANR MIRI(French National Research Agency (ANR)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ-INRIA project RAMPA; Laboratoire International Associe (LIA) LIRIO; Marie-France Sagot (LBBE, UCBL-CNRS-INRIA, France); National Science Foundation[USA](National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research leading to these results was funded by: the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement n<SUP>omicron</SUP>[247073]10; the French project ANR MIRI BLAN08-1335497; FAPERJ grant coordinated by Dr. Cristina Motta and the FAPERJ-INRIA project RAMPA; by the Laboratoire International Associe (LIA) LIRIO co-coordinated by Ana Tereza R. de Vasconcelos (Labinfo, LNCC, Brazil) and Marie-France Sagot (LBBE, UCBL-CNRS-INRIA, France); the National Science Foundation [USA, grant number NSF DEB-0830056 to Gregory Buck]; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) to Cristina Motta, Marta M. G. Teixeira and Erney P. Camargo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Alves JMP, 2013, BMC EVOL BI IN PRESS; Alves JMP, 2007, CHEM BIODIVERS, V4, P2593, DOI 10.1002/cbdv.200790212; Alves JMP, 2013, GENOME BIOL EVOL, V5, P338, DOI 10.1093/gbe/evt012; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; Bacher A, 2001, VITAM HORM, V61, P1; Begley TP, 1998, TOP CURR CHEM, V195, P93; Begley TP, 2001, VITAM HORM, V61, P103; Begley TP, 2001, VITAM HORM, V61, P157; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; CHANG KP, 1974, J PROTOZOOL, V21, P699, DOI 10.1111/j.1550-7408.1974.tb03733.x; CHANG KP, 1975, J PROTOZOOL, V22, P271, DOI 10.1111/j.1550-7408.1975.tb05866.x; CHANG KP, 1974, SCIENCE, V183, P531, DOI 10.1126/science.183.4124.531; COWPERTHWAITE J, 1953, ANN NY ACAD SCI, V56, P972, DOI 10.1111/j.1749-6632.1953.tb30277.x; DEMENEZES MCND, 1991, J PROTOZOOL, V38, P122; Donlin Maureen J, 2009, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0909s28; Drewke C, 2001, VITAM HORM, V61, P121; DU YB, 1994, P NATL ACAD SCI USA, V91, P8437, DOI 10.1073/pnas.91.18.8437; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FIORINI JE, 1989, MEM I OSWALDO CRUZ, V84, P69, DOI 10.1590/S0074-02761989000100013; FREYMULLER E, 1981, J PROTOZOOL, V28, P175, DOI 10.1111/j.1550-7408.1981.tb02829.x; Gabelli SB, 2007, STRUCTURE, V15, P1014, DOI 10.1016/j.str.2007.06.018; Gazanion E, 2011, MOL MICROBIOL, V82, P21, DOI 10.1111/j.1365-2958.2011.07799.x; GILL JW, 1963, J PROTOZOOL, V10, P148, DOI 10.1111/j.1550-7408.1963.tb01653.x; GUTTMAN HN, 1966, J PROTOZOOL, V13, P390, DOI 10.1111/j.1550-7408.1966.tb01926.x; GUTTMAN HN, 1965, NATURE, V206, P113, DOI 10.1038/206113a0; Guttman HN, 1962, PTER CHEM P, P255; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; HUTNER SH, 1980, NUTR REV, V38, P361, DOI 10.1111/j.1753-4887.1980.tb05942.x; Hutner SH, 1979, BIOL KINETOPLASTIDA, P645; KIDDER GW, 1958, J GEN MICROBIOL, V18, P621, DOI 10.1099/00221287-18-3-621; Klaus SMJ, 2005, J BIOL CHEM, V280, P5274, DOI 10.1074/jbc.M413759200; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Lwoff M, 1940, RECHERCHES POUVOIR S; Motta MCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060209; Motta MCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012415; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Motta Maria Cristina M., 2010, Open Parasitology Journal, V4, P139; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; MUNDIM MH, 1977, J PROTOZOOL, V24, P329, DOI 10.1111/j.1550-7408.1977.tb00988.x; MUNDIM MH, 1974, J PROTOZOOL, V21, P518, DOI 10.1111/j.1550-7408.1974.tb03691.x; NATHAN HA, 1960, NATURE, V188, P35, DOI 10.1038/188035a0; NATHAN HA, 1956, NATURE, V178, P741, DOI 10.1038/178741a0; NATHAN HA, 1955, J PROTOZOOL, V2, P37, DOI 10.1111/j.1550-7408.1955.tb02394.x; NEWTON BA, 1956, NATURE, V177, P279, DOI 10.1038/177279b0; NEWTON BA, 1957, J GEN MICROBIOL, V17, P708, DOI 10.1099/00221287-17-3-708; Noguchi H, 1926, J EXP MED, V44, P307, DOI 10.1084/jem.44.3.307; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; RANGANATHAN G, 1995, INT J PARASITOL, V25, P279, DOI 10.1016/0020-7519(94)00131-7; ROITMAN C, 1972, J PROTOZOOL, V19, P346, DOI 10.1111/j.1550-7408.1972.tb03473.x; Roitman I., 1985, Parasitology Today, V1, P143, DOI 10.1016/0169-4758(85)90060-2; SILVA PMFE, 1991, J PROTOZOOL, V38, P489, DOI 10.1111/j.1550-7408.1991.tb04822.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Teixeira MMG, 2011, PROTIST, V162, P503, DOI 10.1016/j.protis.2011.01.001; Vickers TJ, 2011, ESSAYS BIOCHEM, V51, P63, DOI [10.1042/BSE0510063, 10.1042/bse0510063]; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Yang Y, 1998, J BACTERIOL, V180, P4294, DOI 10.1128/JB.180.16.4294-4299.1998; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	64	39	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79786	10.1371/journal.pone.0079786	http://dx.doi.org/10.1371/journal.pone.0079786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260300	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900046
J	Kurosu, T; Nagao, T; Wu, N; Oshikawa, G; Miura, O				Kurosu, Tetsuya; Nagao, Toshikage; Wu, Nan; Oshikawa, Gaku; Miura, Osamu			Inhibition of the PI3K/Akt/GSK3 Pathway Downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD Downregulates DNA Damage-Induced Chk1 Activation as Well as G2/M Arrest and Prominently Enhances Induction of Apoptosis	PLOS ONE			English	Article							CHECKPOINT ACTIVATION; HEMATOPOIETIC-CELLS; KINASE INHIBITORS; POTENT INHIBITORS; MYELOID-LEUKEMIA; PHASE-I; SORAFENIB; MUTATIONS; THERAPY; TRIAL	Constitutively-activated tyrosine kinase mutants, such as BCR/ABL, FLT3-ITD, and Jak2-V617F, play important roles in pathogenesis of hematopoietic malignancies and in acquisition of therapy resistance. We previously found that hematopoietic cytokines enhance activation of the checkpoint kinase Chk1 in DNA-damaged hematopoietic cells by inactivating GSK3 through the PI3K/Akt signaling pathway to inhibit apoptosis. Here we examine the possibility that the kinase mutants may also protect DNA-damaged cells by enhancing Chk1 activation. In cells expressing BCR/ABL, FLT3-ITD, or Jak2-V617F, etoposide induced a sustained activation of Chk1, thus leading to the G2/M arrest of cells. Inhibition of these kinases by their inhibitors, imatinib, sorafenib, or JakI-1, significantly abbreviated Chk1 activation, and drastically enhanced apoptosis induced by etoposide. The PI3K inhibitor GD-0941 or the Akt inhibitor MK-2206 showed similar effects with imatinib on etoposide-treated BCR/ABL-expressing cells, including those expressing the imatinib-resistant T315I mutant, while expression of the constitutively activated Akt1-myr mutant conferred resistance to the combined treatment of etoposide and imatinib. GSK3 inhibitors, including LiCl and SB216763, restored the sustained Chk1 activation and mitigated apoptosis in cells treated with etoposide and the inhibitors for aberrant kinases, PI3K, or Akt. These observations raise a possilibity that the aberrant kinases BCR/ABL, FLT3-ITD, and Jak2-V617F may prevent apoptosis induced by DNA-damaging chemotherapeutics, at least partly through enhancement of the Chk1-mediated G2/M checkpoint activation, by inactivating GSK3 through the PI3K/Akt signaling pathway. These results shed light on the molecular mechanisms for chemoresistance of hematological malignancies and provide a rationale for the combined treatment with chemotherapy and the tyrosine kinase or PI3K/Akt pathway inhibitors against these diseases.	[Kurosu, Tetsuya; Nagao, Toshikage; Wu, Nan; Oshikawa, Gaku; Miura, Osamu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Miura, O (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan.	miura.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054	Ministry of Education, Culture, Sports, Science and Technology of Japan [21591194, 24591384, 22591030, 24790966]; Grants-in-Aid for Scientific Research [24790966] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from Ministry of Education, Culture, Sports, Science and Technology of Japan (grant numbers 21591194, 24591384, 22591030, and 24790966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Henry MK, 2001, BLOOD, V98, P834, DOI 10.1182/blood.V98.3.834; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; Jin ZH, 2005, ONCOGENE, V24, P1973, DOI 10.1038/sj.onc.1208408; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Karp JE, 2012, CLIN CANCER RES, V18, P6723, DOI 10.1158/1078-0432.CCR-12-2442; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; King FW, 2004, CELL CYCLE, V3, P634; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; Kurosu T, 2007, ONCOGENE, V26, P2975, DOI 10.1038/sj.onc.1210117; Kurosu T, 2009, CANCER RES, V69, P3927, DOI 10.1158/0008-5472.CAN-08-2978; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Li P, 2012, MOL BIOL CELL, V23, P1582, DOI 10.1091/mbc.E11-10-0883; Lierman E, 2007, HAEMATOL-HEMATOL J, V92, P27, DOI 10.3324/haematol.10692; Markman B, 2010, ANN ONCOL, V21, P683, DOI 10.1093/annonc/mdp347; Mathisen MS, 2011, CURR HEMATOL MALIG R, V6, P187, DOI 10.1007/s11899-011-0093-y; Maugeri-Sacca M, 2013, CANCER TREAT REV, V39, P525, DOI 10.1016/j.ctrv.2012.10.007; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; MIURA O, 1993, MOL CELL BIOL, V13, P1788, DOI 10.1128/MCB.13.3.1788; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027397; Nimbalkar D, 2008, CELL CYCLE, V7, P2877, DOI 10.4161/cc.7.18.6675; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; Oshikawa G, 2011, J BIOL CHEM, V286, P30263, DOI 10.1074/jbc.M111.232348; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Quintas-Cardama A, 2011, NAT REV DRUG DISCOV, V10, P127, DOI 10.1038/nrd3264; Ray-David H, 2013, ONCOGENE IN PRESS; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Tonic I, 2010, J BIOL CHEM, V285, P23790, DOI 10.1074/jbc.M110.104372; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Witherington J, 2003, BIOORG MED CHEM LETT, V13, P1581, DOI 10.1016/S0960-894X(03)00135-5; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Xu NH, 2010, J CELL BIOL, V190, P297, DOI 10.1083/jcb.201003004; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263	40	30	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79478	10.1371/journal.pone.0079478	http://dx.doi.org/10.1371/journal.pone.0079478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260231	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500065
J	Mrizova, K; Jiskrova, E; Vyroubalova, S; Novak, O; Ohnoutkova, L; Pospisilova, H; Frebort, I; Harwood, WA; Galuszka, P				Mrizova, Katarina; Jiskrova, Eva; Vyroubalova, Sarka; Novak, Ondrej; Ohnoutkova, Ludmila; Pospisilova, Hana; Frebort, Ivo; Harwood, Wendy A.; Galuszka, Petr			Overexpression of Cytokinin Dehydrogenase Genes in Barley (Hordeum vulgare cv. Golden Promise) Fundamentally Affects Morphology and Fertility	PLOS ONE			English	Article							TRANSGENIC BARLEY; ARABIDOPSIS; EXPRESSION; OXIDASE; TRANSFORMATION; METABOLISM; PROMOTERS; GROWTH; PLANTS; WHEAT	Barley is one of the most important cereal crops grown worldwide. It has numerous applications, but its utility could potentially be extended by genetically manipulating its hormonal balances. To explore some of this potential we identified gene families of cytokinin dehydrogenases (CKX) and isopentenyl transferases, enzymes that respectively irreversibly degrade and synthesize cytokinin (CK) plant hormones, in the raw sequenced barley genome. We then examined their spatial and temporal expression patterns by immunostaining and qPCR. Two CKX-specific antibodies, anti-HvCKX1 and anti-HvCKX9, predominantly detect proteins in the aleurone layer of maturing grains and leaf vasculature, respectively. In addition, two selected CKX genes were used for stable, Agrobacterium tumefaciens-mediated transformation of the barley cultivar Golden Promise. The results show that constitutive overexpression of CKX causes morphological changes in barley plants and prevents their transition to flowering. In all independent transgenic lines roots proliferated more rapidly and root-to-shoot ratios were higher than in wild-type plants. Only one transgenic line, overexpressing CKX under the control of a promoter from a phosphate transporter gene, which is expressed more strongly in root tissue than in aerial parts, yielded progeny. Analysis of several T1-generation plants indicates that plants tend to compensate for effects of the transgene and restore CK homeostasis later during development. Depleted CK levels during early phases of development are restored by down-regulation of endogenous CKX genes and reinforced de novo biosynthesis of CKs.	[Mrizova, Katarina; Jiskrova, Eva; Vyroubalova, Sarka; Ohnoutkova, Ludmila; Pospisilova, Hana; Frebort, Ivo; Galuszka, Petr] Palacky Univ, Dept Mol Biol, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Novak, Ondrej] Palacky Univ, Lab Growth Regulatory, CR-77147 Olomouc, Czech Republic; [Novak, Ondrej] Inst Expt Bot, Olomouc, Czech Republic; [Harwood, Wendy A.] John Innes Ctr Plant Sci Res, Dept Crop Genet, Norwich NR4 7UH, Norfolk, England	Palacky University Olomouc; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Galuszka, P (corresponding author), Palacky Univ, Dept Mol Biol, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic.	petr.galuszka@upol.cz	Frébort, Ivo/G-6382-2018; NOVAK, Ondrej/F-7031-2014; Ohnoutková, Ludmila/H-4105-2014	Frébort, Ivo/0000-0002-4032-4961; NOVAK, Ondrej/0000-0003-3452-0154; Mikova, Eva/0000-0002-2471-0280; Harwood, Wendy/0000-0002-4323-9009	Czech Ministry of Education Youth and Sports [OP RDI ED0007/01/01]; National Science Foundation, Czech Republic [P501/10/1141]; Grant Agency of the Academy of Science, Czech Republic [IAA601370901]	Czech Ministry of Education Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); National Science Foundation, Czech Republic(Czech Republic Government); Grant Agency of the Academy of Science, Czech Republic(Grant Agency of the Czech Republic)	This work was supported by the Czech Ministry of Education Youth and Sports (grant number OP RD&I ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research), the National Science Foundation, Czech Republic (grant number P501/10/1141) and the Grant Agency of the Academy of Science, Czech Republic (grant number IAA601370901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bartlett JG, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-22; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bilyeu KD, 2001, PLANT PHYSIOL, V125, P378, DOI 10.1104/pp.125.1.378; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho MJ, 1998, PLANT SCI, V138, P229, DOI 10.1016/S0168-9452(98)00162-9; Chu ZX, 2011, GENET MOL RES, V10, P3316, DOI 10.4238/2011.December.8.3; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dunwell Jim M., 2009, V478, P333, DOI 10.1007/978-1-59745-379-0_20; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; Frebort I, 2002, ANAL BIOCHEM, V306, P1, DOI 10.1006/abio.2002.5670; Furtado A, 2008, PLANT BIOTECHNOL J, V6, P679, DOI 10.1111/j.1467-7652.2008.00352.x; Furtado A, 2009, PLANT BIOTECHNOL J, V7, P240, DOI 10.1111/j.1467-7652.2008.00394.x; Galuszka P, 2004, EUR J BIOCHEM, V271, P3990, DOI 10.1111/j.1432-1033.2004.04334.x; Galuszka P, 2001, EUR J BIOCHEM, V268, P450, DOI 10.1046/j.1432-1033.2001.01910.x; Hensel G, 2011, GENETIC TRANSFORMATION, P171; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang S, 2003, PLANT PHYSIOL, V131, P1270, DOI 10.1104/pp.102.018598; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Lara MEB, 2004, PLANT CELL, V16, P1276, DOI 10.1105/tpc.018929; Lomin SN, 2011, J EXP BOT, V62, P5149, DOI 10.1093/jxb/err220; Mameaux S, 2012, PLANT BIOTECHNOL J, V10, P67, DOI 10.1111/j.1467-7652.2011.00645.x; Morris RO, 1997, ADV CELL MOL BIOL PL, V4, P117; Novak O, 2003, ANAL CHIM ACTA, V480, P207, DOI 10.1016/S0003-2670(03)00025-4; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; Nuutila AM, 1999, PLANT MOL BIOL, V41, P777, DOI 10.1023/A:1006318206471; Podlesakova K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039293; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schunmann PHD, 2004, PLANT PHYSIOL, V136, P4205, DOI 10.1104/pp.104.045823; Smehilova M, 2009, J EXP BOT, V60, P2701, DOI 10.1093/jxb/erp126; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Vyroubalova S, 2011, BIOL PLANTARUM, V55, P213, DOI 10.1007/s10535-011-0032-8; Vyroubalova S, 2009, PLANT PHYSIOL, V151, P433, DOI 10.1104/pp.109.142489; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Werner T, 2008, J EXP BOT, V59, P2659, DOI 10.1093/jxb/ern134; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Wulfetange K, 2011, PLANT PHYSIOL, V156, P1808, DOI 10.1104/pp.111.180539; Ye XD, 2008, TRANSGENIC RES, V17, P827, DOI 10.1007/s11248-008-9169-4; Zalabak D, 2013, BIOTECHNOL ADV, V31, P97, DOI 10.1016/j.biotechadv.2011.12.003; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; Zatloukal M, 2008, BIOORGAN MED CHEM, V16, P9268, DOI 10.1016/j.bmc.2008.09.008	44	42	44	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79029	10.1371/journal.pone.0079029	http://dx.doi.org/10.1371/journal.pone.0079029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260147	gold, Green Submitted, Green Published			2022-12-25	WOS:000327258600015
J	Numata, S; Yasuda, M; Suzuki, RO; Hosaka, T; Noor, NSM; Fletcher, CD; Hashim, M				Numata, Shinya; Yasuda, Masatoshi; Suzuki, Ryo O.; Hosaka, Tetsuro; Noor, Nur Supardi Md.; Fletcher, Christine D.; Hashim, Mazlan			Geographical Pattern and Environmental Correlates of Regional-Scale General Flowering in Peninsular Malaysia	PLOS ONE			English	Article							DIPTEROCARP FORESTS; CLIMATE-CHANGE; EL-NINO; REPRODUCTIVE PHENOLOGY; ASEASONAL TROPICS; RAIN-FOREST; BORNEO; IMPACT; LONG; DIVERSITY	In South-East Asian dipterocarp forests, many trees synchronize their reproduction at the community level, but irregularly, in a phenomenon known as general flowering (GF). Several proximate cues have been proposed as triggers for the synchronization of Southeast Asian GF, but the debate continues, as many studies have not considered geographical variation in climate and flora. We hypothesized that the spatial pattern of GF forests is explained by previously proposed climatic cues if there are common cues for GF among regions. During the study, GF episodes occurred every year, but the spatial occurrence varied considerably from just a few forests to the whole of Peninsular Malaysia. In 2001, 2002 and 2005, minor and major GF occurred widely throughout Peninsular Malaysia (GF2001, GF2002, and GF2005), and the geographical patterns of GF varied between the episodes. In the three regional-scale GF episodes, most major events occurred in regions where prolonged drought (PD) had been recorded prior, and significant associations between GF scores and PD were found in GF2001 and GF2002. However, the frequency of PD was higher than that of GF throughout the peninsula. In contrast, low temperature (LT) was observed during the study period only before GF2002 and GF2005, but there was no clear spatial relationship between GF and LT in the regional-scale episodes. There was also no evidence that last GF condition influenced the magnitude of GF. Thus, our results suggest that PD would be essential to trigger regional-scale GF in the peninsula, but also that PD does not fully explain the spatial and temporal patterns of GF. The coarse relationships between GF and the proposed climatic cues may be due to the geographical variation in proximate cues for GF, and the climatic and floristic geographical variations should be considered to understand the proximate factors of GF.	[Numata, Shinya; Hosaka, Tetsuro] Tokyo Metropolitan Univ, Dept Tourism Sci, Tokyo 158, Japan; [Yasuda, Masatoshi] Kyushu Res Ctr, Forestry & Forest Prod Res Inst, Kumamoto, Japan; [Suzuki, Ryo O.] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano, Japan; [Noor, Nur Supardi Md.; Fletcher, Christine D.] Forest Res Inst Malaysia, Div Forestry, Kepong, Selangor, Malaysia; [Hashim, Mazlan] Univ Teknol Malaysia, Inst Geospatial Sci & Technol, Skudai, Johor Bahru, Malaysia	Tokyo Metropolitan University; Forestry & Forest Products Research Institute - Japan; University of Tsukuba; Institute Penyelidikan Perhutanan Malaysia; Universiti Teknologi Malaysia	Numata, S (corresponding author), Tokyo Metropolitan Univ, Dept Tourism Sci, Tokyo 158, Japan.	nmt@tmu.ac.jp	Hosaka, Tetsuro/I-2847-2018; Hashim, Mazlan/J-7291-2012	Hashim, Mazlan/0000-0001-8284-3332	Environment Research and Technology Development Fund of Ministry of the Environment of Japan [RFd-1101]	Environment Research and Technology Development Fund of Ministry of the Environment of Japan	This study was financially supported by a grant from the Environment Research and Technology Development Fund of Ministry of the Environment of Japan (RFd-1101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPANAH S, 1993, J BIOSCIENCES, V18, P457, DOI 10.1007/BF02703079; ASHTON PS, 1988, ANNU REV ECOL SYST, V19, P347, DOI 10.1146/annurev.es.19.110188.002023; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Brearley FQ, 2007, J ECOL, V95, P828, DOI 10.1111/j.1365-2745.2007.01258.x; Burgess P. F., 1972, Malayan Forester, V35, P103; Cannon CH, 2007, ECOL LETT, V10, P956, DOI 10.1111/j.1461-0248.2007.01089.x; Cheang B-k, 1993, J EARTH SYST SCI, V102, P219; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Corlett RT., 2009, ECOLOGY TROPICAL E A; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DALE WL, 1959, J TROP GEOGR, V13, P23; DALE WL, 1960, J TROP GEOGR, V14, P11; Desa MMN, 1996, HYDROLOG SCI J, V41, P345, DOI 10.1080/02626669609491507; Doi H, 2008, GLOBAL ECOL BIOGEOGR, V17, P556, DOI 10.1111/j.1466-8238.2008.00398.x; Doi H, 2010, GLOBAL CHANGE BIOL, V16, P373, DOI 10.1111/j.1365-2486.2009.01993.x; Foxworthy F. W., 1932, MALAYAN FOREST RECOR, V10; Gomyo M, 2009, SOLA, V5, P41, DOI 10.2151/sola.2009-011; Hamann A, 2004, J ECOL, V92, P24, DOI 10.1111/j.1365-2745.2004.00845.x; Ichie T, 2013, ECOL RES, P1; Isagi Y, 1997, J THEOR BIOL, V187, P231, DOI 10.1006/jtbi.1997.0442; Kettle CJ, 2010, SCIENCE, V330, P584, DOI 10.1126/science.330.6004.584-a; Kishimoto-Yamada K, 2008, BIOTROPICA, V40, P600, DOI 10.1111/j.1744-7429.2008.00410.x; Malaysian Meteorological Department, 2009, CLIM CHANG SCEN MAL; Masaki T, 2008, POPUL ECOL, V50, P357, DOI 10.1007/s10144-008-0104-6; Medway FLSL, 1972, BIOL J LINN SOC, V4, P117; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Numata S, 2003, AM J BOT, V90, P1025, DOI 10.3732/ajb.90.7.1025; Numata S, 2004, FLOWER NEWSL, V37, P32; Numata S, 2012, J FOREST RES-JPN, V17, P378, DOI 10.1007/s10310-011-0308-z; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; Sakai S, 2006, AM J BOT, V93, P1134, DOI 10.3732/ajb.93.8.1134; Sasaki S., 1979, MALAYSIAN FORESTER, V42, P38; Satake A, 2002, ECOLOGY, V83, P993, DOI 10.1890/0012-9658(2002)083[0993:SLPEAA]2.0.CO;2; SORK VL, 1993, VEGETATIO, V108, P133; Suzuki W, 2005, FOREST ECOL MANAG, V205, P105, DOI 10.1016/j.foreco.2004.10.050; Symington CF, 2004, FORESTERS MANUAL DIP; Tangang FT, 2004, J CLIMATE, V17, P3616, DOI 10.1175/1520-0442(2004)017&lt;3616:MOMRA&gt;2.0.CO;2; Whitmore T.C., 1984, TROPICAL RAM FORESTS; Wich SA, 2000, J TROP ECOL, V16, P563, DOI 10.1017/S0266467400001577; Yap SK, 1990, REPROD ECOLOGY TROPI; Yasuda M, 1999, J TROP ECOL, V15, P437, DOI 10.1017/S0266467499000930	43	10	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79095	10.1371/journal.pone.0079095	http://dx.doi.org/10.1371/journal.pone.0079095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260159	Green Submitted, gold, Green Published			2022-12-25	WOS:000327258600020
J	Triana-Baltzer, G; Pavlicek, A; Goulart, A; Huang, H; Pirie-Shepherd, S; Levin, N				Triana-Baltzer, Gallen; Pavlicek, Adam; Goulart, Ariadne; Huang, Hanhua; Pirie-Shepherd, Steven; Levin, Nancy			Predictive Markers of Efficacy for an Angiopoietin-2 Targeting Therapeutic in Xenograft Models	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER; TIE2 RECEPTOR; CELL-CELL; ANGIOGENESIS; BEVACIZUMAB; EXPRESSION; PATHWAY; METASTASIS; BIOMARKERS	The clinical efficacy of anti-angiogenic therapies has been difficult to predict, and biomarkers that can predict responsiveness are sorely needed in this era of personalized medicine. CVX-060 is an angiopoietin-2 (Ang2) targeting therapeutic, consisting of two peptides that bind Ang2 with high affinity and specificity, covalently fused to a scaffold antibody. In order to optimize the use of this compound in the clinic the construction of a predictive model is described, based on the efficacy of CVX-060 in 13 cell line and 2 patient-derived xenograft models. Pretreatment size tumors from each of the models were profiled for the levels of 27 protein markers of angiogenesis, SNP haplotype in 5 angiogenesis genes, and somatic mutation status for 11 genes implicated in tumor growth and/or vascularization. CVX-060 efficacy was determined as tumor growth inhibition (TGI%) at termination of each study. A predictive statistical model was constructed based on the correlation of these efficacy data with the marker profiles, and the model was subsequently tested by prospective analysis in 11 additional models. The results reveal a range of CVX-060 efficacy in xenograft models of diverse tissue types (0-64% TGI, median = 27%) and define a subset of 3 proteins (Ang1, EGF, Emmprin), the levels of which may be predictive of TGI by Ang2 blockade. The direction of the associations is such that better efficacy correlates with high levels of target and low levels of compensatory/antagonizing molecules. This effort has revealed a set of candidate predictive markers for CVX-060 efficacy that will be further evaluated in ongoing clinical trials.	[Triana-Baltzer, Gallen; Goulart, Ariadne; Huang, Hanhua; Levin, Nancy] Pfizer Worldwide Res & Dev, CovX Res, San Diego, CA USA; [Pavlicek, Adam; Pirie-Shepherd, Steven] Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA	Pfizer; Pfizer	Pirie-Shepherd, S (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA.	Steven.Pirie-Shepherd@pfizer.com			Pfizer, Inc.	Pfizer, Inc.(Pfizer)	This work was supported by Pfizer, Inc. All authors were employees of Pfizer at the time of this work and played roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Bozec A, 2006, CURR OPIN ONCOL, V18, P330, DOI 10.1097/01.cco.0000228737.78003.06; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; di Tomaso E, 2011, CANCER RES, V71, P19, DOI 10.1158/0008-5472.CAN-10-2602; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Ferrara N, 2000, RECENT PROG HORM RES, V55, P15; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gerger A, 2011, CANCER J, V17, P134, DOI 10.1097/PPO.0b013e318212db3c; Giatromanolaki A, 2010, ANTICANCER RES, V30, P2831; Hanrahan EO, 2010, J CLIN ONCOL, V28, P193, DOI 10.1200/JCO.2009.22.4279; Herbst RS, 2005, J CLIN ONCOL, V23, P2544, DOI 10.1200/JCO.2005.02.477; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Huang HH, 2011, CLIN CANCER RES, V17, P1001, DOI 10.1158/1078-0432.CCR-10-2317; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Jahangiri A, 2012, BBA-REV CANCER, V1825, P86, DOI 10.1016/j.bbcan.2011.10.004; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Kim HZ, 2009, BBA-MOL CELL RES, V1793, P772, DOI 10.1016/j.bbamcr.2009.01.018; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marti HH, 2005, EXP SUPPL, V94, P163; Maxwell PH, 2001, ADV EXP MED BIOL, V502, P365; Monnier J, 2010, CANCER LETT, V296, P144, DOI 10.1016/j.canlet.2010.06.011; Newbold RF, 2010, ANTICANCER RES, V30, P3309; Newman JR, 2009, CANCER LETT, V274, P313, DOI 10.1016/j.canlet.2008.09.033; Pusztai L, 2007, CLIN CANCER RES, V13, P6080, DOI 10.1158/1078-0432.CCR-07-0809; Rosen LS, 2012, J CLIN ONCOL S, V30, P2; Rosen LS, 2010, J CLIN ONCOL S15S, V28; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Simon R, 2007, CANCER INFORM, V3, P11; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Voigt H, 2009, CANCER INVEST, V27, P329, DOI 10.1080/07357900802392675; Walter JW, 2002, GENE CHROMOSOME CANC, V33, P295, DOI 10.1002/gcc.10028; Wu WJ, 2007, MOL CANCER THER, V6, P471, DOI 10.1158/1535-7163.MCT-06-0416; Xu CF, 2011, J CLIN ONCOL, V29, P2557, DOI 10.1200/JCO.2010.32.9110; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	50	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80132	10.1371/journal.pone.0080132	http://dx.doi.org/10.1371/journal.pone.0080132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244628	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800126
J	Zhao, F; Huang, WW; Ousman, T; Zhang, B; Han, YY; Clotaire, DZJ; Wang, C; Chang, HH; Luo, HN; Ren, XY; Lei, M				Zhao, Fei; Huang, Weiwei; Ousman, Tamgue; Zhang, Bin; Han, Yangyang; Clotaire, Daguia Zambe John; Wang, Chen; Chang, Huanhuan; Luo, Huanan; Ren, Xiaoyong; Lei, Ming			Triptolide Induces Growth Inhibition and Apoptosis of Human Laryngocarcinoma Cells by Enhancing p53 Activities and Suppressing E6-Mediated p53 Degradation	PLOS ONE			English	Article							NATURAL-PRODUCT TRIPTOLIDE; RIBOSOMAL-PROTEIN L26; KAPPA-B ACTIVATION; CANCER CELLS; DNA-DAMAGE; IN-VITRO; CARCINOMA-CELLS; NUCLEAR-FACTOR; MESSENGER-RNA; PATHWAY	Triptolide, an active compound extracted from Chinese herb Leigongteng (Tripterygium wilfordii Hook F.), shows a broad-spectrum of anticancer activity through its cytotoxicity. However, the efficacy of triptolide on laryngocarcinoma rarely been evaluated, and the mechanism by which triptolide-induced cellular apoptosis is still not well understood. In this study, we found that triptolide significantly inhibited the laryngocarcinoma HEp-2 cells proliferation, migration and survivability. Triptolide induces HEp-2 cell cycle arrest at the G1 phase and apoptosis through intrinsic and extrinsic pathways since both caspase-8 and -9 are activated. Moreover, triptolide enhances p53 expression by increasing its stability via down-regulation of E6 and E6AP. Increased p53 transactivates down-stream target genes to initiate apoptosis. In addition, we found that short time treatment with triptolide induced DNA damage, which was consistent with the increase in p53. Furthermore, the cytotoxicity of triptolide is decreased by p53 knockdown or use of caspases inhibitor. In conclusion, our results demonstrated that triptolide inhibits cell proliferation and induces apoptosis in laryngocarcinoma cells by enhancing p53 expression and activating p53 functions through induction of DNA damage and suppression of E6 mediated p53 degradation. These studies indicate that triptolide is a potential anti-laryngocarcinoma drug.	[Zhao, Fei; Huang, Weiwei; Ousman, Tamgue; Zhang, Bin; Han, Yangyang; Clotaire, Daguia Zambe John; Wang, Chen; Lei, Ming] Northwest A&F Univ, Coll Life Sci, Key Lab Agr Mol Biol, Yangling, Shaanxi Provinc, Peoples R China; [Chang, Huanhuan; Luo, Huanan; Ren, Xiaoyong] Xi An Jiao Tong Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Xian 710049, Shaanxi Provinc, Peoples R China	Northwest A&F University - China; Xi'an Jiaotong University	Ren, XY (corresponding author), Xi An Jiao Tong Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Xian 710049, Shaanxi Provinc, Peoples R China.	renxiaoyong@vip.sina.com; leiming70@hotmail.com	Tamgue, Ousman/AAS-7640-2020; han, yang/GRS-2388-2022; haung, weiwei/M-8866-2019	Tamgue, Ousman/0000-0001-6991-8088; 	National Natural Science Foundation of China [61178084]; National Forestry Public Welfare Industry Research Project [201204603]; Second Hospital Xi'an JiaoTong University [YJ(ZD)201207]; Science and Technology Research and Development Project in Shaanxi province [2011K3-03-09]; Northwest AF University [Z111021306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Forestry Public Welfare Industry Research Project; Second Hospital Xi'an JiaoTong University; Science and Technology Research and Development Project in Shaanxi province; Northwest AF University	This work was supported by National Natural Science Foundation of China (61178084) and National Forestry Public Welfare Industry Research Project (201204603) to Ming lei; the Scientific Research Fund of the Second Hospital Xi'an JiaoTong University (YJ(ZD)201207) and Science and Technology Research and Development Project in Shaanxi province (2011K3-03-09) to Xiaoyong Ren; the Starting Resaerch Fund from Northwest A&F University (Z111021306) to Weiwei Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhim Z, 2013, ACTA OTO-LARYNGOL, V133, P761, DOI 10.3109/00016489.2013.773405; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bernard X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025981; Boyer SN, 1996, CANCER RES, V56, P4620; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carter BZ, 2012, LEUKEMIA, V26, P443, DOI 10.1038/leu.2011.246; Carter BZ, 2006, BLOOD, V108, P630, DOI 10.1182/blood-2005-09-3898; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chaturvedi AK, 2012, HEAD NECK PATHOL S1, V6, pS16, DOI [DOI 10.1007/s12105-012-0377-0, 10.1007/s12105-012-0377-0]; Chen J, 2012, J BIOL CHEM, V287, P16467, DOI 10.1074/jbc.M112.349274; Chueh FS, 2013, ONCOL REP, V29, P613, DOI 10.3892/or.2012.2170; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hellin AC, 1998, ONCOGENE, V16, P1187, DOI 10.1038/sj.onc.1201638; Howlader N, 2013, SEER CANC STAT REV; Hu XW, 2012, MOL BIOL REP, V39, P8763, DOI 10.1007/s11033-012-1737-2; Huang M, 2013, MOL CANCER THER, V12, P184, DOI 10.1158/1535-7163.MCT-12-0425; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jiang XH, 2001, ONCOGENE, V20, P8009, DOI 10.1038/sj.onc.1204981; Johnson SM, 2011, J SURG RES, V168, P197, DOI 10.1016/j.jss.2009.07.002; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kim MJ, 2010, INT J ONCOL, V37, P1177, DOI 10.3892/ijo_00000769; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kiviharju TM, 2002, CLIN CANCER RES, V8, P2666; Lee KY, 2002, EXP MOL MED, V34, P462, DOI 10.1038/emm.2002.64; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li JJ, 2011, ONCOL REP, V25, P979, DOI 10.3892/or.2011.1158; Lin J, 2007, J INT MED RES, V35, P637, DOI 10.1177/147323000703500508; Liu QY, 2011, INT IMMUNOPHARMACOL, V11, P377, DOI 10.1016/j.intimp.2011.01.012; Lu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035722; Manzo SG, 2012, CANCER RES, V72, P5363, DOI 10.1158/0008-5472.CAN-12-1006; Matsui Y, 2008, ONCOGENE, V27, P4603, DOI 10.1038/onc.2008.89; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Moll UM, 2003, MOL CANCER RES, V1, P1001; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Panichakul T, 2006, ANTICANCER RES, V26, P259; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Tan BJ, 2011, ONCOL REP, V26, P1315, DOI 10.3892/or.2011.1406; Tan W, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-27; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vilborg A, 2010, J MOL MED, V88, P645, DOI 10.1007/s00109-010-0609-2; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Vu HL, 2010, CANCER LETT, V288, P149, DOI 10.1016/j.canlet.2009.06.026; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Wang W, 2012, J INT MED RES, V40, P2284, DOI 10.1177/030006051204000626; Wang W, 2007, CLIN CANCER RES, V13, P4891, DOI 10.1158/1078-0432.CCR-07-0416; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023993; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Yang SM, 2003, MOL CANCER THER, V2, P65; Zhao HX, 2012, EXP MOL MED, V44, P633, DOI 10.3858/emm.2012.44.11.072; Zhu WB, 2010, VASC PHARMACOL, V52, P46, DOI 10.1016/j.vph.2009.10.006; Zhu WB, 2009, ONCOL REP, V22, P1397, DOI 10.3892/or_00000580	59	22	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80784	10.1371/journal.pone.0080784	http://dx.doi.org/10.1371/journal.pone.0080784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244715	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800162
J	Acuna, LG; Cardenas, JP; Covarrubias, PC; Haristoy, JJ; Flores, R; Nunez, H; Riadi, G; Shmaryahu, A; Valdes, J; Dopson, M; Rawlings, DE; Banfield, JF; Holmes, DS; Quatrini, R				Acuna, Lillian G.; Pablo Cardenas, Juan; Covarrubias, Paulo C.; Jose Haristoy, Juan; Flores, Rodrigo; Nunez, Harold; Riadi, Gonzalo; Shmaryahu, Amir; Valdes, Jorge; Dopson, Mark; Rawlings, Douglas E.; Banfield, Jillian F.; Holmes, David S.; Quatrini, Raquel			Architecture and Gene Repertoire of the Flexible Genome of the Extreme Acidophile Acidithiobacillus caldus	PLOS ONE			English	Article							ARSENIC-RESISTANT STRAINS; ESCHERICHIA-COLI; THIOBACILLUS-CALDUS; MERCURY RESISTANCE; ALTEROMONAS-MACLEODII; METABOLIC VERSATILITY; HORIZONTAL TRANSFER; PSEUDOMONAS-PUTIDA; HEME-A; TOOL	Background: Acidithiobacillus caldus is a sulfur oxidizing extreme acidophile and the only known mesothermophile within the Acidithiobacillales. As such, it is one of the preferred microbes for mineral bioprocessing at moderately high temperatures. In this study, we explore the genomic diversity of A. caldus strains using a combination of bioinformatic and experimental techniques, thus contributing first insights into the elucidation of the species pangenome. Principal Findings: Comparative sequence analysis of A. caldus ATCC 51756 and SM-1 indicate that, despite sharing a conserved and highly syntenic genomic core, both strains have unique gene complements encompassing nearly 20% of their respective genomes. The differential gene complement of each strain is distributed between the chromosomal compartment, one megaplasmid and a variable number of smaller plasmids, and is directly associated to a diverse pool of mobile genetic elements (MGE). These include integrative conjugative and mobilizable elements, genomic islands and insertion sequences. Some of the accessory functions associated to these MGEs have been linked previously to the flexible gene pool in microorganisms inhabiting completely different econiches. Yet, others had not been unambiguously mapped to the flexible gene pool prior to this report and clearly reflect strain-specific adaption to local environmental conditions. Significance: For many years, and because of DNA instability at low pH and recurrent failure to genetically transform acidophilic bacteria, gene transfer in acidic environments was considered negligible. Findings presented herein imply that a more or less conserved pool of actively excising MGEs occurs in the A. caldus population and point to a greater frequency of gene exchange in this econiche than previously recognized. Also, the data suggest that these elements endow the species with capacities to withstand the diverse abiotic and biotic stresses of natural environments, in particular those associated with its extreme econiche.	[Acuna, Lillian G.; Pablo Cardenas, Juan; Covarrubias, Paulo C.; Jose Haristoy, Juan; Flores, Rodrigo; Nunez, Harold; Shmaryahu, Amir; Holmes, David S.; Quatrini, Raquel] Fdn Ciencia & Vida, Santiago, Chile; [Acuna, Lillian G.; Pablo Cardenas, Juan; Covarrubias, Paulo C.; Holmes, David S.; Quatrini, Raquel] Univ Andres Bello, Fac Ciencias Biol, Santiago, Chile; [Riadi, Gonzalo] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile; [Valdes, Jorge] Fraunhofer Chile, Ctr Syst Biotechnol, Santiago, Chile; [Dopson, Mark] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden; [Rawlings, Douglas E.] Univ Stellenbosch, Dept Microbiol, Matieland, South Africa; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Universidad Andres Bello; Universidad de Talca; Linnaeus University; Stellenbosch University; University of California System; University of California Berkeley	Quatrini, R (corresponding author), Fdn Ciencia & Vida, Santiago, Chile.	rquatrini@yahoo.com.ar	Riadi, Gonzalo/ABG-2144-2020; Dopson, Mark/A-7028-2013; Quatrini, Raquel/S-4099-2019; Valdes, Jorge/AAL-2779-2021; Quatrini, Raquel/GSD-7689-2022; Cardenas, Juan Pablo/AAB-2469-2020	Quatrini, Raquel/0000-0003-2600-2605; Cardenas, Juan Pablo/0000-0001-6715-7270; Acuna, Lillian/0000-0002-9327-2122; Banfield, Jill/0000-0001-8203-8771; Holmes, David/0000-0001-9555-138X; Riadi, Gonzalo/0000-0002-7633-2365; Rawlings, Douglas/0000-0002-2521-8167	Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt [1100887, 1090451]; Programa de Financiamiento Basal de la Comision Nacional de Investigacion Cientifica y Tecnologica [PFB16]	Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Financiamiento Basal de la Comision Nacional de Investigacion Cientifica y Tecnologica(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	This work was supported by the Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt (http://www.conicyt.cl/fondecyt/) [grant numbers 1100887, 1090451], and the Programa de Financiamiento Basal de la Comision Nacional de Investigacion Cientifica y Tecnologica (http://www.conicyt.cl/pia/category/lineas-del-programa/creacion-consolidacion-centros/ [grant number PFB16]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aston JE, 2010, ENVIRON TOXICOL CHEM, V29, P2669, DOI 10.1002/etc.338; Auchtung JM, 2005, P NATL ACAD SCI USA, V102, P12554, DOI 10.1073/pnas.0505835102; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Bellanger X, 2007, J BACTERIOL, V189, P1478, DOI 10.1128/JB.01125-06; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bogdanova E, 2001, RES MICROBIOL, V152, P503, DOI 10.1016/S0923-2508(01)01224-4; Bruggemann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034171; Bugaytsova Z, 2004, EUR J BIOCHEM, V271, P272, DOI 10.1046/j.1432-1033.2003.03926.x; Bustamante P, 2012, J MOL MICROB BIOTECH, V22, P399, DOI 10.1159/000346669; CADIZ R, 1994, MOL MICROBIOL, V12, P165, DOI 10.1111/j.1365-2958.1994.tb01005.x; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cava F, 2004, J BIOL CHEM, V279, P45369, DOI 10.1074/jbc.M404785200; Chen LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039470; COLBEAU A, 1990, MOL GEN GENET, V220, P393, DOI 10.1007/BF00391744; Court DL, 2007, J BACTERIOL, V189, P298, DOI 10.1128/JB.01215-06; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Dopson M, 1999, APPL ENVIRON MICROB, V65, P36; Dopson M, 2003, MICROBIOL-SGM, V149, P1959, DOI 10.1099/mic.0.26296-0; Dopson M, 2002, EXTREMOPHILES, V6, P123, DOI 10.1007/s007920100231; Dopson M, 2001, EXTREMOPHILES, V5, P247, DOI 10.1007/s007920100196; Dwivedi B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-33; Edwards KJ, 2000, ENVIRON MICROBIOL, V2, P324, DOI 10.1046/j.1462-2920.2000.00111.x; Fernandez-Gomez B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-347; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; GORDON D, 2003, CURR PROTOC BIOINFOR, V11; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Greie JC, 2011, EUR J CELL BIOL, V90, P705, DOI 10.1016/j.ejcb.2011.04.011; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; HALLBERG KB, 1994, MICROBIOL-SGM, V140, P3451, DOI 10.1099/13500872-140-12-3451; Hallberg KB, 2010, EXTREMOPHILES, V71-73, P167; Hallberg KB, 2010, EXTREMOPHILES, V14, P9, DOI 10.1007/s00792-009-0282-y; Hamer R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-3; Hedrich S, 2013, INT J SYST IN PRESS; Hickey WJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00125; Holmes D.S., 1989, BIOHYDROMETALLURGY, P116; HORN JM, 1994, APPL ENVIRON MICROB, V60, P357, DOI 10.1128/AEM.60.1.357-362.1994; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jakes KS, 2010, MOL MICROBIOL, V75, P567, DOI 10.1111/j.1365-2958.2009.06966.x; KEIGHTLEY JA, 1995, J BIOL CHEM, V270, P20345, DOI 10.1074/jbc.270.35.20345; KELLY DP, 2005, BERGEYS MANUAL SYS B, V2, P60; Klughammer B, 1999, MOL MICROBIOL, V32, P1305, DOI 10.1046/j.1365-2958.1999.01457.x; KONDRATYEVA TF, 1995, MICROBIOL-UK, V141, P1157, DOI 10.1099/13500872-141-5-1157; Kotze AA, 2006, MICROBIOL-SGM, V152, P3551, DOI 10.1099/mic.0.29247-0; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Liu XM, 2007, J MICROBIOL BIOTECHN, V17, P162; Lopez-Perez M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00696; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maeda S, 2006, FEMS MICROBIOL LETT, V255, P115, DOI 10.1111/j.1574-6968.2005.00072.x; Mangold S, 2013, EXTREMOPHILES, V17, P75, DOI 10.1007/s00792-012-0495-3; Mangold S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00017; MARSH RM, 1983, FEMS MICROBIOL LETT, V17, P311; McGrath BM, 2005, FEMS MICROBIOL LETT, V243, P461, DOI 10.1016/j.femsle.2005.01.013; Mulder Nicola, 2007, V396, P59; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Ng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004695; Nguyen KT, 2010, J BACTERIOL, V192, P5134, DOI 10.1128/JB.00650-10; Ni YQ, 2008, FEMS MICROBIOL ECOL, V64, P248, DOI 10.1111/j.1574-6941.2008.00457.x; Nieto PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-63; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Osborn AM, 1997, FEMS MICROBIOL REV, V19, P239, DOI 10.1111/j.1574-6976.1997.tb00300.x; Osorio H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-203; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Portillo MC, 2009, J APPL GENET, V50, P421, DOI 10.1007/BF03195703; Qiu XY, 2006, P NATL ACAD SCI USA, V103, P19830, DOI 10.1073/pnas.0606810104; Rabsch W, 2007, J BACTERIOL, V189, P5658, DOI 10.1128/JB.00437-07; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rawlings DE, 2005, PLASMID, V53, P137, DOI 10.1016/j.plasmid.2005.01.001; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Riadi G, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/678761; Rodriguez-Valera Francisco, 2012, F1000Res, V1, P16, DOI 10.12688/f1000research.1-16.v1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Rzhepishevska OI, 2007, APPL ENVIRON MICROB, V73, P7367, DOI 10.1128/AEM.01497-07; Sakai D, 2002, J BACTERIOL, V184, P444, DOI 10.1128/JB.184.2.444-451.2002; Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001; Seed KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002917; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; SONE N, 1991, FEBS LETT, V288, P154, DOI 10.1016/0014-5793(91)81024-3; Soupene E, 2002, J BACTERIOL, V184, P3396, DOI 10.1128/JB.184.12.3396-3400.2002; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; SVENSSON B, 1993, MOL MICROBIOL, V10, P193, DOI 10.1111/j.1365-2958.1993.tb00915.x; Tapia P, 2012, J VIROL, V86, P12452, DOI 10.1128/JVI.02261-12; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tuffin IM, 2005, MICROBIOL-SGM, V151, P3027, DOI 10.1099/mic.0.28131-0; Valdes J, 2009, J BACTERIOL, V191, P5877, DOI 10.1128/JB.00843-09; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; van Zyl LJ, 2008, APPL ENVIRON MICROB, V74, P4300, DOI 10.1128/AEM.00864-08; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000439; Xia LX, 2010, J BASIC MICROB, V50, P591, DOI 10.1002/jobm.201000051; Yagi JM, 2009, ENVIRON MICROBIOL, V11, P2253, DOI 10.1111/j.1462-2920.2009.01947.x; Yan Q, 2012, MOL PLANT PATHOL, V13, P923, DOI 10.1111/j.1364-3703.2012.00800.x; You XY, 2011, J GENET GENOMICS, V38, P243, DOI 10.1016/j.jgg.2011.04.006; Zhang R, 2004, BIOINFORMATICS, V20, P612, DOI 10.1093/bioinformatics/btg453; Zhilenkov EL, 2006, VIROL J, V3, DOI 10.1186/1743-422x-3-50; ZIMMERMANN BH, 1988, P NATL ACAD SCI USA, V85, P5779, DOI 10.1073/pnas.85.16.5779	113	48	51	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78237	10.1371/journal.pone.0078237	http://dx.doi.org/10.1371/journal.pone.0078237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250794	gold, Green Published			2022-12-25	WOS:000327216200015
J	Frei, SM; Hemsley, C; Pesch, T; Lang, S; Weber, A; Jehle, E; Ruhl, A; Fried, M; Rogler, G; Scharl, M				Frei, Sandra Michaela; Hemsley, Colette; Pesch, Theresa; Lang, Silvia; Weber, Achim; Jehle, Ekkehard; Ruehl, Anne; Fried, Michael; Rogler, Gerhard; Scharl, Michael			The Role for Dickkopf-Homolog-1 in the Pathogenesis of Crohn's Disease-Associated Fistulae	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; ANTAGONIST DICKKOPF-1 GENE; HUMAN-COLON-CANCER; COLORECTAL-CANCER; BETA-CATENIN; EXPRESSION; PROGRESSION; INFLIXIMAB; CARCINOMA; PATHWAY	Background: One of the most challenging conditions in Crohn's disease (CD) patients is the treatment of perianal fistulae. We have recently shown that epithelial-to-mesenchymal transition (EMT) plays a crucial role during CD-fistulae development. Dickkopf-homolog 1 (DKK-1) is known to play a key role during EMT. Here, we investigated a role for DKK-1 in the pathogenesis of CD-associated fistulae. Methods: Dkk-1 protein expression in CD-fistula specimens were investigated by immunohistochemistry. Colonic lamina propria fibroblasts (CLPF) were obtained from either non-IBD control patients or patients with fistulizing CD. HT-29 intestinal epithelial cells (IEC) were either grown as monolayers or spheroids. Cells were treated with either TNF-alpha, TGF-beta or IL-13. Knock-down of DKK-1 or beta-Catenin was induced in HT-29-IEC by siRNA technique. mRNA expression was determined by real-time-PCR. Results: Dkk-1 protein was specifically expressed in transitional cells lining the fistula tracts. TGF-beta induced DKK-1 mRNA expression in HT-29-IEC, but decreased it in fistula CLPF. On a functional level, DKK-1 knock-down prevented TGF-beta-induced IL-13 mRNA expression in HT-29-IEC. Further, loss of beta-Catenin was accompanied by reduced levels of DKK-1 and, again, IL-13 in IEC in response to TGF-beta. In turn, treatment of HT-29-IEC as well as fistula CLPF with IL-13 resulted in decreased levels of DKK-1 mRNA. Treatment with TNF-alpha or the bacterial wall component, muramyl-dipeptide, decreased DKK-1 mRNA levels in HT-29-IEC, but enhanced it in fistula CLPF. Discussion: We demonstrate that DKK-1 is strongly expressed in cells lining the CD-fistula tracts and regulates factors involved in EMT initiation. These data provide evidence for a role of DKK-1 in the pathogenesis of CD-associated perianal fistulae.	[Frei, Sandra Michaela; Hemsley, Colette; Pesch, Theresa; Lang, Silvia; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Weber, Achim] Univ Zurich Hosp, Inst Surg Pathol, Dept Pathol, CH-8091 Zurich, Switzerland; [Jehle, Ekkehard] Oberschwaben Klin, Dept Surg, Ravensburg, Germany; [Weber, Achim; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Scharl, M (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	michael.scharl@usz.ch	Rogler, Gerhard/O-5308-2015	Rogler, Gerhard/0000-0002-1733-9188; Scharl, Michael/0000-0002-6729-1469; Weber, Achim/0000-0003-0073-3637	Fonds zur Forderung des akademischen Nachwuchses (FAN) of the Zurcher Universitatsverein (ZUNIV); Swiss Philanthropy Foundation; University of Zurich; Swiss National Science Foundation (SNF) [314730-146204, 310030-120312]; Swiss IBD Cohort [3347CO-108792]; Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich	Fonds zur Forderung des akademischen Nachwuchses (FAN) of the Zurcher Universitatsverein (ZUNIV); Swiss Philanthropy Foundation; University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss IBD Cohort; Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich	This research was supported by a grant from Fonds zur Forderung des akademischen Nachwuchses (FAN) of the Zurcher Universitatsverein (ZUNIV) to MS, a research grant from the Swiss Philanthropy Foundation to MS and GR, a research credit from the University of Zurich to MS, research grants from the Swiss National Science Foundation (SNF) to MS (grant number 314730-146204), GR (grant number 310030-120312) and the Swiss IBD Cohort (grant number 3347CO-108792) and by research grants from the Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich to MS and GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Bataille F, 2004, GUT, V53, P1314, DOI 10.1136/gut.2003.038208; Bataille F, 2008, INFLAMM BOWEL DIS, V14, P1514, DOI 10.1002/ibd.20590; Bates RC, 2005, CELL CYCLE, V4, P1350, DOI 10.4161/cc.4.10.2053; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Felley C, 2007, DIGESTION, V76, P109, DOI 10.1159/000111024; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Hamilton G, 1998, CANCER LETT, V131, P29, DOI 10.1016/S0304-3835(98)00198-0; HANAUER SB, 1993, AM J GASTROENTEROL, V88, P646; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koch S, 2009, MOL BIOL CELL, V20, P4816, DOI 10.1091/mbc.E09-05-0415; KORELITZ BI, 1985, DIGEST DIS SCI, V30, P58, DOI 10.1007/BF01318372; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; MICHELASSI F, 1993, ANN SURG, V218, P660, DOI 10.1097/00000658-199321850-00012; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Pendas-Franco N, 2008, ANTICANCER RES, V28, P2613; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Radlmayr M, 2002, GASTROENTEROLOGY, V122, P2091, DOI 10.1053/gast.2002.34020; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Scharl M, 2012, GUT; Scharl M, 2011, INFLAMM BOWEL DIS, V17, P1907, DOI [10.1002/ibd.21555, 10.1002/ibd.21913]; Schwartz DA, 2002, GASTROENTEROLOGY, V122, P875, DOI 10.1053/gast.2002.32362; Solomon MJ, 1996, INT J COLORECTAL DIS, V11, P222, DOI 10.1007/s003840050051; Sullivan DE, 2005, AM J RESP CELL MOL, V32, P342, DOI 10.1165/rcmb.2004-0288OC; Thiery JP, 2010, B CANCER, V97, P1285, DOI 10.1684/bdc.2010.1206; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78882	10.1371/journal.pone.0078882	http://dx.doi.org/10.1371/journal.pone.0078882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250816	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327216200049
J	Toet, A; van Schaik, M; Theunissen, NCM				Toet, Alexander; van Schaik, Martin; Theunissen, Nicolet C. M.			No Effect of Ambient Odor on the Affective Appraisal of a Desktop Virtual Environment with Signs of Disorder	PLOS ONE			English	Article							DISCRIMINANT VALIDITY; SUBJECTIVE RESPONSES; EMOTIONAL RESPONSES; RESIDENTIAL AREAS; VISUAL PROPERTIES; TASK-PERFORMANCE; PERCEIVED DANGER; POSITIVE AFFECT; STREET BLOCKS; FEAR	Background: Desktop virtual environments (VEs) are increasingly deployed to study the effects of environmental qualities and interventions on human behavior and safety related concerns in built environments. For these applications it is essential that users appraise the affective qualities of the VE similar to those of its real world counterpart. Previous studies have shown that factors like simulated lighting, sound and dynamic elements all contribute to the affective appraisal of a desktop VE. Since ambient odor is known to affect the affective appraisal of real environments, and has been shown to increase the sense of presence in immersive VEs, it may also be an effective tool to tune the affective appraisal of desktop VEs. This study investigated if exposure to ambient odor can modulate the affective appraisal of a desktop VE with signs of public disorder. Method: Participants explored a desktop VE representing a suburban neighborhood with signs of public disorder (neglect, vandalism and crime), while being exposed to either room air or subliminal levels of unpleasant (tar) or pleasant (cut grass) ambient odor. Whenever they encountered signs of disorder they reported their safety related concerns and associated affective feelings. Results: Signs of crime in the desktop VE were associated with negative affective feelings and concerns for personal safety and personal property. However, there was no significant difference between reported safety related concerns and affective connotations in the control (no-odor) and in each of the two ambient odor conditions. Conclusion: Ambient odor did not affect safety related concerns and affective connotations associated with signs of disorder in the desktop VE. Thus, semantic congruency between ambient odor and a desktop VE may not be sufficient to influence its affective appraisal, and a more realistic simulation in which simulated objects appear to emit scents may be required to achieve this goal.	[Toet, Alexander] TNO, Perceptual & Cognit Syst, Soesterberg, Netherlands; [Toet, Alexander] Univ Utrecht, Dept Informat & Comp Sci, Utrecht, Netherlands; [van Schaik, Martin; Theunissen, Nicolet C. M.] TNO, Training & Performance, Soesterberg, Netherlands	Netherlands Organization Applied Science Research; Utrecht University; Netherlands Organization Applied Science Research	Toet, A (corresponding author), TNO, Perceptual & Cognit Syst, Soesterberg, Netherlands.	lextoet@gmail.com	Toet, Alexander/E-6733-2016	Toet, Alexander/0000-0003-1051-5422; Theunissen, Nicolet C.M./0000-0001-5707-0163				Andrews M, 2010, J ENVIRON PSYCHOL, V30, P473, DOI 10.1016/j.jenvp.2010.04.001; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; [Anonymous], 2009, P 25 SPRING C COMP G; [Anonymous], 2013, PSYCHOLOGY, DOI DOI 10.4236/PSYCH.2013.43A032; Armstrong T, 2010, JUSTICE Q, V27, P280, DOI 10.1080/07418820802506198; Austin D. Mark, 2007, J CRIMINAL JUSTICE P, V14, P292; Banks SJ, 2012, NEUROSCI LETT, V514, P71, DOI 10.1016/j.neulet.2012.02.059; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; BARON RA, 1990, J APPL SOC PSYCHOL, V20, P368, DOI 10.1111/j.1559-1816.1990.tb00417.x; BARON RA, 1994, ENVIRON BEHAV, V26, P766, DOI 10.1177/0013916594266003; Baron RA, 1997, PERS SOC PSYCHOL B, V23, P498, DOI 10.1177/0146167297235005; Baus O., 2010, J CYBERTHERAPY REHAB, V3, P31; Begall K, 2006, THESIS U GRONINGEN G; Bell PA, 2010, ENV PSYCHOL; Bishop ID, 2003, LANDSCAPE URBAN PLAN, V65, P261, DOI 10.1016/S0169-2046(03)00070-7; BITNER MJ, 1992, J MARKETING, V56, P57, DOI 10.2307/1252042; Blobaum A, 2005, ENVIRON BEHAV, V37, P465, DOI 10.1177/0013916504269643; Bordnick PS, 2008, ADDICT BEHAV, V33, P743, DOI 10.1016/j.addbeh.2007.12.010; Davis SB, 2007, PEOPLE AND COMPUTERS XX - ENGAGE, P25, DOI 10.1007/978-1-84628-664-3_3; Brosch T, 2010, COGNITION EMOTION, V24, P377, DOI 10.1080/02699930902975754; Caughy MO, 2001, HEALTH PLACE, V7, P225, DOI 10.1016/S1353-8292(01)00012-0; Chalmers A, 2009, VISUAL COMPUT, V25, P1101, DOI 10.1007/s00371-009-0389-2; Chebat JC, 2003, J BUS RES, V56, P529, DOI 10.1016/S0148-2963(01)00247-8; Chrea C, 2009, CHEM SENSES, V34, P49, DOI 10.1093/chemse/bjn052; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Cozens P, 2002, P 18 ARCOM ANN C ASS, P461; Cozens P., 2003, INT J TRANSP MANAG, V1, P121, DOI [10.1016/j.ijtm.2003.10.001, DOI 10.1016/J.IJTM.2003.10.001]; COZENS P., 2004, J PUBLIC TRANSPORT, V7, P23; Cozens P.M., 2003, FACILITIES, V21, P188, DOI DOI 10.1108/02632770310489936; CRUZNEIRA C, 1992, COMMUN ACM, V35, P64, DOI 10.1145/129888.129892; Dang A., 2012, GEOSPATIAL TECHNIQUE, P131; Dematte ML, 2007, CHEM SENSES, V32, P603, DOI 10.1093/chemse/bjm030; Dinh HQ, 1999, P IEEE VIRT REAL ANN, P222, DOI 10.1109/VR.1999.756955; EHRLICHMAN H, 1988, J PERS SOC PSYCHOL, V55, P769, DOI 10.1037/0022-3514.55.5.769; Elmes DG, 2008, CHEMOSENS PERCEPT, V1, P247, DOI 10.1007/s12078-008-9032-2; FISHER BS, 1992, ENVIRON BEHAV, V24, P35, DOI 10.1177/0013916592241002; Foster S, 2011, J ENVIRON PSYCHOL, V31, P79, DOI 10.1016/j.jenvp.2010.03.005; Franz G, 2005, AUTOMAT CONSTR, V14, P165, DOI 10.1016/j.autcon.2004.07.009; Freeman J, 2005, P 8 ANN INT WORKSH P; Gabriel U, 2003, BRIT J CRIMINOL, V43, P600; Gerardi M, 2008, J TRAUMA STRESS, V21, P209, DOI 10.1002/jts.20331; Ghinea G, 2011, MULTIMED TOOLS APPL, V55, P601, DOI 10.1007/s11042-010-0581-4; Hanyu K, 1997, J ENVIRON PSYCHOL, V17, P301, DOI 10.1006/jevp.1997.0067; Hanyu K, 2000, J ENVIRON PSYCHOL, V20, P273, DOI 10.1006/jevp.1999.0163; Henshaw V, 2013, PHD C UND PLAC; Henshaw V., 2012, AMBIANCES ACTIONAMBI, P449; Herz RS, 2002, OLFACTION, TASTE, AND COGNITION, P160, DOI 10.1017/CBO9780511546389.016; Herzog TR, 2001, ENVIRON BEHAV, V33, P653, DOI 10.1177/00139160121973179; Hietanen JK, 2007, PSYCHOL RES-PSYCH FO, V71, P539, DOI 10.1007/s00426-006-0064-4; Holland RW, 2005, PSYCHOL SCI, V16, P689, DOI 10.1111/j.1467-9280.2005.01597.x; Houtkamp J., 2012, THESIS U UTRECHT UTR; Houtkamp J. M., 2012, DIGITAL LANDSCAPE AR, P508; HOUTKAMP JM, 2007, PREDICTING FUTURE 25, P77; Houtkamp J, 2008, VIS 2008: INTERNATIONAL CONFERENCE VISUALISATION, PROCEEDINGS, P11, DOI 10.1109/VIS.2008.18; Houtkamp J, 2007, IEEE INT CONF INF VI, P559; Houtkamp JM, 2012, SIMULAT GAMING, V43, P778, DOI 10.1177/1046878112444564; ISEN AM, 1982, SOC PSYCHOL QUART, V45, P58, DOI 10.2307/3033676; Jackson J., 2005, INT J SOC RES METHOD, V8, P297, DOI [10.1080/13645570500299165, DOI 10.1080/13645570500299165]; James AL, 2006, J UNDERGRADUATE PSYC, V1, P13; Kavakli M, 2004, P 9 ANN INT CPTED C, P1; KIRKSMITH MD, 1987, CHEM SENSES, V12, P159, DOI 10.1093/chemse/12.1.159; Krusemark EA, 2012, CHEMOSENS PERCEPT, V5, P37, DOI 10.1007/s12078-011-9111-7; LAGRANGE RL, 1992, J RES CRIME DELINQ, V29, P311, DOI 10.1177/0022427892029003004; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; Lewis JL, 2012, J URBAN TECHNOL, V19, P85, DOI 10.1080/10630732.2012.673057; Li W, 2007, PSYCHOL SCI, V18, P1044, DOI 10.1111/j.1467-9280.2007.02023.x; Liljenquist K, 2010, PSYCHOL SCI, V21, P381, DOI 10.1177/0956797610361426; Lorenc T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-496; Lorenc T, 2012, HEALTH PLACE, V18, P757, DOI 10.1016/j.healthplace.2012.04.001; Michael GA, 2005, BEHAV NEUROSCI, V119, P708, DOI 10.1037/0735-7044.119.3.708; Michael GA, 2003, NEUROSCI LETT, V352, P221, DOI 10.1016/j.neulet.2003.08.068; Miller J, 2008, INT J SOC RES METHOD, V11, P307, DOI 10.1080/13645570701606093; Mochizuki A., 2004, ACM SIGGRAPH 2004 SK, P123; Morrin M, 2000, J BUS RES, V49, P157, DOI 10.1016/S0148-2963(99)00006-5; Nasar JL, 2008, AM J PREV MED, V34, P357, DOI 10.1016/j.amepre.2008.01.013; Nasar JL, 2011, ENVIRON BEHAV, V43, P387, DOI 10.1177/0013916510364500; Nasar JL, 1997, ENVIRON BEHAV, V29, P291, DOI 10.1177/001391659702900301; Noel S, 2004, 3RD IEEE INTERNATIONAL WORKSHOP ON HAPTIC, AUDIO AND VISUAL ENVIRONMENTS AND THEIR APPLICATIONS - HAVE 2004, P63, DOI 10.1109/HAVE.2004.1391883; Oshima C., 2007, WORKSH DSP IN VEH MO; Palmer JF, 2001, LANDSCAPE URBAN PLAN, V54, P149, DOI 10.1016/S0169-2046(01)00133-5; Park A. J., 2011, 2011 European Intelligence and Security Informatics Conference, P63, DOI 10.1109/EISIC.2011.68; Park Andrew J., 2010, 2010 IEEE International Conference on Intelligence and Security Informatics (ISI 2010), P7, DOI 10.1109/ISI.2010.5484785; Park AJ, 2008, THESIS S FRASER U BU; Park A, 2008, COMPUT ANIMAT VIRT W, V19, P331, DOI 10.1002/cav.243; Park A, 2012, J EXP CRIMINOL, V8, P29, DOI 10.1007/s11292-011-9132-x; Park AJ, 2008, PSYCHNOLOGY J, V6, P119; Perkins DD, 1996, AM J COMMUN PSYCHOL, V24, P63, DOI 10.1007/BF02511883; PERKINS DD, 1992, J ENVIRON PSYCHOL, V12, P21, DOI 10.1016/S0272-4944(05)80294-4; Phillips T, 2004, J SOCIOL, V40, P378, DOI 10.1177/1440783304048382; Retiveau AN, 2004, J SENS STUD, V19, P373, DOI 10.1111/j.1745-459x.2004.102803.x; Richard E., 2006, VIRTUAL REAL-LONDON, V10, P207, DOI [10.1007/s10055-006-0040-8, DOI 10.1007/S10055-006-0040-8]; Riener R, 2012, VIRTUAL REALITY MED, P149; Riva G, 2007, CYBERPSYCHOL BEHAV, V10, P45, DOI 10.1089/cpb.2006.9993; Rodriguez-Ardura I, 2013, COMPUTERS HUMAN BEHA; Rohrmann B, 2002, J ENVIRON PSYCHOL, V22, P319, DOI 10.1006/jevp.2001.0206; ROTTON J, 1983, BASIC APPL SOC PSYCH, V4, P171, DOI 10.1207/s15324834basp0402_5; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Russell J.A., 1987, HDB ENV PSYCHOL, V1, P245; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sampson RJ, 1999, AM J SOCIOL, V105, P603, DOI 10.1086/210356; Schifferstein HNJ, 2002, CHEM SENSES, V27, P539, DOI 10.1093/chemse/27.6.539; SCHIFFMAN SS, 1995, BRAIN RES BULL, V37, P369, DOI 10.1016/0361-9230(95)00015-1; SCHIFFMAN SS, 1995, BRAIN RES BULL, V36, P19, DOI 10.1016/0361-9230(94)00133-L; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Schwarz N., 1990, MOTIVATION COGNITION, V2, P527, DOI [10.2307/, DOI 10.2307/2072281]; Schweitzer JH, 1999, J URBAN TECHNOL, V6, P59, DOI 10.1080/10630739983588; Seigneuric A, 2010, PERCEPTION, V39, P1541, DOI 10.1068/p6740; Sela L, 2010, EXP BRAIN RES, V205, P13, DOI 10.1007/s00221-010-2348-6; Seo HS, 2010, APPETITE, V54, P544, DOI 10.1016/j.appet.2010.02.011; Skogan W.G., 1990, DISORDER DECLINE CRI; SMARDON RC, 1988, LANDSCAPE URBAN PLAN, V15, P85, DOI 10.1016/0169-2046(88)90018-7; Spangenberg ER, 1996, J MARKETING, V60, P67, DOI 10.2307/1251931; Spielberger C. D., 1983, MIND GARDEN; Stamps AE, 2002, ENVIRON BEHAV, V34, P781, DOI 10.1177/001391602237246; Stamps AE, 2010, PERCEPT MOTOR SKILL, V111, P355, DOI 10.2466/22.24.27.PMS.111.5.355-364; Steenbeek W, 2011, CRIMINOLOGY, V49, P833, DOI 10.1111/j.1745-9125.2011.00241.x; Taylor RB, 1997, J RES CRIME DELINQ, V34, P113, DOI 10.1177/0022427897034001006; TAYLOR RB, 1999, MEAS WHAT MATT P POL; Teller C, 2012, J MARKET MANAG-UK, V28, P14, DOI 10.1080/0267257X.2011.560719; Todd RM, 2012, TRENDS COGN SCI, V16, P365, DOI 10.1016/j.tics.2012.06.003; TODRANK J, 1995, LEARN MOTIV, V26, P116, DOI 10.1016/0023-9690(95)90001-2; Toet A, 2012, J ENVIRON PSYCHOL, V32, P260, DOI 10.1016/j.jenvp.2012.04.001; Toet A, 2009, CYBERPSYCHOL BEHAV, V12, P363, DOI 10.1089/cpb.2008.0293; Toffolo MBJ, 2012, COGNITION EMOTION, V26, P83, DOI 10.1080/02699931.2011.555475; Tomono A, 2011, ELECTR COMMUN JPN, V94, P9, DOI 10.1002/ecj.10319; Tortell R., 2007, Virtual Reality, V11, P61, DOI 10.1007/s10055-006-0056-0; Traylor AC, 2009, CYBERPSYCHOL BEHAV, V12, P373, DOI 10.1089/cpb.2009.0070; Van Hagen M., 2011, WAITING EXPERIENCE T; van Reekum CM, 1999, COGNITION EMOTION, V13, P831, DOI 10.1080/026999399379104; Vernet-Maury E, 1999, J AUTONOM NERV SYST, V75, P176, DOI 10.1016/S0165-1838(98)00168-4; Walla P, 2010, SENSORS-BASEL, V10, P8185, DOI 10.3390/s100908185; Wang K, 2006, J ENVIRON PSYCHOL, V26, P269, DOI 10.1016/j.jenvp.2006.07.006; Ward P, 2007, SERV BUS, V1, P295, DOI 10.1007/s11628-006-0018-3; WARR M, 1984, SOC SCI QUART, V65, P681; WARR M, 1990, SOC FORCES, V68, P891, DOI 10.2307/2579359; Washburn D.A., 2003, MODEL SIMUL MAG, V2, P19; Worrall JL, 2006, JUSTICE Q, V23, P360, DOI 10.1080/07418820600869137; Wrzesniewski A, 1999, CHEM SENSES, V24, P713, DOI 10.1093/chemse/24.6.713; Yanagida Y, 2004, P IEEE VIRT REAL ANN, P43, DOI 10.1109/VR.2004.1310054; Yanigada Y, 2003, INT C COMP GRAPH INT, P1; Yanigada Y, 2005, HCI INT 2005 LAS VEG; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639; Youngblut C, 2007, D3411 IDA; Yu J., 2003, P 13 INT C ART REAL, P136; Zacharias J, 2006, LANDSCAPE URBAN PLAN, V78, P1, DOI 10.1016/j.landurbplan.2005.05.002; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119	147	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78721	10.1371/journal.pone.0078721	http://dx.doi.org/10.1371/journal.pone.0078721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255CG	24250810	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200043
J	Wu, HY; Cai, KP; Zhou, J; Li, B; Li, LT				Wu, Hongya; Cai, Kunpeng; Zhou, Ji; Li, Bo; Li, Longtu			Unipolar memristive Switching in Bulk Negative Temperature Coefficient Thermosensitive Ceramics	PLOS ONE			English	Article							NONVOLATILE	A memristive phenomenon was observed in macroscopic bulk negative temperature coefficient nickel monoxide (NiO) ceramic material. Current-voltage characteristics of memristors, pinched hysteretic loops were systematically observed in the Ag/NiO/Ag cell. A thermistor-based model for materials with negative temperature coefficient was proposed to explain the mechanism of the experimental phenomena. Most importantly, the results demonstrate the potential for a realization of memristive systems based on macroscopic bulk materials.	[Wu, Hongya; Cai, Kunpeng; Zhou, Ji; Li, Longtu] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China; [Li, Bo] Tsinghua Univ, Shenzhen Grad Sch, Adv Mat Inst, Shenzhen 518057, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen	Zhou, J (corresponding author), Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.	zhouji@mail.tsinghua.edu.cn			National Natural Science Foundation of China [51032003, 11274198]; National High Technology Research and Development Program of China [2012AA030403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China under Grant Nos. 51032003, 11274198, and National High Technology Research and Development Program of China under Grant No. 2012AA030403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avizienis AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042772; Borresen J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048498, DOI 10.1371/J0URNAL.P0NE.0048498.PUBMED:23173034]; Cao X, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236573; Chua L, 2011, APPL PHYS A-MATER, V102, P765, DOI 10.1007/s00339-011-6264-9; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Driscoll T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3485060; Driscoll T, 2009, SCIENCE, V325, P1518, DOI 10.1126/science.1176580; Driscoll T, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3187531; Feteira A, 2009, J AM CERAM SOC, V92, P967, DOI 10.1111/j.1551-2916.2009.02990.x; Ho YP, 2011, IEEE T CIRCUITS-I, V58, P724, DOI 10.1109/TCSI.2010.2078710; Kim DJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733328; Liu ZJ, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3701722; Long SB, 2011, APPL PHYS A-MATER, V102, P915, DOI 10.1007/s00339-011-6273-8; Moreno C, 2010, NANO LETT, V10, P3828, DOI 10.1021/nl1008162; Panda D, 2010, J APPL PHYS, V108, DOI 10.1063/1.3514036; Robinett W, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/23/235203; Shkabko A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238563; Shkabko A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3139761; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Ungureanu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052042; Wang JP, 2010, PHYS STATUS SOLIDI A, V207, P484, DOI 10.1002/pssa.200925467; Xia QF, 2010, NANO LETT, V10, P2909, DOI 10.1021/nl1017157	22	4	5	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79832	10.1371/journal.pone.0079832	http://dx.doi.org/10.1371/journal.pone.0079832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255717	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200090
J	Sjoestroem, C; Khosravi, S; Zhang, GH; Martinka, M; Li, G				Sjoestroem, Cecilia; Khosravi, Shahram; Zhang, Guohong; Martinka, Magdalena; Li, Gang			C-Terminal Tensin-Like Protein Is a Novel Prognostic Marker for Primary Melanoma Patients	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; K-RAS MUTATIONS; TUMOR PROGRESSION; COLORECTAL-CANCER; CELL MOTILITY; CTEN; BRAF; ONCOGENE; PROMOTES; GENE	Background: C-terminal tensin-like protein (Cten) is a focal adhesion protein originally identified as a tumor suppressor in prostate cancer. It has since been found to be overexpressed and function as an oncogene in numerous other cancers, but the expression status of Cten in melanoma is still unknown. Methods: Using tissue microarrays containing 562 melanocytic lesions, we evaluated Cten protein expression by immunohistochemistry. The association between Cten expression and patient survival was examined using Kaplan-Meier survival analysis, and univariate and multivariate Cox regression analyses were used to estimate the crude and adjusted hazard ratios. Results: Strong Cten expression was detected in 7%, 24%, 41%, and 46% of normal nevi, dysplastic nevi, primary melanoma, and metastatic melanoma samples, respectively, and Cten expression was found to be significantly higher in dysplastic nevi compared to normal nevi (P = 0.046), and in primary melanoma compared to dysplastic nevi (P = 0.003), but no difference was observed between metastatic and primary melanoma. Cten staining also correlated with AJCC stages (P = 0.015) and primary tumor thickness (P = 0.002), with Cten expression being induced in the transition from thin (<1mm) to thick (>= 1mm) melanomas. Strong Cten expression was significantly associated with a worse 5-year overall (P = 0.008) and disease-specific survival (P = 0.004) for primary melanoma patients, and multivariate Cox regression analysis revealed that Cten expression was an independent prognostic marker for these patients (P = 0.038 for overall survival; P = 0.021 for disease-specific survival). Conclusion: Our findings indicate that induction of Cten protein expression is a relatively early event in melanoma progression, and that Cten has the potential to serve as a prognostic marker for primary melanoma patients.	[Sjoestroem, Cecilia; Khosravi, Shahram; Zhang, Guohong; Li, Gang] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Martinka, Magdalena] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia	Sjoestroem, C (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada.	cecilia.sjoestroem@alumni.ubc.ca			Canadian Institutes of Health Research [MOP-93810, MOP-110974]; Canadian Dermatology Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation	This project is funded by grants from the Canadian Institutes of Health Research (MOP-93810 and MOP-110974) and Canadian Dermatology Foundation to G. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi S, 2013, PANCREAS, V42, P135, DOI 10.1097/MPA.0b013e3182557ceb; Al-Ghamdi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020919; Albasri A, 2011, ONCOGENE, V30, P2997, DOI 10.1038/onc.2011.26; Albasri A, 2011, BREAST CANCER RES TR, V126, P47, DOI 10.1007/s10549-010-0890-3; Albasri A, 2009, J PATHOL, V218, P57, DOI 10.1002/path.2508; American Cancer Society Inc, 2011, CANC FACTS FIG 2011, P20; BALCH CM, 1978, ANN SURG, V188, P732, DOI 10.1097/00000658-197812000-00004; Berwick M, 2011, MELANOMA DEVELOPMENT: MOLECULAR BIOLOGY, GENETICS AND CLINICAL APPLICATION, P35, DOI 10.1007/978-3-7091-0371-5_3; Brose MS, 2002, CANCER RES, V62, P6997; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demunter A, 2001, J INVEST DERMATOL, V117, P1483, DOI 10.1046/j.0022-202x.2001.01601.x; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Hung SY, 2013, MOL CARCINOGEN, DOI [10.1002/mc.22034, DOI 10.1002/MC.22034.PUBMED:23625726]; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Liao YC, 2009, CANCER RES, V69, P4563, DOI 10.1158/0008-5472.CAN-09-0117; Lo SH, 2002, CANCER RES, V62, P4217; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI [10.1016/S1357-2725(03)00171-7, DOI 10.1016/S1357-2725(03)00171-7.PUBMED:14592531]; Martuszewska D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004350; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Sakashita K, 2008, ANN SURG ONCOL, V15, P2606, DOI 10.1245/s10434-008-9989-8; Sasaki H, 2003, TUMOR BIOL, V24, P271, DOI 10.1159/000076141; Sasaki H, 2003, LUNG CANCER, V40, P151, DOI 10.1016/S0169-5002(03)00037-0; Wasif N, 2011, J SURG ONCOL, V104, P111, DOI 10.1002/jso.21903; Yuen ST, 2002, CANCER RES, V62, P6451	26	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80492	10.1371/journal.pone.0080492	http://dx.doi.org/10.1371/journal.pone.0080492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244691	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900081
J	Kaur, J; Olkhova, E; Malviya, VN; Grell, E; Michel, H				Kaur, Jagdeep; Olkhova, Elena; Malviya, Viveka Nand; Grell, Ernst; Michel, Hartmut			A L-Lysine Transporter of High Stereoselectivity of the Amino Acid-Polyamine-Organocation (APC) Superfamily PRODUCTION, FUNCTIONAL CHARACTERIZATION, AND STRUCTURE MODELING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Homology Modeling; Isothermal Titration Calorimetry; Protein Purification; Site-directed Mutagenesis; APC Superfamily; Quantitative l-Lysine Binding; Secondary Active Transporter	ESCHERICHIA-COLI; PYROCOCCUS-HORIKOSHII; PROTEIN INTOLERANCE; MOLECULAR-BASIS; IDENTIFICATION; PERMEASE; GENE; MECHANISM; PURIFICATION; RECOGNITION	Background: LysP plays an important role in transport of lysine in bacteria. Results: Binding of lysine to purified STM2200 was investigated using ITC; key residues involved in binding are predicted by structure modeling and verified experimentally. Conclusion: l-Lysine binds to STM2200 selectively, and important residues were identified. Significance: Our findings provide a functional characterization of a lysine transporter. Membrane proteins of the amino acid-polyamine-organocation (APC) superfamily transport amino acids and amines across membranes and play an important role in the regulation of cellular processes. We report the heterologous production of the LysP-related transporter STM2200 from Salmonella typhimurium in Escherichia coli, its purification, and functional characterization. STM2200 is assumed to be a proton-dependent APC transporter of l-lysine. The functional interaction between basic amino acids and STM2200 was investigated by thermoanalytical methods, i.e. differential scanning and isothermal titration calorimetry. Binding of l-lysine to STM2200 in its solubilized monomer form is entropy-driven. It is characterized by a dissociation constant of 40 m at pH 5.9 and is highly selective; no evidence was found for the binding of l-arginine, l-ornithine, l-2,4-diaminobutyric acid, and l-alanine. d-Lysine is bound 45 times more weakly than its l-chiral form. We thus postulate that STM2200 functions as a specific transport protein. Based on the crystal structure of ApcT (Shaffer, P. L., Goehring, A., Shankaranarayanan, A., and Gouaux, E. (2009) Science 325, 1010-1014), a proton-dependent amino acid transporter of the APC superfamily, a homology model of STM2200 was created. Docking studies allowed identification of possible ligand binding sites. The resulting predictions indicated that Glu-222 and Arg-395 of STM2200 are markedly involved in ligand binding, whereas Lys-163 is suggested to be of structural and functional relevance. Selected variants of STM2200 where these three amino acid residues were substituted using single site-directed mutagenesis showed no evidence for l-lysine binding by isothermal titration calorimetry, which confirmed the predictions. Molecular aspects of the observed ligand specificity are discussed.	[Kaur, Jagdeep; Olkhova, Elena; Malviya, Viveka Nand; Grell, Ernst; Michel, Hartmut] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Max Planck Society	Michel, H (corresponding author), Max Planck Inst Biophys, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	hartmut.michel@biophys.mpg.de			European Membrane Protein Consortium (EMeP); Cluster of Excellence Frankfurt ("Macromolecular complexes"); Deutsche Forschungsgemeinschaft [SFB807]; Max-Planck-Gesellschaft	European Membrane Protein Consortium (EMeP); Cluster of Excellence Frankfurt ("Macromolecular complexes"); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by the European Membrane Protein Consortium (EMeP), the Cluster of Excellence Frankfurt ("Macromolecular complexes"), Deutsche Forschungsgemeinschaft Grant SFB807 (Transport and Communication across biological membranes), and Max-Planck-Gesellschaft.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; CLOSS EI, 1993, J BIOL CHEM, V268, P7538; Cosgriff AJ, 1997, J BACTERIOL, V179, P3317, DOI 10.1128/jb.179.10.3317-3323.1997; Cosgriff AJ, 2000, J BACTERIOL, V182, P2207, DOI 10.1128/JB.182.8.2207-2217.2000; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Goswami D, 2012, BIOL CHEM, V393, P617, DOI 10.1515/hsz-2012-0101; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; Kim YM, 2002, J BIOCHEM, V132, P71, DOI 10.1093/oxfordjournals.jbchem.a003201; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Ruiz J, 2011, J BACTERIOL, V193, P2536, DOI 10.1128/JB.00815-10; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; SOPHIANOPOULOU V, 1995, FEMS MICROBIOL REV, V16, P53, DOI 10.1016/0168-6445(94)00091-C; STEFFES C, 1992, J BACTERIOL, V174, P3242, DOI 10.1128/jb.174.10.3242-3249.1992; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Vangelatos I, 2009, MOL MEMBR BIOL, V26, P356, DOI 10.1080/09687680903170546; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yeramian A, 2006, J IMMUNOL, V176, P5918, DOI 10.4049/jimmunol.176.10.5918; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	40	10	11	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1377	1387		10.1074/jbc.M113.510743	http://dx.doi.org/10.1074/jbc.M113.510743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24257746	hybrid, Green Published			2022-12-25	WOS:000332401700016
J	Cherry, AD; Suliman, HB; Bartz, RR; Piantadosi, CA				Cherry, Anne D.; Suliman, Hagir B.; Bartz, Raquel R.; Piantadosi, Claude A.			Peroxisome Proliferator-activated Receptor gamma Co-activator 1-alpha as a Critical Co-activator of the Murine Hepatic Oxidative Stress Response and Mitochondrial Biogenesis in Staphylococcus aureus Sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antioxidants; Mitochondrial Metabolism; Oxidative Stress; Sepsis; Superoxide Dismutase (SOD); Co-immunoprecipitation; Peroxisome Proliferator-activated Receptor; Co-activator 1	SKELETAL-MUSCLE; EXPRESSION; METABOLISM; DAMAGE; SURVIVAL; PD-1; DYSFUNCTIONS; GLUTATHIONE; ADAPTATIONS; EXERCISE	A key transcriptional regulator of cell metabolism, the peroxisome proliferator-activated receptor co-activator 1- (PPARGC-1- or PGC-1), also regulates mitochondrial biogenesis, but its role in antioxidant gene regulation is not well understood. Here, we asked whether genetic heterozygosity of PGC-1 modulates gene expression for the mitochondrial antioxidant enzyme SOD-2 during hepatic inflammatory stress. Using Staphylococcus aureus peritonitis in mice, we found significant Sod2 gene induction in WT mice, whereas PGC-1 heterozygotes (PGC-1(+/-)) failed to augment Sod2 mRNA and protein levels. Impaired Sod2 regulation in PGC-1(+/-) mice was accompanied by oxidative stress shown by elevated mitochondrial GSSG/GSH and protein carbonyls. In silico analysis of the mouse proximal Sod2 promoter region revealed consensus binding sites for the Nfe2l2 (Nrf2) transcription factor. Chromatin immunoprecipitation demonstrated diminished Nfe2l2 protein binding to the antioxidant response element promoter site proximal to the Sod2 start site in PGC-1 heterozygous mice, implicating PGC-1 in facilitation of Nfe2l2 DNA binding. Nuclear protein co-immunoprecipitation demonstrated an interaction between hepatic Nfe2l2 and PGC-1 in WT mice that was greatly reduced in PGC-1(+/-) mice. The data indicate that PGC-1 promotes mitochondrial antioxidant enzyme expression through Nfe2l2-mediated SOD-2 expression in sepsis. The presence of this new PGC-1-dependent signaling axis indicates that PGC-1 opposes mitochondrial oxidative stress by means of selective induction of one or more antioxidant response element-driven genes. By implication, exploitation of this axis could lead to new pharmacological interventions to improve the antioxidant defenses during oxidative stress-induced mitochondrial damage.	Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Cherry, AD (corresponding author), Duke Univ, Dept Anesthesiol, DUMC Box 3094, Durham, NC 27710 USA.	anne.cherry@dm.duke.edu			National Institutes of Health [RO1-A1095424, R01-HL108801]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095424] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-A1095424 and R01-HL108801 (to C. A. P.).	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; CLARK JB, 1970, J BIOL CHEM, V245, P4724; Clayton CE, 2001, AM J PHYSIOL-LUNG C, V281, pL949, DOI 10.1152/ajplung.2001.281.4.L949; Das KC, 1997, AM J RESP CELL MOL, V17, P713, DOI 10.1165/ajrcmb.17.6.2809; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Guidet B, 2005, CHEST, V127, P942, DOI 10.1378/chest.127.3.942; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Holley AK, 2011, INT J MOL SCI, V12, P7114, DOI 10.3390/ijms12107114; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; HOPPELER H, 1973, PFLUG ARCH EUR J PHY, V344, P217, DOI 10.1007/BF00588462; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kantrow SP, 1997, ARCH BIOCHEM BIOPHYS, V345, P278, DOI 10.1006/abbi.1997.0264; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lowes DA, 2011, BIOCHEM J, V436, P123, DOI 10.1042/BJ20102135; Lu ZB, 2010, ANTIOXID REDOX SIGN, V13, P1011, DOI 10.1089/ars.2009.2940; MacGarvey NC, 2012, AM J RESP CRIT CARE, V185, P851, DOI 10.1164/rccm.201106-1152OC; NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x; Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Russell AP, 2005, FASEB J, V19, P986, DOI 10.1096/fj.04-3168fje; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; Sweeney T. E., 2010, PLOS ONE, V5; TAYLOR DE, 1995, ARCH BIOCHEM BIOPHYS, V316, P70, DOI 10.1006/abbi.1995.1011; VALCARCE C, 1988, J BIOL CHEM, V263, P7767; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang KQ, 2011, CARDIOVASC RES, V89, P426, DOI 10.1093/cvr/cvq296	49	54	55	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					41	52		10.1074/jbc.M113.512483	http://dx.doi.org/10.1074/jbc.M113.512483			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24253037	Green Published, hybrid			2022-12-25	WOS:000329370900004
J	Feng, Y; Maity, R; Whitelegge, JP; Hadjikyriacou, A; Li, ZW; Zurita-Lopez, C; Al-Hadid, Q; Clark, AT; Bedford, MT; Masson, JY; Clarke, SG				Feng, You; Maity, Ranjan; Whitelegge, Julian P.; Hadjikyriacou, Andrea; Li, Ziwei; Zurita-Lopez, Cecilia; Al-Hadid, Qais; Clark, Amander T.; Bedford, Mark T.; Masson, Jean-Yves; Clarke, Steven G.			Mammalian Protein Arginine Methyltransferase 7 (PRMT7) Specifically Targets RXR Sites in Lysine- and Arginine-rich Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Methylation; Mass Spectrometry (MS); Post-translational Modification; Protein Methylation; S-Adenosylmethionine (AdoMet); Methyltransferases; Protein-arginine Methyltransferases (PRMT)	HISTONE H4; POSTTRANSLATIONAL MODIFICATIONS; SYMMETRIC DIMETHYLATION; KINETIC MECHANISM; CRYSTAL-STRUCTURE; DNA-DAMAGE; IN-VIVO; METHYLATION; ACETYLATION; RESIDUES	The mammalian protein arginine methyltransferase 7 (PRMT7) has been implicated in roles of transcriptional regulation, DNA damage repair, RNA splicing, cell differentiation, and metastasis. However, the type of reaction that it catalyzes and its substrate specificity remain controversial. In this study, we purified a recombinant mouse PRMT7 expressed in insect cells that demonstrates a robust methyltransferase activity. Using a variety of substrates, we demonstrate that the enzyme only catalyzes the formation of -monomethylarginine residues, and we confirm its activity as the prototype type III protein arginine methyltransferase. This enzyme is active on all recombinant human core histones, but histone H2B is a highly preferred substrate. Analysis of the specific methylation sites within intact histone H2B and within H2B and H4 peptides revealed novel post-translational modification sites and a unique specificity of PRMT7 for methylating arginine residues in lysine- and arginine-rich regions. We demonstrate that a prominent substrate recognition motif consists of a pair of arginine residues separated by one residue (RXR motif). These findings will significantly accelerate substrate profile analysis, biological function study, and inhibitor discovery for PRMT7.	[Feng, You; Hadjikyriacou, Andrea; Zurita-Lopez, Cecilia; Al-Hadid, Qais; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Inst Mol Biol, Los Angeles, CA 90095 USA; [Li, Ziwei; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Inst Mol Biol, Los Angeles, CA 90095 USA; [Maity, Ranjan; Masson, Jean-Yves] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec Res Ctr, Genome Stabil Lab, Quebec City, PQ G1R 2J6, Canada; [Whitelegge, Julian P.] Univ Calif Los Angeles, NPI Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Laval University; University of California System; University of California Los Angeles; University of Texas System; UTMD Anderson Cancer Center	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	clarke@chem.ucla.edu	Zurita-Lopez, Cecilia I./AAC-6509-2020	Feng, You/0000-0002-4710-7396; Masson, Jean Yves/0000-0002-4403-7169	National Institutes of Health [GM026020, S10 RR023045, DK62248]; Canadian Institute of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062248, P30DK063491, R01DK062248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 (to S. G. C.), S10 RR023045 (to J. P. W.), and DK62248 (to M. T. B.). This work was also supported by the Canadian Institute of Health Research (to J. Y. M.).	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Auclair Y, 2013, DNA REPAIR, V12, P459, DOI 10.1016/j.dnarep.2013.04.006; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bleibel WK, 2009, HUM GENET, V125, P173, DOI 10.1007/s00439-008-0607-4; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Buhr N, 2008, ELECTROPHORESIS, V29, P2381, DOI 10.1002/elps.200700738; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Butler JS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202416; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dillon MBC, 2013, J BIOL CHEM, V288, P27872, DOI 10.1074/jbc.M113.491092; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Golebiowski F, 2005, MOL CELL BIOCHEM, V279, P133, DOI 10.1007/s11010-005-8285-1; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Obianyo O, 2012, J BIOL CHEM, V287, P6062, DOI 10.1074/jbc.M111.333609; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Siarheyeva A, 2012, STRUCTURE, V20, P1425, DOI 10.1016/j.str.2012.06.001; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Takahashi Y, 2011, J RECEPT SIG TRANSD, V31, P168, DOI 10.3109/10799893.2011.555768; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Thangaraj B, 2010, PROTEOMICS, V10, P3644, DOI 10.1002/pmic.201000190; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Verbiest V, 2008, FEBS LETT, V582, P1483, DOI 10.1016/j.febslet.2008.03.031; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P1; Wang L, 2013, NUCLEIC ACIDS RES, V41, P6870, DOI 10.1093/nar/gkt415; Wyrick JJ, 2009, BBA-GENE REGUL MECH, V1789, P37, DOI 10.1016/j.bbagrm.2008.07.001; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323; Zoroddu MA, 2000, BBA-GEN SUBJECTS, V1475, P163, DOI 10.1016/S0304-4165(00)00066-0; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	56	113	115	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37010	37025		10.1074/jbc.M113.525345	http://dx.doi.org/10.1074/jbc.M113.525345			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24247247	Green Published, hybrid			2022-12-25	WOS:000329189700022
J	Frouz, J; Thebault, E; Pizl, V; Adl, S; Cajthaml, T; Baldrian, P; Hanel, L; Stary, J; Tajovsky, K; Materna, J; Novakova, A; de Ruiter, PC				Frouz, Jan; Thebault, Elisa; Pizl, Vaclav; Adl, Sina; Cajthaml, Tomas; Baldrian, Petr; Hanel, Ladislav; Stary, Josef; Tajovsky, Karel; Materna, Jan; Novakova, Alena; de Ruiter, Peter C.			Soil Food Web Changes during Spontaneous Succession at Post Mining Sites: A Possible Ecosystem Engineering Effect on Food Web Organization?	PLOS ONE			English	Article							SPONTANEOUS VEGETATION SUCCESSION; TERRESTRIAL ECOSYSTEMS; MICROBIAL BIOMASS; TOPSOIL LAYER; STABILITY; FAUNA; BIODIVERSITY; HEAPS	Parameters characterizing the structure of the decomposer food web, biomass of the soil microflora (bacteria and fungi) and soil micro-, meso- and macrofauna were studied at 14 non-reclaimed 1- 41-year-old post-mining sites near the town of Sokolov (Czech Republic). These observations on the decomposer food webs were compared with knowledge of vegetation and soil microstructure development from previous studies. The amount of carbon entering the food web increased with succession age in a similar way as the total amount of C in food web biomass and the number of functional groups in the food web. Connectance did not show any significant changes with succession age, however. In early stages of the succession, the bacterial channel dominated the food web. Later on, in shrub-dominated stands, the fungal channel took over. Even later, in the forest stage, the bacterial channel prevailed again. The best predictor of fungal bacterial ratio is thickness of fermentation layer. We argue that these changes correspond with changes in topsoil microstructure driven by a combination of plant organic matter input and engineering effects of earthworms. In early stages, soil is alkaline, and a discontinuous litter layer on the soil surface promotes bacterial biomass growth, so the bacterial food web channel can dominate. Litter accumulation on the soil surface supports the development of the fungal channel. In older stages, earthworms arrive, mix litter into the mineral soil and form an organo-mineral topsoil, which is beneficial for bacteria and enhances the bacterial food web channel.	[Frouz, Jan; Pizl, Vaclav; Hanel, Ladislav; Stary, Josef; Tajovsky, Karel; Novakova, Alena] Acad Sci Czech Republ, Inst Soil Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Frouz, Jan] Charles Univ Prague, Inst Environm Studies, Prague, Czech Republic; [Thebault, Elisa] CNRS, Lab Biogeochim & Ecol Milieux Continentaux, Unite Mixte Rech 7618, Paris, France; [Adl, Sina] Univ Saskatchewan, Dept Soil Sci, Saskatoon, SK S7N 0W0, Canada; [Cajthaml, Tomas; Baldrian, Petr] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Materna, Jan] Museum Krkonose Vrchlabi, Krkonose Natl Pk, Vrchlabi, Czech Republic; [de Ruiter, Peter C.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Charles University Prague; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; University of Saskatchewan; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Wageningen University & Research	Frouz, J (corresponding author), Acad Sci Czech Republ, Inst Soil Biol, Ctr Biol, Na Sadkach 7, CR-37005 Ceske Budejovice, Czech Republic.	frouz@natur.cuni.cz	Háněl, Ladislav/G-2732-2014; Adl, Sina/R-3187-2016; Novakova, Alena/S-7299-2018; Frouz, Jan/G-2220-2014; Baldrian, Petr/A-9170-2009; Pizl, Vaclav/B-2636-2009; Tajovsky, Karel/G-2815-2014; Frouz, Jan/P-4388-2016; Starý, Josef/G-2721-2014; Cajthaml, Tomas/I-1971-2014	Adl, Sina/0000-0001-6324-6065; Novakova, Alena/0000-0003-0911-3565; Baldrian, Petr/0000-0002-8983-2721; Frouz, Jan/0000-0002-0908-8606; Thebault, Elisa/0000-0002-9669-5227; Cajthaml, Tomas/0000-0002-3393-1333	Czech Science foundation [P504/12/1288]	Czech Science foundation(Grant Agency of the Czech Republic)	Czech Science foundation (http://www.gacr.cz/en/) grant no P504/12/1288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl M.S., 2007, SOIL SAMPLING METHOD, P455; Adl SM, 2008, MICROBES ENVIRON, V23, P13, DOI 10.1264/jsme2.23.13; Aira M, 2009, J SOIL SEDIMENT, V9, P54, DOI 10.1007/s11368-008-0055-8; Baldrian P, 2008, SOIL BIOL BIOCHEM, V40, P2107, DOI 10.1016/j.soilbio.2008.02.019; Bohlen PJ, 2004, ECOSYSTEMS, V7, P1, DOI 10.1007/s10021-003-0126-z; Brussaard L, 1998, APPL SOIL ECOL, V9, P123, DOI 10.1016/S0929-1393(98)00066-3; Chapman SK, 2006, NEW PHYTOL, V169, P27, DOI 10.1111/j.1469-8137.2005.01571.x; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Dempsey MA, 2011, SOIL BIOL BIOCHEM, V43, P2135, DOI 10.1016/j.soilbio.2011.06.017; DERUITER PC, 1994, TRENDS ECOL EVOL, V9, P378, DOI 10.1016/0169-5347(94)90059-0; DUNGER W, 1991, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V118, P423; DUNGER W, 1968, ABH BER NATURKUNDEMU, V43, P1; Frouz J, 2005, GEODERMA, V129, P54, DOI 10.1016/j.geoderma.2004.12.033; Frouz J, 1999, AGR ECOSYST ENVIRON, V74, P167, DOI 10.1016/S0167-8809(99)00036-5; Frouz J, 2001, ECOL ENG, V17, P275, DOI 10.1016/S0925-8574(00)00144-0; Frouz J, 2008, EUR J SOIL BIOL, V44, P109, DOI 10.1016/j.ejsobi.2007.09.002; Frouz J, 2007, EUR J SOIL BIOL, V43, pS184, DOI 10.1016/j.ejsobi.2007.08.033; Frouz J, 2007, APPL SOIL ECOL, V37, P72, DOI 10.1016/j.apsoil.2007.04.001; Glenn-Lewin D.C., 1992, PLANT SUCCESSION; Griffiths BS, 1999, PEDOBIOLOGIA, V25, P383; HANEL L, 1995, NEMATOLOGICA, V41, P197, DOI 10.1163/003925995X00170; Hanel L, 2003, BIOLOGIA, V58, P205; Hedlund K, 2004, BASIC APPL ECOL, V5, P495, DOI 10.1016/j.baae.2004.09.002; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Holtkamp R, 2008, APPL SOIL ECOL, V39, P23, DOI 10.1016/j.apsoil.2007.11.002; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Kaufmann R, 2001, ECOLOGY, V82, P2261; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; Luken J.O., 1990, DIRECTING ECOLOGICAL; Makulec G, 2002, POL J ECOL, V50, P301; MAY RM, 1973, ECOLOGY, V54, P638, DOI 10.2307/1935352; Moore JC, 2000, INVERTEBRATES AS WEB-MASTERS IN ECOSYSTEMS, P161, DOI 10.1079/9780851993942.0161; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; PAUSTIAN K, 1990, J APPL ECOL, V27, P60, DOI 10.2307/2403568; PIZL V, 1992, SOIL BIOL BIOCHEM, V24, P1623, DOI 10.1016/0038-0717(92)90160-Y; Ponge JF, 2003, SOIL BIOL BIOCHEM, V35, P935, DOI 10.1016/S0038-0717(03)00149-4; Prach K, 2001, APPL VEG SCI, V4, P111, DOI 10.1111/j.1654-109X.2001.tb00241.x; Prach K, 2001, APPL VEG SCI, V4, P83, DOI 10.1111/j.1654-109X.2001.tb00237.x; Prach K, 1999, RESTOR ECOL, V7, P15, DOI 10.1046/j.1526-100X.1999.07102.x; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; RUSEK J, 1978, PEDOBIOLOGIA, V18, P426; Scheu S, 1998, ECOLOGY, V79, P1573, DOI 10.1890/0012-9658(1998)079[1573:BUCOTS]2.0.CO;2; SOHLENIUS B, 1990, BIOL FERT SOILS, V9, P168, DOI 10.1007/BF00335802; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; WARDLE DA, 1995, OIKOS, V73, P155, DOI 10.2307/3545904; WARDLE DA, 1993, OECOLOGIA, V93, P303, DOI 10.1007/BF00317685; Williams RJ, 2004, EUR PHYS J B, V38, P297, DOI 10.1140/epjb/e2004-00122-1; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003; Yeates GW, 1998, PHYSIOLOGY AND BIOCHEMISTRY OF FREE-LIVING AND PLANT-PARASITIC NEMATODES, P245	52	26	26	0	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79694	10.1371/journal.pone.0079694	http://dx.doi.org/10.1371/journal.pone.0079694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260281	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900041
J	Lindner, R; Sullivan, C; Offor, O; Lezon-Geyda, K; Halligan, K; Fischbach, N; Shah, M; Bossuyt, V; Schulz, V; Tuck, DP; Harris, LN				Lindner, Robert; Sullivan, Catherine; Offor, Onyinye; Lezon-Geyda, Kimberly; Halligan, Kyle; Fischbach, Neal; Shah, Mansi; Bossuyt, Veerle; Schulz, Vincent; Tuck, David P.; Harris, Lyndsay N.			Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy	PLOS ONE			English	Article							MICROARRAY ANALYSIS; ANDROGEN RECEPTOR; EXPRESSION; IDENTIFICATION; PROGNOSIS; SURVIVAL; SUBTYPES; TUMORS; PORTRAITS; BRCA1	Triple negative breast cancer (TNBC) is characterized by high proliferation, poor differentiation and a poor prognosis due to high rates of recurrence. Despite lower overall incidence African American (AA) patients suffer from higher breast cancer mortality in part due to the higher proportion of TNBC cases among AA patients compared to European Americans (EA). It was recently shown that the clinical heterogeneity of TNBC is reflected by distinct transcriptional programs with distinct drug response profiles in preclinical models. In this study, gene expression profiling and immunohistochemistry were used to elucidate potential differences between TNBC tumors of EA and AA patients on a molecular level. In a retrospective cohort of 136 TNBC patients, a major transcriptional signature of proliferation was found to be significantly upregulated in samples of AA ethnicity. Furthermore, transcriptional profiles of AA tumors showed differential activation of insulin-like growth factor 1 (IGF1) and a signature of BRCA1 deficiency in this cohort. Using signatures derived from the meta-analysis of TNBC gene expression carried out by Lehmann et al., tumors from AA patients were more likely of basal-like subtypes whereas transcriptional features of many EA samples corresponded to mesenchymal-like or luminal androgen receptor driven subtypes. These results were validated in The Cancer Genome Atlas mRNA and protein expression data, again showing enrichment of a basal-like phenotype in AA tumors and mesenchymal subtypes in EA tumors. In addition, increased expression of VEGF-activated genes together with elevated microvessel area determined by the AQUA method suggest that AA patients exhibit higher tumor vascularization. This study confirms the existence of distinct transcriptional programs in triple negative breast cancer in two separate cohorts and that these programs differ by racial group. Differences in TNBC subtypes and levels of tumor angiogenesis in AA versus EA patients suggest that targeted therapy choices should be considered in the context of race.	[Lindner, Robert; Bossuyt, Veerle; Tuck, David P.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Sullivan, Catherine; Offor, Onyinye; Lezon-Geyda, Kimberly; Halligan, Kyle; Harris, Lyndsay N.] Yale Canc Ctr, New Haven, CT USA; [Fischbach, Neal; Shah, Mansi] Bridgeport Hosp, Dept Oncol, Bridgeport, CT USA; [Schulz, Vincent] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Lindner, Robert] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Harris, Lyndsay N.] Case Western Reserve Univ, Univ Hosp, Cleveland, OH 44106 USA	Yale University; Yale University; Yale University; Ruprecht Karls University Heidelberg; Case Western Reserve University; University Hospitals of Cleveland	Harris, LN (corresponding author), Yale Canc Ctr, New Haven, CT USA.	lyndsay.harris@case.edu		Schulz, Vincent/0000-0001-6333-4284; Lezon-Geyda, Kimberly/0000-0002-1958-0354	Breast Cancer Research Foundation (BCRF)	Breast Cancer Research Foundation (BCRF)	The work was funded by a grant from the Breast Cancer Research Foundation (BCRF, http://www.bcrfcure.org) to LNH.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Burstein HJ, 2008, J CLIN ONCOL, V26, P1810, DOI 10.1200/JCO.2007.14.5375; Burtrum D, 2003, CANCER RES, V63, P8912; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; De Amicis F, 2010, BREAST CANCER RES TR, V121, P1, DOI 10.1007/s10549-009-0436-8; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Kang HC, 2004, CLIN CANCER RES, V10, P272, DOI 10.1158/1078-0432.CCR-1025-3; Kaufman P, 2011, CANCER RES, V70, DOI [10.1158/0008-5472.SABCS10-S1-4, DOI 10.1158/0008-5472.SABCS10-S1-4]; Kibriya MG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-622; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Linn Sabine C, 2009, Eur J Cancer, V45 Suppl 1, P11, DOI 10.1016/S0959-8049(09)70012-7; Litzenburger BC, 2010, CLIN CANC RES, V2010; Loo LWM, 2011, BREAST CANCER RES TR, V127, P297, DOI 10.1007/s10549-010-1297-x; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; McBride R, 2007, CANCER-AM CANCER SOC, V110, P1201, DOI 10.1002/cncr.22884; Moulder S, APPROACHES TREATMENT, V25; Mu L, 2012, BREAST CANC RES TREA; Nakshatri H, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001008; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Offor O, 2010, CANCER RES, V70, DOI 10.1158/0008-5472.SABCS10-P6-15-09; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan CAW, 2009, HUM PATHOL, V40, P156, DOI 10.1016/j.humpath.2008.07.005; Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Yoo PS, 2009, ANN SURG ONCOL, V16, P200, DOI 10.1245/s10434-008-0209-3; Yu KD, 2013, CLIN CANCER RES, V19, P2723, DOI 10.1158/1078-0432.CCR-12-2986	38	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e71915	10.1371/journal.pone.0071915	http://dx.doi.org/10.1371/journal.pone.0071915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260093	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500001
J	Liu, SYV; Chan, CLC; Lin, O; Hu, CS; Chen, CA				Liu, Shang-Yin Vanson; Chan, Chia-Ling Carynn; Lin, Oceana; Hu, Chieh-Shen; Chen, Chaolun Allen			DNA Barcoding of Shark Meats Identify Species Composition and CITES-Listed Species from the Markets in Taiwan	PLOS ONE			English	Article							PELAGIC SHARKS; IDENTIFICATION; FISHES; CARCHARHINIFORMES; ATLANTIC; RATES; COAST	Background: An increasing awareness of the vulnerability of sharks to exploitation by shark finning has contributed to a growing concern about an unsustainable shark fishery. Taiwan's fleet has the 4th largest shark catch in the world, accounting for almost 6% of the global figures. Revealing the diversity of sharks consumed by Taiwanese is important in designing conservation plans. However, fins make up less than 5% of the total body weight of a shark, and their bodies are sold as filets in the market, making it difficult or impossible to identify species using morphological traits. Methods: In the present study, we adopted a DNA barcoding technique using a 391-bp fragment of the mitochondrial cytochrome oxidase I (COI) gene to examine the diversity of shark filets and fins collected from markets and restaurants island-wide in Taiwan. Results: Amongst the 548 tissue samples collected and sequenced, 20 major clusters were apparent by phylogenetic analyses, each of them containing individuals belonging to the same species (most with more than 95% bootstrap values), corresponding to 20 species of sharks. Additionally, Alopias pelagicus, Carcharhinus falciformis, Isurus oxyrinchus, and Prionace glauca consisted of 80% of the samples we collected, indicating that these species might be heavily consumed in Taiwan. Approximately 5% of the tissue samples used in this study were identified as species listed in CITES Appendix II, including two species of Sphyrna, C. longimanus and Carcharodon carcharias. Conclusion: DNA barcoding provides an alternative method for understanding shark species composition when species-specific data is unavailable. Considering the global population decline, stock assessments of Appendix II species and highly consumed species are needed to accomplish the ultimate goal of shark conservation.	[Liu, Shang-Yin Vanson; Chan, Chia-Ling Carynn; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Liu, Shang-Yin Vanson] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Lin, Oceana; Hu, Chieh-Shen] Soc Wilderness, Taipei, Taiwan; [Chen, Chaolun Allen] Acad Sinica, Taiwan Int Grad Program Biodivers, Taipei 115, Taiwan; [Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	Academia Sinica - Taiwan; University of California System; University of California Los Angeles; Academia Sinica - Taiwan; National Taiwan University	Chen, CA (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	cac@gate.sinica.edu.tw			Society of Wildness (SOW)	Society of Wildness (SOW)	This study was supported by a funding from the Society of Wildness (SOW) to CAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock E.A., 2008, SHARKS OPEN OCEAN BI; Baum JK, 2005, FISHERIES, V30, P27; Cailliet GM, 2009, IUCN 2012; Camhi Merry D., 2008, Fish and Aquatic Resources Series, V13, P397; Campana SE, 2004, 2004069 CSAS; Chen GCT, 1996, TRAFFIC REPORT SHARK; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; Compagno L.J.V., 2005, SHARKS WORLD; Compagno LJV, 2001, FAO SPECIES CATALOG, V2, P78; Compagno LJV, 1984, FAO SPECIES CATALOGU, V4, P125; Corrigan S, 2008, J FISH BIOL, V73, P1662, DOI 10.1111/j.1095-8649.2008.02039.x; Rodrigues LFS, 2009, GENET MOL BIOL, V32, P405, DOI 10.1590/S1415-47572009005000039; Dosay-Akbulut M, 2008, CR BIOL, V331, P500, DOI 10.1016/j.crvi.2008.04.001; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fowler G.M., 2009, COLLECT VOL SCI PAP, V64, P1650; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Holts DB, 1998, FISH RES, V39, P115, DOI 10.1016/S0165-7836(98)00178-7; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hueter RE, 2008, SHARKS OPEN OCEAN BI; Human BA, 2006, MOL PHYLOGENET EVOL, V39, P384, DOI 10.1016/j.ympev.2005.09.009; Iglesias SP, 2005, MOL PHYLOGENET EVOL, V34, P569, DOI 10.1016/j.ympev.2004.10.022; Joung SJ, 2005, ZOOL STUD, V44, P337; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Last PR, 2009, SHARKS RAYS AUSTR; Libralato S, 2006, ECOL MODEL, V195, P153, DOI 10.1016/j.ecolmodel.2005.11.029; Liu K.M., 2011, ISC SHARK WORK GROUP; Liu K-M., 2009, COLLECTIVE VOLUME SC, V64, P1703; Liu SYV, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-6; Lopez JA, 2006, MOL PHYLOGENET EVOL, V40, P50, DOI 10.1016/j.ympev.2006.02.011; Lucifora LO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019356; Martin A, 1992, THESIS U HAWAII HONO; Moftah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027001; Nakano H, 2005, ICCAT COL VOL SCI PA, V58, P1127; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Reardon M, 2009, IUCN 2012; Sant G, 2011, FUTURE SHARKS REV AC; Simpfendorfer CA, 2002, FISH RES, V55, P175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Stevens JD, 1999, AM FISH S S, V23, P11; Taiwan Fisheries Agency, 2006, TAIW NAT PLAN ACT CO; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tillett BJ, 2012, FISH RES, V127, P109, DOI 10.1016/j.fishres.2012.04.007; Trejo T., 2005, THESIS CALIFORNIA ST; Tsai WP, 2010, MAR FRESHWATER RES, V61, P1056, DOI 10.1071/MF09303; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Ward P, 2005, ECOLOGY, V86, P835, DOI 10.1890/03-0746; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, ENDANGERED SPECIES U, V26, P3; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; White W.T., 2006, EC IMPORTANT SHARKS; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030621, 10.1371/journal.pone.0039076]	60	46	49	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79373	10.1371/journal.pone.0079373	http://dx.doi.org/10.1371/journal.pone.0079373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260209	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500054
J	Motwani, NH; Gorokhova, E				Motwani, Nisha H.; Gorokhova, Elena			Mesozooplankton Grazing on Picocyanobacteria in the Baltic Sea as Inferred from Molecular Diet Analysis	PLOS ONE			English	Article							COPEPOD CALANUS-PACIFICUS; ESTUARY WEST-AFRICA; COMMUNITY STRUCTURE; AUTOTROPHIC PICOPLANKTON; CYANOBACTERIAL BLOOMS; PLANKTONIC COMMUNITY; NODULARIA-SPUMIGENA; ALGAL PICOPLANKTON; ACARTIA-BIFILOSA; QUANTITATIVE PCR	Our current knowledge on the microbial component of zooplankton diet is limited, and it is generally assumed that bacteria-sized prey is not directly consumed by most mesozooplankton grazers in the marine food webs. We questioned this assumption and conducted field and laboratory studies to examine picocyanobacteria contribution to the diets of Baltic Sea zooplankton, including copepods. First, qPCR targeting ITS-1 rDNA sequence of the picocyanobacteria Synechococcus spp. was used to examine picocyanobacterial DNA occurrence in the guts of Baltic zooplankton (copepods, cladocerans and rotifers). All field-collected zooplankton were found to consume picocyanobacteria in substantial quantities. In terms of Synechococcus quantity, the individual gut content was highest in cladocerans, whereas biomass-specific gut content was highest in rotifers and copepod nauplii. Moreover, the gut content in copepods was positively related to the picocyanobacteria abundance and negatively to the total phytoplankton abundance in the water column at the time of sampling. This indicates that increased availability of picocyanobacteria resulted in the increased intake of this prey and that copepods may rely more on picoplankton when food in the preferred size range declines. Second, a feeding experiments with a laboratory reared copepod Acartia tonsa fed a mixture of the picocyanobacterium Synechococcus bacillaris and microalga Rhodomonas salina confirmed that copepods ingested Synechococcus, even when the alternative food was plentiful. Finally, palatability of the picocyanobacteria for A. tonsa was demonstrated using uptake of C-13 by the copepods as a proxy for carbon uptake in feeding experiment with C-13-labeled S. bacillaris. These findings suggest that, if abundant, picoplankton may become an important component of mesozooplankton diet, which needs to be accounted for in food web models and productivity assessments.	[Motwani, Nisha H.; Gorokhova, Elena] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; [Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Gorokhova, E (corresponding author), Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden.	elena.gorokhova@itm.su.se	Gorokhova, Elena/E-7105-2018	Gorokhova, Elena/0000-0002-4192-6956	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Stockholm University's strategic marine environmental research program "Baltic Ecosystem Adaptive Management"	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Stockholm University's strategic marine environmental research program "Baltic Ecosystem Adaptive Management"	Financial support was received from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) and Stockholm University's strategic marine environmental research program "Baltic Ecosystem Adaptive Management". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2000, LIMNOL OCEANOGR, V45, P591, DOI 10.4319/lo.2000.45.3.0591; Albertano P, 1997, J PLANKTON RES, V19, P1405, DOI 10.1093/plankt/19.10.1405; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bartram W.C., 1980, J PLANKTON RES, V3, P25, DOI DOI 10.1093/PLANKT/3.1.25; Becker S, 2002, APPL ENVIRON MICROB, V68, P4486, DOI 10.1128/AEM.68.9.4486-4494.2002; Becker S, 2007, FEMS MICROBIOL ECOL, V62, P64, DOI 10.1111/j.1574-6941.2007.00366.x; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Berglund J, 2007, LIMNOL OCEANOGR, V52, P121, DOI 10.4319/lo.2007.52.1.0121; Bouvy M, 2006, J PLANKTON RES, V28, P195, DOI 10.1093/plankt/fbi112; BOYD CM, 1976, LIMNOL OCEANOGR, V21, P175, DOI 10.4319/lo.1976.21.1.0175; Burdloff D, 2002, J EXP MAR BIOL ECOL, V274, P1, DOI 10.1016/S0022-0981(02)00133-8; Callieri C, 2011, APPL ENVIRON MICROB, V77, P7533, DOI 10.1128/AEM.05392-11; Callieri Cristiana, 2002, Journal of Limnology, V61, P1; CONOVER RJ, 1973, MAR BIOL, V18, P272; COWLES TJ, 1988, MAR BIOL, V100, P41, DOI 10.1007/BF00392953; Durbin EG, 2012, J PLANKTON RES, V34, P72, DOI 10.1093/plankt/fbr082; Engstrom-Ost J, 2011, AQUAT MICROB ECOL, V62, P39, DOI 10.3354/ame01456; Ernst A, 2003, MICROBIOL-SGM, V149, P217, DOI 10.1099/mic.0.25475-0; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Galluzzi L, 2010, J APPL PHYCOL, V22, P1, DOI 10.1007/s10811-009-9411-3; Gasparini S, 1997, J PLANKTON RES, V19, P877, DOI 10.1093/plankt/19.7.877; GELLER W, 1981, OECOLOGIA, V49, P316, DOI 10.1007/BF00347591; Giraffa G, 2000, J MICROBIOL METH, V42, P175, DOI 10.1016/S0167-7012(00)00172-X; GLOVER HE, 1986, MAR BIOL, V91, P193, DOI 10.1007/BF00569435; Gorokhova E, 2005, LIMNOL OCEANOGR-METH, V3, P143, DOI 10.4319/lom.2005.3.143; Gorokhova E, 2009, HARMFUL ALGAE, V8, P264, DOI 10.1016/j.hal.2008.06.006; Gorsky G, 1999, J GEOPHYS RES-OCEANS, V104, P3381, DOI 10.1029/98JC01850; Hajdu S, 2007, HARMFUL ALGAE, V6, P189, DOI 10.1016/j.hal.2006.07.006; HARBISON GR, 1980, LIMNOL OCEANOGR, V25, P971, DOI 10.4319/lo.1980.25.6.0971; Haverkamp T, 2008, ENVIRON MICROBIOL, V10, P174, DOI 10.1111/j.1462-2920.2007.01442.x; *HELC, 2008, MAN MAR MON COMBINE; Hernroth L, 1985, BALTIC MARINE BIOL P, V10; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; Johansson M, 2004, J PLANKTON RES, V26, P67, DOI 10.1093/plankt/fbg115; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; KUOSA H, 1988, OPHELIA, V28, P85; LANDRY MR, 1981, MAR BIOL, V65, P77, DOI 10.1007/BF00397070; Lipej L, 1997, HYDROBIOLOGIA, V360, P197, DOI 10.1023/A:1003180030116; MULLIN MM, 1966, LIMNOL OCEANOGR, V11, P307, DOI 10.4319/lo.1966.11.2.0307; Nejstgaard JC, 2008, MAR BIOL, V153, P565, DOI 10.1007/s00227-007-0830-x; OCONNORS HB, 1980, MAR BIOL, V56, P65, DOI 10.1007/BF00390595; Ohlendieck U, 2000, J MARINE SYST, V25, P213, DOI 10.1016/S0924-7963(00)00016-6; Olsen BR, 2012, J PLANKTON RES, V34, P277, DOI 10.1093/plankt/fbr110; PACE ML, 1990, LIMNOL OCEANOGR, V35, P795, DOI 10.4319/lo.1990.35.4.0795; Pagano M, 2006, ESTUAR COAST SHELF S, V67, P369, DOI 10.1016/j.ecss.2005.10.018; Pahlow M, 2010, MAR ECOL PROG SER, V403, P129, DOI 10.3354/meps08466; Pandolfini E, 2000, J PLANKTON RES, V22, P305, DOI 10.1093/plankt/22.2.305; Ploug H, 2011, ISME J, V5, P1549, DOI 10.1038/ismej.2011.20; RICHMAN S, 1977, MAR BIOL, V42, P69, DOI 10.1007/BF00392015; ROFF JC, 1995, AQUAT MICROB ECOL, V9, P165, DOI 10.3354/ame009165; ROMAN MR, 1980, LIMNOL OCEANOGR, V25, P982, DOI 10.4319/lo.1980.25.6.0982; Sanchez-Baracaldo P, 2008, MICROBIOL-SGM, V154, P3347, DOI 10.1099/mic.0.2008/019836-0; SANDERS RW, 1989, LIMNOL OCEANOGR, V34, P673, DOI 10.4319/lo.1989.34.4.0673; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; Stal LJ, 1999, AQUAT MICROB ECOL, V18, P165, DOI 10.3354/ame018165; STOCKNER JG, 1989, HYDROBIOLOGIA, V173, P151, DOI 10.1007/BF00015525; STOCKNER JG, 1986, CAN J FISH AQUAT SCI, V43, P2472, DOI 10.1139/f86-307; Stomp M, 2007, ECOL LETT, V10, P290, DOI 10.1111/j.1461-0248.2007.01026.x; TAKAHASHI M, 1985, MAR BIOL, V89, P63, DOI 10.1007/BF00392878; Tomaru Y, 2000, MAR ECOL PROG SER, V192, P195, DOI 10.3354/meps192195; Uitto Anna, 2000, Boreal Environment Research, V5, P137; Vaitomaa J, 2003, APPL ENVIRON MICROB, V69, P7289, DOI 10.1128/AEM.69.12.7289-7297.2003; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721; Wilson SE, 2010, MAR ECOL PROG SER, V412, P11, DOI 10.3354/meps08648; WYLIE JL, 1991, LIMNOL OCEANOGR, V36, P708, DOI 10.4319/lo.1991.36.4.0708	67	51	51	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79230	10.1371/journal.pone.0079230	http://dx.doi.org/10.1371/journal.pone.0079230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260175	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500038
J	Ruby, P; Blochet, C; Eichenlaub, JB; Bertrand, O; Morlet, D; Bidet-Caulet, A				Ruby, Perrine; Blochet, Camille; Eichenlaub, Jean-Baptiste; Bertrand, Olivier; Morlet, Dominique; Bidet-Caulet, Aurelie			Alpha Reactivity to Complex Sounds Differs during REM Sleep and Wakefulness	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; STIMULUS DEVIANCE; EEG; OSCILLATIONS; RESPONSES; BRAIN; MEMORY; CONSCIOUSNESS; ATTENTION; NAME	We aimed at better understanding the brain mechanisms involved in the processing of alerting meaningful sounds during sleep, investigating alpha activity. During EEG acquisition, subjects were presented with a passive auditory oddball paradigm including rare complex sounds called Novels (the own first name - OWN, and an unfamiliar first name - OTHER) while they were watching a silent movie in the evening or sleeping at night. During the experimental night, the subjects' quality of sleep was generally preserved. During wakefulness, the decrease in alpha power (8-12 Hz) induced by Novels was significantly larger for OWN than for OTHER at parietal electrodes, between 600 and 900 ms after stimulus onset. Conversely, during REM sleep, Novels induced an increase in alpha power (from 0 to 1200 ms at all electrodes), significantly larger for OWN than for OTHER at several parietal electrodes between 700 and 1200 ms after stimulus onset. These results show that complex sounds have a different effect on the alpha power during wakefulness (decrease) and during REM sleep (increase) and that OWN induce a specific effect in these two states. The increased alpha power induced by Novels during REM sleep may 1) correspond to a short and transient increase in arousal; in this case, our study provides an objective measure of the greater arousing power of OWN over OTHER, 2) indicate a cortical inhibition associated with sleep protection. These results suggest that alpha modulation could participate in the selection of stimuli to be further processed during sleep.	[Ruby, Perrine; Blochet, Camille; Eichenlaub, Jean-Baptiste; Bertrand, Olivier; Morlet, Dominique; Bidet-Caulet, Aurelie] CNRS, INSERM, Lyon Neurosci Res Ctr CRNL, Brain Dynam & Cognit Team, Lyon, France; [Ruby, Perrine; Blochet, Camille; Eichenlaub, Jean-Baptiste; Bertrand, Olivier; Morlet, Dominique; Bidet-Caulet, Aurelie] Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Ruby, P (corresponding author), CNRS, INSERM, Lyon Neurosci Res Ctr CRNL, Brain Dynam & Cognit Team, Lyon, France.	perrine.ruby@inserm.fr	Bertrand, Olivier/B-6165-2008; Ruby, Perrine Marie/K-8903-2017; Eichenlaub, Jean-Baptiste/E-5864-2015; Bidet-Caulet, Aurelie/K-3328-2017	Bertrand, Olivier/0000-0003-0733-7979; Eichenlaub, Jean-Baptiste/0000-0002-4610-1566; Blochet, Camille/0000-0001-5620-9290	French National Research Agency (ANR) [ANR-07-JCJC-0095]; LABEX CORTEX of Universite de Lyon [ANR-11-LABX-0042, ANR-11-IDEX-0007]; LABEX CELYA of Universite de Lyon [ANR-11-IDEX-0007, ANR-10-LABX-0060]	French National Research Agency (ANR)(French National Research Agency (ANR)); LABEX CORTEX of Universite de Lyon; LABEX CELYA of Universite de Lyon	This work was supported by a grant awarded to Dr Perrine Ruby (ANR-07-JCJC-0095) from the French National Research Agency (ANR), and by the LABEX CORTEX (ANR-11-LABX-0042) of Universite de Lyon, within the program "Investissements d'Avenir'' (ANR-11-IDEX-0007) operated by the French ANR. This work was also performed within the framework of the LABEX CELYA (ANR-10-LABX-0060) of Universite de Lyon, within the program "Investissements d'Avenir'' (ANR-11-IDEX-0007) operated by the French ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera PE, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/158970; [Anonymous], 1992, SLEEP, V15, P174; Babiloni C, 2011, CORTEX, V47, P1082, DOI 10.1016/j.cortex.2011.05.006; Bastuji H, 1999, SLEEP MED REV, V3, P23, DOI 10.1016/S1087-0792(99)90012-6; BASTUJI H, 1995, J CLIN NEUROPHYSIOL, V12, P155, DOI 10.1097/00004691-199503000-00006; Benca RM, 1999, PSYCHOPHYSIOLOGY, V36, P430, DOI 10.1111/1469-8986.3640430; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Berthomier C, 2007, SLEEP, V30, P1587, DOI 10.1093/sleep/30.11.1587; Bidet-Caulet A, 2012, EUR J NEUROSCI, V36, P2996, DOI 10.1111/j.1460-9568.2012.08223.x; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; BRAIN R, 1958, BRAIN, V81, P426, DOI 10.1093/brain/81.3.426; Caclin A, 2008, J COGNITIVE NEUROSCI, V20, P49, DOI 10.1162/jocn.2008.20001; Cantero JL, 2002, NEUROPHYSIOL CLIN, V32, P54, DOI 10.1016/S0987-7053(01)00289-1; DUMERMUTH G, 1983, EUR NEUROL, V22, P322, DOI 10.1159/000115579; Edgington E. S., 1995, RANDOMIZATION TESTS; Edwards E, 2009, J NEUROPHYSIOL, V102, P377, DOI 10.1152/jn.90954.2008; Eichenlaub JB, 2013, CEREB CORTEX; Eichenlaub JB, 2012, BRAIN RES, V1447, P65, DOI 10.1016/j.brainres.2012.01.072; Fellinger R, 2011, CLIN NEUROPHYSIOL, V122, P2177, DOI 10.1016/j.clinph.2011.03.004; FORMBY D, 1967, DEV MED CHILD NEUROL, V9, P293; Graham KS, 2003, COGN AFFECT BEHAV NE, V3, P234, DOI 10.3758/CABN.3.3.234; Hanslmayr S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00074; Hardcastle W. J., 1999, COARTICULATION THEOR; Hirshkowitz M, 2004, MED CLIN N AM, V88, P551, DOI 10.1016/j.mcna.2004.01.001; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Holler Y, 2011, INT J PSYCHOPHYSIOL, V80, P227, DOI 10.1016/j.ijpsycho.2011.03.012; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P99, DOI 10.1016/j.clinph.2010.05.029; Ibanez AM, 2009, INT J PSYCHOL, V44, P290, DOI 10.1080/00207590802194234; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Klimesch W, 2006, CEREB CORTEX, V16, P280, DOI 10.1093/cercor/bhi107; Klimesch W, 1997, COGNITIVE BRAIN RES, V6, P83, DOI 10.1016/S0926-6410(97)00018-9; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Loomis AL, 1939, J NEUROPHYSIOL, V2, P413; Mazaheri A, 2005, COGNITIVE BRAIN RES, V24, P81, DOI 10.1016/j.cogbrainres.2004.12.013; McKinney SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017351; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Muzet A, 2006, M S-MED SCI, V22, P973, DOI 10.1051/medsci/20062211973; Nir Y, 2010, TRENDS COGN SCI, V14, P88, DOI 10.1016/j.tics.2009.12.001; Obleser J, 2012, CEREB CORTEX, V22, P2466, DOI 10.1093/cercor/bhr325; Perrin F, 2002, NEUROREPORT, V13, P1345, DOI 10.1097/00001756-200207190-00026; Perrin F, 2000, NEUROREPORT, V11, P1637, DOI 10.1097/00001756-200006050-00008; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; RECHTSCH.A, 1966, PERCEPT MOTOR SKILL, V22, P927, DOI 10.2466/pms.1966.22.3.927; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Ruby P, 2008, J COGNITIVE NEUROSCI, V20, P296, DOI 10.1162/jocn.2008.20023; Sabri M, 2005, J SLEEP RES, V14, P113, DOI 10.1111/j.1365-2869.2005.00446.x; Sallinen M, 1997, ELECTROEN CLIN NEURO, V102, P363, DOI 10.1016/S0013-4694(96)96614-6; Sato Y, 2007, SLEEP, V30, P511, DOI 10.1093/sleep/30.4.511; Shahin AJ, 2009, BRAIN COGNITION, V70, P259, DOI 10.1016/j.bandc.2009.02.008; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tavabi K, 2011, NEUROREPORT, V22, P474, DOI 10.1097/WNR.0b013e3283476b84; Vidal JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00195; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Weisz N, 2013, CEREB CORTEX; Weisz N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00073; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255; Yordanova J, 2001, PSYCHOPHYSIOLOGY, V38, P143, DOI 10.1017/S0048577201990079; Zanto TP, 2013, NEUROIMAGE; Zygierewicz J, 2009, ACTA NEUROBIOL EXP, V69, P254	62	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79989	10.1371/journal.pone.0079989	http://dx.doi.org/10.1371/journal.pone.0079989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256KH	24260331	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500112
J	Franks, SE; Fernandez, G; Hodkinson, DJ; Kyser, TK; Lank, DB				Franks, Samantha E.; Fernandez, Guillermo; Hodkinson, David J.; Kyser, T. Kurt; Lank, David B.			The Long and the Short of It: No Dietary Specialisation between Male and Female Western Sandpipers Despite Strong Bill Size Dimorphism	PLOS ONE			English	Article							SEX-RELATED DIFFERENCES; BAR-TAILED GODWITS; CALIDRIS-MAURI; STABLE-ISOTOPES; SEMIPALMATED SANDPIPERS; MIGRATORY SHOREBIRD; FORAGING BEHAVIOR; HABITAT USE; DIFFERENTIAL MIGRATION; LATITUDINAL CLINES	Many bird species show spatial or habitat segregation of the sexes during the non-breeding season. One potential ecological explanation is that differences in bill morphology favour foraging niche specialisation and segregation. Western sandpipers Calidris mauri have pronounced bill size dimorphism, with female bills averaging 15% longer than those of males. The sexes differ in foraging behaviour and exhibit partial latitudinal segregation during the non-breeding season, with males predominant in the north and females in the south. Niche specialisation at a local scale might account for this broad geographic pattern, and we investigated whether longer-billed females and shorter-billed males occupy different foraging niches at 16 sites across the non-breeding range. We used stable-nitrogen (delta N-15) isotope analysis of whole blood to test for dietary specialisation according to bill length and sex. Stable-nitrogen isotope ratios increase with trophic level. We predicted that delta N-15 values would increase with bill length and would be higher for females, which use a greater proportion of foraging behaviour that targets higher-trophic level prey. We used stable-carbon (delta C-13) isotope analysis to test for habitat segregation according to bill length and sex. Stable-carbon isotope ratios vary between marine-and freshwater-influenced habitats. We predicted that delta C-13 values would differ between males and females if the sexes segregate between habitat types. Using a model selection approach, we found little support for a relationship between delta N-15 and either bill length or sex. There was some indication, however, that more marine delta C-13 values occur with shorter bill lengths. Our findings provide little evidence that male and female western sandpipers exhibit dietary specialisation as a function of their bill size, but indicate that the sexes may segregate in different habitats according to bill length at some non-breeding sites. Potential ecological factors underlying habitat segregation between sexes include differences in preferred habitat type and predation risk.	[Franks, Samantha E.; Lank, David B.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Fernandez, Guillermo] Univ Nacl Autonoma Mexico, Unidad Acad Mazatlan, Inst Ciencias Mar & Limnol, Mazatlan, Sinaloa, Mexico; [Hodkinson, David J.] Aspect Ecol Ltd, Banbury, England; [Kyser, T. Kurt] Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON, Canada	Simon Fraser University; Universidad Nacional Autonoma de Mexico; Queens University - Canada	Franks, SE (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	samantha.franks@gmail.com	Fernandez, Guillermo/B-7534-2008	Fernandez, Guillermo/0000-0002-8478-5575; Kyser, Kurt/0000-0001-9667-4103	Natural Sciences and Engineering Research Council of Canada [STPSC 357054]; US Fish and Wildlife Service Neotropical Migratory Bird Conservation Act Grant [C2-N521]; Mexican National Council for Science and Technology [CB2007-82671, CB2010-155353]; Universidad Nacional Autonoma de MA(C)xico [IN212809-3]; American Ornithologists' Union; Centre for Wildlife Ecology at Simon Fraser University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); US Fish and Wildlife Service Neotropical Migratory Bird Conservation Act Grant; Mexican National Council for Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de MA(C)xico; American Ornithologists' Union; Centre for Wildlife Ecology at Simon Fraser University	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada (STPSC 357054 and Postgraduate Scholarships to SEF), a US Fish and Wildlife Service Neotropical Migratory Bird Conservation Act Grant (C2-N521), the Mexican National Council for Science and Technology (CB2007-82671 & CB2010-155353), Universidad Nacional Autonoma de MA (c) xico (IN212809-3), the American Ornithologists' Union, and the Centre for Wildlife Ecology at Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves JA, 2013, ECOL EVOL, V3, P1079, DOI 10.1002/ece3.503; Bates D, 2012, LINEAR MIXED EFFECTS; Both C, 2003, ARDEA, V91, P268; Burnham KP, 2002, MULTIMODEL INFERENCE; CARTAR RV, 1984, WILSON BULL, V96, P277; Casey MM, 2011, EARTH-SCI REV, V106, P131, DOI 10.1016/j.earscirev.2011.02.001; Catry P., 2006, SEXUAL SEGREGATION V, P351, DOI DOI 10.1017/CBO9780511525629.019; Catry T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033811; COLWELL MA, 1993, CONDOR, V95, P94, DOI 10.2307/1369390; Davis CA, 2001, AUK, V118, P484, DOI 10.1642/0004-8038(2001)118[0484:FSANDO]2.0.CO;2; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Durell SEALD, 2000, BIOL REV, V75, P503; DURELL SEALD, 1993, J ANIM ECOL, V62, P205, DOI 10.2307/5495; Elner Robert W., 2003, Wader Study Group Bulletin, V100, P30; Elner RW, 2005, MAR BIOL, V146, P1223, DOI 10.1007/s00227-004-1521-5; Fernandez G, 2008, WILSON B, V150, P518; Fernandez G, 2006, CONDOR, V108, P547, DOI 10.1650/0010-5422(2006)108[547:SAABSD]2.0.CO;2; Franks SE, 2009, J FIELD ORNITHOL, V80, P51, DOI 10.1111/j.1557-9263.2009.00205.x; Gardiner RJ, 2012, THESIS S FRASER U; Gauthreaux SA, 1978, PERSPECTIVES ETHOLOG, V3, P93; GERRITSEN AFC, 1985, NETH J ZOOL, V35, P671, DOI 10.1163/002829685X00235; HARRINGTON BA, 1982, J FIELD ORNITHOL, V53, P258; Jehl J.R. Jr, 1986, Current Ornithology, V3, P1; Jing K, 2007, ECOL RES, V22, P559, DOI 10.1007/s11284-006-0302-7; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; KELSEY MG, 1989, ORNIS SCAND, V20, P250, DOI 10.2307/3676488; Ketterson E.D., 1983, Current Ornithology, V1, P357; KETTERSON ED, 1976, ECOLOGY, V57, P679, DOI 10.2307/1936182; Kuwae T, 2008, ECOLOGY, V89, P599, DOI 10.1890/07-1442.1; Kuwae T, 2012, ECOL LETT, V15, P347, DOI 10.1111/j.1461-0248.2012.01744.x; Mathot KJ, 2007, ECOLOGY, V88, P781, DOI 10.1890/06-1225; Mathot KJ, 2004, CAN J ZOOL, V82, P1035, DOI 10.1139/Z04-080; Mathot KJ, 2005, THESIS S FRASER U; Mazerolle MJ, 2011, MODEL SELECTION MULT; MYERS JP, 1981, CAN J ZOOL, V59, P1527, DOI 10.1139/z81-207; Nebel S, 2005, BEHAV ECOL SOCIOBIOL, V59, P44, DOI 10.1007/s00265-005-0007-x; Nebel S, 2005, ANIM BIOL, V55, P235, DOI 10.1163/1570756054472818; Nebel S, 2005, ACTA OECOL, V28, P33, DOI 10.1016/j.actao.2005.02.002; Nebel S, 2002, AUK, V119, P922, DOI 10.1642/0004-8038(2002)119[0922:WSCMDT]2.0.CO;2; O'Hara PD, 2006, CONDOR, V108, P225, DOI 10.1650/0010-5422(2006)108[0225:DMIWSW]2.0.CO;2; Ogden LJE, 2004, AUK, V121, P170, DOI 10.1642/0004-8038(2004)121[0170:BICANT]2.0.CO;2; PAGE G, 1971, BIRD BANDING, V42, P297, DOI 10.2307/4511799; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Pomeroy AC, 2006, OIKOS, V112, P629, DOI 10.1111/j.0030-1299.2006.14403.x; Pomeroy AC, 2008, AVIAN CONSERVATION E, V3, P86; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Prater A.J, 1977, GUIDE IDENTIFICATION; PUTTICK GM, 1981, ORNIS SCAND, V12, P13, DOI 10.2307/3675899; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sandercock Brett K., 2001, Wader Study Group Bulletin, V96, P64; Stein RW, 2008, CAN J ZOOL, V86, P601, DOI 10.1139/Z08-033; Sutherland TF, 2000, MAR BIOL, V137, P983, DOI 10.1007/s002270000406; Szekely T, 2000, EVOLUTION, V54, P1404, DOI 10.1111/j.0014-3820.2000.tb00572.x; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; TOWNSHEND DJ, 1981, FEEDING SURVIVAL STR, P261; Warnock SE, 1996, IBIS, V138, P160, DOI 10.1111/j.1474-919X.1996.tb04323.x; WOLF N, 2001, THESIS S FRASER U BU; Zharikov Y, 2002, CAN J ZOOL, V80, P1918, DOI 10.1139/Z02-178	60	3	3	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79835	10.1371/journal.pone.0079835	http://dx.doi.org/10.1371/journal.pone.0079835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260305	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600049
J	Cannon, JL; Asperti-Boursin, F; Letendre, KA; Brown, IK; Korzekwa, KE; Blaine, KM; Oruganti, SR; Sperling, AI; Moses, ME				Cannon, Judy L.; Asperti-Boursin, Francois; Letendre, Kenneth A.; Brown, Ivy K.; Korzekwa, Katy E.; Blaine, Kelly M.; Oruganti, Sreenivasa R.; Sperling, Anne I.; Moses, Melanie E.			PKC theta Regulates T Cell Motility via Ezrin-Radixin-Moesin Localization to the Uropod	PLOS ONE			English	Article							PROTEIN-KINASE-C; LYMPHOCYTES IN-VIVO; HYDROPHOBIC-MOTIF; CONTACT SITE; LYMPH-NODES; POLARIZATION; ACTIVATION; MIGRATION; CHEMOKINE; ADHESION	Cell motility is a fundamental process crucial for function in many cell types, including T cells. T cell motility is critical for T cell-mediated immune responses, including initiation, activation, and effector function. While many extracellular receptors and cytoskeletal regulators have been shown to control T cell migration, relatively few signaling mediators have been identified that can modulate T cell motility. In this study, we find a previously unknown role for PKC theta in regulating T cell migration to lymph nodes. PKC theta localizes to the migrating T cell uropod and regulates localization of the MTOC, CD43 and ERM proteins to the uropod. Furthermore, PKC theta-deficient T cells are less responsive to chemokine induced migration and are defective in migration to lymph nodes. Our results reveal a novel role for PKC theta in regulating T cell migration and demonstrate that PKC theta signals downstream of CCR7 to regulate protein localization and uropod formation.	[Cannon, Judy L.; Asperti-Boursin, Francois; Letendre, Kenneth A.; Brown, Ivy K.; Korzekwa, Katy E.; Oruganti, Sreenivasa R.] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Cannon, Judy L.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; [Asperti-Boursin, Francois; Letendre, Kenneth A.; Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Blaine, Kelly M.; Sperling, Anne I.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA	University of New Mexico; University of New Mexico; University of New Mexico; University of Chicago	Cannon, JL (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	jucannon@salud.unm.edu	Sperling, Anne/ACZ-2351-2022	Sperling, Anne I./0000-0002-4265-9212	American Heart Association [09SDG2260379]; American Cancer Society from University of New Mexico; National Institutes of Health [5R01AI097202]; Spatiotemporal Modeling Center (STMC); Center for Evolutionary and Theoretical Immunology (CETI) at the University of New Mexico; UNM Cancer Center; Irvington Institute Fellowship Program of the Cancer Research Institute; NSF [1038682]; DARPA CRASH [P-1070-113237]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097202] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Cancer Society from University of New Mexico; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spatiotemporal Modeling Center (STMC); Center for Evolutionary and Theoretical Immunology (CETI) at the University of New Mexico; UNM Cancer Center; Irvington Institute Fellowship Program of the Cancer Research Institute; NSF(National Science Foundation (NSF)); DARPA CRASH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a Scientist Development Grant #09SDG2260379 from the American Heart Association (J.L.C.), an Internal Research Grant from the American Cancer Society from University of New Mexico (J.L.C.) and National Institutes of Health Grant 5R01AI097202 (J.L.C.). Postdoctoral support was received from the Spatiotemporal Modeling Center (STMC) and Center for Evolutionary and Theoretical Immunology (CETI) at the University of New Mexico (F. A. B.), and the UNM Cancer Center (S.R.O.) and the Irvington Institute Fellowship Program of the Cancer Research Institute to (J.L.C.). M. M. is supported by NSF EF #1038682 and DARPA CRASH #P-1070-113237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Bauer B, 2001, J BIOL CHEM, V276, P31627, DOI 10.1074/jbc.M103098200; Bauer B, 2000, EUR J IMMUNOL, V30, P3645, DOI 10.1002/1521-4141(200012)30:12<3645::AID-IMMU3645>3.0.CO;2-#; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Cannon JL, 2011, MOL BIOL CELL, V22, P954, DOI 10.1091/mbc.E10-07-0586; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Chen EJH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052368; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Faroudi M, 2010, BLOOD, V116, P5536, DOI 10.1182/blood-2010-08-299438; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Freeley M, 2005, BIOCHEM BIOPH RES CO, V334, P619, DOI 10.1016/j.bbrc.2005.06.136; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Liu Y, 2012, BLOOD, V119, P445, DOI 10.1182/blood-2011-07-368860; Manicassamy S, 2006, J MOL BIOL, V355, P347, DOI 10.1016/j.jmb.2005.10.043; Martinelli S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00084; Mody PD, 2007, BLOOD, V110, P2974, DOI 10.1182/blood-2007-01-065276; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Norman MU, 2005, TISSUE ANTIGENS, V66, P163, DOI 10.1111/j.1399-0039.2005.00434.x; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Ratner S, 1997, J IMMUNOL, V159, P1063; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Shahabi NA, 2007, J LEUKOC BIOL; Shahabi NA, 2008, J LEUKOCYTE BIOL, V83, P663, DOI 10.1189/jlb.0607420; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Skvara H, 2008, J CLIN INVEST, V118, P3151, DOI 10.1172/JCI35636; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; SOUTHERN C, 1995, IMMUNOLOGY, V84, P326; Sperling AI, 1998, J IMMUNOL, V161, P6459; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thorp KM, 1996, IMMUNOLOGY, V87, P434, DOI 10.1046/j.1365-2567.1996.486567.x; Volkov Y, 1998, J IMMUNOL, V161, P6487; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang XY, 1999, J IMMUNOL, V162, P3378; Ward SG, 2009, BIOCHEM J, V418, P13, DOI 10.1042/BJ20081969; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	55	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78940	10.1371/journal.pone.0078940	http://dx.doi.org/10.1371/journal.pone.0078940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250818	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200051
J	Rajapakse, BN; Neeman, T; Dawson, AH				Rajapakse, Bishan N.; Neeman, Teresa; Dawson, Andrew H.			The Effectiveness of a 'Train the Trainer' Model of Resuscitation Education for Rural Peripheral Hospital Doctors in Sri Lanka	PLOS ONE			English	Article							BASIC LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; CPR PERFORMANCE; MANAGEMENT; SKILLS; RELIABILITY; COMPETENCE; PATTERNS; FEEDBACK; STUDENTS	Background: Sri Lankan rural doctors based in isolated peripheral hospitals routinely resuscitate critically ill patients but have difficulty accessing training. We tested a train-the-trainer model that could be utilised in isolated rural hospitals. Methods: Eight selected rural hospital non-specialist doctors attended a 2-day instructor course. These "trained trainers" educated their colleagues in advanced cardiac life support at peripheral hospital workshops and we tested their students in resuscitation knowledge and skills pre and post training, and at 6- and 12-weeks. Knowledge was assessed through 30 multiple choice questions (MCQ), and resuscitation skills were assessed by performance in a video recorded simulated scenario of a cardiac arrest using a Resuci Anne Skill Trainer mannequin. Results/Discussion/Conclusion: Fifty seven doctors were trained. Pre and post training assessment was possible in 51 participants, and 6-week and 12-week follow up was possible for 43, and 38 participants respectively. Mean MCQ scores significantly improved over time (p<0.001), and a significant improvement was noted in "average ventilation volume", "compression count", and "compressions with no error", "adequate depth", "average depth", and "compression rate" (p<0.01). The proportion of participants with compression depth >= 40mm increased post intervention (p<0.05) and at 12-week follow up (p<0.05), and proportion of ventilation volumes between 400-1000mls increased post intervention (p<0.001). A significant increase in the proportion of participants who "checked for responsiveness", "opened the airway", "performed a breathing check", who used the "correct compression ratio", and who used an "appropriate facemask technique" was also noted (p<0.001). A train-the-trainer model of resuscitation education was effective in improving resuscitation knowledge and skills in Sri Lankan rural peripheral hospital doctors. Improvement was sustained to 12 weeks for most components of resuscitation knowledge and skills. Further research is needed to identify which components of training are most effective in leading to sustained improvement in resuscitation.	[Rajapakse, Bishan N.; Dawson, Andrew H.] Australian Natl Univ, Canberra, ACT, Australia; [Rajapakse, Bishan N.] Univ Peradeniya, South Asian Clin Toxicol Res Collaborat, Peradeniya, Sri Lanka; [Neeman, Teresa] Australian Natl Univ, Stat Consulting Unit, Canberra, ACT, Australia; [Dawson, Andrew H.] Univ Sydney, Royal Prince Alfred Hosp, Cent Clin Sch, Sydney, NSW 2006, Australia	Australian National University; University of Peradeniya; Australian National University; University of Sydney	Rajapakse, BN (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	bishan.rajapakse@gmail.com	Dawson, Andrew H/U-8041-2019	Dawson, Andrew H/0000-0002-8047-397X	international collaborative research Wellcome Trust/National Health and Medical Research Council [GR071669]	international collaborative research Wellcome Trust/National Health and Medical Research Council	This research was funded by an international collaborative research Wellcome Trust/National Health and Medical Research Council grant GR071669. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; Altintas KH, 2005, TOHOKU J EXP MED, V205, P157, DOI 10.1620/tjem.205.157; Arnold JL, 2005, EMERG MED CLIN N AM, V23, P133, DOI 10.1016/j.emc.2004.10.001; Aslan D, 2006, EUR J EMERG MED, V13, P9, DOI 10.1097/00063110-200602000-00003; Brennan RT, 1996, RESUSCITATION, V32, P85, DOI 10.1016/0300-9572(96)00967-7; Couper I D, 2005, Rural Remote Health, V5, P459; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; Delasobera BE, 2010, RESUSCITATION, V81, P217, DOI 10.1016/j.resuscitation.2009.10.013; Donnelly P, 2000, RESUSCITATION, V45, P195, DOI 10.1016/S0300-9572(00)00186-6; Eddleston M, 2000, QJM-INT J MED, V93, P715, DOI 10.1093/qjmed/93.11.715; Eddleston M, 2006, QJM-INT J MED, V99, P513, DOI 10.1093/qjmed/hcl065; Eddleston M, 2004, BMJ-BRIT MED J, V328, P42, DOI 10.1136/bmj.328.7430.42; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Enweronu-Laryea C, 2009, RESUSCITATION, V80, P1308, DOI 10.1016/j.resuscitation.2009.08.005; Finn J, 2010, RESUSCITATION, V81, P790, DOI 10.1016/j.resuscitation.2010.05.010; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Hazinski MF, 2005, CIRCULATION, V112, pIV206, DOI 10.1161/CIRCULATIONAHA.105.170809; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Krautter M, 2011, TEACH LEARN MED, V23, P244, DOI 10.1080/10401334.2011.586917; KROMANN CB, 2009, ADV HLTH SCI ED THEO; Kromann CB, 2009, MED EDUC, V43, P21, DOI 10.1111/j.1365-2923.2008.03245.x; Kularatne SAM, 2002, POSTGRAD MED J, V78, P276, DOI 10.1136/pmj.78.919.276; Mpotos N, 2011, RESUSCITATION, V82, P896, DOI 10.1016/j.resuscitation.2011.02.024; Napier F, 2009, RESUSCITATION, V80, P1034, DOI 10.1016/j.resuscitation.2009.04.043; Nolan JP, 2010, RESUSCITATION, V81, pE1, DOI 10.1016/j.resuscitation.2010.08.002; O'Reilly GM, 2011, EMERG MED AUSTRALAS, V23, P632, DOI 10.1111/j.1742-6723.2011.01459.x; Opiyo N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001599; Perkins GD, 2008, RESUSCITATION, V77, P69, DOI 10.1016/j.resuscitation.2007.10.012; Perkins GD, 2006, INTENS CARE MED, V32, P1632, DOI 10.1007/s00134-006-0273-8; Perkins GD, 2010, RESUSCITATION, V81, P877, DOI 10.1016/j.resuscitation.2010.03.019; Perkins GD, 2002, INTENS CARE MED, V28, P698, DOI 10.1007/s00134-002-1291-9; Rajacich D, 2001, J Contin Educ Nurs, V32, P27; RAJAPAKSE BN, 2012, TXB EMERGENCY MED; Ringsted C, 2007, RESUSCITATION, V75, P153, DOI 10.1016/j.resuscitation.2007.03.003; Rosenthal ME, 2006, CHEST, V129, P1453, DOI 10.1378/chest.129.6.1453; Semeraro F, 2006, RESUSCITATION, V68, P101, DOI 10.1016/j.resuscitation.2005.06.011; Senarathna L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-593; Senarathna L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-373; Spooner BB, 2007, RESUSCITATION, V73, P417, DOI 10.1016/j.resuscitation.2006.10.017; Tweed M, 2001, RESUSCITATION, V51, P179, DOI 10.1016/S0300-9572(01)00404-X; WALKER M, 2004, POCKET GUIDE TEACHIN; Wayne DB, 2005, TEACH LEARN MED, V17, P210; Whitfield RH, 2003, RESUSCITATION, V59, P291, DOI 10.1016/S0300-9572(03)00246-6; 2010, CIRCULATION, V122, pS606, DOI DOI 10.1161/CIR.0B013E3181FE3E4C	45	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79491	10.1371/journal.pone.0079491	http://dx.doi.org/10.1371/journal.pone.0079491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255702	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200067
J	Lindeque, PK; Parry, HE; Harmer, RA; Somerfield, PJ; Atkinson, A				Lindeque, Penelope K.; Parry, Helen E.; Harmer, Rachel A.; Somerfield, Paul J.; Atkinson, Angus			Next Generation Sequencing Reveals the Hidden Diversity of Zooplankton Assemblages	PLOS ONE			English	Article							SPECIES IDENTIFICATION; COPEPOD DIVERSITY; MOLECULAR METHOD; COMMUNITY; LARVAE; ABUNDANCE; ATLANTIC; PATTERNS; BIOSPHERE; L4	Background: Zooplankton play an important role in our oceans, in biogeochemical cycling and providing a food source for commercially important fish larvae. However, difficulties in correctly identifying zooplankton hinder our understanding of their roles in marine ecosystem functioning, and can prevent detection of long term changes in their community structure. The advent of massively parallel next generation sequencing technology allows DNA sequence data to be recovered directly from whole community samples. Here we assess the ability of such sequencing to quantify richness and diversity of a mixed zooplankton assemblage from a productive time series site in the Western English Channel. Methodology/Principle Findings: Plankton net hauls (200 mu m) were taken at the Western Channel Observatory station L4 in September 2010 and January 2011. These samples were analysed by microscopy and metagenetic analysis of the 18S nuclear small subunit ribosomal RNA gene using the 454 pyrosequencing platform. Following quality control a total of 419,041 sequences were obtained for all samples. The sequences clustered into 205 operational taxonomic units using a 97% similarity cut-off. Allocation of taxonomy by comparison with the National Centre for Biotechnology Information database identified 135 OTUs to species level, 11 to genus level and 1 to order, <2.5% of sequences were classified as unknowns. By comparison a skilled microscopic analyst was able to routinely enumerate only 58 taxonomic groups. Conclusions: Metagenetics reveals a previously hidden taxonomic richness, especially for Copepoda and hard-to-identify meroplankton such as Bivalvia, Gastropoda and Polychaeta. It also reveals rare species and parasites. We conclude that Next Generation Sequencing of 18S amplicons is a powerful tool for elucidating the true diversity and species richness of zooplankton communities. While this approach allows for broad diversity assessments of plankton it may become increasingly attractive in future if sequence reference libraries of accurately identified individuals are better populated.	[Lindeque, Penelope K.; Parry, Helen E.; Harmer, Rachel A.; Somerfield, Paul J.; Atkinson, Angus] Plymouth Marine Lab, Plymouth, Devon, England	Plymouth Marine Laboratory	Lindeque, PK (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.	pkw@pml.ac.uk	Somerfield, Paul J/J-9189-2014; Lindeque, Penelope/AAE-9193-2019	Somerfield, Paul J/0000-0002-7581-5621; Lindeque, Penelope/0000-0003-1789-7515	EU INTERREG IV CHARM 3 project [4037/1938]; Natural Environment Research Council [R8-H12-84]; NERC [pml010009, pml010004] Funding Source: UKRI; Natural Environment Research Council [pml010009, pml010004] Funding Source: researchfish	EU INTERREG IV CHARM 3 project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was in part funded by the EU INTERREG IV CHARM 3 project (www.charm-project.org)(Management number 4037/1938) and the Natural Environment Research Council National Capability funding for the Western Channel Observatory (Agreement number R8-H12-84). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Batchelder HP, 2012, PROG OCEANOGR, V97, P15, DOI 10.1016/j.pocean.2011.11.010; Beaugrand G, 2003, FISH OCEANOGR, V12, P270, DOI 10.1046/j.1365-2419.2003.00248.x; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Boyko Christopher B., 2009, Crustacean Issues, V18, P197; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; Bucklin A, 2004, SCI PLAN CENSUS MARI; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke K.R, 2006, PRIMER V6 USER MANUA; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Darwin CR, 1839, ZOOLOGY VOYAGE HM SH; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eloire D, 2010, J PLANKTON RES, V32, P657, DOI 10.1093/plankt/fbq009; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gaspar JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060458; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hare MP, 2000, MAR BIOL, V137, P953, DOI 10.1007/s002270000402; Harris R, 2000, ICES ZOOPLANKTON MET; Harris R, 2010, J PLANKTON RES, V32, P577, DOI 10.1093/plankt/fbq021; Heimeier D, 2010, MAR GENOM, V3, P165, DOI 10.1016/j.margen.2010.09.004; Highfield JM, 2010, J PLANKTON RES, V32, P681, DOI 10.1093/plankt/fbp139; Hill RS, 2001, MAR BIOL, V139, P279; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Howson CM, 1997, SPECIES DIRECTORY MA; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Kabata Z, 1979, PARASITIC COPEPODA B, pXii; Liang BH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026745; Lindeque PK, 2013, MAR BIOL, V160, P737, DOI 10.1007/s00227-012-2108-1; Lindeque PK, 2006, J PLANKTON RES, V28, P221, DOI 10.1093/plankt/fbi115; Lindeque PK, 1999, MAR BIOL, V133, P91, DOI 10.1007/s002270050446; Machida RJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-438; MBA (Marine Biological Association), 1957, PLYM MAR FAUN; McEvoy A, 2012, PLYMOUTH MAR LAB, DOI [10.1594/PANGAEA.778092, DOI 10.1594/PANGAEA.778092]; Nielsen S.-O., 1970, Sarsia, VNo. 42,1970, P17; Nogueira E, 2012, PROG OCEANOGR, V97, P92, DOI 10.1016/j.pocean.2011.11.009; O'Rorke R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042757; Pan M, 2008, MAR BIOL, V153, P859, DOI 10.1007/s00227-007-0858-y; Parry HE, 2013, PLYMOUTH MAR LAB, DOI [10.1594/PANGAEA.817188, DOI 10.1594/PANGAEA.817188]; PINGREE RD, 1978, J GEOPHYS RES-OCEANS, V83, P4615, DOI 10.1029/JC083iC09p04615; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Postel L., 2000, P83, DOI 10.1016/B978-012327645-2/50005-0; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ranasinghe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040875; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Skovgaard A, 2005, PROTIST, V156, P413, DOI 10.1016/j.protis.2005.08.002; Skovgaard A, 2005, AQUAT MICROB ECOL, V38, P93, DOI 10.3354/ame038093; Smyth TJ, 2010, J PLANKTON RES, V32, P585, DOI 10.1093/plankt/fbp128; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; THEODORIDES J, 1989, ADV MAR BIOL, V25, P117; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Vandepitte L, 2010, HYDROBIOLOGIA, V644, P1, DOI 10.1007/s10750-010-0108-z; Wang S, 2006, J PLANKTON RES, V28, P375, DOI 10.1093/plankt/fbi122; Ward BA, 2012, LIMNOL OCEANOGR, V57, P1877, DOI 10.4319/lo.2012.57.6.1877; White JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038204; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037	69	128	140	3	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e81327	10.1371/journal.pone.0081327	http://dx.doi.org/10.1371/journal.pone.0081327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244737	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000327162900088
J	Pan, S; Yu, ZX; Ma, YT; Liu, F; Yang, YN; Ma, X; Fu, ZY; Li, XM; Xie, X; Chen, Y; Chen, B; He, CH				Pan, Shuo; Yu, Zi-Xiang; Ma, Yi-Tong; Liu, Fen; Yang, Yi-Ning; Ma, Xiang; Fu, Zhen-Yan; Li, Xiao-Mei; Xie, Xiang; Chen, You; Chen, Bangdang; He, Chun-Hui			Appropriate Body Mass Index and Waist Circumference Cutoffs for Categorization of Overweight and Central Adiposity among Uighur Adults in Xinjiang	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; OBESITY; FAT; NUTRITION; STATEMENT; TAIWANESE; COUNCIL	Objective: The current overweight and central adiposity guidelines based on Western populations were not consistent with many studied based on the Asian populations. Uighur people live in Xinjiang Uighur Autonomous Region which is located in the center of Asia. Their overweight and central cutoffs were largely unknown. We aimed to identify cutoffs for body mass index (BMI; in kg/m(2)) and waist circumference (WC; in cm) for categorization of overweight and central adiposity among Uighur adults in Xinjiang. Methods: 4767 Uighur participants were selected from the Cardiovascular Risk Survey (CRS) which was carried out from October 2007 to March 2010. The age of the participants were from 35 to 101 years old with the mean age of 50.09 years. Anthropometric data, blood pressure, serum concentration of serum total cholesterol, triglyceride, low density lipoprotein (LDL), high density lipoprotein (HDL) and fasting glucose were documented. The prevalence, sensitivity, specificity and distance on the receiver operating characteristic (ROC) curve of each BMI and waist circumference values were calculated. Results: The prevalence of hypertension, hypercholesterolemia and hypertriglyceridemia were higher with higher BMI for both men and women. The prevalence of hypertension and hypercholesterolemia were higher with higher waist circumference for both men and women. In women, the prevalence of hypertriglyceridemia was noticed to increase as the waist circumference increased. The shortest distance in the receiver operating characteristic curves for hypertension, dyslipidemia, diabetes, or >= 2 of these risk factors suggested a BMI cutoff of 26 and a waist circumference cutoff of 90 cm for both men and women. Conclusions: Higher cutoffs for BMI and waist circumference are needed in the identification of Uighur patients at high risk of cardiovascular disease.	[Pan, Shuo; Yu, Zi-Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Ma, Xiang; Fu, Zhen-Yan; Li, Xiao-Mei; Xie, Xiang; Chen, You; He, Chun-Hui] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Pan, Shuo; Yu, Zi-Xiang; Ma, Yi-Tong; Liu, Fen; Yang, Yi-Ning; Ma, Xiang; Fu, Zhen-Yan; Li, Xiao-Mei; Xie, Xiang; Chen, You; Chen, Bangdang; He, Chun-Hui] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		Science and Technology Planning Project of Xinjiang Uygur Autonomous Region [201233138]	Science and Technology Planning Project of Xinjiang Uygur Autonomous Region	This work was supported by Science and Technology Planning Project of Xinjiang Uygur Autonomous Region (201233138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 1992, AM J HYPERTENS, V5, P207; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Government Office for Science, 2008, FOR TACKL OB FUT 3 C; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Ito H, 2003, INT J OBESITY, V27, P232, DOI 10.1038/sj.ijo.802226; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lavie CJ, 2003, J AM COLL CARDIOL, V42, P677, DOI 10.1016/S0735-1097(03)00784-8; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Li G, 2002, Obes Rev, V3, P167, DOI 10.1046/j.1467-789X.2002.00067.x; Logue J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c154; Manson JE, 2003, JAMA-J AM MED ASSOC, V289, P229, DOI 10.1001/jama.289.2.229; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Moon O R, 2002, Obes Rev, V3, P191; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Samsen Maiyadhaj, 2012, Journal of the Medical Association of Thailand, V95, P1156; Vikram NK, 2003, NUTRITION, V19, P503, DOI 10.1016/S0899-9007(02)01083-3; Walker A., 2003, COST DOING NOTHING E; WHO, 1998, OBES RES, V6, pS51; WHO, 2000, ASIA PACIFIC PERSPEC, P1; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; Xie X, 2011, BLOOD PRESSURE, V20, P232, DOI 10.3109/08037051.2011.566244; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	36	21	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80185	10.1371/journal.pone.0080185	http://dx.doi.org/10.1371/journal.pone.0080185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244645	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900066
J	Zhang, ZX; Zhang, SL; Huang, X; Orwig, KE; Sheng, Y				Zhang, Zhengxing; Zhang, Siliang; Huang, Xin; Orwig, Kyle E.; Sheng, Yi			Rapid Assembly of Customized TALENs into Multiple Delivery Systems	PLOS ONE			English	Article							EFFECTOR NUCLEASES TALENS; MEDIATED BAC TRANSGENESIS; HIGH-EFFICIENCY; GENE KNOCKOUT; FUNCTIONAL-ANALYSIS; GENOME; MOUSE; GENERATION; ENDONUCLEASE; PIGGYBAC	Transcriptional activator-like effector nucleases (TALENs) have become a powerful tool for genome editing. Here we present an efficient TALEN assembly approach in which TALENs are assembled by direct Golden Gate ligation into Gateway (R) Entry vectors from a repeat variable di-residue (RVD) plasmid array. We constructed TALEN pairs targeted to mouse Ddx3 subfamily genes, and demonstrated that our modified TALEN assembly approach efficiently generates accurate TALEN moieties that effectively introduce mutations into target genes. We generated "user friendly" TALEN Entry vectors containing TALEN expression cassettes with fluorescent reporter genes that can be efficiently transferred via Gateway (LR) recombination into different delivery systems. We demonstrated that the TALEN Entry vectors can be easily transferred to an adenoviral delivery system to expand application to cells that are difficult to transfect. Since TALENs work in pairs, we also generated a TALEN Entry vector set that combines a TALEN pair into one PiggyBac transposon-based destination vector. The approach described here can also be modified for construction of TALE transcriptional activators, repressors or other functional domains.	[Zhang, Zhengxing; Zhang, Siliang; Huang, Xin; Orwig, Kyle E.; Sheng, Yi] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst & Fdn, Pittsburgh, PA 15260 USA; [Huang, Xin] Univ Pittsburgh, Womens Canc Res Ctr, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sheng, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst & Fdn, Pittsburgh, PA 15260 USA.	shengy@upmc.edu		Orwig, Kyle/0000-0002-7952-8419	National Institutes of Health [RR31300, HD055475]; Magee-Womens Research Institute and Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055475] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR031300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Magee-Womens Research Institute and Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (www.nih.gov) to YS (RR31300) and KEO (HD055475) and by Magee-Womens Research Institute and Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, GENE THER, V12, pS18, DOI 10.1038/sj.gt.3302612; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Baxter S, 2012, NUCLEIC ACIDS RES, V40, P7985, DOI 10.1093/nar/gks502; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237; Christian ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045383; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Davies B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060216; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Engler C, 2011, METHODS MOL BIOL, V729, P167, DOI 10.1007/978-1-61779-065-2_11; Friddle CJ, 2003, COLD SPRING HARB SYM, V68, P311, DOI 10.1101/sqb.2003.68.311; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Jacoby K, 2012, NUCLEIC ACIDS RES, V40, P4954, DOI 10.1093/nar/gkr1303; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Li MA, 2013, MOL CELL BIOL, V33, P1317, DOI 10.1128/MCB.00670-12; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li M, 2012, AM J STEM CELLS, V1, P75; Li RB, 2013, DIS MODEL MECH, V6, P828, DOI 10.1242/dmm.010827; Li Ting, 2013, Methods Mol Biol, V978, P63, DOI 10.1007/978-1-62703-293-3_5; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Qiu ZW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt258; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rostovskaya M, 2013, GENESIS, V51, P135, DOI 10.1002/dvg.22362; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Stroud DA, 2013, J BIOL CHEM, V288, P1685, DOI 10.1074/jbc.C112.436766; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Sung YH, 2012, BMB REP, V45, P686, DOI 10.5483/BMBRep.2012.45.12.242; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Taylor GK, 2012, NUCLEIC ACIDS RES, V40, pW110, DOI 10.1093/nar/gks365; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Uhde-Stone C, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-3; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066459; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	69	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80281	10.1371/journal.pone.0080281	http://dx.doi.org/10.1371/journal.pone.0080281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244669	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327162900076
J	MacDonald, LC; Berger, BW				MacDonald, Logan C.; Berger, Bryan W.			A Polysaccharide Lyase from Stenotrophomonas maltophilia with a Unique, pH-regulated Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofilm; Host-Pathogen Interactions; Hyaluronate; Multifunctional Enzymes; Polysaccharide	EXOTYPE ALGINATE LYASE; CHONDROITIN AC LYASE; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; HYALURONATE LYASE; ESCHERICHIA-COLI; GLUCURONAN LYASE; ACTION PATTERN; PURIFICATION; MECHANISM	Polysaccharide lyases (PLs) catalyze the depolymerization of anionic polysaccharides via a -elimination mechanism. PLs also play important roles in microbial pathogenesis, participating in bacterial invasion and toxin spread into the host tissue via degradation of the host extracellular matrix, or in microbial biofilm formation often associated with enhanced drug resistance. Stenotrophomonas maltophilia is a Gram-negative bacterium that is among the emerging multidrug-resistant organisms associated with chronic lung infections as well as with cystic fibrosis patients. A putative alginate lyase (Smlt1473) from S. maltophilia was heterologously expressed in Escherichia coli, purified in a one-step fashion via affinity chromatography, and activity as well as specificity determined for a range of polysaccharides. Interestingly, Smlt1473 catalyzed the degradation of not only alginate, but poly--d-glucuronic acid and hyaluronic acid as well. Furthermore, the pH optimum for enzymatic activity is substrate-dependent, with optimal hyaluronic acid degradation at pH 5, poly--d-glucuronic acid degradation at pH 7, and alginate degradation at pH 9. Analysis of the degradation products revealed that each substrate was cleaved endolytically into oligomers comprised predominantly of even numbers of sugar groups, with lower accumulation of trimers and pentamers. Collectively, these results imply that Smlt1473 is a multifunctional PL that exhibits broad substrate specificity, but utilizes pH as a mechanism to achieve selectivity.	[MacDonald, Logan C.; Berger, Bryan W.] Lehigh Univ, Program Bioengn, Bethlehem, PA 18015 USA; [Berger, Bryan W.] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University	Berger, BW (corresponding author), B320 Iacocca Hall,111 Res Dr, Bethlehem, PA 18015 USA.	bwb209@lehigh.edu	Berger, Bryan/D-7985-2014	Berger, Bryan/0000-0002-6135-8677	Lehigh University; Lehigh Valley Hospital; Faculty Innovation Grant (FIG); Div Of Chem, Bioeng, Env, & Transp Sys [1227924] Funding Source: National Science Foundation	Lehigh University; Lehigh Valley Hospital; Faculty Innovation Grant (FIG); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by Lehigh University, Lehigh Valley Hospital, and a Faculty Innovation Grant (FIG).	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; [Anonymous], 2012, F225910 ASTM INT, DOI 10.1520/F2259-10R12E01; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Botzki A, 2004, J BIOL CHEM, V279, P45990, DOI 10.1074/jbc.M406146200; BOYD A, 1993, GENE, V131, P1, DOI 10.1016/0378-1119(93)90662-M; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cescutti P, 2011, CARBOHYD RES, V346, P1916, DOI 10.1016/j.carres.2011.05.007; Da Costa A, 2001, APPL ENVIRON MICROB, V67, P5197, DOI 10.1128/AEM.67.11.5197-5203.2001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farrell EK, 2012, BIOCHEMISTRY-US, V51, P10259, DOI 10.1021/bi301425r; Fylstra D, 1998, INTERFACES, V28, P29, DOI 10.1287/inte.28.5.29; GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265, DOI 10.1128/AEM.56.7.2265-2267.1990; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gase K, 1998, BBA-GENE STRUCT EXPR, V1398, P86, DOI 10.1016/S0167-4781(98)00045-1; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heyraud A, 1996, CARBOHYD RES, V291, P115; Hirayama Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000643; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; Isogai A, 1998, CELLULOSE, V5, P153, DOI 10.1023/A:1009208603673; Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005; JANDIK KA, 1994, GLYCOBIOLOGY, V4, P289, DOI 10.1093/glycob/4.3.289; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Konno N, 2008, CELLULOSE, V15, P453, DOI 10.1007/s10570-007-9195-z; Konno N, 2006, CARBOHYD POLYM, V64, P589, DOI 10.1016/j.carbpol.2005.11.015; Konno N, 2009, APPL ENVIRON MICROB, V75, P101, DOI 10.1128/AEM.01749-08; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee SI, 2012, APPL MICROBIOL BIOT, V95, P1643, DOI 10.1007/s00253-012-4266-y; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Miyake O, 2003, PROTEIN EXPRES PURIF, V29, P33, DOI 10.1016/S1046-5928(03)00018-4; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pompilio A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-102; PREISS J, 1962, J BIOL CHEM, V237, P309; PRESTON JF, 1992, J BACTERIOL, V174, P2039, DOI 10.1128/jb.174.6.2039-2042.1992; Ray B, 2006, CARBOHYD POLYM, V66, P408, DOI 10.1016/j.carbpol.2006.03.027; Sambrook J, 2001, MOL CLONING LAB MANU; Sebaihia M, 2006, J BACTERIOL, V188, P6002, DOI 10.1128/JB.01927-05; Shaya D, 2010, J BIOL CHEM, V285, P20051, DOI 10.1074/jbc.M110.101071; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Tahiri C, 2000, CELLULOSE, V7, P177, DOI 10.1023/A:1009276009711; TAYLOR KACC, 1995, APPL BIOCHEM BIOTECH, V53, P207, DOI 10.1007/BF02783496; Tondervik A, 2010, J BIOL CHEM, V285, P35284, DOI 10.1074/jbc.M110.162800; VONHEIJNE G, 1989, PROTEIN ENG, V2, P531, DOI 10.1093/protein/2.7.531; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Xiao L, 2006, WORLD J MICROB BIOT, V22, P81, DOI 10.1007/s11274-005-7713-4; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yoon HJ, 2000, PROTEIN EXPRES PURIF, V19, P84, DOI 10.1006/prep.2000.1226; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c	68	19	22	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					312	325		10.1074/jbc.M113.489195	http://dx.doi.org/10.1074/jbc.M113.489195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257754	Green Published, hybrid			2022-12-25	WOS:000329370900027
J	Kunkler, N; Brandl, R; Brandle, M				Kuenkler, Nora; Brandl, Roland; Braendle, Martin			Changes in Clonal Poplar Leaf Chemistry Caused by Stem Galls Alter Herbivory and Leaf Litter Decomposition	PLOS ONE			English	Article							ADAPTIVE SIGNIFICANCE; SOLIDAGO-ALTISSIMA; SELF-SELECTION; PLANT; NUTRIENT; INSECTS; RESISTANCE; LEAVES; CONSEQUENCES; ARCHITECTURE	Gall-inducing insects are highly specialized herbivores that modify the phenotype of their host plants. Beyond the direct manipulation of plant morphology and physiology in the immediate environment of the gall, there is also evidence of plant-mediated effects of gall-inducing insects on other species of the assemblages and ecosystem processes associated with the host plant. We analysed the impact of gall infestation by the aphid Pemphigus spirothecae on chemical leaf traits of clonal Lombardy poplars (Populus nigra var. italica) and the subsequent effects on intensity of herbivory and decomposition of leaves across five sites. We measured the herbivory of two feeding guilds: leaf-chewing insects that feed on the blade (e. g. caterpillars and sawfly larvae) and skeletonising insects that feed on the mesophyll of the leaves (e. g. larvae of beetles). Galled leaves had higher phenol (35%) and lower nitrogen and cholorophyll contents (35% respectively 37%) than non-galled leaves, and these differences were stronger in August than in June. Total herbivory intensity was 27% higher on galled than on non-galled leaves; damage by leaf chewers was on average 61% higher on gall infested leaves, whereas damage by skeletonising insects was on average 39% higher on non-galled leaves. After nine months the decomposition rate of galled leaf litter was 15% lower than that of non-galled leaf litter presumably because of the lower nitrogen content of the galled leaf litter. This indicated after-life effects of gall infestation on the decomposers. We found no evidence for galling x environment interactions.	[Kuenkler, Nora; Brandl, Roland; Braendle, Martin] Univ Marburg, Fac Biol, Dept Ecol Anim Ecol, Marburg, Germany	Philipps University Marburg	Brandle, M (corresponding author), Univ Marburg, Fac Biol, Dept Ecol Anim Ecol, Marburg, Germany.	braendle@staff.uni-marburg.de						ABRAHAMSON WG, 1986, OECOLOGIA, V68, P174, DOI 10.1007/BF00384784; ABRAHAMSON WG, 1991, BIOCHEM SYST ECOL, V19, P615, DOI 10.1016/0305-1978(91)90077-D; Ananthakrishnan T.N., 1984, BIOL GALL INSECTS; Bates D., 2011, PACKAGE LME4 LINEAR; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Bresinsky A., 2008, STRASBURGER LEHRBUCH; CHOUDHURY D, 1988, OIKOS, V51, P389, DOI 10.2307/3565324; Cooper WR, 2009, ENVIRON ENTOMOL, V38, P417, DOI 10.1603/022.038.0215; CORNELL HV, 1983, AM MIDL NAT, V110, P225, DOI 10.2307/2425263; Crutsinger GM, 2008, PLANT SOIL, V303, P95, DOI 10.1007/s11104-007-9490-3; Dawkins, 1999, EXTENDED PHENOTYPE L, P327; Dickson LL, 1996, OECOLOGIA, V106, P400, DOI 10.1007/BF00334568; FAY PA, 1993, OECOLOGIA, V93, P114, DOI 10.1007/BF00321200; FERNANDES GW, 1992, OECOLOGIA, V90, P14, DOI 10.1007/BF00317803; Fernandes GW, 2001, ECOL ENTOMOL, V26, P46, DOI 10.1046/j.1365-2311.2001.00290.x; Findlay S, 1996, ECOL APPL, V6, P269, DOI 10.2307/2269570; Folin O, 1927, J BIOL CHEM, V73, P627; Foss LK, 2004, ECOL ENTOMOL, V29, P273, DOI 10.1111/j.1365-2311.2004.00595.x; Frost CJ, 2012, FUNCT ECOL, V26, P628, DOI 10.1111/j.1365-2435.2012.01986.x; Grime JP, 1996, OIKOS, V77, P489, DOI 10.2307/3545938; Hartley SE, 1998, OECOLOGIA, V113, P492, DOI 10.1007/s004420050401; HARTLEY SE, 1992, J ANIM ECOL, V61, P113, DOI 10.2307/5514; Hartley SE, 1999, OIKOS, V84, P333, DOI 10.2307/3546731; Holden M, 1965, CHLOROPHYLL CHEM BIO, P462; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; KIRST GO, 1974, BIOCHEM PHYSIOL PFL, V165, P445; Larson KC, 1997, OECOLOGIA, V109, P575, DOI 10.1007/s004420050119; Larson KC, 1998, OECOLOGIA, V115, P161, DOI 10.1007/s004420050503; Nakamura M, 2003, FUNCT ECOL, V17, P851, DOI 10.1111/j.1365-2435.2003.00786.x; Nyman T, 2000, EVOLUTION, V54, P526, DOI 10.1111/j.0014-3820.2000.tb00055.x; Raman Anantanarayanan, 2005, P1; Rathmacher G, 2008, TREES-STRUCT FUNCT, V23, P573; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; SCHIFF NM, 1989, ENTOMOL EXP APPL, V52, P261, DOI 10.1007/BF00414052; Schoonhoven L. M., 2005, Insect-plant biology; Schopfer P., 2010, PFLANZENPHYSIOLOGIE; Schweitzer JA, 2005, OIKOS, V110, P133, DOI 10.1111/j.0030-1299.2005.13650.x; Shorthouse JD, 2005, BASIC APPL ECOL, V6, P407, DOI 10.1016/j.baae.2005.07.001; Simpson S.J., 1990, P111; Stiling P, 1996, ECOLOGY, V77, P2212, DOI 10.2307/2265714; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Stone GN, 1998, P ROY SOC B-BIOL SCI, V265, P979, DOI 10.1098/rspb.1998.0387; Tooker JF, 2008, NEW PHYTOL, V178, P657, DOI 10.1111/j.1469-8137.2008.02392.x; Urban J., 2002, Journal of Forest Science (Prague), V48, P248; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; WEIS AE, 1988, ANNU REV ENTOMOL, V33, P467, DOI 10.1146/annurev.en.33.010188.002343; WESTPHAL E, 1981, CAN J BOT, V59, P875, DOI 10.1139/b81-122; WILLIAMS AG, 1986, ECOLOGY, V67, P1619, DOI 10.2307/1939093; Wimmer CA, 2001, KURZE GESCH SAULENPA; Wool D, 1999, ENTOMOL EXP APPL, V91, P183, DOI 10.1023/A:1003609609395; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; ZUCKER WV, 1982, ECOLOGY, V63, P972, DOI 10.2307/1937237	53	16	17	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79994	10.1371/journal.pone.0079994	http://dx.doi.org/10.1371/journal.pone.0079994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260333	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900055
J	Tschinkel, WR				Tschinkel, Walter R.			The Morphometry of Solenopsis Fire Ants	PLOS ONE			English	Article							WORKER CASTE; HARVESTER ANT; TROPICAL ANT; COLONY SIZE; ALLOMETRY; HYMENOPTERA; POLYMORPHISM; EVOLUTION; SOCIOGENESIS; FORMICIDAE	Size-related changes of body shape were explored in 15 polymorphic species of Solenopsis fire ants by analyzing body weight along with linear measurements of 24 body parts. Log regression slopes were used to detect changes of shape with increasing size. Within species, the largest workers weighed from about 5 to 30-fold as much as the smallest. The range of within-species body lengths varied from 1.6 mm to 4 mm. As worker size increased, the gaster tended to make up a larger proportion of body length, usually at the cost of the petiole, and rarely at the cost of head length or mesosoma length. In most, the relative volume of the gaster increased and that of the head and mesosoma decreased. Most also showed an increasingly "humped'' mesosoma. For all species, head shape changed from barrel-shaped to heart-shaped as worker size increased. Antennae became relatively shorter as the relative size of the club decreased. Shape changes of the legs were more variable. S. geminata was exceptional in the extreme nature of its head shape change, and was the only species in which relative head volume increased and gaster volume decreased with increasing body size. With the exception of S. geminata, the allometric rules governing shape are remarkably similar across species, suggesting a genus-level developmental scheme that is not easily modified by evolution. It also suggests that the evolution of shape is highly constrained by these conserved growth rules, and that it acts primarily (perhaps only) through allometric growth. The results are discussed in light of the growth of imaginal discs in a resource-limited body (the pupa). The substantial variation of allometries within species and across localities is also discussed in relation to using allometric patterns to identify species or to construct phylogenies.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Science Foundation (NSF) [IBN 93-17853, NSF 0212085]; United States Department of Agriculture-National Research Initiative (USDA-NRI) [2003-01453]	National Science Foundation (NSF)(National Science Foundation (NSF)); United States Department of Agriculture-National Research Initiative (USDA-NRI)(United States Department of Agriculture (USDA))	This work was carried out during the tenure of National Science Foundation (NSF) grants IBN 93-17853, NSF 0212085, and United States Department of Agriculture-National Research Initiative (USDA-NRI) Grant 2003-01453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9401; Breed MD, 2002, INSECT SOC, V49, P125, DOI 10.1007/s00040-002-8290-2; Bruce AI, 2012, P ROY SOC B-BIOL SCI, V279, P2442, DOI 10.1098/rspb.2011.2583; BUSHER CE, 1985, ANN ENTOMOL SOC AM, V78, P221, DOI 10.1093/aesa/78.2.221; CALABI P, 1989, J INSECT PHYSIOL, V35, P643, DOI 10.1016/0022-1910(89)90127-3; CARROLL CR, 1984, OECOLOGIA, V61, P388, DOI 10.1007/BF00379640; DINIZ JAF, 1994, INSECT SOC, V41, P153, DOI 10.1007/BF01240475; Emlen DJ, 2010, EVOLUTION EMERGING E, P149; Espadaler X, 2001, FUNCT ECOL, V15, P136, DOI 10.1046/j.1365-2435.2001.00490.x; Feener DH, 1988, FUNCT ECOL, V2, P509, DOI 10.2307/2389394; Franks NR, 1987, IND COLL BEH SOC INS, V54, P253; Frears SL, 1996, PHYSIOL ENTOMOL, V21, P212, DOI 10.1111/j.1365-3032.1996.tb00857.x; Holldobler B., 1990, pi; Holldobler B, 2008, SUPERORGANISM BEAUTY; HOWARD R A, 1989, Moscosoa, V5, P216; Huang MH, 2011, INSECT SOC, V58, P539, DOI 10.1007/s00040-011-0176-8; Huxley J, 1932, PROBLEMS RELATIVE GR, P2; Kenne M, 2000, INSECT SOC, V47, P50, DOI 10.1007/s000400050008; Knell RJ, 2009, ECOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-2311.2008.01022.x; Litsinger J. A., 1987, IRRI Research Paper Series, International Rice Research Institute; MOSIMANN JE, 1979, EVOLUTION, V33, P444, DOI 10.1111/j.1558-5646.1979.tb04697.x; Nijhout HF, 1996, AM NAT, V148, P40, DOI 10.1086/285910; Oster G.F., 1978, Monographs in Population Biology, pi; Pie MR, 2007, J ZOOL, V271, P99, DOI 10.1111/j.1469-7998.2006.00239.x; Pitts JP, 2005, ZOOL SCR, V34, P493, DOI 10.1111/j.1463-6409.2005.00203.x; PORTER SD, 1985, ANN ENTOMOL SOC AM, V78, P381, DOI 10.1093/aesa/78.3.381; Powell S, 2006, FUNCT ECOL, V20, P1105, DOI 10.1111/j.1365-2435.2006.01184.x; RISSING SW, 1984, J KANSAS ENTOMOL SOC, V57, P347; Schoning C, 2005, OIKOS, V110, P231, DOI 10.1111/j.0030-1299.2005.13672.x; Seid MA, 2011, BRAIN BEHAV EVOLUT, V77, P5, DOI 10.1159/000322530; Smith CR, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_32.1; TENNANT LE, 1991, J ENTOMOL SCI, V26, P450, DOI 10.18474/0749-8004-26.4.450; Tobler A, 2010, EVOL DEV, V12, P592, DOI 10.1111/j.1525-142X.2010.00444.x; TRABANINO CR, 1989, TROP AGR, V66, P225; Tschinkel WR, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.2; TSCHINKEL WR, 1988, BEHAV ECOL SOCIOBIOL, V22, P103, DOI 10.1007/BF00303545; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; TSCHINKEL WR, 1995, J ANIM ECOL, V64, P473, DOI 10.2307/5650; Tschinkel WR., 2006, FIRE ANTS; Vogt JT, 1999, J INSECT PHYSIOL, V45, P655, DOI 10.1016/S0022-1910(99)00036-0; Waters JS, 2010, AM NAT, V176, P501, DOI 10.1086/656266; Wehner R, 2007, BRAIN BEHAV EVOLUT, V69, P220, DOI 10.1159/000097057; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; WILSON E O, 1978, Journal of the Kansas Entomological Society, V51, P615; WILSON EO, 1985, FORTS ZOOL, V31, P307; WILSON EO, 1985, SCIENCE, V228, P1489, DOI 10.1126/science.228.4707.1489; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512; WILSON EO, 1979, P AM PHILOS SOC, V123, P204	48	17	18	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79559	10.1371/journal.pone.0079559	http://dx.doi.org/10.1371/journal.pone.0079559			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260250	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900029
J	Aili, A; Hasim, A; Kelimu, A; Guo, X; Mamtimin, B; Abudula, A; Upur, H				Aili, Aixingzi; Hasim, Ayshamgul; Kelimu, Alimujiang; Guo, Xia; Mamtimin, Batur; Abudula, Abuliz; Upur, Halmurat			Association of the Plasma and Tissue Riboflavin Levels with C20orf54 Expression in Cervical Lesions and Its Relationship to HPV16 Infection	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; DNA METHYLATION; DIETARY-INTAKE; CANCER; RISK; FOLATE; CARCINOGENESIS; IDENTIFICATION; TRANSCRIPTION; ANTIOXIDANT	Riboflavin deficiency can cause a variety of metabolic problems that lead to skin and mucosal disorders. Limited evidence suggests that high intake of riboflavin may reduce overall risks of cancer. However, association of this deficiency with cervical cancer and precancerous lesions are still not definitively known. In this study, we characterized the relationship between plasma and tissue riboflavin levels and C20orf54 protein expression in patients with cervical intraepithelial neoplasia (CIN) and cervical squamous cell carcinoma (CSCC) as well as the relationship of these levels with human papillomavirus virus 16, 18 (HPV16/18) infections. High-performance liquid chromatography (HPLC) was used to measure blood riboflavin levels in patients with CIN and CSCC, and an enzyme-linked immunosorbent assay (ELISA) was used to determine tissue riboflavin levels in patients with CSCC and matched normal mucous epithelia. The expression of C20orf54 in fresh CSCC and matched tissues were detected by qRT-PCR and western blot, respectively. And it was further confirmed by immunohistochemistry (IHC) with formalin-fixed, paraffin-embedded CIN and CSCC. An HPV genotyping chip was used to analyze HPV infection and typing. The results showed that patients with CIN and CSCC had decreased plasma riboflavin levels as compared with normal controls. There was also significantly decreased riboflavin in tissues from CSCC patients, when compared with normal cervical epithelia. C20orf54 expression were significantly up-regulated in CSCC compared to matched control on both mRNA and protein level. Tissue riboflavin levels were significantly lower in HPV16/18 positive tissue compared with HPV16/18-negative tissue, and an inverse association was found between tissue riboflavin levels and C20orf54 mRNA and protein expression in CSCC. Additionally, C20orf54 was significantly correlated with tumor stages. In conclusion, C20orf54 tend to play a protective role in Uyghur cervical carcinogenesis of which modulating riboflavin absorption, and it is also related with HPV infection.	[Aili, Aixingzi] Xinjiang Med Univ, Affiliated Hosp 1, Dept Gynecol, Urumqi, Xinjiang, Peoples R China; [Hasim, Ayshamgul] Med Univ Xinjiang, Dept Pathol, Urumqi, Xinjiang, Peoples R China; [Kelimu, Alimujiang] Xinjiang Med Univ, Affiliated Hosp 1, Dept Neurosurg, Urumqi, Xinjiang, Peoples R China; [Guo, Xia; Abudula, Abuliz; Upur, Halmurat] Xinjiang Med Univ, Urumqi, Xinjiang, Peoples R China; [Mamtimin, Batur] Xinjiang Med Univ, Pharmaceut Coll, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Upur, H (corresponding author), Xinjiang Med Univ, Urumqi, Xinjiang, Peoples R China.	halmurat@263.net			National Natural Science Foundation of China [81360332]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81360332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ai-fang J, 2012, CANC RES PREVENTION, V39, P467; Ayshamgul H, 2012, PLOS ONE, V9; BROCK KE, 1988, J NATL CANCER I, V80, P580, DOI 10.1093/jnci/80.8.580; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Corneanu LM, 2011, ROM J MORPHOL EMBRYO, V52, P89; De Souza AC, 2006, APOPTOSIS, V11, P1761, DOI 10.1007/s10495-006-9549-2; Queiroz KCD, 2007, CANCER LETT, V258, P126, DOI 10.1016/j.canlet.2007.08.024; Eli M, 2012, WORLD J GASTROENTERO, V18, P3112, DOI 10.3748/wjg.v18.i24.3112; Fujimura M, 2010, J NUTR, V140, P1722, DOI 10.3945/jn.110.128330; Hassan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036273; He YT, 2009, ASIAN PAC J CANCER P, V10, P619; Hernandez BY, 2003, CANCER CAUSE CONTROL, V14, P859, DOI 10.1023/B:CACO.0000003841.54413.98; IARC. International Agency on Research on Cancer, 1995, MON CANC HUM PAP, V64; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Khan NA, 2008, BRIT J CANCER, V99, P408, DOI 10.1038/sj.bjc.6604502; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; LIU TP, 1993, CANCER EPIDEM BIOMAR, V2, P525; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; Murphy SJ, 2010, J NUTR, V140, P1757, DOI 10.3945/jn.110.124362; Petteys BJ, 2011, CLIN CHIM ACTA, V412, P38, DOI 10.1016/j.cca.2010.08.037; Tuan PA, 2012, J AGR FOOD CHEM, V60, P11980, DOI 10.1021/jf3036963; Piyathilake CJ, 2007, NUTRITION, V23, P203, DOI 10.1016/j.nut.2006.12.002; Piyathilake CJ, 2007, NUTRITION, V23, P229, DOI 10.1016/j.nut.2006.12.006; Potischman N, 1996, CANCER CAUSE CONTROL, V7, P113, DOI 10.1007/BF00115643; Powers HJ, 2005, J NUTR, V135, p2960S, DOI 10.1093/jn/135.12.2960S; Prusty BK, 2005, INT J CANCER, V113, P951, DOI 10.1002/ijc.20668; Rosl F, 1997, J VIROL, V71, P362; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Sedjo RL, 2002, CANCER EPIDEM BIOMAR, V11, P353; Selhub J, 2002, J Nutr Health Aging, V6, P39; Shen YH, 2005, CHIN J CHROMATOGR, V23, P538; Shrubsole MJ, 2011, AM J EPIDEMIOL, V173, P1171, DOI 10.1093/aje/kwq491; Siassi F, 2005, CANCER DETECT PREV, V29, P464, DOI 10.1016/j.cdp.2005.08.001; Singh SM, 2003, CLIN GENET, V64, P451, DOI 10.1046/j.1399-0004.2003.00190.x; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Suzuk Lalai, 2006, J XINJIANG MED U, V29, P569; van den Donk M, 2005, CANCER EPIDEM BIOMAR, V14, P1562, DOI 10.1158/1055-9965.EPI-04-0419; Webster RP, 1996, CANCER LETT, V98, P129; Yamamoto S, 2009, J BIOCHEM, V145, P437, DOI 10.1093/jb/mvn181; Yang BH, 2004, INT J CANCER, V109, P418, DOI 10.1002/ijc.11719; Yonezawa A, 2008, AM J PHYSIOL-CELL PH, V295, pC632, DOI 10.1152/ajpcell.00019.2008; Zhu XY, 2006, P NATL ACAD SCI USA, V103, P3581, DOI 10.1073/pnas.0600251103; Ziegler RG, 2007, JNCI-J NATL CANCER I, V99, P1214, DOI 10.1093/jnci/djm105	44	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79937	10.1371/journal.pone.0079937	http://dx.doi.org/10.1371/journal.pone.0079937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260322	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500108
J	Mei, SY				Mei, Suyu			Probability Weighted Ensemble Transfer Learning for Predicting Interactions between HIV-1 and Human Proteins	PLOS ONE			English	Article							GENE ONTOLOGY; DATA SETS; GP120; DATABASE; LOCALIZATION; COEXPRESSION; INFORMATION; ACTIVATION; MECHANISM	Reconstruction of host-pathogen protein interaction networks is of great significance to reveal the underlying microbic pathogenesis. However, the current experimentally-derived networks are generally small and should be augmented by computational methods for less-biased biological inference. From the point of view of computational modelling, data scarcity, data unavailability and negative data sampling are the three major problems for host-pathogen protein interaction networks reconstruction. In this work, we are motivated to address the three concerns and propose a probability weighted ensemble transfer learning model for HIV-human protein interaction prediction (PWEN-TLM), where support vector machine (SVM) is adopted as the individual classifier of the ensemble model. In the model, data scarcity and data unavailability are tackled by homolog knowledge transfer. The importance of homolog knowledge is measured by the ROC-AUC metric of the individual classifiers, whose outputs are probability weighted to yield the final decision. In addition, we further validate the assumption that only the homolog knowledge is sufficient to train a satisfactory model for host-pathogen protein interaction prediction. Thus the model is more robust against data unavailability with less demanding data constraint. As regards with negative data construction, experiments show that exclusiveness of subcellular co-localized proteins is unbiased and more reliable than random sampling. Last, we conduct analysis of overlapped predictions between our model and the existing models, and apply the model to novel host-pathogen PPIs recognition for further biological research.	Shenyang Normal Univ, Software Coll, Shenyang, Peoples R China	Shenyang Normal University	Mei, SY (corresponding author), Shenyang Normal Univ, Software Coll, Shenyang, Peoples R China.	meisygle@gmail.com						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Cheung R, 2008, J IMMUNOL, V180, P6675, DOI 10.4049/jimmunol.180.10.6675; Davis J., 2006, P 23 INT C MACH LEAR, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; De Bodt S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-288; Dong JX, 2005, IEEE T PATTERN ANAL, V27, P603, DOI 10.1109/TPAMI.2005.77; Doolittle J, 2010, VIROL J, V7, P82; Dyer MD, 2007, BIOINFORMATICS, V23, pI159, DOI 10.1093/bioinformatics/btm208; Dyer MD, 2011, INFECT GENET EVOL, V11, P917, DOI 10.1016/j.meegid.2011.02.022; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gibellini D, 2010, BIOCHEM BIOPH RES CO, V401, P429, DOI 10.1016/j.bbrc.2010.09.071; Gupta P, 2011, J MOL BIOL, V410, P681, DOI 10.1016/j.jmb.2011.03.022; Jiang J, 2010, CARDIOVASC RES, V87, P366, DOI 10.1093/cvr/cvq013; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Maetschke SR, 2012, BIOINFORMATICS, V28, P69, DOI 10.1093/bioinformatics/btr610; Mei SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037716; Mei SY, 2012, J THEOR BIOL, V293, P121, DOI 10.1016/j.jtbi.2011.10.015; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Mukhopadhyay A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032289; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Patil A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-100; Platt J., 1999, ADV LARGE MARGIN CLA; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Saha RN, 2007, FREE RADICAL BIO MED, V42, P1866, DOI 10.1016/j.freeradbiomed.2007.03.022; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Tirosh I, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-40; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Vashistha H, 2009, RENAL FAILURE, V31, P303, DOI 10.1080/08860220902780101; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang XQ, 2009, MOL IMMUNOL, V46, P3462, DOI 10.1016/j.molimm.2009.08.001; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026960; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Yu JT, 2010, BIOINFORMATICS, V26, P2610, DOI 10.1093/bioinformatics/btq483; Zhou C, 2011, J BIOL CHEM, V286, P44869, DOI 10.1074/jbc.M111.267393	43	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79606	10.1371/journal.pone.0079606	http://dx.doi.org/10.1371/journal.pone.0079606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260261	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500080
J	Molina-Quiroz, RC; Loyola, DE; Munoz-Villagran, CM; Quatrini, R; Vasquez, CC; Perez-Donoso, JM				Molina-Quiroz, Roberto C.; Loyola, David E.; Munoz-Villagran, Claudia M.; Quatrini, Raquel; Vasquez, Claudio C.; Perez-Donoso, Jose M.			DNA, Cell Wall and General Oxidative Damage Underlie the Tellurite/Cefotaxime Synergistic Effect in Escherichia coli	PLOS ONE			English	Article							STRESS-RESPONSE; ANTIBIOTICS; TELLURITE; SYSTEM; DEATH; MODULATION; PROTEINS; COMPLEX; CLPB	The constant emergence of antibiotic multi-resistant pathogens is a concern worldwide. An alternative for bacterial treatment using nM concentrations of tellurite was recently proposed to boost antibiotic-toxicity and a synergistic effect of tellurite/cefotaxime (CTX) was described. In this work, the molecular mechanism underlying this phenomenon is proposed. Global changes of the transcriptional profile of Escherichia coli exposed to tellurite/CTX were determined by DNA microarrays. Induction of a number of stress regulators (as SoxS), genes related to oxidative damage and membrane transporters was observed. Accordingly, increased tellurite adsorption/uptake and oxidative injuries to proteins and DNA were determined in cells exposed to the mixture of toxicants, suggesting that the tellurite-mediated CTX-potentiating effect is dependent, at least in part, on oxidative stress. Thus, the synergistic tellurite-mediated CTX-potentiating effect depends on increased tellurite uptake/adsorption which results in damage to proteins, DNA and probably other macromolecules. Our findings represent a contribution to the current knowledge of bacterial physiology under antibiotic stress and can be of great interest in the development of new antibiotic-potentiating strategies.	[Molina-Quiroz, Roberto C.; Loyola, David E.; Munoz-Villagran, Claudia M.; Vasquez, Claudio C.] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Mol Microbiol Lab, Santiago, Chile; [Quatrini, Raquel] Fdn Ciencia & Vida, Lab Ecofisiol Microbiana, Santiago, Chile; [Perez-Donoso, Jose M.] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Microbiol & Bionanotechnol Res Grp,Lab Bioquim, Santiago, Chile; [Perez-Donoso, Jose M.] Univ Andres Bello, Fac Ciencias Biol, CBIB, Bionanotechnol & Microbiol Lab, Santiago, Chile	Universidad de Santiago de Chile; Universidad de Chile; Universidad Andres Bello	Vasquez, CC (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Mol Microbiol Lab, Santiago, Chile.	claudio.vasquez@usach.cl; jose.perez@unab.cl	Quatrini, Raquel/GSD-7689-2022; Molina-Quiroz, Roberto C/H-4696-2019; Quatrini, Raquel/S-4099-2019; Pérez-Donoso, José M./G-3668-2013	Molina-Quiroz, Roberto C/0000-0003-3653-7160; Quatrini, Raquel/0000-0003-2600-2605; Pérez-Donoso, José M./0000-0002-9506-1716; Loyola, David/0000-0003-4532-6373	FONDECYT (Fondo Nacional de Investigacion Cientifica y Tecnologica) [1090097, 11110077]; Dicyt (Direccion de Investigacion)-USACH	FONDECYT (Fondo Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Dicyt (Direccion de Investigacion)-USACH	This work was supported by FONDECYT (Fondo Nacional de Investigacion Cientifica y Tecnologica) grants # 1090097 (C. C. V.) and # 11110077 (J.M.P.). Support from Dicyt (Direccion de Investigacion)-USACH is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS SC, 1988, BIOCHEM J, V255, P35, DOI 10.1042/bj2550035; ARIZA RR, 1994, J BACTERIOL, V176, P143, DOI 10.1128/JB.176.1.143-148.1994; Banin E, 2008, P NATL ACAD SCI USA, V105, P16761, DOI 10.1073/pnas.0808608105; Boyd N, 2011, PHARMACOTHERAPY, V31, P1073, DOI 10.1592/phco.31.11.1073; Calderon IL, 2009, MICROBIOL-SGM, V155, P1840, DOI 10.1099/mic.0.026260-0; Castro ME, 2009, BIOCHEM BIOPH RES CO, V380, P148, DOI 10.1016/j.bbrc.2009.01.078; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Halwani M, 2009, INT J PHARMACEUT, V373, P141, DOI 10.1016/j.ijpharm.2009.02.001; Hesketh A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-226; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KOW YW, 1990, MUTAT RES, V235, P147, DOI 10.1016/0921-8777(90)90068-G; Lara-Ortiz T, 2012, CAN J MICROBIOL, V58, P195, DOI [10.1139/W11-118, 10.1139/w11-118]; Lepercq J, 2009, ANTIMICROB AGENTS CH, V53, P2342, DOI 10.1128/AAC.01429-08; LIOCHEV SI, 1993, ARCH BIOCHEM BIOPHYS, V301, P379, DOI 10.1006/abbi.1993.1159; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Los JM, 2010, FEMS IMMUNOL MED MIC, V58, P322, DOI 10.1111/j.1574-695X.2009.00644.x; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Mitchell G, 2012, J ANTIMICROB CHEMOTH, V67, P559, DOI 10.1093/jac/dkr510; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Molina RC, 2010, APPL ENVIRON MICROB, V76, P4901, DOI 10.1128/AEM.00598-10; Molina-Quiroz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035452; ORREN DK, 1992, J BIOL CHEM, V267, P780; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Pringent-Combaret C, 2012, ENVIRON MICROBIOL, V14, P2645; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Renggli S, 2013, J BACTERIOL, V195, P4067, DOI 10.1128/JB.00393-13; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sandoval JM, 2010, BIOMETALS, V23, P623, DOI 10.1007/s10534-010-9316-2; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Syed HC, 2012, INT J MICROBIOL, V2012; Taylor A, 1996, BIOL TRACE ELEM RES, V55, P231, DOI 10.1007/BF02785282; Vidales LE, 2009, J BACTERIOL, V191, P506, DOI 10.1128/JB.01210-08; Voukeng Igor K, 2012, BMC Res Notes, V5, P299, DOI 10.1186/1756-0500-5-299; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Young KD, 1996, J BACTERIOL, V178, P3962, DOI 10.1128/jb.178.13.3962-3966.1996	46	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79499	10.1371/journal.pone.0079499	http://dx.doi.org/10.1371/journal.pone.0079499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260236	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500068
J	Wilson, MC; Kraus, M; Marzban, H; Sarna, JR; Wang, YS; Hawkes, R; Halestrap, AP; Beesley, PW				Wilson, Marieangela C.; Kraus, Michaela; Marzban, Hassan; Sarna, Justyna R.; Wang, Yisong; Hawkes, Richard; Halestrap, Andrew P.; Beesley, Philip W.			The Neuroplastin Adhesion Molecules Are Accessory Proteins That Chaperone the Monocarboxylate Transporter MCT2 to the Neuronal Cell Surface	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IMMUNOGLOBULIN SUPERFAMILY; POSTSYNAPTIC DENSITIES; ANCILLARY PROTEIN; PURKINJE-CELLS; BASIGIN CD147; ZEBRIN-II; EXPRESSION; RAT; BRAIN	Background: The neuroplastins np65 and np55 are two synapse-enriched immunoglobulin (Ig) superfamily adhesion molecules that contain 3 and 2 Ig domains respectively. Np65 is implicated in long term, activity dependent synaptic plasticity, including LTP. Np65 regulates the surface expression of GluR1 receptor subunits and the localisation of GABA(A) receptor subtypes in hippocampal neurones. The brain is dependent not only on glucose but on monocarboxylates as sources of energy. The. monocarboxylate transporters (MCTs) 1-4 are responsible for the rapid proton-linked translocation of monocarboxylates including pyruvate and lactate across the plasma membrane and require association with either embigin or basigin, proteins closely related to neuroplastin, for plasma membrane expression and activity. MCT2 plays a key role in providing lactate as an energy source to neurons. Methodology/Findings: Here we use co-transfection of neuroplastins and monocarboxylate transporters into COS-7 cells to demonstrate that neuroplastins can act as ancillary proteins for MCT2. We also show that Xenopus laevis oocytes contain endogenous neuroplastin and its knockdown with antisense RNA reduces the surface expression of MCT2 and associated lactate transport. Immunocytochemical studies show that MCT2 and the neuroplastins are co-localised in rat cerebellum. Strikingly neuroplastin and MCT2 are enriched in the same parasagittal zebrin II-negative stripes. Conclusions: These data strongly suggest that neuroplastins act as key ancillary proteins for MCT2 cell surface localisation and activity in some neuronal populations, thus playing an important role in facilitating the uptake of lactate for use as a respiratory fuel.	[Kraus, Michaela; Beesley, Philip W.] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Wilson, Marieangela C.; Halestrap, Andrew P.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Marzban, Hassan; Sarna, Justyna R.; Wang, Yisong; Hawkes, Richard] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada; [Marzban, Hassan; Sarna, Justyna R.; Wang, Yisong; Hawkes, Richard] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of London; Royal Holloway University London; University of Bristol; University of Calgary; University of Calgary	Beesley, PW (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England.	p.beesley@rhul.ac.uk	Hawkes, Richard/F-7971-2011	Marzban, Hassan/0000-0001-6885-2590; Wilson, Marieangela/0000-0001-6218-3533; Halestrap, Andrew/0000-0001-5374-2778	Wellcome Trust [079792/z/06]; Canadian Institutes of Health Research [1970]	Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Wellcome Trust grant 079792/z/06, Canadian Institutes of Health Research grant no. 1970 (http://www.cihr-irsc.gc.ca/e/193.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN AH, 1994, DEVELOPMENT, V120, P2081; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Armstrong CL, 2000, BIOCHEM CELL BIOL, V78, P551, DOI 10.1139/bcb-78-5-551; Barmack NH, 2000, J COMP NEUROL, V427, P235, DOI 10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; Bergersen L, 2002, NEUROCHEM RES, V27, P89, DOI 10.1023/A:1014806723147; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bergersen LH, 2005, CEREB CORTEX, V15, P361, DOI 10.1093/cercor/bhh138; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Debernardi R, 2003, J NEUROSCI RES, V73, P141, DOI 10.1002/jnr.10660; Dehnes Y, 1998, J NEUROSCI, V18, P3606; EISENMAN LM, 1993, J COMP NEUROL, V335, P586, DOI 10.1002/cne.903350410; Empson RM, 2006, J NEUROCHEM, V99, P850, DOI 10.1111/j.1471-4159.2006.04123.x; Fan QW, 1998, NEUROSCI RES, V30, P53, DOI 10.1016/S0168-0102(97)00119-3; Furutama D, 2010, J NEUROSCI RES, V88, P2810, DOI 10.1002/jnr.22451; Gerhart DZ, 1999, NEUROSCIENCE, V92, P367, DOI 10.1016/S0306-4522(98)00699-X; Gerhart DZ, 1998, GLIA, V22, P272; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; HILL IE, 1988, BRAIN RES, V461, P27, DOI 10.1016/0006-8993(88)90722-6; HUANG RP, 1993, DEV BIOL, V155, P307, DOI 10.1006/dbio.1993.1030; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Koehler-Stec EM, 1998, AM J PHYSIOL-ENDOC M, V275, pE516, DOI 10.1152/ajpendo.1998.275.3.E516; Langnaese K, 1998, FEBS LETT, V429, P284, DOI 10.1016/S0014-5793(98)00616-4; Langnaese K, 1997, J BIOL CHEM, V272, P821, DOI 10.1074/jbc.272.2.821; Little LN, 2011, THESIS U N FLORIDA; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; Marzban H, 2003, J COMP NEUROL, V462, P286, DOI 10.1002/cne.10719; Mateos J. M., 2001, EUR J ANAT, V5, P15; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Ochrietor JD, 2004, DEV NEUROSCI-BASEL, V26, P380, DOI 10.1159/000082280; Ovens MJ, 2010, BIOCHEM J, V431, P217, DOI 10.1042/BJ20100890; Owczarek S, 2012, INT J BIOCHEM CELL B, V44, P1, DOI 10.1016/j.biocel.2011.10.006; Owczarek S, 2011, J NEUROCHEM, V117, P984, DOI 10.1111/j.1471-4159.2011.07269.x; Owczarek S, 2010, FASEB J, V24, P1139, DOI 10.1096/fj.09-140509; Ozol K, 1999, J COMP NEUROL, V412, P95; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pierre K, 2003, J NEUROCHEM, V86, P1468, DOI 10.1046/j.1471-4159.2003.01964.x; Pierre K, 2002, J CEREBR BLOOD F MET, V22, P586, DOI 10.1097/00004647-200205000-00010; Poole RC, 1997, J BIOL CHEM, V272, P14624, DOI 10.1074/jbc.272.23.14624; Rafiki A, 2003, NEUROSCIENCE, V122, P677, DOI 10.1016/j.neuroscience.2003.08.040; Sarna JR, 2006, J COMP NEUROL, V496, P303, DOI 10.1002/cne.20912; Sarto-Jackson I, 2012, J BIOL CHEM, V287, P14201, DOI 10.1074/jbc.M111.293175; Smalla KH, 2000, P NATL ACAD SCI USA, V97, P4327, DOI 10.1073/pnas.080389297; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; WILLMOTT T, 1992, J NEUROCHEM, V58, P2037, DOI 10.1111/j.1471-4159.1992.tb10944.x; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200	53	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e78654	10.1371/journal.pone.0078654	http://dx.doi.org/10.1371/journal.pone.0078654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260123	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500008
J	Alrfaei, BM; Vemuganti, R; Kuo, JS				Alrfaei, Bahauddeen M.; Vemuganti, Raghu; Kuo, John S.			microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; STEM-CELLS; GLIOMA-CELLS; CANCER; TEMOZOLOMIDE; MODULATION; HDAC3; MECHANISMS; REPRESSION; RESISTANCE	Glioblastoma (GBM) is the most frequently diagnosed malignant human glioma, and current median patient survival is less than two years despite maximal surgery followed by temozolomide chemoradiation therapies. Novel microRNA-related therapies are now being developed for cancers such as GBM. Differential microRNA expression profiling revealed that miR-100 expression is down-regulated in GBM compared to normal controls. We report that miR-100 expression reduces GBM tumorigenicity. In vitro, four GBM lines (U87, U251, 22T, and 33T) demonstrated reduced proliferation 24 hours after transient miR100 overexpression via transfection. miR-100 triggered cell death an average 70% more than scrambled miR controls 24 hours after transient transfection (p < 0.01). miR-100 targeted inhibition of the "silencing mediator of retinoid or thyroid hormone receptor-2" (SMRT/NCOR2) gene was confirmed via reporter assays. Ki67 proliferation index was decreased 40% in tumor xenografts generated from stable miR-100 transfected GBM lines versus controls (p < 0.01). Furthermore, treatment of tumor xenografts with a single premir-100 injection (60 pmol) significantly extended survival of mice bearing intracranial GBM xenografts 25% more than scrambled controls (p < 0.01; n=8). These studies establish miR-100's effect on tumor GBM growth, and suggest clinical potential for microRNA-related GBM therapy.	[Alrfaei, Bahauddeen M.; Vemuganti, Raghu; Kuo, John S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol Surg, Madison, WI 53706 USA; [Alrfaei, Bahauddeen M.; Vemuganti, Raghu] Univ Wisconsin, Sch Med & Publ Hlth, Cellular & Mol Pathol Training Program, Madison, WI USA; [Kuo, John S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Cellular & Mol Pathol Training Program, Madison, WI USA; [Kuo, John S.] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kuo, JS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol Surg, Madison, WI 53706 USA.	j.kuo@neurosurgery.wisc.edu	Kuo, John S/D-3561-2013; Alrfaei, Bahauddeen/P-7314-2018	Kuo, John S/0000-0001-6809-4806; Alrfaei, Bahauddeen/0000-0002-5740-9187	National Institutes of Health [R21NS074444, R21NS079585, UL1RR025011, RC4AA020476]; National Cancer Institute [HHSN261201000130C, P30CA014520]; University of Wisconsin Center for Stem Cell and Regenerative Medicine; University of Wisconsin (Graduate School and Department of Neurological Surgery); Saudi National Guard Health Affairs; HEADRUSH Brain Tumor Research Professorship; Roger Loff Memorial Fund for GBM Research; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074444, R21NS079585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC4AA020476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Wisconsin Center for Stem Cell and Regenerative Medicine; University of Wisconsin (Graduate School and Department of Neurological Surgery); Saudi National Guard Health Affairs; HEADRUSH Brain Tumor Research Professorship; Roger Loff Memorial Fund for GBM Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors appreciate National Institutes of Health funding (R21NS074444, R21NS079585, UL1RR025011, RC4AA020476, National Cancer Institute HHSN261201000130C, P30CA014520), the Wisconsin Partnership Program core grant support from University of Wisconsin Center for Stem Cell and Regenerative Medicine, from the University of Wisconsin (Graduate School and Department of Neurological Surgery), stipend support for BMA from a Saudi National Guard Health Affairs fellowship and support for JSK from the HEADRUSH Brain Tumor Research Professorship and Roger Loff Memorial Fund for GBM Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Campos B, 2011, CANCER SCI, V102, P387, DOI 10.1111/j.1349-7006.2010.01792.x; Case N, 2011, J BIOL CHEM, V286, P39450, DOI 10.1074/jbc.M111.265330; CBTRUS, 2006, PRIM BRAIN TUM US ST; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Clark PA, 2012, NEOPLASIA, V14, P420, DOI 10.1596/neo.12432; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Froud S J, 1999, Dev Biol Stand, V99, P157; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hercbergs A, 2009, CELL CYCLE, V8, P2586, DOI 10.4161/cc.8.16.9328; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Khanim FL, 2004, ONCOGENE, V23, P6712, DOI 10.1038/sj.onc.1207772; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee JH, 2005, MAGN RESON MED, V53, P640, DOI 10.1002/mrm.20368; Lee YS, 2006, CURR OPIN INVEST DR, V7, P560; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-519; Marionneau C, 2012, J NEUROSCI, V32, P5716, DOI 10.1523/JNEUROSCI.6450-11.2012; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Purow B, 2011, J NEURO-ONCOL, V103, P429, DOI 10.1007/s11060-010-0449-5; Sauvageot CME, 2009, NEURO-ONCOLOGY, V11, P109, DOI 10.1215/15228517-2008-060; SILBERGELD DL, 1991, J NEUROSURG, V75, P604, DOI 10.3171/jns.1991.75.4.0604; Singh SK, 2003, CANCER RES, V63, P5821; Snowden AW, 2003, CANCER RES, V63, P8968; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Su G, 2006, AM J PATHOL, V168, P2014, DOI 10.2353/ajpath.2006.050800; Ulasov IV, 2011, MOL MED, V17, P103, DOI 10.2119/molmed.2010.00062; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; VANDIERENDONCK JH, 1989, CANCER RES, V49, P2999; Vivanco I, 2010, CURR OPIN ONCOL, V22, P573, DOI 10.1097/CCO.0b013e32833edbdf; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; WESTERMARK B, 1973, ACTA PATH MICRO IM A, VA 81, P791; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Xia HP, 2013, NEURO-ONCOLOGY, V15, P413, DOI 10.1093/neuonc/nos296; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Zhu J, 2013, BRAIN RES, V1520, P15, DOI 10.1016/j.brainres.2013.04.061; Zorniak M, 2012, CLIN CANCER RES, V18, P3628, DOI 10.1158/1078-0432.CCR-12-0339	49	44	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80865	10.1371/journal.pone.0080865	http://dx.doi.org/10.1371/journal.pone.0080865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244722	Green Submitted, gold, Green Published			2022-12-25	WOS:000327143800169
J	Chakrabarti, A; Bhattacharya, D; Deb, S; Chakraborty, M				Chakrabarti, Abhijit; Bhattacharya, Dipankar; Deb, Sanghamitra; Chakraborty, Madhumita			Differential Thermal Stability and Oxidative Vulnerability of the Hemoglobin Variants, HbA(2) and HbE	PLOS ONE			English	Article							HEINZ BODY FORMATION; ACID DENATURATION; CROSS-LINKING; BLOOD; DITYROSINE; MECHANISM; PROTEINS; THALASSEMIA; MYOGLOBIN; SPECTRIN	Apart from few early biophysical studies, the relative thermal instability of HbE has been only shown by clinical investigations. We have compared in vitro thermal stability of HbE with HbA(2) and HbA using optical spectroscopy. From absorption measurements in the soret region, synchronous fluorescence spectroscopy and dynamic light scattering experiments, we have found thermal stability of the three hemoglobin variants following the order HbE<HbA<HbA(2) in terms of structural unfolding and aggregation pattern. We have found formation of intermolecular dityrosine fluorophores with characteristic fluorescence signature, at pH >11.0 in all the three variants. Under oxidative stress conditions in presence of hydrogen peroxide, HbE has been found to be more vulnerable to aggregation compared to HbA and HbA(2). Taken together, these studies have shown thermal and oxidative instability of HbE and points towards the role of HbE in the upregulation of redox regulators and chaperone proteins in erythrocyte proteome of patients suffering from HbEbeta thalassemia.	[Chakrabarti, Abhijit; Bhattacharya, Dipankar; Deb, Sanghamitra; Chakraborty, Madhumita] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, India	Saha Institute of Nuclear Physics	Chakrabarti, A (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, India.	abhijit.chakrabarti@saha.ac.in						Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; ALLIS JW, 1970, BIOCHEMISTRY-US, V9, P2286, DOI 10.1021/bi00813a010; Bhattacharya D, 2007, PROTEOM CLIN APPL, V1, P561, DOI 10.1002/prca.200700178; Bhattacharya D, 2010, PROTEOM CLIN APPL, V4, P480, DOI 10.1002/prca.200900073; Chakrabarti A, 2011, PROTEOM CLIN APPL, V5, P98, DOI 10.1002/prca.201000063; Chakraborty M, 2010, BIOPHYS CHEM, V149, P92, DOI 10.1016/j.bpc.2010.04.005; CHOTHIA C, 1976, P NATL ACAD SCI USA, V73, P3793, DOI 10.1073/pnas.73.11.3793; CHOU J, 1995, MICROCHEM J, V52, P159, DOI 10.1006/mchj.1995.1080; Dasgupta J, 2003, BIOCHEM BIOPH RES CO, V303, P619, DOI 10.1016/S0006-291X(03)00379-6; Datta P, 2003, BLOOD CELL MOL DIS, V30, P248, DOI 10.1016/S1079-9796(03)00019-6; Datta P, 2006, BLOOD CELL MOL DIS, V37, P77, DOI 10.1016/j.bcmd.2006.06.001; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; DIIORIO EE, 1981, METHOD ENZYMOL, V76, P67; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; FRISCHER H, 1975, J LAB CLIN MED, V85, P531; GEORGE P, 1952, BIOCHEM J, V52, P511, DOI 10.1042/bj0520511; GIULIVI C, 1994, METHOD ENZYMOL, V233, P363; Giulivi C, 2001, J BIOL CHEM, V276, P24129, DOI 10.1074/jbc.M010697200; GUTTERIDGE JMC, 1986, FEBS LETT, V201, P291, DOI 10.1016/0014-5793(86)80626-3; JACOB HS, 1970, SEMIN HEMATOL, V7, P341; Jetsrisuparb A, 2006, J PEDIAT HEMATOL ONC, V28, P249, DOI 10.1097/01.mph.0000212910.99394.e0; KINDERLE.J, 1970, BIOCHEM J, V119, pP66; KINDERLERER J, 1973, BIOCHEM J, V135, P805, DOI 10.1042/bj1350805; Kristinsson HG, 2004, J AGR FOOD CHEM, V52, P5482, DOI 10.1021/jf035062y; Kristinsson HG, 2004, J AGR FOOD CHEM, V52, P3633, DOI 10.1021/jf034563g; Kristinsson HG, 2002, J AGR FOOD CHEM, V50, P7669, DOI 10.1021/jf0256788; MACDONALD VW, 1983, J LAB CLIN MED, V102, P762; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; MALENCIK DA, 1987, BIOCHEMISTRY-US, V26, P695, DOI 10.1021/bi00377a006; OKAJIMA T, 1990, BIOCHEMISTRY-US, V29, P9168, DOI 10.1021/bi00491a010; OSAWA Y, 1991, P NATL ACAD SCI USA, V88, P7081, DOI 10.1073/pnas.88.16.7081; PERUTZ MF, 1974, NATURE, V247, P341, DOI 10.1038/247341a0; Phumala N, 2003, FREE RADICAL RES, V37, P129, DOI 10.1080/1071576031000060607; Pscheidt Sandra, 2003, J. Bras. Patol. Med. Lab., V39, P37, DOI 10.1590/S1676-24442003000100007; Reeder BJ, 2002, BIOCHEMISTRY-US, V41, P367, DOI 10.1021/bi011335b; Rees DC, 1998, BLOOD, V92, P2141, DOI 10.1182/blood.V92.6.2141.418k05_2141_2146; Richards MP, 2002, J AGR FOOD CHEM, V50, P555, DOI 10.1021/jf010562h; Roche CJ, 2011, J BIOL CHEM, V286, P23452, DOI 10.1074/jbc.M110.183186; Sen U, 2004, BIOCHEMISTRY-US, V43, P12477, DOI 10.1021/bi048903i; SOLAR I, 1990, ARCH BIOCHEM BIOPHYS, V283, P81, DOI 10.1016/0003-9861(90)90615-6; Vasseur-Godbillon C, 2006, FEBS J, V273, P230, DOI 10.1111/j.1742-4658.2005.05063.x; Vazquez S, 2002, J BIOL CHEM, V277, P4867, DOI 10.1074/jbc.M107529200; Vollaard NBJ, 2005, FREE RADICAL BIO MED, V39, P1216, DOI 10.1016/j.freeradbiomed.2005.06.012; Weatherall DJ, 1996, NAT MED, V2, P847, DOI 10.1038/nm0896-847; WINTERBOURN CC, 1974, J CLIN INVEST, V54, P678, DOI 10.1172/JCI107806; YAN LJ, 2002, CURR PROTOC CELL BIO, pCH7	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81820	10.1371/journal.pone.0081820	http://dx.doi.org/10.1371/journal.pone.0081820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244748	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800186
J	Chen, XF; Rateri, DL; Howatt, DA; Balakrishnan, A; Moorleghen, JJ; Morris, AJ; Charnigo, R; Cassis, LA; Daugherty, A				Chen, Xiaofeng; Rateri, Debra L.; Howatt, Deborah A.; Balakrishnan, Anju; Moorleghen, Jessica J.; Morris, Andrew J.; Charnigo, Richard; Cassis, Lisa A.; Daugherty, Alan			Amlodipine Reduces AngII-Induced Aortic Aneurysms and Atherosclerosis in Hypercholesterolemic Mice	PLOS ONE			English	Article							II-INDUCED ATHEROSCLEROSIS; RENIN-ANGIOTENSIN SYSTEM; CALCIUM-CHANNEL BLOCKERS; BLOOD-PRESSURE; GENE-EXPRESSION; GUINEA-PIG; PROGRESSION; DEFICIENCY; INHIBITION; RECEPTORS	Background: The purpose of this study was to determine effects of amlodipine, a dihydropyridine calcium channel blocker, on development of angiotensin II (AngII)-induced vascular pathologies. Methods and Results: Male LDL receptor -/- mice were infused with vehicle, amlodipine (5 mg/kg/d), AngII (1,000 ng/kg/min), or AngII + amlodipine for 4 weeks through osmotic pumps (n=10/group). Mice were fed a saturated fat-enriched diet for 1 week prior to pump implantation and during 4 weeks of infusion. Infusion of amlodipine resulted in plasma concentrations of 32 +/- 2 ng/ml and 27 +/- 2 ng/ml for mice in saline + amlodipine and AngII + amlodipine groups, respectively. This infusion rate of amlodipine did not affect AngII-induced increases in systolic blood pressure. Three of 10 (30%) mice infused with AngII died of aortic rupture, while aortic rupture did not occur in mice co-infused with AngII + amlodipine. Suprarenal aortic width and intimal area of ascending aortas were measured to define aortic aneurysms. In the absence of AngII infusion, amlodipine did not change suprarenal aortic width and ascending aortic area. Infusion of AngII led to profound increases of suprarenal aortic width (saline + vehicle versus AngII + vehicle: 0.86 +/- 0.02 versus 1.72 +/- 0.26 mm; P=0.0006), whereas co-infusion of AngII and amlodipine diminished abdominal dilation (1.02 +/- 0.14 mm; P=0.003). As expected, AngII infusion increased mean intimal area of ascending aortas (saline + vehicle versus AngII + vehicle: 8.5 +/- 0.3 versus 12.5 +/- 1.1 mm(2); P=0.001), while co-infusion of AngII and amlodipine ablated dilation of the ascending aorta (8.6 +/- 0.2 mm(2); P=0.03). Co-administration of amlodipine also significantly attenuated AngII-induced atherosclerosis in the thoracic region as quantified by percent lesion area (AngII + vehicle versus AngII + amlodipine: 5.8 +/- 2.1 % versus 0.3 +/- 0.1%; P=0.05). Conclusions: Amlodipine inhibited AngII-induced aortic aneurysms in both the abdominal and ascending regions, and atherosclerosis in hypercholesterolemic mice.	[Chen, Xiaofeng; Rateri, Debra L.; Howatt, Deborah A.; Balakrishnan, Anju; Moorleghen, Jessica J.; Morris, Andrew J.; Daugherty, Alan] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Charnigo, Richard] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Cassis, Lisa A.] Univ Kentucky, Dept Mol & Biochem Pharmacol, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Daugherty, A (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA.	Alan.Daugherty@uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Institutes of Health [R01 HL107319]; National Marfan Foundation; National Center for Research Resources [P20 RR021954]; National Institute of General Medical Sciences [P20 GM103527]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954, S10RR024598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a funding from the National Institutes of Health (R01 HL107319 to AD) and a McKusick Fellowship grant from the National Marfan Foundation to XC. Mass Spectrometry equipment used for plasma amlodipine measurement was provided by funds from the National Center for Research Resources (P20 RR021954) and the National Institute of General Medical Sciences (P20 GM103527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn HG, 1996, ARTERIOSCL THROM VAS, V16, P963, DOI 10.1161/01.ATV.16.8.963; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Bengtsson H, 1996, ANN NY ACAD SCI, V800, P1, DOI 10.1111/j.1749-6632.1996.tb33294.x; Bhatt J, 2007, J CHROMATOGR SCI, V45, P91, DOI 10.1093/chromsci/45.2.91; Bhatt J, 2007, BIOMED CHROMATOGR, V21, P169, DOI 10.1002/bmc.730; Bruemmer D, 2011, ANN NY ACAD SCI, V1245, P7, DOI 10.1111/j.1749-6632.2011.06332.x; Candido R, 2004, CIRCULATION, V109, P1536, DOI 10.1161/01.CIR.0000124061.78478.94; CASSIS LA, 1992, AM J PHYSIOL, V262, pE105, DOI 10.1152/ajpendo.1992.262.1.E105; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Das R, 2009, CIRC RES, V105, P167, DOI 10.1161/CIRCRESAHA.109.200311; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2005, METHODS, V36, P129, DOI 10.1016/j.ymeth.2004.11.008; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; Daugherty Alan, 2009, J Vis Exp, DOI 10.3791/1291; Daugherty A, 2011, J ZHEJIANG UNIV-SC B, V12, P624, DOI 10.1631/jzus.B1101002; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Daugherty A, 2008, FUTURE LIPIDOL, V3, P625, DOI 10.2217/17460875.3.6.625; Delsing DJM, 2003, J CARDIOVASC PHARM, V42, P63, DOI 10.1097/00005344-200307000-00010; Deng GG, 2003, CIRC RES, V92, P510, DOI 10.1161/01.RES.0000061571.49375.E1; Doran DE, 2007, ATHEROSCLEROSIS, V195, P39, DOI 10.1016/j.atherosclerosis.2006.11.030; Duncan JL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2958; FAULKNER JK, 1986, BRIT J CLIN PHARMACO, V22, P21, DOI 10.1111/j.1365-2125.1986.tb02874.x; Findeisen HM, 2011, ARTERIOSCL THROM VAS, V31, P253, DOI 10.1161/ATVBAHA.110.218545; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Henriques TA, 2004, ENDOCRINOLOGY, V145, P3866, DOI 10.1210/en.2003-1615; Homme JL, 2006, AM J SURG PATHOL, V30, P1159, DOI 10.1097/01.pas.0000213270.38091.69; Jeppesen P, 1998, PHARMACOL TOXICOL, V82, P250, DOI 10.1111/j.1600-0773.1998.tb01433.x; Kanematsu Y, 2010, HYPERTENSION, V55, P1267, DOI 10.1161/HYPERTENSIONAHA.109.140558; Kataoka C, 2004, AM J PHYSIOL-HEART C, V286, pH768, DOI 10.1152/ajpheart.00937.2002; King VL, 2009, CIRCULATION, V119, P426, DOI 10.1161/CIRCULATIONAHA.108.785949; LICHTLEN PR, 1990, LANCET, V335, P1109, DOI 10.1016/0140-6736(90)91121-P; Lu Hong, 2007, V139, P77; Lu H, 2008, J CLIN INVEST, V118, P984, DOI 10.1172/JCI32970; Lu H, 2007, CURR DRUG TARGETS, V8, P1181, DOI 10.2174/138945007782403829; Lu H, 2012, CLIN SCI, V123, P531, DOI 10.1042/CS20120097; Lu H, 2012, BRIT J PHARMACOL, V165, P2000, DOI 10.1111/j.1476-5381.2011.01712.x; Mancini GBJ, 2002, PROG CARDIOVASC DIS, V45, P1, DOI 10.1053/pcad.2002.122694; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Nakandakare ER, 2008, ATHEROSCLEROSIS, V200, P410, DOI 10.1016/j.atherosclerosis.2007.12.034; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Noguchi K, 1998, J PHARM PHARMACOL, V50, P329, DOI 10.1111/j.2042-7158.1998.tb06869.x; Nussberger J, 2008, HYPERTENSION, V51, P1306, DOI 10.1161/HYPERTENSIONAHA.108.110932; Owens AP, 2011, ARTERIOSCL THROM VAS, V31, P2813, DOI 10.1161/ATVBAHA.111.238642; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rateri DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051483; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Rossi-Foulkes R, 1999, AM J CARDIOL, V83, P1364, DOI 10.1016/S0002-9149(99)00101-0; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Schricker K, 1996, BRIT J PHARMACOL, V119, P744, DOI 10.1111/j.1476-5381.1996.tb15735.x; Subramanian V, 2010, CIRC RES, V107, P953, DOI 10.1161/CIRCRESAHA.110.219089; Suen RS, 2011, AM J PATHOL, V179, P1549, DOI 10.1016/j.ajpath.2011.05.014; Tomita N, 2008, INT J MOL MED, V21, P239; Trion A, 2006, J CARDIOVASC PHARM, V47, P89, DOI 10.1097/01.fjc.0000195603.65858.27; Uchida HA, 2011, ARTERIOSCL THROM VAS, V31, P2845, DOI 10.1161/ATVBAHA.111.234997; Uchida HA, 2010, ATHEROSCLEROSIS, V211, P399, DOI 10.1016/j.atherosclerosis.2010.02.034; van de Poll SWE, 2003, J MOL CELL CARDIOL, V35, P109; van de Poll SWE, 2002, ATHEROSCLEROSIS, V164, P65, DOI 10.1016/S0021-9150(02)00055-2; Wang SP, 2012, ATHEROSCLEROSIS, V220, P375, DOI 10.1016/j.atherosclerosis.2011.11.013; WATERS D, 1990, CIRCULATION, V82, P1940, DOI 10.1161/01.CIR.82.6.1940; Weiss D, 2001, CIRCULATION, V103, P448; Weiss D, 2008, HYPERTENSION, V51, P218, DOI 10.1161/HYPERTENSIONAHA.107.095885; Wilmink ABM, 2002, J VASC SURG, V36, P751, DOI 10.1067/mva.2002.126550; Yokokura H, 2007, SURG TODAY, V37, P468, DOI 10.1007/s00595-006-3367-6; Yoshii T, 2006, HYPERTENS RES, V29, P457, DOI 10.1291/hypres.29.457; Yue H, 2004, J CARDIOVASC PHARM, V44, P223, DOI 10.1097/00005344-200408000-00012; Zanchetti A, 2002, CIRCULATION, V106, P2422, DOI 10.1161/01.CIR.0000039288.86470.DD	72	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81743	10.1371/journal.pone.0081743	http://dx.doi.org/10.1371/journal.pone.0081743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244746	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800184
J	Miuma, S; Saldivar, JC; Karras, JR; Waters, CE; Paisie, CA; Wang, Y; Jin, V; Sun, J; Druck, T; Zhang, J; Huebner, K				Miuma, Satoshi; Saldivar, Joshua C.; Karras, Jenna R.; Waters, Catherine E.; Paisie, Carolyn A.; Wang, Yao; Jin, Victor; Sun, Jin; Druck, Teresa; Zhang, Jie; Huebner, Kay			Fhit Deficiency-Induced Global Genome Instability Promotes Mutation and Clonal Expansion	PLOS ONE			English	Article							CELL-CYCLE; FRAGILE SITES; GENE; CANCER; P53; ACTIVATION; INDUCTION; PROTEIN; REPAIR; BETA	Loss of Fhit expression, encoded at chromosome fragile site FRA3B, leads to increased replication stress, genome instability and accumulation of genetic alterations. We have proposed that Fhit is a genome 'caretaker' whose loss initiates genome instability in preneoplastic lesions. We have characterized allele copy number alterations and expression changes observed in Fhit-deficient cells in conjunction with alterations in cellular proliferation and exome mutations, using cells from mouse embryo fibroblasts (MEFs), mouse kidney, early and late after establishment in culture, and in response to carcinogen treatment. Fhit(-/-) MEFs escape senescence to become immortal more rapidly than Fhit(+/+) MEFs; -/- MEFs and kidney cultures show allele losses and gains, while +/+ derived cells show few genomic alterations. Striking alterations in expression of p53, p21, Mcl1 and active caspase 3 occurred in mouse kidney -/- cells during progressive tissue culture passage. To define genomic changes associated with preneoplastic changes in vivo, exome DNAs were sequenced for +/+ and -/- liver tissue after treatment of mice with the carcinogen, 7,12-dimethylbenz[a] anthracene, and for +/+ and -/- kidney cells treated in vitro with this carcinogen. The -/- exome DNAs, in comparison with +/+ DNA, showed small insertions, deletions and point mutations in more genes, some likely related to preneoplastic changes. Thus, Fhit loss provides a 'mutator' phenotype, a cellular environment in which mild genome instability permits clonal expansion, through proliferative advantage and escape from apoptosis, in response to pressures to survive.	[Miuma, Satoshi; Saldivar, Joshua C.; Karras, Jenna R.; Waters, Catherine E.; Paisie, Carolyn A.; Sun, Jin; Druck, Teresa; Huebner, Kay] Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Wang, Yao; Jin, Victor; Zhang, Jie] Ohio State Univ, Wexner Med Ctr, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Huebner, K (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	kay.huebner@osumc.edu		Miuma, Satoshi/0000-0003-2639-7299; Saldivar, Joshua/0000-0001-7821-1615	National Institutes of Health (United States Public Health Service) [CA120516, CA132453, CA115965, F31CA157150, T32GM068412]; Ohio State University Wexner Medical Center; NATIONAL CANCER INSTITUTE [F31CA157150, R01CA132453, R01CA115965, R01CA120516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER	National Institutes of Health (United States Public Health Service)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Ohio State University Wexner Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (United States Public Health Service) to KH (CA120516, CA132453, CA115965), to JCS (F31CA157150, T32GM068412), and funding from Ohio State University Wexner Medical Center (to CEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Becker K, 2008, BRIT J DERMATOL, V159, P1282, DOI 10.1111/j.1365-2133.2008.08783.x; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; DJALALI M, 1987, HUM GENET, V77, P157, DOI 10.1007/BF00272384; Fong LYY, 2000, P NATL ACAD SCI USA, V97, P4742, DOI 10.1073/pnas.080063497; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hachiya N, 1999, MUTAT RES-GEN TOX EN, V444, P283, DOI 10.1016/S1383-5718(99)00063-7; Hollander MC, 2001, CANCER RES, V61, P2487; Hosseini SA, 2013, GENE CHROMOSOME CANC, V52, P1017, DOI 10.1002/gcc.22097; Ishii H, 2003, FASEB J, V17, P1768, DOI 10.1096/fj.03-0241fje; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Litaker JR, 1998, INT J ONCOL, V13, P951; MERIKALLIO H, 2003, P NATL ACAD SCI USA, V100, P3233, DOI DOI 10.1073/PNAS.2628034100.PUBMED:12629205; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Moolmuang B, 2011, CELL CYCLE, V10, P518, DOI 10.4161/cc.10.3.14756; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Pichiorri F, 2008, FUTURE ONCOL, V4, P815, DOI 10.2217/14796694.4.6.815; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Saldivar JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003077; Saldiyar JC, 2010, J CELL BIOCHEM, V109, P858, DOI 10.1002/jcb.22481; Sard L, 1999, P NATL ACAD SCI USA, V96, P8489, DOI 10.1073/pnas.96.15.8489; Sozzi G, 1998, CANCER RES, V58, P5032; Stephenson-Famy A, 2012, MOL ENDOCRINOL, V26, P320, DOI 10.1210/me.2011-1282; Suzuki T, 1999, MUTAT RES-GEN TOX EN, V444, P259, DOI 10.1016/S1383-5718(99)00104-7; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Weyemi U, 2012, MUTAT RES-REV MUTAT, V751, P77, DOI 10.1016/j.mrrev.2012.04.002; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yoshihara Y, 2012, BIOCHEM BIOPH RES CO, V421, P57, DOI 10.1016/j.bbrc.2012.03.108; Zanesi N, 2001, P NATL ACAD SCI USA, V98, P10250, DOI 10.1073/pnas.191345898; ZHU L, 1995, GENE DEV, V9, P1740, DOI 10.1101/gad.9.14.1740	36	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80730	10.1371/journal.pone.0080730	http://dx.doi.org/10.1371/journal.pone.0080730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244712	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800160
J	Tong, JY; Ding, JD; Shen, XB; Chen, L; Bian, YP; Ma, GS; Yao, YY; Yang, F				Tong, Jiayi; Ding, Jiandong; Shen, Xiangbo; Chen, Long; Bian, Yeping; Ma, Genshan; Yao, Yuyu; Yang, Fang			Mesenchymal Stem Cell Transplantation Enhancement in Myocardial Infarction Rat Model under Ultrasound Combined with Nitric Oxide Microbubbles	PLOS ONE			English	Article							OXIDATIVE STRESS; DESTRUCTION; DYSFUNCTION; DELIVERY	Objective:This study evaluated the effects of ultrasound combined with the homemade nitric oxide (NO) micro-bubble destruction on the in vitro proliferation, apoptosis, and migration of mesenchymal stem cells (MSCs). Furthermore, we studied whether or not irradiation of the NO microbubble combined with bone-marrow derived MSC infusion had a better effect on treating myocardial infarction. The possible mechanism of MSC delivery into the infarcted myocardium was also investigated. Methods:The murine bone marrow-derived MSCs were isolated, cultured, irradiated, and combined with different concentrations of NO microbubbles. MTT proliferation assay, annexin V-FITC apoptosis detection, migration assay, and RT-PCR were performed 24 h after the irradiation. The NO micro-bubbles was a intravenously injected, followed by the infusion of MSCs, which were labeled by CM-Dil. Myocardium was harvested 48 h later and the distribution of MSCs was observed by laser scanning confocal microscope after frozen sectioning. Echocardiography, histological examination, RT-PCR, and western blotting were performed four weeks after the cell transplantation. Results:Ultrasound combined with 1:70 NO micro-bubbles had no significant impact on the proliferation or apoptosis of MSCs. Transwell chamber findings demonstrated that MSCs migrated more efficiently in group that underwent ultrasound combined with 1:70 NO micro-bubbles. The Real-time PCR results indicated that the expression of CXCR4 was much higher in the group undergoing ultrasound combined with 1:70 NO micro-bubbles. The normalized fluorescence intensity greatly increased in the group of US+NO micro-bubbles and the cardiac function was also markedly improved. Immunohistochemical staining showed that the capillary density was much greater in the group of US+NO micro-bubbles as compared to that of the other groups. RT-PCR and western blotting also revealed a higher SDF-1 and VEGF expression in the group of US+NO micro-bubbles. Conclusions:NO micro-bubbles could be used in the cell transplantation, which efficiently promoted the MSC homing into the infarcted myocardium.	[Tong, Jiayi; Ding, Jiandong; Shen, Xiangbo; Chen, Long; Ma, Genshan; Yao, Yuyu] Southeast Univ, Inst Cardiol, Nanjing, Jiangsu, Peoples R China; [Bian, Yeping] Jiangsu Prov Official Hosp, Nanjing, Jiangsu, Peoples R China; [Yang, Fang] Southeast Univ, Sch Biol Sci & Med Engn, Jiangsu Key Lab Biomat & Devices, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Tong, JY (corresponding author), Southeast Univ, Inst Cardiol, Nanjing, Jiangsu, Peoples R China.	jytong88@aliyun.com; yangfang2080@seu.edu.cn			National Natural Science Foundation of China [81070265]; Specialized Research Fund for the Doctoral Program of Higher Education [20090092120059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was support by National Natural Science Foundation of China (No. 81070265) and Specialized Research Fund for the Doctoral Program of Higher Education (NO. 20090092120059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bertuglia S, 2003, AM J PHYSIOL-HEART C, V285, pH1064, DOI 10.1152/ajpheart.00124.2003; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Dorner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056841; Gkaliagkousi E, 2011, FRONT BIOSCI-LANDMRK, V16, P1873, DOI 10.2741/3828; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Kang Shih-Tsung, 2012, Chang Gung Med J, V35, P125; Laing ST, 2009, CARDIOVASC RES, V83, P626, DOI 10.1093/cvr/cvp192; Li P, 2003, ULTRASOUND MED BIOL, V29, P1341, DOI 10.1016/S0301-5629(03)00988-8; MacFarlane NG, 2000, AM J PHYSIOL-CELL PH, V278, pC739, DOI 10.1152/ajpcell.2000.278.4.C739; Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0; Panovsky R, 2008, ECHOCARDIOGR-J CARD, V25, P888, DOI 10.1111/j.1540-8175.2008.00696.x; RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1; Schachinger V, 2006, HERZ, V31, P127, DOI 10.1007/s00059-006-2794-x; Song J, 2002, CIRCULATION, V106, P1550, DOI 10.1161/01.CIR.0000028810.33423.95; ter Haar G, 2009, MED BIOL ENG COMPUT, V47, P893, DOI 10.1007/s11517-009-0507-3; Terada LS, 2002, CRIT CARE MED, V30, pS186, DOI 10.1097/00003246-200205001-00003; Teupe C, 2002, CIRCULATION, V105, P1104, DOI 10.1161/hc0902.104720; Tiemann K, 2000, ECHOCARDIOGR-J CARD, V17, P17, DOI 10.1111/j.1540-8175.2000.tb00989.x; Zen K, 2006, J MOL CELL CARDIOL, V40, P799, DOI 10.1016/j.yjmcc.2006.03.012; Zhong SG, 2012, ULTRASONICS, V52, P281, DOI 10.1016/j.ultras.2011.08.013	22	34	39	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80186	10.1371/journal.pone.0080186	http://dx.doi.org/10.1371/journal.pone.0080186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244646	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800135
J	Lin, ZZ; Shau, WY; Hsu, C; Shao, YY; Yeh, YC; Kuo, RNC; Hsu, CH; Yang, JCH; Cheng, AL; Lai, MS				Lin, Zhong-Zhe; Shau, Wen-Yi; Hsu, Chiun; Shao, Yu-Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii; Lai, Mei-Shu			Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACETIC-ACID INJECTION; THERMAL ABLATION; CLINICAL-TRIALS; CIRRHOSIS; METAANALYSIS; MANAGEMENT; THERAPIES; SURVIVAL; ICD-9-CM	Background: Randomized trials suggest that radiofrequency ablation (RFA) may be more effective than percutaneous ethanol injection (PEI) in the treatment of hepatocellular carcinoma (HCC). However, the survival advantage of RFA needs confirmation in daily practice. Methods: We conducted a population-based cohort study using the Taiwan Cancer Registry, National Health Insurance claim database and National Death Registry data from 2004 through 2009. Patients receiving PEI or RFA as first-line treatment for newly-diagnosed stage I-II HCC were enrolled. Results: A total of 658 patients receiving RFA and 378 patients receiving PEI treatment were included for final analysis. The overall survival (OS) rates of patients in the RFA and PEI groups at 5-year were 55% and 42%, respectively (p < 0.01). Compared to patients that received PEI, those that received RFA had lower risks of overall mortality and first-line treatment failure (FTF), with adjusted hazard ratios (HRs) [95% confidence interval (CI)] of 0.60 (0.50-0.73) for OS and 0.54 (0.46-0.64) for FTF. The favorable outcomes for the RFA group were consistently significant for patients with tumors > 2 cm as well as for those with tumors < 2 cm. Consistent results were also observed in other subgroup analyses defined by gender, age, tumor stage, and co-morbidity status. Conclusion: RFA provides better survival benefits than PEI for patients with unresectable stage I-II HCC, irrespective of tumors > 2 cm or <= 2 cm, in contemporary clinical practice.	[Lin, Zhong-Zhe; Hsu, Chiun; Shao, Yu-Yun; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Lin, Zhong-Zhe; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Shau, Wen-Yi] Ctr Drug Evaluat, Div Hlth Technol Assessment, Taipei, Taiwan; [Hsu, Chiun; Shao, Yu-Yun; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii] Natl Taiwan Univ, Grad Inst Oncol, Coll Med, Taipei, Taiwan; [Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Lai, Mei-Shu] Natl Taiwan Univ Hosp, Ctr Comparat Effectiveness Res, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Kuo, Raymond Nien-Chen; Lai, Mei-Shu] Taiwan Canc Registry, Dept Hlth, Taipei, Taiwan; [Kuo, Raymond Nien-Chen] Natl Taiwan Univ, Grad Inst Hlth Policy & Management, Coll Publ Hlth, Taipei 10764, Taiwan; [Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Cheng, AL (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan.	alcheng@ntu.edu.tw; mslai@cph.ntu.edu.tw	Shao, Yu-Yun/K-6434-2012; Kuo, Raymond N./N-2558-2018; Yang, James Chih-Hsin/W-1587-2019	Shao, Yu-Yun/0000-0001-7334-1912; Kuo, Raymond N./0000-0003-4980-853X; Lai, Mei-shu/0000-0001-6130-3468; Cheng, Ann-Lii/0000-0002-9152-6512; HSU, CHIH-HUNG/0000-0003-0495-973X; Hsu, Chiun/0000-0002-1122-0055; Yang, James Chih-Hsin/0000-0002-5586-5138	Department of Health, Taiwan [DOH99-TD-B-111-001, DOH100-TD-B-111-001, DOH101-TD-B-111-001, DOH102-TD-B-111-001]; National Science Council, Taiwan [NSC 101-2314-B-002-164, NSC 102-2314-B-002-128-MY2]	Department of Health, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants DOH99-TD-B-111-001, DOH100-TD-B-111-001, DOH101-TD-B-111-001, DOH102-TD-B-111-001 from the Department of Health, Taiwan; NSC 101-2314-B-002-164, NSC 102-2314-B-002-128-MY2 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 2010UREAU NAT HLTH I; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Brunello F, 2008, SCAND J GASTROENTERO, V43, P727, DOI 10.1080/00365520701885481; Chen CJ, 2002, JPN J CLIN ONCOL, V32, pS66, DOI 10.1093/jjco/hye138; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; Clark TWI, 2007, TECH VASC INTERV RAD, V10, P58, DOI 10.1053/j.tvir.2007.08.004; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Edwards SJ., 1998, HEALTH TECHNOL ASSES, V2, P1; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002; Germani G, 2010, J HEPATOL, V52, P380, DOI 10.1016/j.jhep.2009.12.004; Greene FL, 2002, AJCC CANC STAGING MA, P131; Kuo SH, 2005, LUNG CANCER, V48, P275, DOI 10.1016/j.lungcan.2004.10.004; LAI ECS, 1995, ANN SURG, V221, P291, DOI 10.1097/00000658-199503000-00012; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Lin SM, 2005, GUT, V54, P1151, DOI 10.1136/gut.2004.045203; Lin SM, 2004, GASTROENTEROLOGY, V127, P1714, DOI 10.1053/j.gastro.2004.09.003; Lin ZZ, 2012, ONCOLOGIST, V17, P970, DOI 10.1634/theoncologist.2011-0411; Livraghi T, 1999, RADIOLOGY, V210, P655, DOI 10.1148/radiology.210.3.r99fe40655; Livraghi T, 2001, HEPATO-GASTROENTEROL, V48, P20; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Orlando A, 2009, AM J GASTROENTEROL, V104, P514, DOI 10.1038/ajg.2008.80; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PARKIN DM, 2005, CANC INCIDENCE 5 CON, V8; Poon RTP, 2002, ANN SURG, V235, P466, DOI 10.1097/00000658-200204000-00004; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rossi S, 1995, Cancer J Sci Am, V1, P73; Sala M, 2004, HEPATOLOGY, V40, P1352, DOI 10.1002/hep.20465; Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892	33	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80276	10.1371/journal.pone.0080276	http://dx.doi.org/10.1371/journal.pone.0080276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244668	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600199
J	Cheng, YT; Liu, J; Yang, LQ; Sun, C; Kong, QP				Cheng, Yao-Ting; Liu, Jia; Yang, Li-Qin; Sun, Chang; Kong, Qing-Peng			Mitochondrial DNA Content Contributes to Climate Adaptation Using Chinese Populations as a Model	PLOS ONE			English	Article							ETHNIC POPULATIONS; GENETIC-STRUCTURE; HUMAN MTDNA; SELECTION; SEQUENCE; EXPRESSION; DIVERSITY; EVOLUTION; DIFFERENTIATION; POLYMORPHISMS	Maintaining a balance between ATP synthesis and heat generation is crucial for adapting to changes in climate. Variation in the mitochondrial DNA (mtDNA), which encodes 13 subunits of the respiratory chain complexes, may contribute to climate adaptation by regulating thermogenesis and the use of bioenergy. However, studies looking for a relationship between mtDNA haplogroups and climate have obtained mixed results, leaving unresolved the role of mtDNA in climate adaptation. Since mtDNA content can regulate human bioenergy processes and is known to influence many physiological traits and diseases, it is possible that mtDNA content contributes to climate adaptation in human populations. Here, we analyze the distribution of mtDNA content among 27 Chinese ethnic populations residing across China and find a significant association between mtDNA content and climate, with northern populations having significantly higher mtDNA content than southern populations. Functional studies have shown that high mtDNA content correlates with an increase in the expression of energy metabolism enzymes, which may accelerate thermogenesis. This suggests that the significantly higher mtDNA content observed in northern populations may confer a selective advantage in adapting to colder northern climates	[Cheng, Yao-Ting; Liu, Jia; Yang, Li-Qin; Kong, Qing-Peng] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Cheng, Yao-Ting; Liu, Jia; Yang, Li-Qin; Kong, Qing-Peng] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Peoples R China; [Sun, Chang] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; [Sun, Chang] Yunnan Univ, Key Lab Microbial Divers Southwest China, Minist Educ, Kunming, Yunnan, Peoples R China; [Cheng, Yao-Ting; Liu, Jia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Kong, QP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	kongqp@mail.kiz.ac.cn			National Natural Science Foundation of China [81272309, 31123005]; Chinese Academy of Sciences [KSCXZ-EW-J-23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (81272309, 31123005) and the Chinese Academy of Sciences (KSCXZ-EW-J-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BLIER PU, 1993, J EXP BIOL, V176, P145; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Diez-Sanchez C, 2003, BIOL REPROD, V68, P180, DOI 10.1095/biolreprod.102.005140; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Guderley H, 2007, COLD OCEAN PHYSL, V66, P58; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; JOHNSTON IA, 1994, J EXP BIOL, V195, P293; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2003, HUM GENET, V113, P391, DOI 10.1007/s00439-003-1004-7; Li H, 2007, AM J PHYS ANTHROPOL, V134, P481, DOI 10.1002/ajpa.20690; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moilanen JS, 2003, MOL BIOL EVOL, V20, P2132, DOI 10.1093/molbev/msg230; MORAES CT, 1991, AM J HUM GENET, V48, P492; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Sun C, 2007, GENOMICS, V89, P338, DOI 10.1016/j.ygeno.2006.11.005; Talbot DA, 2004, J PHYSIOL-LONDON, V558, P123, DOI 10.1113/jphysiol.2004.063768; Wang WZ, 2010, AM J PHYS ANTHROPOL, V141, P124, DOI 10.1002/ajpa.21124; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010; Zhang YJ, 2005, FORENSIC SCI INT, V151, P299, DOI 10.1016/j.forsciint.2005.02.002	35	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79536	10.1371/journal.pone.0079536	http://dx.doi.org/10.1371/journal.pone.0079536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255706	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200072
J	Li, YL; Ning, GZ; Wu, Q; Wu, QL; Li, Y; Feng, SQ				Li, YuLin; Ning, GuangZhi; Wu, Qiang; Wu, QiuLi; Li, Yan; Feng, ShiQing			Review of Literature of Radial Nerve Injuries Associated with Humeral Fractures-An Integrated Management Strategy	PLOS ONE			English	Review							SHAFT FRACTURES; OPERATIVE TREATMENT; PALSY; EXPLORATION; PARALYSIS	Background: Radial nerve palsy associated with fractures of the shaft of the humerus is the most common nerve lesion complicating fractures of long bones. However, the management of radial nerve injuries associated with humeral fractures is debatable. There was no consensus between observation and early exploration. Methods and Findings: The PubMed, Embase, Cochrane Central Register of Controlled Trials, Google Scholar, CINAHL, International Bibliography of the Social Sciences, and Social Sciences Citation Index were searched. Two authors independently searched for relevant studies in any language from 1966 to Jan 2013. Thirty studies with 2952 humeral fractures participants were identified. Thirteen studies favored conservative strategy. No significant difference between early exploration and no exploration groups (OR, 1.03, 95% CI 0.61, 1.72; I-2 = 0.0%, p = 0.918 n.s.). Three studies recommend early radial nerve exploration in patients with open fractures of humerus with radial nerve injury. Five studies proposed early exploration was performed in high-energy humeral shaft fractures with radial nerve injury. Conclusions: The conservative strategy was a good choice for patients with low-energy closed fractures of humerus with radial nerve injury. We recommend early radial nerve exploration (within the first 2 weeks) in patients with open fractures or high-energy closed fractures of humerus with radial nerve injury.	[Li, YuLin; Ning, GuangZhi; Wu, Qiang; Wu, QiuLi; Li, Yan; Feng, ShiQing] Tianjin Med Univ, Gen Hosp, Dept Orthopaed, Tianjin, Peoples R China	Tianjin Medical University	Feng, SQ (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Orthopaed, Tianjin, Peoples R China.	fengsq321@gmail.com			Science and Technology Commission of Tianjin, China [10JCZDJC18800]	Science and Technology Commission of Tianjin, China	This work is sponsored by the Applied Basic Research Programs of Science and Technology Commission of Tianjin, China (10JCZDJC18800). The funders had a key role in data collection, analysis and publish process.	Amillo S, 1993, J Orthop Trauma, V7, P211; BLEEKER WA, 1991, ACTA ORTHOP SCAND, V62, P148, DOI 10.3109/17453679108999244; BOSTMAN O, 1985, INJURY, V16, P499, DOI 10.1016/0020-1383(85)90181-0; DAMERON TB, 1981, SOUTHERN MED J, V74, P1461; DeFranco MJ, 2006, J HAND SURG-AM, V31A, P655, DOI 10.1016/j.jhsa.2006.02.013; Ekholm R, 2006, J BONE JOINT SURG BR, V88B, P1469, DOI 10.1302/0301-620X.88B11.17634; Elton SG, 2008, J RECONSTR MICROSURG, V24, P569, DOI 10.1055/s-0028-1090623; FOSTER RJ, 1993, J HAND SURG-AM, V18A, P121, DOI 10.1016/0363-5023(93)90255-2; Goldhahn S, 1996, Unfallchirurgie, V22, P209, DOI 10.1007/BF02641222; KETTELKAMP DB, 1967, J TRAUM, V7, P424, DOI 10.1097/00005373-196705000-00007; Kim DH, 2001, J NEUROSURG, V95, P573, DOI 10.3171/jns.2001.95.4.0573; Klenerman L, 1966, J Bone Joint Surg Br, V48, P105; Korompilias AV, 2013, INJURY, V22; Kwasny O, 1992, Unfallchirurgie, V18, P168, DOI 10.1007/BF02588269; Larsen LB, 2000, SCAND J PLAST RECONS, V34, P363; Lin J, 2002, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000026567.55792.cc; Mahabier KC, 2013, INJURY, V44, P427, DOI 10.1016/j.injury.2012.08.003; MARTY B, 1994, UNFALLCHIRURG, V97, P424; MAST JW, 1975, CLIN ORTHOP RELAT R, P254; Noaman H, 2008, MICROSURG, V28, P635, DOI 10.1002/micr.20542; Ogawa K, 1998, AM J SPORT MED, V26, P242, DOI 10.1177/03635465980260021401; Ouyang HB, 2013, J SHOULDER ELB SURG, V22, P387, DOI 10.1016/j.jse.2012.06.007; PACKER JW, 1972, CLIN ORTHOP RELAT R, P34; POLLOCK FH, 1981, J BONE JOINT SURG AM, V63, P239, DOI 10.2106/00004623-198163020-00009; Ring D, 2004, J HAND SURG-AM, V29A, P144, DOI 10.1016/j.jhsa.2003.09.013; ROMMENS PM, 1989, UNFALLCHIRURG, V92, P565; SAMARDZIC M, 1990, INJURY, V21, P220, DOI 10.1016/0020-1383(90)90006-G; SARMIENTO A, 1990, J BONE JOINT SURG BR, V72, P283, DOI 10.1302/0301-620X.72B2.2312570; Sarmiento A, 2000, J BONE JOINT SURG AM, V82A, P478, DOI 10.2106/00004623-200004000-00003; SHAH JJ, 1983, CLIN ORTHOP RELAT R, P171; Shao YC, 2005, J BONE JOINT SURG BR, V87B, P1647, DOI 10.1302/0301-620X.87B12.16132; SHAW JL, 1967, J BONE JOINT SURG AM, VA 49, P899, DOI 10.2106/00004623-196749050-00006; Shivarathre DG, 2008, SURG-J R COLL SURG E, V6, P76, DOI 10.1016/S1479-666X(08)80068-6; SONNEVELD GJ, 1987, INJURY, V18, P404, DOI 10.1016/0020-1383(87)90287-7; Venouziou AI, 2011, INJURY, V42, P1289, DOI 10.1016/j.injury.2011.01.020; Wang X, 2013, EUR J ORTHOP SURG TR, V22	36	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78576	10.1371/journal.pone.0078576	http://dx.doi.org/10.1371/journal.pone.0078576			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250799	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200032
J	Mijouin, L; Hillion, M; Ramdani, Y; Jaouen, T; Duclairoir-Poc, C; Follet-Gueye, ML; Lati, E; Yvergnaux, F; Driouich, A; Lefeuvre, L; Farmer, C; Misery, L; Feuilloley, MGJ				Mijouin, Lily; Hillion, Melanie; Ramdani, Yasmina; Jaouen, Thomas; Duclairoir-Poc, Cecile; Follet-Gueye, Marie-Laure; Lati, Elian; Yvergnaux, Florent; Driouich, Azzedine; Lefeuvre, Luc; Farmer, Christine; Misery, Laurent; Feuilloley, Marc G. J.			Effects of a Skin Neuropeptide (Substance P) on Cutaneous Microflora	PLOS ONE			English	Article							BACILLUS-CEREUS; ANTIMICROBIAL PEPTIDES; ATOPIC-DERMATITIS; NEUROGENIC INFLAMMATION; PSEUDOMONAS-AERUGINOSA; ELONGATION-FACTOR; S-LAYER; EF-TU; BACTERIA; TOXIN	Background: Skin is the largest human neuroendocrine organ and hosts the second most numerous microbial population but the interaction of skin neuropeptides with the microflora has never been investigated. We studied the effect of Substance P (SP), a peptide released by nerve endings in the skin on bacterial virulence. Methodology/Principal Findings: Bacillus cereus, a member of the skin transient microflora, was used as a model. Exposure to SP strongly stimulated the cytotoxicity of B. cereus (+553 +/- 3% with SP 10(-6) M) and this effect was rapid (<5 min). Infection of keratinocytes with SP treated B. cereus led to a rise in caspase1 and morphological alterations of the actin cytoskeleton. Secretome analysis revealed that SP stimulated the release of collagenase and superoxide dismutase. Moreover, we also noted a shift in the surface polarity of the bacteria linked to a peel-off of the S-layer and the release of Slayer proteins. Meanwhile, the biofilm formation activity of B. cereus was increased. The Thermo unstable ribosomal Elongation factor (Ef-Tu) was identified as the SP binding site in B. cereus. Other Gram positive skin bacteria, namely Staphylococcus aureus and Staphylococcus epidermidis also reacted to SP by an increase of virulence. Thermal water from Uriage-les-Bains and an artificial polysaccharide (Teflose (R)) were capable to antagonize the effect of SP on bacterial virulence. Conclusions/Significance: SP is released in sweat during stress and is known to be involved in the pathogenesis of numerous skin diseases through neurogenic inflammation. Our study suggests that a direct effect of SP on the skin microbiote should be another mechanism.	[Mijouin, Lily; Hillion, Melanie; Jaouen, Thomas; Duclairoir-Poc, Cecile; Farmer, Christine; Feuilloley, Marc G. J.] Univ Rouen, Normandie Univ, LMSM, EA 4312, Evreux, France; [Ramdani, Yasmina; Follet-Gueye, Marie-Laure; Driouich, Azzedine] Univ Rouen, Normandie Univ, GlycoMev EA 4358, Mont St Aignan, France; [Lati, Elian] BioEC Lab, Longjumeau, France; [Yvergnaux, Florent] BioEurope Res, Anet, France; [Lefeuvre, Luc] Dermatol Labs Uriage, Courbevoie, France; [Misery, Laurent] Univ Western Britanny, EA 4685, Brest, France; [Misery, Laurent] Univ Hosp Brest, Dept Dermatol, Brest, France	Universite de Rouen Normandie; Universite de Rouen Normandie; CHU Brest; Universite de Bretagne Occidentale	Feuilloley, MGJ (corresponding author), Univ Rouen, Normandie Univ, LMSM, EA 4312, Evreux, France.	marc.feuilloley@univ-rouen.fr	Hillion, Melanie/H-9858-2015; Misery, Laurent/I-1186-2019	FEUILLOLEY, Marc G.J./0000-0001-6467-4336; Hillion, Melanie/0000-0003-2973-6153	FUI program Skin-O-Flor; French Government (DGCIS); European Union (FEDER); Department of Eure et Loir; Regions Centre and Haute-Normandie	FUI program Skin-O-Flor; French Government (DGCIS); European Union (FEDER)(European Commission); Department of Eure et Loir; Regions Centre and Haute-Normandie(Region Normandie)	This work was supported by the FUI program Skin-O-Flor certified by the world's leading perfumery cosmetics network Cosmetic Valley and financed by the French Government (DGCIS), European Union (FEDER), Department of Eure et Loir and the Regions Centre and Haute-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubdool AA, 2011, J INVEST DERM SYMP P, V15, P33, DOI 10.1038/jidsymp.2011.8; Auger S, 2009, APPL ENVIRON MICROB, V75, P6616, DOI 10.1128/AEM.00155-09; Barbey C, 2012, J PROTEOME RES, V11, P206, DOI 10.1021/pr200936q; BECK BD, 1979, EUR J BIOCHEM, V97, P495, DOI 10.1111/j.1432-1033.1979.tb13137.x; Beecher DJ, 2000, INFECT IMMUN, V68, P5269, DOI 10.1128/IAI.68.9.5269-5276.2000; BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6; Blier AS, 2011, MICROBIOL-SGM, V157, P1929, DOI 10.1099/mic.0.046755-0; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Carvalho B, 2010, ANESTH ANALG, V111, P1452, DOI 10.1213/ANE.0b013e3181f579de; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; Cizza G, 2008, BIOL PSYCHIAT, V64, P907, DOI 10.1016/j.biopsych.2008.05.035; Dallo SF, 2012, THESCIENTIFICWORLDJO, V2012, DOI DOI 10.1100/2012/128705; de la Fuente-Nunez C, 2012, APPL ENVIRON MICROB, V78, P5452, DOI 10.1128/AEM.01493-12; EGELSEER E, 1995, J BACTERIOL, V177, P1444, DOI 10.1128/jb.177.6.1444-1451.1995; Ehling-Schulz M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-20; Galkowska H, 2006, J SURG RES, V134, P252, DOI 10.1016/j.jss.2006.02.006; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Gardner SE, 2013, DIABETES, V62, P923, DOI 10.2337/db12-0771; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Haggblom MM, 2002, APPL ENVIRON MICROB, V68, P2479, DOI 10.1128/AEM.68.5.2479-2483.2002; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hansen CJ, 2006, J NEUROIMMUNOL, V177, P215, DOI 10.1016/j.jneuroim.2006.05.011; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hosokawa C, 2009, J DERMATOL, V36, P185, DOI 10.1111/j.1346-8138.2009.00621.x; Jaaskelainen EL, 2003, TOXICOL IN VITRO, V17, P737, DOI 10.1016/S0887-2333(03)00096-1; Karunakaran E, 2011, APPL MICROBIOL BIOT, V89, P1161, DOI 10.1007/s00253-010-2919-2; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Lange-Asschenfeldt B, 2011, SKIN PHARMACOL PHYS, V24, P305, DOI 10.1159/000328728; Lesouhaitier O, 2009, SENSORS-BASEL, V9, P6967, DOI 10.3390/s90906967; Li WW, 2009, PAIN, V147, P277, DOI 10.1016/j.pain.2009.09.032; Mijouin L, 2012, FASEB J, V26, P1569, DOI 10.1096/fj.11-189647; Misery L, 2011, CLIN REV ALLERG IMMU, V41, P259, DOI 10.1007/s12016-010-8225-z; Moller-Jensen J, 2005, CURR OPIN CELL BIOL, V17, P75, DOI 10.1016/j.ceb.2004.11.002; Ostlere LS, 1995, CLIN EXP DERMATOL, V20, P462, DOI 10.1111/j.1365-2230.1995.tb01378.x; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Pereira U, 2010, EXP DERMATOL, V19, P931, DOI 10.1111/j.1600-0625.2010.01119.x; Peters EMJ, 2006, J INVEST DERMATOL, V126, P1937, DOI 10.1038/sj.jid.5700429; Raap U, 2011, CURR OPIN ALLERGY CL, V11, P420, DOI 10.1097/ACI.0b013e32834a41c2; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Sastalla I, 2009, APPL ENVIRON MICROB, V75, P2099, DOI 10.1128/AEM.02066-08; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Shi XY, 2011, ANESTH ANALG, V113, P175, DOI 10.1213/ANE.0b013e31821a0258; Sinha S, 2002, COMPAR FUNCT GENOM, V3, P470, DOI 10.1002/cfg.211; SMIT J, 1992, J BACTERIOL, V174, P6527, DOI 10.1128/JB.174.20.6527-6538.1992; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Taylor-McCabe KJ, 2012, J GEN APPL MICROBIOL, V58, P113; Thwaite JE, 2009, LETT APPL MICROBIOL, V48, P373, DOI 10.1111/j.1472-765X.2008.02543.x; Toyoda Masahiko, 2001, Medical Electron Microscopy, V34, P29, DOI 10.1007/s007950100002; Veron W, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-114; WALLENGREN J, 1991, BRIT J DERMATOL, V124, P324, DOI 10.1111/j.1365-2133.1991.tb00591.x; Zaborina O, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030035	54	40	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78773	10.1371/journal.pone.0078773	http://dx.doi.org/10.1371/journal.pone.0078773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250813	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200046
J	Rodrigues, HA; Fonseca, MD; Camargo, WL; Lima, PMA; Martinelli, PM; Naves, LA; Prado, VF; Prado, MAM; Guatimosim, C				Rodrigues, Hermann A.; Fonseca, Matheus de C.; Camargo, Wallace L.; Lima, Patricia M. A.; Martinelli, Patricia M.; Naves, Ligia A.; Prado, Vania F.; Prado, Marco A. M.; Guatimosim, Cristina			Reduced Expression of the Vesicular Acetylcholine Transporter and Neurotransmitter Content Affects Synaptic Vesicle Distribution and Shape in Mouse Neuromuscular Junction	PLOS ONE			English	Article							MOTOR-NERVE TERMINALS; TRANSMITTER RELEASE; GLUTAMATE TRANSPORTER; QUANTAL SIZE; CHOLINE-ACETYLTRANSFERASE; HIPPOCAMPAL SYNAPSES; SYMPATHETIC-GANGLION; GROWTH-FACTOR; MICE; ENDOCYTOSIS	In vertebrates, nerve muscle communication is mediated by the release of the neurotransmitter acetylcholine packed inside synaptic vesicles by a specific vesicular acetylcholine transporter (VAChT). Here we used a mouse model (VAChT KDHOM) with 70% reduction in the expression of VAChT to investigate the morphological and functional consequences of a decreased acetylcholine uptake and release in neuromuscular synapses. Upon hypertonic stimulation, VAChT KDHOM mice presented a reduction in the amplitude and frequency of miniature endplate potentials, FM 1-43 staining intensity, total number of synaptic vesicles and altered distribution of vesicles within the synaptic terminal. In contrast, under electrical stimulation or no stimulation, VAChT KDHOM neuromuscular junctions did not differ from WT on total number of vesicles but showed altered distribution. Additionally, motor nerve terminals in VAChT KDHOM exhibited small and flattened synaptic vesicles similar to that observed in WT mice treated with vesamicol that blocks acetylcholine uptake. Based on these results, we propose that decreased VAChT levels affect synaptic vesicle biogenesis and distribution whereas a lower ACh content affects vesicles shape.	[Rodrigues, Hermann A.; Fonseca, Matheus de C.; Martinelli, Patricia M.; Guatimosim, Cristina] Univ Fed Minas Gerais, ICB, Dept Morfol, Belo Horizonte, MG, Brazil; [Camargo, Wallace L.; Naves, Ligia A.] Univ Fed Minas Gerais, ICB, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Lima, Patricia M. A.] Univ Fed Sao Joao Del Rei, Dept Engn Biossistemas, Sao Joao Del Rei, Brazil; [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol & Anat & Cell Biol, London, ON, Canada	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Sao Joao del-Rei; Western University (University of Western Ontario); Western University (University of Western Ontario)	Guatimosim, C (corresponding author), Univ Fed Minas Gerais, ICB, Dept Morfol, Belo Horizonte, MG, Brazil.	cguati@icb.ufmg.br	Fonseca, Matheus C./L-8006-2017; Prado, Vania Ferreira/K-7630-2013; Fonseca, Matheus C./O-9213-2019; Martinelli, Patricia/H-6341-2014; Prado, Marco Antonio Maximo/K-7638-2013; Fonseca, Matheus/GYU-2786-2022	Fonseca, Matheus C./0000-0001-9048-9775; Prado, Vania Ferreira/0000-0003-4994-6393; Fonseca, Matheus C./0000-0001-9048-9775; Prado, Marco Antonio Maximo/0000-0002-3028-5778; 	CNPq [472286/2009-9, 306483/2010-6]; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by funds from CNPq (472286/2009-9 and 306483/2010-6) and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi AA, 2012, COLD SPRING HARB PER, V4, P1; ANDERSON DC, 1983, MOL PHARMACOL, V24, P48; Barbosa J, 2002, J NEUROCHEM, V82, P1221, DOI 10.1046/j.1471-4159.2002.01068.x; Becherer U, 2001, J NEUROSCI, V21, P782, DOI 10.1523/JNEUROSCI.21-03-00782.2001; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; Bogen IL, 2009, NEUROCHEM INT, V55, P13, DOI 10.1016/j.neuint.2009.02.006; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Budzinski KL, 2009, BIOPHYS J, V97, P2577, DOI 10.1016/j.bpj.2009.08.032; Chen KH, 2011, J ALZHEIMERS DIS, V26, P755, DOI 10.3233/JAD-2011-110002; Cheng H, 1999, J NEUROPHYSIOL, V81, P1428, DOI 10.1152/jn.1999.81.3.1428; Colliver TL, 2000, J NEUROSCI, V20, P5276, DOI 10.1523/JNEUROSCI.20-14-05276.2000; Croft BG, 2005, MOL BIOL CELL, V16, P306, DOI 10.1091/mbc.e04-07-0559; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Ferreira LT, 2005, J NEUROCHEM, V94, P957, DOI 10.1111/j.1471-4159.2005.03244.x; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; HUBBARD JI, 1968, J PHYSIOL-LONDON, V197, P639, DOI 10.1113/jphysiol.1968.sp008579; Kamin D, 2010, BIOPHYS J, V99, P675, DOI 10.1016/j.bpj.2010.04.054; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Katz B., 1969, RELEASE NEURAL TRANS; Kim MH, 2004, J BIOL CHEM, V279, P12580, DOI 10.1074/jbc.M310681200; KITA H, 1977, J NEUROPHYSIOL, V40, P212, DOI 10.1152/jn.1977.40.2.212; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lima RD, 2010, J NEUROCHEM, V113, P943, DOI 10.1111/j.1471-4159.2010.06657.x; MARSHALL IG, 1970, BRIT J PHARMACOL, V38, P503, DOI 10.1111/j.1476-5381.1970.tb10592.x; Martyn AC, 2012, P NATL ACAD SCI USA, V109, P17651, DOI 10.1073/pnas.1215381109; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Nguyen ML, 1998, BIOCHEMISTRY-US, V37, P13400, DOI 10.1021/bi9802263; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Parsons RL, 1999, J NEUROPHYSIOL, V81, P2696, DOI 10.1152/jn.1999.81.6.2696; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Petralia RS, 2013, NEUROMOL MED, V15, P49, DOI 10.1007/s12017-012-8194-x; Pothos EN, 2000, J NEUROSCI, V20, P7297; PRADO MAM, 1993, J NEUROCHEM, V61, P45, DOI 10.1111/j.1471-4159.1993.tb03536.x; Prado VF, 2013, BIOCHEM J, V450, P265, DOI 10.1042/BJ20121662; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Prado VF, 2002, CELL MOL NEUROBIOL, V22, P565, DOI 10.1023/A:1021884319363; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rodrigues HA, 2013, EUR J NEURO IN PRESS; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Siksou L, 2013, EUR J NEUROSCI, V37, P1631, DOI 10.1111/ejn.12199; Smith R, 2006, HUM MOL GENET, V15, P3119, DOI 10.1093/hmg/ddl252; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Terry AV, 2007, NEUROSCIENCE, V150, P413, DOI 10.1016/j.neuroscience.2007.09.014; Terry AV, 2006, J PHARMACOL EXP THER, V318, P709, DOI 10.1124/jpet.105.099218; Van der Kloot W, 2002, J PHYSIOL-LONDON, V541, P385, DOI 10.1113/jphysiol.2001.014407; WHITTON PS, 1986, BRAIN RES, V385, P189, DOI 10.1016/0006-8993(86)91565-9; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	56	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78342	10.1371/journal.pone.0078342	http://dx.doi.org/10.1371/journal.pone.0078342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260111	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200019
J	Yang, XH; Zhu, DH; Liu, ZW; Zhao, L; Su, CY				Yang, Xiao-Hui; Zhu, Dao-Hong; Liu, Zhiwei; Zhao, Ling; Su, Cheng-Yuan			High Levels of Multiple Infections, Recombination and Horizontal Transmission of Wolbachia in the Andricus mukaigawae (Hymenoptera; Cynipidae) Communities	PLOS ONE			English	Article							GALL WASPS HYMENOPTERA; FEMINIZING WOLBACHIA; MOLECULAR EVIDENCE; WSP GENE; PHYLOGENY; STRAINS; DIVERSITY; SYMBIONT; CLASSIFICATION; POPULATIONS	Wolbachia are maternally inherited endosymbiotic bacteria of arthropods and nematodes. In arthropods, they manipulate the reproduction of their hosts to facilitate their own spread in host populations, causing cytoplasmic incompatibility, parthenogenesis induction, feminization of genetic males and male-killing. In this study, we investigated Wolbachia infection and studied wsp (Wolbachia surface protein) sequences in three wasp species associated with the unisexual galls of A. mukaigawae with the aim of determining the transmission mode and the reason for multiple infections of Wolbachia. Frequency of Wolbachia infected populations for A. mukaigawae, Synergus japonicus (inquiline), and Torymus sp. (parasitoid) was 75%, 100%, and 100%, respectively. Multiple Wolbachia infections were detected in A. mukaigawae and S. japonicus, with 5 and 8 Wolbachia strains, respectively. The two host species shared 5 Wolbachia strains and were infected by identical strains in several locations, indicating horizontal transmission of Wolbachia. The transmission potentially takes place through gall tissues, which the larvae of both wasps feed on. Furthermore, three recombination events of Wolbachia were observed: the strains W-8, W-2 and W-6 apparently have derived from W-3 and W-5a, W-6 and W-7, W-4 and W-9, respectively. W-8 and W-2 and their respective parental strains were detected in S. japonicus. W-6 was detected with only one parent (W-4) in S. japonicus; W-9 was detected in Torymus sp., suggesting horizontal transmission between hosts and parasitoids. In conclusion, our research supports earlier studies that horizontal transmission of Wolbachia, a symbiont of the Rickettsiales order, may be plant-mediated or take place between hosts and parasitoids. Our research provides novel molecular evidence for multiple recombination events of Wolbachia in gall wasp communities. We suggest that genomic recombination and potential plant-mediated horizontal transmission may be attributable to the high levels of multiple Wolbachia infections observed in A. mukaigawae and S. japonicus.	[Yang, Xiao-Hui; Zhu, Dao-Hong; Zhao, Ling; Su, Cheng-Yuan] Cent South Univ Forestry & Technol, Lab Insect Behav & Evolutionary Ecol, Changsha, Hunan, Peoples R China; [Liu, Zhiwei] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA	Central South University of Forestry & Technology; Eastern Illinois University	Zhu, DH (corresponding author), Cent South Univ Forestry & Technol, Lab Insect Behav & Evolutionary Ecol, Changsha, Hunan, Peoples R China.	daohongzhu@yeah.net	Liu, Zhiwei/AAI-7700-2020		National Natural Science Foundation of China (NSFC) [30872036]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC grant no. 30872036) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1997, APPL ENTOMOL ZOOL, V32, P135, DOI 10.1303/aez.32.135; Abe Y., 1990, Akitu, P1; Abe Y, 2002, ANN ENTOMOL SOC AM, V95, P583, DOI 10.1603/0013-8746(2002)095[0583:DWIUIO]2.0.CO;2; ABE Y, 1986, APPL ENTOMOL ZOOL, V21, P436, DOI 10.1303/aez.21.436; Abe Y, 2012, ENTOMOL SCI, V15, P340, DOI 10.1111/j.1479-8298.2011.00510.x; Arthofer W, 2009, MOL ECOL, V18, P3816, DOI 10.1111/j.1365-294X.2009.04321.x; Askew R.R., 1984, P223; Awadalla P, 2003, NAT REV GENET, V4, P50, DOI 10.1038/nrg964; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; BRAIG HR, 1994, NATURE, V367, P453, DOI 10.1038/367453a0; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Chust G, 2007, ECOL ENTOMOL, V32, P82, DOI 10.1111/j.1365-2311.2006.00850.x; Csoka Gyorgy, 2005, P573; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Freeman S, 2007, ADAPTIVE SIGNIFICANC, P302; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Haine ER, 2005, ECOL ENTOMOL, V30, P464, DOI 10.1111/j.0307-6946.2005.00715.x; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hiroki M, 2004, P ROY SOC B-BIOL SCI, V271, P1751, DOI 10.1098/rspb.2004.2769; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Jamnongluk W, 2002, CURR MICROBIOL, V45, P255, DOI 10.1007/s00284-002-3746-1; Jiggins FM, 2002, MOL BIOL EVOL, V19, P1640, DOI 10.1093/oxfordjournals.molbev.a004228; Kittayapong P, 2003, MOL ECOL, V12, P1049, DOI 10.1046/j.1365-294X.2003.01793.x; Kondo N, 2002, MOL ECOL, V11, P167, DOI 10.1046/j.0962-1083.2001.01432.x; Malloch G, 2005, MOL ECOL, V14, P627, DOI 10.1111/j.1365-294X.2005.02432.x; Malloch G, 2000, MOL ECOL, V9, P77, DOI 10.1046/j.1365-294x.2000.00836.x; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Mitsuhashi W, 2002, INSECT MOL BIOL, V11, P577, DOI 10.1046/j.1365-2583.2002.00368.x; Pattabhiramaiah M., 2010, INT J ENV SCI, V2, P526; Plantard O, 1999, INSECT MOL BIOL, V8, P185, DOI 10.1046/j.1365-2583.1999.820185.x; Plantard O, 1998, P ROY SOC B-BIOL SCI, V265, P1075, DOI 10.1098/rspb.1998.0401; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rasgon JL, 2006, APPL ENVIRON MICROB, V72, P6934, DOI 10.1128/AEM.01673-06; Reuter M, 2003, MOL BIOL EVOL, V20, P748, DOI 10.1093/molbev/msg082; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; Rokas A, 2002, MOL ECOL, V11, P1815, DOI 10.1046/j.1365-294X.2002.01556.x; Ronquist F, 1999, ZOOL SCR, V28, P139, DOI 10.1046/j.1463-6409.1999.00022.x; Ros VID, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S13; Schilthuizen M, 1998, HEREDITY, V81, P270, DOI 10.1046/j.1365-2540.1998.00385.x; Schuler H, 2011, ENTOMOL EXP APPL, V139, P138, DOI 10.1111/j.1570-7458.2011.01115.x; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; Van Borm S, 2001, J EVOLUTION BIOL, V14, P805, DOI 10.1046/j.1420-9101.2001.00321.x; van Meer MMM, 1999, INSECT MOL BIOL, V8, P399, DOI 10.1046/j.1365-2583.1999.83129.x; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Verne S, 2007, GENE, V397, P58, DOI 10.1016/j.gene.2007.04.006; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; West SA, 1998, MOL ECOL, V7, P1457, DOI 10.1046/j.1365-294x.1998.00467.x; Witiak S, 2009, HORMONAL MOL INVESTI; Xu ZF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-203; Yang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037960; Yang Xiao-Hui, 2012, Acta Entomologica Sinica, V55, P247; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zhu DH, 2007, ENTOMOL EXP APPL, V124, P279, DOI 10.1111/j.1570-7458.2007.00578.x; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388	66	12	14	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78970	10.1371/journal.pone.0078970	http://dx.doi.org/10.1371/journal.pone.0078970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250820	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200053
J	Datta, P; Li, GY; Yang, B; Zhao, X; Baik, JY; Gemmill, TR; Sharfstein, ST; Linhardt, RJ				Datta, Payel; Li, Guoyun; Yang, Bo; Zhao, Xue; Baik, Jong Youn; Gemmill, Trent R.; Sharfstein, Susan T.; Linhardt, Robert J.			Bioengineered Chinese Hamster Ovary Cells with Golgi-targeted 3-O-Sulfotransferase-1 Biosynthesize Heparan Sulfate with an Antithrombin-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antithrombin; Golgi; Heparan Sulfate; Heparin; Metabolic Engineering; Sulfotransferase	N-DEACETYLASE/N-SULFOTRANSFERASE; D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE; PROTEIN LINKAGE REGION; MAST-CELLS; SUBSTRATE-SPECIFICITY; MOLECULAR-CLONING; MICE DEFICIENT; CORE PROTEIN; EXPRESSION; PROTEOGLYCANS	HS3st1 (heparan sulfate 3-O-sulfotransferase isoform-1) is a critical enzyme involved in the biosynthesis of the antithrombin III (AT)-binding site in the biopharmaceutical drug heparin. Heparin is a highly sulfated glycosaminoglycan that shares a common biosynthetic pathway with heparan sulfate (HS). Although only granulated cells, such as mast cells, biosynthesize heparin, all animal cells are capable of biosynthesizing HS. As part of an effort to bioengineer CHO cells to produce heparin, we previously showed that the introduction of both HS3st1 and NDST2 (N-deacetylase/N-sulfotransferase isoform-2) afforded HS with a very low level of anticoagulant activity. This study demonstrated that untargeted HS3st1 is broadly distributed throughout CHO cells and forms no detectable AT-binding sites, whereas Golgi-targeted HS3st1 localizes in the Golgi and results in the formation of a single type of AT-binding site and high anti-factor Xa activity (137 +/- 36 units/mg). Moreover, stable overexpression of HS3st1 also results in up-regulation of 2-O-, 6-O-, and N-sulfo group-containing disaccharides, further emphasizing a previously unknown concerted interplay between the HS biosynthetic enzymes and suggesting the need to control the expression level of all of the biosynthetic enzymes to produce heparin in CHO cells.	[Datta, Payel; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Datta, Payel; Li, Guoyun; Yang, Bo; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Li, Guoyun; Yang, Bo; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Li, Guoyun; Zhao, Xue] Ocean Univ China, Coll Food Sci & Technol, Qingdao 266003, Peoples R China; [Baik, Jong Youn; Gemmill, Trent R.; Sharfstein, Susan T.] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12203 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Ocean University of China; State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	linhar@rpi.edu	Sharfstein, Susan T./AAF-2739-2020; Sharfstein, Susan T./M-5397-2018	Sharfstein, Susan T./0000-0002-0908-4197; Datta, Payel/0000-0001-5977-448X	National Institutes of Health [R01 GM090127]; Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM090127. This work was also supported by a fellowship from the Rensselaer Polytechnic Institute (to P. D.).	Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Anower-E-Khuda MF, 2013, J BIOL CHEM, V288, P3705, DOI 10.1074/jbc.M112.416651; Baik JY, 2012, METAB ENG, V14, P81, DOI 10.1016/j.ymben.2012.01.008; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Carlsson Pernilla, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-23056-1_2; Chen JH, 2005, BBA-GEN SUBJECTS, V1725, P190, DOI 10.1016/j.bbagen.2005.06.012; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; Datta P., 2013, THESIS RENSSLAER POL; Datta P, 2013, BIOTECHNOL BIOENG, V110, P1255, DOI 10.1002/bit.24841; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Duelli A, 2009, J IMMUNOL, V183, P7073, DOI 10.4049/jimmunol.0900309; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; ESKO JD, 1987, J BIOL CHEM, V262, P12189; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Fu L, 2013, J PHARM SCI-US, V102, P1447, DOI 10.1002/jps.23501; Girardin EP, 2005, J BIOL CHEM, V280, P38059, DOI 10.1074/jbc.M507997200; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; Jemth P, 2003, J BIOL CHEM, V278, P24371, DOI 10.1074/jbc.M212155200; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; MONTGOMERY RI, 1992, P NATL ACAD SCI USA, V89, P11327, DOI 10.1073/pnas.89.23.11327; Moon AF, 2012, P NATL ACAD SCI USA, V109, P5265, DOI 10.1073/pnas.1117923109; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Shworak NW, 2010, PROG MOL BIOL TRANSL, V93, P153, DOI [10.1016/S1877-1173(10)9.3008-1, 10.1016/S1877-1173(10)93008-1]; Shworak NW, 2002, GLYCOCONJUGATE J, V19, P355, DOI 10.1023/A:1025377206600; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Wang ZY, 2010, BIOTECHNOL BIOENG, V107, P964, DOI 10.1002/bit.22898; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yang B, 2012, J CHROMATOGR A, V1225, P91, DOI 10.1016/j.chroma.2011.12.063; Zhang FM, 2011, ANAL BIOANAL CHEM, V401, P2793, DOI 10.1007/s00216-011-5367-7; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9; Zhang LJ, 2001, J BIOL CHEM, V276, P28806, DOI 10.1074/jbc.M100204200; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200; Zhao WJ, 2011, FEBS LETT, V585, P2461, DOI 10.1016/j.febslet.2011.06.023; Zhao X, 2013, ANAL BIOCHEM, V434, P215, DOI 10.1016/j.ab.2012.12.009	54	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37308	37318		10.1074/jbc.M113.519033	http://dx.doi.org/10.1074/jbc.M113.519033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24247246	hybrid, Green Published			2022-12-25	WOS:000329189700047
J	Mao, QY; Cheng, T; Zhu, FC; Li, JX; Wang, YP; Li, YP; Gao, FP; Yang, LS; Yao, X; Shao, J; Xia, NS; Liang, ZL; Wang, JZ				Mao, Qunying; Cheng, Tong; Zhu, Fengcai; Li, Jingxin; Wang, Yiping; Li, Yanping; Gao, Fan; Yang, Lisheng; Yao, Xin; Shao, Jie; Xia, Ningshao; Liang, Zhenglun; Wang, Junzhi			The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children	PLOS ONE			English	Article							MICRONEUTRALIZATION ASSAY; ANTIBODY-RESPONSES; MOUTH-DISEASE; DOUBLE-BLIND; EV71; EVOLUTION; IMMUNOGENICITY; INFECTION; STRAINS; TAIWAN	Background: EV71 is one of major etiologic causes of hand-foot-mouth disease (HFMD) and leads to severe neurological complications in young children and infants. Recently inactivated EV71 vaccines have been developed by five manufactures and clinically show good safety and immunogenicity. However, the cross-neutralizing activity of these vaccines remains unclear, and is of particular interest because RNA recombination is seen more frequently in EV71 epidemics. Methodology/Principal Findings: In this post-hoc study, sera from a subset of 119 infants and children in two clinical trials of EV71 subgenotype C4 vaccines (ClinicalTrials.gov Identifier: NCT01313715 and NCT01273246), were detected for neutralizing antibody (NTAb) titres with sera from infected patients as controls. Cytopathogenic effect method was employed to test NTAb against EV71 subgenotype B4, B5, C2, C4 and C5, which were prominent epidemic strains worldwide over the past decade. To validate the accuracy of the results, ELISpot assay was employed in parallel to detect NTAb in all the post-vaccine sera. After two-dose vaccination, 49 out of 53 participants in initially seronegative group and 52 out of 53 participants in initially seropositive group showed less than 4-fold differences in NTAb titers against five EV71 strains, whereas corresponding values among sera from pediatric patients recovering from EV71-induced HFMD and subclinically infected participants were 8/8 and 41/43, respectively. The geometric mean titers of participants against five subgenotypes EV71 all grew significantly after vaccinations, irrespective of the baseline NTAb titer. The relative fold increase in antibody titers (NTAb-FI) against B4, B5, C2, and C5 displayed a positive correlation to the NTAb-FI against C4. Conclusions/Significance: The results demonstrated broad cross-neutralizing activity induced by two C4 EV71 vaccines in healthy Chinese infants and children. However, the degree of induced cross-protective immunity, and the potential escape evolution for EV71 still need to be monitored and researched in future for these new vaccines.	[Mao, Qunying; Wang, Yiping; Gao, Fan; Yao, Xin; Shao, Jie; Liang, Zhenglun; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Cheng, Tong; Yang, Lisheng; Xia, Ningshao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Life Sci, Xiamen, Peoples R China; [Zhu, Fengcai; Li, Jingxin] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Li, Yanping] Ctr Dis Control & Prevent Guangxi Zhuang Autonomo, Nanning, Peoples R China	National Institute of Food & Drug Control - China; Xiamen University; Jiangsu Provincial Center for Disease Control & Prevention	Liang, ZL (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.	lzhenglun@126.com; wangjz@nicpbp.org.cn	li, yan/GTI-4638-2022	Xia, Ningshao/0000-0003-0179-5266; Cheng, Tong/0000-0002-1638-6214	Ministry of Science and Technology of the People's Republic of China [2012ZX10004701]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The current study was sponsored by the National 12th Five Major Special Projects Funding Program (No. 2012ZX10004701) from the Ministry of Science and Technology of the People's Republic of China. The funding agency did not participate in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abai AM, 2007, J IMMUNOL METHODS, V322, P82, DOI 10.1016/j.jim.2007.02.001; AbuBakar S, 2000, NEW ENGL J MED, V342, P355; AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; [Anonymous], 2008, NOTICE HAND FOOT MOU; Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chen YX, 2013, VACCINE, V31, P425, DOI 10.1016/j.vaccine.2012.10.032; Cheng T, 2013, J VIROL MET IN PRESS; Chong P, 2012, HUM VACC IMMUNOTHER, V8, P1775, DOI 10.4161/hv.21739; Chou AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034834; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Huang ML, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002067; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang YP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-277; Ku ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057601; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Liang Y, 2012, J CLIN IMMUNOL, V32, P1048, DOI 10.1007/s10875-012-9690-3; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Mao QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046043; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; van der Sanden S, 2010, J GEN VIROL, V91, P1949, DOI 10.1099/vir.0.019695-0; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhu FC, 2013, LANCET, V381, P1037, DOI 10.1016/S0140-6736(12)61764-4; Zhu FC, 2012, PEDIATR INFECT DIS J, V31, P1158, DOI 10.1097/INF.0b013e31826eba74; Zielinska E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-84	39	51	63	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79599	10.1371/journal.pone.0079599	http://dx.doi.org/10.1371/journal.pone.0079599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260259	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900033
J	Yang, C; Gu, LK; Deng, DJ				Yang, Chen; Gu, Liankun; Deng, Dajun			Bone Marrow-Derived Cells May Not Be the Original Cells for Carcinogen-Induced Mouse Gastrointestinal Carcinomas	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; STEM-CELL; MYOFIBROBLAST DIFFERENTIATION; CANCER; INFLAMMATION; MECHANISMS; FUSION; LIVER	Aim: It has been reported that bone marrow-derived cells (BMDC) can be original cells of mouse gastric cancers induced by Helicobacter felis (H. felis) infection. However, it is unknown whether BMDCs are also the original cells of mouse gastrointestinal cancers induced by gastric carcinogens N-nitroso-N-methylurea (NMU) and H. felis infection. Methods: C57BL/6 recipient mice were initially irradiated with 10Gy X-ray, reconstituted with bone marrow cells from the C57BL/6-Tg (CAG-EGFP) donor mice to label BMDCs with green fluorescence protein (GFP). After 4 weeks of recovery, the bone marrow-transplanted mice were given NMU in drinking water (240 ppm) and subsequently infected with H. felis by gavage. Eighty weeks later, all mice were euthanized for pathological examination. The BMDCs expressing GFP were detected in tissues using direct GFP fluorescence confocal microscopy analysis and immunohistochemistry staining (IHC) assays. Results: Neoplastic lesions were induced by NMU treatment and/or H. felis infection at the antrum of the glandular stomach and small intestine. In the direct GFP fluorescence confocal assay, GFP(+) epithelial cell cluster or glands were not observed in these gastrointestinal tumors, however, most GFP(+) BMDCs sporadically located in the tumor stromal tissues. Some of these GFP(+) stromal BMDCs co-expressed the hematopoietic marker CD45 or myofibroblasts markers alpha SMA and SRF. In the indirect GFP IHC assay, similar results were observed among 11 gastric intraepithelial neoplasia lesions and 2 small intestine tumors. Conclusion: These results demonstrated that BMDCs might not be the source of gastrointestinal tumor cells induced by NMU and/or H. felis infection.	[Yang, Chen; Gu, Liankun; Deng, Dajun] Peking Univ, Canc Hosp & Inst, Div Etiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China	Peking University	Deng, DJ (corresponding author), Peking Univ, Canc Hosp & Inst, Div Etiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	dengdajun@bjmu.edu.cn	Deng, Dajun/D-4605-2009	Deng, Dajun/0000-0001-5161-5943	National NSFC [90919015, 30921140311]; National Basic Research Program of China (973 Program) [2010CB529303]	National NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National NSFC funds (#90919015 and #30921140311) and National Basic Research Program of China (973 Program 2010CB529303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2009, CURR OPIN ONCOL, V21, P77, DOI 10.1097/CCO.0b013e32831de4cf; Chai JY, 2007, GUT, V56, P621, DOI 10.1136/gut.2006.106674; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Deng DJ, 2000, WORLD J GASTROENTERO, V6, P613; Deng DJ, 2000, J AGR FOOD CHEM, V48, P2495, DOI 10.1021/jf990967q; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Han Z, 2012, HEPATOLOGY, V56, P350, DOI 10.1002/hep.25672; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; IARC WHO, 1978, IARC MON EV CARC RIS, V17, P227; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Leininger J R, 1994, IARC Sci Publ, P167; Marrache F, 2008, GUT, V57, P1113, DOI 10.1136/gut.2007.143271; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Nam KT, 2004, CLIN CANCER RES, V10, P8105, DOI 10.1158/1078-0432.CCR-04-0896; Placencio VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012920; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Sakai G, 2012, ANTICANCER RES, V32, P4097; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Scarlett CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026088; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539	24	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79615	10.1371/journal.pone.0079615	http://dx.doi.org/10.1371/journal.pone.0079615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260263	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900035
J	Comar, M; De Rocco, D; Cappelli, E; Zanotta, N; Bottega, R; Svahn, J; Farruggia, P; Misuraca, A; Corsolini, F; Dufour, C; Savoia, A				Comar, Manola; De Rocco, Daniela; Cappelli, Enrico; Zanotta, Nunzia; Bottega, Roberta; Svahn, Johanna; Farruggia, Piero; Misuraca, Aldo; Corsolini, Fabio; Dufour, Carlo; Savoia, Anna			Fanconi Anemia Patients Are More Susceptible to Infection with Tumor Virus SV40	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; HIGH-RISK; SIMIAN-VIRUS-40 INFECTION; HYPERENDEMIC AREA; POLYOMAVIRUS; PATHWAY; REPAIR; TRANSFORMATION; ASSOCIATION; EXPRESSION	Fanconi anemia (FA) is a recessive DNA repair disease characterized by a high predisposition to developing neoplasms. DNA tumor polyomavirus simian virus 40 (SV40) transforms FA fibroblasts at high efficiency suggesting that FA patients could be highly susceptible to SV40 infection. To test this hypothesis, the large tumor (LT) antigen of SV40, BKV, JCV and Merkel Cell (MC) polyomaviruses were tested in blood samples from 89 FA patients and from 82 of their parents. Two control groups consisting of 47 no-FA patients affected by other genetic bone marrow failure diseases and 91 healthy subjects were also evaluated. Although JCV, BKV and MC were not found in any of the FA samples, the prevalence and viral load of SV40 were higher in FA patients (25%; mean viral load: 1.1X10(2) copies/10(5) cells) as compared with healthy individuals (4.3%; mean viral load: 0.8X10(1) copies/10(5) cells) and genetic controls (0%) (p<0.005). A marked age-dependent frequency of SV40 was found in FA with respect to healthy subjects suggesting that, although acquired early in life, the virus can widespread more easily in specific groups of population. From the analysis of family pedigrees, 60% of the parents of SV40-positive probands were positive for the virus compared to 2% of the parents of the SV40-negative probands (p<0.005). It is worthy of note that the relative frequency of SV40-positive relatives detected in this study was the highest ever reported, showing that asymptomatic FA carriers are also more susceptible to SV40. In conclusion, we favor the hypothesis that SV40 spread could be facilitated by individuals who are genetically more susceptible to infection, such as FA patients. The increased susceptibility to SV40 infection seems to be associated with a specific defect of the immune system which supports a potential interplay of SV40 with an underlying genetic alteration that increases the risk of malignancies.	[Comar, Manola; Zanotta, Nunzia; Savoia, Anna] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Comar, Manola; De Rocco, Daniela; Bottega, Roberta; Savoia, Anna] Univ Trieste, Dept Med Sci, Trieste, Italy; [Cappelli, Enrico; Svahn, Johanna; Corsolini, Fabio; Dufour, Carlo] IRCCS Giannina Gaslini, Haematol Unit, Genoa, Italy; [Farruggia, Piero] Di Cristina Hosp, ARNAS Civ, Pediat Hematol & Oncol Unit, Dept Oncol, Palermo, Italy; [Farruggia, Piero] Benefratelli Hosp, ARNAS Civ, Dept Oncol, Pediat Hematol & Oncol Unit, Palermo, Italy; [Misuraca, Aldo] Santobono Pausilipon Hosp, Pediat Hematol Unit, Naples, Italy	IRCCS Burlo Garofolo; University of Trieste; University of Genoa; IRCCS Istituto Giannina Gaslini; A.R.N.A.S. Ospedali Civico Di Cristina Benfratelli; A.R.N.A.S. Ospedali Civico Di Cristina Benfratelli	Comar, M (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.	comar@burlo.trieste.it	Bottega, Roberta/J-1025-2018; De Rocco, Daniela/K-6753-2016; Savoia, Anna/AIC-4560-2022; Comar, Manola/K-4613-2016; Savoia, Anna/B-6463-2014; Bottega, Roberta/AAB-5099-2020; Cappelli, Enrico/K-7954-2016; Corsolini, Fabio/AAC-6663-2020; Dufour, Carlo/AAB-1000-2021; COMAR, Manola/K-4613-2016; Farruggia, Piero/N-3930-2018; Zanotta, Nunzia/K-4539-2016	Bottega, Roberta/0000-0001-7431-7543; De Rocco, Daniela/0000-0002-4536-9798; Savoia, Anna/0000-0002-2407-2696; Comar, Manola/0000-0001-6310-3320; Savoia, Anna/0000-0002-2407-2696; Cappelli, Enrico/0000-0001-5910-9260; Corsolini, Fabio/0000-0003-0016-3400; COMAR, Manola/0000-0002-9487-861X; Farruggia, Piero/0000-0002-3412-0399; Svahn, Johanna/0000-0002-7135-9171; Zanotta, Nunzia/0000-0002-6458-1946	IRCCS Burlo Garofolo Hospital [RC 11/11]; Telethon Foundation, Italy [GGP11076]	IRCCS Burlo Garofolo Hospital; Telethon Foundation, Italy(Fondazione Telethon)	This study was supported by grants (RC 11/11) from IRCCS Burlo Garofolo Hospital and from Telethon Foundation (GGP11076), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004; Boichuk S, 2010, J VIROL, V84, P8007, DOI 10.1128/JVI.00334-10; Butel JS, 2012, CURR OPIN VIROL, V2, P508, DOI 10.1016/j.coviro.2012.06.004; Comar M, 2007, CANCER RES, V67, P8456, DOI 10.1158/0008-5472.CAN-07-2232; Comar M, 2012, TUMORI J, V98, P210, DOI 10.1700/1088.11931; Comar M, 2010, J MED VIROL, V82, P1236, DOI 10.1002/jmv.21786; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Cutrone R, 2005, CANCER RES, V65, P10273, DOI 10.1158/0008-5472.CAN-05-2028; Dahl J, 2005, J VIROL, V79, P13007, DOI 10.1128/JVI.79.20.13007-13017.2005; de Araujo MR, 2011, ORAL DIS, V17, P572, DOI 10.1111/j.1601-0825.2011.01803.x; Digweed M, 2002, ONCOGENE, V21, P4873, DOI 10.1038/sj.onc.1205616; Garcea RL, 2003, J VIROL, V77, P5039, DOI 10.1128/JVI.77.9.5039-5045.2003; Gheit T, 2006, J CLIN MICROBIOL, V44, P2025, DOI 10.1128/JCM.02305-05; Goh S, 2009, EMERG INFECT DIS, V15, P489, DOI 10.3201/eid1503.081206; Hein J, 2009, J VIROL, V83, P117, DOI 10.1128/JVI.01515-08; Hmeljak J, 2010, TUMORI J, V96, P667, DOI 10.1177/030089161009600504; Hoskins EE, 2012, J VIROL, V86, P8131, DOI 10.1128/JVI.00408-12; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; Liu JM, 1996, BIOCHEM BIOPH RES CO, V223, P685, DOI 10.1006/bbrc.1996.0956; Lopez-Rios F, 2004, LANCET, V364, P1157, DOI 10.1016/S0140-6736(04)17102-X; Lowe DB, 2007, CELL MOL LIFE SCI, V64, P803, DOI 10.1007/s00018-007-6414-6; LUBINIECKI AS, 1980, AM J HEMATOL, V8, P389, DOI 10.1002/ajh.2830080407; Malkin D, 2001, ONCOGENE, V20, P4441, DOI 10.1038/sj.onc.1204583; Martini Fernanda, 2007, Infect Agent Cancer, V2, P13, DOI 10.1186/1750-9378-2-13; Mathew CG, 2006, ONCOGENE, V25, P5875, DOI 10.1038/sj.onc.1209878; Mazzoni E, 2012, P NATL ACAD SCI USA, V109, P18066, DOI 10.1073/pnas.1213238109; Myers KC, 2011, BRIT J HAEMATOL, V154, P234, DOI 10.1111/j.1365-2141.2011.08721.x; Polesel J, 2012, BRIT J CANCER, V106, P222, DOI 10.1038/bjc.2011.519; Schmitt M, 2010, J CLIN MICROBIOL, V48, P143, DOI 10.1128/JCM.00991-09; SHAH K, 1976, AM J EPIDEMIOL, V103, P1; Shah KV, 2007, INT J CANCER, V120, P215, DOI 10.1002/ijc.22425; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Soulier J, 2011, HEMATOL-AM SOC HEMAT, P492, DOI 10.1182/asheducation-2011.1.492; Taronna A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061182; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; TODARO GJ, 1966, SCIENCE, V153, P1252, DOI 10.1126/science.153.3741.1252; Vilchez RA, 2003, ONCOGENE, V22, P5164, DOI 10.1038/sj.onc.1206547; Vilchez Regis A, 2003, Curr Oncol Rep, V5, P372, DOI 10.1007/s11912-003-0021-y; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07	42	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79683	10.1371/journal.pone.0079683	http://dx.doi.org/10.1371/journal.pone.0079683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260277	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500087
J	Defauw, A; Kazbanov, IV; Dierckx, H; Dawyndt, P; Panfilov, AV				Defauw, Arne; Kazbanov, Ivan V.; Dierckx, Hans; Dawyndt, Peter; Panfilov, Alexander V.			Action Potential Duration Heterogeneity of Cardiac Tissue Can Be Evaluated from Cell Properties Using Gaussian Green's Function Approach	PLOS ONE			English	Article								Action potential duration (APD) heterogeneity of cardiac tissue is one of the most important factors underlying initiation of deadly cardiac arrhythmias. In many cases such heterogeneity can be measured at tissue level only, while it originates from differences between the individual cardiac cells. The extent of heterogeneity at tissue and single cell level can differ substantially and in many cases it is important to know the relation between them. Here we study effects from cell coupling on APD heterogeneity in cardiac tissue in numerical simulations using the ionic TP06 model for human cardiac tissue. We show that the effect of cell coupling on APD heterogeneity can be described mathematically using a Gaussian Green's function approach. This relates the problem of electrotonic interactions to a wide range of classical problems in physics, chemistry and biology, for which robust methods exist. We show that, both for determining effects of tissue heterogeneity from cell heterogeneity (forward problem) as well as for determining cell properties from tissue level measurements (inverse problem), this approach is promising. We illustrate the solution of the forward and inverse problem on several examples of 1D and 2D systems.	[Defauw, Arne; Kazbanov, Ivan V.; Dierckx, Hans; Panfilov, Alexander V.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium; [Dawyndt, Peter] Univ Ghent, Dept Appl Math & Comp Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University	Defauw, A (corresponding author), Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium.	arne.defauw@ugent.be	Dierckx, Hans/AAH-1714-2019; Panfilov, Alexander/G-8459-2016	Panfilov, Alexander/0000-0003-2643-642X; Defauw, Arne/0000-0003-1946-9178; Dierckx, Hans/0000-0003-0899-8082; Dawyndt, Peter/0000-0002-1623-9070	Ghent University; Research-Foundation Flanders (FWO)	Ghent University(Ghent University); Research-Foundation Flanders (FWO)(FWO)	A.Defauw, P.Dawyndt and A.V.Panfilov acknowledge the support of Ghent University (Multidisciplinary Research Partnership - Bioinformatics: from nucleotides to networks). H.Dierckx and I.Kazbanov are supported by the Research-Foundation Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Hansen P, 2008, REGULATIZATION TOOLS; Hansen P.C., 2006, DEBLURRING IMAGES MA; HENRIQUEZ CS, 1993, CRIT REV BIOMED ENG, V21, P1; Keener J., 1998, MATH PHYSL; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; KRINSKII VI, 1966, BIOPHYS-USSR, V11, P776; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; Potse Mark, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3895; RUSH S, 1978, IEEE T BIO-MED ENG, V25, P389, DOI 10.1109/TBME.1978.326270; Sampson KJ, 2005, AM J PHYSIOL-HEART C, V289, pH350, DOI 10.1152/ajpheart.00507.2004; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Vogel C. R., 2002, FRONT APPL MATH, DOI DOI 10.1137/1.9780898717570; Walton RD, 2009, IEEE ENG MED BIO, P4190, DOI 10.1109/IEMBS.2009.5334052; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	16	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79607	10.1371/journal.pone.0079607	http://dx.doi.org/10.1371/journal.pone.0079607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260262	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500081
J	Melito, S; Sias, A; Petretto, GL; Chessa, M; Pintore, G; Porceddu, A				Melito, Sara; Sias, Angela; Petretto, Giacomo L.; Chessa, Mario; Pintore, Giorgio; Porceddu, Andrea			Genetic and Metabolite Diversity of Sardinian Populations of Helichrysum italicum	PLOS ONE			English	Article							ESSENTIAL OILS; SSP MICROPHYLLUM; PHYLOGENETIC-RELATIONSHIPS; ANTIINFLAMMATORY ACTIVITY; CHEMICAL-COMPOSITION; SUBSP ITALICUM; CORSICA FRANCE; GREEK ORIGIN; GNAPHALIEAE; ASTERACEAE	Background:Helichrysum italicum (Asteraceae) is a small shrub endemic to the Mediterranean Basin, growing in fragmented and diverse habitats. The species has attracted attention due to its secondary metabolite content, but little effort has as yet been dedicated to assessing the genetic and metabolite diversity present in these populations. Here, we describe the diversity of 50 H. italicum populations collected from a range of habitats in Sardinia. Methods: H. italicum plants were AFLP fingerprinted and the composition of their leaf essential oil characterized by GC-MS. The relationships between the genetic structure of the populations, soil, habitat and climatic variables and the essential oil chemotypes present were evaluated using Bayesian clustering, contingency analyses and AMOVA. Key results: The Sardinian germplasm could be partitioned into two AFLP-based clades. Populations collected from the southwestern region constituted a homogeneous group which remained virtually intact even at high levels of K. The second, much larger clade was more diverse. A positive correlation between genetic diversity and elevation suggested the action of natural purifying selection. Four main classes of compounds were identified among the essential oils, namely monoterpenes, oxygenated monoterpenes, sesquiterpenes and oxygenated sesquiterpenes. Oxygenated monoterpene levels were significantly correlated with the AFLP-based clade structure, suggesting a correspondence between gene pool and chemical diversity. Conclusions: The results suggest an association between chemotype, genetic diversity and collection location which is relevant for the planning of future collections aimed at identifying valuable sources of essential oil.	[Melito, Sara] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy; [Sias, Angela; Petretto, Giacomo L.; Chessa, Mario; Pintore, Giorgio] Univ Sassari, Dipartimento Chim & Farm, I-07100 Sassari, Italy; [Melito, Sara; Pintore, Giorgio; Porceddu, Andrea] Ctr Interdipartimentale Conservaz & Valorizz Biod, Sassari, Italy	University of Sassari; University of Sassari	Melito, S (corresponding author), Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy.	smelito@uniss.it		Petretto, Giacomo Luigi/0000-0001-9528-5632; Melito, Sara/0000-0002-4910-2353; PINTORE, Giorgio Antonio Mario/0000-0001-8421-1750; , Mario/0000-0002-9218-6863	RAS (Autonomous Region of Sardinia) Postdoctoral Fellowship Promotion of the Scientific Research; Technological Innovation in Sardinia (Sardinia POR) [ID:CRP1_385]; Fondazione Banco di Sardegna	RAS (Autonomous Region of Sardinia) Postdoctoral Fellowship Promotion of the Scientific Research; Technological Innovation in Sardinia (Sardinia POR); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This research was supported by the RAS (Autonomous Region of Sardinia) Postdoctoral Fellowship Promotion of the Scientific Research and of the Technological Innovation in Sardinia (Sardinia POR, FSE 2007-2013 funds, L.R. 7/2007)(ID:CRP1_385) and Fondazione Banco di Sardegna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RP, 2001, IDENTIFICATION ESSEN; Addinsoft, 2007, XLSTAT 2007 DAT AN S; Anderberg A. A., 1991, OPERA BOT, V104, P1; Angioni A, 2003, J AGR FOOD CHEM, V51, P1030, DOI 10.1021/jf025940c; [Anonymous], 1997, TFPGA TOOLS POPULATI; Appendino G, 2007, J NAT PROD, V70, P608, DOI 10.1021/np060581r; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bianchini A, 2003, FLAVOUR FRAG J, V18, P487, DOI 10.1002/ffj.1231; Bianchini A, 2001, FLAVOUR FRAG J, V16, P30, DOI 10.1002/1099-1026(200101/02)16:1&lt;30::AID-FFJ941&gt;3.0.CO;2-F; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chinou IB, 1996, PLANTA MED, V62, P377, DOI 10.1055/s-2006-957914; Chinou IB, 1997, PLANTA MED, V63, P181, DOI 10.1055/s-2006-957641; European Commission, 1991, 125873 EUR; European Pharmacopeia, 2002, EUR PHARM, P183; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Galbany-Casals M, 2004, AUST SYST BOT, V17, P241, DOI 10.1071/SB03031; Galbany-Casals M, 2011, PLANT BIOLOGY, V13, P678, DOI 10.1111/j.1438-8677.2010.00411.x; Galbany-Casals M, 2008, BOT J LINN SOC, V158, P511, DOI 10.1111/j.1095-8339.2008.00889.x; Galbany-Casals M, 2006, CAN J BOT, V84, P1203, DOI 10.1139/B06-082; Galbany-Casals M, 2010, TAXON, V59, P1671, DOI 10.1002/tax.596003; Joulain D, 1998, ATLAS SPECTRAL DATA; Lorenzi V, 2009, ANTIMICROB AGENTS CH, V53, P2209, DOI 10.1128/AAC.00919-08; Mastelic J, 2005, CHEM NAT COMPD+, V41, P35, DOI 10.1007/s10600-005-0069-z; Morone-Fortunato I, 2010, IND CROP PROD, V32, P639, DOI 10.1016/j.indcrop.2010.07.023; NEI M, 1978, GENETICS, V89, P583; Nostro A, 2004, LETT APPL MICROBIOL, V38, P423, DOI 10.1111/j.1472-765X.2004.01509.x; Nostro A, 2003, MICROBIOLOGICA, V26, P125; Nostro A, 2002, LETT APPL MICROBIOL, V35, P181, DOI 10.1046/j.1472-765X.2002.01166.x; Nostro A, 2001, INT J ANTIMICROB AG, V18, P305, DOI 10.1016/S0924-8579(01)00409-5; Paolini J, 2006, FLAVOUR FRAG J, V21, P805, DOI 10.1002/ffj.1726; Perrini R, 2009, IND CROP PROD, V29, P395, DOI 10.1016/j.indcrop.2008.07.010; Pritchard JK, 2000, GENETICS, V155, P945; Sala A, 2001, J NAT PROD, V64, P1360, DOI 10.1021/np010125x; Sala A, 2003, EUR J PHARMACOL, V461, P53, DOI 10.1016/S0014-2999(02)02953-9; Sala A, 2002, J PHARM PHARMACOL, V54, P365, DOI 10.1211/0022357021778600; *SAS I INC, 2007, JMP; Usai M, 2010, J ESSENT OIL RES, V22, P373, DOI 10.1080/10412905.2010.9700350; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407	41	33	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79043	10.1371/journal.pone.0079043	http://dx.doi.org/10.1371/journal.pone.0079043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260149	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500020
J	Wei, DD; Chen, EH; Ding, TB; Chen, SC; Dou, W; Wang, JJ				Wei, Dan-Dan; Chen, Er-Hu; Ding, Tian-Bo; Chen, Shi-Chun; Dou, Wei; Wang, Jin-Jun			De Novo Assembly, Gene Annotation, and Marker Discovery in Stored-Product Pest Liposcelis entomophila (Enderlein) Using Transcriptome Sequences	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; PSOCIDS PSOCOPTERA LIPOSCELIDIDAE; HEAT-SHOCK PROTEINS; HUMAN-BODY LOUSE; RYANODINE RECEPTOR; DIAMONDBACK MOTH; FIELD POPULATIONS; SNP DETECTION; EXPRESSION; RESISTANCE	Background: As a major stored-product pest insect, Liposcelis entomophila has developed high levels of resistance to various insecticides in grain storage systems. However, the molecular mechanisms underlying resistance and environmental stress have not been characterized. To date, there is a lack of genomic information for this species. Therefore, studies aimed at profiling the L. entomophila transcriptome would provide a better understanding of the biological functions at the molecular levels. Methodology/Principal Findings: We applied Illumina sequencing technology to sequence the transcriptome of L. entomophila. A total of 54,406,328 clean reads were obtained and that de novo assembled into 54,220 unigenes, with an average length of 571 bp. Through a similarity search, 33,404 (61.61%) unigenes were matched to known proteins in the NCBI non-redundant (Nr) protein database. These unigenes were further functionally annotated with gene ontology (GO), cluster of orthologous groups of proteins (COG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. A large number of genes potentially involved in insecticide resistance were manually curated, including 68 putative cytochrome P450 genes, 37 putative glutathione S-transferase (GST) genes, 19 putative carboxyl/cholinesterase (CCE) genes, and other 126 transcripts to contain target site sequences or encoding detoxification genes representing eight types of resistance enzymes. Furthermore, to gain insight into the molecular basis of the L. entomophila toward thermal stresses, 25 heat shock protein (Hsp) genes were identified. In addition, 1,100 SSRs and 57,757 SNPs were detected and 231 pairs of SSR primes were designed for investigating the genetic diversity in future. onclusions/Significance: We developed a comprehensive transcriptomic database for L. entomophila. These sequences and putative molecular markers would further promote our understanding of the molecular mechanisms underlying insecticide resistance or environmental stress, and will facilitate studies on population genetics for psocids, as well as providing useful information for functional genomic research in the future.	[Wei, Dan-Dan; Chen, Er-Hu; Ding, Tian-Bo; Chen, Shi-Chun; Dou, Wei; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Wang, JJ (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	jjwang7008@yahoo.com			Fundamental Research Funds for the Central Universities, China [XDJK2013C051, XDJK2013A005]; Doctor Foundation Project of Southwest University [SWU112046]; National Natural Sciences Foundation [31000860]; Specialized Research Fund for the Doctoral Program of Higher Education [20100182120022]	Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Doctor Foundation Project of Southwest University; National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded in part by the Fundamental Research Funds for the Central Universities, China (XDJK2013C051; XDJK2013A005), the Doctor Foundation Project of Southwest University (SWU112046), the National Natural Sciences Foundation (31000860), and the Specialized Research Fund for the Doctoral Program of Higher Education (20100182120022). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Ahmedani MS, 2010, APPL ENTOMOL ZOOL, V45, P89, DOI 10.1303/aez.2010.89; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bao YY, 2012, GENOMICS, V99, P256, DOI 10.1016/j.ygeno.2012.02.002; Behar A, 2010, APPL ENVIRON MICROB, V76, P2280, DOI 10.1128/AEM.00026-10; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Chen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020308; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Ding W, 2002, J STORED PROD RES, V38, P229, DOI 10.1016/S0022-474X(01)00017-0; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Dou W, 2010, AGR SCI CHINA, V9, P1008, DOI 10.1016/S1671-2927(09)60184-X; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fernandez-Silva I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055990; Gautam SG, 2013, J ECON ENTOMOL, V106, P491, DOI 10.1603/EC12253; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu J, 2012, INSECT MOL BIOL, V21, P535, DOI 10.1111/j.1365-2583.2012.01158.x; Guedes RNC, 2008, J ECON ENTOMOL, V101, P1974, DOI 10.1603/0022-0493-101.6.1974; Guo L, 2012, PEST MANAG SCI, V68, P1605, DOI 10.1002/ps.3357; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Hlavica P, 2011, J INORG BIOCHEM, V105, P1354, DOI 10.1016/j.jinorgbio.2011.05.003; Huang LH, 2008, CELL RES, V18, P1074, DOI 10.1038/cr.2008.283; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Isaacs AK, 2012, CHEM RES TOXICOL, V25, P1571, DOI 10.1021/tx300326m; Jiang HB, 2012, J ECON ENTOMOL, V105, P560, DOI 10.1603/EC11324; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu QN, 2013, J INSECT PHYSIOL, V59, P848, DOI 10.1016/j.jinsphys.2013.06.001; Lu MX, 2014, CELL STRESS CHAPERON, V19, P91, DOI 10.1007/s12192-013-0437-8; LYAL CHC, 1985, SYST ENTOMOL, V10, P145; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mikheyev AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011212; Mittapalli O, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2001; Nakao T, 2012, J PESTIC SCI, V37, P37, DOI 10.1584/jpestics.D11-018; Nayak MK, 2007, PEST MANAG SCI, V63, P104, DOI 10.1002/ps.1313; Nayak MK, 2010, PEST MANAG SCI, V66, P295, DOI 10.1002/ps.1873; Nayak MK, 1998, J ECON ENTOMOL, V91, P1208, DOI 10.1093/jee/91.5.1208; Nayak MK, 2003, J STORED PROD RES, V39, P343, DOI 10.1016/S0022-474X(02)00029-2; Oakeshott J.G., 2010, P229; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Opit GP, 2009, J ECON ENTOMOL, V102, P1369, DOI 10.1603/029.102.0365; Opit GP, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.13901; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Reid WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047163; Rozen S, 2000, Methods Mol Biol, V132, P365; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059721; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao Y, 2013, INSECT BIOCHEM MOLEC, V43, P820, DOI 10.1016/j.ibmb.2013.06.006; Troczka B, 2012, INSECT BIOCHEM MOLEC, V42, P873, DOI 10.1016/j.ibmb.2012.09.001; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036623; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033973; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033883; Wei DD, 2011, J ECON ENTOMOL, V104, P1720, DOI 10.1603/EC11177; [魏丹丹 WEI Dandan], 2011, [生态学报, Acta Ecologica Sinica], V31, P4182; Wu SA, 2009, ARCH INSECT BIOCHEM, V70, P136, DOI 10.1002/arch.20285; Xiao LS, 2010, ARCH INSECT BIOCHEM, V75, P158, DOI 10.1002/arch.20378; Yamamoto K, 2007, BIOSCI BIOTECH BIOCH, V71, P553, DOI 10.1271/bbb.60592; Yang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061820; Yang QQ, 2012, J STORED PROD RES, V48, P120, DOI 10.1016/j.jspr.2011.10.007; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063168; Zhao L, 2012, ISJ-INVERT SURVIV J, V9, P93; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291; Zou D, 2013, GENOMICS, V102, P57, DOI 10.1016/j.ygeno.2013.02.014	78	28	31	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80046	10.1371/journal.pone.0080046	http://dx.doi.org/10.1371/journal.pone.0080046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244605	Green Submitted, gold, Green Published			2022-12-25	WOS:000327143800112
J	Xu, ZS; Xue, W; Xiong, AS; Lin, YQ; Xu, J; Zhu, B; Zhao, W; Peng, RH; Yao, QH				Xu, Zhi-Sheng; Xue, Wei; Xiong, Ai-Sheng; Lin, Ya-Qiu; Xu, Jing; Zhu, Bo; Zhao, Wei; Peng, Ri-He; Yao, Quan-Hong			Characterization of a Bifunctional O- and N-Glucosyltransferase from Vitis vinifera in Glucosylating Phenolic Compounds and 3,4-dichloroaniline in Pichia pastoris and Arabidopsis thaliana	PLOS ONE			English	Article							TRANSGENIC ARABIDOPSIS; MEDICAGO-TRUNCATULA; CHLORINATED PHENOLS; CRYSTAL-STRUCTURES; METABOLISM; XENOBIOTICS; PLANTS; GLYCOSYLTRANSFERASE; PHYTOREMEDIATION; SEQUENCES	2,4,5-Trichlorophenol, 2,6-dimethylphenol, 3-methylcatechol, phenol, hydroquinone, catechol, and 3,4-dichloroaniline are present in the environment and are risky to humans and animals because of their wide applications in many industries. In this study, a putative uridine diphosphate glucose-dependent glycosyltransferase from Vitis vinifera (VvUGT72B1) displayed high O-glucosyltransferase or N-glucosyltransferase activity toward all these xenbiotics and was able to enhance the resistance of P. pastoris to them. Compared with wild-type Arabidopsis plants, VvUGT72B1-transgenic Arabidopsis plants showed higher resistance to all the xenobiotics except for phenol and exhibited higher removal efficiencies against all xenobiotics. Glucosides of 3-methylcatechol, 2,6-dimethylphenol, phenol, and 3,4-dichloroaniline were exported to the surrounding media by Arabidopsis plants while transgenic Arabidopsis plants exported more glucosides than wild-type Arabidopsis plants. Our findings have the potential to provide a broader spectrum remediation strategy for the phytoremoval and degradation of phenolic compounds and 3,4-dichloroaniline than previous works.	[Xu, Zhi-Sheng; Xue, Wei; Lin, Ya-Qiu; Xu, Jing; Zhu, Bo; Zhao, Wei; Peng, Ri-He; Yao, Quan-Hong] Shanghai Acad Agr Sci, Agrobiotechnol Res Ctr, Shanghai, Peoples R China; [Xu, Zhi-Sheng; Xiong, Ai-Sheng; Lin, Ya-Qiu; Yao, Quan-Hong] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Xue, Wei] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences; Nanjing Agricultural University; Shanghai Ocean University	Peng, RH (corresponding author), Shanghai Acad Agr Sci, Agrobiotechnol Res Ctr, Shanghai, Peoples R China.	pengrihe69@yahoo.com; yaoquanhong_sh@aliyun.com		Xiong, Ai-Sheng/0000-0002-7900-5001	Key Project Fund of the Shanghai Municipal Committee of Agriculture [2009-6-4, 2011-1-8]; International Scientific and Technological Cooperation [2010DFA62320, 11230705900]; National Natural Science Foundation [31071486]	Key Project Fund of the Shanghai Municipal Committee of Agriculture; International Scientific and Technological Cooperation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was supported by the Key Project Fund of the Shanghai Municipal Committee of Agriculture (No. 2009-6-4), the Key Project Fund of the Shanghai Municipal Committee of Agriculture (No. 2011-1-8), the International Scientific and Technological Cooperation (2010DFA62320, 11230705900), and the National Natural Science Foundation (31071486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiu S, 1988, NATURE, V12, P138; Bozena B, 2004, CELL BIOL INT, V28, P557, DOI [10.1016/j.cellbi.2004.04.013, DOI 10.1016/J.CELLBI.2004.04.013.PUBMED:15261164]; Brazier-Hicks M, 2005, PLANT J, V42, P556, DOI 10.1111/j.1365-313X.2005.02398.x; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Dietz AC, 2001, ENVIRON HEALTH PERSP, V109, P163, DOI 10.2307/3434854; Eapen S, 2007, BIOTECHNOL ADV, V25, P442, DOI 10.1016/j.biotechadv.2007.05.001; George ESB, 2007, BRAZ ARCH BIOL TECHN, V50, P839; GOERLITZ DF, 1985, ENVIRON SCI TECHNOL, V19, P955, DOI 10.1021/es00140a012; Gouet P, 2002, BIOINFORMATICS, V18, P767, DOI 10.1093/bioinformatics/18.5.767; Hard GC, 1997, TOXICOL PATHOL, V25, P132, DOI 10.1177/019262339702500202; Hubner A, 1998, APPL ENVIRON MICROB, V64, P2086; Joachim A, 2000, PHYTOCHEMISTRY, V53, P187, DOI [10.1016/S0031-9422(99)00539-7, DOI 10.1016/S0031-9422(99)00539-7.PUBMED:10680170]; Karns S, 1983, APPL ENVIRON MICROB, V46, P1182; Lao SH, 2003, PHYTOCHEMISTRY, V63, P653, DOI 10.1016/S0031-9422(03)00289-9; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; Liao Y, 2006, PLANT PHYSIOL, V142, P620, DOI 10.1104/pp.106.085936; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; SANDERMANN H, 1991, ARCH BIOCHEM BIOPHYS, V287, P341, DOI 10.1016/0003-9861(91)90488-5; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Sharma HA, 1997, ENVIRON TOXICOL CHEM, V16, P346, DOI [10.1002/etc.5620160233, 10.1897/1551-5028(1997)016&lt;0346:ACOTTA&gt;2.3.CO;2]; Su ZH, 2012, ENVIRON SCI TECHNOL, V46, P4016, DOI 10.1021/es203753b; Tobias H, 1976, BIOORGAN MED CHEM, V10, P1731; Wendy O, 2006, EMBO J, V25, P1396, DOI [10.1038/sj.emboj.7600970, DOI 10.1038/SJ.EMB0J.7600970.PUBMED:16482224]; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Xu ZS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066878	30	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80449	10.1371/journal.pone.0080449	http://dx.doi.org/10.1371/journal.pone.0080449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244688	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800146
J	Wang, ZH; Liang, YB; Tang, H; Chen, ZB; Li, ZY; Hu, XC; Ma, ZF				Wang, Zhong-hua; Liang, Yan-bing; Tang, Hao; Chen, Zhi-bin; Li, Zhen-yu; Hu, Xu-chu; Ma, Zhong-fu			Dexamethasone Down-Regulates the Expression of microRNA-155 in the Livers of Septic Mice	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION; INFLAMMATION; ACTIVATION; MIR-155; CANCER; INDUCTION; CYTOKINES; DIAGNOSIS; ROLES	To investigate the expression of microRNA-155 (miRNA-155) in the livers of mice with lipopolysaccharide (LPS)-induced sepsis and to determine the role of dexamethasone (DXM) in the regulation of miRNA-155 expression, we pretreated mice with or without DXM prior to LPS exposure. Our study demonstrated that the expression of miRNA-155 and inflammatory factors increased in the liver tissues of mice with LPS-induced sepsis and that DXM down-regulated their expression in a dose-dependent manner. Moreover, DXM alone inhibited the expression of miRNA-155 to below the baseline level, but did not impact the expression of inflammatory factors, suggesting that the down-regulation of miRNA-155 by DXM may partially, but not completely, depend on the suppression of pro-inflammatory cytokines by DXM. Our data indicate that the overexpression of miRNA-155 in the livers of mice with LPS-induced sepsis may play an important role in the pathological processes of sepsis and that the down-regulation of miRNA-155 by DXM may be a novel mechanism regulating inflammation and immunity.	[Wang, Zhong-hua] Guangdong Gen Hosp, Dept Intens Care Unit, Guangzhou, Guangdong, Peoples R China; [Liang, Yan-bing; Tang, Hao; Chen, Zhi-bin; Li, Zhen-yu; Ma, Zhong-fu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gen Internal Med, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Xu-chu] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University; Sun Yat Sen University	Ma, ZF (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gen Internal Med, Guangzhou 510275, Guangdong, Peoples R China.	mazhongfu06@sohu.com			Science and Technology Planning Project of Guangdong Province, China [2009B080701070, 2009B080701004]	Science and Technology Planning Project of Guangdong Province, China	This work was supported by grants from Science and Technology Planning Project of Guangdong Province, China (No. 2009B080701070 and No. 2009B080701004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Cheung ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071336; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Haake SM, 2009, HEARING RES, V255, P22, DOI 10.1016/j.heares.2009.05.003; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kutty RK, 2010, BIOCHEM BIOPH RES CO, V402, P390, DOI 10.1016/j.bbrc.2010.10.042; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee HJ, 2006, CYTOKINE, V35, P67, DOI 10.1016/j.cyto.2006.07.009; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Mraz M, 2013, LEUKEMIA LYMPHOMA, V54, P1836, DOI 10.3109/10428194.2013.796055; Nikiforova MN, 2008, EXPERT REV MOL DIAGN, V8, P83, DOI 10.1586/14737159.8.1.83; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Romania P, 2008, BRIT J HAEMATOL, V143, P570, DOI 10.1111/j.1365-2141.2008.07382.x; Skrzypski M, 2011, MUTAT RES-FUND MOL M, V717, P25, DOI 10.1016/j.mrfmmm.2011.04.002; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang Zhong-hua, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P154; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	35	40	46	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80547	10.1371/journal.pone.0080547	http://dx.doi.org/10.1371/journal.pone.0080547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244697	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600211
J	Zhou, YP; Wang, JJ; Zhou, I; Lou, HB; Li, CZ; Chen, ZR; Zhang, ZH; Liu, SW; Wu, SG; Tan, WL; Jiang, SB; Zhou, C				Zhou, Yuanping; Wang, Junjie; Zhou, Ivan; Lou, Haibo; Li, Chang-Zheng; Chen, Zhen-Rui; Zhang, Zhe-Huan; Liu, Shuwen; Wu, Shuguang; Tan, Wanlong; Jiang, Shibo; Zhou, Chen			Simultaneous Expression of Displayed and Secreted Antibodies for Antibody Screen	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; AFFINITY; PHAGE; CONSTRUCTION	The display of full-length antibody on the cell surface was achieved by fusing a transmembrane domain of the platelet-derived growth factor receptor (PDGFR) to the C-terminus of the heavy chain constant region. We also incorporated a furin cleavage site between the constant region and PDGFR transmembrane domain to obtain secreted antibodies. As a result, antibodies can be expressed simultaneously on the cell surface in a membrane-anchored version for screening and selecting through fluorescence-activated cell sorting (FACS) analysis, as well as in conditioned medium in a secreted version for function analysis.	[Zhou, Yuanping; Wang, Junjie; Lou, Haibo; Li, Chang-Zheng; Chen, Zhen-Rui; Zhang, Zhe-Huan; Tan, Wanlong] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Zhou, Ivan; Liu, Shuwen; Wu, Shuguang] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Li, Chang-Zheng; Zhou, Chen] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Hlth, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Lindsley F Kimball Res Inst, New York, NY USA; [Zhou, Chen] Dgen Biotech Ltd, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Fudan University; Fudan University; Fudan University	Jiang, SB (corresponding author), Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	shibojiang@fudan.edu.cn; czhou0068@gmail.com	Jiang, Shibo/L-4500-2014; Li, Changzheng/F-4465-2014	Jiang, Shibo/0000-0001-8283-7135; 	National Natural Science Foundation of China [81173098]; Dgen Biotech Ltd., Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dgen Biotech Ltd., Hong Kong	This work was partly supported by grants from the National Natural Science Foundation of China (#81173098 to SJ) and from Dgen Biotech Ltd., Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 2007, J IMMUNOL METHODS, V327, P40, DOI 10.1016/j.jim.2007.07.007; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brown DT, 2004, United States Patent, Patent No. 7223390; Chiba Y, 1998, J BIOL CHEM, V273, P26298, DOI 10.1074/jbc.273.41.26298; de Bruin R, 1999, NAT BIOTECHNOL, V17, P397, DOI 10.1038/7959; Feldhaus MJ, 2004, J IMMUNOL METHODS, V290, P69, DOI 10.1016/j.jim.2004.04.009; FRANCISCO JA, 1992, P NATL ACAD SCI USA, V89, P2713, DOI 10.1073/pnas.89.7.2713; He Wei, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P308; Higuchi K, 1997, J IMMUNOL METHODS, V202, P193, DOI 10.1016/S0022-1759(97)00010-0; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Invitrogen, 2006, FLP IN SYST GEN STAB; Li CZ, 2012, CELL MOL IMMUNOL, V9, P184, DOI 10.1038/cmi.2011.55; Low NM, 1996, J MOL BIOL, V260, P359, DOI 10.1006/jmbi.1996.0406; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Zhou Chen, 2012, Methods Mol Biol, V907, P293, DOI 10.1007/978-1-61779-974-7_17; Zhou C, 2010, MABS-AUSTIN, V2, P508, DOI 10.4161/mabs.2.5.12970; Zhou I, 2011, ACTA BIOCH BIOPH SIN, V43, P232, DOI 10.1093/abbs/gmq126; Zhou Y, 2010, ACTA BIOCH BIOPH SIN, V42, P575, DOI 10.1093/abbs/gmq055	22	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80005	10.1371/journal.pone.0080005	http://dx.doi.org/10.1371/journal.pone.0080005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244593	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600170
J	Arumugam, A; Weng, ZP; Talwelkar, SS; Chaudhary, SC; Kopelovich, L; Elmets, CA; Afaq, F; Athar, M				Arumugam, Aadithya; Weng, Zhiping; Talwelkar, Sarang S.; Chaudhary, Sandeep C.; Kopelovich, Levy; Elmets, Craig A.; Afaq, Farrukh; Athar, Mohammad			Inhibiting Cycloxygenase and Ornithine Decarboxylase by Diclofenac and Alpha-Difluoromethylornithine Blocks Cutaneous SCCs by Targeting Akt-ERK Axis	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; SIGNALING PATHWAYS; EPITHELIAL-CELLS; DOUBLE-BLIND; EXPRESSION; PREVENTION; APOPTOSIS; TUMORS; PHOSPHORYLATION; CHEMOPREVENTION	Non-melanoma skin cancer (NMSC) is the most common type of skin cancer in Caucasian populations. Its increasing incidence has been a major public health concern. Elevated expressions of ODC and COX-2 are associated with both murine and human NMSCs. Inhibition of these molecular targets singly employing their respective small molecule inhibitors showed limited success. Here, we show that combined blockade of ODC and COX-2 using their potent inhibitors, DFMO and diclofenac respectively abrogates growth of A431 epidermal xenograft tumors in nu/nu mice by more than 90%. The tumor growth inhibition was associated with a diminution in the proliferation and enhancement in apoptosis. The proliferation markers such as PCNA and cyclin D1 were reduced. TUNEL-positive apoptotic cells and cleaved caspase-3 were increased in the residual tumors. These agents also manifested direct target-unrelated effects. Reduced expression of phosphorylated MAPKAP-2, ERK, and Akt (ser(473) & thr(308)) were noticed. The mechanism by which combined inhibition of ODC/COX attenuated tumor growth and invasion involved reduction in EMT. Akt activation by ODC+COX-2 over-expression was the key player in this regard as Akt inhibition manifested effects similar to those observed by the combined inhibition of ODC+COX-2 whereas forced over-expression of Akt resisted against DFMO+diclofenac treatment. These data suggest that ODC+COX-2 over-expression together leads to pathogenesis of aggressive and invasive cutaneous carcinomas by activating Akt signaling pathway, which through augmenting EMT contributes to tumor invasion.	[Arumugam, Aadithya; Weng, Zhiping; Talwelkar, Sarang S.; Chaudhary, Sandeep C.; Elmets, Craig A.; Afaq, Farrukh; Athar, Mohammad] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Elmets, Craig A.; Athar, Mohammad] Univ Alabama Birmingham, Skin Dis Res Ctr, Birmingham, AL 35294 USA; [Kopelovich, Levy] NCI, Canc Prevent Div, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Athar, M (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	mathar@uab.edu	Talwelkar, Sarang/C-8925-2015		NIH [R01 CA138998, NO1-CN-43300]; NATIONAL CANCER INSTITUTE [R01CA138998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH grants R01 CA138998 and NO1-CN-43300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2010, PHOTOCHEM PHOTOBIOL, V86, P1318, DOI 10.1111/j.1751-1097.2010.00815.x; Ahmad N, 2001, AM J PATHOL, V159, P885, DOI 10.1016/S0002-9440(10)61764-6; An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; Arumugam A, 2012, BIOCHEM BIOPH RES CO, V425, P177, DOI 10.1016/j.bbrc.2012.07.062; Bailey HH, 2010, CANCER PREV RES, V3, P35, DOI 10.1158/1940-6207.CAPR-09-0096; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Brouxhon SM, 2013, ONCOGENE, P1; Burns EM, 2013, CARCINOGENESIS, V34, P370, DOI 10.1093/carcin/bgs349; Chaudhary SC, 2013, TOXICOL APPL PHARM, V268, P249, DOI 10.1016/j.taap.2012.12.009; DANZIN C, 1979, LIFE SCI, V24, P519, DOI 10.1016/0024-3205(79)90173-5; Ehrhart JC, 2003, PHOTOCHEM PHOTOBIOL, P2825; Elmets CA, 2010, JNCI-J NATL CANCER I, V102, P1; Elmets CA, 2010, CANCER PREV RES, V3, P8, DOI 10.1158/1940-6207.CAPR-09-0248; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Feith DJ, 2006, CARCINOGENESIS, V27, P1090, DOI 10.1093/carcin/bgi343; Fischer SM, 1999, MOL CARCINOGEN, V25, P231; Fischer SM, 2003, CARCINOGENESIS, V24, P945, DOI 10.1093/carcin/bgg046; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Gan TJ, 2010, CURR MED RES OPIN, V26, P1715, DOI 10.1185/03007995.2010.486301; GILMOUR SK, 1987, CANCER RES, V47, P1221; Gilmour SK, 2007, TOXICOL APPL PHARM, V224, P249, DOI 10.1016/j.taap.2006.11.023; Grille SJ, 2003, CANCER RES, V63, P2172; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Hayes CS, 2011, CARCINOGENESIS, V32, P1340, DOI 10.1093/carcin/bgr129; Hitti Edward, 2007, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V6, P85, DOI 10.2174/187152307779939741; Johannesdottir SA, 2012, CANCER-AM CANCER SOC, V118, P4768, DOI 10.1002/cncr.27406; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Koomoa DLT, 2008, CANCER RES, V68, P9825, DOI 10.1158/0008-5472.CAN-08-1865; KOZA RA, 1991, CARCINOGENESIS, V12, P1619, DOI 10.1093/carcin/12.9.1619; Kreul SM, 2012, CANCER PREV RES, V5, P1368, DOI 10.1158/1940-6207.CAPR-12-0233; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; MAMONT PS, 1978, BIOCHEM BIOPH RES CO, V81, P58, DOI 10.1016/0006-291X(78)91630-3; Marks F, 2003, RECENT RESULTS CANC, V163, P46; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Robinson JK, 2005, JAMA-J AM MED ASSOC, V294, P1541, DOI 10.1001/jama.294.12.1541; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; ROSEN CF, 1990, BIOCHEM J, V270, P565, DOI 10.1042/bj2700565; Saba N, 2013, CANC PREV R IN PRESS, V6, DOI [10.1158/1940-6207, DOI 10.1158/1940-6207]; Sales KJ, 2004, J CLIN ENDOCR METAB, V89, P6112, DOI 10.1210/jc.2004-0892; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Singh T, 2012, PHOTOCHEM PHOTOBIOL, V88, P1141, DOI 10.1111/j.1751-1097.2012.01093.x; Tang XW, 2004, J CLIN INVEST, V113, P867, DOI 10.1172/JCI200420732; United Nations Environmental Programme (UNEP), 1998, ENV EFF OZ DEPL 1998; Zhang HFM, 2004, J BIOL CHEM, V279, P22539, DOI 10.1074/jbc.M314337200	46	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80076	10.1371/journal.pone.0080076	http://dx.doi.org/10.1371/journal.pone.0080076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260338	gold, Green Submitted, Green Published			2022-12-25	WOS:000327216200101
J	Casanova, R; Hsu, FC; Sink, KM; Rapp, SR; Williamson, JD; Resnick, SM; Espeland, MA				Casanova, Ramon; Hsu, Fang-Chi; Sink, Kaycee M.; Rapp, Stephen R.; Williamson, Jeff D.; Resnick, Susan M.; Espeland, Mark A.		Alzheimer's Dis Neuroimaging Initi	Alzheimer's Disease Risk Assessment Using Large-Scale Machine Learning Methods	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; CORPUS-CALLOSUM; ATROPHY; MRI; CLASSIFICATION; BRAIN; DEGENERATION; IMPACT; IMAGES	The goal of this work is to introduce new metrics to assess risk of Alzheimer's disease (AD) which we call AD Pattern Similarity (AD-PS) scores. These metrics are the conditional probabilities modeled by large-scale regularized logistic regression. The AD-PS scores derived from structural MRI and cognitive test data were tested across different situations using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. The scores were computed across groups of participants stratified by cognitive status, age and functional status. Cox proportional hazards regression was used to evaluate associations with the distribution of conversion times from mild cognitive impairment to AD. The performances of classifiers developed using data from different types of brain tissue were systematically characterized across cognitive status groups. We also explored the performance of anatomical and cognitive-anatomical composite scores generated by combining the outputs of classifiers developed using different types of data. In addition, we provide the AD-PS scores performance relative to other metrics used in the field including the Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD) index and total hippocampal volume for the variables examined.	[Casanova, Ramon; Hsu, Fang-Chi; Sink, Kaycee M.; Rapp, Stephen R.; Williamson, Jeff D.; Resnick, Susan M.; Espeland, Mark A.; Alzheimer's Dis Neuroimaging Initi] Wake Forest Sch Med, Winston Salem, NC 27157 USA	Wake Forest University	Casanova, R (corresponding author), Wake Forest Sch Med, Winston Salem, NC 27157 USA.	Casanova@wakehealth.edu	Sink, Kaycee/AAY-5920-2020	Sink, Kaycee/0000-0001-9608-3856	Alzheimer's Association [NIRP-12-259281]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Intramural Research Program, National Institute on Aging, NIH; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [P30AG010129, P30AG021332, ZIAAG000191, K01AG030514] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program, National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Alzheimer's Association (NIRP-12-259281). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and this research was also supported by NIH grants P30 AG010129 and K01 AG030514. SMR is supported by the Intramural Research Program, National Institute on Aging, NIH. ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private Rev November 7, 2012 sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bach FR, 2008, J MACH LEARN RES, V9, P1179; Biffi A, ARCH NEUROL, V67, P677; Black SE, 2000, CAN J NEUROL SCI, V27, P204, DOI 10.1017/S0317167100000846; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Canu E, 2012, NEUROBIOL AGING, V33, P1023, DOI 10.1016/j.neurobiolaging.2010.09.021; Casanova R, 2011, FRONTIERS NEUROSCIEN, V5; Casanova R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044877; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; Crane PK, 2012, BRAIN IMAGING BEHAV, V6, P502, DOI 10.1007/s11682-012-9186-z; Cuingnet R, 2010, NEUROIMAGE; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Di Paola M, 2011, EXPERT REV NEUROTHER, V11, P1557, DOI [10.1586/ERN.11.130, 10.1586/ern.11.130]; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Donoho D, 2000, LECT AUG 8 2000 AM M; Felsky D, 2012, SORL1 WHITE MATTER T; Friedman J, 2007, ANN APPL STAT, V1, P302, DOI 10.1214/07-AOAS131; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gold BT, 2010, NEUROIMAGE, V52, P1487, DOI 10.1016/j.neuroimage.2010.05.036; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Liu JM, 2009, NEUROINFORMATICS, V7, P131, DOI 10.1007/s12021-009-9046-1; Llano DA, 2011, ALZ DIS ASSOC DIS, V25, P73, DOI 10.1097/WAD.0b013e3181f5b8d8; Moon WJ, 2008, AM J NEURORADIOL, V29, P1308, DOI 10.3174/ajnr.A1103; NARAYANA PA, 1988, MAGN RESON IMAGING, V6, P271, DOI 10.1016/0730-725X(88)90401-8; Pavlidis P, 2002, J COMPUT BIOL, V9, P401, DOI 10.1089/10665270252935539; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Ryali S, 2011, NEUROIMAGE, V54, P807, DOI 10.1016/j.neuroimage.2010.09.052; Smith CD, 2010, NEUROBIOL AGING, V31, P1122, DOI 10.1016/j.neurobiolaging.2008.08.006; Teipel SJ, 2007, NEUROIMAGE, V38, P13, DOI 10.1016/j.neuroimage.2007.07.008; Tomaiuolo F, 2007, DEMENT GERIATR COGN, V23, P96, DOI 10.1159/000097371; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	46	75	75	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e77949	10.1371/journal.pone.0077949	http://dx.doi.org/10.1371/journal.pone.0077949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250789	gold, Green Submitted, Green Published			2022-12-25	WOS:000327216200010
J	Chauhan, BS				Chauhan, Bhagirath S.			Seed Germination Ecology of Feather Lovegrass [Eragrostis tenella (L.) Beauv. Ex Roemer & JA Schultes]	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; LEPTOCHLOA-CHINENSIS; WEED; EMERGENCE; TILLAGE; LIGHT; RICE; MANAGEMENT; DORMANCY; RESIDUE	Feather lovegrass [Eragrostis tenella (L.) Beauv. Ex Roemer & J.A. Schultes] is a C-4 grass weed that has the ability to grow in both lowland and upland conditions. Experiments were conducted in the laboratory and screenhouse to evaluate the effect of environmental factors on germination, emergence, and growth of this weed species. Germination in the light/dark regime was higher at alternating day/night temperatures of 30/20 degrees C (98%) than at 35/25 degrees C (83%) or 25/15 degrees C (62%). Germination was completely inhibited by darkness. The osmotic potential and sodium chloride concentrations required for 50% inhibition of maximum germination were -0.7 MPa and 76 mM, respectively. The highest seedling emergence (69%) was observed from the seeds sown on the soil surface and no seedlings emerged from seeds buried at depths of 0.5 cm or more. The use of residue as mulches significantly reduced the emergence and biomass of feather lovegrass seedlings. A residue amount of 0.5 t ha(-1) was needed to suppress 50% of the maximum seedlings. Because germination was strongly stimulated by light and seedling emergence was the highest for the seeds sown on the soil surface, feather lovegrass is likely to become a problematic weed in zero-till systems. The knowledge gained from this study could help in developing effective and sustainable weed management strategies.	Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Metro Manila, Philippines	CGIAR; International Rice Research Institute (IRRI)	Chauhan, BS (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Metro Manila, Philippines.	b.chauhan@irri.org	Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668	International Rice Research Institute (IRRI)	International Rice Research Institute (IRRI)	Funded by International Rice Research Institute (IRRI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin C.C., 1998, SEEDS ECOLOGY BIOGEO, P666; Benvenuti S, 2004, WEED RES, V44, P87, DOI 10.1111/j.1365-3180.2003.00376.x; Benvenuti S, 2003, AGRON J, V95, P191, DOI 10.2134/agronj2003.0191; Bhowmik PC, 1997, WEED SCI, V45, P349, DOI 10.1017/S0043174500092973; Bolfrey-Arku GEK, 2011, WEED SCI, V59, P182, DOI 10.1614/WS-D-10-00095.1; Boyd N, 2004, WEED SCI, V52, P589, DOI 10.1614/WS-03-15R2; Buhler DD, 1996, WEED RES, V36, P153, DOI 10.1111/j.1365-3180.1996.tb01811.x; Burke IC, 2003, WEED SCI, V51, P342, DOI 10.1614/0043-1745(2003)051[0342:IOEFOA]2.0.CO;2; Chauhan BS, 2008, WEED SCI, V56, P722, DOI 10.1614/WS-08-049.1; Chauhan BS, 2008, WEED SCI, V56, P699, DOI 10.1614/WS-08-048.1; Chauhan BS, 2013, WEED SCI, V61, P403, DOI 10.1614/WS-D-12-00147.1; Chauhan BS, 2012, WEED TECHNOL, V26, P1, DOI 10.1614/WT-D-11-00105.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2008, WEED SCI, V56, P820, DOI 10.1614/WS-08-070.1; Chauhan BS, 2012, CROP PROT, V38, P57, DOI 10.1016/j.cropro.2012.03.010; Cousens R., 1993, Proceedings I of the 10th Australian Weeds Conference and 14th Asian Pacific Weed Science Society Conference, Brisbane, Australia, 6-10 September, 1993, P376; Cristaudo A, 2007, WEED RES, V47, P327, DOI 10.1111/j.1365-3180.2007.00574.x; CRUTCHFIELD DA, 1986, WEED SCI, V34, P110, DOI 10.1017/S0043174500026564; Galinato M.I., 1999, UPLAND RICE WEEDS S, P156; Gopal R, 2010, TECHNICAL B INT MAIZ; Gupta R. K., 2006, RICE WHEAT CONSORTIU, V8; Kumar V, 2011, ADV AGRON, V111, P297, DOI 10.1016/B978-0-12-387689-8.00001-1; Lafitte H.R., 2006, ORYZA, V43, P171; Mahajan G, 2013, CROP PROT, V49, P52, DOI 10.1016/j.cropro.2013.03.008; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; MOHLER CL, 1992, J APPL ECOL, V29, P21, DOI 10.2307/2404343; MOHLER CL, 1991, WEED TECHNOL, V5, P545, DOI 10.1017/S0890037X00027305; Moody K., 1989, WEEDS REPORTED RICE; PANCHO J. V., 1964, Philippine Agriculturist, V48, P307; Schutz W, 2002, ANN BOT-LONDON, V90, P707, DOI 10.1093/aob/mcf250; Sushil Pandey, 2005, Rice is life: scientific perspectives for the 21st century. Proceedings of the World Rice Research Conference held in Tsukuba, Japan, 4-7 November 2004, P178; TEASDALE JR, 1991, WEED SCI, V39, P195, DOI 10.1017/S0043174500071460; TEASDALE JR, 1993, AGRON J, V85, P673, DOI 10.2134/agronj1993.00021962008500030029x; Teuton TC, 2004, WEED SCI, V52, P376, DOI 10.1614/WS-03-121R1; WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597	35	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79398	10.1371/journal.pone.0079398	http://dx.doi.org/10.1371/journal.pone.0079398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255700	Green Submitted, gold, Green Published			2022-12-25	WOS:000327216200063
J	Czikora, A; Rutkai, I; Pasztor, ET; Szalai, A; Porszasz, R; Boczan, J; Edes, I; Papp, Z; Toth, A				Czikora, Agnes; Rutkai, Ibolya; Pasztor, Eniko T.; Szalai, Andrea; Porszasz, Robert; Boczan, Judit; Edes, Istvan; Papp, Zoltan; Toth, Attila			Different Desensitization Patterns for Sensory and Vascular TRPV1 Populations in the Rat: Expression, Localization and Functional Consequences	PLOS ONE			English	Article							VANILLOID RECEPTOR TRPV1; CAPSAICIN RECEPTOR; DEPENDENT DESENSITIZATION; NEUROGENIC INFLAMMATION; NEONATAL CAPSAICIN; SUBSTANCE-P; PHOSPHORYLATION; VR1; SOMATOSTATIN; STIMULATION	Background and purpose: TRPV1 is expressed in sensory neurons and vascular smooth muscle cells, contributing to both pain perception and tissue blood distribution. Local desensitization of TRPV1 in sensory neurons by prolonged, high dose stimulation is re-engaged in clinical practice to achieve analgesia, but the effects of such treatments on the vascular TRPV1 are not known. Experimental approach: Newborn rats were injected with capsaicin for five days. Sensory activation was measured by eye wiping tests and plasma extravasation. Isolated, pressurized skeletal muscle arterioles were used to characterize TRPV1 mediated vascular responses, while expression of TRPV1 was detected by immunohistochemistry. Key results: Capsaicin evoked sensory responses, such as eye wiping (3.6 +/- 2.5 versus 15.5 +/- 1.4 wipes, p<0.01) or plasma extravasation (evans blue accumulation 10 +/- 3 versus 3367 mu g/g, p<0.05) were reduced in desensitized rats. In accordance, the number of TRPV1 positive sensory neurons in the dorsal root ganglia was also decreased. However, TRPV1 expression in smooth muscle cells was not affected by the treatment. There were no differences in the diameter (192 +/- 27 versus 194 +/- 8 mu m), endothelium mediated dilations (evoked by acetylcholine), norepinephrine mediated constrictions, myogenic response and in the capsaicin evoked constrictions of arterioles isolated from skeletal muscle. Conclusion and implications: Systemic capsaicin treatment of juvenile rats evokes anatomical and functional disappearance of the TRPV1-expressing neuronal cells but does not affect the TRPV1-expressing cells of the arterioles, implicating different effects of TRPV1 stimulation on the viability of these cell types.	[Czikora, Agnes; Rutkai, Ibolya; Pasztor, Eniko T.; Edes, Istvan; Papp, Zoltan; Toth, Attila] Univ Debrecen, Inst Cardiol, Div Clin Physiol, Debrecen, Hungary; [Szalai, Andrea; Porszasz, Robert] Univ Debrecen, Inst Pharmacol, Dept Pharmacol & Pharmacotherapy, Debrecen, Hungary; [Boczan, Judit] Univ Debrecen, Dept Neurol, Debrecen, Hungary; [Edes, Istvan; Papp, Zoltan; Toth, Attila] Univ Debrecen, Med & Hlth Sci Ctr, Res Ctr Mol Med, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Toth, A (corresponding author), Univ Debrecen, Inst Cardiol, Div Clin Physiol, Debrecen, Hungary.	atitoth@med.unideb.hu	Tóth, Attila/F-4859-2010; Papp, Zoltán/HDO-3347-2022; Porszasz, Robert/HGD-4008-2022	Tóth, Attila/0000-0001-6503-3653; Porszasz, Robert/0000-0001-7910-9145	TAMOP [4.2.2.A-11/1/KONV-2012-0045]; European Social Fund; Hungarian Academy of Sciences OTKA [K84300]; Bolyai Janos Research Fellowship; Baross Gabor EletMent; National Office for Research and Technology, Hungary	TAMOP; European Social Fund(European Social Fund (ESF)); Hungarian Academy of Sciences OTKA(Hungarian Academy of SciencesOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Janos Research Fellowship(Hungarian Academy of Sciences); Baross Gabor EletMent; National Office for Research and Technology, Hungary(National Office for Research and Technology)	The work is supported by the TAMOP 4.2.2.A-11/1/KONV-2012-0045 project (to IE, ZP and AT, National Development Agency, http://www.nfu.hu/?lang=en). This project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund. In addition, the study was supported by the Hungarian Academy of Sciences OTKA (K84300 to AT, RP, http://www.otka.hu/en) and Bolyai Janos Research Fellowship (to AT, http://mta.hu/english/) and by Baross Gabor EletMent grant by the National Office for Research and Technology, Hungary (http://www.nih.gov.hu/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi K, 2010, PHARMACOL THERAPEUT, V125, P181, DOI 10.1016/j.pharmthera.2009.10.005; Backonja M, 2008, LANCET NEUROL, V7, P1106, DOI 10.1016/S1474-4422(08)70228-X; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Cortright DN, 2004, EUR J BIOCHEM, V271, P1814, DOI 10.1111/j.1432-1033.2004.04082.x; Czikora A, 2012, BRIT J PHARMACOL, V165, P1801, DOI 10.1111/j.1476-5381.2011.01645.x; Czikora A, 2012, LIFE SCI, V90, P407, DOI 10.1016/j.lfs.2011.12.016; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Helyes Z, 2007, PEPTIDES, V28, P1847, DOI 10.1016/j.peptides.2007.07.001; Helyes Z, 2000, NEUROSCI LETT, V278, P185, DOI 10.1016/S0304-3940(99)00936-2; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; JANCSO G, 1981, J NEUROCYTOL, V10, P963, DOI 10.1007/BF01258524; JANCSO N, 1968, BRIT J PHARMACOL, V33, P32, DOI 10.1111/j.1476-5381.1968.tb00471.x; JANCSO N, 1967, BRIT J PHARM CHEMOTH, V31, P138, DOI 10.1111/j.1476-5381.1967.tb01984.x; JANCSOGABOR A, 1970, J PHYSIOL-LONDON, V208, P449, DOI 10.1113/jphysiol.1970.sp009130; JANCSOGABOR A, 1970, J PHYSIOL-LONDON, V206, P495, DOI 10.1113/jphysiol.1970.sp009027; Kark T, 2008, MOL PHARMACOL, V73, P1405, DOI 10.1124/mol.107.043323; Khairatkar-Joshi N, 2009, TRENDS MOL MED, V15, P14, DOI 10.1016/j.molmed.2008.11.004; Kissin I, 2011, CURR TOP MED CHEM, V11, P2159, DOI 10.2174/156802611796904924; Lizanecz E, 2006, MOL PHARMACOL, V69, P1015, DOI 10.1124/mol.105.015644; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; NAGY JI, 1980, BRAIN RES, V186, P435, DOI 10.1016/0006-8993(80)90987-7; Noto C, 2009, CURR OPIN INVEST DR, V10, P702; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; PINTER E, 1995, NEUROSCIENCE, V68, P603, DOI 10.1016/0306-4522(95)00104-Q; RALEVIC V, 1995, J PHARMACOL EXP THER, V274, P64; SCADDING JW, 1980, J ANAT, V131, P471; Szallasi A, 1999, PHARMACOL REV, V51, P159; SZOLCSANYI J, 1983, NEUROSCI LETT, V42, P83, DOI 10.1016/0304-3940(83)90426-3; SZOLCSANYI J, 1977, J PHYSIOL-PARIS, V73, P251; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Wong GY, 2009, BRAIN RES REV, V60, P267, DOI 10.1016/j.brainresrev.2008.12.006; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	42	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78184	10.1371/journal.pone.0078184	http://dx.doi.org/10.1371/journal.pone.0078184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250792	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200013
J	Gerencser, L; Vasarhelyi, G; Nagy, M; Vicsek, T; Miklosi, A				Gerencser, Linda; Vasarhelyi, Gabor; Nagy, Mate; Vicsek, Tamas; Miklosi, Adam			Identification of Behaviour in Freely Moving Dogs (Canis familiaris) Using Inertial Sensors	PLOS ONE			English	Article							ACCELERATION DATA; ACCELEROMETER; CLASSIFICATION	Monitoring and describing the physical movements and body postures of animals is one of the most fundamental tasks of ethology. The more precise the observations are the more sophisticated the interpretations can be about the biology of a certain individual or species. Animal-borne data loggers have recently contributed much to the collection of motion-data from individuals, however, the problem of translating these measurements to distinct behavioural categories to create an ethogram is not overcome yet. The objective of the present study was to develop a "behaviour tracker": a system composed of a multiple sensor data-logger device (with a tri-axial accelerometer and a tri-axial gyroscope) and a supervised learning algorithm as means of automated identification of the behaviour of freely moving dogs. We collected parallel sensor measurements and video recordings of each of our subjects (Belgian Malinois, N=12; Labrador Retrievers, N=12) that were guided through a predetermined series of standard activities. Seven behavioural categories (lay, sit, stand, walk, trot, gallop, canter) were pre-defined and each video recording was tagged accordingly. Evaluation of the measurements was performed by support vector machine (SVM) classification. During the analysis we used different combinations of independent measurements for training and validation (belonging to the same or different individuals or using different training data size) to determine the robustness of the application. We reached an overall accuracy of above 90% perfect identification of all the defined seven categories of behaviour when both training and validation data belonged to the same individual, and over 80% perfect recognition rate using a generalized training data set of multiple subjects. Our results indicate that the present method provides a good model for an easily applicable, fast, automatic behaviour classification system that can be trained with arbitrary motion patterns and potentially be applied to a wide range of species and situations.	[Gerencser, Linda; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Vasarhelyi, Gabor; Nagy, Mate; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Vasarhelyi, Gabor; Nagy, Mate; Vicsek, Tamas] Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary; [Nagy, Mate] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Miklosi, Adam] MTA ELTE Comparat Res Grp, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; University of Oxford	Gerencser, L (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	linda.gerencser@gmail.com	Vásárhelyi, Gábor/A-5632-2013; Nagy, Máté/B-3180-2011; Miklosi, Adam/N-5147-2017	Vásárhelyi, Gábor/0000-0002-5797-2340; Nagy, Máté/0000-0001-8817-087X; Gerencser, Linda/0000-0001-7030-178X; Miklosi, Adam/0000-0003-4831-8985	Swiss National Science Foundation Sinergia project SWARMIX [CRSI22_133059]; European Union European Research Council COLLMOT project [227878]; Hungarian Academy of Science [MTA 01-031]; Royal Society Newton International Fellowship; Somerville College, Oxford; European Union European Social Fund [TAMOP-4.2.1/B-09/1/KMR]	Swiss National Science Foundation Sinergia project SWARMIX; European Union European Research Council COLLMOT project; Hungarian Academy of Science(Hungarian Academy of Sciences); Royal Society Newton International Fellowship; Somerville College, Oxford; European Union European Social Fund(European Social Fund (ESF)European Commission)	This research has been partially funded by the Swiss National Science Foundation Sinergia project SWARMIX, project number CRSI22_133059 for LG and AM, and also partly supported by the European Union European Research Council COLLMOT project (grant No. 227878). During this time AM also received support from the Hungarian Academy of Science (MTA 01-031). MN was supported by a Royal Society Newton International Fellowship, Somerville College, Oxford, and European Union European Social Fund TAMOP-4.2.1/B-09/1/KMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy I, 2009, NEUROMUSCULAR DISORD, V19, P788, DOI 10.1016/j.nmd.2009.07.014; Bidder OR, 2012, ZOOLOGY, V115, P58, DOI 10.1016/j.zool.2011.09.003; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Boyd I, 2004, MEM NATL I POLAR RES, P1; Britt WR, 2011, PERS UBIQUIT COMPUT, V15, P61, DOI 10.1007/s00779-010-0298-4; Brown DC, 2010, AM J VET RES, V71, P322, DOI 10.2460/ajvr.71.3.322; Call KA, 2007, DEEP-SEA RES PT II, V54, P298, DOI 10.1016/j.dsr2.2006.11.016; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Elliott KH, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0919; Fourati H, 2011, BIOMED SIGNAL PROCES, V6, P94, DOI 10.1016/j.bspc.2010.06.004; Fourati H, 2011, IEEE SENS J, V11, P233, DOI 10.1109/JSEN.2010.2053353; Gillette RL, 2008, VET J, V178, P165, DOI 10.1016/j.tvjl.2008.01.009; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gleiss AC, 2009, FISH RES, V97, P11, DOI 10.1016/j.fishres.2008.12.012; Green JA, 2005, J EXP BIOL, V208, P2581, DOI 10.1242/jeb.01679; Halsey LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022311; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Hansen BD, 2007, AM J VET RES, V68, P468, DOI 10.2460/ajvr.68.5.468; Hooker SK, 2007, DEEP-SEA RES PT II, V54, P177, DOI 10.1016/j.dsr2.2007.01.001; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Kooyman Gerald L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P15; Lander Michelle E., 2010, Endangered Species Research, V10, P145, DOI 10.3354/esr00260; Marchioro GF, 2011, COMPUT ELECTRON AGR, V77, P110, DOI 10.1016/j.compag.2011.04.004; Michel KE, 2011, AM J VET RES, V72, P866, DOI 10.2460/ajvr.72.7.866; Moreau M, 2009, APPL ANIM BEHAV SCI, V119, P158, DOI 10.1016/j.applanim.2009.04.008; Nagy M, 2013, P NATL ACAD SCI USA, DOI [10.1073/pnas.1305552110, DOI 10.1073/PNAS.1305552110.PUBMED:23878247]; Preston T, 2012, RES VET SCI, V93, P412, DOI 10.1016/j.rvsc.2011.08.005; Ribeiro C, 2008, SYST SYST ENG 2008 S, P1, DOI DOI 10.1109/SYSOSE.2008.4724172; Ringgenberg N, 2010, APPL ANIM BEHAV SCI, V128, P37, DOI 10.1016/j.applanim.2010.09.018; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sato K, 2008, J EXP BIOL, V211, P58, DOI 10.1242/jeb.009811; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Stiles EK, 2011, J VET BEHAV, V6, P328, DOI 10.1016/j.jveb.2011.03.001; Stockard TK, 2005, J EXP BIOL, V208, P2973, DOI 10.1242/jeb.01687; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wrigglesworth DJ, 2011, AM J VET RES, V72, P1151, DOI 10.2460/ajvr.72.9.1151; Yamada M, 2000, J VET MED SCI, V62, P443, DOI 10.1292/jvms.62.443; Yoda K, 2001, J EXP BIOL, V204, P685	44	54	54	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77814	10.1371/journal.pone.0077814	http://dx.doi.org/10.1371/journal.pone.0077814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24250745	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300116
J	Le, DTL; Tran, TL; Duviau, MP; Meyrand, M; Guerardel, Y; Castelain, M; Loubiere, P; Chapot-Chartier, MP; Dague, E; Mercier-Bonin, M				Doan Thanh Lam Le; Thi-Ly Tran; Duviau, Marie-Pierre; Meyrand, Mickael; Guerardel, Yann; Castelain, Mickael; Loubiere, Pascal; Chapot-Chartier, Marie-Pierre; Dague, Etienne; Mercier-Bonin, Muriel			Unraveling the Role of Surface Mucus-Binding Protein and Pili in Muco-Adhesion of Lactococcus lactis	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; HUMAN INTESTINAL MUCUS; HUMAN COLONIC MUCIN; FORCE SPECTROSCOPY; FLOW CHAMBER; IN-VITRO; LACTOBACILLI; IDENTIFICATION; GLYCOPROTEINS; COLONIZATION	Adhesion of bacteria to mucus may favor their persistence within the gut and their beneficial effects to the host. Interactions between pig gastric mucin (PGM) and a natural isolate of Lactococcus lactis (TIL448) were measured at the single-cell scale and under static conditions, using atomic force microscopy (AFM). In parallel, these interactions were monitored at the bacterial population level and under shear flow. AFM experiments with a L. lactis cell-probe and a PGM-coated surface revealed a high proportion of specific adhesive events (60%) and a low level of non-adhesive ones (2%). The strain muco-adhesive properties were confirmed by the weak detachment of bacteria from the PGM-coated surface under shear flow. In AFM, rupture events were detected at short (1002200 nm) and long distances (up to 6002800 nm). AFM measurements on pili and mucus-binding protein defective mutants demonstrated the comparable role played by these two surface proteinaceous components in adhesion to PGM under static conditions. Under shear flow, a more important contribution of the mucus-binding protein than the pili one was observed. Both methods differ by the way of probing the adhesion force, i.e. negative force contact vs. sedimentation and normal-to-substratum retraction vs. tangential detachment conditions, using AFM and flow chamber, respectively. AFM blocking assays with free PGM or O-glycan fractions purified from PGM demonstrated that neutral oligosaccharides played a major role in adhesion of L. lactis TIL448 to PGM. This study dissects L. lactis muco-adhesive phenotype, in relation with the nature of the bacterial surface determinants.	[Doan Thanh Lam Le; Thi-Ly Tran; Duviau, Marie-Pierre; Castelain, Mickael; Loubiere, Pascal; Mercier-Bonin, Muriel] Univ Toulouse, INSA, UPS, LISBP,INP, Toulouse, France; [Doan Thanh Lam Le; Thi-Ly Tran; Duviau, Marie-Pierre; Castelain, Mickael; Loubiere, Pascal; Mercier-Bonin, Muriel] INRA, Ingn Syst Biol & Proc UMR792, F-31931 Toulouse, France; [Doan Thanh Lam Le; Thi-Ly Tran; Duviau, Marie-Pierre; Castelain, Mickael; Loubiere, Pascal; Mercier-Bonin, Muriel] CNRS, UMR5504, Toulouse, France; [Doan Thanh Lam Le; Dague, Etienne] CNRS, LAAS, F-31077 Toulouse, France; [Doan Thanh Lam Le; Dague, Etienne] CNRS, ITAV UMS3039, Toulouse, France; [Doan Thanh Lam Le; Dague, Etienne] Univ Toulouse, LAAS, Toulouse, France; [Meyrand, Mickael; Chapot-Chartier, Marie-Pierre] INRA, UMR1319, Jouy En Josas, France; [Meyrand, Mickael; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Guerardel, Yann] Univ Lille 1, UGSF, F-59655 Villeneuve Dascq, France; [Guerardel, Yann] CNRS, UMR 8576, Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Dague, E (corresponding author), CNRS, LAAS, F-31077 Toulouse, France.	edague@laas.fr; Muriel.Mercier-Bonin@jouy.inra.fr	Dague, Etienne/C-6454-2008; MERCIER-BONIN, Muriel/AAO-5286-2021; Castelain, Mickaël/A-9647-2011	Castelain, Mickaël/0000-0002-0256-7663; Dague, Etienne/0000-0003-3290-9166; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519; Guerardel, Yann/0000-0003-4967-9512	INRA (CEPIA Department); INRA (MICA Department); University of Science and Technology of Hanoi (USTH), Vietnam	INRA (CEPIA Department); INRA (MICA Department); University of Science and Technology of Hanoi (USTH), Vietnam	This work was supported by INRA (CEPIA and MICA Departments) through the doctoral grant of Doan Thanh Lam Le (2008-2011). Thi-Ly Tran was recipient of a Ph.D. grant from the University of Science and Technology of Hanoi (USTH), Vietnam. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; Beaussart A, 2013, BIOPHYS J, V104, P1886, DOI 10.1016/j.bpj.2013.03.046; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Boguslawska J, 2009, APPL ENVIRON MICROB, V75, P6352, DOI 10.1128/AEM.00470-09; Buck BL, 2005, APPL ENVIRON MICROB, V71, P8344, DOI 10.1128/AEM.71.12.8344-8351.2005; Castelain M, 2009, CHEMPHYSCHEM, V10, P1533, DOI 10.1002/cphc.200900195; Dague E, 2010, LANGMUIR, V26, P11010, DOI 10.1021/la101862n; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; Decave E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108101; Doan TLL, 2012, BIOFOULING, V28, P479, DOI 10.1080/08927014.2012.688103; Doan TLL, 2011, BIOPHYS J, V101, P2843, DOI 10.1016/j.bpj.2011.10.034; Finegold S., 1983, HUMAN INTESTINAL MIC; Giaouris E, 2009, INT J FOOD MICROBIOL, V131, P2, DOI 10.1016/j.ijfoodmicro.2008.09.006; Gunning AP, 2013, FASEB J, V27, P2342, DOI 10.1096/fj.12-221416; Jeffrey B, 2003, AM J PHYSIOL-GASTR L, V285, pG907, DOI 10.1152/ajpgi.00062.2003; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Karlsson NG, 1997, BIOCHEM J, V326, P911, DOI 10.1042/bj3260911; Kinoshita H, 2007, J APPL MICROBIOL, V102, P116, DOI 10.1111/j.1365-2672.2006.03061.x; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Lorthois S, 2001, J COLLOID INTERF SCI, V241, P52, DOI 10.1006/jcis.2001.7679; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mercier-Bonin M, 2011, INT J FOOD MICROBIOL, V146, P182, DOI 10.1016/j.ijfoodmicro.2011.02.025; Mercier-Bonin M, 2009, J COLLOID INTERF SCI, V338, P73; Mercier-Bonin M, 2012, BIOFOULING, V28, P881, DOI 10.1080/08927014.2012.719160; Meyrand M, 2013, MOL CELL PROTEOMICS, V12, P3935, DOI 10.1074/mcp.M113.029066; Nejadnik MR, 2008, APPL ENVIRON MICROB, V74, P916, DOI 10.1128/AEM.01557-07; Nordman H, 1997, BIOCHEM J, V326, P903, DOI 10.1042/bj3260903; Ouwehand AC, 2001, INT J FOOD MICROBIOL, V64, P119, DOI 10.1016/S0168-1605(00)00440-2; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006; Tsubokawa D, 2007, FEBS J, V274, P1833, DOI 10.1111/j.1742-4658.2007.05731.x; Tuomola EM, 2000, INT J FOOD MICROBIOL, V60, P75, DOI 10.1016/S0168-1605(00)00319-6; Uchida H, 2004, BIOSCI BIOTECH BIOCH, V68, P1004, DOI 10.1271/bbb.68.1004; Vlieg JETV, 2006, CURR OPIN BIOTECH, V17, P183, DOI 10.1016/j.copbio.2006.02.007; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Wang YP, 2011, J MICROBIOL METH, V86, P390, DOI 10.1016/j.mimet.2011.06.009; Xu CP, 2008, APPL ENVIRON MICROB, V74, P7522, DOI 10.1128/AEM.00948-08	50	36	37	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79850	10.1371/journal.pone.0079850	http://dx.doi.org/10.1371/journal.pone.0079850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260308	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500103
J	Joyner, C; Mills, MK; Nayduch, D				Joyner, Chester; Mills, Mary Katherine; Nayduch, Dana			Pseudomonas aeruginosa in Musca domestica L.: Temporospatial Examination of Bacteria Population Dynamics and House Fly Antimicrobial Responses	PLOS ONE			English	Article							AEROMONAS-CAVIAE; DIGESTIVE-TRACT; IMMUNE-RESPONSE; HOST-DEFENSE; DROSOPHILA; INFECTION; PEPTIDE; EXPRESSION; DIPTERA; FATE	House flies associate with microbes throughout their life history. Bacteria ingested by adult flies enter the alimentary canal and face a hostile environment including antimicrobial defenses. Because the outcome of this interaction impacts bacterial survival and dissemination, our primary objective was to understand the temporospatial dynamics of fly-bacteria associations. We concurrently examined the temporospatial fate of GFP-expressing Pseudomonas aeruginosa (GFP-P. aeruginosa) in the house fly alimentary canal along with antimicrobial peptide (AMP) expression. Motile, viable GFP-P. aeruginosa were found in all regions of the alimentary canal and were culturable throughout the observation period (2-24 h). A significant decrease in recoverable bacteria occurred between 2 and 12 h, followed by an increase between 12 and 24 h. qRT-PCR analysis showed expression of the AMPs cecropin, diptericin, and defensin both locally (gut) and systemically. Furthermore, mRNA of all AMPs were expressed throughout gut tissues, with some tissue-specific temporal variation. Interestingly, fluctuation in recoverable P. aeruginosa was associated with AMP protein expression in the gut (immunofluorescent signal detection), but not with mRNA (qRTPCR). In regards to vector competence, flies excreted GFP-P. aeruginosa throughout the 24 h period, serving as both reservoirs and disseminators of this bacterium. Collectively, our data show flies can harbor and disseminate P. aeruginosa, and that the interactions of fly defenses with bacteria can influence vector competence.	[Joyner, Chester; Mills, Mary Katherine; Nayduch, Dana] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	University System of Georgia; Georgia Southern University	Nayduch, D (corresponding author), ARS, USDA, Ctr Grain & Anim Hlth Res, Arthropod Borne Anim Dis Res Unit, Manhattan, KS USA.	dana.nayduch@ars.usda.gov	Mills, Mary/N-6471-2019	Nayduch, Dana/0000-0002-9258-6066; Mills, Mary/0000-0002-9483-5986	National Institutes of Health [1R15AI084029-01]; Chandler Foundation; University Honors Program at Georgia Southern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI084029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chandler Foundation; University Honors Program at Georgia Southern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R15 Academic Research Enhancement Award (AREA) 1R15AI084029-01 from the National Institutes of Health awarded to DN. Additional support was awarded to CJ from the Chandler Foundation and University Honors Program at Georgia Southern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Barnes RJ, 2008, CAN J MICROBIOL, V54, P48, DOI [10.1139/W07-118, 10.1139/w07-118]; Brown AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004490; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Chavasse DC, 1999, LANCET, V353, P22, DOI 10.1016/S0140-6736(98)03366-2; COHEN D, 1991, LANCET, V337, P993, DOI 10.1016/0140-6736(91)92657-N; Dang XL, 2010, J MED ENTOMOL, V47, P1141, DOI 10.1603/ME10016; Doud CW, 2012, J MED ENTOMOL, V49, P150, DOI 10.1603/ME11167; Forster M, 2007, PARASITOL RES, V101, P243, DOI 10.1007/s00436-007-0522-y; Gendrin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069742; Gendrin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000694; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; Greenberg B, 1973, FLIES DIS ECOLOGY CL; Greenberg B, 1971, FLIES DIS ECOLOGY CL; Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; McGauchey J, 2009, J MED ENTOMOL, V46, P123, DOI 10.1603/033.046.0116; Moulton RC, 1979, J BACTERIOL, V137, P247; Nayduch D, 2005, INVERTEBR BIOL, V124, P74, DOI 10.1111/j.1744-7410.2005.1241-09.x; Nayduch D, 2002, MED VET ENTOMOL, V16, P193, DOI 10.1046/j.1365-2915.2002.00363.x; Nayduch D, 2013, J MED ENTOMOL, V50, P171, DOI 10.1603/ME12189; Nazni W.A., 2005, Tropical Biomedicine, V22, P225; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rahuma N, 2005, ANN TROP MED PARASIT, V99, P795, DOI 10.1179/136485905X65134; RICHARDS AG, 1977, ANNU REV ENTOMOL, V22, P219, DOI 10.1146/annurev.en.22.010177.001251; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Sukontason Kabkaew L., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P38; Terra WR, 1966, BIOL INSECT MIDGUT, P153; West L.S., 1951, HOUSE FLY ITS NATURA; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zurek L, 2000, J MED ENTOMOL, V37, P924, DOI 10.1603/0022-2585-37.6.924	39	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79224	10.1371/journal.pone.0079224	http://dx.doi.org/10.1371/journal.pone.0079224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260174	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500037
J	Putt, KS; Pugh, RB				Putt, Karson S.; Pugh, Randall B.			A High-Throughput Microtiter Plate Based Method for the Determination of Peracetic Acid and Hydrogen Peroxide	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PEROXYCARBOXYLIC ACIDS; PEROXYACETIC ACID; LARGE EXCESS; DISINFECTION	Peracetic acid is gaining usage in numerous industries who have found a myriad of uses for its antimicrobial activity. However, rapid high throughput quantitation methods for peracetic acid and hydrogen peroxide are lacking. Herein, we describe the development of a high-throughput microtiter plate based assay based upon the well known and trusted titration chemical reactions. The adaptation of these titration chemistries to rapid plate based absorbance methods for the sequential determination of hydrogen peroxide specifically and the total amount of peroxides present in solution are described. The results of these methods were compared to those of a standard titration and found to be in good agreement. Additionally, the utility of the developed method is demonstrated through the generation of degradation curves of both peracetic acid and hydrogen peroxide in a mixed solution.	[Putt, Karson S.; Pugh, Randall B.] Johnson & Johnson Vis Care Inc, Jacksonville, FL USA	Johnson & Johnson	Putt, KS (corresponding author), Johnson & Johnson Vis Care Inc, Jacksonville, FL USA.	kputt@its.jnj.com			Johnson Johnson	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA)	Funding was provided by Johnson & Johnson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad MI, 2012, ANAL CHIM ACTA, V730, P60, DOI 10.1016/j.aca.2011.10.070; Awad MI, 2003, J ELECTROANAL CHEM, V544, P35, DOI 10.1016/S0022-0728(03)00057-3; Bauermeister LJ, 2008, POULTRY SCI, V87, P2390, DOI 10.3382/ps.2008-00087; BoulangePetermann L, 1996, BIOFOULING, V10, P275, DOI 10.1080/08927019609386287; CAIRNS GT, 1975, J CHROMATOGR, V103, P381, DOI 10.1016/S0021-9673(00)87232-5; Carter Yvonne, 2011, Nurs Times, V107, P22; DIFURIA F, 1984, ANALYST, V109, P985, DOI 10.1039/an9840900985; Furia F. D., 1988, ANALYST, V113, P793; Galban J, 2010, ANAL BIOANAL CHEM, V398, P2117, DOI 10.1007/s00216-010-4145-2; GREENSPAN FP, 1948, ANAL CHEM, V20, P1061, DOI 10.1021/ac60023a020; Guglielmotti DM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00282; Jimenez L, 2008, BIORESOURCE TECHNOL, V99, P1474, DOI 10.1016/j.biortech.2007.01.061; KIRK O, 1992, J CHROMATOGR, V606, P49, DOI 10.1016/0021-9673(92)85256-S; Kitis M, 2004, ENVIRON INT, V30, P47, DOI 10.1016/S0160-4120(03)00147-8; Li J, 2011, ELECTROCHIM ACTA, V56, P3159, DOI 10.1016/j.electacta.2011.01.060; Mari M, 2003, J APPL MICROBIOL, V94, P761, DOI 10.1046/j.1365-2672.2003.01920.x; PINKERNELL U, 1994, ANAL CHEM, V66, P2599, DOI 10.1021/ac00087a028; Pinkernell U, 1997, ANALYST, V122, P567, DOI 10.1039/a700509a; Pinkernell U, 1996, J CHROMATOGR A, V730, P203, DOI 10.1016/0021-9673(95)01346-6; Rajkowski KT, 2009, FOODBORNE PATHOG DIS, V6, P1041, DOI 10.1089/fpd.2009.0267; Rutala WA, 1999, J HOSP INFECT, V43, pS43, DOI 10.1016/S0195-6701(99)90065-8; Sagsen B, 2012, J ENDODONT, V38, P1197, DOI 10.1016/j.joen.2012.06.026; Straus DL, 2012, J FISH DIS, V35, P505, DOI 10.1111/j.1365-2761.2012.01383.x; Toniolo R, 2006, ELECTROANAL, V18, P2079, DOI 10.1002/elan.200603641; Yin DL, 2011, BIORESOURCE TECHNOL, V102, P5183, DOI 10.1016/j.biortech.2011.01.079	25	12	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79218	10.1371/journal.pone.0079218	http://dx.doi.org/10.1371/journal.pone.0079218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260173	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500036
J	Salley, TN; Mishra, M; Tiwari, S; Jadhav, A; Ndisang, JF				Salley, Tatiana Ntube; Mishra, Manish; Tiwari, Shuchita; Jadhav, Ashok; Ndisang, Joseph Fomusi			The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; IMPROVES INSULIN SENSITIVITY; ALTERNATIVE ACTIVATION; CLINICAL-IMPLICATIONS; GLUCOSE-METABOLISM; HYPERTENSIVE-RATS; OXIDATIVE STRESS; ADIPOSE-TISSUE; DISEASE; STEATOHEPATITIS	The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-alpha, IL-6, IL-1 beta, macrophage-inflammatory-protein-1 alpha (MIP-1 alpha) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-beta 1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-alpha, IL-6, IL-1 beta, MIP-1 alpha and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology.	[Salley, Tatiana Ntube; Mishra, Manish; Tiwari, Shuchita; Jadhav, Ashok; Ndisang, Joseph Fomusi] Univ Saskatchewan, Coll Med, Dept Physiol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Ndisang, JF (corresponding author), Univ Saskatchewan, Coll Med, Dept Physiol, Saskatoon, SK S7N 0W0, Canada.	joseph.ndisang@usask.ca			Heart & Stroke Foundation of Saskatchewan, Canada	Heart & Stroke Foundation of Saskatchewan, Canada	This work was supported by a grant from the Heart & Stroke Foundation of Saskatchewan, Canada to Dr. Joseph Fomusi Ndisang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2004, HEPATOLOGY, V40, P475, DOI 10.1002/hep.20323; Aki K, 2010, AM J PHYSIOL-RENAL, V298, pF870, DOI 10.1152/ajprenal.00374.2009; Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Barbuio R, 2007, J ENDOCRINOL, V194, P539, DOI 10.1677/JOE-07-0234; Barnes MA, 2013, HEPATOLOGY, V57, P1980, DOI 10.1002/hep.26169; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Deng CY, 2012, J PHARMACOL EXP THER, V341, P146, DOI 10.1124/jpet.111.189498; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Finer G, 2012, KIDNEY INT, V82, P525, DOI 10.1038/ki.2012.139; Flisiak R, 2000, CYTOKINE, V12, P677, DOI 10.1006/cyto.1999.0660; Fracanzani AL, 2011, J HEPATOL, V54, P1244, DOI 10.1016/j.jhep.2010.09.037; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Hayashi H, 2011, AM J PHYSIOL-GASTR L, V300, pG729, DOI 10.1152/ajpgi.00013.2011; Haynes P, 2004, CLIN LIVER DIS, V8, pviii; Haynes Paul, 2004, Clin Liver Dis, V8, P535, DOI 10.1016/j.cld.2004.04.007; Jadhav A, 2013, J PHARMACOL EXP THER, V345, P239, DOI 10.1124/jpet.112.200808; Jadhav A, 2012, FREE RADICAL BIO MED, V53, P2277, DOI 10.1016/j.freeradbiomed.2012.10.529; Jadhav A, 2009, AM J PHYSIOL-RENAL, V296, pF521, DOI 10.1152/ajprenal.00510.2007; Jing F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060067; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Kathirvel E, 2010, J GASTROEN HEPATOL, V25, P1136, DOI 10.1111/j.1440-1746.2009.06196.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lackner C, 2011, EXPERT REV GASTROENT, V5, P223, DOI [10.1586/EGH.11.8, 10.1586/egh.11.8]; Lee HJ, 2002, BIOCHEM BIOPH RES CO, V296, P293, DOI 10.1016/S0006-291X(02)00822-7; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039165; Machado MV, 2011, EXPERT REV GASTROENT, V5, P213, DOI [10.1586/egh.11.16, 10.1586/EGH.11.16]; Malaguarnera L, 2005, J HEPATOL, V42, P585, DOI 10.1016/j.jhep.2004.11.040; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157; Mauricio M. D., 2013, CURR PHARM DES; Mishra M., 2013, CURR PHARM DES; Morel OE, 2005, PHYSIOL BEHAV, V86, P145, DOI 10.1016/j.physbeh.2005.07.003; Moro C, 2007, DIABETOLOGIA, V50, P1038, DOI 10.1007/s00125-007-0614-3; Mosen H, 2005, ENDOCRINOLOGY, V146, P1553, DOI 10.1210/en.2004-0851; Mosen H, 2006, J ENDOCRINOL, V190, P681, DOI 10.1677/joe.1.06890; Navarro-Gonzalez JF, 2011, CONTRIB NEPHROL, V170, P113, DOI 10.1159/000325646; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Ndisang J. F., 2013, CURR PHARM DES; Ndisang JF, 2003, BLOOD, V101, P3893, DOI 10.1182/blood-2002-08-2608; Ndisang JF, 2002, EXPERT OPIN THER PAT, V12, P1237; Ndisang JF, 2008, J HYPERTENS, V26, P1188, DOI 10.1097/HJH.0b013e3282fad93d; Ndisang JF, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/359732; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2098, DOI 10.1210/en.2008-0239; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE829, DOI 10.1152/ajpendo.90783.2008; Okamoto T, 2011, J PHARM PHARMACOL, V63, P952, DOI 10.1111/j.2042-7158.2011.01299.x; Pathil A, 2012, HEPATOLOGY, V55, P1369, DOI 10.1002/hep.25531; Reed DR, 2011, PHYSIOL BEHAV, V103, P523, DOI 10.1016/j.physbeh.2011.04.006; Satapati S, 2008, DIABETES, V57, P2012, DOI 10.2337/db08-0226; Satoh-Asahara N, 2012, DIABETES CARE, V35, P2631, DOI 10.2337/dc12-0269; Shen C, 2012, FRONT BIOSCI-LANDMRK, V17, P2356, DOI 10.2741/4057; Shiota Masakazu, 2012, Methods Mol Biol, V933, P103, DOI 10.1007/978-1-62703-068-7_8; Tarantino G, 2007, J GASTROEN HEPATOL, V22, P293, DOI 10.1111/j.1440-1746.2007.04824.x; Tiwari S, 2013, CURR PHARM DES; Wang Rong-qi, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P680, DOI 10.3760/cma.j.issn.1007-3418.2010.09.009; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Yang YY, 2012, HEPATOLOGY, V55, P1540, DOI 10.1002/hep.25534	61	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79270	10.1371/journal.pone.0079270	http://dx.doi.org/10.1371/journal.pone.0079270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260182	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600026
J	Losino, N; Waisman, A; Solari, C; Luzzani, C; Espinosa, DF; Sassone, A; Muro, AF; Miriuka, S; Sevlever, G; Baranao, L; Guberman, A				Losino, Noelia; Waisman, Ariel; Solari, Claudia; Luzzani, Carlos; Fernandez Espinosa, Dario; Sassone, Alina; Muro, Andres F.; Miriuka, Santiago; Sevlever, Gustavo; Baranao, Lino; Guberman, Alejandra			EDA-Containing Fibronectin Increases Proliferation of Embryonic Stem Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CELLULAR FIBRONECTIN; GENE-EXPRESSION; MESSENGER-RNA; SELF-RENEWAL; EXTRA DOMAIN; RECEPTOR; ADHESION; GROWTH; INVOLVEMENT	Embryonic stem cells (ESC) need a set of specific factors to be propagated. They can also grow in conditioned medium (CM) derived from a bovine granulosa cell line BGC (BGC-CM), a medium that not only preserves their main features but also increases ESC's proliferation rate. The mitogenic properties of this medium were previously reported, ascribing this effect to an alternative spliced generated fibronectin isoform that contains the extra domain A (FN EDA(+)). Here, we investigated if the FN EDA+ isoform increased proliferation of mouse and human ES cells. We analyzed cell proliferation using conditioned media produced by different mouse embryonic fibroblast (MEF) lines genetically engineered to express FN constitutively including or excluding the EDA domain (FN EDA(-)), and in media supplemented with recombinant peptides containing or not the EDA. We found that the presence of EDA in the medium increased mouse and human ESC's proliferation rate. Here we showed for the first time that this FN isoform enhances ESC's proliferation. These findings suggest a possible conserved behavior for regulation of ES cells proliferation by this FN isoform and could contribute to improve their culturing conditions both for research and cell therapy.	[Losino, Noelia; Waisman, Ariel; Solari, Claudia; Luzzani, Carlos; Sassone, Alina; Baranao, Lino; Guberman, Alejandra] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Regulac Genica Celulas Madre, Buenos Aires, DF, Argentina; [Losino, Noelia; Waisman, Ariel; Solari, Claudia; Luzzani, Carlos; Baranao, Lino; Guberman, Alejandra] UBA Consejo Nacl Invest Cient & Tecn CONICET, Inst Quim Biol Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [Fernandez Espinosa, Dario; Miriuka, Santiago; Sevlever, Gustavo] Fdn Lucha Enfermedades Neurol Infancia, Lab Biol Desarrollo Celular, Buenos Aires, DF, Argentina; [Muro, Andres F.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Guberman, Alejandra] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina	University of Buenos Aires; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Buenos Aires	Guberman, A (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Regulac Genica Celulas Madre, Buenos Aires, DF, Argentina.	algub@qb.fcen.uba.ar	Miriuka, Santiago/AAM-4051-2020; Waisman, Ari/C-7383-2015; Muro, Andrés F/K-3156-2016; Miriuka, Santiago/ABE-9614-2020; Sevlever, Gustavo/Q-2219-2015	Miriuka, Santiago/0000-0003-2402-3920; Waisman, Ari/0000-0003-4304-8234; Muro, Andrés F/0000-0002-9628-0494; Waisman, Ariel/0000-0002-6860-9512; Sevlever, Gustavo/0000-0002-9567-7553	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 112-200801-03003]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PID 115-PAE37075]; Biosidus SA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Biosidus SA	This work was supported by grants (to AG) from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (PIP 112-200801-03003), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (PID 115-PAE37075) and by Biosidus SA. NL, AW, CS, and CL are fellows from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005341; Abraham S, 2010, ACTA BIOMATER, V6, P4622, DOI 10.1016/j.actbio.2010.07.029; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Allen MD, 2011, J PATHOL, V223, P646, DOI 10.1002/path.2833; BERNATH VA, 1990, J BIOL CHEM, V265, P18219; Colman-Lerner A, 1999, ENDOCRINOLOGY, V140, P2541, DOI 10.1210/en.140.6.2541; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413; FFRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261, DOI 10.1006/excr.1995.1374; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Heydarkhan-Hagvall S, 2012, BIOMATERIALS, V33, P2032, DOI 10.1016/j.biomaterials.2011.11.065; Hunt GC, 2012, EXP CELL RES, V318, P1820, DOI 10.1016/j.yexcr.2012.06.009; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Kim YH, 2010, J CELL PHYSIOL, V223, P397, DOI 10.1002/jcp.22048; Kohan M, 2011, J ALLERGY CLIN IMMUN, V127, P439, DOI 10.1016/j.jaci.2010.10.021; Kohan M, 2010, FASEB J, V24, P4503, DOI 10.1096/fj.10-154435; Kuwada SK, 2000, MOL BIOL CELL, V11, P2485, DOI 10.1091/mbc.11.7.2485; Lee MY, 2009, STEM CELLS, V27, P1858, DOI 10.1002/stem.124; Lee SH, 2011, J CELL PHYSIOL, V226, P484, DOI 10.1002/jcp.22358; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; LERNER AAC, 1995, J CELL PHYSIOL, V164, P395, DOI 10.1002/jcp.1041640220; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Losino N, 2011, STEM CELLS DEV, V20, P1439, DOI 10.1089/scd.2010.0336; Luzzani C, 2011, BIOCHEM BIOPH RES CO, V410, P816, DOI 10.1016/j.bbrc.2011.06.070; MACLAREN LA, 1995, BIOL REPROD, V53, P153, DOI 10.1095/biolreprod53.1.153; Manabe R, 1999, J BIOL CHEM, V274, P5919, DOI 10.1074/jbc.274.9.5919; McFadden JP, 2011, CLIN DERMATOL, V29, P257, DOI 10.1016/j.clindermatol.2010.11.003; MOULD AP, 1990, J BIOL CHEM, V265, P4020; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Muro AF, 1998, FEBS LETT, V437, P137, DOI 10.1016/S0014-5793(98)01201-0; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; NORTON PA, 1987, MOL CELL BIOL, V7, P4297, DOI 10.1128/MCB.7.12.4297; Orlando L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030234; Ou JJ, 2011, J CELL BIOCHEM, V112, P2106, DOI 10.1002/jcb.23130; OYAMA F, 1989, J BIOL CHEM, V264, P10331; PAGANI F, 1991, J CELL BIOL, V113, P1223, DOI 10.1083/jcb.113.5.1223; Park JH, 2011, J CELL PHYSIOL, V226, P267, DOI 10.1002/jcp.22338; Park JH, 2004, J CELL PHYSL, V226, P267; Ritzenthaler JD, 2008, MOL BIOSYST, V4, P1160, DOI 10.1039/b800533h; Rodriguez Luis G., 2004, V294, P23; Scassa ME, 2011, STEM CELL RES, V6, P13, DOI 10.1016/j.scr.2010.09.002; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Solari C, 2011, BIOCHEM BIOPH RES CO, V410, P252, DOI 10.1016/j.bbrc.2011.05.126; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Toh YC, 2010, INTEGR BIOL-UK, V2, P305, DOI 10.1039/c0ib00004c; VARTIO T, 1987, J CELL SCI, V88, P419; Welham MJ, 2011, BIOCHEM SOC T, V39, P674, DOI 10.1042/BST0390674; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Zoppi N, 2012, BBA-GEN SUBJECTS, V1820, P1576, DOI 10.1016/j.bbagen.2012.06.004	52	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80681	10.1371/journal.pone.0080681	http://dx.doi.org/10.1371/journal.pone.0080681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244705	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800156
J	Ydreborg, M; Westin, J; Rembeck, K; Lindh, M; Norrgren, H; Holmberg, A; Wejstal, R; Norkrans, G; Cardell, K; Weiland, O; Lagging, M				Ydreborg, Magdalena; Westin, Johan; Rembeck, Karolina; Lindh, Magnus; Norrgren, Hans; Holmberg, Anna; Wejstal, Rune; Norkrans, Gunnar; Cardell, Kristina; Weiland, Ola; Lagging, Martin			Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Transient Elastography in Chronic Hepatitis C Infection	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; GENOME-WIDE ASSOCIATION; VIRUS GENOTYPE 2; GENETIC-VARIATION; PEGINTERFERON ALPHA-2A; VIROLOGICAL RESPONSE; INTERFERON-ALPHA; VIRAL KINETICS; PLUS RIBAVIRIN; UP-REGULATION	Background and Aims: Recently, several genome-wide association studies have revealed that single nucleotide polymorphisms (SNPs) in proximity to IL28B predict spontaneous clearance of hepatitis C virus (HCV) infection as well as outcome following pegylated interferon and ribavirin therapy among genotype 1 infected patients. Additionally the presence of the otherwise favorable IL28B genetic variants in the context of HCV genotype 3 infection reportedly entail more pronounced liver fibrosis and steatosis. The present study aimed to evaluate the impact of IL28B SNP variability on liver stiffness as accessed by transient elastography. Methods: Seven hundred and seventy-one Swedish HCV infected patients sequentially undergoing liver stiffness measurement by means of Fibroscan (R) in the context of a real-life trial had samples available for IL28B genotyping (rs12979860) and HCV genotyping. Results: CCrs12979860 was more common among HCV genotype 2 or 3 infected treatment-naive patients than among those infected with genotype 1 (P<0.0001). Additionally CCrs12979860 among HCV genotype 3 infected patients was associated with higher liver stiffness values (P = 0.004), and higher AST to platelet ratio index (APRI; p = 0.02) as compared to carriers of the T allele. Among HCV genotype 1 infected patients, CCrs12979860 was significantly associated with higher viral load (P = 0.001), with a similar non-significant trend noted among HCV genotype 3 infected patients. Conclusion: This study confirms previous reports that the CCrs12979860 SNP is associated with more pronounced liver pathology in patients chronically infected with HCV genotype 3 as compared to genotype 1, suggesting that IL28B genetic variants differently regulates the course of HCV infection across HCV genotypes.	[Ydreborg, Magdalena; Westin, Johan; Rembeck, Karolina; Lindh, Magnus; Wejstal, Rune; Norkrans, Gunnar; Lagging, Martin] Univ Gothenburg, Inst Biomed, Dept Infect Diseases Virol, Gothenburg, Sweden; [Norrgren, Hans; Holmberg, Anna] Skane Univ Hosp, Dept Infect Dis, Lund, Sweden; [Cardell, Kristina] Linkoping Univ Hosp, Dept Infect Dis, S-58185 Linkoping, Sweden; [Weiland, Ola] Karolinska Univ Hosp, Karolinska Inst, Dept Infect Dis, Karolinska, Sweden	University of Gothenburg; Lund University; Skane University Hospital; Linkoping University; Karolinska Institutet; Karolinska University Hospital	Lagging, M (corresponding author), Univ Gothenburg, Inst Biomed, Dept Infect Diseases Virol, Gothenburg, Sweden.	martin.lagging@medfak.gu.se	Lagging, Martin/D-7734-2015	Lagging, Martin/0000-0002-7995-3626; Weiland, Ola/0000-0002-6934-9724; Norrgren, Hans/0000-0001-5780-530X	Swedish Medical Research Council [2427, 3821]; ALF Funds at the Sahlgrenska University Hospital [Diarienr ALFGBG-143271]; Merck Sharp & Dohme (Sweden) AB	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); ALF Funds at the Sahlgrenska University Hospital; Merck Sharp & Dohme (Sweden) AB(Merck & Company)	This work was supported by the Swedish Medical Research Council (Diarienr 2008: 2427 and 2011: 3821), and ALF Funds at the Sahlgrenska University Hospital (Diarienr ALFGBG-143271). An unrestricted grant from Merck Sharp & Dohme (Sweden) AB also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Ackefors M, 2013, J VIRAL HEP IN PRESS; Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Arena U, 2008, GUT, V57, P1288, DOI 10.1136/gut.2008.149708; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bochud PY, 2011, J HEPATOL, V55, P980, DOI 10.1016/j.jhep.2011.01.050; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Boursier J, 2013, J GASTROENTEROLOGY; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hepatitis C-globalprevalence(update), 1999, WKLY EPIDEMIOL REC, V74, P425; Hofer H, 2002, AM J GASTROENTEROL, V97, P2880, DOI 10.1111/j.1572-0241.2002.07056.x; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lindh M, 2011, J VIRAL HEPATITIS, V18, pE325, DOI 10.1111/j.1365-2893.2010.01425.x; Lindh M, 2011, J INFECT DIS, V203, P1748, DOI 10.1093/infdis/jir193; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Moghaddam A, 2011, HEPATOLOGY, V53, P746, DOI 10.1002/hep.24154; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Noureddin M, 2013, HEPATOLOGY IN PRESS; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rembeck K, 2012, HEPATOLOGY, V56, P394, DOI 10.1002/hep.25598; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sanchez-Conde M, 2011, J VIRAL HEPATITIS, V18, pE278, DOI 10.1111/j.1365-2893.2010.01407.x; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Scherzer TM, 2011, J HEPATOL, V54, P866, DOI 10.1016/j.jhep.2010.08.024; STENKVIST J, 2013, VIRAL HEPATITIS, V20, P193; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932, DOI 10.1016/j.cgh.2012.01.015; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; Westin J, 2007, J VIRAL HEPATITIS, V14, P29, DOI 10.1111/j.1365-2893.2006.00777.x; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	53	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80172	10.1371/journal.pone.0080172	http://dx.doi.org/10.1371/journal.pone.0080172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244641	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800131
J	Zhao, LH; Cui, XZ; Yuan, HJ; Liang, B; Zheng, LL; Liu, YX; Luo, MJ; Tan, JH				Zhao, Li-Hua; Cui, Xiang-Zhong; Yuan, Hong-Jie; Liang, Bo; Zheng, Liang-Liang; Liu, Yu-Xiang; Luo, Ming-Jiu; Tan, Jing-He			Restraint Stress Inhibits Mouse Implantation: Temporal Window and the Involvement of HB-EGF, Estrogen and Progesterone	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; EMBRYO IMPLANTATION; GROWTH-FACTOR; EMOTIONAL ADJUSTMENT; BIOMEDICAL-RESEARCH; PREGNANCY OUTCOMES; IVF; BLASTOCYSTS; GENE; UTERUS	It is known that psychological stress affects reproduction in women, but it is unknown whether the effect is by impairing implantation. Although studies suggest that long periods of auditory or restraint stress may inhibit implantation in rats and mice, the exact stage of pregnancy at which stress impairs implantation is unclear. Furthermore, whether stress impairs implantation by decreasing the heparin-binding epidermal growth factor-like growth factor (HB-EGF), estrogen and/or progesterone and whether by acting on embryos or on the uterus need further investigations. In this study, a 24-h restraint stress was initiated at 15:30 of day 3 (regimen 1) or at 07:30 (regimen 2) or 15:30 of day 4 (regimen 3) of pregnancy (vaginal plug = day 1) to observe effects of restraint stress applied at different peri-implantation stages on implantation. Among the three regimens, whereas regimens 1 and 3 affected neither term pregnancy nor litter size, regimen 2 reduced both. Further observations indicated that regimen 2 of restraint stress also delayed blastocyst hatching and the attachment reaction, decreased serum concentrations of progesterone and estradiol, and down regulated the expression of HB-EGF in both the endometrium and blastocysts. Taken together, the results suggested that restraint stress inhibited mouse implantation in a temporal window-dependent manner and by impairing blastocyst activation and hatching and uterine receptivity via down-regulating HB-EGF, estrogen and progesterone. Thus, the stress applied within the implantation window impaired implantation by acting on both embryos and the uterus.	[Zhao, Li-Hua; Cui, Xiang-Zhong; Yuan, Hong-Jie; Liang, Bo; Zheng, Liang-Liang; Liu, Yu-Xiang; Luo, Ming-Jiu; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Tan, JH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn	Luo, Mingjiu/AAU-8570-2021		National Basic Research Program of China [2012CB944403, 2014CB138503]; China National Natural Science Foundation [31272444, 30972096]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2012CB944403 and 2014CB138503) and the China National Natural Science Foundation (Nos. 31272444 and 30972096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; Al-Inany HG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub2; Albina ML, 2002, EXP BIOL MED, V227, P779, DOI 10.1177/153537020222700909; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Cousineau TM, 2007, BEST PRACT RES CL OB, V21, P293, DOI 10.1016/j.bpobgyn.2006.12.003; Csemiczky G, 2000, ACTA OBSTET GYN SCAN, V79, P113, DOI 10.1034/j.1600-0412.2000.079002113.x; DAS SK, 1995, MOL ENDOCRINOL, V9, P691, DOI 10.1210/me.9.6.691; DAS SK, 1994, DEVELOPMENT, V120, P1071; Davies I J, 1972, Vitam Horm, V30, P223, DOI 10.1016/S0083-6729(08)60797-9; Dawson A. A., 2005, Archives of Gynecology and Obstetrics, V273, P3, DOI 10.1007/s00404-005-0010-5; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Enders A C, 1976, J Reprod Fertil Suppl, P1; Giudice LC, 1999, HUM REPROD, V14, P3, DOI 10.1093/humrep/14.suppl_2.3; GLAVIN GB, 1994, NEUROSCI BIOBEHAV R, V18, P223, DOI 10.1016/0149-7634(94)90027-2; Golub MS, 2004, BIRTH DEFECTS RES B, V71, P26, DOI 10.1002/bdrb.10058; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Kee BS, 2000, J ASSIST REPROD GEN, V17, P445; Klonoff-Cohen H, 2004, FERTIL STERIL, V81, P982, DOI 10.1016/j.fertnstert.2003.08.050; Klonoff-Cohen H, 2001, FERTIL STERIL, V76, P675, DOI 10.1016/S0015-0282(01)02008-8; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048083; MACNIVEN E, 1992, PHYSIOL BEHAV, V52, P159, DOI 10.1016/0031-9384(92)90446-9; Neggers Y, 2006, ACTA OBSTET GYN SCAN, V85, P277, DOI 10.1080/00016340600566121; PARE WP, 1986, NEUROSCI BIOBEHAV R, V10, P339, DOI 10.1016/0149-7634(86)90017-5; Paria BC, 1998, ENDOCRINOLOGY, V139, P5235, DOI 10.1210/en.139.12.5235; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P55, DOI 10.1073/pnas.90.1.55; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Polinder S, 2008, HUM REPROD, V23, P316, DOI 10.1093/humrep/dem372; PSYCHOYOS A, 1986, ANN NY ACAD SCI, V476, P36, DOI 10.1111/j.1749-6632.1986.tb20920.x; Raab G, 1996, DEVELOPMENT, V122, P637; SAUER MJ, 1979, J REPROD FERTIL, V56, P725; Schroder AK, 2004, REPROD BIOMED ONLINE, V8, P600, DOI 10.1016/S1472-6483(10)61110-8; SUGINO N, 1994, J REPROD FERTIL, V101, P23; SURANI MAH, 1977, J CELL SCI, V25, P265; Verhaak CM, 2007, HUM REPROD UPDATE, V13, P27, DOI 10.1093/humupd/dml040; Verhaak CM, 2005, HUM REPROD, V20, P2253, DOI 10.1093/humrep/dei015; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; WIEBOLD JL, 1986, J REPROD FERTIL, V78, P185, DOI 10.1530/jrf.0.0780185; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Zhang SY, 2011, BIOL REPROD, V84, P672, DOI 10.1095/biolreprod.110.087890; Zhang XH, 2013, MOL CELL ENDOCRINOL, V381, P272, DOI 10.1016/j.mce.2013.08.011; Zondek B, 1967, EFFECTS EXTERNAL STI, V26, P4	43	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80472	10.1371/journal.pone.0080472	http://dx.doi.org/10.1371/journal.pone.0080472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244689	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800147
J	DeSimone, DC; Baddour, LM; Lahr, BD; Chung, HH; Wilson, WR; Steckelberg, JM				DeSimone, Daniel C.; Baddour, Larry M.; Lahr, Brian D.; Chung, Heath H.; Wilson, Walter R.; Steckelberg, James M.		Mayo Cardiovasc Infections	Euthermic Endocarditis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTIONS; CLINICAL-FEATURES; ELDERLY-PATIENTS; Q-FEVER; ASSOCIATION; BACTEREMIA; PROGNOSIS; MORTALITY; DIAGNOSIS; SURVIVAL	Background: Most patients with infective endocarditis (IE) manifest fever. Comparison of endocarditis patients with and without fever, and whether the lack of fever in IE is a marker for poorer outcomes, such as demonstrated in other severe infectious diseases, have not been defined. Methods and Results: Cases from the Mayo Clinic, Rochester, Minnesota, Division of Infectious Diseases IE registry, a single-center database that contains all cases of IE treated at our center. Diagnosis date between 1970 and 2006, which met the modified Duke criteria for definite endocarditis, without fever was included. There were 240 euthermic endocarditis cases included in this analysis, with 282 febrile controls selected by frequency matching on gender and decade of diagnosis. Euthermic patients had a median age of 63.6 years (+/- 16.1) as compared to 59.0 years (+/- 16.4) in the febrile control group (p=0.001). Median (IQR) symptom duration prior to diagnosis was 4.0 (1.0, 12.0) weeks in the euthermic group compared to 3.0 (1.0, 8.0) weeks in the febrile controls (p=0.006). From unadjusted analyses, survival rates were 87% in euthermic cases versus 83% in febrile controls across 28-day follow-up (p=0.164), and 72% in euthermic group cases versus 69% in febrile controls across 1-year follow-up (p=0.345). Also unadjusted, the 1-year cumulative incidence rate of valve surgery was higher in euthermic cases versus febrile controls (50% vs. 39%, p=0.004). Conclusions: Patients with euthermic endocarditis are older, and lack of fever was associated with longer symptom duration and delayed diagnosis prior to IE diagnosis. Despite a higher unadjusted rate of valve surgery in euthermic patients, the result was not significant when adjusting for baseline confounders. Differences in survival rates at both 28-days and 365-days were not statistically significant between the two groups.	[DeSimone, Daniel C.; Baddour, Larry M.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Lahr, Brian D.; Wilson, Walter R.; Steckelberg, James M.] Mayo Clin, Rochester, MN USA; [Chung, Heath H.] Univ Hawaii, John A Burns Sch Med, Handicap Int, Honolulu, HI 96822 USA	Mayo Clinic; Mayo Clinic; University of Hawaii System	DeSimone, DC (corresponding author), Mayo Clin, Coll Med, Rochester, MN 55905 USA.	desimone.daniel@mayo.edu			Baddour Family Fund award	Baddour Family Fund award	This work was supported by the Baddour Family Fund award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahkee S, 1997, SOUTHERN MED J, V90, P296, DOI 10.1097/00007611-199703000-00006; Arons MM, 1999, CRIT CARE MED, V27, P699, DOI 10.1097/00003246-199904000-00020; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Bradley SF, 2002, CLIN INFECT DIS, V34, P211, DOI 10.1086/338150; BRYANT RE, 1971, ARCH INTERN MED, V127, P120, DOI 10.1001/archinte.127.1.120; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cecchi Enrico, 2004, Ital Heart J, V5, P249; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; CLEMMER TP, 1992, CRIT CARE MED, V20, P1395, DOI 10.1097/00003246-199210000-00006; Durante-Mangoni E, 2008, ARCH INTERN MED, V168, P2095, DOI 10.1001/archinte.168.19.2095; Guerrero MLF, 2012, MEDICINE, V91, P152, DOI 10.1097/MD.0b013e31825631ea; Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013; Groeneveld ABJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1189, DOI 10.1128/CDLI.8.6.1189-1195.2001; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; Landais C, 2007, CLIN INFECT DIS, V44, P1337, DOI 10.1086/515401; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marik PE, 2000, CHEST, V117, P855, DOI 10.1378/chest.117.3.855; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Netzer ROM, 2000, HEART, V84, P25, DOI 10.1136/heart.84.1.25; Ortega M, 2007, EUR J CLIN MICROBIOL, V26, P453, DOI 10.1007/s10096-007-0304-6; Scott JW, 2008, AM J MED SCI, V336, P53, DOI 10.1097/MAJ.0b013e31815cff75; TERPENNING MS, 1987, AM J MED, V83, P626, DOI 10.1016/0002-9343(87)90890-4; WEINSTEIN MP, 1978, AM J MED, V64, P592, DOI 10.1016/0002-9343(78)90578-8; Werner GS, 1996, AM J MED, V100, P90, DOI 10.1016/S0002-9343(96)90017-0; Yusuf SW, 2006, MEDICINE, V85, P86, DOI 10.1097/01.md.0000208503.06288.7b	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80144	10.1371/journal.pone.0080144	http://dx.doi.org/10.1371/journal.pone.0080144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244630	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600185
J	Ma, MJ; Zhou, XH; Qi, W; Liu, K; Jia, P; Du, GZ				Ma, Miaojun; Zhou, Xianhui; Qi, Wei; Liu, Kun; Jia, Peng; Du, Guozhen			Seasonal Dynamics of the Plant Community and Soil Seed Bank along a Successional Gradient in a Subalpine Meadow on the Tibetan Plateau	PLOS ONE			English	Article							VEGETATION SUCCESSION; LONG-TERM; SIZE; RESTORATION; ABUNDANCE; MASS; GRASSLANDS; EMERGENCE; NUMBER; NICHE	Background: Knowledge about how change the importance of soil seed bank and relationship between seed mass and abundance during vegetation succession is crucial for understanding vegetation dynamics. Many studies have been conducted, but their ecological mechanisms of community assembly are not fully understood. Methodology: We examined the seasonal dynamics of the vegetation and soil seed bank as well as seed size distribution along a successional gradient. We also explored the potential role of the soil seed bank in plant community regeneration, the relationship between seed mass and species abundance, and the relative importance of deterministic and stochastic processes along a successional gradient. Principal Findings: Species richness of seed bank increased (shallow layer and the total) and seed density decreased (each layer and the total) significantly with succession. Species richness and seed density differed significantly between different seasons and among soil depths. Seed mass showed a significant negative relationship with relative abundance in the earliest successional stage, but the relationships were not significant in later stages. Seed mass showed no relationship with relative abundance in the whole successional series in seed bank. Results were similar for both July 2005 and April 2006. Conclusions: The seed mass and abundance relationship was determined by a complex interaction between small and larger seeded species and environmental factors. Both stochastic processes and deterministic processes were important determinants of the structure of the earliest stage. The importance of seed bank decreased with succession. The restoration of abandoned farmed and grazed meadows to the species-rich subalpine meadow in Tibetan Plateau can be successfully achieved from the soil seed bank. However, at least 20 years are required to fully restore an abandoned agricultural meadow to a natural mature subalpine meadow.	[Ma, Miaojun; Zhou, Xianhui; Qi, Wei; Liu, Kun; Jia, Peng; Du, Guozhen] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University	Du, GZ (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	guozdu@lzu.edu.cn	Ma, Miaojun/E-1320-2012	Ma, Miaojun/0000-0001-7046-9574; Liu, Kun/0000-0001-9127-053X	Natural Science Foundation of China [41101527, 40930533]; Research Fund for the Doctoral Program of Higher Education of China [20110211120026]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The study was funded by the Natural Science Foundation of China (Grant No. 41101527 and 40930533), the Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110211120026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker JP, 2002, APPL VEG SCI, V5, P107, DOI 10.1658/1402-2001(2002)005[0107:EOLTCI]2.0.CO;2; Bekker RM, 2000, J ECOL, V88, P594, DOI 10.1046/j.1365-2745.2000.00485.x; Bisteau E, 2005, APPL VEG SCI, V8, P167, DOI 10.1658/1402-2001(2005)008[0167:VASBIA]2.0.CO;2; Bossuyt B, 2004, J VEG SCI, V15, P449, DOI 10.1111/j.1654-1103.2004.tb02283.x; Caballero I, 2008, OIKOS, V117, P1788, DOI 10.1111/j.1600-0706.2008.17138.x; Chu CJ, 2007, ANN BOT-LONDON, V100, P807, DOI 10.1093/aob/mcm166; Coomes DA, 2002, OIKOS, V96, P421, DOI 10.1034/j.1600-0706.2002.960304.x; Dyer AR, 2000, ECOL LETT, V3, P523, DOI 10.1046/j.1461-0248.2000.00187.x; Eriksson O, 2005, OECOLOGIA, V144, P98, DOI 10.1007/s00442-005-0001-z; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Guo QF, 2000, ECOLOGY, V81, P2149, DOI 10.1890/0012-9658(2000)081[2149:COSSOP]2.0.CO;2; Guo QF, 2003, OIKOS, V101, P639, DOI 10.1034/j.1600-0706.2003.12428.x; Harper J. L., 1977, Population biology of plants.; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Kalamees R, 1998, ACTA OECOL, V19, P175, DOI 10.1016/S1146-609X(98)80021-0; Kalamees R, 2012, APPL VEG SCI, V15, P208, DOI 10.1111/j.1654-109X.2011.01169.x; KIIRIKKI M, 1993, ANN BOT FENN, V30, P139; Klimes L, 2010, APPL VEG SCI, V13, P403, DOI 10.1111/j.1654-109X.2010.01084.x; Leishman MR, 2001, OIKOS, V94, P151, DOI 10.1034/j.1600-0706.2001.10392.x; Ma MJ, 2013, PLANT SOIL, V369, P283, DOI 10.1007/s11104-012-1560-5; Ma MJ, 2012, ECOL ENG, V44, P18, DOI 10.1016/j.ecoleng.2012.03.017; Ma MJ, 2011, PLANT SOIL, V346, P19, DOI 10.1007/s11104-011-0790-2; Ma MJ, 2010, PLANT SOIL, V336, P291, DOI 10.1007/s11104-010-0480-5; Ma MJ, 2010, FLORA, V205, P128, DOI 10.1016/j.flora.2009.02.006; Ma MJ, 2009, ARCT ANTARCT ALP RES, V41, P469, DOI 10.1657/1938-4246-41.4.999; Mabry CM, 2004, OIKOS, V107, P497, DOI 10.1111/j.0030-1299.2004.13314.x; Martinez-Duro E, 2010, APPL VEG SCI, V13, P234, DOI 10.1111/j.1654-109X.2009.01064.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Murray BR, 2005, OIKOS, V110, P191, DOI 10.1111/j.0030-1299.2005.13943.x; Murray BR, 2003, OIKOS, V101, P643, DOI 10.1034/j.1600-0706.2003.12717.x; Ortega M, 1997, J BIOGEOGR, V24, P177, DOI 10.1046/j.1365-2699.1997.00080.x; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Royo AA, 2013, J VEG SCI, V24, P724, DOI 10.1111/jvs.12011; Scott AJ, 2010, THESIS LA TROBE U ME; Scott AJ, 2012, J VEG SCI, V23, P721, DOI 10.1111/j.1654-1103.2011.01382.x; TerHeerdt GNJ, 1996, FUNCT ECOL, V10, P144, DOI 10.2307/2390273; Torok P, 2009, FOLIA GEOBOT, V44, P31, DOI 10.1007/s12224-009-9027-z; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; van de Voorde TFJ, 2012, OIKOS, V121, P1251, DOI 10.1111/j.1600-0706.2011.19964.x; Wagner M, 2003, ANN BOT FENN, V40, P87; Wearne LJ, 2006, PLANT ECOL, V183, P361, DOI 10.1007/s11258-005-9046-7; Welling P, 2004, ARCT ANTARCT ALP RES, V36, P229, DOI 10.1657/1523-0430(2004)036[0229:TASSBI]2.0.CO;2; Westhoff V., 1973, CLASSIFICATION PLANT, V5, P617, DOI [10.1007/978-94-010-2701-4_20, DOI 10.1007/978-94-009-9183-5_9]; Zhang H, 2013, OIKOS, V122, P952, DOI 10.1111/j.1600-0706.2012.20828.x; Zhang ST, 2004, FOLIA GEOBOT, V39, P129, DOI 10.1007/BF02805242	45	20	22	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80220	10.1371/journal.pone.0080220	http://dx.doi.org/10.1371/journal.pone.0080220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244655	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600194
J	Lu, Y; Zhou, Q; Shi, YB; Liu, J; Zhong, F; Hao, X; Li, C; Chen, N; Wang, WM				Lu, Ying; Zhou, Qiao; Shi, Yongbing; Liu, Jian; Zhong, Fang; Hao, Xu; Li, Cong; Chen, Nan; Wang, Weiming			SUMOylation of PPAR gamma by Rosiglitazone Prevents LPS-Induced NCoR Degradation Mediating Down Regulation of Chemokines Expression in Renal Proximal Tubular Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; KAPPA-B; TISSUE INFLAMMATION; KIDNEY-DISEASE; TRANSREPRESSION; INJURY; MODEL; FACES; HK-2; MICE	Rosiglitazone (RGL), a synthetic agonist for peroxisome proliferator activated receptor gamma (PPAR gamma), exhibits a potent anti-inflammatory activity by attenuating local infiltration of neutrophils and monocytes in the renal interstitium. To evaluate the mechanisms that account for inhibiting inflammatory cells infiltration, we investigated the effect of RGL on chemokines secretion and nuclear factor-kappa B (NF-kappa B) activation in human renal proximal tubular cells (PTCs). We demonstrated that RGL significantly inhibited lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) production in a dose-dependent manner, without appreciable cytotoxicity. Chromatin immunoprecipitation (ChIP) assays clearly revealed that, RGL inhibited p65 binding to IL-8/MCP-1 gene promoters in LPS-stimulated PTCs. Interestingly, further experiments showed RGL reversed LPS-induced nuclear receptor corepressor (NCoR) degradation. In addition, knockdown of protein inhibitor of activated STAT1 (PIAS1), an indispensable small ubiquitin-like modifier (SUMO) ligase, abrogated the effects of RGL on antagonizing LPS-induced IL-8/MCP-1 overexpression and NCoR degradation. These findings suggest that, RGL activates PPAR. SUMOylation, inhibiting NCoR degradation and NF-kappa B activation in LPS-stimulated PTCs, which in turn decrease chemokines expression. The results unveil a new mechanism triggered by RGL for prevention of tubular inflammatory injury.	[Lu, Ying; Zhou, Qiao; Liu, Jian; Zhong, Fang; Hao, Xu; Li, Cong; Chen, Nan; Wang, Weiming] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Nephrol, Shanghai 200030, Peoples R China; [Lu, Ying; Shi, Yongbing] Soochow Univ, Affiliated Hosp 2, Dept Nephrol, Suzhou, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Wang, WM (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Nephrol, Shanghai 200030, Peoples R China.	wweiming@medmail.com.cn			National Nature Science Foundation of China [30270613, 30771000]; Shanghai Science and Technology Commission [08dz1900502]; Shanghai Leading Academic Discipline Project, China [T0201]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project, China(Shanghai Leading Academic Discipline Project)	This work was supported by the grants from the National Nature Science Foundation of China (30270613 and 30771000), Leading projects of Shanghai Science and Technology Commission (08dz1900502) and Shanghai Leading Academic Discipline Project (T0201), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2006, KIDNEY INT, V69, P29, DOI 10.1038/sj.ki.5000053; Bae EH, 2010, HYPERTENS RES, V33, P255, DOI 10.1038/hr.2009.217; Banba N, 2000, KIDNEY INT, V58, P684, DOI 10.1046/j.1523-1755.2000.00214.x; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; Efrati S, 2008, AM J NEPHROL, V28, P238, DOI 10.1159/000110681; Efrati S, 2009, NEPHROLOGY, V14, P189, DOI 10.1111/j.1440-1797.2008.01032.x; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; Lee S, 2006, NEPHROL DIAL TRANSPL, V21, P2096, DOI 10.1093/ndt/gfl194; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Nareika A, 2005, AM J PHYSIOL-ENDOC M, V289, pE534, DOI 10.1152/ajpendo.00462.2004; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Panzer U, 2006, CURR DRUG TARGETS, V7, P65, DOI 10.2174/138945006775270213; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Renga B, 2011, INFLAMM RES, V60, P577, DOI 10.1007/s00011-010-0306-1; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; Wang WM, 2011, AM J NEPHROL, V34, P152, DOI 10.1159/000329120; Yoshihara D, 2011, AM J PHYSIOL-RENAL, V300, pF465, DOI 10.1152/ajprenal.00460.2010; Zhang YJ, 2006, AM J NEPHROL, V26, P356, DOI 10.1159/000094735	22	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79815	10.1371/journal.pone.0079815	http://dx.doi.org/10.1371/journal.pone.0079815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260304	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200088
J	Olsen, NJ; Pedersen, J; Handel, MN; Stougaard, M; Mortensen, EL; Heitmann, BL				Olsen, Nanna J.; Pedersen, Jeanett; Handel, Mina N.; Stougaard, Maria; Mortensen, Erik L.; Heitmann, Berit L.			Child Behavioural Problems and Body Size among 2-6 Year Old Children Predisposed to Overweight. Results From the "Healthy Start" Study	PLOS ONE			English	Article							HPA-AXIS ACTIVITY; PARENTAL STRESS; BIRTH-WEIGHT; DIFFICULTIES QUESTIONNAIRE; SOCIOECONOMIC-STATUS; OBESITY; ASSOCIATION; STABILITY; STRENGTHS; SYMPTOMS	Objective: Psychological adversities among young children may be associated with childhood overweight and obesity. We examined if an increased level of child behavioural problems was associated with body size among a selected group of 2-6 year old children, who were all predisposed to develop overweight. Methods: Cross-sectional analyses were conducted using baseline data from the "Healthy Start" intervention study. A total of 3058 children were invited to participate, and data from 583 children who were all predisposed for obesity was analyzed. The Danish version of the Strengths and Difficulties Questionnaire (SDQ) was used to assess child stress by the SDQ Total Difficulties (SDQ-TD) score and the Prosocial Behavior (PSB) score. Height and weight were measured, and BMI z-scores were calculated. Results: A direct, but non-significant linear trend was found between SDQ-TD score and BMI z-score (beta = 0.021, p = 0.11). Having an SDQ-TD score above the 90th percentile was associated with BMI z-score (beta = 0.36, p = 0.05). PSB score was not associated with BMI z-score. Analyses were adjusted for parental socioeconomic status, parental BMI, family structure, dietary factors, physical activity, and family stress level. Conclusion: The results suggested a threshold effect between SDQ-TD score and BMI z-score, where BMI z-score was associated with childhood behavioural problems only for those with the highest scores of SDQ-TD. No significant association between PSB score and BMI z-score was found.	[Olsen, Nanna J.; Pedersen, Jeanett; Handel, Mina N.; Stougaard, Maria; Heitmann, Berit L.] Bispebjerg Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-2400 Copenhagen, Denmark; [Olsen, Nanna J.; Pedersen, Jeanett; Handel, Mina N.; Stougaard, Maria; Heitmann, Berit L.] Frederiksberg Univ Hosp, Inst Prevent Med, Res Unit Dietary Studies, Copenhagen, Denmark; [Olsen, Nanna J.] Univ Copenhagen, Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Sydney, Sydney Med Sch, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Heitmann, Berit L.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Sydney; University of Southern Denmark	Olsen, NJ (corresponding author), Bispebjerg Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-2400 Copenhagen, Denmark.	nanna.julie.olsen@regionh.dk	Olsen, Nanna Julie/G-6723-2016; Handel, Mina Nicole/G-4591-2016	Rohde, Jeanett Friis/0000-0002-9300-9009; Handel, Mina Nicole/0000-0001-8256-8756; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Olsen, Nanna Julie/0000-0001-5765-3000; Stougaard, Maria/0000-0002-5573-4971; Mortensen, Erik Lykke/0000-0002-6985-451X	TrygFoundation [7984-07]; Danish Medical Research Councel [271-07-0281]; Health Foundation [2008B101]	TrygFoundation; Danish Medical Research Councel; Health Foundation	Funding provided by the TrygFoundation (http://trygfonden.dk/Om-TrygFonden/In-English), grant number 7984-07, the Danish Medical Research Councel (http://www.fi.dk/raad-og-udvalg/det-frie-forskningsraad/om-dff/faglige-raad/sundhed-og-sygdom), grant number 271-07-0281 and the Health Foundation (http://helsefonden.dk/pages.asp?id=63), grant number 2008B101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Danielzik S, 2004, INT J OBESITY, V28, P1494, DOI 10.1038/sj.ijo.0802756; Drukker M, 2009, INT J PEDIATR OBES, V4, P91, DOI 10.1080/17477160802395442; Engell Rikke, 2007, Ugeskr Laeger, V169, P311; Garthus-Niegel S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-626; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gundersen C, 2011, OBES REV, V12, pe54, DOI 10.1111/j.1467-789X.2010.00813.x; Hatzinger M, 2007, J PSYCHIATR RES, V41, P861, DOI 10.1016/j.jpsychires.2006.07.012; JENNIFER J, 2008, RUTTERS CHILD ADOLES; Krantz G, 2005, EUR J PUBLIC HEALTH, V15, P209, DOI 10.1093/eurpub/cki079; Marsman R, 2008, PSYCHONEUROENDOCRINO, V33, P789, DOI 10.1016/j.psyneuen.2008.03.005; Newell Astrid, 2007, Prev Chronic Dis, V4, pA31; Niclasen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032025; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Obel C, 2004, EUR CHILD ADOLES PSY, V13, P32, DOI 10.1007/s00787-004-2006-2; Olsen NJ, 2012, CURR OBES REP, V1, DOI 10.1007/s13679-011-0004-5; Olsen NJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-590; Ostberg M, 1998, ACTA PAEDIATR, V87, P69, DOI 10.1080/08035259850157903; Ostberg M, 1997, SCAND J PSYCHOL, V38, P199, DOI 10.1111/1467-9450.00028; Ouellet-Morin I, 2011, BIOL PSYCHIAT, V70, P1016, DOI 10.1016/j.biopsych.2011.06.017; Pitrou I, 2010, OBESITY, V18, P809, DOI 10.1038/oby.2009.278; Puder JJ, 2010, INT J OBESITY, V34, pS37, DOI 10.1038/ijo.2010.238; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Ruttle PL, 2011, HORM BEHAV, V59, P123, DOI 10.1016/j.yhbeh.2010.10.015; Sawyer MG, 2006, AMBUL PEDIATR, V6, P306, DOI 10.1016/j.ambp.2006.08.005; Sawyer MG, 2011, PEDIATRICS, V128, P677, DOI 10.1542/peds.2010-3132; Sondeijker FEPL, 2007, J PSYCHIATR RES, V41, P570, DOI 10.1016/j.jpsychires.2006.04.002; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Tiffin Paul A, 2011, Child Adolesc Psychiatry Ment Health, V5, P31, DOI 10.1186/1753-2000-5-31; Tommiska V, 2002, ARCH DIS CHILD-FETAL, V86, P161, DOI 10.1136/fn.86.3.F161; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Tyrka AR, 2010, PSYCHONEUROENDOCRINO, V35, P1167, DOI 10.1016/j.psyneuen.2010.02.002; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; van Egmond-Frohlich AWA, 2012, INT J OBESITY, V36, P963, DOI 10.1038/ijo.2012.78; VANAELST B, 2013, INT J BEHAV MED, P77786; von Stumm S, 2011, J CHILD PSYCHOL PSYC, V52, P992, DOI 10.1111/j.1469-7610.2011.02373.x	37	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78974	10.1371/journal.pone.0078974	http://dx.doi.org/10.1371/journal.pone.0078974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255CG	24250821	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200054
J	Xiao, FX; Kim, YC; Wen, HX; Luo, JT; Chen, PX; Cowan, K; Wang, SM				Xiao, Fengxia; Kim, Yeong C.; Wen, Hongxiu; Luo, Jiangtao; Chen, Peixian; Cowan, Kenneth; Wang, San Ming			The Genome of Polymorphonuclear Neutrophils Maintains Normal Coding Sequences	PLOS ONE			English	Article							CANCER; MUTATIONS; MEDULLOBLASTOMA	Genetic studies often use genomic DNA from whole blood cells, of which the majority are the polymorphonuclear myeloid cells. Those cells undergo dramatic change of nuclear morphology following cellular differentiation. It remains elusive if the nuclear morphological change accompanies sequence alternations from the intact genome. If such event exists, it will cause a serious problem in using such type of genomic DNA for genetic study as the sequences will not represent the intact genome in the host individuals. Using exome sequencing, we compared the coding regions between neutrophil, which is the major type of polymorphonuclear cells, and CD4+ T cell, which has an intact genome, from the same individual. The results show that exon sequences between the two cell types are essentially the same. The minor differences represented by the missed exons and base changes between the two cell types were validated to be mainly caused by experimental errors. Our study concludes that genomic DNA from whole blood cells can be safely used for genetic studies.	[Xiao, Fengxia; Kim, Yeong C.; Wen, Hongxiu; Wang, San Ming] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Chen, Peixian] Univ Nebraska Med Ctr, Coll Med, Dept Med, Omaha, NE USA; [Luo, Jiangtao] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Cowan, Kenneth] Univ Nebraska Med Ctr, Fred & Pamela Buffet Canc Ctr, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, SM (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	sanming.wang@unmc.edu	, san ming wang/ABG-4910-2020		NATIONAL CANCER INSTITUTE [R21CA180008] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA180008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Casella G., 2002, STAT INFERENCE, V2nd; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; ORD DC, 1990, J BIOL CHEM, V265, P7760; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Thomas PS, 1995, BLOOD PRINCIPLES PRA; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023	17	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78685	10.1371/journal.pone.0078685	http://dx.doi.org/10.1371/journal.pone.0078685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250807	Green Submitted, gold, Green Published			2022-12-25	WOS:000327216200040
J	Yumoto, T; Nakadate, K; Nakamura, Y; Sugitani, Y; Sugitani-Yoshida, R; Ueda, S; Sakakibara, S				Yumoto, Takahito; Nakadate, Kazuhiko; Nakamura, Yuki; Sugitani, Yoshinobu; Sugitani-Yoshida, Reiko; Ueda, Shuichi; Sakakibara, Shin-ichi			Radmis, a Novel Mitotic Spindle Protein that Functions in Cell Division of Neural Progenitors	PLOS ONE			English	Article							RADIAL GLIA; STEM-CELLS; VENTRICULAR ZONE; PRECURSOR CELLS; KEN BOX; EXPRESSION; NEURONS; IDENTIFICATION; BINDING; DIFFERENTIATION	Developmental dynamics of neural stem/progenitor cells (NSPCs) are crucial for embryonic and adult neurogenesis, but its regulatory factors are not fully understood. By differential subtractive screening with NSPCs versus their differentiated progenies, we identified the radmis (radial fiber and mitotic spindle)/ckap2l gene, a novel microtubule-associated protein (MAP) enriched in NSPCs. Radmis is a putative substrate for the E3-ubiquitin ligase, anaphase promoting complex/cyclosome (APC/C), and is degraded via the KEN box. Radmis was highly expressed in regions of active neurogenesis throughout life, and its distribution was dynamically regulated during NSPC division. In embryonic and perinatal brains, radmis localized to bipolar mitotic spindles and radial fibers (basal processes) of dividing NSPCs. As central nervous system development proceeded, radmis expression was lost in most brain regions, except for several neurogenic regions. In adult brain, radmis expression persisted in the mitotic spindles of both slowly-dividing stem cells and rapid amplifying progenitors. Overexpression of radmis in vitro induced hyperstabilization of microtubules, severe defects in mitotic spindle formation, and mitotic arrest. In vivo gain-of-function using in utero electroporation revealed that radmis directed a reduction in NSPC proliferation and a concomitant increase in cell cycle exit, causing a reduction in the Tbr2-positive basal progenitor population and shrinkage of the embryonic subventricular zone. Besides, radmis loss-of-function by shRNAs induced the multipolar mitotic spindle structure, accompanied with the catastrophe of chromosome segregation including the long chromosome bridge between two separating daughter nuclei. These findings uncover the indispensable role of radmis in mitotic spindle formation and cell-cycle progression of NSPCs.	[Yumoto, Takahito; Nakamura, Yuki; Sakakibara, Shin-ichi] Waseda Univ, Grad Sch Human Sci, Mol Neurobiol Lab, Tokorozawa, Saitama, Japan; [Nakadate, Kazuhiko] Meiji Pharmaceut Univ, Educ & Res Ctr Pharm, Dept Basic Biol, Kiyose, Tokyo, Japan; [Sugitani, Yoshinobu] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Koto Ku, Tokyo 170, Japan; [Sugitani, Yoshinobu; Sugitani-Yoshida, Reiko] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Sugitani-Yoshida, Reiko] Natl Ctr Global Hlth & Med, Res Inst, Dept Mol Immunol & Inflammat, Shinjuku Ku, Tokyo, Japan; [Ueda, Shuichi] Dokkyo Med Univ, Grad Sch Med, Dept Histol & Neurobiol, Mibu, Tochigi, Japan; [Sakakibara, Shin-ichi] Waseda Univ, Inst Appl Brain Sci, Tokorozawa, Saitama, Japan	Waseda University; Meiji Pharmaceutical University; Japanese Foundation for Cancer Research; RIKEN; National Center for Global Health & Medicine - Japan; Dokkyo Medical University; Waseda University	Sakakibara, S (corresponding author), Waseda Univ, Grad Sch Human Sci, Mol Neurobiol Lab, Tokorozawa, Saitama, Japan.	sakakiba@waseda.jp		Sakakibara, Shin-ichi/0000-0001-8983-2249	JSPS KAKENHI [20590196, 17590173]; Waseda University [2011B-260]; MEXT KIBANKEISEI	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Waseda University; MEXT KIBANKEISEI	This work was supported by JSPS KAKENHI to SS (Grant numbers 20590196 and 17590173) and partially by a Waseda University Grant for Special Research Projects (Grant number 2011B-260) and MEXT KIBANKEISEI (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 2009, CELL RES, V19, P1324, DOI 10.1038/cr.2009.119; ALTMAN J, 1972, J COMP NEUROL, V146, P355, DOI 10.1002/cne.901460305; Bae CD, 2003, J CANCER RES CLIN, V129, P621, DOI 10.1007/s00432-003-0484-0; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Diatchenko L, 1999, METHOD ENZYMOL, V303, P349; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Hodge RD, 2013, J NEUROSCI, V33, P4165, DOI 10.1523/JNEUROSCI.4185-12.2013; Holmfeldt P, 2003, J CELL SCI, V116, P3701, DOI 10.1242/jcs.00685; Hong KU, 2007, MOL CELL BIOL, V27, P3667, DOI 10.1128/MCB.01386-06; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jin Y, 2004, CANCER SCI, V95, P815, DOI 10.1111/j.1349-7006.2004.tb02187.x; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Koirala S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009198; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; KUHAR SG, 1993, DEVELOPMENT, V117, P97; Kuninger D, 2004, GENOMICS, V84, P876, DOI 10.1016/j.ygeno.2004.07.013; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Maouche-Chretien L, 1998, ONCOGENE, V17, P1245, DOI 10.1038/sj.onc.1202048; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Pfleger CM, 2000, GENE DEV, V14, P655; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sakakibara S, 2008, J COMP NEUROL, V511, P65, DOI 10.1002/cne.21817; Samora CP, 2011, NAT CELL BIOL, V13, P1040, DOI 10.1038/ncb2297; Seki A, 2007, J BIOL CHEM, V282, P15103, DOI 10.1074/jbc.M701688200; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Sild M, 2011, NEUROSCIENTIST, V17, P288, DOI 10.1177/1073858410385870; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Takahashi T, 1999, J NEUROSCI, V19, P10357; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026	58	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79895	10.1371/journal.pone.0079895	http://dx.doi.org/10.1371/journal.pone.0079895			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260314	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200094
J	Chung, H; Ramachandran, R; Hollenberg, MD; Muruve, DA				Chung, Hyunjae; Ramachandran, Rithwik; Hollenberg, Morley D.; Muruve, Daniel A.			Proteinase-activated Receptor-2 Transactivation of Epidermal Growth Factor Receptor and Transforming Growth Factor-beta Receptor Signaling Pathways Contributes to Renal Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Fibrosis; Kidney; Receptors; Transforming Growth Factor (TGF); PAR2	ACUTE KIDNEY INJURY; MAST-CELL TRYPTASE; URINARY TRYPSIN-INHIBITOR; TUBULE EPITHELIAL-CELLS; TGF-BETA; CAMOSTAT MESILATE; INTESTINAL INFLAMMATION; INTERSTITIAL FIBROSIS; PROTEASE INHIBITOR; BLOOD-PRESSURE	Chronic kidney diseases cause significant morbidity and mortality in the population. During renal injury, kidney-localized proteinases can signal by cleaving and activating proteinase-activated receptor-2 (PAR2), a G-protein-coupled receptor involved in inflammation and fibrosis that is highly expressed in renal tubular cells. Following unilateral ureteric obstruction, PAR2-deficient mice displayed reduced renal tubular injury, fibrosis, collagen synthesis, connective tissue growth factor (CTGF), and -smooth muscle actin gene expression at 7 days, compared with wild-type controls. In human proximal tubular epithelial cells in vitro, PAR2 stimulation with PAR2-activating peptide (PAR2-AP) alone significantly up-regulated the expression of CTGF, a potent profibrotic cytokine. The induction of CTGF by PAR2-AP was synergistically increased when combined with transforming growth factor- (TGF-). Consistent with these findings, treating human proximal tubular epithelial cells with PAR2-AP induced Smad2/3 phosphorylation in the canonical TGF- signaling pathway. The Smad2 phosphorylation and CTGF induction required signaling via both the TGF-receptor and EGF receptor suggesting that PAR2 utilizes transactivation mechanisms to initiate fibrogenic signaling. Taken together, our data support the hypothesis that PAR2 synergizes with the TGF signaling pathway to contribute to renal injury and fibrosis.	[Chung, Hyunjae; Hollenberg, Morley D.; Muruve, Daniel A.] Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 4N1, Canada; [Ramachandran, Rithwik; Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Muruve, DA (corresponding author), Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 4N1, Canada.	dmuruve@ucalgary.ca	Ramachandran, Rithwik/N-7815-2015; Hollenberg, Morley/AFV-6966-2022	Ramachandran, Rithwik/0000-0001-9557-9905; 	Canadian Institutes of Health Research (CIHR); University of Alberta; Snyder Institute for Chronic Diseases Live Cell Imaging Facility; Canadian Foundation Innovation (CFI); Alberta Science and Research Authority	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Alberta(University of Alberta); Snyder Institute for Chronic Diseases Live Cell Imaging Facility; Canadian Foundation Innovation (CFI)(Canada Foundation for Innovation); Alberta Science and Research Authority	This work was supported by Operating Grants from the Canadian Institutes of Health Research (CIHR), an Emerging Team Grant from the University of Alberta, and by the Snyder Institute for Chronic Diseases Live Cell Imaging Facility funded by an equipment and infrastructure grant from the Canadian Foundation Innovation (CFI) and the Alberta Science and Research Authority.	Al-Ani B, 1999, J PHARMACOL EXP THER, V290, P753; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Burch ML, 2010, J BIOL CHEM, V285, P26798, DOI 10.1074/jbc.M109.092767; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; Gore-Hyer E, 2002, AM J PHYSIOL-RENAL, V283, pF707, DOI 10.1152/ajprenal.00007.2002; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Gui Y, 2003, AM J PHYSIOL-RENAL, V285, pF95, DOI 10.1152/ajprenal.00396.2002; Hao JM, 2000, AM J PHYSIOL-HEART C, V279, pH3020, DOI 10.1152/ajpheart.2000.279.6.H3020; Hyun E, 2008, GUT, V57, P1222, DOI 10.1136/gut.2008.150722; Ishikura H, 2007, LIFE SCI, V80, P1999, DOI 10.1016/j.lfs.2007.02.044; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Katoh H, 2010, J RADIAT RES, V51, P325, DOI 10.1269/jrr.09108; Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784; Kondo S, 2001, J AM SOC NEPHROL, V12, P1668, DOI 10.1681/ASN.V1281668; Kono T, 2011, EXP BIOL MED, V236, P1314, DOI 10.1258/ebm.2011.011173; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Liu H, 2010, INFLAMM RES, V59, P551, DOI 10.1007/s00011-010-0159-7; Maekawa A, 2009, J HYPERTENS, V27, P181, DOI 10.1097/HJH.0b013e328317a762; Morinaga J, 2013, AM J PHYSIOL-RENAL, V305, pF173, DOI 10.1152/ajprenal.00586.2012; Morla L, 2013, J BIOL CHEM, V288, P10124, DOI 10.1074/jbc.M112.446393; Murray DB, 2012, J CELL COMMUN SIGNAL, V6, P45, DOI 10.1007/s12079-011-0146-y; Okuno M, 2001, GASTROENTEROLOGY, V120, P1784, DOI 10.1053/gast.2001.24832; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; Su X, 2009, ANAT REC, V292, P580, DOI 10.1002/ar.20846; Tang JH, 2013, AM J PATHOL, V183, P160, DOI 10.1016/j.ajpath.2013.04.005; Vesey DA, 2007, AM J PHYSIOL-RENAL, V293, pF1441, DOI 10.1152/ajprenal.00088.2007; White LR, 2007, AM J PHYSIOL-RENAL, V292, pF567, DOI 10.1152/ajprenal.00212.2006; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Xiong Jing, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P523; Yu Q, 2000, GENE DEV, V14, P163; Zhang C, 2004, CELL BIOL INT, V28, P863, DOI 10.1016/j.cellbi.2004.09.003; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103	51	68	75	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37319	37331		10.1074/jbc.M113.492793	http://dx.doi.org/10.1074/jbc.M113.492793			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24253040	hybrid, Green Published			2022-12-25	WOS:000329189700048
J	de Melo, NR; Abdrahman, A; Greig, C; Mukherjee, K; Thornton, C; Ratcliffe, NA; Vilcinskas, A; Butt, TM				de Melo, Nadja Rodrigues; Abdrahman, Ahmed; Greig, Carolyn; Mukherjee, Krishnendu; Thornton, Catherine; Ratcliffe, Norman A.; Vilcinskas, Andreas; Butt, Tariq M.			Myriocin Significantly Increases the Mortality of a Non-Mammalian Model Host during Candida Pathogenesis	PLOS ONE			English	Article							GALLERIA-MELLONELLA LARVAE; LIPID-PEROXIDATION; ALBICANS MUTANTS; WAX MOTH; VIRULENCE; LEPIDOPTERA; HSP90; MICE; CYCLOSPORINE; METABOLISM	Candida albicans is a major human pathogen whose treatment is challenging due to antifungal drug toxicity, drug resistance and paucity of antifungal agents available. Myrocin (MYR) inhibits sphingosine synthesis, a precursor of sphingolipids, an important cell membrane and signaling molecule component. MYR also has dual immune suppressive and antifungal properties, potentially modulating mammalian immunity and simultaneously reducing fungal infection risk. Wax moth (Galleria mellonella) larvae, alternatives to mice, were used to establish if MYR suppressed insect immunity and increased survival of C. albicans-infected insects. MYR effects were studied in vivo and in vitro, and compared alone and combined with those of approved antifungal drugs, fluconazole (FLC) and amphotericin B (AMPH). Insect immune defenses failed to inhibit C. albicans with high mortalities. In insects pretreated with the drug followed by C. albicans inoculation, MYR+C. albicans significantly increased mortality to 93% from 67% with C. albicans alone 48 h post-infection whilst AMPH+C. albicans and FLC+C. albicans only showed 26% and 0% mortalities, respectively. MYR combinations with other antifungal drugs in vivo also enhanced larval mortalities, contrasting the synergistic antifungal effect of the MYR+AMPH combination in vitro. MYR treatment influenced immunity and stress management gene expression during C. albicans pathogenesis, modulating transcripts putatively associated with signal transduction/regulation of cytokines, I-kappaB kinase/NF-kappaB cascade, G-protein coupled receptor and inflammation. In contrast, all stress management gene expression was down-regulated in FLC and AMPH pretreated C. albicans - infected insects. Results are discussed with their implications for clinical use of MYR to treat sphingolipid-associated disorders.	[de Melo, Nadja Rodrigues; Thornton, Catherine] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Abdrahman, Ahmed; Greig, Carolyn; Ratcliffe, Norman A.; Butt, Tariq M.] Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales; [Mukherjee, Krishnendu; Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Angew Zool, Abt Angew Entomol, Giessen, Germany; [Ratcliffe, Norman A.] Univ Fed Fluminense, Dept Biol Sci, Rio De Janeiro, Brazil	Swansea University; Swansea University; Justus Liebig University Giessen; Universidade Federal Fluminense	Butt, TM (corresponding author), Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales.	t.butt@swansea.ac.uk	Mukherjee, Krishnendu/A-8186-2011; Mukherjee, Krishnendu/U-7159-2017	Mukherjee, Krishnendu/0000-0003-3470-9117; Butt, Tariq/0000-0002-8789-9543	DFG [VI 219/3-1]; DFG [VI 219/3-1]	DFG(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	KM and AV were funded by the DFG Priority Program 1399 "Host-Parasite-Coevolution - rapid reciprocal adaptation and its genetic basis" to AV (VI 219/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2010, ACTA TROP, V113, P1, DOI 10.1016/j.actatropica.2009.08.022; ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chiba K, 1996, TRANSPLANT P, V28, P1056; Contreras FX, 2006, BIOPHYS J, V90, P4085, DOI 10.1529/biophysj.105.076471; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; Desbois AP, 2011, J ANTIMICROB CHEMOTH, V66, P1785, DOI 10.1093/jac/dkr198; Dubovskiy IM, 2008, COMP BIOCHEM PHYS C, V148, P1, DOI 10.1016/j.cbpc.2008.02.003; Dubovskiy IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060248; Dunphy GB, 2003, CAN J MICROBIOL, V49, P514, DOI 10.1139/W03-064; Filler SG, 2012, CYTOKINE, V58, P129, DOI 10.1016/j.cyto.2011.09.018; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Glaros EN, 2008, J LIPID RES, V49, P324, DOI 10.1194/jlr.M700261-JLR200; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hannich JT, COLD SPRING HARB PER, V3; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jiang XC, 2011, ADV EXP MED BIOL, V721, P19, DOI 10.1007/978-1-4614-0650-1_2; KLUEPFEL D, 1972, J ANTIBIOT, V25, P109, DOI 10.7164/antibiotics.25.109; Lee YS, 2012, CANCER BIOL THER, V13, P92, DOI 10.4161/cbt.13.2.18870; Lilic D, 2012, CURR OPIN MICROBIOL, V15, P420, DOI 10.1016/j.mib.2012.06.003; Lionakis MS, 2011, VIRULENCE, V2, P521, DOI 10.4161/viru.2.6.18520; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; Melo NR, 2009, MED MYCOL, V47, P149, DOI 10.1080/13693780802195315; Morgan Juliette, 2005, Curr Infect Dis Rep, V7, P429, DOI 10.1007/s11908-005-0044-7; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; NCCLS, 2008, M27A3 NCCLS, V67, P2982; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Rael LT, 2004, J BIOCHEM MOL BIOL, V37, P749; RATCLIFFE NA, 1977, TISSUE CELL, V9, P73, DOI 10.1016/0040-8166(77)90050-7; Rowan R, 2009, BIOMETALS, V22, P461, DOI 10.1007/s10534-008-9182-3; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Staheli JR, 2011, METHODS MOL BIOL, V687, P57, DOI 10.1007/978-1-60761-944-4_5; Strader CR, 2011, J NAT PROD, V74, P900, DOI 10.1021/np2000528; Strettoi E, 2010, P NATL ACAD SCI USA, V107, P18706, DOI 10.1073/pnas.1007644107; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tortorano AM, 2006, INT J ANTIMICROB AG, V27, P359, DOI 10.1016/j.ijantimicag.2006.01.002; Vilcinskas A, 1999, COMP BIOCHEM PHYS C, V122, P83, DOI 10.1016/S0742-8413(98)10082-8; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Xu PJ, 2011, EUR J ENTOMOL, V108, P164, DOI 10.14411/eje.2011.020	45	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e78905	10.1371/journal.pone.0078905	http://dx.doi.org/10.1371/journal.pone.0078905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260135	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600010
J	Zakrzewski, SS; Richter, JF; Krug, SM; Jebautzke, B; Lee, IFM; Rieger, J; Sachtleben, M; Bondzio, A; Schulzke, JD; Fromm, M; Gunzel, D				Zakrzewski, Silke S.; Richter, Jan F.; Krug, Susanne M.; Jebautzke, Britta; Lee, In-Fah M.; Rieger, Juliane; Sachtleben, Monika; Bondzio, Angelika; Schulzke, Joerg D.; Fromm, Michael; Guenzel, Dorothee			Improved Cell Line IPEC-J2, Characterized as a Model for Porcine Jejunal Epithelium	PLOS ONE			English	Article							IN-VITRO; TIGHT JUNCTIONS; SMALL-INTESTINE; BARRIER; EXPRESSION; VIMENTIN; PERMEABILITY; DISRUPTION; RESISTANCE; APOPTOSIS	Cell lines matching the source epithelium are indispensable for investigating porcine intestinal transport and barrier properties on a subcellular or molecular level and furthermore help to reduce animal usage. The porcine jejunal cell line IPEC-J2 is established as an in vitro model for porcine infection studies but exhibits atypically high transepithelial resistances (TER) and only low active transport rates so that the effect of nutritional factors cannot be reliably investigated. This study aimed to properly remodel IPEC-J2 and then to re-characterize these cells regarding epithelial architecture, expression of barrier-relevant tight junction (TJ) proteins, adequate TER and transport function, and reaction to secretagogues. For this, IPEC-J2 monolayers were cultured on permeable supports, either under conventional (fetal bovine serum, FBS) or species-specific (porcine serum, PS) conditions. Porcine jejunal mucosa was analyzed for comparison. Main results were that under PS conditions (IPEC-J2/PS), compared to conventional FBS culture (IPEC-J2/FBS), the cell height increased 6-fold while the cell diameter was reduced by 50%. The apical cell membrane of IPEC-J2/PS exhibited typical microvilli. Most importantly, PS caused a one order of magnitude reduction of TER and of trans-and paracellular resistance, and a 2-fold increase in secretory response to forskolin when compared to FBS condition. TJ ultrastructure and appearance of TJ proteins changed dramatically in IPEC-J2/PS. Most parameters measured under PS conditions were much closer to those of typical pig jejunocytes than ever reported since the cell line's initial establishment in 1989. In conclusion, IPEC-J2, if cultured under defined species-specific conditions, forms a suitable model for investigating porcine paracellular intestinal barrier function.	[Zakrzewski, Silke S.; Richter, Jan F.; Krug, Susanne M.; Lee, In-Fah M.; Fromm, Michael; Guenzel, Dorothee] Charite, Inst Clin Physiol, D-13353 Berlin, Germany; [Jebautzke, Britta; Schulzke, Joerg D.] Charite, Dept Gastroenterol, Div Nutr Med, D-13353 Berlin, Germany; [Rieger, Juliane; Sachtleben, Monika] Free Univ Berlin, Inst Vet Anat, Berlin, Germany; [Bondzio, Angelika] Free Univ Berlin, Inst Vet Biochem, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Free University of Berlin	Gunzel, D (corresponding author), Charite, Inst Clin Physiol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	dorothee.guenzel@charite.de	Krug, Susanne M/AAY-6221-2020; Rieger, Juliane/G-8878-2015; Fromm, Michael/K-6203-2013	Krug, Susanne M/0000-0002-1293-2484; Rieger, Juliane/0000-0003-1659-9460; Fromm, Michael/0000-0003-4497-7983; Gunzel, Dorothee/0000-0002-7998-7164	Deutsche Forschungsgemeinschaft (DFG, Collaborative Research Center) [SFB 852/1]; Sonnenfeld-Stiftung Berlin	Deutsche Forschungsgemeinschaft (DFG, Collaborative Research Center)(German Research Foundation (DFG)); Sonnenfeld-Stiftung Berlin	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, Collaborative Research Center (SFB 852/1) "Nutrition and Intestinal Microbiota - Host interactions in the pig"; http://www.dfg.de/en/) and by the Sonnenfeld-Stiftung Berlin (http://www.sonnenfeld-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; BENZEEV A, 1984, J CELL BIOL, V99, P1424, DOI 10.1083/jcb.99.4.1424; BERSCHNEIDER HM, 1989, ANN M AM GASTR ASS; Botic T, 2007, INT J FOOD MICROBIOL, V115, P227, DOI 10.1016/j.ijfoodmicro.2006.10.044; Chapman JC, 2012, PEDIATR RES, V72, P576, DOI 10.1038/pr.2012.137; CLAUDE P, 1978, J MEMBRANE BIOL, V39, P219, DOI 10.1007/BF01870332; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Flynn AN, 2008, MICROB PATHOGENESIS, V45, P98, DOI 10.1016/j.micpath.2007.12.004; FROMM M, 1985, J MEMBRANE BIOL, V87, P141, DOI 10.1007/BF01870660; Geens MM, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/469583; Gitter AH, 1997, J BIOCHEM BIOPH METH, V35, P81, DOI 10.1016/S0165-022X(97)00028-6; Goossens J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-245; Grainger CI, 2006, PHARM RES, V23, P1482, DOI 10.1007/s11095-006-0255-0; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Gunzel D, 2012, COMPR PHYSIOL, V2, P1819, DOI 10.1002/cphy.c110045; Gunzel D, 2012, ANN NY ACAD SCI, V1257, P142, DOI 10.1111/j.1749-6632.2012.06540.x; Gunzel D, 2010, CURR TOP MEMBR, V65, P39, DOI 10.1016/S1063-5823(10)65003-X; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Klingspor S, 2013, J ANIM SCI, V91, P1707, DOI 10.2527/jas.2012-5648; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Krug SM, 2009, BIOPHYS J, V97, P2202, DOI 10.1016/j.bpj.2009.08.003; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; Loiseau N, 2007, BIOCHEM PHARMACOL, V74, P144, DOI 10.1016/j.bcp.2007.03.031; MA TY, 1992, J LAB CLIN MED, V120, P329; Markov AG, 2010, J COMP PHYSIOL B, V180, P591, DOI 10.1007/s00360-009-0440-7; MORK C, 1990, DIFFERENTIATION, V43, P146; Mulisch M, 2010, ROMEIS MIKROSKOPISCH; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Nossol C, 2011, HISTOCHEM CELL BIOL, V136, P103, DOI 10.1007/s00418-011-0826-y; Petto C, 2011, CELLS TISSUES ORGANS, V194, P457, DOI 10.1159/000323916; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rasschaert K, 2010, VET IMMUNOL IMMUNOP, V137, P243, DOI 10.1016/j.vetimm.2010.05.016; Richter JF, 2013, BR J NUTR IN PRESS; Rusu D, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-42; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062913; SCHULTZ SG, 1972, J GEN PHYSIOL, V59, P794, DOI 10.1085/jgp.59.6.794; STEVENSON BR, 1988, J CELL BIOL, V107, P2401, DOI 10.1083/jcb.107.6.2401; Stumpff F, 2011, J EXP BIOL, V214, P2871, DOI 10.1242/jeb.055582; Veldhuizen EJA, 2009, VET MICROBIOL, V136, P69, DOI 10.1016/j.vetmic.2008.09.072; Wiese F, 2003, ANAT HISTOL EMBRYOL, V32, P102, DOI 10.1046/j.1439-0264.2003.00430.x; Yin XH, 2009, APPL ENVIRON MICROB, V75, P4975, DOI 10.1128/AEM.00297-09; Zhang KeShan, 2012, African Journal of Biotechnology, V11, P12118	50	70	71	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79643	10.1371/journal.pone.0079643	http://dx.doi.org/10.1371/journal.pone.0079643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260272	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600042
J	Easson, CG; Slattery, M; Momm, HG; Olson, JB; Thacker, RW; Gochfeld, DJ				Easson, Cole G.; Slattery, Marc; Momm, Henrique G.; Olson, Julie B.; Thacker, Robert W.; Gochfeld, Deborah J.			Exploring Individual-to Population-Level Impacts of Disease on Coral Reef Sponges: Using Spatial Analysis to Assess the Fate, Dynamics, and Transmission of Aplysina Red Band Syndrome (ARBS)	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PHASE-SHIFTS; MORTALITY; PATTERNS; AUTOCORRELATION; ECOLOGY; DENSITY; CLIMATE	Background: Marine diseases are of increasing concern for coral reef ecosystems, but often their causes, dynamics and are unknown. The current study investigated the epidemiology of Aplysina Red Band Syndrome (ARBS), a disease affecting the Caribbean sponge Aplysina cauliformis, at both the individual and population levels. The fates of marked healthy and ARBS-infected sponges were examined over the course of a year. Population-level impacts and transmission mechanisms of ARBS were investigated by monitoring two populations of A. cauliformis over a three year period using digital photography and diver-collected data, and analyzing these data with GIS techniques of spatial analysis. In this study, three commonly used spatial statistics (Ripley's K, Getis-Ord General G, and Moran's Index) were compared to each other and with direct measurements of individual interactions using join-counts, to determine the ideal method for investigating disease dynamics and transmission mechanisms in this system. During the study period, Hurricane Irene directly impacted these populations, providing an opportunity to assess potential storm effects on A. cauliformis and ARBS. Results: Infection with ARBS caused increased loss of healthy sponge tissue over time and a higher likelihood of individual mortality. Hurricane Irene had a dramatic effect on A. cauliformis populations by greatly reducing sponge biomass on the reef, especially among diseased individuals. Spatial analysis showed that direct contact between A. cauliformis individuals was the likely transmission mechanism for ARBS within a population, evidenced by a significantly higher number of contact-joins between diseased sponges compared to random. Of the spatial statistics compared, the Moran's Index best represented true connections between diseased sponges in the survey area. This study showed that spatial analysis can be a powerful tool for investigating disease dynamics and transmission in a coral reef	[Easson, Cole G.; Slattery, Marc; Gochfeld, Deborah J.] Univ Mississippi, Environm Toxicol Res Program, University, MS 38677 USA; [Slattery, Marc; Gochfeld, Deborah J.] Univ Mississippi, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Slattery, Marc] Univ Mississippi, Dept Pharmacognosy, University, MS 38677 USA; [Momm, Henrique G.] Middle Tennessee State Univ, Dept Geosci, Murfreesboro, TN 37130 USA; [Olson, Julie B.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Thacker, Robert W.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA	University of Mississippi; University of Mississippi; University of Mississippi; Middle Tennessee State University; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Birmingham	Easson, CG (corresponding author), Univ Mississippi, Environm Toxicol Res Program, University, MS 38677 USA.	cgeasson@uab.edu	Momm, Henrique/C-7139-2013	Momm, Henrique/0000-0003-3775-7958	National Science Foundation [OCE-0727996, OCE-1214303]; National Institute of Underwater Science and Technology [NA16RU1496]; Directorate For Geosciences [1214303] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Underwater Science and Technology; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The work was supported by the following: National Science Foundation OCE-0727996; National Science Foundation OCE-1214303; and National Institute of Underwater Science and Technology NA16RU1496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; [Anonymous], 1988, STAT INFERENCE SPATI, DOI DOI 10.1017/CBO9780511624131; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 1997, J URBAN ECON, V42, P422, DOI 10.1006/juec.1997.2032; Anselin L, 2007, SOC INDIC RES, V82, P287, DOI 10.1007/s11205-006-9034-x; Aronson RB, 2004, ECOLOGY, V85, P1876, DOI 10.1890/03-0108; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Bailey T, 1995, INTERACTIVE SPATIAL; Ban SS, 2013, CORAL REEFS, V32, P1, DOI 10.1007/s00338-012-0944-6; Bolker B. M., 1995, P399, DOI 10.1017/CBO9780511629396.016; Boots B.N., 1988, POINT PATTERN ANAL; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; CARPENTER RC, 1990, MAR BIOL, V104, P67, DOI 10.1007/BF01313159; Ciminiello P, 1999, J NAT PROD, V62, P590, DOI 10.1021/np9805138; Cliff A. D., 1981, SPATIAL PROCESSES MO; Cole RG, 1999, J ECOL, V87, P963, DOI 10.1046/j.1365-2745.1999.00418.x; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Engel S, 2000, MAR ECOL PROG SER, V207, P273, DOI 10.3354/meps207273; Freeman CJ, 2013, ISME J, V7, P1116, DOI 10.1038/ismej.2013.7; Freeman CJ, 2011, LIMNOL OCEANOGR, V56, P1577, DOI 10.4319/lo.2011.56.5.1577; GAINO E, 1992, B ZOOL, V59, P79, DOI 10.1080/11250009209386652; Gardner B, 2008, CAN J FISH AQUAT SCI, V65, P2461, DOI 10.1139/F08-152; GETIS A, 1984, ENVIRON PLANN A, V16, P173, DOI 10.1068/a160173; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; Gochfeld DJ, 2012, MAR ECOL PROG SER, V456, P101, DOI 10.3354/meps09716; Gochfeld DJ, 2012, J CHEM ECOL, V38, P451, DOI 10.1007/s10886-012-0099-5; Goodchild M. F., 1986, SPATIAL AUTOCORRELAT; Griffith DA, 1987, A PRIMER; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jolles AE, 2002, ECOLOGY, V83, P2373, DOI 10.1890/0012-9658(2002)083[2373:DTOAIS]2.0.CO;2; LeDrew EF, 2004, REMOTE SENS ENVIRON, V91, P271, DOI 10.1016/j.rse.2003.10.007; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lentz JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021830; Lloyd C., 2010, SPATIAL DATA ANAL IN; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Mann ME, 2009, NATURE, V460, P880, DOI 10.1038/nature08219; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Mitchell A., 2005, ESRI GUIDE GIS ANAL; Moraes RM, 2005, PLANTA MED, V71, P1157, DOI 10.1055/s-2005-873166; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Olson J, FEMS MICROB IN PRESS; Olson JB, 2006, DIS AQUAT ORGAN, V71, P163, DOI 10.3354/dao071163; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Real LA, 1996, ECOLOGY, V77, P1011, DOI 10.2307/2265572; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; RODRIGUEZ AD, 1993, J NAT PROD, V56, P907, DOI 10.1021/np50096a014; Roff G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026829; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; RUTZLER K, 1988, DIS AQUAT ORGAN, V5, P143, DOI 10.3354/dao005143; Sato Y, 2009, P R SOC B, V276, P2795, DOI 10.1098/rspb.2009.0481; Scott L, 2005, ARCUSER ONLINE   APR; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Thacker RW, 2012, ADV MAR BIOL, V62, P57, DOI 10.1016/B978-0-12-394283-8.00002-3; Tsurumi M, 1997, INVERTEBR REPROD DEV, V32, P1, DOI 10.1080/07924259.1997.9672598; VACELET J, 1994, SPONGES TIME SPACE; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Wassenberg DM, 2004, ENVIRON HEALTH PERSP, V112, P1658, DOI 10.1289/ehp.7168; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2002, MAR ECOL PROG SER, V232, P305, DOI 10.3354/meps232305; Wulff JL, 2007, J MAR BIOL ASSOC UK, V87, P1715, DOI 10.1017/S002531540705881X; Wulff JL, 2006, CORAL REEFS, V25, P419, DOI 10.1007/s00338-006-0110-0; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z; Zvuloni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004993	72	13	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79976	10.1371/journal.pone.0079976	http://dx.doi.org/10.1371/journal.pone.0079976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244583	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800106
J	Euser, AS; Evans, BE; Greaves-Lord, K; van de Wetering, BJM; Huizink, AC; Franken, IHA				Euser, Anja S.; Evans, Brittany E.; Greaves-Lord, Kirstin; van de Wetering, Ben J. M.; Huizink, Anja C.; Franken, Ingmar H. A.			Multifactorial Determinants of Target and Novelty-Evoked P300 Amplitudes in Children of Addicted Parents	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; EVENT-RELATED POTENTIALS; FAMILY-HISTORY; ANTISOCIAL-BEHAVIOR; EXTERNALIZING PSYCHOPATHOLOGY; HUMAN ELECTROENCEPHALOGRAM; CORTISOL RESPONSES; BRAIN-DEVELOPMENT; ADOLESCENT BRAIN; LIFE STRESSORS	Background: Although P300 amplitude reductions constitute a persistent finding in children of addicted parents, relatively little is known about the specificity of this finding. The major aim of this study was to investigate the association between parental rearing, adverse life events, stress-reactivity, substance use and psychopathology on the one hand, and P300 amplitude in response to both target and novel distracter stimuli on the other hand. Moreover, we assessed whether risk group status (i.e., having a parental history of Substance Use Disorders [SUD]) uniquely contributed to P300 amplitude variation above and beyond these other variables. Methods: Event-related potentials were recorded in high-risk adolescents with a parental history of SUD (HR; n=80) and normal-risk controls (NR; n=100) while performing a visual Novelty Oddball paradigm. Stress-evoked cortisol levels were assessed and parenting, life adversities, substance use and psychopathology were examined by using self-reports. Results: HR adolescents displayed smaller P300 amplitudes in response to novel-and to target stimuli than NR controls, while the latter only approached significance. Interestingly, the effect of having a parental history of SUD on target-P300 disappeared when all other variables were taken into account. Externalizing problem behavior was a powerful predictor of target-P300. In contrast, risk group status uniquely predicted novelty-P300 amplitude reductions above and beyond all other factors. Conclusion: Overall, the present findings suggest that the P300 amplitude reduction to novel stimuli might be a more specific endophenotype for SUD than the target-P300 amplitude. This pattern of results underscores the importance of conducting multifactorial assessments when examining important cognitive processes in at-risk adolescents.	[Euser, Anja S.; Franken, Ingmar H. A.] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands; [Euser, Anja S.; Evans, Brittany E.; Greaves-Lord, Kirstin; Franken, Ingmar H. A.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Evans, Brittany E.; Huizink, Anja C.] Vrije Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands; [Evans, Brittany E.; Huizink, Anja C.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care, Amsterdam, Netherlands; [van de Wetering, Ben J. M.] Bouman Mental Hlth Care, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Euser, AS (corresponding author), Erasmus Univ, Dept Psychol, Rotterdam, Netherlands.	euser@fsw.eur.nl	Franken, Ingmar/AAB-7562-2019; Franken, Ingmar/C-2382-2008	Franken, Ingmar/0000-0002-7853-2694; Franken, Ingmar/0000-0002-7853-2694	Netherlands Organization for Health Research and Development (ZonMW) [3116.0002]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This project is financially supported by the Netherlands Organization for Health Research and Development (ZonMW; 3116.0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardal E, 1995, EUR J CLIN CHEM CLIN, V33, P927; Achenbach T. M., 1991, MANUAL SELF REPORT 1; Amone-P'olak K, 2009, J AM ACAD CHILD PSY, V48, P1031, DOI 10.1097/CHI.0b013e3181b39595; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barnow S, 2002, J STUD ALCOHOL, V63, P305, DOI 10.15288/jsa.2002.63.305; Bauer L. O., 1997, DRUG ALCOHOL DEPEN, V44, P1; Bauer LO, 1999, BIOL PSYCHIAT, V46, P263, DOI 10.1016/S0006-3223(98)00335-7; Carlson SR, 2007, J ABNORM PSYCHOL, V116, P565, DOI 10.1037/0021-843X.116.3.565; Carlson SR, 1999, PSYCHOPHYSIOLOGY, V36, P583, DOI 10.1111/1469-8986.3650583; Casey BJ, 2010, J AM ACAD CHILD PSY, V49, P1189, DOI 10.1016/j.jaac.2010.08.017; Charmandari E, 2003, HORM RES, V59, P161, DOI 10.1159/000069325; Chassin L, 1999, J ABNORM PSYCHOL, V108, P106, DOI 10.1037/0021-843X.108.1.106; CONGER AJ, 1974, EDUC PSYCHOL MEAS, V34, P35, DOI 10.1177/001316447403400105; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dieleman GC, 2010, PSYCHONEUROENDOCRINO, V35, P1223, DOI 10.1016/j.psyneuen.2010.02.012; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dunn MG, 2002, CLIN PSYCHOL REV, V22, P1063, DOI 10.1016/S0272-7358(02)00132-0; Euser AS, 2012, NEUROSCI BIOBEHAV R, V36, P572, DOI 10.1016/j.neubiorev.2011.09.002; Evans BE, ORTISOL LEVELS UNPUB; Evans BE, 2011, ADDICTION; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Frangou S, 1997, SCHIZOPHR RES, V23, P45, DOI 10.1016/S0920-9964(96)00089-8; Franken IHA, 2008, PSYCHIAT RES, V158, P155, DOI 10.1016/j.psychres.2007.06.002; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Giancola PR, 1999, PSYCHOL SCI, V10, P203, DOI 10.1111/1467-9280.00135; GOLDSTEIN A, 1990, SCIENCE, V249, P1513, DOI 10.1126/science.2218493; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greaves-Lord K, DEV SCI IN PRESS; Hardie TL, 2002, PSYCHIAT RES, V112, P121, DOI 10.1016/S0165-1781(02)00182-8; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hicks BM, 2007, PSYCHOPHYSIOLOGY, V44, P98, DOI 10.1111/j.1469-8986.2006.00471.x; Holguin SR, 1999, BIOL PSYCHIAT, V46, P281, DOI 10.1016/S0006-3223(98)00247-9; Holguin SR, 1998, ALCOHOL ALCOHOLISM, V33, P281; Huizink AC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-350; Hussong AM, 2008, J FAM PSYCHOL, V22, P819, DOI 10.1037/a0013704; Iacono WG, 2002, ARCH GEN PSYCHIAT, V59, P750, DOI 10.1001/archpsyc.59.8.750; Iacono WG, 2011, CHILD DEV PERSPECT, V5, P239, DOI 10.1111/j.1750-8606.2011.00205.x; Ivanov I, 2008, AM J DRUG ALCOHOL AB, V34, P239, DOI 10.1080/00952990802013334; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Kendler KS, 1997, BRIT J PSYCHIAT, V170, P541, DOI 10.1192/bjp.170.6.541; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Kimble MO, 2010, PSYCHIAT RES, V178, P501, DOI 10.1016/j.psychres.2009.10.009; Klein BS, 2001, NY TIMES BK REV, P15; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Krueger RF, 2007, J ABNORM PSYCHOL, V116, P645, DOI 10.1037/0021-843X.116.4.645; Latendresse SJ, 2008, ALCOHOL CLIN EXP RES, V32, P322, DOI 10.1111/j.1530-0277.2007.00583.x; Liu JY, 2009, NEUROIMAGE, V46, P809, DOI 10.1016/j.neuroimage.2009.02.045; Lovallo WR, 2012, BIOL PSYCHIAT, V71, P344, DOI 10.1016/j.biopsych.2011.10.018; Luck S.J., 2005, INTRO EVENT RELATED; MacMillan HL, 2009, BIOL PSYCHIAT, V66, P62, DOI 10.1016/j.biopsych.2008.12.014; Malone SM, 2001, PSYCHOPHYSIOLOGY, V38, P367, DOI 10.1017/S0048577201990912; Markus MT, 2003, PERS INDIV DIFFER, V34, P503, DOI 10.1016/S0191-8869(02)00090-9; Masten AS, 2008, PEDIATRICS, V121, pS235, DOI 10.1542/peds.2007-2243A; McEwen B, 1999, J AM ACAD CHILD PSY, V38, P101, DOI 10.1097/00004583-199901000-00027; Morgan PT, 2010, ALCOHOL CLIN EXP RES, V34, P1759, DOI 10.1111/j.1530-0277.2010.01263.x; Muller BW, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-63; OCONNOR S, 1994, PROG NEURO-PSYCHOPH, V18, P1307, DOI 10.1016/0278-5846(94)90095-7; Pandey S., 2010, J SOC SOC WORK RES, V1, P28, DOI [10.5243/jsswr.2010.2, DOI 10.5243/JSSWR.2010.2]; Patrick CJ, 2006, PSYCHOPHYSIOLOGY, V43, P84, DOI 10.1111/j.1469-8986.2006.00376.x; PERRIS C, 1980, ACTA PSYCHIAT SCAND, V61, P265, DOI 10.1111/j.1600-0447.1980.tb00581.x; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; PIHL RO, 1990, J ABNORM PSYCHOL, V99, P291, DOI 10.1037/0021-843X.99.3.291; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2004, CLIN NEUROPHYSIOL, V115, P1374, DOI 10.1016/j.clinph.2004.01.026; POLICH J, 1994, PSYCHOL BULL, V115, P55, DOI 10.1037/0033-2909.115.1.55; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Rhee SH, 2003, ARCH GEN PSYCHIAT, V60, P1256, DOI 10.1001/archpsyc.60.12.1256; Rosnick CB, 2007, J AGING HEALTH, V19, P612, DOI 10.1177/0898264307300975; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SINHA R, 2008, CHRONIC STRESS DRUG, V1141, P105; Sorocco KH, 2006, INT J PSYCHOPHYSIOL, V59, P210, DOI 10.1016/j.ijpsycho.2005.10.009; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Tick NT, 2007, ACTA PSYCHIAT SCAND, V116, P473, DOI 10.1111/j.1600-0447.2007.01068.x; Uhart M, 2006, NEUROPSYCHOPHARMACOL, V31, P2255, DOI 10.1038/sj.npp.1301063; van Beijsterveldt CEM, 2002, BIOL PSYCHOL, V61, P111, DOI 10.1016/S0301-0511(02)00055-8; van der Stelt O, 1998, ALCOHOL CLIN EXP RES, V22, P1877, DOI 10.1097/00000374-199812000-00001; Van der Stelt O, 1998, ALCOHOL, V15, P119, DOI 10.1016/S0741-8329(97)00106-7; VANBEIJSTERVELDT CEM, 1994, HUM GENET, V94, P319, DOI 10.1007/BF00201587; Veenstra R, 2006, INT J BEHAV DEV, V30, P422, DOI 10.1177/0165025406071490; Verhulst F. C., 1997, HANDLEIDING YOUTH SE	88	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80087	10.1371/journal.pone.0080087	http://dx.doi.org/10.1371/journal.pone.0080087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244616	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800120
J	Holzer, TR; Fulford, AD; Nedderman, DM; Umberger, TS; Hozak, RR; Joshi, A; Melemed, SA; Benjamin, LE; Plowman, GD; Schade, AE; Ackermann, BL; Konrad, RJ; Nasir, A				Holzer, Timothy R.; Fulford, Angie D.; Nedderman, Drew M.; Umberger, Tara S.; Hozak, Rebecca R.; Joshi, Adarsh; Melemed, Symantha A.; Benjamin, Laura E.; Plowman, Gregory D.; Schade, Andrew E.; Ackermann, Bradley L.; Konrad, Robert J.; Nasir, Aejaz			Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung	PLOS ONE			English	Article							COLORECTAL-CANCER; OVARIAN-CARCINOMA; BREAST-CANCER; CONTAINING REGIMENS; TISSUE MICROARRAYS; PANCREATIC-CANCER; TARGETED THERAPY; MURINE MODEL; FACTOR VEGF; IN-SITU	A robust immunohistochemical (IHC) assay for VEGFR2 was developed to investigate its utility for patient tailoring in clinical trials. The sensitivity, specificity, and selectivity of the IHC assay were established by siRNA knockdown, immunoblotting, mass spectrometry, and pre-absorption experiments. Characterization of the assay included screening a panel of multiple human cancer tissues and an independent cohort of non-small cell lung carcinoma (NSCLC, n = 118) characterized by TTF-1, p63, CK5/6, and CK7 IHC. VEGFR2 immunoreactivity was interpreted qualitatively (VEGFR2 positive/negative) in blood vessels and by semi-quantitative evaluation using H-scores in tumor cells (0-300). Associations were determined among combinations of VEGFR2 expression in blood vessels and tumor cells, and clinico-pathologic characteristics (age, sex, race, histologic subtype, disease stage) and overall survival using Kaplan-Meier analyses and appropriate statistical models. VEGFR2 expression both in blood vessels and in tumor cells in carcinomas of the lung, cervix, larynx, breast, and others was demonstrated. In the validation cohort, 99/118 (83.9%) NSCLC tissues expressed VEGFR2 in the blood vessels and 46/118 (39.0%) showed high tumor cell positivity (H-score >= 10). Vascular and tumor cell expression were inversely correlated (p = 0.0175). High tumor cell expression of VEGFR2 was associated with a 3.7-fold reduction in median overall survival in lung squamous-cell carcinoma (SCC, n = 25, p = 0.0134). The inverse correlation between vascular and tumor cell expression of VEGFR2 and the adverse prognosis associated with high VEGFR2 expression in immunohistochemically characterized pulmonary SCC are new findings with potential therapeutic implications. The robustness of this novel IHC assay will support further evaluation of its utility for patient tailoring in clinical trials of antiangiogenic agents.	[Holzer, Timothy R.; Fulford, Angie D.; Nedderman, Drew M.; Umberger, Tara S.; Melemed, Symantha A.; Benjamin, Laura E.; Plowman, Gregory D.; Schade, Andrew E.; Ackermann, Bradley L.; Konrad, Robert J.; Nasir, Aejaz] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Hozak, Rebecca R.; Joshi, Adarsh] Eli Lilly & Co, Oncol Stat Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Nasir, A (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	nasir_aejaz@lilly.com	Holzer, Timothy/M-4002-2014; Holzer, Timothy/AAH-7952-2020	Holzer, Timothy/0000-0002-4274-8741; Holzer, Timothy/0000-0002-4274-8741; Plowman, Gregory D/0000-0002-6465-309X				Adham SAI, 2010, LAB INVEST, V90, P709, DOI 10.1038/labinvest.2010.52; Amaya H, 1997, CANCER LETT, V119, P227, DOI 10.1016/S0304-3835(97)00280-2; Anagnostou VK, 2009, CLIN CANCER RES, V15, P4157, DOI 10.1158/1078-0432.CCR-09-0099; Anagnostou VK, 2009, J CLIN ONCOL, V27, P271, DOI 10.1200/JCO.2008.17.0043; Ballas MS, 2010, 2010 AM SOC CLIN ONC; Belotti D, 1996, CLIN CANCER RES, V2, P1843; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Bruns CJ, 2000, CANCER, V89, P488, DOI 10.1002/1097-0142(20000801)89:3<488::AID-CNCR3>3.3.CO;2-O; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Carvajal RD, 2010, 2010 AM SOC CLIN ONC; Chung GG, 2006, CANCER, V106, P1677, DOI 10.1002/cncr.21783; COX DR, 1972, J R STAT SOC B, V34, P187; Pau ECD, 2009, CANCER-AM CANCER SOC, V115, P1701, DOI 10.1002/cncr.24193; Decaussin M, 1999, J PATHOL, V188, P369; Domingues I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025668; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Douillard JY, 2007, J THORAC ONCOL, V2, P939, DOI 10.1097/JTO.0b013e318153fa2b; Duff SE, 2006, EUR J CANCER, V42, P112, DOI 10.1016/j.ejca.2005.09.018; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrer FA, 1999, UROLOGY, V54, P567, DOI 10.1016/S0090-4295(99)00156-9; Garcia JA, 2010, 2010 AM SOC CLIN ONC; Garcia-Carbonero R, 2012, 2012 AM SOC CLIN ONC; Gasparini G, 2005, J CLIN ONCOL, V23, P1295, DOI 10.1200/JCO.2005.10.022; Gerber HP, 2003, J MOL MED, V81, P20, DOI 10.1007/s00109-002-0397-4; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Ghosh S, 2008, HUM PATHOL, V39, P1835, DOI 10.1016/j.humpath.2008.06.004; Giatromanolaki A, 2007, EUR J CLIN INVEST, V37, P878, DOI 10.1111/j.1365-2362.2007.01866.x; Grossi F, 2010, ONCOLOGIST, V15, P1102, DOI 10.1634/theoncologist.2010-0322; Grossi F, 2009, ONCOLOGIST, V14, P497, DOI 10.1634/theoncologist.2008-0260; Gurtler J, 2010, 2010 INT LIV CANC AS; Hanna JA, 2012, BIOTECHNIQUES, V52, P235, DOI 10.2144/000113837; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Inoue K, 2000, CLIN CANCER RES, V6, P2635; Itakura J, 2000, INT J CANCER, V85, P27; Kajita T, 2001, BRIT J CANCER, V85, P255, DOI 10.1054/bjoc.2001.1882; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kollermann J, 2001, AM J CLIN PATHOL, V116, P115; Konig JE, 2000, RESPIRATION, V67, P36, DOI 10.1159/000029460; Koukourakis MI, 2000, CANCER RES, V60, P3088; Lacal PM, 2000, J INVEST DERMATOL, V115, P1000, DOI 10.1046/j.1523-1747.2000.00199.x; Le Chevalier T, 2005, LUNG CANCER, V47, P69, DOI 10.1016/j.lungcan.2004.10.014; LU C, 1993, J CELL BIOL, V120, P1281, DOI 10.1083/jcb.120.5.1281; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Miettinen M, 2012, AM J SURG PATHOL, V36, P629, DOI 10.1097/PAS.0b013e318243555b; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Molhoek KR, 2011, INT J CANCER, V129, P2807, DOI 10.1002/ijc.25963; Moore KN, 2012, ASCO M; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Pajares MJ, 2012, J CLIN ONCOL; Prewett M, 1999, CANCER RES, V59, P5209; Price DJ, 2001, CELL GROWTH DIFFER, V12, P129; Rekhtman N, 2011, MODERN PATHOL, V24, P1348, DOI 10.1038/modpathol.2011.92; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Ryden L, 2003, BREAST CANCER RES TR, V82, P147, DOI 10.1023/B:BREA.0000004357.92232.cb; Santos SCR, 2004, BLOOD, V103, P3883, DOI 10.1182/BLOOD-2003-05-1634; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Shibuya K, 2007, INT J RADIAT ONCOL, V69, P1534, DOI 10.1016/j.ijrobp.2007.07.2350; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Stewart M, 2003, HISTOPATHOLOGY, V43, P33, DOI 10.1046/j.1365-2559.2003.01644.x; Wu WJ, 2007, MOL CANCER THER, V6, P471, DOI 10.1158/1535-7163.MCT-06-0416; Wulfing P, 2005, BRIT J CANCER, V92, P1720, DOI 10.1038/sj.bjc.6602567; Yang XH, 2006, BIOCHEM BIOPH RES CO, V349, P31, DOI 10.1016/j.bbrc.2006.07.213; Yao J, 2011, P NATL ACAD SCI USA, V108, P11590, DOI 10.1073/pnas.1109029108; Zhu ZP, 2002, CURR CANCER DRUG TAR, V2, P135, DOI 10.2174/1568009023333881; Zito CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031331	68	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80292	10.1371/journal.pone.0080292	http://dx.doi.org/10.1371/journal.pone.0080292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244672	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800141
J	Perreault, M; Bialek, A; Trottier, J; Verreault, M; Caron, P; Milkiewicz, P; Barbier, O				Perreault, Martin; Bialek, Andrzej; Trottier, Jocelyn; Verreault, Melanie; Caron, Patrick; Milkiewicz, Piotr; Barbier, Olivier			Role of Glucuronidation for Hepatic Detoxification and Urinary Elimination of Toxic Bile Acids during Biliary Obstruction	PLOS ONE			English	Article							LITHOCHOLATE-3-O-GLUCURONIDE-INDUCED CHOLESTASIS; SERUM; RECEPTORS; EXCRETION; TRANSPORT; MRP3	Biliary obstruction, a severe cholestatic condition, results in a huge accumulation of toxic bile acids (BA) in the liver. Glucuronidation, a conjugation reaction, is thought to protect the liver by both reducing hepatic BA toxicity and increasing their urinary elimination. The present study evaluates the contribution of each process in the overall BA detoxification by glucuronidation. Glucuronide (G), glycine, taurine conjugates, and unconjugated BAs were quantified in pre- and post-biliary stenting urine samples from 12 patients with biliary obstruction, using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The same LC-MS/MS procedure was used to quantify intra-and extracellular BA-G in Hepatoma HepG2 cells. Bile acid-induced toxicity in HepG2 cells was evaluated using MTS reduction, caspase-3 and flow cytometry assays. When compared to post-treatment samples, pre-stenting urines were enriched in glucuronide-, taurine-and glycine-conjugated BAs. Biliary stenting increased the relative BA-G abundance in the urinary BA pool, and reduced the proportion of taurine- and glycine-conjugates. Lithocholic, deoxycholic and chenodeoxycholic acids were the most cytotoxic and pro-apoptotic/necrotic BAs for HepG2 cells. Other species, such as the cholic, hyocholic and hyodeoxycholic acids were nontoxic. All BA-G assayed were less toxic and displayed lower pro-apoptotic/necrotic effects than their unconjugated precursors, even if they were able to penetrate into HepG2 cells. Under severe cholestatic conditions, urinary excretion favors the elimination of amidated BAs, while glucuronidation allows the conversion of cytotoxic BAs into nontoxic derivatives.	[Perreault, Martin; Trottier, Jocelyn; Verreault, Melanie; Caron, Patrick; Barbier, Olivier] Univ Laval, CHU Quebec Res Ctr, Mol Pharmacol Lab, Quebec City, PQ, Canada; [Perreault, Martin; Trottier, Jocelyn; Verreault, Melanie; Caron, Patrick; Barbier, Olivier] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Bialek, Andrzej] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Milkiewicz, Piotr] Pomeranian Med Univ, Liver Res Labs, Szczecin, Poland; [Milkiewicz, Piotr] Med Univ Warsaw, Dept Surg & Liver Transplantat, Liver Unit, Warsaw, Poland	Laval University; Laval University; Pomeranian Medical University; Pomeranian Medical University; Medical University of Warsaw	Barbier, O (corresponding author), Univ Laval, CHU Quebec Res Ctr, Mol Pharmacol Lab, Quebec City, PQ, Canada.	olivier.barbier@crchul.ulaval.ca	Bialek, Andrzej/A-8135-2015	Milkiewicz, Piotr/0000-0002-1817-0724; Barbier, Olivier/0000-0002-3067-1134	Canadian Institute of Health Research (CIHR); Canadian Liver Foundation; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; "Fonds pour la Recherche en Sante du Quebec" (FRSQ); CIHR [MSH95330]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Liver Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); "Fonds pour la Recherche en Sante du Quebec" (FRSQ)(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the Canadian Institute of Health Research (CIHR), the Canadian Liver Foundation, the Natural Sciences and Engineering Research Council of Canada and the Canadian Foundation for Innovation. M. Perreault is holder of a scholarship from the "Fonds pour la Recherche en Sante du Quebec" (FRSQ). O. Barbier is holder of a salary grant from CIHR (New investigator #MSH95330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2002, PHARMACEUT RES, V19, P34, DOI 10.1023/A:1013699130991; ALME B, 1980, J STEROID BIOCHEM, V13, P907, DOI 10.1016/0022-4731(80)90164-8; Barbier O, 2009, MOL CELL BIOCHEM, V326, P3, DOI 10.1007/s11010-008-0001-5; Barnabas Ashley, 2012, Curr Gastroenterol Rep, V14, P17, DOI 10.1007/s11894-011-0230-8; Caron P, 2006, MOL PHARMACEUT, V3, P293, DOI 10.1021/mp060021l; Donner MG, 2001, HEPATOLOGY, V34, P351, DOI 10.1053/jhep.2001.26213; Dutton G.F., 1980, GLUCURONIDATION DRUG; Hofmann AF, 2004, DRUG METAB REV, V36, P703, DOI 10.1081/DMR-200033475; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jonker JW, 2012, J STEROID BIOCHEM, V130, P147, DOI 10.1016/j.jsbmb.2011.06.012; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li TG, 2013, DRUG METAB REV, V45, P145, DOI 10.3109/03602532.2012.740048; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; OELBERG DG, 1984, J CLIN INVEST, V73, P1507, DOI 10.1172/JCI111356; Pauli-Magnus C, 2005, J HEPATOL, V43, P342, DOI 10.1016/j.jhep.2005.03.017; Paumgartner G, 2010, J DIGEST DIS, V11, P119, DOI 10.1111/j.1751-2980.2010.00427.x; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Regan SL, 2010, BIOPHARM DRUG DISPOS, V31, P367, DOI 10.1002/bdd.720; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Rolo AP, 2003, BBA-MOL BASIS DIS, V1637, P127, DOI 10.1016/S0925-4439(02)00224-7; Sharma R, 2010, BIOORGAN MED CHEM, V18, P6886, DOI 10.1016/j.bmc.2010.07.030; Song PZ, 2011, TOXICOL SCI, V123, P359, DOI 10.1093/toxsci/kfr177; STIEHL A, 1982, CLIN CHIM ACTA, V123, P275, DOI 10.1016/0009-8981(82)90172-3; STIEHL A, 1985, HEPATOLOGY, V5, P492, DOI 10.1002/hep.1840050325; TAKIKAWA H, 1993, DIGEST DIS SCI, V38, P1543, DOI 10.1007/BF01308618; Takikawa H, 1984, Gastroenterol Jpn, V19, P104; TAKIKAWA H, 1995, J HEPATOL, V22, P88, DOI 10.1016/0168-8278(95)80265-7; Trottier J, 2013, CLIN PHARMACOL THER, V94, P533, DOI 10.1038/clpt.2013.122; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Trottier J, 2006, MOL PHARMACEUT, V3, P212, DOI 10.1021/mp060020t; Trottier J, 2012, DIGEST LIVER DIS, V44, P303, DOI 10.1016/j.dld.2011.10.025; Trottier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022094; Verreault M, 2010, DRUG METAB REV, V42, P110, DOI 10.3109/03602530903219220; WIETHOLTZ H, 1991, HEPATOLOGY, V13, P656, DOI 10.1002/hep.1840130408; Zein Claudia O, 2010, Curr Gastroenterol Rep, V12, P13, DOI 10.1007/s11894-009-0079-2; Zollner G, 2010, PHARMACOL THERAPEUT, V126, P228, DOI 10.1016/j.pharmthera.2010.03.005	38	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80994	10.1371/journal.pone.0080994	http://dx.doi.org/10.1371/journal.pone.0080994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244729	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800174
J	Furukawa, S; Kawasaki, Y; Miyamoto, M; Hiyoshi, M; Kitayama, J; Akiyama, T				Furukawa, Shiori; Kawasaki, Yoshihiro; Miyamoto, Masaya; Hiyoshi, Masaya; Kitayama, Joji; Akiyama, Tetsu			The miR-1-NOTCH3-Asef Pathway Is Important for Colorectal Tumor Cell Migration	PLOS ONE			English	Article							MICRORNA EXPRESSION; EXCHANGE FACTOR; CANCER; WNT; ASEF; NOTCH3; MIR-1; FATE; APC; INHIBITION	The tumor suppressor adenomatous polyposis coli (APC) is mutated in sporadic and familial colorectal tumors. APC stimulates the activity of the Cdc42- and Rac1-specific guanine nucleotide exchange factor Asef and promotes the migration and invasion of colorectal tumor cells. Furthermore, Asef is overexpressed in colorectal tumors and is required for colorectal tumorigenesis. It is also known that NOTCH signaling plays critical roles in colorectal tumorigenesis and fate determination of intestinal progenitor cells. Here we show that NOTCH3 up-regulates Asef expression by activating the Asef promoter in colorectal tumor cells. Moreover, we demonstrate that microRNA-1 (miR-1) is down-regulated in colorectal tumors and that miR-1 has the potential to suppress NOTCH3 expression through direct binding to its 3'-UTR region. These results suggest that the miR-1-NOTCH3-Asef pathway is important for colorectal tumor cell migration and may be a promising molecular target for the treatment of colorectal tumors.	[Furukawa, Shiori; Kawasaki, Yoshihiro; Miyamoto, Masaya; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo, Japan; [Hiyoshi, Masaya; Kitayama, Joji] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan	University of Tokyo; University of Tokyo	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo, Japan.	akiyama@iam.u-tokyo.ac.jp			Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kobayashi Foundation for Cancer Research; MEXT, Japan; Grants-in-Aid for Scientific Research [25670138] Funding Source: KAKEN	Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks), Grants-in-Aid for Scientific Research on Innovative Areas (Integrative Research on Cancer Microenvironment Network, and Regulation of Polarity Signaling during Morphogenesis, Remodeling, and Breakdown of Epithelial Tubule Structure), Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Kobayashi Foundation for Cancer Research and in part by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2008, GASTROENTEROLOGY, V134, P131, DOI 10.1053/j.gastro.2007.10.008; Anton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026257; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Gotthardt K, 2007, BIOL CHEM, V388, P67, DOI 10.1515/BC.2007.008; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Huang F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/216286; Indraccolo S, 2009, CANCER RES, V69, P1314, DOI 10.1158/0008-5472.CAN-08-2791; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kawasaki Y, 2010, J BIOL CHEM, V285, P1199, DOI 10.1074/jbc.M109.040691; Kawasaki Y, 2009, EMBO REP, V10, P1355, DOI 10.1038/embor.2009.233; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Migliore C, 2012, CLIN CANCER RES, V18, P737, DOI 10.1158/1078-0432.CCR-11-1699; Nasser MW, 2006, J BOIL CANC, V283, P33394; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Nohata N, 2011, ONCOTARGET, V2, P29; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Reid JF, 2012, MOL CANCER RES, V10, P504, DOI 10.1158/1541-7786.MCR-11-0342; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Serafin V, 2011, J PATHOL, V224, P448, DOI 10.1002/path.2895; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659	38	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80609	10.1371/journal.pone.0080609	http://dx.doi.org/10.1371/journal.pone.0080609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244701	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600213
J	Grodeland, G; Mjaaland, S; Tunheim, G; Fredriksen, AB; Bogen, B				Grodeland, Gunnveig; Mjaaland, Siri; Tunheim, Gro; Fredriksen, Agnete B.; Bogen, Bjarne			The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype	PLOS ONE			English	Article							STIMULATORY FACTOR-I; ANTIGEN-PRESENTING CELLS; CYTOTOXIC T-LYMPHOCYTES; TUMOR-ANTIGEN; DNA VACCINES; B-CELLS; SKIN ELECTROPORATION; VIRUS CHALLENGE; CD4(+); ANTIBODY	Different diseases require different immune responses for efficient protection. Thus, prophylactic vaccines should prime the immune system for the particular type of response needed for protection against a given infectious agent. We have here tested fusion DNA vaccines which encode proteins that bivalently target influenza hemagglutinins (HA) to different surface molecules on antigen presenting cells (APC). We demonstrate that targeting to MHC class II molecules predominantly induced an antibody/Th2 response, whereas targeting to CCR1/3/5 predominantly induced a CD8+/Th1 T cell response. With respect to antibodies, the polarizing effect was even more pronounced upon intramuscular (i.m) delivery as compared to intradermal (i.d.) vaccination. Despite these differences in induced immune responses, both vaccines protected against a viral challenge with influenza H1N1. Substitution of HA with ovalbumin (OVA) demonstrated that polarization of immune responses, as a consequence of APC targeting specificity, could be extended to other antigens. Taken together, the results demonstrate that vaccination can be tailor-made to induce a particular phenotype of adaptive immune responses by specifically targeting different surface molecules on APCs.	[Grodeland, Gunnveig; Tunheim, Gro; Fredriksen, Agnete B.; Bogen, Bjarne] Univ Oslo, Inst Immunol, Oslo, Norway; [Grodeland, Gunnveig; Tunheim, Gro; Fredriksen, Agnete B.; Bogen, Bjarne] Oslo Univ Hosp, Oslo, Norway; [Grodeland, Gunnveig; Mjaaland, Siri; Bogen, Bjarne] Univ Oslo, KG Jebsen Ctr Influenza Vaccine Res, Oslo, Norway; [Bogen, Bjarne] Univ Oslo, CIR, Oslo, Norway; [Mjaaland, Siri] Norwegian Inst Publ Hlth, Dept Bacteriol & Infect Immunol, Div Infect Dis Control, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Grodeland, G (corresponding author), Univ Oslo, Inst Immunol, Oslo, Norway.	gunnveig.grodeland@medisin.uio.no; bjarne.bogen@medisin.uio.no		Grodeland, Gunnveig/0000-0001-6285-3162; Mjaaland, Siri/0000-0002-3870-5861	GLOBVAC (The Research Council of Norway); Helse Sor-Ost (Regional Health Authority), Norway	GLOBVAC (The Research Council of Norway); Helse Sor-Ost (Regional Health Authority), Norway	This study was funded by GLOBVAC (The Research Council of Norway) and Helse Sor-Ost (Regional Health Authority), Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Andreasson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011580; APOSTOLOPOULOS V, 1995, P NATL ACAD SCI USA, V92, P10128, DOI 10.1073/pnas.92.22.10128; BAIER G, 1995, J VIROL, V69, P2357, DOI 10.1128/JVI.69.4.2357-2365.1995; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Biragyn A, 2004, BLOOD, V104, P1961, DOI 10.1182/blood-2004-02-0637; Biragyn A, 1999, NAT BIOTECHNOL, V17, P253, DOI 10.1038/6995; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; CASTEN LA, 1988, J IMMUNOL, V140, P404; Chow YH, 1998, J IMMUNOL, V160, P1320; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Conway MA, 2001, VACCINE, V19, P1940, DOI 10.1016/S0264-410X(00)00433-3; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Epstein SL, 2000, INT IMMUNOL, V12, P91, DOI 10.1093/intimm/12.1.91; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Fredriksen AB, 2006, MOL THER, V13, P776, DOI 10.1016/j.ymthe.2005.10.019; Fredriksen AB, 2007, BLOOD, V110, P1797, DOI 10.1182/blood-2006-06-032938; Glimcher LH, 2000, GENE DEV, V14, P1693; Grodeland G, 2013, J IMMUNOL, V191, P3221, DOI 10.4049/jimmunol.1300504; GRUN JL, 1989, CELL IMMUNOL, V121, P134, DOI 10.1016/0008-8749(89)90011-7; HACKETT CJ, 1983, J EXP MED, V158, P294, DOI 10.1084/jem.158.2.294; Hickling JK, 2011, B WORLD HEALTH ORGAN, V89, P221, DOI 10.2471/BLT.10.079426; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; KAWAMURA H, 1986, J IMMUNOL, V136, P58; LEES A, 1990, J IMMUNOL, V145, P3594; Lunde E, 1999, NAT BIOTECHNOL, V17, P670, DOI 10.1038/10883; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Peng BW, 2007, VACCINE, V25, P2064, DOI 10.1016/j.vaccine.2006.11.042; PRAT M, 1984, P NATL ACAD SCI-BIOL, V81, P4515, DOI 10.1073/pnas.81.14.4515; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; RABIN EM, 1985, P NATL ACAD SCI USA, V82, P2935, DOI 10.1073/pnas.82.9.2935; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Roos AK, 2009, MOL THER, V17, P1637, DOI 10.1038/mt.2009.120; Ruffini PA, 2010, VACCINE, V29, P191, DOI 10.1016/j.vaccine.2010.10.057; Schiavo R, 2006, BLOOD, V107, P4597, DOI 10.1182/blood-2005-08-3207; Schjetne KW, 2007, J IMMUNOL, V178, P4169, DOI 10.4049/jimmunol.178.7.4169; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; SNIDER DP, 1987, J IMMUNOL, V139, P1609; STAUDT LM, 1983, J EXP MED, V157, P687, DOI 10.1084/jem.157.2.687; Tamura M, 1998, J VIROL, V72, P9404, DOI 10.1128/JVI.72.11.9404-9406.1998; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wille-Reece U, 2005, J IMMUNOL, V174, P7676, DOI 10.4049/jimmunol.174.12.7676; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244	55	30	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80008	10.1371/journal.pone.0080008	http://dx.doi.org/10.1371/journal.pone.0080008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244595	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600172
J	Henry, I; Antoniazza, S; Dubey, S; Simon, C; Waldvogel, C; Burri, R; Roulin, A				Henry, Isabelle; Antoniazza, Sylvain; Dubey, Sylvain; Simon, Celine; Waldvogel, Celine; Burri, Reto; Roulin, Alexandre			Multiple Paternity in Polyandrous Barn Owls (Tyto alba)	PLOS ONE			English	Article							FEMALE BROOD DESERTION; EXTRA-PAIR PATERNITY; PARENTAL INVESTMENT; OFFSPRING DESERTION; SEXUAL SELECTION; CARE; CONFLICT; BIRDS; INCREASES	In polyandrous species females produce successive clutches with several males. Female barn owls (Tyto alba) often desert their offspring and mate to produce a 2nd annual brood with a second male. We tested whether copulating during chick rearing at the 1st annual brood increases the male's likelihood to obtain paternity at the 2nd annual breeding attempt of his female mate in case she deserts their brood to produce a second brood with a different male. Using molecular paternity analyses we found that 2 out of 26 (8%) second annual broods of deserting females contained in total 6 extra-pair young out of 15 nestlings. These young were all sired by the male with whom the female had produced the 1st annual brood. In contrast, none of the 49 1st annual breeding attempts (219 offspring) and of the 20 2nd annual breeding attempts (93 offspring) of non-deserting females contained extra-pair young. We suggest that female desertion can select male counter-strategies to increase paternity and hence individual fitness. Alternatively, females may copulate with the 1st male to derive genetic benefits, since he is usually of higher quality than the 2nd male which is commonly a yearling individual.	[Henry, Isabelle; Antoniazza, Sylvain; Dubey, Sylvain; Simon, Celine; Waldvogel, Celine; Burri, Reto; Roulin, Alexandre] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Lausanne	Roulin, A (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, Lausanne, Switzerland.	alexandre.roulin@unil.ch	Dubey, Sylvain/B-3662-2013		SNSF (Swiss Science National Science Foundation) [31003A_120517]	SNSF (Swiss Science National Science Foundation)	31003A_120517 SNSF (Swiss Science National Science Foundation; www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhler P., 1980, Journal fuer Ornithologie, V121, P36, DOI 10.1007/BF01643255; Bunn D. S., 1982, THE BARN OWL; Burri R, 2008, MOL ECOL RESOUR, V8, P977, DOI 10.1111/j.1755-0998.2008.02121.x; Chen TC, 2008, J NAT HIST, V42, P2991, DOI 10.1080/00222930802389817; Dale J, 1999, BEHAV ECOL SOCIOBIOL, V46, P50, DOI 10.1007/s002650050591; Eldegard K, 2012, J ORNITHOL, V153, P385, DOI 10.1007/s10336-011-0753-7; Eldegard K, 2009, P ROY SOC B-BIOL SCI, V276, P1713, DOI 10.1098/rspb.2008.1775; Epple W., 1985, Oekologie der Voegel, V7, P1; Frey C, 2011, J ORNITHOL, V152, P279, DOI 10.1007/s10336-010-0579-8; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griggio M, 2005, BEHAV ECOL, V16, P435, DOI 10.1093/beheco/ari009; Haig SM, 2003, J HERED, V94, P302, DOI 10.1093/jhered/esg072; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Korpimaki E, 2011, BEHAV ECOL SOCIOBIOL, V65, P1093, DOI 10.1007/s00265-010-1118-6; Krakauer AH, 2008, CONDOR, V110, P1, DOI 10.1525/cond.2008.110.1.1; Lack D., 1968, pvii; Lessells CM, 2012, P ROY SOC B-BIOL SCI, V279, P1506, DOI 10.1098/rspb.2011.1690; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Muller Y, 1991, RAPACES NOCTURNES, P173; Olson VA, 2008, P ROY SOC B-BIOL SCI, V275, P301, DOI 10.1098/rspb.2007.1395; OWENS IPF, 1995, BEHAV ECOL, V6, P14, DOI 10.1093/beheco/6.1.14; Owens IPF, 2002, P ROY SOC LOND B BIO, V275, P301; Pilastro A, 2001, J AVIAN BIOL, V32, P68, DOI 10.1034/j.1600-048X.2001.320109.x; Queller DC, 1997, P ROY SOC B-BIOL SCI, V264, P1555, DOI 10.1098/rspb.1997.0216; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roulin A, 2004, J AVIAN BIOL, V35, P492, DOI 10.1111/j.0908-8857.2004.03294.x; Roulin A, 2002, AUK, V119, P515, DOI 10.1642/0004-8038(2002)119[0515:ODBDBF]2.0.CO;2; SMITH JM, 1977, ANIM BEHAV, V25, P1, DOI 10.1016/0003-3472(77)90062-8; Trotschel P., 1973, Vogelwelt, V94, P64; VALLE CA, 1994, AUK, V111, P476, DOI 10.2307/4088613; Webb JN, 2002, PHILOS T R SOC B, V357, P331, DOI 10.1098/rstb.2001.0934	35	15	15	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80112	10.1371/journal.pone.0080112	http://dx.doi.org/10.1371/journal.pone.0080112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244622	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600181
J	Shi, DY; Zheng, X; Li, L; Lin, WH; Xie, WJ; Yang, JP; Chen, SJ; Jin, WW				Shi, Dianyi; Zheng, Xu; Li, Liang; Lin, Wanhuang; Xie, Wenjun; Yang, Jianping; Chen, Shaojiang; Jin, Weiwei			Chlorophyll Deficiency in the Maize elongated mesocotyl2 Mutant Is Caused by a Defective Heme Oxygenase and Delaying Grana Stacking	PLOS ONE			English	Article							PHYTOCHROME-CHROMOPHORE BIOSYNTHESIS; UP-REGULATION; YELLOW-GREEN-2 MUTANTS; POPULATION-SIZE; SOYBEAN PLANTS; ARABIDOPSIS; GENE; EXPRESSION; LIGHT; FAMILY	Background: Etiolated seedlings initiate grana stacking and chlorophyll biosynthesis in parallel with the first exposure to light, during which phytochromes play an important role. Functional phytochromes are biosynthesized separately for two components. One phytochrome is biosynthesized for apoprotein and the other is biosynthesized for the chromophore that includes heme oxygenase (HO). Methodology/Principal Finding: We isolated a ho1 homolog by map-based cloning of a maize elongated mesocotyl2 (elm2) mutant. cDNA sequencing of the ho1 homolog in elm2 revealed a 31 bp deletion. De-etiolation responses to red and far-red light were disrupted in elm2 seedlings, with a pronounced elongation of the mesocotyl. The endogenous HO activity in the elm2 mutant decreased remarkably. Transgenic complementation further confirmed the dysfunction in the maize ho1 gene. Moreover, non-appressed thylakoids were specifically stacked at the seedling stage in the elm2 mutant. Conclusion: The 31 bp deletion in the ho1 gene resulted in a decrease in endogenous HO activity and disrupted the de-etiolation responses to red and far-red light. The specific stacking of non-appressed thylakoids suggested that the chlorophyll biosynthesis regulated by HO1 is achieved by coordinating the heme level with the regulation of grana stacking.	[Shi, Dianyi; Li, Liang; Xie, Wenjun; Chen, Shaojiang; Jin, Weiwei] China Agr Univ, Minist Agr, Key Lab Crop Genet Improvement & Genome, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Shi, Dianyi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Zheng, Xu; Yang, Jianping] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Lin, Wanhuang] Hunan Agr Univ, Hunan Prov Key Lab Phytohormones & Growth Dev, Changsha, Hunan, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Hunan Agricultural University	Shi, DY (corresponding author), China Agr Univ, Minist Agr, Key Lab Crop Genet Improvement & Genome, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China.	dyshi@sibs.ac.cn; weiweijin@cau.edu.cn	Xie, Wenjun/F-7895-2015	Xie, Wenjun/0000-0001-8101-5519	National Science Foundation of China [31025018]; Ministry of Science and Technology [2012AA10A305]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Science Foundation of China (31025018) and the Ministry of Science and Technology (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni F, 2011, BIOL CONSERV, V144, P35, DOI 10.1016/j.biocon.2010.08.016; Balestrasse KB, 2008, BIOMETALS, V21, P433, DOI 10.1007/s10534-008-9132-0; Basu D, 2000, PLANT MOL BIOL, V44, P27, DOI 10.1023/A:1006488119301; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Byers DL, 1999, ANNU REV ECOL SYST, V30, P479, DOI 10.1146/annurev.ecolsys.30.1.479; Cao ZY, 2011, J EXP BOT, V62, P4675, DOI 10.1093/jxb/err190; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Childs KL, 1997, PLANT PHYSIOL, V113, P611, DOI 10.1104/pp.113.2.611; CHRISTENSEN AH, 1989, GENE, V85, P381, DOI 10.1016/0378-1119(89)90431-9; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; Emborg TJ, 2006, PLANT PHYSIOL, V140, P856, DOI 10.1104/pp.105.074211; Frick G, 2003, PLANT J, V35, P141, DOI 10.1046/j.1365-313X.2003.01798.x; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Han B, 2012, PLANT SCI, V184, P63, DOI 10.1016/j.plantsci.2011.12.012; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Izawa T, 2000, PLANT J, V22, P391, DOI 10.1046/j.1365-313X.2000.00753.x; Jiang HW, 2007, PLANT J, V52, P197, DOI 10.1111/j.1365-313X.2007.03221.x; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; KOORNNEEF M, 1985, J PLANT PHYSIOL, V120, P153, DOI 10.1016/S0176-1617(85)80019-5; KRAEPIEL Y, 1994, MOL GEN GENET, V242, P559, DOI 10.1007/BF00285279; Lichtenthaler H.K., 1983, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Masuda T, 2003, PLANT CELL PHYSIOL, V44, P963, DOI 10.1093/pcp/pcg128; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mathews S, 1996, MOL BIOL EVOL, V13, P1141, DOI 10.1093/oxfordjournals.molbev.a025677; McCormac AC, 2002, PLANT J, V32, P549, DOI 10.1046/j.1365-313X.2002.01443.x; Muramoto T, 2002, PLANT PHYSIOL, V130, P1958, DOI 10.1104/pp.008128; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Noriega GO, 2004, BIOCHEM BIOPH RES CO, V323, P1003, DOI 10.1016/j.bbrc.2004.08.199; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; Reinbothe S, 1996, PLANT PHYSIOL, V111, P1, DOI 10.1104/pp.111.1.1; Santa-Cruz DM, 2010, PHYTOCHEMISTRY, V71, P1700, DOI 10.1016/j.phytochem.2010.07.009; Sawers RJH, 2004, PLANT PHYSIOL, V136, P2771, DOI 10.1104/pp.104.046417; Sawers RJH, 2002, PLANT PHYSIOL, V130, P155, DOI 10.1104/pp.006411; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Takano M, 2009, P NATL ACAD SCI USA, V106, P14705, DOI 10.1073/pnas.0907378106; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Terry MJ, 1996, J BIOL CHEM, V271, P21681, DOI 10.1074/jbc.271.35.21681; TERRY MJ, 1995, J BIOL CHEM, V270, P11111, DOI 10.1074/jbc.270.19.11111; Terry MJ, 1997, PLANT CELL ENVIRON, V20, P740, DOI 10.1046/j.1365-3040.1997.d01-102.x; Terry MJ, 1999, PLANT PHYSIOL, V119, P143, DOI 10.1104/pp.119.1.143; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wang PR, 2010, PLANT PHYSIOL, V153, P994, DOI 10.1104/pp.110.158477; Weller JL, 1997, PLANT J, V11, P1177, DOI 10.1046/j.1365-313X.1997.11061177.x; Weller JL, 1996, PLANT CELL, V8, P55; Wu MZ, 2011, J EXP BOT, V62, P235, DOI 10.1093/jxb/erq261; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Xie YJ, 2011, PLANT J, V66, P280, DOI 10.1111/j.1365-313X.2011.04488.x; Xie YJ, 2012, J EXP BOT, V63, P3869, DOI [10.1093/jxb/ers078, 10.1093/jxb/ers201]; Xie YJ, 2008, PLANT CELL ENVIRON, V31, P1864, DOI 10.1111/j.1365-3040.2008.01888.x; Xuan W, 2008, PLANT PHYSIOL, V148, P881, DOI 10.1104/pp.108.125567; Yannarelli GG, 2006, PLANTA, V224, P1154, DOI 10.1007/s00425-006-0297-x; YOKOO M, 1993, JPN J BREED, V43, P1	63	29	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80107	10.1371/journal.pone.0080107	http://dx.doi.org/10.1371/journal.pone.0080107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244620	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600180
J	Huang, H; Hu, K; Han, KT; Xiang, QY; Dai, SL				Huang He; Hu Ke; Han Keting; Xiang Qiaoyan; Dai Silan			Flower Colour Modification of Chrysanthemum by Suppression of F3 ' H and Overexpression of the Exogenous Senecio cruentus F3 ' 5 ' H Gene	PLOS ONE			English	Article							FLAVONOID BIOSYNTHETIC-PATHWAY; TORENIA-HYBRIDA; ANTHOCYANIN; PLANTS; CDNA; BLUE; IDENTIFICATION; EXPRESSION; PIGMENTS; BIOCHEMISTRY	Chrysanthemum (Chrysanthemum x morifolium) is one of the most important ornamental plants in the world. They are typically used as cut flowers or potted plants. Chrysanthemum can exhibit red, purple, pink, yellow and white flowers, but lack bright red and blue flowers. In this study, we identified two chrysanthemum cultivars, C x morifolium 'LPi' and C x morifolium 'LPu', that only accumulate flavonoids in their ligulate flowers. Next, we isolated seven anthocyanin biosynthesis genes, namely CmCHS, CmF3H, CmF3'H, CmDFR, CmANS, CmCHI and Cm3GT in these cultivars. RT-PCR and qRT-PCR analyses showed that CmF3'H was the most important enzyme required for cyanidin biosynthsis. To rebuild the delphinidin pathway, we downregulated CmF3'H using RNAi and overexpressed the Senecio cruentus F3'5'H (PCFH) gene in chrysanthemum. The resultant chrysanthemum demonstrated a significantly increased content of cyanidin and brighter red flower petals but did not accumulate delphinidin. These results indicated that CmF3'H in chrysanthemum is important for anthocyanin accumulation, and Senecio cruentus F3'5'H only exhibited F3' H activity in chrysanthemum but did not rebuild the delphinidin pathway to form blue flower chrysanthemum.	[Huang He; Hu Ke; Han Keting; Dai Silan] Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China; [Xiang Qiaoyan] Wuhan Bot Garden, Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Hunan, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Dai, SL (corresponding author), Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China.	silandai@sina.com			National Natural Science Foundation of China [31071823, 31272192]; Youth Chenguang Project of Science and Technology of Wuhan City [201050231024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Chenguang Project of Science and Technology of Wuhan City	This study was supported by the National Natural Science Foundation of China (31071823 & 31272192) and the Youth Chenguang Project of Science and Technology of Wuhan City (201050231024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boase MR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-107; BOLWELL GP, 1994, PHYTOCHEMISTRY, V37, P1491, DOI 10.1016/S0031-9422(00)89567-9; Brugliera F, 1999, PLANT J, V19, P441, DOI 10.1046/j.1365-313X.1999.00539.x; BRUGLIERA F, 2009, GOOGLE PATENTS; Chandler SF, 2011, BIOTECHNOL LETT, V33, P207, DOI 10.1007/s10529-010-0424-4; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; da Silva JAT, 2004, PLANT CELL TISS ORG, V79, P1, DOI 10.1023/B:TICU.0000049444.67329.b9; DEBENER T, 2010, ORNAMENTALS GENETIC; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Forkmann G, 2001, CURR OPIN BIOTECH, V12, P155, DOI 10.1016/S0958-1669(00)00192-0; Fukui Y, 2003, PHYTOCHEMISTRY, V63, P15, DOI 10.1016/S0031-9422(02)00684-2; Gion K, 2012, ACTA HORTIC, V953, P209, DOI 10.17660/ActaHortic.2012.953.29; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HAN KT, 2009, J BEIJING FORESTRY U, V2, P102; HOLTON TA, 1994, TRENDS BIOTECHNOL, V12, P40, DOI 10.1016/0167-7799(94)90097-3; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; Huang H, 2012, PLANT SCI, V193, P18, DOI 10.1016/j.plantsci.2012.05.004; HUGHES J, 1994, DNA SEQUENCE, V5, P41, DOI 10.3109/10425179409039703; Katsumoto Y, 2007, PLANT CELL PHYSIOL, V48, P1589, DOI 10.1093/pcp/pcm131; Lai JP, 2007, J CHROMATOGR B, V848, P215, DOI 10.1016/j.jchromb.2006.10.028; Lewis DFV, 1998, MUTAT RES-REV MUTAT, V410, P245, DOI 10.1016/S1383-5742(97)00040-9; Li F, 2006, PLANT PHYSIOL BIOCH, V44, P455, DOI 10.1016/j.plaphy.2006.08.006; Lin LZ, 2010, FOOD CHEM, V120, P319, DOI 10.1016/j.foodchem.2009.09.083; Lukacin R, 1997, EUR J BIOCHEM, V249, P748, DOI 10.1111/j.1432-1033.1997.t01-2-00748.x; MEYER P, 1987, NATURE, V330, P677, DOI 10.1038/330677a0; Nakamura N, 2010, PLANT BIOTECHNOL-NAR, V27, P375, DOI 10.5511/plantbiotechnology.10.0610a; Nakatsuka T, 2006, MOL BREEDING, V17, P91, DOI 10.1007/s11032-005-2520-z; Nakatsuka T, 2008, PLANT BIOTECHNOL-NAR, V25, P61, DOI 10.5511/plantbiotechnology.25.61; Nakatsuka T, 2007, PLANT CELL REP, V26, P1951, DOI 10.1007/s00299-007-0401-0; Nakayama M, 1997, BIOSCI BIOTECH BIOCH, V61, P1607, DOI 10.1271/bbb.61.1607; Nishihara M, 2005, FEBS LETT, V579, P6074, DOI 10.1016/j.febslet.2005.09.073; Nishihara M, 2011, BIOTECHNOL LETT, V33, P433, DOI 10.1007/s10529-010-0461-z; Okinaka Y, 2003, BIOSCI BIOTECH BIOCH, V67, P161, DOI 10.1271/bbb.67.161; Seitz C, 2003, ACTA HORTIC, P83, DOI 10.17660/ActaHortic.2003.612.10; Seitz C, 2006, PLANT MOL BIOL, V61, P365, DOI 10.1007/s11103-006-0012-0; Seitz C, 2007, PHYTOCHEMISTRY, V68, P824, DOI 10.1016/j.phytochem.2006.12.012; Shen GA, 2006, BIOSCIENCE REP, V26, P19, DOI 10.1007/s10540-006-9007-y; [孙卫 Sun Wei], 2010, [植物学报, Chinese Bulletin of Botany], V45, P327; Sun Wei, 2010, Acta Horticulturae Sinica, V37, P777; Sun Y, 2013, PHYSIOL PLANTARUM, V149, P151, DOI 10.1111/ppl.12034; Suzuki K, 2000, MOL BREEDING, V6, P239, DOI 10.1023/A:1009678514695; Tanaka Y, 2005, PLANT CELL TISS ORG, V80, P1, DOI 10.1007/s11240-004-0739-8; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tanaka Y, 2008, CURR OPIN BIOTECH, V19, P190, DOI 10.1016/j.copbio.2008.02.015; Tanaka Yoshikazu, 2006, Phytochemistry Reviews, V5, P283, DOI 10.1007/s11101-006-9003-7; Tanaka Y, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0432; Tanaka Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1760, DOI 10.1271/bbb.100358; Tanaka Y, 2009, INT J MOL SCI, V10, P5350, DOI 10.3390/ijms10125350; Ueyama Y, 2006, PLANT BIOTECHNOL, V23, P19, DOI DOI 10.5511/plantbiotechnology.23.19; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z; Zufall RA, 2004, NATURE, V428, P847, DOI 10.1038/nature02489	54	44	54	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e74395	10.1371/journal.pone.0074395	http://dx.doi.org/10.1371/journal.pone.0074395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250783	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200004
J	Machado, LR; Bowdrey, J; Ngaimisi, E; Habtewold, A; Minzi, O; Makonnen, E; Yimer, G; Amogne, W; Mugusi, S; Janabi, M; Aderaye, G; Mugusi, F; Viskaduraki, M; Aklillu, E; Hollox, EJ				Machado, Lee R.; Bowdrey, Jennifer; Ngaimisi, Eliford; Habtewold, Abiy; Minzi, Omary; Makonnen, Eyasu; Yimer, Getnet; Amogne, Wondwossen; Mugusi, Sabina; Janabi, Mohammed; Aderaye, Getachew; Mugusi, Ferdinand; Viskaduraki, Maria; Aklillu, Eleni; Hollox, Edward J.			Copy Number Variation of Fc Gamma Receptor Genes in HIV-Infected and HIV-Tuberculosis Co-Infected Individuals in Sub-Saharan Africa	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; NK CELLS; SUSCEPTIBILITY; POLYMORPHISM; IGG; ASSOCIATION; EXPRESSION; PROTECTION; AFFINITY; DISEASE	AIDS, caused by the retrovirus HIV, remains the largest cause of morbidity in sub-Saharan Africa yet almost all genetic studies have focused on cohorts from Western countries. HIV shows high co-morbidity with tuberculosis (TB), as HIV stimulates the reactivation of latent tuberculosis (TB). Recent clinical trials suggest that an effective anti-HIV response correlates with non-neutralising antibodies. Given that Fc gamma receptors are critical in mediating the non-neutralising effects of antibodies, analysis of the extensive variation at Fc gamma. receptor genes is important. Single nucleotide variation and copy number variation (CNV) of Fc gamma receptor genes affects the expression profile, activatory/inhibitory balance, and IgG affinity of the Fc gamma receptor repertoire of each individual. In this study we investigated whether CNV of FCGR2C, FCGR3A and FCGR3B as well as the HNA1 allotype of FCGR3B is associated with HIV load, response to highly-active antiretroviral therapy (HAART) and co-infection with TB. We confirmed an effect of TB-co-infection status on HIV load and response to HAART, but no conclusive effect of the genetic variants we tested. We observed a small effect, in Ethiopians, of FCGR3B copy number, where deletion was more frequent in HIV-TB co-infected patients than those infected with HIV alone.	[Machado, Lee R.; Bowdrey, Jennifer; Hollox, Edward J.] Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England; [Ngaimisi, Eliford; Habtewold, Abiy; Yimer, Getnet; Aklillu, Eleni] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Ngaimisi, Eliford; Minzi, Omary] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Pharmacol Unit, Dar Es Salaam, Tanzania; [Habtewold, Abiy; Makonnen, Eyasu; Yimer, Getnet] Univ Addis Ababa, Dept Pharmacol, Addis Ababa, Ethiopia; [Amogne, Wondwossen; Aderaye, Getachew] Univ Addis Ababa, Addis Ababa, Ethiopia; [Amogne, Wondwossen] Karolinska Inst, Karolinska Univ Hosp, Inst Med, Infect Dis Unit, Huddinge, Sweden; [Mugusi, Sabina] Muhimbili Natl Hosp, Dept Internal Med, Dar Es Salaam, Tanzania; [Janabi, Mohammed; Mugusi, Ferdinand] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Viskaduraki, Maria] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester LE1 7RH, Leics, England	University of Leicester; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Addis Ababa University; Addis Ababa University; Karolinska Institutet; Karolinska University Hospital; Muhimbili University of Health & Allied Sciences; University of Leicester	Hollox, EJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	Ejh33@le.ac.uk	Degu, Wondwossen Amogne/GON-3590-2022; Amogne, Wondwossen/AGM-9855-2022; Aklillu, Eleni/ABG-3461-2021; Yimer, Getnet/A-9436-2015	Makonnen, Eyasu/0000-0002-9259-5288; Machado, Lee/0000-0001-7974-2178; Aklillu, Eleni/0000-0002-9788-0790; Yimer, Getnet/0000-0002-1469-837X; Hollox, Edward/0000-0002-0115-2298	Wellcome Trust [087663]; United Kingdom Medical Research Council [GO801123]; European AMP; Developing Countries Clinical Trials Partnership [CT.2005.32030.001, CG_TA.05.40204_005]; Swedish International Development Cooperation Agency/Department for Research Cooperation [HIV-2006-031, SWE 2007-270, VR 521-2011-3437]	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European AMP; Developing Countries Clinical Trials Partnership; Swedish International Development Cooperation Agency/Department for Research Cooperation	This work was supported by the Wellcome Trust [grant number 087663] and a United Kingdom Medical Research Council New Investigator award [grant number GO801123] to E.J.H.; European & Developing Countries Clinical Trials Partnership [grant numbers CT.2005.32030.001, CG_TA.05.40204_005]; and the Swedish International Development Cooperation Agency/Department for Research Cooperation [grant numbers HIV-2006-031, SWE 2007-270, VR 521-2011-3437]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Brouwer KC, 2004, AIDS, V18, P1187, DOI 10.1097/00002030-200405210-00012; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Bux J, 2008, VOX SANG, V94, P277, DOI 10.1111/j.1423-0410.2007.01031.x; Day JH, 2004, J INFECT DIS, V190, P1677, DOI 10.1086/424851; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Hardwick RJ, 2012, J INFECT DIS, V206, P1012, DOI 10.1093/infdis/jis448; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; Junqueira-Kipnis AP, 2003, J IMMUNOL, V171, P6039, DOI 10.4049/jimmunol.171.11.6039; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Machado LR, 2012, AM J HUM GENET, V90, P973, DOI 10.1016/j.ajhg.2012.04.018; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Metes D, 1998, BLOOD, V91, P2369, DOI 10.1182/blood.V91.7.2369.2369_2369_2380; Mueller M, 2013, AM J HUM GENET, V92, P28, DOI 10.1016/j.ajhg.2012.11.013; Mugusi SF, 2012, ANTIVIR THER, V17, P265, DOI 10.3851/IMP1956; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Niederer HA, 2010, ANN NY ACAD SCI, V1183, P69, DOI 10.1111/j.1749-6632.2009.05132.x; ORY PA, 1989, J CLIN INVEST, V84, P1688, DOI 10.1172/JCI114350; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Robinson JI, 2012, HUM MUTAT, V33, P741, DOI 10.1002/humu.22031; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; van der Heijden J, 2012, J IMMUNOL, V188, P1318, DOI 10.4049/jimmunol.1003945; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413	31	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78165	10.1371/journal.pone.0078165	http://dx.doi.org/10.1371/journal.pone.0078165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250791	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200012
J	Shen, Y; Xu, Q; Ren, ML; Feng, X; Cai, YL; Gao, YX				Shen, Yang; Xu, Qian; Ren, Mulan; Feng, Xu; Cai, Yunlang; Gao, Yongxing			Measurement of Phenolic Environmental Estrogens in Women with Uterine Leiomyoma	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; BAR SORPTIVE EXTRACTION; BISPHENOL-A; HUMAN URINE; DERIVATIZATION; 4-NONYLPHENOL; POPULATION; EXPOSURE	Objectives: To investigate the effect of phenolic environmental estrogens on uterine leiomyoma from the perspective of clinical epidemiology. Methods: Urine and blood samples were collected from Han women with uterine leiomyoma and women without uterine leiomyoma, living in Nanjing, China, between September 2011 and February 2013. A total of 156 urine samples and 214 blood samples were collected from the uterine leiomyoma group and 106 urine samples and 126 blood plasma samples from the control group. Bisphenol A (BPA), nonylphenol (NP) and octylphenol (OP) concentrations were determined by solid-phase extraction (SPE) coupled with liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Results: Phenolic environmental estrogens in the uterine leiomyoma and control groups were compared based on: gravida >3 and gravida <= 3. In participants with gravida >3, urine OP concentration was significantly (P<0.05) higher in the uterine leiomyoma group than in the control group. In participants with gravida <= 3, urine NP concentration was significantly (P<0.05) higher in the uterine leiomyoma group compared to controls. Despite obstetric history, urine BPA mean exposure concentration was significantly (P<0.05) different between uterine leiomyoma group and control group. The urine BPA concentration was not significantly (P>0.05) different between gravida >3 and gravida <= 3 patients. There was no significant (P>0.05) difference in plasma concentrations of BPA, OP and NP between the leiomyoma group and control group. Mean exposure concentration and range of distribution of BPA, OP and NP plasma concentration differed between the uterine leiomyoma and control group. Conclusion: Exposure level of phenolic environmental estrogens in human was related with leiomyoma tumorigenesis.	[Shen, Yang; Ren, Mulan; Feng, Xu; Cai, Yunlang; Gao, Yongxing] Southeast Univ, Sch Med, Zhongda Hosp, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China; [Xu, Qian] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Xu, Qian] Southeast Univ, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Shen, Y (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China.	shenyang0924@sina.cn			Jiangsu Province Health Department [Q201305]; Science and Technology Project Nanjing Municipal [201201054]; National Natural Science Pre-research Project funds of the Southeast University [3290001102]; SRTP Project of the Southeast University [T11431001]	Jiangsu Province Health Department; Science and Technology Project Nanjing Municipal; National Natural Science Pre-research Project funds of the Southeast University; SRTP Project of the Southeast University	This work was supported by the Youth fund projects of Jiangsu Province Health Department (Q201305), the Science and Technology Project Nanjing Municipal (201201054), the National Natural Science Pre-research Project funds of the Southeast University (3290001102), and the SRTP Project of the Southeast University (T11431001). Dr. Shen is the leader of all of the projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Duhan N, 2010, EUR J OBSTET GYN R B, V152, P119, DOI 10.1016/j.ejogrb.2010.05.010; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Islam MS, 2013, J CLIN ENDOCR METAB, V98, P921, DOI 10.1210/jc.2012-3237; Kawaguchi M, 2006, J PHARMACEUT BIOMED, V40, P82, DOI 10.1016/j.jpba.2005.05.024; Kawaguchi M, 2005, J CHROMATOGR B, V820, P49, DOI 10.1016/j.jchromb.2005.03.019; Kuklenyik Z, 2003, ANAL CHEM, V75, P6820, DOI 10.1021/ac0303158; Mao LH, 2004, ANAL CHIM ACTA, V522, P241, DOI 10.1016/j.aca.2004.04.071; Maruo T, 2004, HUM REPROD UPDATE, V10, P207, DOI 10.1093/humupd/dmh019; Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d; Yu L, 2012, J SIGNAL TRANSDUCT, V2012, P204	13	33	38	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79838	10.1371/journal.pone.0079838	http://dx.doi.org/10.1371/journal.pone.0079838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255718	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200091
J	Maund, SL; Shi, LH; Cramer, SD				Maund, Sophia L.; Shi, Lihong; Cramer, Scott D.			A Role for Interleukin-1 Alpha in the 1,25 Dihydroxyvitamin D-3 Response in Mammary Epithelial Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; VITAMIN-D ANALOG; 1,25-DIHYDROXYVITAMIN D-3; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; ESTROGEN-RECEPTOR; GLAND DEVELOPMENT; BOUND IL-1-ALPHA; GENE-EXPRESSION; KAPPA-B; EB 1089	Breast cancer is the most common non-cutaneous malignancy in American women, and better preventative strategies are needed. Epidemiological and laboratory studies point to vitamin D-3 as a promising chemopreventative agent for breast cancer. Vitamin D-3 metabolites induce anti-proliferative effects in breast cancer cells in vitro and in vivo, but few studies have investigated their effects in normal mammary epithelial cells. We hypothesized that 1,25(OH)(2)D-3, the metabolically active form of vitamin D-3, is growth suppressive in normal mouse mammary epithelial cells. In addition, we have previously established a role for the cytokine interleukin-1 alpha (IL1 alpha) in the anti-proliferative effects of 1,25(OH)(2)D-3 in normal prostate cells, and so we hypothesized that IL1 alpha is involved in the 1,25(OH)(2)D-3 response in mammary cells. Evaluation of cell viability, clonogenicity, senescence, and induction of cell cycle regulators p21 and p27 supported an anti-proliferative role for 1,25(OH)(2)D-3 in mammary epithelial cells. Furthermore, 1,25(OH)(2)D-3 increased the intracellular expression of IL1 alpha, which was necessary for the anti-proliferative effects of 1,25(OH)(2)D-3 in mammary cells. Together, these findings support the chemopreventative potential of vitamin D-3 in the mammary gland and present a role for IL1 alpha in regulation of mammary cell proliferation by 1,25(OH)(2)D-3.	[Maund, Sophia L.; Shi, Lihong] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Cramer, Scott D.] Univ Colorado, Dept Pharmacol, Aurora, CO USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Cramer, SD (corresponding author), Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO USA.	scott.cramer@ucdenver.edu			 [T32CA079448];  [RO1CA10102];  [RO1CA150105]; NATIONAL CANCER INSTITUTE [T32CA079448, R01CA150105] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T32CA079448, RO1CA10102, RO1CA150105; www.grants.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Axanova LS, 2010, PROSTATE, V70, P1658, DOI 10.1002/pros.21201; Barclay WW, 2008, STEM CELLS, V26, P600, DOI 10.1634/stemcells.2007-0309; Barclay WW, 2005, PROSTATE, V63, P291, DOI 10.1002/pros.20193; BERGER U, 1991, CANCER RES, V51, P239; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Colston KW, 2002, ENDOCR-RELAT CANCER, V9, P45, DOI 10.1677/erc.0.0090045; DANFORTH DN, 1991, CANCER RES, V51, P1488; ELLER MS, 1995, J CELL SCI, V108, P2741; Engel LS, 2012, CANCER EPIDEM BIOMAR, V21, P1856, DOI 10.1158/1055-9965.EPI-12-0551; Ewald JA, 2012, TRANSL ONCOL, V5, P278, DOI 10.1593/tlo.12181; FRYLING C, 1989, CANCER RES, V49, P3333; GAFFNEY EV, 1988, CANCER RES, V48, P5455; GARFINKEL S, 1994, P NATL ACAD SCI USA, V91, P1559, DOI 10.1073/pnas.91.4.1559; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Giovannucci E, 2008, ADV EXP MED BIOL, V624, P31, DOI 10.1007/978-0-387-77574-6_3; GRENFELL S, 1989, BIOCHEM J, V264, P813, DOI 10.1042/bj2640813; GROVES RW, 1992, J INVEST DERMATOL, V98, P384, DOI 10.1111/1523-1747.ep12499816; Gulliford T, 1998, BRIT J CANCER, V78, P6, DOI 10.1038/bjc.1998.434; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; Hansen CM, 2000, CURR PHARM DESIGN, V6, P803, DOI 10.2174/1381612003400371; Hirsch CL, 2004, FEBS LETT, V570, P37, DOI 10.1016/j.febslet.2004.06.018; Janowsky EC, 1999, PUBLIC HEALTH NUTR, V2, P283, DOI 10.1017/S1368980099000385; Jimi E, 1998, J BIOL CHEM, V273, P8799, DOI 10.1074/jbc.273.15.8799; Kemmis CM, 2008, J CELL BIOCHEM, V105, P980, DOI 10.1002/jcb.21896; Kemmis CM, 2006, J NUTR, V136, P887, DOI 10.1093/jn/136.4.887; KILIAN PL, 1991, CANCER RES, V51, P1823; Koli K, 2000, CELL GROWTH DIFFER, V11, P221; Krishnan AV, 2012, J STEROID BIOCH MOL; Lader CS, 1998, ENDOCRINOLOGY, V139, P3157, DOI 10.1210/en.139.7.3157; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Lopes N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3178; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Lowe L, 2003, RECENT RESULTS CANC, V164, P99; Luheshi NM, 2009, EUR J IMMUNOL, V39, P2973, DOI 10.1002/eji.200939712; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; Matthews D, 2010, J STEROID BIOCHEM, V121, P362, DOI 10.1016/j.jsbmb.2010.03.061; Maund SL, 2011, CANC RES; Mehta RG, 2012, CANC LETT; MIZEL SB, 1987, J IMMUNOL, V138, P2906; Murai T, 2001, J BIOL CHEM, V276, P6797, DOI 10.1074/jbc.M009355200; Nalca A, 1998, J BIOL CHEM, V273, P30517, DOI 10.1074/jbc.273.46.30517; NAM MJ, 1995, PROSTAG LEUKOTR ESS, V53, P69, DOI 10.1016/0952-3278(95)90086-1; Narvaez CJ, 2001, STEROIDS, V66, P301, DOI 10.1016/S0039-128X(00)00202-6; ONOZAKI K, 1985, J IMMUNOL, V135, P3962; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; PACIOTTI GF, 1988, MOL ENDOCRINOL, V2, P459, DOI 10.1210/mend-2-5-459; Paduch R, 2005, CELL BIOL TOXICOL, V21, P247, DOI 10.1007/s10565-005-0002-z; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Pendas-Franco N, 2007, DIFFERENTIATION, V75, P193, DOI 10.1111/j.1432-0436.2006.00131.x; Peppone L, 2011, CANCER EPIDEM BIOMAR, V20, P717, DOI 10.1158/1055-9965.EPI-11-0089; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Singer C F, 2006, Int J Gynecol Cancer, V16 Suppl 2, P556, DOI 10.1111/j.1525-1438.2006.00695.x; Singer CF, 2003, CLIN CANCER RES, V9, P4877; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Sui G, 2005, METH MOL B, V309, P205; Swami S, 2003, BREAST CANCER RES TR, V80, P49, DOI 10.1023/A:1024487118457; Thorburn J, 2005, MOL BIOL CELL, V16, P1189, DOI 10.1091/mbc.E04-10-0906; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Wade WN, 2002, J BIOL CHEM, V277, P37301, DOI 10.1074/jbc.M204162200; Wang Q, 2001, BREAST CANCER RES TR, V67, P157, DOI 10.1023/A:1010643323268; WARNER RL, 1995, AM J RESP CELL MOL, V12, P649, DOI 10.1165/ajrcmb.12.6.7539274; WELSH J, 1994, BIOCHEM CELL BIOL, V72, P537, DOI 10.1139/o94-072; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Wolf JS, 2001, CLIN CANCER RES, V7, P1812; Yao S, 2013, J STEROID BIOCHEM, V136, P337, DOI 10.1016/j.jsbmb.2012.09.010; Yousef FM, 2013, AM J CLIN NUTR, V98, P105, DOI 10.3945/ajcn.112.054445; Zinser GA, 2004, J STEROID BIOCHEM, V89-90, P433, DOI 10.1016/j.jsbmb.2004.03.012; Zinser GM, 2004, MOL ENDOCRINOL, V18, P2208, DOI 10.1210/me.2003-0469	73	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e81367	10.1371/journal.pone.0081367	http://dx.doi.org/10.1371/journal.pone.0081367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244740	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900089
J	Xu, JP; Wei, Y				Xu, Jiuping; Wei, Ying			Social Support as a Moderator of the Relationship between Anxiety and Depression: An Empirical Study with Adult Survivors of Wenchuan Earthquake	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSION; SYMPTOMS; DISASTER; HEALTH; SAMPLE; MODEL	Background: On May 12th 2008, an earthquake with a magnitude of 8.0 on the Richter scale struck China, causing a large number of casualties and significant economic losses. By interviewing 2080 survivors of Wenchuan earthquake, the objective of this study is to estimate the role of different types of social support as possible moderating factors between anxiety and depression. Methods: A stratified random sampling strategy about the cross-sectional study was adopted. The self-rating anxiety scale (SAS), Self-Rating Depression Scale (SDS) and Social Support Rating Scale (SSRS) were used. A total of 2080 adult survivors of the Wenchuan earthquake from 19 damaged countries participated in the survey. Correlation analysis and regression analysis were performed to evaluate the moderating role of social support on the relationship between anxiety and depression. Results: One year after the Wenchuan earthquake, anxiety and depression were found to be 37.6% and 40.7%, respectively. Demographic characteristics were seen as significant in the cases of depression, except for age (p=0.599), while age and education level were not found to be significant for anxiety. The results showed that social support, especially subjective support could moderate the association between anxiety and depression. Conclusions: Social support should be particularly focused on female survivors, those of the Han ethnic group, and those with a lower level of education and a lower income. Psychological intervention and care for survivors should focus on those most disoriented by the disaster.	[Xu, Jiuping; Wei, Ying] Sichuan Univ, Uncertainty Decis Making Lab, Chengdu 610064, Peoples R China	Sichuan University	Xu, JP (corresponding author), Sichuan Univ, Uncertainty Decis Making Lab, Chengdu 610064, Peoples R China.	xujiuping@scu.edu.cn			Major Bidding Program of the National Social Science Foundation of China [12ZD217]; Sichuan University [SKG2013001]	Major Bidding Program of the National Social Science Foundation of China; Sichuan University(Sichuan University)	This research was supported by Major Bidding Program of the National Social Science Foundation of China (Grant No. 12&ZD217) and the research funding of Sichuan University (Grant No. SKG2013001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN LS, 1991, MULTIPLE REGRESSION, P105; Batterham PJ, 2013, DEPRESS ANXIETY, V30, P908, DOI 10.1002/da.22066; BLAZER D, 1991, J PSYCHIAT RES, V25, P191, DOI 10.1016/0022-3956(91)90024-5; Bonanno GA, 2006, PSYCHOL SCI, V17, P181, DOI 10.1111/j.1467-9280.2006.01682.x; Brummett BH, 2000, J AFFECT DISORDERS, V61, P41, DOI 10.1016/S0165-0327(99)00191-3; Chen WQ, 2009, STRESS HEALTH, V25, P431, DOI 10.1002/smi.1263; Cheng YB, 2008, PARKINSONISM RELAT D, V14, P43, DOI 10.1016/j.parkreldis.2007.05.011; Dirkzwager AJE, 2006, BRIT J PSYCHIAT, V189, P144, DOI 10.1192/bjp.bp.105.017855; Drageset S, 2003, J Psychiatr Ment Health Nurs, V10, P401, DOI 10.1046/j.1365-2850.2003.00618.x; FAN F, 2012, PLOS ONE, V7, P29404, DOI DOI 10.1371/J0URNAL.P0NE.0029404.PUBMED:22295059; Fentz HN, 2011, J ANXIETY DISORD, V25, P1095, DOI 10.1016/j.janxdis.2011.07.008; Glazier RH, 2004, J PSYCHOSOM OBST GYN, V25, P247, DOI 10.1080/01674820400024406; Han HR, 2007, J CROSS-CULT GERONTO, V22, P115, DOI 10.1007/s10823-006-9022-2; Hansen M, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.18201; Hofmann SG, 2003, J ANXIETY DISORD, V17, P573, DOI 10.1016/S0887-6185(02)00227-X; Holahan CJ, 1997, J PERS SOC PSYCHOL, V72, P918, DOI 10.1037/0022-3514.72.4.918; Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706; Liu ZJ, 2013, DISASTER ADV, V6, P69; Lynch TR, 1999, J AFFECT DISORDERS, V55, P159, DOI 10.1016/S0165-0327(99)00017-8; McLeish AC, 2008, DEPRESS ANXIETY, V25, P416, DOI 10.1002/da.20426; Potochnick SR, 2010, J NERV MENT DIS, V198, P470, DOI 10.1097/NMD.0b013e3181e4ce24; Ritchie K, 2004, BRIT J PSYCHIAT, V184, P147, DOI 10.1192/bjp.184.2.147; SHUMAKER SA, 1984, J SOC ISSUES, V40, P11, DOI 10.1111/j.1540-4560.1984.tb01105.x; STRACK S, 1983, J PERS SOC PSYCHOL, V44, P798, DOI 10.1037/0022-3514.44.4.798; Tull MT, 2008, J ANXIETY DISORD, V22, P199, DOI 10.1016/j.janxdis.2007.03.005; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041665; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Xiao S., 1993, CHINESE MENTAL HLT S, V7, P42; Xu J., 2013, COMMUNITY MENT HLT J, P1; Xu JP, 2013, DISASTER ADV, V6, P58; Xu JP, 2012, SOC BEHAV PERSONAL, V40, P1625, DOI 10.2224/sbp.2012.40.10.1625; Xu JP, 2012, PSYCHIAT CLIN NEUROS, V66, P210, DOI 10.1111/j.1440-1819.2012.02331.x; Zhao CY, 2013, QUAL LIFE RES, V22, P733, DOI 10.1007/s11136-012-0197-4; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	35	47	49	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e79045	10.1371/journal.pone.0079045	http://dx.doi.org/10.1371/journal.pone.0079045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24250754	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300170
J	Kofler, S; Ackaert, C; Samonig, M; Asam, C; Briza, P; Horejs-Hoeck, J; Cabrele, C; Ferreira, F; Duschl, A; Huber, C; Brandstetter, H				Kofler, Stefan; Ackaert, Chloe; Samonig, Martin; Asam, Claudia; Briza, Peter; Horejs-Hoeck, Jutta; Cabrele, Chiara; Ferreira, Fatima; Duschl, Albert; Huber, Christian; Brandstetter, Hans			Stabilization of the Dimeric Birch Pollen Allergen Bet v 1 Impacts Its Immunological Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergen; Crystal Structure; Mass Spectrometry (MS); Post-translational Modification; Protein Assembly; Dimerization; Noncanonical Amino Acid Incorporation; Polysulfide Linking; Position-specific Alteration of Genetic Code	SITE-DIRECTED MUTAGENESIS; IGE-BINDING; CRYSTAL-STRUCTURE; MAJOR ALLERGEN; X-RAY; MONOCLONAL-ANTIBODIES; PROTEIN STRUCTURES; CROSS-REACTIVITY; TYPE-2 RESPONSES; POTENTIAL USE	Many allergens share several biophysical characteristics, including the capability to undergo oligomerization. The dimerization mechanism in Bet v 1 and its allergenic properties are so far poorly understood. Here, we report crystal structures of dimeric Bet v 1, revealing a noncanonical incorporation of cysteine at position 5 instead of genetically encoded tyrosine. Cysteine polysulfide bridging stabilized different dimeric assemblies, depending on the polysulfide linker length. These dimers represent quaternary arrangements that are frequently observed in related proteins, reflecting their prevalence in unmodified Bet v 1. These conclusions were corroborated by characteristic immunologic properties of monomeric and dimeric allergen variants. Hereby, residue 5 could be identified as an allergenic hot spot in Bet v 1. The presented results refine fundamental principles in protein chemistry and emphasize the importance of protein modifications in understanding the molecular basis of allergenicity.	[Kofler, Stefan; Brandstetter, Hans] Salzburg Univ, Dept Mol Biol, Struct Biol Grp, A-5020 Salzburg, Austria; [Ackaert, Chloe; Asam, Claudia; Briza, Peter; Horejs-Hoeck, Jutta; Ferreira, Fatima; Duschl, Albert] Salzburg Univ, Dept Mol Biol, Div Allergy & Immunol, A-5020 Salzburg, Austria; [Samonig, Martin; Cabrele, Chiara; Huber, Christian] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria	Salzburg University; Salzburg University; Salzburg University	Brandstetter, H (corresponding author), Salzburg Univ, Dept Mol Biol, Struct Biol Grp, A-5020 Salzburg, Austria.	Hans.Brandstetter@sbg.ac.at	Ferreira, Fatima/E-4889-2011; Duschl, Albert/E-5872-2011; Briza, Peter/D-7309-2012; Horejs-Hoeck, Jutta/E-5010-2011; Brandstetter, Hans/E-6754-2011; Huber, Christian G./E-5445-2011; Horejs-Hoeck, Jutta/AAF-1735-2019; Cabrele, Chiara/B-8790-2015; Ferreira, Fatima/AAB-4321-2019	Ferreira, Fatima/0000-0003-0989-2335; Duschl, Albert/0000-0002-7034-9860; Briza, Peter/0000-0002-4941-6782; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Brandstetter, Hans/0000-0002-6089-3045; Huber, Christian G./0000-0001-8358-1880; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Cabrele, Chiara/0000-0002-7550-6896; Ferreira, Fatima/0000-0003-0989-2335	Austrian Science Fund [W_01213, P22236_B1]; Austrian Science Fund (FWF) [P 22236] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Projects W_01213 and P22236_B1.	Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Artis D, 1999, J EXP MED, V190, P953, DOI 10.1084/jem.190.7.953; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Del Corno M, 2009, BLOOD, V114, P796, DOI 10.1182/blood-2009-01-199406; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gieras A, 2011, J IMMUNOL, V186, P5333, DOI 10.4049/jimmunol.1000804; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671; JAROLIM E, 1989, INT ARCH ALLER A IMM, V90, P54, DOI 10.1159/000235000; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kikuchi Y, 2006, J IMMUNOL, V177, P1609, DOI 10.4049/jimmunol.177.3.1609; Krebitz M, 2000, FASEB J, V14, P1279, DOI 10.1096/fj.14.10.1279; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; Magler I, 2010, FEBS J, V277, P2598, DOI [10.1111/j.1742-464X.2010.07671.x, 10.1111/j.1742-4658.2010.07671.x]; Maleki SJ, 2000, J IMMUNOL, V164, P5844, DOI 10.4049/jimmunol.164.11.5844; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Michalska K, 2010, J STRUCT BIOL, V169, P161, DOI 10.1016/j.jsb.2009.10.008; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Mohr J, 2010, PROTEOMICS, V10, P3598, DOI 10.1002/pmic.201000341; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007245; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Niu XG, 2011, J MOL BIOL, V405, P479, DOI 10.1016/j.jmb.2010.11.007; PRECUP J, 1989, MOL GEN GENET, V218, P397, DOI 10.1007/BF00332401; Premstaller A, 2001, ANAL CHEM, V73, P2390, DOI 10.1021/ac010046q; Rouvinen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009037; Schein CH, 2010, BIOINFORM BIOL INSIG, V4, P113, DOI 10.4137/BBI.S5737; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; Sippl MJ, 2012, STRUCTURE, V20, P718, DOI 10.1016/j.str.2012.01.024; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verdino P, 2002, EMBO J, V21, P5007, DOI 10.1093/emboj/cdf526; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Weichenberger CX, 2007, NUCLEIC ACIDS RES, V35, pW403, DOI 10.1093/nar/gkm263; Wellhausen A, 1996, Z ERNAHRUNGSWISS, V35, P348, DOI 10.1007/BF01610553; You Z, 2010, BIOCHEMISTRY-US, V49, P1191, DOI 10.1021/bi901844d; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	49	21	22	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					540	551		10.1074/jbc.M113.518795	http://dx.doi.org/10.1074/jbc.M113.518795			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24253036	Green Published, hybrid			2022-12-25	WOS:000329370900046
J	Baker, J; Schorer, J				Baker, Joseph; Schorer, Joerg			The Southpaw Advantage? - Lateral Preference in Mixed Martial Arts	PLOS ONE			English	Article							HANDEDNESS; FREQUENCY	Performers with a left-orientation have a greater likelihood of obtaining elite levels of performance in many interactive sports. This study examined whether combat stance orientation was related to skill and success in Mixed Martial Arts fighters. Data were extracted for 1468 mixed martial artists from a reliable and valid online data source. Measures included fighting stance, win percentage and an ordinal measure of skill based on number of fights. The overall analysis revealed that the fraction of fighters using a southpaw stance was greater than the fraction of left-handers in the general population, but the relationship between stance and hand-preference is not well-understood. Furthermore, t-tests found no statistically significant relationship between laterality and winning percentage, although there was a significant difference between stances for number of fights. Southpaw fighters had a greater number of fights than those using an orthodox stance. These results contribute to an expanding database on the influence of laterality on sport performance and a relatively limited database on variables associated with success in mixed martial arts.	[Baker, Joseph] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Schorer, Joerg] Carl von Ossietzky Univ Oldenburg, Inst Sport Sci, D-26111 Oldenburg, Germany	York University - Canada; Carl von Ossietzky Universitat Oldenburg	Baker, J (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	bakerj@yorku.ca	Baker, Joseph/J-6164-2014	Baker, Joseph/0000-0002-5686-1737; Schorer, Jorg/0000-0002-4888-7048				Faurie C, 2004, P ROY SOC B-BIOL SCI, V271, pS43, DOI 10.1098/rsbl.2003.0092; Goldstein SR, 1996, J COMP PSYCHOL, V110, P164; Hagemann N, 2009, ATTEN PERCEPT PSYCHO, V71, P1641, DOI 10.3758/APP.71.7.1641; Harris LJ, 2010, LATERALITY, V15, P15, DOI 10.1080/13576500701650430; Holtzen DW, 2000, INT J NEUROSCI, V105, P101, DOI 10.3109/00207450009003270; Loffing F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049325; Loffing F, 2012, ATTEN PERCEPT PSYCHO, V74, P446, DOI 10.3758/s13414-011-0252-1; Mikheev M, 2002, NEUROPSYCHOLOGIA, V40, P1209, DOI 10.1016/S0028-3932(01)00227-5; Puterman J, 2010, J SPORT SCI, V28, P1581, DOI 10.1080/02640414.2010.514281; Raymond M, 1996, P ROY SOC B-BIOL SCI, V263, P1627, DOI 10.1098/rspb.1996.0238; Schorer J, 2012, J SPORT SCI, V30, P507, DOI 10.1080/02640414.2012.654811; Sterkowicz S, 2010, ARCH BUDO, V6, P173; World Medical Association, 2008, DECL HELS ETH PRINC	13	25	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79793	10.1371/journal.pone.0079793	http://dx.doi.org/10.1371/journal.pone.0079793			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260301	gold, Green Submitted, Green Published			2022-12-25	WOS:000327311900047
J	Kimmel, C; Visweswaran, S				Kimmel, Chad; Visweswaran, Shyam			An Algorithm for Network-Based Gene Prioritization That Encodes Knowledge Both in Nodes and in Links	PLOS ONE			English	Article							DISEASE; IDENTIFICATION; ASSOCIATION; PREDICTION	Background: Candidate gene prioritization aims to identify promising new genes associated with a disease or a biological process from a larger set of candidate genes. In recent years, network-based methods - which utilize a knowledge network derived from biological knowledge - have been utilized for gene prioritization. Biological knowledge can be encoded either through the network's links or nodes. Current network-based methods can only encode knowledge through links. This paper describes a new network-based method that can encode knowledge in links as well as in nodes. Results: We developed a new network inference algorithm called the Knowledge Network Gene Prioritization (KNGP) algorithm which can incorporate both link and node knowledge. The performance of the KNGP algorithm was evaluated on both synthetic networks and on networks incorporating biological knowledge. The results showed that the combination of link knowledge and node knowledge provided a significant benefit across 19 experimental diseases over using link knowledge alone or node knowledge alone. Conclusions: The KNGP algorithm provides an advance over current network-based algorithms, because the algorithm can encode both link and node knowledge. We hope the algorithm will aid researchers with gene prioritization.	[Kimmel, Chad; Visweswaran, Shyam] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kimmel, C (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15213 USA.	cpk5@pitt.edu		Visweswaran, Shyam/0000-0002-2079-8684	National Library of Medicine in Informatics; University of Pittsburgh; NATIONAL LIBRARY OF MEDICINE [T15LM007059] Funding Source: NIH RePORTER	National Library of Medicine in Informatics; University of Pittsburgh(University of Pittsburgh); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The Sources of Funding were the pre-doctoral fellowship from the National Library of Medicine in Informatics and the pre-doctoral fellowship in the Clinical and Translational Sciences at the University of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chen JX, 2006, PROCEEDINGS OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON VEHICULAR ELECTRONICS AND SAFETY, P367; Chen YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021137; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Gonzalez G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P28; Grolmusz V., 2012, NOTE PAGERANK UNDIRE; Havlin S, 2012, EUR PHYS J-SPEC TOP, V214, P273, DOI 10.1140/epjst/e2012-01695-x; Ivan G, 2011, BIOINFORMATICS, V27, P405, DOI 10.1093/bioinformatics/btq680; Kauppi P, 2000, EUR J HUM GENET, V8, P788, DOI 10.1038/sj.ejhg.5200541; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Madi A, 2011, CHAOS, V21, DOI 10.1063/1.3543800; Madi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017445; McDowall MD, 2009, NUCLEIC ACIDS RES, V37, pD651, DOI 10.1093/nar/gkn870; Moreau Y, 2012, NAT REV GENET, V13, P523, DOI 10.1038/nrg3253; Nitsch D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005526; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Page L, 1999, PAGERANK CITATION RA; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; Roth D, 2010, BIOCOMMUNICATION SOI, P255; Scott MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-239; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79564	10.1371/journal.pone.0079564	http://dx.doi.org/10.1371/journal.pone.0079564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260251	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000327311900030
J	Foster, JD; Goldmann, W; Hunter, N				Foster, James D.; Goldmann, Wilfred; Hunter, Nora			Evidence in Sheep for Pre-Natal Transmission of Scrapie to Lambs from Infected Mothers	PLOS ONE			English	Article							NATURAL SCRAPIE; PRP GENOTYPE; BLOOD-TRANSFUSION; PRION DISEASES; SUFFOLK SHEEP; CLOSED FLOCK; PROTEIN PRP; ACCUMULATION; BRAIN; AGENT	Natural scrapie transmission from infected ewes to their lambs is thought to occur by the oral route around the time of birth. However the hypothesis that scrapie transmission can also occur before birth (in utero) is not currently favoured by most researchers. As scrapie is an opportunistic infection with multiple infection routes likely to be functional in sheep, definitive evidence for or against transmission from ewe to her developing fetus has been difficult to achieve. In addition the very early literature on maternal transmission of scrapie in sheep was compromised by lack of knowledge of the role of the PRNP (prion protein) gene in control of susceptibility to scrapie. In this study we experimentally infected pregnant ewes of known PRNP genotype with a distinctive scrapie strain (SSBP/1) and looked for evidence of transmission of SSBP/1 to the offspring. The sheep were from the NPU Cheviot flock, which has endemic natural scrapie from which SSBP/1 can be differentiated on the basis of histology, genetics of disease incidence and strain typing bioassay in mice. We used embryo transfer techniques to allow sheep fetuses of scrapie-susceptible PRNP genotypes to develop in a range of scrapie-resistant and susceptible recipient mothers and challenged the recipients with SSBP/1. Scrapie clinical disease, caused by both natural scrapie and SSBP/1, occurred in the progeny but evidence (including mouse strain typing) of SSBP/1 infection was found only in lambs born to fully susceptible recipient mothers. Progeny were not protected from transmission of natural scrapie or SSBP/1 by washing of embryos to International Embryo Transfer Society standards or by caesarean derivation and complete separation from their birth mothers. Our results strongly suggest that pre-natal (in utero) transmission of scrapie may have occurred in these sheep.	[Hunter, Nora] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Hunter, N (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	nora.hunter@roslin.ed.ac.uk			Defra (UK Department for the Environment, Food and Rural Affairs) [SE1823]; BBSRC (UK Biotechnology and Biological Sciences Research Council); BBSRC [BBS/E/D/20251967, BBS/E/D/05241340, BBS/E/D/20251968, BBS/E/A/00001651] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251967, BBS/E/D/05241340, BBS/E/D/20251968, BBS/E/I/00000900, BBS/E/A/00001651] Funding Source: researchfish	Defra (UK Department for the Environment, Food and Rural Affairs); BBSRC (UK Biotechnology and Biological Sciences Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The project was funded by Defra (UK Department for the Environment, Food and Rural Affairs) Grant number SE1823 (www.gov.co.uk/defra) with core support funding to the Institute for Animal Health from BBSRC (UK Biotechnology and Biological Sciences Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson J, 2006, J GEN VIROL, V87, P1035, DOI 10.1099/vir.0.81418-0; Andreoletti O, 2002, J GEN VIROL, V83, P2607, DOI 10.1099/0022-1317-83-10-2607; Andreoletti O, 2012, PLOS PATH, V8, DOI [100210.101371/journal.ppat.1002782, DOI 10.101371/J0URNAL.PPAT.1002782]; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; Beck KE, 2012, BRAIN PATHOL, V22, P265, DOI 10.1111/j.1750-3639.2011.00526.x; Begara-McGorum I, 2002, J COMP PATHOL, V127, P59, DOI 10.1053/jcpa.2002.0558; Bossers A, 1999, ARCH VIROL, V144, P829, DOI 10.1007/s007050050548; Brace RA, 2013, REPROD SCI, V20, P326, DOI 10.1177/1933719112453510; BRADLEY RM, 1973, SCIENCE, V179, P1016, DOI 10.1126/science.179.4077.1016; Bulgin MS, 2006, AM J VET RES, V67, P498, DOI 10.2460/ajvr.67.3.498; BURTON GJ, 1976, Q J EXP PHYSIOL CMS, V61, P275, DOI 10.1113/expphysiol.1976.sp002359; Garza MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027525; Couquet C., 2005, Bulletin de l'Academie Veterinaire de France, V158, P25, DOI 10.4267/2042/47748; Dickinson A G, 1976, Front Biol, V44, P209; DICKINSON AG, 1974, J COMP PATHOL, V84, P19, DOI 10.1016/0021-9975(74)90023-1; Elsen JM, 1999, ARCH VIROL, V144, P431, DOI 10.1007/s007050050516; FARQUHAR CF, 1989, J VIROL METHODS, V24, P215, DOI 10.1016/0166-0934(89)90023-2; Foster J, 2006, VET REC, V159, P42, DOI 10.1136/vr.159.2.42; FOSTER JD, 1991, VET REC, V128, P548, DOI 10.1136/vr.128.23.548; Foster JD, 1996, VET REC, V139, P512, DOI 10.1136/vr.139.21.512; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; Fraser H., 1976, Slow virus diseases of animals and man,, P267; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gonzalez L, 2012, J GEN VIROL, V93, P203, DOI 10.1099/vir.0.034652-0; Hoinville LJ, 2010, PREV VET MED, V93, P121, DOI 10.1016/j.prevetmed.2009.10.013; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; Hourrigan J., 1979, Slow transmissible diseases of the nervous system. Volume 1., P331; Houston EF, 2002, J GEN VIROL, V83, P1247, DOI 10.1099/0022-1317-83-5-1247; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; HUNTER N, 1994, ARCH VIROL, V137, P171, DOI 10.1007/BF01311184; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Hunter N, 1997, NATURE, V386, P137, DOI 10.1038/386137a0; Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157; Hunter N, 2012, J VIROL, V86, P11856, DOI 10.1128/JVI.01573-12; Konold T, 2008, BMC VET RES, V4, DOI 10-1186/1746-6148-1184-1114; Lacroux C, 2007, J GEN VIROL, V88, P1056, DOI 10.1099/vir.0.82218-0; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Langevin C, 2011, NEUROBIOL DIS, V41, P219, DOI 10.1016/j.nbd.2010.09.010; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Maddison BC, 2009, J VIROL, V83, P8293, DOI 10.1128/JVI.00051-09; McKelvey B, 1999, IN PRACTICE, V21, P190, DOI 10.1136/inpract.21.4.190; Mossman HW, 1987, ARTIODACTYLA VERTEBR, P279; MYAGKAYA G, 1981, CELL TISSUE RES, V214, P501, DOI 10.1007/BF00233491; Nalls AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071844; ONODERA T, 1993, MICROBIOL IMMUNOL, V37, P311, DOI 10.1111/j.1348-0421.1993.tb03215.x; PATTISON IH, 1972, VET REC, V90, P465, DOI 10.1136/vr.90.17.465; Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669; Rubenstein R, 2012, J GEN VIROL, V93, P1375, DOI 10.1099/vir.0.038802-0; Siso S, 2010, J COMP PATHOL, V142, P300, DOI 10.1016/j.jcpa.2009.12.003; Stringfellow DA, 1990, MANUAL INT EMBRYO TR, V2nd, P19; Stroud B, 2011, IETS NEWSLETT, V29, P14; STUDDERT MJ, 1968, RES VET SCI, V9, P57; Thackray AM, 2008, J VIROL, V82, P11197, DOI 10.1128/JVI.01454-08; Thackray AM, 2012, EXP MOL PATHOL, V92, P167, DOI 10.1016/j.yexmp.2011.11.004; Thackray AM, 2011, J GEN VIROL, V92, P1482, DOI 10.1099/vir.0.028886-0; Tuo WB, 2002, P NATL ACAD SCI USA, V99, P6310, DOI 10.1073/pnas.072071199; WIMSATT WA, 1950, AM J ANAT, V87, P391, DOI 10.1002/aja.1000870304; ZLOTNIK I., 1958, JOUR COMP PATHOL AND THERAP, V68, P148, DOI 10.1016/S0368-1742(58)80016-8; ZLOTNIK I, 1960, NATURE, V185, P785, DOI 10.1038/185785a0; ZLOTNIK I., 1958, JOUR COMP PATH AND THERAP, V68, P428, DOI 10.1016/S0368-1742(58)80048-X; Zlotnik I, 1962, ACTA NEUROPATH     S, P61	67	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79433	10.1371/journal.pone.0079433	http://dx.doi.org/10.1371/journal.pone.0079433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260219	Green Published, gold			2022-12-25	WOS:000327308500059
J	Jiang, DM; Han, J; Zhu, JH; Fu, GS; Zhou, BQ				Jiang, Dong-Mei; Han, Jie; Zhu, Jun-Hui; Fu, Guo-Sheng; Zhou, Bin-Quan			Paracrine Effects of Bone Marrow-Derived Endothelial Progenitor Cells: Cyclooxygenase-2/Prostacyclin Pathway in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							GENE-TRANSFER; GROWTH-FACTOR; PROSTACYCLIN; RATS; THERAPY; TRANSPLANTATION; PROLIFERATION; IMBALANCE; PROTECTS; DISEASE	Background: Endothelial dysfunction is the pathophysiological characteristic of pulmonary arterial hypertension (PAH). Some paracrine factors secreted by bone marrow-derived endothelial progenitor cells (BMEPCs) have the potential to strengthen endothelial integrity and function. This study investigated whether BMEPCs have the therapeutic potential to improve monocrotaline (MCT)-induced PAH via producing vasoprotective substances in a paracrine fashion. Methods and Results: Bone marrow-derived mononuclear cells were cultured for 7 days to yield BMEPCs. 24 hours or 3 weeks after exposure to BMEPCs in vitro or in vivo, the vascular reactivity, cyclooxygenase-2 (COX-2) expression, prostacyclin (PGI(2)) and cAMP release in isolated pulmonary arteries were examined respectively. Treatment with BMEPCs could improve the relaxation of pulmonary arteries in MCT-induced PAH and BMEPCs were grafted into the pulmonary bed. The COX-2/prostacyclin synthase (PGIS) and its progenies PGI(2)/cAMP were found to be significantly increased in BMEPCs treated pulmonary arteries, and this action was reversed by a selective COX-2 inhibitor, NS398. Moreover, the same effect was also observed in conditioned medium obtained from BMEPCs culture. Conclusions: Implantation of BMEPCs effectively ameliorates MCT-induced PAH. Factors secreted in a paracrine fashion from BMEPCs promote vasoprotection by increasing the release of PGI(2) and level of cAMP.	[Jiang, Dong-Mei; Zhu, Jun-Hui; Fu, Guo-Sheng; Zhou, Bin-Quan] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Cardiol,Biomed Res Therapy Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Han, Jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, BQ (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Cardiol,Biomed Res Therapy Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	Benzhou@hotmail.com			Natural Science Committee of Zhejiang Province [Y2090160]; National Natural Sciences Foundation of China [81200191, 30800999, 81070163]	Natural Science Committee of Zhejiang Province; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Committee of Zhejiang Province (No. Y2090160), and the National Natural Sciences Foundation of China (No. 81200191,30800999,81070163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell AIM, 2001, CIRCULATION, V104, P2242, DOI 10.1161/hc4201.097838; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Fullerton DA, 1996, SURGERY, V119, P98, DOI 10.1016/S0039-6060(96)80220-0; FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580; Geraci MW, 1999, J CLIN INVEST, V103, P1509, DOI 10.1172/JCI5911; Haynes Jr J, 1992, AM J PHYSIOL, V262, P511; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; KAY JM, 1982, THORAX, V37, P88, DOI 10.1136/thx.37.2.88; Le Cras TD, 1996, AM J PHYSIOL, V270, P164; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li CY, 2009, J CLIN REHABILITATIV, V14, P2641; Mam V, 2010, J PHARMACOL EXP THER, V332, P455, DOI 10.1124/jpet.109.160119; Murata T, 2005, ARTERIOSCL THROM VAS, V25, P2335, DOI 10.1161/01.ATV.0000186184.33537.48; Murphy JF, 2001, FASEB J, V15, P1667, DOI 10.1096/fj.00-0757fje; Nagaya N, 2000, CIRCULATION, V102, P2005, DOI 10.1161/01.CIR.102.16.2005; Nagaya N, 2003, CIRCULATION, V108, P889, DOI 10.1161/01.CIR.0000079161.56080.22; Nishimura T, 2002, AM J RESP CRIT CARE, V166, P1403, DOI 10.1164/rccm.200203-268OC; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Resta TC, 1997, AM J PHYSIOL, V272, P806; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Vane J, 2003, EUR J VASC ENDOVASC, V26, P571, DOI 10.1016/S1078-5884(03)00385-X; Wang XG, 2007, J AM COLL CARDIOL, V49, P1566, DOI 10.1016/j.jacc.2006.12.037; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; Xia L, 2009, CYTOTHERAPY, V11, P492, DOI 10.1080/14653240902960460; Xue C, 1996, HYPERTENSION, V28, P743, DOI 10.1161/01.HYP.28.5.743; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Yip HK, 2008, CRIT CARE MED, V36, P873, DOI 10.1097/CCM.0B013E318165B7EA; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zhao YD, 2006, AM J RESP CELL MOL, V35, P182, DOI 10.1165/rcmb.2005-0115OC	34	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79215	10.1371/journal.pone.0079215	http://dx.doi.org/10.1371/journal.pone.0079215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260171	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500035
J	Geraets, DT; van Doorn, LJ; Kleter, B; Colau, B; Harper, DM; Quint, WGV				Geraets, Daan T.; van Doorn, Leen-Jan; Kleter, Bernhard; Colau, Brigitte; Harper, Diane M.; Quint, Wim G. V.			Long-Term Follow-Up of HPV16-Positive Women: Persistence of the Same Genetic Variant and Low Prevalence of Variant Co-Infections	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER; MOLECULAR VARIANTS; PARTICLE VACCINE; YOUNG-WOMEN; CLINICAL-EVALUATION; NATURAL-HISTORY; E6 VARIANTS; RISK; IDENTIFICATION	HPV16 variants correlate with geographic origin and ethnicity. The association between infection with a specific variant and the cervical disease risk remains unclear. We studied the prevalence, persistence and association with cervical intraepithelial neoplasia (CIN) of different HPV16 variants, using cervical swabs and whole tissue sections (WTS) of biopsies from 548 women in the placebo group of a HPV16/18 vaccine trial. In HPV16-positive samples, HPV16 variants were identified by a reverse hybridization assay (RHA). Laser-capture micro-dissection (LCM) was performed for localized detection of HPV. HPV16 variants were determined in 47 women. Frequency of mixed HPV16 variant infections was lower (8.5%) than for multiple HPV genotypes (39.1%). Among 35 women having consecutive HPV16 variant-positive swabs, 32 (91.4%) had the same variant while in three (8.6%) women a change in variant(s) was observed. HPV16-positive WTS were obtained from 12 women having consecutive HPV16 variant-positive swabs. The same variant was present in WTS of 10 women, while two were negative. WTS of five women were histologically normal. A single HPV16 variant was detected in four women having CIN1-3, while additional HPV genotypes were found in three other women having CIN2 and CIN3. In the WTS of one woman with mixed genotypes, the HPV16 variant was assigned to a CIN2 lesion by LCM. HPV16 variant infections can be effectively studied in cervical swabs and tissue specimens by the HPV16 variant RHA. Multiple HPV16 variants in one woman are rare. The HPV16 genotype consistently detected in follow-up samples usually involves a persistent infection with the same variant.	[Geraets, Daan T.; van Doorn, Leen-Jan; Kleter, Bernhard; Quint, Wim G. V.] DDL Diagnost Lab, Rijswijk, Netherlands; [Colau, Brigitte] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Harper, Diane M.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03756 USA	DDL Diagnostic Laboratory; GlaxoSmithKline; Dartmouth College; Norris Cotton Cancer Center	Geraets, DT (corresponding author), DDL Diagnost Lab, Rijswijk, Netherlands.	daan.geraets@ddl.nl	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X	GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This work was funded by GlaxoSmithKline Biologicals SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho J, 2004, J INFECT DIS, V190, P46, DOI 10.1086/420787; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bozzetti, 2000, Ann Epidemiol, V10, P466, DOI 10.1016/S1047-2797(00)00147-2; Calleja-Macias IE, 2004, VIROLOGY, V319, P315, DOI 10.1016/j.virol.2003.11.009; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; COX JT, 1995, AM J OBSTET GYNECOL, V172, P946, DOI 10.1016/0002-9378(95)90026-8; Cuzick J, 1999, HEALTH TECHNOL ASSES, V3, pi; De Boer MA, 2005, INT J CANCER, V114, P422, DOI 10.1002/ijc.20727; de Boer MA, 2004, GYNECOL ONCOL, V94, P488, DOI 10.1016/j.ygyno.2004.05.037; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Gonzalez-Losa MD, 2004, J CLIN VIROL, V29, P95, DOI 10.1016/S1386-6532(03)00094-5; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Kammer C, 2002, BRIT J CANCER, V86, P269, DOI 10.1038/sj.bjc.6600024; Kang S, 2005, INT J GYNECOL CANCER, V15, P107, DOI 10.1111/j.1048-891x.2005.15010.x; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Perrons C, 2005, J CLIN VIROL, V32, P278, DOI 10.1016/j.jcv.2004.08.009; Pillai MR, 2009, INT J CANCER, V125, P91, DOI 10.1002/ijc.24322; Quint W, 2012, J PATHOL, V227, P62, DOI 10.1002/path.3970; Sanchez GI, 2011, J CLIN VIROL, V51, P165, DOI 10.1016/j.jcv.2011.03.013; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Schlecht NF, 2005, J GEN VIROL, V86, P2709, DOI 10.1099/vir.0.81060-0; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Swan DC, 2006, J VIROL METHODS, V136, P166, DOI 10.1016/j.jviromet.2006.05.002; Swan DC, 2005, GYNECOL ONCOL, V96, P695, DOI 10.1016/j.ygyno.2004.11.045; Tornesello ML, 2004, J MED VIROL, V74, P117, DOI 10.1002/jmv.20154; van Doorn L J, 2001, Expert Rev Mol Diagn, V1, P394; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 1997, J CLIN MICROBIOL, V35, P11, DOI 10.1128/JCM.35.1.11-19.1997; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Xi LF, 1997, JNCI-J NATL CANCER I, V89, P796, DOI 10.1093/jnci/89.11.796; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Zehbe I, 1998, CANCER RES, V58, P829; Zuna RE, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-19; Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706; ZURHAUSEN H, 1994, ANNU REV MICROBIOL, V48, P427, DOI 10.1146/annurev.micro.48.1.427	47	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80382	10.1371/journal.pone.0080382	http://dx.doi.org/10.1371/journal.pone.0080382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244682	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600207
J	Koma, Y; Onishi, A; Matsuoka, H; Oda, N; Yokota, N; Matsumoto, Y; Koyama, M; Okada, N; Nakashima, N; Masuya, D; Yoshimatsu, H; Suzuki, Y				Koma, Yasuko; Onishi, Akira; Matsuoka, Hirofumi; Oda, Nao; Yokota, Naoya; Matsumoto, Yusuke; Koyama, Midori; Okada, Nobuhiko; Nakashima, Nariyasu; Masuya, Daiki; Yoshimatsu, Harukazu; Suzuki, Yujiro			Increased Red Blood Cell Distribution Width Associates with Cancer Stage and Prognosis in Patients with Lung Cancer	PLOS ONE			English	Article							HEART-FAILURE; INFLAMMATION; SURVIVAL; POPULATION; DIAGNOSIS; MARKERS; ANEMIA; COUNT	Background: Red cell distribution width (RDW), one of many routinely examined parameters, shows the heterogeneity in erythrocyte size. We investigated the association of RDW levels with clinical parameters and prognosis of lung cancer patients. Methods: Clinical and laboratory data from 332 patients with lung cancer in a single institution were retrospectively studied by univariate analysis. Kaplan-Meier survival analysis and Cox proportional hazard models were used to examine the effect of RDW on survival. Results: The RDW levels were divided into two groups: high RDW (>=15%), n=73 vs. low RDW, n=259 (<15%). Univariate analysis showed that there were significant associations of high RDW values with cancer stage, performance status, presence of other disease, white blood cell count, hemoglobin, mean corpuscular volume, platelet count, albumin level, C-reactive protein level, and cytokeratin 19 fragment level. Kruskal-Wallis tests revealed an association of RDW values with cancer stage in patients irrespective of comorbidity (patient with/without comorbidity: p<0.0001, patient without comorbidity: p<0.0001). Stages I-IV lung cancer patients with higher RDW values had poorer prognoses than those with lower RDW values (Wilcoxon test: p=0.002). In particular, the survival rates of stage I and II patients (n=141) were lower in the high RDW group (n=19) than in the low RDW group (n=122) (Wilcoxon test: p<0.001). Moreover, multivariate analysis showed higher RDW is a significant prognostic factor (p=0.040). Conclusion: RDW is associated with several factors that reflect inflammation and malnutrition in lung cancer patients. Moreover, high levels of RDW are associated with poor survival. RDW might be used as a new and convenient marker to determine a patient's general condition and to predict the mortality risk of lung cancer patients.	[Koma, Yasuko; Matsuoka, Hirofumi; Oda, Nao; Yokota, Naoya; Matsumoto, Yusuke; Koyama, Midori; Okada, Nobuhiko; Nakashima, Nariyasu; Masuya, Daiki; Yoshimatsu, Harukazu; Suzuki, Yujiro] Shinko Hosp, Resp Ctr, Kobe, Hyogo, Japan; [Onishi, Akira] Kyoto Univ, Dept Hlth Promot & Human Behav, Grad Sch Med, Sch Publ Hlth, Kyoto, Japan	Kyoto University	Koma, Y (corresponding author), Shinko Hosp, Resp Ctr, Kobe, Hyogo, Japan.	yasukok@shinkohp.or.jp						Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Baicus C, 2011, J INVEST MED, V59, P951, DOI 10.2310/JIM.0b013e31822467a3; Beyazit Y, 2012, HEPATO-GASTROENTEROL, V59, P1469, DOI 10.5754/hge10676; de Gonzalo-Calvo D, 2012, CYTOKINE, V58, P193, DOI 10.1016/j.cyto.2012.01.005; DOUGLAS SW, 1975, BLOOD, V45, P55; FELD R, 1994, LUNG CANCER-J IASLC, V11, pS19, DOI 10.1016/0169-5002(94)91861-9; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Ferrucci Luigi, 2005, Am J Med, V118, P1288; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Grant BJB, 2003, CHEST, V124, P494, DOI 10.1378/chest.124.2.494; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Jo YH, 2013, AM J EMERG MED, V31, P545, DOI 10.1016/j.ajem.2012.10.017; Kim J, 2012, THROMB HAEMOSTASIS, V108, P349, DOI 10.1160/TH12-03-0165; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Li J, 2009, ONCOLOGY-BASEL, V76, P355, DOI 10.1159/000210024; Lou YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037644; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Nathan SD, 2013, CHEST, V143, P1692, DOI 10.1378/chest.12-1368; Ozkalemkas F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-144; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Seretis Charalampos, 2013, J Clin Med Res, V5, P121, DOI 10.4021/jocmr1214w; Seyhan EC, 2013, RED BLOOD CELL DISTR, V10, P416, DOI [10.3109/15412555.2012.758697, DOI 10.3109/15412555.2012.758697]; SPEIGHTS VO, 1992, ARCH PATHOL LAB MED, V116, P258; Spell DW, 2004, CANCER DETECT PREV, V28, P37, DOI 10.1016/j.cdp.2003.10.002; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Yesil A, 2011, GUT LIVER, V5, P460, DOI 10.5009/gnl.2011.5.4.460	28	175	185	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80240	10.1371/journal.pone.0080240	http://dx.doi.org/10.1371/journal.pone.0080240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244659	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600195
J	Li, P; Sun, HJ; Zhang, LL; Ding, L; Han, Y; Zhu, GQ; Zhou, YB				Li, Peng; Sun, Hai-Jian; Zhang, Ling-Li; Ding, Lei; Han, Ying; Zhu, Guo-Qing; Zhou, Ye-Bo			Melanocortin 4 Receptors in the Paraventricular Nucleus Modulate the Adipose Afferent Reflex in Rat	PLOS ONE			English	Article							SYMPATHETIC ACTIVATION; HYPERTENSIVE-RATS; BLOOD-PRESSURE; OUTFLOW NEURONS; INDUCED OBESITY; LEPTIN SENSORS; MESSENGER-RNA; CYCLIC-AMP; SYSTEM; TISSUE	Background and Aim: Paraventricular nucleus (PVN) of hypothalamus is an important central component in modulating adipose afferent reflex (AAR). Melanocortin receptors (MC3/4Rs) expressions are found in the hypothalamic PVN. This study was designed to determine the roles of MC3/4Rs in the PVN in modulating the AAR and its downstream signaling pathway in normal rats. Methodology/Principal Findings: Renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) were recorded in anaesthetized rats. AAR was evaluated using RSNA and MAP responses to capsaicin injection into the inguinal white adipose tissue (iWAT). Microinjection of the MC3/4R agonist melanotan II (MTII) into the PVN enhanced the AAR. The MC3/4R antagonist SHU9119 or MC4R antagonist HS024 attenuated the AAR and abolished MTII-induced AAR response. The adenylate cyclase (AC) inhibitor SQ22536 or the protein kinase A (PKA) inhibitor Rp-cAMP attenuated the AAR and the effect of MTII on the AAR was abolished by pretreatment with SQ22536 or Rp-cAMP in the PVN. Furthermore, both PVN microinjection of MTII and iWAT injection of capsaicin increased the cAMP level in the PVN. SHU9119 in the PVN abolished the increase in cAMP level which induced by iWAT injection of capsaicin. Conclusion: The activation of MC4Rs rather than MC3Rs enhances the AAR, and a cAMP-PKA pathway is involved in the effects of MC4Rs in the PVN.	[Li, Peng; Sun, Hai-Jian; Zhang, Ling-Li; Ding, Lei; Han, Ying; Zhu, Guo-Qing; Zhou, Ye-Bo] Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; [Li, Peng] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhou, YB (corresponding author), Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China.	zhouyebo666@njmu.edu.cn		Zhou, Yebo/0000-0001-9465-1338; Han, Ying/0000-0001-8591-7894; Zhu, Guo-Qing/0000-0002-3132-9592	National Natural Science Foundation of China [81000106, 31171095, 31271213]; Jiangsu Higher Education Institutions of China [10KJB310004]; Nanjing Medical University of China [09JC013, 09NJMUZ04, JX10131801056]; Priority Academic Program Developmennt of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions of China; Nanjing Medical University of China; Priority Academic Program Developmennt of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the funds from the National Natural Science Foundation of China (81000106, 31171095 and 31271213); the Jiangsu Higher Education Institutions of China (10KJB310004); the Nanjing Medical University of China (09JC013, 09NJMUZ04 and JX10131801056) and a project funded by the Priority Academic Program Developmennt of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bariohay B, 2009, ENDOCRINOLOGY, V150, P2646, DOI 10.1210/en.2008-1184; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Crestani CC, 2010, NEUROSCI RES, V67, P317, DOI 10.1016/j.neures.2010.05.001; da Silva AA, 2008, HYPERTENSION, V51, P884, DOI 10.1161/HYPERTENSIONAHA.107.100636; Dubinion JH, 2010, J HYPERTENS, V28, P1466, DOI 10.1097/HJH.0b013e328339f20e; Gao L, 2007, J APPL PHYSIOL, V102, P37, DOI 10.1152/japplphysiol.00681.2006; Goel M, 2010, AM J PHYSIOL-RENAL, V298, pF988, DOI 10.1152/ajprenal.00586.2009; Hansen MJ, 2005, BRAIN RES, V1039, P137, DOI 10.1016/j.brainres.2005.01.063; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Kask A, 1998, ENDOCRINOLOGY, V139, P5006, DOI 10.1210/en.139.12.5006; Li P, 2013, EXP PHYSIOL, V98, P435, DOI 10.1113/expphysiol.2012.067256; Li YF, 2006, AM J PHYSIOL-HEART C, V291, pH2847, DOI 10.1152/ajpheart.00625.2005; Mountjoy KG, 2010, ADV EXP MED BIOL, V681, P29, DOI 10.1007/978-1-4419-6354-3_3; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Niijima A, 1999, NEUROSCI LETT, V262, P125, DOI 10.1016/S0304-3940(99)00054-3; Niijima A, 1998, J AUTONOM NERV SYST, V73, P19, DOI 10.1016/S0165-1838(98)00109-X; Olivan MV, 2001, BRAIN RES, V895, P167, DOI 10.1016/S0006-8993(01)02067-4; RAVI K, 1988, CAN J PHYSIOL PHARM, V66, P946, DOI 10.1139/y88-154; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rossi NF, 2010, EXP PHYSIOL, V95, P845, DOI 10.1113/expphysiol.2009.051789; Shen Y, 2013, J NEUROSCI, V33, P464, DOI 10.1523/JNEUROSCI.3282-12.2013; Shi Z, 2012, J APPL PHYSIOL, V112, P1008, DOI 10.1152/japplphysiol.01164.2011; Siljee-Wong JE, 2011, EUR J PHARMACOL, V660, P234, DOI 10.1016/j.ejphar.2010.10.104; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; Song CK, 2009, AM J PHYSIOL-REG I, V296, pR501, DOI 10.1152/ajpregu.90786.2008; Song CK, 2005, AM J PHYSIOL-REG I, V289, pR1467, DOI 10.1152/ajpregu.00348.2005; Sutton GM, 2005, ENDOCRINOLOGY, V146, P3739, DOI 10.1210/en.2005-0562; Tallant EA, 2003, HYPERTENSION, V42, P574, DOI 10.1161/01.HYP.0000090322.55782.30; Turcato S, 1999, BRIT J PHARMACOL, V126, P845, DOI 10.1038/sj.bjp.0702383; Valenti D, 2011, BIOCHEM J, V435, P679, DOI 10.1042/BJ20101908; Wang WZ, 2006, NEUROSCI LETT, V409, P146, DOI 10.1016/j.neulet.2006.09.032; Xiong XQ, 2012, HYPERTENSION, V60, P1280, DOI 10.1161/HYPERTENSIONAHA.112.198002; Xu Y, 2011, EXP PHYSIOL, V96, P1282, DOI 10.1113/expphysiol.2011.059733	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80295	10.1371/journal.pone.0080295	http://dx.doi.org/10.1371/journal.pone.0080295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244673	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600201
J	Liu, ML; Idkowiak-Baldys, J; Roddy, PL; Baldys, A; Raymond, J; Clarke, CJ; Hannun, YA				Liu, Mengling; Idkowiak-Baldys, Jolanta; Roddy, Patrick L.; Baldys, Aleksander; Raymond, John; Clarke, Christopher J.; Hannun, Yusuf A.			Sustained Activation of Protein Kinase C Induces Delayed Phosphorylation and Regulates the Fate of Epidermal Growth Factor Receptor	PLOS ONE			English	Article							BREAST-CANCER CELLS; PHOSPHOLIPASE-D; RECYCLING ENDOSOMES; COUPLED RECEPTORS; ANGIOTENSIN-II; SEQUESTRATION; DEGRADATION; PATHWAY; INTERNALIZATION; ENDOCYTOSIS	It is well established that acute activation of members of the protein kinase C (PKC) family induced by activation of cellular receptors can transduce extracellular stimuli to intracellular signaling. However, the functions of sustained activation of PKC are not well studied. We have previously shown that sustained activation of classical PKC isoforms over 15-60 min induced the formation of the pericentrion, a subset of recycling endosomes that are sequestered perinuclearly in a PKC- and phospholipase D (PLD)-dependent manner. In this study, we investigated the role of this process in the phosphorylation of EGFR on threonine 654 (Thr-654) and in the regulation of intracellular trafficking and fate of epidermal growth factor receptor (EGFR). Sustained stimulation of the angiotensin II receptor induced translocation of the EGFR to the pericentrion, which in turn prevents full access of EGF to the EGFR. These effects required PKC and PLD activities, and direct stimulation of PKC with phorbol esters was sufficient to reproduce these effects. Furthermore, activation of PKC induced delayed phosphorylation of EGFR on Thr-654 that coincided with the formation of the pericentrion and which was dependent on PLD and endocytosis of EGFR. Thus, Thr-654 phosphorylation required the formation of the pericentrion. On the other hand, using a T654A mutant of EGFR, we find that the phosphorylation on Thr-654 was not required for translocation of EGFR to the pericentrion but was required for protection of EGFR from degradation in response to EGF. Taken together, these results demonstrate a novel role for the pericentrion in the regulation of EGFR phosphorylation, which in turn is important for the fates of EGFR.	[Liu, Mengling; Clarke, Christopher J.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Liu, Mengling; Clarke, Christopher J.; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Liu, Mengling; Idkowiak-Baldys, Jolanta; Roddy, Patrick L.; Clarke, Christopher J.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Baldys, Aleksander] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Baldys, Aleksander] Ralph H Johnson Vet Affairs Med Ctr, Med Serv, Charleston, SC USA; [Baldys, Aleksander] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC USA; [Raymond, John] Med Coll Wisconsin, Milwaukee, WI 53226 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical College of Wisconsin	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	yusuf.hannun@sbumed.org		Liu, Mengling/0000-0003-1309-0087	NIH [HL43707]; Department of Veterans Affairs Merit Award [1I01BX000182]; American Heart Association Mid-Atlantic Affiliate [0725358U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); American Heart Association Mid-Atlantic Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH grant HL43707; Department of Veterans Affairs Merit Award 1I01BX000182; American Heart Association Mid-Atlantic Affiliate grant 0725358U. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Becker KP, 2004, J BIOL CHEM, V279, P28251, DOI 10.1074/jbc.M400770200; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Cai JJ, 2010, J BIOL CHEM, V285, P6952, DOI 10.1074/jbc.M109.055731; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; El-Osta MA, 2011, J BIOL CHEM, V286, P19340, DOI 10.1074/jbc.M110.152330; Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; FAUCHER M, 1988, J BIOL CHEM, V263, P5319; Furukawa M, 2007, DNA CELL BIOL, V26, P178, DOI 10.1089/dna.2006.0573; Grewal JS, 2001, J BIOL CHEM, V276, P27335, DOI 10.1074/jbc.M103578200; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Hirsch DS, 2006, CANCER RES, V66, P3523, DOI 10.1158/0008-5472.CAN-05-1547; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Lahn Michael, 2004, Clin Lung Cancer, V6, P184, DOI 10.3816/CLC.2004.n.032; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Morinelli TA, 2013, AM J PHYSIOL-CELL PH, V304, pC1176, DOI 10.1152/ajpcell.00235.2012; Ohno S, 2002, J BIOCHEM, V132, P509, DOI 10.1093/oxfordjournals.jbchem.a003249; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stewart JR, 2005, MOL CANCER THER, V4, P726, DOI 10.1158/1535-7163.MCT-05-0013; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Uchida N, 1997, J CANCER RES CLIN, V123, P280, DOI 10.1007/s004320050060; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Willmarth NE, 2009, CELL SIGNAL, V21, P212, DOI 10.1016/j.cellsig.2008.10.003; Yarden Y, 2001, EUR J CANCER, V37, pS3; Ye Q, 2013, J BIOL CHEM, V288, P9881, DOI 10.1074/jbc.M113.450593	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80721	10.1371/journal.pone.0080721	http://dx.doi.org/10.1371/journal.pone.0080721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244711	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600215
J	Roossien, DH; Lamoureux, P; Van Vactor, D; Miller, KE				Roossien, Douglas H.; Lamoureux, Phillip; Van Vactor, David; Miller, Kyle E.			Drosophila Growth Cones Advance by Forward Translocation of the Neuronal Cytoskeletal Meshwork In Vivo	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AXONAL-TRANSPORT; MICROTUBULE DYNAMICS; EXTRACELLULAR-MATRIX; TIME-LAPSE; NEURITE OUTGROWTH; ACTIN; LAMININ; MITOCHONDRIA; REGENERATION	In vitro studies conducted in Aplysia and chick sensory neurons indicate that in addition to microtubule assembly, long microtubules in the C-domain of the growth cone move forward as a coherent bundle during axonal elongation. Nonetheless, whether this mode of microtubule translocation contributes to growth cone motility in vivo is unknown. To address this question, we turned to the model system Drosophila. Using docked mitochondria as fiduciary markers for the translocation of long microtubules, we first examined motion along the axon to test if the pattern of axonal elongation is conserved between Drosophila and other species in vitro. When Drosophila neurons were cultured on Drosophila extracellular matrix proteins collected from the Drosophila Kc167 cell line, docked mitochondria moved in a pattern indicative of bulk microtubule translocation, similar to that observed in chick sensory neurons grown on laminin. To investigate whether the C-domain is stationary or advances in vivo, we tracked the movement of mitochondria during elongation of the aCC motor neuron in stage 16 Drosophila embryos. We found docked mitochondria moved forward along the axon shaft and in the growth cone C-domain. This work confirms that the physical mechanism of growth cone advance is similar between Drosophila and vertebrate neurons and suggests forward translocation of the microtubule meshwork in the axon underlies the advance of the growth cone C-domain in vivo. These results highlight the need for incorporating en masse microtubule translocation, in addition to assembly, into models of axonal elongation.	[Roossien, Douglas H.] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Lamoureux, Phillip; Miller, Kyle E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Van Vactor, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Michigan State University; Michigan State University; Harvard University; Harvard Medical School	Miller, KE (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	kmiller@msu.edu		Roossien, Douglas/0000-0003-1184-2919; Miller, Kyle/0000-0003-0401-4736; Van Vactor, Jr., David L./0000-0001-8156-9482	NSF [IOS_0951019];  [NS35909]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035909] Funding Source: NIH RePORTER; Direct For Biological Sciences [0951019] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DVV was supported by NS35909 (http://grants.nih.gov/grants/oer.htm). KEM was supported by NSF grant IOS_0951019 (http://www.nsf.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus CA, 2013, TRENDS CELL BIOL, V23, P305, DOI 10.1016/j.tcb.2013.02.001; ALETTA JM, 1988, J NEUROSCI, V8, P1425; Ayali A, 2012, J MOL HISTOL, V43, P379, DOI 10.1007/s10735-012-9416-0; Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Bai JW, 2009, NAT PROTOC, V4, P1502, DOI 10.1038/nprot.2009.147; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Beadle D. J., 2006, Invertebrate Neuroscience, V6, P95, DOI 10.1007/s10158-006-0024-0; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Broadie K, 2011, DEV NEUROBIOL, V71, P1102, DOI 10.1002/dneu.20935; Campos-Ortega JA, 1997, EMBRYONIC DEV DROSOP, Vxvii; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chang SH, 1999, NAT CELL BIOL, V1, P399, DOI 10.1038/15629; Chang SH, 1998, J NEUROSCI, V18, P821; Chetta J, 2010, CYTOSKELETON, V67, P650, DOI 10.1002/cm.20478; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; CONDIC ML, 1989, J NEUROSCI, V9, P2678; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Evans AR, 2007, DEV NEUROBIOL, V67, P1721, DOI 10.1002/dneu.20540; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gallo G, 2004, EXP NEUROL, V189, P112, DOI 10.1016/j.expneurol.2004.05.019; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; GOLDBERG DJ, 1986, J CELL BIOL, V103, P1921, DOI 10.1083/jcb.103.5.1921; GULLBERG D, 1994, DEV DYNAM, V199, P116, DOI 10.1002/aja.1001990205; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; HIRANO S, 1991, DEVELOPMENT, V113, P1007; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; Hur EM, 2011, P NATL ACAD SCI USA, V108, P5057, DOI 10.1073/pnas.1011258108; Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931; JOSHI HC, 1985, J CELL BIOL, V101, P697, DOI 10.1083/jcb.101.3.697; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Ketschek AR, 2007, DEV NEUROBIOL, V67, P1305, DOI 10.1002/dneu.20455; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Kumagai C, 1997, FEBS LETT, V412, P211, DOI 10.1016/S0014-5793(97)00780-1; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; LAMOUREUX P, 1989, NATURE, V340, P156, DOI 10.1038/340159a0; Lamoureux P, 2010, DEV NEUROBIOL, V70, P135, DOI 10.1002/dneu.20764; Lamoureux PL, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-140; Lee AC, 2008, DEV NEUROBIOL, V68, P1363, DOI 10.1002/dneu.20662; Liu M, 2010, J NEUROSCI, V30, P14896, DOI 10.1523/JNEUROSCI.3739-10.2010; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MARTENSON C, 1993, NATURE, V366, P66, DOI 10.1038/366066a0; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Miller KE, 1996, J CELL BIOL, V133, P1355, DOI 10.1083/jcb.133.6.1355; Miller KE, 2008, EXP CELL RES, V314, P1981, DOI 10.1016/j.yexcr.2008.03.004; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; O'Toole M, 2008, J THEOR BIOL, V255, P369, DOI 10.1016/j.jtbi.2008.09.009; Pan YA, 2003, J NEUROSCI, V23, P11479; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Prokop A, 2012, NEUROMETHODS, P225; Prokop A, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-17; Prokop A, 2013, J CELL SCI, V126, P2331, DOI 10.1242/jcs.126912; Rauch P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015007; Reichardt LF, 2011, DEV NEUROBIOL, V71, P883, DOI 10.1002/dneu.20975; REINSCH SS, 1991, J CELL BIOL, V115, P365, DOI 10.1083/jcb.115.2.365; SABRY J, 1995, NEURON, V14, P1247, DOI 10.1016/0896-6273(95)90271-6; SALVATERRA PM, 1987, J NEUROSCI, V7, P10; Sanchez-Soriano N, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-9; Sanchez-Soriano N, 2010, DEV NEUROBIOL, V70, P58, DOI 10.1002/dneu.20762; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sicaeros Beatriz, 2007, J Vis Exp, P226, DOI 10.3791/226; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Suter DM, 2011, ADV NEUROBIOL, V5, P45, DOI 10.1007/978-1-4419-7368-9_4; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Takagi Y, 1998, NEUROSCI LETT, V244, P149, DOI 10.1016/S0304-3940(98)00145-1; Takagi Y, 1996, J BIOL CHEM, V271, P18074, DOI 10.1074/jbc.271.30.18074; TAKEDA S, 1995, NEURON, V14, P1257, DOI 10.1016/0896-6273(95)90272-4; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wagner OI, 2003, J NEUROSCI, V23, P9046; WALTER MF, 1984, J CELL BIOL, V99, P1468, DOI 10.1083/jcb.99.4.1468; WU CF, 1983, J NEUROSCI, V3, P1888; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	92	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80136	10.1371/journal.pone.0080136	http://dx.doi.org/10.1371/journal.pone.0080136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244629	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600184
J	Hung, AH; Liang, TY; Sukerkar, PA; Meade, TJ				Hung, Andy H.; Liang, Taiyang; Sukerkar, Preeti A.; Meade, Thomas J.			High Dynamic Range Processing for Magnetic Resonance Imaging	PLOS ONE			English	Article							CAMERA RESPONSE; IMAGES; TIME; NANOPARTICLES; ENHANCEMENT; DISPLAY	Purpose: To minimize feature loss in T-1- and T-2-weighted MRI by merging multiple MR images acquired at different T-R and T-E to generate an image with increased dynamic range. Materials and Methods: High Dynamic Range (HDR) processing techniques from the field of photography were applied to a series of acquired MR images. Specifically, a method to parameterize the algorithm for MRI data was developed and tested. T-1- and T-2-weighted images of a number of contrast agent phantoms and a live mouse were acquired with varying T-R and TE parameters. The images were computationally merged to produce HDR-MR images. All acquisitions were performed on a 7.05 T Bruker PharmaScan with a multi-echo spin echo pulse sequence. Results: HDR- MRI delineated bright and dark features that were either saturated or indistinguishable from background in standard T-1- and T-2-weighted MRI. The increased dynamic range preserved intensity gradation over a larger range of T-1 and T-2 in phantoms and revealed more anatomical features in vivo. Conclusions: We have developed and tested a method to apply HDR processing to MR images. The increased dynamic range of HDR- MR images as compared to standard T-1- and T-2-weighted images minimizes feature loss caused by magnetization recovery or low SNR.	[Hung, Andy H.; Liang, Taiyang; Sukerkar, Preeti A.; Meade, Thomas J.] Northwestern Univ, Dept Chem Mol Biosci Neurobiol Biomed Engn & Radi, Evanston, IL 60208 USA	Northwestern University	Meade, TJ (corresponding author), Northwestern Univ, Dept Chem Mol Biosci Neurobiol Biomed Engn & Radi, Evanston, IL 60208 USA.	tmeade@northwestern.edu			National Cancer Institute Center for Cancer Nanotechnology Excellence initiative at Northwestern University [U54CA151880]; National Institute of Biomedical Imaging and Bioengineering [2R01EB005866]; Northwestern University; Biotechnology Cluster Program from Northwestern University; CDMRP Breast Cancer Research Program [BC093977]; ARCS (Achievement Rewards for College Scientists) Foundation Scholar; NCI CCSG [P30 CA060553]; NCRR [1S10RR025624-01]; NATIONAL CANCER INSTITUTE [P30CA060553, U54CA151880] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014806, R01EB005866] Funding Source: NIH RePORTER	National Cancer Institute Center for Cancer Nanotechnology Excellence initiative at Northwestern University; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Northwestern University; Biotechnology Cluster Program from Northwestern University; CDMRP Breast Cancer Research Program; ARCS (Achievement Rewards for College Scientists) Foundation Scholar; NCI CCSG; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Cancer Institute Center for Cancer Nanotechnology Excellence initiative at Northwestern University Award No. U54CA151880, and National Institute of Biomedical Imaging and Bioengineering Award No. 2R01EB005866. TL was supported by the John N. Nicholson fellowship from Northwestern University. AHH was supported by the Biotechnology Cluster Program from Northwestern University. PAS was supported by the CDMRP Breast Cancer Research Program (BC093977) and was an ARCS (Achievement Rewards for College Scientists) Foundation Scholar. The Northwestern University Center for Advanced Molecular Imaging was supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. The 7T Bruker Pharmascan system was purchased with the support of NCRR 1S10RR025624-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreisek G, 2010, RADIOLOGY, V254, P188, DOI 10.1148/radiol.2541090314; BROWN DG, 1990, MAGNET RESON MED, V14, P79, DOI 10.1002/mrm.1910140109; BUXTON RB, 1991, MAGNET RESON MED, V18, P102, DOI 10.1002/mrm.1910180112; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; Debevec P, 2000, COMP GRAPH, P145, DOI 10.1145/344779.344855; Debevec P., 1998, Computer Graphics. Proceedings. SIGGRAPH 98 Conference Proceedings, P189, DOI 10.1145/280814.280864; Debevec P, 2010, HIGH DYNAMIC RANGE I; DEBEVEC PE, 1997, SIGGRAPH 97, P369, DOI DOI 10.1145/258734.258884; DOWLING JE, 1987, RETINA APPROACHABLE, P187; Ferwerda J. A., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P249, DOI 10.1145/237170.237262; Frias JC, 2007, CONTRAST MEDIA MOL I, V2, P16, DOI 10.1002/cmmi.124; Grossberg MD, 2004, IEEE T PATTERN ANAL, V26, P1272, DOI 10.1109/TPAMI.2004.88; Grossberg MD, 2003, IEEE T PATTERN ANAL, V25, P1455, DOI 10.1109/TPAMI.2003.1240119; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Harney AS, 2010, FUTURE MED CHEM, V2, P503, DOI 10.4155/FMC.09.168; Hu FQ, 2010, NANOSCALE, V2, P1884, DOI 10.1039/c0nr00173b; Hu FQ, 2010, CHEM COMMUN, V46, P73, DOI 10.1039/b916562b; Imai FH, 2009, J DENT, V37, pE7, DOI 10.1016/j.jdent.2009.05.006; Jacobs K, 2008, IEEE COMPUT GRAPH, V28, P84, DOI 10.1109/MCG.2008.23; Jacobson RE., 2000, MANUAL PHOTOGRAPHY P, P305; Kao WC, 2008, IEEE T CONSUM ELECTR, V54, P10, DOI 10.1109/TCE.2008.4470017; LEE JN, 1987, MAGN RESON MED, V5, P13, DOI 10.1002/mrm.1910050103; Lin WB, 2009, MRS BULL, V34, P441, DOI 10.1557/mrs2009.120; MANN S, 1995, IS&T'S 48TH ANNUAL CONFERENCE - IMAGING ON THE INFORMATION SUPERHIGHWAY, FINAL PROGRAM AND PROCEEDINGS, P442; Mansson S, 2001, CHEMISTRY OF CONTRAST AGENTS IN MEDICAL MAGNETIC RESONANCE IMAGING, P1; Mastarone DJ, 2011, J AM CHEM SOC, V133, P5329, DOI 10.1021/ja1099616; Mitsunaga T., P 1999 IEEE COMP SOC, P374; Modo M, 2009, NEUROIMAGE, V47, pT133, DOI 10.1016/j.neuroimage.2008.06.017; Pattanaik SN, 2000, COMP GRAPH, P47, DOI 10.1145/344779.344810; Petschnigg G, 2004, ACM T GRAPHIC, V23, P664, DOI 10.1145/1015706.1015777; RIEDERER SJ, 1984, RADIOLOGY, V153, P203, DOI 10.1148/radiology.153.1.6089265; Robertson M. A., 1999, Proceedings 1999 International Conference on Image Processing (Cat. 99CH36348), P159, DOI 10.1109/ICIP.1999.817091; Robertson MA, 2003, J ELECTRON IMAGING, V12, P219, DOI 10.1117/1.1557695; SCHMIEDL U, 1987, MAGNET RESON MED, V4, P471, DOI 10.1002/mrm.1910040508; Seetzen H, 2004, ACM T GRAPHIC, V23, P760, DOI 10.1145/1015706.1015797; Soltanian-Zadeh H., 1992, Journal of Electronic Imaging, V1, P171, DOI 10.1117/12.58698; Sriram R, 2011, NMR BIOMED, V24, P916, DOI 10.1002/nbm.1650; Vo-Dinh T, 2000, FRESEN J ANAL CHEM, V366, P540, DOI 10.1007/s002160051549; Wang ZD, 2008, ADV MATER, V20, P3263, DOI 10.1002/adma.200703181; Ward G., 2003, Journal of Graphics Tools, V8, P17, DOI 10.1080/10867651.2003.10487583; WINDHAM JP, 1988, J COMPUT ASSIST TOMO, V12, P1, DOI 10.1097/00004728-198801000-00001; Ye Z, 2013, CONTRAST MEDIA MOL I, V8, P220, DOI 10.1002/cmmi.1520; ZHU XP, 1994, BRIT J RADIOL, V67, P976, DOI 10.1259/0007-1285-67-802-976	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e77883	10.1371/journal.pone.0077883	http://dx.doi.org/10.1371/journal.pone.0077883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250788	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200009
J	Simard, E; Kovacs, JJ; Miller, WE; Kim, J; Grandbois, M; Lefkowitz, RJ				Simard, Elie; Kovacs, Jeffrey J.; Miller, William E.; Kim, Jihee; Grandbois, Michel; Lefkowitz, Robert J.			beta-Arrestin Regulation of Myosin Light Chain Phosphorylation Promotes AT1aR-mediated Cell Contraction and Migration	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; TYPE-1A RECEPTOR; CLATHRIN ADAPTER; ACTIVATION; PATHWAYS; KINASES; BETA-ARRESTIN2; CYTOSKELETON	Over the last decade, it has been established that G-protein-coupled receptors (GPCRs) signal not only through canonical G-protein-mediated mechanisms, but also through the ubiquitous cellular scaffolds beta-arrestin-1 and beta-arrestin-2. Previous studies have implicated beta-arrestins as regulators of actin reorganization in response to GPCR stimulation while also being required for membrane protrusion events that accompany cellular motility. One of the most critical events in the active movement of cells is the cyclic phosphorylation and activation of myosin light chain (MLC), which is required for cellular contraction and movement. We have identified the myosin light chain phosphatase Targeting Subunit (MYPT-1) as a binding partner of the beta-arrestins and found that beta-arrestins play a role in regulating the turnover of phosphorylated myosin light chain. In response to stimulation of the angiotensin Type 1a Receptor (AT1aR), MLC phosphorylation is induced quickly and potently. We have found that beta-arrestin-2 facilitates dephosphorylation of MLC, while, in a reciprocal fashion, beta-arrestin 1 limits dephosphorylation of MLC. Intriguingly, loss of either beta-arrestin-1 or 2 blocks phospho-MLC turnover and causes a decrease in the contraction of cells as monitored by atomic force microscopy (AFM). Furthermore, by employing the beta-arrestin biased ligand [Sar(1), Ile(4), Ile(8)]-Ang, we demonstrate that AT1aR-mediated cellular motility involves a beta-arrestin dependent component. This suggests that the reciprocal regulation of MLC phosphorylation status by beta-arrestins-1 and 2 causes turnover in the phosphorylation status of MLC that is required for cell contractility and subsequent chemotaxic motility.	[Simard, Elie; Grandbois, Michel] Univ Sherbrooke, Dept Pharmacol, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada; [Grandbois, Michel] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada; [Grandbois, Michel] Univ Sherbrooke, Chaire Rech Canadienne Nanopharmacol & Microscopi, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada; [Kovacs, Jeffrey J.; Kim, Jihee; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Miller, William E.] Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH USA	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	Lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021	Miller, William/0000-0001-6900-4884	NIH [HL 16037, HL 70631]; Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada [90463874]; Chaire de Recherche Canadienne en Nanopharmacologie et Microscopie a Force Atomique; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL070631, R01HL016037] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Chaire de Recherche Canadienne en Nanopharmacologie et Microscopie a Force Atomique; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: NIH HL 16037, NIH HL 70631, Howard Hughes Medical Institute, Natural Sciences and Engineering Research Council of Canada 90463874, Chaire de Recherche Canadienne en Nanopharmacologie et Microscopie a Force Atomique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Auger-Messier M, 2005, EXP CELL RES, V308, P188, DOI 10.1016/j.yexcr.2005.04.015; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Cuerrier CM, 2009, PFLUG ARCH EUR J PHY, V457, P1361, DOI 10.1007/s00424-008-0596-0; D'Angelo G, 2002, AM J PHYSIOL-HEART C, V282, pH602, DOI 10.1152/ajpheart.00221.2001; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Eguchi A, 2010, CELL CYCLE, V9, P424, DOI 10.4161/cc.9.3.10693; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Godin CM, 2010, MOL PHARMACOL, V77, P903, DOI 10.1124/mol.110.063859; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Ikebe R, 1999, J BIOL CHEM, V274, P30122, DOI 10.1074/jbc.274.42.30122; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kim S, 2000, PHARMACOL REV, V52, P11; Kolodney MS, 1999, J PHYSIOL-LONDON, V515, P87, DOI 10.1111/j.1469-7793.1999.087ad.x; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104	27	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80532	10.1371/journal.pone.0080532	http://dx.doi.org/10.1371/journal.pone.0080532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255721	Green Published, gold			2022-12-25	WOS:000327216200114
J	Zhang, XM; Zhang, GM; Chen, QS; Han, XG				Zhang, Ximei; Zhang, Guangming; Chen, Quansheng; Han, Xingguo			Soil Bacterial Communities Respond to Climate Changes in a Temperate Steppe	PLOS ONE			English	Article							SP-NOV; MICROBIAL COMMUNITIES; GRASSLAND; DIVERSITY; PRECIPITATION; WATER; MICROORGANISMS; ECOSYSTEM; PATTERNS	Climate warming and shifting precipitation regimes are affecting biodiversity and ecosystem functioning. Most studies have focused on the influence of warming and altered precipitation on macro-organisms, whereas the responses of soil microbial communities have been neglected. We studied the changes in the abundance, richness, and composition of the entire bacterial kingdom and 16 dominant bacterial phyla/classes in response to increased precipitation, warming, and their combination, by conducting a 5-year experiment in a steppe ecosystem in Inner Mongolia, China. Watering had a greater effect than warming on almost all the bacterial groups as indicated by changes in all the three attributes (abundance, richness, and composition). The 16 phyla/classes responded differentially to the experimental treatments, with Acidobacteria and Gamma-proteobacteria being the most sensitive. Stepwise regression analyses further revealed that climate changes altered the abundance and richness of bacterial groups primarily through direct routes (e. g., increasing soil water content), and changed the community composition through both direct and indirect routes (e. g., reducing soil total nitrogen content and increasing soil pH). The diverse responses of various bacterial groups could imply some potential shift in their ecosystem functions under climate changes; meanwhile, the indirect routes that are important in altering bacterial composition suggest that specific strategies (e. g., adding NH4NO3 to maintain soil nitrogen content and pH) could be adopted to maintain soil microbial composition under climate changes.	[Zhang, Ximei; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Zhang, Ximei; Zhang, Guangming; Chen, Quansheng; Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Han, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	xghan@ibcas.ac.cn	Chen, Quansheng/AGH-8083-2022; Han, Xingguo/K-7552-2016	Chen, Quansheng/0000-0003-2498-3278; Han, Xingguo/0000-0002-1836-975X	National Natural Science Foundation [30830026]; State Key Basic Research Development Program (973 Program) [2009CB825103]; Postdoctoral Science Foundation of China [2012T50158, 2011M500440]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); State Key Basic Research Development Program (973 Program)(National Basic Research Program of China); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation (30830026), the State Key Basic Research Development Program (973 Program) (2009CB825103) and Postdoctoral Science Foundation (2012T50158, 2011M500440) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M. J., 2003, PCO FORTRAN COMPUTER; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; EHRICH S, 1995, ARCH MICROBIOL, V164, P16; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Groisman PY, 2005, J CLIMATE, V18, P1326, DOI 10.1175/JCLI3339.1; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HANADA S, 1995, INT J SYST BACTERIOL, V45, P676, DOI 10.1099/00207713-45-4-676; Hogenhout SA, 2008, CURR OPIN PLANT BIOL, V11, P449, DOI 10.1016/j.pbi.2008.05.007; IPCC, 2007, IPCC WGI 4 ASS REP C; Klappenbach JA, 2004, ARCH MICROBIOL, V181, P17, DOI 10.1007/s00203-003-0615-7; Lennon JT, 2012, ECOLOGY, V93, P1867, DOI 10.1890/11-1745.1; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; Sun Y, 2010, SCI CHINA EARTH SCI, V53, P284, DOI 10.1007/s11430-009-0123-y; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Watson SW, 1994, ARCH MICROBIOL, V144, P62; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zhang XM, 2012, J ENVIRON SCI-CHINA, V24, P1483, DOI 10.1016/S1001-0742(11)60900-5; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zhou XQ, 2013, SCI TOTAL ENVIRON, V444, P552, DOI 10.1016/j.scitotenv.2012.12.023	36	20	25	8	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78616	10.1371/journal.pone.0078616	http://dx.doi.org/10.1371/journal.pone.0078616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250803	Green Submitted, gold, Green Published			2022-12-25	WOS:000327216200036
J	Ohara, S; Sato, S; Oyama, K; Tsutsui, KI; Iijima, T				Ohara, Shinya; Sato, Sho; Oyama, Kei; Tsutsui, Ken-Ichiro; Iijima, Toshio			Rabies Virus Vector Transgene Expression Level and Cytotoxicity Improvement Induced by Deletion of Glycoprotein Gene	PLOS ONE			English	Article							TRANSNEURONAL TRACER; RECOMBINANT; TRANSCRIPTION; ATTENUATION; APOPTOSIS; VARIANTS; NETWORKS; NEURONS; REGIONS; INPUTS	The glycoprotein (G) of rabies virus (RV) is required for binding to neuronal receptors and for viral entry. G-deleted RV vector is a powerful tool for investigating the organization and function of the neural circuits. It gives the investigator the ability to genetically target initial infection to particular neurons and to control trans-synaptic propagation. In this study we have quantitatively evaluated the effect of G gene deletion on the cytotoxicity and transgene expression level of the RV vector. We compared the characteristics of the propagation-competent RV vector (rHEP5.0-CVSG-mRFP) and the G-deleted RV vector (rHEP5.0-Delta G-mRFP), both of which are based on the attenuated HEP-Flury strain and express monomeric red fluorescent protein (mRFP) as a transgene. rHEP5.0-Delta G-mRFP showed lower cytotoxicity than rHEP5.0-CVSG-mRFP, and within 16 days of infection we found no change in the basic electrophysiological properties of neurons infected with the rHEP5.0-Delta G-mRFP. The mRFP expression level of rHEP5.0-Delta G-mRFP was much higher than that of rHEP5.0-CVSG-mRFP, and 3 days after infection the retrogradely infected neurons were clearly visualized by the expressed fluorescent protein without any staining. This may be due to the low cytotoxicity and/or the presumed change in the polymerase gene (L) expression level of the G-deleted RV vector. Although the mechanisms remains to be clarified, the results of this study indicate that deletion of the G gene greatly improves the usability of the RV vector for studying the organization and function of the neural circuits by decreasing the cytotoxicity and increasing the transgene expression level.	[Ohara, Shinya; Sato, Sho; Oyama, Kei; Tsutsui, Ken-Ichiro; Iijima, Toshio] Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan	Tohoku University	Iijima, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan.	t-iijima@m.tohoku.ac.jp	Tsutsui, Ken-Ichiro/B-4378-2008; Ohara, Shinya/AAW-9705-2021	Tsutsui, Ken-Ichiro/0000-0001-5781-2948; Ohara, Shinya/0000-0003-0681-5086; Oyama, Kei/0000-0002-3375-7099	Strategic Research Program for Brain Sciences; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24223004]	Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Strategic Research Program for Brain Sciences and by Grant-in-Aid for Scientific Research (KAKENHI) #24223004 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM G, 1976, P NATL ACAD SCI USA, V73, P1504, DOI 10.1073/pnas.73.5.1504; BALL LA, 1976, P NATL ACAD SCI USA, V73, P442, DOI 10.1073/pnas.73.2.442; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; Faber M, 2002, J VIROL, V76, P3374, DOI 10.1128/JVI.76.7.3374-3381.2002; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; Inoue K, 2004, SOC NEUR ABSTR, V124, P12; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039149; Inoue S, 2003, PATHOL INT, V53, P525, DOI 10.1046/j.1440-1827.2003.01511.x; IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Ohara S, 2009, SOC NEUR ABSTR, V288, P25; Ohara S, 2009, FRONT NEUROSCI-SWITZ, V3, P344, DOI 10.3389/neuro.01.032.2009; Ohara S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.001.2009; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Prehaud C, 2003, J VIROL, V77, P10537, DOI 10.1128/JVI.77.19.10537-10547.2003; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3332; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; WIKTOR TJ, 1984, DEV BIOLOGICALS, V57, P199; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	36	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80245	10.1371/journal.pone.0080245	http://dx.doi.org/10.1371/journal.pone.0080245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244660	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900070
J	Banerjee, J; Sahoo, DK; Dey, N; Houtz, RL; Maiti, IB				Banerjee, Joydeep; Sahoo, Dipak Kumar; Dey, Nrisingha; Houtz, Robert L.; Maiti, Indu Bhushan			An Intergenic Region Shared by At4g35985 and At4g35987 in Arabidopsis thaliana Is a Tissue Specific and Stress Inducible Bidirectional Promoter Analyzed in Transgenic Arabidopsis and Tobacco Plants	PLOS ONE			English	Article							FIGWORT-MOSAIC-VIRUS; LENGTH TRANSCRIPT PROMOTER; GENE-EXPRESSION; REGULATORY ELEMENTS; POLYUBIQUITIN GENES; ORGAN SPECIFICITY; DELETION ANALYSIS; FLT PROMOTER; RICE; IDENTIFICATION	On chromosome 4 in the Arabidopsis genome, two neighboring genes (calmodulin methyl transferase At4g35987 and senescence associated gene At4g35985) are located in a head-to-head divergent orientation sharing a putative bidirectional promoter. This 1258 bp intergenic region contains a number of environmental stress responsive and tissue specific cis-regulatory elements. Transcript analysis of At4g35985 and At4g35987 genes by quantitative real time PCR showed tissue specific and stress inducible expression profiles. We tested the bidirectional promoter-function of the intergenic region shared by the divergent genes At4g35985 and At4g35987 using two reporter genes (GFP and GUS) in both orientations in transient tobacco protoplast and Agro-infiltration assays, as well as in stably transformed transgenic Arabidopsis and tobacco plants. In transient assays with GFP and GUS reporter genes the At4g35985 promoter (P85) showed stronger expression (about 3.5 fold) compared to the At4g35987 promoter (P87). The tissue specific as well as stress responsive functional nature of the bidirectional promoter was evaluated in independent transgenic Arabidopsis and tobacco lines. Expression of P85 activity was detected in the midrib of leaves, leaf trichomes, apical meristemic regions, throughout the root, lateral roots and flowers. The expression of P87 was observed in leaf-tip, hydathodes, apical meristem, root tips, emerging lateral root tips, root stele region and in floral tissues. The bidirectional promoter in both orientations shows differential up-regulation (2.5 to 3 fold) under salt stress. Use of such regulatory elements of bidirectional promoters showing spatial and stress inducible promoter-functions in heterologous system might be an important tool for plant biotechnology and gene stacking applications.	[Banerjee, Joydeep; Sahoo, Dipak Kumar; Maiti, Indu Bhushan] Univ Kentucky, Coll Agr Food & Environm, KTRDC, Lexington, KY USA; [Houtz, Robert L.] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA; [Houtz, Robert L.] Univ Kentucky, Plant Physiol Biochem Mol Biol Program, Lexington, KY 40546 USA; [Dey, Nrisingha] Inst Life Sci, Dept Gene Funct & Regulat, Bhubaneswar, Orissa, India	University of Kentucky; University of Kentucky; University of Kentucky; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Maiti, IB (corresponding author), Univ Kentucky, Coll Agr Food & Environm, KTRDC, Lexington, KY USA.	imaiti@uky.edu	Banerjee, Joydeep/AAF-2786-2020; Sahoo, Dipak Kumar/M-8818-2013	Sahoo, Dipak Kumar/0000-0003-3748-3395	KY state KTRDC grant	KY state KTRDC grant	This work was fully supported by the KY state KTRDC grant to Indu Bhushan Maiti and Robert L. Houtz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; BARFIELD DG, 1991, PLANT CELL REP, V10, P308, DOI 10.1007/BF00193148; BECK CF, 1988, MICROBIOL REV, V52, P318, DOI 10.1128/MMBR.52.3.318-326.1988; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Bhattacharyya S, 2002, VIRUS RES, V90, P47, DOI 10.1016/S0166-0934(02)00146-5; Bondino HG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-95; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chaturvedi CP, 2006, J BIOTECHNOL, V123, P1, DOI 10.1016/j.jbiotec.2005.10.014; CHO TJ, 1989, PLANT CELL, V1, P329, DOI 10.1105/tpc.1.3.329; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; CROUSE GF, 1985, MOL CELL BIOL, V5, P1847, DOI 10.1128/MCB.5.8.1847; Dey N, 1999, PLANT MOL BIOL, V40, P771, DOI 10.1023/A:1006285426523; Dhadi SR, 2009, GENE, V429, P65, DOI 10.1016/j.gene.2008.09.034; DRIESEN M, 1993, VIROLOGY, V195, P203, DOI 10.1006/viro.1993.1361; DYNAN WS, 1989, CELL, V58, P1, DOI 10.1016/0092-8674(89)90393-0; ELMAYAN T, 1995, TRANSGENIC RES, V4, P388, DOI 10.1007/BF01973757; Filichkin SA, 2004, PLANT PHYSIOL, V134, P1080, DOI 10.1104/pp.103.035998; Garreton V, 2002, PLANT PHYSIOL, V130, P1516, DOI 10.1104/pp.009886; He F, 2010, GENETICS, V185, P695, DOI 10.1534/genetics.110.114629; He P, 2005, J EXP BOT, V56, P1117, DOI 10.1093/jxb/eri103; Herr DR, 2004, FEBS LETT, V572, P147, DOI 10.1016/j.febslet.2004.07.026; Himmelbach A, 2010, PLANT CELL, V22, P937, DOI 10.1105/tpc.109.067934; Ikeda S, 2000, BIOCHEM BIOPH RES CO, V273, P1063, DOI 10.1006/bbrc.2000.3071; JEFFERSON RA, 1987, EMBO J, V6, P3901; KEDDIE JS, 1994, PLANT MOL BIOL, V24, P327, DOI 10.1007/BF00020171; Krom N, 2008, PLANT PHYSIOL, V147, P1763, DOI 10.1104/pp.108.122416; Kroumova AB, 2013, PLANT CELL REP, P1; KUHLEMEIER C, 1989, PLANT CELL, V1, P471, DOI 10.1105/tpc.1.4.471; Kumar D, 2012, GENE, V503, P36, DOI 10.1016/j.gene.2012.04.053; Kumar D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024627; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee S, 2008, PLANT PHYSIOL, V147, P1017, DOI 10.1104/pp.108.115824; Li YY, 2006, PLOS COMPUT BIOL, V2, P15; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Lv XM, 2009, J BIOTECHNOL, V141, P104, DOI 10.1016/j.jbiotec.2009.03.009; Maiti IB, 1998, BIOCHEM BIOPH RES CO, V244, P440, DOI 10.1006/bbrc.1998.8287; Maiti IB, 1997, TRANSGENIC RES, V6, P143, DOI 10.1023/A:1018477705019; MCELROY D, 1990, PLANT CELL, V2, P163, DOI 10.1105/tpc.2.2.163; MITRA A, 1989, MOL GEN GENET, V215, P294, DOI 10.1007/BF00339731; Mitra A, 2009, PLANTA, V229, P1015, DOI 10.1007/s00425-008-0859-1; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; NI M, 1995, PLANT J, V7, P661, DOI 10.1046/j.1365-313X.1995.7040661.x; OH SH, 1990, PLANT PHYSIOL, V93, P880, DOI 10.1104/pp.93.3.880; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Patro S, 2013, J BIOTECHNOL, V163, P311, DOI 10.1016/j.jbiotec.2012.11.009; Pattanaik S, 2004, PLANT SCI, V167, P427, DOI 10.1016/j.plantsci.2004.04.011; Qi XT, 2007, PLANT PHYSIOL, V143, P50, DOI 10.1104/pp.106.080283; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Rogers HJ, 2001, PLANT MOL BIOL, V45, P577, DOI 10.1023/A:1010695226241; Sahoo DK, 2013, PLANT BIOTECHNOL J, V11, P362, DOI 10.1111/pbi.12024; Sahoo DK, 2009, J VIROL METHODS, V161, P114, DOI 10.1016/j.jviromet.2009.06.011; SCHARDL CL, 1987, GENE, V61, P1, DOI 10.1016/0378-1119(87)90359-3; Schreiber DN, 2004, PLANT PHYSIOL, V134, P1069, DOI 10.1104/pp.103.030577; Seo E, 2012, MOL CELLS, V33, P415, DOI 10.1007/s10059-012-0017-2; SHAW CH, 1984, NUCLEIC ACIDS RES, V12, P7831, DOI 10.1093/nar/12.20.7831; Shin Y, 2003, PLANT CELL PHYSIOL, V44, P549, DOI 10.1093/pcp/pcg069; SHINSHI H, 1995, PLANT MOL BIOL, V27, P923, DOI 10.1007/BF00037020; Sleight Sean C, 2010, J Biol Eng, V4, P12, DOI 10.1186/1754-1611-4-12; Smykowski A, 2010, PLANT PHYSIOL, V153, P1321, DOI 10.1104/pp.110.157180; Sperotto RA, 2008, PLANT CELL REP, V27, P183, DOI 10.1007/s00299-007-0432-6; Suttipanta N, 2011, PLANT PHYSIOL, V157, P2081, DOI 10.1104/pp.111.181834; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; ULMASOV T, 1994, PLANT MOL BIOL, V26, P1055, DOI 10.1007/BF00040688; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Vijaybhaskar V, 2008, J BIOSCIENCES, V33, P185, DOI 10.1007/s12038-008-0036-5; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang CY, 2008, J PLANT BIOL, V51, P108, DOI 10.1007/BF03030719; Wang JL, 2000, PLANT SCI, V156, P201, DOI 10.1016/S0168-9452(00)00255-7; Wang LK, 2013, PLANT MOL BIOL REP, V31, P120, DOI 10.1007/s11105-012-0482-y; Wang Q, 2009, BMC BIOINFORMATICS, V30, P1471; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Woo YH, 2011, P NATL ACAD SCI USA, V108, P3306, DOI 10.1073/pnas.1100210108; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xie MT, 2001, NAT BIOTECHNOL, V19, P677, DOI 10.1038/90296; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yang G, 1997, J IMMUNOL, V159, P3068; Yang MQ, 2008, BMC BIOINFORMATICS, V28, P1471; Yang S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks972; Zheng HQ, 2011, BIOTECHNOL LETT, V33, P387, DOI 10.1007/s10529-010-0431-5; Zhou X, 2011, MOL CELLS, V31, P303, DOI 10.1007/s10059-011-0047-1	80	35	41	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79622	10.1371/journal.pone.0079622	http://dx.doi.org/10.1371/journal.pone.0079622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260266	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900037
J	Hassan, MI; Waheed, A; Grubb, JH; Klei, HE; Korolev, S; Sly, WS				Hassan, Md Imtaiyaz; Waheed, Abdul; Grubb, Jeffery H.; Klei, Herbert E.; Korolev, Sergey; Sly, William S.			High Resolution Crystal Structure of Human beta-Glucuronidase Reveals Structural Basis of Lysosome Targeting	PLOS ONE			English	Article							UDP-N-ACETYLGLUCOSAMINE; MANNOSE PHOSPHORYLATION; 3-DIMENSIONAL STRUCTURE; ENZYME RECOGNITION; MOLECULAR-BASIS; BINDING-SITES; DNA-SEQUENCE; CATHEPSIN-D; PROTEIN; IDENTIFICATION	Human beta-glucuronidase (GUS) cleaves beta-D-glucuronic acid residues from the non-reducing termini of glycosaminoglycan and its deficiency leads to mucopolysaccharidosis type VII (MPSVII). Here we report a high resolution crystal structure of human GUS at 1.7 angstrom resolution and present an extensive analysis of the structural features, unifying recent findings in the field of lysosome targeting and glycosyl hydrolases. The structure revealed several new details including a new glycan chain at Asn272, in addition to that previously observed at Asn173, and coordination of the glycan chain at Asn173 with Lys197 of the lysosomal targeting motif which is essential for phosphotransferase recognition. Analysis of the high resolution structure not only provided new insights into the structural basis for lysosomal targeting but showed significant differences between human GUS, which is medically important in its own right, and E. coli GUS, which can be selectively inhibited in the human gut to prevent prodrug activation and is also widely used as a reporter gene by plant biologists. Despite these differences, both human and E. coli GUS share a high structure homology in all three domains with most of the glycosyl hydrolases, suggesting that they all evolved from a common ancestral gene.	[Hassan, Md Imtaiyaz; Waheed, Abdul; Grubb, Jeffery H.; Korolev, Sergey; Sly, William S.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Hassan, Md Imtaiyaz] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Klei, Herbert E.] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ USA	Saint Louis University; Jamia Millia Islamia; Bristol-Myers Squibb	Sly, WS (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	slyws@slu.edu	Wahhed, Abdul/AAA-3099-2020; Hassan, Md Imtaiyaz/G-7072-2017; Hassan, Mohammad/GZA-7507-2022; Hassan, Imtaiyaz/ABF-6485-2020; Korolev, Sergey/ABA-7517-2020	Hassan, Md Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004; Hassan, Imtaiyaz/0000-0002-3663-4940; Korolev, Sergey/0000-0001-9313-7126	Indo-US Science and Technology Forum	Indo-US Science and Technology Forum	MIH is highly thankful to the Indo-US Science and Technology Forum for the award of fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHORD DT, 1978, CELL, V15, P269, DOI 10.1016/0092-8674(78)90102-2; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; BARANSKI TJ, 1992, J BIOL CHEM, V267, P23342; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Bones J, 2011, ANAL CHEM, V83, P5344, DOI 10.1021/ac2007784; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cuozzo JW, 1998, J BIOL CHEM, V273, P21067, DOI 10.1074/jbc.273.33.21067; DAMORE MA, 1988, BIOCHEMISTRY-US, V27, P7131, DOI 10.1021/bi00418a070; Dittmer F, 1999, J CELL SCI, V112, P1591; DRENDEL WB, 1993, J MOL BIOL, V233, P173, DOI 10.1006/jmbi.1993.1494; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flores H, 2002, J MOL BIOL, V315, P325, DOI 10.1006/jmbi.2001.5223; Fyfe JC, 1999, GENOMICS, V58, P121, DOI 10.1006/geno.1999.5825; Grubb JH, 2008, P NATL ACAD SCI USA, V105, P2616, DOI 10.1073/pnas.0712147105; HASILIK A, 1981, BIOCHEM BIOPH RES CO, V98, P761, DOI 10.1016/0006-291X(81)91177-3; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Islam MR, 1999, J BIOL CHEM, V274, P23451, DOI 10.1074/jbc.274.33.23451; ISLAM MR, 1993, J BIOL CHEM, V268, P22627; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Juers DH, 2000, PROTEIN SCI, V9, P1685, DOI 10.1110/ps.9.9.1685; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Matsuura T, 2011, J BIOL CHEM, V286, P22028, DOI 10.1074/jbc.M111.240168; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAMURA T, 1990, J BIOL CHEM, V265, P5390; NATOWICZ M, 1982, J BIOL CHEM, V257, P4412; Naz H, 2013, REJUV RES, DOI [10.1089/rej.2013.1407, DOI 10.1089/REJ.2013.1407)]; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; NISHIMURA Y, 1986, P NATL ACAD SCI USA, V83, P7292, DOI 10.1073/pnas.83.19.7292; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Ray J, 1998, GENOMICS, V48, P248, DOI 10.1006/geno.1997.5189; REITMAN ML, 1981, J BIOL CHEM, V256, P4275; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Schierau A, 1999, J BIOL CHEM, V274, P3651, DOI 10.1074/jbc.274.6.3651; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Tikkanen R, 1997, EMBO J, V16, P6684, DOI 10.1093/emboj/16.22.6684; TOMATSU S, 1991, AM J HUM GENET, V48, P89; Tomatsu S, 2009, HUM MUTAT, V30, P511, DOI 10.1002/humu.20828; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WAHEED A, 1982, J BIOL CHEM, V257, P2322; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Warner JB, 2002, J BIOL CHEM, V277, P41897, DOI 10.1074/jbc.M203097200; Wong AW, 1998, J BIOL CHEM, V273, P34057, DOI 10.1074/jbc.273.51.34057; Yadavalli S, 2010, GLYCOCONJUGATE J, V27, P39, DOI 10.1007/s10719-009-9267-4; Yaghootfam A, 2003, J BIOL CHEM, V278, P32653, DOI 10.1074/jbc.M304865200	61	49	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79687	10.1371/journal.pone.0079687	http://dx.doi.org/10.1371/journal.pone.0079687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260279	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900040
J	Reyes-Valdes, MH; Santacruz-Varela, A; Martinez, O; Simpson, J; Hayano-Kanashiro, C; Cortes-Romero, C				Humberto Reyes-Valdes, M.; Santacruz-Varela, Amalio; Martinez, Octavio; Simpson, June; Hayano-Kanashiro, Corina; Cortes-Romero, Celso			Analysis and Optimization of Bulk DNA Sampling with Binary Scoring for Germplasm Characterization	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; SEX DETERMINATION; MAIZE; AFLP; IDENTIFICATION; ENTROPY; MARKERS; POLYMORPHISMS; DISEASE	The strategy of bulk DNA sampling has been a valuable method for studying large numbers of individuals through genetic markers. The application of this strategy for discrimination among germplasm sources was analyzed through information theory, considering the case of polymorphic alleles scored binarily for their presence or absence in DNA pools. We defined the informativeness of a set of marker loci in bulks as the mutual information between genotype and population identity, composed by two terms: diversity and noise. The first term is the entropy of bulk genotypes, whereas the noise term is measured through the conditional entropy of bulk genotypes given germplasm sources. Thus, optimizing marker information implies increasing diversity and reducing noise. Simple formulas were devised to estimate marker information per allele from a set of estimated allele frequencies across populations. As an example, they allowed optimization of bulk size for SSR genotyping in maize, from allele frequencies estimated in a sample of 56 maize populations. It was found that a sample of 30 plants from a random mating population is adequate for maize germplasm SSR characterization. We analyzed the use of divided bulks to overcome the allele dilution problem in DNA pools, and concluded that samples of 30 plants divided into three bulks of 10 plants are efficient to characterize maize germplasm sources through SSR with a good control of the dilution problem. We estimated the informativeness of 30 SSR loci from the estimated allele frequencies in maize populations, and found a wide variation of marker informativeness, which positively correlated with the number of alleles per locus.	[Humberto Reyes-Valdes, M.] Univ Autonoma Agr Antonio Narro, Dept Plant Breeding, Saltillo, Coahuila, Mexico; [Santacruz-Varela, Amalio] Colegio Postgrad, Montecillo, Estado De Mexic, Mexico; [Martinez, Octavio] CINVESTAV, Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad LANGEBIO, Guanajuato, Mexico; [Simpson, June; Hayano-Kanashiro, Corina; Cortes-Romero, Celso] CINVESTAV, Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Plant Genet Engn, Guanajuato, Mexico	Colegio de Postgraduados - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Reyes-Valdes, MH (corresponding author), Univ Autonoma Agr Antonio Narro, Dept Plant Breeding, Saltillo, Coahuila, Mexico.	MathGenome@gmail.com	Martinez, Octavio/F-3951-2014	Martinez, Octavio/0000-0002-7590-0041; Hayano-Kanashiro, Corina/0000-0001-7846-6124	Mexican Government [CIBIOGEM-CONACyT FO-CIBIOGEM-143919]	Mexican Government	This research was funded by the grant CIBIOGEM-CONACyT FO-CIBIOGEM-143919 from the Mexican Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNHEIM N, 1985, P NATL ACAD SCI USA, V82, P6970, DOI 10.1073/pnas.82.20.6970; Arrigo N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-33; Ash R.B., 1965, INFORM THEORY; Butler JM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S72; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Chambers GK, 2000, COMP BIOCHEM PHYS B, V126, P455, DOI 10.1016/S0305-0491(00)00233-9; Deputy JC, 2002, THEOR APPL GENET, V106, P107, DOI 10.1007/s00122-002-0995-0; Dubreuil P, 2006, MAYDICA, V51, P281; Dubreuil P, 1999, PLANT MOL BIOL REP, V17, P123, DOI 10.1023/A:1007571101815; Feng JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059541; Gentra-Systems, 1998, INSTR GEN DNA IS KIT; Hampe J, 2003, HUM GENET, V114, P36, DOI 10.1007/s00439-003-1017-2; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Johnson RC, 2007, CROP SCI, V47, P1728, DOI 10.2135/cropsci2006.12.0757; Kuboki Y., 1995, Rice Genome, V4, P3; Locke M, 2000, STRAND VERSION 2 2 3; Martinez EA, 1999, MOL ECOL, V8, P1533, DOI 10.1046/j.1365-294x.1999.00721.x; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Nothnagel M, 2002, HUM HERED, V54, P186, DOI 10.1159/000070664; Pervaiz ZH, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue3-fulltext-5; R-Development-Core-Team, 2013, R LANG ENV STAT COMP; Reif JC, 2005, THEOR APPL GENET, V111, P838, DOI 10.1007/s00122-005-0004-5; Reyes-Valdes MH, 2005, GENET RES, V85, P81, DOI 10.1017/S0016672305007354; Reyes-Valdes MH, 2012, METHOD MOL BIOL, V1006, P259; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Segovia-Lerma A, 2003, GENOME, V46, P51, DOI 10.1139/G02-100; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; van Treuren R, 2001, EUPHYTICA, V117, P27, DOI 10.1023/A:1004003121622; Wang DW, 2011, INT J MOL SCI, V12, P857, DOI 10.3390/ijms12010857; Yao Qilun, 2007, Journal of Genetics and Genomics, V34, P851, DOI 10.1016/S1673-8527(07)60096-4; Zhao JY, 2005, AM J HUM GENET, V77, P27, DOI 10.1086/431243	34	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79936	10.1371/journal.pone.0079936	http://dx.doi.org/10.1371/journal.pone.0079936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260321	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900052
J	Nguyen, TT; Seoighe, C				Nguyen, Thong T.; Seoighe, Cathal			Integrative Analysis of mRNA Expression and Half-Life Data Reveals Trans-Acting Genetic Variants Associated with Increased Expression of Stable Transcripts	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; POSTTRANSCRIPTIONAL CONTROL; BINDING PROTEINS; DECAY-RATES; STABILITY; ELEMENTS; QUANTIFICATION; DISCOVERY; COMMON	Genetic variation in gene expression makes an important contribution to phenotypic variation and susceptibility to disease. Recently, a subset of cis-acting expression quantitative loci (eQTLs) has been found to result from polymorphisms that affect RNA stability. Here we carried out a search for trans-acting variants that influence RNA stability. We first demonstrate that differences in the activity of trans-acting factors that stabilize RNA can be detected by comparing the expression levels of long-lived (stable) and short-lived (unstable) transcripts in high-throughput gene expression experiments. Using gene expression microarray data generated from eight HapMap3 populations, we calculated the relative expression ranks of long-lived transcripts versus short-lived transcripts in each sample. Treating this as a quantitative trait, we applied genome-wide association and identified a single nucleotide polymorphism (SNP), rs6137010, on chromosome 20p13 with which it is strongly associated in two Asian populations (p=4x10(-10) in CHB - Han Chinese from Beijing; p=1x10(-4) in JPT - Japanese from Tokyo). This SNP is a cis-eQTL for SNRPB in CHB and JPT but not in the other six HapMap3 populations. SNRPB is a core component of the spliceosome, and has previously been shown to affect the expression of many RNA processing factors. We propose that a cis-eQTL of SNRPB may be directly responsible for inter-individual variation in relative expression of long-lived versus short-lived transcript in Asian populations. In support of this hypothesis, knockdown of SNRPB results in a significant reduction in the relative expression of long-lived versus short-lived transcripts. Samples with higher relative expression of long-lived transcripts also had higher relative expression of coding compared to non-coding RNA and of RNA from housekeeping compared to non-housekeeping genes, due to the lower decay rates of coding RNAs, particularly those that perform housekeeping functions, compared to non-coding RNAs.	[Nguyen, Thong T.; Seoighe, Cathal] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland; [Seoighe, Cathal] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	Ollscoil na Gaillimhe-University of Galway; University of Cape Town	Seoighe, C (corresponding author), Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland.	Cathal.Seoighe@nuigalway.ie		Nguyen, Thong/0000-0002-7741-2527	Science Foundation Ireland [07/SK/M1211b]; Irish Research Council for Science Engineering and Technology	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR)	This work was supported by Science Foundation Ireland (07/SK/M1211b) and the Irish Research Council for Science Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Cheng C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r90; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Gupta SK, 2013, J BIOL CHEM, V288, P4991, DOI 10.1074/jbc.M112.416578; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lam LT, 2001, GENOME BIOL, V2; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Misquitta CM, 2001, MOL CELL BIOCHEM, V224, P53, DOI 10.1023/A:1011982932645; Narsai R, 2007, PLANT CELL, V19, P3418, DOI 10.1105/tpc.107.055046; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2012, R LANG ENV STAT COMP; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Saltzman AL, 2011, GENE DEV, V25, P373, DOI 10.1101/gad.2004811; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Thiele BJ, 2004, CIRC RES, V95, P1058, DOI 10.1161/01.RES.0000149166.33833.08; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79627	10.1371/journal.pone.0079627	http://dx.doi.org/10.1371/journal.pone.0079627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260269	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500083
J	Qin, HY; Sun, HR; Wang, XF; Bai, RJ; Li, YJ; Zhao, JK				Qin, Hai-yan; Sun, Haoran; Wang, Xifu; Bai, Renju; Li, Yajun; Zhao, Jinkun			Correlation between CT Perfusion Parameters and Microvessel Density and Vascular Endothelial Growth Factor in Adrenal Tumors	PLOS ONE			English	Article							ANGIOGENESIS; INCIDENTALOMA; MANAGEMENT; MASSES	We evaluated the correlation between computed tomography (CT) perfusion parameters and markers of angiogenesis in adrenal adenomas and non-adenomas to determine if perfusion CT can be used to distinguish between them. Thirty-four patients with pathologically-confirmed adrenal tumors (17 adenomas, 17 non-adenomas) received CT perfusion imaging before surgery. CT perfusion parameters (blood flow [BF], blood volume [BV], mean transit time [MTT], and permeability surface area product [PS]) were calculated. Tumor tissue sections were examined with immunohistochemical methods for vascular endothelial growth factor (VEGF) expression and microvessel density (MVD). The mean age of the 34 patients was 43 years. The median BV was significantly higher in adenomas than in non-adenomas [12.3 ml/100 g, inter-quartile range (IQR): 10.4 to 16.5 ml/100 g vs. 8.8 ml/100 g, IQR: 3.3 to 9.4 ml/100 g, p = 0.001]. Differences in BF, MTT, and PS parameter values between adenomas and non-adenomas were not significant (p>0.05). The mean MVD was significantly higher in adenomas compared to non-adenomas (98.5 +/- 28.5 vs. 53.5 +/- 27.0, p<0.0001). Adenomas also expressed significantly higher median VEGF than non-adenomas (65%, IQR: 50 to 79% vs. 45%, IQR: 35 to 67%, p = 0.02). A moderately strong correlation between BF and VEGF (r = 0.53, p = 0.03) and between BV and MVD among adenomas (r = 0.57, p = 0.02) exist. Morphology, MVD, and VEGF expression in adenomas differ significantly from non-adenomas. Of the CT perfusion parameters examined, both BF and BV correlate with MVD, but only BF correlates with VEGF, and only in adenomas. The significant difference in BV suggests that BV may be used to differentiate adenomas from non-adenomas. However, the small difference in BV shows that it may only be possible to use BV to identify adenomas vs. non-adenomas at extreme BV values.	[Qin, Hai-yan] Harbin Med Univ, Affiliated Hosp 4, Dept Imaging, Harbin, Peoples R China; [Sun, Haoran; Bai, Renju; Li, Yajun] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Wang, Xifu] Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Shanghai 200030, Peoples R China; [Zhao, Jinkun] Tianjin Med Univ, Affiliated Canc Hosp, Dept Radiol, Tianjin, Peoples R China	Harbin Medical University; Tianjin Medical University; Shanghai Jiao Tong University; Tianjin Medical University	Bai, RJ (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	Bairenju2011@163.com			Special Research Funds for Harbin Municipal Science and Technology Creative Scholars [2011RFXYS054]	Special Research Funds for Harbin Municipal Science and Technology Creative Scholars	This study was financially supported by Special Research Funds for Harbin Municipal Science and Technology Creative Scholars supervised by Harbin Science and Technology Bureau, Heilongjiang Province (Grant number: 2011RFXYS054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostis P, 2009, HORM-INT J ENDOCRINO, V8, P163, DOI 10.14310/horm.2002.1233; BARBARESCHI M, 1995, APPL IMMUNOHISTOCHEM, V3, P75; Bernini GP, 2002, J CLIN ENDOCR METAB, V87, P4961, DOI 10.1210/jc.2001-011799; Britvin TA, 2005, B EXP BIOL MED+, V140, P228, DOI 10.1007/s10517-005-0452-6; Cao Y, 2013, CANC RES; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; de Fraipont F, 2000, J CLIN ENDOCR METAB, V85, P4734, DOI 10.1210/jc.85.12.4734; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fox SB, 1996, J PATHOL, V179, P232, DOI 10.1002/(SICI)1096-9896(199607)179:3<232::AID-PATH505>3.0.CO;2-A; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Kasperlik-Zatuska AA, 2008, HORM METAB RES, V40, P338, DOI 10.1055/s-2008-1073167; KLOOS RT, 1995, ENDOCR REV, V16, P460, DOI 10.1210/er.16.4.460; Kolomecki K, 2001, Endocr Regul, V35, P9; KRESTIN GP, 1989, RADIOLOGY, V171, P675, DOI 10.1148/radiology.171.3.2717737; [刘佩芳 Liu Peifang], 2002, [中华放射学杂志, Chinese Journal of Radiology], V36, P967; [刘雅洁 Liu Yajie], 2002, [肿瘤, Tumor], V22, P116; Nieman LK, 2010, J CLIN ENDOCR METAB, V95, P4106, DOI 10.1210/jc.2010-0457; Qin HY, 2012, EUR J RADIOL, V81, P502, DOI 10.1016/j.ejrad.2010.12.072; Schteingart DE, 2000, ENDOCRIN METAB CLIN, V29, P127, DOI 10.1016/S0889-8529(05)70120-1; Xiao XR, 1998, BR J UROL, V82, P99; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	23	12	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79911	10.1371/journal.pone.0079911	http://dx.doi.org/10.1371/journal.pone.0079911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260316	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500106
J	Rossi, S; Doucelin, A; Le Potier, MF; Eraud, C; Gilot-Fromont, E				Rossi, Sophie; Doucelin, Anais; Le Potier, Marie-Frederique; Eraud, Cyril; Gilot-Fromont, Emmanuelle			Innate Immunity Correlates with Host Fitness in Wild Boar (Sus scrofa) Exposed to Classical Swine Fever	PLOS ONE			English	Article							NATURAL ANTIBODIES; LONG-TERM; DISEASE; TIME; AGE; CONSEQUENCES; POPULATION; IMMUNOLOGY; COMPLEMENT; DIAGNOSIS	Constitutive humoral immunity (CHI) is thought to be a first-line of protection against pathogens invading vertebrate hosts. However, clear evidence that CHI correlates with host fitness in natural conditions is still lacking. This study explores the relationship between CHI, measured using a haemagglutination-haemolysis assay (HAHL), and resistance to classical swine fever virus (CSFV) among wild boar piglets. The individual dynamics of HAHL during piglet growth was analysed, using 423 serum samples from 92 piglets repeatedly captured in the absence of CSFV (in 2006) within two areas showing contrasting food availability. Natural antibody levels increased with age, but, in the youngest piglets antibody levels were higher in individuals from areas with the highest food availability. Complement activity depended on natural antibody levels and piglets' body condition. In the presence of CSFV (i.e., in 2005 within one area), serum samples from piglets that were repeatedly captured were used to assess whether piglet HAHL levels affected CSFV status at a later capture. The correlation between CHI and resistance to CSFV was tested using 79 HAHL measures from 23 piglets captured during a CSFV outbreak. Both natural antibodies and complement activity levels measured at a given time correlated negatively to the subsequent probability of becoming viremic. Finally, capture-mark-recapture models showed that piglets with medium/high average complement activity, independently of their age, were significantly less at risk of becoming viremic and more likely to develop a specific immune response than piglets with low complement activity. Additionally, piglets with high average complement activity showed the highest survival prospects. This study provides evidence linking CHI to individual fitness within a natural mammal population. The results also highlight the potential of HAHL assays to explore the dynamics and co-evolution between wildlife mammal hosts and blood-borne parasites interacting with the CHI.	[Rossi, Sophie; Doucelin, Anais] Off Natl Chasse & Faune Sauvage, Unite Sanitaire Faune, Gap, France; [Le Potier, Marie-Frederique] French Agcy Food Environm & Occupat Hlth & Safety, Unite Virol & Immunol Porcine, Ploufragan, France; [Le Potier, Marie-Frederique] Univ Europeenne Bretagne, Rennes, France; [Eraud, Cyril] CNERA Avifaune Migratrice, Off Natl Chasse & Faune Sauvage, Chize, France; [Gilot-Fromont, Emmanuelle] Univ Lyon, Marcy Letoile, France; [Gilot-Fromont, Emmanuelle] Univ Lyon 1, UMR CNRS LBBE 5558, Villeurbanne, France	Universite de Bretagne Occidentale; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rossi, S (corresponding author), Off Natl Chasse & Faune Sauvage, Unite Sanitaire Faune, Gap, France.	sophie.rossi@oncfs.gouv.fr		Gilot-Fromont, Emmanuelle/0000-0003-0011-7519				Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Bonenfant C, 2002, ECOGRAPHY, V25, P446, DOI 10.1034/j.1600-0587.2002.250407.x; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Burnham K. P., 1998, MODEL SELECTION INFE; Cavallero S, 2012, INFECT GENET EVOL, V12, P1020, DOI 10.1016/j.meegid.2012.02.017; Choquet R, 2010, 5175 CEFE UMR; Choquet R., 2005, U CARE 2 2 USERS MAN; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; De Coster G, 2010, J EXP BIOL, V213, P3012, DOI 10.1242/jeb.042721; Depner K, 2007, VET MICROBIOL, V121, P338, DOI 10.1016/j.vetmic.2006.12.027; Depner KR, 1997, VET REC, V140, P506, DOI 10.1136/vr.140.19.506; Depner KR, 2000, DEUT TIERARZTL WOCH, V107, P66; Focardi S, 2008, J MAMMAL, V89, P1113, DOI 10.1644/07-MAMM-A-164.1; FULTON JE, 1990, ANIM GENET, V21, P47, DOI 10.1111/j.1365-2052.1990.tb03206.x; Gilot-Fromont E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045576; Graham AL, 2011, FUNCT ECOL, V25, P5, DOI 10.1111/j.1365-2435.2010.01777.x; Grindstaff JL, 2006, P ROY SOC B-BIOL SCI, V273, P2551, DOI 10.1098/rspb.2006.3608; HUGGETT AS, 1951, J PHYSIOL-LONDON, V114, P306, DOI 10.1113/jphysiol.1951.sp004622; Jullien JM, 1988, B MENSUEL OFFICE NAT, V122, P28; Kramer-Schadt S, 2009, OIKOS, V118, P199, DOI 10.1111/j.1600-0706.2008.16582.x; Lang S, 2000, GENET SEL EVOL, V32, P303, DOI 10.1051/gse:2000120; Lange M, 2012, PREV VET MED, V106, P185, DOI 10.1016/j.prevetmed.2012.01.024; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Le Dimna M, 2008, J VIROL METHODS, V147, P136, DOI 10.1016/j.jviromet.2007.08.013; Le Potier MF, 2002, DIS SWINE; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Mauck RA, 2005, FUNCT ECOL, V19, P1001, DOI 10.1111/j.1365-2435.2005.01060.x; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; MICHAEL JG, 1962, J EXP MED, V115, P131, DOI 10.1084/jem.115.1.131; Moller AP, 2007, FUNCT ECOL, V21, P363, DOI 10.1111/j.1365-2435.2006.01215.x; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; Muller T, 2005, J VET MED B, V52, P432, DOI 10.1111/j.1439-0450.2005.00896.x; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Owen JP, 2007, TRENDS ECOL EVOL, V22, P228, DOI 10.1016/j.tree.2007.02.003; Parmentier HK, 2004, DEV COMP IMMUNOL, V28, P39, DOI 10.1016/S0145-305X(03)00087-9; Prokesova L, 1996, INT J IMMUNOPHARMACO, V18, P661, DOI 10.1016/S0192-0561(96)00050-1; Rossi S, 2010, VET MICROBIOL, V142, P99, DOI 10.1016/j.vetmic.2009.09.050; Rossi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024257; Ruiz-Fons F, 2008, VET J, V176, P158, DOI 10.1016/j.tvjl.2007.02.017; Star L, 2007, POULTRY SCI, V86, P1090, DOI 10.1093/ps/86.6.1090; The R foundation for Statistical Computing, 2011, R STAT SOFTW; Tieleman BI, 2010, COMP BIOCHEM PHYS A, V156, P537, DOI 10.1016/j.cbpa.2010.04.011; Ujvari B, 2006, BEHAV ECOL, V17, P20, DOI 10.1093/beheco/ari091; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Zuur Alain F., 2009, P1	48	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79706	10.1371/journal.pone.0079706	http://dx.doi.org/10.1371/journal.pone.0079706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260286	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500091
J	Cloonan, K; Bedoukian, RH; Leal, W				Cloonan, Kevin; Bedoukian, Robert H.; Leal, Walter			Quasi-Double-Blind Screening of Semiochemicals for Reducing Navel Orangeworm Oviposition on Almonds	PLOS ONE			English	Article							TRANSITELLA WALKER LEPIDOPTERA; AMYELOIS-TRANSITELLA; MOTH LEPIDOPTERA; EGG TRAPS; PYRALIDAE OVIPOSITION; CHILO-PARTELLUS; ESSENTIAL OILS; RESPONSES; BEHAVIOR; EXTRACTS	A three-step, quasi-double-bind approach was used as a proof-of-concept study to screen twenty compounds for their ability to reduce oviposition of gravid female navel orangeworm(NOW), Ameylois transitella (Lepidoptera: Pyralidae). First, the panel of compounds, whose identity was unknown to the experimenters, was tested by electroantennogram (EAG) using antennae of two-day old gravid females as the sensing element. Of the twenty compounds tested three showed significant EAG responses. These three EAG-active compounds and a negative control were then analyzed for their ability to reduce oviposition via small-cage, two-choice laboratory assays. Two of the three compounds significantly reduced oviposition under laboratory conditions. Lastly, these two compounds were deployed in a field setting in an organic almond orchard in Arbuckle, CA using black egg traps to monitor NOW oviposition. One of these two compounds significantly reduced oviposition on black egg traps under these field conditions. Compound 9 (later identified as isophorone) showed a significant reduction in oviposition in field assays and thus has a potential as a tool to control the navel orangeworm as a pest of almonds.	[Cloonan, Kevin; Leal, Walter] Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA; [Bedoukian, Robert H.] Bedoukian Res Inc, Danbury, CT USA	University of California System; University of California Davis	Leal, W (corresponding author), Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240	Bedoukian Research Inc. (BRI); University of California-Davis [201118886]	Bedoukian Research Inc. (BRI); University of California-Davis(University of California System)	This work was supported by Bedoukian Research Inc. (BRI) under a research agreement with the University of California-Davis (number 201118886). Under the terms of the UC Davis-BRI agreement, the findings were disclosed to the sponsor prior to publication. The funder (BRI) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agboka Komi, 2009, International Journal of Tropical Insect Science, V29, P185, DOI 10.1017/S1742758409990348; AGUDELOSILVA F, 1995, FLA ENTOMOL, V78, P516, DOI 10.2307/3495537; ANDERSON P, 1995, PHYSIOL ENTOMOL, V20, P189, DOI 10.1111/j.1365-3032.1995.tb00001.x; Atanassov A, 2002, J ECON ENTOMOL, V95, P803, DOI 10.1603/0022-0493-95.4.803; Beck JJ, 2008, J SCI FOOD AGR, V88, P1363, DOI 10.1002/jsfa.3224; Binder BF, 1997, J AGR FOOD CHEM, V45, P980, DOI 10.1021/jf960400z; Burks CS, 2008, ENTOMOL EXP APPL, V129, P66, DOI 10.1111/j.1570-7458.2008.00754.x; Burks CS, 2011, ENVIRON ENTOMOL, V40, P706, DOI 10.1603/EN10253; Campbell BC, 2003, J TOXICOL-TOXIN REV, V22, P225, DOI 10.1081/TXR-120024093; Eilers EJ, 2009, BIOL CONTROL, V51, P388, DOI 10.1016/j.biocontrol.2009.07.010; Engle C. E., 1983, California Agriculture, V37, P19; Gajmer T, 2002, J APPL ENTOMOL, V126, P238, DOI 10.1046/j.1439-0418.2002.00649.x; GE XS, 1995, J ECON ENTOMOL, V88, P1771, DOI 10.1093/jee/88.6.1771; Gokce A, 2006, J APPL ENTOMOL, V130, P509, DOI 10.1111/j.1439-0418.2006.01101.x; Guerra PC, 2007, J APPL ENTOMOL, V131, P134, DOI 10.1111/j.1439-0418.2007.01138.x; Higbee BS, 2008, J ECON ENTOMOL, V101, P1633, DOI 10.1603/0022-0493(2008)101[1633:EOMDTO]2.0.CO;2; Higbee BS, 2011, J ECON ENTOMOL, V104, P211, DOI 10.1603/EC10162; Higbee BS, 2009, CALIF AGR, V63, P24, DOI 10.3733/ca.v063n01p24; HONDA K, 1995, ARCH INSECT BIOCHEM, V30, P1, DOI 10.1002/arch.940300102; HOUGHGOLDSTEIN J, 1992, ENVIRON ENTOMOL, V21, P837, DOI 10.1093/ee/21.4.837; Jenkins PE, 2007, J ECON ENTOMOL, V100, P855, DOI 10.1603/0022-0493(2007)100[855:RIFCOG]2.0.CO;2; JOHNSON JA, 1989, J ECON ENTOMOL, V82, P1391, DOI 10.1093/jee/82.5.1391; Kuenen LPSB, 2008, CALIF AGR, V62, P36, DOI 10.3733/ca.v062n01p36; LANDOLT PJ, 1991, J KANSAS ENTOMOL SOC, V64, P414; LEGNER EF, 1992, J ECON ENTOMOL, V85, P2153, DOI 10.1093/jee/85.6.2153; Liu ML, 2008, J INSECT PHYSIOL, V54, P656, DOI 10.1016/j.jinsphys.2008.01.002; Liu ZO, 2010, J CHEM ECOL, V36, P787, DOI 10.1007/s10886-010-9811-5; Miller JR, 2009, J ECON ENTOMOL, V102, P2056, DOI 10.1603/029.102.0606; Niu GD, 2012, J ECON ENTOMOL, V105, P410, DOI 10.1603/EC10194; Niu GD, 2009, J CHEM ECOL, V35, P951, DOI 10.1007/s10886-009-9675-8; Opender Koul, 2008, Biopesticides International, V4, P63; Park KC, 2002, CHEM SENSES, V27, P343, DOI 10.1093/chemse/27.4.343; Parra-Pedrazzoli AL, 2006, NEOTROP ENTOMOL, V35, P769, DOI 10.1590/S1519-566X2006000600008; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; RICE RE, 1976, ENVIRON ENTOMOL, V5, P697, DOI 10.1093/ee/5.4.697; RICE RE, 1984, J ECON ENTOMOL, V77, P1352, DOI 10.1093/jee/77.5.1352; Rojas JC, 2003, ENVIRON ENTOMOL, V32, P1386, DOI 10.1603/0046-225X-32.6.1386; SANDERSON JP, 1989, ENVIRON ENTOMOL, V18, P612, DOI 10.1093/ee/18.4.612; Scott IM, 2004, J ECON ENTOMOL, V97, P1390, DOI 10.1603/0022-0493-97.4.1390; SEAMAN WS, 1984, ENVIRON ENTOMOL, V13, P81, DOI 10.1093/ee/13.1.81; Seljasen R, 2006, CROP PROT, V25, P338, DOI 10.1016/j.cropro.2005.05.007; Siegel J, 2004, BIOL CONTROL, V30, P410, DOI 10.1016/j.biocontrol.2003.12.004; Singh R, 2011, ENTOMOL EXP APPL, V138, P55, DOI 10.1111/j.1570-7458.2010.01071.x; Syed Z, 2011, JOVE-J VIS EXP, DOI 10.3791/2489; TABASHNIK BE, 1985, ENVIRON ENTOMOL, V14, P575, DOI 10.1093/ee/14.5.575; TEBBETS JS, 1978, J ECON ENTOMOL, V71, P875, DOI 10.1093/jee/71.6.875; TINGLE FC, 1986, J CHEM ECOL, V12, P1523, DOI 10.1007/BF01012369; (USDA-NASS) USDoA-NASS, 2012, CAL ALM ACR REP; VANSTEENWYK RA, 1987, J ECON ENTOMOL, V80, P1291, DOI 10.1093/jee/80.6.1291; Varshney AK, 2003, J AGR FOOD CHEM, V51, P4008, DOI 10.1021/jf0211074; WADE WILLIAM H., 1961, HILGARDIA, V31, P129; Zalom FG, 2009, UC IPM PEST MANAGEME, P61	52	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80182	10.1371/journal.pone.0080182	http://dx.doi.org/10.1371/journal.pone.0080182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244643	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800133
J	Ding, F; Yao, J; Rettberg, JR; Chen, SH; Brinton, RD				Ding, Fan; Yao, Jia; Rettberg, Jamaica R.; Chen, Shuhua; Brinton, Roberta Diaz			Early Decline in Glucose Transport and Metabolism Precedes Shift to Ketogenic System in Female Aging and Alzheimer's Mouse Brain: Implication for Bioenergetic Intervention	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; ENERGY-METABOLISM; EXPRESSION; LACTATE; DISEASE; HIPPOCAMPAL; ASTROCYTE; OLIGODENDROCYTES; ESTRADIOL; MECHANISM	We previously demonstrated that mitochondrial bioenergetic deficits in the female brain accompanied reproductive senescence and was accompanied by a shift from an aerobic glycolytic to a ketogenic phenotype. Herein, we investigated the relationship between systems of fuel supply, transport and mitochondrial metabolic enzyme expression/activity during aging (3-15 months) in the hippocampus of nontransgenic (nonTg) background and 3xTgAD female mice. Results indicate that during female brain aging, both nonTg and 3xTgAD brains undergo significant decline in glucose transport, as detected by FDG-microPET, between 6-9 months of age just prior to the transition into reproductive senescence. The deficit in brain metabolism was sustained thereafter. Decline in glucose transport coincided with significant decline in neuronal glucose transporter expression and hexokinase activity with a concomitant rise in phosphorylated/inactivated pyruvate dehydrogenase. Lactate utilization declined in parallel to the decline in glucose transport suggesting lactate did not serve as an alternative fuel. An adaptive response in the nonTg hippocampus was a shift to transport and utilization of ketone bodies as an alternative fuel. In the 3xTgAD brain, utilization of ketone bodies as an alternative fuel was evident at the earliest age investigated and declined thereafter. The 3xTgAD adaptive response was to substantially increase monocarboxylate transporters in neurons while decreasing their expression at the BBB and in astrocytes. Collectively, these data indicate that the earliest change in the metabolic system of the aging female brain is the decline in neuronal glucose transport and metabolism followed by decline in mitochondrial function. The adaptive shift to the ketogenic system as an alternative fuel coincided with decline in mitochondrial function. Translationally, these data provide insights into the earliest events in bioenergetic aging of the female brain and provide potential targets for preventing shifts to less efficient bioenergetic fuels and transition to the ketogenic phenotype of the Alzheimer's brain.	[Ding, Fan; Yao, Jia; Chen, Shuhua; Brinton, Roberta Diaz] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Rettberg, Jamaica R.; Brinton, Roberta Diaz] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Brinton, RD (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	rbrinton@usc.edu		Brinton, Roberta/0000-0001-8450-772X	National Institute on Aging [R01AG032236, P01AG026572]; Eileen L. Norris Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032236, P01AG026572] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eileen L. Norris Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported herein was supported by National Institute on Aging (http://www.nia.nih.gov/) R01AG032236 (to RDB), National Institute on Aging (http://www.nia.nih.gov/) P01AG026572 (Project 1 to RDB) and Eileen L. Norris Foundation (http://ktn.org/) (to RDB). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BROCKELHURSTS TXB GE, DOI DOI 10.1016/B978-1-4160-6231-8.X0001-3; Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Brinton RD, 2012, ENDOCRINOLOGY, V153, P3571, DOI 10.1210/en.2012-1340; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; Chou JL, 2011, J PROTEOMICS, V74, P466, DOI 10.1016/j.jprot.2010.12.012; Del Sole A, 2008, EUR J NUCL MED MOL I, V35, P1357, DOI 10.1007/s00259-008-0773-6; DEVASKAR SU, 1992, PEDIATR RES, V31, P1, DOI 10.1203/00006450-199201000-00001; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059825; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; Fattoretti P, 2001, J HISTOCHEM CYTOCHEM, V49, P671, DOI 10.1177/002215540104900518; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; FINCH CE, 1984, ENDOCR REV, V5, P467, DOI 10.1210/edrv-5-4-467; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Hoyer S, 1991, ANN NY ACAD SCI, V640, P53; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; Korotchkina LG, 2006, J BIOL CHEM, V281, P9688, DOI 10.1074/jbc.M511481200; Leybaert L, 2005, J CEREBR BLOOD F MET, V25, P2, DOI 10.1038/sj.jcbfm.9600001; LUNDANDERSEN H, 1979, PHYSIOL REV, V59, P305, DOI 10.1152/physrev.1979.59.2.305; Merlini M, 2011, ACTA NEUROPATHOL, V122, P293, DOI 10.1007/s00401-011-0834-y; Moorthy K, 2004, BIOGERONTOLOGY, V5, P249, DOI 10.1023/B:BGEN.0000038026.89337.02; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Mosconi L, 2006, J NUCL MED, V47, P1778; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100; Nilsen J, 2007, J NEUROSCI, V27, P14069, DOI 10.1523/JNEUROSCI.4391-07.2007; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pauwels EKJ, 2000, J CANCER RES CLIN, V126, P549, DOI 10.1007/PL00008465; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Qutub AA, 2005, BRAIN RES REV, V49, P595, DOI 10.1016/j.brainresrev.2005.03.002; Rasgon NL, 2005, NEUROBIOL AGING, V26, P229, DOI 10.1016/j.neurobiolaging.2004.03.003; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Sanchez-Abarca LI, 2001, GLIA, V36, P321, DOI 10.1002/glia.1119; Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Van Kempen TA, 2011, BRAIN RES, V1379, P176, DOI 10.1016/j.brainres.2010.12.064; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Vannucci SJ, 1998, DEV NEUROSCI-BASEL, V20, P369, DOI 10.1159/000017333; Weber MT, 2013, MENOPAUSE, V20, P511, DOI [10.1097/GME.0b013e31827655e5, 10.1097/gme.0b013e31827655e5]; Weber MT, 2013, J STEROID BIOCH MOL; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; Yao J, 2011, NEUROBIOLOGY AGING; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Yao J, 2010, BBA-GEN SUBJECTS, V1800, P1121, DOI 10.1016/j.bbagen.2010.06.002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yu S, 1998, BRAIN RES, V797, P65, DOI 10.1016/S0006-8993(98)00372-2	60	149	152	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79977	10.1371/journal.pone.0079977	http://dx.doi.org/10.1371/journal.pone.0079977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244584	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600162
J	Mizunoya, W; Iwamoto, Y; Shirouchi, B; Sato, M; Komiya, Y; Razin, FR; Tatsumi, R; Sato, Y; Nakamura, M; Ikeuchi, Y				Mizunoya, Wataru; Iwamoto, Yohei; Shirouchi, Bungo; Sato, Masao; Komiya, Yusuke; Razin, Farzaneh Rahimi; Tatsumi, Ryuichi; Sato, Yusuke; Nakamura, Mako; Ikeuchi, Yoshihide			Dietary Fat Influences the Expression of Contractile and Metabolic Genes in Rat Skeletal Muscle	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; HEAVY-CHAIN ISOFORMS; FIBER TYPES; MESSENGER-RNA; FISH-OIL; ACIDS; FOXO1; MASS; CHOLESTEROL; COACTIVATOR	Dietary fat plays a major role in obesity, lipid metabolism, and cardiovascular diseases. To determine whether the intake of different types of dietary fats affect the muscle fiber types that govern the metabolic and contractile properties of the skeletal muscle, we fed male Wistar rats with a 15% fat diet derived from different fat sources. Diets composed of soybean oil (n-6 polyunsaturated fatty acids (PUFA)-rich), fish oil (n-3 PUFA-rich), or lard (low in PUFAs) were administered to the rats for 4 weeks. Myosin heavy chain (MyHC) isoforms were used as biomarkers to delineate the skeletal muscle fiber types. Compared with soybean oil intake, fish oil intake showed significantly lower levels of the fast-type MyHC2B and higher levels of the intermediate-type MyHC2X composition in the extensor digitorum longus (EDL) muscle, which is a fast-type dominant muscle. Concomitantly, MyHC2X mRNA levels in fish oil-fed rats were significantly higher than those observed in the soybean oil-fed rats. The MyHC isoform composition in the lard-fed rats was an intermediate between that of the fish oil and soybean oil-fed rats. Mitochondrial uncoupling protein 3, pyruvate dehydrogenase kinase 4, and porin mRNA showed significantly upregulated levels in the EDL of fish oil-fed rats compared to those observed in soybean oil-fed and lard-fed rats, implying an activation of oxidative metabolism. In contrast, no changes in the composition of MyHC isoforms was observed in the soleus muscle, which is a slow-type dominant muscle. Fatty acid composition in the serum and the muscle was significantly influenced by the type of dietary fat consumed. In conclusion, dietary fat affects the expression of genes related to the contractile and metabolic properties in the fast-type dominant skeletal muscle, where the activation of oxidative metabolism is more pronounced after fish oil intake than that after soybean oil intake.	[Mizunoya, Wataru; Iwamoto, Yohei; Komiya, Yusuke; Razin, Farzaneh Rahimi; Tatsumi, Ryuichi; Sato, Yusuke; Nakamura, Mako; Ikeuchi, Yoshihide] Kyushu Univ, Dept Bioresource Sci, Grad Sch Agr, Fukuoka 812, Japan; [Shirouchi, Bungo; Sato, Masao] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Agr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Mizunoya, W (corresponding author), Kyushu Univ, Dept Bioresource Sci, Grad Sch Agr, Fukuoka 812, Japan.	wataru_m@agr.kyushu-u.ac.jp	Mizunoya, Wataru/W-1674-2019; Shirouchi, Bungo/J-4849-2019	Mizunoya, Wataru/0000-0002-2258-1964; Shirouchi, Bungo/0000-0003-4237-5081; Nakamura, Mako/0000-0002-6129-7560; Komiya, Yusuke/0000-0003-3225-2491	Japan Society for Promotion of Science [18780096, 22580136]; Uehara Memorial Foundation; Faculty of Agriculture, Kyushu University; Grants-in-Aid for Scientific Research [23380159] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Faculty of Agriculture, Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Young Scientists (B) (#18780096), Grant-in-Aid for Scientific Research (C) (#22580136) from Japan Society for Promotion of Science, and the research grant from the Uehara Memorial Foundation. The costs of publication were supported in part by a Research Grant for Young Investigators of the Faculty of Agriculture, Kyushu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayre KJ, 1996, J NUTR, V126, P653, DOI 10.1093/jn/126.3.653; Azain MJ, 2004, J ANIM SCI, V82, P916; Baillie RA, 1999, PROSTAG LEUKOTR ESS, V60, P351, DOI 10.1016/S0952-3278(99)80011-8; Caiozzo VJ, 1997, AM J PHYSIOL-CELL PH, V273, pC944, DOI 10.1152/ajpcell.1997.273.3.C944; Couet C, 1997, INT J OBESITY, V21, P637, DOI 10.1038/sj.ijo.0800451; Cresser J, 2010, AM J PHYSIOL-REG I, V299, pR470, DOI 10.1152/ajpregu.00431.2009; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; FITZSIMONS DP, 1990, J APPL PHYSIOL, V68, P1950, DOI 10.1152/jappl.1990.68.5.1950; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Forman BM, 1996, ANN NY ACAD SCI, V804, P266, DOI 10.1111/j.1749-6632.1996.tb18621.x; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Gotoh N, 2009, J AGR FOOD CHEM, V57, P11047, DOI 10.1021/jf9026553; HA HJ, 1993, J BIOL CHEM, V268, P12143; HEGSTED DM, 1965, AM J CLIN NUTR, V17, P281; Horakova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043764; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Lee MS, 2013, NUTRIENTS, V5, P1660, DOI 10.3390/nu5051660; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Mizunoya W, 2013, J NUTR SCI VITAMINOL, V59, P289, DOI 10.3177/jnsv.59.289; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Oudart H, 1997, INT J OBESITY, V21, P955, DOI 10.1038/sj.ijo.0800500; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Pette D, 1998, ACTA PHYSIOL SCAND, V162, P367, DOI 10.1046/j.1365-201X.1998.0296e.x; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ren B, 1997, J BIOL CHEM, V272, P26827, DOI 10.1074/jbc.272.43.26827; Rivero JLL, 1998, J MUSCLE RES CELL M, V19, P733, DOI 10.1023/A:1005482816442; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Takahashi Y, 2000, BRIT J NUTR, V84, P175; Talmadge RJ, 2004, BIOCHEM BIOPH RES CO, V325, P296, DOI 10.1016/j.bbrc.2004.10.030; TERMIN A, 1989, HISTOCHEMISTRY, V92, P453, DOI 10.1007/BF00524756; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yoshihara H, 2006, J NUTR SCI VITAMINOL, V52, P183, DOI 10.3177/jnsv.52.183; Zambon A, 1999, J INTERN MED, V246, P191, DOI 10.1046/j.1365-2796.1999.00550.x; Zhang JZ, 2012, J ANIM VET ADV, V11, P1411; Zhou AL, 2012, LIPIDS, V47, P1119, DOI 10.1007/s11745-012-3729-3; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	51	39	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80152	10.1371/journal.pone.0080152	http://dx.doi.org/10.1371/journal.pone.0080152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244634	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600186
J	Dominguez-Ramirez, L; Del Moral-Ramirez, E; Cortes-Hernandez, P; Garcia-Garibay, M; Jimenez-Guzman, J				Dominguez-Ramirez, Lenin; Del Moral-Ramirez, Elizabeth; Cortes-Hernandez, Paulina; Garcia-Garibay, Mariano; Jimenez-Guzman, Judith			beta-Lactoglobulin's Conformational Requirements for Ligand Binding at the Calyx and the Dimer Interphase: a Flexible Docking Study	PLOS ONE			English	Article							TANFORD TRANSITION; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; DYNAMICS; COMPLEX; DISSOCIATION; RECOGNITION; RETINOL; SITES; ACID	beta-lactoglobulin (BLG) is an abundant milk protein relevant for industry and biotechnology, due significantly to its ability to bind a wide range of polar and apolar ligands. While hydrophobic ligand sites are known, sites for hydrophilic ligands such as the prevalent milk sugar, lactose, remain undetermined. Through the use of molecular docking we first, analyzed the known fatty acid binding sites in order to dissect their atomistic determinants and second, predicted the interaction sites for lactose with monomeric and dimeric BLG. We validated our approach against BLG structures co-crystallized with ligands and report a computational setup with a reduced number of flexible residues that is able to reproduce experimental results with high precision. Blind dockings with and without flexible side chains on BLG showed that: i) 13 experimentally-determined ligands fit the calyx requiring minimal movement of up to 7 residues out of the 23 that constitute this binding site. ii) Lactose does not bind the calyx despite conformational flexibility, but binds the dimer interface and an alternate Site C. iii) Results point to a probable lactolation site in the BLG dimer interface, at K141, consistent with previous biochemical findings. In contrast, no accessible lysines are found near Site C. iv) lactose forms hydrogen bonds with residues from both monomers stabilizing the dimer through a claw-like structure. Overall, these results improve our understanding of BLG's binding sites, importantly narrowing down the calyx residues that control ligand binding. Moreover, our results emphasize the importance of the dimer interface as an insufficiently explored, biologically relevant binding site of particular importance for hydrophilic ligands. Furthermore our analyses suggest that BLG is a robust scaffold for multiple ligand-binding, suitable for protein design, and advance our molecular understanding of its ligand sites to a point that allows manipulation to control binding.	[Dominguez-Ramirez, Lenin; Cortes-Hernandez, Paulina] Univ Autonoma Metropolitana Lerma, Dept Ciencias Salud, Lerma De Villada, Lerma, Mexico; [Del Moral-Ramirez, Elizabeth; Garcia-Garibay, Mariano; Jimenez-Guzman, Judith] Univ Autonoma Metropolitana Lerma, Dept Ciencias Alimentac, Lerma De Villada, Lerma, Mexico; [Garcia-Garibay, Mariano] Univ Autonoma Metropolitana Iztapalapa, Dept Biotecnol, Mexico City 09340, DF, Mexico	Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico	Dominguez-Ramirez, L (corresponding author), Univ Autonoma Metropolitana Lerma, Dept Ciencias Salud, Lerma De Villada, Lerma, Mexico.	j.dominguez@correo.ler.uam.mx	Cortes-Hernandez, Paulina/ABC-1133-2020; Cortes-Hernandez, Paulina/GLQ-5915-2022; Dominguez-Ramirez, Lenin/AAG-9864-2020; Garcia-Garibay, Mariano/G-5915-2019	Cortes-Hernandez, Paulina/0000-0001-8226-1703; Dominguez-Ramirez, Lenin/0000-0002-3483-4658; Garcia-Garibay, Mariano/0000-0002-9132-7126	Pew Latin American Fellows Program in the Biomedical Sciences; NVIDIA Corporation	Pew Latin American Fellows Program in the Biomedical Sciences; NVIDIA Corporation	LDR was in part funded by the Pew Latin American Fellows Program in the Biomedical Sciences. The authors gratefully acknowledge the support of NVIDIA Corporation with the donation of the Tesla K20 GPU used for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Belatik A, 2012, J BIOMOL STRUCT DYN, V30, P437, DOI 10.1080/07391102.2012.682209; Bello M, 2008, PROTEINS, V70, P1475, DOI 10.1002/prot.21639; Bello M, 2012, BIOPHYS CHEM, V165, P79, DOI 10.1016/j.bpc.2012.03.009; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Del Moral-Rawirez E, 2008, J AGR FOOD CHEM, V56, P5859, DOI 10.1021/jf703785p; Eberini I, 2008, J MOL GRAPH MODEL, V26, P1004, DOI 10.1016/j.jmgm.2007.08.006; Fogliano V, 1998, BBA-PROTEIN STRUCT M, V1388, P295, DOI 10.1016/S0167-4838(98)00177-0; Fogolari F, 2005, PROTEINS, V59, P91, DOI 10.1002/prot.20384; *FOX PF, 1997, ADV DAIRY CHEM, P1; HALPIN MI, 1985, J DAIRY SCI, V68, P3189, DOI 10.3168/jds.S0022-0302(85)81226-1; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jimenez-Guzman J, 2006, INT DAIRY J, V16, P1169, DOI 10.1016/j.idairyj.2005.10.003; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kontopidis G, 2004, J DAIRY SCI, V87, P785, DOI 10.3168/jds.S0022-0302(04)73222-1; Kontopidis G, 2002, J MOL BIOL, V318, P1043, DOI 10.1016/S0022-2836(02)00017-7; Konuma T, 2007, J MOL BIOL, V368, P209, DOI 10.1016/j.jmb.2007.01.077; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Loch J, 2011, J MOL RECOGNIT, V24, P341, DOI 10.1002/jmr.1084; Loch JI, 2012, INT J BIOL MACROMOL, V50, P1095, DOI 10.1016/j.ijbiomac.2012.03.002; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mensi A, 2013, J AGR FOOD CHEM, V61, P4114, DOI 10.1021/jf400711d; Mercadante D, 2012, BIOPHYS J, V103, P303, DOI 10.1016/j.bpj.2012.05.041; MONACO HL, 1987, J MOL BIOL, V197, P695, DOI 10.1016/0022-2836(87)90476-1; Morgan F, 1998, INT DAIRY J, V8, P95, DOI 10.1016/S0958-6946(98)00025-9; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Niemi M, 2008, ACTA CRYSTALLOGR F, V64, P25, DOI 10.1107/S174430910706160X; Noiseux I, 2002, J AGR FOOD CHEM, V50, P1587, DOI 10.1021/jf010887y; Ohtomo H, 2012, J BIOCHEM, V151, P329, DOI 10.1093/jb/mvr142; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin BY, 1998, FEBS LETT, V438, P272, DOI 10.1016/S0014-5793(98)01199-5; Qin BY, 1998, BIOCHEMISTRY-US, V37, P14014, DOI 10.1021/bi981016t; Sakurai K, 2006, J MOL BIOL, V356, P483, DOI 10.1016/j.jmb.2005.11.038; Sakurai K, 2009, BBA-GEN SUBJECTS, V1790, P527, DOI 10.1016/j.bbagen.2009.04.003; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uhrinova S, 2000, BIOCHEMISTRY-US, V39, P3565, DOI 10.1021/bi992629o; Verheul M, 1999, BIOPOLYMERS, V49, P11, DOI 10.1002/(SICI)1097-0282(199901)49:1<11::AID-BIP2>3.3.CO;2-T; Vijayalakshmi L, 2008, PROTEINS, V71, P241, DOI 10.1002/prot.21695; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wu SY, 1999, J BIOL CHEM, V274, P170, DOI 10.1074/jbc.274.1.170; Yang MC, 2008, PROTEINS, V71, P1197, DOI 10.1002/prot.21811; Yang M, 2008, INDIAN J TRADIT KNOW, V7, P3; ZHU H, DSSP STRIDE PLUGIN P	46	23	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79530	10.1371/journal.pone.0079530	http://dx.doi.org/10.1371/journal.pone.0079530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255705	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200071
J	Roujol, S; Anter, E; Josephson, ME; Nezafat, R				Roujol, Sebastien; Anter, Elad; Josephson, Mark E.; Nezafat, Reza			Characterization of Respiratory and Cardiac Motion from Electro-Anatomical Mapping Data for Improved Fusion of MRI to Left Ventricular Electrograms	PLOS ONE			English	Article							CATHETER ABLATION; MYOCARDIAL-INFARCTION; TISSUE HETEROGENEITY; SPATIAL-RESOLUTION; TACHYCARDIA; INTEGRATION; NAVIGATION; HEART; MAPS	Accurate fusion of late gadolinium enhancement magnetic resonance imaging (MRI) and electro-anatomical voltage mapping (EAM) is required to evaluate the potential of MRI to identify the substrate of ventricular tachycardia. However, both datasets are not acquired at the same cardiac phase and EAM data is corrupted with respiratory motion limiting the accuracy of current rigid fusion techniques. Knowledge of cardiac and respiratory motion during EAM is thus required to enhance the fusion process. In this study, we propose a novel approach to characterize both cardiac and respiratory motion from EAM data using the temporal evolution of the 3D catheter location recorded from clinical EAM systems. Cardiac and respiratory motion components are extracted from the recorded catheter location using multi-band filters. Filters are calibrated for each EAM point using estimates of heart rate and respiratory rate. The method was first evaluated in numerical simulations using 3D models of cardiac and respiratory motions of the heart generated from real time MRI data acquired in 5 healthy subjects. An accuracy of 0.6-0.7 mm was found for both cardiac and respiratory motion estimates in numerical simulations. Cardiac and respiratory motions were then characterized in 27 patients who underwent LV mapping for treatment of ventricular tachycardia. Mean maximum amplitude of cardiac and respiratory motion was 10.2 +/- 2.7 mm (min = 5.5, max = 16.9) and 8.862.3 mm (min = 4.3, max = 14.8), respectively. 3D Cardiac and respiratory motions could be estimated from the recorded catheter location and the method does not rely on additional imaging modality such as X-ray fluoroscopy and can be used in conventional electrophysiology laboratory setting.	[Nezafat, Reza] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Nezafat, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA.	rnezafat@bidmc.harvard.edu		Roujol, Sebastien/0000-0002-7146-0552	NIH [R01EB008743-01A2]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by NIH R01EB008743-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya M, 2012, RADIOLOGY, V264, P691, DOI 10.1148/radiol.12112489; Andreu D, 2011, CIRC-ARRHYTHMIA ELEC, V4, P674, DOI 10.1161/CIRCEP.111.961946; Baker S, 2011, INT J COMPUT VISION, V92, P1, DOI 10.1007/s11263-010-0390-2; Brost A, 2010, MED IMAGE ANAL, V14, P695, DOI 10.1016/j.media.2010.05.006; Desjardins B, 2009, HEART RHYTHM, V6, P644, DOI 10.1016/j.hrthm.2009.02.018; Di Bella G, 2013, EUR HEART J, V34, P104, DOI 10.1093/eurheartj/ehs037; Dickfeld T, 2011, CIRC-ARRHYTHMIA ELEC, V4, P172, DOI 10.1161/CIRCEP.110.958744; Estner HL, 2011, HEART RHYTHM, V8, P1942, DOI 10.1016/j.hrthm.2011.07.027; Faranesh AZ, 2013, MED PHYS, V40, DOI 10.1118/1.4789919; Jain A. K., 1989, FUNDAMENTALS DIGITAL; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4; Ma YL, 2012, IEEE T BIO-MED ENG, V59, P122, DOI 10.1109/TBME.2011.2168393; Perez-David E, 2011, J AM COLL CARDIOL, V57, P184, DOI 10.1016/j.jacc.2010.07.043; Porras AR, 2012, IEEE T BIOMED ENG; Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457; Roujol S, 2013, IEEE T BIO-MED ENG, V60, P1308, DOI 10.1109/TBME.2012.2233738; Schmidt A, 2007, CIRCULATION, V115, P2006, DOI 10.1161/CIRCULATIONAHA.106.653568; Shechter G, 2005, IEEE T MED IMAGING, V24, P441, DOI 10.1109/TMI.2004.839679; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Stevenson WG, 2007, CIRCULATION, V115, P2750, DOI 10.1161/CIRCULATIONAHA.106.655720; Strang G., 1996, WAVELETS FILTER BANK; Tao Q, 2012, J CARDIOVASC ELECTR, V23, P74, DOI 10.1111/j.1540-8167.2011.02167.x; Timinger H, 2005, PHYS MED BIOL, V50, P491, DOI 10.1088/0031-9155/50/3/007; Tukey J. W., 1967, SPECTRAL ANAL TIME S, P25; WANG Y, 1995, MAGNET RESON MED, V33, P713, DOI 10.1002/mrm.1910330517; Wijnmaalen AP, 2011, EUR HEART J, V32, P104, DOI 10.1093/eurheartj/ehq345; Yan AT, 2006, CIRCULATION, V114, P32, DOI 10.1161/CIRCULATIONAHA.106.613414	28	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78852	10.1371/journal.pone.0078852	http://dx.doi.org/10.1371/journal.pone.0078852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250815	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200048
J	Tinzl, M; Chen, BS; Chen, SY; Semenas, J; Abrahamsson, PA; Dizeyi, N				Tinzl, Martina; Chen, Binshen; Chen, Shao-Yong; Semenas, Julius; Abrahamsson, Per-Anders; Dizeyi, Nishtman			Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CELL-PROLIFERATION; CYTOTOXIC INSULT; DOCETAXEL; MITOXANTRONE; PREDNISONE; TRANSFORMATION; EXPRESSION; APOPTOSIS; COMPLEX	Taxane based chemotherapy is the standard of care treatment in castration resistant prostate cancer (CRPC). There is convincing evidence that taxane therapy affects androgen receptor (AR) but the exact mechanisms have to be further elucidated. Our studies identified c-jun as a crucial key player which interacts with AR and thus determines the outcome of the taxane therapy given. Docetaxel (Doc) and paclitaxel (Pac) agents showed different effects on LNCaP and LNb4 evidenced by alteration in the protein and mRNA levels of c-jun, AR and PSA. Docetaxel-induced phophorylation of c-jun occurred before JNK phosphorylation which suggests that c-jun phosphorylation is independent of JNK pathways in prostate cancer cells. A xenograft study showed that mice treated with Pac and bicalutamide showed worse outcome supporting our hypothesis that upregulation of c-jun might act as a potent antiapoptotic factor. We observed in our in vitro studies an inverse regulation of PSA- and AR-mRNA levels in Doc treated LNb4 cells. This was also seen for kallikrein 2 (KLK 2) which followed the same pattern. Given the fact that response to taxane therapy is measured by PSA decrease we have to consider that this might not reflect the true activity of AR in CRPC patients.	[Tinzl, Martina; Chen, Binshen; Abrahamsson, Per-Anders; Dizeyi, Nishtman] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Chen, Shao-Yong] Harvard Univ, Sch Med, BIDMC, Dept Hematol Oncol, Boston, MA USA; [Semenas, Julius] Lund Univ, Dept Lab Med, Malmo, Sweden	Lund University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Lund University	Dizeyi, N (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	nishtman.dizeyi@med.lu.se	binshen, chen/AAS-8613-2020; CHEN, Shaoyong/ABF-3357-2021		Sandbergs private funding; Percy Falk Foundation; Malmo cancer funding	Sandbergs private funding; Percy Falk Foundation; Malmo cancer funding	This project is funded by Sandbergs private funding, Percy Falk Foundation and Malmo cancer funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Balk SP, 2008, NUCL RECEPT SIGNAL, V6, pe001, DOI DOI 10.1621/NRS.06001; Bubulya A, 2001, J BIOL CHEM, V276, P44704, DOI 10.1074/jbc.M107346200; Bubulya A, 2000, ENDOCRINE, V13, P55, DOI 10.1385/ENDO:13:1:55; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Chen Binshen, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P1461; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Comstock CES, 2007, CELL CYCLE, V6, P1307, DOI 10.4161/cc.6.11.4353; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Dass CR, 2010, OLIGONUCLEOTIDES, V20, P51, DOI 10.1089/oli.2009.0219; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; De Dosso S, 2008, EXPERT OPIN PHARMACO, V9, P1969, DOI [10.1517/14656560802222168, 10.1517/14656566.9.11.1969 ]; Edwards J, 2004, J PATHOL, V204, P153, DOI 10.1002/path.1605; Gan L, 2009, CANCER RES, V69, P8386, DOI 10.1158/0008-5472.CAN-09-1504; Hess-Wilson JK, 2006, CANCER RES, V66, P11998, DOI 10.1158/0008-5472.CAN-06-2249; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kuroda K, 2009, PROSTATE, V69, P1579, DOI 10.1002/pros.21004; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Mhaidat NM, 2007, MOL CANCER RES, V5, P1073, DOI 10.1158/1541-7786.MCR-07-0059; Montero A, 2005, LANCET ONCOL, V6, P229, DOI 10.1016/S1470-2045(05)70094-2; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Sato N, 1997, J BIOL CHEM, V272, P17485, DOI 10.1074/jbc.272.28.17485; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thadani-Mulero M, 2012, CANCER RES, V72, P4611, DOI 10.1158/0008-5472.CAN-12-0783; Thorne JL, 2009, INT J BIOCHEM CELL B, V41, P164, DOI 10.1016/j.biocel.2008.08.029; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Xia Y, 2013, J BIOL CHEM, V288, P19321, DOI 10.1074/jbc.M113.475442; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306; Zhu ML, 2010, CANCER RES, V70, P7992, DOI 10.1158/0008-5472.CAN-10-0585	33	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79573	10.1371/journal.pone.0079573	http://dx.doi.org/10.1371/journal.pone.0079573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260253	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200076
J	Ammerman, ML; Tomasello, DL; Faktorova, D; Kafkova, L; Hashimi, H; Lukes, J; Read, LK				Ammerman, Michelle L.; Tomasello, Danielle L.; Faktorova, Drahomira; Kafkova, Lucie; Hashimi, Hassan; Lukes, Julius; Read, Laurie K.			A Core MRB1 Complex Component Is Indispensable for RNA Editing in Insect and Human Infective Stages of Trypanosoma brucei	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; BINDING COMPLEX; PROTEIN; INITIATION; TBRGG2; MITOCHONDRIA; TRANSLATION; PROGRESSION; BIOGENESIS; ABUNDANCE	Uridine insertion/deletion RNA editing is a unique and vital process in kinetoplastids, required for creation of translatable open reading frames in most mitochondrially-encoded RNAs. Emerging as a key player in this process is the mitochondrial RNA binding 1 (MRB1) complex. MRB1 comprises an RNA-independent core complex of at least six proteins, including the GAP1/2 guide RNA (gRNA) binding proteins. The core interacts in an RNA-enhanced or dependent manner with imprecisely defined TbRGG2 subcomplexes, Armadillo protein MRB10130, and additional factors that comprise the dynamic MRB1 complex. Towards understanding MRB1 complex function in RNA editing, we present here functional characterization of the pentein domain-containing MRB1 core protein, MRB11870. Inducible RNAi studies demonstrate that MRB11870 is essential for proliferation of both insect vector and human infective stage T. brucei. MRB11870 ablation causes a massive defect in RNA editing, affecting both pan-edited and minimally edited mRNAs, but does not substantially affect mitochondrial RNA stability or processing of precursor transcripts. The editing defect in MRB1-depleted cells occurs at the initiation stage of editing, as pre-edited mRNAs accumulate. However, the gRNAs that direct editing remain abundant in the knockdown cells. To examine the contribution of MRB11870 to MRB1 macromolecular interactions, we tagged core complexes and analyzed their composition and associated proteins in the presence and absence of MRB11870. These studies demonstrated that MRB11870 is essential for association of GAP1/2 with the core, as well as for interaction of the core with other proteins and subcomplexes. Together, these data support a model in which the MRB1 core mediates functional interaction of gRNAs with the editing machinery, having GAP1/2 as its gRNA binding constituents. MRB11870 is a critical component of the core, essential for its structure and function.	[Ammerman, Michelle L.; Tomasello, Danielle L.; Kafkova, Lucie; Read, Laurie K.] SUNY Buffalo, Sch Med, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Faktorova, Drahomira; Hashimi, Hassan; Lukes, Julius] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Budweis, Czech Republic; [Faktorova, Drahomira; Hashimi, Hassan; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Read, LK (corresponding author), SUNY Buffalo, Sch Med, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	lread@buffalo.edu	Lukes, Julius/H-6760-2012; Faktorová, Drahomíra/G-7292-2014; Hashimi, Hassan/H-6740-2012	Lukes, Julius/0000-0002-0578-6618; Faktorová, Drahomíra/0000-0001-9623-2233; Hashimi, Hassan/0000-0002-6678-1618; Kafkova, Lucie/0000-0001-9072-8019	NIH [RO1 AI061580]; Grant Agency of the Czech Republic [P305/11/2179, P305/12/2261]; RNPnet FP7 program [289007]; Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061580] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); RNPnet FP7 program; Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant RO1 AI061580 to LKR, and by the Grant Agency of the Czech Republic (P305/11/2179 and P305/12/2261), the RNPnet FP7 program (289007), and a Praemium Academiae award to J.L., who is a Fellow of the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2012, NUCLEIC ACIDS RES, V40, P5637, DOI 10.1093/nar/gks211; Ammerman ML, 2011, RNA, V17, P865, DOI 10.1261/rna.2446311; Ammerman ML, 2010, RNA, V16, P2239, DOI 10.1261/rna.2285510; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; Aphasizheva I, 2010, MOL CELL BIOL, V30, P1555, DOI 10.1128/MCB.01281-09; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Bicker KL, 2013, BIOPOLYMERS, V99, P155, DOI 10.1002/bip.22127; Brina D, 2011, CELL CYCLE, V10, P3441, DOI 10.4161/cc.10.20.17796; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Fisk JC, 2009, MOL CELL BIOL, V29, P5214, DOI 10.1128/MCB.00520-09; Foda BM, 2012, EUKARYOT CELL, V11, P1119, DOI 10.1128/EC.00175-12; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2013, TRENDS PARASITOL, V29, P91, DOI 10.1016/j.pt.2012.11.005; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057; Kafkova L, 2012, RNA, V18, P1846, DOI 10.1261/rna.033852.112; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Li F, 2011, P NATL ACAD SCI USA, V108, P3542, DOI 10.1073/pnas.1014152108; Linsky T, 2010, BBA-PROTEINS PROTEOM, V1804, P1943, DOI 10.1016/j.bbapap.2010.07.016; Madina BR, 2011, RNA, V17, P1821, DOI 10.1261/rna.2815911; Miluzio A, 2009, EMBO REP, V10, P459, DOI 10.1038/embor.2009.70; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Simpson L, 2010, PROTIST, V161, P2, DOI 10.1016/j.protis.2009.10.001; Sprehe M, 2010, J BIOL CHEM, V285, P18899, DOI 10.1074/jbc.M109.066597; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	39	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78015	10.1371/journal.pone.0078015	http://dx.doi.org/10.1371/journal.pone.0078015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24250748	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300134
J	Underwood, FM; Burn, RW; Milliken, T				Underwood, Fiona M.; Burn, Robert W.; Milliken, Tom			Dissecting the Illegal Ivory Trade: An Analysis of Ivory Seizures Data	PLOS ONE			English	Article							ENFORCEMENT; GOVERNANCE; DEMAND	Reliable evidence of trends in the illegal ivory trade is important for informing decision making for elephants but it is difficult to obtain due to the covert nature of the trade. The Elephant Trade Information System, a global database of reported seizures of illegal ivory, holds the only extensive information on illicit trade available. However inherent biases in seizure data make it difficult to infer trends; countries differ in their ability to make and report seizures and these differences cannot be directly measured. We developed a new modelling framework to provide quantitative evidence on trends in the illegal ivory trade from seizures data. The framework used Bayesian hierarchical latent variable models to reduce bias in seizures data by identifying proxy variables that describe the variability in seizure and reporting rates between countries and over time. Models produced bias-adjusted smoothed estimates of relative trends in illegal ivory activity for raw and worked ivory in three weight classes. Activity is represented by two indicators describing the number of illegal ivory transactions -Transactions Index - and the total weight of illegal ivory transactions - Weights Index - at global, regional or national levels. Globally, activity was found to be rapidly increasing and at its highest level for 16 years, more than doubling from 2007 to 2011 and tripling from 1998 to 2011. Over 70% of the Transactions Index is from shipments of worked ivory weighing less than 10 kg and the rapid increase since 2007 is mainly due to increased consumption in China. Over 70% of the Weights Index is from shipments of raw ivory weighing at least 100 kg mainly moving from Central and East Africa to Southeast and East Asia. The results tie together recent findings on trends in poaching rates, declining populations and consumption and provide detailed evidence to inform international decision making on elephants.	[Underwood, Fiona M.] Univ Reading, Dept Math & Stat, Reading, Berks, England; [Milliken, Tom] TRAFFIC Int, Harare, Zimbabwe	University of Reading	Underwood, FM (corresponding author), Univ Reading, Dept Math & Stat, Reading, Berks, England.	fiona@fmunderwood.com	Underwood, Fiona/O-6072-2016	Underwood, Fiona/0000-0001-8701-7136	UK Government's Darwin Initiative [17-020]	UK Government's Darwin Initiative	This work was funded by the UK Government's Darwin Initiative Project 17-020 "Enhancing the Elephant Trade Information System to Guide CITES policy". The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], CORR PERC IND ANN UP; Barrett CB, 2006, CONSERV BIOL, V20, P1358, DOI 10.1111/j.1523-1739.2006.00521.x; Beyers RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027129; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; BLANC JJ, 2002, AFRICAN ELEPHANT STA; Blanc JJ, 2007, 23 UCNSSC AFR EL SPE; Bouche P, 2012, ENVIRON MONIT ASSESS, V184, P7001, DOI 10.1007/s10661-011-2475-y; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Bulte EH, 1999, ECOL ECON, V28, P171, DOI 10.1016/S0921-8009(98)00048-2; Bulte EH, 1999, AM J AGR ECON, V81, P453, DOI 10.2307/1244594; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Burn RW, 2013, MATH REPORT SERIES, V1; Catchpole EA, 1998, BIOMETRIKA, V84, P187; CITES, 2012, 46 CITES SC62; CITES Secretariat, 2012, 531 CITES COP16; CITES Secretariat, 2013, 2 SC64 CITES SECR; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2004, BAYESIAN DATA ANAL; Hunter Nigel, 2004, Pachyderm, V36, P116; International Monetary Fund Country Report, 2013, WORLD EC OUTL DAT; Kaufmann Daniel., 2010, WORLDWIDE GOVERNANCE, DOI 10.1017/S1876404511200046; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Lemieux AM, 2009, BRIT J CRIMINOL, V49, P451, DOI 10.1093/bjc/azp030; Lunn D, 2013, BUGS BOOK; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Maingi JK, 2012, WILDLIFE RES, V39, P234, DOI 10.1071/WR11017; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Martin E, 2011, PACHYDERM, P56; Milliken T, 2012, ELEPHANT TRADE INFOR; Milliken T, 1989, IVORY TRADE FUTURE A; Milliken T., 2009, ELEPHANT TRADE INFOR; Milliken T, 2002, 341 COP12 CITES SECR; Milliken T, 2007, 532 COP14 CITES SECR; Naylor RT, 2005, CRIME LAW SOCIAL CH, V42, P261, DOI 10.1007/s10611-005-2143-7; R Core Team, 2012, R LANG ENV STAT COMP; Skrondal A., 2004, GEN LATENT VARIABLE; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; UNEP CITES IUCN TRAFFIC, 2013, EL DUST AFR EL CRIS; United Nations Development Programme, 2011, HUM DEV REP; Venables W.N., 2013, MODERN APPL STAT S; Vigne L, 2008, ORYX, V42, P483; Vigne L, 2011, ORYX, V45, P473; Vigne L, 2010, ORYX, V44, P326	44	106	107	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76539	10.1371/journal.pone.0076539	http://dx.doi.org/10.1371/journal.pone.0076539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24250744	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000326029300036
J	Anttila, J; Ruokolainen, L; Kaitala, V; Laakso, J				Anttila, Jani; Ruokolainen, Lasse; Kaitala, Veijo; Laakso, Jouni			Loss of Competition in the Outside Host Environment Generates Outbreaks of Environmental Opportunist Pathogens	PLOS ONE			English	Article							INFECTIOUS-DISEASES; VIRULENCE; DYNAMICS; DIVERSITY; EVOLUTION; TRANSMISSION; STABILITY; CHOLERA; BIODIVERSITY; EPIDEMIOLOGY	Environmentally transmitted pathogens face ecological interactions (e. g., competition, predation, parasitism) in the outside-host environment and host immune system during infection. Despite the ubiquitousness of environmental opportunist pathogens, traditional epidemiology focuses on obligatory pathogens incapable of environmental growth. Here we ask how competitive interactions in the outside-host environment affect the dynamics of an opportunist pathogen. We present a model coupling the classical SI and Lotka-Volterra competition models. In this model we compare a linear infectivity response and a sigmoidal infectivity response. An important assumption is that pathogen virulence is traded off with competitive ability in the environment. Removing this trade-off easily results in host extinction. The sigmoidal response is associated with catastrophic appearances of disease outbreaks when outside-host species richness, or overall competition pressure, decreases. This indicates that alleviating outside-host competition with antibacterial substances that also target the competitors can have unexpected outcomes by providing benefits for opportunist pathogens. These findings may help in developing alternative ways of controlling environmental opportunist pathogens.	[Anttila, Jani; Ruokolainen, Lasse; Kaitala, Veijo; Laakso, Jouni] Univ Helsinki, Dept Biosci, Integrat Ecol Unit, Helsinki, Finland	University of Helsinki	Anttila, J (corresponding author), Univ Helsinki, Dept Biosci, Integrat Ecol Unit, Helsinki, Finland.	jani.anttila@helsinki.fi	Laakso, Jouni/I-7794-2013	Laakso, Jouni/0000-0001-8245-9912; Ruokolainen, Lasse/0000-0003-0951-9100	Academy of Finland [1255572, 138695]; University of Helsinki	Academy of Finland(Academy of Finland); University of Helsinki	This study was funded by the Academy of Finland projects 1255572 to Jouni Laakso and 138695 to Lasse Ruokolainen and the University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1991, MED VIROL, V10, P83; Abedon S.T, 2008, BACTERIOPHAGE ECOLOG; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Boldin B, 2012, EVOLUTION, V66, P2514, DOI 10.1111/j.1558-5646.2012.01613.x; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Cangelosi GA, 2004, OUTSIDE INSIDE ENV M; CAPASSO V, 1979, REV EPIDEMIOL SANTE, V27, P121; Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1; COLWELL RR, 1994, ANN NY ACAD SCI, V740, P44, DOI 10.1111/j.1749-6632.1994.tb19852.x; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; de Ruiter PC, 2005, SCIENCE, V309, P68, DOI 10.1126/science.1096112; Ding C, 2010, APPL MICROBIOL BIOT, V87, P925, DOI 10.1007/s00253-010-2649-5; Ebert D, 2000, OECOLOGIA, V122, P200, DOI 10.1007/PL00008847; Eveillard M, 2004, INFECT CONT HOSP EP, V25, P114, DOI 10.1086/502360; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; GLYNN JR, 1994, PARASITOL TODAY, V10, P279, DOI 10.1016/0169-4758(94)90147-3; Godfray HCJ, 1999, P ROY SOC B-BIOL SCI, V266, P233, DOI 10.1098/rspb.1999.0627; Gower CM, 2005, EVOLUTION, V59, P544, DOI 10.1111/j.0014-3820.2005.tb01014.x; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Gupta S, 2001, TRENDS MICROBIOL, V9, P181, DOI 10.1016/S0966-842X(01)01986-2; Hanski I, 2012, P NATL ACAD SCI EARL, P1; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Joh RI, 2009, B MATH BIOL, V71, P845, DOI 10.1007/s11538-008-9384-4; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kumar R, 2009, KIDNEY INT, V76, P286, DOI 10.1038/ki.2009.183; Kunttu HMT, 2009, EPIDEMICS-NETH, V1, P96, DOI 10.1016/j.epidem.2009.04.003; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; Merikanto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050158; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mikonranta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043801; NITTA T, 1991, JARQ-JPN AGR RES Q, V25, P6; Pasqual M, 2006, ECOLOGICAL NETWORKS; Paul REL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-30; PIMM SL, 1982, ECOLOGY, V63, P1468, DOI 10.2307/1938873; Pujol JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000399; Pulkkinen K, 2009, P ROYAL SOC B, V277, P593; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Regoes RR, 2002, P ROY SOC B-BIOL SCI, V269, P271, DOI 10.1098/rspb.2001.1816; Rip JMK, 2011, ECOL LETT, V14, P733, DOI 10.1111/j.1461-0248.2011.01636.x; Roche B, 2011, ECOL LETT, V14, P569, DOI 10.1111/j.1461-0248.2011.01619.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475	55	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71621	10.1371/journal.pone.0071621	http://dx.doi.org/10.1371/journal.pone.0071621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	24244752	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200038
J	Kim, JH; Bae, J				Kim, Jae-Hong; Bae, Jeehyeon			MCL-1ES Induces MCL-1L-Dependent BAX- and BAK-Independent Mitochondrial Apoptosis	PLOS ONE			English	Article							BCL-X-L; BH3 DOMAIN; PROTEINS; FAMILY; RESPONSES; VARIANT; MEMBER	MCL-1 (myeloid cell leukemia-1), a member of the BCL-2 family, has three splicing variants, antiapoptotic MCL-1L, proapoptotic MCL-1S, and MCL-1ES. We previously reported cloning MCL-1ES and characterizing it as an apoptotic molecule. Here, we investigated the molecular mechanism by which MCL-1ES promotes cell death. MCL-1ES was distinct from other proapoptotic BCL-2 members that induce apoptosis by promoting BAX or BAK oligomerization, leading to mitochondrial outer membrane permeabilization (MOMP), in that MCL-1ES promoted mitochondrial apoptosis independently of both BAX and BAK. Instead, MCL-1L was crucial for the apoptotic activity of MCL-1ES by facilitating its proper localization to the mitochondria. MCL-1ES did not interact with any BCL-2 family proteins except for MCL-1L, and antiapoptotic BCL-2 members failed to inhibit apoptosis induced by MCL-1ES. The BCL-2 homology 3 (BH3) domain of MCL-1ES was critical for both MCL-1ES association with MCL-1L and apoptotic activity. MCL-1ES formed mitochondrial oligomers, and this process was followed by MOMP and cytochrome c release in a MCL-1L-dependent manner. These findings indicate that MCL-1ES, as a distinct proapoptotic BCL-2 family protein, may be useful for intervening in diseases that involve uncontrolled MCL-1L.	[Kim, Jae-Hong; Bae, Jeehyeon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Chung Ang University	Bae, J (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	jeehyeon@cau.ac.kr		bae, jeehyeon/0000-0003-1995-1378	National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1220090]	National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by a grant from National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1220090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Gillissen B, 2007, J CELL BIOL, V179, P701, DOI 10.1083/jcb.200703040; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Green DR, 1998, NATURE, V396, P629, DOI 10.1038/25248; James D., 2007, NOVART FDN SYMP, V287, P170; James Dominic, 2007, Novartis Found Symp, V287, P170; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kim JH, 2009, FEBS LETT, V583, P2758, DOI 10.1016/j.febslet.2009.08.006; Kim JH, 2009, CELL PHYSIOL BIOCHEM, V23, P43, DOI 10.1159/000204088; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Perciavalle RM, 2013, TRENDS CELL BIOL, V23, P22, DOI 10.1016/j.tcb.2012.08.011; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Vandenberg CJ, 2013, BLOOD, V121, P2285, DOI 10.1182/blood-2013-01-475855; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Xiang ZF, 2010, J CLIN INVEST, V120, P2109, DOI 10.1172/JCI39964	29	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79626	10.1371/journal.pone.0079626	http://dx.doi.org/10.1371/journal.pone.0079626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260268	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500082
J	Noreen, S				Noreen, Saima			Mixed Convection Peristaltic Flow of Third Order Nanofluid with an Induced Magnetic Field	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; ASYMMETRIC CHANNEL; HEAT-TRANSFER; FLUID; TRANSPORT; SLIP	This research is concerned with the peristaltic flow of third order nanofluid in an asymmetric channel. The governing equations of third order nanofluid are modelled in wave frame of reference. Effect of induced magnetic field is considered. Long wavelength and low Reynolds number situation is tackled. Numerical solutions of the governing problem are computed and analyzed. The effects of Brownian motion and thermophoretic diffusion of nano particles are particularly emphasized. Physical quantities such as velocity, pressure rise, temperature, induced magnetic field and concentration distributions are discussed.	Comsats Inst Informat Technol, Dept Math, Pk Rd, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Noreen, S (corresponding author), Comsats Inst Informat Technol, Dept Math, Pk Rd, Islamabad, Pakistan.	laurel_lichen@yahoo.com			Deanship of Scientific Research (DSR), King Abdulaziz University (KAU) [25-130/1433 HiCi]; KAU; academic research at KAU	Deanship of Scientific Research (DSR), King Abdulaziz University (KAU); KAU; academic research at KAU	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University (KAU), under grant no. 25-130/1433 HiCi. The author, therefore, acknowledges technical and financial support of KAU. The support is in the form of project for academic research at KAU. This is to certify that this work is not funded through any external source/research organization including industry etc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmaboud Y, 2011, APPL MATH MODEL, V35, P2695, DOI 10.1016/j.apm.2010.11.031; Akbar NS, 2012, MECCANICA, V47, P1283, DOI 10.1007/s11012-011-9512-3; Akbar NS, 2012, INT J HEAT MASS TRAN, V55, P1855, DOI 10.1016/j.ijheatmasstransfer.2011.11.038; Akbar NS, 2011, COMMUN THEOR PHYS, V56, P761, DOI 10.1088/0253-6102/56/4/28; Arife AS, 2013, J COMPUT THEOR NANOS, V10, P33, DOI 10.1166/jctn.2013.2653; Asproulis N, 2010, J COMPUT THEOR NANOS, V7, P1825, DOI 10.1166/jctn.2010.1547; Bose P. K., 2012, QUANTUM MATTER, V1, P89; Choi S.U.S., 1995, ASME, V66, P99, DOI DOI 10.1115/1.1532008; Christopher DS, 2012, J COMPUT THEOR NANOS, V9, P2217, DOI 10.1166/jctn.2012.2642; Das K, 2012, IRAN J MATH SCI INFO, V7, P35, DOI 10.7508/ijmsi.2012.02.004; DEVRIES K, 1990, AM J OBSTET GYNECOL, V162, P679, DOI 10.1016/0002-9378(90)90983-E; Gavili A, 2011, J COMPUT THEOR NANOS, V8, P2362, DOI 10.1166/jctn.2011.1969; Hayat T, 2012, APPL MATH MECH-ENGL, V33, P1035, DOI 10.1007/s10483-012-1603-6; Hayat T, 2011, COMMUN NONLINEAR SCI, V16, P1363, DOI 10.1016/j.cnsns.2010.06.034; Jancar J, 2010, J COMPUT THEOR NANOS, V7, P1257, DOI 10.1166/jctn.2010.1478; Kothandapani M, 2008, INT J NONLIN MECH, V43, P915, DOI 10.1016/j.ijnonlinmec.2008.06.009; Latham T., 1966, THESIS MIT PRESS CAM; Mahmoodi M, 2011, INT J THERM SCI, V50, P2161, DOI 10.1016/j.ijthermalsci.2011.05.008; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mekheimer KS, 2008, PHYSICA A, V387, P2403, DOI 10.1016/j.physa.2007.12.017; Motsumi TG, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/04/045003; Narayanan M., 2012, QUANTUM MATTER, V1, P53, DOI DOI 10.1166/QM.2012.1005; Nield DA, 2011, INT J HEAT MASS TRAN, V54, P374, DOI 10.1016/j.ijheatmasstransfer.2010.09.034; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Noreen S, 2013, INDIAN J PHYS, V87, P889, DOI 10.1007/s12648-013-0316-2; Ono T., 2012, QUANTUM MATTER, V1, P4, DOI DOI 10.1166/QM.2012.1002; Ozsoy O, 2011, J COMPUT THEOR NANOS, V8, P31, DOI 10.1166/jctn.2011.1654; Paitya N., 2012, QUANTUM MATTER, V1, P63, DOI DOI 10.1166/QM.2012.1007; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; SrinivaS S, 2008, INT COMMUN HEAT MASS, V35, P514, DOI 10.1016/j.icheatmasstransfer.2007.08.011; Srinivas S, 2011, COMMUN NONLINEAR SCI, V16, P1845, DOI 10.1016/j.cnsns.2010.08.004; Tripathi D, 2010, APPL MATH COMPUT, V215, P3645, DOI 10.1016/j.amc.2009.11.002; Tripathi D, 2011, ACTA ASTRONAUT, V69, P30, DOI 10.1016/j.actaastro.2010.12.010; Tuzun B., 2012, QUANTUM MATTER, V1, P136	34	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e78770	10.1371/journal.pone.0078770	http://dx.doi.org/10.1371/journal.pone.0078770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260130	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500010
J	Thompson, MM; Manning, HC; Ellacott, KLJ				Thompson, Misty M.; Manning, H. Charles; Ellacott, Kate L. J.			Translocator Protein 18 kDa (TSPO) Is Regulated in White and Brown Adipose Tissue by Obesity	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; BINDING-SITES; EXPRESSION; FAT; GLUCOCORTICOIDS; THERMOGENESIS; MACROPHAGES; CHANNEL; MICE	Translocator protein 18 kDa (TSPO) is an outer-mitochondrial membrane transporter which has many functions including participation in the mitochondrial permeability transition pore, regulation of reactive oxygen species (ROS), production of cellular energy, and is the rate-limiting step in the uptake of cholesterol. TSPO expression is dysregulated during disease pathologies involving changes in tissue energy demands such as cancer, and is up-regulated in activated macrophages during the inflammatory response. Obesity is associated with decreased energy expenditure, mitochondrial dysfunction, and chronic low-grade inflammation which collectively contribute to the development of the Metabolic Syndrome. Therefore, we hypothesized that dysregulation of TSPO in adipose tissue may be a feature of disease pathology in obesity. Radioligand binding studies revealed a significant reduction in TSPO ligand binding sites in mitochondrial extracts from both white (WAT) and brown adipose tissue (BAT) in mouse models of obesity (diet-induced and genetic) compared to control animals. We also confirmed a reduction in TSPO gene expression in whole tissue extracts from WAT and BAT. Immunohistochemistry in WAT confirmed TSPO expression in adipocytes but also revealed high-levels of TSPO expression in WAT macrophages in obese animals. No changes in TSPO expression were observed in WAT or BAT after a 17 hour fast or 4 hour cold exposure. Treatment of mice with the TSPO ligand PK11195 resulted in regulation of metabolic genes in WAT. Together, these results suggest a potential role for TSPO in mediating adipose tissue homeostasis.	[Thompson, Misty M.; Ellacott, Kate L. J.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Radiol, Nashville, TN 37232 USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Imaging Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Ellacott, KLJ (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA.	Kate.Ellacott@Vanderbilt.edu		Ellacott, Kate/0000-0001-5261-7465	Vanderbilt Digestive Disease Research Center (DDRC) [NIH P30 DK058404]; Vanderbilt University; NIH [K25 CA127349, R01 CA163806, P50 CA128323]; Kleberg Foundation;  [NIH T32 DK007061]; NATIONAL CANCER INSTITUTE [P50CA128323, R01CA163806, K25CA127349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, T32DK007061] Funding Source: NIH RePORTER	Vanderbilt Digestive Disease Research Center (DDRC); Vanderbilt University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kleberg Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a Young Investigator Award from the Vanderbilt Digestive Disease Research Center (DDRC; NIH P30 DK058404) and start-up funds from Vanderbilt University to KLJE. HCM was supported by NIH grants K25 CA127349, R01 CA163806 and P50 CA128323, and the Kleberg Foundation. MMT was supported in part by a upplement to the Vanderbilt Diabetes Research Training Center Training Grant (NIH T32 DK007061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A., 2012, Journal of Molecular Medicine, V90, P887, DOI 10.1007/s00109-012-0858-3; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Boss O, 1997, FEBS LETT, V412, P111, DOI 10.1016/S0014-5793(97)00755-2; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Buck JR, 2011, J NUCL MED, V52, P107, DOI 10.2967/jnumed.110.081703; CALOGERO AE, 1990, J PHARMACOL EXP THER, V253, P729; Campioli E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028750; Campioli E, 2011, OBESITY, V19, P703, DOI 10.1038/oby.2010.244; Carayon P, 1996, BLOOD, V87, P3170, DOI 10.1182/blood.V87.8.3170.bloodjournal8783170; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cinti S, 2011, ANN MED, V43, P104, DOI 10.3109/07853890.2010.535557; Civitarese AE, 2007, CURR OPIN CLIN NUTR, V10, P679, DOI 10.1097/MCO.0b013e3282f0ecd2; Crichton PG, 2010, BIOSCIENCE REP, V30, P187, DOI 10.1042/BSR20090063; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Dimitrova-Shumkovska J, 2010, FOOD CHEM TOXICOL, V48, P910, DOI 10.1016/j.fct.2009.12.032; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gut P, 2013, NAT CHEM BIOL, V9, P97, DOI [10.1038/NCHEMBIO.1136, 10.1038/nchembio.1136]; HIRSCH JD, 1989, MOL PHARMACOL, V35, P157; HIRSCH JD, 1984, COMP BIOCHEM PHYS C, V77, P339, DOI 10.1016/0742-8413(84)90025-2; Hoffler U, 2009, ENDOCRINE, V36, P311, DOI 10.1007/s12020-009-9224-9; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Le Lay S, 2004, BIOCHEM SOC T, V32, P103, DOI 10.1042/BST0320103; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; MEYUHAS O, 1976, BIOCHEM J, V158, P1; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; NECHUSHTAN H, 1987, NUCLEIC ACIDS RES, V15, P6405, DOI 10.1093/nar/15.16.6405; Ogden CL, 2012, PREVALENCE OBESITY U; Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482; SOLVEYRA CG, 1988, LIFE SCI, V42, P393, DOI 10.1016/0024-3205(88)90077-X; Stephens M, 2011, CLIN ENDOCRINOL, V74, P661, DOI 10.1111/j.1365-2265.2011.04018.x; TRAYHURN P, 1988, AM J PHYSIOL, V254, pR11, DOI 10.1152/ajpregu.1988.254.1.R11; van der Laken CJ, 2008, ARTHRITIS RHEUM, V58, P3350, DOI 10.1002/art.23955; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Wade FM, 2005, OBES RES, V13, P818, DOI 10.1038/oby.2005.93; Wang HJ, 2012, CELL TISSUE RES, V350, P261, DOI 10.1007/s00441-012-1478-5; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; WIENER HL, 1992, ANAL BIOCHEM, V207, P58, DOI 10.1016/0003-2697(92)90499-W; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	49	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79980	10.1371/journal.pone.0079980	http://dx.doi.org/10.1371/journal.pone.0079980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260329	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500111
J	Vakana, E; Arslan, AD; Szilard, A; Altman, JK; Platanias, LC				Vakana, Eliza; Arslan, Ahmet Dirim; Szilard, Amy; Altman, Jessica K.; Platanias, Leonidas C.			Regulatory Effects of Sestrin 3 (SESN3) in BCR-ABL Expressing Cells	PLOS ONE			English	Article							MYELOGENOUS LEUKEMIA-CELLS; TYROSINE KINASE; MAMMALIAN TARGET; PHILADELPHIA-CHROMOSOME; POINT MUTATIONS; INHIBITOR; PATHWAY; ACTIVATION; RESISTANCE; RAPAMYCIN	Chronic myeloid leukemia (CML) and Ph+acute lymphoblastic leukemia (ALL) are characterized by the presence of the BCR-ABL oncoprotein, which leads to activation of a plethora of pro-mitogenic and pro-survival pathways, including the mTOR signaling cascade. We provide evidence that in BCR-ABL expressing cells, treatment with tyrosine kinase inhibitors (TKIs) results in upregulation of mRNA levels and protein expression of sestrin3 (SESN3), a unique cellular inhibitor of mTOR complex 1 (mTORC1). Such upregulation appears to be mediated by regulatory effects on mTOR, as catalytic inhibition of the mTOR kinase also induces SESN3. Catalytic mTOR inhibition also results in upregulation of SESN3 expression in cells harboring the TKI-insensitive T315I-BCR-ABL mutant, which is resistant to imatinib mesylate. Overexpression of SESN3 results in inhibitory effects on different Ph+leukemic cell lines including KT-1-derived leukemic precursors, indicating that SESN3 mediates anti-leukemic responses in Ph+cells. Altogether, our findings suggest the existence of a novel mechanism for the generation of antileukemic responses in CML cells, involving upregulation of SESN3 expression.	[Vakana, Eliza; Arslan, Ahmet Dirim; Szilard, Amy; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; [Vakana, Eliza; Arslan, Ahmet Dirim; Szilard, Amy; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL USA; [Altman, Jessica K.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Div Hematol Oncol, Chicago, IL USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA.	l-platanias@northwestern.edu			Department of Veterans Affairs, NIH [CA77816, CA121192, CA155566]; Leukemia and Lymphoma Society of America; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA077816, R01CA155566, R01CA121192, T32CA070085] Funding Source: NIH RePORTER	Department of Veterans Affairs, NIH(US Department of Veterans AffairsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Merit Review Grant, Department of Veterans Affairs, NIH grants CA77816, CA121192, CA155566 and a grant from the Leukemia and Lymphoma Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Carayol N, 2008, J BIOL CHEM, V283, P8601, DOI 10.1074/jbc.M707934200; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Hay N, 2008, CELL METAB, V8, P184, DOI 10.1016/j.cmet.2008.08.010; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Ly C, 2003, CANCER RES, V63, P5716; McNeer JL, 2010, MOL PHARMACOL, V77, P828, DOI 10.1124/mol.109.061507; Mohi MG, 2004, P NATL ACAD SCI USA, V101, P3130, DOI 10.1073/pnas.0400063101; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; O'Hare T, 2011, CLIN CANCER RES, V17, P212, DOI 10.1158/1078-0432.CCR-09-3314; Parmar S, 2005, BLOOD, V106, P2436, DOI 10.1182/blood-2004-10-4003; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Redaelli S, 2012, AM J HEMATOL, V87, pE125, DOI 10.1002/ajh.23338; Redig AJ, 2011, LEUKEMIA LYMPHOMA, V52, P45, DOI 10.3109/10428194.2010.546919; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Sherbenou DW, 2007, J CLIN INVEST, V117, P2067, DOI 10.1172/JCI31988; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Vakana E, 2012, J CELL BIOCHEM, V113, P404, DOI 10.1002/jcb.23369; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; Wu J, 2010, LEUKEMIA, P1	49	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e78780	10.1371/journal.pone.0078780	http://dx.doi.org/10.1371/journal.pone.0078780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260131	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500011
J	Badura, S; Tesanovic, T; Pfeifer, H; Wystub, S; Nijmeijer, BA; Liebermann, M; Falkenburg, JHF; Ruthardt, M; Ottmann, OG				Badura, Susanne; Tesanovic, Tamara; Pfeifer, Heike; Wystub, Sylvia; Nijmeijer, Bart A.; Liebermann, Marcus; Falkenburg, J. H. Frederik; Ruthardt, Martin; Ottmann, Oliver G.			Differential Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway in Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MOLECULAR-MECHANISMS; KINASE INHIBITORS; MAMMALIAN TARGET; PIK3CA GENE; IN-VITRO; MTOR; RAPAMYCIN; RESISTANCE; MUTATIONS	Purpose: Aberrant PI3K/AKT/mTOR signaling has been linked to oncogenesis and therapy resistance in various malignancies including leukemias. In Philadelphia chromosome (Ph) positive leukemias, activation of PI3K by dysregulated BCR-ABL tyrosine kinase (TK) contributes to the pathogenesis and development of resistance to ABLTK inhibitors (TKI). The PI3K pathway thus is an attractive therapeutic target in BCR-ABL positive leukemias, but its role in BCR-ABL negative ALL is conjectural. Moreover, the functional contribution of individual components of the PI3K pathway in ALL has not been established. Experimental Design: We compared the activity of the ATP-competitive pan-PI3K inhibitor NVP-BKM120, the allosteric mTORC1 inhibitor RAD001, the ATP-competitive dual PI3K/mTORC1/C2 inhibitors NVP-BEZ235 and NVP-BGT226 and the combined mTORC1 and mTORC2 inhibitors Torin 1, PP242 and KU-0063794 using long-term cultures of ALL cells (ALL-LTC) from patients with B-precursor ALL that expressed the BCR-ABL or TEL-ABL oncoproteins or were BCR-ABL negative. Results: Dual PI3K/mTOR inhibitors profoundly inhibited growth and survival of ALL cells irrespective of their genetic subtype and their responsiveness to ABL-TKI. Combined suppression of PI3K, mTORC1 and mTORC2 displayed greater antileukemic activity than selective inhibitors of PI3K, mTORC1 or mTORC1 and mTORC2. Conclusions: Inhibition of the PI3K/mTOR pathway is a promising therapeutic approach in patients with ALL. Greater antileukemic activity of dual PI3K/mTORC1/C2 inhibitors appears to be due to the redundant function of PI3K and mTOR. Clinical trials examining dual PI3K/mTORC1/C2 inhibitors in patients with B-precursor ALL are warranted, and should not be restricted to particular genetic	[Badura, Susanne; Tesanovic, Tamara; Pfeifer, Heike; Wystub, Sylvia; Liebermann, Marcus; Ruthardt, Martin; Ottmann, Oliver G.] Goethe Univ Frankfurt, Dept Med Hematol & Oncol, D-60054 Frankfurt, Germany; [Nijmeijer, Bart A.; Falkenburg, J. H. Frederik] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands	Goethe University Frankfurt; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ottmann, OG (corresponding author), Goethe Univ Frankfurt, Dept Med Hematol & Oncol, D-60054 Frankfurt, Germany.	ottmann@em.uni-frankfurt.de	Ottmann, Oliver G/D-5007-2016	Ottmann, Oliver G/0000-0001-9559-1330; Ruthardt, Martin/0000-0003-1021-3811	Deutsche Krebshilfe Verbundprojekt [108690]	Deutsche Krebshilfe Verbundprojekt(Deutsche Krebshilfe)	This research was funded and supported by the Deutsche Krebshilfe Verbundprojekt 108690. OGO holds an endowed professorship of the DJCLS (H06/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2008, EXPERT OPIN THER TAR, V12, P209, DOI [10.1517/14728222.12.2.209, 10.1517/14728222.12.2.209 ]; Ahmad EI, 2011, ONCOTARGETS THER, V4, P115, DOI 10.2147/OTT.S12602; Baeumler J, 2008, CANCER GENET CYTOGEN, V185, P37, DOI 10.1016/j.cancergencyto.2008.05.001; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Brown VI, 2003, P NATL ACAD SCI USA, V100, P15113, DOI 10.1073/pnas.2436348100; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; De P, 2013, CANCER TREAT REV, V39, P403, DOI 10.1016/j.ctrv.2012.12.002; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Faderl S, 1998, BLOOD, V91, P3995, DOI 10.1182/blood.V91.11.3995; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He YL, 2010, EUR J HAEMATOL, V84, P87, DOI 10.1111/j.1600-0609.2009.01350.x; Hofmann WK, 2004, LEUKEMIA LYMPHOMA, V45, P655, DOI 10.1080/10428190310001625755; Hummerdal P, 2006, EUR J HAEMATOL, V77, P86, DOI 10.1111/j.0902-4441.2006.t01-1-EJH2605.x; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kharas MG, 2004, BLOOD, V103, P4268, DOI 10.1182/blood-2003-07-2193; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Lane HA, 2009, CURR OPIN CELL BIOL, V21, P219, DOI 10.1016/j.ceb.2009.01.016; Lebwohl D, 2011, EXPERT OPIN DRUG DIS, V6, P323, DOI 10.1517/17460441.2011.558079; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mahmoud IS, 2008, BRIT J CANCER, V99, P488, DOI 10.1038/sj.bjc.6604512; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Min YH, 2003, LEUKEMIA, V17, P995, DOI 10.1038/sj.leu.2402874; Montiel-Duarte C, 2008, LEUKEMIA RES, V32, P709, DOI 10.1016/j.leukres.2007.09.005; Muller CI, 2007, LEUKEMIA RES, V31, P27, DOI 10.1016/j.leukres.2006.04.011; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Nijimeijer BA, 2009, EXP HEMATOL, V37, P376, DOI 10.1016/j.exphem.2008.11.002; Ottmann Oliver G, 2005, Hematology Am Soc Hematol Educ Program, P118; Ottmann Oliver G, 2009, Hematology Am Soc Hematol Educ Program, P371, DOI 10.1182/asheducation-2009.1.371; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Quentmeier H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-6; Recher C, 2005, BLOOD, V105, P2527, DOI 10.1182/blood-2004-06-2494; Ren SY, 2005, MOL CELL BIOL, V25, P8001, DOI 10.1128/MCB.25.18.8001-8008.2005; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shortt J, 2013, BLOOD, V121, P2964, DOI 10.1182/blood-2012-08-446096; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xing HY, 2012, LEUKEMIA RES, V36, P509, DOI 10.1016/j.leukres.2011.12.018	55	50	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80070	10.1371/journal.pone.0080070	http://dx.doi.org/10.1371/journal.pone.0080070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244612	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800118
J	Greineder, CF; Chacko, AM; Zaytsev, S; Zern, BJ; Carnemolla, R; Hood, ED; Han, JY; Ding, BS; Esmon, CT; Muzykantov, VR				Greineder, Colin F.; Chacko, Ann-Marie; Zaytsev, Sergei; Zern, Blaine J.; Carnemolla, Ronald; Hood, Elizabeth D.; Han, Jingyan; Ding, Bi-Sen; Esmon, Charles T.; Muzykantov, Vladimir R.			Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; DISSEMINATED INTRAVASCULAR COAGULATION; SOLUBLE THROMBOMODULIN; CARDIAC-ARREST; SEVERE SEPSIS; RECEPTOR; DYSFUNCTION; THROMBOSIS; EXPRESSION; PECAM-1	The use of targeted therapeutics to replenish pathologically deficient proteins on the luminal endothelial membrane has the potential to revolutionize emergency and cardiovascular medicine. Untargeted recombinant proteins, like activated protein C (APC) and thrombomodulin (TM), have demonstrated beneficial effects in acute vascular disorders, but have failed to have a major impact on clinical care. We recently reported that TM fused with an scFv antibody fragment to platelet endothelial cell adhesion molecule-1 (PECAM-1) exerts therapeutic effects superior to untargeted TM. PECAM-1 is localized to cell-cell junctions, however, whereas the endothelial protein C receptor (EPCR), the key co-factor of TM/APC, is exposed in the apical membrane. Here we tested whether anchoring TM to the intercellular adhesion molecule (ICAM-1) favors scFv/TM collaboration with EPCR. Indeed: i) endothelial targeting scFv/TM to ICAM-1 provides similar to 15-fold greater activation of protein C than its PECAM-targeted counterpart; ii) blocking EPCR reduces protein C activation by scFv/TM anchored to endothelial ICAM-1, but not PECAM-1; and iii) anti-ICAM scFv/TM fusion provides more profound anti-inflammatory effects than anti-PECAM scFv/TM in a mouse model of acute lung injury. These findings, obtained using new translational constructs, emphasize the importance of targeting protein therapeutics to the proper surface determinant, in order to optimize their microenvironment and beneficial effects.	[Greineder, Colin F.; Zaytsev, Sergei; Zern, Blaine J.; Carnemolla, Ronald; Hood, Elizabeth D.; Han, Jingyan; Ding, Bi-Sen; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Greineder, Colin F.; Chacko, Ann-Marie; Zaytsev, Sergei; Zern, Blaine J.; Carnemolla, Ronald; Hood, Elizabeth D.; Han, Jingyan; Ding, Bi-Sen; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Ctr Targeted Therapeut & Translat Nanomed, Philadelphia, PA 19104 USA; [Chacko, Ann-Marie] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Greineder, Colin F.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Howard Hughes Med Inst, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	Muzykantov, VR (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu		Greineder, Colin/0000-0001-9740-7672; Chacko, Ann-Marie/0000-0001-5140-2622	Institute of Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania; American Heart Association [10FTF4150053]; National Institutes of Health [R01-HL091950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091950] Funding Source: NIH RePORTER	Institute of Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Junior Investigator Preliminary/Feasibility Grant from the Institute of Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania (CFG), as well as an American Heart Association Fellow to Faculty grant 10FTF4150053 (CFG), and National Institutes of Health Grant R01-HL091950 (VRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2005, J AM COLL CARDIOL, V46, P21, DOI 10.1016/j.jacc.2005.03.046; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Chacko AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034958; Chrastina A, 2010, J VASC RES, V47, P531, DOI 10.1159/000313880; Christofidou-Solomidou M, 2002, AM J PATHOL, V160, P1155, DOI 10.1016/S0002-9440(10)64935-8; CROWE JS, 1989, NUCLEIC ACIDS RES, V17, P7992, DOI 10.1093/nar/17.19.7992; Danilov SM, 2001, AM J PHYSIOL-LUNG C, V280, pL1335, DOI 10.1152/ajplung.2001.280.6.L1335; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; DUBEL S, 1994, J IMMUNOL METHODS, V175, P89, DOI 10.1016/0022-1759(94)90334-4; Esmon CT, 2001, CRIT CARE, V5, pS7, DOI 10.1186/cc1333; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002; FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571; Gentry CA, 2009, CRIT CARE MED, V37, P19, DOI 10.1097/CCM.0b013e318192843b; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kim AY, 2002, CIRC RES, V90, P205, DOI 10.1161/hh0202.105097; Kowalski PS, 2011, IUBMB LIFE, V63, P648, DOI 10.1002/iub.487; Laszik ZG, 2001, AM J PATHOL, V159, P797, DOI 10.1016/S0002-9440(10)61753-1; Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x; Lin SM, 2008, CRIT CARE MED, V36, P683, DOI 10.1097/CCM.0B013E31816537D8; Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC; MacGregor IR, 1997, AM J RESP CRIT CARE, V155, P47, DOI 10.1164/ajrccm.155.1.9001288; MOORE KL, 1989, BLOOD, V73, P159; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muro Silvia, 2004, Current Vascular Pharmacology, V2, P281, DOI 10.2174/1570161043385736; Muzykantov Vladimir R, 2005, Expert Opin Drug Deliv, V2, P909, DOI 10.1517/17425247.2.5.909; NAWROTH PP, 1986, P NATL ACAD SCI USA, V83, P3460, DOI 10.1073/pnas.83.10.3460; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Newby AC, 1999, CURR OPIN CARDIOL, V14, P489, DOI 10.1097/00001573-199911000-00007; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; Pasqualini R, 2000, CANCER RES, V60, P722; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; SIDO B, 1995, TRANSPLANTATION, V60, P462, DOI 10.1097/00007890-199509000-00010; Simone E, 2009, CELL TISSUE RES, V335, P283, DOI 10.1007/s00441-008-0676-7; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Su EJ, 2011, J THROMB HAEMOST, V9, P1174, DOI 10.1111/j.1538-7836.2011.04269.x; Tabuchi N, 2004, EUR J CARDIO-THORAC, V26, P995, DOI 10.1016/j.ejcts.2004.07.028; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; TEASDALE MS, 1994, IMMUNOL CELL BIOL, V72, P480, DOI 10.1038/icb.1994.72; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; van Buul JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011336; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; Waugh JM, 1999, CIRC RES, V84, P84; Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496; Zhang N, 2008, BIOCONJUGATE CHEM, V19, P145, DOI 10.1021/bc700227z	54	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80110	10.1371/journal.pone.0080110	http://dx.doi.org/10.1371/journal.pone.0080110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244621	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800123
J	Thorlacius-Ussing, L; Ludvigsen, M; Kirkeby, S; Vorum, H; Honore, B				Thorlacius-Ussing, Louise; Ludvigsen, Maja; Kirkeby, Svend; Vorum, Henrik; Honore, Bent			Proteomic Analysis of Tissue from alpha 1,3-galactosyltransferase Knockout Mice Reveals That a Wide Variety of Proteins and Protein Fragments Change Expression Level	PLOS ONE			English	Article							PIG-KIDNEY; IDENTIFICATION; ANTIGENS; ANTIBODIES; TARGETS; LECTIN; MOUSE	A barrier in a pig-to-man xenotransplantation is that the Gal alpha 1-3Gal beta 1-4GlcNAc-R carbohydrate (alpha-Gal epitope) expressed on pig endothelial cells reacts with naturally occurring antibodies in the recipient's blood leading to rejection. Deletion of the alpha 1,3-galactosyltransferase gene prevents the synthesis of the alpha-Gal epitope. Therefore, knockout models of the alpha 1,3-galactosyltransferase gene are widely used to study xenotransplantation. We have performed proteomic studies on liver and pancreas tissues from wild type and alpha 1,3-galactosyltransferase gene knockout mice. The tissues were analyzed by two-dimensional polyacrylamide gel electrophoresis and liquid chromatography - tandem mass spectrometry. The analyses revealed that a wide variety of proteins and protein fragments are differentially expressed suggesting that knockout of the alpha 1,3-galactosyltransferase gene affects the expression of several other genes.	[Thorlacius-Ussing, Louise; Vorum, Henrik] Aalborg Univ Hosp, Dept Ophthalmol, Aalborg, Denmark; [Ludvigsen, Maja; Honore, Bent] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Kirkeby, Svend] Univ Copenhagen, Inst Odontol, Copenhagen, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University; University of Copenhagen	Honore, B (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	bh@biokemi.au.dk	Honoré, Bent/ABF-3650-2021	Honore, Bent/0000-0002-3459-7429; Ludvigsen, Maja/0000-0001-5089-3271	Bagger-Sorensen Foundation; John and Birthe Meyer Foundation; MEMBRANES Center at Aarhus University	Bagger-Sorensen Foundation; John and Birthe Meyer Foundation; MEMBRANES Center at Aarhus University	The work was supported by the Bagger-Sorensen Foundation, the John and Birthe Meyer Foundation and the MEMBRANES Center at Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartke A, 2008, EXP GERONTOL, V43, P11, DOI 10.1016/j.exger.2007.10.009; Breimer ME, 2011, XENOTRANSPLANTATION, V18, P215, DOI 10.1111/j.1399-3089.2011.00644.x; Byrne GW, 2008, XENOTRANSPLANTATION, V15, P268, DOI 10.1111/j.1399-3089.2008.00480.x; Chen ZC, 2000, MOL IMMUNOL, V37, P455, DOI 10.1016/S0161-5890(00)00064-X; Diswall M, 2010, XENOTRANSPLANTATION, V17, P48, DOI 10.1111/j.1399-3089.2009.00564.x; Everett ML, 2003, BIOCHEM BIOPH RES CO, V301, P751, DOI 10.1016/S0006-291X(03)00043-3; Ito N, 1997, HISTOL HISTOPATHOL, V12, P415; Kirkeby S, 1998, CELL TISSUE RES, V293, P285, DOI 10.1007/s004410051120; Kirkeby S, 2008, IMMUNOL CELL BIOL, V86, P363, DOI 10.1038/icb.2008.1; Kirkeby S, 2006, MICROB PATHOGENESIS, V40, P191, DOI 10.1016/j.micpath.2006.01.006; Mandal Nakul, 2011, Mol Vis, V17, P2634; Maruyama S, 2000, KIDNEY INT, V57, P655, DOI 10.1046/j.1523-1755.2000.00887.x; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Park JY, 2012, CELL REPROGRAM, V14, P353, DOI 10.1089/cell.2011.0083; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rydberg L, 1999, Subcell Biochem, V32, P107; SCHMIDT DO, 2003, BLOOD GROUPS ANIMALS; Strokan V, 1998, TRANSPLANTATION, V66, P1495, DOI 10.1097/00007890-199812150-00013; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80600	10.1371/journal.pone.0080600	http://dx.doi.org/10.1371/journal.pone.0080600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244699	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800153
J	Zhu, CD; Cai, Y; Ma, J; Li, N; Zhu, JF; He, YP; Redmon, P; Qiao, Y				Zhu, Chendi; Cai, Yong; Ma, Jin; Li, Na; Zhu, Jingfen; He, Yaping; Redmon, Pamela; Qiao, Yun			Predictors of Intention to Smoke among Junior High School Students in Shanghai, China: An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model	PLOS ONE			English	Article							YOUTH TOBACCO SURVEY; ADOLESCENT SMOKING; INTERVENTION; PREVALENCE; INITIATION; EXPOSURE; ADULTS	Background: Adolescent smoking is a worldwide problem that is particularly severe in low- and middle-income countries. Many endogenous and environmental factors affect the intention to smoke, so a comprehensive model is needed to understand the significance and relationship of predictors. The study aimed to test the associations among information-motivation-behavioral skills (IMB) model constructs as predictors of intention to smoke in junior high school students in Shanghai, China. Methods: We conducted a cross-sectional study of 16,500 junior high school students in Shanghai, China. Data on tobacco-related information, motivation, behavioral skills, and behaviors were collected from students. Structural equation model (SEM) was used to assess the IMB model. Results: The mean age of participants was 13.8 years old (standard deviation = 1.02; range 11-17). The experimental smoking rate among junior high school students was 6.6% and 8.7% of the participants expected that they would be smokers in 5 years. The IMB model provided acceptable fit to the data (comparative fit index = 0.984, root mean square error of approximation = 0.04). Intention to smoke was predicted by behavioral skills (beta= 0.670, P < 0.001) and motivation (beta= 0.095, P<0.001) among junior high school students. Conclusion: The IMB model provides a good understanding of the predictors of intention to smoke and it suggests future interventions among junior high school students should focus on improving motivation and behavioral skills.	[Zhu, Chendi; Cai, Yong; Ma, Jin; Li, Na; Zhu, Jingfen; He, Yaping] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Redmon, Pamela] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA; [Qiao, Yun] Pudong Inst Hlth Dev, Shanghai, Peoples R China	Shanghai Jiao Tong University; Emory University	Cai, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China.	caiyong202028@hotmail.com; majin@shsmu.edu.cn	zhu, chendi/ABB-5874-2021	zhu, chendi/0000-0003-0956-4278	Bill & Melinda Gates Foundation; Shanghai Municipal Education Commission [12ZS106]; General program for young researchers of humanities and social studies, China Ministry of Education [12YTC840001]; New Hundred Program on Outstanding Teacher of the School of Medicine of Shanghai Jiaotong University; Young Teachers Overseas Visiting and Training Program from Shanghai Municipal Education Commission	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); General program for young researchers of humanities and social studies, China Ministry of Education; New Hundred Program on Outstanding Teacher of the School of Medicine of Shanghai Jiaotong University; Young Teachers Overseas Visiting and Training Program from Shanghai Municipal Education Commission	This study was funded by (or in part by) the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. This publication is also supported by the following: Key liberal arts innovative project, Shanghai Municipal Education Commission (12ZS106); General program for young researchers of humanities and social studies, China Ministry of Education (12YTC840001); The New Hundred Program on Outstanding Teacher of the School of Medicine of Shanghai Jiaotong University and the Young Teachers Overseas Visiting and Training Program from Shanghai Municipal Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee SC., 2009, OPEN ADDICTION J, V2, P12, DOI DOI 10.2174/1874941000902010012; BAUMAN KE, 1992, PSYCHOL REP, V71, P568, DOI 10.2466/PR0.71.6.568-570; Bentler P. M., 2005, EQS 6 STRUCTURAL EQU; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Biglan A, 2000, TOB CONTROL, V9, P24, DOI 10.1136/tc.9.1.24; BOTVIN GJ, 1992, PSYCHOL REP, V70, P171, DOI 10.2466/PR0.70.1.171-178; Brown AK, 2010, J ADOLESCENCE, V33, P603, DOI 10.1016/j.adolescence.2009.12.003; Browne M. W., 1993, SOCIOL METHOD RES, P136; BRUVOLD WH, 1993, AM J PUBLIC HEALTH, V83, P872, DOI 10.2105/AJPH.83.6.872; BURTON D, 1989, J APPL SOC PSYCHOL, V19, P656, DOI 10.1111/j.1559-1816.1989.tb00345.x; Cai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062787; Cai Y, 2012, INT J ENV RES PUB HE, V9, P3421, DOI 10.3390/ijerph9103421; Chen PL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-144; Chen XG, 2001, PREV MED, V32, P437, DOI 10.1006/pmed.2001.0826; COLLINS LM, 1987, J APPL SOC PSYCHOL, V17, P554, DOI 10.1111/j.1559-1816.1987.tb00330.x; Emery S, 2012, AM J PUBLIC HEALTH, V102, P751, DOI 10.2105/AJPH.2011.300443; Fisher JD, 1996, HEALTH PSYCHOL, V15, P114, DOI 10.1037/0278-6133.15.2.114; Fisher WA., 1999, AIDS BEHAV, V3, P13, DOI [10.1023/A:1025411317851, DOI 10.1023/A:1025411317851]; Gao JL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-100; GODIN G, 1992, BRIT J ADDICT, V87, P1335; Gruder CL, 2013, NICOTINE TOB RES, V15, P223, DOI 10.1093/ntr/nts116; Harakeh Z, 2011, EUR ADDICT RES, V17, P316, DOI 10.1159/000330318; Higgins A, 2003, PSYCHOL HEALTH MED, V8, P173, DOI [10.1080/1354850031000087555, DOI 10.1080/1354850031000087555]; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Misovich SJ, 2003, J APPL SOC PSYCHOL, V33, P775, DOI 10.1111/j.1559-1816.2003.tb01924.x; Nichols TR, 2006, J ADOLESCENT HEALTH, V38, P369, DOI 10.1016/j.jadohealth.2005.04.016; Peto R., 2009, CVD PREV CONTROL, V4, P61, DOI [10.1016/S1875-4570(09)60224-2, DOI 10.1016/J.CVDPC.2008.12.001, 10.1016/j.cvdpc.2008.12.001]; Physicians for a Smoke-Free Canada, 2006, FILT TIPS REV CIG MA; Rigdon EE, 1996, STRUCT EQU MODELING, V3, P369, DOI 10.1080/10705519609540052; Rudatsikira E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-176; Shell DF, 2011, AM J HEALTH BEHAV, V35, P568; Stead M, 1996, HLTH ED J, V55, P31, DOI [10.1177/001789699605500105, DOI 10.1177/001789699605500105]; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tickle JJ, 2006, BASIC APPL SOC PSYCH, V28, P117, DOI 10.1207/s15324834basp2802_2; Udry J. R., 1998, NEW PERSPECTIVES ADO, P241, DOI [10.1017/CBO9780511571138.009, DOI 10.1017/CBO9780511571138.009]; Wang MP, 2012, ADDICT BEHAV, V37, P743, DOI 10.1016/j.addbeh.2012.02.016; Warren CW, 2000, B WORLD HEALTH ORGAN, V78, P868; World Health Organization, 2013, GLOB HLTH OBS NONC D; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252; Zhang J, 2011, RESPIROLOGY, V16, P1165, DOI 10.1111/j.1440-1843.2011.02062.x; Zheng PP, 2008, ASIA-PAC J PUBLIC HE, V20, P94, DOI 10.1177/1010539507311182; Zhu C, 2012, LANCET, V379, P779, DOI 10.1016/S0140-6736(11)61933-8	42	4	4	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80482	10.1371/journal.pone.0080482	http://dx.doi.org/10.1371/journal.pone.0080482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244690	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800148
J	Pamaran, RR; Kamigaki, T; Hewe, TT; Flores, KMC; Mercado, ES; Alday, PP; Tan, AG; Oshitani, H; Olveda, RM; Tallo, VL				Pamaran, Rochelle R.; Kamigaki, Taro; Hewe, Teresita T.; Flores, Korrine Madeleine C.; Mercado, Edelwisa S.; Alday, Portia P.; Tan, Alvin G.; Oshitani, Hitoshi; Olveda, Remigio M.; Tallo, Veronica L.			Epidemiological Characterization of Influenza A(H1N1)pdm09 Cases from 2009 to 2010 in Baguio City, the Philippines	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; HOUSEHOLD TRANSMISSION; HOSPITALIZED-PATIENTS; CHILDREN; INFECTION	Background: Baguio City, Philippines experienced its first influenza A(H1N1)pdm09 [ A(H1)pdm09] case in May 2009. In spite of numerous reports describing the epidemiological and clinical features of A(H1)pdm09 cases, there are no studies about A(H1)pdm09 epidemiology in the Philippines, where year-round influenza activity was observed. Objectives: We aimed to investigate the epidemiological and clinical features of A(H1)pdm09 in pandemic and post-pandemic periods. Methods: Data were collected under enhanced surveillance of influenza-like illness (ILI) and severe acute respiratory infection (SARI) from January 2009 to December 2010. RT-PCR was used to detect A(H1)pdm09, following the protocol of the United States Centers for Disease Control and Prevention. The reproduction number was computed as a simple exponential growth rate. Differences in proportional and categorical data were examined using chi-square test or Fishers' exact test. Results and Conclusions: The outbreak was observed from week 25 to 35 in 2009 and from week 24 to 37 in 2010. The highest proportion of cases was among children aged 5-14 years. The number of ILI outpatients was 2.3-fold higher in 2009 than in 2010, while the number of inpatients was 1.8-fold higher in 2009. No significant difference in gender was observed during the two periods. The clinical condition of all patients was generally mild and self-limiting, with only 2 mortalities among inpatients in 2009. The basic reproduction number was estimated as 1.16 in 2009 and 1.05 in 2010 in the assumption of mean generation time as 2.6 days. School children played a significant role in facilitating influenza transmission.	[Pamaran, Rochelle R.; Hewe, Teresita T.; Flores, Korrine Madeleine C.; Mercado, Edelwisa S.; Alday, Portia P.; Tan, Alvin G.; Olveda, Remigio M.; Tallo, Veronica L.] Res Inst Trop Med, Manila, Philippines; [Kamigaki, Taro; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan	Research Institute for Tropical Medicine - Philippines; Tohoku University	Kamigaki, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan.	kamigakit@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019		United States Centers for Disease Prevention and Control [1U51IP000335-01]; Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000335] Funding Source: NIH RePORTER	United States Centers for Disease Prevention and Control; Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study received financial support from the United States Centers for Disease Prevention and Control (grant number 1U51IP000335-01) and a grant-in-aid from the Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CANC REV; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Centers for Disease Control and Prevention, 2009, CDC PROT REALT RT PC; Chao DY, 2011, INT J INFECT DIS, V15, pE695, DOI 10.1016/j.ijid.2011.05.012; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESILVA UC, 2009, EURO SURVEILL, V14; Dhanoa A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-501; Fang LQ, 2012, AM J EPIDEMIOL, V175, P890, DOI 10.1093/aje/kwr411; Hasegawa S, 2011, PEDIAT ALLERG IMM-UK, V22, pe119, DOI 10.1111/j.1399-3038.2010.01090.x; Hien Tran Tinh, 2010, PLoS Med, V7, pe1000277, DOI 10.1371/journal.pmed.1000277; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Horby P, 2012, AM J EPIDEMIOL, V175, P1062, DOI 10.1093/aje/kws121; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Ismail HIM, 2011, EMERG INFECT DIS, V17, P708, DOI 10.3201/eid1704.101212; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kelly H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021828; Kim CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038166; Kloepfer KM, 2012, AM J RESP CRIT CARE, V185, P1275, DOI 10.1164/rccm.201109-1635OC; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; National Statistic Office the Philippines, 2007, 007 CENS HOUS POP; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Viasus D, 2012, CLIN MICROBIOL INFEC, V18, pE55, DOI 10.1111/j.1469-0691.2011.03753.x; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wu P, 2013, INFLUENZA OTHER RESP, V7, P367, DOI 10.1111/j.1750-2659.2012.00420.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yasuda C, 2012, SE ASIAN J TROP MED, V43, P68	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79916	10.1371/journal.pone.0079916	http://dx.doi.org/10.1371/journal.pone.0079916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244578	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600159
J	Berger, AH; Chen, M; Morotti, A; Janas, JA; Niki, M; Bronson, RT; Taylor, BS; Ladanyi, M; Van Aelst, L; Politi, K; Varmus, HE; Pandolfi, PP				Berger, Alice H.; Chen, Ming; Morotti, Alessandro; Janas, Justyna A.; Niki, Masaru; Bronson, Roderick T.; Taylor, Barry S.; Ladanyi, Marc; Van Aelst, Linda; Politi, Katerina; Varmus, Harold E.; Pandolfi, Pier Paolo			DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR GENE-MUTATIONS; PTB DOMAIN; GEFITINIB; CANCER; RECRUITMENT; RESISTANCE; ERLOTINIB; RAS; ATTENUATION	Somatic mutations in the EGFR proto-oncogene occur in similar to 15% of human lung adenocarcinomas and the importance of EGFR mutations for the initiation and maintenance of lung cancer is well established from mouse models and cancer therapy trials in human lung cancer patients. Recently, we identified DOK2 as a lung adenocarcinoma tumor suppressor gene. Here we show that genomic loss of DOK2 is associated with EGFR mutations in human lung adenocarcinoma, and we hypothesized that loss of DOK2 might therefore cooperate with EGFR mutations to promote lung tumorigenesis. We tested this hypothesis using genetically engineered mouse models and find that loss of Dok2 in the mouse accelerates lung tumorigenesis initiated by oncogenic EGFR, but not that initiated by mutated Kras. Moreover, we find that DOK2 participates in a negative feedback loop that opposes mutated EGFR; EGFR mutation leads to recruitment of DOK2 to EGFR and DOK2-mediated inhibition of downstream activation of RAS. These data identify DOK2 as a tumor suppressor in EGFR-mutant lung adenocarcinoma.	[Berger, Alice H.; Chen, Ming; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Dept Med,Med Sch,Canc Genet Program, Boston, MA 02215 USA; [Berger, Alice H.; Chen, Ming; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Dept Pathol,Med Sch,Canc Genet Program, Boston, MA 02215 USA; [Politi, Katerina; Varmus, Harold E.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Janas, Justyna A.; Van Aelst, Linda] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Niki, Masaru] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bronson, Roderick T.] Dana Farber Harvard Canc Ctr, Rodent Histopathol Core, Boston, MA USA; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; University of Iowa; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Dept Med,Med Sch,Canc Genet Program, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Morotti, Alessandro/J-7590-2018; Ladanyi, Marc/AAG-8585-2019	Morotti, Alessandro/0000-0002-8407-2903; Pandolfi, Pier Paolo/0000-0002-5352-5295; Janas, Justyna A/0000-0001-9840-9928; chen, ming/0000-0002-3470-1062	National Cancer Institute (NCI)/National Institutes of Health (NIH) [CA-129243, CA-142787, CA-120247, CA-131488]; NATIONAL CANCER INSTITUTE [R01CA120247, P01CA129243, K99CA131488, R01CA142787, R01CA135053, R00CA131488] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200375] Funding Source: NIH RePORTER	National Cancer Institute (NCI)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Cancer Institute (NCI)/National Institutes of Health (NIH) grants CA-129243 (to ML), CA-142787 (to PPP), CA-120247 (to HV and KP), and CA-131488 (to KP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Honma M, 2006, GENES CELLS, V11, P143, DOI 10.1111/j.1365-2443.2006.00926.x; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Niki M, 2004, J EXP MED, V200, P1689, DOI 10.1084/jem.20041306; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Songyang Z, 2001, J BIOL CHEM, V276, P2459, DOI 10.1074/jbc.M005504200; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Van Slyke P, 2005, MOL CELL BIOL, V25, P3831, DOI 10.1128/MCB.25.9.3831-3841.2005; Wick MJ, 2001, J BIOL CHEM, V276, P42843, DOI 10.1074/jbc.M102116200; Zhang Y, 2004, J MOL BIOL, V343, P1147, DOI 10.1016/j.jmb.2004.08.072; Zhao MM, 2006, MOL CELL BIOL, V26, P2479, DOI 10.1128/MCB.26.7.2479-2489.2006; Zhao MM, 2001, J EXP MED, V194, P265, DOI 10.1084/jem.194.3.265	25	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79526	10.1371/journal.pone.0079526	http://dx.doi.org/10.1371/journal.pone.0079526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255704	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000327216200070
J	Miura, S; Nakao, N; Hanzawa, H; Matsuo, Y; Saku, K; Karnik, SS				Miura, Shin-ichiro; Nakao, Naoki; Hanzawa, Hiroyuki; Matsuo, Yoshino; Saku, Keijiro; Karnik, Sadashiva S.			Reassessment of the Unique Mode of Binding between Angiotensin II Type 1 Receptor and Their Blockers	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; GPCR; ANTAGONISTS; MOLECULE; DOCKING; AGONIST	While the molecular structures of angiotensin II (Ang II) type 1 (AT(1)) receptor blockers (ARBs) are very similar, they are also slightly different. Although each ARB has been shown to exhibit a unique mode of binding to AT(1) receptor, different positions of the AT(1) receptor have been analyzed and computational modeling has been performed using different crystal structures for the receptor as a template and different kinds of software. Therefore, we systematically analyzed the critical positions of the AT(1) receptor, Tyr(113), Tyr(184), Lys(199), His(256) and Gln(257) using a mutagenesis study, and subsequently performed computational modeling of the binding of ARBs to AT(1) receptor using CXCR4 receptor as a new template and a single version of software. The interactions between Tyr(113) in the AT(1) receptor and the hydroxyl group of olmesartan, between Lys(199) and carboxyl or tetrazole groups, and between His(256) or Gln(257) and the tetrazole group were studied. The common structure, a tetrazole group, of most ARBs similarly bind to Lys(199), His(256) and Gln(257) of AT(1) receptor. Lys(199) in the AT(1) receptor binds to the carboxyl group of EXP3174, candesartan and azilsartan, whereas oxygen in the amidecarbonyl group of valsartan may bind to Lys(199). The benzimidazole portion of telmisartan may bind to a lipophilic pocket that includes Tyr(113). On the other hand, the n-butyl group of irbesartan may bind to Tyr(113). In conclusion, we confirmed that the slightly different structures of ARBs may be critical for binding to AT(1) receptor and for the formation of unique modes of binding.	[Miura, Shin-ichiro; Matsuo, Yoshino; Saku, Keijiro] Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 81401, Japan; [Miura, Shin-ichiro; Saku, Keijiro] Fukuoka Univ, Sch Med, Dept Mol Cardiovasc Therapeut, Fukuoka 81401, Japan; [Miura, Shin-ichiro; Karnik, Sadashiva S.] Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Nakao, Naoki; Hanzawa, Hiroyuki] Daiichi Sankyo Co Ltd, R&D Div, Tokyo, Japan	Fukuoka University; Fukuoka University; Cleveland Clinic Foundation; Daiichi Sankyo Company Limited	Miura, S (corresponding author), Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 81401, Japan.	miuras@cis.fukuoka-u.ac.jp	Karnik, Sadashiva/Y-2477-2019; Saku, Keijiro/HGB-6168-2022	Karnik, Sadashiva/0000-0003-0746-2753; 	Daiichi-Sankyo Co. Ltd.	Daiichi-Sankyo Co. Ltd.(Daiichi Sankyo Company Limited)	KS and SM received funding from Daiichi-Sankyo Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bhuiyan MA, 2009, LIFE SCI, V85, P136, DOI 10.1016/j.lfs.2009.05.001; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Deng Z, 2004, J MED CHEM, V47, P337, DOI 10.1021/jm030331x; Fujino M, 2010, HYPERTENS RES, V33, P1044, DOI 10.1038/hr.2010.135; Imaizumi S, 2013, CURR PHARM DESIGN, V19, P3002; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Miura S, 2013, CURR PHARM DESIGN, V19, P2981; Miura S, 2013, HYPERTENS RES, V36, P134, DOI 10.1038/hr.2012.147; Miura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037974; Miura S, 2011, J RENIN-ANGIO-ALDO S, V12, P1, DOI 10.1177/1470320310370852; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; Ohno K, 2011, BIOCHEM BIOPH RES CO, V404, P434, DOI 10.1016/j.bbrc.2010.11.139; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sokkar P, 2011, J MOL MODEL, V17, P1565, DOI 10.1007/s00894-010-0860-z; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Takezako T, 2004, J BIOL CHEM, V279, P15248, DOI 10.1074/jbc.M312728200; Tuccinardi T, 2006, J MED CHEM, V49, P4305, DOI 10.1021/jm060338p; Unal H, 2013, J BIOL CHEM, V288, P540, DOI 10.1074/jbc.M112.392514; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157	32	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79914	10.1371/journal.pone.0079914	http://dx.doi.org/10.1371/journal.pone.0079914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260317	gold, Green Submitted, Green Published			2022-12-25	WOS:000327216200095
J	Guillery, E; Mouraux, A; Thonnard, JL				Guillery, Erwan; Mouraux, Andre; Thonnard, Jean-Louis			Cognitive-Motor Interference While Grasping, Lifting and Holding Objects	PLOS ONE			English	Article							PRECISION GRIP LIFTS; FORCE CONTROL; MANIPULATION; COORDINATION; ATTENTION; EFFICIENT; RESPONSES; STRATEGY; CHILDREN; SIGNALS	In daily life, object manipulation is usually performed concurrently to the execution of cognitive tasks. The aim of the present study was to determine which aspects of precision grip require cognitive resources using a motor-cognitive dual-task paradigm. Eighteen healthy participants took part in the experiment, which comprised two conditions. In the first condition, participants performed a motor task without any concomitant cognitive task. They were instructed to grip, lift and hold an apparatus incorporating strain gauges allowing a continuous measurement of the force perpendicular to each contact surface (grip force, GF) as well as the total tangential force applied on the object (load force, LF). In the second condition, participants performed the same motor task while concurrently performing a cognitive task consisting in a complex visual search combined with counting. In the dual-task condition, we found a significant increase in the duration of the preload phase (time between initial contact of the fingers with the apparatus and onset of the load force), as well as a significant increase of the grip force during the holding phase, indicating that the cognitive task interfered with the initial force scaling performed during the preload phase and the fine-tuning of grip force during the hold phase. These findings indicate that these aspects of precision grip require cognitive resources. In contrast, other aspects of the precision grip, such as the temporal coupling between grip and load forces, were not affected by the cognitive task, suggesting that they reflect more automatic processes. Taken together, our results suggest that assessing the dynamic and temporal parameters of precision grip in the context of a concurrent cognitive task may constitute a more ecological and better-suited tool to characterize motor dysfunction in patients.	[Guillery, Erwan; Mouraux, Andre; Thonnard, Jean-Louis] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium	Universite Catholique Louvain	Thonnard, JL (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	Jean-Louis.Thonnard@uclouvain.be	Mouraux, Andre/F-3724-2012	Mouraux, Andre/0000-0003-1056-5980				ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Adams MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0467; Afifi M, 2012, CLIN NEUROPHYSIOL, V123, P2281, DOI 10.1016/j.clinph.2012.04.013; Andre T, 2010, J NEUROPHYSIOL, V103, P402, DOI 10.1152/jn.00901.2009; Augurelle AS, 2003, EXP BRAIN RES, V148, P533, DOI 10.1007/s00221-002-1322-3; Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Creem SH, 2001, J EXP PSYCHOL HUMAN, V27, P218, DOI 10.1037/0096-1523.27.1.218; Diermayr G, 2011, GERONTOLOGY, V57, P217, DOI 10.1159/000295921; Dispa D, 2013, INT J REHABIL RES, V36, P81, DOI 10.1097/MRR.0b013e32835acfd5; Duque J, 2003, BRAIN, V126, P732, DOI 10.1093/brain/awg069; Enns JT, 2009, PROG BRAIN RES, V176, P215, DOI 10.1016/S0079-6123(09)17612-4; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; FLANAGAN JR, 1994, J EXP PSYCHOL HUMAN, V20, P944, DOI 10.1037/0096-1523.20.5.944; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; GORDON AM, 1991, EXP BRAIN RES, V83, P477; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Hermsdorfer J, 1999, EXP BRAIN RES, V126, P205, DOI 10.1007/s002210050730; Hesse C, 2012, VISION RES, V71, P37, DOI 10.1016/j.visres.2012.08.014; Hesse C, 2011, VISION RES, V51, P1223, DOI 10.1016/j.visres.2011.03.014; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Kahneman D., 1973, ATTENTION EFFORT; Kimberley Teresa Jacobson, 2008, J Neurol Phys Ther, V32, P110, DOI 10.1097/NPT.0b013e318183d716; Li Y, 2009, BEHAV BRAIN RES, V196, P123, DOI 10.1016/j.bbr.2008.07.031; Liu G, 2008, EXP BRAIN RES, V185, P709, DOI 10.1007/s00221-007-1196-5; McBride J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00082; McDonnell MN, 2005, EXP BRAIN RES, V161, P368, DOI 10.1007/s00221-004-2081-0; McIntosh RD, 2010, EXP BRAIN RES, V206, P257, DOI 10.1007/s00221-010-2404-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pereira HS, 2001, NEUROPSYCHOLOGIA, V39, P478, DOI 10.1016/S0028-3932(00)00132-9; Pereira HS, 2000, DEV MED CHILD NEUROL, V42, P545, DOI 10.1017/S0012162200001031; Saling LL, 2007, BRAIN RES BULL, V73, P1, DOI 10.1016/j.brainresbull.2007.02.009; Schabrun SM, 2008, EUR J NEUROSCI, V27, P750, DOI 10.1111/j.1460-9568.2008.06039.x; Singhal A, 2007, J VISION, V7, DOI 10.1167/7.5.5; Spiegel MA, 2013, J EXP PSYCHOL HUMAN, V39, P1326, DOI 10.1037/a0031398; Spiegel MA, 2012, NEUROSCI LETT, V509, P82, DOI 10.1016/j.neulet.2011.12.033; Thonnard JL, 1997, SCAND J WORK ENV HEA, V23, P193, DOI 10.5271/sjweh.198; Voelcker-Rehage C, 2007, J GERONTOL B-PSYCHOL, V62, pP141, DOI 10.1093/geronb/62.3.P141; WESTLING G, 1987, EXP BRAIN RES, V66, P128; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Witney AG, 2004, TRENDS NEUROSCI, V27, P637, DOI 10.1016/j.tins.2004.08.006	45	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80125	10.1371/journal.pone.0080125	http://dx.doi.org/10.1371/journal.pone.0080125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244626	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900063
J	Zubcevic, L; Bavro, VN; Muniz, JRC; Schmidt, MR; Wang, SZ; De Zorzi, R; Venien-Bryan, C; Sansom, MSP; Nichols, CG; Tucker, SJ				Zubcevic, Lejla; Bavro, Vassiliy N.; Muniz, Joao R. C.; Schmidt, Matthias R.; Wang, Shizhen; De Zorzi, Rita; Venien-Bryan, Catherine; Sansom, Mark S. P.; Nichols, Colin G.; Tucker, Stephen J.			Control of KirBac3.1 Potassium Channel Gating at the Interface between Cytoplasmic Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Ion Channels; Membrane Proteins; Molecular Dynamics; Potassium Channels; Channel Gating; Kir Channel; KirBac	RECTIFIER K+ CHANNEL; INWARD RECTIFICATION; KIR2.1 CHANNELS; PH SENSITIVITY; PORE; MUTATIONS; ELECTROSTATICS; SIMULATIONS; PERMEATION; CONDUCTION	KirBac channels are prokaryotic homologs of mammalian inwardly rectifying potassium (Kir) channels, and recent structures of KirBac3.1 have provided important insights into the structural basis of gating in Kir channels. In this study, we demonstrate that KirBac3.1 channel activity is strongly pH-dependent, and we used x-ray crystallography to determine the structural changes that arise from an activatory mutation (S205L) located in the cytoplasmic domain (CTD). This mutation stabilizes a novel energetically favorable open conformation in which changes at the intersubunit interface in the CTD also alter the electrostatic potential of the inner cytoplasmic cavity. These results provide a structural explanation for the activatory effect of this mutation and provide a greater insight into the role of the CTD in Kir channel gating.	[Zubcevic, Lejla; Bavro, Vassiliy N.; Tucker, Stephen J.] Univ Oxford, Clarendon Lab, Biol Phys Grp, Oxford OX1 3PU, England; [Bavro, Vassiliy N.] Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Muniz, Joao R. C.] Univ Sao Paulo, Sao Carlos Inst Phys, BR-13560970 Sao Paulo, Brazil; [Schmidt, Matthias R.; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Struct Bioinformat & Computat Biochem Unit, Oxford OX1 3QU, England; [Wang, Shizhen; Nichols, Colin G.] Washington, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Wang, Shizhen; Nichols, Colin G.] Washington, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [De Zorzi, Rita; Venien-Bryan, Catherine] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Venien-Bryan, Catherine] Univ Paris 06, CNRS UMR 7590, IMPMC, F-75005 Paris, France; [Sansom, Mark S. P.; Tucker, Stephen J.] Univ Oxford, OXION Initiat Ion Channels & Dis, Oxford OX1 3PT, England	University of Oxford; University of Birmingham; Universidade de Sao Paulo; University of Oxford; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); University of Oxford	Tucker, SJ (corresponding author), Univ Oxford, Clarendon Lab, Biol Phys Grp, Parks Rd, Oxford OX1 3PU, England.	stephen.tucker@physics.ox.ac.uk	Bavro, Vassiliy/I-4846-2019; Tucker, Stephen J./ABE-6741-2020; Zubcevic, Lejla/AAA-6713-2021; Tucker, Stephen J./ABE-7468-2020; Wang, Shizhen/N-6577-2017; Sansom, Mark S.P./C-5157-2009; Muniz, Joao R/B-7782-2016	Bavro, Vassiliy/0000-0003-2330-8924; Tucker, Stephen J./0000-0001-8996-2000; Zubcevic, Lejla/0000-0002-1884-9235; Tucker, Stephen J./0000-0001-8996-2000; Wang, Shizhen/0000-0003-1065-4756; Sansom, Mark S.P./0000-0001-6360-7959; Muniz, Joao R/0000-0003-2731-3966; Venien-Bryan, Catherine/0000-0002-7328-3764; DE ZORZI, Rita/0000-0001-7001-7498	National Institute of Health [HL54171]; Biotechnology and Biological Sciences Research Council; Wellcome Trust; BBSRC [BB/L002558/1, BB/I019855/1, BB/H000267/1, BB/F013035/1] Funding Source: UKRI; EPSRC [EP/J010421/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/16011, BB/F013035/1, B19456, BEP17032, BB/H000267/1, BB/L002558/1, BB/I019855/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J010421/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institute of Health Grant HL54171 (to C. G. N.). This work was also supported by grants from the Biotechnology and Biological Sciences Research Council (to S. J. T. and C. V.-B.) and the Wellcome Trust (to M. S. P. S.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baukrowitz T, 1999, EMBO J, V18, P847, DOI 10.1093/emboj/18.4.847; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Casamassima M, 2003, J BIOL CHEM, V278, P43533, DOI 10.1074/jbc.M306596200; Chang HK, 2005, BIOPHYS J, V88, P243, DOI 10.1529/biophysj.104.052217; Chang HK, 2007, J MEMBRANE BIOL, V215, P181, DOI 10.1007/s00232-007-9017-0; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Inanobe A, 2011, J BIOL CHEM, V286, P41801, DOI 10.1074/jbc.M111.278531; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas CM, 1998, AM J PHYSIOL-RENAL, V275, pF972, DOI 10.1152/ajprenal.1998.275.6.F972; Paynter JJ, 2010, J BIOL CHEM, V285, P40754, DOI 10.1074/jbc.M110.175687; Paynter JJ, 2010, CHANNELS, V4, P390, DOI 10.4161/chan.4.5.13006; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shimomura K, 2009, EMBO MOL MED, V1, P166, DOI 10.1002/emmm.200900018; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu HX, 2000, J PHYSIOL-LONDON, V528, P267, DOI 10.1111/j.1469-7793.2000.00267.x; Xu YP, 2009, NAT STRUCT MOL BIOL, V16, P1252, DOI 10.1038/nsmb.1717; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7	40	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					143	151		10.1074/jbc.M113.501833	http://dx.doi.org/10.1074/jbc.M113.501833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257749	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000329370900013
J	Bethge, N; Honne, H; Hilden, V; Troen, G; Eknaes, M; Liestol, K; Holte, H; Delabie, J; Smeland, EB; Lind, GE				Bethge, Nicole; Honne, Hilde; Hilden, Vera; Troen, Gunhild; Eknaes, Mette; Liestol, Knut; Holte, Harald; Delabie, Jan; Smeland, Erlend B.; Lind, Guro E.			Identification of Highly Methylated Genes across Various Types of B-Cell Non-Hodgkin Lymphoma	PLOS ONE			English	Article							DNA METHYLATION; FOLLICULAR LYMPHOMA; HERG1 CHANNELS; CPG-ISLANDS; CANCER; HYPERMETHYLATION; EXPRESSION; BIOMARKERS	Epigenetic alterations of gene expression are important in the development of cancer. In this study, we identified genes which are epigenetically altered in major lymphoma types. We used DNA microarray technology to assess changes in gene expression after treatment of 11 lymphoma cell lines with epigenetic drugs. We identified 233 genes with upregulated expression in treated cell lines and with downregulated expression in B-cell lymphoma patient samples (n = 480) when compared to normal B cells (n = 5). The top 30 genes were further analyzed by methylation specific PCR (MSP) in 18 lymphoma cell lines. Seven of the genes were methylated in more than 70% of the cell lines and were further subjected to quantitative MSP in 37 B-cell lymphoma patient samples (diffuse large B-cell lymphoma (activated B-cell like and germinal center B-cell like subtypes), follicular lymphoma and Burkitts lymphoma) and normal B lymphocytes from 10 healthy donors. The promoters of DSP, FZD8, KCNH2, and PPP1R14A were methylated in 28%, 67%, 22%, and 78% of the 36 tumor samples, respectively, but not in control samples. Validation using a second series of healthy donor controls (n = 42; normal B cells, peripheral blood mononuclear cells, bone marrow, tonsils and follicular hyperplasia) and fresh-frozen lymphoma biopsies (n = 25), confirmed the results. The DNA methylation biomarker panel consisting of DSP, FZD8, KCNH2, and PPP1R14A was positive in 89% (54/61) of all lymphomas. Receiver operating characteristic analysis to determine the discriminative power between lymphoma and healthy control samples showed a c-statistic of 0.96, indicating a possible role for the biomarker panel in monitoring of lymphoma patients.	[Bethge, Nicole; Hilden, Vera; Smeland, Erlend B.] Oslo Univ Hosp, Inst Canc Res, Dept Immunol, Oslo, Norway; [Bethge, Nicole; Honne, Hilde; Hilden, Vera; Eknaes, Mette; Liestol, Knut; Holte, Harald; Smeland, Erlend B.; Lind, Guro E.] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Honne, Hilde; Eknaes, Mette; Lind, Guro E.] Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway; [Troen, Gunhild; Delabie, Jan] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Holte, Harald] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Lind, GE (corresponding author), Univ Oslo, Ctr Canc Biomed, Oslo, Norway.	Guro.Elisabeth.Lind@rr-research.no	Holte, Harald/AAO-5647-2020; Smeland, Erlend/AAO-3214-2020	Delabie, Jan/0000-0001-5023-0689; Liestol, Knut/0000-0002-7929-582X	South-Eastern Norway Regional Health Authority [39232]; Norwegian Cancer Society [33260, PR-2008-0163]	South-Eastern Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the South-Eastern Norway Regional Health Authority (ES: no. 39232, funding NB as PhD), and The Norwegian Cancer Society (ES: no. 33260 and GEL: PR-2008-0163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2000, BLOOD, V96, P2907; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Amara K, 2008, ANN ONCOL, V19, P1774, DOI 10.1093/annonc/mdn374; American Cancer Society, 2013, CANC FACTS FIG 2013; Bende RJ, 2007, LEUKEMIA, V21, P18, DOI 10.1038/sj.leu.2404426; Bennett LB, 2009, GENES CHROMOSOM CANC; Choi JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013020; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; DAM Ali, 2010, THESIS U OSLO; De S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003137; Esteller M, 2003, CLIN IMMUNOL, V109, P80, DOI 10.1016/S1521-6616(03)00208-0; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2002, CANCER RES, V62, P5902; Esteller M, 2002, J NATL CANCER I, V94, P26; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Garcia MJ, 2002, AM J PATHOL, V161, P1007, DOI 10.1016/S0002-9440(10)64261-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayslip J, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-44; Herbst A, 2012, TUMOR BIOL, V33, P297, DOI 10.1007/s13277-012-0346-y; Kisiel JB, 2012, CANCER-AM CANCER SOC, V118, P2623, DOI 10.1002/cncr.26558; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; LIMPENS J, 1995, BLOOD, V85, P2528, DOI 10.1182/blood.V85.9.2528.bloodjournal8592528; Lind GE, 2006, CELL ONCOL, V28, P259; Lind GE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-85; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Pike BL, 2008, LEUKEMIA, V22, P1035, DOI 10.1038/leu.2008.18; Pillozzi S, 2011, BLOOD, V117, P902, DOI 10.1182/blood-2010-01-262691; Pillozzi S, 2010, ADV EXP MED BIOL, V674, P55; RASMUSSEN AM, 1992, J IMMUNOL METHODS, V146, P195, DOI 10.1016/0022-1759(92)90228-L; RIMOKH R, 1989, BRIT J HAEMATOL, V71, P31, DOI 10.1111/j.1365-2141.1989.tb06270.x; Shaknovich R, 2010, BLOOD, V116, pE81, DOI 10.1182/blood-2010-05-285320; Shi HD, 2007, CARCINOGENESIS, V28, P60, DOI 10.1093/carcin/bgl092; Shivapurkar N, 2010, CURR MOL MED, V10, P123, DOI 10.2174/156652410790963303; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Takata K, 2011, CANCER SCI, V102, P1532, DOI 10.1111/j.1349-7006.2011.01980.x; Uccella S, 2009, J CLIN PATHOL, V62, P715, DOI 10.1136/jcp.2009.064741; Utikal J, 2006, INT J CANCER, V119, P2287, DOI 10.1002/ijc.22106; Weisenberger DJ, NUCL ACIDS RES, V33, P6823; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Wilson KS, 2007, LEUKEMIA LYMPHOMA, V48, P1102, DOI 10.1080/10428190701344881; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yang L., 2012, CARCINOGENESIS; Ying J, 2007, TUMOR SPECIFIC METHY	45	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79602	10.1371/journal.pone.0079602	http://dx.doi.org/10.1371/journal.pone.0079602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260260	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900034
J	Peebles, KA; Wielgus, RB; Maletzke, BT; Swanson, ME				Peebles, Kaylie A.; Wielgus, Robert B.; Maletzke, Benjamin T.; Swanson, Mark E.			Effects of Remedial Sport Hunting on Cougar Complaints and Livestock Depredations	PLOS ONE			English	Article							CONSERVATION; POPULATION; MORTALITY; DYNAMICS; CANADA	Remedial sport hunting of predators is often used to reduce predator populations and associated complaints and livestock depredations. We assessed the effects of remedial sport hunting on reducing cougar complaints and livestock depredations in Washington from 2005 to 2010 (6 years). The number of complaints, livestock depredations, cougars harvested, estimated cougar populations, human population and livestock populations were calculated for all 39 counties and 136 GMUs (game management units) in Washington. The data was then analyzed using a negative binomial generalized linear model to test for the expected negative relationship between the number of complaints and depredations in the current year with the number of cougars harvested the previous year. As expected, we found that complaints and depredations were positively associated with human population, livestock population, and cougar population. However, contrary to expectations we found that complaints and depredations were most strongly associated with cougars harvested the previous year. The odds of increased complaints and livestock depredations increased dramatically (36 to 240%) with increased cougar harvest. We suggest that increased young male immigration, social disruption of cougar populations, and associated changes in space use by cougars - caused by increased hunting resulted in the increased complaints and livestock depredations. Widespread indiscriminate hunting does not appear to be an effective preventative and remedial method for reducing predator complaints and livestock depredations.	[Peebles, Kaylie A.; Wielgus, Robert B.] Washington State Univ, Large Carnivore Conservat Lab, Sch Environm, Pullman, WA 99164 USA; [Maletzke, Benjamin T.] Washington Dept Fish & Wildlife, Olympia, WA USA; [Swanson, Mark E.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA	Washington State University; Washington Department of Fish & Wildlife (WDFW); Washington State University	Peebles, KA (corresponding author), Washington State Univ, Large Carnivore Conservat Lab, Sch Environm, Pullman, WA 99164 USA.	kaylie.peebles@email.wsu.edu			Washington State University; Washington Department of Fish and Wildlife	Washington State University; Washington Department of Fish and Wildlife	Washington State University. Washington Department of Fish and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; Balme GA, 2013, MAMMAL REV, V43, P221, DOI 10.1111/j.1365-2907.2012.00219.x; Beausoleil RA, 2013, WILDLIFE SO IN PRESS; BEIER P, 1991, WILDLIFE SOC B, V19, P403; Burnham K.P., 2010, MODEL SELECTION MULT; Canadian Press, 2013, CANADIAN PRESS  0306; Carpenter A., 1998, WORLD ALMANAC US; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Dawn D, 2002, THESIS SAN JOSE STAT; Keehner JR, 2010, BIOL CONSERVAT UNPUB; Kertson B. N., 2011, NW NATURALIST, V92, P175; Kertson B. N, 2010, THESIS U WASHINGTON; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Maletzke B. T, 2010, THESIS WASHINGTON ST; MOSTELLE.F, 1968, J AM STAT ASSOC, V63, P1, DOI 10.2307/2283825; Oregon Department of Fish and Wildlife, 2006, OR COUG MAN PLAN; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; R Core Team, 2012, R LANG ENV STAT COMP; Rabinowitz A, 2005, CONSERV BIOL SER, V9, P278; Robinson HS, 2008, ECOL APPL, V18, P1028, DOI 10.1890/07-0352.1; Sunquist M, 2002, PUMA WILD CATS WORLD; Texas Parks and Wildlife, 2008, MOUNT LIONS TEX; Torres SG, 1996, WILDLIFE SOC B, V24, P451; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; United States Census Bureau, 2000, ANN EST POP COUNT WA; United States Census Bureau, 2010, ANN EST POP COUNT WA; United States Department of Agriculture, 2007, WASH LIV STAT; Washington Department of Fish and Wildlife, 2008, PIL COUG CONTR PROGR; Wielgus RB, 2000, BIOL CONSERV, V93, P145, DOI 10.1016/S0006-3207(99)00152-4; WIELGUS RB, 1994, BIOL CONSERV, V67, P161, DOI 10.1016/0006-3207(94)90362-X; Wielgus RB, 2001, ESTIMATING EFFECTS A; Wyoming Game and Fish Department, 2006, MOUNT LION MAN PLAN; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zimmermann B, 2003, URSUS-SERIES, V14, P72; [No title captured]	36	38	40	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79713	10.1371/journal.pone.0079713	http://dx.doi.org/10.1371/journal.pone.0079713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260291	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900042
J	Hovsepian, E; Penas, F; Siffo, S; Mirkin, GA; Goren, NB				Hovsepian, Eugenia; Penas, Federico; Siffo, Sofia; Mirkin, Gerardo A.; Goren, Nora B.			IL-10 Inhibits the NF-kappa B and ERK/MAPK-Mediated Production of Pro-Inflammatory Mediators by Up-Regulation of SOCS-3 in Trypanosoma cruzi-Infected Cardiomyocytes	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; NECROSIS-FACTOR-ALPHA; CHAGAS-DISEASE; MYOCARDIAL-INFARCTION; CYTOKINE PRODUCTION; IFN-GAMMA; TNF-ALPHA; IN-VITRO; T-CELLS; INTERLEUKIN-10	Trypanosoma cruzi (T. cruzi) infection produces an intense inflammatory response which is critical for the control of the evolution of Chagas' disease. Interleukin (IL)-10 is one of the most important anti-inflammatory cytokines identified as modulator of the inflammatory reaction. This work shows that exogenous addition of IL-10 inhibited ERK1/2 and NF-kappa B activation and reduced inducible nitric oxide synthase (NOS2), metalloprotease (MMP) -9 and MMP-2 expression and activities, as well as tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 expression, in T. cruzi-infected cardiomyocytes. We found that T. cruzi and IL-10 promote STAT3 phosphorylation and up-regulate the expression of suppressor of cytokine signalling (SOCS)-3 thereby preventing NF-kappa B nuclear translocation and ERK1/2 phosphorylation. Specific knockdown of SOCS-3 by small interfering RNA (siRNA) impeded the IL-10-mediated inhibition of NF-kappa B and ERK1/2 activation. As a result, the levels of studied pro-inflammatory mediators were restored in infected cardiomyocytes. Our study reports the first evidence that T. cruzi up-regulates SOCS-3 expression and highlights the relevance of IL-10 in the modulation of pro-inflammatory response of cardiomyocytes in Chagas' disease.	[Hovsepian, Eugenia; Penas, Federico; Siffo, Sofia; Mirkin, Gerardo A.; Goren, Nora B.] Univ Buenos Aires, Fac Med, Inst Microbiol & Parasitol Med, IMPaM,UBA CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Goren, NB (corresponding author), Univ Buenos Aires, Fac Med, Inst Microbiol & Parasitol Med, IMPaM,UBA CONICET, Buenos Aires, DF, Argentina.	ngoren@fmed.uba.ar			Agencia Nacional de Promocion de Ciencia y Tecnologia (ANPCyT) Argentina [995]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina [PIP 1424]; Universidad de Buenos Aires, Buenos Aires, Argentina [UBACyT 20020100100809]	Agencia Nacional de Promocion de Ciencia y Tecnologia (ANPCyT) Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Buenos Aires, Argentina(University of Buenos Aires)	This work was supported by Grants PICT 2007 No 995 from Agencia Nacional de Promocion de Ciencia y Tecnologia (ANPCyT) Argentina and PIP 1424 from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina and UBACyT 20020100100809 from Universidad de Buenos Aires, Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN IA, 1995, J IMMUNOL, V155, P3955; Soto CDA, 2010, VACCINE, V28, P7407, DOI 10.1016/j.vaccine.2010.08.105; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Borges DC, 2013, IMMUNOLOGY, V138, P145, DOI 10.1111/imm.12022; Borges MM, 1998, IMMUNOL LETT, V63, P1, DOI 10.1016/S0165-2478(98)00034-0; Cao XM, 1996, MOL CELL BIOL, V16, P1595; CAPPA SMG, 1981, MEDICINA-BUENOS AIRE, V41, P119; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Chandrasekar B, 1998, AM J PATHOL, V152, P925; Cuenca J, 2006, AM J PATHOL, V169, P1567, DOI 10.2353/ajpath.2006.060109; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; de Melo AS, 2012, CYTOKINE, V58, P207, DOI 10.1016/j.cyto.2012.01.008; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Dutra WO, 2005, TRENDS PARASITOL, V21, P581, DOI 10.1016/j.pt.2005.09.007; Ponce NE, 2013, BBA-MOL BASIS DIS, V1832, P485, DOI 10.1016/j.bbadis.2012.12.003; Esper L, 2012, AM J PATHOL, V181, P130, DOI 10.1016/j.ajpath.2012.03.042; Frangogiannis NG, 2000, J IMMUNOL, V165, P2798, DOI 10.4049/jimmunol.165.5.2798; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Goren N, 2004, CARDIOVASC RES, V64, P289, DOI 10.1016/j.cardiores.2004.06.029; Guedes PMM, 2009, VET IMMUNOL IMMUNOP, V130, P43, DOI 10.1016/j.vetimm.2009.01.004; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Heo YJ, 2010, IMMUNOL LETT, V127, P150, DOI 10.1016/j.imlet.2009.10.006; Hovsepian E, 2011, INT J PARASITOL, V41, P553, DOI 10.1016/j.ijpara.2010.12.002; Hovsepian E, 2010, SHOCK, V34, P60, DOI 10.1097/SHK.0b013e3181cdc398; Huang N, 2012, PHYTOCHEMISTRY, V76, P106, DOI 10.1016/j.phytochem.2011.12.001; Hunter CA, 1997, J IMMUNOL, V158, P3311; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Nair S, 2011, J IMMUNOL, V186, P5413, DOI 10.4049/jimmunol.1000773; Penas F, 2013, BBA-MOL BASIS DIS, V1832, P239, DOI 10.1016/j.bbadis.2012.08.007; Persson S, 1996, SCAND J IMMUNOL, V44, P607, DOI 10.1046/j.1365-3083.1996.d01-355.x; Pinge P, 1999, CELL IMMUNOL, V193, P90, DOI 10.1006/cimm.1999.1463; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Raychaudhuri B, 2000, CYTOKINE, V12, P1348, DOI 10.1006/cyto.2000.0721; REED SG, 1994, J IMMUNOL, V153, P3135; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Roffe E, 2012, J IMMUNOL, V188, P649, DOI 10.4049/jimmunol.1003845; Gutierrez FRS, 2008, J INFECT DIS, V197, P1468, DOI 10.1086/587487; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shames BD, 1998, SHOCK, V10, P389, DOI 10.1097/00024382-199812000-00002; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; SILVA JS, 1992, J EXP MED, V175, P169, DOI 10.1084/jem.175.1.169; Souza PEA, 2004, INFECT IMMUN, V72, P5283, DOI 10.1128/IAI.72.9.5283-5291.2004; Stahl A, 2012, BLOOD, V120, P2925, DOI 10.1182/blood-2012-04-422527; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tao ZY, 2004, LIFE SCI, V74, P1561, DOI 10.1016/j.lfs.2003.09.042; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Torrecilhas ACT, 2009, MICROBES INFECT, V11, P29, DOI 10.1016/j.micinf.2008.10.003; Van Roon JAG, 2003, J RHEUMATOL, V30, P648; Veenbergen S, 2011, ANN RHEUM DIS, V70, P2167, DOI 10.1136/ard.2011.154815; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Yao L, 2008, INT J CARDIOL, V123, P366, DOI 10.1016/j.ijcard.2007.06.069; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	57	56	57	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79445	10.1371/journal.pone.0079445	http://dx.doi.org/10.1371/journal.pone.0079445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260222	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500061
J	Lu, Y; Chen, SR; Yang, N				Lu, Yue; Chen, Sirui; Yang, Ning			Expression and Methylation of FGF2, TGF-beta and Their Downstream Mediators during Different Developmental Stages of Leg Muscles in Chicken	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; SKELETAL-MUSCLE; DNA METHYLATION; MYOGENIC DIFFERENTIATION; MYOBLAST DIFFERENTIATION; PROGENITOR CELLS; FETAL MYOBLASTS; TRANSCRIPTION; PROLIFERATION; GLYCOSYLASE	A number of growth factors determine the proliferation of myoblasts and therefore the number of ultimate myofibers. The members of transforming growth factor-beta (TGF-beta) family and the fibroblast growth factor 2 (FGF2) have profound effects on skeletal myoblasts proliferation in various animal systems. To investigate their involvement in different stages of avian skeletal muscle development in vivo, we detected the mRNA expression and DNA methylation profiles of TGF-beta 2, TGF-beta 3, FGF2 and their downstream mediators in leg muscles at embryonic day 10, day of hatch and day 45 posthatch, using both Arbor Acres meat-type and White Leghorn egg-type chickens. By real-time PCR, we found that the expression levels of TGF-beta 2, TGF-beta 3, Smad3 and FGF2 were significantly (P <= 0.01) higher at embryonic day 10, a developmental window of abundant fetal myoblasts expansion, by comparison to day of hatch and day 45 posthatch. The methylation status of the 5' end region of these four genes was examined subsequently. A section of a CpG island in the 5' end region of FGF2 was significantly hypomethylated (P <= 0.01) at embryonic day 10, compared with neonatal and postnatal stages in both stocks. Our results suggested that TGF-beta 2, TGF-beta 3, Smad3 and FGF2 may play important roles in fetal myoblasts proliferation in chicken hindlimb, and the transcription of FGF2 in this wave of myogenesis could be affected by DNA methylation in 5' flanking region. These outcomes contribute to our knowledge of the growth factors in avian myogenesis. Further investigation is needed to confirm and fully understand their functions in fetal limb myogenesis in birds.	[Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Yang, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	nyang@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	National Scientific Supporting Projects of China [2011BAD28B03]; Program for Changjiang Scholars and Innovative Research in University [IRT1191]	National Scientific Supporting Projects of China; Program for Changjiang Scholars and Innovative Research in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The work was supported in part by the National Scientific Supporting Projects of China (2011BAD28B03), and the Program for Changjiang Scholars and Innovative Research in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbut S, 2008, MEAT SCI, V79, P46, DOI 10.1016/j.meatsci.2007.07.031; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; BRUNETTI A, 1990, J BIOL CHEM, V265, P5960; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Capiati DA, 1999, J CELL BIOCHEM, V74, P292, DOI 10.1002/(SICI)1097-4644(19990801)74:2<292::AID-JCB13>3.0.CO;2-M; CUSELLADEANGELIS MG, 1994, DEVELOPMENT, V120, P925; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; DOLLENMEIER P, 1981, EXP CELL RES, V135, P47, DOI 10.1016/0014-4827(81)90298-6; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fridolfsson AK, 1999, SIMPLE UNIVERSAL MET; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Ge XJ, 2011, CELL RES, V21, P1591, DOI 10.1038/cr.2011.72; Hannon K, 1996, J CELL BIOL, V132, P1151, DOI 10.1083/jcb.132.6.1151; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; JOST JP, 1995, J BIOL CHEM, V270, P9734, DOI 10.1074/jbc.270.17.9734; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Le Bihan-Duval E, 2003, GENET SEL EVOL, V35, P623, DOI 10.1051/gse:2003043; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; Li QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019428; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu X, 2003, DOMEST ANIM ENDOCRIN, V25, P215, DOI 10.1016/S0739-7240(03)00061-4; Ludolph DC, 1995, FASEB J, V9, P1595, DOI 10.1096/fasebj.9.15.8529839; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; Messina G, 2009, GENE DEV, V23, P902, DOI 10.1101/gad.1797009; MOORE JW, 1991, DEVELOPMENT, V111, P741; Olson E N, 1992, Semin Cell Biol, V3, P127; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; Rehfeldt C, 2000, LIVEST PROD SCI, V66, P177, DOI 10.1016/S0301-6226(00)00225-6; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; STOCKDALE FE, 1987, DEV BIOL, V123, P1, DOI 10.1016/0012-1606(87)90420-9; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	41	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79495	10.1371/journal.pone.0079495	http://dx.doi.org/10.1371/journal.pone.0079495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260234	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500067
J	Previdi, S; Scolari, F; Chila, R; Ricci, F; Abbadessa, G; Broggini, M				Previdi, Sara; Scolari, Federica; Chila, Rosaria; Ricci, Francesca; Abbadessa, Giovanni; Broggini, Massimo			Combination of the c-Met Inhibitor Tivantinib and Zoledronic Acid Prevents Tumor Bone Engraftment and Inhibits Progression of Established Bone Metastases in a Breast Xenograft Model	PLOS ONE			English	Article							ARQ 197; ANTITUMOR-ACTIVITY; CANCER METASTASIS; TYROSINE KINASE; TARGETING MET; BISPHOSPHONATES; DENOSUMAB; SURVIVAL; THERAPY; DISEASE	Bone is the most common metastatic site for breast cancer. There is a significant need to understand the molecular mechanisms controlling the engraftment and growth of tumor cells in bone and to discover novel effective therapeutic strategies. The aim of this study was to assess the effects of tivantinib and Zoledronic Acid (ZA) in combination in a breast xenograft model of bone metastases. Cancer cells were intracardially implanted into immunodeficient mice and the effects of drugs alone or in combination on bone metastasis were evaluated by in vivo non-invasive optical and micro-CT imaging technologies. Drugs were administered either before (preventive regimen) or after (therapeutic regimen) bone metastases were detectable. In the preventive regimen, the combination of tivantinib plus ZA was much more effective than single agents in delaying bone metastatic tumor growth. When administered in the therapeutic schedule, the combination delayed metastatic progression and was effective in improving survival. These effects were not ascribed to a direct cytotoxic effect of the combined therapy on breast cancer cells in vitro. The results of this study provide the rationale for the design of new combinatorial strategies with tivantinib and ZA for the treatment of breast cancer bone metastases.	[Previdi, Sara; Scolari, Federica; Chila, Rosaria; Ricci, Francesca; Broggini, Massimo] IRCCS Ist Ric Farmacol Mario Negri, Dept Oncol, Mol Pharmacol Lab, Milan, Italy; [Abbadessa, Giovanni] ArQule Inc, Woburn, MA USA	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Broggini, M (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Oncol, Mol Pharmacol Lab, Milan, Italy.	massimo.broggini@marionegri.it	Ricci, Francesca/AAA-7104-2020; broggini, massimo/AAA-6460-2020	Ricci, Francesca/0000-0003-1705-186X; BROGGINI, MASSIMO/0000-0002-8138-9358				Adjei AA, 2011, ONCOLOGIST, V16, P788, DOI 10.1634/theoncologist.2010-0380; Anderson K, 2007, AACR M, pB184; Bagai R, 2010, IDRUGS, V13, P404; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Brown HK, 2009, CURR CANCER DRUG TAR, V9, P807, DOI 10.2174/156800909789760339; Clemons M, 2012, BONE TARGETED AGENTS; Clezardin P, 2005, CANCER RES, V65, P4971, DOI 10.1158/0008-5472.CAN-05-0264; Clezardin P, 2007, CLIN EXP METASTAS, V24, P599, DOI 10.1007/s10585-007-9112-8; Coleman RE, 2010, BRIT J CANCER, V102, P1099, DOI 10.1038/sj.bjc.6605604; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Coleman RE, 2012, CURR OPIN SUPPORT PA, V6, P322, DOI 10.1097/SPC.0b013e32835689cd; Coleman RE, 2010, CANCER TREAT REV, V36, P615, DOI 10.1016/j.ctrv.2010.04.003; Fasolo A, 2012, ANN ONCOL; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gnant M, 2012, RECENT RESULTS CANC, V192, P65, DOI 10.1007/978-3-642-21892-7_3; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Goldman JW, 2012, CANCER; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; Guise TA, 2010, CURR MED RES OPIN, V26, P6; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hillner BE, 2000, J CLIN ONCOL, V18, P1378, DOI 10.1200/JCO.2000.18.6.1378; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; LI Y, 2007, AACR M, V2007, P2216; Li Y., 2007, AACR M, V2007, P2191; Lipton A, 2008, CANCER TREAT REV, V34, pS25, DOI 10.1016/j.ctrv.2008.03.008; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; Mahtani R, 2010, CLIN BREAST CANCER, V10, P359, DOI 10.3816/CBC.2010.n.047; Martin M, 2012, CLIN CANCER RES, V18, P4841, DOI 10.1158/1078-0432.CCR-11-3310; Morgan GJ, 2011, LANCET ONCOL, V12, P743, DOI 10.1016/S1470-2045(11)70157-7; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Neville-Webbe HL, 2010, EUR J CANCER, V46, P1211, DOI 10.1016/j.ejca.2010.02.041; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Ottewell PD, 2010, INT J CANCER, V126, P522, DOI 10.1002/ijc.24756; Previdi S, 2012, MOL CANCER THER, V11, P214, DOI 10.1158/1535-7163.MCT-11-0277; Previdi S, 2010, EUR J CANCER, V46, P1679, DOI 10.1016/j.ejca.2010.02.036; Rimassa L, 2012, J CLIN ONC, V30; Rosen LS, 2011, CLIN CANCER RES, V17, P7754, DOI 10.1158/1078-0432.CCR-11-1002; Scagliotti GV, 2012, J THORAC ONCOL, V7, P1823, DOI 10.1097/JTO.0b013e31826aec2b; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Syddall SP, 2010, CURR PHARM DESIGN, V16, P2988; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wagner AJ, 2012, CANCER; Woodward EJ, 2010, CURR PHARM DESIGN, V16, P2998; Yap TA, 2011, J CLIN ONCOL, V29, P1271, DOI 10.1200/JCO.2010.31.0367	45	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79101	10.1371/journal.pone.0079101	http://dx.doi.org/10.1371/journal.pone.0079101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260160	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500025
J	Sun, HY; Cao, FB; Wang, NB; Zhang, M; Ahmed, IM; Zhang, GP; Wu, FB				Sun, Hongyan; Cao, Fangbin; Wang, Nanbo; Zhang, Mian; Ahmed, Imrul Mosaddek; Zhang, Guoping; Wu, Feibo			Differences in Grain Ultrastructure, Phytochemical and Proteomic Profiles between the Two Contrasting Grain Cd-Accumulation Barley Genotypes	PLOS ONE			English	Article							NADP-MALIC ENZYME; SUBCELLULAR-LOCALIZATION; EXOGENOUS GLUTATHIONE; CADMIUM CONCENTRATION; ALLIUM-CEPA; ROOT-CELLS; TOLERANCE; PROTEINS; IDENTIFICATION; TOXICITY	To reveal grain physio-chemical and proteomic differences between two barley genotypes, Zhenong8 and W6nk2 of high- and low- grain-Cd-accumulation, grain profiles of ultrastructure, amino acid and proteins were compared. Results showed that W6nk2 possesses significantly lower protein content, with hordein depicting the greatest genotypic difference, compared with Zhenong8, and lower amino acid contents with especially lower proportion of Glu, Tyr, Phe and Pro. Both scanning and transmission electron microscopy observation declared that the size of A-type starch molecule in W6nk2 was considerably larger than that of Zhenong8. Grains of Zhenong8 exhibited more protein-rich deposits around starch granules, with some A-type granules having surface pits. Seventeen proteins were identified in grains, using 2-DE coupled with mass spectrometry, with higher expression in Zhenong8 than that in W6nk2; including z-type serpin, serpin-Z7 and alpha-amylase/trypsin inhibitor CM, carbohydrate metabolism, protein synthesis and signal transduction related proteins. Twelve proteins were less expressed in Zhenong8 than that in W6nk2; including barley trypsin inhibitor chloroform/methanol-soluble protein (BTI-CMe2.1, BTI-CMe2.2), trypsin inhibitor, dehydroascorbate reductase (DHAR), pericentrin, dynein heavy chain and some antiviral related proteins. The data extend our understanding of mechanisms underlying Cd accumulation/tolerance and provides possible utilization of elite genetic resources in developing low-grain-Cd barley cultivars.	[Sun, Hongyan; Cao, Fangbin; Wang, Nanbo; Zhang, Mian; Ahmed, Imrul Mosaddek; Zhang, Guoping; Wu, Feibo] Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Hongyan] Taiyuan Univ Sci & Technol, Coll Chem & Biol Engn, Taiyuan, Peoples R China	Zhejiang University; Taiyuan University of Science & Technology	Wu, FB (corresponding author), Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	wufeibo@zju.edu.cn	Ahmed, Imrul Mosaddek/AGX-5469-2022	Wu, Feibo/0000-0001-8797-3398	National Natural Science Foundation of China [30571097, 31071365]; National 863 program [2012AA101105]; Ph.D. Programs Foundation of Ministry of Education of China [J20120066]; Key Research Foundation of Science and Technology Department of Zhejiang Province of China [2012C12902-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 program(National High Technology Research and Development Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Key Research Foundation of Science and Technology Department of Zhejiang Province of China	The project was supported by the National Natural Science Foundation of China (30571097, 31071365), the National 863 program (2012AA101105), the Ph.D. Programs Foundation of Ministry of Education of China (J20120066), and the Key Research Foundation of Science and Technology Department of Zhejiang Province of China (2012C12902-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZH, 2007, CARBOHYD POLYM, V67, P46, DOI 10.1016/j.carbpol.2006.04.013; Bah AM, 2010, J HAZARD MATER, V184, P191, DOI 10.1016/j.jhazmat.2010.08.023; BOGGESS SF, 1978, AGRON J, V70, P756, DOI 10.2134/agronj1978.00021962007000050015x; Cai Y, 2011, J HAZARD MATER, V192, P1056, DOI 10.1016/j.jhazmat.2011.06.011; Chen F, 2007, CHEMOSPHERE, V67, P2082, DOI 10.1016/j.chemosphere.2006.10.014; Chen F, 2010, PLANT PHYSIOL BIOCH, V48, P663, DOI 10.1016/j.plaphy.2010.05.001; Cheng YX, 2007, BIOTECHNOL LETT, V29, P1129, DOI 10.1007/s10529-007-9347-0; De Diego N, 2013, TREE PHYSIOL, V33, P69, DOI 10.1093/treephys/tps125; Dominguez G, 1991, THESIS GEORGIA STATE; Dong J, 2007, PLANT SOIL ENVIRON, V53, P193, DOI 10.17221/2205-PSE; Forster BP, 2000, J EXP BOT, V51, P19, DOI 10.1093/jexbot/51.342.19; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fu ZY, 2011, BIOL PLANTARUM, V55, P196, DOI 10.1007/s10535-011-0030-x; Gana JA, 1998, PLANT PHYSIOL, V118, P1495, DOI 10.1104/pp.118.4.1495; Grant CA, 2008, SCI TOTAL ENVIRON, V390, P301, DOI 10.1016/j.scitotenv.2007.10.038; Hejgaard J, 2007, MOL CELLULAR ASPECTS, P279; HINESLY TD, 1982, AGRON J, V74, P469, DOI 10.2134/agronj1982.00021962007400030017x; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Kikuchi T, 2008, J HAZARD MATER, V154, P294, DOI 10.1016/j.jhazmat.2007.10.025; KIRSI M, 1973, PHYSIOL PLANTARUM, V29, P141, DOI 10.1111/j.1399-3054.1973.tb03081.x; KUMAMARU T, 1988, THEOR APPL GENET, V76, P11, DOI 10.1007/BF00288825; Li G, 2011, J AGR FOOD CHEM, V59, P13065, DOI 10.1021/jf2035912; LI YM, 1995, CROP SCI, V35, P137, DOI 10.2135/cropsci1995.0011183X003500010025x; Liu D, 2007, BIOL PLANTARUM, V51, P363, DOI 10.1007/s10535-007-0075-z; Liu DH, 2004, J BIOSCIENCES, V29, P329, DOI 10.1007/BF02702615; Liu X, 1998, J VIROL, V72, P4463, DOI 10.1128/JVI.72.5.4463-4466.1998; Liu X, 2000, J VIROL, V74, P5949, DOI 10.1128/JVI.74.13.5949-5956.2000; PENNER GA, 1995, GENOME, V38, P543, DOI 10.1139/g95-070; Petersen ML, 2005, J EXP BOT, V56, P3111, DOI 10.1093/jxb/eri308; Pinto ME, 1999, J PHOTOCH PHOTOBIO B, V48, P200, DOI 10.1016/S1011-1344(99)00031-7; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; Robinson LH, 2007, J CEREAL SCI, V45, P335, DOI 10.1016/j.jcs.2006.08.013; Schat H, 1997, PHYSIOL PLANTARUM, V101, P477, DOI 10.1111/j.1399-3054.1997.tb01026.x; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Stolt JP, 2003, ENVIRON EXP BOT, V49, P21, DOI 10.1016/S0098-8472(02)00045-X; THOMAS GM, 1991, J PLANT NUTR, V14, P953, DOI 10.1080/01904169109364255; Van Belleghem F, 2007, NEW PHYTOL, V173, P495, DOI 10.1111/j.1469-8137.2006.01940.x; Wang Y, 2011, ACTA PHYSIOL PLANT, V33, P349, DOI 10.1007/s11738-010-0554-2; Wei K, 2009, J I BREWING, V115, P208, DOI 10.1002/j.2050-0416.2009.tb00370.x; WOLNIK KA, 1983, J AGR FOOD CHEM, V31, P1240, DOI 10.1021/jf00120a024; World Health Organization, 1972, FAO NUTR M REP SER, V51, P33; Wu FB, 2003, COMMUN SOIL SCI PLAN, V34, P2003, DOI 10.1081/CSS-120023233; Wu FB, 2003, ENVIRON EXP BOT, V50, P67, DOI 10.1016/S0098-8472(02)00113-2; Wu FB, 2007, CHEMOSPHERE, V70, P83, DOI 10.1016/j.chemosphere.2007.06.051; Zhang J.B., 2000, ACTA ECOL SIN, V20, P514, DOI [10.3321/j.issn:1000-0933.2000.03.030, DOI 10.3321/J.ISSN:1000-0933.2000.03.030]	45	21	21	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79158	10.1371/journal.pone.0079158	http://dx.doi.org/10.1371/journal.pone.0079158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260165	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500029
J	Sun, J; Jin, CL; Wu, HA; Zhao, JM; Cui, YH; Liu, HR; Wu, LX; Shi, Y; Zhu, B				Sun, Jie; Jin, Chunlan; Wu, Huangan; Zhao, Jimeng; Cui, Yunhua; Liu, Huirong; Wu, Lingxiang; Shi, Yin; Zhu, Bing			Effects of Electro-Acupuncture on Ovarian P450arom, P450c17 alpha and mRNA Expression Induced by Letrozole in PCOS Rats	PLOS ONE			English	Article							INDUCED POLYCYSTIC OVARIES; LOW-FREQUENCY ELECTROACUPUNCTURE; BLOOD-FLOW RESPONSES; NERVE GROWTH-FACTOR; ANESTHETIZED RATS; GENE-EXPRESSION; GRANULOSA-CELLS; ESTROUS-CYCLE; DIHYDROTESTOSTERONE; STIMULATION	Hyperandrogenism is a core factor in the series of reproductive and endocrine metabolic disorders involved in polycystic ovary syndrome (PCOS). Abnormalities in enzymatic activity and the expression of ovarian granular cell layer P450arom and theca cell P450c17 alpha can lead to an atypical environment of local ovarian hormones, including excessive androgen levels. Rat models prepared with letrozole exhibit similar endocrine and histological changes to those that occur in human PCOS. We used such a model to study the role of electro-acupuncture (EA) in regulating ovarian P450arom and P450C17 alpha enzymatic activity and mRNA expression in PCOS rats. Female Sprague Dawley (SD) rats aged 42 days were randomly divided into 3 groups (control, PCOS, and PCOS EA) consisting of 10 rats each. The PCOS and PCOS EA groups were administered a gavage of 1.0 mg/kg(-1) of letrozole solution once daily for 21 consecutive days. Beginning in the ninth week, the PCOS EA group was administered low-frequency EA treatment daily for 14 consecutive days. After the treatment, we obtained the following results. The estrous cycles were restored in 8 of the 10 rats in the PCOS EA group, and their ovarian morphologies and ultrastructures normalized. The peripheral blood measurements (with ELISA) showed significantly decreased androgens (i.e., androstenedione and testosterone) with significantly increased estrogens (i.e., estrone, estradiol) and increased P450arom with decreased P450C17 alpha. Immunohistochemistry and Western blotting methods showed enhanced expression of ovarian granular cell layer P450arom as well as decreased expression of theca cell layer P450C17 alpha. Fluorescence quantitative PCR methods showed enhanced expression of ovarian granular cell layer P450arom mRNA as well as decreased expression of theca cell layer P450C17 alpha mRNA. These results may help explain the effects of electro-acupuncture in changing the local ovarian hyperandrogenic environment and improving reproductive and endocrine metabolic disorders in PCOS.	[Sun, Jie; Zhao, Jimeng; Shi, Yin] Shanghai Univ TCM, Shanghai, Peoples R China; [Wu, Huangan; Cui, Yunhua; Liu, Huirong; Wu, Lingxiang; Shi, Yin] Shanghai Inst Acupuncture Moxibust & Meridians, Shanghai, Peoples R China; [Jin, Chunlan; Zhu, Bing] China Acad Chinese Med Sci, Inst Acumoxibust, Beijing, Peoples R China	Shanghai University of Traditional Chinese Medicine; China Academy of Chinese Medical Sciences	Shi, Y (corresponding author), Shanghai Univ TCM, Shanghai, Peoples R China.	flysy0636@163.com; zhubing@mail.cintcm.ac.cn			Shanghai Municipal Health Bureau [20124049]; Research Project of Autonomous Selection of China Academy of Traditional Chinese Medicine [ZZKF06004]	Shanghai Municipal Health Bureau; Research Project of Autonomous Selection of China Academy of Traditional Chinese Medicine	This work was supported by grants from Shanghai Municipal Health Bureau (Project No. 20124049, URL: http://www.smhb.gov.cn/); Research Project of Autonomous Selection of China Academy of Traditional Chinese Medicine in 2012 (Project No. ZZKF06004, URL: http://www.catcm.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 1996, J VET MED SCI, V58, P787, DOI 10.1292/jvms.58.787; Bai YH, 2004, GYNECOL OBSTET INVES, V57, P80, DOI 10.1159/000075382; Burger LL, 2007, AM J PHYSIOL-ENDOC M, V293, pE277, DOI 10.1152/ajpendo.00447.2006; Cameron VA, 2002, AM J PHYSIOL-ENDOC M, V282, pE139, DOI 10.1152/ajpendo.2002.282.1.E139; CUMMING DC, 1984, CLIN ENDOCRINOL, V20, P643, DOI 10.1111/j.1365-2265.1984.tb00114.x; Dunaif A, 2001, ANNU REV MED, V52, P401, DOI 10.1146/annurev.med.52.1.401; DUNLAP KD, 1988, PHYSIOL BEHAV, V42, P199, DOI 10.1016/0031-9384(88)90298-3; FAN YS, 1992, GENOMICS, V14, P1110, DOI 10.1016/S0888-7543(05)80140-5; Feng Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006638; Foecking EM, 2008, HORM BEHAV, V53, P673, DOI 10.1016/j.yhbeh.2007.12.013; FRANKS S, 1985, CLIN OBSTET GYNAECOL, V12, P605; Guttmann-Bauman I, 2005, J PEDIATR ENDOCR MET, V18, P499; Harlow CR, 2007, J ENDOCRINOL, V192, P41, DOI 10.1677/joe.1.06689; Iwabuchi J, 2007, J STEROID BIOCHEM, V107, P149, DOI 10.1016/j.jsbmb.2007.01.007; Jedel E, 2011, AM J PHYSIOL-ENDOC M, V300, pE37, DOI 10.1152/ajpendo.00495.2010; Kafali H, 2004, ARCH MED RES, V35, P103, DOI 10.1016/j.arcmed.2003.10.005; Magoffin DA, 2005, INT J BIOCHEM CELL B, V37, P1344, DOI 10.1016/j.biocel.2005.01.016; Manneras L, 2009, AM J PHYSIOL-REG I, V296, pR1124, DOI 10.1152/ajpregu.90947.2008; Manni L, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-21; MCNATTY KP, 1979, J CLIN ENDOCR METAB, V49, P687, DOI 10.1210/jcem-49-5-687; Mettus RV, 2003, ONCOGENE, V22, P8413, DOI 10.1038/sj.onc.1206888; MOON YS, 1978, J CLIN ENDOCR METAB, V47, P263, DOI 10.1210/jcem-47-2-263; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Okubo T, 2000, J CLIN ENDOCR METAB, V85, P4889, DOI 10.1210/jc.85.12.4889; Qin KN, 1998, MOL CELL ENDOCRINOL, V145, P111, DOI 10.1016/S0303-7207(98)00177-4; Qu J.Y., 2009, J INT REPROD HLTH FA, V28, P121; RUSH ME, 1982, P SOC EXP BIOL MED, V169, P216, DOI 10.3181/00379727-169-41334; Sakurada Y, 2006, HISTOCHEM CELL BIOL, V126, P735, DOI 10.1007/s00418-006-0205-2; Shi Y, 2010, CHINESE ARCH TRADITI, V28, P805; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Stener-Victorin E, 2008, J NEUROENDOCRINOL, V20, P290, DOI 10.1111/j.1365-2826.2007.01634.x; Stener-Victorin E, 2000, BIOL REPROD, V63, P1497, DOI 10.1095/biolreprod63.5.1497; Stener-Victorin E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-44; Stener-Victorin E, 2004, BIOL REPROD, V70, P329, DOI 10.1095/biolreprod.103.022368; Stener-Victorin E, 2003, AUTON NEUROSCI-BASIC, V108, P50, DOI 10.1016/j.autneu.2003.08.006; Stener-Victorin E, 2000, ACTA OBSTET GYN SCAN, V79, P180, DOI 10.1034/j.1600-0412.2000.079003180.x; Stener-Victorin E, 2001, NEUROPEPTIDES, V35, P227, DOI 10.1054/npep.2002.0878; Stener-Victorin E, 2006, J APPL PHYSIOL, V101, P84, DOI 10.1152/japplphysiol.01593.2005; Stener-Victorin Elisabet, 2003, Reprod Biol Endocrinol, V1, P33, DOI 10.1186/1477-7827-1-33	39	37	44	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79382	10.1371/journal.pone.0079382	http://dx.doi.org/10.1371/journal.pone.0079382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260211	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500056
J	An, CJ; Zhang, MM; Chu, Y; Zhao, ZW				An, Chunju; Zhang, Mingming; Chu, Yuan; Zhao, Zhangwu			Serine Protease MP2 Activates Prophenoloxidase in the Melanization Immune Response of Drosophila melanogaster	PLOS ONE			English	Article							PRO-PHENOL-OXIDASE; MANDUCA-SEXTA HEMOLYMPH; INNATE IMMUNITY; TOLL PATHWAY; IN-VITRO; PROTEINASE; SYSTEM; SERPIN; CASCADE; INSECT	In arthropods, melanization plays a major role in the innate immune response to encapsulate and kill the invasive organisms. It is mediated by a serine protease cascade and is regulated by serpins. The identification of the molecular components of melanization and the regulation of those components are still unclear in Drosophila melanogaster, although some genetic research on the activation of melanization has been reported. Here we report that Drosophila serine protease MP2 directly cleaves both recombinant and native prophenoloxidase-1. Overexpression or repression of MP2 in flies resulted in increased and decreased rates of cleavage, respectively, of prophenoloxidase-1. Moreover, serine protease inhibitor Spn27A formed SDS-stable complexes with MP2, both in vitro and in vivo. The amidase activity of MP2 was inhibited efficiently by Spn27A. Spn27A also prevented MP2 from cleaving prophenoloxidase-1. Taken together, these results indicate that under our experimental conditions MP2 functions as a prophenoloxidase-activating protease, and that this function is inhibited by Spn27A. MP2 and Spn27A thus constitute a regulatory unit in the prophenoloxidase activation cascade in Drosophila. The combination of genetic, molecular genetic and biochemical approaches should allow further advances in our understanding of the prophenoloxidase-activating cascade in insects and indirectly shed further light on protease-cascades in humans and other vertebrates.	[An, Chunju; Zhang, Mingming; Chu, Yuan; Zhao, Zhangwu] China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China	China Agricultural University	An, CJ (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China.	anchunju@cau.edu.cn; zhaozw@cau.edu.cn			National Natural Science Foundation of China [31172090]; Program for New Century Excellent Talents in University [NCET-11-0476]; 973 Program [2013CB114102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 973 Program(National Basic Research Program of China)	This research was supported by National Natural Science Foundation of China (31172090), Program for New Century Excellent Talents in University (NCET-11-0476), and the 973 Program (2013CB114102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ST, 2009, P NATL ACAD SCI USA, V106, P12168, DOI 10.1073/pnas.0903134106; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; An CJ, 2011, DEV COMP IMMUNOL, V35, P135, DOI 10.1016/j.dci.2010.09.004; An CJ, 2010, INSECT BIOCHEM MOLEC, V40, P683, DOI 10.1016/j.ibmb.2010.07.001; An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Ashida M, 1998, MOL MECH IMMUNE RESP; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Clark KD, 2013, J BIOL CHEM, V288, P14476, DOI 10.1074/jbc.M113.459222; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kanost MR, 2001, ADV EXP MED BIOL, V484, P319; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Lee KY, 2002, FEBS J, V269, P4375; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Li XQ, 2012, DEV COMP IMMUNOL, V36, P648, DOI 10.1016/j.dci.2011.11.005; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Nam HJ, 2012, EMBO J, V31, P1253, DOI 10.1038/emboj.2011.476; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Richer MJ, 2004, P NATL ACAD SCI USA, V101, P10560, DOI 10.1073/pnas.0401406101; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Wang RG, 2001, EUR J BIOCHEM, V268, P895, DOI 10.1046/j.1432-1327.2001.01945.x; Wang Y, 2006, J BIOL CHEM, V281, P9271, DOI 10.1074/jbc.M513797200; Wang Y, 2007, INSECT BIOCHEM MOLEC, V37, P1015, DOI 10.1016/j.ibmb.2007.05.013; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011	61	40	47	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79533	10.1371/journal.pone.0079533	http://dx.doi.org/10.1371/journal.pone.0079533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260243	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600039
J	Yamazaki, H; Takagi, S; Hoshino, Y; Hosoya, K; Okumura, M				Yamazaki, Hiroki; Takagi, Satoshi; Hoshino, Yuki; Hosoya, Kenji; Okumura, Masahiro			Inhibition of Survivin Influences the Biological Activities of Canine Histiocytic Sarcoma Cell Lines	PLOS ONE			English	Article							SMALL-MOLECULE SUPPRESSOR; BREAST-CANCER CELLS; KAPPA-B PATHWAY; UP-REGULATION; PHASE-II; MULTIDRUG-RESISTANCE; GENE-TRANSCRIPTION; DRUG-RESISTANCE; P-GLYCOPROTEIN; LUNG-CANCER	Canine histiocytic sarcoma (CHS) is an aggressive malignant neoplasm that originates from histiocytic lineage cells, including dendritic cells and macrophages, and is characterized by progressive local infiltration and a very high metastatic potential. Survivin is as an apoptotic inhibitory factor that has major functions in cell proliferation, including inhibition of apoptosis and regulation of cell division, and is expressed in most types of human and canine malignant neoplasms, including melanoma and osteosarcoma. To investigate whether survivin was expressed at high levels in CHS and whether its expression was correlated with the aggressive biological behavior of CHS, we assessed relation between survivin expression and CHS progression, as well as the effects of survivin inhibition on the biological activities of CHS cells. We comparatively analyzed the expression of 6 selected anti-apoptotic genes, including survivin, in specimens from 30 dogs with histiocytic sarcoma and performed annexin V staining to evaluate apoptosis, methylthiazole tetrazolium assays to assess cell viability and chemosensitivity, and latex bead assays to measure changes in phagocytic activities in 4 CHS cell lines and normal canine fibroblasts transfected with survivin siRNA. Survivin gene expression levels in 30 specimens were significantly higher than those of the other 6 genes. After transfection with survivin siRNA, apoptosis, cell growth inhibition, enhanced chemosensitivity, and weakened phagocytic activities were observed in all CHS cell lines. In contrast, normal canine fibroblasts were not significantly affected by survivin knockdown. These results suggested that survivin expression may mediate the aggressive biological activities of CHS and that survivin may be an effective therapeutic target for the treatment of CHS.	[Yamazaki, Hiroki; Hosoya, Kenji; Okumura, Masahiro] Hokkaido Univ, Lab Vet Surg, Dept Vet Clin Sci, Grad Sch Vet Med, Sapporo, Hokkaido 060, Japan; [Takagi, Satoshi; Hoshino, Yuki] Hokkaido Univ, Vet Teaching Hosp, Grad Sch Vet Med, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Okumura, M (corresponding author), Hokkaido Univ, Lab Vet Surg, Dept Vet Clin Sci, Grad Sch Vet Med, Sapporo, Hokkaido 060, Japan.	okumuram@vetmed.hokudai.ac.jp	Okumura, Masahiro/AAO-4766-2021	TAKAGI, Satoshi/0000-0001-6653-5890	Japan Society for the Promotion of Science KAKENHI [23780316]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI (Grant number 23780316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Asanuma K, 2004, J IMMUNOL, V172, P3922, DOI 10.4049/jimmunol.172.6.3922; Azakami D, 2006, J VET MED SCI, V68, P1343, DOI 10.1292/jvms.68.1343; Bakhtiyari S, 2013, THER DELIV, V4, P45, DOI [10.4155/TDE.12.136, 10.4155/tde.12.136]; Bongiovanni L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-78; Chu XY, 2012, J SURG ONCOL, V105, P520, DOI 10.1002/jso.22134; Endoh T, 2005, EXP CELL RES, V305, P300, DOI 10.1016/j.yexcr.2004.12.014; Fukuda S, 2002, CELL CYCLE, V1, P322, DOI 10.4161/cc.1.5.149; Fulmer AK, 2007, CAN VET J, V48, P1041; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Guo W, 2013, CHIN J CANC, V24, P253; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Hori M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055710; Jin Yi, 2011, Zhonghua Yi Xue Za Zhi, V91, P2542; Ke SZ, 2013, INT J ONCOL, V42, P1289, DOI 10.3892/ijo.2013.1805; Klahn SL, 2011, JAVMA-J AM VET MED A, V239, P90, DOI 10.2460/javma.239.1.90; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li J, 2013, ACTA BIOCH BIOPH SIN, V13, P2013; Liu F, 2007, BIOL PHARM BULL, V30, P2279, DOI 10.1248/bpb.30.2279; Liu F, 2010, ONCOL REP, V23, P1469, DOI 10.3892/or_00000786; Luo L, 2013, CHEM-BIOL INTERACT, V203, P430, DOI 10.1016/j.cbi.2013.03.009; McKenzie JA, 2010, CANCER RES, V70, P7927, DOI 10.1158/0008-5472.CAN-10-0194; Moore PF, 2006, VET PATHOL, V43, P632, DOI 10.1354/vp.43-5-632; Moriyama M, 2010, J VET MED SCI, V72, P1643, DOI 10.1292/jvms.10-0119; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336; Rassnick KM, 2010, J VET INTERN MED, V24, P1528, DOI 10.1111/j.1939-1676.2010.0588.x; Sakai H, 2003, J VET MED SCI, V65, P731, DOI 10.1292/jvms.65.731; Salz W, 2005, CANCER RES, V65, P3531, DOI 10.1158/0008-5472.CAN-04-4284; Sano J, 2005, RES VET SCI, V78, P183, DOI 10.1016/j.rvsc.2004.07.008; Sapra P, 2010, NUCLEOS NUCLEOT NUCL, V29, P97, DOI 10.1080/15257771003597733; Schlotter YM, 2009, VET IMMUNOL IMMUNOP, V129, P115, DOI 10.1016/j.vetimm.2008.12.004; Shoeneman JK, 2012, CANCER RES, V72, P249, DOI 10.1158/0008-5472.CAN-11-2315; Skorupski KA, 2007, J VET INTERN MED, V21, P121, DOI 10.1892/0891-6640(2007)21[121:CFTTOD]2.0.CO;2; Soare T, 2012, J COMP PATHOL, V146, P168, DOI 10.1016/j.jcpa.2011.05.006; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Spee B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-34; Sunaga T, 2012, J VET MED SCI, V74, P745, DOI 10.1292/jvms.11-0435; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Tomiyasu H, 2010, J VET MED SCI, V72, P1165, DOI 10.1292/jvms.09-0575; Uchide T, 2005, DNA SEQUENCE, V16, P329, DOI 10.1080/10425170500213696; Waligorska-Stachura J, 2003, ACTA PHARMACOL SIN, V24, P1235; Waligorska-Stachura J, 2012, GINEKOL POL, V83, P537; Wang WJ, 2006, J SURG ONCOL, V93, P578, DOI 10.1002/jso.20507; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Yang D, 2004, P NATL ACAD SCI USA, V101, P15100, DOI 10.1073/pnas.0406665101; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046	50	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79810	10.1371/journal.pone.0079810	http://dx.doi.org/10.1371/journal.pone.0079810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260303	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600048
J	Zhao, GJ; Li, J; Tong, ZX; Zhao, B; Mu, RQ; Guan, YF				Zhao, Guojie; Li, Jun; Tong, Zhaoxue; Zhao, Bin; Mu, Runqing; Guan, Yifu			Enzymatic Cleavage of Type II Restriction Endonucleases on the 2 '-O-Methyl Nucleotide and Phosphorothioate Substituted DNA	PLOS ONE			English	Article							RNA TARGETS; ONE-POT; ECORV; RECOGNITION; OLIGODEOXYNUCLEOTIDES; OLIGONUCLEOTIDES; INHIBITION; STABILITY; ENZYMES; PROBES	The effects of nucleotide analogue substitution on the cleavage efficiencies of type II restriction endonucleases have been investigated. Six restriction endonucleases (EcoRV, SpeI, XbaI, XhoI, PstI and SphI) were investigated respectively regarding their cleavage when substrates were substituted by 2'-O-methyl nucleotide (2'-OMeN) and phosphorothioate (PS). Substitutions were made in the recognition sequence and the two nucleotides flanking the recognition sequence for each endonuclease. The endonuclease cleavage efficiencies were determined using FRET-based assay. Results demonstrated a position-dependent inhibitory effect of substitution on the cleavage efficiency for all the six endonucleases. In general, the 2'-OMeN substitutions had greater impact than the PS substitutions on the enzymatic activities. Nucleotides of optimal substitutions for protection against RE cleavage were identified. Experimental results and conclusions in this study facilitate our insight into the DNA-protein interactions and the enzymatic cleavage mechanism, particularly for those whose detailed structure information is not available. In addition, the information could benefit the development of bioengineering and synthetic biology.	[Zhao, Guojie; Li, Jun; Tong, Zhaoxue; Guan, Yifu] China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Liaoning, Peoples R China; [Zhao, Bin] Shenyang Sport Univ, Dept Movement Sci, Shenyang, Liaoning, Peoples R China; [Mu, Runqing] China Med Univ, Affiliated Hosp 1, Dept Lab Med, Shenyang, Liaoning, Peoples R China	China Medical University; Shenyang Sport University; China Medical University	Guan, YF (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Liaoning, Peoples R China.	yfguan55@sina.com	zhao, guojie/I-4238-2012		National Natural Science Foundation of China [31070705]; Doctoral Startup Fund of Liaoning Province [20131139]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Startup Fund of Liaoning Province	This work was supported by a grant from the National Natural Science Foundation of China (No. 31070705) and Doctoral Startup Fund of Liaoning Province (No. 20131139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMPBELL JM, 1990, J BIOCHEM BIOPH METH, V20, P259, DOI 10.1016/0165-022X(90)90084-P; Crouzier L, 2012, BIOORG MED CHEM LETT, V22, P4836, DOI 10.1016/j.bmcl.2012.05.113; Dominick PK, 2004, J AM CHEM SOC, V126, P5050, DOI 10.1021/ja039192z; Eisenschmidt K, 2002, J BIOTECHNOL, V96, P185, DOI 10.1016/S0168-1656(02)00029-9; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; FLIESS A, 1988, NUCLEIC ACIDS RES, V16, P11781, DOI 10.1093/nar/16.24.11781; FLIESS A, 1986, NUCLEIC ACIDS RES, V14, P3463, DOI 10.1093/nar/14.8.3463; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; FREY PA, 1985, SCIENCE, V228, P541, DOI 10.1126/science.2984773; HANCOX EL, 1993, NUCLEIC ACIDS RES, V21, P3485, DOI 10.1093/nar/21.15.3485; Howland SW, 2011, ANAL BIOCHEM, V416, P141, DOI 10.1016/j.ab.2011.04.006; Huang Y, 2011, ANAL CHEM, V83, P8913, DOI 10.1021/ac2013114; JELTSCH A, 1995, BIOCHEMISTRY-US, V34, P6239, DOI 10.1021/bi00018a028; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; Li JS, 2010, ANAL CHEM, V82, P2811, DOI 10.1021/ac100336n; Li XM, 2008, ANAL BIOCHEM, V381, P1, DOI 10.1016/j.ab.2008.06.027; Liu XP, 2010, PROTEIN SCI, V19, P967, DOI 10.1002/pro.374; Macickova-Cahova H, 2009, NUCLEIC ACIDS RES, V37, P7612, DOI 10.1093/nar/gkp845; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; Mazurek M, 1996, BIOCHEMISTRY-US, V35, P11522, DOI 10.1021/bi953012j; MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359; NEWMAN PC, 1990, BIOCHEMISTRY-US, V29, P9891, DOI 10.1021/bi00494a020; NIELSEN PE, 1993, NUCLEIC ACIDS RES, V21, P197, DOI 10.1093/nar/21.2.197; OLSEN DB, 1990, BIOCHEMISTRY-US, V29, P9546, DOI 10.1021/bi00493a008; Pallan PS, 2011, NUCLEIC ACIDS RES, V39, P3482, DOI 10.1093/nar/gkq1270; Perona JJ, 1997, J MOL BIOL, V273, P207, DOI 10.1006/jmbi.1997.1315; Phillips MI, 2000, METHOD ENZYMOL, V313, P46; Piao XY, 2008, ACTA BIOCHIM POL, V55, P713; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; ROBERTS RJ, 1982, NUCLEIC ACIDS RES, V10, pR117; ROBERTS RJ, 1990, NUCLEIC ACIDS RES, V18, P2331, DOI 10.1093/nar/18.suppl.2331; SAYERS JR, 1989, NUCLEIC ACIDS RES, V17, P9495, DOI 10.1093/nar/17.22.9495; Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093; Thorogood H, 1996, J BIOL CHEM, V271, P8855, DOI 10.1074/jbc.271.15.8855; Urata H, 2009, BIOCHEM BIOPH RES CO, V390, P192, DOI 10.1016/j.bbrc.2009.08.164; WATERS TR, 1994, BIOCHEMISTRY-US, V33, P1812, DOI 10.1021/bi00173a026; Wenz C, 1996, J BIOL CHEM, V271, P5565, DOI 10.1074/jbc.271.10.5565; WILLIAMS DM, 1991, BIOCHEMISTRY-US, V30, P4001, DOI 10.1021/bi00230a027; Yan Y, 2012, J BIOSCIENCES, V37, P233, DOI 10.1007/s12038-012-9196-4	40	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79415	10.1371/journal.pone.0079415	http://dx.doi.org/10.1371/journal.pone.0079415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260216	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600034
J	Falleti, E; Cmet, S; Fabris, C; Fattovich, G; Cussigh, A; Bitetto, D; Ceriani, E; Lenisa, I; Dissegna, D; Ieluzzi, D; Rostello, A; Pirisi, M; Toniutto, P				Falleti, Edmondo; Cmet, Sara; Fabris, Carlo; Fattovich, Giovanna; Cussigh, Annarosa; Bitetto, Davide; Ceriani, Elisa; Lenisa, Ilaria; Dissegna, Denis; Ieluzzi, Donatella; Rostello, Anna; Pirisi, Mario; Toniutto, Pierluigi			Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naive Patients with Chronic Hepatitis C	PLOS ONE			English	Article							VIROLOGICAL RESPONSE; ASSOCIATION; THERAPY	Vitamin D serum levels seem to influence antiviral response in chronic hepatitis C. Vitamin D pathway is controlled by genes presenting functional single nucleotide polymorphisms (SNPs). Data regarding the association between these polymorphisms and the rate of sustained viral response (SVR) following antiviral treatment in chronic hepatitis C virus (HCV) infection are largely incomplete. Aim of this study was to evaluate if the carriage of different SNPs of these genes could influence the rate of SVR in patients treated with interferon plus ribavirin. Two hundred and six HCV positive patients treated with PEG-interferon plus ribavirin were retrospectively evaluated. Polymorphic loci rs7041 G>T and rs4588 C>A of the vitamin D transporter GC-globulin, rs10741657 G>A of the vitamin D 25 hydroxylase CYP2R1 and rs10877012 G>T of vitamin D 1-hydroxylase CYP27B1 were genotyped. A genetic model named VDPFA (vitamin D Pathway Functional Alleles) was constructed considering for each patient the sum (from 0 to 8), derived from every functional allele carried, associated with the achievement of SVR. Three groups were identified: those carrying <= 4 VDPFA (N=108), those carrying 5-6 VDPFA (N=78) and those carrying = 7 VDPFA (N=20). Significant associations were found between the rates of SVR and the VDPFA value both in all (61/108, 53/78, 17/20, p=0.009) and in 1/4-5 HCV genotypes (17/56, 23/43, 6/8, p=0.003). Moreover in patients who don't achieve rapid viral response (RVR) SVR and VDPFA were found to be in stronger associations in all (12/55, 17/39, 7/9, p<0.001) and in 1/4-5 HCV genotypes (4/41, 12/31, 5/6, p=0.001). VDPFA value = 7 could aid to select, among RVR negative difficult to treat 1/4-5 HCV genotypes, those achieving SVR. These observations could permit	[Falleti, Edmondo; Cmet, Sara; Fabris, Carlo; Cussigh, Annarosa; Bitetto, Davide; Lenisa, Ilaria; Dissegna, Denis; Toniutto, Pierluigi] Univ Udine, Med Liver Transplantat Unit, Dept Med & Pathol Clin & Expt, I-33100 Udine, Italy; [Fattovich, Giovanna; Ieluzzi, Donatella; Rostello, Anna] Univ Verona, Azienda Osped Univ, Dept Med, Gastroenterol Clin, I-37100 Verona, Italy; [Ceriani, Elisa; Pirisi, Mario] Univ Piemonte Orientale, Dept Clin & Expt Med, Novara, Italy; [Pirisi, Mario] Interdept Res Ctr Autoimmune Dis, Novara, Italy	University of Udine; University of Verona; University of Eastern Piedmont Amedeo Avogadro	Toniutto, P (corresponding author), Univ Udine, Med Liver Transplantat Unit, Dept Med & Pathol Clin & Expt, I-33100 Udine, Italy.	pierluigi.toniutto@uniud.it	Fattovich, giovanna/AAC-7083-2020; Pirisi, Mario/ABF-2102-2020	Pirisi, Mario/0000-0001-9740-0155; Toniutto, Pierluigi/0000-0002-2566-3041				Abu-Mouch S, 2011, WORLD J GASTROENTERO, V17, P5184, DOI 10.3748/wjg.v17.i47.5184; Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Asselah T, 2010, LIVER INT, V30, P1259, DOI 10.1111/j.1478-3231.2010.02283.x; Berry DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037465; Bitetto D, 2011, HEPATOLOGY, V53, P1118, DOI 10.1002/hep.24201; Camma C, 2012, HEPATOLOGY, V56, P850, DOI 10.1002/hep.25734; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Clifton-Bligh RJ, 2011, CALCIFIED TISSUE INT, V88, P109, DOI 10.1007/s00223-010-9434-4; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Dastani Z, 2013, CALCIFIED TISSUE INT, V92, P106, DOI 10.1007/s00223-012-9660-z; Everhart JE, 2013, HEPATOLOGY, V57, P1725, DOI 10.1002/hep.26203; Falleti E, 2012, HEPATOLOGY, V56, P1641, DOI 10.1002/hep.25848; Fattovich G, 2011, ALIMENT PHARM THER, V33, P1162, DOI 10.1111/j.1365-2036.2011.04635.x; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Lange CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040159; Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Nimer A, 2012, WORLD J GASTROENTERO, V18, P800, DOI 10.3748/wjg.v18.i8.800; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Signorello LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028623; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; White JH, 2012, REV ENDOCR METAB DIS, V13, P21, DOI 10.1007/s11154-011-9195-z	26	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80764	10.1371/journal.pone.0080764	http://dx.doi.org/10.1371/journal.pone.0080764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244713	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800161
J	Jung, JW; Kim, JH; Pfeiffer, R; Ahn, YJ; Page, TL; Kwon, HW				Jung, Je Won; Kim, Jin-Hee; Pfeiffer, Rita; Ahn, Young-Joon; Page, Terry L.; Kwon, Hyung Wook			Neuromodulation of Olfactory Sensitivity in the Peripheral Olfactory Organs of the American Cockroach, Periplaneta americana	PLOS ONE			English	Article							AXOLOTLS AMBYSTOMA-MEXICANUM; TACHYKININ-RELATED PEPTIDES; DROSOPHILA ANTENNAL LOBE; RECEPTOR NEURONS; NUTRITIONAL-STATUS; CIRCADIAN-RHYTHMS; MOLECULAR-CLONING; VISUAL EFFERENCE; SENSORY NEURONS; SUBSTANCE-P	Olfactory sensitivity exhibits daily fluctuations. Several studies have suggested that the olfactory system in insects is modulated by both biogenic amines and neuropeptides. However, molecular and neural mechanisms underlying olfactory modulation in the periphery remain unclear since neuronal circuits regulating olfactory sensitivity have not been identified. Here, we investigated the structure and function of these signaling pathways in the peripheral olfactory system of the American cockroach, Periplaneta americana, utilizing in situ hybridization, qRT-PCR, and electrophysiological approaches. We showed that tachykinin was co-localized with the octopamine receptor in antennal neurons located near the antennal nerves. In addition, the tachykinin receptor was found to be expressed in most of the olfactory receptor neurons in antennae. Functionally, the effects of direct injection of tachykinin peptides, dsRNAs of tachykinin, tachykinin receptors, and octopamine receptors provided further support for the view that both octopamine and tachykinin modulate olfactory sensitivity. Taken together, these findings demonstrated that octopamine and tachykinin in antennal neurons are olfactory regulators in the periphery. We propose here the hypothesis that octopamine released from neurons in the brain regulates the release of tachykinin from the octopamine receptor neurons in antennae, which in turn modulates the olfactory sensitivity of olfactory receptor neurons, which house tachykinin receptors.	[Jung, Je Won; Kim, Jin-Hee; Ahn, Young-Joon; Kwon, Hyung Wook] Coll Agr & Life Sci, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea; [Pfeiffer, Rita; Page, Terry L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kwon, HW (corresponding author), Coll Agr & Life Sci, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea.	biomodeling@snu.ac.kr			Korea Science and Engineering Foundation [R31-10056, 2012-008656]; National Research Foundation of Korea; National Science Foundation [IOS-1145605]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Research Foundation of Korea(National Research Foundation of Korea); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the World Class University program (R31-10056) and Basic Science Research Program (No. 2012-008656) through the Korea Science and Engineering Foundation funded by the National Research Foundation of Korea to HWK and by National Science Foundation Grant #IOS-1145605 to TLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baly C, 2007, BRAIN RES, V1129, P130, DOI 10.1016/j.brainres.2006.10.030; Birse RT, 2011, J EXP BIOL, V214, P4201, DOI 10.1242/jeb.062091; Bischof LJ, 2004, INSECT BIOCHEM MOLEC, V34, P511, DOI 10.1016/j.ibmb.2004.02.003; Bolbecker AR, 2009, J NEUROPHYSIOL, V102, P1132, DOI 10.1152/jn.91167.2008; Caillol M, 2003, BRAIN RES, V960, P48, DOI 10.1016/S0006-8993(02)03755-1; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Grosmaitre X, 2001, CHEM SENSES, V26, P653, DOI 10.1093/chemse/26.6.653; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Johard HAD, 2001, BRAIN RES, V919, P94, DOI 10.1016/S0006-8993(01)03004-9; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kawai T, 2010, J NEUROPHYSIOL, V104, P3540, DOI 10.1152/jn.00639.2010; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Leinwand SG, 2011, CURR OPIN GENET DEV, V21, P806, DOI 10.1016/j.gde.2011.07.006; Lim-Kessler CCM, 2008, VISUAL NEUROSCI, V25, P83, DOI 10.1017/S0952523808080103; Lucero MT, 2013, SEMIN CELL DEV BIOL, V24, P58, DOI 10.1016/j.semcdb.2012.09.001; Lucero MT, 1998, BRAIN RES, V807, P234, DOI 10.1016/S0006-8993(98)00825-7; Meer RKV, 2008, NATURWISSENSCHAFTEN, V95, P1155, DOI 10.1007/s00114-008-0432-6; Meola SM, 1998, NEUROCHEM RES, V23, P189, DOI 10.1023/A:1022432909360; Merlin C, 2007, J BIOL RHYTHM, V22, P502, DOI 10.1177/0748730407307737; MOBIUS P, 1993, ACTA BIOL HUNG, V44, P45; Mousley A, 2006, J NEUROSCI, V26, P7707, DOI 10.1523/JNEUROSCI.1977-06.2006; Negroni J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045266; Ni MM, 2008, CLIN EXP PHARMACOL P, V35, P563, DOI 10.1111/j.1440-1681.2007.04840.x; Ogura T, 2011, J NEUROPHYSIOL, V106, P1274, DOI 10.1152/jn.00186.2011; Page TL, 2003, J INSECT PHYSIOL, V49, P697, DOI 10.1016/S0022-1910(03)00071-4; Park D, 2003, CHEM SENSES, V28, P339, DOI 10.1093/chemse/28.4.339; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; Predel R, 2005, FEBS J, V272, P3365, DOI 10.1111/j.1742-4658.2005.04752.x; Prud'homme MJ, 2009, NEUROSCIENCE, V162, P1287, DOI 10.1016/j.neuroscience.2009.05.043; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Saifullah ASM, 2009, J BIOL RHYTHM, V24, P144, DOI 10.1177/0748730408331166; Schendzielorz T, 2012, J BIOL RHYTHM, V27, P388, DOI 10.1177/0748730412456265; SCHOOFS L, 1993, INSECT BIOCHEM MOLEC, V23, P859, DOI 10.1016/0965-1748(93)90104-Z; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Takeuchi H, 2004, CELL TISSUE RES, V316, P281, DOI 10.1007/s00441-004-0865-y; VonNickischRosenegk E, 1996, INSECT BIOCHEM MOLEC, V26, P817, DOI 10.1016/S0965-1748(96)00031-8; Wang JW, 2012, DEV NEUROBIOL, V72, P87, DOI 10.1002/dneu.20936; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Zhukovskaya MI, 2008, PHYSIOL ENTOMOL, V33, P162, DOI 10.1111/j.1365-3032.2008.00615.x; Zhukovskaya MI, 2012, CHEM SENSES, V37, P421, DOI 10.1093/chemse/bjr121; Zhukovskaya MI, 2006, J INSECT PHYSIOL, V52, P76, DOI 10.1016/j.jinsphys.2005.09.005	50	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81361	10.1371/journal.pone.0081361	http://dx.doi.org/10.1371/journal.pone.0081361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244739	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800180
J	Preston, CC; Maurer, MJ; Oberg, AL; Visscher, DW; Kalli, KR; Hartmann, LC; Goode, EL; Knutson, KL				Preston, Claudia C.; Maurer, Matthew J.; Oberg, Ann L.; Visscher, Daniel W.; Kalli, Kimberly R.; Hartmann, Lynn C.; Goode, Ellen L.; Knutson, Keith L.			The Ratios of CD8(+) T Cells to CD4(+) CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer	PLOS ONE			English	Article							DENDRITIC CELLS; TUMOR; INDUCTION; CARCINOMA; IMMUNITY; ANTIBODY; IL-2; CHEMOTHERAPY; CARBOPLATIN; LYMPHOCYTES	Ovarian cancer is an immune reactive malignancy with a complex immune suppressive network that blunts successful immune eradication. This suppressive microenvironment may be mediated by recruitment or induction of CD4(+) regulatory T cells (Tregs). Our study sought to investigate the association of tumor-infiltrating CD4(+)CD25(+)FOXP3(+) Tregs, and other immune factors, with clinical outcome in serous ovarian cancer patients. We performed immunofluorescence and quantification of intraepithelial tumor-infiltrating triple positive Tregs (CD4(+)CD25(+)FOXP3(+)), as well as CD4(+) CD25(+) FOXP3(-), CD3(+) and CD8(+) T cells in tumor specimens from 52 patients with high stage serous ovarian carcinoma. Thirty-one of the patients had good survival (i.e. > 60 months) and 21 had poor survival of < 18 months. Total cell counts as well as cell ratios were compared among these two outcome groups. The total numbers of CD4(+)CD25(+)FOXP3(+) Tregs, CD4(+) CD25(+) FOXP3(-), CD3(+) and CD8(+) cells were not significantly different between the groups. However, higher ratios of CD8(+)/CD4(+)CD25(+)FOXP3(+) Treg, CD8(+)/CD4(+) and CD8/CD4(+)CD25(+)FOXP3-cells were seen in the good outcome group when compared to the patients with poor outcome. These data show for the first time that the ratios of CD8(+) to both CD4(+) CD25(+) FOXP3(+) Tregs and CD4(+)CD25(+)FOXP3(-) T cells are associated with disease outcome in ovarian cancer. The association being apparent in ratios rather than absolute count of T cells suggests that the effector/ suppressor ratio may be a more important indicator of outcome than individual cell count. Thus, immunotherapy strategies that modify the ratio of CD4(+)CD25(+)FOXP3(+) Tregs or CD4(+)CD25(+)FOXP3(-) T cells to CD8(+) effector cells may be useful in improving outcomes in ovarian cancer.	[Preston, Claudia C.; Knutson, Keith L.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Maurer, Matthew J.; Oberg, Ann L.; Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Visscher, Daniel W.; Hartmann, Lynn C.] Mayo Clin, Div Anat Pathol, Rochester, MI USA; [Kalli, Kimberly R.] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Kalli, Kimberly R.] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Knutson, Keith L.] Vaccine & Gene Therapy Inst, Port St Lucie, FL USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Vaccine & Gene Therapy Institute of Florida	Goode, EL (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	egoode@mayo.edu; kknutson@vgtifl.org		Maurer, Matthew/0000-0002-1867-0526	 [P50-CA116201];  [R01-CA122443];  [P50-CA136393]; NATIONAL CANCER INSTITUTE [P50CA136393, R01CA122443, P50CA116201] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to KLK, ELG, LCH: P50-CA116201, R01-CA122443, and P50-CA136393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletti GD, 2007, MAYO CLIN PROC, V82, P751; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chen FX, 2009, INT J GYNECOL CANCER, V19, P1487, DOI 10.1111/IGC.0b013e3181bb70c6; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coleman S, 2005, CANCER RES, V65, P7000, DOI 10.1158/0008-5472.CAN-04-3792; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Ebert EC, 2003, CLIN EXP IMMUNOL, V132, P424, DOI 10.1046/j.1365-2249.2003.02156.x; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Goodell V, 2006, J CLIN ONCOL, V24, P762, DOI 10.1200/JCO.2005.03.2813; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hoskins P, 2010, J NATL CANCER I, V102, P1547, DOI 10.1093/jnci/djq362; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Knutson KL, 2006, J IMMUNOL, V177, P84, DOI 10.4049/jimmunol.177.1.84; Knutson KL, 2004, CANCER RES, V64, P1146, DOI 10.1158/0008-5472.CAN-03-0173; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Ladoire S, 2012, ANN ONCOL, V23, P2552, DOI 10.1093/annonc/mds028; Li X, 2005, CANCER INVEST, V23, P399, DOI 10.1081/CNV-200067142; Lipson EJ, 2011, CLIN CANCER RES, V17, P6958, DOI 10.1158/1078-0432.CCR-11-1595; Magg T, 2012, EUR J IMMUNOL, V42, P1627, DOI 10.1002/eji.201141838; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Noh J, 2012, CELL IMMUNOL, V274, P109, DOI 10.1016/j.cellimm.2012.01.005; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pot C, 2011, SEMIN IMMUNOL, V23, P202, DOI 10.1016/j.smim.2011.07.005; Preston CC, 2011, IMMUNOTHERAPY-UK, V3, P539, DOI [10.2217/IMT.11.20, 10.2217/imt.11.20]; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Siddiqui SA, 2007, CLIN CANCER RES, V13, P2075, DOI 10.1158/1078-0432.CCR-06-2139; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Trimble EL, 2010, INT J GYNECOL CANCER, V20, P1284, DOI 10.1111/IGC.0b013e3181ee1c01; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	44	142	161	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80063	10.1371/journal.pone.0080063	http://dx.doi.org/10.1371/journal.pone.0080063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244610	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800116
J	Elahi, R; Sebens, KP				Elahi, Robin; Sebens, Kenneth P.			Experimental Removal and Recovery of Subtidal Grazers Highlights the Importance of Functional Redundancy and Temporal Context	PLOS ONE			English	Article							URCHINS STRONGYLOCENTROTUS-FRANCISCANUS; SEA-URCHINS; COMMUNITY STRUCTURE; SELECTIVE HERBIVORE; KELP FOREST; PREY; RECRUITMENT; BIODIVERSITY; COMPETITION; ABUNDANCE	The extent to which different grazers are functionally redundant has strong implications for the maintenance of community structure and function. Grazing by red urchins (Strongylocentrotus franciscanus) on temperate rocky reefs can initiate a switch from invertebrate or macroalgal dominance to an algal crust state, but can also cause increases in the density of molluscan mesograzers. In this study, we tested the hypothesis that red urchins and lined chitons (Tonicella spp.) are redundant in the maintenance of available space, defined as encrusting algae and bare rock. In a factorial field experiment replicated at three sites, we reduced the densities of urchins and chitons on subtidal rock walls for nine months. The effects of grazers were interpreted in the context of natural temporal variation by monitoring the benthic community one year before, during, and after grazer removal. The removal of each grazer in isolation had no effect on the epilithic community, but the removal of both grazers caused an increase in sessile invertebrates. The increase was due primarily to clonal ascidians, which displayed a large (similar to 75%) relative increase in response to the removal of both grazers. However, the observed non-additive responses to grazer removal were temporary and smaller than seasonal fluctuations. Our data demonstrate that urchins and chitons can be redundant in the maintenance of available space, and highlight the value of drawing conclusions from experimental manipulations within an extended temporal context.	[Elahi, Robin; Sebens, Kenneth P.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA; [Elahi, Robin; Sebens, Kenneth P.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Sebens, Kenneth P.] Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA	University of Washington; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Elahi, R (corresponding author), Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA.	elahi.robin@gmail.com			Achievement Rewards for College Scientists foundation; Friday Harbor Laboratories; University of Washington Biology; National Science Foundation GK-12 [DGE 0742559]; NSF Biological Oceanography [OCE 0850809]; Division Of Ocean Sciences [0850809] Funding Source: National Science Foundation	Achievement Rewards for College Scientists foundation(General Electric); Friday Harbor Laboratories; University of Washington Biology; National Science Foundation GK-12(National Science Foundation (NSF)); NSF Biological Oceanography(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Achievement Rewards for College Scientists foundation (https://www.arcsfoundation.org), Friday Harbor Laboratories (http://depts.washington.edu/fhl/), University of Washington Biology (http://www.biology.washington.edu), National Science Foundation GK-12 (http://www.gk12.org; DGE 0742559), and NSF Biological Oceanography (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 11696; OCE 0850809) funded this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2011, ECOL LETT, V14, P1246, DOI 10.1111/j.1461-0248.2011.01694.x; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; ANDREW NL, 1993, MAR ECOL PROG SER, V99, P89, DOI 10.3354/meps099089; Babcock RC, 1999, MAR ECOL PROG SER, V189, P125, DOI 10.3354/meps189125; Barnes JR, 1972, ECOLOGY REPROD BIOL; Baynes TW, 1999, B MAR SCI, V64, P419; Bonaviri C, 2012, J SEA RES, V73, P18, DOI 10.1016/j.seares.2012.06.003; BREEN PA, 1976, MAR BIOL, V34, P137, DOI 10.1007/BF00390755; BREITBURG DL, 1984, ECOLOGY, V65, P1136, DOI 10.2307/1938321; Britton-Simmons KH, 2012, LIMNOL OCEANOGR, V57, P176, DOI 10.4319/lo.2012.57.1.0176; Bulleri F, 2002, MAR ECOL PROG SER, V243, P101, DOI 10.3354/meps243101; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; CAMUS PA, 1994, J EXP MAR BIOL ECOL, V184, P171, DOI 10.1016/0022-0981(94)90003-5; Carter SK, 2007, HYDROBIOLOGIA, V579, P233, DOI 10.1007/s10750-006-0403-x; Carter SK, 2002, FISH B-NOAA, V100, P662; Chapman ARO, 1981, MARINE BIOL, V62; Davidson AD, 2010, ECOLOGY, V91, P3189, DOI 10.1890/09-1277.1; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DEAN TA, 1984, MAR BIOL, V78, P301, DOI 10.1007/BF00393016; DEMOPULOS P A, 1975, Veliger, V18, P42; DETHIER MN, 1994, J EXP MAR BIOL ECOL, V177, P37, DOI 10.1016/0022-0981(94)90143-0; DETHIER MN, 1984, AM NAT, V124, P205, DOI 10.1086/284264; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; DUGGINS DO, 1985, OECOLOGIA, V67, P183, DOI 10.1007/BF00384282; Elahi R, 2012, MAR ECOL PROG SER, V452, P131, DOI 10.3354/meps09603; Goldberg NA, 2002, J EXP MAR BIOL ECOL, V278, P31, DOI 10.1016/S0022-0981(02)00334-9; Gonzalez MJ, 1997, FRESHWATER BIOL, V38, P179, DOI 10.1046/j.1365-2427.1997.00204.x; Grey EK, 2010, MAR ECOL PROG SER, V411, P89, DOI 10.3354/meps08645; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kelly JR, 2008, MAR ECOL PROG SER, V373, P1, DOI 10.3354/meps07746; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; LITTLER MM, 1995, ECOLOGY, V76, P1666, DOI 10.2307/1938167; Maechler M., 2011, LME4 LINEAR MIXED EF; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Miller RJ, 2008, ECOLOGY, V89, P452, DOI 10.1890/06-1099.1; Miller RJ, 2011, MAR ECOL PROG SER, V425, P153, DOI 10.3354/meps09025; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Nydam M, 2007, MAR ECOL PROG SER, V337, P93, DOI 10.3354/meps337093; Oksanen J., 2011, VEGAN COMMUNITY ECOL; PAINE RT, 1969, LIMNOL OCEANOGR, V14, P710, DOI 10.4319/lo.1969.14.5.0710; PAINE RT, 1984, ECOLOGY, V65, P1339, DOI 10.2307/1939114; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; R Core Team, 2021, R LANG ENV STAT COMP; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Scheibling RE, 2009, MAR ECOL PROG SER, V382, P113, DOI 10.3354/meps07965; SEBENS KP, 1986, ECOL MONOGR, V56, P73, DOI 10.2307/2937271; Sebens KP, 1986, ECOLOGY ROCKY COASTS, P346; Siddon CE, 2004, ECOLOGY, V85, P2938, DOI 10.1890/03-0519; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steinmetz J, 2008, ENVIRON BIOL FISH, V81, P51, DOI 10.1007/s10641-006-9165-6; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; STENECK RS, 1982, ECOLOGY, V63, P507, DOI 10.2307/1938967; Valentine JP, 2005, BOT MAR, V48, P106, DOI 10.1515/BOT.2005.025; VANCE RR, 1979, ECOLOGY, V60, P537, DOI 10.2307/1936074; WATANABE JM, 1991, MAR ECOL PROG SER, V71, P125, DOI 10.3354/meps071125; WITMAN JD, 1985, ECOL MONOGR, V55, P421, DOI 10.2307/2937130; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	59	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78969	10.1371/journal.pone.0078969	http://dx.doi.org/10.1371/journal.pone.0078969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250819	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200052
J	Mendes-Sousa, AF; Nascimento, AAS; Queiroz, DC; Vale, VF; Fujiwara, RT; Araujo, RN; Pereira, MH; Gontijo, NF				Mendes-Sousa, Antonio Ferreira; Sousa Nascimento, Alexandre Alves; Queiroz, Daniel Costa; Vale, Vladimir Fazito; Fujiwara, Ricardo Toshio; Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Gontijo, Nelder Figueiredo			Different Host Complement Systems and Their Interactions with Saliva from Lutzomyia longipalpis (Diptera, Psychodidae) and Leishmania infantum Promastigotes	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; ARTHROPOD SALIVA; IXODES TICKS; ENDEMIC AREA; RISK-FACTORS; HUMAN-SERUM; EPIDEMIOLOGY; MECHANISMS; PROTEINS; INFECTION	Background: Lutzomyia longipalpis is the vector of Leishmania infantum in the New World, and its saliva inhibits classical and alternative human complement system pathways. This inhibition is important in protecting the insect's midgut from damage by the complement. L. longipalpis is a promiscuous blood feeder and must be protected against its host's complement. The objective of this study was to investigate the action of salivary complement inhibitors on the sera of different host species, such as dogs, guinea pigs, rats and chickens, at a pH of 7.4 (normal blood pH) and 8.15 (the midgut pH immediately after a blood meal). We also investigated the role of the chicken complement system in Leishmania clearance in the presence and absence of vector saliva. Results: The saliva was capable of inhibiting classical pathways in dogs, guinea pigs and rats at both pHs. The alternative pathway was not inhibited except in dogs at a pH of 8.15. The chicken classical pathway was inhibited only by high concentrations of saliva and it was better inhibited by the midgut contents of sand flies. Neither the saliva nor the midgut contents had any effect on the avian alternative pathway. Fowl sera killed L. infantum promastigotes, even at a low concentration (2%), and the addition of L. longipalpis saliva did not protect the parasites. The high body temperature of chickens (40 degrees C) had no effect on Leishmania viability during our assays. Conclusion: Salivary inhibitors act in a species-specific manner. It is important to determine their effects in the natural hosts of Leishmania infantum because they act on canid and rodent complements but not on chickens (which do not harbour the parasite). Moreover, we concluded that the avian complement system is the probable mechanism through which chickens eliminate Leishmania and that their high body temperature does not influence this parasite.	[Mendes-Sousa, Antonio Ferreira; Sousa Nascimento, Alexandre Alves; Queiroz, Daniel Costa; Vale, Vladimir Fazito; Fujiwara, Ricardo Toshio; Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Gontijo, Nelder Figueiredo] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Gontijo, NF (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.	nelder@icb.ufmg.br	Araujo, Ricardo N/O-1967-2017; Gontijo, Nelder F/D-2539-2013; Pereira, Marcos Horácio/AAE-7076-2021; Fujiwara, Ricardo Toshio/J-7579-2012; Pereira, Marcos H/A-3774-2012	Araujo, Ricardo N/0000-0002-1272-4386; Gontijo, Nelder F/0000-0003-3357-2497; Pereira, Marcos Horácio/0000-0003-4843-0088; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Pereira, Marcos H/0000-0003-4843-0088; Queiroz, Daniel Costa/0000-0002-6607-8818	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; INCT Entomologia Molecular; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT Entomologia Molecular; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, INCT Entomologia Molecular, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Barata RA, 2005, REV SOC BRAS MED TRO, V38, P421, DOI 10.1590/S0037-86822005000500012; Barros VC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006047; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caldas AJM, 2002, T ROY SOC TROP MED H, V96, P21, DOI 10.1016/S0035-9203(02)90227-0; Catty D., 1988, ANTIBODIES, V1, P19; Cavalcante RR, 2003, PARASITOLOGY, V127, P87, DOI 10.1017/S0031182003003329; Couvreur B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001400; Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; Dantas-Torres Filipe, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P151, DOI 10.1590/S0036-46652006000300007; Dominguez M, 2002, J EXP MED, V195, P451, DOI 10.1084/jem.20011319; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Gomes RB, 2007, T ROY SOC TROP MED H, V101, P127, DOI 10.1016/j.trstmh.2006.06.002; HOOVER DL, 1985, INFECT IMMUN, V47, P247, DOI 10.1128/IAI.47.1.247-252.1985; Kamhawi S, 2000, MICROBES INFECT, V2, P1765, DOI 10.1016/S1286-4579(00)01331-9; KIERSZENBAUM F, 1976, IMMUNOLOGY, V30, P1; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lawrie CH, 1999, EXP PARASITOL, V93, P207, DOI 10.1006/expr.1999.4456; Lawrie CH, 2005, MOL IMMUNOL, V42, P31, DOI 10.1016/j.molimm.2004.07.001; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Mika A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040489; Mika A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001331; MILNE A, 1949, PARASITOLOGY, V39, P173, DOI 10.1017/S0031182000083736; MODI GB, 1983, J MED ENTOMOL, V20, P568, DOI 10.1093/jmedent/20.5.568; Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393; OLSZEWSKI WL, 1978, CLIN EXP IMMUNOL, V32, P392; Otranto D, 2010, ACTA TROP, V113, P80, DOI 10.1016/j.actatropica.2009.09.014; PEARSON RD, 1980, J IMMUNOL, V125, P2195; Quaresma PF, 2011, T ROY SOC TROP MED H, V105, P579, DOI 10.1016/j.trstmh.2011.07.005; REZAI HR, 1975, ANN TROP MED PARASIT, V69, P29, DOI 10.1080/00034983.1975.11686981; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; Sant'Anna MRV, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-3; Santos VC, 2008, J EXP BIOL, V211, P2792, DOI 10.1242/jeb.019836; Schlein Y., 1994, Bulletin of the Society for Vector Ecology, V19, P82; Schroeder H, 2009, DEV COMP IMMUNOL, V33, P5, DOI 10.1016/j.dci.2008.07.010; Schroeder H, 2007, MICROBES INFECT, V9, P247, DOI 10.1016/j.micinf.2006.10.020; Soares AC, 2006, J INSECT PHYSIOL, V52, P468, DOI 10.1016/j.jinsphys.2006.01.003; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	46	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79787	10.1371/journal.pone.0079787	http://dx.doi.org/10.1371/journal.pone.0079787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255715	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200087
J	Terrazas, PM; Marques, ED; Mariano, LNB; Cechinel, V; Niero, R; Andrade, SF; Maistro, EL				Terrazas, Peterson Menezes; Marques, Eduardo de Souza; Bolda Mariano, Luisa Nathalia; Cechinel-Filho, Valdir; Niero, Rivaldo; Andrade, Sergio Faloni; Maistro, Edson Luis			Benzophenone guttiferone A from Garcinia achachairu Rusby (Clusiaceae) Presents Genotoxic Effects in Different Cells of Mice	PLOS ONE			English	Article							COMET ASSAY; IN-VIVO; POLYISOPRENYLATED BENZOPHENONES; GEL TEST; SUBELLIPTICA; XANTHONES; CONDUCT; SEEDS	Benzophenones from natural sources and those of synthetic analogues present several reports of potent biological properties, and Guttiferone A represents a promising medicinal natural compound with analgesic and gastroprotective profiles. Considering that there are no reports that assess the genetic toxicity of Guttiferone A, the present study was undertaken to investigate the genotoxic potential of this benzophenone isolated from seeds of Garcinia achachairu in terms of DNA damage in different cells of Swiss albino mice using the comet assay, and its clastogenic/aneugenic effects in bone marrow cells in vivo by the micronucleus test. Cytotoxicity was assessed by scoring polychromatic (PCE) and normochromatic (NCE) erythrocytes ratio. Guttiferone A was administered by oral gavage at doses of 15, 30 and 60 mg/kg. The results showed that Guttiferone A produced genotoxic effects in leukocytes, liver, bone marrow, brain and testicle cells and clastogenic/aneugenic effects in bone marrow erythrocytes of mice. The PCE/NCE ratio indicated no cytotoxicity. Since guttiferone A is harmful to the genetic material we suggest caution in its use by humans.	[Terrazas, Peterson Menezes; Marques, Eduardo de Souza; Maistro, Edson Luis] Univ Estadual Paulista, UNESP, Fac Filosofia & Ciencias, Dept Fonoaudiol, Marilia, SP, Brazil; [Bolda Mariano, Luisa Nathalia; Cechinel-Filho, Valdir; Niero, Rivaldo; Andrade, Sergio Faloni] Univ Vale Itajai, UNIVALI, Nucleo Invest Quim Farmaceut, Programa Posgrad Ciencias Farmaceut, Itajai, SC, Brazil	Universidade Estadual Paulista; Universidade do Vale do Itajai	Maistro, EL (corresponding author), Univ Estadual Paulista, UNESP, Fac Filosofia & Ciencias, Dept Fonoaudiol, Marilia, SP, Brazil.	edson.maistro@marilia.unesp.br	Filho, Valdir Cechinel/H-4920-2011; Maistro, Edson/AAQ-7262-2020; Niero, Rivaldo/N-9480-2017; Maistro, Edson/B-3060-2015; de Souza Marques, Eduardo/F-5466-2012; Andrade, Sergio/AAD-9888-2019	Maistro, Edson/0000-0003-0757-7876; Maistro, Edson/0000-0003-0757-7876; de Souza Marques, Eduardo/0000-0002-8249-6817; Andrade, Sergio/0000-0001-9294-7290; Bolda Mariano, Luisa Nathalia/0000-0002-6846-1781	FAPESP, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/17241-8]; Universidade Estadual Paulista, UNESP; CAPES	FAPESP, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Universidade Estadual Paulista, UNESP; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPESP, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant 2012/17241-8) and Universidade Estadual Paulista, UNESP. P.M. Terrazas had CAPES Master's scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna UM, 2009, CURR TOP MED CHEM, V9, P1560, DOI 10.2174/156802609789909830; Almanza GR, 2011, NAT PROD COMMUN, V6, P1269; Alves TMD, 2000, MEM I OSWALDO CRUZ, V95, P367, DOI 10.1590/S0074-02762000000300012; AMPOFO SA, 1986, PHYTOCHEMISTRY, V25, P2617, DOI 10.1016/S0031-9422(00)84521-5; Barbosa W., 2007, FRUTA ACHACHAIRU; Barbosa W, 2008, REV BRAS FRUTIC, V30, P263, DOI 10.1590/S0100-29452008000100049; Beerhues L, 1996, FEBS LETT, V383, P264, DOI 10.1016/0014-5793(96)00265-7; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; Dal Molin MM, 2012, ARCH PHARM RES, V35, P623, DOI 10.1007/s12272-012-0405-3; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; GOLLAPUDI BB, 1995, MUTAT RES LETT, V347, P97; Hartmann A, 1997, TOXICOL LETT, V90, P183, DOI 10.1016/S0378-4274(96)03847-7; International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1997, GEN STAND BATT GEN T; Kada T., 1982, ENV MUTAGENESIS CARC, VVolume 1, P137; Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2; MACGREGOR JT, 1987, MUTAT RES, V189, P103, DOI 10.1016/0165-1218(87)90016-4; Marques ED, 2012, J ETHNOPHARMACOL, V142, P362, DOI 10.1016/j.jep.2012.04.045; Molin M.M.D., 2012, ARCH PHARM RES, V35, P623, DOI DOI 10.1007/S12272-012-0405-3.PUBMED:22553054; Niero R, 2012, N-S ARCH PHARMACOL, V385, P1103, DOI 10.1007/s00210-012-0788-1; Schmid W., 1976, MUTAT RES, V31, P9; Smith CC, 2008, MUTAGENESIS, V23, P233, DOI 10.1093/mutage/gen008; Speit G, 1999, METH MOL B, V113, P203; Wu CC, 2005, J NAT PROD, V68, P1125, DOI 10.1021/np050084v; Wu CC, 2008, J NAT PROD, V71, P246, DOI 10.1021/np070507o	24	18	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e76485	10.1371/journal.pone.0076485	http://dx.doi.org/10.1371/journal.pone.0076485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250785	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200006
J	Vizza, D; Perri, A; Lofaro, D; Toteda, G; Lupinacci, S; Leone, F; Gigliotti, P; Papalia, T; Bonofiglio, R				Vizza, Donatella; Perri, Anna; Lofaro, Danilo; Toteda, Giuseppina; Lupinacci, Simona; Leone, Francesca; Gigliotti, Paolo; Papalia, Teresa; Bonofiglio, Renzo			Exposure to Nerve Growth Factor Worsens Nephrotoxic Effect Induced by Cyclosporine A in HK-2 Cells	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; TRANSCRIPTION FACTORS; P21WAF1 EXPRESSION; UP-REGULATION; NITRIC-OXIDE; CALCINEURIN; APOPTOSIS; INHIBITOR; PATHWAY; MODEL	Nerve growth factor is a neurotrophin that promotes cell growth, differentiation, survival and death through two different receptors: TrkA(NTR) and p75(NTR). Nerve growth factor serum concentrations increase during many inflammatory and autoimmune diseases, glomerulonephritis, chronic kidney disease, end-stage renal disease and, particularly, in renal transplant. Considering that nerve growth factor exerts beneficial effects in the treatment of major central and peripheral neurodegenerative diseases, skin and corneal ulcers, we asked whether nerve growth factor could also exert a role in Cyclosporine A-induced graft nephrotoxicity. Our hypothesis was raised from basic evidence indicating that Cyclosporine A-inhibition of calcineurin-NFAT pathway increases nerve growth factor expression levels. Therefore, we investigated the involvement of nerve growth factor and its receptors in the damage exerted by Cyclosporine A in tubular renal cells, HK-2. Our results showed that in HK-2 cells combined treatment with Cyclosporine A + nerve growth factor induced a significant reduction in cell vitality concomitant with a down-regulation of Cyclin D1 and up-regulation of p21 levels respect to cells treated with Cyclosporine A alone. Moreover functional experiments showed that the co-treatment significantly up-regulated human p21promoter activity by involvement of the Sp1 transcription factor, whose nuclear content was negatively regulated by activated NFATc1. In addition we observed that the combined exposure to Cyclosporine A + nerve growth factor promoted an up-regulation of p75 (NTR) and its target genes, p53 and BAD leading to the activation of intrinsic apoptosis. Finally, the chemical inhibition of p75(NTR) down-regulated the intrinsic apoptotic signal. We describe two new mechanisms by which nerve growth factor promotes growth arrest and apoptosis in tubular renal cells exposed to Cyclosporine A.	[Vizza, Donatella; Perri, Anna; Lofaro, Danilo; Toteda, Giuseppina; Lupinacci, Simona; Leone, Francesca; Gigliotti, Paolo; Papalia, Teresa; Bonofiglio, Renzo] Annunziata Hosp, Dept Nephrol Dialysis & Transplantat, Kidney & Transplantat Res Ctr, Cosenza, Italy		Bonofiglio, R (corresponding author), Annunziata Hosp, Dept Nephrol Dialysis & Transplantat, Kidney & Transplantat Res Ctr, Cosenza, Italy.	rbonofi@gmail.com	Perri, Anna/AAC-9203-2020; Lofaro, Danilo/J-8687-2016	Perri, Anna/0000-0002-2852-0919; Lofaro, Danilo/0000-0002-2081-463X	Associazione Sud Italia Trapiantati	Associazione Sud Italia Trapiantati	The study was supported by "Associazione Sud Italia Trapiantati": http://www.asitonline.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Asai K, 2006, LIVER INT, V26, P595, DOI 10.1111/j.1478-3231.2006.01267.x; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bonofiglio R, 2007, J NEPHROL, V20, P186; Caporali A, 2008, CIRC RES, V103, pE15, DOI 10.1161/CIRCRESAHA.108.177386; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cui YX, 2011, TOXICOL SCI, V124, P23, DOI 10.1093/toxsci/kfr217; Fang ZY, 2007, J CELL BIOCHEM, V101, P654, DOI 10.1002/jcb.21223; Frimat L, 2006, AM J TRANSPLANT, V6, P2725, DOI 10.1111/j.1600-6143.2006.01535.x; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gigliotti P, 2013, TRANSPL P; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoorn EJ, 2012, J NEPHROL, V25, P269, DOI 10.5301/jn.5000174; Ibanez CF, 2002, TRENDS NEUROSCI, V25, P284, DOI 10.1016/S0166-2236(02)02169-0; Imbschweiler I, 2012, GLIA, V60, P358, DOI 10.1002/glia.22270; Khanna AK, 2005, J IMMUNOL, V174, P7610, DOI 10.4049/jimmunol.174.12.7610; Lee JH, 2011, CORNEA, V30, pS19, DOI 10.1097/ICO.0b013e3182281028; Liu BC, 2013, AM J PHYSIOL-RENAL, V305, pF304, DOI 10.1152/ajprenal.00074.2013; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; McMorrow T, 2005, NEPHROL DIAL TRANSPL, V20, P2215, DOI 10.1093/ndt/gfh967; Micera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047316; Moon SK, 2006, BIOCHEM BIOPH RES CO, V350, P662, DOI 10.1016/j.bbrc.2006.09.092; Mufson EJ, 2002, J COMP NEUROL, V443, P136, DOI 10.1002/cne.10122; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nam HK, 2013, AM J NEPHROL, V37, P7, DOI 10.1159/000345990; Pereira MJ, 2013, MOL CELL ENDOCRINOL, V365, P260, DOI 10.1016/j.mce.2012.10.030; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Ponticelli C, 2005, ANN NY ACAD SCI, V1051, P551, DOI 10.1196/annals.1361.099; Rana OR, 2009, J MOL CELL CARDIOL, V46, P568, DOI 10.1016/j.yjmcc.2008.12.006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schmidt A, 2001, NEPHROL DIAL TRANSPL, V16, P1034, DOI 10.1093/ndt/16.5.1034; Truzzi F, 2011, CELL DEATH DIFFER, V18, P948, DOI 10.1038/cdd.2010.162; Tvrdik D, 2006, MED SCI MONITOR, V12, pBR227; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Viola JPB, 2005, BRAZ J MED BIOL RES, V38, P335, DOI 10.1590/S0100-879X2005000300003; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200; Williams D, 2006, ADV CHRONIC KIDNEY D, V13, P47, DOI 10.1053/j.ackd.2005.11.001; Xiao Z, 2013, AM J NEPHROL, V37, P30, DOI 10.1159/000345988; Zhu ZW, 2003, DIGEST DIS SCI, V48, P717, DOI 10.1023/A:1022880524395	41	17	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80113	10.1371/journal.pone.0080113	http://dx.doi.org/10.1371/journal.pone.0080113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244623	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900062
J	Bruntz, RC; Taylor, HE; Lindsley, CW; Brown, HA				Bruntz, Ronald C.; Taylor, Harry E.; Lindsley, Craig W.; Brown, H. Alex			Phospholipase D-2 Mediates Survival Signaling through Direct Regulation of Akt in Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PROTEIN-KINASE; PHOSPHATIDIC-ACID; INDUCED CYTOTOXICITY; BECLIN 1; AUTOPHAGY; GLIOMA; INHIBITION; EXPRESSION; AKT/PKB	The lack of innovative drug targets for glioblastoma multiforme (GBM) limits patient survival to approximately 1 year following diagnosis. The pro-survival kinase Akt provides an ideal target for the treatment of GBM as Akt signaling is frequently activated in this cancer type. However, the central role of Akt in physiological processes limits its potential as a therapeutic target. In this report, we show that the lipid-metabolizing enzyme phospholipase D (PLD) is a novel regulator of Akt in GBM. Studies using a combination of small molecule PLD inhibitors and siRNA knockdowns establish phosphatidic acid, the product of the PLD reaction, as an essential component for the membrane recruitment and activation of Akt. Inhibition of PLD enzymatic activity and subsequent Akt activation decreases GBM cell viability by specifically inhibiting autophagic flux. We propose a mechanism whereby phosphorylation of beclin1 by Akt prevents binding of Rubicon (RUN domain cysteine-rich domain containing beclin1-interacting protein), an interaction known to inhibit autophagic flux. These findings provide a novel framework through which Akt inhibition can be achieved without directly targeting the kinase.	[Bruntz, Ronald C.; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Taylor, Harry E.] Vanderbilt Univ Sch Med, Dept Med, Nashville, TN 37232 USA; [Lindsley, Craig W.] Vanderbilt Univ Sch Med, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Inst Chem Biol, Dept Chem, Nashville, TN 37232 USA; [Lindsley, Craig W.] Vanderbilt Specialized Chem Accelerated Probe Dev, Nashville, TN 37232 USA; [Brown, H. Alex] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Brown, H. Alex] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Brown, HA (corresponding author), Vanderbilt Univ Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Dept Pharmacol, 2220 Pierce Ave South, Nashville, TN 37232 USA.	alex.brown@vanderbilt.edu			National Institutes of Health from NIEHS [P01-ES013125]; McDonnell Foundation for Brain Cancer Research;  [U54 MH084659]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; McDonnell Foundation for Brain Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-ES013125 from NIEHS and Grant U54 MH084659. This work was also supported by the McDonnell Foundation for Brain Cancer Research, a Lai Sulin scholarship (to R. C. B.), and a Bixler-Johnson-Mayes Endowed Chair (to H. A. B.).	Ahn BH, 2003, MOL CELL BIOL, V23, P3103, DOI 10.1128/MCB.23.9.3103-3115.2003; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carlson R. H., 2013, ONCOLOGY TIMES, V35, P46; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Cheng CK, 2009, BRAIN PATHOL, V19, P112, DOI 10.1111/j.1750-3639.2008.00233.x; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Di Fulvio M, 2008, CELL SIGNAL, V20, P176, DOI 10.1016/j.cellsig.2007.10.009; Dowler S., 2002, SCI STKE, V2002, P16; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Edwards JL, 2006, CELL MICROBIOL, V8, P1253, DOI 10.1111/j.1462-5822.2006.00707.x; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Giannone RJ, 2007, BIOTECHNIQUES, V43, P296, DOI 10.2144/000112550; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kumar CC, 2001, BBA-GEN SUBJECTS, V1526, P257, DOI 10.1016/S0304-4165(01)00143-X; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Patel S, 2010, J BIOL CHEM, V285, P32055, DOI 10.1074/jbc.M110.171058; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scott SA, 2013, J BIOL CHEM, V288, P20477, DOI 10.1074/jbc.M113.451708; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	81	46	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					600	616		10.1074/jbc.M113.532978	http://dx.doi.org/10.1074/jbc.M113.532978			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24257753	Green Published, hybrid			2022-12-25	WOS:000330541200002
J	He, QH; Xu, HP; Wang, P; Tian, N				He, Quanhua; Xu, Hong-ping; Wang, Ping; Tian, Ning			Dopamine D1 Receptors Regulate the Light Dependent Development of Retinal Synaptic Responses	PLOS ONE			English	Article							AII AMACRINE CELLS; INNER PLEXIFORM LAYER; RABBIT RETINA; OSCILLATORY POTENTIALS; POSTNATAL-DEVELOPMENT; RAT RETINA; MAMMALIAN RETINA; HORIZONTAL CELLS; B-WAVE; ENDOGENOUS DOPAMINE	Retinal synaptic connections and function are developmentally regulated. Retinal synaptic activity plays critical roles in the development of retinal synaptic circuitry. Dopamine receptors have been thought to play important roles in the activity-dependent synaptic plasticity in central nervous system. The primary goal of this study is to determine whether dopamine D1 receptor regulates the activity-dependent development of retinal light responsiveness. Accordingly, we recorded electroretinogram from wild type mice and mice with genetic deletion of D1 dopamine receptor (D1 -/- mice) raised under cyclic light conditions and constant darkness. Our results demonstrated that D1 -/- mice have reduced amplitudes of all three major components of electroretinogram in adulthood. When the relative strength of the responses is considered, the D1 -/- mice have selective reduction of the amplitudes of a-wave and oscillatory potentials evoked by low-intermediate intensities of lights. During postnatal development, D1 -/- mice have increased amplitude of b-wave at the time of eye-opening but reduced developmental increase of the amplitude of b-wave after eye opening. Light deprivation from birth significantly reduced the amplitudes of b-wave and oscillatory potentials, increased the outer retinal light response gain and altered the light response kinetics of both a-and b-waves of wild type mice. In D1 -/- mice, the effect of dark rearing on the amplitude of oscillatory potentials was diminished and dark rearing induced effects on the response gain of outer retina and the kinetics of a-wave were reversed. These results demonstrated roles of dopamine D1 receptor in the activity-dependent functional development of mouse retina.	[He, Quanhua] Ohio State Univ, Coll Pharm, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Xu, Hong-ping] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Wang, Ping; Tian, Ning] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA	University System of Ohio; Ohio State University; Yale University; Utah System of Higher Education; University of Utah	Tian, N (corresponding author), Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA.	ning.tian@hsc.utah.edu			National Natural Science Foundation of China [61370150, 91024026]; Sichuan Provincial Science and Technology Department [2012FZ0120]; Sino-Swiss Science and Technology Cooperation Program [EG57-092011]; Program of Outstanding PhD Candidate in Academic Research by UESTC [YBXSZC20131029]; NATIONAL EYE INSTITUTE [R01EY012345, P30EY014800] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Provincial Science and Technology Department; Sino-Swiss Science and Technology Cooperation Program; Program of Outstanding PhD Candidate in Academic Research by UESTC; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by the National Natural Science Foundation of China (Grant Nos. 61370150 and 91024026), the Sichuan Provincial Science and Technology Department (Grant No. 2012FZ0120). W.Z. acknowledges the support from Sino-Swiss Science and Technology Cooperation Program (EG57-092011) and the Program of Outstanding PhD Candidate in Academic Research by UESTC (YBXSZC20131029). A.Z. acknowledges the support from China scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABKOFF H, 1977, ANN OPHTHALMOL, V9, P1535; BABKOFF H, 1975, Annals of Ophthalmology, V7, P1335; BALDRIDGE WH, 1995, VISUAL NEUROSCI, V12, P611, DOI 10.1017/S0952523800008907; BAXTER BL, 1961, SCIENCE, V134, P1626, DOI 10.1126/science.134.3490.1626; Ben-Shlomo G, 2006, EXP EYE RES, V83, P417, DOI 10.1016/j.exer.2006.01.020; Bloomfield SA, 1997, VISUAL NEUROSCI, V14, P565, DOI 10.1017/S0952523800012220; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; BRAEKEVELT CR, 1970, AM J ANAT, V127, P281, DOI 10.1002/aja.1001270305; BRETON ME, 1995, INVEST OPHTH VIS SCI, V36, P1588; Bui BV, 1999, DOC OPHTHALMOL, V99, P151, DOI 10.1023/A:1002721315955; Chergui K, 2011, NEUROPHARMACOLOGY, V60, P975, DOI 10.1016/j.neuropharm.2011.01.047; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; Di Marco S, 2009, J NEUROSCI, V29, P13691, DOI 10.1523/JNEUROSCI.3854-09.2009; Dowling J. E., 2012, RETINA; Edelmann E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00025; ELAZAZI M, 1991, ACTA OPHTHALMOL, V69, P505; ELAZAZI M, 1991, ACTA OPHTHALMOL, V69, P6; ELAZAZI M, 1990, ACTA OPHTHALMOL, V68, P401; FISHER LJ, 1979, J EMBRYOL EXP MORPH, V54, P219; FloresGuevara R, 1996, EVOKED POTENTIAL, V100, P422; Fujikado T, 1996, CURR EYE RES, V15, P79, DOI 10.3109/02713689609017614; Giovannelli A, 2008, BIOCHEM BIOPH RES CO, V365, P349, DOI 10.1016/j.bbrc.2007.10.204; GODLEY BF, 1988, BRAIN RES, V452, P393, DOI 10.1016/0006-8993(88)90046-7; GORFINKEL J, 1988, DOC OPHTHALMOL, V69, P237, DOI 10.1007/BF00154404; GORFINKEL J, 1990, CAN J OPHTHALMOL, V25, P138; Guenther E, 2004, FASEB J, V18, P1433, DOI 10.1096/fj.03-0618fje; HAMASAKI DI, 1985, VISION RES, V25, P1537, DOI 10.1016/0042-6989(85)90124-5; Hamilton R, 2005, EARLY HUM DEV, V81, P461, DOI 10.1016/j.earlhumdev.2004.10.019; He QH, 2011, EUR J NEUROSCI, V33, P36, DOI 10.1111/j.1460-9568.2010.07484.x; HENSLER JG, 1986, BRAIN RES, V398, P407, DOI 10.1016/0006-8993(86)91506-4; HENSLER JG, 1987, J PHARMACOL EXP THER, V243, P857; Herrmann R, 2011, NEURON, V72, P101, DOI 10.1016/j.neuron.2011.07.030; Herwerth M, 2012, CEREB CORTEX, V22, P1786, DOI 10.1093/cercor/bhr275; HOLOPIGIAN K, 1994, DOC OPHTHALMOL, V86, P1, DOI 10.1007/BF01224623; Huppe-Gourgues F, 2005, VISION RES, V45, P137, DOI 10.1016/j.visres.2004.08.001; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Kim DY, 2012, KOREAN J PHYSIOL PHA, V16, P219, DOI 10.4196/kjpp.2012.16.3.219; KIRK GR, 1973, EXP NEUROL, V38, P252, DOI 10.1016/0014-4886(73)90149-0; KIRSCH M, 1991, VISION RES, V31, P401, DOI 10.1016/0042-6989(91)90093-K; KIRSCH M, 1989, VISION RES, V29, P147, DOI 10.1016/0042-6989(89)90120-X; Klitten LL, 2008, EXP EYE RES, V87, P471, DOI 10.1016/j.exer.2008.08.004; Kobayashi Akira, 1996, Nippon Ganka Gakkai Zasshi, V100, P111; Kothmann WW, 2009, J NEUROSCI, V29, P14903, DOI 10.1523/JNEUROSCI.3436-09.2009; Kothmann WW, 2008, INVEST OPHTH VIS SCI, V49, P1515; KRAMER SG, 1971, INVEST OPHTH VISUAL, V10, P438; KRATZ KE, 1979, BRAIN RES, V172, P545, DOI 10.1016/0006-8993(79)90586-9; LANKFORD K, 1987, NEUROSCI LETT, V75, P169, DOI 10.1016/0304-3940(87)90292-8; LASATER EM, 1987, P NATL ACAD SCI USA, V84, P7319, DOI 10.1073/pnas.84.20.7319; Lavoie J, 2013, BIOL PSYCHIAT, VS0006-3223, P01032; Lee EJ, 2006, EUR J NEUROSCI, V24, P2118, DOI 10.1111/j.1460-9568.2006.05078.x; Lorenc-Duda A, 2009, J MOL NEUROSCI, V38, P12, DOI 10.1007/s12031-008-9153-8; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; Melamed E, 1986, Brain Res, V391, P280; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; Mills SL, 2007, VISUAL NEUROSCI, V24, P593, DOI 10.1017/S0952523807070575; Miranda-Anaya M, 2002, J BIOL RHYTHM, V17, P526, DOI 10.1177/0748730402238235; Nguyen-Legros J, 1999, MOL NEUROBIOL, V19, P181, DOI 10.1007/BF02821713; Nir I, 2002, J NEUROSCI, V22, P2063, DOI 10.1523/JNEUROSCI.22-06-02063.2002; OLIVIER P, 1987, DOC OPHTHALMOL, V66, P359, DOI 10.1007/BF00213664; Parness-Yossifon R, 2008, CURR OPIN OPHTHALMOL, V19, P398, DOI 10.1097/ICU.0b013e32830abf11; PFEIFFERLINN C, 1993, J GEN PHYSIOL, V102, P277, DOI 10.1085/jgp.102.2.277; Popova E, 2011, VISION RES, V51, P1627, DOI 10.1016/j.visres.2011.05.005; REUTER JH, 1976, PFLUG ARCH EUR J PHY, V363, P7, DOI 10.1007/BF00587395; Sandalon S, 2012, INVEST OPHTH VIS SCI, V53, P6532, DOI 10.1167/iovs.12-10103; Saszik S, 2001, INT J DEV NEUROSCI, V19, P611, DOI 10.1016/S0736-5748(01)00051-X; SCHNEIDER T, 1991, EXP EYE RES, V52, P425, DOI 10.1016/0014-4835(91)90038-G; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; SEVERNS ML, 1994, DOC OPHTHALMOL, V86, P23, DOI 10.1007/BF01224625; Shelke RRJ, 1997, INT J DEV NEUROSCI, V15, P139, DOI 10.1016/S0736-5748(96)00080-9; SHERMAN SM, 1973, BRAIN RES, V60, P224, DOI 10.1016/0006-8993(73)90861-5; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; SOSULA L, 1971, J COMP NEUROL, V141, P427, DOI 10.1002/cne.901410403; SPIRA AW, 1991, DEV BRAIN RES, V62, P142, DOI 10.1016/0165-3806(91)90200-3; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; STONE RA, 1990, CIBA F SYMP, V155, P45; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Surmeier DJ, 2011, NEUROSCIENCE, V198, P3, DOI 10.1016/j.neuroscience.2011.08.051; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Surmeier DJ, 2010, PROG BRAIN RES, V183, P149, DOI 10.1016/S0079-6123(10)83008-0; TIAN N, 1995, VISION RES, V35, P1359, DOI 10.1016/0042-6989(95)98715-L; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; TOOTLE JS, 1993, J NEUROPHYSIOL, V69, P1645, DOI 10.1152/jn.1993.69.5.1645; TUCKER GS, 1982, EXP BRAIN RES, V48, P263; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; Van Hook MJ, 2012, EUR J NEUROSCI, V35, P507, DOI 10.1111/j.1460-9568.2011.07975.x; Vaquero CF, 2001, J NEUROSCI, V21, P8624, DOI 10.1523/JNEUROSCI.21-21-08624.2001; Vistamehr S, 2004, VISUAL NEUROSCI, V21, P23, DOI 10.1017/S0952523804041033; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; WACHTMEISTER L, 1978, INVEST OPHTH VIS SCI, V17, P1176; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; WAGNER HJ, 1993, TRENDS NEUROSCI, V16, P201, DOI 10.1016/0166-2236(93)90155-F; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; WEIDMAN TA, 1969, INVEST OPHTH VISUAL, V8, P60; WEIDMAN TA, 1968, ARCH OPHTHALMOL-CHIC, V79, P470, DOI 10.1001/archopht.1968.03850040472015; Weiler R, 1997, VISUAL NEUROSCI, V14, P351, DOI 10.1017/S0952523800011470; Westall CA, 1999, DOC OPHTHALMOL, V96, P355, DOI 10.1023/A:1001856911730; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; WINGATE RJT, 1994, J NEUROSCI, V14, P6621; Wolf ME, 2010, NEUROTOX RES, V18, P393, DOI 10.1007/s12640-010-9176-0; WOODS JR, 1983, AM J OBSTET GYNECOL, V145, P738, DOI 10.1016/0002-9378(83)90583-5; Wu ML, 2007, BRAIN RES, V1170, P13, DOI 10.1016/j.brainres.2007.06.091; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058; Xin DY, 1999, J COMP NEUROL, V405, P75, DOI 10.1002/(SICI)1096-9861(19990301)405:1<75::AID-CNE6>3.0.CO;2-D; Xing B, 2010, NEUROSCIENCE, V169, P1511, DOI 10.1016/j.neuroscience.2010.06.034; Xu HP, 2007, J COMP NEUROL, V503, P244, DOI 10.1002/cne.21379; Xu TX, 2010, P NATL ACAD SCI USA, V107, P16366, DOI 10.1073/pnas.1004108107; Xue J, 2001, MOL BRAIN RES, V93, P95, DOI 10.1016/S0169-328X(01)00168-1; Xue J, 2001, MOL BRAIN RES, V91, P196, DOI 10.1016/S0169-328X(01)00141-3; Zhang AJ, 2011, J COMP NEUROL, V519, P2125, DOI 10.1002/cne.22604; Zhou XH, 2010, DOC OPHTHALMOL, V121, P205, DOI 10.1007/s10633-010-9248-8; Zhu GQ, 2012, J NEUROCHEM, V122, P582, DOI 10.1111/j.1471-4159.2012.07815.x	112	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79625	10.1371/journal.pone.0079625	http://dx.doi.org/10.1371/journal.pone.0079625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260267	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900038
J	Jones, RM; Chichester, JA; Mett, V; Jaje, J; Tottey, S; Manceva, S; Casta, LJ; Gibbs, SK; Musiychuk, K; Shamloul, M; Norikane, J; Mett, V; Streatfield, SJ; van de Vegte-Bolmer, M; Roeffen, W; Sauerwein, RW; Yusibov, V				Jones, R. Mark; Chichester, Jessica A.; Mett, Vadim; Jaje, Jennifer; Tottey, Stephen; Manceva, Slobodanka; Casta, Louis J.; Gibbs, Sandra K.; Musiychuk, Konstantin; Shamloul, Moneim; Norikane, Joey; Mett, Valentina; Streatfield, Stephen J.; van de Vegte-Bolmer, Marga; Roeffen, Will; Sauerwein, Robert W.; Yusibov, Vidadi			A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice	PLOS ONE			English	Article							AERUGINOSA EXOPROTEIN-A; ALFALFA MOSAIC-VIRUS; PROTECTS FERRETS; PICHIA-PASTORIS; SUBUNIT VACCINE; SEXUAL STAGES; IMMUNOGENICITY; EXPRESSION; INFECTION; PARTICLES	Malaria transmission blocking vaccines (TBVs) are considered an effective means to control and eventually eliminate malaria. The Pfs25 protein, expressed predominantly on the surface of the sexual and sporogonic stages of Plasmodium falciparum including gametes, zygotes and ookinetes, is one of the primary targets for TBV. It has been demonstrated that plants are an effective, highly scalable system for the production of recombinant proteins, including virus-like particles (VLPs). We engineered VLPs (Pfs25-CP VLP) comprising Pfs25 fused to the Alfalfa mosaic virus coat protein (CP) and produced these non-enveloped hybrid VLPs in Nicotiana benthamiana plants using a Tobacco mosaic virus-based 'launch' vector. Purified Pfs25-CP VLPs were highly consistent in size (19.3 +/- 2.4 nm in diameter) with an estimated 20-30% incorporation of Pfs25 onto the VLP surface. Immunization of mice with one or two doses of Pfs25-CP VLPs plus Alhydrogel (R) induced serum antibodies with complete transmission blocking activity through the 6 month study period. These results support the evaluation of Pfs25-CP VLP as a potential TBV candidate and the feasibility of the 'launch' vector technology for the production of VLP-based recombinant vaccines against infectious diseases.	[Jones, R. Mark; Chichester, Jessica A.; Mett, Vadim; Jaje, Jennifer; Tottey, Stephen; Manceva, Slobodanka; Casta, Louis J.; Gibbs, Sandra K.; Musiychuk, Konstantin; Shamloul, Moneim; Norikane, Joey; Mett, Valentina; Streatfield, Stephen J.; Yusibov, Vidadi] Fraunhofer USA Ctr Mol Biotechnol, Newark, DE USA; [van de Vegte-Bolmer, Marga; Roeffen, Will; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Yusibov, V (corresponding author), Fraunhofer USA Ctr Mol Biotechnol, Newark, DE USA.	vyusibov@fraunhofer-cmb.org	Sauerwein, Robert/C-8519-2013; Roeffen, W.F.G./L-4607-2015; Yusibov, Vidadi/AAA-7408-2019		Bill & Melinda Gates Foundation [OPPGH5201]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The study was supported by the Bill & Melinda Gates Foundation (grant number OPPGH5201; http://www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; BOL JF, 1974, VIROLOGY, V58, P101, DOI 10.1016/0042-6822(74)90144-5; Brewer JM, 1999, J IMMUNOL, V163, P6448; Cech PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022273; Chichester JA, 2007, VACCINE, V25, P3111, DOI 10.1016/j.vaccine.2007.01.068; Chichester JA, 2012, VIRUSES-BASEL, V4, P3227, DOI 10.3390/v4113227; Chichester JA, 2009, EXPERT REV VACCINES, V8, P493, DOI 10.1586/ERV.09.3; Chichester JA, 2009, VACCINE, V27, P3471, DOI 10.1016/j.vaccine.2009.01.050; Durrani Z, 1998, J IMMUNOL METHODS, V220, P93, DOI 10.1016/S0022-1759(98)00145-8; Farrance CE, 2011, HUM VACCINES, V7, P191, DOI 10.4161/hv.7.0.14588; Genton B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001018; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Green Brian J., 2009, Biotechnology Journal, V4, P230, DOI 10.1002/biot.200800256; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Kumar A, 1997, J VIROL, V71, P7911, DOI 10.1128/JVI.71.10.7911-7916.1997; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; malERA Consultative Group on Vaccines, 2011, PLOS MED, V8; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; MCLAIN L, 1995, AIDS RES HUM RETROV, V11, P327, DOI 10.1089/aid.1995.11.327; Mett V, 2008, BIOLOGICALS, V36, P354, DOI 10.1016/j.biologicals.2008.09.001; Mett V, 2008, INFLUENZA OTHER RESP, V2, P33, DOI 10.1111/j.1750-2659.2008.00037.x; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; Okitsu SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001278; Outchkourov N, 2007, J BIOL CHEM, V282, P17148, DOI 10.1074/jbc.M700948200; Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI 10.1586/ERV.10.89; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Qian F, 2008, VACCINE, V26, P2521, DOI 10.1016/j.vaccine.2008.03.005; Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073; ROEFFEN W, 1995, INFECT IMMUN, V63, P467, DOI 10.1128/IAI.63.2.467-471.1995; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Shimp RL, 2013, VACCINE, V31, P2954, DOI 10.1016/j.vaccine.2013.04.034; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Shoji Y, 2008, VACCINE, V26, P2930, DOI 10.1016/j.vaccine.2008.03.045; Shoji Y, 2011, HUM VACCINES, V7, P41, DOI 10.4161/hv.7.0.14561; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Thera MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009041; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; VERMEULEN AN, 1985, J EXP MED, V162, P1460, DOI 10.1084/jem.162.5.1460; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Wu Yu-Huan, 2008, P3; Yasawardene SG, 2003, INDIAN J MED RES, V118, P115; Yusibov V, 2005, VACCINE, V23, P2261, DOI 10.1016/j.vaccine.2005.01.039; Yusibov V, 2002, VACCINE, V20, P3155, DOI 10.1016/S0264-410X(02)00260-8; Yusibov V, 1997, P NATL ACAD SCI USA, V94, P5784, DOI 10.1073/pnas.94.11.5784; Yusibov V, 2013, CURR PHARM DESIGN, V19, P5574, DOI 10.2174/13816128113199990335; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207; Zou LL, 2003, VACCINE, V21, P1650, DOI 10.1016/S0264-410X(02)00701-6	56	73	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79538	10.1371/journal.pone.0079538	http://dx.doi.org/10.1371/journal.pone.0079538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260245	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500073
J	Lopez, R; Arumugam, A; Joseph, R; Monga, K; Boopalan, T; Agullo, P; Gutierrez, C; Nandy, S; Subramani, R; de la Rosa, JM; Lakshmanaswamy, R				Lopez, Rebecca; Arumugam, Arunkumar; Joseph, Riya; Monga, Kanika; Boopalan, Thiyagarajan; Agullo, Pamela; Gutierrez, Christina; Nandy, Sushmita; Subramani, Ramadevi; de la Rosa, Jose Manuel; Lakshmanaswamy, Rajkumar			Hyperglycemia Enhances the Proliferation of Non-Tumorigenic and Malignant Mammary Epithelial Cells through Increased leptin/IGF1R Signaling and Activation of AKT/mTOR	PLOS ONE			English	Article							BREAST-CANCER CELLS; METABOLIC SYNDROME; INSULIN; OBESITY	Obesity and diabetes are associated with increased breast cancer risk and worse disease progression once cancer is diagnosed; however, the exact etiology behind these observations remains to be fully elucidated. Due to the global obesity/diabetes pandemic, it is imperative to understand how these diseases promote and enhance breast cancer and other common cancers. In this study we demonstrate that hyperglycemia promotes breast cancer by altering leptin/IGF1R and AKT/mTOR signaling. To our knowledge, we show for the first time that in breast epithelial cells, hyperglycemia alone directly impacts leptin signaling. Hyperglycemia increased proliferation of both non-tumorigenic and malignant mammary epithelial cells. These observations coincided with increased leptin receptor and IGF1R receptor, as well as, increased levels of GRB2, pJAK2, pSTAT3, pIRS1/2, pAKT, and p-mTOR. Moreover, pJAK2 was almost completely colocalized with leptin receptor under high glucose conditions. These results demonstrate how hyperglycemia can potentially increase the risk of breast cancer in premalignant lesions and enhance cancer progression in malignant cells.	[Lopez, Rebecca; Arumugam, Arunkumar; Joseph, Riya; Monga, Kanika; Boopalan, Thiyagarajan; Agullo, Pamela; Gutierrez, Christina; Nandy, Sushmita; Subramani, Ramadevi; de la Rosa, Jose Manuel; Lakshmanaswamy, Rajkumar] Texas Tech Univ, Paul L Foster Sch Med, Dept Biomed Sci MSB1,Hlth Sci Ctr, Ctr Excellence Canc Res,Ctr Excellence Diabet Res, El Paso, TX USA	Texas Tech University System; Texas Tech University	Lakshmanaswamy, R (corresponding author), Texas Tech Univ, Paul L Foster Sch Med, Dept Biomed Sci MSB1,Hlth Sci Ctr, Ctr Excellence Canc Res,Ctr Excellence Diabet Res, El Paso, TX USA.	rajkumar.lakshmanaswamy@ttuhsc.edu			HRSA [D34HP16043]	HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	This work was partially supported by HRSA Grant # D34HP16043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson GL, 2012, CANCER PREV RES, V5, P515, DOI 10.1158/1940-6207.CAPR-12-0091; Attner B, 2012, CANCER CAUSE CONTROL, V23, P769, DOI 10.1007/s10552-012-9946-5; Bosak Kelly, 2012, Nurse Pract, V37, P14, DOI 10.1097/01.NPR.0000415871.60058.69; Chen J, 2011, OBES REV, V12, P1063, DOI 10.1111/j.1467-789X.2011.00917.x; Cleveland RJ, 2012, CANCER CAUSE CONTROL, V23, P1193, DOI 10.1007/s10552-012-9989-7; Cohen DH, 2012, ENDOCR-RELAT CANCER, V19, pF27, DOI 10.1530/ERC-11-0374; Davis AA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/809291; Galgani M, 2010, J IMMUNOL, V185, P7474, DOI 10.4049/jimmunol.1001674; Guerra B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003466; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Maiti B, 2010, BREAST CANCER RES TR, V121, P479, DOI 10.1007/s10549-009-0591-y; Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050; McTiernan A, 2010, J CLIN ONCOL, V28, P4074, DOI 10.1200/JCO.2010.27.9752; Michels KB, 2003, DIABETES CARE, V26, P1752, DOI 10.2337/diacare.26.6.1752; Nam SY, 1997, INT J OBESITY, V21, P355, DOI 10.1038/sj.ijo.0800412; Okumura M, 2002, BBA-MOL CELL RES, V1592, P107, DOI 10.1016/S0167-4889(02)00276-8; Olofsson LE, 2009, P NATL ACAD SCI USA, V106, P15932, DOI 10.1073/pnas.0904747106; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singleton JR, 2001, DIABETES CARE, V24, P1448, DOI 10.2337/diacare.24.8.1448; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Su HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031636; Villarreal-Garza C, 2012, EXP DIABETES RES, DOI 10.1155/2012/732027; Walsh LA, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-10; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yamamoto M, 1999, INT J CANCER, V83, P98, DOI 10.1002/(SICI)1097-0215(19990924)83:1<98::AID-IJC18>3.0.CO;2-V; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800; Zeng L, 2010, ENDOCR-RELAT CANCER, V17, P539, DOI 10.1677/ERC-09-0221	29	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79708	10.1371/journal.pone.0079708	http://dx.doi.org/10.1371/journal.pone.0079708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260287	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500092
J	Perry, AN; Westenbroek, C; Becker, JB				Perry, Adam N.; Westenbroek, Christel; Becker, Jill B.			The Development of a Preference for Cocaine over Food Identifies Individual Rats with Addiction-Like Behaviors	PLOS ONE			English	Article							SEX-DIFFERENCES; DRUG-USE; INTRAVENOUS COCAINE; ESTROUS-CYCLE; D-AMPHETAMINE; FEMALE; REINSTATEMENT; DEPENDENCE; SCHEDULE; GENDER	Rationale: Cocaine dependence is characterized by compulsive drug taking that supercedes other recreational, occupational or social pursuits. We hypothesized that rats vulnerable to addiction could be identified within the larger population based on their preference for cocaine over palatable food rewards. Objectives: To validate the choice self-administration paradigm as a preclinical model of addiction, we examined changes in motivation for cocaine and recidivism to drug seeking in cocaine-preferring and pellet-preferring rats. We also examined behavior in males and females to identify sex differences in this "addicted" phenotype. Methods: Preferences were identified during self-administration on a fixed-ratio schedule with cocaine-only, pellet-only and choice sessions. Motivation for each reward was probed early and late during self-administration using a progressive-ratio schedule. Reinstatement of cocaine-and pellet-seeking was examined following exposure to their cues and non-contingent delivery of each reward. Results: Cocaine preferring rats increased their drug intake at the expense of pellets, displayed increased motivation for cocaine, attenuated motivation for pellets and greater cocaine and cue-induced reinstatement of drug seeking. Females were more likely to develop cocaine preferences and recidivism of cocaine-and pellet-seeking was sexually dimorphic. Conclusions: The choice self-administration paradigm is a valid preclinical model of addiction. The unbiased selection criteria also revealed sex-specific vulnerability factors that could be differentiated from generalized sex differences in behavior, which has implications for the neurobiology of addiction and effective treatments in each sex.	[Perry, Adam N.; Westenbroek, Christel; Becker, Jill B.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Becker, Jill B.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Becker, Jill B.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Perry, AN (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	adperry@umich.edu			National Institute on Drug Abuse [DA012677, DA032856]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012677, T32DA007268, R21DA032856] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute on Drug Abuse (DA012677 to JBB, DA032856 to JBB and ANP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2012, NEUROSCIENCE, V211, P107, DOI 10.1016/j.neuroscience.2011.08.014; Ahmed SH, 2013, CURR OPIN NEUROBIOL, V23, P581, DOI 10.1016/j.conb.2013.01.028; Ahmed SH, 2010, NEUROSCI BIOBEHAV R, V35, P172, DOI 10.1016/j.neubiorev.2010.04.005; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Anker JJ, 2010, DRUG ALCOHOL DEPEN, V107, P264, DOI 10.1016/j.drugalcdep.2009.11.002; Banks ML, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/281768; Barnea-Ygael N, 2012, PSYCHOPHARMACOLOGY, V219, P875, DOI 10.1007/s00213-011-2416-z; Barr AM, 1999, PHARMACOL BIOCHEM BE, V64, P597, DOI 10.1016/S0091-3057(99)00156-2; Barr AM, 1999, PSYCHOPHARMACOLOGY, V141, P99, DOI 10.1007/s002130050812; Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Buffalari DM, 2012, PHYSIOL BEHAV, V105, P209, DOI 10.1016/j.physbeh.2011.08.020; Caine SB, 2004, NEUROPSYCHOPHARMACOL, V29, P929, DOI 10.1038/sj.npp.1300387; Cantin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011592; Chen KW, 2011, DRUG ALCOHOL DEPEN, V118, P92, DOI 10.1016/j.drugalcdep.2011.03.003; Cooper A, 2007, PSYCHOPHARMACOLOGY, V194, P117, DOI 10.1007/s00213-007-0827-7; Cooper ZD, 2013, HORM BEHAV, V63, P105, DOI 10.1016/j.yhbeh.2012.10.008; Cosgrove KP, 2002, PHARMACOL BIOCHEM BE, V73, P663, DOI 10.1016/S0091-3057(02)00853-5; Cotto JH, 2010, GENDER MED, V7, P402, DOI 10.1016/j.genm.2010.09.004; Cummings Jennifer A, 2011, Biol Sex Differ, V2, P3, DOI 10.1186/2042-6410-2-3; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; ESTEP DQ, 1978, HORM BEHAV, V11, P259, DOI 10.1016/0018-506X(78)90029-6; Feltenstein MW, 2011, PSYCHOPHARMACOLOGY, V216, P53, DOI 10.1007/s00213-011-2187-6; Feltenstein MW, 2009, PSYCHONEUROENDOCRINO, V34, P343, DOI 10.1016/j.psyneuen.2008.09.014; Fox HC, 2009, ALCOHOL ALCOHOLISM, V44, P575, DOI 10.1093/alcalc/agp060; Haas AL, 2000, J SUBST ABUSE, V12, P241, DOI 10.1016/S0899-3289(00)00053-5; Hecht GS, 1999, DEV PSYCHOBIOL, V35, P136; Jason Osborne, 2010, IMPROVING YOUR DATA, P1; Kennedy AP, 2013, DRUG ALCOHOL DEPEN, V132, P29, DOI 10.1016/j.drugalcdep.2012.12.025; Kerstetter KA, 2011, J ADDICT RES THER, pS4; Kerstetter KA, 2012, NEUROPSYCHOPHARMACOL, V37, P2605, DOI 10.1038/npp.2012.99; Kippin TE, 2005, PSYCHOPHARMACOLOGY, V182, P245, DOI 10.1007/s00213-005-0071-y; Klingerman CM, 2010, HORM BEHAV, V58, P563, DOI 10.1016/j.yhbeh.2010.06.019; Lack CM, 2008, PSYCHOPHARMACOLOGY, V195, P517, DOI 10.1007/s00213-007-0919-4; Laviano A, 1996, AM J PHYSIOL-REG I, V270, pR413, DOI 10.1152/ajpregu.1996.270.2.R413; Lejuez CW, 2007, EXP CLIN PSYCHOPHARM, V15, P165, DOI 10.1037/1064-1297.15.2.165; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Lenoir M, 2013, NEUROPSYCHOPHARMACOL, V38, P1209, DOI 10.1038/npp.2013.17; Lynch WJ, 2008, PSYCHOPHARMACOLOGY, V197, P237, DOI 10.1007/s00213-007-1028-0; Lynch WJ, 2009, PHARMACOL BIOCHEM BE, V94, P43, DOI 10.1016/j.pbb.2009.07.004; Lynch WJ, 2005, NEUROPSYCHOPHARMACOL, V30, P927, DOI 10.1038/sj.npp.1300656; Lynch WJ, 2004, NEUROPSYCHOPHARMACOL, V29, P943, DOI 10.1038/sj.npp.1300389; Lynch WJ, 2000, PSYCHOPHARMACOLOGY, V148, P196, DOI 10.1007/s002130050042; Mahoney JJ, 2010, GENDER MED, V7, P414, DOI 10.1016/j.genm.2010.09.003; Negus SS, 2005, PSYCHOPHARMACOLOGY, V181, P244, DOI 10.1007/s00213-005-2266-7; Negus SS, 2003, NEUROPSYCHOPHARMACOL, V28, P919, DOI 10.1038/sj.npp.1300096; Oleson EB, 2009, NEUROPSYCHOPHARMACOL, V34, P796, DOI 10.1038/npp.2008.195; Orsini C, 2001, NEUROPSYCHOPHARMACOL, V25, P789, DOI 10.1016/S0893-133X(01)00270-6; QUINTANA SM, 1994, J EDUC STAT, V19, P57, DOI 10.2307/1165177; Ramoa CP, 2013, NEUROPSYCHOPHARMACOL, V38, P1698, DOI 10.1038/npp.2013.68; Rawson RA, 2002, J SUBST ABUSE TREAT, V22, P103, DOI 10.1016/S0740-5472(01)00215-X; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Roberts DCS, 2007, PROG NEURO-PSYCHOPH, V31, P1614, DOI 10.1016/j.pnpbp.2007.08.028; ROBERTS DCS, 1989, PSYCHOPHARMACOLOGY, V98, P408, DOI 10.1007/BF00451696; Substance Abuse and Mental Health Services Administration, 2012, RES 2011 NAT SURV DR; Tunstall BJ, 2014, ADDICT BIOL, V19, P838, DOI 10.1111/adb.12054; Volkow ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016573; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; Wagner FA, 2007, DRUG ALCOHOL DEPEN, V86, P191, DOI 10.1016/j.drugalcdep.2006.06.003; Walsh SL, 2010, DRUG ALCOHOL DEPEN, V106, P28, DOI 10.1016/j.drugalcdep.2009.07.011; Washington IV., 2000, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349.7443, DOI 10.1176/APPI.B00KS.9780890423349.7443]; Wellman PJ, 2008, LIFE SCI, V82, P359, DOI 10.1016/j.lfs.2007.11.004; Zernig G, 2007, PHARMACOLOGY, V80, P65, DOI 10.1159/000103923	63	66	66	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79465	10.1371/journal.pone.0079465	http://dx.doi.org/10.1371/journal.pone.0079465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260227	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500063
J	Portuesi, R; Pozzilli, P; Boehm, B; Buzzetti, R; Filippi, S				Portuesi, Rosalba; Pozzilli, Paolo; Boehm, Bernhard; Buzzetti, Raffaella; Filippi, Simonetta			Assessment of Type 1 Diabetes Risk Conferred by HLA-DRB1, INS-VNTR and PTPN22 Genes Using the Bayesian Network Approach	PLOS ONE			English	Article							REGION-ENCODED SUSCEPTIBILITY; INSULIN GENE; MULTIPLEX FAMILIES; FUNCTIONAL VARIANT; HLA; MELLITUS; LOCUS; AUTOIMMUNITY; METAANALYSIS; GENOTYPES	Background: Determining genetic risk is a fundamental prerequisite for the implementation of primary prevention trials for type 1 diabetes (T1D). The aim of this study was to assess the risk conferred by HLA-DRB1, INS-VNTR and PTPN22 single genes on the onset of T1D and the joint risk conferred by all these three susceptibility loci using the Bayesian Network (BN) approach in both population-based case-control and family clustering data sets. Methodology/Principal Findings: A case-control French cohort, consisting of 868 T1D patients and 73 French control subjects, a French family data set consisting of 1694 T1D patients and 2340 controls were analysed. We studied both samples separately applying the BN probabilistic approach, that is a graphical model that encodes probabilistic relationships among variables of interest. As expected HLA-DRB1 is the most relevant susceptibility gene. We proved that INS and PTPN22 genes marginally influence T1D risk in all risk HLA-DRB1 genotype categories. The absolute risk conferred by carrying simultaneously high, moderate or low risk HLA-DRB1 genotypes together with at risk INS and PTPN22 genotypes, was 11.5%, 1.7% and 0.1% in the case-control sample and 19.8%, 6.6% and 2.2% in the family cohort, respectively. Conclusions/Significance: This work represents, to the best of our knowledge, the first study based on both case-control and family data sets, showing the joint effect of HLA, INS and PTPN22 in a T1D Caucasian population with a wide range of age at T1D onset, adding new insights to previous findings regarding data sets consisting of patients and controls,15 years at onset.	[Portuesi, Rosalba; Pozzilli, Paolo] Univ Campus Biomed, Dept Endocrinol & Diabet, Rome, Italy; [Portuesi, Rosalba] Univ Campus Biomed, Dept Gynecol, Rome, Italy; [Pozzilli, Paolo] Univ London, St Bartholomews & London Sch Med, Ctr Diabet, Blizard Inst, London, England; [Boehm, Bernhard] Univ Ulm, Div Endocrinol & Diabet, D-89069 Ulm, Germany; [Buzzetti, Raffaella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Filippi, Simonetta] Univ Campus Biomed, Lab Non Linear Phys & Math Models, Rome, Italy	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University of London; Queen Mary University London; Ulm University; Sapienza University Rome; University Campus Bio-Medico - Rome Italy	Buzzetti, R (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	raffaella.buzzetti@uniroma1.it	Buzzetti, Raffaella/K-3090-2016; Boehm, Bernhard Otto/F-8750-2015; Filippi, Simonetta/G-1261-2014	Buzzetti, Raffaella/0000-0003-1490-6041; FILIPPI, Simonetta/0000-0003-1952-0834; Pozzilli, Paolo/0000-0001-5090-636X; Portuesi, Rosalba/0000-0002-8784-2192	Ministry of University and Research of Italy	Ministry of University and Research of Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by a Grant from Ministry of University and Research of Italy (PRIN project 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1974, AUTOMATIC CONTROL IE, V19, P716, DOI [DOI 10.1109/TAC.1974.1100705, 10.1109/tac.1974.1100705]; BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bjornvold M, 2008, DIABETOLOGIA, V51, P589, DOI 10.1007/s00125-008-0932-0; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Chelala C, 2007, DIABETES, V56, P522, DOI 10.2337/db06-0942; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; Cowell R.G., 1999, PROBABILISTIC NETWOR; Fourlanos S, 2008, DIABETES CARE, V31, P1546, DOI 10.2337/dc08-0239; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Ghandil P, 2005, MOL GENET METAB, V86, P379, DOI 10.1016/j.ymgme.2005.07.029; Hathout EH, 2003, PEDIATRICS, V111, P860, DOI 10.1542/peds.111.4.860; Holm P, 2001, AM J HUM GENET, V69, P1301; Jensen FV, 2007, BAYESIAN NETWORKS DE; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; METCALFE KA, 1995, DIABETOLOGIA, V38, P1223, DOI 10.1007/BF00422373; Motzo C, 2004, DIABETES, V53, P3286, DOI 10.2337/diabetes.53.12.3286; Mueller PW, 2006, J AM SOC NEPHROL, V17, P1782, DOI 10.1681/ASN.2005080822; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Noble JA, 1996, AM J HUM GENET, V59, P1134; Noble JA, 2010, DIABETES, V59, P2972, DOI 10.2337/db10-0699; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Shafer Glenn, 1996, ART CAUSAL CONJECTUR; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Thomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; VANDERAUWERA B, 1995, J CLIN ENDOCR METAB, V80, P2567, DOI 10.1210/jc.80.9.2567; Vehik K, 2007, DIABETES CARE, V30, P503, DOI 10.2337/dc06-1837; Walter M, 2003, DIABETOLOGIA, V46, P712, DOI 10.1007/s00125-003-1082-z	35	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79506	10.1371/journal.pone.0079506	http://dx.doi.org/10.1371/journal.pone.0079506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260237	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500069
J	Zhang, P; Xu, X; Hu, XL; Wang, H; Fassett, J; Huo, YQ; Chen, YJ; Bache, RJ				Zhang, Ping; Xu, Xin; Hu, Xinli; Wang, Huan; Fassett, John; Huo, Yuqing; Chen, Yingjie; Bache, Robert J.			DDAH1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR EXPRESSION; DIMETHYLARGININE DIMETHYLAMINOHYDROLASE; ASYMMETRIC DIMETHYLARGININE; TUMOR-SUPPRESSOR; PHOSPHORYLATION; NEUROFIBROMIN; PROLIFERATION; INACTIVATION; INHIBITION	Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthase (NOS). ADMA is eliminated largely by the action of dimethylarginine dimethylaminohydrolase1 (DDAH1). Decreased DDAH activity is found in several pathological conditions and is associated with increased risk of vascular disease. Overexpression of DDAH1 has been shown to augment endothelial proliferation and angiogenesis. To better understand the mechanism by which DDAH1 influences endothelial proliferation, this study examined the effect of DDAH1 deficiency on cell cycle progression and the expression of some cell cycle master regulatory proteins. DDAH1 KO decreased in vivo Matrigel angiogenesis and depressed endothelial repair in a mouse model of carotid artery wire injury. DDAH1 deficiency decreased VEGF expression in HUVEC and increased NF1 expression in both HUVEC and DDAH1 KO mice. The expression of active Ras could overcome the decreased VEGF expression caused by the DDAH1 depletion. The addition of VEGF and knockdown NF1 could both restore proliferation in cells with DDAH1 depletion. Flow cytometry analysis revealed that DDAH1 sRNAi knockdown in HUVEC caused G1 and G2/M arrest that was associated with decreased expression of CDC2, CDC25C, cyclin D1 and cyclin E. MEF cells from DDAH1 KO mice also demonstrated G2/M arrest that was associated with decreased cyclin D1 expression and Akt activity. Our findings indicate that DDAH1 exerts effects on cyclin D1 and cyclin E expression through multiple mechanisms, including VEGF, the NO/cGMP/PKG pathway, the Ras/PI3K/Akt pathway, and NF1 expression. Loss of DDAH1 effects on these pathways results in impaired endothelial cell proliferation and decreased angiogenesis. The findings provide background information that may be useful in the development of therapeutic strategies to manipulate DDAH1 expression in cardiovascular diseases or tumor angiogenesis.	[Zhang, Ping; Xu, Xin; Wang, Huan; Fassett, John; Chen, Yingjie; Bache, Robert J.] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA; [Hu, Xinli] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Huo, Yuqing] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Vasc Biol Ctr, Augusta, GA USA	University of Minnesota System; University of Minnesota Twin Cities; Peking University; University System of Georgia; Augusta University	Zhang, P (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA.	zhang074@umn.edu	Bache, Robert/AAW-7602-2021; Chen, Yingjie/AAX-5295-2020	Chen, Yingjie/0000-0002-4059-7847	US Public Health Service from the National Heart, Lung, and Blood Institute [HL20598, HL021872, R21HL098669, R21HL102597, HL095556-01, DK095862-01, R21HL108922]; American Heart Association [0330136N, 09SDG2170072, 0160275Z]; American Heart Association National Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL020598, R01HL021872, R21HL098669, R21HL108922, R01HL020598, R21HL102597, R01HL095556, R01HL105406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095862] Funding Source: NIH RePORTER	US Public Health Service from the National Heart, Lung, and Blood Institute; American Heart Association(American Heart Association); American Heart Association National Center(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by US Public Health Service Grants HL20598, HL021872, R21HL098669, R21HL102597, HL095556-01, DK095862-01 and R21HL108922 from the National Heart, Lung, and Blood Institute; Research Grants 0330136N, 09SDG2170072, and 0160275Z from the American Heart Association. Drs Zhang and Hu are recipients of a Scientist Development Award from the American Heart Association National Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2005, VASC MED, V10, P7, DOI 10.1191/1358863x05vm580oa; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Bajaj A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049222; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Chen YJ, 2005, AM J PHYSIOL-HEART C, V289, pH2212, DOI 10.1152/ajpheart.00224.2005; Cheng T, 2004, ONCOGENE, V23, P7256, DOI 10.1038/sj.onc.1207945; Cooke JP, 2003, ATHEROSCLEROSIS SUPP, V4, P53, DOI 10.1016/S1567-5688(03)00034-5; Dai XM, 2010, CIRC RES, V106, P1870, DOI 10.1161/CIRCRESAHA.109.212746; Ding H, 2010, CIRC RES, V106, P1145, DOI 10.1161/CIRCRESAHA.109.215616; Feng LP, 2004, FEBS LETT, V557, P275, DOI 10.1016/S0014-5793(03)01507-2; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; Hasegawa K, 2006, ARTERIOSCL THROM VAS, V26, P1488, DOI 10.1161/01.ATV.0000219615.88323.b4; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; Jacobi J, 2005, CIRCULATION, V111, P1431, DOI 10.1161/01.CIR.0000158487.80483.09; Jang JJ, 2000, CIRCULATION, V102, P1414, DOI 10.1161/01.CIR.102.12.1414; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Konishi H, 2007, J AM COLL CARDIOL, V49, P1099, DOI 10.1016/j.jacc.2006.10.068; Leiper J, 2011, NAT REV DRUG DISCOV, V10, P277, DOI 10.1038/nrd3358; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Maity A, 2000, CANCER RES, V60, P5879; Malinda Katherine M., 2009, V467, P287, DOI 10.1007/978-1-59745-241-0_17; Munchhof AM, 2006, HUM MOL GENET, V15, P1858, DOI 10.1093/hmg/ddl108; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Ozerdem Ugur, 2004, Angiogenesis, V7, P307, DOI 10.1007/s10456-004-6643-3; Pemov A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-194; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; RAK J, 1995, CANCER RES, V55, P4575; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Sarkar R, 1997, AM J PHYSIOL-HEART C, V272, pH1810, DOI 10.1152/ajpheart.1997.272.4.H1810; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Tanner FC, 2000, CIRCULATION, V101, P1982, DOI 10.1161/01.CIR.101.16.1982; Tokuo H, 2001, FEBS LETT, V494, P48, DOI 10.1016/S0014-5793(01)02309-2; Wang H, 2009, ARTERIOSCL THROM VAS, V29, P1046, DOI 10.1161/ATVBAHA.109.188839; Zhang P, 2011, ARTERIOSCL THROM VAS, V31, P890, DOI 10.1161/ATVBAHA.110.215640; Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451	41	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79444	10.1371/journal.pone.0079444	http://dx.doi.org/10.1371/journal.pone.0079444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260221	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500060
J	Zhao, LX; Li, DD; Hu, DD; Hu, GH; Yan, L; Wang, Y; Jiang, YY				Zhao, Lan-Xue; Li, De-Dong; Hu, Dan-Dan; Hu, Gan-Hai; Yan, Lan; Wang, Yan; Jiang, Yuan-Ying			Effect of Tetrandrine against Candida albicans Biofilms	PLOS ONE			English	Article							CELL-SURFACE HYDROPHOBICITY; STAPHYLOCOCCUS-AUREUS BIOFILMS; IN-VITRO ACTIVITY; ANTIFUNGAL RESISTANCE; FUNGAL PATHOGEN; VIRULENCE; ADHERENCE; MORPHOGENESIS; FANGCHINOLINE; ACTIVATION	Candida albicans is the most common human fungal pathogen and has a high propensity to develop biofilms that are resistant to traditional antifungal agents. In this study, we investigated the effect of tetrandrine (TET) on growth, biofilm formation and yeast-to-hypha transition of C. albicans. We characterized the inhibitory effect of TET on hyphal growth and addressed its possible mechanism of action. Treatment of TET at a low concentration without affecting fungal growth inhibited hyphal growth in both liquid and solid Spider media. Real-time RT-PCR revealed that TET down-regulated the expression of hypha-specific genes ECE1, ALS3 and HWP1, and abrogated the induction of EFG1 and RAS1, regulators of hyphal growth. Addition of cAMP restored the normal phenotype of the SC5314 strain. These results indicate that TET may inhibit hyphal growth through the Ras1p-cAMP-PKA pathway. In vivo, at a range of concentrations from 4 mg/L to 32 mg/L, TET prolonged the survival of C. albicans-infected Caenorhabditis elegans significantly. This study provides useful information for the development of new strategies to reduce the incidence of C. albicans biofilm-associated infections.	[Zhao, Lan-Xue; Li, De-Dong; Hu, Dan-Dan; Hu, Gan-Hai; Yan, Lan; Wang, Yan; Jiang, Yuan-Ying] Second Mil Med Univ, Sch Pharm, New Drug Res & Dev Ctr, Shanghai, Peoples R China; [Zhao, Lan-Xue] Shanghai Jiao Tong Univ, Sch Med, Dept Pharm, Inst Med Sci, Shanghai 200030, Peoples R China; [Hu, Gan-Hai] Fujian Univ Tradit Chinese Med, Dept Pharm, Fuzhou, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Fujian University of Traditional Chinese Medicine	Wang, Y (corresponding author), Second Mil Med Univ, Sch Pharm, New Drug Res & Dev Ctr, Shanghai, Peoples R China.	wangyansmmu@126.com; jiangyuanying@126.com	Li, Dedong/R-7044-2019; jiang, anyi/GPT-0379-2022	Wang, Yan/0000-0003-1084-1957	National Key Basic Research Program of China [2013CB531602]; National Natural Science Foundation of China [81273558, 81072678, 90913008]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2011ZX09102-002-01]; Shanghai Science and Technology Major Project [10431902200]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; Shanghai Science and Technology Major Project	This work was supported by the National Key Basic Research Program of China (2013CB531602), the National Natural Science Foundation of China (81273558, 81072678 and 90913008), the National Science and Technology Major Project of the Ministry of Science and Technology of China (2011ZX09102-002-01), and Shanghai Science and Technology Major Project (10431902200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BD, 1997, DRUGS, V54, P657, DOI 10.2165/00003495-199754050-00002; Arikan S, 1997, MYCOSES, V40, P291, DOI 10.1111/j.1439-0507.1997.tb00234.x; Azie N, 2012, DIAGN MICR INFEC DIS, V73, P293, DOI 10.1016/j.diagmicrobio.2012.06.012; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Braga PC, 2008, INT J ANTIMICROB AG, V31, P472, DOI 10.1016/j.ijantimicag.2007.12.013; Braun BR, 2000, GENETICS, V155, P57; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Cao YY, 2008, INT J ANTIMICROB AG, V32, P73, DOI 10.1016/j.ijantimicag.2008.01.026; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chen F, 1997, BIOCHEM BIOPH RES CO, V231, P99, DOI 10.1006/bbrc.1997.6057; Chen LL, 2013, NEUROL RES, V35, P614, DOI 10.1179/1743132813Y.0000000175; Chen YJ, 1999, BIOL PHARM BULL, V22, P703, DOI 10.1248/bpb.22.703; Chen Y, 2009, ANTICANCER RES, V29, P3163; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Dong Y, 1997, LIFE SCI, V60, pPL135, DOI 10.1016/S0024-3205(96)00695-9; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; Fallarero A, 2013, INT J MOL SCI, V14, P12054, DOI 10.3390/ijms140612054; Fang JH, 1996, CHIN PHARM J, V31, P454; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Ferreira AV, 2013, MYCOPATHOLOGIA, V175, P265, DOI 10.1007/s11046-013-9638-z; Fu LW, 2002, EUR J CANCER, V38, P418, DOI 10.1016/S0959-8049(01)00356-2; Gao Y, 1965, CHINESE J INTERN MED, V13, P504; GRALLA EJ, 1974, CANCER CHEMOTH REP 3, V5, P79; Hasan F, 2009, MICROBES INFECT, V11, P753, DOI 10.1016/j.micinf.2009.04.018; HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128; Hogan DA, 2009, FUTURE MICROBIOL, V4, P1263, DOI 10.2217/FMB.09.106; Kim HS, 1997, J ETHNOPHARMACOL, V58, P117, DOI 10.1016/S0378-8741(97)00092-5; KLOTZ SA, 1985, INFECT IMMUN, V50, P97, DOI 10.1128/IAI.50.1.97-101.1985; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Lee JH, 2002, INT J ONCOL, V21, P1239; Li DD, 2013, FUNGAL GENET BIOL, V51, P50, DOI 10.1016/j.fgb.2012.11.010; LI Q, 1981, Chinese Journal of Tuberculosis and Respiratory Diseases, V4, P321; LI TL, 1982, ECOTOX ENVIRON SAFE, V6, P528, DOI 10.1016/0147-6513(82)90034-3; Liang RM, 2009, ACTA PHARMACOL SIN, V30, P1709, DOI 10.1038/aps.2009.157; Luo G, 2002, APMIS, V110, P601, DOI 10.1034/j.1600-0463.2002.1100902.x; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; MartinezMartinez L, 1996, J ANTIMICROB CHEMOTH, V38, P1107, DOI 10.1093/jac/38.6.1107; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; NGUYEN MH, 1995, ARCH INTERN MED, V155, P2429, DOI 10.1001/archinte.155.22.2429; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Pompilio A, 2008, FEMS MICROBIOL LETT, V287, P41, DOI 10.1111/j.1574-6968.2008.01292.x; Pukkila-Worley R, 2009, EUKARYOT CELL, V8, P1750, DOI 10.1128/EC.00163-09; Quan H, 2006, ANTIMICROB AGENTS CH, V50, P1096, DOI 10.1128/AAC.50.3.1096-1099.2006; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Samaranayake YH, 1995, APMIS, V103, P707, DOI 10.1111/j.1699-0463.1995.tb01427.x; Sandberg M, 2008, INT J ANTIMICROB AG, V32, P233, DOI 10.1016/j.ijantimicag.2008.04.022; Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x; Shen YC, 2001, MOL PHARMACOL, V60, P1083, DOI 10.1124/mol.60.5.1083; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Tobudic S, 2010, MYCOSES, V53, P208, DOI 10.1111/j.1439-0507.2009.01690.x; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Vila TVM, 2013, J ANTIMICROB CHEMOTH, V68, P113, DOI 10.1093/jac/dks353; Wang G, 2004, TRENDS PHARMACOL SCI, V25, P120, DOI 10.1016/j.tips.2004.01.009; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; Xu WL, 2006, LEUKEMIA RES, V30, P407, DOI 10.1016/j.leukres.2005.08.005; Yao WX, 2002, ACTA PHARMACOL SIN, V23, P1069; YU XF, 1983, ECOTOX ENVIRON SAFE, V7, P306, DOI 10.1016/0147-6513(83)90075-1; Zhang D, 2010, CHINESE J ZOONOSES, V3, P010; Zhang H, 2010, PLANTA MED, V76, P53, DOI 10.1055/s-0029-1185973; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	80	48	54	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79671	10.1371/journal.pone.0079671	http://dx.doi.org/10.1371/journal.pone.0079671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260276	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500086
J	Bloom, AJ; Martinez, M; Chen, LS; Bierut, LJ; Murphy, SE; Goate, A				Bloom, A. Joseph; Martinez, Maribel; Chen, Li-Shiun; Bierut, Laura J.; Murphy, Sharon E.; Goate, Alison			CYP2B6 Non-Coding Variation Associated with Smoking Cessation Is Also Associated with Differences in Allelic Expression, Splicing, and Nicotine Metabolism Independent of Common Amino-Acid Changes	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; BUPROPION HYDROXYLATION; CYTOCHROME P4502B6; HEPATIC CYP2B6; PLASMA-LEVELS; GENOTYPE; MUTATIONS; EFAVIRENZ; CYCLOPHOSPHAMIDE; CYP2B6-ASTERISK-6	The Cytochrome P450 2B6 (CYP2B6) enzyme makes a small contribution to hepatic nicotine metabolism relative to CYP2A6, but CYP2B6 is the primary enzyme responsible for metabolism of the smoking cessation drug bupropion. Using CYP2A6 genotype as a covariate, we find that a non-coding polymorphism in CYP2B6 previously associated with smoking cessation (rs8109525) is also significantly associated with nicotine metabolism. The association is independent of the well-studied non-synonymous variants rs3211371, rs3745274, and rs2279343 (CYP2B6*5 and *6). Expression studies demonstrate that rs8109525 is also associated with differences in CYP2B6 mRNA expression in liver biopsy samples. Splicing assays demonstrate that specific splice forms of CYP2B6 are associated with haplotypes defined by variants including rs3745274 and rs8109525. These results indicate differences in mRNA expression and splicing as potential molecular mechanisms by which non-coding variation in CYP2B6 may affect enzymatic activity leading to differences in metabolism and smoking cessation.	[Bloom, A. Joseph; Martinez, Maribel; Chen, Li-Shiun; Bierut, Laura J.; Goate, Alison] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Murphy, Sharon E.] Univ Minnesota, Dept Biochem Mol Biol & BioPhys, Minneapolis, MN USA	Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities	Bloom, AJ (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	bloomj@psychiatry.wustl.edu	Bierut, Laura Jean/W-6806-2019	Bierut, Laura Jean/0000-0002-9952-4810; Goate, Alison/0000-0002-0576-2472; Bloom, Joseph/0000-0002-6731-5539	National Institute of Mental Health [5T32MH014677-33]; National Cancer Institute [P01 CA-089392]; National Institute on Drug Abuse [K02 DA-021237]; National Human Genome Research Institute [U01 HG-004422]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA030398] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the National Institute of Mental Health (5T32MH014677-33); and the National Cancer Institute (P01 CA-089392); and the National Institute on Drug Abuse (K02 DA-021237); and the National Human Genome Research Institute (U01 HG-004422). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Koudsi N, 2010, XENOBIOTICA, V40, P381, DOI 10.3109/00498251003713958; Ariyoshi N, 2011, DRUG METAB DISPOS, V39, P2045, DOI 10.1124/dmd.111.039586; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bloom AJ, 2012, HUM MOL GENET, V21, P3050, DOI 10.1093/hmg/dds114; Bloom AJ, 2013, PHARMACOGENET GENOMI; Bloom J, 2011, PHARMACOGENET GENOM, V21, P403, DOI 10.1097/FPC.0b013e328346e8c0; Bunten H, 2011, ADDICT BIOL, V16, P142, DOI 10.1111/j.1369-1600.2010.00274.x; Burgess R, 2009, J MED GENET, V46, P620, DOI 10.1136/jmg.2008.059881; Carlini DB, 2006, J MOL EVOL, V62, P89, DOI 10.1007/s00239-005-0055-x; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Crane AL, 2012, TOXICOLOGY, V293, P115, DOI 10.1016/j.tox.2012.01.006; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; David SP, 2007, NICOTINE TOB RES, V9, P821, DOI 10.1080/14622200701382033; Dicke KE, 2005, DRUG METAB DISPOS, V33, P1760, DOI 10.1124/dmd.105.006718; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Fan L, 2009, EUR J CLIN PHARMACOL, V65, P403, DOI 10.1007/s00228-008-0594-3; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gaildrat P, 2012, J MED GENET; Heil SG, 2012, THER DRUG MONIT, V34, P153, DOI 10.1097/FTD.0b013e31824868f3; Hesse LM, 2004, PHARMACOGENETICS, V14, P225, DOI 10.1097/00008571-200404000-00002; Hofmann MH, 2008, J PHARMACOL EXP THER, V325, P284, DOI 10.1124/jpet.107.133306; Honda M, 2011, DRUG METAB DISPOS, V39, P1860, DOI 10.1124/dmd.111.040352; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; King DP, 2012, NEUROPSYCHOPHARMACOL, V37, P641, DOI 10.1038/npp.2011.232; Koopmans JR, 1999, BEHAV GENET, V29, P383, DOI 10.1023/A:1021618719735; Lamba V, 2003, J PHARMACOL EXP THER, V307, P906, DOI 10.1124/jpet.103.054866; Lang T, 2004, J PHARMACOL EXP THER, V311, P34, DOI 10.1124/jpet.104.068973; Lee AM, 2007, BIOL PSYCHIAT, V62, P635, DOI 10.1016/j.biopsych.2006.10.005; Lee AM, 2007, CANCER EPIDEM BIOMAR, V16, P1312, DOI 10.1158/1055-9965.EPI-07-0188; Lerman C, 2002, PHARMACOGENETICS, V12, P627, DOI 10.1097/00008571-200211000-00007; Levran O, 2011, ADDICT BIOL; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Liu T, 2011, ADDICTION, V106, P985, DOI 10.1111/j.1360-0443.2010.03353.x; Maimbo M, 2012, EUR J CLIN PHARMACOL, V68, P267, DOI 10.1007/s00228-011-1118-0; Malaiyandi V, 2005, CLIN PHARMACOL THER, V77, P145, DOI 10.1016/j.clpt.2004.10.011; McVety S, 2006, J MED GENET, V43, P153, DOI 10.1136/jmg.2005.031997; MILES JS, 1989, NUCLEIC ACIDS RES, V17, P8241, DOI 10.1093/nar/17.20.8241; Mukherjee O, 2008, HUM MUTAT, V29, P512, DOI 10.1002/humu.20681; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Nakajima M, 2007, PHARMACOGENET GENOM, V17, P431, DOI 10.1097/FPC.0b013e328045c4fb; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Qin WJ, 2012, BR J CLIN PHARMACOL; Ring HZ, 2007, PHARMACOGENET GENOM, V17, P1007, DOI 10.1097/01.fpc.0000220560.59972.33; Sanchez A, 2011, ANTIMICROB AGENTS CH, V55, P5314, DOI 10.1128/AAC.00194-11; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Sullivan P.F., 1999, NICOTINE TOB RES S2, V1, pS69; Suphapeetiporn K, 2006, JPN J CLIN ONCOL, V36, P814, DOI 10.1093/jjco/hyl107; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Torimoto Yoshihiro, 2008, Gan To Kagaku Ryoho, V35, P1090; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Yimer G, 2011, PHARMACOGENOMICS J	59	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79700	10.1371/journal.pone.0079700	http://dx.doi.org/10.1371/journal.pone.0079700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260284	Green Published, gold			2022-12-25	WOS:000327258600045
J	Sun, F; Yuan, X; Xu, QF; Zhou, T; Fan, YJ; Zhou, YJ				Sun, Feng; Yuan, Xia; Xu, Qiufang; Zhou, Tong; Fan, Yongjian; Zhou, Yijun			Overexpression of Rice Black-Streaked Dwarf Virus P7-1 in Arabidopsis Results in Male Sterility Due to Non-Dehiscent Anthers	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN; SELF-INTERACTS; EXPRESSION; TRANSCRIPTION; MECHANISM; THALIANA; PATHWAY; GENOME; PLANTS; CHINA	Rice black-streaked dwarf virus (RBSDV), a member of the genus Fijivirus in the family Reoviridae, is propagatively transmitted by the small brown planthopper (Laodelphax striatellus Fallen). RBSDV causes rice black-streaked dwarf and maize rough dwarf diseases, which lead to severe yield losses in crops in China. Although several RBSDV proteins have been studied in detail, the functions of the nonstructural protein P7-1 are still largely unknown. To investigate the role of the P7-1 protein in virus pathogenicity, transgenic Arabidopsis thaliana plants were generated in which the P7-1 gene was expressed under the control of the 35S promoter. The RBSDV P7-1-transgenic Arabidopsis plants (named P7-1-OE) were male sterility. Flowers and pollen from P7-1-transgenic plants were of normal size and shape, and anthers developed to the normal size but failed to dehisce. The non-dehiscent anthers observed in P7-1-OE were attributed to decreased lignin content in the anthers. Furthermore, the reactive oxygen species levels were quite low in the transgenic plants compared with the wild type. These results indicate that ectopic expression of the RBSDV P7-1 protein in A. thaliana causes male sterility, possibly through the disruption of the lignin biosynthesis and H2O2-dependent polymerization pathways.	[Sun, Feng; Yuan, Xia; Xu, Qiufang; Zhou, Tong; Fan, Yongjian; Zhou, Yijun] Jiangsu Acad Agr Sci, Inst Plant Protect, Key Lab Monitoring & Management Plant Virus Dis, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Zhou, YJ (corresponding author), Jiangsu Acad Agr Sci, Inst Plant Protect, Key Lab Monitoring & Management Plant Virus Dis, Nanjing, Jiangsu, Peoples R China.	yjzhou@jaas.ac.cn			National Basic Research Program of China (973 Plan) [2010CB126203]; National Nature Science Foundation of China [31201484, 31000841]; Special Fund for Agro-scientific Research in the Public Interest [201003031, 201303021]	National Basic Research Program of China (973 Plan)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This research was supported by grants from the National Basic Research Program of China (973 Plan, 2010CB126203), the National Nature Science Foundation of China (31201484, 31000841), the Special Fund for Agro-scientific Research in the Public Interest (201003031, 201303021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai FW, 2002, VIRUS GENES, V25, P201, DOI 10.1023/A:1020170020581; Berberich T, 1995, PLANT MOL BIOL, V29, P611, DOI 10.1007/BF00020988; BONNER LJ, 1989, NEW PHYTOL, V113, P97, DOI 10.1111/j.1469-8137.1989.tb02399.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dawson J, 1999, NEW PHYTOL, V144, P213, DOI 10.1046/j.1469-8137.1999.00507.x; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Isogai M, 1998, J GEN VIROL, V79, P1487, DOI 10.1099/0022-1317-79-6-1487; Karkonen A, 2010, J INTEGR PLANT BIOL, V52, P176, DOI 10.1111/j.1744-7909.2010.00913.x; KEIJZER CJ, 1987, NEW PHYTOL, V105, P487, DOI 10.1111/j.1469-8137.1987.tb00886.x; Lee Y, 2013, CELL, V153, P402, DOI 10.1016/j.cell.2013.02.045; Liu CJ, 2012, MOL PLANT, V5, P304, DOI 10.1093/mp/ssr121; Liu HJ, 2007, VIRUS RES, V127, P34, DOI 10.1016/j.virusres.2007.03.017; Liu HJ, 2007, FEBS LETT, V581, P2534, DOI 10.1016/j.febslet.2007.04.071; Liu Y, 2011, ARCH VIROL, V156, P1729, DOI 10.1007/s00705-011-1041-9; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; Owens RJ, 2004, J VIROL, V78, P6649, DOI 10.1128/JVI.78.12.6649-6656.2004; Ren B, 2010, J VIROL, V84, P12914, DOI 10.1128/JVI.00864-10; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; SHIKATA E, 1977, VIROLOGY, V77, P826, DOI 10.1016/0042-6822(77)90502-5; Steiner-Lange S, 2003, PLANT J, V34, P519, DOI 10.1046/j.1365-313X.2003.01745.x; Sun LY, 2013, J GEN VIROL, V94, P1908, DOI 10.1099/vir.0.051698-0; Sun ZT, 2013, ARCH VIROL, V158, P1055, DOI 10.1007/s00705-012-1585-3; Supyani S, 2007, J GEN VIROL, V88, P342, DOI 10.1099/vir.0.82318-0; Thevenin J, 2011, MOL PLANT, V4, P70, DOI 10.1093/mp/ssq045; Villarreal F, 2009, PLANT MOL BIOL, V70, P471, DOI 10.1007/s11103-009-9484-z; Wang QA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-24; Wang ZH, 2003, VIRUS GENES, V27, P163, DOI 10.1023/A:1025776527286; Wilson ZA, 2011, J EXP BOT, V62, P1633, DOI 10.1093/jxb/err014; Wu JX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-114; Xie YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049800; Yang CY, 2007, PLANT CELL, V19, P534, DOI 10.1105/tpc.106.046391; Zhang CZ, 2008, J GEN VIROL, V89, P1770, DOI 10.1099/vir.0.2008/000109-0; Zhang HM, 2001, ARCH VIROL, V146, P2331, DOI 10.1007/s007050170006; Zhang LD, 2005, CHINESE SCI BULL, V50, P305, DOI 10.1360/982004-731; Zhou T, 2011, RICE SCI, V18, P152, DOI 10.1016/S1672-6308(11)60022-X	36	11	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79514	10.1371/journal.pone.0079514	http://dx.doi.org/10.1371/journal.pone.0079514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260239	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600038
J	Cheng, SW; Tsai, HW; Lin, YJ; Cheng, PN; Chang, YC; Yen, CJ; Huang, HP; Chuang, YP; Chang, TT; Lee, CT; Chao, AN; Chou, CY; Chan, SH; Chow, NH; Ho, CL				Cheng, Shu-Wen; Tsai, Hung-Wen; Lin, Yih-Jyh; Cheng, Pin-Nan; Chang, Yu-Chung; Yen, Chia-Jui; Huang, Hsuan-Pang; Chuang, Yun-Pei; Chang, Ting-Tsung; Lee, Chung-Ta; Chao, Anning; Chou, Cheng-Yang; Chan, Shih-Huang; Chow, Nan-Haw; Ho, Chung-Liang			Lin28B Is an Oncofetal Circulating Cancer Stem Cell-Like Marker Associate with Recurrence of Hepatocellular Carcinoma	PLOS ONE			English	Article							FETOPROTEIN MESSENGER-RNA; METASTATIC BREAST-CANCER; TUMOR-CELLS; PERIPHERAL-BLOOD; PROMOTES TRANSFORMATION; CLINICAL-SIGNIFICANCE; QUANTIFICATION; TRANSCRIPTION; PROGRESSION; EXPRESSION	By using an expressed sequence tag bioinformatic algorithm, we identified that Lin28 homolog B (Lin28B) may have an oncofetal expression pattern which may facilitate detecting cancer cells in adults. It is also reported to be a potential marker for cancer stem cells. Therefore, we sought to verify oncofetal-stemness characters of Lin28B and test its potential as a circulating cancer stem cell-like marker in adult HCC patients. Lin28B mRNA was examined in a panel of fetal tissue, adult tissue and tumors. Lin28B was over-expressed or knocked down in HepG2 cells to evaluate its potential as a stem cell-like marker. RT-qPCR for Lin28B was performed in the peripheral blood mononuclear cells from patients with HCC receiving surgery (n=96) and non-HCC controls (n=60) and analyzed its clinical significance. Lin28B showed an oncofetal expression pattern. Its overexpression could upregulate stemness markers (OCT4, Nanog and SOX2) and enhance tumorsphere formation in vitro. Lin28B knockdown had opposite effects. Circulating Lin28B was detected in peripheral blood mononuclear cells in 3 cases (5%) of non-HCC controls and 32 cases (33.3%) of HCC patients. In HCC patients, circulating Lin28B was associated with high tumor grade (P=0.046), large size (P=0.005), high AJCC stage (P=0.044) and BCLC stage (P=0.017). Circulating Lin28B was significantly associated with decreased recurrence-free survival (P<0.001). Circulating Lin28B separated early stage HCC into 2 recurrence-free survival curves (P=0.003). In multivariate analysis, circulating Lin28B was an independent variable associated with early recurrence (P=0.045) and recurrence in early stage HCC (P=0.006). In conclusion, the oncofetal gene Lin28B is a potential oncofetal cancer-stem-cell-like circulating tumor cell marker that correlates with HCC recurrence after hepatectomy. Circulating Lin28B could refine early AJCC stages. Our finding supports the possible use of a TNMC (C for circulating tumor cells) staging system in HCC.	[Cheng, Shu-Wen; Chow, Nan-Haw; Ho, Chung-Liang] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tsai, Hung-Wen; Chuang, Yun-Pei; Lee, Chung-Ta; Chow, Nan-Haw; Ho, Chung-Liang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70101, Taiwan; [Tsai, Hung-Wen; Lin, Yih-Jyh; Yen, Chia-Jui] Natl Cheng Kung Univ, Coll Med, Grad Inst Clin Med, Tainan 70101, Taiwan; [Tsai, Hung-Wen; Cheng, Pin-Nan; Chang, Ting-Tsung; Ho, Chung-Liang] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Lin, Yih-Jyh; Chang, Yu-Chung] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70101, Taiwan; [Cheng, Pin-Nan; Yen, Chia-Jui; Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Huang, Hsuan-Pang; Ho, Chung-Liang] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Chao, Anning] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chao, Anning] Chang Gung Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chao, Anning] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chou, Cheng-Yang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan 70101, Taiwan; Natl Cheng Kung Univ, Dept Stat, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Ho, CL (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	clh9@mail.ncku.edu.tw		Chao, An-Ning/0000-0002-4761-9244	Department of Health, Taiwan [DOH101-TD-C-111-003]; National Science Council, Taiwan [NSC 97-2320-B-006 -027 -MY3, NSC-99-2628-B-006-034-MY2]; NCKUH Research Grant (95) from National Cheng Kung University Hospital, Taiwan. [67]	Department of Health, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NCKUH Research Grant (95) from National Cheng Kung University Hospital, Taiwan.	This was supported by grant DOH101-TD-C-111-003 from the Department of Health, Taiwan, grant NSC 97-2320-B-006 -027 -MY3 and grant NSC-99-2628-B-006-034-MY2 from the National Science Council, Taiwan, and NCKUH Research Grant (95) No. 67 from National Cheng Kung University Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts J, 2001, ANN ONCOL, V12, P39, DOI 10.1023/A:1008317512253; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Andergassen U, 2013, INT J MOL SCI, V14, P1093, DOI 10.3390/ijms14011093; Aselmann H, 2001, LANGENBECK ARCH SURG, V386, P118, DOI 10.1007/s004230000199; Bidard FC, 2008, CLIN CANCER RES, V14, P3306, DOI 10.1158/1078-0432.CCR-07-4749; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Crea F, 2011, J CLIN ONCOL, V29, P3487, DOI 10.1200/JCO.2011.37.0122; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dawood S, 2008, CANCER-AM CANCER SOC, V113, P2422, DOI 10.1002/cncr.23852; Elshimali YI, 2006, DIAGN MOL PATHOL, V15, P187, DOI 10.1097/01.pdm.0000213463.98763.b9; Fan ST, 2011, ANN SURG, V254, P569, DOI 10.1097/SLA.0b013e3182300a1d; Ghossein RA, 1999, CLIN CANCER RES, V5, P1950; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Hsu CC, 2011, ONCOGENE, V30, P654, DOI 10.1038/onc.2010.451; Iinuma H, 2011, J CLIN ONCOL, V29, P1547, DOI 10.1200/JCO.2010.30.5151; Ijichi M, 2002, HEPATOLOGY, V35, P853, DOI 10.1053/jhep.2002.32100; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Liu LL, 2011, STEM CELLS DEV, V20, P2023, DOI 10.1089/scd.2011.0012; Louha M, 1997, HEPATOLOGY, V26, P998; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Minata M, 2001, J GASTROEN HEPATOL, V16, P445, DOI 10.1046/j.1440-1746.2001.02461.x; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pu YS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-39; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sarandakou A, 2007, CRIT REV CL LAB SCI, V44, P151, DOI 10.1080/10408360601003143; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Stathopoulou A, 2003, CLIN CANCER RES, V9, P5145; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang TH, 2010, MOL CELL PROTEOMICS, V9, P1873, DOI 10.1074/mcp.M110.000802; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Wong IHN, 1999, CLIN CANCER RES, V5, P4021; Wu Wei, 2006, Hepatobiliary Pancreat Dis Int, V5, P538; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004	46	43	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80053	10.1371/journal.pone.0080053	http://dx.doi.org/10.1371/journal.pone.0080053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244607	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800114
J	Labuschagne, CF; van den Broek, NJF; Postma, P; Berger, R; Brenkman, AB				Labuschagne, Christiaan F.; van den Broek, Niels J. F.; Postma, Pjotr; Berger, Ruud; Brenkman, Arjan B.			A Protocol for Quantifying Lipid Peroxidation in Cellular Systems by F2-Isoprostane Analysis	PLOS ONE			English	Article							IN-VIVO; CAENORHABDITIS-ELEGANS; PEROXYL; DAMAGE	Cellular systems are essential model systems to study reactive oxygen species and oxidative damage but there are widely accepted technical difficulties with available methods for quantifying endogenous oxidative damage in these systems. Here we present a stable isotope dilution UPLC-MS/MS protocol for measuring F2-isoprostanes as accurate markers for endogenous oxidative damage in cellular systems. F2-isoprostanes are chemically stable prostaglandin-like lipid peroxidation products of arachidonic acid, the predominant polyunsaturated fatty acid in mammalian cells. This approach is rapid and highly sensitive, allowing for the absolute quantification of endogenous lipid peroxidation in as little as ten thousand cells as well as damage originating from multiple ROS sources. Furthermore, differences in the endogenous cellular redox state induced by transcriptional regulation of ROS scavenging enzymes were detected by following this protocol. Finally we showed that the F2-isoprostane5-iPF(2 alpha)-VI is a metabolically stable end product, which is excreted from cells. Overall, this protocol enables accurate, specific and sensitive quantification of endogenous lipid peroxidation in cellular systems.	[Labuschagne, Christiaan F.; van den Broek, Niels J. F.; Postma, Pjotr; Brenkman, Arjan B.] Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands; [Labuschagne, Christiaan F.; van den Broek, Niels J. F.; Postma, Pjotr; Berger, Ruud; Brenkman, Arjan B.] Netherlands Metabol Ctr, Utrecht, Netherlands; [Berger, Ruud] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC	Brenkman, AB (corresponding author), Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands.	a.b.brenkman@umcutrecht.nl		Labuschagne, Christiaan/0000-0001-9474-5174	Netherlands Metabolomics Centre	Netherlands Metabolomics Centre	Authors were financed by grants from the Netherlands Metabolomics Centre which is part of the Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2005, ANTIOXID REDOX SIGN, V7, P221, DOI 10.1089/ars.2005.7.221; CHAMULITRAT W, 1989, J BIOL CHEM, V264, P7889; CHAMULITRAT W, 1989, J BIOL CHEM, V264, P20968; Courtois F, 2002, J NUTR, V132, P1289, DOI 10.1093/jn/132.6.1289; de Keizer PLJ, 2011, ANTIOXID REDOX SIGN, V14, P1093, DOI 10.1089/ars.2010.3403; DOOLEY MM, 1990, FREE RADICAL BIO MED, V9, P199, DOI 10.1016/0891-5849(90)90028-H; Gao L, 2006, J BIOL CHEM, V281, P14092, DOI 10.1074/jbc.M601035200; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; KRALL J, 1988, J BIOL CHEM, V263, P1910; Labuschagne CF, 2013, AGING CELL, V12, P214, DOI 10.1111/acel.12043; Milne GL, 2013, FREE RADICAL BIO MED, V59, P36, DOI 10.1016/j.freeradbiomed.2012.09.030; Milne GL, 2011, CHEM REV, V111, P5973, DOI 10.1021/cr200160h; MILNE GL, 2012, FREE RADIC BIOL MED; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Putker M, 2013, MOL CELL, V49, P730, DOI 10.1016/j.molcel.2012.12.014; SCHULZ E, 2012, ANTIOXID REDOX SIGN, P57349; Sircar D, 2007, CLIN CHEM, V53, P251, DOI 10.1373/clinchem.2006.074989; Taber DF, 1997, PROSTAGLANDINS, V53, P63, DOI 10.1016/S0090-6980(97)00005-1; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x	27	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80935	10.1371/journal.pone.0080935	http://dx.doi.org/10.1371/journal.pone.0080935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244726	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800173
J	van Haren, SD; Wroblewska, A; Herczenik, E; Kaijen, PH; Ruminska, A; ten Brinke, A; Meijer, AB; Voorberg, J				van Haren, Simon D.; Wroblewska, Aleksandra; Herczenik, Eszter; Kaijen, Paul H.; Ruminska, Aleksandra; ten Brinke, Anja; Meijer, Alexander B.; Voorberg, Jan			Limited Promiscuity of HLA-DRB1 Presented Peptides Derived of Blood Coagulation Factor VIII	PLOS ONE			English	Article							CLASS-II SYNTHESIS; T-CELL RESPONSES; COMPLEX CLASS-II; HEMOPHILIA-A; DENDRITIC CELLS; ANTIGEN PRESENTATION; ACQUIRED HEMOPHILIA; EPITOPE REPERTOIRE; IMMUNE-RESPONSE; C1 DOMAIN	The formation of inhibitory antibodies directed against coagulation factor VIII (FVIII) is a severe complication in the treatment of hemophilia A patients. The induction of anti-FVIII antibodies is a CD4(+) T cell-dependent process. Activation of FVIII-specific CD4+ T cells is dependent on the presentation of FVIII-derived peptides on MHC class II by antigen-presenting cells. Previously, we have shown that FVIII-pulsed human monocyte-derived dendritic cells can present peptides from several FVIII domains. In this study we show that FVIII peptides are presented on immature as well as mature dendritic cells. In immature dendritic cells half of the FVIII-loaded MHC class II molecules are retained within the cell, whereas in LPS-matured dendritic cells the majority of MHC class II/peptide complexes is present on the plasma membrane. Time-course studies revealed that presentation of FVIII-derived peptides was optimal between 12 and 24 hours after maturation but persisted for at least 96 hours. We also show that macrophages are able to internalize FVIII as efficiently as dendritic cells, however FVIII was presented on MHC class II with a lower efficiency and with different epitopes compared to dendritic cells. In total, 48 FVIII core-peptides were identified using a DCs derived of 8 different donors. Five HLA-promiscuous FVIII peptide regions were found - these were presented by at least 4 out of 8 donors. The remaining 42 peptide core regions in FVIII were presented by DCs derived from a single (30 peptides) or two to three donors (12 peptides). Overall, our findings show that a broad repertoire of FVIII peptides can be presented on HLA-DR.	[van Haren, Simon D.; Wroblewska, Aleksandra; Herczenik, Eszter; Kaijen, Paul H.; Ruminska, Aleksandra; Meijer, Alexander B.; Voorberg, Jan] Sanquin AMC Landsteiner & Creveld Lab, Dept Plasma Prot, Amsterdam, Netherlands; [ten Brinke, Anja] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands; [Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Utrecht University	Voorberg, J (corresponding author), Sanquin AMC Landsteiner & Creveld Lab, Dept Plasma Prot, Amsterdam, Netherlands.	j.voorberg@sanquin.nl	van Haren, Simon/K-7066-2019	van Haren, Simon/0000-0002-1791-0161; Wroblewska, Aleksandra/0000-0003-2059-6158; ten Brinke, Anja/0000-0002-0135-7496; Voorberg, Jan/0000-0003-4585-2621				Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Burster T, 2007, IMMUNOLOGY, V121, P82, DOI 10.1111/j.1365-2567.2007.02540.x; Burster T, 2008, BIOCHEM BIOPH RES CO, V377, P1299, DOI 10.1016/j.bbrc.2008.10.162; Creasy BM, 2011, CELL IMMUNOL, V267, P56, DOI 10.1016/j.cellimm.2010.11.004; Dasgupta S, 2007, P NATL ACAD SCI USA, V104, P8965, DOI 10.1073/pnas.0702120104; Ettinger RA, 2010, HAEMOPHILIA, V16, P44, DOI 10.1111/j.1365-2516.2008.01905.x; Ettinger RA, 2009, BLOOD, V114, P1423, DOI 10.1182/blood-2009-01-200725; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goldstein OG, 2008, CANCER IMMUNOL IMMUN, V57, P1461, DOI 10.1007/s00262-008-0483-8; Herczenik E, 2012, J ALLERGY CLIN IMMUN, V129, P501, DOI 10.1016/j.jaci.2011.08.029; Howson JMM, 2011, DIABETES, V60, P2635, DOI 10.2337/db11-0131; Jacquemin M, 2003, BLOOD, V101, P1351, DOI 10.1182/blood-2002-05-1369; James EA, 2007, J THROMB HAEMOST, V5, P2399, DOI 10.1111/j.1538-7836.2007.02762.x; Jones TD, 2005, J THROMB HAEMOST, V3, P991, DOI 10.1111/j.1538-7836.2005.01309.x; Moise L, 2012, CLIN IMMUNOL, V142, P320, DOI 10.1016/j.clim.2011.11.010; Navarrete A, 2009, J THROMB HAEMOST, V7, P1816, DOI 10.1111/j.1538-7836.2009.03571.x; Pavlova A, 2009, J THROMB HAEMOST, V7, P2006, DOI 10.1111/j.1538-7836.2009.03636.x; Pratt KP, 2004, THROMB HAEMOSTASIS, V92, P522, DOI 10.1160/TH03-12-0755; Qadura M, 2008, J THROMB HAEMOST, V6, P2095, DOI 10.1111/j.1538-7836.2008.03165.x; Ragni MV, 2009, EXP HEMATOL, V37, P744, DOI 10.1016/j.exphem.2009.02.011; Reding MT, 1999, THROMB HAEMOSTASIS, V82, P509, DOI 10.1055/s-0037-1615873; Reding MT, 2004, J THROMB HAEMOST, V2, P1385, DOI 10.1111/j.1538-7836.2004.00850.x; Reding MT, 2003, J THROMB HAEMOST, V1, P1777, DOI 10.1046/j.1538-7836.2003.00251.x; Reding MT, 2002, THROMB HAEMOSTASIS, V88, P568; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; SMOLEN JS, 1987, ANN RHEUM DIS, V46, P457, DOI 10.1136/ard.46.6.457; Steinitz KN, 2012, BLOOD, V119, P4073, DOI 10.1182/blood-2011-08-374645; van Haren SD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002246; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Wang SF, 2011, VIRAL IMMUNOL, V24, P421, DOI 10.1089/vim.2011.0024; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wroblewska A, 2012, J THROMB HAEMOST, V12, P12065; Wroblewska A, 2012, BLOOD, V119, P5294, DOI 10.1182/blood-2011-11-391680; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665	40	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80239	10.1371/journal.pone.0080239	http://dx.doi.org/10.1371/journal.pone.0080239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244658	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800139
J	Shen, Z; Qin, Y; Liu, Y; Lu, Y; Munker, S; Chen, LH; Yu, CH; Chen, P; Li, YM				Shen, Zhe; Qin, Yu'e; Liu, Yi; Lu, Yi; Munker, Stefan; Chen, Lihua; Yu, Chaohui; Chen, Peng; Li, Youming			Helicobacter pylori Infection Is Associated with the Presence of Thyroid Nodules in the Euthyroid Population	PLOS ONE			English	Article							INSULIN-RESISTANCE; DISEASE; AUTOIMMUNITY	Helicobacter pylori infection is associated with extragastric diseases. The thyroid may be one of the targets of chronic inflammation. Here, we sought to investigate whether H. pylori infections were associated with the presence of thyroid nodules. A total of 988 euthyroid subjects from China were included in this cross-sectional study. Four hundred thirty-five (44.0%) subjects were diagnosed as having thyroid nodules, and 486 (49.2%) were diagnosed with H. pylori infections. The thyroid nodules group had a higher proportion of H. pylori infections than the control group (P = 0.002). Free thyroxine (FT4) levels were lower and the prevalence of thyroid nodules was higher in patients with H. pylori infection compared to those without infection, even after adjustment for age, gender, and body mass index (BMI; all P < 0.05). The prevalence of H. pylori infection showed a decreasing trend as serum FT4 level increased (P-trend = 0.020). Stepwise logistic regression analysis showed that H. pylori infection was significantly associated with the risk of thyroid nodules (odds ratio: 1.390, 95% confidence interval: 1.059-1.824, P = 0.018). Our results suggested that H. pylori infections were positively associated with the presence of thyroid nodules in the euthyroid population, whose thyroid functions were in the reference range.	[Shen, Zhe; Liu, Yi; Lu, Yi; Chen, Lihua; Yu, Chaohui; Li, Youming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Qin, Yu'e; Chen, Peng] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Int Hlth Care Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Munker, Stefan] Heidelberg Univ, Fac Med Mannheim, Med Clin 2, Mannheim, Germany	Zhejiang University; Zhejiang University; Ruprecht Karls University Heidelberg	Li, YM (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	zjulym@126.com		Ma, Han/0000-0001-9985-3035	Zhejiang Provincial Laboratory Animal Science Technology Program of China [2011C37088]; Zhejiang Provincial Natural Science Foundation of China [LY12H03011, LY13H030003]; Natural Science Foundation of Ningbo City [2012A610244]	Zhejiang Provincial Laboratory Animal Science Technology Program of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Ningbo City	This study was supported by Zhejiang Provincial Laboratory Animal Science Technology Program of China (number 2011C37088); Zhejiang Provincial Natural Science Foundation of China (numbers LY12H03011 and LY13H030003); Natural Science Foundation of Ningbo City (number 2012A610244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi V, 2012, WORLD J GASTROENTERO, V18, P1093, DOI 10.3748/wjg.v18.i10.1093; Bassi V, 2010, HELICOBACTER, V15, P558, DOI 10.1111/j.1523-5378.2010.00802.x; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Fredricks DN, 1998, CURR CLIN TOPICS INF, V18, P180; Gasbarrini A, 1998, EUR J GASTROEN HEPAT, V10, P469, DOI 10.1097/00042737-199806000-00006; Herrera V, 2009, CLIN MICROBIOL INFEC, V15, P971, DOI 10.1111/j.1469-0691.2009.03031.x; Iyer NG, 2010, CLIN ONCOL-UK, V22, P405, DOI 10.1016/j.clon.2010.03.009; JOASOO A, 1975, LANCET, V2, P125; Junik R, 2006, ACTA RADIOL, V47, P687, DOI 10.1080/02841850600806308; Kim JY, 2012, J KOREAN SURG SOC, V82, P13, DOI 10.4174/jkss.2012.82.1.13; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Marshall TG, 2008, BIOESSAYS, V30, P173, DOI 10.1002/bies.20708; Mohan S, 1996, J CLIN ENDOCR METAB, V81, P3817, DOI 10.1210/jc.81.11.3817; Polyzos SA, 2013, METABOLISM, V62, P121, DOI 10.1016/j.metabol.2012.06.007; Polyzos SA, 2011, HELICOBACTER, V16, P79, DOI 10.1111/j.1523-5378.2011.00822.x; Pordeus V, 2008, CLIN REV ALLERG IMMU, V34, P283, DOI 10.1007/s12016-007-8048-8; Proal AD, 2009, ANN NY ACAD SCI, V1173, P252, DOI 10.1111/j.1749-6632.2009.04672.x; Rapoport B, 2001, J CLIN INVEST, V108, P1253, DOI 10.1172/JCI14321; Rezzonico J, 2008, THYROID, V18, P461, DOI 10.1089/thy.2007.0223; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; SANTISTEBAN P, 1992, MOL ENDOCRINOL, V6, P1310, DOI 10.1210/me.6.8.1310; Shin DW, 2012, J CLIN GASTROENTEROL, V46, P840, DOI 10.1097/MCG.0b013e3182522477; Stechova K, 2009, EXP CLIN ENDOCR DIAB, V117, P423, DOI 10.1055/s-0029-1214385; Stojadinovic A, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-12; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Triantafillidis John K, 2003, Hepatogastroenterology, V50 Suppl 2, pcccxviii; VALTONEN VV, 1986, ACTA MED SCAND, V219, P105; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z	28	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80042	10.1371/journal.pone.0080042	http://dx.doi.org/10.1371/journal.pone.0080042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244604	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600175
J	Gadgeel, SM; Chen, W; Cote, ML; Bollig-Fischer, A; Land, S; Schwartz, AG; Bepler, G				Gadgeel, Shirish M.; Chen, Wei; Cote, Michele L.; Bollig-Fischer, Aliccia; Land, Susan; Schwartz, Ann G.; Bepler, Gerold			Fibroblast Growth Factor Receptor 1 Amplification in Non-Small Cell Lung Cancer by Quantitative Real-Time PCR	PLOS ONE			English	Article							GENE AMPLIFICATION; FGFR1 AMPLIFICATION; HYBRIDIZATION	Introduction: Amplification of the fibroblast growth factor receptor 1 (FGFR1) gene has been described in tumors of non-small-cell lung cancer (NSCLC) patients. Prior reports showed conflicting rates of amplification frequency and clinical relevance. Materials and Methods: We developed a reliable real-time quantitative PCR assay to assess the frequency of FGFR1 amplification and assessed the optimal cutoff level of amplification for clinical application. Results: In a training cohort of 203 NSCLCs, we established that a 3.5-fold amplification optimally divided patients into groups with different survival rates with a clear threshold level. Those with FGFR1 amplification levels above 3.5-fold had an inferior survival. These data were confirmed in a validation cohort of 142 NSCLC. After adjusting for age, sex, performance status, stage, and histology, patients with FGFR1 amplification levels above 3.5 fold had a hazard ratio of 2.91 (95% Cl- 1.14, 7.41; pvalue-0.025) for death in the validation cohort. The rates of FGFR1 amplification using the cutoff level of 3.5 were 5.1% in squamous cell and 4.1% in adenocarcinomas. There was a non-significant trend towards higher amplifications rates in heavy smokers (> 15 pack-years of cigarette consumption) as compared to light smokers. Discussion: Our data suggest that a 3.5-fold amplification of FGFR1 is of clinical importance in NSCLC. Our cutpoint analysis showed a clear threshold effect for the impact of FGFR1 amplification on patients' survival, which can be used as an initial guide for patient selection in trials assessing efficacy of novel FGFR inhibitors.	[Gadgeel, Shirish M.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA; Wayne State Univ, Dept Oncol, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Gadgeel, SM (corresponding author), Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA.	gadgeels@karmanos.org		Bollig-Fischer, Aliccia/0000-0003-4832-9457	Department of Defense [W81XWH-11-1-0050]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Department of Defense grant W81XWH-11-1-0050. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad I, 2012, BBA-MOL CELL RES, V1823, P850, DOI 10.1016/j.bbamcr.2012.01.004; Bepler G, 2002, J CLIN ONCOL, V20, P1353, DOI 10.1200/JCO.20.5.1353; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Gru AA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3340; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Heist RS, 2012, J THORAC ONCOL, V7, P1775, DOI 10.1097/JTO.0b013e31826aed28; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Larsen JE, 2011, CANCER J, V17, P512, DOI 10.1097/PPO.0b013e31823e701a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayr D, 2006, AM J CLIN PATHOL, V126, P101, DOI 10.1309/N6X5MB24BP42KP20; Oxnard GR, 2013, J CLIN ONCOL, V31, P1097, DOI 10.1200/JCO.2012.42.9829; Pros E, 2013, INT J CANCER, V133, P898, DOI 10.1002/ijc.28090; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reis JS, 2006, CLIN CANCER RES, V12, P6652, DOI 10.1158/1078-0432.CCR-06-1164; RUBIN DB, 1977, J AM STAT ASSOC, V72, P538, DOI 10.2307/2286214; Rubin DB, 2004, MULTIPLE IMPUTATION; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Tomlinson DC, 2012, ADV UROL; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wolf J, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-LB-122; Young RJ, 2013, ORAL ONCOL, V49, P576, DOI 10.1016/j.oraloncology.2013.01.006; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694	23	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79820	10.1371/journal.pone.0079820	http://dx.doi.org/10.1371/journal.pone.0079820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255716	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200089
J	Martini, FH; Beulig, A				Martini, Frederic H.; Beulig, Alfred			Morphometics and Gonadal Development of the Hagfish Eptatretus cirrhatus in New Zealand	PLOS ONE			English	Article							MYXINE GLUTINOSA L; SEASONAL MIGRATION; BURGERI; GULF; REPRODUCTION; PREDATORS; FISHERIES; CARBON; MAINE	Hagfishes have been the target of commercial fisheries in many areas of the world, with the catch processed for leather and for human consumption. A fishery has been operating in New Zealand waters for the last six years, harvesting the bearded hagfish, Eptatretus cirrhatus. The fishery has thus far been unregulated. Based on samples collected dockside over a two-year period, this report expands the morphometric database for this species, provides information on the size and weight of the harvested animals, determines the sizes at the onset of gonadal development and the minimum sizes at sexual maturation for males and females, and indicates that E. cirrhatus, like most other hagfish species, has no specific breeding season. Although females appear in the population at smaller sizes, the sex ratio for mature animals is 1: 1 and the sizes of the largest males and females are comparable. The changes observed in sex ratio as a function of TL suggest differences in the timing and rates of gonadal development in females versus males rather than protogyny. Based on the size of the eggs, the number of eggs per female, the proportion of the population that contains large eggs, and the number of postovulatory females, it is clear that E. cirrhatus, like other hagfish species, are potentially vulnerable to overexploitation.	[Martini, Frederic H.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Beulig, Alfred] New Coll Florida, Div Nat Sci, Sarasota, FL USA	University of Hawaii System; University of Hawaii Manoa; State University System of Florida; New College Florida	Martini, FH (corresponding author), Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA.	martini@maui.net			New College of Florida	New College of Florida	A partial travel grant was provided to Dr. Beulig by New College of Florida, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external or institutional funding was received for this study. All research costs were paid by the investigators.	Barss W.H., 1993, MAR FISH REV, V55, P19; Dawson JA, 1960, BIOL MYXINE, P231; Dean B, 1903, AM NAT, V37, P295, DOI 10.1086/278288; Dean B, 1904, J COLL SCI IMP U TOK, V19, P1; FERNHOLM B, 1981, FISH B-NOAA, V79, P69; FERNHOLM B, 1982, B MAR SCI, V32, P434; Fernholm B, 1998, BIOLOGY OF HAGFISHES, P33; FERNHOLM B, 1975, Acta Zoologica (Stockholm), V56, P199; Glover CN, 2011, P ROY SOC B-BIOL SCI, V278, P3096, DOI 10.1098/rspb.2010.2784; GORBMAN A, 1990, FISHERIES, V15, P12, DOI 10.1577/1548-8446(1990)015<0012:THOJ>2.0.CO;2; GORBMAN A, 1990, GEN COMP ENDOCR, V77, P309, DOI 10.1016/0016-6480(90)90315-D; Grant S, 2009, ASSESSMENT EMERGING, VP-275; Grant SM, 2009, ASSESSMENT EMERGING, VP-276; Honma Y, 1998, BIOLOGY OF HAGFISHES, P45; JESPERSEN A, 1975, Acta Zoologica (Stockholm), V56, P189; Johnson E. W., 1994, THESIS CALIFORNIA ST; KUENSTNER SE, 1996, HARVESTING VALUE ADD; Macavoy SE, 2008, J SHELLFISH RES, V27, P153, DOI 10.2983/0730-8000(2008)27[153:CPIBHI]2.0.CO;2; MacAvoy SE, 2003, CHEM GEOL, V201, P229, DOI 10.1016/S0009-2541(03)00204-3; MALMBERG G, 1989, ZOOL SCR, V18, P187, DOI 10.1111/j.1463-6409.1989.tb00444.x; Martini F, 1997, FISH B-NOAA, V95, P311; Martini F, 1997, J EXP MAR BIOL ECOL, V214, P97, DOI 10.1016/S0022-0981(97)00018-X; Martini F, 2009, WORKSH CAN SCI MAN S, V2009, P4; Martini FH, 1998, BIOLOGY OF HAGFISHES, P57; McLeod RJ, 2007, ECOLOGY, V88, P809, DOI 10.1890/06-1342; MCMILLAN C B, 1984, Proceedings of the California Academy of Sciences, V43, P249; Mincarone MM, 2010, J FISH BIOL, V77, P779, DOI 10.1111/j.1095-8649.2010.02661.x; Mincarone MM, 2006, COPEIA, P225, DOI 10.1643/0045-8511(2006)6[225:ANSOGS]2.0.CO;2; New England Fisheries Management Council, 2003, FIN REP ATL HAGF WOR; Nozaki M, 2000, ZOOL SCI, V17, P225, DOI 10.2108/zsj.17.225; Ota KG, 2007, NATURE, V446, P672, DOI 10.1038/nature05633; Patzner RA, 1998, BIOLOGY OF HAGFISHES, P378; Patzner RA, 1977, ACTA ZOOLOGICA, V58, P57; Powell ML, 2005, INTEGR COMP BIOL, V45, P158, DOI 10.1093/icb/45.1.158; SCHREINER KE, 1955, U BERGEN ARB NATURV, V8, P1; SHELTON RGJ, 1978, J MAR BIOL ASSOC UK, V58, P81, DOI 10.1017/S0025315400024413; STRAHAN R, 1975, Australian Zoologist, V18, P137; TSUNEKI K, 1983, JPN J ICHTHYOL, V29, P429; TSUNEKI K, 1985, ACTA ZOOL-STOCKHOLM, V66, P151, DOI 10.1111/j.1463-6395.1985.tb00833.x; Zintzen V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00131	40	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78740	10.1371/journal.pone.0078740	http://dx.doi.org/10.1371/journal.pone.0078740			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250811	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200044
J	Miyauchi, E; Ogita, T; Miyamoto, J; Kawamoto, S; Morita, H; Ohno, H; Suzuki, T; Tanabe, S				Miyauchi, Eiji; Ogita, Tasuku; Miyamoto, Junki; Kawamoto, Seiji; Morita, Hidetoshi; Ohno, Hiroshi; Suzuki, Takuya; Tanabe, Soichi			Bifidobacterium longum Alleviates Dextran Sulfate Sodium-Induced Colitis by Suppressing IL-17A Response: Involvement of Intestinal Epithelial Costimulatory Molecules	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELLS; EXPRESSION; ANTIGEN; LACTOBACILLUS; PATHOGENESIS; PROBIOTICS; EXPANSION; MODERATE; STRAINS	Although some bacterial strains show potential to prevent colitis, their mechanisms are not fully understood. Here, we investigated the anti-colitic mechanisms of Bifidobacterium longum subsp. infantis JCM 1222(T), focusing on the relationship between interleukin (IL)-17A secreting CD4(+) T cells and intestinal epithelial costimulatory molecules in mice. Oral administration of JCM 1222(T) to mice alleviated dextran sulfate sodium (DSS)-induced acute colitis. The expression of type 1 helper T (Th1)- and IL-17 producing helper T (Th17)-specific cytokines and transcriptional factors was suppressed by JCM 1222(T) treatment. Intestinal epithelial cells (IECs) from colitic mice induced IL-17A production from CD4(+) T cells in a cell-cell contact-dependent manner, and this was suppressed by oral treatment with JCM 1222(T). Using blocking antibodies for costimulatory molecules, we revealed that epithelial costimulatory molecules including CD80 and CD40, which were highly expressed in IECs from colitic mice, were involved in IEC-induced IL-17A response. Treatment of mice and intestinal epithelial cell line Colon-26 cells with JCM 1222(T) decreased the expression of CD80 and CD40. Collectively, these data indicate that JCM 1222(T) negatively regulate epithelial costimulatory molecules, and this effect might be attributed, at least in part, to suppression of IL-17A in DSS-induced colitis.	[Miyauchi, Eiji; Ogita, Tasuku; Miyamoto, Junki; Suzuki, Takuya; Tanabe, Soichi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan; [Miyauchi, Eiji; Ohno, Hiroshi] RIKEN, Ctr Integrat Med Sci IMS RCAI, Lab Intestinal Ecosyst, Yokohama, Kanagawa, Japan; [Kawamoto, Seiji] Hiroshima Univ, Grad Sch Adv Sci Matter, Higashihiroshima, Hiroshima 724, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan	Hiroshima University; RIKEN; Hiroshima University; Azabu University	Tanabe, S (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan.	stanabe@hiroshima-u.ac.jp	Kawamoto, Seiji/F-3423-2015; Suzuki, Takuya/H-3750-2019; Tanabe, Soichi/R-6229-2019; Ohno, Hiroshi/L-7899-2014; 宮本, 潤基/ABG-8169-2020	Kawamoto, Seiji/0000-0002-2056-4802; Suzuki, Takuya/0000-0003-3709-543X; Ohno, Hiroshi/0000-0001-8776-9661; 	Japan Society for the Promotion of Science (JSPS) [22380076, 25292074]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (JSPS), a Grant-in Aid for Scientific Research (B) for ST (Nos. 22380076 and 25292074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Azuma YT, 2008, J CELL PHYSIOL, V216, P111, DOI 10.1002/jcp.21381; Borcherding F, 2010, AM J PATHOL, V176, P1816, DOI 10.2353/ajpath.2010.090461; Burakoff R, 2006, INFLAMM BOWEL DIS, V12, P558, DOI 10.1097/01.ibd.0000225337.14356.31; Cruickshank SM, 2004, GUT, V53, P678, DOI 10.1136/gut.2003.029967; Dotan I, 2007, AM J PHYSIOL-GASTR L, V292, pG1630, DOI 10.1152/ajpgi.00294.2006; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fina D, 2008, GASTROENTEROLOGY, V134, P1038, DOI 10.1053/j.gastro.2008.01.041; Fitzpatrick LR, 2010, INFLAMM BOWEL DIS, V16, P1763, DOI 10.1002/ibd.21264; Ghadimi D, 2010, INFLAMM BOWEL DIS, V16, P410, DOI 10.1002/ibd.21057; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; Heuvelin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005184; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Khokhlova EV, 2012, MICROBIOL IMMUNOL, V56, P27, DOI 10.1111/j.1348-0421.2011.00398.x; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; KLAUS SJ, 1994, J IMMUNOL, V152, P5643; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Fernandez EM, 2011, GUT, V60, P1444, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; Miyauchi E, 2009, J DAIRY SCI, V92, P2400, DOI 10.3168/jds.2008-1698; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Odamaki T, 2012, ANAEROBE, V18, P14, DOI 10.1016/j.anaerobe.2011.11.004; Ogita T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/378417; Olsen T, 2011, CYTOKINE, V56, P633, DOI 10.1016/j.cyto.2011.08.036; Prisciandaro L, 2009, INFLAMM BOWEL DIS, V15, P1906, DOI 10.1002/ibd.20938; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Roselli M, 2009, INFLAMM BOWEL DIS, V15, P1526, DOI 10.1002/ibd.20961; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shin T, 2003, J EXP MED, V198, P31, DOI 10.1084/jem.20030242; Singh N, 2013, FEMS MICROBIOL ECOL; Tanabe S, 2013, INT REV IMMUNOL; Tanabe S, 2008, INT J MOL MED, V22, P181, DOI 10.3892/ijmm_00000006; Telega GW, 2000, GASTROENTEROLOGY, V119, P1548, DOI 10.1053/gast.2000.20168; TSURUO T, 1983, CANCER RES, V43, P5437; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; Verdier J, 2012, INFLAMM BOWEL DIS, V18, P1260, DOI 10.1002/ibd.21905; Wall R, 2012, AM J CLIN NUTR, V95, P1278, DOI 10.3945/ajcn.111.026435; Westendorf AM, 2009, GUT, V58, P211, DOI 10.1136/gut.2008.151720	43	47	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79735	10.1371/journal.pone.0079735	http://dx.doi.org/10.1371/journal.pone.0079735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255712	Green Submitted, gold, Green Published			2022-12-25	WOS:000327216200084
J	Zhang, MQ; Powell, CA; Benyon, LS; Zhou, H; Duan, YP				Zhang, Muqing; Powell, Charles A.; Benyon, Lesley S.; Zhou, Hui; Duan, Yongping			Deciphering the Bacterial Microbiome of Citrus Plants in Response to 'Candidatus Liberibacter asiaticus'-Infection and Antibiotic Treatments	PLOS ONE			English	Article							SAO-PAULO STATE; GREENING DISEASE; DIVERSITY; XYLOSOXYDANS; ALGORITHM; SEQUENCE; MODEL; TREES	The bacterial microbiomes of citrus plants were characterized in response to 'Candidatus Liberibacter asiaticus' (Las)-infection and treatments with ampicillin (Amp) and gentamicin (Gm) by Phylochip-based metagenomics. The results revealed that 7,407 of over 50,000 known Operational Taxonomic Units (OTUs) in 53 phyla were detected in citrus leaf midribs using the PhyloChip (TM) G3 array, of which five phyla were dominant, Proteobacteria (38.7%), Firmicutes (29.0%), Actinobacteria (16.1%), Bacteroidetes (6.2%) and Cyanobacteria (2.3%). The OTU62806, representing 'Candidatus Liberibacter', was present with a high titer in the plants graft-inoculated with Las-infected scions treated with Gm at 100 mg/L and in the water-treated control (CK1). However, the Las bacterium was not detected in the plants graft-inoculated with Las-infected scions treated with Amp at 1.0 g/L or in plants graft-inoculated with Las-free scions (CK2). The PhyloChip array demonstrated that more OTUs, at a higher abundance, were detected in the Gm-treated plants than in the other treatment and the controls. Pairwise comparisons indicated that 23 OTUs from the Achromobacter spp. and 12 OTUs from the Methylobacterium spp. were more abundant in CK2 and CK1, respectively. Ten abundant OTUs from the Stenotrophomonas spp. were detected only in the Amp-treatment. These results provide new insights into microbial communities that may be associated with the progression of citrus huanglongbing (HLB) and the potential effects of antibiotics on the disease and microbial ecology.	[Zhang, Muqing; Powell, Charles A.] IFAS UF, Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Zhang, Muqing; Benyon, Lesley S.; Duan, Yongping] USDA ARS, US Hort Lab, Ft Pierce, FL 34945 USA; [Zhang, Muqing; Zhou, Hui] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China	United States Department of Agriculture (USDA); Guangxi University	Duan, YP (corresponding author), USDA ARS, US Hort Lab, Ft Pierce, FL 34945 USA.	yongping.duan@ars.usda.gov	Benyon, Lesley/GXV-7974-2022	zhang, muqing/0000-0003-3138-3422	Florida Citrus Research and Development Foundation [161, 162]; Florida Department of Agriculture and Consumer Service-Specialty Crop Block [018023]	Florida Citrus Research and Development Foundation; Florida Department of Agriculture and Consumer Service-Specialty Crop Block	This work was supported by the Florida Citrus Research and Development Foundation awards 161 and 162 and the Florida Department of Agriculture and Consumer Service-Specialty Crop Block Grant 018023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; Aubert B., 1990, REHABILITATION CITRU, P133; Barcia-Macay M, 2006, ANTIMICROB AGENTS CH, V50, P841, DOI 10.1128/AAC.50.3.841-851.2006; BLUMBERG PM, 1974, BACTERIOL REV, V38, P291, DOI 10.1128/MMBR.38.3.291-335.1974; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; Costa LED, 2012, BRAZ J MICROBIOL, V43, P1562, DOI [10.1590/S1517-83822012000400041, 10.1590/S1517-838220120004000041]; Donnua S, 2012, CROP PROT, V41, P128, DOI 10.1016/j.cropro.2012.04.030; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Heidari F., 2012, Middle East Journal of Scientific Research, V12, P336; Hodges A, 2012, EC IMPACTS CITRUS GR; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Meyer JM, 2007, J INVERTEBR PATHOL, V95, P101, DOI 10.1016/j.jip.2007.01.005; Moretti M., 2008, International Journal of Botany, V4, P369; Nariani T.K., 1981, P INT SOC CITRICULT, V1, P471; Probst A, 2010, APPL ENVIRON MICROB, V76, P2837, DOI 10.1128/AEM.02167-09; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Sagaram US, 2009, APPL ENVIRON MICROB, V75, P1566, DOI 10.1128/AEM.02404-08; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Su H.J., 1974, P INT C EL MICR, V2, P628; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Trivedi P, 2011, MICROB ECOL, V62, P324, DOI 10.1007/s00248-011-9822-y; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Vaidya RJ, 2001, WORLD J MICROB BIOT, V17, P691, DOI 10.1023/A:1012927116756; Van Bambeke F, 2006, CURR OPIN DRUG DISC, V9, P218; Wolf A, 2002, INT J SYST EVOL MICR, V52, P1937, DOI [10.1099/ijs.0.02135-0, 10.1099/00207713-52-6-1937]; Yan PS, 2004, APPL ENVIRON MICROB, V70, P7466, DOI 10.1128/AEM.70.12.7466-7473.2004; YUEN GY, 1986, PHYTOPATHOLOGY, V76, P171, DOI 10.1094/Phyto-76-171; Zhang MQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-112; Zhang MQ, 2012, PHYTOPATHOLOGY, V102, P567, DOI 10.1094/PHYTO-09-11-0265; Zhang MQ, 2011, PHYTOPATHOLOGY, V101, P1097, DOI 10.1094/PHYTO-09-10-0262	42	24	25	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e76331	10.1371/journal.pone.0076331	http://dx.doi.org/10.1371/journal.pone.0076331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250784	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200005
J	Novakova, L; Valentova, JV; Havlicek, J				Novakova, Lenka; Valentova, Jaroslava Varella; Havlicek, Jan			Olfactory Performance Is Predicted by Individual Sex-Atypicality, but Not Sexual Orientation	PLOS ONE			English	Article							ODOR IDENTIFICATION; PUTATIVE PHEROMONES; GENDER-DIFFERENCES; HOMOSEXUAL-MEN; BRAIN RESPONSE; FINGER-LENGTH; AGGRESSION; BEHAVIOR; FEMALE; HORMONES	Many previous studies have reported robust sex differences in olfactory perception. However, both men and women can be expected to vary in the degree to which they exhibit olfactory performance considered typical of their own or the opposite sex. Sex-atypicality is often described in terms of childhood gender nonconformity, which, however, is not a perfect correlate of non-heterosexual orientation. Here we explored intrasexual variability in psychophysical olfactory performance in a sample of 156 individuals (83 non-heterosexual) and found the lowest odor identification scores in heterosexual men. However, when childhood gender nonconformity was entered in the model along with sexual orientation, better odor identification scores were exhibited by gender-nonconforming men, and greater olfactory sensitivity by gender-conforming women, irrespective of their sexual orientation. Thus, sex-atypicality, but not sexual orientation predicts olfactory performance, and we propose that this might not be limited to olfaction, but represent a more general phenomenon.	[Novakova, Lenka] Charles Univ Prague, Fac Humanities, Dept Anthropol, Prague, Czech Republic; [Valentova, Jaroslava Varella] Charles Univ Prague, Ctr Theoret Study, Prague, Czech Republic; [Valentova, Jaroslava Varella] Acad Sci Czech Republ, Prague, Czech Republic; [Havlicek, Jan] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Charles University Prague	Novakova, L (corresponding author), Charles Univ Prague, Fac Humanities, Dept Anthropol, Prague, Czech Republic.	lenka.novakova@fhs.cuni.cz	Valentova, Jaroslava Varella/K-8765-2012; Martinec Nováková, Lenka/F-6474-2015; Havlíček, Jan/F-8985-2011	Valentova, Jaroslava Varella/0000-0002-2113-3385; Martinec Nováková, Lenka/0000-0002-5695-2903; Havlíček, Jan/0000-0003-2374-7337	Charles University [SVV-2013-267 702]; Ministry of Education, Youth and Sports; Charles University Research Center [UNCE 204004]; Grant Agency of the Czech Republic [GACR 13-16959P]	Charles University; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Charles University Research Center; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	LN was supported by the grant SVV-2013-267 702 of the Charles University and by The Ministry of Education, Youth and Sports - Institutional Support for Longterm Development of Research Organizations - Charles University, Faculty of Humanities (Charles Univ, Fac Human 2013). JVV and JH were supported by the Charles University Research Center (UNCE 204004). JVV was further supported by the Grant Agency of the Czech Republic (GACR 13-16959P). The funding sources had no involvement in study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the article for publication.	ALLEN LS, 1989, J NEUROSCI, V9, P497; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; BAILEY JM, 1995, DEV PSYCHOL, V31, P43, DOI 10.1037/0012-1649.31.1.43; Bailey JM, 1996, MASCULINITY FEMININI; Baird AD, 2007, J NEUROL NEUROSUR PS, V78, P1042, DOI 10.1136/jnnp.2006.107193; Berg N, 2006, APPL ECON, V38, P757, DOI 10.1080/00036840500427114; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Bocklandt S, 2007, ADV GENET, V59, P245, DOI 10.1016/S0065-2660(07)59009-7; Brand G, 2001, Q J EXP PSYCHOL-B, V54, P259, DOI 10.1080/02724990143000045; Cooke BM, 2005, J NEUROSCI, V25, P10759, DOI 10.1523/JNEUROSCI.2919-05.2005; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI 10.1037//0022-3514.81.2.322; Diamond LM, 2008, DEV PSYCHOL, V44, P5, DOI 10.1037/0012-1649.44.1.5; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Fergusson DM, 2005, PSYCHOL MED, V35, P971, DOI 10.1017/S0033291704004222; Field A., 2009, DISCOVERING STAT USI; Fuwa M, 2007, SOC SCI RES, V36, P512, DOI 10.1016/j.ssresearch.2006.04.005; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; GLADUE BA, 1995, PSYCHONEUROENDOCRINO, V20, P487, DOI 10.1016/0306-4530(94)00075-L; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Gur RC, 1999, J NEUROSCI, V19, P4065; Halari R, 2006, EXP BRAIN RES, V169, P1, DOI 10.1007/s00221-005-0118-7; Halpern D., 2013, SEX DIFFERENCES COGN, V4th; Hassan B, 2007, BEHAV NEUROSCI, V121, P625, DOI 10.1037/0735-7044.121.3.625; Havlicek J, 2012, PERCEPTION, V41, P1246, DOI 10.1068/p7244; Havlicek J, 2010, VITAM HORM, V83, P47, DOI 10.1016/S0083-6729(10)83003-1; Hines M, 2011, FRONT NEUROENDOCRIN, V32, P170, DOI 10.1016/j.yfrne.2011.02.006; HOCKENBERRY SL, 1987, ARCH SEX BEHAV, V16, P475, DOI 10.1007/BF01541712; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; IBM, 2011, CAT REGR OPT; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Lippa RA, 2006, PSYCHOL SCI, V17, P46, DOI 10.1111/j.1467-9280.2005.01663.x; Lippa RA, 2003, J PERS SOC PSYCHOL, V85, P179, DOI 10.1037/0022-3514.85.1.179; Lippa Richard A., 2005, GENDER NATURE NURTUR, V2nd, DOI 10.4324/9781410612946; Lorig TS, 1999, NEUROSCI BIOBEHAV R, V23, P391, DOI 10.1016/S0149-7634(98)00041-4; Lundstrom JN, 2003, CHEM SENSES, V28, P643, DOI 10.1093/chemse/bjg057; Manning JT., 2002, DIGIT RATIO POINTER; McCarthy MM, 2010, J NEUROENDOCRINOL, V22, P736, DOI 10.1111/j.1365-2826.2010.02021.x; MCCORMICK CM, 1991, PSYCHONEUROENDOCRINO, V16, P459, DOI 10.1016/0306-4530(91)90030-W; McFadden D, 2005, ARCH SEX BEHAV, V34, P341, DOI 10.1007/s10508-005-3123-9; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mock SE, 2012, ARCH SEX BEHAV, V41, P641, DOI 10.1007/s10508-011-9761-1; Neave N, 1999, BRAIN COGNITION, V41, P245, DOI 10.1006/brcg.1999.1125; Ostrov JM, 2004, SOC DEV, V13, P255, DOI 10.1111/j.1467-9507.2004.000266.x; Peters M, 2002, AM J PHYS ANTHROPOL, V117, P209, DOI 10.1002/ajpa.10029; Peterson ZD, 2010, ARCH SEX BEHAV, V39, P880, DOI 10.1007/s10508-009-9546-y; Rahman Q, 2004, BEHAV NEUROSCI, V118, P243, DOI 10.1037/0735-7044.118.1.243; Rahman Q, 2003, NEUROPSYCHOLOGY, V17, P240, DOI 10.1037/0894-4105.17.2.240; Rahman Q, 2012, ARCH SEX BEHAV, V41, P623, DOI 10.1007/s10508-011-9737-1; Santtila P, 2008, BIOL PSYCHOL, V77, P102, DOI 10.1016/j.biopsycho.2007.08.006; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; SCHLAEPFER TE, 1995, PSYCHIAT RES-NEUROIM, V61, P129, DOI 10.1016/0925-4927(95)02634-A; Sergeant MJT, 2006, PERS INDIV DIFFER, V40, P475, DOI 10.1016/j.paid.2005.07.002; THYSEN B, 1968, STEROIDS, V11, P73, DOI 10.1016/S0039-128X(68)80052-2	57	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80234	10.1371/journal.pone.0080234	http://dx.doi.org/10.1371/journal.pone.0080234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244657	gold, Green Published, Green Submitted			2022-12-25	WOS:000327162900069
J	Tabashnik, BE; Fabrick, JA; Unnithan, GC; Yelich, AJ; Masson, L; Zhang, J; Bravo, A; Soberon, M				Tabashnik, Bruce E.; Fabrick, Jeffrey A.; Unnithan, Gopalan C.; Yelich, Alex J.; Masson, Luke; Zhang, Jie; Bravo, Alejandra; Soberon, Mario			Efficacy of Genetically Modified Bt Toxins Alone and in Combinations Against Pink Bollworm Resistant to Cry1Ac and Cry2Ab	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; INSECT RESISTANCE; PECTINOPHORA-GOSSYPIELLA; FIELD-RESISTANCE; LEPIDOPTERA; COTTON; CROPS; POPULATIONS; NOCTUIDAE; TOLERANCE	Evolution of resistance in pests threatens the long-term efficacy of insecticidal proteins from Bacillus thuringiensis (Bt) used in sprays and transgenic crops. Previous work showed that genetically modified Bt toxins Cry1AbMod and Cry1AcMod effectively countered resistance to native Bt toxins Cry1Ab and Cry1Ac in some pests, including pink bollworm (Pectinophora gossypiella). Here we report that Cry1AbMod and Cry1AcMod were also effective against a laboratory-selected strain of pink bollworm resistant to Cry2Ab as well as to Cry1Ab and Cry1Ac. Resistance ratios based on the concentration of toxin killing 50% of larvae for the resistant strain relative to a susceptible strain were 210 for Cry2Ab, 270 for Cry1Ab, and 310 for Cry1Ac, but only 1.6 for Cry1AbMod and 2.1 for Cry1AcMod. To evaluate the interactions among toxins, we tested combinations of Cry1AbMod, Cry1Ac, and Cry2Ab. For both the resistant and susceptible strains, the net results across all concentrations tested showed slight but significant synergism between Cry1AbMod and Cry2Ab, whereas the other combinations of toxins did not show consistent synergism or antagonism. The results suggest that the modified toxins might be useful for controlling populations of pink bollworm resistant to Cry1Ac, Cry2Ab, or both.	[Tabashnik, Bruce E.; Unnithan, Gopalan C.; Yelich, Alex J.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Fabrick, Jeffrey A.] ARS, USDA, US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Masson, Luke] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Zhang, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Bravo, Alejandra; Soberon, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	University of Arizona; United States Department of Agriculture (USDA); National Research Council Canada; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Universidad Nacional Autonoma de Mexico	Tabashnik, BE (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	brucet@cals.arizona.edu	de la Parra, Maria Alejandra Bravo/R-6740-2017	Fabrick, Jeffrey/0000-0002-3893-9545; Bravo, Alejandra/0000-0002-7573-7475	USDA-Agriculture and Food Research Initiative [2008-35302-0390]	USDA-Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	This work was supported by USDA-Agriculture and Food Research Initiative Grant 2008-35302-0390. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara E, 2011, CROP PROT, V30, P554, DOI 10.1016/j.cropro.2010.12.019; Alvi AHK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047309; An JJ, 2010, J ECON ENTOMOL, V103, P2169, DOI 10.1603/EC10105; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Beard CE, 2008, CURR MICROBIOL, V57, P175, DOI 10.1007/s00284-008-9098-8; Caccia S, 2012, APPL ENVIRON MICROB, V78, P5690, DOI 10.1128/AEM.00523-12; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Chougule NP, 2013, P NATL ACAD SCI USA, V110, P8465, DOI 10.1073/pnas.1222144110; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Finney D, 1971, PROBIT ANAL, P50; Franklin MT, 2009, APPL ENVIRON MICROB, V75, P5739, DOI 10.1128/AEM.00664-09; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Huang Fangneng, 2012, GM Crops Food, V3, P245, DOI 10.4161/gmcr.20539; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Ingram W. R., 1994, P107; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Liu YB, 1998, APPL ENVIRON MICROB, V64, P1385; Liu YB, 2001, J ECON ENTOMOL, V94, P248, DOI 10.1603/0022-0493-94.1.248; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Mahon RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039192; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Moar WJ, 2007, SCIENCE, V318, P1561, DOI 10.1126/science.1151313; Munoz-Garay C, 2009, BBA-BIOMEMBRANES, V1788, P2229, DOI 10.1016/j.bbamem.2009.06.014; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102; Porta H, 2011, INSECT BIOCHEM MOLEC, V41, P513, DOI 10.1016/j.ibmb.2011.04.013; Sainsbury F, 2012, TOXINS, V4, P455, DOI 10.3390/toxins4060455; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Software Leora, 1987, POLO PC US GUID PROB; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 2002, APPL ENVIRON MICROB, V68, P3790, DOI 10.1128/AEM.68.8.3790-3794.2002; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik Bruce E, 2012, GM Crops Food, V3, P194, DOI 10.4161/gmcr.20329; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Fernandez-Luna MT, 2010, J INVERTEBR PATHOL, V104, P231, DOI 10.1016/j.jip.2010.03.007; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wirth MC, 1997, P NATL ACAD SCI USA, V94, P10536, DOI 10.1073/pnas.94.20.10536; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	50	45	46	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80496	10.1371/journal.pone.0080496	http://dx.doi.org/10.1371/journal.pone.0080496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244692	gold, Green Submitted, Green Published			2022-12-25	WOS:000327162900082
J	Beleigoli, AM; Boersma, E; Diniz, MDH; Vidigal, PG; Lima-Costa, MF; Ribeiro, AL				Beleigoli, Alline M.; Boersma, Eric; Diniz, Maria de Fatima H.; Vidigal, Pedro G.; Lima-Costa, Maria Fernanda; Ribeiro, Antonio L.			C-Reactive Protein and B-Type Natriuretic Peptide Yield Either a Non-Significant or a Modest Incremental Value to Traditional Risk Factors in Predicting Long-Term Overall Mortality in Older Adults	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIOVASCULAR EVENTS; MULTIPLE BIOMARKERS; BAMBUI COHORT; DEATH; INTERLEUKIN-6; POPULATION; DISEASE; HOSPITALIZATION; BIOCHEMISTRY	Background: New biomarkers may aid in preventive and end-of-life decisions in older adults if they enhance the prognostic ability of traditional risk factors. We investigated whether C-reactive protein (CRP) and/or B-type natriuretic peptide (BNP) improve the ability to predict overall mortality among the elderly of the Bambu, Brazil Study of Aging when added to traditional risk factors. Methods: From 1997 to 2007, 1,470 community-dwelling individuals (>= 60 years) were followed-up. Death was ascertained by continuous verification of death certificates. We calculated hazard ratios per 1 standard deviation change (HR) of death for traditional risk factors only (old model), and traditional risk factors plus CRP and/or BNP (new models) and assessed calibration of the models. Subsequently, we compared c-statistic of each of the new models to the old one, and calculated integrated discriminative improvement (IDI) and net reclassification improvement (NRI). Results: 544 (37.0%) participants died in a mean follow-up time of 9.0 years. CRP (HR 1.28, 95% CI 1.17-1.40), BNP (HR 1.31 95% CI 1.19-1.45), and CRP plus BNP (HR 1.26, 95% CI 1.15-1.38, and HR 1.29, 95% CI 1.16-1.42, respectively) were independent determinants of mortality. All models were well-calibrated. Discrimination was similar among the old (c-statistic 0.78 [0.78-0.81]) and new models (p=0.43 for CRP; p=0.57 for BNP; and p=0.31 for CRP plus BNP). Compared to the old model, CRP, BNP, and CRP plus BNP models led to an IDI of 0.009 (p<0.001), -0.005 (p<0.001) and -0.003 (p=0.84), and a NRI of 0.04 (p=0.24), 0.07 (p=0.08) and 0.06 (p=0.10), respectively. Conclusions: Despite being independent predictors of long-term risk of death, compared to traditional risk factors CRP and/or BNP led to either a modest or non-significant improvement in the ability of predicting all-cause mortality in older adults.	[Beleigoli, Alline M.; Diniz, Maria de Fatima H.; Lima-Costa, Maria Fernanda; Ribeiro, Antonio L.] Univ Fed Minas Gerais, Fac Med, Dept Internal Med, Belo Horizonte, MG, Brazil; [Beleigoli, Alline M.; Diniz, Maria de Fatima H.; Ribeiro, Antonio L.] Univ Fed Minas Gerais, Fac Med, Postgrad Dept, Belo Horizonte, MG, Brazil; [Boersma, Eric] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Vidigal, Pedro G.] Univ Fed Minas Gerais, Fac Med, Dept Diagnost Med, Belo Horizonte, MG, Brazil; [Lima-Costa, Maria Fernanda] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Erasmus University Rotterdam; Erasmus MC; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Ribeiro, AL (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Internal Med, Belo Horizonte, MG, Brazil.	abeleigoli@gmail.com	Vidigal, Pedro G/K-4834-2016; Ribeiro, Ana Cristina/HHN-7466-2022; Costa, Maria Fernanda Furtado de Lima e/ABE-3779-2021; Ribeiro, Antonio L/C-2707-2009; Vidigal, Pedro/AAD-5740-2020	Vidigal, Pedro G/0000-0001-8035-1350; Ribeiro, Ana Cristina/0000-0002-0493-8376; Costa, Maria Fernanda Furtado de Lima e/0000-0002-3474-2980; Ribeiro, Antonio L/0000-0002-2740-0042; Beleigoli, Alline/0000-0002-7848-3183	Financiadora de Estudos e Projetos, Rio de Janeiro, Brazil; Ministerio da Saude, Brasilia, Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Belo Horizonte, Brazil; Programa de Doutorando com Estagio no Exterior do Conselho de Aperfeicoamento de Pessoal Superior, Brazil	Financiadora de Estudos e Projetos, Rio de Janeiro, Brazil(Financiadora de Inovacao e Pesquisa (Finep)); Ministerio da Saude, Brasilia, Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Belo Horizonte, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Programa de Doutorando com Estagio no Exterior do Conselho de Aperfeicoamento de Pessoal Superior, Brazil	This work was supported by Financiadora de Estudos e Projetos, Rio de Janeiro, Brazil; Ministerio da Saude, Brasilia, Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Belo Horizonte, Brazil. M. F. Lima-Costa and A. L. Ribeiro are fellows of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. A. M. Beleigoli was supported by the Programa de Doutorando com Estagio no Exterior do Conselho de Aperfeicoamento de Pessoal Superior, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assuncao LG, 2012, BRAZ J MED BIOL RES; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V284, pE481, DOI 10.1152/ajpendo.00319.2002; Beleigoli AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052111; Beleigoli AM, 2011, PEPTIDES, V32, P1787, DOI 10.1016/j.peptides.2011.08.013; Blackburn R, 2001, ARTERIOSCL THROM VAS, V21, P1962, DOI 10.1161/hq1201.099433; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Cartier A, 2009, METABOLISM, V58, P1452, DOI 10.1016/j.metabol.2009.04.025; Cesari M, 2009, J NUTR HEALTH AGING, V13, P587, DOI 10.1007/s12603-009-0168-9; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Costa MFFLE, 2001, INT J EPIDEMIOL, V30, P887, DOI 10.1093/ije/30.4.887; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; D'Agostino R, 2004, HANDBOOK OF STATISTI; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Doust JA, 2005, BRIT MED J, V330, P625, DOI 10.1136/bmj.330.7492.625; Giovannini S, 2011, J AM GERIATR SOC, V59, P1679, DOI 10.1111/j.1532-5415.2011.03570.x; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Lima-Costa MF, 2011, CAD SAUDE PUBLICA, V27, pS360, DOI 10.1590/S0102-311X2011001500006; Lima-Costa MF, 2011, INT J EPIDEMIOL, V40, P862, DOI 10.1093/ije/dyq143; Lima-Costa MF, 2010, AM J EPIDEMIOL, V172, P190, DOI 10.1093/aje/kwq106; Maugeri D, 1998, ARCH GERONTOL GERIAT, V27, P159, DOI 10.1016/S0167-4943(98)00110-1; Myers GL, 2009, CLIN CHEM, V55, P378, DOI 10.1373/clinchem.2008.115899; NAKAO K, 1992, J HYPERTENS, V10, P907; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P1105, DOI 10.1111/j.1532-5415.2004.52308.x; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Ribeiro ALP, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b787; Rost NS, 2012, STROKE, V43, P441, DOI 10.1161/STROKEAHA.111.629212; Rutten JHW, 2010, HYPERTENSION, V55, P785, DOI 10.1161/HYPERTENSIONAHA.109.143313; Salanitro AH, 2012, ARCH GERONTOL GERIAT, V54, pE387, DOI 10.1016/j.archger.2012.01.006; Schett G, 2006, ARCH INTERN MED, V166, P2495, DOI 10.1001/archinte.166.22.2495; SHERMAN SE, 1994, AM HEART J, V128, P965, DOI 10.1016/0002-8703(94)90596-7; Shimizu Y, 2009, GERIATR GERONTOL INT, V9, P148, DOI 10.1111/j.1447-0594.2009.00514.x; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tice JA, 2003, AM J MED, V114, P199, DOI 10.1016/S0002-9343(02)01497-3; Ueda R, 2003, AM J MED, V114, P266, DOI 10.1016/S0002-9343(02)01525-5; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Wallen T, 1997, HEART, V77, P264, DOI 10.1136/hrt.77.3.264; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; WHO, WHO COUNTRYPROFILES; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	48	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75809	10.1371/journal.pone.0075809	http://dx.doi.org/10.1371/journal.pone.0075809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24244755	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700113
J	Rather, MI; Swamy, S; Gopinath, KS; Kumar, A				Rather, Mohammad Iqbal; Swamy, Shivananda; Gopinath, Kodaganur S.; Kumar, Arun			Transcriptional Repression of Tumor Suppressor CDC73, Encoding an RNA Polymerase II Interactor, by Wilms Tumor 1 Protein (WT1) Promotes Cell Proliferation IMPLICATION FOR CANCER THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE WT1; HRPT2 GENE; PARAFIBROMIN EXPRESSION; PARATHYROID CARCINOMA; PROGENITOR CELLS; PAF1 COMPLEX; METHYLATION; INVOLVEMENT; GROWTH; HYPERPARATHYROIDISM	The Wilms tumor 1 gene (WT1) can either repress or induce the expression of genes. Inconsistent with its tumor suppressor role, elevated WT1 levels have been observed in leukemia and solid tumors. WT1 has also been suggested to act as an oncogene by inducing the expression of MYC and BCL-2. However, these are only the correlational studies, and no functional study has been performed to date. Consistent with its tumor suppressor role, CDC73 binds to RNA polymerase II as part of a PAF1 transcriptional regulatory complex and causes transcriptional repression of oncogenes MYC and CCND1. It also represses beta-catenin-mediated transcription. Based on the reduced level of CDC73 in oral squamous cell carcinoma (OSCC) samples in the absence of loss-of-heterozygosity, promoter methylation, and mutations, we speculated that an inhibitory transcription factor is regulating its expression. The bioinformatics analysis predicted WT1 as an inhibitory transcription factor to regulate the CDC73 level. Our results showed that overexpression of WT1 decreased CDC73 levels and promoted proliferation of OSCC cells. ChIP and EMSA results demonstrated binding of WT1 to the CDC73 promoter. The 5-azacytidine treatment of OSCC cells led to an up-regulation of WT1 with a concomitant down-regulation of CDC73, further suggesting regulation of CDC73 by WT1. Exogenous CDC73 attenuated the protumorigenic activity of WT1 by apoptosis induction. An inverse correlation between expression levels of CDC73 and WT1 was observed in OSCC samples. These observations indicated that WT1 functions as an oncogene by repressing the expression of CDC73 in OSCC. We suggest that targeting WT1 could be a therapeutic strategy for cancer, including OSCC.	[Rather, Mohammad Iqbal; Kumar, Arun] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Swamy, Shivananda; Gopinath, Kodaganur S.] HCG Bangalore Inst Oncol, Dept Surg Oncol, Bangalore 560027, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Kumar, A (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	karun@mrdg.iisc.ernet.in	Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219	Department of Science and Technology, New Delhi, India	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology, New Delhi, India.	Bajaj V, 2008, GENE, V424, P40, DOI 10.1016/j.gene.2008.07.032; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cetani F, 2004, J CLIN ENDOCR METAB, V89, P5583, DOI 10.1210/jc.2004-0294; Chakraborty S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-163; Hahn MA, 2010, ENDOCR-RELAT CANCER, V17, P273, DOI 10.1677/ERC-09-0291; Han YQ, 2004, ONCOGENE, V23, P6933, DOI 10.1038/sj.onc.1207609; Hewitt KM, 2007, ANN OTO RHINOL LARYN, V116, P928, DOI 10.1177/000348940711601210; Inoue K, 1998, BLOOD, V91, P2969, DOI 10.1182/blood.V91.8.2969.2969_2969_2976; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeb DM, 2001, CANCER RES, V61, P921; Mayo MW, 1999, EMBO J, V18, P3990, DOI 10.1093/emboj/18.14.3990; Mikami T, 2013, J ORAL PATHOL MED, V42, P133, DOI 10.1111/j.1600-0714.2012.01182.x; Oji Y, 1999, JPN J CANCER RES, V90, P194, DOI 10.1111/j.1349-7006.1999.tb00733.x; Oka Y, 2000, IMMUNOGENETICS, V51, P99, DOI 10.1007/s002510050018; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Osaka M, 1997, INT J CANCER, V72, P696, DOI 10.1002/(SICI)1097-0215(19970807)72:4<696::AID-IJC23>3.0.CO;2-8; Pannone G, 2010, ONCOL REP, V24, P1035, DOI 10.3892/or_00000952; Rather MI, 2013, J BIOL CHEM, V288, P608, DOI 10.1074/jbc.M112.425736; REDDY JC, 1995, J BIOL CHEM, V270, P29976; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Satoh Y, 2003, J BIOCHEM, V133, P303, DOI 10.1093/jb/mvg041; Selvarajan S, 2008, J CLIN PATHOL, V61, P64, DOI 10.1136/jcp.2007.048694; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Tsuboi A, 1999, LEUKEMIA RES, V23, P499, DOI 10.1016/S0145-2126(99)00037-5; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yamagami T, 1996, BLOOD, V87, P2878, DOI 10.1182/blood.V87.7.2878.bloodjournal8772878; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Zhang C, 2006, BIOCHEM BIOPH RES CO, V350, P17, DOI 10.1016/j.bbrc.2006.08.169; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zheng HC, 2008, VIRCHOWS ARCH, V452, P147, DOI 10.1007/s00428-007-0551-z	34	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					968	976		10.1074/jbc.M113.483255	http://dx.doi.org/10.1074/jbc.M113.483255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24257751	Green Published, hybrid			2022-12-25	WOS:000330541200031
J	Bronisz, A; Carey, HA; Godlewski, J; Sif, S; Ostrowski, MC; Sharma, SM				Bronisz, Agnieszka; Carey, Heather A.; Godlewski, Jakub; Sif, Said; Ostrowski, Michael C.; Sharma, Sudarshana M.			The Multifunctional Protein Fused in Sarcoma (FUS) Is a Coactivator of Microphthalmia-associated Transcription Factor (MITF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Osteoclast; Phosphorylation; Sumoylation; Transcription Coactivators	RNA-POLYMERASE-II; AMYOTROPHIC-LATERAL-SCLEROSIS; OSTEOCLAST DIFFERENTIATION; REPRESS TRANSCRIPTION; BINDING PROTEIN; FAMILY-MEMBERS; TET FAMILY; P38 MAPK; GENE; TLS	The microphthalmia-associated transcription factor (MITF) is required for terminal osteoclast differentiation and is a signaling effector engaged by macrophage colony-stimulating factor 1 (CSF-1) and receptor activator of nuclear factor-B ligand (RANKL). MITF exerts its regulatory functions through its association with cofactors. Discovering the identity of its various partners will provide insights into the mechanisms governing gene expression during osteoclastogenesis. Here, we demonstrate that the proto-oncogene fused in sarcoma (FUS), the chromatin remodeling ATPase BRG1, and MITF form a trimeric complex that is regulated by phosphorylation of MITF at Ser-307 by p38 MAPK during osteoclast differentiation. FUS was recruited to MITF target gene promoters Acp5 and Ctsk during osteoclast differentiation, and FUS knockdown abolished efficient transcription of Acp5 and Ctsk. Furthermore, sumoylation of MITF at Lys-316, known to negatively regulate MITF transcriptional activity, inhibited MITF interactions with FUS and BRG1 in a p38 MAPK phosphorylation-dependent manner. These results demonstrate that FUS is a coregulator of MITF activity and provide new insights into how the RANKL/p38 MAPK signaling nexus controls gene expression in osteoclasts.	[Bronisz, Agnieszka; Carey, Heather A.; Sif, Said; Ostrowski, Michael C.; Sharma, Sudarshana M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Godlewski, Jakub] Ohio State Univ, Dept Neurol Surg, Dardinger Family Lab Neurooncol & Neurosci, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ostrowski, MC (corresponding author), 598 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu; Sudarshana.sharma@osumc.edu	Godlewski, Jakub/U-4700-2019; Bronisz, Agnieszka/G-5980-2019; Bronisz, Agnieszka/M-3485-2019; Sif, Said/AAE-5554-2019; Sharma, Sudarshana Mangalore/AAI-2475-2019; Ostrowski, Michael/H-3108-2011	Bronisz, Agnieszka/0000-0002-5841-1051; Bronisz, Agnieszka/0000-0002-5841-1051; Sif, Said/0000-0001-6268-1145; Ostrowski, Michael/0000-0003-2948-6297; Sharma, Sudarshana/0000-0002-9745-0061; Godlewski, Jakub/0000-0003-2122-9798	National Institutes of Health from NIAMS [R01-AR-0447129]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044719] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR-0447129 from NIAMS (to M. C. O.).	Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Gascoyne DM, 2004, ONCOGENE, V23, P3830, DOI 10.1038/sj.onc.1207497; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hallier M, 1998, J BIOL CHEM, V273, P4838, DOI 10.1074/jbc.273.9.4838; Harlow E, 2006, CSH PROTOC; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Kim J, 1999, PHYSIOL GENOMICS, V1, P127, DOI 10.1152/physiolgenomics.1999.1.3.127; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kurokawa R, 2011, ADV EXP MED BIOL, V722, P196, DOI 10.1007/978-1-4614-0332-6_12; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Powers CA, 1998, MOL ENDOCRINOL, V12, P4, DOI 10.1210/mend.12.1.0043; PRASAD DDK, 1994, ONCOGENE, V9, P3717; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Tan AY, 2012, P NATL ACAD SCI USA, V109, P6030, DOI 10.1073/pnas.1203028109; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Wei G, 2004, J IMMUNOL, V173, P1374, DOI 10.4049/jimmunol.173.2.1374; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	36	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					326	334		10.1074/jbc.M113.493874	http://dx.doi.org/10.1074/jbc.M113.493874			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257758	hybrid, Green Published			2022-12-25	WOS:000329370900028
J	Hund, L; Northrop-Clewes, CA; Nazario, R; Suleymanova, D; Mirzoyan, L; Irisova, M; Pagano, M; Valadez, JJ				Hund, Lauren; Northrop-Clewes, Christine A.; Nazario, Ronald; Suleymanova, Dilora; Mirzoyan, Lusine; Irisova, Munira; Pagano, Marcello; Valadez, Joseph J.			A Novel Approach to Evaluating the Iron and Folate Status of Women of Reproductive Age in Uzbekistan after 3 Years of Flour Fortification with Micronutrients	PLOS ONE			English	Article								Background: The Uzbekistan 1996 Demographic Health Survey reported 60.4% of women of reproductive age (WRA) had low hemoglobin concentrations (< 120 g/L), and anemia was an important public health problem. Fortification of wheat flour was identified as an appropriate intervention to address anemia due to the ubiquitous consumption of wheat flour. A National Flour Fortification Program (NFFP) was implemented in 2005. Methodology/Principal Findings: After 3-years of the NFFP, a national survey using large country-lot quality assurance sampling was carried out to assess iron, folate, hemoglobin and inflammation status of WRA; the coverage and knowledge of the fortified first grade UzDonMakhsulot (UDM) flour/grey loaf program; and consumption habits of women to investigate the dietary factors associated with anemia. Estimated anemia prevalence was 34.4% (95% CI: 32.0, 36.7), iron depletion 47.5% (95% CI: 45.1, 49.9) and folate deficiency 28.8% (95% CI: 26.8, 30.8); the effect of inflammation was minimal (4% with CRP > 5 mg/L). Severe anemia was more prevalent among folate deficient than iron depleted WRA. Presence of UDM first grade flour or the grey loaf was reported in 71.3% of households. Among WRA, 32.1% were aware of UDM fortification; only 3.7% mentioned the benefits of fortification and 12.5% understood causes of anemia. Consumption of heme iron-containing food (91%) and iron absorption enhancers (97%) was high, as was the consumption of iron absorption inhibitors (95%). Conclusions/Significance: The NFFP coincided with a substantial decline in the prevalence of anemia. Folate deficiency was a stronger predictor of severe anemia than iron depletion. However, the prevalence of iron depletion was high, suggesting that women are not eating enough iron or iron absorption is inhibited. Fortified products were prevalent throughout Uzbekistan, though UDM flour must be adequately fortified and monitored in the future. Knowledge of fortification and anemia was low, suggesting consumer education should be prioritized.	[Hund, Lauren; Pagano, Marcello] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Northrop-Clewes, Christine A.] Global Alliance Improved Nutr, Geneva, Switzerland; [Nazario, Ronald] Inst Invest Nutr, Lima, Peru; [Suleymanova, Dilora] Minist Hlth, Res Inst Hematol & Blood Transfus, Tashkent, Uzbekistan; [Mirzoyan, Lusine; Irisova, Munira] Joint Projects Implementat Bur Hlth 2 & Women & C, Tashkent, Uzbekistan; [Mirzoyan, Lusine; Valadez, Joseph J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hund, Lauren] Univ New Mexico, Albuquerque, NM 87131 USA	Harvard University; Harvard T.H. Chan School of Public Health; Liverpool School of Tropical Medicine; University of Liverpool; University of New Mexico	Northrop-Clewes, CA (corresponding author), Global Alliance Improved Nutr, Geneva, Switzerland.	christinaclewes@btinternet.com		Suleymanova, Dilora/0000-0002-8471-0194; Valadez, Joseph/0000-0002-6575-6592	GAIN	GAIN	The survey was funded by GAIN. The funder played no role in the survey design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analytical and Information Center Ministry of Health of the Republic of Uzbekistan State Department of Statistics Ministry of Macroeconomics and Statistics, 2004, UZB HLTH EX SURV 200; [Anonymous], 2009, UZB FLOUR FORT PROJ; [Anonymous], 2008, FOOD NUTR B, V29, pS238; Centers for Disease Control, 2010, LAB PROC MAN FOL SER; FAO/WHO, 2001, JOINT FAO WHO EXP CO; Hedt B, 2008, LARGE COUNTRY LOT QU, P60; Institute of Obstetrics and Gynecology Ministry of Health of the Republic of Uzbekistan, 1997, UZB DEM HLTH SURV 19; Koury MJ, 2004, ANNU REV NUTR, V24, P105, DOI 10.1146/annurev.nutr.24.012003.132306; Ministry of Health, 2006, AN PREV CONTR PROGR; Pena-Rosas Juan Pablo, 2007, UZBEKISTAN FLOUR FOR; Ranum P., 2009, PROMOTING WHEAT FLOU; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Tazhibayev S, 2008, FOOD NUTR BULL, V29, P255, DOI 10.1177/156482650802900402; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; VALADEZ JJ, 2003, ASSESSING COMMUNITY; Valadez JJ, 1991, ASSESSING CHILD SURV; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2011, SER FERR CONC ASS IR; WHO, 2001, IRON DEFICIENCY ANAE	19	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79726	10.1371/journal.pone.0079726	http://dx.doi.org/10.1371/journal.pone.0079726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260293	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327311900044
J	Hur, YG; Gorak-Stolinska, P; Ben-Smith, A; Lalor, MK; Chaguluka, S; Dacombe, R; Doherty, TM; Ottenhoff, TH; Dockrell, HM; Crampin, AC				Hur, Yun-Gyoung; Gorak-Stolinska, Patricia; Ben-Smith, Anne; Lalor, Maeve K.; Chaguluka, Steven; Dacombe, Russell; Doherty, T. Mark; Ottenhoff, Tom H.; Dockrell, Hazel M.; Crampin, Amelia C.			Combination of Cytokine Responses Indicative of Latent TB and Active TB in Malawian Adults	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CELL RESPONSES; IMMUNE-RESPONSES; IFN-GAMMA; INFECTION; VACCINATION; ANTIGENS; DISEASE; ESAT-6; RISK	Background: An IFN-gamma response to M. tuberculosis-specific antigens is an effective biomarker for M. tuberculosis infection but it cannot discriminate between latent TB infection and active TB disease. Combining a number of cytokine/chemokine responses to M. tuberculosis antigens may enable differentiation of latent TB from active disease. Methods: Asymptomatic recently-exposed individuals (spouses of TB patients) were recruited and tuberculin skin tested, bled and followed-up for two years. Culture supernatants, from a six-day culture of diluted whole blood samples stimulated with M. tuberculosis-derived PPD or ESAT-6, were measured for IFN-gamma, IL-10, IL-13, IL-17, TNF-alpha and CXCL10 using cytokine ELISAs. In addition, 15 patients with sputum smear-positive pulmonary TB were recruited and tested. Results: Spouses with positive IFN-gamma responses to M. tuberculosis ESAT-6 (>62.5 pg/mL) and TB patients showed high production of IL-17, CXCL10 and TNF-alpha. Higher production of IL-10 and IL-17 in response to ESAT-6 was observed in the spouses compared with TB patients while the ratios of IFN-gamma/IL-10 and IFN-gamma/IL-17 in response to M. tuberculosis-derived PPD were significantly higher in TB patients compared with the spouses. Tuberculin skin test results did not correlate with cytokine responses. Conclusions: CXCL10 and TNF-alpha may be used as adjunct markers alongside an IFN-gamma release assay to diagnose M. tuberculosis infection, and IL-17 and IL-10 production may differentiate individuals with LTBI from active TB.	[Hur, Yun-Gyoung; Gorak-Stolinska, Patricia; Ben-Smith, Anne; Lalor, Maeve K.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England; [Dacombe, Russell; Crampin, Amelia C.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England; [Ben-Smith, Anne; Chaguluka, Steven; Dacombe, Russell; Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [Doherty, T. Mark] GSK, Copenhagen, Denmark; [Ottenhoff, Tom H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit; GlaxoSmithKline; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hur, YG (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England.	hur1225@gmail.com		Crampin, Amelia/0000-0002-1513-4330; Hur, Yun Gyoung/0000-0003-3986-4394; Dockrell, Hazel/0000-0003-1869-9107	Gordon Smith Travelling Scholarship; EU FP7; Bill and Melinda Gates Foundation; Wellcome Trust	Gordon Smith Travelling Scholarship; EU FP7(European Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	Financial support for this work was provided by the Gordon Smith Travelling Scholarship, the EU FP7 funded NEWTBVAC Consortium and the GC6-74 consortium funded by the Bill and Melinda Gates Foundation. The Karonga Prevention Study was supported by funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR 2011; Arend SM, 2000, J INFECT DIS, V181, P1850, DOI 10.1086/315448; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Borgstrom E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043438; Brock I, 2001, INT J TUBERC LUNG D, V5, P462; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Chen DY, 2011, INT J TUBERC LUNG D, V15, P192; Claessens NJM, 2002, INT J TUBERC LUNG D, V6, P266; Crampin A, 2011, TROP MED INT HEALTH, V16, P811, DOI 10.1111/j.1365-3156.2011.02763.x; Crampin AC, 2008, INT J TUBERC LUNG D, V12, P612; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kobashi Y, 2010, LUNG, V188, P283, DOI 10.1007/s00408-010-9238-3; Lalor MK, 2009, J INFECT DIS, V199, P795, DOI 10.1086/597069; Mazo Dana, 2007, INT GAMM RESP SPOUS; Onyebujoh P, 2004, NAT REV MICROBIOL, V2, P930, DOI 10.1038/nrmicro1050; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Perreau M, 2013, EUR J IMMUNOL, V43, P939, DOI 10.1002/eji.201243090; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221	29	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79742	10.1371/journal.pone.0079742	http://dx.doi.org/10.1371/journal.pone.0079742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260295	Green Published, Green Accepted, gold			2022-12-25	WOS:000327308500096
J	Li, SF; Huang, XF; Zhang, DP; Huang, QL; Pei, GS; Wang, LX; Jiang, WH; Hu, QG; Tan, RX; Hua, ZC				Li, Shufeng; Huang, Xiaofeng; Zhang, Dapeng; Huang, Qilai; Pei, Guoshun; Wang, Lixiang; Jiang, Wenhui; Hu, Qingang; Tan, Renxiang; Hua, Zi-Chun			Requirement of PEA3 for Transcriptional Activation of FAK Gene in Tumor Metastasis	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR; BREAST-CARCINOMA; N-MYC; EXPRESSION; CANCER; INVASION; MOTILITY; E1AF	Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase critically involved in cancer metastasis. We found an elevation of FAK expression in highly metastatic melanoma B16F10 cells compared with its less metastatic partner B16F1 cells. Down-regulation of the FAK expression by either small interfering RNA or dominant negative FAK (FAK Related Non-Kinase, FRNK) inhibited the B16F10 cell migration in vitro and invasiveness in vivo. The mechanism by which FAK activity is up-regulated in highly metastatic cells remains unclear. In this study, we reported for the first time that one of the Est family proteins, PEA3, is able to transactivate FAK expression through binding to the promoter region of FAK. We identified a PEA3-binding site between nucleotides -170 and +43 in the FAK promoter that was critical for the responsiveness to PEA3. A stronger affinity of PEA3 to this region contributed to the elevation of FAK expression in B16F10 cells. Both in vitro and in vivo knockdown of PEA3 gene successfully mimicked the cell migration and invasiveness as that induced by FAK down-regulation. The activation of the well-known upstream of PEA3, such as epidermal growth factor, JNK, and ERK can also induce FAK expression. Furthermore, in the metastatic human clinic tumor specimens from the patients with human primary oral squamous cell carcinoma, we observed a strong positive correlation among PEA3, FAK, and carcinoma metastasis. Taking together, we hypothesized that PEA3 might play an essential role in the activation of the FAK gene during tumor metastasis.	[Li, Shufeng; Huang, Xiaofeng; Zhang, Dapeng; Huang, Qilai; Pei, Guoshun; Wang, Lixiang; Jiang, Wenhui; Hu, Qingang; Tan, Renxiang; Hua, Zi-Chun] Nanjing Univ, Affiliated Stomatol Hosp, Coll Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Li, Shufeng; Huang, Xiaofeng; Zhang, Dapeng; Huang, Qilai; Pei, Guoshun; Wang, Lixiang; Jiang, Wenhui; Hu, Qingang; Tan, Renxiang; Hua, Zi-Chun] Nanjing Univ, Affiliated Stomatol Hosp, Sch Stomatol, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Jiangsu TargetPharma Labs Inc, Changzhou, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macao, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Macau University of Science & Technology	Hua, ZC (corresponding author), Nanjing Univ, Affiliated Stomatol Hosp, Coll Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	zchua@nju.edu.cn	Huang, Qilai/B-4725-2015; jiang, wen/GYI-9662-2022	Huang, Qilai/0000-0002-4252-3980; Zhang, Dapeng/0000-0001-8535-7620	Chinese National Nature Sciences Foundation [31070706, 81121062, 50973046, 31071196, 31200572]; National Key Basic Research Program from Ministry of Science and Technology [2012CB967004]; Jiangsu Provincial Nature Science Foundation [BZ2010074, BZ2012050, BK2011573, BE2013630]; Bureau of Science and Technology of Changzhou [CM20122003, CZ20120004]; Science and Technology Development Fund of the Macau Special Administrative Region [071/2009/A3, 091/2009/A]	Chinese National Nature Sciences Foundation; National Key Basic Research Program from Ministry of Science and Technology; Jiangsu Provincial Nature Science Foundation; Bureau of Science and Technology of Changzhou; Science and Technology Development Fund of the Macau Special Administrative Region	The project was supported by grants from the Chinese National Nature Sciences Foundation (31070706, 81121062, 50973046, 31071196, 31200572), National Key Basic Research Program from Ministry of Science and Technology (2012CB967004), the Jiangsu Provincial Nature Science Foundation (BZ2010074, BZ2012050, BK2011573, BE2013630), Bureau of Science and Technology of Changzhou (CM20122003, CZ20120004) and the Science and Technology Development Fund of the Macau Special Administrative Region (Nos. 071/2009/A3 and 091/2009/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsohn MS, 2003, LARYNGOSCOPE, V113, P1944, DOI 10.1097/00005537-200311000-00017; Beierle EA, 2007, J BIOL CHEM, V282, P12503, DOI 10.1074/jbc.M701450200; Benz CC, 1997, ONCOGENE, V15, P1513, DOI 10.1038/sj.onc.1201331; Bieche I, 2004, CARCINOGENESIS, V25, P405, DOI 10.1093/carcin/bgh024; Corsi JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-198; D'Orazio D, 1997, GENE, V201, P179, DOI 10.1016/S0378-1119(97)00445-9; Davidson B, 2004, CLIN EXP METASTAS, V21, P191, DOI 10.1023/B:CLIN.0000037703.37275.35; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Dunn KB, 2010, ANTI-CANCER AGENT ME, V10, P722; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Hanzawa M, 2000, CARCINOGENESIS, V21, P1079, DOI 10.1093/carcin/21.6.1079; Hiroumi H, 2001, INT J CANCER, V93, P786, DOI 10.1002/ijc.1410; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Katayama S, 2005, HISTOL HISTOPATHOL, V20, P119, DOI 10.14670/HH-20.119; Kurio N, 2012, ORAL ONCOL, V48, P1159, DOI 10.1016/j.oraloncology.2012.05.019; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Li SF, 2007, MOL THER, V15, P515, DOI 10.1038/sj.mt.6300072; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mylona EE, 2006, CANCER DETECT PREV, V30, P111, DOI 10.1016/j.cdp.2006.03.006; O'Hagan RC, 1998, ONCOGENE, V16, P301, DOI 10.1038/sj.onc.1201547; OHagan RC, 1996, ONCOGENE, V13, P1323; OWENS LV, 1995, CANCER RES, V55, P2752; RORTH P, 1990, NUCLEIC ACIDS RES, V18, P5009, DOI 10.1093/nar/18.17.5009; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Tafolla E, 2005, J BIOL CHEM, V280, P19992, DOI 10.1074/jbc.M500331200; Taguchi K, 1997, JPN J CANCER RES, V88, P394, DOI 10.1111/j.1349-7006.1997.tb00395.x; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Watanabe T, 2012, J CANCER RES CLIN, V138, P859, DOI 10.1007/s00432-012-1159-5; Zabuawala T, 2010, CANCER RES, V70, P1323, DOI 10.1158/0008-5472.CAN-09-1474; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; Zhu XY, 2005, J BIOL CHEM, V280, P12503, DOI 10.1074/jbc.M413631200	43	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79336	10.1371/journal.pone.0079336	http://dx.doi.org/10.1371/journal.pone.0079336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260201	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500047
J	Li, XQ; Du, DL				Li, Xiu-Qing; Du, Donglei			RNA Polyadenylation Sites on the Genomes of Microorganisms, Animals, and Plants	PLOS ONE			English	Article							LARGE-SCALE ANALYSIS; MESSENGER-RNA; ALTERNATIVE POLYADENYLATION; CYTOPLASMIC POLYADENYLATION; PREDICTION; CLEAVAGE; SIGNALS; EST; IDENTIFICATION; DETERMINANTS	Pre-messenger RNA (mRNA) 3'-end cleavage and subsequent polyadenylation strongly regulate gene expression. In comparison with the upstream or downstream motifs, relatively little is known about the feature differences of polyadenylation [poly(A)] sites among major kingdoms. We suspect that the precise poly(A) sites are very selective, and we therefore mapped mRNA poly(A) sites on complete and nearly complete genomes using mRNA sequences available in the National Center for Biotechnology Information (NCBI) Nucleotide database. In this paper, we describe the mRNA nucleotide [i.e., the poly(A) tail attachment position] that is directly in attachment with the poly(A) tail and the pre-mRNA nucleotide [i.e., the poly(A) tail starting position] that corresponds to the first adenosine of the poly(A) tail in the 29 most-mapped species (2 fungi, 2 protists, 18 animals, and 7 plants). The most representative pre-mRNA dinucleotides covering these two positions were UA, CA, and GA in 17, 10, and 2 of the species, respectively. The pre-mRNA nucleotide at the poly(A) tail starting position was typically an adenosine [i.e., A-type poly(A) sites], sometimes a uridine, and occasionally a cytidine or guanosine. The order was U>C>G at the attachment position but A >> U>C >= G at the starting position. However, in comparison with the mRNA nucleotide composition (base composition), the poly(A) tail attachment position selected C over U in plants and both C and G over U in animals, in both A-type and non-A-type poly(A) sites. Animals, dicot plants, and monocot plants had clear differences in C/G ratios at the poly(A) tail attachment position of the non-A-type poly(A) sites. This study of poly(A) site evolution indicated that the two positions within poly(A) sites had distinct nucleotide compositions and were different among kingdoms.	[Li, Xiu-Qing] Agr & Agri Food Canada, Potato Res Ctr, Mol Genet Lab, Fredericton, NB, Canada; [Du, Donglei] Univ New Brunswick, Fac Business Adm, Quantitat Methods Res Grp, Fredericton, NB, Canada	Agriculture & Agri Food Canada; CGIAR; International Potato Center (CIP); University of New Brunswick	Li, XQ (corresponding author), Agr & Agri Food Canada, Potato Res Ctr, Mol Genet Lab, Fredericton, NB, Canada.	Xiu-Qing.Li@agr.gc.ca		Li, Xiu-Qing/0000-0002-7308-0596; Du, Donglei/0000-0003-0111-8572	Agriculture and Agri-Food Canada (AAFC) [1439]; AAFC SAGE project; Potato genomics project; Canadian Food Inspection Agency project [CHA-P-1101]	Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); AAFC SAGE project; Potato genomics project; Canadian Food Inspection Agency project	The research was supported by LXQ's research grants: Agriculture and Agri-Food Canada (AAFC) project 1439 (on functional allele markers), AAFC SAGE project, Potato genomics project, and Canadian Food Inspection Agency project CHA-P-1101 (on RNA bioinformatics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-646; Barkoff A, 1998, EMBO J, V17, P3168, DOI 10.1093/emboj/17.11.3168; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; Blum E, 1999, J BIOL CHEM, V274, P4009, DOI 10.1074/jbc.274.7.4009; Cai B, 2008, SCI HORTIC-AMSTERDAM, V115, P292, DOI 10.1016/j.scienta.2007.10.009; CHAMBERS A, 1988, DEV BIOL, V125, P237, DOI 10.1016/0012-1606(88)90207-2; CHEN F, 1995, NUCLEIC ACIDS RES, V23, P2614, DOI 10.1093/nar/23.14.2614; Choi YS, 2012, RNA, V18, P394, DOI 10.1261/rna.029306.111; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Fuentes V, 2012, EUKARYOT CELL, V11, P725, DOI 10.1128/EC.05322-11; Gautheret D, 1998, GENOME RES, V8, P524, DOI 10.1101/gr.8.5.524; Glaunsinger BA, 2010, RNA BIOL, V7, P13, DOI 10.4161/rna.7.1.10255; Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055; Gruber AR, 2012, RNA BIOL, V9, P1405, DOI 10.4161/rna.22570; Ji GL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-43; Ji GL, 2010, J THEOR BIOL, V265, P287, DOI 10.1016/j.jtbi.2010.05.015; Jin YF, 2004, RNA, V10, P1695, DOI 10.1261/rna.7610404; Juge F, 2002, EMBO J, V21, P6603, DOI 10.1093/emboj/cdf633; Kalkatawi M, 2012, BIOINFORMATICS, V28, P127, DOI 10.1093/bioinformatics/btr602; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lee CY, 2013, BIOINFORMATICS, V29, P1713, DOI 10.1093/bioinformatics/btt288; Legendre M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-7; Li XQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00982; Li XQ, 1998, P NATL ACAD SCI USA, V95, P10032, DOI 10.1073/pnas.95.17.10032; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Palaniswamy V, 2006, NAT STRUCT MOL BIOL, V13, P429, DOI 10.1038/nsmb1080; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Schisa JA, 1998, DEVELOPMENT, V125, P2995; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; Steller MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-463; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Takemori H, 1997, EUR J BIOCHEM, V250, P197, DOI 10.1111/j.1432-1033.1997.00197.x; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wang L, 2013, RNA, V19, P413, DOI 10.1261/rna.035360.112; Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yang Q, 2011, WIRES RNA, V2, P732, DOI 10.1002/wrna.88; Zamorano A, 2008, COMPUT BIOL CHEM, V32, P256, DOI 10.1016/j.compbiolchem.2008.03.019; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	48	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79511	10.1371/journal.pone.0079511	http://dx.doi.org/10.1371/journal.pone.0079511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260238	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500070
J	Wu, W; Wang, Y; Deng, XL; Sun, HY; Li, GR				Wu, Wei; Wang, Yan; Deng, Xiu-Ling; Sun, Hai-Ying; Li, Gui-Rong			Cholesterol Down-Regulates BK Channels Stably Expressed in HEK 293 Cells	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CONTENT MODULATES ACTIVATION; K+ CHANNELS; LARGE-CONDUCTANCE; BETA-SUBUNIT; TRANSMEMBRANE DOMAIN; POTASSIUM CHANNELS; LIPID RAFTS; CALCIUM; HYPERCHOLESTEROLEMIA	Cholesterol is one of the major lipid components of the plasma membrane in mammalian cells and is involved in the regulation of a number of ion channels. The present study investigates how large conductance Ca2+-activated K+ (BK) channels are regulated by membrane cholesterol in BK-HEK 293 cells expressing both the alpha-subunit hKCa1.1 and the auxiliary beta 1-subunit or in hKCa1.1-HEK 293 cells expressing only the alpha-subunit hKCa1.1 using approaches of electrophysiology, molecular biology, and immunocytochemistry. Membrane cholesterol was depleted in these cells with methyl-beta-cyclodextrin (MbCD), and enriched with cholesterol-saturated MbCD (MbCD-cholesterol) or low-density lipoprotein (LDL). We found that BK current density was decreased by cholesterol enrichment in BK-HEK 293 cells, with a reduced expression of KCa1.1 protein, but not the beta 1-subunit protein. This effect was fully countered by the proteasome inhibitor lactacystin or the lysosome function inhibitor bafilomycin A1. Interestingly, in hKCa1.1-HEK 293 cells, the current density was not affected by cholesterol enrichment, but directly decreased by MbCD, suggesting that the down-regulation of BK channels by cholesterol depends on the auxiliary beta 1-subunit. The reduced KCa1.1 channel protein expression was also observed in cultured human coronary artery smooth muscle cells with cholesterol enrichment using MbCD-cholesterol or LDL. These results demonstrate the novel information that cholesterol down-regulates BK channels by reducing KCa1.1 protein expression via increasing the channel protein degradation, and the effect is dependent on the auxiliary beta 1-subunit.	[Wu, Wei; Wang, Yan; Sun, Hai-Ying; Li, Gui-Rong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Wang, Yan; Deng, Xiu-Ling] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian 710049, Peoples R China; [Li, Gui-Rong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Physiol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; Xi'an Jiaotong University; University of Hong Kong	Li, GR (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China.	grli@hkucc.hku.hk	, 李贵荣（沧海一粟）/AAZ-4335-2020; Li, Gui-Rong/C-4341-2009	, 李贵荣（沧海一粟）/0000-0002-9437-2280; 	Sun Chieh Yeh Heart Foundation of Hong Kong; National Nature Science Foundation of China [81170137]; University of Hong Kong	Sun Chieh Yeh Heart Foundation of Hong Kong; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Hong Kong(University of Hong Kong)	The research was supported by a grant from Sun Chieh Yeh Heart Foundation of Hong Kong, and a grant (No. 81170137) from the National Nature Science Foundation of China. Wei Wu was supported by a Postgraduate Scholarship from the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Barman SA, 2003, AM J PHYSIOL-LUNG C, V284, pL1004, DOI 10.1152/ajplung.00295.2002; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Bringmann A, 1998, NEUROSCIENCE, V86, P1291, DOI 10.1016/S0306-4522(98)00079-7; Bukiya AN, 2008, FEBS LETT, V582, P673, DOI 10.1016/j.febslet.2008.01.036; Bukiya AN, 2011, P NATL ACAD SCI USA, V108, P20207, DOI 10.1073/pnas.1112901108; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; CHANG HM, 1995, J MEMBRANE BIOL, V143, P51; Christian AE, 1997, J LIPID RES, V38, P2264; Chun YS, 2010, J NEUROCHEM, V112, P1286, DOI 10.1111/j.1471-4159.2009.06545.x; Denson DD, 2000, AM J PHYSIOL-CELL PH, V279, pC1211, DOI 10.1152/ajpcell.2000.279.4.C1211; Dopico AM, 2012, PHARMACOL THERAPEUT, V135, P133, DOI 10.1016/j.pharmthera.2012.05.002; Du P, 2006, ACTA BIOCH BIOPH SIN, V38, P893, DOI 10.1111/j.1745-7270.2006.00236.x; Fang Y, 2006, CIRC RES, V98, P1064, DOI 10.1161/01.RES.0000218776.87842.43; Foutz RM, 2008, AM J PHYSIOL-RENAL, V294, pF1465, DOI 10.1152/ajprenal.00012.2008; Gao Z, 2005, BRIT J PHARMACOL, V144, P595, DOI 10.1038/sj.bjp.0706113; Genda S, 2002, J AM COLL CARDIOL, V40, P1339, DOI 10.1016/S0735-1097(02)02156-3; He YZ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001450; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; King JT, 2006, J NEUROPHYSIOL, V95, P2878, DOI 10.1152/jn.01352.2005; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; LI GR, 1995, J PHYSIOL-LONDON, V484, P629, DOI 10.1113/jphysiol.1995.sp020692; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; Lu T, 2012, DIABETES, V61, P1860, DOI 10.2337/db11-1658; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Mohler ER, 2007, BIOCHEM BIOPH RES CO, V358, P317, DOI 10.1016/j.bbrc.2007.04.138; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Peng ZF, 2008, NITRIC OXIDE-BIOL CH, V18, P136, DOI 10.1016/j.niox.2007.11.002; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Singh DK, 2011, BBA-BIOMEMBRANES, V1808, P2527, DOI 10.1016/j.bbamem.2011.07.006; Sun P, 2009, J AM SOC NEPHROL, V20, P513, DOI 10.1681/ASN.2008040427; Sun X, 2007, J NEUROPHYSIOL, V97, P62, DOI 10.1152/jn.00700.2006; Tajima N, 2011, J BIOL CHEM, V286, P5624, DOI 10.1074/jbc.M110.149898; Tao R, 2011, J CELL MOL MED, V15, P2684, DOI 10.1111/j.1582-4934.2011.01263.x; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang J, 1999, J Neurosci, V19, pRC4; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; WU CC, 1995, J MOL CELL CARDIOL, V27, P1263, DOI 10.1016/S0022-2828(05)82388-0; Yang Y, 2013, HYPERTENSION, V61, P519, DOI 10.1161/HYPERTENSIONAHA.111.00211; Zhang DY, 2009, PFLUG ARCH EUR J PHY, V457, P1275, DOI 10.1007/s00424-008-0608-0; Zhang YH, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0282-4; Zhou Y, 2002, J NEUROSCI, V22, P3855, DOI 10.1523/JNEUROSCI.22-10-03855.2002	59	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79952	10.1371/journal.pone.0079952	http://dx.doi.org/10.1371/journal.pone.0079952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260325	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500109
J	Derenko, M; Malyarchuk, B; Bahmanimehr, A; Denisova, G; Perkova, M; Farjadian, S; Yepiskoposyan, L				Derenko, Miroslava; Malyarchuk, Boris; Bahmanimehr, Ardeshir; Denisova, Galina; Perkova, Maria; Farjadian, Shirin; Yepiskoposyan, Levon			Complete Mitochondrial DNA Diversity in Iranians	PLOS ONE			English	Article							NEAR-EASTERN; HAPLOGROUP-H; MTDNA VARIATION; HOMO-SAPIENS; SOUTH; WEST; TREE; RECONSTRUCTION; PALEOCLIMATE; PERSPECTIVE	Due to its pivotal geographical location and proximity to transcontinental migratory routes, Iran has played a key role in subsequent migrations, both prehistoric and historic, between Africa, Asia and Europe. To shed light on the genetic structure of the Iranian population as well as on the expansion patterns and population movements which affected this region, the complete mitochondrial genomes of 352 Iranians were obtained. All Iranian populations studied here exhibit similarly high diversity values comparable to the other groups from the Caucasus, Anatolia and Europe. The results of AMOVA and MDS analyses did not associate any regional and/or linguistic group of populations in the Anatolia/Caucasus and Iran region pointing to close genetic positions of Persians and Qashqais to each other and to Armenians, and Azeris from Iran to Georgians. By reconstructing the complete mtDNA phylogeny of haplogroups R2, N3, U1, U3, U5a1g, U7, H13, HV2, HV12, M5a and C5c we have found a previously unexplored genetic connection between the studied Iranian populations and the Arabian Peninsula, India, Near East and Europe, likely the result of both ancient and recent gene flow. Our results for Persians and Qashqais point to a continuous increase of the population sizes from similar to 24 kya to the present, although the phase between 14-24 kya is thought to be hyperarid according to the Gulf Oasis model. Since this would have affected hunter-gatherer ranges and mobility patterns and forced them to increasingly rely on coastal resources, this transition can explain the human expansion across the Persian Gulf region.	[Derenko, Miroslava; Malyarchuk, Boris; Denisova, Galina; Perkova, Maria] Russian Acad Sci, Inst Biol Problems N, Magadan, Russia; [Bahmanimehr, Ardeshir; Yepiskoposyan, Levon] Natl Acad Sci Armenia, Inst Mol Biol, Yerevan, Armenia; [Farjadian, Shirin] Shiraz Univ Med Sci, Dept Immunol, Shiraz, Iran	Institute of Biological Problems of the North; Russian Academy of Sciences; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Shiraz University of Medical Science	Derenko, M (corresponding author), Russian Acad Sci, Inst Biol Problems N, Magadan, Russia.	mderenko@mail.ru	Denisova, Galina/AAZ-4310-2020; Bahmanimehr, Ardeshir/K-4367-2019; Malyarchuk, Boris/D-5783-2018; Derenko, Miroslava/J-1495-2018; Farjadian, Shirin/U-4348-2017	Malyarchuk, Boris/0000-0002-0304-0652; Derenko, Miroslava/0000-0002-1849-784X; Farjadian, Shirin/0000-0002-1369-8466	Presidium of Russian Academy of Sciences [12-I-P30-12]; Far-Eastern Branch of the Russian Academy of Sciences [12-III-A-06-101]; Russian Foundation for Basic Research [11-04-00620]	Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Far-Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This study was supported by grants from the Presidium of Russian Academy of Sciences (12-I-P30-12) (to B. M.), the Far-Eastern Branch of the Russian Academy of Sciences (12-III-A-06-101) (to MD), and the Russian Foundation for Basic Research (11-04-00620) (to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed AM, 2000, PALAEOGEOGR PALAEOCL, V160, P23, DOI 10.1016/S0031-0182(00)00042-0; Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Abu-Amero KK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-32; Al-Abri A, 2012, AM J PHYS ANTHROPOL, V149, P291, DOI 10.1002/ajpa.22131; Alizadeh A, 2010, CURR ANTHROPOL, V51, P353, DOI 10.1086/652437; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ANTHONY DW, 1986, CURR ANTHROPOL, V27, P291, DOI 10.1086/203441; Badro DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054616; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; Bogotova ZI, 2009, THESIS I BIOCH GENET; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza L. L., 1996, ORIGINS SPREAD AGR P, P51; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Cerny V, 2011, MOL BIOL EVOL, V28, P71, DOI 10.1093/molbev/msq178; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards I.E.S., 1992, CAMBRIDGE ANCIENT HI; Ennafaa H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-8; Farjadian S, 2011, HUM HERED, V72, P73, DOI 10.1159/000330166; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Forde CD, 1948, HABITAT EC SOC GEOGR; Forster P, 1996, AM J HUM GENET, V59, P935; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Garthwaite G. R., 2005, PERSIANS; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Irwin JA, 2010, INT J LEGAL MED, V124, P195, DOI 10.1007/s00414-009-0406-z; Johanson L., 1998, TURK LANG, P81; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kujanova M, 2009, AM J PHYS ANTHROPOL, V140, P336, DOI 10.1002/ajpa.21078; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mielnik-Sikorska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054360; Morozova I, 2012, AM J PHYS ANTHROPOL, V147, P341, DOI 10.1002/ajpa.21649; Musilova E, 2011, AM J PHYS ANTHROPOL, V145, P592, DOI 10.1002/ajpa.21522; Nasidze I, 2008, ANN HUM GENET, V72, P241, DOI 10.1111/j.1469-1809.2007.00413.x; Nasidze I, 2006, CURR BIOL, V16, P668, DOI 10.1016/j.cub.2006.02.021; Nasidze I, 2004, ANN HUM GENET, V68, P205, DOI 10.1046/j.1529-8817.2004.00092.x; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Perry CA, 2000, P NATL ACAD SCI USA, V97, P12433, DOI 10.1073/pnas.230423297; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; Renfrew C., 1996, ORIGINS SPREAD AGR P, P70; RENFREW C, 1987, ARCHAEOLOGY LANGUAGE; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rose JI, 2010, CURR ANTHROPOL, V51, P849, DOI 10.1086/657397; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schneider S., 2000, ARLEQUIN VER 2 000 S; Schonberg A, 2011, EUR J HUM GENET, V19, P988, DOI 10.1038/ejhg.2011.62; Shea JJ, 2008, QUATERNARY SCI REV, V27, P2253, DOI 10.1016/j.quascirev.2008.08.015; Shepard EM, 2006, J HUM GENET, V51, P467, DOI 10.1007/s10038-006-0387-4; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002105; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Terreros MC, 2011, J HUM GENET, V56, P235, DOI 10.1038/jhg.2010.174; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; Vaks A, 2003, QUATERNARY RES, V59, P182, DOI 10.1016/S0033-5894(03)00013-9; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zvelebil M., 1980, CAMBRIDGE ENCY ARCHA, P252; ZVELEBIL Marek, 1995, J EUROPEAN ARCHAEOLO, V3, P33, DOI [10.1179/096576695800688278, DOI 10.1179/096576695800688278]	82	70	72	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80673	10.1371/journal.pone.0080673	http://dx.doi.org/10.1371/journal.pone.0080673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244704	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800155
J	Zhao, M; Zhao, ZM				Zhao, Min; Zhao, Zhongming			CNVannotator: A Comprehensive Annotation Server for Copy Number Variation in the Human Genome	PLOS ONE			English	Article							SEGMENTAL DUPLICATIONS; VARIANTS; CANCER; DATABASE; FEATURES; CATALOG; LOCI	Copy number variation (CNV) is one of the most prevalent genetic variations in the genome, leading to an abnormal number of copies of moderate to large genomic regions. High-throughput technologies such as next-generation sequencing often identify thousands of CNVs involved in biological or pathological processes. Despite the growing demand to filter and classify CNVs by factors such as frequency in population, biological features, and function, surprisingly, no online web server for CNV annotations has been made available to the research community. Here, we present CNVannotator, a web server that accepts an input set of human genomic positions in a user-friendly tabular format. CNVannotator can perform genomic overlaps of the input coordinates using various functional features, including a list of the reported 356,817 common CNVs, 181,261 disease CNVs, as well as, 140,342 SNPs from genome-wide association studies. In addition, CNVannotator incorporates 2,211,468 genomic features, including ENCODE regulatory elements, cytoband, segmental duplication, genome fragile site, pseudogene, promoter, enhancer, CpG island, and methylation site. For cancer research community users, CNVannotator can apply various filters to retrieve a subgroup of CNVs pinpointed in hundreds of tumor suppressor genes and oncogenes. In total, 5,277,234 unique genomic coordinates with functional features are available to generate an output in a plain text format that is free to download. In summary, we provide a comprehensive web resource for human CNVs. The annotated results along with the server can be accessed at http://bioinfo.mc.vanderbilt.edu/CNVannotator/.	[Zhao, Min; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zhao, ZM (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Zhao, Min/J-6588-2019	Zhao, Min/0000-0001-5498-3434	National Institutes of Health [R01LM011177, R21HG006037, R03CA167695, P30CA68485, P50CA095103]; NATIONAL CANCER INSTITUTE [R03CA167695, P50CA095103, P30CA068485] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006037] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was partially supported by grants from National Institutes of Health (R01LM011177, R21HG006037, R03CA167695, P30CA68485, and P50CA095103), The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (to ZZ), and Ingram Professorship Funds (to ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buysse K, 2009, EUR J MED GENET, V52, P398, DOI 10.1016/j.ejmg.2009.09.002; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chen WX, 2013, GENOMICS, V102, P27, DOI 10.1016/j.ygeno.2013.02.003; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gai XW, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-74; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jia PL, 2013, GENOME RES, V23, P1434, DOI 10.1101/gr.152322.112; Jia PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017162; Kim P, 2010, NUCLEIC ACIDS RES, V38, pD81, DOI 10.1093/nar/gkp982; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Lappalainen I, 2013, NUCLEIC ACIDS RES, V41, pD936, DOI 10.1093/nar/gks1213; Ledet EM, 2013, PROSTATE, V73, P614, DOI 10.1002/pros.22602; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Lv J, 2012, NUCLEIC ACIDS RES, V40, pD1030, DOI 10.1093/nar/gkr1169; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qiu FJ, 2012, HUM MUTAT, V33, pE2375, DOI 10.1002/humu.22163; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Rodriguez-Revenga L, 2007, GENET MED, V9, P600, DOI 10.1097/GIM.0b013e318149e1e3; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Southard AE, 2012, PEDIATRICS, V129, P755, DOI 10.1542/peds.2011-2337; Vandeweyer G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-4; Xia JF, 2012, HUM MUTAT, V33, pE2341, DOI 10.1002/humu.22096; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zhao M, 2013, MOL BIOSYST, V9, P3187, DOI 10.1039/c3mb70172g; Zhao M, 2012, IEEE INT WORK GENOM, P101, DOI 10.1109/GENSIPS.2012.6507738; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zhao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044175	47	14	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80170	10.1371/journal.pone.0080170	http://dx.doi.org/10.1371/journal.pone.0080170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244640	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800130
J	Ghazarian, AA; Murphy, MA; Khan, MR; Saksvig, BI; Altekruse, SF				Ghazarian, Armen A.; Murphy, Megan A.; Khan, Maria R.; Saksvig, Brit I.; Altekruse, Sean F.			Area-Level Attributes and Esophageal Adenocarcinoma in Surveillance, Epidemiology and End Results Registries	PLOS ONE			English	Article							BREAST-CANCER; STAGE; SURVIVAL; RISK; DIAGNOSIS; PATTERNS	Purpose: To examine the associations between area-level socioeconomic attributes and stage of esophageal adenocarcinoma diagnoses in 16 SEER cancer registries during 2000-2007. Methods: Odds ratios (OR) and 95% confidence intervals (CI) were calculated using multivariable logistic regression models to assess the relationship between distant-stage esophageal adenocarcinoma and individual, census tract, and county-level attributes. Results: Among cases with data on birthplace, no significant association was seen between reported birth within versus outside the United States and distant-stage cancer (adjusted OR=1.02, 95% CI: 0.85-1.22). Living in an area with a higher percentage of residents born outside the United States than the national average was associated with distant-stage esophageal adenocarcinoma; census tract level: >11.8%, (OR=1.10, 95% CI: 1.01-1.19), county level: >11.8%, (OR=1.14, 95% CI: 1.05-1.24). No association was observed between median household income and distant-stage cancer at either census tract or county levels. Conclusion: The finding of greater odds of distant-stage esophageal adenocarcinoma among cases residing in SEER areas with higher proportion of non-U.S. Natives suggests local areas where esophageal cancer control efforts might be focused. Missing data at the individual level was a limitation of the present study. Furthermore, inconsistent associations with foreign birth at individual-versus area-levels cautions against using area-level attributes as proxies for case attributes.	[Ghazarian, Armen A.; Murphy, Megan A.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Khan, Maria R.; Saksvig, Brit I.] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Altekruse, Sean F.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ghazarian, AA (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	armen.ghazarian@nih.gov			National Cancer Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funding source for this manuscript is through the National Cancer Institute contracts to SEER registries The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; [Anonymous], 2010, AM DEM CULT TRANSF I; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Falk GW, 2009, SURG ONCOL CLIN N AM, V18, P469, DOI 10.1016/j.soc.2009.03.005; Freeman H, 1990, CANC SOCIOECONOMICAL; Hebert James R, 2006, J S C Med Assoc, V102, P201; Hispanic Center Pew, STAT PORTR HISP US P; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195; Jansson C, 2005, CANCER EPIDEM BIOMAR, V14, P1754, DOI 10.1158/1055-9965.EPI-05-0140; Keegan THM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-603; Kubo A, 2010, NUTR RES REV, V23, P230, DOI 10.1017/S0954422410000132; NCI, 2010, ES CANC SCREEN; Reyes-Ortiz CA, 2008, CANCER EPIDEM BIOMAR, V17, P2931, DOI 10.1158/1055-9965.EPI-07-0430; Singh GK, 2002, JNCI-J NATL CANCER I, V94, P904, DOI 10.1093/jnci/94.12.904; Taplin SH, 2004, JNCI-J NATL CANCER I, V96, P1518, DOI 10.1093/jnci/djh284; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e81613	10.1371/journal.pone.0081613	http://dx.doi.org/10.1371/journal.pone.0081613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244745	gold, Green Submitted, Green Published			2022-12-25	WOS:000327221600221
J	Sebastian, V; Vergel, T; Baig, R; Schrott, LM; Serrano, PA				Sebastian, Veronica; Vergel, Tatyana; Baig, Raheela; Schrott, Lisa M.; Serrano, Peter A.			PKM zeta Differentially Utilized between Sexes for Remote Long-Term Spatial Memory	PLOS ONE			English	Article							PROTEIN-KINASE-C; WATER MAZE PERFORMANCE; RADIAL-ARM MAZE; POSTSYNAPTIC AMPA RECEPTORS; FEMALE RATS; SYNAPTIC PLASTICITY; LEARNING-STRATEGY; TASK-DIFFICULTY; NAVIGATION TASK; ADULT RATS	It is well established that male rats have an advantage in acquiring place-learning strategies, allowing them to learn spatial tasks more readily than female rats. However many of these differences have been examined solely during acquisition or in 24h memory retention. Here, we investigated whether sex differences exist in remote long-term memory, lasting 30d after training, and whether there are differences in the expression pattern of molecular markers associated with long-term memory maintenance. Specifically, we analyzed the expression of protein kinase M zeta (PKM zeta) and the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluA2. To adequately evaluate memory retention, we used a robust training protocol to attenuate sex differences in acquisition and found differential effects in memory retention 1d and 30d after training. Female cohorts tested for memory retention 1d after 60 training trials outperformed males by making significantly fewer reference memory errors at test. In contrast, male cohorts tested 30d after 60 training trials outperformed females of the same condition, making fewer reference memory errors and achieving significantly higher retention test scores. Furthermore, given 60 training trials, females tested 30d later showed significantly worse memory compared to females tested 1d later, while males tested 30d later did not differ from males tested 1d later. Together these data suggest that with robust training males do no retain spatial information as well as females do 24h post-training but maintain this spatial information for longer. Males also showed a significant increase in synaptic PKM zeta expression and a positive correlation with retention test scores, while females did not. Interestingly, both sexes showed a positive correlation between retention test scores and synaptic GluA2 expression. Furthermore, the increased expression of synaptic PKM zeta, associated with male memory but not with female memory, identifies another potential sex-mediated difference in memory processing.	[Sebastian, Veronica; Vergel, Tatyana; Baig, Raheela; Serrano, Peter A.] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA; [Schrott, Lisa M.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA; [Serrano, Peter A.] CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; City University of New York (CUNY) System	Serrano, PA (corresponding author), CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10021 USA.	serrano@genectr.hunter.cuny.edu			RCMI from the National Center for Research Resources (NCRR) [RR003037]; Department of Defense [W81XWH-08-1-0243]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS080686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA012136] Funding Source: NIH RePORTER	RCMI from the National Center for Research Resources (NCRR); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded in part by the RCMI grant number RR003037 from the National Center for Research Resources (NCRR) and the Department of Defense W81XWH-08-1-0243 to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; BEATTY WW, 1985, NEUROBIOL AGING, V6, P219, DOI 10.1016/0197-4580(85)90053-3; Beiko J, 2004, BEHAV BRAIN RES, V151, P239, DOI 10.1016/j.bbr.2003.08.019; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bowman RE, 2009, PHYSIOL BEHAV, V97, P21, DOI 10.1016/j.physbeh.2009.01.012; Bowman RE, 2003, HORM BEHAV, V43, P48, DOI 10.1016/S0018-506X(02)00022-3; Bowman RE, 2001, BRAIN RES, V904, P279, DOI 10.1016/S0006-8993(01)02474-X; Chow C, 2013, PSYCHONEUROENDOCRINO, V38, P1236, DOI 10.1016/j.psyneuen.2012.11.007; Clint EK, 2012, Q REV BIOL, V87, P289, DOI 10.1086/668168; Colombo PJ, 1997, P NATL ACAD SCI USA, V94, P14195, DOI 10.1073/pnas.94.25.14195; Daumas S, 2008, LEARN MEMORY, V15, P625, DOI 10.1101/lm.990208; Diano S, 1997, ENDOCRINOLOGY, V138, P778, DOI 10.1210/en.138.2.778; Epp JR, 2010, HIPPOCAMPUS, V20, P866, DOI 10.1002/hipo.20692; Galea LAM, 1996, J EXP BIOL, V199, P195; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; GAULIN SJC, 1986, AM NAT, V127, P74, DOI 10.1086/284468; Genn RF, 2003, NEUROSCI BIOBEHAV R, V27, P155, DOI 10.1016/S0149-7634(03)00017-4; Grissom EM, 2013, HIPPOCAMPUS, V23, P313, DOI 10.1002/hipo.22085; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Hawley WR, 2012, PHYSIOL BEHAV, V105, P1014, DOI 10.1016/j.physbeh.2011.11.021; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hodges H, 1996, COGNITIVE BRAIN RES, V3, P167, DOI 10.1016/0926-6410(96)00004-3; Honig WK, 1978, COGNITIVE PROCESS, P213; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; Kanit L, 2000, PHYSIOL BEHAV, V71, P277, DOI 10.1016/S0031-9384(00)00327-9; Kanit L, 1998, BRAIN RES BULL, V46, P441, DOI 10.1016/S0361-9230(98)00008-2; Kanit L, 2000, BRAIN RES BULL, V52, P243, DOI 10.1016/S0361-9230(00)00232-X; Korol DL, 2004, HORM BEHAV, V45, P330, DOI 10.1016/j.yhbeh.2004.01.005; Lehmann J, 1999, PHARMACOL BIOCHEM BE, V64, P705, DOI 10.1016/S0091-3057(99)00150-1; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Mendez-Lopez M, 2009, PHYSIOL BEHAV, V98, P307, DOI 10.1016/j.physbeh.2009.06.006; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Mizuno K, 2007, NEUROSCIENCE, V145, P393, DOI 10.1016/j.neuroscience.2006.11.056; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; Nakhost A, 1998, J NEUROCHEM, V71, P1221; NOGUES X, 1994, HIPPOCAMPUS, V4, P71, DOI 10.1002/hipo.450040109; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Osten P, 1996, J NEUROSCI, V16, P2444; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Peters M, 2003, J NEUROSCI, V23, P9752; Ris L, 2005, EUR J NEUROSCI, V21, P3023, DOI 10.1111/j.1460-9568.2005.04137.x; Rodriguez CA, 2010, J EXP PSYCHOL-ANIM B, V36, P395, DOI 10.1037/a0017297; Roof RL, 1999, PHYSIOL BEHAV, V68, P81, DOI 10.1016/S0031-9384(99)00162-6; Rummel J, 2010, HORM BEHAV, V58, P582, DOI 10.1016/j.yhbeh.2010.07.009; Ryves WJ, 1996, NEUROREPORT, V8, P323, DOI 10.1097/00001756-199612200-00064; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Schrott LM, 2008, BRAIN RES, V1198, P132, DOI 10.1016/j.brainres.2008.01.020; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Seymoure P, 1996, PSYCHOBIOLOGY, V24, P33; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2009, LEARN MEMORY, V16, P122, DOI 10.1101/lm.1183309; Silverman I, 2007, ARCH SEX BEHAV, V36, P261, DOI 10.1007/s10508-006-9168-6; Spreng M, 2002, BEHAV BRAIN RES, V128, P103, DOI 10.1016/S0166-4328(01)00266-2; STEWART J, 1989, NEUROBIOL AGING, V10, P669, DOI 10.1016/0197-4580(89)90003-1; SUZUKI S, 1980, LEARN MOTIV, V11, P1, DOI 10.1016/0023-9690(80)90018-1; WALLACE JE, 1980, J GERONTOL, V35, P355, DOI 10.1093/geronj/35.3.355; WEHNER JM, 1990, BRAIN RES, V523, P181, DOI 10.1016/0006-8993(90)91485-Y; WILLIAMS CL, 1990, BEHAV NEUROSCI, V104, P84, DOI 10.1037/0735-7044.104.1.84; Woolley DG, 2010, BEHAV BRAIN RES, V208, P408, DOI 10.1016/j.bbr.2009.12.019; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Zhang M, 2011, J NEUROSCI, V31, P10174, DOI 10.1523/JNEUROSCI.0009-11.2011	67	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e81121	10.1371/journal.pone.0081121	http://dx.doi.org/10.1371/journal.pone.0081121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244733	Green Published, gold			2022-12-25	WOS:000327221600220
J	Brabcova, J; Prchalova, D; Demianova, Z; Bucankova, A; Vogel, H; Valterova, I; Pichova, I; Zarevucka, M				Brabcova, Jana; Prchalova, Darina; Demianova, Zuzana; Bucankova, Alena; Vogel, Heiko; Valterova, Irena; Pichova, Iva; Zarevucka, Marie			Characterization of Neutral Lipase BT-1 Isolated from the Labial Gland of Bombus terrestris Males	PLOS ONE			English	Article							FAT-BODY; PHOSPHOLIPASE A(2); BUMBLEBEE MALES; TRIACYLGLYCEROL LIPASE; MARKING PHEROMONES; APIS-MELLIFERA; MANDUCA-SEXTA; PURIFICATION; BIOSYNTHESIS; PROTEINS	Background: In addition to their general role in the hydrolysis of storage lipids, bumblebee lipases can participate in the biosynthesis of fatty acids that serve as precursors of pheromones used for sexual communication. Results: We studied the temporal dynamics of lipolytic activity in crude extracts from the cephalic part of Bombus terrestris labial glands. Extracts from 3-day-old males displayed the highest lipolytic activity. The highest lipase gene expression level was observed in freshly emerged bumblebees, and both gene expression and lipase activity were lower in bumblebees older than 3 days. Lipase was purified from labial glands, further characterized and named as BT-1. The B. terrestris orthologue shares 88% sequence identity with B. impatiens lipase HA. The molecular weight of B. terrestris lipase BT-1 was approximately 30 kDa, the pH optimum was 8.3, and the temperature optimum was 50 degrees C. Lipase BT-1 showed a notable preference for C8-C10 p-nitrophenyl esters, with the highest activity toward p-nitrophenyl caprylate (C8). The Michaelis constant (K-m) and maximum reaction rate (V-max) for p-nitrophenyl laurate hydrolysis were K-m = 0.0011 mM and V-max = 0.15 U/mg. Conclusion: This is the first report describing neutral lipase from the labial gland of B. terrestris. Our findings help increase understanding of its possible function in the labial gland.	[Brabcova, Jana; Prchalova, Darina; Demianova, Zuzana; Valterova, Irena; Pichova, Iva; Zarevucka, Marie] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic; [Bucankova, Alena] Agr Res Ltd, Troubsko, Czech Republic; [Vogel, Heiko] Max Planck Inst Chem Ecol, Jena, Germany	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Research Institute for Fodder Crops, Ltd. Troubsko; Max Planck Society	Zarevucka, M (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic.	zarevucka@uochb.cas.cz	Pichova, Iva/G-7917-2014; Prchalová, Darina/I-9127-2014	Valterova, Irena/0000-0001-5723-6143; demianova, zuzana/0000-0003-2822-2177	Technology Agency of the Czech Republic [TA01020969]; Czech Science Foundation [203/09/1446]; Institute of Organic Chemistry and Biochemistry [RVO: 61388963]	Technology Agency of the Czech Republic; Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry	The authors are grateful for the financial support of the Technology Agency of the Czech Republic (grant No. TA01020969), the Czech Science Foundation (grant No. 203/09/1446), and the Institute of Organic Chemistry and Biochemistry (research project RVO: 61388963). The authors also wish to thank Prof. Vladimir Ptacek for insect supply and Radka Kopecka and Martina Kojecka for technical assistance, J. Kindl for dissecting bumblebee tissues, and H. Hoffman for proof-reading of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliza ARN, 1998, INSECT BIOCHEM MOLEC, V28, P561, DOI 10.1016/S0965-1748(98)00050-2; Aliza ARN, 1999, INSECT BIOCHEM MOLEC, V29, P1029, DOI 10.1016/S0965-1748(99)00080-6; Arreguin-Espinosa R, 2000, BIOTECHNOL APPL BIOC, V31, P239, DOI 10.1042/BA19990088; ARRESE EL, 1994, J LIPID RES, V35, P1652; Auerswald L, 2006, INSECT BIOCHEM MOLEC, V36, P759, DOI 10.1016/j.ibmb.2006.07.004; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Bergstrom G, 1981, BIOSYSTEMATICS SOCIA, V19, P175; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucek A, 2013, INSECT BIOCHEM MOLEC, V43, P724, DOI 10.1016/j.ibmb.2013.05.003; Chahinian H, 2002, LIPIDS, V37, P653, DOI 10.1007/s11745-002-0946-7; Chapman R. F., 1998, INSECT STRUCTURE FUN; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Graaf DC, 2010, INSECT MOL BIOL, V19, P1, DOI 10.1111/j.1365-2583.2009.00913.x; DEREEPER A, 2008, NUCL ACIDS RES, V36; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; Diaz P, 1999, BIOTECHNIQUES, V27, P696, DOI 10.2144/99274bm14; Fernandez-Lorente G, 2005, BIOTECHNOL BIOENG, V92, P773, DOI 10.1002/bit.20656; GILBERT LAWRENCE L, 1965, J INSECT PHYSIOL, V11, P1057, DOI 10.1016/0022-1910(65)90178-2; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Horne I, 2009, INSECT BIOCHEM MOLEC, V39, P547, DOI 10.1016/j.ibmb.2009.06.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luxova A, 2003, CHEMOECOLOGY, V13, P81, DOI 10.1007/s00049-003-0230-8; Matsuoka K, 2006, INSECT BIOCHEM MOLEC, V36, P576, DOI 10.1016/j.ibmb.2006.04.006; Mrdakovic M, 2008, FOLIA BIOL-KRAKOW, V56, P103, DOI 10.3409/fb56_1-2.103-110; Pan D, 2011, ANAL BIOCHEM, V411, P277, DOI 10.1016/j.ab.2011.01.015; Patel RT, 2005, J BIOL CHEM, V280, P22624, DOI 10.1074/jbc.M413128200; Peiren N, 2005, BBA-PROTEINS PROTEOM, V1752, P1, DOI 10.1016/j.bbapap.2005.07.017; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Ptacek V., 2000, Pszczelnicze Zeszyty Naukowe, V44, P305; Rana RL, 1997, COMP BIOCHEM PHYS B, V118, P375, DOI 10.1016/S0305-0491(97)00105-3; RIVERS DB, 1995, J INVERTEBR PATHOL, V66, P104, DOI 10.1006/jipa.1995.1071; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Rozen S, 2000, Methods Mol Biol, V132, P365; Sharon C, 1998, J IND MICROBIOL BIOT, V20, P304, DOI 10.1038/sj.jim.2900528; Sidell BD, 2002, POLAR BIOL, V25, P517, DOI 10.1007/s00300-002-0375-x; SMITH GM, 1994, BIOCHEM J, V304, P775, DOI 10.1042/bj3040775; Sobotnik J, 2008, J INSECT PHYSIOL, V54, P204, DOI 10.1016/j.jinsphys.2007.09.003; Sommer P, 1997, APPL ENVIRON MICROB, V63, P3553, DOI 10.1128/AEM.63.9.3553-3560.1997; Song X, 2008, EUR J LIPID SCI TECH, V110, P1095, DOI 10.1002/ejlt.200800073; Sun D, 2002, ARCH INSECT BIOCHEM, V49, P149, DOI 10.1002/arch.10014; Valterova I, 1997, CHEM LISTY, V91, P846; van Antwerpen R, 1998, INSECT BIOCHEM MOLEC, V28, P399, DOI 10.1016/S0965-1748(98)00012-5; Volpato G, 2010, J CHROMATOGR A, V1217, P473, DOI 10.1016/j.chroma.2009.11.055; VORDERWULBECKE T, 1992, ENZYME MICROB TECH, V14, P631, DOI 10.1016/0141-0229(92)90038-P; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Zacek P, 2013, CHEMBIOCHEM, V14, P361, DOI 10.1002/cbic.201200684; Zacek P, 2009, J CHEM ECOL, V35, P698, DOI 10.1007/s10886-009-9650-4	49	10	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80066	10.1371/journal.pone.0080066	http://dx.doi.org/10.1371/journal.pone.0080066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260337	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200100
J	Chen, PS; Pang, SS; Yang, NQ; Meng, HY; Liu, J; Zhou, NT; Zhang, M; Xu, ZH; Gao, W; Chen, B; Tao, ZX; Wang, LS; Yang, ZJ				Chen, Pengsheng; Pang, Sisi; Yang, Naiquan; Meng, Haoyu; Liu, Jia; Zhou, Ningtian; Zhang, Min; Xu, Zhihui; Gao, Wei; Chen, Bo; Tao, Zhengxian; Wang, Liansheng; Yang, Zhijian			Beneficial Effects of Schisandrin B on the Cardiac Function in Mice Model of Myocardial Infarction	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE; ISCHEMIA/REPERFUSION INJURY; HSP70 EXPRESSION; HEART-FAILURE; IN-VIVO; KAPPA-B; ANTIOXIDANT; APOPTOSIS; REPAIR	The fruit of Schisandra chinensis has been used in the traditional Chinese medicine for thousands of years. Accumulating evidence suggests that Schisandrin B (Sch B) has cardioprotection effect on myocardial ischemia in vitro. However, it is unclear whether Sch B has beneficial effects on continuous myocardial ischemia in vivo. The aim of the present study was to investigate whether Sch B could improve cardiac function and attenuate myocardial remodeling after myocardial infarction (MI) in mice. Mice model of MI was established by permanent ligation of the left anterior descending (LAD) coronary artery. Then the MI mice were randomly treated with Sch B or vehicle alone. After treatment for 3 weeks, Sch B could increase survival rate, improve heart function and decrease infarct size compared with vehicle. Moreover, Sch B could down-regulate some inflammatory cytokines, activate eNOS pathway, inhibit cell apoptosis, and enhance cell proliferation. Further in vitro study on H9c2 cells showed similar effects of Sch B on prevention of hypoxia-induced inflammation and cell apoptosis. Taken together, our results demonstrate that Sch B can reduce inflammation, inhibit apoptosis, and improve cardiac function after ischemic injury. It represents a potential novel therapeutic approach for treatment of ischemic heart disease.	[Chen, Pengsheng; Meng, Haoyu; Zhou, Ningtian; Zhang, Min; Xu, Zhihui; Gao, Wei; Chen, Bo; Tao, Zhengxian; Wang, Liansheng; Yang, Zhijian] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Pang, Sisi; Yang, Zhijian] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China; [Yang, Naiquan] Xuzhou Med Coll, Huaian Peoples Hosp 2, Dept Cardiol, Huaian, Peoples R China; [Liu, Jia] Nanjing Med Univ, Clin Diabet Ctr Jiangsu Prov, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University; Nanjing Medical University	Yang, ZJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	zhijianyangnj@njmu.edu.cn		Xu, Zhi-Hui/0000-0002-9944-3770	National Natural Science Foundation of China [81170102/H0203]; Priority Academic Program Development of Jiangsu Higher Education Institutions [BL2012011]; Chinese Medical Association of the Sunlight Foundation [SCRFCMDA201217]; Fourth Period Progect "333" of Jiangsu Province [BRA2012207]; Science and Technological Innovation Group of Jiangsu Higher Education Institution "Qing-Lan Project" [JX2161015030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Chinese Medical Association of the Sunlight Foundation; Fourth Period Progect "333" of Jiangsu Province; Science and Technological Innovation Group of Jiangsu Higher Education Institution "Qing-Lan Project"	Project supported by the National Natural Science Foundation of China (No. 81170102/H0203), the Priority Academic Program Development of Jiangsu Higher Education Institutions (BL2012011), the Chinese Medical Association of the Sunlight Foundation (SCRFCMDA201217), the Fourth Period Progect "333" of Jiangsu Province (BRA2012207), and the Science and Technological Innovation Group of Jiangsu Higher Education Institution "Qing-Lan Project" (JX2161015030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RM, 2003, J MOL CELL CARDIOL, V35, P185, DOI 10.1016/S0022-2828(02)00310-3; Brunner F, 2003, CARDIOVASC RES, V57, P55, DOI 10.1016/S0008-6363(02)00649-1; Buccini S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0301-5; Checker R, 2012, FREE RADICAL BIO MED, V53, P1421, DOI 10.1016/j.freeradbiomed.2012.08.006; Chen N, 2008, BIOL PHARM BULL, V31, P1387, DOI 10.1248/bpb.31.1387; Chiu PY, 2006, BIOFACTORS, V26, P221, DOI 10.1002/biof.5520260401; Chiu PY, 2005, LIFE SCI, V77, P2887, DOI 10.1016/j.lfs.2005.03.026; Chiu PY, 2004, MOL CELL BIOCHEM, V266, P139, DOI 10.1023/B:MCBI.0000049151.79238.30; Cho SW, 2006, BIOCHEM BIOPH RES CO, V340, P573, DOI 10.1016/j.bbrc.2005.12.044; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Fox KF, 2001, EUR HEART J, V22, P228, DOI 10.1053/euhj.2000.2289; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Ip SP, 2000, MOL CELL BIOCHEM, V205, P111, DOI 10.1023/A:1007065917665; Ip SP, 2001, CELL STRESS CHAPERON, V6, P44, DOI 10.1379/1466-1268(2001)006<0044:EOSBPO>2.0.CO;2; Kim EY, 2011, J ETHNOPHARMACOL, V134, P668, DOI 10.1016/j.jep.2011.01.019; Ko KM, 2001, MOL CELL BIOCHEM, V220, P141, DOI 10.1023/A:1010979404447; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Lee TH, 2012, FOOD CHEM TOXICOL, V50, P4239, DOI 10.1016/j.fct.2012.08.047; Li L, 2007, CLIN CANCER RES, V13, P6753, DOI 10.1158/1078-0432.CCR-07-1579; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li YW, 2006, CARDIOVASC RES, V71, P684, DOI 10.1016/j.cardiores.2006.06.003; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; NAKAJIMA K, 1983, YAKUGAKU ZASSHI, V103, P743, DOI 10.1248/yakushi1947.103.7_743; Oba T, 2012, J AM COLL CARDIOL, V59, P838, DOI 10.1016/j.jacc.2011.10.887; Panossian A, 2008, J ETHNOPHARMACOL, V118, P183, DOI 10.1016/j.jep.2008.04.020; Park EJ, 2012, BIOCHEM PHARMACOL, V83, P378, DOI 10.1016/j.bcp.2011.11.002; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Salto-Tellez M, 2004, CARDIOVASC PATHOL, V13, P91, DOI 10.1016/s1054-8807(03)00129-7; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2012, ANN NY ACAD SCI, V1270, P66, DOI 10.1111/j.1749-6632.2012.06696.x; Stacchiotti A, 2011, TOXICOLOGY, V286, P48, DOI 10.1016/j.tox.2011.05.005; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; Yim TK, 1999, BIOCHEM PHARMACOL, V57, P77, DOI 10.1016/S0006-2952(98)00297-4; Yim TK, 1999, MOL CELL BIOCHEM, V196, P151, DOI 10.1023/A:1006927926495; Yoshida Y, 2012, CIRC RES, V111, P1108, DOI 10.1161/CIRCRESAHA.112.278820; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao X, 2002, AM J PHYSIOL-HEART C, V283, pH2371, DOI 10.1152/ajpheart.00383.2002	47	47	53	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79418	10.1371/journal.pone.0079418	http://dx.doi.org/10.1371/journal.pone.0079418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260217	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200064
J	Peng, QQ; Basang, Z; Cui, CY; Li, L; Qian, J; Gesang, Q; Yang, L; La, Z; De, Y; Dawa, P; Qu, N; Suo, Q; Dan, Z; Xiao, DJ; Wang, XF; Jin, L				Peng, Qian-qian; Basang, Zhuoma; Cui, Chao-ying; Li, Lei; Qian, Ji; Gesang, Quzhen; Yang, La; La, Zong; De, Yang; Dawa, Puchi; Qu, Ni; Suo, Qu; Dan, Zhen; Xiao, Duoji; Wang, Xiao-feng; Jin, Li			Physiological Responses and Evaluation of Effects of BMI, Smoking and Drinking in High Altitude Acclimatization: A Cohort Study in Chinese Han Young Males	PLOS ONE			English	Article							RAILROAD CONSTRUCTION WORKERS; CIGARETTE-SMOKING; BLOOD-PRESSURE; ALCOHOL; PERFORMANCE; HYPOXIA	High altitude acclimatization is a series of physiological responses taking places when subjects go to altitude. Many factors could influence these processes, such as altitude, ascending speed and individual characteristics. In this study, based on a repeated measurement design of three sequential measurements at baseline, acute phase and chronic phase, we evaluated the effect of BMI, smoking and drinking on a number of physiological responses in high altitude acclimatization by using mixed model and partial least square path model on a sample of 755 Han Chinese young males. We found that subjects with higher BMI responses were reluctant to hypoxia. The effect of smoking was not significant at acute phase. But at chronic phase, red blood cell volume increased less while respiratory function increased more for smoking subjects compared with nonsmokers. For drinking subjects, red blood cell volume increased less than nondrinkers at both acute and chronic phases, while blood pressures increased more than nondrinkers at acute phase and respiratory function, red blood cell volume and oxygen saturation increased more than nondrinkers at chronic phase. The heavy and long-term effect of smoking, drinking and other factors in high altitude acclimatization needed to be further studied.	[Peng, Qian-qian; Li, Lei; Qian, Ji; Wang, Xiao-feng; Jin, Li] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Peng, Qian-qian; Li, Lei; Qian, Ji; Wang, Xiao-feng; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Basang, Zhuoma; Cui, Chao-ying; Gesang, Quzhen; Yang, La; La, Zong; De, Yang; Dawa, Puchi; Qu, Ni; Suo, Qu; Dan, Zhen; Xiao, Duoji] Tibet Univ, High Altitude Hlth Sci Res Ctr, Tibet Autonomous Region, Peoples R China; [Qian, Ji; Wang, Xiao-feng; Jin, Li] CMC Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China	Fudan University; Fudan University; Tibet University	Basang, Z (corresponding author), Tibet Univ, High Altitude Hlth Sci Res Ctr, Tibet Autonomous Region, Peoples R China.	1207452530@qq.com; lijin.fudan@gmail.com	Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Peng, Qianqian/0000-0002-2018-5706	General Program of the National Natural Science Foundation of China [30760274, 81060161]; Major Program of the National Natural Science Foundation of China [30890034]; National High-tech R&D Program of China [2012AA021802]; National Program on Key Basic Research Project [2012CB944600]; National Science & Technology Support Program [2011BAI09B00]	General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); National Program on Key Basic Research Project(National Basic Research Program of China); National Science & Technology Support Program	This work was supported by the General Program of the National Natural Science Foundation of China (30760274, 81060161), the Major Program of the National Natural Science Foundation of China (30890034), the National High-tech R&D Program of China (2012AA021802), the National Program on Key Basic Research Project (2012CB944600), and the National Science & Technology Support Program (2011BAI09B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard HS, 1997, ALCOHOL HEALTH RES W, V21, P42; Bisgard GE, 1996, VENTILATORY RESPONSE; Chin W.W, 2003, PLS RELATED METHODS, P33; Chin W.W., 2000, FREQUENTLY ASKED QUE; Curtis R, 1998, HIGH ALTITUDE ACCLIM; Fiori G, 2000, AM J PHYS ANTHROPOL, V113, P47, DOI 10.1002/1096-8644(200009)113:1<47::AID-AJPA5>3.0.CO;2-K; FORGEY WW, 2006, WILDERNESS MED SOC P, P46; Fulco CS, 1998, AVIAT SPACE ENVIR MD, V69, P793; Gallagher SA, 2004, EMERG MED CLIN N AM, V22, P329, DOI 10.1016/j.emc.2004.02.001; Ge RL, 2005, RESP PHYSIOL NEUROBI, V146, P47, DOI 10.1016/j.resp.2004.11.009; Haenlein M., 2004, UNDERSTANDING STAT, V3, P283, DOI [10.1207/s15328031us0304_4, DOI 10.1207/S15328031US0304_4]; HANSEN JE, 1975, AVIAT SPACE ENVIR MD, V46, P1123; KLATSKY AL, 1977, NEW ENGL J MED, V296, P1194, DOI 10.1056/NEJM197705262962103; KONTOS HA, 1967, J APPL PHYSIOL, V23, P381, DOI 10.1152/jappl.1967.23.3.381; LINDGARDE F, 1984, ACTA MED SCAND, V216, P317; Mandal C. R., 2011, Asian Pacific Journal of Tropical Disease, V1, P55; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; Martin DS, 2010, EXP PHYSIOL, V95, P463, DOI 10.1113/expphysiol.2009.047589; MCDONALD TP, 1978, BLOOD, V51, P165; Muza S.R., 2004, ALTITUDE ACCLIMATIZA; Muza SR, 2010, HIGH ALT MED BIOL, V11, P87, DOI 10.1089/ham.2010.1006; Myers SR, 2000, POLYCYCL AROMAT COMP, V21, P151, DOI 10.1080/10406630008028531; NORDENBERG D, 1990, JAMA-J AM MED ASSOC, V264, P1556, DOI 10.1001/jama.264.12.1556; Sherpa LY, 2010, INT J ENV RES PUB HE, V7, P1670, DOI 10.3390/ijerph7041670; Siu Stanton T, 2010, Perm J, V14, P11; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; Tarazi IS, 2008, J CLIN LAB ANAL, V22, P119, DOI 10.1002/jcla.20228; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; TENENHAUS M., 1998, REGRESSION PLS THEOR; Verbeke G, 2000, LINEAR MIXED MODELS; Verbeke G, 1997, LINEAR MIXED MODELS; WARD MP, 2000, HIGH ALTITUDE MED PH; Wolfinger R D, 1997, J Biopharm Stat, V7, P481, DOI 10.1080/10543409708835203; Wu TY, 2007, HIGH ALT MED BIOL, V8, P88, DOI 10.1089/ham.2007.1015; Wu TY, 2007, WORLD J GASTROENTERO, V13, P774, DOI 10.3748/wjg.v13.i5.774; Wu TY, 2012, CHINESE MED J-PEKING, V125, P1393, DOI 10.3760/cma.j.issn.0366-6999.2012.08.006; Young AJ, 2002, TXB MILITARY MED MED, V2, P644; ZAPATAORTIZ V, 1967, ACTA PHYSIOL LAT AM, V17, P189	38	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79346	10.1371/journal.pone.0079346	http://dx.doi.org/10.1371/journal.pone.0079346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260204	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200062
J	Fung, G; Ng, CS; Zhang, JC; Shi, JY; Wong, J; Piesik, P; Han, LL; Chu, FN; Jagdeo, J; Jan, E; Fujita, T; Luo, HL				Fung, Gabriel; Ng, Chen Seng; Zhang, Jingchun; Shi, Junyan; Wong, Jerry; Piesik, Paulina; Han, Lillian; Chu, Fanny; Jagdeo, Julienne; Jan, Eric; Fujita, Takashi; Luo, Honglin			Production of a Dominant-Negative Fragment Due to G3BP1 Cleavage Contributes to the Disruption of Mitochondria-Associated Protective Stress Granules during CVB3 Infection	PLOS ONE			English	Article							COXSACKIEVIRUS B3 REPLICATION; CYTOPLASMIC MESSENGER-RNA; POLY(A)-BINDING PROTEIN; IN-VITRO; 2A PROTEASE; TRANSLATION; INHIBITION; CELLS; PHOSPHORYLATION; ENTEROVIRUS	Stress granules (SGs) are dynamic cytosolic aggregates containing messenger ribonucleoproteins and target polyadenylated (A)-mRNA. A key component of SGs is Ras-GAP SH3 domain binding protein-1 (G3BP1), which in part mediates protein-protein and protein-RNA interactions. SGs are modulated during infection by several viruses, however, the function and significance of this process remains poorly understood. In this study, we investigated the interplay between SGs and Coxsackievirus type B3 (CVB3), a member of the Picornaviridae family. Our studies demonstrated that SGs were formed early during CVB3 infection; however, G3BP1-positive SGs were actively disassembled at 5 hrs post-infection, while poly(A)positive RNA granules persisted. Furthermore, we confirmed G3BP1 cleavage by 3C(pro) at Q325. We also demonstrated that overexpression of G3BP1-SGs negatively impacted viral replication at the RNA, protein, and viral progeny levels. Using electron microscopy techniques, we showed that G3BP1-positive SGs localized near mitochondrial surfaces. Finally, we provided evidence that the C-terminal cleavage product of G3BP1 inhibited SG formation and promoted CVB3 replication. Taken together, we conclude that CVB3 infection selectively targets G3BP1-SGs by cleaving G3BP1 to produce a dominant-negative fragment that further inhibits G3BP1-SG formation and facilitates viral replication.	[Fung, Gabriel; Zhang, Jingchun; Shi, Junyan; Wong, Jerry; Piesik, Paulina; Han, Lillian; Chu, Fanny; Luo, Honglin] Univ British Columbia, Dept Pathol & Lab Med, James Hogg Res Ctr, Providence Heart Lung Inst,St Pauls Hosp Vancouve, Vancouver, BC V5Z 1M9, Canada; [Ng, Chen Seng; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Ng, Chen Seng; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Mol Cell Biol Lab, Kyoto, Japan; [Jagdeo, Julienne; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; Kyoto University; Kyoto University; University of British Columbia	Luo, HL (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, James Hogg Res Ctr, Providence Heart Lung Inst,St Pauls Hosp Vancouve, Vancouver, BC V5Z 1M9, Canada.	honglin.luo@hli.ubc.ca	Shi, Junyan/T-1777-2019; Jan, Eric/O-1923-2019	Piesik, Paulina/0000-0003-4210-5006	Canadian Institutes of Health Research; Grants-in-Aid for Scientific Research [23249023, 24115004] Funding Source: KAKEN	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Canadian Institutes of Health Research (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10; Bovee ML, 1998, VIROLOGY, V245, P241, DOI 10.1006/viro.1998.9172; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Carthy CM, 1998, J VIROL, V72, P7669, DOI 10.1128/JVI.72.9.7669-7675.1998; Chau DHW, 2007, APOPTOSIS, V12, P513, DOI 10.1007/s10495-006-0013-0; COLLER BAG, 1990, J VIROL, V64, P2692, DOI 10.1128/JVI.64.6.2692-2701.1990; de Breyne S, 2008, VIROLOGY, V378, P118, DOI 10.1016/j.virol.2008.05.019; Feuer R, 2009, J VIROL, V83, P9356, DOI 10.1128/JVI.02382-07; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kerekatte V, 1999, J VIROL, V73, P709, DOI 10.1128/JVI.73.1.709-717.1999; Khong A, 2011, J VIROL, V85, P1439, DOI 10.1128/JVI.02220-10; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kuyumcu-Martinez M, 2004, J VIROL, V78, P8172, DOI 10.1128/JVI.78.15.8172-8182.2004; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; LIEBIG HD, 1993, BIOCHEMISTRY-US, V32, P7581, DOI 10.1021/bi00080a033; Lindquist ME, 2010, J VIROL, V84, P12274, DOI 10.1128/JVI.00260-10; Linero FN, 2011, J GEN VIROL, V92, P2889, DOI 10.1099/vir.0.033407-0; Lloyd RE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002741; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; MORROW CD, 1985, CELL, V40, P913, DOI 10.1016/0092-8674(85)90351-4; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Ng CS, 2013, J VIROL; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08	42	70	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79546	10.1371/journal.pone.0079546	http://dx.doi.org/10.1371/journal.pone.0079546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260247	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500075
J	Pascal, LE; Ai, JK; Masoodi, KZ; Wang, YJ; Wang, D; Eisermann, K; Rigatti, LH; O'Malley, KJ; Ma, HM; Wang, XH; Dar, JA; Parwani, AV; Simons, BW; Ittman, MM; Li, LY; Davies, BJ; Wang, Z				Pascal, Laura E.; Ai, Junkui; Masoodi, Khalid Z.; Wang, Yujuan; Wang, Dan; Eisermann, Kurtis; Rigatti, Lora H.; O'Malley, Katherine J.; Ma, Hei M.; Wang, Xinhui; Dar, Javid A.; Parwani, Anil V.; Simons, Brian W.; Ittman, Michael M.; Li, Luyuan; Davies, Benjamin J.; Wang, Zhou			Development of a Reactive Stroma Associated with Prostatic Intraepithelial Neoplasia in EAF2 Deficient Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER XENOGRAFTS; TUMOR PROGRESSION; FACTOR EXPRESSION; CRUCIAL ROLE; ANDROGEN; THROMBOSPONDIN-1; ANGIOGENESIS; CARCINOMA; PTEN	ELL-associated factor 2 (EAF2) is an androgen-responsive tumor suppressor frequently deleted in advanced prostate cancer that functions as a transcription elongation factor of RNA Pol II through interaction with the ELL family proteins. EAF2 knockout mice on a 129P2/OLA-C57BL/6J background developed late-onset lung adenocarcinoma, hepatocellular carcinoma, B-cell lymphoma and high-grade prostatic intraepithelial neoplasia. In order to further characterize the role of EAF2 in the development of prostatic defects, the effects of EAF2 loss were compared in different murine strains. In the current study, aged EAF2(-/-) mice on both the C57BL/6J and FVB/NJ backgrounds exhibited mPIN lesions as previously reported on a 129P2/OLA-C57BL/6J background. In contrast to the 129P2/OLA-C57BL/6J mixed genetic background, the mPIN lesions in C57BL/6J and FVB/NJ EAF2(-/-) mice were associated with stromal defects characteristic of a reactive stroma and a statistically significant increase in prostate microvessel density. Stromal inflammation and increased microvessel density was evident in EAF2-deficient mice on a pure C57BL/6J background at an early age and preceded the development of the histologic epithelial hyperplasia and neoplasia found in the prostates of older EAF2(-/-) animals. Mice deficient in EAF2 had an increased recovery rate and a decreased overall response to the effects of androgen deprivation. EAF2 expression in human cancer was significantly down-regulated and microvessel density was significantly increased compared to matched normal prostate tissue; furthermore EAF2 expression was negatively correlated with microvessel density. These results suggest that the EAF2 knockout mouse on the C57BL/6J and FVB/NJ genetic backgrounds provides a model of PIN lesions associated with an altered prostate microvasculature and reactive stromal compartment corresponding to that reported in human prostate tumors.	[Pascal, Laura E.; Ai, Junkui; Masoodi, Khalid Z.; Wang, Yujuan; Wang, Dan; Eisermann, Kurtis; O'Malley, Katherine J.; Ma, Hei M.; Dar, Javid A.; Davies, Benjamin J.; Wang, Zhou] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15260 USA; [Rigatti, Lora H.] Univ Pittsburgh, Sch Med, Div Lab Anim Resources, Pittsburgh, PA USA; [Wang, Xinhui] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Parwani, Anil V.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Simons, Brian W.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Ittman, Michael M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Li, Luyuan] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Wang, Zhou] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA; [Wang, Zhou] Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wang, Zhou] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Baylor College of Medicine; Nankai University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, Z (corresponding author), Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15260 USA.	wangz2@upmc.edu	Simons, Brian W./G-7352-2015; Masoodi, KhalidZ./ABG-5492-2021; parwani, anil/AAH-5464-2020; Dar, Javid/D-6276-2015; Masoodi, Khalid Z/F-1787-2015; Pascal, Laura E./AAH-5743-2019	Simons, Brian W./0000-0003-0644-211X; Masoodi, KhalidZ./0000-0002-4889-5558; Dar, Javid/0000-0002-4102-6202; Masoodi, Khalid Z/0000-0002-4889-5558; Pascal, Laura E./0000-0003-3840-1662	National Institutes of Health [R37 DK 51193, R01 CA120386, P50 CA090386, T32 DK007774]; Tippins Foundation; Mellam Foundation;  [P30CA047904]; NATIONAL CANCER INSTITUTE [P50CA090386, P30CA047904, R01CA120386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007774, R37DK051193] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tippins Foundation; Mellam Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by National Institutes of Health grants R37 DK 51193, R01 CA120386, P50 CA090386, and T32 DK007774 and scholarships from the Tippins Foundation (LEP) and the Mellam Foundation (KZM). This project used the UPCI Animal Facility and Tissue and Research Pathology Services (TARPS) and was supported in part by award P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala G, 2003, CLIN CANCER RES, V9, P4792; Ayala GE, 2011, AM J PATHOL, V178, P79, DOI 10.1016/j.ajpath.2010.09.042; Barron DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013751; Bastia E, 2005, NEUROPSYCHOPHARMACOL, V30, P891, DOI 10.1038/sj.npp.1300630; Bianchi-Frias D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012501; Buttyan R, 2000, Curr Opin Urol, V10, P415, DOI 10.1097/00042307-200009000-00009; Chen SF, 2010, ANGIOGENESIS, V13, P59, DOI 10.1007/s10456-010-9164-2; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Colombel M, 2005, CANCER RES, V65, P300; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Cyriac J, 2002, PROSTATE, V50, P252, DOI 10.1002/pros.10052; Doll JA, 2001, PROSTATE, V49, P293, DOI 10.1002/pros.10025; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Freeman KW, 2003, CANCER RES, V63, P8256; Fu JD, 2005, FASEB J, V19, P181, DOI 10.1096/fj.05-4501fje; Furlow JD, 1997, DEV BIOL, V182, P284, DOI 10.1006/dbio.1996.8478; Godoy A, 2011, AM J PHYSIOL-ENDOC M, V300, pE263, DOI 10.1152/ajpendo.00210.2010; Gustavsson H, 2009, BJU INT, V104, P1786, DOI 10.1111/j.1464-410X.2009.08676.x; Hermans KG, 2004, GENE CHROMOSOME CANC, V39, P171, DOI 10.1002/gcc.10311; Jennbacken K, 2009, PROSTATE, V69, P1164, DOI 10.1002/pros.20965; Kajdacsy-Balla A, 2007, J MOL HISTOL, V38, P113, DOI 10.1007/s10735-006-9054-5; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kwak C, 2002, BJU INT, V89, P303, DOI 10.1046/j.1464-4096.2001.01417.x; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Li M, 2003, DEV DYNAM, V228, P273, DOI 10.1002/dvdy.10367; Malik G, 2010, CANCER RES, V70, P4327, DOI 10.1158/0008-5472.CAN-09-3312; Mehta R, 2001, CLIN CANCER RES, V7, P81; O'Malley KJ, 2009, PROSTATE, V69, P1716, DOI 10.1002/pros.21034; Olumi AF, 1999, CANCER RES, V59, P5002; Pascal LE, 2011, ANGIOGENESIS, V14, P331, DOI 10.1007/s10456-011-9217-1; Pascal LE, 2011, CANCER MICROENVIRON, V4, P51, DOI 10.1007/s12307-010-0061-4; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stewart RJ, 2001, J UROLOGY, V165, P688, DOI 10.1097/00005392-200102000-00095; Su F, 2010, ONCOGENE, V29, P421, DOI 10.1038/onc.2009.326; Su F, 2013, CANC MICROENVIRON; Suzuki H, 1998, CANCER RES, V58, P204; TEMPONI M, 1989, HYBRIDOMA, V8, P85, DOI 10.1089/hyb.1989.8.85; True LD, 2010, MODERN PATHOL, V23, P1346, DOI 10.1038/modpathol.2010.122; Tuxhorn JA, 2002, CANCER RES, V62, P6021; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Wang XH, 2005, J IMMUNOL METHODS, V299, P139, DOI 10.1016/j.jim.2005.02.006; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595; Xue Y, 1998, ANTICANCER RES, V18, P2679	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79542	10.1371/journal.pone.0079542	http://dx.doi.org/10.1371/journal.pone.0079542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260246	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000327308500074
J	Viet, MH; Chen, CY; Hu, CK; Chen, YR; Li, MS				Viet, Man Hoang; Chen, Chun-Yu; Hu, Chin-Kun; Chen, Yun-Ru; Li, Mai Suan			Discovery of Dihydrochalcone as Potential Lead for Alzheimer's Disease: In Silico and In Vitro Study	PLOS ONE			English	Article							BETA FIBRIL FORMATION; EXPERIMENTAL CONSTRAINTS; AMYLOID FIBRILS; HYDROGEN-BOND; AGGREGATION; INHIBITORS; MECHANISM; EXCITABILITY; PREDICTION; PEPTIDES	By the virtual screening method we have screened out Dihydrochalcone as a top-lead for the Alzheimer's disease using the database of about 32364 natural compounds. The binding affinity of this ligand to amyloid beta (A beta) fibril has been thoroughly studied by computer simulation and experiment. Using the Thioflavin T (ThT) assay we have obtained the inhibition constant IC50 approximate to 2: 46 mu M. This result is in good agreement with the estimation of the binding free energy obtained by the molecular mechanic-Poisson Boltzmann surface area method and all-atom simulation with the force field CHARMM 27 and water model TIP3P. Cell viability assays indicated that Dihydrochalcone could effectively reduce the cytotoxicity induced by A beta. Thus, both in silico and in vitro studies show that Dihydrochalcone is a potential drug for the Alzheimers disease.	[Viet, Man Hoang; Li, Mai Suan] Polish Acad Sci, Inst Phys, Warsaw, Poland; [Chen, Chun-Yu; Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Hu, Chin-Kun] Acad Sinica, Inst Phys, Taipei, Taiwan; [Li, Mai Suan] Quang Trung Software City, Inst Computat Sci & Technol, Ho Chi Minh City, Vietnam	Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Chen, YR (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	yrchen@gate.sinica.edu.tw; masli@ifpan.edu.pl	Man, Viet Hoang/A-5763-2018; viet, man/ABD-9247-2020; Chen, Yun-Ru/C-9304-2014; Li, Mai Suan/D-6304-2015	Man, Viet Hoang/0000-0002-8907-6479; viet, man/0000-0002-8907-6479; Chen, Yun-Ru/0000-0002-6596-6338; Li, Mai Suan/0000-0001-7021-7916; Hu, Chin-Kun/0000-0002-3620-8319	Narodowe Centrum Nauki in Poland [2011/01/B/NZ1/01622]; Department of Science and Technology at Ho Chi Minh city, Vietnam; National Science Council in Taiwan [NSC-100-2923-M-001-003-MY3]; National Center for Theoretical Sciences in Taiwan	Narodowe Centrum Nauki in Poland; Department of Science and Technology at Ho Chi Minh city, Vietnam; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); National Center for Theoretical Sciences in Taiwan	The work was supported by Narodowe Centrum Nauki in Poland (grant No 2011/01/B/NZ1/01622) and Department of Science and Technology at Ho Chi Minh city, Vietnam. CKH is supported by National Science Council in Taiwan under grant number NSC-100-2923-M-001-003-MY3 and National Center for Theoretical Sciences in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Bendheim PE, 2002, J MOL NEUROSCI, V19, P213, DOI 10.1007/s12031-002-0036-0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Clark DE, 1999, J PHARM SCI, V88, P815, DOI 10.1021/js980402t; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; DuPre DB, 2005, J PHYS CHEM A, V109, P622, DOI 10.1021/jp046542a; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Garg P, 2006, J CHEM INF MODEL, V46, P289, DOI 10.1021/ci050303i; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Henderson A. S., 2002, DEMENTIA; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Martorana A, 2008, J NEURAL TRANSM, V115, P1313, DOI 10.1007/s00702-008-0082-z; Martorana A, 2009, NEUROPSYCHOPHARMACOL, V34, P2323, DOI 10.1038/npp.2009.60; McGaughey GB, 2007, J CHEM INF MODEL, V47, P1504, DOI 10.1021/ci700052x; Ngo ST, 2012, J PHYS CHEM B, V116, P10165, DOI 10.1021/jp302506a; Nguyen KV, 2002, BIOCHEM BIOPH RES CO, V291, P764, DOI 10.1006/bbrc.2002.6514; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Ni CL, 2011, FASEB J, V25, P1390, DOI 10.1096/fj.10-175539; Owens J, 2003, DRUG DISCOV TODAY, V8, P12, DOI 10.1016/S1359-6446(02)02556-4; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Srinivasan V, 2006, Behav Brain Funct, V2, P15, DOI 10.1186/1744-9081-2-15; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vainio MJ, 2009, J CHEM INF MODEL, V49, P492, DOI 10.1021/ci800315d	34	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79151	10.1371/journal.pone.0079151	http://dx.doi.org/10.1371/journal.pone.0079151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260164	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500028
J	Zhu, YX; Huang, JM; Zhang, ZK; Zhang, QM; Zhou, T; Ahn, YY				Zhu, Yu-Xiao; Huang, Junming; Zhang, Zi-Ke; Zhang, Qian-Ming; Zhou, Tao; Ahn, Yong-Yeol			Geography and Similarity of Regional Cuisines in China	PLOS ONE			English	Article								Food occupies a central position in every culture and it is therefore of great interest to understand the evolution of food culture. The advent of the World Wide Web and online recipe repositories have begun to provide unprecedented opportunities for data-driven, quantitative study of food culture. Here we harness an online database documenting recipes from various Chinese regional cuisines and investigate the similarity of regional cuisines in terms of geography and climate. We find that geographical proximity, rather than climate proximity, is a crucial factor that determines the similarity of regional cuisines. We develop a model of regional cuisine evolution that provides helpful clues for understanding the evolution of cuisines and cultures.	[Zhu, Yu-Xiao; Zhang, Qian-Ming; Zhou, Tao] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Web Sci Ctr, Chengdu 610054, Peoples R China; [Zhu, Yu-Xiao; Ahn, Yong-Yeol] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Zhu, Yu-Xiao; Zhang, Qian-Ming; Zhou, Tao] Beijing Computat Sci Res Ctr, Beijing, Peoples R China; [Huang, Junming] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China; [Zhang, Zi-Ke] Hangzhou Normal Univ, Alibaba Business Coll, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China	University of Electronic Science & Technology of China; Indiana University System; Indiana University Bloomington; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC); Chinese Academy of Sciences; Institute of Computing Technology, CAS; Hangzhou Normal University	Ahn, YY (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	yyahn@indiana.edu	zhou, tao/GQA-3572-2022; Ahn, Yong-Yeol/C-6334-2011; Huang, Junming/H-9135-2019	Ahn, Yong-Yeol/0000-0002-4352-4301; Huang, Junming/0000-0002-2532-4090; Zhou, Tao/0000-0003-0561-2316	National Natural Science Foundation of China under UESTC [11105024, 11205042, 11105025, 11305043, YBXSZC20131035, YBXSZC20131034]; China Scholarship Council	National Natural Science Foundation of China under UESTC; China Scholarship Council(China Scholarship Council)	Funding came from National Natural Science Foundation of China under Grant Nos. 11105024, 11205042, 11105025, and 11305043 Program of Outstanding PhD Candidate in Academic Research by UESTC (Grant Nos. YBXSZC20131035, YBXSZC20131034) and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L.A., 2000, ZIPF POWER LAW PARET; Ahn YY, 2013, LEONARDO, V46, P272, DOI 10.1162/LEON_a_00569; Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196; [Anonymous], 1996, GARLIC HLTH HIST WOR; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beardsworth A., 1997, MENU INVITATION STUD; Civitello, 2011, CUISINE CULTURE HIST; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Counihan Carole, 1997, FOOD CULTURE READER; Curtin DW., 1992, COOKING EATING THINK; Diamond, 1999, GUNS GERMS STEEL FAT; Firth R, 1934, AFRICA, V7, P401, DOI 10.2307/1155875; Freedman D.A., 2009, STAT MODELS THEORY P; Germov J, 2008, SOCIOLOGY FOOD NUTR; Harald C, 1999, MATH METHODS STAT; Jolliffe TT, 2008, PRINCIPAL COMPONENT; Kinouchi O, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073020; Lu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014139; Mennell S., 1993, SOCIOLOGY FOOD EATIN; Richards AI, 1939, HUNGER WORK SAVAGE T; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Salton G., 1986, INTRO MODERN INFORM; Sherman PW, 1999, BIOSCIENCE, V49, P453, DOI 10.2307/1313553; Skubal Susanne M., 2002, WORD MOUTH FOOD FICT; Symons Michael, 2007, FOOD PHILOS EAT THIN, P20; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Tregear A, 2003, STILTON VIMTO USING	27	41	44	6	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79161	10.1371/journal.pone.0079161	http://dx.doi.org/10.1371/journal.pone.0079161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260166	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500030
J	Al-Dossary, AA; Strehler, EE; Martin-DeLeon, PA				Al-Dossary, Amal A.; Strehler, Emanuel E.; Martin-DeLeon, Patricia A.			Expression and Secretion of Plasma Membrane Ca2+-ATPase 4a (PMCA4a) during Murine Estrus: Association with Oviductal Exosomes and Uptake in Sperm	PLOS ONE			English	Article							MALE-FERTILITY; CA2+ PUMPS; JAM-A; SPAM1; MOUSE; MOTILITY; BINDING; PROTEIN; CELLS; EPIDIDYMOSOMES	PMCA4, a membrane protein, is the major Ca2+ efflux pump in murine sperm where its deletion leads to a severe loss of hyperactivated motility and to male infertility. We have previously shown that the PMCA4b splice variant interacts with CASK (Ca2+/CaM-dependent serine kinase) in regulating sperm Ca2+. More recently we detected that PMCA4a isoform, in addition to its presence in testis, is secreted in the epididymal luminal fluid and transferred to sperm. Here we show that Pmca4 mRNA is expressed in both the 4a and 4b variants in the vagina, uterus, and oviduct. Immunofluorescence reveals that PMCA4a is similarly expressed and is elevated during estrus, appearing in the glandular and luminal epithelia. Western analysis detected PMCA4a in all tissues and in the luminal fluids (LF) of the vagina (VLF), uterus (ULF), and the oviduct (OLF) collected during estrus. It was similar to 9- and 4-fold higher in OLF than in VLF and ULF, and only marginally present in LF collected at metestrus/diestrus. Fractionation of the LF collected at estrus, via ultracentrifugation, revealed that 100% of the PMCA4a resides in the vesicular fraction of the ULF and OLF. Transmission electron microscopy (TEM) revealed that OLF vesicles have an exosomal orientation (with the cytoplasmic-side inward), a size range of 25-100 nm, with the characteristic CD9 biomarker. Thus, we dubbed these vesicles "oviductosomes", to which PMCA4a was immunolocalized. Incubation of caudal sperm in the combined LF or exosomes resulted in up to a similar to 3-fold increase of sperm PMCA4a, as detected by flow cytometry, indicating in vitro uptake. Our results are consistent with the increased requirement of Ca2+ efflux in the oviduct. They show for the first time the presence of oviductal exosomes and highlight their role, along with uterosomes and vaginal exosomes, in post-testicular sperm acquisition of PMCA4a which is essential for hyperactivated motility and fertility.	[Al-Dossary, Amal A.; Martin-DeLeon, Patricia A.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Strehler, Emanuel E.] Mayo Clin, Dept Biochem, Rochester, MN USA	University of Delaware; Mayo Clinic	Martin-DeLeon, PA (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	pdeleon@udel.edu		Al-Dossary, Amal/0000-0002-4634-6483	NIH [5P20RR015588]; Saudi Arabia Cultural Mission;  [NIH-RO3HD073523A]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; EPSCoR [0814251] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saudi Arabia Cultural Mission; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by: NIH-RO3HD073523A, NIH 5P20RR015588, and the Saudi Arabia Cultural Mission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JC, 1994, BIOL REPROD, V51, P1238, DOI 10.1095/biolreprod51.6.1238; Aravindan RG, 2012, J CELL PHYSIOL, V227, P3138, DOI 10.1002/jcp.24000; BARRATT CLR, 1991, INT J ANDROL, V14, P394, DOI 10.1111/j.1365-2605.1991.tb01268.x; Belan PV, 1996, J BIOL CHEM, V271, P7615, DOI 10.1074/jbc.271.13.7615; Boilard M, 2002, BIOL REPROD, V67, P1125, DOI 10.1095/biolreprod67.4.1125; Brandenburger T, 2011, J BIOL CHEM, V286, P7938, DOI 10.1074/jbc.M110.142836; Caballero JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065364; Caride AJ, 2007, J BIOL CHEM, V282, P25640, DOI 10.1074/jbc.M701129200; Chen H, 2006, BIOL REPROD, V74, P923, DOI 10.1095/biolreprod.105.048587; Coy P, 2012, REPRODUCTION, V144, P649, DOI 10.1530/REP-12-0279; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Frenette G, 2001, MOL REPROD DEV, V59, P115, DOI 10.1002/mrd.1013; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Griffiths GS, 2008, MOL REPROD DEV, V75, P1627, DOI 10.1002/mrd.20907; Griffiths GS, 2008, REPRODUCTION, V135, P293, DOI 10.1530/REP-07-0340; Griffiths GS, 2009, BIOL REPROD, V81, P562, DOI 10.1095/biolreprod.108.075739; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; Kirchhoff C, 1997, ADV EXP MED BIOL, V424, P221; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Morales P, 1996, HUM REPROD, V11, P1504; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Patel R, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108712; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Post H, 2002, PROSTATE, V52, P159, DOI 10.1002/pros.10109; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rodriguez-Martinez H, 2007, THERIOGENOLOGY, V68, pS138, DOI 10.1016/j.theriogenology.2007.03.018; Saez F, 2003, J ANDROL, V24, P149; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Shao MH, 2008, DEV BIOL, V313, P246, DOI 10.1016/j.ydbio.2007.10.013; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; YEUNG CH, 2002, ACQUISITION DEV SPER; Zhang H, 2003, BIOL REPROD, V69, P446, DOI 10.1095/biolreprod.102.013854	40	106	114	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80181	10.1371/journal.pone.0080181	http://dx.doi.org/10.1371/journal.pone.0080181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244642	Green Submitted, gold, Green Published			2022-12-25	WOS:000327143800132
J	Suberu, JO; Gorka, AP; Jacobs, L; Roepe, PD; Sullivan, N; Barker, GC; Lapkin, AA				Suberu, John O.; Gorka, Alexander P.; Jacobs, Lauren; Roepe, Paul D.; Sullivan, Neil; Barker, Guy C.; Lapkin, Alexei A.			Anti-Plasmodial Polyvalent Interactions in Artemisia annua L. Aqueous Extract - Possible Synergistic and Resistance Mechanisms	PLOS ONE			English	Article							IN-VITRO; ANTIMALARIAL ACTIVITY; CHLOROGENIC ACID; HERBAL TEA; ROSMARINIC ACID; QING-HAO; ANTIOXIDANT; FALCIPARUM; CHEMISTRY; DIHYDROARTEMISININ	Artemisia annua hot water infusion (tea) has been used in in vitro experiments against P. falciparum malaria parasites to test potency relative to equivalent pure artemisinin. High performance liquid chromatography (HPLC) and mass spectrometric analyses were employed to determine the metabolite profile of tea including the concentrations of artemisinin (47.5 +/- 0.8 mg L-1), dihydroartemisinic acid (70.0 +/- 0.3 mg L-1), arteannuin B (1.3 +/- 0.0 mg L-1), isovitexin (105.0 +/- 7.2 mg L-1) and a range of polyphenolic acids. The tea extract, purified compounds from the extract, and the combination of artemisinin with the purified compounds were tested against chloroquine sensitive and chloroquine resistant strains of P. falciparum using the DNA-intercalative SYBR Green I assay. The results of these in vitro tests and of isobologram analyses of combination effects showed mild to strong antagonistic interactions between artemisinin and the compounds (9-epi-artemisinin and artemisitene) extracted from A. annua with significant (IC50 < 1 mu M) anti-plasmodial activities for the combination range evaluated. Mono-caffeoylquinic acids, tri-caffeoylquinic acid, artemisinic acid and arteannuin B showed additive interaction while rosmarinic acid showed synergistic interaction with artemisinin in the chloroquine sensitive strain at a combination ratio of 1: 3 (artemisinin to purified compound). In the chloroquine resistant parasite, using the same ratio, these compounds strongly antagonised artemisinin anti-plasmodial activity with the exception of arteannuin B, which was synergistic. This result would suggest a mechanism targeting parasite resistance defenses for arteannuin B's potentiation of artemisinin.	[Suberu, John O.; Barker, Guy C.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Gorka, Alexander P.; Jacobs, Lauren; Roepe, Paul D.] Georgetown Univ, Dept Chem, Ctr Infect Dis, Washington, DC 20057 USA; [Sullivan, Neil] Sensapharm Ltd, Business & Innovat Ctr, Sunderland, England; [Lapkin, Alexei A.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England	University of Warwick; Georgetown University; University of Cambridge	Barker, GC (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	guy.barker@warwick.ac.uk	Lapkin, Alexei/CAG-1632-2022	Barker, Guy Cameron/0000-0002-3250-0355	Engineering and Physical Sciences Research Council (EPSRC, UK); SensaPharm Ltd; Chemistry Innovation Knowledge Transfer Network (CIKTN, UK)	Engineering and Physical Sciences Research Council (EPSRC, UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); SensaPharm Ltd; Chemistry Innovation Knowledge Transfer Network (CIKTN, UK)	This study was funded by Engineering and Physical Sciences Research Council (EPSRC, UK) and SensaPharm Ltd via an Industrial CASE PhD studentship. The award was allocated competitively by Chemistry Innovation Knowledge Transfer Network (CIKTN, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACTON N, 1987, PLANTA MED, P266, DOI 10.1055/s-2006-962700; AGRAWAL PK, 1991, PHYTOCHEMISTRY, V30, P3469, DOI 10.1016/0031-9422(91)83234-C; [Anonymous], 2012, WO POS STAT EFF NONP; Belkaid A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-7; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Bilia AR, 2002, LIFE SCI, V70, P769, DOI 10.1016/S0024-3205(01)01447-3; Bozdech Z, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-23; Bray PG, 2005, BIOCHEM PHARMACOL, V70, P1158, DOI 10.1016/j.bcp.2005.07.021; Cao DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021071; Carbonara T, 2012, J PHARMACEUT BIOMED, V62, P79, DOI 10.1016/j.jpba.2012.01.015; Cui L, 2012, MOL MICROBIOL, V86, P111, DOI 10.1111/j.1365-2958.2012.08180.x; De Donno A, 2012, T ROY SOC TROP MED H, V106, P696, DOI 10.1016/j.trstmh.2012.07.008; de Magalhaes PM, 2012, FOOD CHEM, V134, P864, DOI 10.1016/j.foodchem.2012.02.195; de Ridder S, 2008, J ETHNOPHARMACOL, V120, P302, DOI 10.1016/j.jep.2008.09.017; Ding XC, 2011, TRENDS PARASITOL, V27, P73, DOI 10.1016/j.pt.2010.11.006; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; ELFORD BC, 1987, T ROY SOC TROP MED H, V81, P434, DOI 10.1016/0035-9203(87)90161-1; Erkan N, 2008, FOOD CHEM, V110, P76, DOI 10.1016/j.foodchem.2008.01.058; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s; Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011; Gulcin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011; Haynes RK, 2006, CURR TOP MED CHEM, V6, P509, DOI 10.2174/156802606776743129; Haynes RK, 2003, ANTIMICROB AGENTS CH, V47, P1175, DOI 10.1128/AAC.47.3.1175.2003; Hsu E, 2006, T ROY SOC TROP MED H, V100, P505, DOI 10.1016/j.trstmh.2005.09.020; Hsu E, 2006, BRIT J CLIN PHARMACO, V61, P666, DOI 10.1111/j.1365-2125.2006.02673.x; Jansen FH, 2006, T ROY SOC TROP MED H, V100, P285, DOI 10.1016/j.trstmh.2005.08.004; Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; LANSBURY PT, 1986, TETRAHEDRON LETT, V27, P3967, DOI 10.1016/S0040-4039(00)84886-8; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; LIU KCSC, 1992, PLANT CELL REP, V11, P637, DOI 10.1007/BF00236389; Miketova P, 1999, J MASS SPECTROM, V34, P1240, DOI 10.1002/(SICI)1096-9888(199912)34:12<1240::AID-JMS896>3.0.CO;2-B; Mouton J, 2013, PLANTA MED, V79, P468, DOI 10.1055/s-0032-1328324; Nemekaite-Ceniene A, 2005, ARCH BIOCHEM BIOPHYS, V441, P182, DOI 10.1016/j.abb.2005.07.002; Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; Rath K, 2004, AM J TROP MED HYG, V70, P128, DOI 10.4269/ajtmh.2004.70.128; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Suberu J, 2013, J PHARMACEUT BIOMED, V84, P269, DOI 10.1016/j.jpba.2013.06.025; Tepe B, 2007, FOOD CHEM, V100, P985, DOI 10.1016/j.foodchem.2005.10.062; VANDERKOOY F, 2011, J PLANT RES, V77, P1754, DOI DOI 10.1055/S-0030-1271065; Vivas L, 2007, J ANTIMICROB CHEMOTH, V59, P658, DOI 10.1093/jac/dkl563; Wagner H, 2005, PURE APPL CHEM, V77, P1, DOI 10.1351/pac200577010001; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Wagner H, 2011, FITOTERAPIA, V82, P34, DOI 10.1016/j.fitote.2010.11.016; Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582; Wang LH, 2007, J CHEM ENG DATA, V52, P757, DOI 10.1021/je0603426; Weathers PJ, 2012, PLANTA MED, V78, P1024, DOI 10.1055/s-0032-1314949; Weina P. J., 2008, Parassitologia (Rome), V50, P25; Willcox M, 2004, TRA HERB, V4, P43; Willcox M, 2009, J ALTERN COMPLEM MED, V15, P101, DOI 10.1089/acm.2008.0327; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; Wright CW, 2010, MOLECULES, V15, P804, DOI 10.3390/molecules15020804; Xu JG, 2012, J AGR FOOD CHEM, V60, P11625, DOI 10.1021/jf303771s; Yordi E. G., 2012, ANTIOXIDANT PROOXIDA; Zhang B, 2008, SEP PURIF TECHNOL, V62, P480, DOI 10.1016/j.seppur.2008.02.013	62	49	51	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80790	10.1371/journal.pone.0080790	http://dx.doi.org/10.1371/journal.pone.0080790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244716	Green Published, gold			2022-12-25	WOS:000327143800163
J	Goodwin, K; Syme, C; Abrahamowicz, M; Leonard, GT; Richer, L; Perron, M; Veillette, S; Gaudet, D; Paus, T; Pausova, Z				Goodwin, Katie; Syme, Catriona; Abrahamowicz, Michal; Leonard, Gabriel T.; Richer, Louis; Perron, Michel; Veillette, Suzanne; Gaudet, Daniel; Paus, Tomas; Pausova, Zdenka			Routine Clinical Measures of Adiposity as Predictors of Visceral Fat in Adolescence: A Population-Based Magnetic Resonance Imaging Study	PLOS ONE			English	Article							TOTAL-BODY FAT; NUTRITION-EXAMINATION-SURVEY; AMERICAN-HEART-ASSOCIATION; METABOLIC SYNDROME; RISK-FACTORS; CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; SUBCUTANEOUS FAT; SCIENTIFIC STATEMENT; ABDOMINAL ADIPOSITY	Objective: Visceral fat (VF) increases cardiometabolic risk more than fat stored subcutaneously. Here, we investigated how well routine clinical measures of adiposity, namely body mass index (BMI) and waist circumference (waist), predict VF and subcutaneous fat (SF) in a large population-based sample of adolescents. As body-fat distribution differs between males and females, we performed these analyses separately in each sex. Design and Methods: VF and SF were measured by magnetic resonance imaging in 1,002 adolescents (482 males, age 12-18 years). Relationships of BMI and waist with VF and SF were tested in multivariable analyses, which adjusted for potentially confounding effects of age and height. Results: In both males and females, BMI and waist were highly correlated with VF and SF, and explained 55-76% of their total variance. When VF was adjusted for SF, however, BMI and waist explained, respectively, only 0% and 4% of VF variance in males, and 4% and 11% of VF variance in females. In contrast, when SF was adjusted for VF, BMI and waist explained, respectively, 36% and 21% of SF variance in males, and 48% and 23% of SF variance in females. These relationships were similar during early and late puberty. Conclusions and Relevance: During adolescence, routine clinical measures of adiposity predict well SF but not VF. This holds for both sexes and throughout puberty. Further longitudinal studies are required to assess how well these measures predict changes of VF and SF over time. Given the clinical importance of VF, development of cost-effective imaging techniques and/or robust biomarkers of VF accumulation that would be suitable in everyday clinical practice is warranted.	[Goodwin, Katie; Syme, Catriona; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Abrahamowicz, Michal] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Leonard, Gabriel T.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Richer, Louis] Univ Quebec Chicoutimi, Dept Psychol, Chicoutimi, PQ, Canada; [Veillette, Suzanne] Univ Quebec Chicoutimi, Dept Human Sci, Chicoutimi, PQ, Canada; [Gaudet, Daniel] Univ Montreal, Chicoutimi Hosp, Community Genom Ctr, Chicoutimi, PQ, Canada; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Chicoutimi; Universite de Montreal; University of Toronto; University Toronto Affiliates; Baycrest	Pausova, Z (corresponding author), Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada.	zdenka.pausova@sickkids.ca		Goodwin, Katharine/0000-0002-4823-7491; Abrahamowicz, Michal/0000-0002-3172-3952	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Foundation for Innovation(Canada Foundation for Innovation)	The Canadian Institutes of Health Research (Zdenka Pausova, Tomas Paus), Heart and Stroke Foundation of Canada (Zdenka Pausova), and the Canadian Foundation for Innovation (Zdenka Pausova) support the Saguenay Youth Study. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University. Tomas Paus is the Tanenbaum Chair in Population Neuroscience at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alligier M, 2013, J CLIN ENDOCR METAB, V98, P802, DOI 10.1210/jc.2012-3289; Anis AH, 2010, OBES REV, V11, P31, DOI 10.1111/j.1467-789X.2009.00579.x; Arbatan T, 2012, ADV HEALTHC MATER, V1, P80, DOI 10.1002/adhm.201100016; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Benfield LL, 2008, INT J OBESITY, V32, P91, DOI 10.1038/sj.ijo.0803780; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; BOLINDER J, 1983, DIABETES, V32, P117, DOI 10.2337/diabetes.32.2.117; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Caprio S, 1996, AM J CLIN NUTR, V64, P12, DOI 10.1093/ajcn/64.1.12; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; Demerath EW, 2007, OBESITY, V15, P2984, DOI 10.1038/oby.2007.356; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Goran MI, 1998, INT J OBESITY, V22, P549, DOI 10.1038/sj.ijo.0800624; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hocking S, 2013, ENDOCR REV, V34, P463, DOI 10.1210/er.2012-1041; Johnson WD, 2009, ARCH PEDIAT ADOL MED, V163, P371, DOI 10.1001/archpediatrics.2009.3; Katzmarzyk PT, 2012, PEDIATR OBES, V7, pE42, DOI 10.1111/j.2047-6310.2012.00073.x; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Liu A, 2009, OBES SURG, V19, P1564, DOI 10.1007/s11695-009-9949-9; MARSHALL WA, 1974, ANN HUM BIOL, V1, P29, DOI 10.1080/03014467400000031; McGill HC, 2003, JAMA-J AM MED ASSOC, V290, P2320, DOI 10.1001/jama.290.17.2320; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pausova Z, 2006, CURR OPIN NEPHROL HY, V15, P173, DOI 10.1097/01.mnh.0000214775.42103.a5; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; Pausova Z, 2012, HYPERTENSION, V59, P572, DOI 10.1161/HYPERTENSIONAHA.111.180372; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Pou KM, 2009, DIABETES CARE, V32, P481, DOI 10.2337/dc08-1359; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Shen W, 2011, INT J PEDIATR OBES, V6, P149, DOI 10.3109/17477166.2010.486833; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Siegel MJ, 2007, RADIOLOGY, V242, P846, DOI 10.1148/radiol.2423060111; Smith JD, 2012, J CLIN ENDOCR METAB, V97, P1517, DOI 10.1210/jc.2011-2550; Staiano AE, 2012, INT J OBESITY, V36, P1261, DOI 10.1038/ijo.2012.95; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Suliga E, 2009, NUTR RES REV, V22, P137, DOI 10.1017/S0954422409990096; Syme C, 2008, ARCH PEDIAT ADOL MED, V162, P453, DOI 10.1001/archpedi.162.5.453; Taksali SE, 2008, DIABETES, V57, P367, DOI 10.2337/db07-0932; Thorne A, 2002, INT J OBESITY, V26, P193, DOI 10.1038/sj.ijo.0801871; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	53	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79896	10.1371/journal.pone.0079896	http://dx.doi.org/10.1371/journal.pone.0079896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244574	Green Accepted, Green Published, gold			2022-12-25	WOS:000327221600157
J	Zhang, Y; Tseng, CC; Tsai, YL; Fu, XY; Schiff, R; Lee, AS				Zhang, Yi; Tseng, Chun-Chih; Tsai, Yuan-Li; Fu, Xiaoyong; Schiff, Rachel; Lee, Amy S.			Cancer Cells Resistant to Therapy Promote Cell Surface Relocalization of GRP78 Which Complexes with PI3K and Enhances PI(3,4,5)P3 Production	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; RESPONSE REGULATOR GRP78/BIP; PROTEIN GRP78; ER CHAPERONE; ENDOTHELIAL-CELLS; DRUG-RESISTANCE; TERMINAL DOMAIN; BREAST-CANCER; RECEPTOR; GROWTH	Traditionally, GRP78 has been regarded as an endoplasmic reticulum (ER) lumenal protein due to its carboxyl KDEL retention motif. Recently, a subfraction of GRP78 is found to localize to the surface of specific cell types, serving as co-receptors and regulating signaling. However, the physiological relevance of cell surface GRP78 (sGRP78) expression in cancer and its functional interactions at the cell surface are just emerging. In this report, we combined biochemical, imaging and mutational approaches to address these issues. For detection of sGRP78, we utilized a mouse monoclonal antibody highly potent and specific for GRP78 or epitope-tagged GRP78, coupled with imaging and biochemical techniques that allowed detection of sGRP78 but not intracellular GRP78. Our studies revealed that breast and prostate cancer cells resistant to hormonal therapy actively promote GRP78 to the cell surface, which can be further elevated by a variety of ER stress-inducing conditions. We showed that sGRP78 forms complex with PI3K, and overexpression of sGRP78 promotes PIP3 formation, indicative of PI3K activation. We further discovered that an insertion mutant of GRP78 at its N-terminus domain, while retaining stable expression and the ability to translocate to the cell surface as the wild-type protein, exhibited reduced complex formation with p85 and production of PIP3. Thus, our studies provide a mechanistic explanation for the regulation of the PI3K/AKT signaling by sGRP78. Our findings suggest that targeting sGRP78 may suppress therapeutic resistance in cancer cells and offer a novel strategy to suppress PI3K activity.	[Zhang, Yi; Tseng, Chun-Chih; Tsai, Yuan-Li; Lee, Amy S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Fu, Xiaoyong; Schiff, Rachel] Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA	University of Southern California; Baylor College of Medicine	Lee, AS (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	amylee@ccnt.usc.edu	Tseng, Chun-Chih/AAS-3712-2020	Tseng, Chun-Chih/0000-0001-9285-0712; Lee, Amy/0000-0002-0378-5443	National Institutes of Health (NIH) [R01 CA027607, P01 AG034906]; Breast Cancer Research Foundation; SU2C/Breast program; USC Norris Comprehensive Cancer Center's Cell and Tissue Imaging Core [P30 CA014089]; USC Research Center for Liver Diseases Cell and Tissue Imaging Core [P30 DK048522]; Breast Cancer SPORE [P50 CA058183, P01 CA030195]; NATIONAL CANCER INSTITUTE [R01CA027607, P30CA014089, P01CA030195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG034906] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; SU2C/Breast program; USC Norris Comprehensive Cancer Center's Cell and Tissue Imaging Core; USC Research Center for Liver Diseases Cell and Tissue Imaging Core; Breast Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grants R01 CA027607 and P01 AG034906 to ASL; P50 CA058183 (Breast Cancer SPORE), P01 CA030195, The Breast Cancer Research Foundation and SU2C/Breast program to RS; P30 CA014089 (USC Norris Comprehensive Cancer Center's Cell and Tissue Imaging Core) and P30 DK048522 (USC Research Center for Liver Diseases Cell and Tissue Imaging Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Delie F, 2012, J ONCOL, V2012, DOI 10.1155/2012/468615; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu R, 2013, CLIN CANC R IN PRESS; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Ray R, 2012, J BIOL CHEM, V287, P32755, DOI 10.1074/jbc.M112.399808; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhou H, 2011, J BIOL CHEM, V286, P25687, DOI 10.1074/jbc.M110.212944; Zhu GY, 2013, FASEB J, V27, P955, DOI 10.1096/fj.12-213330	50	88	92	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80071	10.1371/journal.pone.0080071	http://dx.doi.org/10.1371/journal.pone.0080071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244613	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600177
J	Guo, JJ; Zhang, X; Wang, L; Guo, Y; Xie, MH				Guo, Jianjun; Zhang, Xi; Wang, Ling; Guo, Yan; Xie, Minhao			Prevalence of Metabolic Syndrome and Its Components among Chinese Professional Athletes of Strength Sports with Different Body Weight Categories	PLOS ONE			English	Article							INSULIN-RESISTANCE; RISK-FACTORS; FOOTBALL; DISEASE	Background: There is an increasing concern on cardiometabolic health in young professional athletes at heavy-weight class. Objective: Our cross-sectional survey aimed to evaluate the prevalence of metabolic syndrome and clustering of metabolic risk factors in a population of young and active professional athletes of strength sports in China. Methods: From July 2006 to December 2008, a total of 131 male and 130 female athletes of strength sports were enrolled. We used two criteria provided by the Chinese Diabetes Society (2004) and the National Cholesterol Education Program's Adult Treatment Panel III (2002) to define the metabolic syndrome and its individual components, respectively. Results: Regardless of their similar ages (mean: 21 years) and exercise levels, athletes in the heaviest-weight-class with unlimited maximum body weight (UBW) boundaries (mean weight and BMI: 130 kg and 38 kg/m(2) for men, 110 kg and 37 kg/m(2) for women) had significantly higher prevalence of metabolic syndrome than did those in all other body-weight-class with limited body weight (LBW) boundaries (mean weight and BMI: 105 kg and 32 kg/m(2) for men, 70 kg and 26 kg/m(2) for women). Prevalence of metabolic syndrome using CDS criteria (UBW vs. LBW: 89% vs. 18% for men, 47% vs. 0% for women) and its individual components, including central obesity, hypertension, hypertriglyceridemia, low high-density lipoprotein-cholesterol levels, and impaired fasting glucose, were all significantly higher in athletes at the heaviest weight group with UBW than all other weight groups with LBW. Conclusions: Our study suggests that professional athletes of strength sports at the heaviest-weight-class are at a significant increased risk of cardiometabolic disease compared with those at all other weight categories. The findings support the importance of developing and implementing the strategy of early screening, awareness, and interventions for weight-related health among young athletes.	[Guo, Jianjun; Guo, Yan] China Inst Sport Sci, Ctr Youth Sport Res & Dev, Beijing, Peoples R China; [Zhang, Xi] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China; [Wang, Ling] Peking Univ, Sch Publ Hlth, Hlth Sci Ctr, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Xie, Minhao] Beijing Sports Univ, Beijing, Peoples R China	China Institute of Sport Science; Peking University; Peking University; Beijing Sport University	Guo, JJ (corresponding author), China Inst Sport Sci, Ctr Youth Sport Res & Dev, Beijing, Peoples R China.	guojianjun@ciss.cn	Guo, jianjun/AAH-1715-2020		General Administration of Sport of China [05-09]	General Administration of Sport of China	The work was supported by the funding from General Administration of Sport of China (No. 05-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista C, 2013, J CARDIOL, V61, P440, DOI 10.1016/j.jjcc.2013.01.011; Berge HM, 2013, BRIT J SPORT MED, V47, P521, DOI 10.1136/bjsports-2013-092354; Borchers JR, 2009, MED SCI SPORT EXER, V41, P2105, DOI 10.1249/MSS.0b013e3181abdfec; Buell JL, 2008, J ATHL TRAINING, V43, P608, DOI 10.4085/1062-6050-43.6.608; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cui Han-bin, 2007, Chinese Medical Sciences Journal, V22, P216; Group CDSM, 2004, SUGG CHIN DIAB SOC C, P156; Karamanos BG, 2001, DIABETIC MED, V18, P32, DOI 10.1046/j.1464-5491.2001.00386.x; KUJALA UM, 1994, METABOLISM, V43, P1255, DOI 10.1016/0026-0495(94)90219-4; KYLE JM, 1991, J FAM PRACTICE, V33, P172; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Malina RM, 2007, J PEDIATR-US, V151, P378, DOI 10.1016/j.jpeds.2007.03.044; Miller MA, 2008, AM J CARDIOL, V101, P1281, DOI 10.1016/j.amjcard.2007.12.029; PATSCH JR, 1983, P NATL ACAD SCI-BIOL, V80, P1449, DOI 10.1073/pnas.80.5.1449; Tuan NT, 2009, AM J CLIN NUTR, V89, P1905, DOI 10.3945/ajcn.2008.26809; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; Vogel RA, 1997, AM J CARDIOL, V79, P350, DOI 10.1016/S0002-9149(96)00760-6; Wilkerson GB, 2010, J ATHL TRAINING, V45, P67, DOI 10.4085/1062-6050-45.1.67	19	21	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79758	10.1371/journal.pone.0079758	http://dx.doi.org/10.1371/journal.pone.0079758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255714	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200086
J	Iwata, TN; Cowley, TJ; Sloma, M; Ji, YW; Qi, L; Lee, SS				Iwata, Terri N.; Cowley, Timothy J.; Sloma, Michael; Ji, Yewei; Qi, Ling; Lee, Siu Sylvia			The Transcriptional Co-Regulator HCF-1 Is Required for INS-1 beta-cell Glucose-Stimulated Insulin Secretion	PLOS ONE			English	Article							FACTOR PDX-1; MLL FAMILY; GENE; GROWTH; COMPLEX; METHYLTRANSFERASES; EXPRESSION; MUTATION; PATHWAY; E2F1	The transcriptional co-regulator host cell factor-1 (HCF-1) plays critical roles in promoting cell cycle progression in diverse cell types, and in maintaining self-renewal of embryonic stem cells, but its role in pancreatic beta-cell function has not been investigated. Immunhistochemistry of mouse pancreas revealed nuclear expression of HCF-1 in pancreatic islets. Reducing HCF-1 expression in the INS-1 pancreatic beta-cell line resulted in reduced cell proliferation, reduced glucose-stimulated insulin secretion, and reduced expression of the critical beta-cell transcription factor Pdx1. HCF-1 is a known co-activator of the E2F1 transcription factor, and loss of E2F1 results in pancreatic beta-cell dysfunction and reduced expression of Pdx1. Therefore we wondered whether HCF-1 might be required for E2F1 regulation of Pdx1. Chromatin immunoprecipitation experiments revealed that HCF-1 and E2F1 co-localize to the Pdx1 promoter. These results indicate that HCF-1 represents a novel transcriptional regulator required for maintaining pancreatic beta-cell function.	[Iwata, Terri N.; Cowley, Timothy J.; Sloma, Michael; Ji, Yewei; Qi, Ling; Lee, Siu Sylvia] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Cornell University	Lee, SS (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	sylvia.lee@cornell.edu	Ji, Yewei/F-5040-2014	Ji, Yewei/0000-0002-4249-6812; Iwata, Terri/0000-0002-6262-1422; Qi, Ling/0000-0001-8229-0184	National Institute on Aging [AG024425]; Cornell Center for Vertebrate Genomics; Juvenile Diabetes Research Foundation; National Institute of Child Health and Human Development [T32HD052471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024425] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cornell Center for Vertebrate Genomics; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by R01 grant AG024425 from the National Institute on Aging, a seed grant from the Cornell Center for Vertebrate Genomics, and an innovation award from the Juvenile Diabetes Research Foundation awarded to SSL. TNI was supported by a Reproductive Genomics Training grant T32HD052471 from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; DeFronzo RA, 2011, J CLIN ENDOCR METAB, V96, P2354, DOI 10.1210/jc.2011-0246; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Macfarlane WM, 1999, J CLIN INVEST, V104, pR33, DOI 10.1172/JCI7449; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Rizki G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002235; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Stoffers DA, 1998, J CLIN INVEST, V102, P232, DOI 10.1172/JCI2242; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463	32	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78841	10.1371/journal.pone.0078841	http://dx.doi.org/10.1371/journal.pone.0078841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250814	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200047
J	Yu, YH; Zhang, L; Wu, DS; Zhang, Z; Huang, FF; Zhang, J; Chen, XP; Liang, DS; Zeng, H; Chen, FP				Yu, Yan-Hui; Zhang, Li; Wu, Deng-Shu; Zhang, Zheng; Huang, Fang-Fang; Zhang, Jian; Chen, Xiao-Ping; Liang, De-Sheng; Zeng, Hui; Chen, Fang-Ping			MiR-223 Regulates Human Embryonic Stem Cell Differentiation by Targeting the IGF-1R/Akt Signaling Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SELF-RENEWAL; PROLIFERATION; GROWTH; PLURIPOTENCY; CROSSTALK; CIRCUITRY; ENDODERM	Currently, there are difficulties associated with the culturing of pluripotent human embryonic stem cells (hESCs), and knowledge regarding their regulatory mechanisms is limited. MicroRNAs (miRNAs) regulate gene expression and have critical functions in stem cell self-renewal and differentiation. Moreover, fibroblast growth factor (FGF) and the insulin-like growth factor receptor (IGF-1R) are key activators of signaling in hESCs. Based on the identification of complementary binding sites in miR-223 and IGF-1R mRNA, it is proposed that miR-223 acts as a local regulator of IGF-1R. Therefore, levels of miR-223 were detected in differentiated versus undifferentiated hESCs. In addition, proliferation, apoptosis, and differentiation were assayed in these two hESC populations and were compared in the presence of exogenous miR-223 and miR-223 inhibitor. Inhibition of miR-223 was found to maintain the undifferentiated state of hESCs, while addition of miR-223 induced differentiation. Furthermore, these effects were found to be likely dependent on IGF-1R/Akt signaling.	[Yu, Yan-Hui; Wu, Deng-Shu; Huang, Fang-Fang; Zhang, Jian; Zeng, Hui; Chen, Fang-Ping] Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha, Hunan, Peoples R China; [Zhang, Li] Si Chuan Univ, West China Hosp, Dept Hematol, Chengdu, Sichuan, Peoples R China; [Zhang, Zheng] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China; [Chen, Xiao-Ping] Cent S Univ, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha, Hunan, Peoples R China; [Liang, De-Sheng] Cent S Univ, State Key Lab Med Genet China, Changsha, Hunan, Peoples R China	Central South University; Sichuan University; Central South University; Central South University; Central South University	Zeng, H (corresponding author), Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha, Hunan, Peoples R China.	androps2011@hotmail.com; xychenfp@2118.cn	Liang, Desheng/ABH-2349-2021	Liang, Desheng/0000-0002-9451-8585	National Natural Science Foundation of China [81170477, 81100328]; Ministry of Education of China [20110162120010]; Fundamental Research Funds for Central Universities [2011QNT151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 81170477) to F.-P. C., the National Natural Science Foundation of China (Grant No. 81100328), the Doctoral Fund of Ministry of Education of China (Grant No. 20110162120010), and the Fundamental Research Funds for Central Universities (Grant No. 2011QNT151) to H.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen YG, 2012, CELL STEM CELL, V10, P231, DOI 10.1016/j.stem.2012.02.008; Estan MC, 2012, BIOCHEM PHARMACOL, V84, P1604, DOI 10.1016/j.bcp.2012.09.022; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Freund C, 2008, STEM CELLS, V26, P724, DOI 10.1634/stemcells.2007-0617; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kim SJ, 2006, FEBS LETT, V580, P1529, DOI 10.1016/j.febslet.2006.01.068; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; McDevitt TC, 2005, J MOL CELL CARDIOL, V39, P865, DOI 10.1016/j.yjmcc.2005.09.007; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Miyagawa Y, 2011, TISSUE ENG PT A, V17, P513, DOI [10.1089/ten.tea.2009.0810, 10.1089/ten.TEA.2009.0810]; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Song L, 2012, ARCH BIOCHEM BIOPHYS, V528, P204, DOI 10.1016/j.abb.2012.08.015; Standley PR, 1999, AM J PHYSIOL-ENDOC M, V276, pE697, DOI 10.1152/ajpendo.1999.276.4.E697; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wilmut I, 2005, SCIENCE, V310, P1903; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	28	17	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78769	10.1371/journal.pone.0078769	http://dx.doi.org/10.1371/journal.pone.0078769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250812	gold, Green Submitted, Green Published			2022-12-25	WOS:000327216200045
J	Yan, YQ; Salazar, TE; Dominguez, JM; Nguyen, DV; Calzi, SL; Bhatwadekar, AD; Qi, XP; Busik, JV; Boulton, ME; Grant, MB				Yan, Yuanqing; Salazar, Tatiana E.; Dominguez, James M., II; Nguyen, Dung V.; Calzi, Sergio Li; Bhatwadekar, Ashay D.; Qi, Xiaoping; Busik, Julia V.; Boulton, Michael E.; Grant, Maria B.			Dicer Expression Exhibits a Tissue-Specific Diurnal Pattern That Is Lost during Aging and in Diabetes	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; ENZYME DICER; MICRORNAS; CLOCK; DELETION; DISRUPTION; GENETICS; RELEASE; LIVER; HEART	Dysregulation of circadian rhythmicity is identified as a key factor in disease pathogenesis. Circadian rhythmicity is controlled at both a transcriptional and post-transcriptional level suggesting the role of microRNA (miRNA) and double-stranded RNA (dsRNA) in this process. Endonuclease Dicer controls miRNA and dsRNA processing, however the role of Dicer in circadian regulation is not known. Here we demonstrate robust diurnal oscillations of Dicer expression in central and peripheral clock control systems including suprachiasmatic nucleolus (SCN), retina, liver, and bone marrow (BM). The Dicer oscillations were either reduced or phase shifted with aging and Type 2 diabetes. The decrease and phase shift of Dicer expression was associated with a similar decrease and phase shift of miRNAs 146a and 125a-5p and with an increase in toxic Alu RNA. Restoring Dicer levels and the diurnal patterns of Dicer-controlled miRNA and RNA expression may provide new therapeutic strategies for metabolic disease and aging-associated complications.	[Yan, Yuanqing; Salazar, Tatiana E.] Univ Florida, Genet & Genom Grad Program, Gainesville, FL USA; [Yan, Yuanqing; Salazar, Tatiana E.; Dominguez, James M., II; Nguyen, Dung V.; Calzi, Sergio Li; Bhatwadekar, Ashay D.; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA; [Yan, Yuanqing; Salazar, Tatiana E.; Grant, Maria B.] Univ Florida, Genet Inst, Gainesville, FL USA; [Qi, Xiaoping; Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA; [Busik, Julia V.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Michigan State University	Busik, JV (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	grantma@ufl.edu	Busik, Julia V/A-2698-2010; Bhatwadekar, Ashay/AAT-5933-2020	Busik, Julia V/0000-0003-3453-7124; 	National Institutes of Health (NIH) [EY007739, EY012601, DK090730-02, U01HL087366, EY018358]; NATIONAL EYE INSTITUTE [R01EY018358, R01EY012601, R01EY007739, R29EY007739] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK090730] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were partially supported by National Institutes of Health (NIH) - EY007739, EY012601, DK090730-02, and U01HL087366 to MBG and EY018358 to MEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Brown SA, 2011, AGING-US, V3, P813, DOI 10.18632/aging.100366; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Debono M, 2013, CLIN ENDOCRINOL, V78, P659, DOI 10.1111/cen.12117; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Frezzetti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027648; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Gale JE, 2011, J BIOL RHYTHM, V26, P423, DOI 10.1177/0748730411416341; Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hansen KF, 2011, GENOME MED, V3, DOI 10.1186/gm224; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hazra S, 2012, DIABETES, V61, P3270, DOI 10.2337/db11-1596; Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Li Calzi S, 2010, EPMA J, V1, P88, DOI 10.1007/s13167-010-0011-8; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mehta N, 2013, J MOL BIOL, V425, P3609, DOI 10.1016/j.jmb.2012.10.022; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Paddison PJ, 2008, CURR TOP MICROBIOL, V320, P1; Pegoraro M, 2008, J GENET, V87, P505, DOI 10.1007/s12041-008-0073-8; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606; Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012; Sequeira-Lopez MLS, 2010, J AM SOC NEPHROL, V21, P460, DOI 10.1681/ASN.2009090964; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Zhang L, 2010, STEM CELLS, V28, P1260, DOI 10.1002/stem.455	53	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80029	10.1371/journal.pone.0080029	http://dx.doi.org/10.1371/journal.pone.0080029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244599	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900059
J	Heinicke, LA; Nabet, B; Shen, SH; Jiang, P; van Zalen, S; Cieply, B; Russell, JE; Xing, Y; Carstens, RP				Heinicke, Laurie A.; Nabet, Behnam; Shen, Shihao; Jiang, Peng; van Zalen, Sebastiaan; Cieply, Benjamin; Russell, J. Eric; Xing, Yi; Carstens, Russ P.			The RNA Binding Protein RBM38 (RNPC1) Regulates Splicing during Late Erythroid Differentiation	PLOS ONE			English	Article							PRE-MESSENGER-RNA; P53 FAMILY; GENE-EXPRESSION; SPECTRIN; TARGET; DOMAIN; EXON; PURIFICATION; EXPANSION; ARREST	Alternative pre-mRNA splicing is a prevalent mechanism in mammals that promotes proteomic diversity, including expression of cell-type specific protein isoforms. We characterized a role for RBM38 (RNPC1) in regulation of alternative splicing during late erythroid differentiation. We used an Affymetrix human exon junction (HJAY) splicing microarray to identify a panel of RBM38-regulated alternatively spliced transcripts. Using microarray databases, we noted high RBM38 expression levels in CD71(+) erythroid cells and thus chose to examine RBM38 expression during erythroid differentiation of human hematopoietic stem cells, detecting enhanced RBM38 expression during late erythroid differentiation. In differentiated erythroid cells, we validated a subset of RBM38-regulated splicing events and determined that RBM38 regulates activation of Protein 4.1R (EPB41) exon 16 during late erythroid differentiation. Using Epb41 minigenes, Rbm38 was found to be a robust activator of exon 16 splicing. To further address the mechanism of RBM38-regulated alternative splicing, a novel mammalian protein expression system, followed by SELEX-Seq, was used to identify a GU-rich RBM38 binding motif. Lastly, using a tethering assay, we determined that RBM38 can directly activate splicing when recruited to a downstream intron. Together, our data support the role of RBM38 in regulating alternative splicing during erythroid differentiation.	[Heinicke, Laurie A.; van Zalen, Sebastiaan; Cieply, Benjamin; Russell, J. Eric] Univ Penn, Dept Med, Perelman Sch Med, Hematol Oncol Div, Philadelphia, PA 19104 USA; [Nabet, Behnam; Carstens, Russ P.] Univ Penn, Dept Med, Perelman Sch Med, Div Renal, Philadelphia, PA 19104 USA; [Shen, Shihao; Jiang, Peng; Xing, Yi] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Shen, Shihao; Xing, Yi] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Russell, J. Eric] Univ Penn, Dept Pediat Hematol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Russell, J. Eric] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Carstens, Russ P.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Iowa; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Carstens, RP (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Renal, Philadelphia, PA 19104 USA.	russcars@upenn.edu	Nabet, Behnam/AAZ-4987-2020	Nabet, Behnam/0000-0002-6738-4200	National Institutes of Health [R01 GM088809, R01 GM088342, P30 DK054759]; T32 National Institutes of Health Hematopoiesis Training Grant [5T32DK007780-13]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759, T32DK007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088342, R01GM088809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 National Institutes of Health Hematopoiesis Training Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 GM088809 (RC), R01 GM088342 and P30 DK054759 (YX), and T32 National Institutes of Health Hematopoiesis Training Grant 5T32DK007780-13 (LH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Anyanful A, 2004, J CELL BIOL, V167, P639, DOI 10.1083/jcb.200407085; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Burgess DJ, 2012, NAT REV GENET, V13, P518, DOI 10.1038/nrg3288; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Cho SJ, 2012, J BIOL CHEM, V287, P14535, DOI 10.1074/jbc.M111.326827; CONBOY J, 1986, P NATL ACAD SCI USA, V83, P9512, DOI 10.1073/pnas.83.24.9512; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; DISCHER D, 1993, J BIOL CHEM, V268, P7186; Dittmar KA, 2012, MOL CELL BIOL, V32, P1468, DOI 10.1128/MCB.06536-11; Geng J, 2006, PROTEIN EXPRES PURIF, V48, P142, DOI 10.1016/j.pep.2006.01.021; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; HORNE WC, 1993, BLOOD, V82, P2558; Hotte GJ, 2012, RADIAT RES, V177, P272, DOI 10.1667/RR2776.1; Hou VC, 2002, EMBO J, V21, P6195, DOI 10.1093/emboj/cdf625; Irimia M, 2012, CURR OPIN CELL BIOL, V24, P323, DOI 10.1016/j.ceb.2012.03.005; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kuroyanagi H, 2007, MOL CELL BIOL, V27, P8612, DOI 10.1128/MCB.01508-07; Leveille N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1519; Liu PC, 2011, PHYSIOL GENOMICS, V43, P1117, DOI 10.1152/physiolgenomics.00099.2011; Marturana F, 2011, CYTOTHERAPY, V13, P366, DOI 10.3109/14653249.2010.518610; Newman EA, 2006, RNA, V12, P1129, DOI 10.1261/rna.34906; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Ohno G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002991; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; SCHISCHMANOFF PO, 1995, J BIOL CHEM, V270, P21243, DOI 10.1074/jbc.270.36.21243; Shen SH, 2010, BIOINFORMATICS, V26, P268, DOI 10.1093/bioinformatics/btp643; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun YH, 2009, CANCER INVEST, V27, P891, DOI 10.3109/07357900902744536; Tehranchi R, 2005, BLOOD, V106, P247, DOI 10.1182/blood-2004-12-4649; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; van Zalen S, 2012, BLOOD, V119, P1045, DOI 10.1182/blood-2011-10-387316; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Xu E, 2013, ONCOGENE, V32, P2169, DOI 10.1038/onc.2012.238; Yamamoto ML, 2009, BLOOD, V113, P3363, DOI 10.1182/blood-2008-05-160325; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107	50	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78031	10.1371/journal.pone.0078031	http://dx.doi.org/10.1371/journal.pone.0078031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24250749	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300136
J	Gruning, CSR; Klinker, S; Wolff, M; Schneider, M; Toksoz, K; Klein, AN; Nagel-Steger, L; Willbold, D; Hoyer, W				Gruening, Clara S. R.; Klinker, Stefan; Wolff, Martin; Schneider, Mario; Toksoez, Kuepra; Klein, Antonia N.; Nagel-Steger, Luitgard; Willbold, Dieter; Hoyer, Wolfgang			The Off-rate of Monomers Dissociating from Amyloid-beta Protofibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Fluorescence; Kinetics; Protein Aggregation; Protein Engineering; Protein Misfolding; Scaffold Proteins; Spectroscopy	PROTEIN FIBRILLOGENESIS; PEPTIDE; A-BETA-40; THERMODYNAMICS; FLUORESCENCE; MECHANISMS; OLIGOMERS; KINETICS; BINDING	The interconversion of monomers, oligomers, and amyloid fibrils of the amyloid- peptide (A) has been implicated in the pathogenesis of Alzheimer disease. The determination of the kinetics of the individual association and dissociation reactions is hampered by the fact that forward and reverse reactions to/from different aggregation states occur simultaneously. Here, we report the kinetics of dissociation of A monomers from protofibrils, prefibrillar high molecular weight oligomers previously shown to possess pronounced neurotoxicity. An engineered binding protein sequestering specifically monomeric A was employed to follow protofibril dissociation by tryptophan fluorescence, precluding confounding effects of reverse or competing reactions. A protofibril dissociation into monomers follows exponential decay kinetics with a time constant of approximate to 2 h at 25 degrees C and an activation energy of 80 kJ/mol, values typical for high affinity biomolecular interactions. This study demonstrates the high kinetic stability of A protofibrils toward dissociation into monomers and supports the delineation of the A folding and assembly energy landscape.	[Gruening, Clara S. R.; Klinker, Stefan; Wolff, Martin; Schneider, Mario; Toksoez, Kuepra; Nagel-Steger, Luitgard; Willbold, Dieter; Hoyer, Wolfgang] Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany; [Wolff, Martin; Klein, Antonia N.; Nagel-Steger, Luitgard; Willbold, Dieter; Hoyer, Wolfgang] Res Ctr Julich, Inst Struct Biochem ICS 6, D-52425 Julich, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Hoyer, W (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany.	wolfgang.hoyer@uni-duesseldorf.de	Hoyer, Wolfgang/H-6193-2013; Willbold, Dieter/A-6280-2013; Nagel-Steger, Luitgard/H-6415-2013	Hoyer, Wolfgang/0000-0003-4301-5416; Willbold, Dieter/0000-0002-0065-7366; Nagel-Steger, Luitgard/0000-0001-5232-2149	Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	This work was supported by the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen.	Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gronwall C, 2007, J BIOTECHNOL, V128, P162, DOI 10.1016/j.jbiotec.2006.09.013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hoyer W, 2008, J MOL BIOL, V378, P398, DOI 10.1016/j.jmb.2008.02.040; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Kheterpal I, 2003, BIOCHEMISTRY-US, V42, P14092, DOI 10.1021/bi0357816; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Macao B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-82; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; OJCIUS DM, 1993, BIOCHEM BIOPH RES CO, V197, P1216, DOI 10.1006/bbrc.1993.2606; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Sanchez L, 2011, J AM CHEM SOC, V133, P6505, DOI 10.1021/ja1117123; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	40	22	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37104	37111		10.1074/jbc.M113.513432	http://dx.doi.org/10.1074/jbc.M113.513432			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24247242	hybrid, Green Published			2022-12-25	WOS:000329189700030
J	Lebel, K; Boissy, P; Hamel, M; Duval, C				Lebel, Karina; Boissy, Patrick; Hamel, Mathieu; Duval, Christian			Inertial Measures of Motion for Clinical Biomechanics: Comparative Assessment of Accuracy under Controlled Conditions - Effect of Velocity	PLOS ONE			English	Article							MEASUREMENT UNITS	Background: Inertial measurement of motion with Attitude and Heading Reference Systems (AHRS) is emerging as an alternative to 3D motion capture systems in biomechanics. The objectives of this study are: 1) to describe the absolute and relative accuracy of multiple units of commercially available AHRS under various types of motion; and 2) to evaluate the effect of motion velocity on the accuracy of these measurements. Methods: The criterion validity of accuracy was established under controlled conditions using an instrumented Gimbal table. AHRS modules were carefully attached to the center plate of the Gimbal table and put through experimental static and dynamic conditions. Static and absolute accuracy was assessed by comparing the AHRS orientation measurement to those obtained using an optical gold standard. Relative accuracy was assessed by measuring the variation in relative orientation between modules during trials. Findings: Evaluated AHRS systems demonstrated good absolute static accuracy (mean error < 0.5 degrees) and clinically acceptable absolute accuracy under condition of slow motions (mean error between 0.5 degrees and 3.1 degrees). In slow motions, relative accuracy varied from 2 degrees to 7 degrees depending on the type of AHRS and the type of rotation. Absolute and relative accuracy were significantly affected (p < 0.05) by velocity during sustained motions. The extent of that effect varied across AHRS. Interpretation: Absolute and relative accuracy of AHRS are affected by environmental magnetic perturbations and conditions of motions. Relative accuracy of AHRS is mostly affected by the ability of all modules to locate the same global reference coordinate system at all time. Conclusions: Existing AHRS systems can be considered for use in clinical biomechanics under constrained conditions of use. While their individual capacity to track absolute motion is relatively consistent, the use of multiple AHRS modules to compute relative motion between rigid bodies needs to be optimized according to the conditions of operation.	[Lebel, Karina; Boissy, Patrick] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Surg, Orthoped Serv, Sherbrooke, PQ J1K 2R1, Canada; [Lebel, Karina; Boissy, Patrick; Hamel, Mathieu] Res Ctr Aging, Sherbrooke, PQ, Canada; [Lebel, Karina; Boissy, Patrick] Univ Sherbrooke, Interdisciplinary Inst Technol Innovat 3IT, Sherbrooke, PQ J1K 2R1, Canada; [Duval, Christian] Univ Quebec, Dept Kinesiol, Montreal, PQ H3C 3P8, Canada; [Duval, Christian] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Quebec; University of Quebec Montreal; Universite de Montreal	Boissy, P (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Surg, Orthoped Serv, Sherbrooke, PQ J1K 2R1, Canada.	Patrick.Boissy@Usherbrooke.Ca	Boissy, Patrick/F-7068-2016	Boissy, Patrick/0000-0001-6582-4519	Canadian Institutes for Health Research (CIHR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by a grant from the Canadian Institutes for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Brennan A, 2011, GAIT POSTURE, V34, P320, DOI 10.1016/j.gaitpost.2011.05.018; Brodie MA, 2008, COMPUT METHOD BIOMEC, V11, P641, DOI 10.1080/10255840802326736; Brodie MA, 2008, COMPUT METHOD BIOMEC, V11, P235, DOI 10.1080/10255840802125526; Cutti Andrea Giovanni, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5912; Cutti AG, 2008, MED BIOL ENG COMPUT, V46, P169, DOI 10.1007/s11517-007-0296-5; Cutti AG, 2010, MED BIOL ENG COMPUT, V48, P17, DOI 10.1007/s11517-009-0545-x; De Agostino Mattia, 2010, 2010 IEEE/ION Position, Location and Navigation Symposium - PLANS 2010, P187, DOI 10.1109/PLANS.2010.5507128; de Vries WHK, 2009, GAIT POSTURE, V29, P535, DOI 10.1016/j.gaitpost.2008.12.004; Ferrari A, 2010, MED BIOL ENG COMPUT, V48, P1, DOI 10.1007/s11517-009-0544-y; Giansanti D, 2007, MED BIOL ENG COMPUT, V45, P969, DOI 10.1007/s11517-007-0224-8; Hathaway AS, 2009, PRIMER QUATERNIONS; Picerno P, 2011, GAIT POSTURE, V33, P373, DOI 10.1016/j.gaitpost.2010.12.006; Roetenberg D, 2006, INERTIAL MAGNETIC SE, P126; Schulze M, 2012, IEEE ENG MED BIO, P1968, DOI 10.1109/EMBC.2012.6346341; Sessa S, 2012, J INTELLIGENT ROBOTI, P1; Zhou HY, 2008, BIOMED SIGNAL PROCES, V3, P1, DOI 10.1016/j.bspc.2007.09.001	17	79	79	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79945	10.1371/journal.pone.0079945	http://dx.doi.org/10.1371/journal.pone.0079945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260324	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900054
J	Martinez-Alberola, F; del Campo, EM; Lazaro-Gimeno, D; Mezquita-Claramonte, S; Molins, A; Mateu-Andres, I; Pedrola-Monfort, J; Casano, LM; Barreno, E				Martinez-Alberola, Fernando; del Campo, Eva M.; Lazaro-Gimeno, David; Mezquita-Claramonte, Sergio; Molins, Arantxa; Mateu-Andres, Isabel; Pedrola-Monfort, Joan; Casano, Leonardo M.; Barreno, Eva			Balanced Gene Losses, Duplications and Intensive Rearrangements Led to an Unusual Regularly Sized Genome in Arbutus unedo Chloroplasts	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MESSENGER-RNA; GENERATION; EVOLUTION; NDHA; DNA; CHLORORESPIRATION; SUBSTITUTION; TRANSCRIPTS; ANGIOSPERMS	Completely sequenced plastomes provide a valuable source of information about the duplication, loss, and transfer events of chloroplast genes and phylogenetic data for resolving relationships among major groups of plants. Moreover, they can also be useful for exploiting chloroplast genetic engineering technology. Ericales account for approximately six per cent of eudicot diversity with 11,545 species from which only three complete plastome sequences are currently available. With the aim of increasing the number of ericalean complete plastome sequences, and to open new perspectives in understanding Mediterranean plant adaptations, a genomic study on the basis of the complete chloroplast genome sequencing of Arbutus unedo and an updated phylogenomic analysis of Asteridae was implemented. The chloroplast genome of A. unedo shows extensive rearrangements but a medium size (150,897 nt) in comparison to most of angiosperms. A number of remarkable distinct features characterize the plastome of A. unedo: five-fold dismissing of the SSC region in relation to most angiosperms; complete loss or pseudogenization of a number of essential genes; duplication of the ndhH-D operon and its location within the two IRs; presence of large tandem repeats located near highly re-arranged regions and pseudogenes. All these features outline the primary evolutionary split between Ericaceae and other ericalean families. The newly sequenced plastome of A. unedo with the available asterid sequences allowed the resolution of some uncertainties in previous phylogenies of Asteridae.	[Martinez-Alberola, Fernando; Lazaro-Gimeno, David; Mezquita-Claramonte, Sergio; Molins, Arantxa; Mateu-Andres, Isabel; Pedrola-Monfort, Joan; Barreno, Eva] Univ Valencia, Dept Bot, ICBIBE, Fac Ciencias Biol, Valencia, Spain; [del Campo, Eva M.; Casano, Leonardo M.] Univ Alcala, Fac Biol Ciencias Ambientales & Quim, Dept Ciencias Vida, Madrid, Spain	University of Valencia; Universidad de Alcala	del Campo, EM (corresponding author), Univ Alcala, Fac Biol Ciencias Ambientales & Quim, Dept Ciencias Vida, Madrid, Spain.	eva.campo@uah.es	Molins Piqueres, Arantxa/N-7246-2013; Martínez Alberola, Fernando/H-4451-2015; DEL CAMPO, EVA MARÍA M/M-3003-2014; Mateu-Andrés, Isabel/H-9082-2015; Rodríguez, Eva Barreno/M-2525-2014; Casano, Leonardo M. M/H-1036-2015	Molins Piqueres, Arantxa/0000-0003-3449-1023; DEL CAMPO, EVA MARÍA M/0000-0003-4796-6227; Mateu-Andrés, Isabel/0000-0002-0086-8673; Rodríguez, Eva Barreno/0000-0002-2622-4550; Casano, Leonardo M. M/0000-0002-2304-7317; Lazaro Gimeno, David/0000-0003-3107-841X	Generalitat Valenciana [PROMETEO 174/2008, PROMETEO II 021/2013]; Spanish Ministry of Science and Innovation MINECO [CGL2012-40058-C02-01/02]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Ministry of Science and Innovation MINECO(Spanish Government)	This study was funded by the Generalitat Valenciana (PROMETEO 174/2008; PROMETEO II 021/2013, GVA) and the Spanish Ministry of Science and Innovation MINECO (CGL2012-40058-C02-01/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderberg AA, 2002, AM J BOT, V89, P677, DOI 10.3732/ajb.89.4.677; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beck N., 2009, RNAWEASEL WEBSERVER; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Casano LM, 2001, PLANT PHYSIOL, V125, P1450, DOI 10.1104/pp.125.3.1450; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; del Campo EM, 2006, BIOCHIMIE, V88, P347, DOI 10.1016/j.biochi.2005.09.005; del Campo EM, 2002, J BIOL CHEM, V277, P36457, DOI 10.1074/jbc.M204500200; del Campo EM, 2000, NUCLEIC ACIDS RES, V28, P1092, DOI 10.1093/nar/28.5.1092; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erixon P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001386; Fajardo D, 2013, TREE GENET GENOMES, V9, P489, DOI 10.1007/s11295-012-0573-9; Gao L, 2010, J SYST EVOL, V48, P77, DOI 10.1111/j.1759-6831.2010.00071.x; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Geuten K, 2004, MOL PHYLOGENET EVOL, V31, P711, DOI 10.1016/j.ympev.2003.09.014; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Krichevsky A, 2012, BIOTECHNOL GENET ENG, V28, P1, DOI 10.5661/bger-28-1; Kron KA, 2002, BOT REV, V68, P335, DOI 10.1663/0006-8101(2002)068[0335:PCOEMA]2.0.CO;2; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lopez-Serrano M, 2001, J EXP BOT, V52, P179, DOI 10.1093/jexbot/52.354.179; Maliga P, 2004, ANNU REV PLANT BIOL, V55, P289, DOI 10.1146/annurev.arplant.55.031903.141633; Martin M, 1996, PLANT CELL PHYSIOL, V37, P293, DOI 10.1093/oxfordjournals.pcp.a028945; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Paredes M, 2013, J PLANT PHYSIOL, V170, P165, DOI 10.1016/j.jplph.2012.09.010; Peng LW, 2011, BBA-BIOENERGETICS, V1807, P945, DOI 10.1016/j.bbabio.2010.10.015; Rambaut A., 2007, TRACER V1 4; Rambaut A., 2008, FIGTREE TREE FIGURE; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Rozas J, 2009, METHOD MOL BIOL, P341; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Staden R, 2000, Methods Mol Biol, V132, P115; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stevens PF, 2013, ANGIOSPERM PHYLOGENY; Thierry A, 2010, CELL MOL LIFE SCI, V67, P671, DOI 10.1007/s00018-009-0216-y; Torres JA, 2002, PLANT ECOL, V160, P207, DOI 10.1023/A:1015864821706; Ueda M, 2008, MOL BIOL EVOL, V25, P1566, DOI 10.1093/molbev/msn102; Wen J, 2009, J SYST EVOL, V47, P331, DOI 10.1111/j.1759-6831.2009.00054.x; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	38	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79685	10.1371/journal.pone.0079685	http://dx.doi.org/10.1371/journal.pone.0079685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260278	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500088
J	Santhi, N; Groeger, JA; Archer, SN; Gimenez, M; Schlangen, LJM; Dijk, DJ				Santhi, Nayantara; Groeger, John A.; Archer, Simon N.; Gimenez, Marina; Schlangen, Luc J. M.; Dijk, Derk-Jan			Morning Sleep Inertia in Alertness and Performance: Effect of Cognitive Domain and White Light Conditions	PLOS ONE			English	Article							PSYCHOMOTOR VIGILANCE; TIME-COURSE; SUSTAINED ATTENTION; CIRCADIAN-RHYTHMS; ARTIFICIAL DAWN; PHASE; TEMPERATURE; IMPAIRMENT; INSTRUMENT; NIGHTTIME	The transition from sleep to wakefulness entails a temporary period of reduced alertness and impaired performance known as sleep inertia. The extent to which its severity varies with task and cognitive processes remains unclear. We examined sleep inertia in alertness, attention, working memory and cognitive throughput with the Karolinska Sleepiness Scale (KSS), the Psychomotor Vigilance Task (PVT), n-back and add tasks, respectively. The tasks were administered 2 hours before bedtime and at regular intervals for four hours, starting immediately after awakening in the morning, in eleven participants, in a four-way cross-over laboratory design. We also investigated whether exposure to Blue-Enhanced or Bright Blue-Enhanced white light would reduce sleep inertia. Alertness and all cognitive processes were impaired immediately upon awakening (p<0.01). However, alertness and sustained attention were more affected than cognitive throughput and working memory. Moreover, speed was more affected than accuracy of responses. The light conditions had no differential effect on performance except in the 3-back task (p<0.01), where response times (RT) at the end of four hours in the two Blue-Enhanced white light conditions were faster (200 ms) than at wake time. We conclude that the effect of sleep inertia varies with cognitive domain and that it's spectral/intensity response to light is different from that of sleepiness. That is, just increasing blue-wavelength in light may not be sufficient to reduce sleep inertia. These findings have implications for critical professions like medicine, law-enforcement etc., in which, personnel routinely wake up from night-time sleep to respond to emergency situations.	[Santhi, Nayantara; Archer, Simon N.; Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England; [Groeger, John A.] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; [Gimenez, Marina; Schlangen, Luc J. M.] Philips Res, Eindhoven, Netherlands	University of Surrey; University of Hull; Philips; Philips Research	Santhi, N (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England.	n.santhi@surrey.ac.uk	Groeger, John/AAK-2799-2020; Groeger, John/AAQ-8187-2021; Groeger, John/B-5671-2014	Groeger, John/0000-0002-3582-1058; Santhi, Nayantara/0000-0003-4568-1447; Schlangen, Luc/0000-0002-8424-7240	Royal Philips Electronics N. V., The Netherlands	Royal Philips Electronics N. V., The Netherlands	Funding from Royal Philips Electronics N. V., The Netherlands supported this work. LJMS and MG who are co-authors on this manuscript are/were employees of Royal Philips. They had a role in the study design and preparation of the manuscript.	Achermann P, 1995, ARCH ITAL BIOL, V134, P109; AKERSTEDT T, 1994, PERCEPT MOTOR SKILL, V79, P287, DOI 10.2466/pms.1994.79.1.287; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Asaoka S, 2010, J SLEEP RES, V19, P436, DOI 10.1111/j.1365-2869.2009.00811.x; Balkin TJ, 2002, BRAIN, V125, P2308, DOI 10.1093/brain/awf228; BALKIN TJ, 1988, BIOL PSYCHOL, V27, P245, DOI 10.1016/0301-0511(88)90034-8; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Bruck D, 1999, J SLEEP RES, V8, P95, DOI 10.1046/j.1365-2869.1999.00150.x; Buysse D J, 1989, Psychiatry Res, V28, P193; Chee MWL, 2008, J NEUROSCI, V28, P5519, DOI 10.1523/JNEUROSCI.0733-08.2008; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Chellappa SL, 2011, PROG BRAIN RES, V190, P119, DOI 10.1016/B978-0-444-53817-8.00007-4; Chen YN, 2008, CLIN NEUROPHYSIOL, V119, P1546, DOI 10.1016/j.clinph.2008.03.003; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DINGES DF, 1987, SLEEP, V10, P313; Dinges DF, 1997, SLEEP, V20, P267; Ferrara M, 2000, AVIAT SPACE ENVIR MD, V71, P225; Ferrara M, 2000, AVIAT SPACE ENVIR MD, V71, P843; Gimenez MC, 2010, CHRONOBIOL INT, V27, P1219, DOI 10.3109/07420528.2010.496912; Groeger JA, 2011, BEHAV NEUROSCI, V125, P252, DOI 10.1037/a0022692; Hofer-Tinguely G, 2005, COGNITIVE BRAIN RES, V22, P323, DOI 10.1016/j.cogbrainres.2004.09.013; Iber C, 2007, AASM MANUAL SCORING; JEANNERET PR, 1963, PERCEPT MOTOR SKILL, V17, P759, DOI 10.2466/pms.1963.17.3.759; Jewett ME, 1999, J SLEEP RES, V8, P1, DOI 10.1111/j.1365-2869.1999.00128.x; Jewett ME, 1999, J BIOL RHYTHM, V14, P588, DOI 10.1177/074873099129000920; Jung CM, 2011, J SLEEP RES, V20, P348, DOI 10.1111/j.1365-2869.2010.00877.x; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Klerman EB, 2007, J BIOL RHYTHM, V22, P91, DOI 10.1177/0748730407299200; Kubo T, 2010, CHRONOBIOL INT, V27, P1031, DOI 10.3109/07420528.2010.489502; Lazar AS, 2012, CHRONOBIOL INT, V29, P131, DOI 10.3109/07420528.2011.641193; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; MONK TH, 1990, J NERV MENT DIS, V178, P120, DOI 10.1097/00005053-199002000-00007; O'Donnell D, 2009, J SLEEP RES, V18, P254, DOI 10.1111/j.1365-2869.2008.00719.x; Raymann RJEM, 2007, SLEEP, V30, P96, DOI 10.1093/sleep/30.1.96; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Santhi Nayantara, 2012, J Pineal Res, V53, P47, DOI 10.1111/j.1600-079X.2011.00970.x; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Scheer FAJL, 2008, J BIOL RHYTHM, V23, P353, DOI 10.1177/0748730408318081; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Signal TL, 2012, CHRONOBIOL INT, V29, P769, DOI 10.3109/07420528.2012.686547; Silva EJ, 2008, BEHAV NEUROSCI, V122, P928, DOI 10.1037/0735-7044.122.4.928; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Thorn L, 2004, PSYCHONEUROENDOCRINO, V29, P925, DOI 10.1016/j.psyneuen.2003.08.005; van de Werken M, 2010, J SLEEP RES, V19, P425, DOI 10.1111/j.1365-2869.2010.00828.x; Van Dongen HPA, 2001, CHRONOBIOL INT, V18, P85, DOI 10.1081/CBI-100001178; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Wagner U, 2005, BIOL PSYCHIAT, V58, P885, DOI 10.1016/j.biopsych.2005.05.008; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; WYATT JK, 1999, AM J PHYSIOL-REG I, V277, pR1152	51	64	66	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79688	10.1371/journal.pone.0079688	http://dx.doi.org/10.1371/journal.pone.0079688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260280	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500089
J	Duwaerts, CC; Sun, EP; Cheng, CW; van Rooijen, N; Gregory, SH				Duwaerts, Caroline C.; Sun, Eric P.; Cheng, Chao-Wen; van Rooijen, Nico; Gregory, Stephen H.			Cross-Activating Invariant NKT Cells and Kupffer Cells Suppress Cholestatic Liver Injury in a Mouse Model of Biliary Obstruction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; KILLER T-CELLS; NEUTROPHIL MIGRATION; DEFICIENT MICE; CUTTING EDGE; IFN-GAMMA; MECHANISM; REPERFUSION; LYMPHOCYTES; MACROPHAGES	Both Kupffer cells and invariant natural killer T (iNKT) cells suppress neutrophil-dependent liver injury in a mouse model of biliary obstruction. We hypothesize that these roles are interdependent and require iNKT cell-Kupffer cell cross-activation. Female, wild-type and iNKT cell-deficient C57Bl/6 mice were injected with magnetic beads 3 days prior to bile duct ligation (BDL) in order to facilitate subsequent Kupffer cell isolation. On day three post-BDL, the animals were euthanized and the livers dissected. Necrosis was scored; Kupffer cells were isolated and cell surface marker expression (flow cytometry), mRNA expression (qtPCR), nitric oxide (NO.) production (Griess reaction), and protein secretion (cytometric bead-array or ELISAs) were determined. To address the potential role of NO. in suppressing neutrophil accumulation, a group of WT mice received 1400W, a specific inducible nitric oxide synthase (iNOS) inhibitor, prior to BDL. To clarify the mechanisms underlying Kupffer cell-iNKT cell cross-activation, WT animals were administered anti-IFN-gamma or anti-lymphocyte function-associated antigen (LFA)-1 antibody prior to BDL. Compared to their WT counterparts, Kupffer cells obtained from BDL iNKT cell-deficient mice expressed lower iNOS mRNA levels, produced less NO center dot, and secreted more neutrophil chemoattractants. Both iNOS inhibition and IFN-gamma neutralization increased neutrophil accumulation in the livers of BDL WT mice. Anti-LFA-1 pretreatment reduced iNKT cell accumulation in these same animals. These data indicate that the LFA-1-dependent cross-activation of iNKT cells and Kupffer cells inhibits neutrophil accumulation and cholestatic liver injury.	[Duwaerts, Caroline C.; Sun, Eric P.; Cheng, Chao-Wen; Gregory, Stephen H.] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Duwaerts, Caroline C.; Sun, Eric P.; Cheng, Chao-Wen; Gregory, Stephen H.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Cell Biol, Amsterdam, Netherlands	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Vrije Universiteit Amsterdam	Duwaerts, CC (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA.	duwaertsc@medsfgh.ucsf.edu	Van Rooijen, Nico/Z-1578-2019	Sun, Eric/0000-0003-4322-0786	National Institutes of Health [DK068097]; Rhode Island Hospital; Sigma Delta Epsilon Fellowship; NSC [99-2320-B-038-015]; NCCR SIG [1S10RR021051-01A2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Hospital; Sigma Delta Epsilon Fellowship; NSC(Ministry of Science and Technology, Taiwan); NCCR SIG; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Research Grants DK068097 and funds provided by Rhode Island Hospital. CCD was supported, in part, by the Sigma Delta Epsilon Fellowship. CWC was supported, in part, by the NSC grant 99-2320-B-038-015. Purchase and operation of FACSAria was supported by NCCR SIG grant #1S10RR021051-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 1998, IMMUNOLOGY, V95, P625; Alexander B, 1998, NUTRITION, V14, P376, DOI 10.1016/S0899-9007(97)00492-9; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bourgeois EA, 2011, EUR J IMMUNOL, V41, P299, DOI 10.1002/eji.201040647; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brossay L, 1997, J IMMUNOL, V159, P1216; Cao J, 2000, INFLAMM RES, V49, P578, DOI 10.1007/s000110050634; Cheng CW, 2011, J HEPATOL, V54, P746, DOI 10.1016/j.jhep.2010.07.018; Dal Secco D, 2006, NITRIC OXIDE-BIOL CH, V15, P77, DOI 10.1016/j.niox.2006.02.004; Duwaerts CC, 2013, LIVER INT, V33, P255, DOI 10.1111/liv.12048; Duwaerts CC, 2011, EXPERT OPIN THER TAR, V15, P973, DOI 10.1517/14728222.2011.584874; Emoto M, 1999, J IMMUNOL, V162, P5094; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gehring S, 2006, GASTROENTEROLOGY, V130, P810, DOI 10.1053/j.gastro.2005.11.015; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; GREGORY SH, 1993, J IMMUNOL, V151, P1401; Hammond KJL, 2001, J IMMUNOL, V167, P1164, DOI 10.4049/jimmunol.167.3.1164; Kimura T, 2004, J IMMUNOL, V172, P5782, DOI 10.4049/jimmunol.172.9.5782; Kinjo Y, 2005, J CLIN IMMUNOL, V25, P522, DOI 10.1007/s10875-005-8064-5; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Leite ACRM, 2009, BRIT J PHARMACOL, V156, P818, DOI 10.1111/j.1476-5381.2008.00094.x; Lisbonne M, 2011, EUR J IMMUNOL, V41, P1720, DOI 10.1002/eji.201041006; Luckey SW, 2001, EXP MOL PATHOL, V71, P226, DOI 10.1006/exmp.2001.2399; Martinez-Mier G, 2002, J INVEST SURG, V15, P287, DOI 10.1080/08941930290086083; Matsuda H, 2005, AM J RESPIR CELL MOL; Miyamoto M, 2000, J IMMUNOL, V165, P1729, DOI 10.4049/jimmunol.165.4.1729; Muriel P, 2003, J APPL TOXICOL, V23, P103, DOI 10.1002/jat.892; Norris S, 1999, HUM IMMUNOL, V60, P20, DOI 10.1016/S0198-8859(98)00098-6; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; OBOLENSKAYA M, 1994, BIOCHEM BIOPH RES CO, V204, P1305, DOI 10.1006/bbrc.1994.2605; Ohteki T, 1999, J IMMUNOL, V162, P3753; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; Phillips L, 2009, J INVEST SURG, V22, P46, DOI 10.1080/08941930802709470; Ramos MV, 2009, J ETHNOPHARMACOL, V125, P387, DOI 10.1016/j.jep.2009.07.030; Salkowski CA, 1997, J IMMUNOL, V158, P905; Schneider DF, 2011, J SURG RES, V171, P361, DOI 10.1016/j.jss.2010.03.030; Sewnath ME, 2002, HEPATOLOGY, V36, P1466, DOI 10.1053/jhep.2002.37196; Sokol RJ, 2006, J PEDIATR GASTR NUTR, V43, pS4, DOI 10.1097/01.mpg.0000226384.71859.16; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wintermeyer P, 2009, GASTROENTEROLOGY, V136, P1048, DOI 10.1053/j.gastro.2008.10.027	43	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79702	10.1371/journal.pone.0079702	http://dx.doi.org/10.1371/journal.pone.0079702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260285	gold, Green Submitted, Green Published			2022-12-25	WOS:000327258600046
J	Lin, Z; Tan, SB; Liu, Y; Cheng, XQ; Xu, XK				Lin, Zheng; Tan, Songbo; Liu, Yue; Cheng, Xueqi; Xu, Xueke			Cross-Language Opinion Lexicon Extraction Using Mutual-Reinforcement Label Propagation	PLOS ONE			English	Article								There is a growing interest in automatically building opinion lexicon from sources such as product reviews. Most of these methods depend on abundant external resources such as WordNet, which limits the applicability of these methods. Unsupervised or semi-supervised learning provides an optional solution to multilingual opinion lexicon extraction. However, the datasets are imbalanced in different languages. For some languages, the high-quality corpora are scarce or hard to obtain, which limits the research progress. To solve the above problems, we explore a mutual-reinforcement label propagation framework. First, for each language, a label propagation algorithm is applied to a word relation graph, and then a bilingual dictionary is used as a bridge to transfer information between two languages. A key advantage of this model is its ability to make two languages learn from each other and boost each other. The experimental results show that the proposed approach outperforms baseline significantly.	[Lin, Zheng; Tan, Songbo; Liu, Yue; Cheng, Xueqi; Xu, Xueke] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Computing Technology, CAS	Lin, Z (corresponding author), Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China.	linzheng@ict.ac.cn	Cheng, Xueqi/F-1706-2010		National Natural Science Foundation of China [60933005, 61100083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was mainly supported by two funds, i.e., the National Natural Science Foundation of China (60933005 & 61100083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreevskaia A., 2006, P C EUR CHAPT ASS CO; Bautin M., 2008, ICWSM 2008; Beineke P., 2003, AAAI SPRING S EXPL A, P12; Blitzer J, 2007, P ACL 07; Chmiel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022207; Cohn DA, 1996, J ARTIF INTELL RES, V4, P129, DOI 10.1613/jair.295; Ding X., 2008, P 2008 INT C WEB SEA, P231, DOI DOI 10.1145/1341531.1341561; Esuli A, 2007, P 45 ANN M ASS COMPU, P424; Esuli A., 2006, LREC, P417, DOI DOI 10.1155/2015/715730; Friston KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006421; Hassan A, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P395; Hatzivassiloglou V, 1997, 35TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 8TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P174, DOI 10.3115/976909.979640; Hu M., 2004, P 10 ACM SIGKDD INT, P168, DOI DOI 10.1145/1014052.1014073; Kamps Jaap, 2004, P 4 INT C LANG RES E, P1115; Kim S.M., 2004, P 20 INT C COMP LING, V1367, DOI DOI 10.3115/1220355.1220555; Li J, 2007, P IEEE NLPKE; Lin Z, 2012, P CIKM 12, P1542; Qiu GA, 2011, COMPUT LINGUIST, V37, P9, DOI 10.1162/coli_a_00034; Sebastiani F., 2010, P INT C LANG RES EV; Shoushan L, 2010, P ACL 10; Sutton RS, 1996, ADV NEUR IN, V8, P1038; Thelen M., 2002, P EMNLP 02; Turney PD, 2003, ACM T INFORM SYST, V21, P315, DOI 10.1145/944012.944013; Wiebe J, 2005, LANG RESOUR EVAL, V39, P165, DOI 10.1007/s10579-005-7880-9; Wiebe J, 2004, COMPUT LINGUIST, V30, P277, DOI 10.1162/0891201041850885; Wiebe JM, 2000, SEVENTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-2001) / TWELFTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-2000), P735; Zhang Q, 2008, P AIRS 08; Zhu X.J, 2005, SEMISUPERVISED LEARN	28	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79294	10.1371/journal.pone.0079294	http://dx.doi.org/10.1371/journal.pone.0079294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260190	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600029
J	Ishii, Y; Nakahara, T; Kataoka, M; Kusumoto-Matsuo, R; Mori, S; Takeuchi, T; Kukimoto, I				Ishii, Yoshiyuki; Nakahara, Tomomi; Kataoka, Michiyo; Kusumoto-Matsuo, Rika; Mori, Seiichiro; Takeuchi, Takamasa; Kukimoto, Iwao			Identification of TRAPPC8 as a Host Factor Required for Human Papillomavirus Cell Entry	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; SURFACE HEPARAN-SULFATE; HUMAN KERATINOCYTES; GAMMA SECRETASE; 31B INFECTION; L2; TYPE-16; AUTOPHAGY; PATHWAY; PSEUDOVIRIONS	Human papillomavirus (HPV) is a non-enveloped virus composed of a circular DNA genome and two capsid proteins, L1 and L2. Multiple interactions between its capsid proteins and host cellular proteins are required for infectious HPV entry, including cell attachment and internalization, intracellular trafficking and viral genome transfer into the nucleus. Using two variants of HPV type 51, the Ma and Nu strains, we have previously reported that MaL2 is required for efficient pseudovirus (PsV) transduction. However, the cellular factors that confer this L2 dependency have not yet been identified. Here we report that the transport protein particle complex subunit 8 (TRAPPC8) specifically interacts with MaL2. TRAPPC8 knockdown in HeLa cells yielded reduced levels of reporter gene expression when inoculated with HPV51Ma, HPV16, and HPV31 PsVs. TRAPPC8 knockdown in HaCaT cells also showed reduced susceptibility to infection with authentic HPV31 virions, indicating that TRAPPC8 plays a crucial role in native HPV infection. Immunofluorescence microscopy revealed that the central region of TRAPPC8 was exposed on the cell surface and colocalized with inoculated PsVs. The entry of Ma, Nu, and L2-lacking PsVs into cells was equally impaired in TRAPPC8 knockdown HeLa cells, suggesting that TRAPPC8-dependent endocytosis plays an important role in HPV entry that is independent of L2 interaction. Finally, expression of GFP-fused L2 that can also interact with TRAPPC8 induced dispersal of the Golgi stack structure in HeLa cells, a phenotype also observed by TRAPPC8 knockdown. These results suggest that during viral intracellular trafficking, binding of L2 to TRAPPC8 inhibits its function resulting in Golgi destabilization, a process that may assist HPV genome escape from the trans-Golgi network.	[Ishii, Yoshiyuki; Kusumoto-Matsuo, Rika; Mori, Seiichiro; Takeuchi, Takamasa; Kukimoto, Iwao] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Nakahara, Tomomi] Natl Canc Ctr, Res Inst, Div Virol, Tokyo 104, Japan; [Kataoka, Michiyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Cancer Center - Japan; National Institute of Infectious Diseases (NIID)	Ishii, Y (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.	yishii@nih.go.jp	Kukimoto, I/I-3995-2019	Kukimoto, I/0000-0001-9080-1642	Ministry of Education, Culture, Sports, Science, and Technology [22590425]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research (C) 22590425 from the Ministry of Education, Culture, Sports, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bergant M, 2013, J VIROL, V87, P1270, DOI 10.1128/JVI.01991-12; Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Combita AL, 2001, FEMS MICROBIOL LETT, V204, P183, DOI 10.1111/j.1574-6968.2001.tb10883.x; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2013, J VIROL, V87, P3862, DOI 10.1128/JVI.03222-12; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Dziduszko A, 2013, J VIROL, V87, P7502, DOI 10.1128/JVI.00519-13; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Evander M, 1997, J VIROL, V71, P2449, DOI 10.1128/JVI.71.3.2449-2456.1997; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Griffin LM, 2013, VIROLOGY, V437, P12, DOI 10.1016/j.virol.2012.12.004; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; Horvath CAJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-11; Huang HS, 2010, VIROLOGY, V407, P391, DOI 10.1016/j.virol.2010.09.002; Ishii Y, 2013, BIOCHEM BIOPH RES CO, V433, P385, DOI 10.1016/j.bbrc.2013.02.130; Ishii Y, 2010, VIROLOGY, V406, P181, DOI 10.1016/j.virol.2010.07.019; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kakuta S, 2012, J BIOL CHEM, V287, P44261, DOI 10.1074/jbc.M112.411454; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Karanam B, 2010, J VIROL, V84, P10661, DOI 10.1128/JVI.01081-10; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Kondo K, 2009, VIROLOGY, V394, P259, DOI 10.1016/j.virol.2009.08.034; Laniosz V, 2009, J VIROL, V83, P8221, DOI 10.1128/JVI.00576-09; Lipovsky A, 2013, P NATL ACAD SCI USA, V110, P7452, DOI 10.1073/pnas.1302164110; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Marusic MB, 2012, TRAFFIC, V13, P455, DOI 10.1111/j.1600-0854.2011.01320.x; McMillan NAJ, 1999, VIROLOGY, V261, P271, DOI 10.1006/viro.1999.9825; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Nonnenmacher M, 2011, CELL HOST MICROBE, V10, P563, DOI 10.1016/j.chom.2011.10.014; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; Ozbun MA, 2002, J VIROL, V76, P11291, DOI 10.1128/JVI.76.22.11291-11300.2002; Patterson NA, 2005, J VIROL, V79, P6838, DOI 10.1128/JVI.79.11.6838-6847.2005; Pereira R, 2009, ARCH VIROL, V154, P187, DOI 10.1007/s00705-009-0310-3; Raff AB, 2013, J VIROL; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Scheffer KD, 2013, J VIROL, V87, P3435, DOI 10.1128/JVI.02906-12; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schelhaas M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000148; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Smith JL, 2008, J VIROL, V82, P9505, DOI 10.1128/JVI.01014-08; Spoden G, 2013, J VIROL, V87, P7765, DOI 10.1128/JVI.00370-13; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Surviladze Z, 2013, J VIROL, V87, P2508, DOI 10.1128/JVI.02319-12; Surviladze Z, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002519; Wang JW, 2013, VIROLOGY; Woodham AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043519	60	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80297	10.1371/journal.pone.0080297	http://dx.doi.org/10.1371/journal.pone.0080297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244674	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800142
J	Oe, M; Ogawa, H				Oe, Momoko; Ogawa, Hiroto			Neural Basis of Stimulus-Angle-Dependent Motor Control of Wind-Elicited Walking Behavior in the Cricket Gryllus bimaculatus	PLOS ONE			English	Article							CERCAL SENSORY SYSTEM; EVOKED ESCAPE BEHAVIOR; DIRECTIONAL SENSITIVITY; IDENTIFIED NEURONS; TERMINAL GANGLION; INTERNEURONS; INFORMATION; MECHANISMS; COCKROACH; DISCHARGE	Crickets exhibit oriented walking behavior in response to air-current stimuli. Because crickets move in the opposite direction from the stimulus source, this behavior is considered to represent 'escape behavior' from an approaching predator. However, details of the stimulus-angle-dependent control of locomotion during the immediate phase, and the neural basis underlying the directional motor control of this behavior remain unclear. In this study, we used a spherical-treadmill system to measure locomotory parameters including trajectory, turn angle and velocity during the immediate phase of responses to air-puff stimuli applied from various angles. Both walking direction and turn angle were correlated with stimulus angle, but their relationships followed different rules. A shorter stimulus also induced directionally-controlled walking, but reduced the yaw rotation in stimulus-angle-dependent turning. These results suggest that neural control of the turn angle requires different sensory information than that required for oriented walking. Hemi-severance of the ventral nerve cords containing descending axons from the cephalic to the prothoracic ganglion abolished stimulus-angle-dependent control, indicating that this control required descending signals from the brain. Furthermore, we selectively ablated identified ascending giant interneurons (GIs) in vivo to examine their functional roles in wind-elicited walking. Ablation of GI8-1 diminished control of the turn angle and decreased walking distance in the initial response. Meanwhile, GI9-1b ablation had no discernible effect on stimulus-angle-dependent control or walking distance, but delayed the reaction time. These results suggest that the ascending signals conveyed by GI8-1 are required for turn-angle control and maintenance of walking behavior, and that GI9-1b is responsible for rapid initiation of walking. It is possible that individual types of GIs separately supply the sensory signals required to control wind-elicited walking.	[Oe, Momoko] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Ogawa, Hiroto] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan; [Ogawa, Hiroto] Japan Sci & Technol Agcy JST, PREST, Kawaguchi, Saitama, Japan	Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Ogawa, H (corresponding author), Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan.	hogawa@sci.hokudai.ac.jp			Japan Science and Technology Agency (JST), Precursory Research for Embryonic Science and Technology (PRESTO); JSPS; MEXT KAKENHI [24120502]	Japan Science and Technology Agency (JST), Precursory Research for Embryonic Science and Technology (PRESTO)(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Science and Technology Agency (JST), Precursory Research for Embryonic Science and Technology (PRESTO), and JSPS and MEXT KAKENHI grant 24120502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baba Y, 1997, ZOOL SCI, V14, P587, DOI 10.2108/zsj.14.587; BACON JP, 1984, J PHYSIOL-LONDON, V352, P601, DOI 10.1113/jphysiol.1984.sp015312; BOYAN GS, 1986, J COMP PHYSIOL A, V159, P773, DOI 10.1007/BF00603731; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; Bullock T.H., 1984, P1; CAMHI JM, 1978, J COMP PHYSIOL, V128, P193, DOI 10.1007/BF00656852; Camhi JM, 1983, NEUROETHOLOGY NERVE; Casas J, 2010, ANNU REV ENTOMOL, V55, P505, DOI 10.1146/annurev-ento-112408-085342; COMER CM, 1985, BRAIN RES, V335, P342, DOI 10.1016/0006-8993(85)90490-1; Dangles O, 2007, J EXP BIOL, V210, P3165, DOI 10.1242/jeb.004648; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Domenici P, 2011, J EXP BIOL, V214, P2474, DOI 10.1242/jeb.053801; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; Fotowat H, 2011, NEURON, V69, P147, DOI 10.1016/j.neuron.2010.12.007; GNATZY W, 1986, NATURWISSENSCHAFTEN, V73, P212, DOI 10.1007/BF00417728; Gras H, 1998, J COMP PHYSIOL A, V182, P351, DOI 10.1007/s003590050185; GRAS H, 1992, J EXP BIOL, V171, P189; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Hedrick AV, 2007, J NEUROSCI METH, V164, P86, DOI 10.1016/j.jneumeth.2007.04.004; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; HIROTA K, 1993, ZOOL SCI, V10, P705; Jacobs GA, 1996, J NEUROSCI, V16, P769; JACOBS GA, 1985, SCIENCE, V228, P344, DOI 10.1126/science.3983633; JACOBS GA, 1986, J NEUROSCI, V6, P2298; Jacobs GA, 2008, J EXP BIOL, V211, P1819, DOI 10.1242/jeb.016402; Kagaya K, 2010, J NEUROSCI, V30, P1348, DOI 10.1523/JNEUROSCI.4885-09.2010; Kalb J, 2006, J NEUROSCI, V26, P7898, DOI 10.1523/JNEUROSCI.1327-06.2006; KANOU M, 1985, ZOOL SCI, V2, P629; Kanou M, 1999, ZOOL SCI, V16, P71, DOI 10.2108/zsj.16.71; Kanou M, 1996, ZOOL SCI, V13, P35, DOI 10.2108/zsj.13.35; Miller JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027873; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1416, DOI 10.1152/jn.1982.48.6.1416; MILLER JP, 1991, J NEUROPHYSIOL, V66, P1680, DOI 10.1152/jn.1991.66.5.1680; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; MURPHEY RK, 1985, J COMP PHYSIOL A, V156, P357, DOI 10.1007/BF00610728; Ogawa H, 2006, J NEUROBIOL, V66, P293, DOI 10.1002/neu.20220; Ogawa H, 2004, NEUROSCI LETT, V358, P185, DOI 10.1016/j.neulet.2004.01.023; Ogawa H, 2008, J NEUROSCI, V28, P4592, DOI 10.1523/JNEUROSCI.5354-07.2008; PALKA J, 1977, J COMP PHYSIOL, V119, P267, DOI 10.1007/BF00656638; Paydar S, 1999, J NEUROSCI, V19, P1771; PEARSON KG, 1970, J EXP BIOL, V52, P139; SELVERSTON AI, 1985, J NEUROSCI, V5, P1283; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P485, DOI 10.1007/BF00611913; TAUBER E, 1995, J EXP BIOL, V198, P1895; TROYER TW, 1994, MICROSC RES TECHNIQ, V29, P329, DOI 10.1002/jemt.1070290502; Vedenina VY, 1998, J COMP PHYSIOL A, V183, P553, DOI 10.1007/s003590050281; WINE JJ, 1972, J EXP BIOL, V56, P1; Witney AG, 2011, J EXP BIOL, V214, P69, DOI 10.1242/jeb.044800	50	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80184	10.1371/journal.pone.0080184	http://dx.doi.org/10.1371/journal.pone.0080184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244644	Green Published, gold			2022-12-25	WOS:000327143800134
J	Nadatani, Y; Watanabe, T; Tanigawa, T; Ohkawa, F; Takeda, S; Higashimori, A; Sogawa, M; Yamagami, H; Shiba, M; Watanabe, K; Tominaga, K; Fujiwara, Y; Takeuchi, K; Arakawa, T				Nadatani, Yuji; Watanabe, Toshio; Tanigawa, Tetsuya; Ohkawa, Fumikazu; Takeda, Shogo; Higashimori, Akira; Sogawa, Mitsue; Yamagami, Hirokazu; Shiba, Masatsugu; Watanabe, Kenji; Tominaga, Kazunari; Fujiwara, Yasuhiro; Takeuchi, Koji; Arakawa, Tetsuo			High-Mobility Group Box 1 Inhibits Gastric Ulcer Healing through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ISCHEMIA-REPERFUSION INJURY; SMALL-INTESTINAL DAMAGE; ISCHEMIA/REPERFUSION INJURY; PROINFLAMMATORY CYTOKINE; MURINE COLITIS; KINASE PATHWAY; UP-REGULATION; EARLY PHASE; PROTEIN	High-mobility group box 1 (HMGB1) was initially discovered as a nuclear protein that interacts with DNA as a chromatin-associated non-histone protein to stabilize nucleosomes and to regulate the transcription of many genes in the nucleus. Once leaked or actively secreted into the extracellular environment, HMGB1 activates inflammatory pathways by stimulating multiple receptors, including Toll-like receptor (TLR) 2, TLR4, and receptor for advanced glycation end products (RAGE), leading to tissue injury. Although HMGB1's ability to induce inflammation has been well documented, no studies have examined the role of HMGB1 in wound healing in the gastrointestinal field. The aim of this study was to evaluate the role of HMGB1 and its receptors in the healing of gastric ulcers. We also investigated which receptor among TLR2, TLR4, or RAGE mediates HMGB1's effects on ulcer healing. Gastric ulcers were induced by serosal application of acetic acid in mice, and gastric tissues were processed for further evaluation. The induction of ulcer increased the immunohistochemical staining of cytoplasmic HMGB1 and elevated serum HMGB1 levels. Ulcer size, myeloperoxidase (MPO) activity, and the expression of tumor necrosis factor alpha (TNF alpha) mRNA peaked on day 4. Intraperitoneal administration of HMGB1 delayed ulcer healing and elevated MPO activity and TNF alpha expression. In contrast, administration of anti-HMGB1 antibody promoted ulcer healing and reduced MPO activity and TNF alpha expression. TLR4 and RAGE deficiency enhanced ulcer healing and reduced the level of TNF alpha, whereas ulcer healing in TLR2 knockout (KO) mice was similar to that in wild-type mice. In TLR4 KO and RAGE KO mice, exogenous HMGB1 did not affect ulcer healing and TNF alpha expression. Thus, we showed that HMGB1 is a complicating factor in the gastric ulcer healing process, which acts through TLR4 and RAGE to induce excessive inflammatory responses.	[Nadatani, Yuji; Watanabe, Toshio; Tanigawa, Tetsuya; Takeda, Shogo; Higashimori, Akira; Sogawa, Mitsue; Yamagami, Hirokazu; Shiba, Masatsugu; Watanabe, Kenji; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo] Osaka City Univ Grad Sch Med, Dept Gastroenterol, Osaka, Japan; [Ohkawa, Fumikazu; Takeuchi, Koji] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol & Expt Therapeut, Kyoto 607, Japan	Osaka Metropolitan University; Kyoto Pharmaceutical University	Watanabe, T (corresponding author), Osaka City Univ Grad Sch Med, Dept Gastroenterol, Osaka, Japan.	watanabet@med.osaka-cu.ac.jp	Tanigawa, Tetsuya/J-6131-2019	Tanigawa, Tetsuya/0000-0002-9305-1637	Mitsubishi Tanabe Pharma Corporation; Abbott Japan Co., LTD.; Speaking and Teaching: Abbott Japan Co., LTD.; Yasuhiro Fujiwara - Speaking and Teaching: Eisai Co. Ltd Tetsuo Arakawa - Advisory Committees or Review Panels: Eisai Co. Ltd; Otsuka Pharmaceutical Co. Ltd.	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Abbott Japan Co., LTD.(Abbott Laboratories); Speaking and Teaching: Abbott Japan Co., LTD.; Yasuhiro Fujiwara - Speaking and Teaching: Eisai Co. Ltd Tetsuo Arakawa - Advisory Committees or Review Panels: Eisai Co. Ltd; Otsuka Pharmaceutical Co. Ltd.(Otsuka Pharmaceutical)	Kenji Watanabe - Grant/Research Support from the Mitsubishi Tanabe Pharma Corporation, Abbott Japan Co., LTD.; Mitsubishi Tanabe Pharma Corporation; Speaking and Teaching: Abbott Japan Co., LTD. Yasuhiro Fujiwara - Speaking and Teaching: Eisai Co. Ltd Tetsuo Arakawa - Advisory Committees or Review Panels: Eisai Co. Ltd, Otsuka Pharmaceutical Co. Ltd. The other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Biscetti F, 2010, DIABETES, V59, P1496, DOI 10.2337/db09-1507; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Esmon C, 2005, NAT MED, V11, P475, DOI 10.1038/nm0505-475; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Inoue Y, 2013, ROLE SERUM HIGH MOBI; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Lei C, 2013, NEUROSCIENCE, V229, P12, DOI 10.1016/j.neuroscience.2012.10.054; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Maeda S, 2007, BIOCHEM BIOPH RES CO, V360, P394, DOI 10.1016/j.bbrc.2007.06.065; Marsche G, 2007, FASEB J, V21, P1145, DOI 10.1096/fj.06-7439com; Nadatani Y, 2012, AM J PATHOL, V181, P98, DOI 10.1016/j.ajpath.2012.03.039; Nagato M, 2009, CRIT CARE MED, V37, P2181, DOI 10.1097/CCM.0b013e3181a55184; OKABE S, 1971, AM J DIG DIS, V16, P277, DOI 10.1007/BF02235252; Otani K, 2012, BIOCHEM BIOPH RES CO, V426, P342, DOI 10.1016/j.bbrc.2012.08.080; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Radin JN, 2011, INFECT IMMUN, V79, P2535, DOI 10.1128/IAI.01370-10; Ranzato E, 2010, CELL BIOCHEM BIOPHYS, V57, P9, DOI 10.1007/s12013-010-9077-0; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Sawa H, 2006, WORLD J GASTROENTERO, V12, P7666, DOI 10.3748/wjg.v12.i47.7666; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shimizu N, 2000, DIGESTION, V61, P157, DOI 10.1159/000007752; Shimizu T, 2000, DIGESTION, V62, P87, DOI 10.1159/000007800; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Susa Y, 2009, CRIT CARE MED, V37, P2619, DOI 10.1097/CCM.0b013e3181a930f7; Suzuki N, 1998, J PHYSIOL PHARMACOL, V49, P515; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Takahashi M, 1997, BIOCHEM BIOPH RES CO, V234, P493, DOI 10.1006/bbrc.1997.5974; Tanigawa T, 2010, DIGESTION, V81, P86, DOI 10.1159/000243719; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Urbonaviciute V, 2011, J INTERN MED, V270, P309, DOI 10.1111/j.1365-2796.2011.02432.x; van Zoelen MAD, 2009, SHOCK, V31, P280, DOI 10.1097/SHK.0b013e318186262d; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; WATANABE T, 1995, DIGEST DIS SCI, V40, P1340, DOI 10.1007/BF02065548; Watanabe T, 2002, DIGEST DIS SCI, V47, P1582, DOI 10.1023/A:1015879421739; Watanabe T, 2012, AM J PHYSIOL-GASTR L, V303, pG324, DOI 10.1152/ajpgi.00075.2012; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zeng S, 2009, J HEPATOL, V50, P929, DOI 10.1016/j.jhep.2008.11.022; Zhang Q, 2012, J SURG RES, V176, P343, DOI 10.1016/j.jss.2011.06.069	58	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80130	10.1371/journal.pone.0080130	http://dx.doi.org/10.1371/journal.pone.0080130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244627	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600183
J	Belgrano, FS; da Silva, ICD; de Oliveira, FMB; Fantappie, MR; Mohana-Borges, R				Belgrano, Fabricio S.; de Abreu da Silva, Isabel C.; Bastos de Oliveira, Francisco M.; Fantappie, Marcelo R.; Mohana-Borges, Ronaldo			Role of the Acidic Tail of High Mobility Group Protein B1 (HMGB1) in Protein Stability and DNA Bending	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; GROUP BOX 1; CHROMATIN PROTEIN; CONFORMATIONAL-CHANGES; COOPERATIVE BINDING; CRYSTAL-STRUCTURE; LEXA REPRESSOR; TATA-BOX; DOMAINS; HMG-1	High mobility group box (HMGB) proteins are abundant nonhistone proteins found in all eukaryotic nuclei and are capable of binding/bending DNA. The human HMGB1 is composed of two binding motifs, known as Boxes A and B, are L-shaped alpha-helix structures, followed by a random-coil acidic tail that consists of 30 Asp and Glu residues. This work aimed at evaluating the role of the acidic tail of human HMGB1 in protein stability and DNA interactions. For this purpose, we cloned, expressed and purified HMGB1 and its tailless form, HMGB1 Delta C, in E. coli strain. Tryptophan fluorescence spectroscopy and circular dichroism (CD) experiments clearly showed an increase in protein stability promoted by the acidic tail under different conditions, such as the presence of the chemical denaturant guanidine hydrochloride (Gdn.HCl), high temperature and low pH. Folding intermediates found at low pH for both proteins were denatured only in the presence of chemical denaturant, thus showing a relatively high stability. The acidic tail did not alter the DNA-binding properties of the protein, although it enhanced the DNA bending capability from 76 degrees (HMGB1 Delta C) to 91 degrees (HMGB1), as measured using the fluorescence resonance energy transfer technique. A model of DNA bending in vivo was proposed, which might help to explain the interaction of HMGB1 with DNA and other proteins, i.e., histones, and the role of that protein in chromatin remodeling.	[Belgrano, Fabricio S.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chages Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil; [de Abreu da Silva, Isabel C.; Fantappie, Marcelo R.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Helmintol & Entomol Mol, Rio De Janeiro, Brazil; [Bastos de Oliveira, Francisco M.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Cornell University	Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chages Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.	mohana@biof.ufrj.br	Borges, Ronaldo S Mohana/C-5575-2013; de Oliveira, Francisco Bastos/I-3540-2013	de Oliveira, Francisco Bastos/0000-0003-3314-3940; Belgrano, Fabricio/0000-0002-0411-7244	Brazilian funding agency CAPES; Brazilian funding agency CNPq; Brazilian funding agency FAPERJ; Brazilian funding agency IMBEBB; National Institutes of Science and Technology in Structural Biology and Bioimaging (INCT-INBEB)	Brazilian funding agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian funding agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian funding agency IMBEBB; National Institutes of Science and Technology in Structural Biology and Bioimaging (INCT-INBEB)	This work was supported by grants from the following Brazilian funding agencies: CAPES, CNPq, FAPERJ, IMBEBB, and the National Institutes of Science and Technology in Structural Biology and Bioimaging (INCT-INBEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA S, 1994, BIOCHEMISTRY-US, V33, P14690, DOI 10.1021/bi00253a006; Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter ML., 2001, DNA PROTEIN INTERACT, P491, DOI [10.1385/1-59259-208-2:491, DOI 10.1385/1-59259-208-2:491]; Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001; Dragan AI, 2004, J MOL BIOL, V343, P371, DOI 10.1016/j.jmb.2004.08.035; Dragan AI, 2003, J MOL BIOL, V331, P795, DOI 10.1016/S0022-2836(03)00785-X; Dragan AI, 2008, METHOD ENZYMOL, V450, P185, DOI 10.1016/S0076-6879(08)03409-5; Elenkov I, 2011, INT J BIOL SCI, V7, P691, DOI 10.7150/ijbs.7.691; Ellwood KB, 2000, MOL CELL BIOL, V20, P4359, DOI 10.1128/MCB.20.12.4359-4370.2000; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; HAMADA H, 1985, BIOCHEMISTRY-US, V24, P1428, DOI 10.1021/bi00327a022; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; Heyduk E, 1997, J BIOL CHEM, V272, P19763, DOI 10.1074/jbc.272.32.19763; Hieb AR, 2007, J MOL BIOL, V372, P619, DOI 10.1016/j.jmb.2007.06.061; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Knapp S, 2004, BIOCHEMISTRY-US, V43, P11992, DOI 10.1021/bi049364k; Kugel JF, 2008, BIOCHEM MOL BIOL EDU, V36, P341, DOI 10.1002/bmb.20202; Lorenz M, 1999, BIOCHEMISTRY-US, V38, P12150, DOI 10.1021/bi990459+; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; Masters KM, 2003, J BIOL CHEM, V278, P31685, DOI 10.1074/jbc.M305201200; McCauley M, 2005, BIOPHYS J, V89, P353, DOI 10.1529/biophysj.104.052068; McCauley MJ, 2007, J MOL BIOL, V374, P993, DOI 10.1016/j.jmb.2007.09.073; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pace CN, 2000, PROTEINS, P1; Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y; Payet D, 1997, J MOL BIOL, V266, P66, DOI 10.1006/jmbi.1996.0782; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Polyanichko AM, 2002, J BIOMOL STRUCT DYN, V19, P1053, DOI 10.1080/07391102.2002.10506808; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sessa L, 2007, GENE, V387, P133, DOI 10.1016/j.gene.2006.08.034; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; Sousa FJR, 2006, J MOL BIOL, V359, P1059, DOI 10.1016/j.jmb.2006.03.069; Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045; Stros M, 1998, J BIOL CHEM, V273, P10355; STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; TAKASHI R, 1977, P NATL ACAD SCI USA, V74, P2334, DOI 10.1073/pnas.74.6.2334; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d; Ueda T, 2004, BIOCHEMISTRY-US, V43, P9901, DOI 10.1021/bi035975l; Wang Q, 2007, BIOCHEM BIOPH RES CO, V360, P14, DOI 10.1016/j.bbrc.2007.05.130; Watson M, 2007, J MOL BIOL, V374, P1286, DOI 10.1016/j.jmb.2007.09.075; Webb M, 2001, J MOL BIOL, V309, P79, DOI 10.1006/jmbi.2001.4667; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Wu J, 2001, J BIOL CHEM, V276, P14614, DOI 10.1074/jbc.M004402200; Zhang JY, 2009, NUCLEIC ACIDS RES, V37, P1107, DOI 10.1093/nar/gkn1011; Zimmerman J, 2008, BIOCHEM BIOPH RES CO, V371, P79, DOI 10.1016/j.bbrc.2008.04.024	62	32	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79572	10.1371/journal.pone.0079572	http://dx.doi.org/10.1371/journal.pone.0079572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255708	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200075
J	El Hajj, H; Ali, J; Ghantous, A; Hodroj, D; Daher, A; Zibara, K; Journo, C; Otrock, Z; Zaatari, G; Mahieux, R; El Sabban, M; Bazarbachi, A; Abou Merhi, R				El Hajj, Hiba; Ali, Jihane; Ghantous, Akram; Hodroj, Dana; Daher, Ahmad; Zibara, Kazem; Journo, Chloe; Otrock, Zaher; Zaatari, Ghazi; Mahieux, Renaud; El Sabban, Marwan; Bazarbachi, Ali; Abou Merhi, Raghida			Combination of Arsenic and Interferon-alpha Inhibits Expression of KSHV Latent Transcripts and Synergistically Improves Survival of Mice with Primary Effusion Lymphomas	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; CAVITY-BASED LYMPHOMA; DNA-SEQUENCES; NUCLEAR ANTIGEN; IN-VIVO; INDUCED APOPTOSIS; PHASE-II; TRIOXIDE; CELLS; PML	Background: Kaposi sarcoma-associated herpesvirus (KSHV) is the etiologic agent of primary effusion lymphomas (PEL). PEL cell lines infected with KSHV, but negative for Epstein-Barr virus have a tumorigenic potential in non-obese diabetic/severe combined immunodeficient mice and result in efficient engraftment and formation of malignant ascites with notable abdominal distension, consistent with the clinical manifestations of PEL in humans. Methodology/Principal Findings: Using this preclinical mouse model, we demonstrate that the combination of arsenic trioxide and interferon-alpha (IFN) inhibits proliferation, induces apoptosis and downregulates the latent viral transcripts LANA-1, v-FLIP and v-Cyc in PEL cells derived from malignant ascites. Furthermore, this combination decreases the peritoneal volume and synergistically increases survival of PEL mice. Conclusion/Significance: These results provide a promising rationale for the therapeutic use of arsenic/IFN in PEL patients.	[El Hajj, Hiba; Bazarbachi, Ali] Amer Univ Beirut, Fac Med, Dept Internal Med, Beirut, Lebanon; [Ali, Jihane; Hodroj, Dana; Daher, Ahmad; Abou Merhi, Raghida] Lebanese Univ, Fac Sci, Dept Biol, Hadath, Lebanon; [Ghantous, Akram] Int Agcy Res Canc, F-69372 Lyon, France; [Zibara, Kazem] Lebanese Univ, Fac Sci, Dept Biol, Sect 5, Nabatieh, Lebanon; [Journo, Chloe; Mahieux, Renaud] Ecole Normale Super Lyon, Equipe Labelisee Ligue Natl Canc INSERM U1111, CIRI Int Ctr Infectiol Res, Equipe Oncogenese Retrovirale,CNRS UMR5308,Biol D, F-69364 Lyon, France; [Otrock, Zaher] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH 44106 USA; [Zaatari, Ghazi] Amer Univ Beirut, Dept Pathol & Lab Med, Fac Med, Beirut, Lebanon; [El Sabban, Marwan] Amer Univ Beirut, Dept Anat Cell Biol & Physiol, Fac Med, Beirut, Lebanon	American University of Beirut; Lebanese University; World Health Organization; International Agency for Research on Cancer (IARC); Lebanese University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Cleveland Clinic Foundation; American University of Beirut; American University of Beirut	Bazarbachi, A (corresponding author), Amer Univ Beirut, Fac Med, Dept Internal Med, Beirut, Lebanon.	bazarbac@aub.edu.lb; raboumerhi@ul.edu.lb	Otrock, Zaher/ABI-4940-2020; GHANTOUS, Akram/C-1689-2017	Otrock, Zaher/0000-0002-5823-2694; GHANTOUS, Akram/0000-0002-2582-6402; Bazarbachi, Ali/0000-0002-7171-4997; mahieux, renaud/0000-0002-5129-6804; Zibara, Kazem/0000-0002-9887-072X; Journo, Chloe/0000-0002-0973-0777	Lebanese National Council for Scientific Research (LNCSR); Lebanese University/EDST; American University of Beirut	Lebanese National Council for Scientific Research (LNCSR); Lebanese University/EDST; American University of Beirut	This project is supported by grants from the Lebanese National Council for Scientific Research (LNCSR), Lebanese University/EDST, and American University of Beirut (Medical Practice Plan and University Research Board). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Merhi R, 2007, LEUKEMIA, V21, P1792, DOI 10.1038/sj.leu.2404797; An J, 2004, LEUKEMIA, V18, P1699, DOI 10.1038/sj.leu.2403460; Ansari MQ, 1996, AM J CLIN PATHOL, V105, P221; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Bazarbachi A, 2004, LANCET ONCOL, V5, P664, DOI 10.1016/S1470-2045(04)01608-0; Bazarbachi A, 1999, BLOOD, V93, P278, DOI 10.1182/blood.V93.1.278.401k22_278_283; Boulanger E, 2005, INT J CANCER, V115, P511, DOI 10.1002/ijc.20926; Boulanger E, 2003, AM J HEMATOL, V73, P143, DOI 10.1002/ajh.10341; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Carbone A, 2005, J MOL DIAGN, V7, P17, DOI 10.1016/S1525-1578(10)60004-9; Carbone A, 1997, BRIT J HAEMATOL, V97, P515, DOI 10.1046/j.1365-2141.1997.00064.x; Carbone A, 2008, CANCER CYTOPATHOL, V114, P225, DOI 10.1002/cncr.23597; Cesarman E, 1996, AM J PATHOL, V149, P53; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen HS, 2012, J VIROL, V86, P9454, DOI 10.1128/JVI.00787-12; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; DePond W, 1997, AM J SURG PATHOL, V21, P719, DOI 10.1097/00000478-199706000-00013; El Hajj H, 2010, J EXP MED, V207, P2785, DOI 10.1084/jem.20101095; El-Sabban ME, 2000, BLOOD, V96, P2849; Fakhari FD, 2006, J CLIN INVEST, V116, P735, DOI 10.1172/JCI26190; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Gessain A, 1996, BLOOD, V87, P414; Ghavamzadeh A, 2011, J CLIN ONCOL, V29, P2753, DOI 10.1200/JCO.2010.32.2107; Ghosh SK, 2003, BLOOD, V101, P2321, DOI 10.1182/blood-2002-08-2525; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Goto H, 2012, CANCER SCI, V103, P775, DOI 10.1111/j.1349-7006.2012.02212.x; Halfdanarson TR, 2006, ANN ONCOL, V17, P1849, DOI 10.1093/annonc/mdl139; Hermine O, 2004, HEMATOL J, V5, P130, DOI 10.1038/sj.thj.6200374; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Huang Q, 2002, AM J SURG PATHOL, V26, P1363, DOI 10.1097/00000478-200210000-00014; Hussain AR, 2011, FREE RADICAL BIO MED, V50, P978, DOI 10.1016/j.freeradbiomed.2010.12.034; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kchour G, 2009, BLOOD, V113, P6528, DOI 10.1182/blood-2009-03-211821; Kogan SC, 2009, CANCER CELL, V15, P7, DOI 10.1016/j.ccr.2008.12.012; Komatsu T, 2002, FRONT BIOSCI, V7, pD726, DOI 10.2741/komatsu; Koopal S, 2007, PLOS PATHOG, V3, P1348, DOI 10.1371/journal.ppat.0030140; Lacoste V, 2007, BRIT J HAEMATOL, V138, P487, DOI 10.1111/j.1365-2141.2007.06697.x; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee RK, 1999, CANCER RES, V59, P5514; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Low W, 2001, J VIROL, V75, P2938, DOI 10.1128/JVI.75.6.2938-2945.2001; Lubyova B, 2007, J BIOL CHEM, V282, P31944, DOI 10.1074/jbc.M706430200; Mahieux R, 2005, LEUKEMIA LYMPHOMA, V46, P347, DOI 10.1080/10428190400019966; Mahieux R, 2001, BLOOD, V98, P3762, DOI 10.1182/blood.V98.13.3762; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Nasr R, 2003, BLOOD, V101, P4576, DOI 10.1182/blood-2002-09-2986; Nasr R, 2009, CLIN CANCER RES, V15, P6321, DOI 10.1158/1078-0432.CCR-09-0209; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Otsuki T, 1996, LEUKEMIA, V10, P1358; Petre CE, 2007, J VIROL, V81, P1912, DOI 10.1128/JVI.01757-06; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Renne R, 2001, J VIROL, V75, P458, DOI 10.1128/JVI.75.1.458-468.2001; Riva G, 2012, BLOOD, V120, P4150, DOI 10.1182/blood-2012-04-421412; Sarosiek KA, 2010, P NATL ACAD SCI USA, V107, P13069, DOI 10.1073/pnas.1002985107; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Simonelli C, 2003, J CLIN ONCOL, V21, P3948, DOI 10.1200/JCO.2003.06.013; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Song MJ, 2003, J VIROL, V77, P9451, DOI 10.1128/JVI.77.17.9451-9462.2003; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Sunil Meena, 2010, Curr Infect Dis Rep, V12, P147, DOI 10.1007/s11908-010-0092-5; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Toomey NL, 2001, ONCOGENE, V20, P7029, DOI 10.1038/sj.onc.1204895; Uddin S, 2005, CLIN CANCER RES, V11, P3102, DOI 10.1158/1078-0432.CCR-04-1857; Verma SC, 2007, CURR TOP MICROBIOL, V312, P101; Verschuren EW, 2004, CANCER RES, V64, P581, DOI 10.1158/0008-5472.CAN-03-1863; Waddington TW, 2004, AIDS PATIENT CARE ST, V18, P67, DOI 10.1089/108729104322802498; Wang YF, 2004, ANN HEMATOL, V83, P739, DOI 10.1007/s00277-004-0949-5; Wies E, 2008, BLOOD, V111, P320, DOI 10.1182/blood-2007-05-092288; Wu W, 2005, LEUKEMIA RES, V29, P545, DOI 10.1016/j.leukres.2004.11.010; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	76	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79474	10.1371/journal.pone.0079474	http://dx.doi.org/10.1371/journal.pone.0079474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250827	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200065
J	Friedrich, V; Bederson, JB; Sehba, FA				Friedrich, Victor; Bederson, Joshua B.; Sehba, Fatima A.			Gender Influences the Initial Impact of Subarachnoid Hemorrhage: An Experimental Investigation	PLOS ONE			English	Article							CEREBRAL BLOOD-FLOW; RUPTURED INTRACRANIAL ANEURYSM; SEX-DIFFERENCES; FLUORO-JADE; PRESSURE; RAT; DIFFERENCE; STROKE; INJURY; DEATH	Aneurysmal subarachnoid hemorrhage (SAH) carries high early patient mortality. More women than men suffer from SAH and the average age of female SAH survivors is greater than that of male survivors; however, the overall mortality and neurological outcomes are not better in males despite their younger age. This pattern suggests the possibility of gender differences in the severity of initial impact and/or in subsequent pathophysiology. We explored gender differences in survival and pathophysiology following subarachnoid hemorrhage induced in age-matched male and female rats by endovascular puncture. Intracranial pressure (ICP), cerebral blood flow (CBF), blood pressure (BP) and cerebral perfusion pressure (CPP) were recorded at and after induction of SAH. Animals were sacrificed 3 hours after lesion and studied for subarachnoid hematoma size, vascular pathology (collagen and endothelium immunostaining), inflammation (platelet and neutrophil immunostaining), and cell death (TUNEL assay). In a second cohort, 24-hour survival was determined. Subarachnoid hematoma, post-hemorrhage ICP peak, BP elevation, reduction in CPP, intraluminal platelet aggregation and neutrophil accumulation, loss of vascular collagen, and neuronal and non-neuronal cell death were greater in male than in female rats. Hematoma size did not correlate with the number of apoptotic cells, platelet aggregates or neutrophil. The ICP peak correlated with hematoma size and with number of apoptotic cells but not with platelet aggregates and neutrophil number. This suggests that the intensity of ICP rise at SAH influences the severity of apoptosis but not of inflammation. Mortality was markedly greater in males than females. Our data demonstrate that in rats gender influences the initial impact of SAH causing greater bleed and early injury in males as compared to females.	[Bederson, Joshua B.; Sehba, Fatima A.] Mt Sinai Sch Med, Dept Neurosurg, New York, NY 10029 USA; [Friedrich, Victor; Sehba, Fatima A.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sehba, FA (corresponding author), Mt Sinai Sch Med, Dept Neurosurg, New York, NY 10029 USA.	fatima.sehba@mssm.edu			American Heart Association [10GRNT4570012]	American Heart Association(American Heart Association)	This study was supported by American Heart Association 10GRNT4570012 (FAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUTIUNOV AI, 1974, J NEUROSURG, V40, P459, DOI 10.3171/jns.1974.40.4.0459; Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; BRINKER T, 1992, ACTA NEUROCHIR, V115, P47, DOI 10.1007/BF01400590; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Capodanno D, 2010, THROMB HAEMOSTASIS, V104, P471, DOI 10.1160/TH10-04-0232; Cha KC, 2010, J KOREAN NEUROSURG S, V47, P119, DOI 10.3340/jkns.2010.47.2.119; Colombo JA, 2002, J HISTOCHEM CYTOCHEM, V50, P1135, DOI 10.1177/002215540205000815; CRAWFORD MD, 1965, LANCET, V2, P1254; Cushing H, 1902, AM J MED SCI, V124, P375, DOI 10.1097/00000441-190209000-00001; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; Ding C, 2013, J NEUROINTERV SURG; Eshel-Green T, 2009, THROMB HAEMOSTASIS, V102, P958, DOI 10.1160/TH08-09-0624; FARACI FM, 1993, NEUROSURGERY, V33, P648, DOI 10.1227/00006123-199310000-00014; Forte P, 1998, HYPERTENSION, V32, P730, DOI 10.1161/01.HYP.32.4.730; Friedrich V, 2010, NEUROSCIENCE, V165, P968, DOI 10.1016/j.neuroscience.2009.10.038; Friedrich V, 2012, NEUROSCI LETT, V512, P6, DOI 10.1016/j.neulet.2012.01.036; Friedrich V, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-103; Friedrich V, 2010, BRAIN RES, V1354, P179, DOI 10.1016/j.brainres.2010.07.040; Gonzales RJ, 2005, AM J PHYSIOL-HEART C, V289, pH578, DOI 10.1152/ajpheart.00958.2004; Gupta NC, 2012, ARTERIOSCL THROM VAS, V32, P1936, DOI 10.1161/ATVBAHA.112.251520; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; Haque SF, 2001, ENDOCR J, V48, P33, DOI 10.1507/endocrj.48.33; HELPERN M, 1950, AM J MED SCI, V220, P262, DOI 10.1097/00000441-195022030-00004; Hockel K, 2012, STROKE, V43, P227, DOI 10.1161/STROKEAHA.111.626168; Horiuchi T, 2006, NEUROL MED-CHIR, V46, P328, DOI 10.2176/nmc.46.328; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Kehl F, 2002, AM J PHYSIOL-HEART C, V282, pH1556, DOI 10.1152/ajpheart.00924.2001; Kongable GL, 1996, J NEUROSURG, V84, P43, DOI 10.3171/jns.1996.84.1.0043; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; LONGSTRETH WT, 1985, STROKE, V16, P377, DOI 10.1161/01.STR.16.3.377; NORNES H, 1973, J NEUROSURG, V39, P226, DOI 10.3171/jns.1973.39.2.0226; Orendacova J, 2005, GEN PHYSIOL BIOPHYS, V24, P75; Ostbye T, 1997, STROKE, V28, P793, DOI 10.1161/01.STR.28.4.793; Park SK, 2008, J CLIN NEUROSCI, V15, P389, DOI 10.1016/j.jocn.2007.04.007; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Preacher KJ, 2001, CALCULATION CHI SQUA; PROVOST P, 1994, ARTERIOSCLER THROMB, V14, P331, DOI 10.1161/01.ATV.14.3.331; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Schwartz AY, 2000, J NEUROSCI METH, V96, P161, DOI 10.1016/S0165-0270(00)00156-4; Schwertz DW, 2001, HEART LUNG, V30, P401, DOI 10.1067/mhl.2001.118764; SECHERHANSEN E, 1964, ACTA NEUROL SCAND, V40, P115; Sehba FA, 2004, J NEUROSURG, V101, P633, DOI 10.3171/jns.2004.101.4.0633; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Sehba FA, 2011, ACTA NEUROCHIR SUPPL, V110, P49, DOI 10.1007/978-3-7091-0353-1_9; Sehba FA, 2010, J NEUROSURG, V113, P826, DOI 10.3171/2009.9.JNS09802; SHALIT MN, 1974, J NEUROSURG, V40, P594, DOI 10.3171/jns.1974.40.5.0594; Uchida M, 2009, J CEREBR BLOOD F MET, V29, P1454, DOI 10.1038/jcbfm.2009.60; Vaartjes I, 2009, CEREBROVASC DIS, V28, P564, DOI 10.1159/000247600; Voldby B, 1988, Acta Neurochir Suppl (Wien), V45, P1	52	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80101	10.1371/journal.pone.0080101	http://dx.doi.org/10.1371/journal.pone.0080101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250830	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200102
J	Pei, JM; Grishin, NV				Pei, Jimin; Grishin, Nick V.			A New Family of Predicted Kruppel-Like Factor Genes and Pseudogenes in Placental Mammals	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; SP1-LIKE PROTEIN; GENERATION; REPRESSORS; EXPRESSION; ZFP352; BLAST; BOX	Kruppel-like factors (KLF) and specificity proteins (SP) constitute a family of zinc-finger-containing transcription factors that play important roles in a wide range of processes including differentiation and development of various tissues. The human genome possesses 17 KLF genes (KLF1-KLF17) and nine SP genes (SP1-SP9) with diverse functions. We used sequence similarity searches and gene synteny analysis to identify a new putative KLF gene/pseudogene named KLF18 that is present in most of the placental mammals with sequenced genomes. KLF18 is a chromosomal neighbor of the KLF17 gene and is likely a product of its duplication. Phylogenetic analyses revealed that mammalian predicted KLF18 proteins and KLF17 proteins experienced elevated rates of evolution and are grouped with KLF1/KLF2/KLF4 and non-mammalian KLF17. Predicted KLF18 proteins maintain conserved features in the zinc fingers of the SP/KLF family, while possessing repeats of a unique sequence motif in their N-terminal regions. No expression data have been reported for KLF18, suggesting that it either has highly restricted expression patterns and specialized functions, or could have become a pseudogene in extant placental mammals. Besides KLF18 genes/pseudogenes, we identified several KLF18-like genes such as Zfp352, Zfp352-like, and Zfp353 in the genomes of mouse and rat. These KLF18-like genes do not possess introns inside their coding regions, and gene expression data indicate that some of them may function in early embryonic development. They represent further expansions of KLF members in the murine lineage, most likely resulted from several events of retrotransposition and local gene duplication starting from an ancient spliced mRNA of KLF18.	[Pei, Jimin; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pei, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	jpei@chop.swmed.edu			National Institutes of Health [GM094575]; Welch Foundation [I-1505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (GM094575 to NVG) and the Welch Foundation (I-1505 to NVG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antin PB, 2010, DEV DYNAM, V239, P1879, DOI 10.1002/dvdy.22318; Asher RJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-102; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Chen HH, 2002, GENOMICS, V79, P18, DOI 10.1006/geno.2001.6664; Chen ZL, 2010, GENOMICS, V95, P111, DOI 10.1016/j.ygeno.2009.11.001; Choo KB, 2001, MOL REPROD DEV, V59, P249, DOI 10.1002/mrd.1029; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ding G, 2009, NUCLEIC ACIDS RES, V37, pD267, DOI 10.1093/nar/gkn782; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; HASEGAWA M, 1991, J MOL EVOL, V32, P443, DOI 10.1007/BF02101285; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaczynski J, 2001, J BIOL CHEM, V276, P36749, DOI 10.1074/jbc.M105831200; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Karolchik Donna, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s40; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu TYC, 2003, MOL REPROD DEV, V64, P52, DOI 10.1002/mrd.10218; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oates AC, 2001, BLOOD, V98, P1792, DOI 10.1182/blood.V98.6.1792; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Seetharam A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-276; Shimeld S, 2008, DEV GENES EVOL, V218, P639, DOI 10.1007/s00427-008-0248-6; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yan W, 2002, MECH DEVELOP, V118, P233, DOI 10.1016/S0925-4773(02)00258-7; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	44	26	33	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e81109	10.1371/journal.pone.0081109	http://dx.doi.org/10.1371/journal.pone.0081109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244731	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900086
J	Dahiya, V; Chaudhuri, TK				Dahiya, Vinay; Chaudhuri, Tapan K.			Chaperones GroEL/GroES Accelerate the Refolding of a Multidomain Protein through Modulating On-pathway Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Molecular Chaperone; Protein Conformation; Protein Dynamics; Protein Folding; GroEL; Malate Synthase G; Folding Intermediates; Large Protein Folding; Refolding Kinetics	THERMODYNAMIC COUPLING MECHANISM; ESCHERICHIA-COLI PROTEINS; IN-VIVO; MOLECULAR CHAPERONES; FOLDING REACTION; GROEL; BINDING; ATP; POLYPEPTIDE; RECONSTITUTION	Despite a vast amount information on the interplay of GroEL, GroES, and ATP in chaperone-assisted folding, the molecular details on the conformational dynamics of folding polypeptide during its GroEL/GroES-assisted folding cycle is quite limited. Practically no such studies have been reported to date on large proteins, which often have difficulty folding in vitro. The effect of the GroEL/GroES chaperonin system on the folding pathway of an 82-kDa slow folding protein, malate synthase G (MSG), was investigated. GroEL bound to the burst phase intermediate of MSG and accelerated the slowest kinetic phase associated with the formation of native topology in the spontaneous folding pathway. GroEL slowly induced conformational changes on the bound burst phase intermediate, which was then transformed into a more folding-compatible form. Subsequent addition of ATP or GroES/ATP to the GroEL-MSG complex led to the formation of the native state via a compact intermediate with the rate several times faster than that of spontaneous refolding. The presence of GroES doubled the ATP-dependent reactivation rate of bound MSG by preventing multiple cycles of its GroEL binding and release. Because GroES bound to the trans side of GroEL-MSG complex, it may be anticipated that confinement of the substrate underneath the co-chaperone is not required for accelerating the rate in the assisted folding pathway. The potential role of GroEL/GroES in assisted folding is most likely to modulate the conformation of MSG intermediates that can fold faster and thereby eliminate the possibility of partial aggregation caused by the slow folding intermediates during its spontaneous refolding pathway.	[Dahiya, Vinay; Chaudhuri, Tapan K.] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Chaudhuri, TK (corresponding author), Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 110016, India.	tkchaudhuri@bioschool.iitd.ac.in		Dahiya, Vinay/0000-0003-1900-0468	Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Recipient of the Council of Scientific and Industrial Research, Government of India Senior Research Fellowship.; Recipient of financial assistance from the Department of Biotechnology, Government of India.	Bhutani N, 2000, J MOL BIOL, V297, P1037, DOI 10.1006/jmbi.2000.3648; Bhutani N, 2001, J MOL BIOL, V314, P1167, DOI 10.1006/jmbi.2000.5193; BRUNSCHIER R, 1993, J BIOL CHEM, V268, P2767; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chuang JL, 1999, J BIOL CHEM, V274, P10395, DOI 10.1074/jbc.274.15.10395; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Dahiya V, 2013, BIOCHEMISTRY-US, V52, P4517, DOI 10.1021/bi400328a; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Fenton WA, 1997, PROTEIN SCI, V6, P743; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Gervasoni P, 1996, P NATL ACAD SCI USA, V93, P12189, DOI 10.1073/pnas.93.22.12189; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GULUKOTA K, 1994, P NATL ACAD SCI USA, V91, P9292, DOI 10.1073/pnas.91.20.9292; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horst R, 2007, P NATL ACAD SCI USA, V104, P20788, DOI 10.1073/pnas.0710042105; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lau CK, 1999, BBA-PROTEIN STRUCT M, V1431, P282, DOI 10.1016/S0167-4838(99)00050-3; LILIE H, 1995, P NATL ACAD SCI USA, V92, P8100, DOI 10.1073/pnas.92.18.8100; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MATTINGLY JR, 1995, J BIOL CHEM, V270, P1138, DOI 10.1074/jbc.270.3.1138; Noivirt-Brik O, 2007, BIOINFORMATICS, V23, P3276, DOI 10.1093/bioinformatics/btm513; Paul S, 2007, FASEB J, V21, P2874, DOI 10.1096/fj.06-7958com; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Takagi F, 2003, P NATL ACAD SCI USA, V100, P11367, DOI 10.1073/pnas.1831920100; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; Walter S, 1996, P NATL ACAD SCI USA, V93, P9425, DOI 10.1073/pnas.93.18.9425; WAXMAN L, 1986, SCIENCE, V232, P500, DOI 10.1126/science.2938257; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Zahn R, 1996, J MOL BIOL, V261, P43, DOI 10.1006/jmbi.1996.0440; ZAHN R, 1994, J MOL BIOL, V242, P150, DOI 10.1006/jmbi.1994.1566	48	17	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					286	298		10.1074/jbc.M113.518373	http://dx.doi.org/10.1074/jbc.M113.518373			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24247249	Green Published, hybrid			2022-12-25	WOS:000329370900025
J	Lutkenhoner, B; Basel, T				Luetkenhoener, Bernd; Basel, Tuerker			Predictive Modeling for Diagnostic Tests with High Specificity, but Low Sensitivity: A Study of the Glycerol Test in Patients with Suspected Meniere's Disease	PLOS ONE			English	Article							ROC CURVE; AREA; ACCURACY; RISK	A high specificity does not ensure that the expected benefit of a diagnostic test outweighs its cost. Problems arise, in particular, when the investigation is expensive, the prevalence of a positive test result is relatively small for the candidate patients, and the sensitivity of the test is low so that the information provided by a negative result is virtually negligible. The consequence may be that a potentially useful test does not gain broader acceptance. Here we show how predictive modeling can help to identify patients for whom the ratio of expected benefit and cost reaches an acceptable level so that testing these patients is reasonable even though testing all patients might be considered wasteful. Our application example is based on a retrospective study of the glycerol test, which is used to corroborate a suspected diagnosis of Meniere's disease. Using the pretest hearing thresholds at up to 10 frequencies, predictions were made by K-nearest neighbor classification or logistic regression. Both methods estimate, based on results from previous patients, the posterior probability that performing the considered test in a new patient will have a positive outcome. The quality of the prediction was evaluated using leave-one-out cross-validation, making various assumptions about the costs and benefits of testing. With reference to all 356 cases, the probability of a positive test result was almost 0.4. For subpopulations selected by K-nearest neighbor classification, which was clearly superior to logistic regression, this probability could be increased up to about 0.6. Thus, the odds of a positive test result were more than doubled.	[Luetkenhoener, Bernd; Basel, Tuerker] Munster Univ Hosp, ENT Clin, Munster, Germany	University of Munster	Lutkenhoner, B (corresponding author), Munster Univ Hosp, ENT Clin, Munster, Germany.	Lutkenh@uni-muenster.de			Deutsche Forschungsgemeinschaft; University of Munster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Munster	The authors acknowledge support by Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of the University of Munster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, P655; Adams ME, 2010, OTOLARYNG CLIN N AM, V43, P995, DOI 10.1016/j.otc.2010.05.008; Arts HA, 1997, OTOLARYNG CLIN N AM, V30, P987; ASCH DA, 1990, MED DECIS MAKING, V10, P47, DOI 10.1177/0272989X9001000108; Basel T, 2013, EAR HEARING, V34, P370, DOI 10.1097/AUD.0b013e31826d0c08; Bishop C.M., 2006, PATTERN RECOGNITION; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brown CD, 2006, CHEMOMETR INTELL LAB, V80, P24, DOI 10.1016/j.chemolab.2005.05.004; Buttrey SE, 1998, COMPUT STAT DATA AN, V28, P157, DOI 10.1016/S0167-9473(98)00032-2; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Drummond C, 2006, MACH LEARN, V65, P95, DOI 10.1007/s10994-006-8199-5; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FIX E, 1989, INT STAT REV, V57, P238, DOI 10.2307/1403797; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; Gerds TA, 2008, BIOMETRICAL J, V50, P457, DOI 10.1002/bimj.200810443; Green DM, 1966, SIGNAL DETECTION THE; Hand DJ, 2013, PATTERN RECOGN LETT, V34, P492, DOI 10.1016/j.patrec.2012.12.004; Hand DJ, 2006, STAT SCI, V21, P1, DOI 10.1214/088342306000000060; HILDEN J, 1991, MED DECIS MAKING, V11, P95, DOI 10.1177/0272989X9101100204; Hitchcock C, 2004, BRIT J PHILOS SCI, V55, P1, DOI 10.1093/bjps/55.1.1; Johnson NP, 2004, STAT MED, V23, P2257, DOI 10.1002/sim.1835; Klockhoff I, 1966, Acta Otolaryngol, V61, P459, DOI 10.3109/00016486609127084; Kumar V, 2005, HDB DATA STRUCTURES; Mayer D, 2008, HANDB STAT, V27, P712, DOI 10.1016/S0169-7161(07)27024-5; McCullagh P, 1989, GEN LINEAR MODELS; MOROFF S V, 1984, Einstein Quarterly Journal of Biology and Medicine, V2, P157; Moskowitz CS, 2004, BIOSTATISTICS, V5, P113, DOI 10.1093/biostatistics/5.1.113; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; PAUKER SG, 1975, NEW ENGL J MED, V293, P229, DOI 10.1056/NEJM197507312930505; Pepe M. S., 2003, STAT EVALUATION MED; Power Michael, 2013, Evid Based Med, V18, P5, DOI 10.1136/eb-2012-100645; Rao C. R., 1999, LINEAR MODELS LEAST; Rao R. B., 2008, P 2008 SIAM INT C DA, P588, DOI DOI 10.1137/1.9781611972788.54; Salzberg SL, 1997, DATA MIN KNOWL DISC, V1, P317, DOI 10.1023/A:1009752403260; Shapiro DE, 1999, STAT METHODS MED RES, V8, P113, DOI 10.1177/096228029900800203; SILVERMAN BW, 1989, INT STAT REV, V57, P233, DOI 10.2307/1403796; SIMPSON AJ, 1973, PSYCHOL BULL, V80, P481, DOI 10.1037/h0035203; Soreide K, 2011, ANN SURG, V253, P27, DOI 10.1097/SLA.0b013e318204a892; Spitznagel EL, 2008, HANDB STAT, V27, P187, DOI 10.1016/S0169-7161(07)27006-3; Tan CM, 2013, JARO-J ASSOC RES OTO, V14, P275, DOI 10.1007/s10162-013-0371-6; Urbanke R., 2002, COMMUNICATIONS HDB; Verde MF, 2006, PERCEPT PSYCHOPHYS, V68, P643, DOI 10.3758/BF03208765; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vittinghoff E, 2008, HANDB STAT, V27, P148, DOI 10.1016/S0169-7161(07)27005-1; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929; ZWEIG MH, 1993, CLIN CHEM, V39, P561	50	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79315	10.1371/journal.pone.0079315	http://dx.doi.org/10.1371/journal.pone.0079315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260193	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500041
J	Tao, X; Xu, ZW				Tao, Xin; Xu, Ziwei			MicroRNA Transcriptome in Swine Small Intestine during Weaning Stress	PLOS ONE			English	Article							CELL-PROLIFERATION; MIR-150 PROMOTES; RT-PCR; EXPRESSION; SYSTEM; GENES; DIFFERENTIATION; MOLECULES; DISCOVERY; TRANSIENT	MicroRNAs (miRNAs) play important roles in intestinal diseases; however, the role of miRNAs during weaning stress is unknown. In our study, six jejunal small RNA libraries constructed from weaning piglets at 1, 4 and 7 d after weaning (libraries W1, W4 and W7, respectively) and from suckling piglets on the same days as the weaning piglets (libraries S1, S4 and S7, respectively) were sequenced using Solexa high-throughput sequencing technology. Overall, 260 known swine miRNAs and 317 novel candidate miRNA precursors were detected in the six libraries. The results revealed that 16 differentially expressed miRNAs were found between W1 and S1; 98 differentially expressed miRNAs were found between W4 and S4 (ssc-mir-146b had the largest difference); and 22 differentially expressed miRNAs were found between W7 and S7. Sequencing miRNA results were validated using RT-qPCR. Approximately 11,572 miRNA-mRNA interactions corresponding to 3,979 target genes were predicted. The biological analysis further describe that the differentially expressed miRNAs regulated small intestinal metabolisms, stressful responses and immune functions in piglets. Therefore, the small intestine miRNA transcriptome was significantly different between weaning and suckling piglets; the difference varied with the number of days after weaning.	[Tao, Xin; Xu, Ziwei] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Xu, ZW (corresponding author), Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China.	xzwfyz@sina.com			National Natural Science Fundation of China [31101725]; Science Technology Department of Zhejiang Province; Modern Agro-industry Technology Research System of China [CARS-36]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Department of Zhejiang Province; Modern Agro-industry Technology Research System of China	This work was supported by funding from the National Natural Science Fundation of China (31101725), Science Technology Department of Zhejiang Province, and the Modern Agro-industry Technology Research System of China (CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Quraishy S, 2011, PARASITOL RES, V109, P387, DOI 10.1007/s00436-011-2266-y; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bazett M, 2011, MOL GENET METAB, V103, P38, DOI 10.1016/j.ymgme.2011.01.012; Boudry G, 2004, J NUTR, V134, P2256, DOI 10.1093/jn/134.9.2256; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Chassin C, 2010, CELL HOST MICROBE, V8, P358, DOI 10.1016/j.chom.2010.09.005; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Dkhil M, 2011, EXP PARASITOL, V127, P581, DOI 10.1016/j.exppara.2010.11.002; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; Gladka MM, 2012, J MOL CELL CARDIOL, V52, P74, DOI 10.1016/j.yjmcc.2011.09.015; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grongnet JF, 2003, DIGEST DIS SCI, V48, P365, DOI 10.1023/A:1021948031333; Gu XH, 2002, ARCH ANIM NUTR, V56, P275, DOI 10.1080/00039420214345; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Karaayvaz M, 2011, CLIN COLORECTAL CANC, V10, P340, DOI 10.1016/j.clcc.2011.06.002; KELLY D, 1991, BRIT J NUTR, V65, P169, DOI 10.1079/BJN19910078; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lackeyram D, 2010, J NUTR, V140, P461, DOI 10.3945/jn.109.117267; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CC, 2013, DEV COMP IMMUNOL, V39, P110, DOI 10.1016/j.dci.2012.01.001; Li SC, 2013, MODERN PATHOL, V26, P685, DOI 10.1038/modpathol.2012.216; Lian CJ, 2012, FEBS J, V279, P964, DOI 10.1111/j.1742-4658.2012.08480.x; Liao YL, 2013, GENES NUTR, V8, P69, DOI 10.1007/s12263-012-0297-3; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Marion J, 2005, J PEDIATR GASTR NUTR, V41, P401, DOI 10.1097/01.mpg.0000177704.99786.07; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Mei J, 2005, BRIT J NUTR, V93, P37, DOI 10.1079/BJN20041302; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Piepoli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033663; Scholven J, 2009, CELL PHYSIOL BIOCHEM, V23, P143, DOI 10.1159/000204103; Selcuklu SD, 2012, J BIOL CHEM, V287, P29516, DOI 10.1074/jbc.M111.335943; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Sharbati-Tehrani S, 2008, BIOCHEM BIOPH RES CO, V375, P484, DOI 10.1016/j.bbrc.2008.08.048; Sharma Renu, 2010, J Biomed Biotechnol, V2010, P305879, DOI 10.1155/2010/305879; Singh N, 2012, INT J BIOL SCI, V8, P171, DOI 10.7150/ijbs.8.171; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Song LB, 2010, BIOCHEM BIOPH RES CO, V402, P135, DOI 10.1016/j.bbrc.2010.10.003; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; van Beers-Schreurs HMG, 1998, J NUTR, V128, P947, DOI 10.1093/jn/128.6.947; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Wijtten PJA, 2011, BRIT J NUTR, V105, P967, DOI 10.1017/S0007114510005660; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043741; Yu J, 2011, FUNCT INTEGR GENOMIC, V11, P203, DOI 10.1007/s10142-010-0198-8; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang J, 2013, INT J MED SCI, V10, P585, DOI 10.7150/ijms.5794; Zhang N, 2013, FEBS LETT, V587, P2346, DOI 10.1016/j.febslet.2013.05.059; Zhang YZ, 2013, J GASTROEN HEPATOL, V28, P565, DOI 10.1111/j.1440-1746.2012.07271.x; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhong X, 2011, J ANIM SCI, V89, P3634, DOI 10.2527/jas.2010-3751; Zhou QQ, 2010, GUT, V59, P775, DOI 10.1136/gut.2009.181834	66	16	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79343	10.1371/journal.pone.0079343	http://dx.doi.org/10.1371/journal.pone.0079343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260202	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500048
J	Zhang, Q; Xiao, XH; Li, M; Li, WH; Yu, M; Zhang, HB; Wang, ZX; Xiang, HD				Zhang, Qian; Xiao, Xinhua; Li, Ming; Li, Wenhui; Yu, Miao; Zhang, Huabing; Wang, Zhixin; Xiang, Hongding			Acarbose Reduces Blood Glucose by Activating miR-10a-5p and miR-664 in Diabetic Rats	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INFLAMMATORY-BOWEL-DISEASE; INSULIN-RESISTANCE; UNITED-STATES; OBESITY; PREVALENCE; EXPRESSION; MICRORNAS; CYTOKINES; KINASE	MicroRNAs (miRNAs) are non-coding RNA molecules involved in the post-transcriptional regulation of a large number of genes, including those involved in glucose metabolism. Acarbose is an a-glucosidase inhibitor that improves glycemic control by decreasing the intestinal absorption of glucose, thereby decreasing the elevation of postprandial blood glucose. However, acarbose is poorly absorbed into the blood stream from the gut. Therefore, the exact mechanisms by which acarbose affects glucose metabolism are unclear. This study investigated the effect of acarbose on glucose metabolism in diabetic rats and tested the hypothesis that acarbose acts directly through miRNA-regulated expression in the intestinal epithelium. Rats were divided into four groups: a control group, a diabetic group (DM), a low dose of acarbose group (AcarL) and a high dose of acarbose group (AcarH). Ileum samples were analyzed using miRCURY LNA (TM) microRNA Array, qPCR and immunohistochemistry. We found that 8-week treatment with acarbose significantly decreased fasting blood glucose. Oral glucose tolerance tests (OGTT) showed that blood glucose was significantly reduced in the AcarL and AcarH groups at 30 min, 60 min and 120 min after oral glucose administration. We found that miR-151*, miR-10a-5p, miR-205, miR-17-5p, miR-145 and miR-664 were up-regulated in the AcarH group, while miR-541 and miR-135b were down-regulated. Through target gene analysis, real time PCR and immunohistochemistry verification, we found that these miRNAs suppressed the expression of proinflammatory cytokines [IL6 (interleukin 6) and TNF (tumor necrosis factor)] and mitogen activated protein kinase 1 (MAPK1). Our data suggest that acarbose can improve blood glucose in diabetic rats through the MAPK pathway and can down-regulate proinflammatory factors by activating miR-10a-5p and miR-664 in the ileum.	[Zhang, Qian; Xiao, Xinhua; Li, Ming; Li, Wenhui; Yu, Miao; Zhang, Huabing; Wang, Zhixin; Xiang, Hongding] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrinol,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Xiao, XH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrinol,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China.	xiaoxinhua@medmail.com.cn	Zhang, Huabing/ABD-6216-2020; wang, zhixin/GZH-2500-2022	Zhang, Huabing/0000-0001-6259-7584; 	National Natural Science Foundation of China [81170736]; National Natural Science Foundation for Young Scholars of China [81300649]; National Key Program of Clinical Science and Peking Union Medical College Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Key Program of Clinical Science and Peking Union Medical College Hospital	This work was funded by National Natural Science Foundation of China (No. 81170736), National Natural Science Foundation for Young Scholars of China (No. 81300649) and National Key Program of Clinical Science and Peking Union Medical College Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhahi Waleed, 2003, Curr Diab Rep, V3, P293, DOI 10.1007/s11892-003-0020-2; BALFOUR JA, 1993, DRUGS, V46, P1025, DOI 10.2165/00003495-199346060-00007; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen H, 2006, PHARMACOL RES, V53, P469, DOI 10.1016/j.phrs.2006.03.003; Choi SE, 2004, TRANSPL IMMUNOL, V13, P43, DOI 10.1016/j.trim.2004.04.001; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Heeckt PF, 2000, LANGENBECK ARCH SURG, V385, P50, DOI 10.1007/s004230050011; HOGAN P, 2002, DIABETES CARE, V26, P917; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang J., 2004, CHIN J CLIN PHARM TH, V09, P1069; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin AE, 1996, AM J HEALTH-SYST PH, V53, P2277, DOI 10.1093/ajhp/53.19.2277; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228	26	29	30	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79697	10.1371/journal.pone.0079697	http://dx.doi.org/10.1371/journal.pone.0079697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260283	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500090
J	Amadou, A; Fabre, A; Torres-Mejia, G; Ortega-Olvera, C; Angeles-Lierenas, A; McKenzie, F; Biessy, C; Hainaut, P; Romieu, I				Amadou, Amina; Fabre, Alban; Torres-Mejia, Gabriela; Ortega-Olvera, Carolina; Angeles-Lierenas, Angelica; McKenzie, Fiona; Biessy, Carine; Hainaut, Pierre; Romieu, Isabelle			Hormonal Therapy and Risk of Breast Cancer in Mexican Women	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; ORAL-CONTRACEPTIVE USE; REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; DIFFERENT REGIMENS; HEALTH; MAMMOGRAPHY; COHORT	The use of hormonal therapies, including hormonal contraceptives (HC) and postmenopausal hormone replacement therapy (HRT) have been shown to influence breast cancer (BC) risk. However, the variations of these effects among populations and ethnic groups are not completely documented, especially among Hispanic women. We evaluated the association between HC and premenopausal BC risk, and between HRT and postmenopausal BC risk in Mexican women. Data from a Mexican multi-center population-based case-control study ofwomen aged 35 to 69 years were analysed. A total of 1000 cases and 1074 matched controls were recruited between 2004 and 2007. Information on hormonal therapy was collected through a structured questionnaire. Results were analysed using conditional logistic regression models. Overall, HC were used by 422/891 (47.3%) premenopausal women and HRT was used by 220/1117 (19.7%) postmenopausal women. For HC, odds ratios (ORs) for BC were 1.11 (95% confidence interval (CI): 0.82, 1.49) for current users and 1.68 (95% CI: 0.67, 4.21) for ever-users. No clear effect of duration of use was observed. For HRT, the OR for BC was significantly increased in ever users (OR: 1.45; 95% CI: 1.01, 2.08). A non-significant increased risk was observed for combined estrogen/progestin, (OR = 1.85; 95% CI: 0.84, 4.07) whereas no effect was observed for the use of estrogen alone (OR = 1.14; 95% CI: 0.68, 1.91). Our results indicate that, HC had a non-significant effect on the risk of pre-menopausal BC, but suggested that injected contraceptives may slightly increase the risk, whereas HRT had a significant effect on post-menopausal BC in this population. This study provides new information about the effects of HC and HRT on BC risk in a Mexican population, which may be of relevance for the population of Latin America as a whole.	[Amadou, Amina; McKenzie, Fiona; Biessy, Carine; Romieu, Isabelle] Int Agcy Res Canc, Nutr & Metab Sect, Nutr Epidemiol Grp, F-69372 Lyon, France; [Fabre, Alban; Torres-Mejia, Gabriela; Ortega-Olvera, Carolina; Angeles-Lierenas, Angelica] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, France; [Fabre, Alban] INSERM, U1018, Nutr Hormones & Womens Hlth Inst Gustave Roussy, Paris, France	World Health Organization; International Agency for Research on Cancer (IARC); Instituto Nacional de Salud Publica; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Romieu, I (corresponding author), Int Agcy Res Canc, Nutr & Metab Sect, Nutr Epidemiol Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	romieui@iarc.fr	Ortega-Olvera, Carolina/GSN-9621-2022; Hainaut, Pierre/B-6018-2012	Hainaut, Pierre/0000-0002-1303-1610	Mexican National Council of Science and Technology (CONACyT in Spanish) [SALUD 2002-C01-7462]	Mexican National Council of Science and Technology (CONACyT in Spanish)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was financially supported by the Mexican National Council of Science and Technology (CONACyT in Spanish; SALUD 2002-C01-7462). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadou A, 2013, J ONCOL, V2013, DOI 10.1155/2013/906495; Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beasley JM, 2010, CANCER CAUSE CONTROL, V21, P863, DOI 10.1007/s10552-010-9513-x; Beral V, 2005, BJOG-INT J OBSTET GY, V112, P692, DOI 10.1111/j.1471-0528.2005.00541.x; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bernstein Leslie, 2003, Cancer, V97, P222, DOI 10.1002/cncr.11014; Bjelic-Radisic V, 2010, WIEN MED WOCHENSCHR, V160, P483, DOI 10.1007/s10354-010-0807-0; Blamey R, 2004, HUM REPROD UPDATE, V10, P281, DOI 10.1093/humupd/dmh025; Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; BRONFMAN M, 1988, ARCH INVEST MED, V19, P351; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Chavarri-Guerra Y, 2012, LANCET ONCOL, V13, pE335, DOI 10.1016/S1470-2045(12)70246-2; Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Chlebowski RT, 2005, JNCI-J NATL CANCER I, V97, P439, DOI 10.1093/jnci/dji064; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cogliano V, 2005, LANCET ONCOL, V6, P552, DOI 10.1016/S1470-2045(05)70273-4; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Fournier A, 2005, INT J CANCER, V114, P448, DOI 10.1002/ijc.20710; Gilliland FD, 1998, AM J EPIDEMIOL, V148, P683, DOI 10.1093/aje/148.7.683; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V91, P1; Iatrakis G, 2011, CLIN EXP OBSTET GYN, V38, P225; Iodice S, 2010, EUR J CANCER, V46, P2275, DOI 10.1016/j.ejca.2010.04.018; Jernstrom H, 2003, CANCER CAUSE CONTROL, V14, P673, DOI 10.1023/A:1025635720208; Kahlenborn C, 2006, MAYO CLIN PROC, V81, P1290, DOI 10.4065/81.10.1290; Lee S, 2006, INT J CANCER, V118, P1285, DOI 10.1002/ijc.21481; Lee SA, 2005, BRIT J CANCER, V92, P2049, DOI 10.1038/sj.bjc.6602617; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P3254, DOI 10.1001/jama.289.24.3254; Li R, 2002, CANCER-AM CANCER SOC, V95, P960, DOI 10.1002/cncr.10791; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Pike MC, 2002, CANCER EPIDEM BIOMAR, V11, P795; Purmonen S, 2008, ONCOL REP, V19, P1627; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Sather Sarah, 2012, Tidsskr Nor Laegeforen, V132, P1330, DOI 10.4045/tidsskr.11.1055; Sexton KR, 2011, CANCER-AM CANCER SOC, V117, P5271, DOI 10.1002/cncr.26217; Stahlberg C, 2004, INT J CANCER, V109, P721, DOI 10.1002/ijc.20016; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Sweeney C, 2007, INT J CANCER, V121, P2517, DOI 10.1002/ijc.22970; Tjonneland A, 2004, CANCER-AM CANCER SOC, V100, P2328, DOI 10.1002/cncr.20250; Urban M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001182	42	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79695	10.1371/journal.pone.0079695	http://dx.doi.org/10.1371/journal.pone.0079695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260282	Green Submitted, gold, Green Published			2022-12-25	WOS:000327258600044
J	Bulleri, F; Couraudon-Reale, M; de Loma, TL; Claudet, J				Bulleri, Fabio; Couraudon-Reale, Marine; de Loma, Thierry Lison; Claudet, Joachim			Variability in the Effects of Macroalgae on the Survival and Growth of Corals: The Consumer Connection	PLOS ONE			English	Article							PHASE-SHIFTS; TURBINARIA-ORNATA; REEFS; COMPETITION; HERBIVORY; CORALLIVORY; DIVERSITY; DEFENSE; ALGAE	Shifts in dominance from corals to macroalgae are occurring in many coral reefs worldwide. Macroalgal canopies, while competing for space with coral colonies, may also form a barrier to herbivorous and corallivorous fish, offering protection to corals. Thus, corals could either suffer from enhanced competition with canopy-forming and understorey macroalgae or benefit from predator exclusion. Here, we tested the hypothesis that the effects of the brown, canopy-forming macroalga, Turbinaria ornata, on the survival and growth of corals can vary according to its cover, to the presence or absence of herbivorous and corallivorous fish and to the morphological types of corals. Over a period of 66 days, two coral species differing in growth form, Acropora pulchra and Porites rus, were exposed to three different covers of T. ornata (absent versus medium versus high), in the presence or absence of fish. Irrespective of the cover of T. ornata, fish exclusion reduced mortality rates of A. pulchra. Following fish exclusion, a high cover of T. ornata depressed the growth of this branched coral, whilst it had no effect when fish species were present. P. rus suffered no damage from corallivorous fish, but its growth was decreased by high covers of T. ornata, irrespective of the presence or absence of fish. These results show that negative effects of T. ornata on some coral species are subordinate to those of fish predation and are, therefore, likely to manifest only on reefs severely depleted of predators. In contrast, space dominance by T. ornata may decrease the growth of other coral species regardless of predation intensity. In general, this study shows that susceptibility to predation may determine the severity of the effects of canopy-forming macroalgae on coral growth.	[Bulleri, Fabio] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Couraudon-Reale, Marine; de Loma, Thierry Lison; Claudet, Joachim] Univ Perpignan, Natl Ctr Sci Res, USR CNRS EPHE CRIOBE 3278, F-66025 Perpignan, France; [Couraudon-Reale, Marine; de Loma, Thierry Lison; Claudet, Joachim] Lab Excellence CORAIL, Perpignan, France	University of Pisa; Universite Perpignan Via Domitia	Bulleri, F (corresponding author), Univ Pisa, Dipartimento Biol, Pisa, Italy.	fbulleri@biologia.unipi.it	Claudet, Joachim/C-6335-2008	Claudet, Joachim/0000-0001-6295-1061; Bulleri, Fabio/0000-0002-7335-6791	LIVE AND LET DIE (ANR - Agence Nationale de la Recherche (France)); CORALSPOT (ANR - Agence Nationale de la Recherche (France)); ECOLOG (ANR - Agence Nationale de la Recherche (France))	LIVE AND LET DIE (ANR - Agence Nationale de la Recherche (France))(French National Research Agency (ANR)); CORALSPOT (ANR - Agence Nationale de la Recherche (France))(French National Research Agency (ANR)); ECOLOG (ANR - Agence Nationale de la Recherche (France))(French National Research Agency (ANR))	Financial support for this study was provided by the programs LIVE AND LET DIE (ANR - Agence Nationale de la Recherche (France)), CORALSPOT (ANR - Agence Nationale de la Recherche (France)) and ECOLOG (ANR - Agence Nationale de la Recherche (France)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bittick SJ, 2010, MAR BIOL, V157, P317, DOI 10.1007/s00227-009-1319-6; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bulleri F, 2011, J ECOL, V99, P335, DOI 10.1111/j.1365-2745.2010.01750.x; Burkepile DE, 2012, CORAL REEFS, V31, P111, DOI 10.1007/s00338-011-0824-5; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; DAVIES PS, 1989, MAR BIOL, V101, P389; Dizon RM, 2006, MAR POLLUT BULL, V52, P928, DOI 10.1016/j.marpolbul.2005.12.009; Elahi R, 2006, BIOL BULL, V212, P20; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; GLYNN PW, 1985, MAR ECOL PROG SER, V26, P295, DOI 10.3354/meps026295; Gochfeld DJ, 2010, MAR ECOL PROG SER, V398, P137, DOI 10.3354/meps08302; Harper J. L., 1974, Annual Review of Ecology and Systematics, V5, P419, DOI 10.1146/annurev.es.05.110174.002223; HAY ME, 1986, AM NAT, V128, P617, DOI 10.1086/284593; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kayal M, 2011, CORAL REEFS, V30, P827, DOI 10.1007/s00338-011-0763-1; Lenihan HS, 2011, ECOLOGY, V92, P1959, DOI 10.1890/11-0108.1; Lenihan HS, 2008, MAR ECOL PROG SER, V370, P127, DOI 10.3354/meps07622; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McKeon CS, 2012, OECOLOGIA, V169, P1095, DOI 10.1007/s00442-012-2275-2; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Penin L, 2011, HYDROBIOLOGIA, V663, P259, DOI 10.1007/s10750-010-0569-0; Rasher DB, 2013, ECOLOGY IN PRESS; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Shantz AA, 2011, CORAL REEFS, V30, P363, DOI 10.1007/s00338-010-0694-2; Stewart HL, 2008, INTEGR COMP BIOL, V48, P713, DOI 10.1093/icb/icn028; Stiger V, 1999, BOT MAR, V42, P295, DOI 10.1515/BOT.1999.033; Thurber RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044246; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Venera-Ponton DE, 2011, MAR ECOL PROG SER, V421, P109, DOI 10.3354/meps08869; White JSS, 2010, ECOLOGY, V91, P3538, DOI 10.1890/09-2322.1	42	11	11	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79712	10.1371/journal.pone.0079712	http://dx.doi.org/10.1371/journal.pone.0079712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260290	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600047
J	Chroboczek, T; Boisset, S; Rasigade, JP; Tristan, A; Bes, M; Meugnier, H; Vandenesch, F; Etienne, J; Laurent, F				Chroboczek, Tomasz; Boisset, Sandrine; Rasigade, Jean-Philippe; Tristan, Anne; Bes, Michele; Meugnier, Helene; Vandenesch, Francois; Etienne, Jerome; Laurent, Frederic			Clonal Complex 398 Methicillin Susceptible Staphylococcus aureus: A Frequent Unspecialized Human Pathogen with Specific Phenotypic and Genotypic Characteristics	PLOS ONE			English	Article							RESISTANCE GENE; ST398; CC398; MRSA; IDENTIFICATION; INFECTIONS; PREVALENCE; EMERGENCE; STRAIN; HOST	Clonal complex 398 livestok-associated-MRSA (CC398 LA-MRSA) clone is described as a major animal pathogen that can also colonize and infect humans. CC398 methicillin susceptible Staphylococcus aureus (CC398 MSSA) is less described. We identified 126 CC398 MSSA strains of human origin within 6380 S. aureus isolates gathered between 2009 and 2011, from the French National Reference Centre for Staphylococci. They were characterized using antimicrobial susceptibility testing, spa typing, DNA microarrays (Identibac S. aureus Genotyping (R), Alere), CC398-specific sequence PCR, ermT (encoding macrolides resistance) PCR. Fifty-three CC398 LA-MRSA collected from French pigs and veal were used as comparators, and phylogenetic relations between human CC398 MSSA and animal CC398 MRSA populations were explored on the basis of spa-typing and DNA microarrays. CC398 MSSA were able to induce a large spectrum of infections (especially skin, bloodstream, and pneumonias). The prevalence rate of this clone was high in MSSA population, i.e., 24.7% in a local prospective study on nasal colonization, and 7.5% in a national prospective study on infective endocarditis. CC398 MSSA isolates were frequently (89%) erythromycin resistant, due to the presence of the ermT gene, a gene not detected in erythromycin resistant CC398 LA-MRSA strains. Expression of staphylococcal complement inhibitor (scn) and the chemotaxis inhibitory protein (chp), was also specific to this population. The CC398 MRSA signature included also a panel of antibiotic resistance genes, especially a type IV or V cassette mec and tetM. CC398 MSSA and CC398 LA-MRSA populations were closely related based on spa-typing and DNA microarrays, with the MRSA strains forming the most derived lineage in phylogenic trees. Both MSSA and MRSA populations may come from common ancestors, which would have evolved in the settings of different selective pressures, explaining the acquisition of ermT, chp and scn for MSSA, and antibiotic resistance genes for MRSA.	[Chroboczek, Tomasz; Rasigade, Jean-Philippe; Tristan, Anne; Bes, Michele; Meugnier, Helene; Vandenesch, Francois; Etienne, Jerome; Laurent, Frederic] Hosp Civils Lyon, French Natl Reference Ctr Staphylococci, Lyon, France; [Chroboczek, Tomasz] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France; [Boisset, Sandrine] Ctr Hosp Univ Grenoble, Dept Agents Infect, Lab Bacteriol, Grenoble, France; [Boisset, Sandrine] Univ Grenoble 1, CNRS, UMR 5163, Grenoble, France; [Rasigade, Jean-Philippe; Tristan, Anne; Bes, Michele; Meugnier, Helene; Vandenesch, Francois; Etienne, Jerome; Laurent, Frederic] Univ Lyon, INSERM, U851, Fac Med Lyon Est, Lyon, France	CHU Lyon; CHU Lyon; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Tristan, A (corresponding author), Hosp Civils Lyon, French Natl Reference Ctr Staphylococci, Lyon, France.	anne.tristan@chu-lyon.fr	Vandenesch, Francois/C-7209-2014; Boisset, Sandrine SB/D-8144-2014; LAURENT, Frederic/AGM-0706-2022; Rasigade, Jean-Philippe/AAE-1667-2021; ETIENNE, Jerome/C-5471-2014; Laurent, Frederic/M-4719-2014; Tristan, Anne/L-9464-2014; Chroboczek, Jadwiga/M-6554-2014; Rasigade, Jean-Philippe/L-9320-2014; TRISTAN, Anne/GSN-8306-2022	Vandenesch, Francois/0000-0001-9412-7106; Boisset, Sandrine SB/0000-0001-8717-8749; ETIENNE, Jerome/0000-0002-3348-3315; Rasigade, Jean-Philippe/0000-0002-8264-0452; TRISTAN, Anne/0000-0001-9471-2655; laurent, frederic/0000-0003-0609-9091				Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; FSf Microbiology, 2012, REC COM ANT SOC FRAN; Gomez-Sanz E, 2010, FOODBORNE PATHOG DIS, V7, P1269, DOI 10.1089/fpd.2010.0610; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P915, DOI 10.1128/AAC.01091-09; Kadlec K, 2009, ANTIMICROB AGENTS CH, V53, P776, DOI 10.1128/AAC.01128-08; Lozano C, 2011, INT J MED MICROBIOL, V301, P500, DOI 10.1016/j.ijmm.2011.02.004; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; McCaskill ML, 2007, PEDIATR INFECT DIS J, V26, P1122, DOI 10.1097/INF.0b013e31814536e0; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Mellmann A, 2008, J CLIN MICROBIOL, V46, P2805, DOI 10.1128/JCM.00071-08; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Jimenez JN, 2011, EMERG INFECT DIS, V17, P1970, DOI 10.3201/eid1710.110638; Price LB, 2012, HOST ADAPTATION EMER, VCC398, P3, DOI DOI 10.1128/MBI0.00305-11; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Schmidt T, 2012, CLIN MICROBIOL INFEC; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Uhlemann AC, 2011, EUROPEAN J CLIN MICR; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2011, J ANTIMICROBIAL CHEM; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x; Zhao CJ, 2012, PLOS ONE, P7	39	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e68462	10.1371/journal.pone.0068462	http://dx.doi.org/10.1371/journal.pone.0068462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260092	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600001
J	Louchart, A; Sire, JY; Mourer-Chauvire, C; Geraads, D; Viriot, L; de Buffrenil, V				Louchart, Antoine; Sire, Jean-Yves; Mourer-Chauvire, Cecile; Geraads, Denis; Viriot, Laurent; de Buffrenil, Vivian			Structure and Growth Pattern of Pseudoteeth in Pelagornis mauretanicus (Aves, Odontopterygiformes, Pelagornithidae)	PLOS ONE			English	Article							BONY-TOOTHED BIRD; EOCENE; TISSUE; RECORD; TEETH	The extinct Odontopterygiformes are the sole birds known to possess strong and sharp bony pseudoteeth, the shape and location of which are closely mimetic of real teeth. The structure of the pseudoteeth is investigated here in a late Pliocene/early Pleistocene species, Pelagornis mauretanicus, using X-ray microtomography and thin sections. The results are interpreted with regard to the pseudotooth mode of growth, and have implications concerning aspects of Pelagornis ecology. The larger pseudoteeth are hollow and approximately cone-shaped, and the smaller ones are rostro-caudally constricted. The walls of pseudoteeth are composed of bone tissue of the fibro-lamellar type, which is intensively remodeled by Haversian substitution. The jaw bones display the same structure as the pseudoteeth, but their vascular canals are oriented parallel to the long axis of the bones, whereas they are perpendicular to this direction in the pseudoteeth. There is no hiatus or evidence of a fusion between the pseudoteeth and the jaw bones. Two possible models for pseudotooth growth are derived from the histological data. The most plausible model is that pseudotooth growth began after the completion of jaw bone growth, as a simple local protraction of periosteal osteogenic activity. Pseudotooth development thus occurred relatively late during ontogeny. The highly vascularized structure and the relative abundance of parallel-fibered bone tissue in the pseudoteeth suggest poor mechanical capabilities. The pseudoteeth were most likely covered and protected by the hardened, keratinized rhamphotheca in the adult during life. The late development of the pseudoteeth would involve a similarly late and/or partial hardening of the rhamphotheca, as displayed by extant Anseriformes, Apterygiformes and some Charadriiformes. This would add support to the hypothesis of a close phylogenetic relationship between Odontopterygiformes and Anseriformes. The late maturation of the Pelagornis feeding apparatus, and hence the delayed capability for efficient prey catching, suggests that Pelagornis was altricial.	[Louchart, Antoine; Viriot, Laurent] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonctionnelle Lyon, Ctr Natl Rech Sci,Unite Mixte Rech 5242, F-69365 Lyon, France; [Sire, Jean-Yves] Univ Paris 06, Unite Mixte Rech Syst Adaptat Evolut Equipe Evol, Paris, France; [Mourer-Chauvire, Cecile] Univ Lyon 1, Ecole Normale Super Lyon, Lab Geol Lyon, Ctr Natl Rech Sci,Unite Mixte Rech 5276, F-69365 Lyon, France; [Geraads, Denis] Museum Natl Hist Nat, Dept Hist Terre, Ctr Rech Palebiodiversite & Paleoenvironnem, Ctr Natl Rech Sci,Unit Mixte Rech 7207, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Louchart, A (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonctionnelle Lyon, Ctr Natl Rech Sci,Unite Mixte Rech 5242, F-69365 Lyon, France.	antoine.louchart@ens-lyon.fr	Geraads, Denis/AAY-6051-2020; GERAADS, Denis/AAC-7241-2021	GERAADS, Denis/0000-0003-2475-8011; Viriot, Laurent/0000-0003-2092-588X; Louchart, Antoine/0000-0003-3847-6007; de Buffrenil, Vivian/0000-0003-3414-0186	The French ANR-Jeune-chercheur Programme "PIAFS" [ANR-11-JSV7-004-01]	The French ANR-Jeune-chercheur Programme "PIAFS"(French National Research Agency (ANR))	The French ANR-Jeune-chercheur Programme "PIAFS", ANR-11-JSV7-004-01 to AL. The programme "Prehistoire du Grand Casablanca" of the Institut National des Sciences de l'Archeologie et du Patrimoine to DG for excavations at Ahl al Oughlam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boessenecker RW, 2011, J VERTEBR PALEONTOL, V31, P652, DOI 10.1080/02724634.2011.562268; Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0; Bourdon E, 2005, NATURWISSENSCHAFTEN, V92, P586, DOI 10.1007/s00114-005-0047-0; Bourdon E., 2011, LIVING DINOSAURS, P209; Bourdon E, 2010, AM MUS NOVIT, P1, DOI 10.1206/3704.2; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Chinsamy A., 2005, MICROSTRUCTURE DINOS; Chinsamy Anusuya, 2002, P421; Coles B, 2007, ESSENTIALS AVIAN MED; Currey JD, 2010, J MECH BEHAV BIOMED, V3, P357, DOI 10.1016/j.jmbbm.2010.03.002; Currey J.D., 2002, BONES STRUCTURE MECH; CURREY JD, 1969, J BIOMECH, V2, P1, DOI 10.1016/0021-9290(69)90036-0; Davit-Beal T, 2009, J ANAT, V214, P477, DOI 10.1111/j.1469-7580.2009.01060.x; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; Francillon-Vieillot H., 1990, P471; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Howard H., 1957, Santa Barbara Mus nat Hist Bull, Vno. 1, P1; HOWARD HILDEGARDE, 1962, LOS ANGELES COUNTY MUS CONTR SCI, V52, P1; Louchart A, 2011, TRENDS ECOL EVOL, V26, P663, DOI 10.1016/j.tree.2011.09.004; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Mayr G, 2012, J VERTEBR PALEONTOL, V32, P914, DOI 10.1080/02724634.2012.676114; Mayr G, 2011, ZOOL SCR, V40, P448, DOI 10.1111/j.1463-6409.2011.00484.x; Mayr G, 2010, J VERTEBR PALEONTOL, V30, P1313, DOI 10.1080/02724634.2010.501465; MEISTER W, 1962, ANAT REC, V143, P377, DOI 10.1002/ar.1091430408; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Mourer-Chauvire Cecile, 2008, Oryctos, V7, P169; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1991, Ornithological Monographs, P1; Owen R, 1873, Q J GEOL SOC LOND, V29, P511, DOI DOI 10.1144/GSL.JGS.1873.029.01-02.45; Sorenson MD, 1999, P ROY SOC B-BIOL SCI, V266, P2187, DOI 10.1098/rspb.1999.0907; Spulski B., 1910, Z DTSCH GEOLOGISCHEN, V62, P507; Starck J. Matthias, 1998, Oxford Ornithology Series, V8, P3; Stidham Thomas A., 2004, Paleobios, V24, P7; Wilson James W., 1994, P205; Zioupos P, 2000, CONNECT TISSUE RES, V41, P229, DOI 10.3109/03008200009005292; ZUSI R L, 1992, Natural History Museum of Los Angeles County Science Series, P351	37	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80372	10.1371/journal.pone.0080372	http://dx.doi.org/10.1371/journal.pone.0080372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244680	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800143
J	Britto, RPD; Florencio, TMT; Silva, AAB; Sesso, R; Cavalcante, JC; Sawaya, AL				de Alencar Britto, Revilane Parente; Toledo Florencio, Telma Maria; Benedito Silva, Ana Amelia; Sesso, Ricardo; Cavalcante, Jairo Calado; Sawaya, Ana Lydia			Influence of Maternal Height and Weight on Low Birth Weight: A Cross-Sectional Study in Poor Communities of Northeastern Brazil	PLOS ONE			English	Article							BODY-MASS INDEX; LOW-INCOME POPULATION; FOR-GESTATIONAL-AGE; PRETERM BIRTH; SHORT STATURE; OBESITY; RISK; INFANT; FETAL; HEALTH	Background: Low birth weight (LBW) is associated with an increased risk of mortality, adverse metabolic conditions, and long-term chronic morbidities. The relationship between LWB and short maternal stature coupled with nutritional status was investigated in poor communities. Methods/Principal Findings: A cross-sectional population-based study involving 2226 mother-child pairs was conducted during the period 2009-2010 in shantytowns of Maceio, Alagoas, Brazil. Associations between LBW and maternal sociodemographics, stature and nutritional status were investigated. The outcome variable was birth weight (< 2500g and >= 2500g). The independent variables were the age, income, educational background, stature and nutritional status (eutrophic, underweight, overweight and obese) of the mother. The frequency of LBW was 10%. Short-statured mothers (1st quartile of stature <= 152cm) showed a tendency of increased risk of LBW children compared to mothers in the 4th quartile of stature (> 160.4cm) (OR: 1.42, 95% CI: 0.96 - 1.09, p = 0.078). Children from short-statured mothers weighed an average of 125g less than those from taller mothers (3.18 +/- 0.56kg vs. 3.30 +/- 0.58kg, respectively p = 0.002). Multivariate analyses showed that short stature, age < 20y (OR: 3.05, 95% CI: 1.44 - 6.47) or were underweight (OR: 2.26, 95% CI: 0.92 - 5.95) increased the risk of LBW, while overweight (OR: 0.38, 95% CI: 0.16 - 0.95) and obesity (OR: 0.39, 95% CI: 0.11 - 1.31) had lower risk for LBW. In taller mothers, lower income and underweight were associated with LBW (OR: 1.88, 95% CI: 1.07 - 3.29 and 2.85, 95% CI: 1.09 - 7.47, respectively), and obese mothers showed a trend of increased risk of LBW (OR: 1.66, 95% CI: 0.84 - 3.25). Conclusions/Significance: Overweight was found to have a protective effect in short-statured mothers, indicating that a surplus of energy may diminish the risk of LBW. Short-statured younger mothers, but not taller ones, showed higher risk of LBW. The mother being underweight, regardless of stature, was associated with LBW.	[de Alencar Britto, Revilane Parente; Sawaya, Ana Lydia] Univ Fed Sao Paulo, Escola Paulista Med, Programa Posgrad Ciencias Endocrinol, Sao Paulo, Brazil; [Toledo Florencio, Telma Maria] Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil; [Benedito Silva, Ana Amelia] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil; [Sesso, Ricardo] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Escola Paulista Med, Sao Paulo, Brazil; [Cavalcante, Jairo Calado] Univ Fed Alagoas, Fac Med, Maceio, Alagoas, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Alagoas	Britto, RPD (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Programa Posgrad Ciencias Endocrinol, Sao Paulo, Brazil.	rbrittof@uol.com.br	Florencio, Telma/AAE-3394-2019; Sawaya, Ana Lydia/D-3845-2014	Sawaya, Ana Lydia/0000-0002-2580-9557; Sesso, Ricardo/0000-0002-1062-0073	Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)	Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL))	The authors wish to thank the Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL) for financial support. The funding authority had no role in the study design, data collection and analysis, decision to publish the material or in the preparation of the manuscript.	[Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; Baumann R, 2008, EMPREGO DESENVOLVIME; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Britto RPA, 2011, VER BRAS MED, V68, P277; Bryan SM, 2006, HORM RES, V65, P19, DOI 10.1159/000091502; Colen CG, 2006, AM J PUBLIC HEALTH, V96, P2032, DOI 10.2105/AJPH.2005.076547; da Saude Ministerio, SAUD IND IND DAD BAS; DdS Barbas, 2009, EPIDEMIOL SERV SAUDE; Dibben C, 2006, J EPIDEMIOL COMMUN H, V60, P1053, DOI 10.1136/jech.2005.042853; Elshibly EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-244; Ferreira HD, 2010, REV SAUDE PUBL, V44, P377, DOI 10.1590/S0034-89102010005000001; Florencio TT, 2007, EUR J CARDIOV PREV R, V14, P346, DOI 10.1097/HJR.0b013e328010f24d; Florencio TMDT, 2001, BRIT J NUTR, V86, P277, DOI 10.1079/BJN2001396; Florencio TT, 2004, NUTR METAB CARDIOVAS, V14, P26, DOI 10.1016/S0939-4753(04)80044-9; Goplan C, 1995, NUTR CHILDREN DEV CO, P1; Han Z, 2012, J OBSTET GYNAECOL CA, V34, P721, DOI 10.1016/S1701-2163(16)35337-3; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Howson C, 2012, BORN TOO SOON GLOBAL; IBGE, 2010, BANC DAD EST AL; IBGE(Instituto Brasileiro de Geografia e Estatistica), 2010, CENS DEM 2010 AGL SU; Imdad A, 2013, J PEDIATR-US, V162, pS107, DOI 10.1016/j.jpeds.2012.11.060; IPEA, 2010, COM IPEA 58; Joseph KS, 2009, AM J EPIDEMIOL, V169, P616, DOI 10.1093/aje/kwn374; Kalk P, 2009, EUR J MED RES, V14, P216; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; KUH D, 1989, INT J EPIDEMIOL, V18, P663, DOI 10.1093/ije/18.3.663; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Olson ME, 2010, PEDIATRICS, V126, P1165, DOI 10.1542/peds.2009-3378; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Pandey M, 2009, MATERNAL HLTH CHILD; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Sebayang SK, 2012, TROP MED INT HEALTH, V17, P938, DOI 10.1111/j.1365-3156.2012.03039.x; de Andrade CLT, 2008, CAD SAUDE PUBLICA, V24, P2564, DOI 10.1590/S0102-311X2008001100011; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; Uchimura Taqueco Teruya, 2008, Rev Gaucha Enferm, V29, P33; Vasudevan C, 2011, ARCH DIS CHILD-FETAL, V96, pF378, DOI 10.1136/adc.2009.170928; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walton E, 2009, J HEALTH SOC BEHAV, V50, P427, DOI 10.1177/002214650905000404; WHO, 2011, HO ANTHR VERS 3 2 2; World Health Organization, 2006, CHILD GROWTH STAND; World Health Organization (WHO), 2007, GROWTH REF 5 19 YEAR; World Health Organization (WHO), 2004, LOW BIRTH WEIGHT COU	47	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80159	10.1371/journal.pone.0080159	http://dx.doi.org/10.1371/journal.pone.0080159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244636	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600187
J	Park, JK; Paik, WH; Ryu, JK; Kim, YT; Kim, YJ; Kim, J; Song, BJ; Park, JM; Yoon, YB				Park, Joo Kyung; Paik, Woo Hyun; Ryu, Ji Kon; Kim, Yong-Tae; Kim, Youn Joo; Kim, Jaihwan; Song, Byeong Jun; Park, Jin Myung; Yoon, Yong Bum			Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single Institution	PLOS ONE			English	Article							CARBOHYDRATE ANTIGEN 19-9; TUMOR-MARKER; SERUM CA-19-9; SURVIVAL; CHEMOTHERAPY; GEMCITABINE; BIOMARKER; UTILITY; CA19-9; DIAGNOSIS	Background: Life expectancy of pancreatic ductal adenocarcinoma (PDAC) patients is usually short and selection of the most appropriate treatment is crucial. The aim of this study was to investigate the usefulness of serum CA 19-9 as a surrogate marker under no impress excluding other factors affecting CA 19-9 level other than tumor itself. Methods: We recruited 1,446 patients with PDACs and patients with Lewis antigen both negative or obstructive jaundice were excluded to eliminate the false effects on CA 19-9 level. The clinicopathologic factors were reviewed including initial and post-treatment CA 19-9, and statistical analysis was done to evaluate the association of clinicopathologic factors with overall survival (OS). Results: The total of 944 patients was enrolled, and205 patients (22%) underwent operation with curative intention and 541 patients (57%) received chemotherapy and/or radiotherapy. The median CA 19-9 levels of initial and post-treatment were 670 IU/ml and 147 IU/ml respectively. The prognostic factors affecting OS were performance status, AJCC stage and post-treatment CA 19-9 level in multivariate analysis. Subgroup analysis was done for the patients who underwent R0 and R1 resection, and patients with normalized post-operative CA 19-9 (<= 37 IU/mL) had significantly longer OS and DFS regardless of initial CA 19-9 level; 32 vs. 18 months, P<0.001, 16 vs. 9 months, P=0.004 respectively. Conclusions: Post-treatment CA 19-9 and normalized post-operative CA 19-9 (R0 and R1 resected tumors) were independent factors associated with OS and DFS, however, initial CA 19-9 level was not statistically significant in multivariate analysis.	[Ryu, Ji Kon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Ryu, JK (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	jkryu@snu.ac.kr; yongtkim@snu.ac.kr	Paik, Woo Hyun/B-9003-2016	Paik, Woo Hyun/0000-0001-8708-3280; Park, Jinmyung/0000-0002-8798-0587; Kim, Jaihwan/0000-0003-0693-1415				Argani P, 2001, CANCER RES, V61, P4320; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Barton JG, 2009, J GASTROINTEST SURG, V13, P2050, DOI 10.1007/s11605-009-0849-z; Berger AC, 2008, J CLIN ONCOL, V26, P5918, DOI 10.1200/JCO.2008.18.6288; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bhat K, 2012, CURR PHARM DESIGN, V18, P2439, DOI 10.2174/13816128112092439; Boeck S, 2006, ONCOLOGY-BASEL, V70, P255, DOI 10.1159/000094888; Boeck S, 2010, CLIN CANCER RES, V16, P986, DOI 10.1158/1078-0432.CCR-09-2205; Conlon KC, 1996, ANN SURG, V223, P273, DOI 10.1097/00000658-199603000-00007; DEUGNIER YM, 1994, GUT, V35, P1107, DOI 10.1136/gut.35.8.1107; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; GLENN J, 1988, J CLIN ONCOL, V6, P462, DOI 10.1200/JCO.1988.6.3.462; Gold DV, 2010, CANCER EPIDEM BIOMAR, V19, P2786, DOI 10.1158/1055-9965.EPI-10-0667; Gold DV, 2006, J CLIN ONCOL, V24, P252, DOI 10.1200/JCO.2005.02.8282; HAGLUND C, 1986, BRIT J CANCER, V53, P197, DOI 10.1038/bjc.1986.35; Halm U, 2000, BRIT J CANCER, V82, P1013; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hata S, 2012, ANN SURG ONCOL, V19, P636, DOI 10.1245/s10434-011-2020-9; Hess V, 2008, LANCET ONCOL, V9, P132, DOI 10.1016/S1470-2045(08)70001-9; Hori SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003110; Ko AH, 2005, BRIT J CANCER, V93, P195, DOI 10.1038/sj.bjc.6602687; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; MAGNANI JL, 1982, J BIOL CHEM, V257, P4365; Maisey NR, 2005, BRIT J CANCER, V93, P740, DOI 10.1038/sj.bjc.6602760; Maithel SK, 2008, ANN SURG ONCOL, V15, P3512, DOI 10.1245/s10434-008-0134-5; Mancuso A, 2006, CRIT REV ONCOL HEMAT, V58, P231, DOI 10.1016/j.critrevonc.2006.02.004; Park JK, 2012, PANCREAS, V41, P95, DOI 10.1097/MPA.0b013e318221c903; PEARCE S, 1994, GUT, V35, P707, DOI 10.1136/gut.35.5.707; PLESKOW DK, 1989, ANN INTERN MED, V110, P704, DOI 10.7326/0003-4819-110-9-704; Reni M, 2009, CANCER-AM CANCER SOC, V115, P2630, DOI 10.1002/cncr.24302; Schlieman MG, 2003, ARCH SURG-CHICAGO, V138, P951, DOI 10.1001/archsurg.138.9.951; SCHMIEGEL WH, 1985, GUT, V26, P456, DOI 10.1136/gut.26.5.456; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Suwa H, 1997, GUT, V40, P647, DOI 10.1136/gut.40.5.647; TEMPERO MA, 1987, CANCER RES, V47, P5501; Wasan HS, 2009, BRIT J CANCER, V101, P1162, DOI 10.1038/sj.bjc.6605243; Yue TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029180; Ziske C, 2003, BRIT J CANCER, V89, P1413, DOI 10.1038/sj.bjc.6601263	38	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78977	10.1371/journal.pone.0078977	http://dx.doi.org/10.1371/journal.pone.0078977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250822	Green Submitted, gold, Green Published			2022-12-25	WOS:000327216200055
J	Tan, SJ; Kee, MZL; Mathuru, AS; Burkholder, WF; Jesuthasan, SJ				Tan, Swee Jin; Kee, Michelle Z. L.; Mathuru, Ajay Sriram; Burkholder, William F.; Jesuthasan, Suresh J.			A Microfluidic Device to Sort Cells Based on Dynamic Response to a Stimulus	PLOS ONE			English	Article							OLFACTORY SENSORY NEURONS; SINGLE-CELL; ODORANT RECEPTOR; ZEBRAFISH; EXPRESSION; CALCIUM; FOCUS	Single cell techniques permit the analysis of cellular properties that are obscured by studying the average behavior of cell populations. One way to determine how gene expression contributes to phenotypic differences among cells is to combine functional analysis with transcriptional profiling of single cells. Here we describe a microfluidic device for monitoring the responses of single cells to a ligand and then collecting cells of interest for transcriptional profiling or other assays. As a test, cells from the olfactory epithelium of zebrafish were screened by calcium imaging to identify sensory neurons that were responsive to the odorant L-lysine. Single cells were subsequently recovered for transcriptional profiling by qRT-PCR. Responsive cells all expressed TRPC2 but not OMP, consistent with known properties of amino-acid sensitive olfactory neurons. The device can be adapted for other areas in biology where there is a need to sort and analyze cells based on their signaling responses.	[Tan, Swee Jin; Burkholder, William F.] Natl Univ Singapore, Inst Mol & Cell Biol, Microfluid Syst Biol Lab, Singapore 117548, Singapore; [Kee, Michelle Z. L.; Jesuthasan, Suresh J.] Duke Natl Univ Singapore, Grad Sch Med, Neurosci & Behav Disorders Program, Singapore, Singapore; [Mathuru, Ajay Sriram; Jesuthasan, Suresh J.] Natl Univ Singapore, Inst Mol & Cell Biol, Neural Circuitry & Behav Lab, Singapore 117548, Singapore; [Jesuthasan, Suresh J.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Jesuthasan, SJ (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Neurosci & Behav Disorders Program, Singapore, Singapore.	sureshjj@imcb.a-star.edu.sg	Kee, Michelle Z.L/HGF-2319-2022; Jesuthasan, Suresh/B-7870-2016; Mathuru, Ajay S./T-8787-2019	Jesuthasan, Suresh/0000-0002-5733-6555; Mathuru, Ajay S./0000-0003-4591-5274	Joint Council Office (JCO) of the Agency for Science, Technology and Research in Singapore; VIP [092-110-0080]; JCO Career Development Award [12302FG014]; Biomedical Research Council, Singapore	Joint Council Office (JCO) of the Agency for Science, Technology and Research in Singapore; VIP; JCO Career Development Award; Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Joint Council Office (JCO) of the Agency for Science, Technology and Research in Singapore (http://www.a-star.edu.sg/About-A-STAR/A-STAR-Joint-Council.aspx), VIP Grant 092-110-0080 (Stephen R. Quake, W. F. B. program leader), JCO Career Development Award (12302FG014 to S.J.T.), and the Biomedical Research Council, Singapore (http://www.a-star.edu.sg/About-A-STAR/Biomedical-Research-Council.aspx) (S.J.J.). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams JD, 2008, P NATL ACAD SCI USA, V105, P18165, DOI 10.1073/pnas.0809795105; Albantakis L, 2009, J NEUROSCI METH, V184, P206, DOI 10.1016/j.jneumeth.2009.08.004; Alioto TS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-309; Ashworth R, 2004, CELL CALCIUM, V35, P393, DOI 10.1016/j.ceca.2004.01.002; Bang HW, 2006, MICROSYST TECHNOL, V12, P746, DOI 10.1007/s00542-005-0076-9; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Cho SH, 2010, LAB CHIP, V10, P1567, DOI 10.1039/c000136h; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Corotto FS, 1996, J EXP BIOL, V199, P1115; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Davis JA, 2006, P NATL ACAD SCI USA, V103, P14779, DOI 10.1073/pnas.0605967103; Eddings MA, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/6/067001; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567; Iourov IY, 2012, CURR GENOMICS, V13, P477, DOI 10.2174/138920212802510439; Jiang ZY, 2011, J IMMUNOL, V186, P1173, DOI 10.4049/jimmunol.1002342; Koide T, 2009, P NATL ACAD SCI USA, V106, P9884, DOI 10.1073/pnas.0900470106; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; Saraiva LR, 2007, GENOME RES, V17, P1448, DOI 10.1101/gr.6553207; Sato Y, 2005, J NEUROSCI, V25, P4889, DOI 10.1523/JNEUROSCI.0679-05.2005; Sato Y, 2007, J NEUROSCI, V27, P1606, DOI 10.1523/JNEUROSCI.4218-06.2007; Schubert C, 2011, NATURE, V480, P133, DOI 10.1038/480133a; Strober W, 2001, CURR PROTOC IMMUNOL, V3; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Voldman J, 2002, ANAL CHEM, V74, P3984, DOI 10.1021/ac0256235; Weth F, 1996, P NATL ACAD SCI USA, V93, P13321, DOI 10.1073/pnas.93.23.13321; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Wolff A, 2003, LAB CHIP, V3, P22, DOI 10.1039/b209333b; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	42	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78261	10.1371/journal.pone.0078261	http://dx.doi.org/10.1371/journal.pone.0078261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250795	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200016
J	Luo, SJ; Wang, F; Li, ZD; Deng, JF				Luo, Shijian; Wang, Feng; Li, Zhendong; Deng, Jinfeng			Effect of the+781C/T Polymorphism in the Interleukin-8 Gene on Atherosclerotic Cerebral Infarction, and Its Interaction with Smoking and Drinking	PLOS ONE			English	Article							ISCHEMIC-STROKE; CAROTID ATHEROSCLEROSIS; DISEASE-SUSCEPTIBILITY; ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; APOLIPOPROTEIN-E; YOUNG-ADULTS; HAN CHINESE; RISK; ASSOCIATION	Objective: The aims of this study were to investigate the association between the +781C/T polymorphism of interleukin-8 (IL-8) and atherosclerotic cerebral infarction and the interaction between the +781C/T polymorphism and smoking or drinking in cerebral infarction in the Han Chinese population. Methods: We investigated the +781C/T polymorphism of IL-8 in 308 consecutive Han Chinese patients who were diagnosed with atherosclerotic cerebral infarction and in 294 age-and gender-matched healthy control subjects. The patients were classified using the Oxfordshire Community Stroke Project (OCSP) classification. The patients and subjects' histories of smoking and drinking were recorded, and atherosclerosis (AS) of the internal carotid artery (ICA) was evaluated in the patients. The +781C/T polymorphism was determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis. Results: The +781C/T polymorphism and allele frequencies were not significantly different between the patients and controls and were not significantly associated with the OCSP classifications. We found that the 781C allele was significantly associated with AS of the ICA in the patients (p = 0.017), and the CT genotype was more prevalent in patients without AS of the ICA (p = 0.035). No interactions were observed between the +781C/T polymorphism and smoking or drinking. Conclusion: Our results demonstrated that the +781C/T polymorphism of IL-8 did not play a role and had no interaction with smoking or drinking in the occurrence of cerebral infarction in the Han Chinese population. However, the C allele and the CT genotype might be associated with AS of the ICA in patients with ischemic stroke.	[Luo, Shijian; Wang, Feng; Li, Zhendong; Deng, Jinfeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Zhuhai, Guangdong, Peoples R China	Sun Yat Sen University	Li, ZD (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Zhuhai, Guangdong, Peoples R China.	lizdsysu@163.com			Guangdong Provincial Natural Science Foundation [S2011010005416]	Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	The Project of Guangdong Provincial Natural Science Foundation (No. S2011010005416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Boisvert WA, 2000, IMMUNOL RES, V21, P129, DOI 10.1385/IR:21:2-3:129; Chapman CML, 2001, ATHEROSCLEROSIS, V159, P209, DOI 10.1016/S0021-9150(01)00499-3; Colobran R, 2007, CLIN EXP IMMUNOL, V150, P1, DOI 10.1111/j.1365-2249.2007.03489.x; Djousse L, 2009, J STROKE CEREBROVASC, V18, P384, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.008; Djuric T, 2008, CLIN BIOCHEM, V41, P1326, DOI 10.1016/j.clinbiochem.2008.08.081; Drogan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032176; Enquobahrie DA, 2008, AM J CARDIOL, V101, P1683, DOI 10.1016/j.amjcard.2008.02.052; Fatini C, 2004, EUR J VASC ENDOVASC, V27, P540, DOI 10.1016/j.ejvs.2004.02.008; Gao R, 2008, J BRAIN NERVOUS DIS, V16, P416; Grau AJ, 2001, J NEUROL SCI, V192, P41, DOI 10.1016/S0022-510X(01)00590-1; Grau AJ, 2001, EUR J CLIN INVEST, V31, P999, DOI 10.1046/j.1365-2362.2001.00923.x; Hacking D, 2004, GENES IMMUN, V5, P274, DOI 10.1038/sj.gene.6364067; Heinzmann A, 2004, J ALLERGY CLIN IMMUN, V114, P671, DOI 10.1016/j.jaci.2004.06.038; Jiang ZD, 2003, J INFECT DIS, V188, P506, DOI 10.1086/377102; Kis Z, 2007, NEW MICROBIOL, V30, P213; Kostulas N, 1999, STROKE, V30, P2174, DOI 10.1161/01.STR.30.10.2174; Kruman II, 2012, EXP BIOL MED, V237, P740, DOI 10.1258/ebm.2012.011421; Lee CR, 2006, PHARMACOGENET GENOM, V16, P891, DOI 10.1097/01.fpc.0000236324.96056.16; Lee Ken W. K., 2013, Frontiers in Genetics, V4, P132, DOI 10.3389/fgene.2013.00132; Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735; Li ZD, 2012, J NEUROL SCI, V320, P12, DOI 10.1016/j.jns.2012.05.044; Lu X, 2008, TROP MED, V8, P218; Lu X, 2008, TROP MED, V8, P209; Matarin M, 2010, J INTERN MED, V267, P139, DOI 10.1111/j.1365-2796.2009.02202.x; Matsumoto T, 1997, LAB INVEST, V77, P119; Michaud DS, 2006, CANCER RES, V66, P4525, DOI 10.1158/0008-5472.CAN-05-3987; Ministry of Health of; China PR, 2008, 3 NAT SURV DEATH CAU; Oksala NKJ, 2007, STROKE, V38, P50, DOI 10.1161/01.STR.0000251719.59141.36; Pezzini A, 2004, STROKE, V35, P438, DOI 10.1161/01.STR.0000112973.00867.98; Pezzini A, 2005, STROKE, V36, P533, DOI 10.1161/01.STR.0000155741.31499.c2; Qureshi IA, 2013, ARCH NEUROL-CHICAGO, V67, P1316; Rundek T, 2002, STROKE, V33, P1420, DOI 10.1161/01.STR.0000015558.63492.B6; Savage SA, 2006, CANCER EPIDEM BIOMAR, V15, P589, DOI 10.1158/1055-9965.EPI-05-0887; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Tsai YY, 2008, INVEST OPHTH VIS SCI, V49, P693, DOI 10.1167/iovs.07-0125; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Villa P, 2007, MOL MED, V13, P125, DOI 10.2119/2007-00008.Villa; Yao Chung-Tay, 2011, Human Genomics, V5, P569; Zhang Lin-feng, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P954	40	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80246	10.1371/journal.pone.0080246	http://dx.doi.org/10.1371/journal.pone.0080246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244661	gold, Green Submitted, Green Published			2022-12-25	WOS:000327162900071
J	Farmer, NA; Karnauskas, M				Farmer, Nicholas A.; Karnauskas, Mandy			Spatial Distribution and Conservation of Speckled Hind and Warsaw Grouper in the Atlantic Ocean off the Southeastern U. S.	PLOS ONE			English	Article							MARINE RESERVES; NORTH-CAROLINA; UNITED-STATES; REEF; FISHES; SUSTAINABILITY; ECOSYSTEM; DESIGN; COAST	There is broad interest in the development of efficient marine protected areas (MPAs) to reduce bycatch and end overfishing of speckled hind (Epinephelus drummondhayi) and warsaw grouper (Hyporthodus nigritus) in the Atlantic Ocean off the southeastern U. S. We assimilated decades of data from many fishery-dependent, fishery-independent, and anecdotal sources to describe the spatial distribution of these data limited stocks. A spatial classification model was developed to categorize depth-grids based on the distribution of speckled hind and warsaw grouper point observations and identified benthic habitats. Logistic regression analysis was used to develop a quantitative model to predict the spatial distribution of speckled hind and warsaw grouper as a function of depth, latitude, and habitat. Models, controlling for sampling gear effects, were selected based on AIC and 10-fold cross validation. The best-fitting model for warsaw grouper included latitude and depth to explain 10.8% of the variability in probability of detection, with a false prediction rate of 28-33%. The best-fitting model for speckled hind, per cross-validation, included latitude and depth to explain 36.8% of the variability in probability of detection, with a false prediction rate of 25-27%. The best-fitting speckled hind model, per AIC, also included habitat, but had false prediction rates up to 36%. Speckled hind and warsaw grouper habitats followed a shelf-edge hardbottom ridge from North Carolina to southeast Florida, with speckled hind more common to the north and warsaw grouper more common to the south. The proportion of habitat classifications and model-estimated stock contained within established and proposed MPAs was computed. Existing MPAs covered 10% of probable shelf-edge habitats for speckled hind and warsaw grouper, protecting 3-8% of speckled hind and 8% of warsaw grouper stocks. Proposed MPAs could add 24% more probable shelf-edge habitat, and protect an additional 14-29% of speckled hind and 20% of warsaw grouper stocks.	[Farmer, Nicholas A.] NOAA, Natl Marine Fisheries Serv, Southeast Reg Off, St Petersburg, FL USA; [Karnauskas, Mandy] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Farmer, NA (corresponding author), NOAA, Natl Marine Fisheries Serv, Southeast Reg Off, St Petersburg, FL USA.	nick.farmer@noaa.gov		Karnauskas, Mandy/0000-0002-6631-0592				Akaike H, 1974, AUTOMATIC CONTROL IE, V19, P716, DOI [DOI 10.1109/TAC.1974.1100705, 10.1109/tac.1974.1100705]; Ault J. S., 2007, FISHERY INDEPENDENT; Ault JS, 2006, B MAR SCI, V78, P633; Bakun A., 1996, OCEAN PROCESSES MARI; Bartholomew A, 2008, LANDSCAPE ECOL, V23, P55, DOI 10.1007/s10980-007-9136-0; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; BOHNSACK JA, 2004, WHY HAVE NO TAKE MAR, V42, P185; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Botsford LW, 2001, ECOL LETT, V4, P144; Brandt ME, 2009, COOPERATIVE MULTIAGE; Crowder LB, 2000, B MAR SCI, V66, P799; FAO (Food and Agriculture Organization), 2011, FISH MAN; Farmer NA, 2011, MAR ECOL PROG SER, V433, P169, DOI 10.3354/meps09198; Frost J, 2006, SPIRITUAL SLAVERY SP; FWC: Florida Fish and Wildlife Conservation Commission, 2001, SEAMAP BOTT MAPP PRO, P166; GRIMES CB, 1982, B MAR SCI, V32, P277; Heyman WD, 2011, PROF GEOGR, V63, P475, DOI 10.1080/00330124.2011.585078; Heyman WD, 2011, PROF GEOGR, V63, P429, DOI 10.1080/00330124.2011.585074; Huff DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045852; Humston R, 2000, FISH OCEANOGR, V9, P136, DOI 10.1046/j.1365-2419.2000.00132.x; Huntsman G, 1992, 1 S ATL FISH MAN COU; Karnauskas M., 2013, USE CONNECTIVITY MOD; Karnauskas M, 2012, LIMNOL OCEANOGR, V57, P1403, DOI 10.4319/lo.2012.57.5.1403; Kohavi R., 1995, STUDY CROSS VALIDATI, V2, P1137; Longhurst AR, 1987, ECOLOGY TROPICAL OCE; LUBCHENCO J, 2003, ECOL APPL, V13, P3, DOI DOI 10.1890/1051-0761(2003)013[0003:PAHITO]2.0.CO;2; MacCall AD, 1990, DYNAMIC GEOGRAPHY MA; Mann KH, 1996, DYNAMICS MARINE ECOS, P480, DOI 10.2307/2960585; National Marine Fisheries Service, 2012, STAT STOCKS ANN C ST; National Research Council (NRC) Ocean Studies Board, 2001, MAR PROT AR TOOLS SU; Paz M, 2008, IDENTIFYING BLACK GR, P577; Potts JC, 1998, TRENDS CATCH DATA ES; Potts JC, 2001, METHODS, V2, P4; R Development Core Team, 2009, R FDN STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rothschild B.J., 1986, DYNAMICS MARINE FISH; Rudershausen PJ, 2010, FISH RES, V105, P254, DOI 10.1016/j.fishres.2010.05.005; Rudershausen PJ, 2008, T AM FISH SOC, V137, P1389, DOI 10.1577/T07-159.1; South Atlantic Fishery Management Council MPA Expert Workgroup, 2013, 2 S ATL FISH MAN COU; Southeast Data Assessment and Review (SEDAR), 2004, STOCK ASS DEEPW SNAP; Staff of the Beaufort Laboratory Southeast Fisheries Science Center, 1991, S ATL SNAPP GROUP AS; Stankey G.H, 2005, ADAPTIVE MANAGEMENT; Tester PA, 1983, REEF FISH DISTRIBUTI; Ziskin GL, 2011, T AM FISH SOC, V140, P384, DOI 10.1080/00028487.2011.567863; Ziskin GL, 2008, AGE GROWTH REPROD SP	45	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e78682	10.1371/journal.pone.0078682	http://dx.doi.org/10.1371/journal.pone.0078682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260126	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900009
J	Olivera-Castillo, L; Davalos, A; Grant, G; Valadez-Gonzalez, N; Montero, J; Barrera-Perez, HAM; Chim-Chi, Y; Olvera-Novoa, MA; Ceja-Moreno, V; Acereto-Escoffie, P; Rubio-Pina, J; Rodriguez-Canul, R				Olivera-Castillo, Leticia; Davalos, Alberto; Grant, George; Valadez-Gonzalez, Nina; Montero, Jorge; Moshe Barrera-Perez, Hirian Alonso; Chim-Chi, Yasser; Angel Olvera-Novoa, Miguel; Ceja-Moreno, Victor; Acereto-Escoffie, Pablo; Rubio-Pina, Jorge; Rodriguez-Canul, Rossanna			Diets Containing Sea Cucumber (Isostichopus badionotus) Meals Are Hypocholesterolemic in Young Rats	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; FATTY LIVER; CHOLESTEROL EFFLUX; LIFE-STYLE; BILE-ACIDS; RECEPTOR; GLYCINE; PROFILE; PLASMA	Sea cucumber is widely consumed as a putative functional food. It contains many biologically-active substances, but only limited research on its properties in vivo has been done. The effects of different meals containing Isostichopus badionotus, a sea cucumber from southeast Mexico, on growth performance and body lipid profile in young rats were analyzed. Sea cucumber body wall was either lyophilized, cooked (100 degrees C, 1 h in water) and lyophilized, or ovendried (70 degrees C for 12 h). It was then ground and incorporated into cholesterol-containing diets. I. badionotus meals supported growth and improved lipid profile in rats. In particular, serum cholesterol, low density lipoproteins, triglycerides concentration and atherogenic index values were greatly reduced by some I. badionotus containing diets. Liver total lipids, triglycerides and cholesterol were also reduced. Cooking or heat-treatment of the meals lowered but did not abolish their hypolipidemic potency. Gene expression analysis of several key genes involved in cholesterol and lipid metabolism in liver showed that diets containing I. badionotus repressed the induction of key genes associated with dyslipidemia exerted by cholesterol supplementation. Consumption of I. badionotus from the Yucatan Peninsula is beneficial for dyslipidemia, although biological effect is clearly dependent on preparation method.	[Olivera-Castillo, Leticia; Montero, Jorge; Chim-Chi, Yasser; Angel Olvera-Novoa, Miguel; Ceja-Moreno, Victor; Rubio-Pina, Jorge; Rodriguez-Canul, Rossanna] Inst Politecn Nacl, Ctr Invest & Estudio Avanzados, Unidad Merida, Merida, Yucatan, Mexico; [Davalos, Alberto] Univ Autonoma Madrid, CSIC, Inst Madrileno Estudios Avanzados, Madrid, Spain; [Grant, George] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Valadez-Gonzalez, Nina] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Merida, Yucatan, Mexico; [Moshe Barrera-Perez, Hirian Alonso] Lab Anat Patol, Merida, Yucatan, Mexico; [Acereto-Escoffie, Pablo] Univ Autonoma Yucatan, Fac Ingn Quim, Merida, Yucatan, Mexico	Instituto Politecnico Nacional - Mexico; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); University of Aberdeen; Universidad Autonoma de Yucatan; Universidad Autonoma de Yucatan	Olivera-Castillo, L (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudio Avanzados, Unidad Merida, Merida, Yucatan, Mexico.	olivera@mda.cinvestav.mx	Rodríguez-Canul, Rossanna/AAH-1895-2020; Olvera-Novoa, Miguel Angel Angel/ABF-9261-2020; Davalos, Alberto/AAA-9949-2021	Rodríguez-Canul, Rossanna/0000-0003-0469-1489; Olvera-Novoa, Miguel Angel Angel/0000-0002-8304-3668; Chim Chi, Yasser Alejandro/0000-0002-4720-8445; Davalos, Alberto/0000-0001-5709-6443; Rubio-Pina, Jorge Alberto/0000-0001-7114-5010	FOMIX Yucatan [Clave M0023, 108373]; Spanish Instituto de Salud Carlos III grant [PI11/00315]; Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	FOMIX Yucatan; Spanish Instituto de Salud Carlos III grant; Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	The research reported in this article was funded by FOMIX Yucatan through the project 'El pepino del mar como un alimento functional: Obtencion de sus principios activos, caracterizacion biologica y efectos sobre el metabolism y sistema immune utilizando un modelo murino' (Clave M0023, No. 108373). AD is supported by a Spanish Instituto de Salud Carlos III grant (PI11/00315). GG is supported by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish or manuscript preparation.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Araujo P, 2008, J CHROMATOGR A, V1212, P106, DOI 10.1016/j.chroma.2008.10.006; Ayo J, 2007, MEAT SCI, V77, P173, DOI 10.1016/j.meatsci.2007.02.026; Damiani MC, 2010, BIORESOURCE TECHNOL, V101, P3801, DOI 10.1016/j.biortech.2009.12.136; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Conan DC, 1988, MARINE INVERTEBRATE, P647; Diagnostics Roche, 2009, CHOL GEN 2 2009 12 V, V6; Duan X, 2010, J FOOD ENG, V96, P491, DOI 10.1016/j.jfoodeng.2009.08.031; FOLCH J, 1957, J BIOL CHEM, V226, P497; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GRANT G, 1993, J NUTR, V123, P2207, DOI 10.1093/jn/123.12.2207; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Hasegawa N, 2014, AQUAC RES, V45, P2021, DOI 10.1111/are.12149; Hawa I Jr, 1999, Malays J Nutr, V5, P55; Heinecke JW, 2010, J CLIN LIPIDOL, V4, P371, DOI 10.1016/j.jacl.2010.08.005; HERRMANN RG, 1959, CIRC RES, V7, P224, DOI 10.1161/01.RES.7.2.224; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hossain Z, 2011, FISHERIES SCI, V77, P1081, DOI 10.1007/s12562-011-0407-y; Hu XQ, 2012, BIOSCI BIOTECH BIOCH, V76, P2214, DOI 10.1271/bbb.120495; Hu XQ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-25; Hu XQ, 2012, J MED FOOD, V15, P909, DOI [10.1094/jmf.2011.2042, 10.1089/jmf.2011.2042]; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kelly MS, 2005, PROG MOLEC, V39, P139; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KOMANO H, 1980, J BIOL CHEM, V255, P2919; Koyoc Cruz M, 2003, BIOMASS ESTIMATION 2, V54, P298; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Leontowicz H, 2002, J NUTR BIOCHEM, V13, P603, DOI 10.1016/S0955-2863(02)00206-1; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu HH, 2002, J AGR FOOD CHEM, V50, P3602, DOI 10.1021/jf020070k; Liu K, 2012, CIRCULATION, V125, P996, DOI 10.1161/CIRCULATIONAHA.111.060681; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendis S, 2011, GLOBAL ATLAS CARDIOV, P156; MERTZ DP, 1980, MED KLIN, V75, P12; MILLER GJ, 1975, LANCET, V1, P16; MILLER NE, 1985, NATURE, V314, P109, DOI 10.1038/314109a0; Mojica Elmer-Rico E., 2005, International Journal of Zoological Research, V1, P59; Najwa S, 1991, J NUTR BIOCH, V2, P150, DOI [10.1016/0955-2863(91)90007-R, DOI 10.1016/0955-2863(91)90007-R]; Odegaard AO, 2011, CIRCULATION, V124, P2847, DOI 10.1161/CIRCULATIONAHA.111.048843; Olivera L, 2003, J AGR FOOD CHEM, V51, P319, DOI 10.1021/jf0257749; Park T, 1999, NUTR RES, V19, P1777, DOI 10.1016/S0271-5317(99)00118-9; Rajamohan T., 1997, Indian Journal of Experimental Biology, V35, P1218; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rodriguez E, 2000, J PHYSIOL BIOCHEM, V56, P39, DOI 10.1007/BF03179775; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Saemann MD, 2010, EUR J CLIN INVEST, V40, P1131, DOI 10.1111/j.1365-2362.2010.02361.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; SOKAL RR, 1995, PRINCIPLE PRACTICE S; Sugawara T, 2006, BIOSCI BIOTECH BIOCH, V70, P2906, DOI 10.1271/bbb.60318; Torres N, 2006, J NUTR BIOCHEM, V17, P365, DOI 10.1016/j.jnutbio.2005.11.005; TYROLER HA, 1984, AM J CARDIOL, V54, pC14; van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; *WAT CORP, 1984, PIC TAG AM AC AN SYS; Wen J, 2010, J SCI FOOD AGR, V90, P2469, DOI 10.1002/jsfa.4108; Yahyavi M, 2012, AFR J BIOTECHNOL, V11, P2668; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhong Y, 2007, J AGR FOOD CHEM, V55, P1188, DOI 10.1021/jf063085h	63	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79446	10.1371/journal.pone.0079446	http://dx.doi.org/10.1371/journal.pone.0079446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260223	Green Published, gold			2022-12-25	WOS:000327311900023
J	Arens, J; Duong, TT; Dehmelt, L				Arens, Julia; Thanh-Thuy Duong; Dehmelt, Leif			A Morphometric Screen Identifies Specific Roles for Microtubule-Regulating Genes in Neuronal Development of P19 Stem Cells	PLOS ONE			English	Article							POINTED-END COMPLEX; CYTOPLASMIC DYNEIN; NEURITE INITIATION; RNA INTERFERENCE; MAMMALIAN-CELLS; AXON GUIDANCE; PLUS END; PROTEINS; GROWTH; EXPRESSION	The first morphological change after neuronal differentiation is the microtubule-dependent initiation of thin cell protrusions called neurites. Here we performed a siRNA-based morphometric screen in P19 stem cells to evaluate the role of 408 microtubule-regulating genes during this early neuromorphogenesis step. This screen uncovered several novel regulatory factors, including specific complex subunits of the microtubule motor dynein involved in neurite initiation and a novel role for the microtubule end-binding protein EB2 in attenuation of neurite outgrowth. Epistasis analysis suggests that competition between EB1 and EB2 regulates neurite length, which links its expression to neurite outgrowth. We propose a model that explains how microtubule regulators can mediate cellular morphogenesis during the early steps of neuronal development by controlling microtubule stabilization and organizing dynein-generated forces.	[Dehmelt, Leif] Dortmund Univ Technol, Dept System Cell Biol, Max Planck Inst Mol Physiol, Dortmund, Germany; Dortmund Univ Technol, Fachbereich Biol Chem, Dortmund, Germany	Dortmund University of Technology; Max Planck Society; Dortmund University of Technology	Dehmelt, L (corresponding author), Dortmund Univ Technol, Dept System Cell Biol, Max Planck Inst Mol Physiol, Dortmund, Germany.	leif.dehmelt@mpi-dortmund.mpg.de	Dehmelt, Leif/AAF-9616-2020	Dehmelt, Leif/0000-0002-6559-6496	FORSYS partner initiative of the German Federal Ministry of Education and Research (BMBF)	FORSYS partner initiative of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was funded by the FORSYS partner initiative of the German Federal Ministry of Education and Research (BMBF, grant 0315258) to LD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Ahmad FJ, 2006, TRAFFIC, V7, P524, DOI 10.1111/j.1600-0854.2006.00403.x; Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Bain G, 1991, CULTURING NERVE CELL, P189; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Blackmore MG, 2010, MOL CELL NEUROSCI, V44, P43, DOI 10.1016/j.mcn.2010.02.002; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Bullmore E., 2012, NAT REV NEUROSCI; Chan SW, 2005, GENE, V353, P189, DOI 10.1016/j.gene.2005.04.025; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dehmelt L, 2006, BRAIN CELL BIOL, V35, P39, DOI 10.1007/s11068-006-9001-0; Dehmelt L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-100; Dent E.W., 2011, COLD SPRING HARB PER, V3; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Farah MH, 2000, DEVELOPMENT, V127, P693; Goldspink DA, 2013, J CELL SCI, V126, P4000, DOI 10.1242/jcs.129759; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Hoogenraad CC, 2009, TRENDS CELL BIOL, V19, P669, DOI 10.1016/j.tcb.2009.08.006; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Lee IH, 2001, MOL BIOL CELL, V12, P2195, DOI 10.1091/mbc.12.7.2195; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Mikami A, 2002, J CELL SCI, V115, P4801, DOI 10.1242/jcs.00168; Myers KA, 2006, TRAFFIC, V7, P1333, DOI 10.1111/j.1600-0854.2006.00476.x; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Yeh TY, 2012, MOL BIOL CELL, V23, P3827, DOI 10.1091/mbc.E12-07-0496; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79796	10.1371/journal.pone.0079796	http://dx.doi.org/10.1371/journal.pone.0079796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260302	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500100
J	Prashek, J; Truong, T; Yao, XL				Prashek, Jennifer; Trung Truong; Yao, Xiaolan			Crystal Structure of the Pleckstrin Homology Domain from the Ceramide Transfer Protein: Implications for Conformational Change upon Ligand Binding	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE; NONVESICULAR TRAFFICKING; ENDOPLASMIC-RETICULUM; MEMBRANE; RECOGNITION; PH; CERT; PHOSPHORYLATION; ASSOCIATION; REFINEMENT	Ceramide transfer protein (CERT) is responsible for the nonvesicular trafficking of ceramide from the endoplasmic reticulum (ER) to the trans Golgi network where it is converted to sphingomyelin (SM). The N-terminal pleckstrin homology (PH) domain is required for Golgi targeting of CERT by recognizing the phosphatidylinositol 4-phosphate (PtdIns(4)P) enriched in the Golgi membrane. We report a crystal structure of the CERT PH domain. This structure contains a sulfate that is hydrogen bonded with residues in the canonical ligand-binding pocket of PH domains. Our nuclear magnetic resonance (NMR) chemical shift perturbation (CSP) analyses show sulfate association with CERT PH protein resembles that of PtdIns(4) P, suggesting that the sulfate bound structure likely mimics the holo form of CERT PH protein. Comparison of the sulfate bound structure with the apo form solution structure shows structural rearrangements likely occur upon ligand binding, suggesting conformational flexibility in the ligand-binding pocket. This structural flexibility likely explains CERT PH domain's low affinity for PtdIns(4) P, a property that is distinct from many other PH domains that bind to their phosphoinositide ligands tightly. This unique structural feature of CERT PH domain is probably tailored towards the transfer activity of CERT protein where it needs to shuttle between ER and Golgi and therefore requires short resident time on ER and Golgi membranes.	[Prashek, Jennifer; Trung Truong; Yao, Xiaolan] Univ Missouri, Div Mol Biol & Biochem, Sch Biol Sci, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Yao, XL (corresponding author), Univ Missouri, Div Mol Biol & Biochem, Sch Biol Sci, Kansas City, MO 64110 USA.	yaoxia@umkc.edu		Yao, Xiaolan/0000-0002-6570-3730	University of Missouri Research Board grant	University of Missouri Research Board grant	This work was supported by a University of Missouri Research Board grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lenoir M, 2010, EMBO REP, V11, P279, DOI 10.1038/embor.2010.28; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Sugiki T, 2009, PROTEIN SCI, V18, P1115, DOI 10.1002/pro.92; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8	46	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79590	10.1371/journal.pone.0079590	http://dx.doi.org/10.1371/journal.pone.0079590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260258	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500079
J	van Lierop, PPE; Swagemakers, SM; de Bie, CI; Middendorp, S; van Baarlen, P; Samsom, JN; van IJcken, WFJ; Escher, JC; van der Spek, PJ; Nieuwenhuis, EES				van Lierop, Pieter P. E.; Swagemakers, Sigrid M.; de Bie, Charlotte I.; Middendorp, Sabine; van Baarlen, Peter; Samsom, Janneke N.; van IJcken, Wilfred F. J.; Escher, Johanna C.; van der Spek, Peter J.; Nieuwenhuis, Edward E. S.			Gene Expression Analysis of Peripheral Cells for Subclassification of Pediatric Inflammatory Bowel Disease in Remission	PLOS ONE			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; CYTOKINE PRODUCTION; IBD; PROFILES; ONSET; RISK; SUSCEPTIBILITY; VALIDATION; CHILDREN	Objective: In current clinical practice, optimal treatment of inflammatory bowel disease (IBD) aims at the induction and maintenance of clinical remission. Clinical remission is apparent when laboratory markers of inflammation are normal and clinical symptoms are absent. However, sub-clinical inflammation can still be present. A detailed analysis of the immune status during this inactive state of disease may provide a useful tool to categorize patients with clinical remission into subsets with variable states of immune activation. Design: By using Affymetrix GeneChips, we analysed RNA gene expression profiles of peripheral blood leukocytes from pediatric IBD patients in clinical remission and controls. We performed (un)supervised clustering analysis of IBD-associated genes and applied Ingenuity (R) pathway software to identify specific molecular profiles between patients. Results: Pediatric IBD patients with disease in clinical remission display heterogeneously distributed gene expression profiles that are significantly distinct from controls. We identified three clusters of IBD patients, each displaying specific expression profiles of IBD-associated genes. Conclusion: The expression of immune-and IBD-associated genes in peripheral blood leukocytes from pediatric IBD patients in clinical remission was different from healthy controls, indicating that sub-clinical immune mechanisms are still active during remission. As such, RNA profiling of peripheral blood may allow for non-invasive patient subclassification and new perspectives in treatment regimes of IBD patients in the future.	[van Lierop, Pieter P. E.; de Bie, Charlotte I.; Middendorp, Sabine; Samsom, Janneke N.; Escher, Johanna C.; Nieuwenhuis, Edward E. S.] Sophia Childrens Univ Hosp, Dept Paediat, Erasmus MC, Rotterdam, Netherlands; [Swagemakers, Sigrid M.; van der Spek, Peter J.] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Swagemakers, Sigrid M.] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [Swagemakers, Sigrid M.] Erasmus MC, Canc Genom Ctr, Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [van Baarlen, Peter] Top Inst Food & Nutr, Wageningen, Netherlands; [van Lierop, Pieter P. E.; Middendorp, Sabine; Nieuwenhuis, Edward E. S.] UMC Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Gastroenterol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Top Institute Food & Nutrition; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Nieuwenhuis, EES (corresponding author), Sophia Childrens Univ Hosp, Dept Paediat, Erasmus MC, Rotterdam, Netherlands.	E.E.S.Nieuwenhuis@umcutrecht.nl	Middendorp, Sabine/B-8357-2013; Middendorp, Sabine/J-8205-2012; van Baarlen, Peter/B-8699-2009; van ijcken, willem/N-9805-2018	Middendorp, Sabine/0000-0002-0925-0095; Middendorp, Sabine/0000-0002-0925-0095; van Baarlen, Peter/0000-0003-3530-5472; van ijcken, willem/0000-0002-0421-8301	ZonMW [VIDI 91786322]; NWO; NBIC; NPC; KWF	ZonMW(Netherlands Organization for Health Research and Development); NWO(Netherlands Organization for Scientific Research (NWO)); NBIC; NPC; KWF	Grant support: ZonMW (VIDI 91786322) EESN, NWO, NBIC, NPC, KWF and CTMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Arsenescu R, 2008, MUCOSAL IMMUNOL, V1, P399, DOI 10.1038/mi.2008.32; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Canto E, 2006, CLIN IMMUNOL, V119, P156, DOI 10.1016/j.clim.2005.12.005; Consigny Y, 2006, INFLAMM BOWEL DIS, V12, P551, DOI 10.1097/01.ibd.0000225334.60990.5b; Damen GM, 2008, GUT, V57, P1480, DOI 10.1136/gut.2008.148650; Damen GM, 2006, J PEDIATR GASTR NUTR, V42, P142, DOI 10.1097/01.mpg.0000189336.70021.8a; Diamanti A, 2008, INFLAMM BOWEL DIS, V14, P1229, DOI 10.1002/ibd.20472; Doecke JD, 2013, INFLAMM BOWEL DIS, V19, P240, DOI 10.1097/MIB.0b013e3182810041; Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Hedl M, 2007, P NATL ACAD SCI US; HYAMS JS, 1991, J PEDIATR GASTR NUTR, V12, P439, DOI 10.1097/00005176-199105000-00005; Katsuta T, 2000, AM J GASTROENTEROL, V95, P3157; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Levine A, 2005, AM J GASTROENTEROL, V100, P407, DOI 10.1111/j.1572-0241.2005.41126.x; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Matsuda R, 2008, INFLAMM BOWEL DIS; Nieuwenhuis EES, 2008, DIGEST LIVER DIS, V40, P12, DOI 10.1016/j.dld.2007.07.166; Olsen J, 2009, INFLAMM BOWEL DIS, V15, P1032, DOI 10.1002/ibd.20879; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Rutgeerts P, 2007, GUT, V56, P453, DOI 10.1136/gut.2005.088732; Smith AM, 2009, J EXP MED; Turner D, 2007, GASTROENTEROLOGY, V133, P423, DOI 10.1053/j.gastro.2007.05.029; Turunen P, 2009, INFLAMM BOWEL DIS, V15, P56, DOI 10.1002/ibd.20558; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Lierop PPE, 2006, LANCET, V368, P578, DOI 10.1016/S0140-6736(06)69193-9; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Weersma RK, 2009, GUT, V58, P388, DOI 10.1136/gut.2007.144865; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Yamamoto T, 2005, INFLAMM BOWEL DIS, V11, P589, DOI 10.1097/01.MIB.0000161917.97136.e2; Yamamoto T, 2005, INFLAMM BOWEL DIS, V11, P580, DOI 10.1097/01.MIB.0000161307.58327.96	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79549	10.1371/journal.pone.0079549	http://dx.doi.org/10.1371/journal.pone.0079549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260248	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500076
J	Warton, DI; Renner, IW; Ramp, D				Warton, David I.; Renner, Ian W.; Ramp, Daniel			Model-Based Control of Observer Bias for the Analysis of Presence-Only Data in Ecology	PLOS ONE			English	Article							POINT PROCESS MODELS; SPECIES DISTRIBUTIONS; PREDICTION; ABSENCE; MAXENT	Presence-only data, where information is available concerning species presence but not species absence, are subject to bias due to observers being more likely to visit and record sightings at some locations than others (hereafter "observer bias"). In this paper, we describe and evaluate a model-based approach to accounting for observer bias directly - by modelling presence locations as a function of known observer bias variables (such as accessibility variables) in addition to environmental variables, then conditioning on a common level of bias to make predictions of species occurrence free of such observer bias. We implement this idea using point process models with a LASSO penalty, a new presence-only method related to maximum entropy modelling, that implicitly addresses the "pseudo-absence problem" of where to locate pseudo-absences (and how many). The proposed method of bias-correction is evaluated using systematically collected presence/absence data for 62 plant species endemic to the Blue Mountains near Sydney, Australia. It is shown that modelling and controlling for observer bias significantly improves the accuracy of predictions made using presence-only data, and usually improves predictions as compared to pseudo-absence or "inventory" methods of bias correction based on absences from non-target species. Future research will consider the potential for improving the proposed bias-correction approach by estimating the observer bias simultaneously across multiple species.	[Warton, David I.; Renner, Ian W.] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia; [Warton, David I.; Renner, Ian W.] Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW 2052, Australia; [Ramp, Daniel] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Technology Sydney	Warton, DI (corresponding author), Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia.	David.Warton@unsw.edu.au	Ramp, Daniel/C-3692-2008; Warton, David/B-5791-2009	Ramp, Daniel/0000-0003-3202-9898; Warton, David/0000-0001-9441-6645; Renner, Ian/0000-0003-3116-2486	Australian Research Council [LP0774833, FT120100501]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council Linkage project (LP0774833) awarded to DR and DIW, a Future Fellowship (FT120100501) awarded to DIW, and an Australia Postgraduate Award to IWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2012, METHODS ECOL EVOL, V3, P177, DOI 10.1111/j.2041-210X.2011.00141.x; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; BERMAN M, 1992, J R STAT SOC C-APPL, V41, P31; Chakraborty A, 2011, J R STAT SOC C-APPL, V60, P757, DOI 10.1111/j.1467-9876.2011.01023.x; Cressie N.A.C., 2015, STAT SPATIAL DATA; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Diggle P., 2003, STAT ANAL SPATIAL PO; Dorazio RM, 2012, BIOMETRICS, V68, P1303, DOI 10.1111/j.1541-0420.2012.01779.x; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Dudik M, 2006, ADV NEURAL INF PROCE, P323; Efron B, 2004, J AM STAT ASSOC, V99, P619, DOI 10.1198/016214504000000692; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2011, ARCGIS DESKT REL 10; Fisher RA, STAT METHODS RES WOR; Fithian W, ANN APPL ST IN PRESS; Franklin J, 2009, MAPPING SPECIES DIST; Gaston A, 2011, ECOL MODEL, V222, P2037, DOI 10.1016/j.ecolmodel.2011.04.015; Hastie T, 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Laffan SW, 2013, J BIOGEOGR, V40, P570, DOI 10.1111/jbi.12001; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; New South Wales Office of Environment and Heritage, 2012, ATL NEW S WAL WILDL; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; R Core Team, 2021, R LANG ENV STAT COMP; Ramp D, 2005, BIOL CONSERV, V126, P474, DOI 10.1016/j.biocon.2005.07.001; Reineking B, 2006, ECOL MODEL, V193, P675, DOI 10.1016/j.ecolmodel.2005.10.003; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Warton DI, 2010, ANN APPL STAT, V4, P1383, DOI 10.1214/10-AOAS331; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	39	95	99	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79168	10.1371/journal.pone.0079168	http://dx.doi.org/10.1371/journal.pone.0079168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260167	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500031
J	Dan-Goor, M; Nasereddin, A; Jaber, H; Jaffe, CL				Dan-Goor, Mary; Nasereddin, Abedelmajeed; Jaber, Hanan; Jaffe, Charles L.			Identification of a Secreted Casein Kinase 1 in Leishmania donovani: Effect of Protein over Expression on Parasite Growth and Virulence	PLOS ONE			English	Article							METACYCLIC PROMASTIGOTES; INTRACELLULAR TARGETS; TRYPANOSOMA-CRUZI; DIFFERENTIATION; TEMPERATURE; PREDICTION; INHIBITORS; INFECTION; EXOSOMES; RELEASE	Casein kinase 1 (CK1) plays an important role in eukaryotic signaling pathways, and their substrates include key regulatory proteins involved in cell differentiation, proliferation and chromosome segregation. The Leishmania genome encodes six potential CK1 isoforms, of which five have orthologs in other trypanosomatidae. Leishmania donovani CK1 isoform 4 (Ldck1.4, orthologous to LmjF27.1780) is unique to Leishmania and contains a putative secretion signal peptide. The full-length gene and three shorter constructs were cloned and expressed in E. coli as His-tag proteins. Only the full-length 62.3 kDa protein showed protein kinase activity indicating that the N-terminal and C-terminal domains are essential for protein activity. LdCK1.4-FLAG was stably over expressed in L. donovani, and shown by immunofluorescence to be localized primarily in the cytosol. Western blotting using anti-FLAG and anti-CK1.4 antibodies showed that this CK1 isoform is expressed and secreted by promastigotes. Over expression of LdCK1.4 had a significant effect on promastigote growth in culture with these parasites growing to higher cell densities than the control parasites (wild-type or Ld:luciferase, P<0.001). Analysis by flow cytometry showed a higher percentage, similar to 4-5-fold, of virulent metacyclic promastigotes on day 3 among the LdCK1.4 parasites. Finally, parasites over expressing LdCK1.4 gave significantly higher infections of mouse peritoneal macrophages compared to wild-type parasites, 28.6% versus 6.3%, respectively (p = 0.0005). These results suggest that LdCK1.4 plays an important role in parasite survival and virulence. Further studies are needed to validate CK1.4 as a therapeutic target in Leishmania.	[Dan-Goor, Mary; Nasereddin, Abedelmajeed; Jaber, Hanan; Jaffe, Charles L.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet,IMRIC, Kuvin Ctr Study Infect & Trop Dis,Natl Ctr Leishm, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Jaffe, CL (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet,IMRIC, Kuvin Ctr Study Infect & Trop Dis,Natl Ctr Leishm, IL-91010 Jerusalem, Israel.	cjaffe@cc.huji.ac.il	Jaffe, Charles/AAU-8686-2020; Nasereddin, Abedelmajeed/N-4150-2017	Jaffe, Charles/0000-0002-2042-9993; Nasereddin, Abedelmajeed/0000-0001-8162-420X	Basic Research Foundation; Israeli Academy of Sciences and Humanities; European commission [LSHB-CT-2004-503467]	Basic Research Foundation; Israeli Academy of Sciences and Humanities; European commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the Basic Research Foundation, Israeli Academy of Sciences and Humanities, and the European commission (Contract No. LSHB-CT-2004-503467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco JJ, 2006, INT J PARASITOL, V36, P1249, DOI 10.1016/j.ijpara.2006.06.013; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beverley SM, 1993, METHOD MOL BIOL, P338; Bhardwaj S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/109189; Corrales RM, 2010, FEMS IMMUNOL MED MIC, V58, P27, DOI 10.1111/j.1574-695X.2009.00608.x; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Diez H, 2008, VECTOR-BORNE ZOONOT, V8, P93, DOI 10.1089/vbz.2006.0650; Ehrenfreund-Kleinman T, 2005, J PARASITOL, V91, P158, DOI 10.1645/GE-3379; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Florez AF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-484; Foucher AL, 2013, ANTIMICROB AGENTS CH, V57, P1252, DOI 10.1128/AAC.01983-12; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Hassani K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018724; HERMOSO T, 1991, EMBO J, V10, P4061, DOI 10.1002/j.1460-2075.1991.tb04982.x; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Knockaert M, 2002, J BIOL CHEM, V277, P25493, DOI 10.1074/jbc.M202651200; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Ma HT, 2011, BIOCHEM J, V435, P17, DOI 10.1042/BJ20100284; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Sacerdoti-Sierra N, 1997, J BIOL CHEM, V272, P30760, DOI 10.1074/jbc.272.49.30760; Saraiva EM, 2005, EXP PARASITOL, V110, P39, DOI 10.1016/j.exppara.2005.01.004; Shimony O, 2008, J MICROBIOL METH, V75, P196, DOI 10.1016/j.mimet.2008.05.026; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2011, CELL MICROBIOL, V13, P1, DOI 10.1111/j.1462-5822.2010.01537.x; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; STEBECK CE, 1995, MOL BIOCHEM PARASIT, V71, P1, DOI 10.1016/0166-6851(95)00022-S; Talmi-Frank D, 2012, VET PARASITOL, V187, P57, DOI 10.1016/j.vetpar.2011.12.035; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urbaniak MD, 2009, MOL BIOCHEM PARASIT, V166, P183, DOI 10.1016/j.molbiopara.2009.03.001; VANCURA A, 1994, J BIOL CHEM, V269, P19271; Vieira LL, 2002, INT J PARASITOL, V32, P1085, DOI 10.1016/S0020-7519(02)00067-X; Yao CQ, 2008, EXP PARASITOL, V118, P129, DOI 10.1016/j.exppara.2007.06.012; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	45	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79287	10.1371/journal.pone.0079287	http://dx.doi.org/10.1371/journal.pone.0079287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260187	gold, Green Submitted, Green Published			2022-12-25	WOS:000327258600028
J	Gryseels, C; Uk, S; Erhart, A; Gerrets, R; Sluydts, V; Durnez, L; Ribera, JM; Muela, SH; Menard, D; Heng, S; Sochantha, T; D'Alessandro, U; Coosemans, M; Grietens, KP				Gryseels, Charlotte; Uk, Sambunny; Erhart, Annette; Gerrets, Rene; Sluydts, Vincent; Durnez, Lies; Ribera, Joan Muela; Muela, Susanna Hausmann; Menard, Didier; Heng, Somony; Sochantha, Tho; D'Alessandro, Umberto; Coosemans, Marc; Grietens, Koen Peeters			Injections, Cocktails and Diviners: Therapeutic Flexibility in the Context of Malaria Elimination and Drug Resistance in Northeast Cambodia	PLOS ONE			English	Article							FALCIPARUM-MALARIA; ANTIMALARIAL-DRUGS; COUNTERFEIT; AGE	Background: Adherence to effective malaria medication is extremely important in the context of Cambodia's elimination targets and drug resistance containment. Although the public sector health facilities are accessible to the local ethnic minorities of Ratanakiri province (Northeast Cambodia), their illness itineraries often lead them to private pharmacies selling "cocktails" and artemether injections, or to local diviners prescribing animal sacrifices to appease the spirits. Methods: The research design consisted of a mixed methods study, combining qualitative (in-depth interviews and participant observation) and quantitative methods (household and cross-sectional survey). Results: Three broad options for malaria treatment were identified: i) the public sector; ii) the private sector; iii) traditional treatment based on divination and ceremonial sacrifice. Treatment choice was influenced by the availability of treatment and provider, perceived side effects and efficacy of treatments, perceived etiology of symptoms, and patient-health provider encounters. Moreover, treatment paths proved to be highly flexible, changing mostly in relation to the perceived efficacy of a chosen treatment. Conclusions: Despite good availability of anti-malarial treatment in the public health sector, attendance remained low due to both structural and human behavioral factors. The common use and under-dosage of anti-malaria monotherapy in the private sector (single-dose injections, single-day drug cocktails) represents a threat not only for individual case management, but also for the regional plan of drug resistance containment and malaria elimination.	[Gryseels, Charlotte; Erhart, Annette; Sluydts, Vincent; Durnez, Lies; Coosemans, Marc; Grietens, Koen Peeters] Inst Trop Med, B-2000 Antwerp, Belgium; [Uk, Sambunny; Heng, Somony; Sochantha, Tho] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Gerrets, Rene] Univ Amsterdam, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Ribera, Joan Muela; Muela, Susanna Hausmann; Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [Menard, Didier] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [D'Alessandro, Umberto] MRC, Fajara, Gambia; [Coosemans, Marc] Univ Antwerp, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); National Center Parasitology, Entomology & Malaria Control; University of Amsterdam; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; University of London; London School of Hygiene & Tropical Medicine; University of Antwerp	Gryseels, C (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	cgryseels@itg.be	Peeters Grietens, Koen/G-7028-2019; Menard, Didier/O-3294-2013; Ribera, JM/B-8181-2009; Sluydts, Vincent/AAU-8776-2020; D'Alessandro, Umberto/D-3457-2015	Peeters Grietens, Koen/0000-0001-6570-9887; Menard, Didier/0000-0003-1357-4495; Ribera, JM/0000-0003-1042-6024; Sluydts, Vincent/0000-0001-5213-851X; D'Alessandro, Umberto/0000-0001-6341-5009; muela ribera, joan/0000-0003-2111-6275; Gryseels, Charlotte/0000-0002-8963-4469	Institute of Tropical Medicine (ITM), Antwerp, Belgium; National Center for Parasitology, Entomology and Malaria Control (CNM), Phnom Penh, Cambodia; Bill and Melinda Gates Foundation	Institute of Tropical Medicine (ITM), Antwerp, Belgium; National Center for Parasitology, Entomology and Malaria Control (CNM), Phnom Penh, Cambodia; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The qualitative study and the household survey received financial support from the Belgian Cooperation within the Framework Agreement III consisting of a bilateral cooperation between the Institute of Tropical Medicine (ITM), Antwerp, Belgium and the National Center for Parasitology, Entomology and Malaria Control (CNM), Phnom Penh, Cambodia. The cross-sectional survey was financially supported by the Bill and Melinda Gates Foundation within the framework of the project 'Repellents as an added control measure to LLINs in Southeast Asia'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, EM RESP ART RES GREA; Asian Development Bank, 2002, IND PEOPL ETHN MIN P; Bourdier F., 2006, MOUNTAIN PRECIOUS ST; Bourdier F., 2009, DEV DOMINION INDIGEN; Coosemans M, 2006, P INT C HUBS HARB DE, P551; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Good CM., 1987, ETHNOMEDICAL SYSTEMS; Hausmann-Muela S, 2012, MALAR REP, V2, P17; Nguyen HV, 2012, AM J TROP MED HYG, V87, P989, DOI 10.4269/ajtmh.2012.12-0047; Kingdom of Cambodia Ministry of Health Cambodia, 2011, TRAT PLAN EL MAL CAM; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Meessen B, 2011, HEALTH POLICY PLANN, V26, pi30, DOI 10.1093/heapol/czr026; Montagu D, 2010, LARGE SCALE MALARIA; Muela SH, 2002, SOC SCI MED, V55, P403; National Center for Parasitology Entomology and Malaria Control, 2009, VILL MAL WORK PROJ S; National Center for Parasitology Entomology and Malaria Control Kingdom of Cambodia Ministry of Health Cambodia, 2012, MIS NAT MAL PROGR; Newton PN, 2003, LANCET, V362, P169, DOI 10.1016/S0140-6736(03)13872-X; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; O'Connell KA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-335; Ovesen J, 2004, CIVILIZING THE MARGINS: SOUTHEAST ASIAN GOVERNMENT POLICIES FOR THE DEVELOPMENT OF MINORITIES, P241; Ovesen J., 2007, MEDICAL IDENTITIES H, P36; Packard, 2016, HIST GLOBAL HLTH INT; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; SBJ (Statistics Bureau of Japan), 2008, REV 2008 GEN POPULAT; Shanks GD, 2006, J POSTGRAD MED, V52, P277; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Thriemer K, 2013, TROP MED INT HEALTH, V18, P66; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; Yasuoka J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-109; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x; Yeung S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-96	34	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80343	10.1371/journal.pone.0080343	http://dx.doi.org/10.1371/journal.pone.0080343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244678	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600204
J	Badar, N; Aamir, UB; Mehmood, MR; Nisar, N; Alam, MM; Kazi, BM; Zaidi, SSZ				Badar, Nazish; Aamir, Uzma Bashir; Mehmood, Muhammad Rashid; Nisar, Nadia; Alam, Muhammad Masroor; Kazi, Birjees Mazhar; Zaidi, Syed Sohail Zahoor			Influenza Virus Surveillance in Pakistan during 2008-2011	PLOS ONE			English	Article							PANDEMIC INFLUENZA; EPIDEMIOLOGY; EMERGENCE; EVOLUTION; ECOLOGY; IMPACT	Background: There is little information about influenza among the Pakistani population. In order to assess the trends of Influenza-like-Illness (ILI) and to monitor the predominant circulating strains of influenza viruses, a country-wide lab-based surveillance system for ILI and Severe Acute Respiratory Illness (SARI) with weekly sampling and reporting was established in 2008. This system was necessary for early detection of emerging novel influenza subtypes and timely response for influenza prevention and control. Methods: Five sentinel sites at tertiary care hospitals across Pakistan collected epidemiological data and respiratory samples from Influenza-like illness (ILI) and severe acute respiratory illness (SARI) cases from January 2008 to December 2011. Samples were typed and sub-typed by Real-Time RT-PCR assay. Results: A total of 6258 specimens were analyzed; influenza virus was detected in 1489 (24%) samples, including 1066 (72%) Influenza type A and 423 (28%) influenza type B viruses. Amongst influenza A viruses, 25 (2%) were seasonal A/H1N1, 169 (16%) were A/H3N2 and 872 (82 %) were A(H1N1)pdm09. Influenza B virus circulation was detected throughout the year along with few cases of seasonal A/H1N1 virus during late winter and spring. Influenza A/H3N2 virus circulation was mainly observed during summer months (August-October). Conclusions: The findings of this study emphasize the need for continuous and comprehensive influenza surveillance. Prospective data from multiple years is needed to predict seasonal trends for vaccine development and to further fortify pandemic preparedness.	[Badar, Nazish; Aamir, Uzma Bashir; Mehmood, Muhammad Rashid; Nisar, Nadia; Alam, Muhammad Masroor; Kazi, Birjees Mazhar; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan		Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	zaidis@pak.emro.who.int	Zaidi, Syed Sohail Zahoor/F-7432-2015		NIH - CDC [U50/CCU024406]	NIH - CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institutes of Health (NIH) - USA)	This work was supported under the NIH - CDC cooperative agreement No. U50/CCU024406 for Development of Influenza Surveillance Network in Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayrak N, 2012, J PUBLIC HLTH EPIDEM, V2, P199; Anupam Mukherjee, 2010, Journal of Public Health and Epidemiology, V2, P171; Broor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029129; COUCH RB, 1986, J INFECT DIS, V153, P431, DOI 10.1093/infdis/153.3.431; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Ellis J, 2011, EUROSURVEILLANCE, V6, P16; Esposito S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-271; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Gensheimer KF, 1999, EMERG INFECT DIS, V5, P297, DOI 10.3201/eid0502.990219; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; Nguyen HLK, 2007, J INFECTION, V55, P58, DOI 10.1016/j.jinf.2006.12.001; Karageorgopoulos D. E., 2011, PLoS ONE, pe21690, DOI 10.1371/journal.pone.0021690; Kitler ME, 2002, VACCINE, V20, pS5, DOI 10.1016/S0264-410X(02)00121-4; Layne SP, 2001, SCIENCE, V293, P1729, DOI 10.1126/science.293.5536.1729; Lindblade Kim A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015826, DOI 10.1371/J0URNAL.P0NE.0015826.PUBMED:21209850]; Moura FA, 2006, CURR OPIN INFECT DIS, V23, P415; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Shu Y-L, 2010, CHINA EMERG INFECT D, V16; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Tang JLWT, 2010, ANN ACAD MED SINGAP, V39, P291; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2007, REC LAB PROC DET AV; WHO, 2010, SIT UPD EUR REG OV I; World Health Organization, 2009, HUM INF PAND H1N1 20; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	29	22	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79959	10.1371/journal.pone.0079959	http://dx.doi.org/10.1371/journal.pone.0079959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260327	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200096
J	Liu, XJ; Cui, Y; Li, MX; Xu, HF; Zuo, J; Fang, FD; Chang, YS				Liu, Xiaojun; Cui, Ying; Li, Meixia; Xu, Haifeng; Zuo, Jin; Fang, Fude; Chang, Yongsheng			Cobalt Protoporphyrin Induces HO-1 Expression Mediated Partially by FOXO1 and Reduces Mitochondria-Derived Reactive Oxygen Species Production	PLOS ONE			English	Article							HEME OXYGENASE-1; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; CYTOCHROME-C; FORKHEAD BOX; CELLS; ACTIVATION; APOPTOSIS; CATALASE	Background: Reactive oxygen species arise in the mitochondria as byproducts of respiration and oxidase activity and have important roles in many physiological and pathophysiological conditions. The level of reactive oxygen species is regulated by a number of enzymes and physiological antioxidants, including HO-1, Sod2, catalase and COX-2, etc. And HO-1 against oxidative stress requires an increase in stress-responsive genes, such as Sod2 and catalase. Especially for the activity of HO-1, cobalt protoporphyrin is known to be a potent and effective inducer in many tissues. The transcription factor, FOXO1 is resistant to oxidative stress through downregulating reactive oxygen species production. Previous study showed that FOXO1 induces HO-1 expression by binding to HO-1 promoter. The question whether cobalt protoporphyrin induces HO-1 expression mediated by FOXO1 and subsequently lessens reactive oxygen species production remains to be elucidated. Results: Cobalt protoporphyrin enhances the expression of FOXO1 and facilitates FOXO1 binding to HO-1 promoter and increasing its transcriptional activity without influencing the FOXO1 protein stability. CoPP induces HO-1 and other oxidative stress-responsive genes expression, such as catalase, cytochrome c, Sod2, and COX-2, and decreases mitochondria-derived reactive oxygen species production, which are mediated partially by FOXO1. Conclusions: Cobalt protoporphyrin induces HO-1 and other oxidative stress-responsive genes expression mediated partially by FOXO1, and has an important role in reducing cellular reactive oxygen species level. Cobalt protoporphyrin may be a more promising therapeutic agent to upregulate some antioxidantive genes.	[Liu, Xiaojun; Cui, Ying; Zuo, Jin; Fang, Fude; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Liu, Xiaojun; Cui, Ying; Zuo, Jin; Fang, Fude; Chang, Yongsheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Meixia] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Xu, Haifeng] Peking Univ, Canc Hosp & Inst, Dept Intervent Therapy, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University	Liu, XJ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	xiaojunliu@ibms.pumc.edu.cn; cuiying119@163.com; fangfd@vip.sina.com	Liu, Xiaojun/CAG-4249-2022		Major State Basic Research Development Program of China (973 Program) [2012CB517504]; National Natural Science Foundation of China [81170763, 81100608, 31371191]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by collective grants from the Major State Basic Research Development Program of China (973 Program 2012CB517504), the National Natural Science Foundation of China (Grants No. 81170763, 81100608 and 31371191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; Abraham NG, 2002, CELL MOL BIOL, V48, P895; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Atlante A, 2000, J BIOL CHEM, V275, P37159, DOI 10.1074/jbc.M002361200; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053; Cai CX, 2012, J BIOL CHEM, V287, P33720, DOI 10.1074/jbc.M112.385542; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Di Noia MA, 2006, J BIOL CHEM, V281, P15687, DOI 10.1074/jbc.M510595200; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Gabunia K, 2012, J BIOL CHEM, V287, P2477, DOI 10.1074/jbc.M111.312470; Glanemann M, 2005, TRANSPLANT P, V37, P3223, DOI 10.1016/j.transproceed.2005.07.002; Glauser DA, 2007, J ENDOCRINOL, V193, P195, DOI 10.1677/JOE-06-0191; Hsu BRS, 2005, TRANSPL P, V37, P1826, DOI 10.1016/j.transproceed.2005.02.085; Kim EH, 2008, CARCINOGENESIS, V29, P688, DOI 10.1093/carcin/bgm299; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; Min KJ, 2011, CELL SIGNAL, V23, P1505, DOI 10.1016/j.cellsig.2011.05.013; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200; Shan Y, 2002, ARCH BIOCHEM BIOPHYS, V399, P159, DOI 10.1006/abbi.2001.2742; Shan Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P219, DOI 10.1006/abbi.2000.1921; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; SRIVASTAVA KK, 1993, EUR J BIOCHEM, V213, P909, DOI 10.1111/j.1432-1033.1993.tb17835.x; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Turkseven S, 2005, AM J PHYSIOL-HEART C, V289, pH701, DOI 10.1152/ajpheart.00024.2005; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336	40	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80521	10.1371/journal.pone.0080521	http://dx.doi.org/10.1371/journal.pone.0080521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255720	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200113
J	Rossi, AR; Angelo, MF; Villarreal, A; Lukin, JN; Ramos, AJ				Raquel Rossi, Alicia; Florencia Angelo, Maria; Villarreal, Alejandro; Lukin, Jeronimo; Javier Ramos, Alberto			Gabapentin Administration Reduces Reactive Gliosis and Neurodegeneration after Pilocarpine-Induced Status Epilepticus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; DEPENDENT CALCIUM-CHANNELS; NEURONAL DEGENERATION; SPONTANEOUS SEIZURES; LITHIUM-PILOCARPINE; TIME-COURSE; MODEL; BRAIN; RATS; EPILEPTOGENESIS	The lithium-pilocarpine model of epilepsy reproduces in rodents several features of human temporal lobe epilepsy, by inducing an acute status epilepticus (SE) followed by a latency period. It has been proposed that the neuronal network reorganization that occurs during latency determines the subsequent appearance of spontaneous recurrent seizures. The aim of this study was to evaluate neuronal and glial responses during the latency period that follows SE. Given the potential role of astrocytes in the post-SE network reorganization, through the secretion of synaptogenic molecules such as thrombospondins, we also studied the effect of treatment with the alpha 2 delta 1 thrombospondin receptor antagonist gabapentin. Adult male Wistar rats received 3 mEq/kg LiCl, and 20 h later 30 mg/kg pilocarpine. Once SE was achieved, seizures were stopped with 20 mg/kg diazepam. Animals then received 400 mg/kg/day gabapentin or saline for either 4 or 14 days. In vitro experiments were performed in dissociated mixed hippocampal cell culture exposed to glutamate, and subsequently treated with gabapentin or vehicle. During the latency period, the hippocampus and pyriform cortex of SE-animals presented a profuse reactive astrogliosis, with increased GFAP and nestin expression. Gliosis intensity was dependent on the Racine stage attained by the animals and peaked 15 days after SE. Microglia was also reactive after SE, and followed the same pattern. Neuronal degeneration was present in SE-animals, and also depended on the Racine stage and the SE duration. Polysialic-acid NCAM (PSA-NCAM) expression was increased in hippocampal CA-1 and dentate gyrus of SE-animals. Gabapentin treatment was able to reduce reactive gliosis, decrease neuronal loss and normalize PSA-NCAM staining in hippocampal CA-1. In vitro, gabapentin treatment partially prevented the dendritic loss and reactive gliosis caused by glutamate excitotoxicity. Our results show that gabapentin treatment during the latency period after SE protects neurons and normalizes PSA-NCAM probably by direct interaction with neurons and glia.	[Raquel Rossi, Alicia; Florencia Angelo, Maria; Villarreal, Alejandro; Lukin, Jeronimo; Javier Ramos, Alberto] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia Prof E De Robert, RA-1053 Buenos Aires, DF, Argentina	University of Buenos Aires	Ramos, AJ (corresponding author), Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia Prof E De Robert, Ciudad Buenos Aires, RA-1053 Buenos Aires, DF, Argentina.	jramos@fmed.uba.ar	Ramos, Alberto Javier/AAR-7796-2020	Ramos, Alberto Javier/0000-0003-4009-6337; Lukin, Jeronimo/0000-0002-2284-7152; Villarreal, Alejandro/0000-0001-8624-8119	ANPCYT-FONCYT [PICT 2008-1590]; CONICET [PIP 1728/2009]; University of Buenos Aires [20020110100141]	ANPCYT-FONCYT(ANPCyTFONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires)	The work has been founded by ANPCYT-FONCYT grant Nr. PICT 2008-1590 (http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt) CONICET grant PIP 1728/2009 (www.conicet.gov.ar) and University of Buenos Aires grant Nr. 20020110100141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Baluchnejadmojarad T, 2013, J MOL NEUROSCI, V49, P194, DOI 10.1007/s12031-012-9886-2; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Borges K, 2006, EXP NEUROL, V201, P416, DOI 10.1016/j.expneurol.2006.04.031; Burgos M, 2007, GLIA, V55, P1437, DOI 10.1002/glia.20555; Cheng JK, 2006, J PHARMACOL SCI, V100, P471, DOI 10.1254/jphs.CR0050020; Crespel A, 2002, BRAIN RES, V952, P159, DOI 10.1016/S0006-8993(02)03050-0; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; do Nascimento AL, 2012, BRAIN RES, V1470, P98, DOI 10.1016/j.brainres.2012.06.008; Duveau V, 2010, EUR J NEUROSCI, V32, P89, DOI 10.1111/j.1460-9568.2010.07272.x; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Estrada FS, 2012, NEUROSCI LETT, V514, P51, DOI 10.1016/j.neulet.2012.02.055; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Gualtieri F, 2012, NEUROSCIENCE, V218, P278, DOI 10.1016/j.neuroscience.2012.05.018; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; Holopainen IE, 2008, NEUROCHEM INT, V52, P935, DOI 10.1016/j.neuint.2007.10.021; Jaako K, 2011, EUR J PHARMACOL, V666, P61, DOI 10.1016/j.ejphar.2011.05.008; Jacobs MP, 2009, EPILEPSY BEHAV, V14, P438, DOI 10.1016/j.yebeh.2009.02.036; JENSEN FE, 2009, EPILEPSIA S2, V50, P1, DOI DOI 10.1111/J.1528-1167.2008.02003.X; Kim DS, 2008, J COMP NEUROL, V511, P581, DOI 10.1002/cne.21851; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lee William, 2012, Methods Mol Biol, V846, P261, DOI 10.1007/978-1-61779-536-7_23; Lehtimaki KA, 2011, EPILEPSY RES, V95, P184, DOI 10.1016/j.eplepsyres.2011.03.004; Lehtimaki KA, 2010, NEUROIMMUNOMODULAT, V17, P19, DOI 10.1159/000243081; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Li XW, 2013, BRAIN RES BULL, V91, P8, DOI 10.1016/j.brainresbull.2012.11.007; Lively S, 2008, J NEUROSCI RES, V86, P2895, DOI 10.1002/jnr.21735; Lo FS, 2011, J NEUROPHYSIOL, V106, P2876, DOI 10.1152/jn.00312.2011; Loss CM, 2012, BRAIN RES, V1474, P110, DOI 10.1016/j.brainres.2012.07.046; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Muller CJ, 2009, EUR J PHARMACOL, V619, P15, DOI 10.1016/j.ejphar.2009.07.020; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Pekcec A, 2007, NEUROBIOL DIS, V27, P54, DOI 10.1016/j.nbd.2007.04.002; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Sankar R, 1998, J NEUROSCI, V18, P8382; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sutton KG, 2002, BRIT J PHARMACOL, V135, P257, DOI 10.1038/sj.bjp.0704439; Vezzani A, 2010, CURR OPIN INVEST DR, V11, P43; Wang L, 2008, BRAIN RES, V1241, P157, DOI 10.1016/j.brainres.2008.07.097; Wodarski R, 2009, EUR J PAIN, V13, P807, DOI 10.1016/j.ejpain.2008.09.010; Aviles-Reyes RX, 2010, J NEUROCHEM, V112, P854, DOI 10.1111/j.1471-4159.2009.06535.x; Xu ZC, 2011, NEUROCHEM RES, V36, P2208, DOI 10.1007/s11064-011-0576-1; Yan XX, 2012, EXP NEUROL, V235, P228, DOI 10.1016/j.expneurol.2012.01.003; Yang JL, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-18; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	52	51	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78516	10.1371/journal.pone.0078516	http://dx.doi.org/10.1371/journal.pone.0078516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250797	Green Submitted, gold, Green Published			2022-12-25	WOS:000327216200030
J	Koneczny, I; Cossins, J; Waters, P; Beeson, D; Vincent, A				Koneczny, Inga; Cossins, Judith; Waters, Patrick; Beeson, David; Vincent, Angela			MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters	PLOS ONE			English	Article							MUSCLE-SPECIFIC KINASE; NEUROMUSCULAR-JUNCTION SYNAPTOPATHY; TYROSINE KINASE; ANTIBODIES; RECEPTOR; MICE; AUTOANTIBODIES; IMMUNIZATION; RITUXIMAB; PROTEIN	A variable proportion of patients with generalized myasthenia gravis (MG) have autoantibodies to muscle specific tyrosine kinase (MuSK). During development agrin, released from the motor nerve, interacts with low density lipoprotein receptor-related protein-4 (LRP4), which then binds to MuSK; MuSK interaction with the intracellular protein Dok7 results in clustering of the acetylcholine receptors (AChRs) on the postsynaptic membrane. In mature muscle, MuSK helps maintain the high density of AChRs at the neuromuscular junction. MuSK antibodies are mainly IgG4 subclass, which does not activate complement and can be monovalent, thus it is not clear how the antibodies cause disruption of AChR numbers or function to cause MG. We hypothesised that MuSK antibodies either reduce surface MuSK expression and/or inhibit the interaction with LRP4. We prepared MuSK IgG, monovalent Fab fragments, IgG1-3 and IgG4 fractions from MuSK-MG plasmas. We asked whether the antibodies caused endocytosis of MuSK in MuSK-transfected cells or if they inhibited binding of LRP4 to MuSK in co-immunoprecipitation experiments. In parallel, we investigated their ability to reduce AChR clusters in C2C12 myotubes induced by a) agrin, reflecting neuromuscular development, and b) by Dok7-overexpression, producing AChR clusters that more closely resemble the adult neuromuscular synapse. Total IgG, IgG4 or IgG1-3 MuSK antibodies were not endocytosed unless cross-linked by divalent anti-human IgG. MuSK IgG, Fab fragments and IgG4 inhibited the binding of LRP4 to MuSK and reduced agrin-induced AChR clustering in C2C12 cells. By contrast, IgG1-3 antibodies did not inhibit LRP4-MuSK binding but, surprisingly, did inhibit agrin-induced clustering. Moreover, both IgG4 and IgG1-3 preparations dispersed agrin-independent AChR clusters in Dok7-overexpressing C2C12 cells. Thus interference by IgG4 antibodies of the LRP4-MuSK interaction will be one pathogenic mechanism of MuSK antibodies, but IgG1-3 MuSK antibodies will also contribute to the reduced AChR density and neuromuscular dysfunction in myasthenia patients with MuSK antibodies.	[Koneczny, Inga; Cossins, Judith; Waters, Patrick; Beeson, David; Vincent, Angela] Univ Oxford, Neurosci Grp, Nuffield Dept Clin Neurosci, Weatherall Inst Mol Med, Oxford, England	University of Oxford	Vincent, A (corresponding author), Univ Oxford, Neurosci Grp, Nuffield Dept Clin Neurosci, Weatherall Inst Mol Med, Oxford, England.	angela.vincent@ndcn.ox.ac.uk	Waters, Patrick/Y-3753-2019; Waters, Patrick/AAF-2658-2019; Vincent, Angela/AAE-7310-2019	Waters, Patrick/0000-0003-4142-2667; Waters, Patrick/0000-0003-4142-2667; Koneczny, Inga/0000-0002-0567-021X	University of Oxford; Myasthenia Gravis Association; Muscular Dystrophy Campaign; Oxford NIHR Biomedical Research Centre; Austrian Academy of Sciences (OADW); Medical Research Council; NHS National Commissioning Service for NMO; Myasthenia Gravis Foundation of America; MRC [G0701521] Funding Source: UKRI; Medical Research Council [G0701521] Funding Source: researchfish	University of Oxford; Myasthenia Gravis Association; Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Austrian Academy of Sciences (OADW); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS National Commissioning Service for NMO; Myasthenia Gravis Foundation of America; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AV is supported by the University of Oxford and her work on myasthenia has been funded previously by the Myasthenia Gravis Association, the Muscular Dystrophy Campaign and the Oxford NIHR Biomedical Research Centre. IK was supported by a studentship from the Austrian Academy of Sciences (OADW). JC receives salary support from the Medical Research Council. PW receives salary support from the University of Oxford and the NHS National Commissioning Service for NMO. DB receives salary support from the University of Oxford and research support from the Muscular Dystrophy Campaign, the Medical Research Council and the Myasthenia Gravis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; AUCOUTURIER P, 1984, J IMMUNOL METHODS, V74, P151, DOI 10.1016/0022-1759(84)90376-4; Bartoccioni E, 2006, NEUROLOGY, V67, P505, DOI 10.1212/01.wnl.0000228225.23349.5d; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Burden SJ, 2013, COLD SPRING HARB PER, V5; Cole RN, 2010, J PHYSIOL-LONDON, V588, P3217, DOI 10.1113/jphysiol.2010.190298; Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371; Cossins J, 2012, ANN NY ACAD SCI, V1275, P123, DOI 10.1111/j.1749-6632.2012.06833.x; Cossins J, 2012, HUM MOL GENET, V21, P3765, DOI 10.1093/hmg/dds198; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Diaz-Manera J, 2012, NEUROLOGY, V78, P189, DOI 10.1212/WNL.0b013e3182407982; Farrugia ME, 2007, J NEUROIMMUNOL, V185, P136, DOI 10.1016/j.jneuroim.2007.01.010; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Ghazanfari N, 2011, INT J BIOCHEM CELL B, V43, P295, DOI 10.1016/j.biocel.2010.10.008; Gordon LR, 2012, DEVELOPMENT, V139, P1023, DOI 10.1242/dev.071555; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113; Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016; KEMENY DM, 1983, J ALLERGY CLIN IMMUN, V72, P376, DOI 10.1016/0091-6749(83)90503-1; Keung B, 2013, J NEUROL NEUROSUR PS; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Khosroshahi A, 2010, ARTHRITIS RHEUM-US, V62, P1755, DOI 10.1002/art.27435; Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Klooster R, 2012, BRAIN, V135, P1081, DOI 10.1093/brain/aws025; Koneczny I, 2013, J ANAT; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; LESSOF MH, 1978, JOHNS HOPKINS MED J, V142, P1; MARGNI RA, 1988, ANNU REV IMMUNOL, V6, P535, DOI 10.1146/annurev.iy.06.040188.002535; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Mori S, 2012, J NEUROIMMUNOL; Mori S, 2012, AM J PATHOL, V180, P798, DOI 10.1016/j.ajpath.2011.10.031; Niks EH, 2008, J NEUROIMMUNOL, V195, P151, DOI 10.1016/j.jneuroim.2008.01.013; Nirula A, 2011, CURR OPIN RHEUMATOL, V23, P119, DOI 10.1097/BOR.0b013e3283412fd4; Ohno K, 2012, CLIN NEUROL, V52, P1306; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Punga AR, 2011, EUR J NEUROSCI, V33, P890, DOI 10.1111/j.1460-9568.2010.07569.x; Punga AR, 2012, CURR OPIN PHARMACOL, V12, P340, DOI 10.1016/j.coph.2012.02.002; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Shigemoto K, 2006, J CLIN INVEST, V116, P1016, DOI 10.1172/JCI21545; Spillane J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8497; Takamori M, 2013, J NEUROIMMUNOL, V254, P183, DOI 10.1016/j.jneuroim.2012.09.001; ter Beek WP, 2009, AM J PATHOL, V175, P1536, DOI 10.2353/ajpath.2009.090040; Tuzun E, 2011, MED PRIN PRACT, V20, P581, DOI 10.1159/000330031; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; Viegas S, 2012, EXP NEUROL, V234, P506, DOI 10.1016/j.expneurol.2012.01.025; VINCENT A, 1987, ANN NY ACAD SCI, V505, P106, DOI DOI 10.1111/J.1749-6632.1987.TB51286.X.PUBMED:2446546; Xu DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067900; Xu K, 2006, NEUROSCIENCE, V143, P655, DOI 10.1016/j.neuroscience.2006.09.022; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang B, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-7; Zhang W, 2011, J BIOL CHEM, V286, P40624, DOI 10.1074/jbc.M111.279307	57	105	111	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80695	10.1371/journal.pone.0080695	http://dx.doi.org/10.1371/journal.pone.0080695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244707	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900085
J	Reuscher, S; Akiyama, M; Mori, C; Aoki, K; Shibata, D; Shiratake, K				Reuscher, Stefan; Akiyama, Masahito; Mori, Chiharu; Aoki, Koh; Shibata, Daisuke; Shiratake, Katsuhiro			Genome-Wide Identification and Expression Analysis of Aquaporins in Tomato	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; MAJOR INTRINSIC PROTEINS; ARABIDOPSIS-THALIANA; NODULIN 26; PERIBACTEROID MEMBRANE; PLANT AQUAPORINS; HIGHLY DIVERGENT; WATER CHANNELS; MICRO-TOM; TRANSPORT	The family of aquaporins, also called water channels or major intrinsic proteins, is characterized by six transmembrane domains that together facilitate the transport of water and a variety of low molecular weight solutes. They are found in all domains of life, but show their highest diversity in plants. Numerous studies identified aquaporins as important targets for improving plant performance under drought stress. The phylogeny of aquaporins is well established based on model species like Arabidopsis thaliana, which can be used as a template to investigate aquaporins in other species. In this study we comprehensively identified aquaporin encoding genes in tomato (Solanum lycopersicum), which is an important vegetable crop and also serves as a model for fleshy fruit development. We found 47 aquaporin genes in the tomato genome and analyzed their structural features. Based on a phylogenetic analysis of the deduced amino acid sequences the aquaporin genes were assigned to five subfamilies (PIPs, TIPs, NIPs, SIPs and XIPs) and their substrate specificity was assessed on the basis of key amino acid residues. As ESTs were available for 32 genes, expression of these genes was analyzed in 13 different tissues and developmental stages of tomato. We detected tissue-specific and development-specific expression of tomato aquaporin genes, which is a first step towards revealing the contribution of aquaporins to water and solute transport in leaves and during fruit development.	[Reuscher, Stefan; Akiyama, Masahito; Mori, Chiharu; Shiratake, Katsuhiro] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Aoki, Koh] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan; [Shibata, Daisuke] Kazusa DNA Res Inst, Kisarazu, Japan	Nagoya University; Osaka Metropolitan University; Kazusa DNA Research Institute	Shiratake, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	shira@agr.nagoya-u.ac.jp	Shiratake, Katsuhiro/I-6888-2014		Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Society for the Promotion of Science (JSPS)	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from Bio-oriented Technology Research Advancement Institution (BRAIN) and by Grant-in-Aids for Scientific Research from The Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Azad AK, 2008, PLANT CELL PHYSIOL, V49, P1196, DOI 10.1093/pcp/pcn095; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bienert GP, 2011, PLANT J, V66, P306, DOI 10.1111/j.1365-313X.2011.04496.x; Bombarely A, 2011, NUCLEIC ACIDS RES, V39, pD1149, DOI 10.1093/nar/gkq866; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Chiba Y, 2009, PLANT J, V57, P810, DOI 10.1111/j.1365-313X.2008.03728.x; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Dean RM, 1999, BIOCHEMISTRY-US, V38, P347, DOI 10.1021/bi982110c; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; FAO, 2007, COPING WATER SCARCIT; Flexas J, 2006, PLANT J, V48, P427, DOI 10.1111/j.1365-313X.2006.02879.x; Forrest KL, 2008, FUNCT INTEGR GENOMIC, V8, P115, DOI 10.1007/s10142-007-0065-4; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Gerbeau P, 1999, PLANT J, V18, P577, DOI 10.1046/j.1365-313x.1999.00481.x; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Heckwolf M, 2011, PLANT J, V67, P795, DOI 10.1111/j.1365-313X.2011.04634.x; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; Johanson U, 2002, MOL BIOL EVOL, V19, P456, DOI 10.1093/oxfordjournals.molbev.a004101; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Johansson I, 1996, PLANT CELL, V8, P1181, DOI 10.1105/tpc.8.7.1181; Katsuhara M, 2008, FUNCT PLANT BIOL, V35, P1, DOI 10.1071/FP07130; Klebl F, 2003, FEBS LETT, V547, P69, DOI 10.1016/S0014-5793(03)00671-9; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li T, 2011, BIOCHEMISTRY-US, V50, P6633, DOI 10.1021/bi2004476; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Lopez D, 2012, J EXP BOT, V63, P2217, DOI 10.1093/jxb/err404; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; LUDEVID D, 1992, PLANT PHYSIOL, V100, P1633, DOI 10.1104/pp.100.4.1633; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Meissner R, 1997, PLANT J, V12, P1465, DOI 10.1046/j.1365-313x.1997.12061465.x; Mitani N, 2009, PLANT CELL, V21, P2133, DOI 10.1105/tpc.109.067884; Mitani-Ueno N, 2011, J EXP BOT, V62, P4391, DOI 10.1093/jxb/err158; Miwa K, 2010, ADV EXP MED BIOL, V679, P83; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Niemietz CM, 2000, FEBS LETT, V465, P110, DOI 10.1016/S0014-5793(99)01729-9; Page RD, 2002, CURR PROT BIOINFO; Pang Y, 2010, J GENET GENOMICS, V37, P1; Pang YQ, 2010, J GENET GENOMICS, V37, P389, DOI 10.1016/S1673-8527(09)60057-6; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Peret B, 2012, NAT CELL BIOL, V14, P991, DOI 10.1038/ncb2573; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rivers RL, 1997, J BIOL CHEM, V272, P16256, DOI 10.1074/jbc.272.26.16256; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Saito T, 2011, PLANT CELL PHYSIOL, V52, P283, DOI 10.1093/pcp/pcr004; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Soto G, 2008, FEBS LETT, V582, P4077, DOI 10.1016/j.febslet.2008.11.002; Soto G, 2010, PLANT J, V64, P1038, DOI 10.1111/j.1365-313X.2010.04395.x; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Van Wilder V, 2008, PLANT CELL PHYSIOL, V49, P1364, DOI 10.1093/pcp/pcn112; Wallace IS, 2006, BBA-BIOMEMBRANES, V1758, P1165, DOI 10.1016/j.bbamem.2006.03.024; Wallace IS, 2005, BIOCHEMISTRY-US, V44, P16826, DOI 10.1021/bi0511888; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Wallace IS, 2002, FEBS LETT, V523, P109, DOI 10.1016/S0014-5793(02)02955-1; WEAVER CD, 1991, PLANT PHYSIOL, V95, P222, DOI 10.1104/pp.95.1.222; Whiteman SA, 2008, PLANT J, V56, P146, DOI 10.1111/j.1365-313X.2008.03578.x; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Yano K, 2007, PLANT BIOTECHNOL-NAR, V24, P17, DOI 10.5511/plantbiotechnology.24.17; Zhang DY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056312, 10.1371/journal.pone.0077345]	82	131	136	7	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79052	10.1371/journal.pone.0079052	http://dx.doi.org/10.1371/journal.pone.0079052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260152	gold, Green Published, Green Submitted			2022-12-25	WOS:000327311900012
J	Johnson, SN; Riegler, M				Johnson, Scott N.; Riegler, Markus			Root Damage by Insects Reverses the Effects of Elevated Atmospheric CO2 on Eucalypt Seedlings	PLOS ONE			English	Article							CARBON-DIOXIDE; HERBIVORE INTERACTIONS; PLANT-RESPONSES; METAANALYSIS; PHOTOSYNTHESIS; TEMPERATURE; GROWTH; PESTS; PERFORMANCE; ACCLIMATION	Predicted increases in atmospheric carbon dioxide (CO2) are widely anticipated to increase biomass accumulation by accelerating rates of photosynthesis in many plant taxa. Little, however, is known about how soil-borne plant antagonists might modify the effects of elevated CO2 (eCO(2)), with root-feeding insects being particularly understudied. Root damage by insects often reduces rates of photosynthesis by disrupting root function and imposing water deficits. These insects therefore have considerable potential for modifying plant responses to eCO(2). We investigated how root damage by a soildwelling insect (Xylotrupes gideon australicus) modified the responses of Eucalyptus globulus to eCO(2). eCO(2) increased plant height when E. globulus were 14 weeks old and continued to do so at an accelerated rate compared to those grown at ambient CO2 (aCO(2)). Plants exposed to root-damaging insects showed a rapid decline in growth rates thereafter. In eCO(2), shoot and root biomass increased by 46 and 35%, respectively, in insect-free plants but these effects were arrested when soil-dwelling insects were present so that plants were the same size as those grown at aCO(2). Specific leaf mass increased by 29% under eCO(2), but at eCO(2) root damage caused it to decline by 16%, similar to values seen in plants at aCO(2) without root damage. Leaf C:N ratio increased by >30% at eCO(2) as a consequence of declining leaf N concentrations, but this change was also moderated by soil insects. Soil insects also reduced leaf water content by 9% at eCO(2), which potentially arose through impaired water uptake by the roots. We hypothesise that this may have impaired photosynthetic activity to the extent that observed plant responses to eCO(2) no longer occurred. In conclusion, soil-dwelling insects could modify plant responses to eCO(2) predicted by climate change plant growth models.	[Johnson, Scott N.; Riegler, Markus] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia	Western Sydney University	Johnson, SN (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia.	Scott.Johnson@uws.edu.au	Johnson, Scott/HDN-6310-2022; Johnson, Scott N/B-2268-2012	Johnson, Scott/0000-0002-8388-8345; Riegler, Markus/0000-0001-7363-431X	University of Western Sydney	University of Western Sydney	This research was funded with a personal start-up research allowance from the University of Western Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2013, ADV INSECT PHYSIOL, V45, P1, DOI 10.1016/B978-0-12-417165-7.00001-5; Barton CVM, 2010, AGR FOREST METEOROL, V150, P941, DOI 10.1016/j.agrformet.2010.03.001; BEDFORD G O, 1975, Journal of the Australian Entomological Society, V14, P213; COWIE RH, 1989, B ENTOMOL RES, V79, P173, DOI 10.1017/S0007485300018150; Coyle DR, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P134, DOI 10.1079/9781845934613.0134; Crous KY, 2011, GLOBAL CHANGE BIOL, V17, P1560, DOI 10.1111/j.1365-2486.2010.02325.x; Eldridge K., 1993, EUCALYPT DOMESTICATI; Frew A, 2013, FOREST ECOL MANAG, V306, P275, DOI 10.1016/j.foreco.2013.06.051; Ghannoum O, 2010, PLANT CELL ENVIRON, V33, P1671, DOI 10.1111/j.1365-3040.2010.02172.x; Gleadow RM, 1998, PLANT CELL ENVIRON, V21, P12, DOI 10.1046/j.1365-3040.1998.00258.x; Gregory P.J., 2006, PLANT ROOTS GROWTH A; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Hangay G., 2010, GUIDE BEETLES AUSTR; Henery ML, 2008, OECOLOGIA, V156, P847, DOI 10.1007/s00442-008-1042-x; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; IPCC, 2007, CONTRIBUTION WORKING, P391; JACOB J, 1995, PLANT CELL ENVIRON, V18, P875, DOI 10.1111/j.1365-3040.1995.tb00596.x; Johnson SN, 2012, ECOLOGY, V93, P2208, DOI 10.1890/11-2272.1; Johnson SN, 2011, GLOBAL CHANGE BIOL, V17, P688, DOI 10.1111/j.1365-2486.2010.02264.x; Johnson SN, 2010, OECOLOGIA, V162, P209, DOI 10.1007/s00442-009-1428-4; Johnson SN, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P1, DOI 10.1079/9781845934613.0000; JONGEN M, 1995, GLOB CHANGE BIOL, V1, P361, DOI 10.1111/j.1365-2486.1995.tb00034.x; Keane PJ, 2000, DIS PATHOGENS EUCALY; KILE GA, 1979, J AUST ENTOMOL SOC, V18, P7; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; McKiernan AB, 2012, J CHEM ECOL, V38, P204, DOI 10.1007/s10886-012-0071-4; Menzel C., 2002, LYCHEE CROP ASIA PAC; Murray TJ, 2013, GLOBAL CHANGE BIOL, V19, P1407, DOI 10.1111/gcb.12142; Murray TJ, 2013, OECOLOGIA, V171, P1025, DOI 10.1007/s00442-012-2467-9; Newingham BA, 2007, OECOLOGIA, V153, P913, DOI 10.1007/s00442-007-0791-2; Newman J.A., 2011, CLIMATE CHANGE BIOL; Newton AC, 2011, EUPHYTICA, V179, P3, DOI 10.1007/s10681-011-0359-4; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; OHMART CP, 1991, ANNU REV ENTOMOL, V36, P637, DOI 10.1146/annurev.en.36.010191.003225; Paine TD, 2011, ANNU REV ENTOMOL, V56, P181, DOI 10.1146/annurev-ento-120709-144817; Passioura JB, 2006, FUNCT PLANT BIOL, V33, P1075, DOI 10.1071/FP06223; PRIOR SA, 1995, J ENVIRON QUAL, V24, P678, DOI 10.2134/jeq1995.00472425002400040019x; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Rapley LP, 2007, CHEMOECOLOGY, V17, P235, DOI 10.1007/s00049-007-0382-z; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; Roden JS, 1996, GLOBAL CHANGE BIOL, V2, P115, DOI 10.1111/j.1365-2486.1996.tb00056.x; Roden JS, 1999, AUST J PLANT PHYSIOL, V26, P37, DOI 10.1071/PP98134; ROGERS HH, 1994, ENVIRON POLLUT, V83, P155, DOI 10.1016/0269-7491(94)90034-5; Rogers HH, 1996, PLANT SOIL, V187, P229, DOI 10.1007/BF00017090; RUEHLE JL, 1973, ANNU REV PHYTOPATHOL, V11, P99, DOI 10.1146/annurev.py.11.090173.000531; Salt DT, 1996, OIKOS, V77, P326, DOI 10.2307/3546072; Staley JT, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P192, DOI 10.1079/9781845934613.0192; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Turnbull JW, 1999, NEW FOREST, V17, P37, DOI 10.1023/A:1006524911242; Wilcken CF, 2002, SOCIOBIOLOGY, V40, P179; Wylie FR, 2011, INSECT PESTS TROPICA; Zavala JA, 2013, ANNU REV ENTOMOL, V58, P79, DOI 10.1146/annurev-ento-120811-153544; Zvereva EL, 2012, OECOLOGIA, V169, P441, DOI 10.1007/s00442-011-2210-y	53	11	12	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79479	10.1371/journal.pone.0079479	http://dx.doi.org/10.1371/journal.pone.0079479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260232	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500066
J	Lamb, DG; Calabrese, RL				Lamb, Damon G.; Calabrese, Ronald L.			Correlated Conductance Parameters in Leech Heart Motor Neurons Contribute to Motor Pattern Formation	PLOS ONE			English	Article							RHYTHMICALLY ACTIVE NEURONS; PREMOTOR SYNAPTIC INPUT; MEDICINAL LEECH; ALTERNATIVE OUTPUTS; HIRUDO-MEDICINALIS; INTERSEGMENTAL COORDINATION; LOCOMOTOR CIRCUITS; IDENTIFIED NEURONS; VOLTAGE CLAMP; GENERATOR	Neurons can have widely differing intrinsic membrane properties, in particular the density of specific conductances, but how these contribute to characteristic neuronal activity or pattern formation is not well understood. To explore the relationship between conductances, and in particular how they influence the activity of motor neurons in the well characterized leech heartbeat system, we developed a new multi-compartmental Hodgkin-Huxley style leech heart motor neuron model. To do so, we evolved a population of model instances, which differed in the density of specific conductances, capable of achieving specific output activity targets given an associated input pattern. We then examined the sensitivity of measures of output activity to conductances and how the model instances responded to hyperpolarizing current injections. We found that the strengths of many conductances, including those with differing dynamics, had strong partial correlations and that these relationships appeared to be linked by their influence on heart motor neuron activity. Conductances that had positive correlations opposed one another and had the opposite effects on activity metrics when perturbed whereas conductances that had negative correlations could compensate for one another and had similar effects on activity metrics.	[Lamb, Damon G.; Calabrese, Ronald L.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Calabrese, RL (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	ronald.calabrese@emory.edu		Calabrese, Ronald L./0000-0001-7135-3469	National Institutes of Health [NS-24072]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024072, R01NS085006, R56NS024072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by National Institutes of Health NS-24072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGSTADT JD, 1991, J NEUROSCI, V11, P746; Bower JM, 1998, BOOK GENESIS EXPLORI; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Crank J, 1947, PRACTICAL METHOD NUM, P50; Fisher R.A., 1924, METRON, V3, P329; Garcia PS, 2008, J NEUROPHYSIOL, V100, P1354, DOI 10.1152/jn.90579.2008; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; GRAMOLL S, 1994, J EXP BIOL, V186, P157; Grashow R, 2009, P NATL ACAD SCI USA, V106, P11742, DOI 10.1073/pnas.0905614106; Hendrickson EB, 2011, J COMPUT NEUROSCI, V30, P301, DOI 10.1007/s10827-010-0258-z; Hill AAV, 2002, J NEUROPHYSIOL, V87, P1586, DOI 10.1152/jn.00337.2001; Hill AAV, 2003, J NEUROPHYSIOL, V90, P531, DOI 10.1152/jn.00338.2003; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hudson AE, 2010, PHYSIOLOGY, V25, P311, DOI 10.1152/physiol.00019.2010; Hudson AE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000838; Ivanov AI, 2003, J NEUROSCI, V23, P1206, DOI 10.1523/JNEUROSCI.23-04-01206.2003; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kiehn O, 2010, BIOCHEM BIOPH RES CO, V396, P11, DOI 10.1016/j.bbrc.2010.02.107; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; Lamb Damon G, 2011, Neural Syst Circuits, V1, P13, DOI 10.1186/2042-1001-1-13; Lu J, 1999, J COMP PHYSIOL A, V184, P311, DOI 10.1007/s003590050329; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; MARANTO AR, 1984, J COMP PHYSIOL, V154, P367, DOI 10.1007/BF00605236; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; Mullins OJ, 2011, PROG NEUROBIOL, V93, P244, DOI 10.1016/j.pneurobio.2010.11.001; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2992, DOI 10.1152/jn.00877.2007; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2983, DOI 10.1152/jn.00407.2007; Norris BJ, 2006, J NEUROPHYSIOL, V96, P309, DOI 10.1152/jn.00011.2006; Norris BJ, 2011, J NEUROSCI, V31, P4663, DOI 10.1523/JNEUROSCI.5072-10.2011; Opdyke CA, 1995, J NEUROPHYSIOL, V74, P2524, DOI 10.1152/jn.1995.74.6.2524; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Ramirez JM, 2011, BRAIN, V134, P8, DOI 10.1093/brain/awq357; Ransdell JL, 2013, J NEUROSCI, V33, P9950, DOI 10.1523/JNEUROSCI.1095-13.2013; Rinberg A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002857; Roffman RC, 2012, J NEUROPHYSIOL, V107, P1681, DOI 10.1152/jn.00903.2011; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Smolinski TG, 2008, HYBRIDIZATION ROUGH, P204; Smolinski TG, 2009, BMC NEUROSCIENCE, V10; Smolinski TG, 2009, COMPUTATIONAL INTELL, P2964; Soofi W, 2012, J COMPUT NEUROSCI, V33, P77, DOI 10.1007/s10827-011-0375-3; Tang LS, 2012, J NEUROSCI, V32, P10075, DOI 10.1523/JNEUROSCI.1443-12.2012; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; THOMPSON WJ, 1976, J COMP PHYSIOL, V111, P309, DOI 10.1007/BF00606470; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2107, DOI 10.1152/jn.00026.2006; Tobin AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006742; TOLBERT LP, 1985, CELL TISSUE RES, V242, P257; Vanier MC, 1999, J COMPUT NEUROSCI, V7, P149, DOI 10.1023/A:1008972005316; Wenning A, 2004, J NEUROPHYSIOL, V91, P382, DOI 10.1152/jn.00526.2003; Wenning A, 2011, J NEUROPHYSIOL, V106, P2201, DOI 10.1152/jn.00519.2011; Wright TM, 2011, J NEUROPHYSIOL, V106, P538, DOI 10.1152/jn.00101.2011; Wright TM, 2011, J NEUROSCI, V31, P17555, DOI 10.1523/JNEUROSCI.4723-11.2011; Zhao SB, 2012, J NEUROSCI, V32, P13380, DOI 10.1523/JNEUROSCI.6500-11.2012	58	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79267	10.1371/journal.pone.0079267	http://dx.doi.org/10.1371/journal.pone.0079267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260181	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500039
J	Zeng, W; Zeng, A; Shang, MS; Zhang, YC				Zeng, Wei; Zeng, An; Shang, Ming-Sheng; Zhang, Yi-Cheng			Information Filtering in Sparse Online Systems: Recommendation via Semi-Local Diffusion	PLOS ONE			English	Article							DIVERSITY; ACCURACY	With the rapid growth of the Internet and overwhelming amount of information and choices that people are confronted with, recommender systems have been developed to effectively support users' decision-making process in the online systems. However, many recommendation algorithms suffer from the data sparsity problem, i.e. the user-object bipartite networks are so sparse that algorithms cannot accurately recommend objects for users. This data sparsity problem makes many well-known recommendation algorithms perform poorly. To solve the problem, we propose a recommendation algorithm based on the semi-local diffusion process on the user-object bipartite network. The simulation results on two sparse datasets, Amazon and Bookcross, show that our method significantly outperforms the state-of-the-art methods especially for those small-degree users. Two personalized semi-local diffusion methods are proposed which further improve the recommendation accuracy. Finally, our work indicates that sparse online systems are essentially different from the dense online systems, so it is necessary to reexamine former algorithms and conclusions based on dense data in sparse systems.	[Zeng, Wei; Shang, Ming-Sheng; Zhang, Yi-Cheng] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Zeng, Wei; Zeng, An; Zhang, Yi-Cheng] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Shang, Ming-Sheng; Zhang, Yi-Cheng] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China	University of Electronic Science & Technology of China; University of Fribourg; Hangzhou Normal University	Zeng, A (corresponding author), Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland.	an.zeng@unifr.ch; shang.mingsheng@gmail.com	Zeng, Wei/O-4804-2017		opening foundation of Institute of Information Economy in Hangzhou Normal University [PD12001003002002]; Sichuan Provincial Science and Technology Department [2012FZ0120]; Sino-Swiss Science and Technology Cooperation Program [EG57-092011]; China Scholarship Council	opening foundation of Institute of Information Economy in Hangzhou Normal University; Sichuan Provincial Science and Technology Department; Sino-Swiss Science and Technology Cooperation Program; China Scholarship Council(China Scholarship Council)	This work is supported by the opening foundation of Institute of Information Economy in Hangzhou Normal University (Grant No. PD12001003002002) and the Sichuan Provincial Science and Technology Department (Grant No. 2012FZ0120). W.Z. acknowledges the support from Sino-Swiss Science and Technology Cooperation Program (EG57-092011). A.Z. acknowledges the support from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Hu YF, 2008, IEEE DATA MINING, P263, DOI 10.1109/ICDM.2008.22; Jamali M., 2010, P 4 ACM C REC SYST, P135, DOI DOI 10.1145/1864708.1864736; Jamali M, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P397; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Ma H., 2011, P WSDM, P287, DOI 10.1145/1935826.1935877; Maslov S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248701; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Qiu T, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/58003; Shang MS, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48006; Shang MS, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/68008; Shi Y, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P175, DOI 10.1145/2348283.2348310; Slanina F, 2005, ACTA PHYS POL B, V36, P2797; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049126; Yang SH, 2011, P 20 INT C WORLD WID, P537; Yuan Quan, 2011, FACTORIZATION VS REG, P245, DOI DOI 10.1145/2043932.2043975; Zeng A, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18005; Zeng W, 2010, INT J MOD PHYS C, V21, P1217, DOI 10.1142/S0129183110015786; Zhang FG, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/58005; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062624; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648; Zhou T, 2010, P NATL ACAD SCI USA, V107, P4511, DOI 10.1073/pnas.1000488107; Zhou T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123008; ZIEGLER CN, 2005, P 14 INT C WORLD WID	29	16	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79354	10.1371/journal.pone.0079354	http://dx.doi.org/10.1371/journal.pone.0079354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260206	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500051
J	Haeri, M; Calvert, PD; Solessio, E; Pugh, EN; Knox, BE				Haeri, Mohammad; Calvert, Peter D.; Solessio, Eduardo; Pugh, Edward N., Jr.; Knox, Barry E.			Regulation of Rhodopsin-eGFP Distribution in Transgenic Xenopus Rod Outer Segments by Light	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; VERTEBRATE PHOTORECEPTORS; FUSION PROTEIN; INTRAFLAGELLAR TRANSPORT; MONOCLONAL-ANTIBODIES; MEMBRANE ADDITION; RETINAL RODS; C-TERMINUS; BIREFRINGENCE; EXPRESSION	The rod outer segment (OS), comprised of tightly stacked disk membranes packed with rhodopsin, is in a dynamic equilibrium governed by a diurnal rhythm with newly synthesized membrane inserted at the OS base balancing membrane loss from the distal tip via disk shedding. Using transgenic Xenopus and live cell confocal imaging, we found OS axial variation of fluorescence intensity in cells expressing a fluorescently tagged rhodopsin transgene. There was a light synchronized fluctuation in intensity, with higher intensity in disks formed at night and lower intensity for those formed during the day. This fluctuation was absent in constant light or dark conditions. There was also a slow modulation of the overall expression level that was not synchronized with the lighting cycle or between cells in the same retina. The axial variations of other membrane-associated fluorescent proteins, eGFP-containing two geranylgeranyl acceptor sites and eGFP fused to the transmembrane domain of syntaxin, were greatly reduced or not detectable, respectively. In acutely lightadapted rods, an arrestin-eGFP fusion protein also exhibited axial variation. Both the light-sensitive Rho-eGFP and arrestineGFP banding were in phase with the previously characterized birefringence banding (Kaplan, Invest. Ophthalmol. Vis. Sci. 21, 395-402 1981). In contrast, endogenous rhodopsin did not exhibit such axial variation. Thus, there is an axial inhomogeneity in membrane composition or structure, detectable by the rhodopsin transgene density distribution and regulated by the light cycle, implying a light-regulated step for disk assembly in the OS. The impact of these results on the use of chimeric proteins with rhodopsin fused to fluorescent proteins at the carboxyl terminus is discussed.	[Haeri, Mohammad; Calvert, Peter D.; Solessio, Eduardo; Knox, Barry E.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Haeri, Mohammad; Calvert, Peter D.; Solessio, Eduardo; Knox, Barry E.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Haeri, Mohammad; Calvert, Peter D.; Solessio, Eduardo; Knox, Barry E.] SUNY Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA; [Pugh, Edward N., Jr.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of California System; University of California Davis	Knox, BE (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.	knoxb@upstate.edu			National Institutes of Health [EY-11256, EY-12975 (BEK), EY018421 (PDC), EY02660 (ENP)]; Research to Prevent Blindness; Lions of CNY; NATIONAL EYE INSTITUTE [R01EY011256, R01EY012975, R01EY018421, R01EY002660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Lions of CNY; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the National Institutes of Health grants EY-11256, EY-12975 (BEK), EY018421 (PDC) and EY02660 (ENP), Research to Prevent Blindness (Unrestricted Grant to SUNY UMU Department of Ophthalmology) and the Lions of CNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; ANDREWS LD, 1985, INVEST OPHTH VIS SCI, V26, P778; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; BESHARSE JC, 1977, J CELL BIOL, V75, P507, DOI 10.1083/jcb.75.2.507; BESHARSE JC, 1977, SCIENCE, V196, P536, DOI 10.1126/science.300504; Besharse JC, 1980, LIGHT MEMBRANE BIOGE, P409; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P18867; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; CORLESS JM, 1979, BIOPHYS J, V26, P543, DOI 10.1016/S0006-3495(79)85270-4; Green CB, 1996, MOL BRAIN RES, V37, P157, DOI 10.1016/0169-328X(95)00307-E; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Haeri M, 2013, BIOPHYS J, V104, P300, DOI 10.1016/j.bpj.2012.11.3835; Haeri Mohammad, 2012, Methods Mol Biol, V884, P17, DOI 10.1007/978-1-61779-848-1_2; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hollemann T, 1998, DEVELOPMENT, V125, P2425; HOLLYFIELD JG, 1982, EXP EYE RES, V34, P115, DOI 10.1016/0014-4835(82)90013-6; HOLLYFIELD JG, 1982, INVEST OPHTH VIS SCI, V23, P631; HOLLYFIELD JG, 1982, INVEST OPHTH VIS SCI, V22, P417; Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554; Jin S, 2003, FEBS LETT, V542, P142, DOI 10.1016/S0014-5793(03)00368-5; KAPLAN MW, 1989, EXP EYE RES, V49, P1045, DOI 10.1016/S0014-4835(89)80025-9; KAPLAN MW, 1978, BIOPHYS J, V23, P59, DOI 10.1016/S0006-3495(78)85432-0; KAPLAN MW, 1982, VISION RES, V22, P1119, DOI 10.1016/0042-6989(82)90076-1; KAPLAN MW, 1981, INVEST OPHTH VIS SCI, V21, P395; KAPLAN MW, 1982, METHOD ENZYMOL, V81, P655; KAPLAN MW, 1981, J OPT SOC AM, V71, P1467, DOI 10.1364/JOSA.71.001467; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; KRETZER F, 1982, J MICROSC-OXFORD, V128, P287, DOI 10.1111/j.1365-2818.1982.tb04631.x; Luo WQ, 2004, J NEUROSCI, V24, P2623, DOI 10.1523/JNEUROSCI.5302-03.2004; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Mani SS, 1999, J BIOL CHEM, V274, P15590, DOI 10.1074/jbc.274.22.15590; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Najafi M, 2012, J GEN PHYSIOL, V140, P249, DOI 10.1085/jgp.201210818; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pearring JN, 2013, PROG RETIN EYE RES; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; Roberts NW, 2006, VISION RES, V46, P3259, DOI 10.1016/j.visres.2006.03.019; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; SCHNETKAMP PPM, 1993, J BIOL CHEM, V268, P12449; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700	55	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80059	10.1371/journal.pone.0080059	http://dx.doi.org/10.1371/journal.pone.0080059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260336	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600053
J	Pisani, F; Sparaneo, A; Tortorella, C; Ruggieri, M; Trojano, M; Mola, MG; Nicchia, GP; Frigeri, A; Svelto, M				Pisani, Francesco; Sparaneo, Angelo; Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria; Mola, Maria Grazia; Nicchia, Grazia Paola; Frigeri, Antonio; Svelto, Maria			Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity	PLOS ONE			English	Article							INDIRECT IMMUNOFLUORESCENCE ASSAYS; MULTIPLE-SCLEROSIS; WATER CHANNEL; ANTI-AQUAPORIN-4 ANTIBODIES; SCANNING MECHANISM; IGG; TRANSLATION; ASTROCYTES; DIAGNOSIS; JAPANESE	Neuromyelitis Optica (NMO) is an autoimmune demyelinating disease, characterized by the presence of autoantibody (NMO-IgG) to Aquaporin-4 (AQP4). NMO-IgG identification supports NMO diagnosis and several diagnostic tests have been developed, but their sensitivity is too variable, and some assay show low sensitivity. This impairs correct diagnosis of NMO. By cell based assay (CBA) we here evaluate the efficacy of different strategies to express AQP4 in mammalian cells in terms of: a) AQP4 translation initiation signals; b) AQP4 isoforms (M1 and M23) and fluorescent tag position; c) NMO serum concentration and AQP4 degradation. Our results demonstrate that when using AQP4-M1, the nucleotide in position -3 of the AUG greatly affects the AQP4-M1/M23 protein ratio, NMO-IgG binding, and consequently test sensitivity. Test sensitivity was highest with M23 expressing cells (97.5%) and only 27.5% with AQP4-M1. The fluorescent tag added to the N-terminus of AQP4-M23 considerably affected the NMO-IgG binding, and test sensitivity, due to disruption of AQP4 suprastructures. Furthermore, sera used at high concentration resulted in AQP4 degradation which affected test sensitivity. To further evaluate the reliability of the M23 based CBA test, samples of one NMO patient collected during about 2 years clinical follow-up were tested. The results of serum titer correlated with disease activity and treatment response. In conclusion, we provide a molecular explanation for the contrasting CBA test data reported and suggest the use of M23 with a C-terminus fluorescent tag as the proper test for NMO diagnosis.	[Pisani, Francesco; Sparaneo, Angelo; Mola, Maria Grazia; Nicchia, Grazia Paola; Frigeri, Antonio; Svelto, Maria] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Pisani, Francesco; Sparaneo, Angelo; Mola, Maria Grazia; Nicchia, Grazia Paola; Frigeri, Antonio; Svelto, Maria] Univ Bari Aldo Moro, Ctr Excellence Comparat Genom, Bari, Italy; [Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria] Univ Bari Aldo Moro, Dept Neurosci & Sense Organs, Bari, Italy; [Nicchia, Grazia Paola; Frigeri, Antonio] Dominick P Purpura Dept Neurosci, Bronx, NY USA	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Frigeri, A (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	antonio.frigeri@uniba.it	Svelto, Maria/P-6186-2014; frigeri, Antonio/AAC-6336-2022; Mola, Maria Grazia/I-3507-2019; PISANI, Francesco/AAC-1749-2019; Sparaneo, Angelo/B-4689-2017; tortorella, carla/J-2557-2012	Mola, Maria Grazia/0000-0002-4421-9237; PISANI, Francesco/0000-0001-8511-117X; Svelto, Maria/0000-0002-5584-9541; Trojano, Maria/0000-0002-6329-8946; tortorella, carla/0000-0001-9037-7300; Sparaneo, Angelo/0000-0002-3211-3072; Frigeri, Antonio/0000-0002-5284-2934	MIUR; FIRB [RBFR12SJA8]; PON project [01_01297]	MIUR(Ministry of Education, Universities and Research (MIUR)); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PON project(Ministry of Education, Universities and Research (MIUR))	This work was financially supported by: MIUR, FIRB project RBFR12SJA8 and PON project 01_01297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Apiwattanakul M, 2012, J NEUROL SCI, V320, P118, DOI 10.1016/j.jns.2012.07.014; Chan KH, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-50; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Fan Y, 2005, J NEUROSCI RES, V82, P458, DOI 10.1002/jnr.20664; Fazio R, 2009, MULT SCLER J, V15, P1153, DOI 10.1177/1352458509106851; FRIGERI A, 1995, P NATL ACAD SCI USA, V92, P4328, DOI 10.1073/pnas.92.10.4328; Grazia Paola Nicchia FP, 2013, WILEY INTERDISCIPLIN; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hinson SR, 2012, P NATL ACAD SCI USA, V109, P1245, DOI 10.1073/pnas.1109980108; Iorio R, 2013, J AUTOIMMUN, V40, P21, DOI 10.1016/j.jaut.2012.07.008; Isobe N, 2012, MULT SCLER J, V18, P1541, DOI 10.1177/1352458512443917; Jarius S, 2012, J NEUROL SCI, V320, P32, DOI 10.1016/j.jns.2012.06.002; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jiao Y, 2013, NEUROLOGY; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Kim W, 2012, MULT SCLER J, V18, P578, DOI 10.1177/1352458511424590; Kim YJ, 2012, J CLIN LAB ANAL, V26, P184, DOI 10.1002/jcla.21508; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Marignier R, 2013, NEUROLOGY; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; McKeon A, 2009, ARCH NEUROL-CHICAGO, V66, P1134, DOI 10.1001/archneurol.2009.178; Nicchia GP, 2010, NEUROSCIENCE, V168, P903, DOI 10.1016/j.neuroscience.2010.02.008; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Pisani F, 2011, GLIA, V59, P1923, DOI 10.1002/glia.21234; Pisani F, 2011, J BIOL CHEM, V286, P9216, DOI 10.1074/jbc.M110.123000; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rossi A, 2012, GLIA, V60, P2027, DOI 10.1002/glia.22417; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Sato DK, 2013, NEUROLOGY; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Waters P, 2008, Int MS J, V15, P99; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Yoshimura S, 2013, J NEUROL NEUROSUR PS, V84, P29, DOI 10.1136/jnnp-2012-302925	41	24	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79185	10.1371/journal.pone.0079185	http://dx.doi.org/10.1371/journal.pone.0079185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260168	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600021
J	Ferrandez-Ayela, A; Micol-Ponce, R; Sanchez-Garcia, AB; Alonso-Peral, MM; Micol, JL; Ponce, MR				Ferrandez-Ayela, Almudena; Micol-Ponce, Rosa; Belen Sanchez-Garcia, Ana; Magdalena Alonso-Peral, Maria; Micol, Jose Luis; Ponce, Maria Rosa			Mutation of an Arabidopsis NatB N-Alpha-Terminal Acetylation Complex Component Causes Pleiotropic Developmental Defects	PLOS ONE			English	Article							SMALL RNAS; SEQUENCE REQUIREMENTS; LEAF MORPHOGENESIS; PROTEIN-KINASE; GTPASE ARL3P; GENE; YEAST; ACETYLTRANSFERASE; IDENTIFICATION; DEGRADATION	N-alpha-terminal acetylation is one of the most common, but least understood modifications of eukaryotic proteins. Although a high degree of conservation exists between the N-alpha-terminal acetylomes of plants and animals, very little information is available on this modification in plants. In yeast and humans, N-alpha-acetyltransferase complexes include a single catalytic subunit and one or two auxiliary subunits. Here, we report the positional cloning of TRANSCURVATA2 (TCU2), which encodes the auxiliary subunit of the NatB N-alpha-acetyltransferase complex in Arabidopsis. The phenotypes of loss-of-function tcu2 alleles indicate that NatB complex activity is required for flowering time regulation and for leaf, inflorescence, flower, fruit and embryonic development. In double mutants, tcu2 alleles synergistically interact with alleles of ARGONAUTE10, which encodes a component of the microRNA machinery. In summary, NatB-mediated N-alpha-terminal acetylation of proteins is pleiotropically required for Arabidopsis development and seems to be functionally related to the microRNA pathway.	[Ferrandez-Ayela, Almudena; Micol-Ponce, Rosa; Belen Sanchez-Garcia, Ana; Magdalena Alonso-Peral, Maria; Micol, Jose Luis; Ponce, Maria Rosa] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain	Universidad Miguel Hernandez de Elche	Ponce, MR (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Campus Elche, Elche, Spain.	mrponce@umh.es	Micol-Ponce, Rosa/T-9815-2017; Micol, José Luis/B-4832-2010; Ponce, María Rosa/C-8203-2014	Micol-Ponce, Rosa/0000-0001-9389-2906; Micol, José Luis/0000-0002-0396-1750; Ponce, María Rosa/0000-0003-0770-4230; Sanchez-Garcia, Ana Belen/0000-0002-1315-8400	Ministerio de Economia y Competitividad of Spain [BIO2008-01900]; Generalitat Valenciana [PROMETEO/2009/112]; Ministerio de Ciencia e Innovacion of Spain	Ministerio de Economia y Competitividad of Spain(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by grants from the Ministerio de Economia y Competitividad of Spain (BIO2008-01900 to M.R.P.) and the Generalitat Valenciana (PROMETEO/2009/112 to M. R. P. and J.L.M.). A. F.-A. and M. M. A.-P. hold fellowships from the Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aivaliotis M, 2007, J PROTEOME RES, V6, P2195, DOI 10.1021/pr0700347; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Berna G, 1999, GENETICS, V152, P729; Bienvenut WV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015131; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Caesar R, 2006, EUKARYOT CELL, V5, P368, DOI 10.1128/EC.5.2.368-378.2006; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Candela H, 1999, DEV BIOL, V205, P205, DOI 10.1006/dbio.1998.9111; Carles CC, 2003, TRENDS PLANT SCI, V8, P394, DOI 10.1016/S1360-1385(03)00164-X; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coulton AT, 2010, J CELL SCI, V123, P3235, DOI 10.1242/jcs.069971; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Falb M, 2006, J MOL BIOL, V362, P915, DOI 10.1016/j.jmb.2006.07.086; Fischer K, 1997, PLANT CELL, V9, P453, DOI 10.1105/tpc.9.3.453; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Geissenhoner A, 2004, MOL CELL BIOL, V24, P10300, DOI 10.1128/MCB.24.23.10300-10312.2004; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Goldshmidt A, 2008, PLANT CELL, V20, P1217, DOI 10.1105/tpc.107.057877; Gonzalez-Bayon R, 2006, J EXP BOT, V57, P3019, DOI 10.1093/jxb/erl063; Gonzalez-Reig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003020; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; JEFFERSON RA, 1987, EMBO J, V6, P3901; Ji LZ, 2011, PURE APPL MATH Q, V7, P1, DOI 10.1371/journal.pgen.1001358; JORNVALL H, 1975, J THEOR BIOL, V55, P1, DOI 10.1016/S0022-5193(75)80105-6; Jover-Gil S, 2005, INT J DEV BIOL, V49, P733, DOI 10.1387/ijdb.052015sj; Jover-Gil S, 2012, PLANT CELL PHYSIOL, V53, P1322, DOI 10.1093/pcp/pcs077; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Kinsman EA, 1998, DEVELOPMENT, V125, P1815; Kreft SG, 2011, J BIOL CHEM, V286, P20163, DOI 10.1074/jbc.M110.196360; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LI HM, 1995, PLANT CELL, V7, P1599, DOI 10.1105/tpc.7.10.1599; Liu QL, 2009, PLANT J, V58, P27, DOI 10.1111/j.1365-313X.2008.03757.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Perez-Perez JM, 2013, PLANT PHYSIOL, V162, P589, DOI 10.1104/pp.113.217323; MCCONNELL JR, 1995, DEV GENET, V16, P358, DOI 10.1002/dvg.1020160409; Molla-Morales A, 2011, PLANT J, V65, P335, DOI 10.1111/j.1365-313X.2010.04425.x; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Murthi A, 2005, GENETICS, V170, P1553, DOI 10.1534/genetics.105.043620; NARITA K, 1958, BIOCHIM BIOPHYS ACTA, V28, P184, DOI 10.1016/0006-3002(58)90445-1; Pena MMO, 2009, J BIOL CHEM, V284, P31597, DOI 10.1074/jbc.M109.038455; Perez-Perez JM, 2004, PLANT PHYSIOL, V134, P101, DOI 10.1104/pp.103.032524; Perrot M, 2008, YEAST, V25, P513, DOI 10.1002/yea.1602; PERSSON B, 1985, EUR J BIOCHEM, V152, P523, DOI 10.1111/j.1432-1033.1985.tb09227.x; Pesaresi P, 2003, PLANT CELL, V15, P1817, DOI 10.1105/tpc.012377; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Ponce M. Rosa, 2006, V323, P105; Ponce MR, 1999, MOL GEN GENET, V261, P408, DOI 10.1007/s004380050982; Ponce MR, 1998, PLANT J, V14, P497, DOI 10.1046/j.1365-313X.1998.00146.x; Pulido A, 2010, J EXP BOT, V61, P1277, DOI 10.1093/jxb/erp397; Ripoll JJ, 2006, DEV BIOL, V289, P346, DOI 10.1016/j.ydbio.2005.10.037; Robles P, 2001, MOL GENET GENOMICS, V266, P12, DOI [10.1007/s004380100353, 10.1007/s004380100535]; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Rosar C, 2012, MOL PLANT, V5, P1227, DOI 10.1093/mp/sss045; Rubio-Diaz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036500; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Starheim Kristian K, 2009, BMC Proc, V3 Suppl 6, pS3, DOI 10.1186/1753-6561-3-S6-S3; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang XR, 2004, GENETICS, V168, P547, DOI 10.1534/genetics.104.028803; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x; Zhang ZH, 2012, CURR OPIN PLANT BIOL, V15, P652, DOI 10.1016/j.pbi.2012.05.007; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	89	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80697	10.1371/journal.pone.0080697	http://dx.doi.org/10.1371/journal.pone.0080697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244708	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800158
J	Vafiadaki, E; Arvanitis, DA; Sanoudou, D; Kranias, EG				Vafiadaki, Elizabeth; Arvanitis, Demetrios A.; Sanoudou, Despina; Kranias, Evangelia G.			Identification of a Protein Phosphatase-1/Phospholamban Complex That Is Regulated by cAMP-Dependent Phosphorylation	PLOS ONE			English	Article							GLYCOGEN-TARGETING SUBUNIT; RABBIT SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; PHOSPHATASE 1; CARDIAC PHYSIOLOGY; INSULIN-RESISTANCE; CATALYTIC SUBUNIT; PHOSPHOLAMBAN; INHIBITOR-1; CONTRACTILITY	In human and experimental heart failure, the activity of the type 1 phosphatase is significantly increased, associated with dephosphorylation of phospholamban, inhibition of the sarco(endo) plasmic reticulum Ca2+ transport ATPase (SERCA2a) and depressed function. In the current study, we investigated the molecular mechanisms controlling protein phosphatase-1 activity. Using recombinant proteins and complementary in vitro binding studies, we identified a multi-protein complex centered on protein phosphatase-1 that includes its muscle specific glycogen-targeting subunit GM and substrate phospholamban. GM interacts directly with phospholamban and this association is mediated by the cytosolic regions of the proteins. Our findings suggest the involvement of GM in mediating formation of the phosphatase-1/GM/phospholamban complex through the direct and independent interactions of GM with both protein phosphatase-1 and phospholamban. Importantly, the protein phosphatase-1/GM/phospholamban complex dissociates upon protein kinase A phosphorylation, indicating its significance in the beta-adrenergic signalling axis. Moreover, protein phosphatase-1 activity is regulated by two binding partners, inhibitor-1 and the small heat shock protein 20, Hsp20. Indeed, human genetic variants of inhibitor-1 (G147D) or Hsp20 (P20L) result in reduced binding and inhibition of protein phosphatase-1, suggesting aberrant enzymatic regulation in human carriers. These findings provide insights into the mechanisms underlying fine-tuned regulation of protein phosphatase-1 and its impact on the SERCA2/phospholamban interactome in cardiac function.	[Vafiadaki, Elizabeth; Arvanitis, Demetrios A.; Sanoudou, Despina; Kranias, Evangelia G.] Acad Athens, Biomed Res Fdn, Div Mol Biol, Athens, Greece; [Sanoudou, Despina] Univ Athens, Sch Med, Dept Pharmacol, GR-10679 Athens, Greece; [Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; University System of Ohio; University of Cincinnati	Kranias, EG (corresponding author), Acad Athens, Biomed Res Fdn, Div Mol Biol, Athens, Greece.	Litsa.Kranias@uc.edu	Arvanitis, Demetrios A/J-6434-2017; Sanoudou, Despina/AAD-8139-2019; Vafiadaki, Elizabeth/K-1171-2019	Arvanitis, Demetrios A/0000-0003-1231-320X; Sanoudou, Despina/0000-0003-3704-1941; 	European Community [HEALTH-F2-2009-241526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026057, R01HL064018] Funding Source: NIH RePORTER	European Community(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research leading to these results has received funding from the European Community's Seventh Framework Program FP7/2007-2013 under grant agreement no HEALTH-F2-2009-241526, EUTrigTreat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Arvanitis DA, 2007, AM J PHYSIOL-HEART C, V293, pH1581, DOI 10.1152/ajpheart.00278.2007; Aschenbach WG, 2001, J BIOL CHEM, V276, P39959, DOI 10.1074/jbc.M105518200; Beca S, 2013, CIRC RES, V112, P289, DOI 10.1161/CIRCRESAHA.111.300003; Berrebi-Bertrand I, 1998, FEBS LETT, V439, P224, DOI 10.1016/S0014-5793(98)01364-7; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Brixius K, 2003, EUR HEART J, V24, P16, DOI 10.1016/S0195-668X(03)93706-7; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Chen GL, 2008, FASEB J, V22, P1790, DOI 10.1096/fj.07-097428; Choy MS, 2012, BIOCHEM SOC T, V40, P969, DOI 10.1042/BST20120094; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Chu GX, 2004, CIRC RES, V94, P184, DOI 10.1161/01.RES.0000107198.90218.21; COHEN P, 1989, J BIOL CHEM, V264, P21435; Delibegovic M, 2003, DIABETES, V52, P596, DOI 10.2337/diabetes.52.3.596; Dohke T, 2006, J CARD FAIL, V12, P77, DOI 10.1016/j.cardfail.2005.07.006; Edwards HV, 2012, BIOCHEM J, V446, P437, DOI 10.1042/BJ20120570; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; El-Armouche A, 2004, CARDIOVASC RES, V61, P87, DOI 10.1016/j.cardiores.2003.11.005; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Fan GC, 2011, J MOL CELL CARDIOL, V51, P574, DOI 10.1016/j.yjmcc.2010.09.013; Fish KM, 2013, CIRC-HEART FAIL, V6, P310, DOI 10.1161/CIRCHEARTFAILURE.112.971325; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; HUBBARD MJ, 1990, EUR J BIOCHEM, V189, P243, DOI 10.1111/j.1432-1033.1990.tb15483.x; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P701, DOI 10.1111/j.1432-1033.1989.tb15263.x; Ikeda Y, 2008, PHYSIOLOGY, V23, P6, DOI 10.1152/physiol.00033.2007; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Kuschel M, 1999, AM J PHYSIOL-HEART C, V276, pH1625, DOI 10.1152/ajpheart.1999.276.5.H1625; Lee LCY, 2013, FUTURE MED CHEM, V5, P451, DOI [10.4155/FMC.12.216, 10.4155/fmc.12.216]; Liu J, 2000, J BIOL CHEM, V275, P26074, DOI 10.1074/jbc.M003843200; Liu J, 2000, BIOCHEM J, V346, P77, DOI 10.1042/0264-6021:3460077; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MacLennan DH, 1998, ANN NY ACAD SCI, V853, P31, DOI 10.1111/j.1749-6632.1998.tb08254.x; Miyazaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035875; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Nicolaou P, 2009, FRONT BIOSCI-LANDMRK, V14, P3571, DOI 10.2741/3472; Nicolaou P, 2008, J BIOL CHEM, V283, P33465, DOI 10.1074/jbc.M802307200; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Qian J, 2011, CIRC RES, V108, P1429, DOI 10.1161/CIRCRESAHA.110.237644; Qian J, 2009, CIRC RES, V105, P1223, DOI 10.1161/CIRCRESAHA.109.200378; Savage David B, 2008, PLoS Med, V5, pe27, DOI 10.1371/journal.pmed.0050027; Savage DB, 2002, NAT GENET, V31, P379, DOI 10.1038/ng926; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897; Sin YY, 2011, J MOL CELL CARDIOL, V50, P872, DOI 10.1016/j.yjmcc.2011.02.006; Singh A, 2011, MOL PHARMACOL, V79, P533, DOI 10.1124/mol.110.065425; STRALFORS P, 1985, EUR J BIOCHEM, V149, P295, DOI 10.1111/j.1432-1033.1985.tb08926.x; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Vafiadaki E, 2007, J MOL BIOL, V367, P65, DOI 10.1016/j.jmb.2006.10.057; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; Walker KS, 2000, FEBS LETT, V466, P121, DOI 10.1016/S0014-5793(99)01771-8; Wittkopper K, 2011, CARDIOVASC RES, V91, P392, DOI 10.1093/cvr/cvr058; Wu J, 1998, FEBS LETT, V439, P185, DOI 10.1016/S0014-5793(98)01371-4; Xia J, 1998, DIABETES, V47, P1519, DOI 10.2337/diabetes.47.9.1519	58	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80867	10.1371/journal.pone.0080867	http://dx.doi.org/10.1371/journal.pone.0080867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244723	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800170
J	Ong, SJ; Huang, YC; Tan, HY; Ma, DHK; Lin, HC; Yeh, LK; Chen, PYF; Chen, HC; Chuang, CC; Chang, CJ; Hsiao, CH				Ong, Sherine Jue; Huang, Yhu-Chering; Tan, Hsin-Yuan; Ma, David H. K.; Lin, Hsin-Chiung; Yeh, Lung-Kun; Chen, Phil Y. F.; Chen, Hung-Chi; Chuang, Chih-Chun; Chang, Chee-Jen; Hsiao, Ching-Hsi			Staphylococcus aureus Keratitis: A Review of Hospital Cases	PLOS ONE			English	Review							METHICILLIN-RESISTANT; BACTERIAL KERATITIS; MOLECULAR EPIDEMIOLOGY; MICROBIAL KERATITIS; OCULAR INFECTIONS; SHIFTING TRENDS; RISK-FACTORS; TAIWAN; LEVOFLOXACIN; BACTEREMIA	Background: Methicillin-resistant Staphylococcus aureus (MRSA) infection is an important public health issue. The study aimed to characterize the patient demographics, clinical features, antibiotic susceptibility, and clinical outcomes of keratitis caused by S. aureus, and to make a comparison between MRSA and methicillin-sensitive S. aureus (MSSA) isolates. Methodology/Principal findings: Patients (n = 59) with culture-proven S. aureus keratitis treated in Chang Gung Memorial Hospital between January 1, 2006, and December 31, 2010, were included in our study. Patients' demographic and clinical data were retrospectively reviewed. Twenty-six MRSA (44%) and 33 MSSA (56%) isolates were collected. The MRSA keratitis was significantly more common among the patients with healthcare exposure (P = 0.038), but 46.2% (12/26) of patients with MRSA keratitis were considered to have community-associated infections. All isolates were susceptible to vancomycin. MRSA isolates were significantly more resistant to clindamycin, erythromycin, and sulfamethoxazole/trimethoprim. Ocular surface disease was a significant risk factor for MRSA keratitis (P = 0.011). Visual outcome did not differ significantly between the MRSA and MSSA groups. However, age (B = 0.01, P = 0.035, 95% confidence interval [CI]: 0.001-0.019) and visual acuity at presentation (B = 0.749, P<0.001, 95% CI: 0.573-0.926) were significantly correlated with visual outcome. Conclusions/Significance: Ocular surface disease is an important predisposing factor for S. aureus keratitis, especially for MRSA infections. Advanced age and poor visual acuity at presentation are important prognostic indicators for poor visual outcome in S. aureus keratitis. Oxacillin resistance may not be a significant prognostic indicator.	[Ong, Sherine Jue; Tan, Hsin-Yuan; Ma, David H. K.; Lin, Hsin-Chiung; Yeh, Lung-Kun; Chen, Phil Y. F.; Chen, Hung-Chi; Hsiao, Ching-Hsi] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp, Div Pediat Infect Dis, Dept Pediat, Linkou, Taiwan; [Huang, Yhu-Chering; Tan, Hsin-Yuan; Ma, David H. K.; Lin, Hsin-Chiung; Yeh, Lung-Kun; Chen, Phil Y. F.; Chen, Hung-Chi; Hsiao, Ching-Hsi] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chuang, Chih-Chun] Yuan Sheng Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chuang, Chih-Chun] Changhua Christian Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Changhua Christian Hospital; Chang Gung University; Chang Gung University	Hsiao, CH (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan.	hsiao.chinghsi@gmail.com			Chang Gung Memorial Hospital, Linkou, Taiwan [CMRPG381511]	Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital)	This work was supported in part by Chang Gung Memorial Hospital, Linkou, Taiwan, grant number CMRPG381511. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrakis G, 2000, OPHTHALMOLOGY, V107, P1497, DOI 10.1016/S0161-6420(00)00179-2; Asbell PA, 2008, AM J OPHTHALMOL, V145, P951, DOI 10.1016/j.ajo.2008.01.025; Asbell PA, 2008, J CATARACT REFR SURG, V34, P814, DOI 10.1016/j.jcrs.2008.01.016; Blomquist Preston Howard, 2006, Trans Am Ophthalmol Soc, V104, P322; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Chuang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042437; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; De Kaspar HM, 2008, AM J OPHTHALMOL, V145, P136, DOI 10.1016/j.ajo.2007.08.031; Freidlin J, 2007, AM J OPHTHALMOL, V144, P313, DOI 10.1016/j.ajo.2007.03.032; Fukuda M, 2002, CORNEA, V21, pS86, DOI 10.1097/01.ico.0000263125.99262.42; Goldstein MH, 1999, OPHTHALMOLOGY, V106, P1313, DOI 10.1016/S0161-6420(99)00716-2; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Hori Y, 2008, J CATARACT REFR SURG, V34, P711, DOI 10.1016/j.jcrs.2007.12.028; Hori Y, 2009, JPN J OPHTHALMOL, V53, P61, DOI 10.1007/s10384-008-0616-9; Hsiao CH, 2012, OPHTHALMOLOGY, V119, P522, DOI 10.1016/j.ophtha.2011.08.038; Huang YC, 2004, J CLIN MICROBIOL, V42, P307, DOI 10.1128/JCM.42.1.307-310.2004; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Kato T, 1998, JPN J OPHTHALMOL, V42, P461; Lichtinger A, 2012, OPHTHALMOLOGY, V119, P1785, DOI 10.1016/j.ophtha.2012.03.031; Major JC, 2010, AM J OPHTHALMOL, V149, P278, DOI 10.1016/j.ajo.2009.08.023; Marangon FB, 2004, AM J OPHTHALMOL, V137, P453, DOI 10.1016/j.ajo.2003.10.026; McCarthy NL, 2010, AM J INFECT CONTROL, V38, P600, DOI 10.1016/j.ajic.2010.01.006; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; Miedziak AI, 1999, OPHTHALMOLOGY, V106, P1166, DOI 10.1016/S0161-6420(99)90250-6; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nomi N, 2008, JPN J OPHTHALMOL, V52, P440, DOI 10.1007/s10384-008-0537-7; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otri AM, 2012, ACTA OPHTHA IN PRESS; Rubinfeld RS, 2001, J CATARACT REFR SURG, V27, P1523, DOI 10.1016/S0886-3350(00)00783-5; Rudd JC, 2001, J CATARACT REFR SURG, V27, P471, DOI 10.1016/S0886-3350(00)00882-8; Schaefer F, 2001, BRIT J OPHTHALMOL, V85, P842, DOI 10.1136/bjo.85.7.842; SCOTT IU, 1994, ARCH OPHTHALMOL-CHIC, V112, P329, DOI 10.1001/archopht.1994.01090150059023; Shanmuganathan VA, 2005, EYE, V19, P284, DOI 10.1038/sj.eye.6701465; Solomon R, 2007, AM J OPHTHALMOL, V143, P629, DOI 10.1016/j.ajo.2006.12.029; Sotozono C, 2002, CORNEA, V21, pS94, DOI 10.1097/01.ico.0000263127.84015.3f; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995	38	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80119	10.1371/journal.pone.0080119	http://dx.doi.org/10.1371/journal.pone.0080119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244625	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600182
J	Wang, HZ; Zhang, K; Zhu, J; Song, WW; Zhao, L; Zhang, XG				Wang, Huizheng; Zhang, Kai; Zhu, Jie; Song, Weiwei; Zhao, Li; Zhang, Xiuguo			Structure Reveals Regulatory Mechanisms of a MaoC-Like Hydratase from Phytophthora capsici Involved in Biosynthesis of Polyhydroxyalkanoates (PHAs)	PLOS ONE			English	Article							COENZYME-A HYDRATASE; ENOYL-COA HYDRATASE; CRYSTAL-STRUCTURE; MOLECULAR CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; PROTEIN; GENES; CLONING; THIOESTERASE; DEHYDRATASE	Background: Polyhydroxyalkanoates (PHAs) have attracted increasing attention as "green plastic" due to their biodegradable, biocompatible, thermoplastic, and mechanical properties, and considerable research has been undertaken to develop low cost/high efficiency processes for the production of PHAs. MaoC-like hydratase (MaoC), which belongs to (R)-hydratase involved in linking the beta-oxidation and the PHA biosynthetic pathways, has been identified recently. Understanding the regulatory mechanisms of (R)-hydratase catalysis is critical for efficient production of PHAs that promise synthesis an environment-friendly plastic. Methodology/Principal Findings: We have determined the crystal structure of a new MaoC recognized from Phytophthora capsici. The crystal structure of the enzyme was solved at 2.00 angstrom resolution. The structure shows that MaoC has a canonical (R)-hydratase fold with an N-domain and a C-domain. Supporting its dimerization observed in structure, MaoC forms a stable homodimer in solution. Mutations that disrupt the dimeric MaoC result in a complete loss of activity toward crotonyl-CoA, indicating that dimerization is required for the enzymatic activity of MaoC. Importantly, structure comparison reveals that a loop unique to MaoC interacts with an alpha-helix that harbors the catalytic residues of MaoC. Deletion of the loop enhances the enzymatic activity of MaoC, suggesting its inhibitory role in regulating the activity of MaoC. Conclusions/Significance: The data in our study reveal the regulatory mechanism of an (R)-hydratase, providing information on enzyme engineering to produce low cost PHAs.	[Wang, Huizheng; Zhu, Jie; Song, Weiwei; Zhao, Li; Zhang, Xiuguo] Shandong Agr Univ, Dept Plant Pathol, Tai An, Shandong, Peoples R China; [Zhang, Kai] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Shandong Agricultural University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, XG (corresponding author), Shandong Agr Univ, Dept Plant Pathol, Tai An, Shandong, Peoples R China.	zhxg@sdau.edu.cn		Zhu, Jie/0000-0002-5217-6249; Zhang, Kai/0000-0001-8617-2855	Special Fund for Agro-Scientific Research in the Public interest of China [201003004]	Special Fund for Agro-Scientific Research in the Public interest of China	This research was supported by Special Fund for Agro-Scientific Research in the Public interest of China (201003004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYROM D, 1992, FEMS MICROBIOL LETT, V103, P247, DOI 10.1016/0378-1097(92)90316-G; Castell A, 2005, PROTEIN SCI, V14, P1850, DOI 10.1110/ps.051442305; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Fiedler S, 2002, ARCH MICROBIOL, V178, P149, DOI 10.1007/s00203-002-0444-0; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Fukui T, 1997, J BACTERIOL, V179, P4821, DOI 10.1128/jb.179.15.4821-4830.1997; Grage K, 2009, BIOMACROMOLECULES, V10, P660, DOI 10.1021/bm801394s; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Hisano T, 2003, J BIOL CHEM, V278, P617, DOI 10.1074/jbc.M205484200; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Li J, 2000, NAT STRUCT BIOL, V7, P555; Li R, 2007, BIORESOURCE TECHNOL, V98, P2313, DOI 10.1016/j.biortech.2006.09.014; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; MOTHES G, 1995, CAN J MICROBIOL, V41, P68, DOI 10.1139/m95-170; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SJ, 2003, J BACTERIOL, V185, P5391, DOI 10.1128/JB.185.18.5391-5397.2003; Pidugu LS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-37; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reiser SE, 2000, APPL MICROBIOL BIOT, V53, P209, DOI 10.1007/s002530050010; Robert L, 1998, ATHEROSCLEROSIS, V140, P281, DOI 10.1016/S0021-9150(98)00171-3; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Tsuge T, 2000, FEMS MICROBIOL LETT, V184, P193, DOI 10.1111/j.1574-6968.2000.tb09013.x; Tsuge T, 2003, APPL ENVIRON MICROB, V69, P4830, DOI 10.1128/AEM.69.8.4830-4836.2003; Tsuge T, 2003, INT J BIOL MACROMOL, V31, P195, DOI 10.1016/S0141-8130(02)00082-X; Wang HZ, 2010, ACTA CRYSTALLOGR F, V66, P272, DOI 10.1107/S1744309109053391	40	6	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80024	10.1371/journal.pone.0080024	http://dx.doi.org/10.1371/journal.pone.0080024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244597	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600173
J	Albarado-Ibanez, A; Avelino-Cruz, JE; Velasco, M; Torres-Jacome, J; Hiriart, M				Albarado-Ibanez, Alondra; Everardo Avelino-Cruz, Jose; Velasco, Myrian; Torres-Jacome, Julian; Hiriart, Marcia			Metabolic Syndrome Remodels Electrical Activity of the Sinoatrial Node and Produces Arrhythmias in Rats	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; UP-REGULATION; CELLS; RISK	In the last ten years, the incidences of metabolic syndrome and supraventricular arrhythmias have greatly increased. The metabolic syndrome is a cluster of alterations, which include obesity, hypertension, hypertriglyceridemia, glucose intolerance and insulin resistance, that increase the risk of developing, among others, atrial and nodal arrhythmias. The aim of this study is to demonstrate that metabolic syndrome induces electrical remodeling of the sinus node and produces arrhythmias. We induced metabolic syndrome in 2-month-old male Wistar rats by administering 20% sucrose in the drinking water. Eight weeks later, the rats were anesthetized and the electrocardiogram was recorded, revealing the presence of arrhythmias only in treated rats. Using conventional microelectrode and voltage clamp techniques, we analyzed the electrical activity of the sinoatrial node. We observed that in the sinoatrial node of "metabolic syndrome rats", compared to controls, the spontaneous firing of all cells decreased, while the slope of the diastolic depolarization increased only in latent pacemaker cells. Accordingly, the pacemaker currents I-f and Ist increased. Furthermore, histological analysis showed a large amount of fat surrounding nodal cardiomyocytes and a rise in the sympathetic innervation. Finally, Poincare plot denoted irregularity in the R-R and P-P ECG intervals, in agreement with the variability of nodal firing potential recorded in metabolic syndrome rats. We conclude that metabolic syndrome produces a dysfunction SA node by disrupting normal architecture and the electrical activity, which could explain the onset of arrhythmias in rats.	[Albarado-Ibanez, Alondra; Velasco, Myrian; Hiriart, Marcia] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Everardo Avelino-Cruz, Jose] Benemerita Univ Autonoma Puebla, Inst Fisiol, Mol Cardiol Lab, Puebla, Mexico; [Torres-Jacome, Julian] Benemerita Univ Autonoma Puebla, Inst Fisiol, Lab Fisiopatol Cardiovasc, Puebla, Mexico	Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla	Torres-Jacome, J (corresponding author), Benemerita Univ Autonoma Puebla, Inst Fisiol, Lab Fisiopatol Cardiovasc, Puebla, Mexico.	jtorresjacome@gmail.com; mhiriart@ifc.unam.mx	torres, julian/ABB-9917-2020; Hiriart, Marcia/A-3988-2008	Hiriart, Marcia/0000-0001-5711-8868; Torres-Jacome, Julian/0000-0002-8575-2839; Avelino Cruz, Jose Everardo/0000-0001-9685-4710; Velasco, Myrian/0000-0002-9276-1928	Gobierno del Distrito Federal [PICDS08-72]; CONACYT [CB2009-131647]; DGAPA-PAPIIT [IN215611]; Universidad Nacional Autonoma de Mexico	Gobierno del Distrito Federal; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	Gobierno del Distrito Federal PICDS08-72, CONACYT CB2009-131647, and DGAPA-PAPIIT IN215611, Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya RA, 2004, MED BIOL ENG COMPUT, V42, P288, DOI 10.1007/BF02344702; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Arechiga-Figueroa IA, 2010, PFLUG ARCH EUR J PHY, V459, P345, DOI 10.1007/s00424-009-0734-3; Assoumou HGN, 2010, REJUV RES, V13, P653, DOI 10.1089/rej.2010.1019; Boyett MR, 1998, AM J PHYSL, V275; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Chen GC, 2011, METABOLISM, V60, P155, DOI 10.1016/j.metabol.2009.12.002; Corbi GM, 2002, J CLIN ENDOCR METAB, V87, P2080, DOI 10.1210/jc.87.5.2080; Deng W, 2012, J BIOL CHEM, V287, P4925, DOI 10.1074/jbc.M111.306134; Haffner S, 2003, CIRCULATION, V108, P1541, DOI 10.1161/01.CIR.0000088845.17586.EC; Hofer J, 2007, ARCH MED SCI, V3, pS69; Karmakar CK, 2009, PHYSIOL MEAS, V30, P1227, DOI 10.1088/0967-3334/30/11/007; Kodama I, 1999, AM J PHYSL, V276; KUMAGAI K, 1991, CIRCULATION, V84, P1662, DOI 10.1161/01.CIR.84.4.1662; Larque C, 2011, IUBMB LIFE, V63, P831, DOI 10.1002/iub.544; Lin YK, 2010, MED HYPOTHESES, V74, P1026, DOI 10.1016/j.mehy.2010.01.004; Opthof T, 1998, CARDIOVASC RES, V38, P537; Oren RV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001041; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; PASTELIN G, 1978, CIRC RES, V42, P386, DOI 10.1161/01.RES.42.3.386; Rosiak M, 2002, ANN NONINVAS ELECTRO, V7, P363, DOI 10.1111/j.1542-474X.2002.tb00186.x; Ryan VH, 2008, HORM METAB RES, V40, P861, DOI 10.1055/s-0028-1083782; Shinagawa Y, 2000, J PHYSIOL-LONDON, V523, P593, DOI 10.1111/j.1469-7793.2000.t01-2-00593.x; Sornelli F, 2009, GEN PHYSIOL BIOPHYS, V28, P179; Sutyagin PV, 2005, B EXP BIOL MED+, V139, P256, DOI 10.1007/s10517-005-0263-9; Tang RB, 2009, CIRC J, V73, P438, DOI 10.1253/circj.CJ-08-0832; Vinogradova T, 2002, CIRCULATION RES, V91; Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271; Yanni J, 2010, J MOL CELL CARDIOL, V48, P653, DOI 10.1016/j.yjmcc.2009.08.023; Zhang H, 2001, CIRCULATION, V103, P584, DOI 10.1161/01.CIR.103.4.584	31	15	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e76534	10.1371/journal.pone.0076534	http://dx.doi.org/10.1371/journal.pone.0076534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250786	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200007
J	Bianchi, S; Frati, ER; Panatto, D; Martinelli, M; Amicizia, D; Zotti, CM; Martinese, M; Bonanni, P; Boccalini, S; Coppola, RC; Masia, G; Meloni, A; Castiglia, P; Piana, A; Gasparini, R; Tanzi, E				Bianchi, Silvia; Frati, Elena Rosanna; Panatto, Donatella; Martinelli, Marianna; Amicizia, Daniela; Zotti, Carla Maria; Martinese, Morena; Bonanni, Paolo; Boccalini, Sara; Coppola, Rosa Cristina; Masia, Giuseppina; Meloni, Angelo; Castiglia, Paolo; Piana, Andrea; Gasparini, Roberto; Tanzi, Elisabetta			Detection and Genotyping of Human Papillomavirus in Urine Samples from Unvaccinated Male and Female Adolescents in Italy	PLOS ONE			English	Article							HPV-DNA DETECTION; SEXUAL-BEHAVIOR; YOUNG-PEOPLE; RISK-FACTORS; PREVALENCE; INFECTION; VACCINATION; SUGGESTIONS; WOMEN; ASSAY	The introduction of vaccination against Human Papillomavirus (HPV) in adolescent girls in 2006 has focused virological surveillance on this age group. As few studies have evaluated HPV infections in young populations, further data are needed in order to improve and extend prophylactic policy and to monitor epidemiological changes. The present study aimed at evaluating overall and type-specific HPV prevalence in both female and male adolescents in Italy. HPV DNA detection and genotyping was performed on urine samples collected from 870 unvaccinated adolescents (369 females, 501 males, 11-18 years of age) in five cities in Italy. Following DNA extraction by means of a commercial kit (NucliSENS (R)-miniMAG (R), bioMerieux), the L1 gene fragment was PCR amplified and genotyped by restriction fragment length polymorphism analysis. HPV DNA was detected in 1.5% of all samples, and in 3% and 0.4% of samples from females and males, respectively. In approximately 70% of HPV DNA positive adolescents, the infection was due to a single genotype, with 88.9% of genotypes belonging to the HR-clade. The only two HPV-positive boys (14 and 18 years old) had HPV-70 genotype. Only one of the 11 HPV-infected girls was in the 11-14 age-group. HPV prevalence was 4.2% in girls aged 15-18 years and 60% of infections were due to vaccine types HPV-16 or HPV-6/-11. This is one of the few studies, the first conducted in Italy, on HPV infection in adolescents. Urine testing is the easier way of detecting HPV infection in younger populations. Our data revealed a very low HPV prevalence, and no infections were observed in the 12-year-old vaccine target population. The majority of infections were seen in females aged 15-18 years. Overall, more than 50% and 30% of the potentially persistent HPV infections detected in this group could have been prevented by the quadrivalent and the bivalent vaccines, respectively.	[Bianchi, Silvia; Frati, Elena Rosanna; Martinelli, Marianna; Tanzi, Elisabetta] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Panatto, Donatella; Amicizia, Daniela; Gasparini, Roberto] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Zotti, Carla Maria; Martinese, Morena] Univ Turin, Dept Publ Hlth & Paediat Sci, Turin, Italy; [Bonanni, Paolo; Boccalini, Sara] Univ Florence, Dept Hlth Sci, Florence, Italy; [Coppola, Rosa Cristina; Masia, Giuseppina; Meloni, Angelo] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy; [Castiglia, Paolo; Piana, Andrea] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Panatto, Donatella; Amicizia, Daniela; Gasparini, Roberto; Tanzi, Elisabetta] Univ Genoa, Inter Univ Ctr Res Influenza & Other Transmitted, Dept Hlth Sci, Genoa, Italy	University of Milan; University of Genoa; University of Turin; University of Florence; University of Cagliari; University of Sassari; University of Genoa	Tanzi, E (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	elisabetta.tanzi@unimi.it	Tanzi, Elisabetta/M-9066-2016; Martinelli, Marianna/AAD-5306-2019; Bianchi, Silvia/M-8586-2016; Bragazzi, Nicola Luigi/G-1672-2011; Bonanni, Paolo/AAB-9823-2019	Tanzi, Elisabetta/0000-0002-4119-701X; Martinelli, Marianna/0000-0003-2273-6986; Bianchi, Silvia/0000-0002-1365-9408; Bragazzi, Nicola Luigi/0000-0001-8409-868X; PIANA, Andrea Fausto/0000-0002-6609-8886; Zotti, Carla Maria/0000-0003-3898-1206; Panatto, Donatella/0000-0002-2677-0551; Castiglia, Paolo/0000-0002-0972-4828; Coppola, Rosa Cristina/0000-0002-1592-8093; Gasparini, Roberto/0000-0002-1012-6913; Frati, Elena/0000-0001-7021-2525	Italian Ministry of University and Research [20074B5ZBC]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	The study was financed by the Italian Ministry of University and Research (project PRIN 2007; Grant number: 20074B5ZBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarossi A, 2009, J MED VIROL, V81, P529, DOI 10.1002/jmv.21347; Alameda Francesc, 2007, J Low Genit Tract Dis, V11, P5, DOI 10.1097/01.lgt.0000230204.65742.e4; American Academy of Paediatrics [AAP], 2012, HPV VACC REC; [Anonymous], 2007, GAZZETTA UFFICIALE; Brown DR, 2005, J INFECT DIS, V191, P182, DOI 10.1086/426867; Centers for Disease Control & Prevention, 2010, HPV VACC; Collins S, 2002, BJOG-INT J OBSTET GY, V109, P96, DOI 10.1111/j.1471-0528.2002.01053.x; Crochard A, 2009, GYNECOL ONCOL, V115, pS7, DOI 10.1016/j.ygyno.2009.06.003; Enerly Espen, 2013, Clin Epidemiol, V5, P67, DOI 10.2147/CLEP.S39799; European Centre for Disease Prevention and Control (ECDC), 2012, INTR HPV VACC EUR UN; Gasparini R, 2009, EPIDEMIOL INFECT, V137, P794, DOI 10.1017/S0950268808001441; Giuliano AR, 2007, J INFECT DIS, V196, P1146, DOI 10.1086/521629; Hussain S, 2012, J MED VIROL, V84, P298, DOI 10.1002/jmv.22261; IARC, 2011, IARC MON EV CARC R B, P261; Italian Minister of Health, 2007, HPV VACC IT; Italian Minister of Health, 2009, HPV VACC COV 95; Leval A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020624; Mollers M, 2012, CANCER EPIDEMIOL, V36, P519, DOI 10.1016/j.canep.2012.07.006; Moscicki AB, 2007, DIS MARKERS, V23, P229, DOI 10.1155/2007/136906; Norbe RG, 2008, J CLIN VIROL, V42, P13, DOI [10.1016/j.jcv.2007.11.021, DOI 10.1016/J.JCV.2007.11.021]; O'Leary MC, 2011, BRIT J CANCER, V104, P1221, DOI 10.1038/bjc.2011.30; Panatto D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-623; Panatto D, 2009, VACCINE, V27, pA6, DOI 10.1016/j.vaccine.2008.10.057; Partridge JM, 2007, J INFECT DIS, V196, P1128, DOI 10.1086/521192; Piana A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-785; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Sehgal A, 2009, J OBSTET GYNAECOL, V29, P583, DOI 10.1080/01443610903061736; Shew ML, 2013, J INFECT DIS, V207, P1012, DOI 10.1093/infdis/jis775; Tanzi E, 2013, J MED VIROL, V85, P91, DOI 10.1002/jmv.23434; Widdice L, 2011, J ADOLESCENT HEALTH, V48, pS2, DOI 10.1016/j.jadohealth.2010.11.011; Winer RL, 2010, CANCER EPIDEM BIOMAR, V19, P1682, DOI 10.1158/1055-9965.EPI-10-0226	31	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79719	10.1371/journal.pone.0079719	http://dx.doi.org/10.1371/journal.pone.0079719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255711	Green Published, gold			2022-12-25	WOS:000327216200083
J	Buss, S; Dobra, J; Goerg, K; Hoffmann, S; Kippenberger, S; Kaufmann, R; Hofmann, M; Bernd, A				Buss, Stephan; Dobra, Jadranka; Goerg, Kerstin; Hoffmann, Stephanie; Kippenberger, Stefan; Kaufmann, Roland; Hofmann, Matthias; Bernd, August			Visible Light Is a Better Co-Inducer of Apoptosis for Curcumin-Treated Human Melanoma Cells than UVA	PLOS ONE			English	Article							COLON-CANCER CELLS; NF-KAPPA-B; CYTOCHROME-C; P53-DEPENDENT MANNER; INDUCED CYTOTOXICITY; MITOTIC CATASTROPHE; ECTOPIC EXPRESSION; HUMAN MELANOCYTES; OXIDATIVE DAMAGE; DOWN-REGULATION	Curcumin attracts worldwide scientific interest due to its anti-proliferative and apoptosis inducing effects on different tumor cells at concentrations ranging from 10 to 150 mu M (3.7-55 mu g/ml). Unfortunately, because of a low oral bioavailability, only low and pharmacologically ineffective serum levels are achievable. In this study, an alternative treatment concept consisting of low concentration curcumin (0.2-5 mu g/ml) and irradiation with UVA or visible light (VL) has been tested. The experimental results show clearly that this treatment decreases the proliferation and the viability of human melanoma cells while the cell membrane integrity remains intact. We identified the onset of apoptosis characterized by typical markers such as active caspases 8, 9 and 3 as well as DNA fragmentation accompanied by the loss of cell adhesion. The mitochondrial apoptosis signaling pathway is predominant due to an early activation of caspase-9. The present data indicate a higher efficacy of a combination of curcumin and VL than curcumin and UVA. Reduced effects as a result of light absorption by heavily pigmented skin are unlikely if VL is used. These results indicate that a combination of curcumin and light irradiation may be a useful additional therapy in the treatment of malignant disease.	[Buss, Stephan; Dobra, Jadranka; Goerg, Kerstin; Hoffmann, Stephanie; Kippenberger, Stefan; Kaufmann, Roland; Hofmann, Matthias; Bernd, August] Goethe Univ Frankfurt, Univ Hosp, Dept Dermatol Venereol & Allergol, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Bernd, A (corresponding author), Goethe Univ Frankfurt, Univ Hosp, Dept Dermatol Venereol & Allergol, D-60054 Frankfurt, Germany.	bernd@em.uni-frankfurt.de		Hofmann, Matthias/0000-0003-4107-7197	LOEWE PraeBionik network of the state of Hesse [BOSS4]	LOEWE PraeBionik network of the state of Hesse	This research was partly supported by the LOEWE PraeBionik network of the state of Hesse (BOSS4 to MH and RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Araujo CAC, 2001, MEM I OSWALDO CRUZ, V96, P723, DOI 10.1590/S0074-02762001000500026; Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658; Barry J, 2009, J AM CHEM SOC, V131, P4490, DOI 10.1021/ja809217u; Bernd A, 2014, PHYTOCHEM REV, V13, P183, DOI 10.1007/s11101-013-9296-2; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Chan WH, 2006, FOOD CHEM TOXICOL, V44, P1362, DOI 10.1016/j.fct.2006.03.001; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; DAHL TA, 1989, ARCH MICROBIOL, V151, P183, DOI 10.1007/BF00414437; DAHL TA, 1994, PHOTOCHEM PHOTOBIOL, V59, P290, DOI 10.1111/j.1751-1097.1994.tb05036.x; De Leeuw SM, 2001, J PHOTOCH PHOTOBIO B, V61, P106, DOI 10.1016/S1011-1344(01)00168-3; Dujic J, 2007, J INVEST DERMATOL, V127, P1992, DOI 10.1038/sj.jid.5700801; Dujic J, 2009, INT J CANCER, V124, P1422, DOI 10.1002/ijc.23997; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Fiorillo C, 2008, FREE RADICAL BIO MED, V45, P839, DOI 10.1016/j.freeradbiomed.2008.06.013; Ingolfsson HI, 2007, BIOCHEMISTRY-US, V46, P10384, DOI 10.1021/bi701013n; Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105; JACOB SW, 1986, CRYOBIOLOGY, V23, P14, DOI 10.1016/0011-2240(86)90014-3; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Karmakar S, 2006, NEUROSCI LETT, V407, P53, DOI 10.1016/j.neulet.2006.08.013; Koo JY, 2004, J MED FOOD, V7, P117, DOI 10.1089/1096620041224229; Kunwar A, 2006, BBA-GEN SUBJECTS, V1760, P1513, DOI 10.1016/j.bbagen.2006.06.012; Kurbanov BM, 2005, J INVEST DERMATOL, V125, P1010, DOI 10.1111/j.0022-202X.2005.23900.x; Laubach V, 2007, THESIS JW GOETHE U G; Lee JH, 2010, INT J MOL MED, V26, P101, DOI 10.3892/ijmm_00000440; Liu EY, 2007, J NEURO-ONCOL, V85, P263, DOI 10.1007/s11060-007-9421-4; Magalska A, 2006, INT J CANCER, V119, P1811, DOI 10.1002/ijc.22055; MEYERARENDT J, 1954, EXPERIENTIA, V10, P371, DOI 10.1007/BF02160543; O'Sullivan-Coyne G, 2009, BRIT J CANCER, V101, P1585, DOI 10.1038/sj.bjc.6605308; Pae HO, 2007, BIOCHEM BIOPH RES CO, V353, P1040, DOI 10.1016/j.bbrc.2006.12.133; Park C, 2006, ONCOL REP, V15, P1225; Piwocka K, 2001, FREE RADICAL BIO MED, V31, P670, DOI 10.1016/S0891-5849(01)00629-3; Placzek M, 2007, BRIT J DERMATOL, V156, P843, DOI 10.1111/j.1365-2133.2007.07795.x; Rashmi R, 2005, CARCINOGENESIS, V26, P713, DOI 10.1093/carcin/bgi025; Rashmi R, 2003, FEBS LETT, V538, P19, DOI 10.1016/S0014-5793(03)00099-1; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Shankar Sharmila, 2007, J Mol Signal, V2, P10, DOI 10.1186/1750-2187-2-10; Shim JS, 2001, J BIOCHEM MOL BIOL, V34, P189; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Singh M, 2010, MED ONCOL, V27, P1096, DOI 10.1007/s12032-009-9341-6; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; TONNESEN HH, 1987, J PHARM SCI, V76, P371, DOI 10.1002/jps.2600760506; Tu CX, 2012, PHYTOTHER RES, V26, P174, DOI 10.1002/ptr.3517; Uddin S, 2005, ONCOGENE, V24, P7022, DOI 10.1038/sj.onc.1208864; Walters DK, 2008, INVEST NEW DRUG, V26, P289, DOI 10.1007/s10637-007-9099-7; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577; Wolanin K, 2006, MOL CANCER RES, V4, P457, DOI 10.1158/1541-7786.MCR-05-0172; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; Wu XW, 2001, ARTHRITIS RHEUM, V44, P2642, DOI 10.1002/1529-0131(200111)44:11<2642::AID-ART444>3.0.CO;2-8; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Zhang CL, 2010, J INVEST DERMATOL, V130, P2110, DOI 10.1038/jid.2010.86; Zhu YG, 2004, ACTA PHARMACOL SIN, V25, P1606	54	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79748	10.1371/journal.pone.0079748	http://dx.doi.org/10.1371/journal.pone.0079748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255713	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200085
J	Lampasona, V; Passerini, L; Barzaghi, F; Lombardoni, C; Bazzigaluppi, E; Brigatti, C; Bacchetta, R; Bosi, E				Lampasona, Vito; Passerini, Laura; Barzaghi, Federica; Lombardoni, Carlo; Bazzigaluppi, Elena; Brigatti, Cristina; Bacchetta, Rosa; Bosi, Emanuele			Autoantibodies to Harmonin and Villin Are Diagnostic Markers in Children with IPEX Syndrome	PLOS ONE			English	Article							REGULATORY T-CELLS; USHER-SYNDROME TYPE-1; X-LINKED SYNDROME; IMMUNE DYSREGULATION; B-CELLS; CUTTING EDGE; ENTEROPATHY; POLYENDOCRINOPATHY; FOXP3; IDENTIFICATION	Autoantibodies to enterocyte antigens harmonin (75 kDa USH1C protein) and villin (actin-binding 95 kDa protein) are associated with the Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome. In this study we evaluated the diagnostic value of harmonin and villin autoantibodies in IPEX and IPEX-like syndromes. Harmonin and villin autoantibodies were measured by a novel Luminescent-Immuno-Precipitation-System (LIPS) quantitative assay, in patients with IPEX, IPEX-like syndrome, Primary Immunodeficiencies (PID) with enteropathy, all diagnosed by sequencing of the FOXP3 gene, and in type 1 diabetes (T1D), celiac disease and healthy blood donors as control groups. Harmonin and villin autoantibodies were detected in 12 (92%) and 6 (46%) of 13 IPEX patients, and in none of the IPEX-like, PID, T1D, celiac patients, respectively. All IPEX patients, including one case with late and atypical clinical presentation, had either harmonin and/or villin autoantibodies and tested positive for enterocyte antibodies by indirect immunofluorescence. When measured in IPEX patients in remission after immunosuppressive therapy or hematopoietic stem cell transplantation, harmonin and villin autoantibodies became undetectable or persisted at low titers in all cases but one in whom harmonin autoantibodies remained constantly high. In one patient, a peak of harmonin antibodies paralleled a relapse phase of enteropathy. Our study demonstrates that harmonin and villin autoantibodies, measured by LIPS, are sensitive and specific markers of IPEX, differentiate IPEX, including atypical cases, from other early childhood disorders associated with enteropathy, and are useful for screening and clinical monitoring of affected children.	[Lampasona, Vito; Lombardoni, Carlo] Hosp San Raffaele, Inst Sci, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Passerini, Laura; Barzaghi, Federica; Bacchetta, Rosa] Hosp San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, Inst Sci, Telethon Inst Gene Therapy, I-20132 Milan, Italy; [Brigatti, Cristina; Bosi, Emanuele] Hosp San Raffaele, Inst Sci, Diabet Res Inst, I-20132 Milan, Italy; [Bosi, Emanuele] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Bacchetta, R (corresponding author), Hosp San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, Inst Sci, Telethon Inst Gene Therapy, I-20132 Milan, Italy.	bosi.emanuele@hsr.it; rosa.bacchetta@hsr.it	Passerini, Laura/J-7791-2016; brigatti, cristina/AAN-5030-2020; bazzigaluppi, elena/AAN-5052-2020; Lampasona, Vito/E-8999-2012	Passerini, Laura/0000-0002-4020-7386; brigatti, cristina/0000-0002-2914-1654; bazzigaluppi, elena/0000-0002-6715-7454; Lampasona, Vito/0000-0001-5162-8445; Bacchetta, Rosa/0000-0002-0606-6268	Telethon Foundation [Tele 10A4]; Seventh Framework project (FP7) of the European Community (Cell-PID)	Telethon Foundation(Fondazione Telethon); Seventh Framework project (FP7) of the European Community (Cell-PID)	This work was supported in part by the Telethon Foundation (Tele 10A4 to RB) and the Seventh Framework project (FP7) of the European Community (Cell-PID to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Barzaghi F, 2012, J AUTOIMMUN, V38, P49, DOI 10.1016/j.jaut.2011.12.009; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Bazzigaluppi E, 1999, J AUTOIMMUN, V12, P51, DOI 10.1006/jaut.1998.0253; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BONIFACIO E, 1995, DIABETOLOGIA, V38, P816, DOI 10.1007/s001250050358; BONIFACIO E, 1995, J IMMUNOL, V155, P5419; Burbelo PD, 2008, DIABETES CARE, V31, P1824, DOI 10.2337/dc08-0286; Burbelo PD, 2010, DIABETES CARE, V33, P754, DOI 10.2337/dc09-1938; Burbelo PD, 2009, AUTOIMMUNITY, V42, P515, DOI 10.1080/08916930902911738; Ching KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032001; de Serre NPM, 2009, MODERN PATHOL, V22, P95, DOI 10.1038/modpathol.2008.161; Friederich E, 1999, J BIOL CHEM, V274, P26751, DOI 10.1074/jbc.274.38.26751; Gambineri Eleonora, 2008, J Allergy Clin Immunol, V122, P1105, DOI 10.1016/j.jaci.2008.09.027; Hsu WT, 2006, CLIN EXP IMMUNOL, V145, P513, DOI 10.1111/j.1365-2249.2006.03173.x; Iikuni N, 2009, J IMMUNOL, V183, P1518, DOI 10.4049/jimmunol.0901163; Jang E, 2011, J IMMUNOL, V186, P1546, DOI 10.4049/jimmunol.1002942; Kang SM, 2008, MOL CELLS, V25, P64; Kinnunen T, 2013, BLOOD, V121, P1595, DOI 10.1182/blood-2012-09-457465; Kobayashi I, 1999, GASTROENTEROLOGY, V117, P823, DOI 10.1016/S0016-5085(99)70340-9; Kobayashi I, 1998, CLIN EXP IMMUNOL, V111, P527; Kobayashi I, 2011, CLIN IMMUNOL, V141, P83, DOI 10.1016/j.clim.2011.05.010; Lampasona V, 2011, CLIN CHEM, V1702; Lampasona V, 2010, DIABETES CARE, V33, P104, DOI 10.2337/dc08-2305; Leonardo SM, 2010, J IMMUNOL, V185, P2147, DOI 10.4049/jimmunol.1000136; Li M, 2009, AM J GASTROENTEROL, V104, P154, DOI 10.1038/ajg.2008.8; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Ludwig-Portugall I, 2008, J IMMUNOL, V181, P4447, DOI 10.4049/jimmunol.181.7.4447; Mazzolari E, 2005, BONE MARROW TRANSPL, V35, P1033, DOI 10.1038/sj.bmt.1704954; McMurchy AN, 2010, J ALLERGY CLIN IMMUN, V126, P1242, DOI 10.1016/j.jaci.2010.09.001; MIRAKIAN R, 1986, BRIT MED J, V293, P1132, DOI 10.1136/bmj.293.6555.1132; Moes N, 2010, GASTROENTEROLOGY, V139, P770, DOI 10.1053/j.gastro.2010.06.006; Naserke HE, 1998, DIABETOLOGIA, V41, P681, DOI 10.1007/s001250050968; Passerini L, 2011, EUR J IMMUNOL, V41, P1120, DOI 10.1002/eji.201040909; Piquer S, 2005, CLIN IMMUNOL, V117, P31, DOI 10.1016/j.clim.2005.06.009; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Reiners J, 2005, MOL VIS, V11, P347; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; Schlosser M, 2010, DIABETOLOGIA, V53, P2611, DOI 10.1007/s00125-010-1915-5; Seo SJ, 2002, IMMUNITY, V16, P535, DOI 10.1016/S1074-7613(02)00298-4; Soderbergh A, 2004, J CLIN ENDOCR METAB, V89, P557, DOI 10.1210/jc.2003-030279; Torgerson TR, 2007, J ALLERGY CLIN IMMUN, V120, P744, DOI 10.1016/j.jaci.2007.08.044; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502	48	39	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78664	10.1371/journal.pone.0078664	http://dx.doi.org/10.1371/journal.pone.0078664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250806	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200039
J	Dihal, AA; Boot, A; van Roon, EH; Schrumpf, M; Farina-Sarasqueta, A; Fiocco, M; Zeestraten, ECM; Kuppen, PJK; Morreau, H; van Wezel, T; Boer, JM				Dihal, Ashwin A.; Boot, Arnoud; van Roon, Eddy H.; Schrumpf, Melanie; Farina-Sarasqueta, Arantza; Fiocco, Marta; Zeestraten, Eliane C. M.; Kuppen, Peter J. K.; Morreau, Hans; van Wezel, Tom; Boer, Judith M.			The Homeobox Gene MEIS1 Is Methylated in BRAF(p.V600E) Mutated Colon Tumors	PLOS ONE			English	Article							COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; BRAF MUTATION; CELL-LINES; PROMOTER METHYLATION; DNA METHYLATION; MESSENGER-RNA; EXPRESSION; CARCINOMA; SUBGROUPS	Development of colorectal cancer (CRC) can occur both via gene mutations in tumor suppressor genes and oncogenes, as well as via epigenetic changes, including DNA methylation. Site-specific methylation in CRC regulates expression of tumor-associated genes. Right-sided colon tumors more frequently have BRAF(p.V600E) mutations and have higher methylation grades when compared to left-sided malignancies. The aim of this study was to identify DNA methylation changes associated with BRAF(p.V600E) mutation status. We performed methylation profiling of colon tumor DNA, isolated from frozen sections enriched for epithelial cells by macro-dissection, and from paired healthy tissue. Single gene analyses comparing BRAF(p.V600E) with BRAF wild type revealed MEIS1 as the most significant differentially methylated gene (log(2) fold change: 0.89, false discovery rate-adjusted P-value 2.8*10(-9)). This finding was validated by methylation-specific PCR that was concordant with the microarray data. Additionally, validation in an independent cohort (n=228) showed a significant association between BRAF(p.V600E) and MEIS1 methylation (OR: 13.0, 95% CI: 5.2 - 33.0, P<0.0001). MEIS1 methylation was associated with decreased MEIS1 gene expression in both patient samples and CRC cell lines. The same was true for gene expression of a truncated form of MEIS1, MEIS1(D27), which misses exon 8 and has a proposed tumor suppression function. To trace the origin of MEIS1 promoter methylation, 14 colorectal tumors were flow-sorted. Four out of eight BRAF(p.V600E) tumor epithelial fractions (50%) showed MEIS1 promoter methylation, as well as three out of eight BRAF(p.V600E) stromal fractions (38%). Only one out of six BRAF wild type showed MEIS1 promoter methylation in both the epithelial tumor and stromal fractions (17%). In conclusion, BRAF(p.V600E) colon tumors showed significant MEIS1 promoter methylation, which was associated with decreased MEIS1 gene expression.	[Dihal, Ashwin A.; Boot, Arnoud; van Roon, Eddy H.; Boer, Judith M.] Leiden Univ Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; [Boot, Arnoud; van Roon, Eddy H.; Schrumpf, Melanie; Farina-Sarasqueta, Arantza; Morreau, Hans; van Wezel, Tom] Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands; [Fiocco, Marta] Leiden Univ Med Ctr, Dept Med Stat, Leiden, Netherlands; [Zeestraten, Eliane C. M.; Kuppen, Peter J. K.] Leiden Univ Med Ctr, Dept Surg, Leiden, Netherlands; [Boer, Judith M.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol, Rotterdam, Netherlands; [Boer, Judith M.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	van Wezel, T (corresponding author), Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands.	t.van_wezel@lumc.nl; j.m.boer@erasmusmc.nl	van Wezel, Tom/Z-3092-2019; Dijkstra, Sander/F-2513-2017; van Wezel, Tom/A-9599-2008; Kuppen, Peter/J-2342-2016; van Wezel, Tom/AAL-5626-2021	van Wezel, Tom/0000-0001-5773-7730; Dijkstra, Sander/0000-0001-5368-757X; van Wezel, Tom/0000-0001-5773-7730; Kuppen, Peter/0000-0002-0294-3251; Boot, Arnoud/0000-0002-7717-7416; Farina Sarasqueta, Aranzazu/0000-0002-6173-592X; Boer, Judith/0000-0003-4848-7789; Farina Sarasqueta, Arantza/0000-0002-4307-1568	Centre for Medical Systems Biology, a Centre of Excellence; Netherlands Genomics Initiative	Centre for Medical Systems Biology, a Centre of Excellence; Netherlands Genomics Initiative	This work was supported by the Centre for Medical Systems Biology, a Centre of Excellence supported by the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; Banerjea A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-21; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Corver WE, 2008, CANCER RES, V68, P10333, DOI 10.1158/0008-5472.CAN-08-2665; Crist RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023665; Curtin Karen, 2011, Patholog Res Int, V2011, P902674, DOI 10.4061/2011/902674; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Miranda NFCC, 2012, MUTAGENESIS, V27, P247, DOI 10.1093/mutage/ger077; DEXTER DL, 1979, CANCER RES, V39, P1020; DREWINKO B, 1976, CANCER RES, V36, P467; Eklof V, 2013, BRIT J CANCER, V108, P2153, DOI 10.1038/bjc.2013.212; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Gavin PG, 2012, CLIN CANCER RES, V18, P6531, DOI 10.1158/1078-0432.CCR-12-0605; Hawkins N, 2002, GASTROENTEROLOGY, V122, P1376, DOI 10.1053/gast.2002.32997; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; LILIENBAUM A, 1986, EMBO J, V5, P2809, DOI 10.1002/j.1460-2075.1986.tb04572.x; Lombaerts M, 2004, BIOCHEM BIOPH RES CO, V319, P697, DOI 10.1016/j.bbrc.2004.05.041; MURAKAMI H, 1980, P NATL ACAD SCI-BIOL, V77, P3464, DOI 10.1073/pnas.77.6.3464; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Oliveira C, 2003, ONCOGENE, V22, P9192, DOI 10.1038/sj.onc.1207061; Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674; QUINN LA, 1979, CANCER RES, V39, P4914; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sarasqueta AF, 2011, CELL ONCOL, V34, P523, DOI 10.1007/s13402-011-0054-4; Serrano E, 2006, ACTA HAEMATOL-BASEL, V116, P77, DOI 10.1159/000093636; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; SUARDET L, 1992, CANCER RES, V52, P3705; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; van Puijenbroek M, 2005, J MOL DIAGN, V7, P623, DOI 10.1016/S1525-1578(10)60596-X; van Roon EH, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-2; van Wezel T, 2005, BREAST CANCER RES, V7, pR998, DOI 10.1186/bcr1337; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042	47	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79898	10.1371/journal.pone.0079898	http://dx.doi.org/10.1371/journal.pone.0079898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244575	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900057
J	Maksimov, P; Zerweck, J; Dubey, JP; Pantchev, N; Frey, CF; Maksimov, A; Reimer, U; Schutkowski, M; Hosseininejad, M; Ziller, M; Conraths, FJ; Schares, G				Maksimov, Pavlo; Zerweck, Johannes; Dubey, Jitender P.; Pantchev, Nikola; Frey, Caroline F.; Maksimov, Aline; Reimer, Ulf; Schutkowski, Mike; Hosseininejad, Morteza; Ziller, Mario; Conraths, Franz J.; Schares, Gereon			Serotyping of Toxoplasma gondii in Cats (Felis domesticus) Reveals Predominance of Type II Infections in Germany	PLOS ONE			English	Article							HIGHLY MOUSE-VIRULENT; GENETIC-CHARACTERIZATION; CONGENITAL TOXOPLASMOSIS; POLYMORPHIC PEPTIDES; TISSUE DISTRIBUTION; EPIGENETIC FACTORS; RISK-FACTORS; BLACK BEAR; STRAINS; SEROPREVALENCE	Background: Cats are definitive hosts of Toxoplasma gondii and play an essential role in the epidemiology of this parasite. The study aims at clarifying whether cats are able to develop specific antibodies against different clonal types of T. gondii and to determine by serotyping the T. gondii clonal types prevailing in cats as intermediate hosts in Germany. Methodology: To establish a peptide-microarray serotyping test, we identified 24 suitable peptides using serological T. gondii positive (n=21) and negative cat sera (n=52). To determine the clonal type-specific antibody response of cats in Germany, 86 field sera from T. gondii seropositive naturally infected cats were tested. In addition, we analyzed the antibody response in cats experimentally infected with non-canonical T. gondii types (n=7). Findings: Positive cat reference sera reacted predominantly with peptides harbouring amino acid sequences specific for the clonal T. gondii type the cats were infected with. When the array was applied to field sera from Germany, 98.8% (85/86) of naturally-infected cats recognized similar peptide patterns as T. gondii type II reference sera and showed the strongest reaction intensities with clonal type II-specific peptides. In addition, naturally infected cats recognized type II-specific peptides significantly more frequently than peptides of other type-specificities. Cats infected with non-canonical types showed the strongest reactivity with peptides presenting amino-acid sequences specific for both, type I and type III. Conclusions: Cats are able to mount a clonal type-specific antibody response against T. gondii. Serotyping revealed for most seropositive field sera patterns resembling those observed after clonal type II-T. gondii infection. This finding is in accord with our previous results on the occurrence of T. gondii clonal types in oocysts shed by cats in Germany.	[Maksimov, Pavlo; Maksimov, Aline; Conraths, Franz J.; Schares, Gereon] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany; [Zerweck, Johannes; Reimer, Ulf] Peptide Technol GmbH, JPT, Berlin, Germany; [Dubey, Jitender P.] ARS, Anim Parasit Dis Lab, USDA, ANRI,BARC East, Beltsville, MD USA; [Pantchev, Nikola] Vet Med Labor GmbH, Div IDEXX Labs, Ludwigsburg, Germany; [Frey, Caroline F.] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Schutkowski, Mike] Univ Halle Wittenberg, Dept Enzymol, Inst Biochem & Biotechnol, D-06108 Halle, Saale, Germany; [Hosseininejad, Morteza] Univ Shahrekord, Fac Vet Med, Shahrekord, Iran; [Ziller, Mario] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Workgrp Biomath, Greifswald, Germany	Friedrich Loeffler Institute; United States Department of Agriculture (USDA); Vet Med Labor GmbH; University of Bern; Martin Luther University Halle Wittenberg; Shahrekord University; Friedrich Loeffler Institute	Maksimov, P (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany.	pavlo_maksimov@gmx.de; gereon.schares@fli.bund.de	Schares, Gereon R.M./F-9850-2019; Maksimov, Pavlo/AAC-3916-2019	Schares, Gereon R.M./0000-0002-3217-289X; Maksimov, Pavlo/0000-0002-9457-0658; Reimer, Ulf/0000-0002-3375-6889; Frey, Caroline/0000-0002-6478-7493; Conraths, Franz/0000-0002-7400-9409; Schutkowski, MIke/0000-0003-0919-7076	German Federal Ministry of Education and Research [Toxonet01, Toxonet02, 01KI0765, 01KI1002F]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was supported by the German Federal Ministry of Education and Research (Toxonet01 and Toxonet02) by funds to G. Schares (01KI0765; 01KI1002F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Ajzenberg Daniel, 2011, Expert Rev Anti Infect Ther, V9, P169, DOI 10.1586/eri.10.169; Al-Kappany YM, 2010, J PARASITOL, V96, P1115, DOI 10.1645/GE-2554.1; Al-Kappany YM, 2010, J PARASITOL, V96, P1112, DOI 10.1645/GE-2608.1; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Buydens LMC, 2007, J STAT SOFTW, P21; Chen ZW, 2011, VET PARASITOL, V183, P166, DOI 10.1016/j.vetpar.2011.06.013; Conraths FJ, 2006, VET PARASITOL, V136, P91, DOI 10.1016/j.vetpar.2005.12.004; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; de Azevedo SS, 2010, REV BRAS PARASITOL V, V19, P80, DOI 10.1590/S1984-29612010000200002; de Kok JB, 2002, CANCER RES, V62, P2695; Demar M, 2012, CLIN MICROBIOL INFEC, V18, pE221, DOI 10.1111/j.1469-0691.2011.03648.x; Dubey JP, 2010, J PARASITOL, V96, P713, DOI 10.1645/GE-2429.1; Dubey JP, 2009, PARASITOLOGY, V136, P589, DOI 10.1017/S0031182009006015; Dubey JR, 2008, J PARASITOL, V94, P42, DOI 10.1645/GE-1349.1; Dubey JR, 2007, J PARASITOL, V93, P710, DOI 10.1645/GE-1120R.1; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; DUBEY JP, 1995, J PARASITOL, V81, P410, DOI 10.2307/3283823; Dubey JP, 2004, J PARASITOL, V90, P721, DOI 10.1645/GE-382R; Dubey JP, 1996, J PARASITOL, V82, P957, DOI 10.2307/3284206; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Dubremetz JF, 2012, MICROBES INFECT, V14, P1403, DOI 10.1016/j.micinf.2012.09.005; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Fazaeli A, 2007, PARASITOL RES, V101, P99, DOI 10.1007/s00436-006-0449-8; Fazaeli A, 2000, INT J PARASITOL, V30, P637, DOI 10.1016/S0020-7519(00)00036-9; Fekkar A, 2011, J CLIN MICROBIOL, V49, P1513, DOI 10.1128/JCM.02196-10; Fischer HG, 1998, MOL BIOCHEM PARASIT, V91, P251, DOI 10.1016/S0166-6851(97)00227-2; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Herrmann DC, 2012, VET PARASITOL, V185, P78, DOI 10.1016/j.vetpar.2011.10.030; Herrmann DC, 2010, INT J PARASITOL, V40, P285, DOI 10.1016/j.ijpara.2009.08.001; Herrmann DC, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-39; Hosseininejad M, 2012, EXP PARASITOL, V132, P556, DOI 10.1016/j.exppara.2012.09.009; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Jamieson SE, 2010, GENES IMMUN, V11, P374, DOI 10.1038/gene.2010.31; Jamieson SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002285; Jamieson SE, 2009, MEM I OSWALDO CRUZ, V104, P162, DOI 10.1590/S0074-02762009000200006; Kong JT, 2003, J INFECT DIS, V187, P1484, DOI 10.1086/374647; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Latifi SM, 2006, J BABOL U MED SCI, V8, P55; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Lin SYH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S10; LUNDE MN, 1983, J PARASITOL, V69, P806, DOI 10.2307/3281034; Maksimov P, 2011, VET PARASITOL, V182, P140, DOI 10.1016/j.vetpar.2011.05.049; Maksimov P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034212; Maksimov P, 2012, CLIN VACCINE IMMUNOL, V19, P865, DOI 10.1128/CVI.00119-12; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; MELSSEN W, 2006, SUPERVISED KOHONEN N, V83, P99; Meyer D, 2006, J STAT SOFTW, P17; Montoya A, 2009, VET PARASITOL, V160, P159, DOI 10.1016/j.vetpar.2008.10.029; Morisset S, 2008, MICROBES INFECT, V10, P742, DOI 10.1016/j.micinf.2008.04.001; Nahtman T, 2007, J IMMUNOL METHODS, V328, P1, DOI 10.1016/j.jim.2007.07.015; Ngo Y, 2009, J IMMUNOL METHODS, V343, P68, DOI 10.1016/j.jim.2008.12.004; Nowakowska D, 2006, J CLIN MICROBIOL, V44, P1382, DOI 10.1128/JCM.44.4.1382-1389.2006; Opsteegh M, 2012, PREV VET MED, V104, P317, DOI 10.1016/j.prevetmed.2012.01.003; Pamelard F, 2009, METHODS MOL BIOL, V570, P413, DOI 10.1007/978-1-60327-394-7_24; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; Peyron F, 2006, MICROBES INFECT, V8, P2333, DOI 10.1016/j.micinf.2006.03.023; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Schares G, 2008, VET PARASITOL, V152, P34, DOI 10.1016/j.vetpar.2007.12.004; Schares G, 1998, VET PARASITOL, V80, P87, DOI 10.1016/S0304-4017(98)00195-2; Sousa S, 2008, CLIN VACCINE IMMUNOL, V15, P1380, DOI 10.1128/CVI.00186-08; Sousa S, 2010, VET PARASITOL, V169, P24, DOI 10.1016/j.vetpar.2009.12.025; Sousa S, 2009, CLIN VACCINE IMMUNOL, V16, P1158, DOI 10.1128/CVI.00092-09; Spycher A, 2011, J VET DIAGN INVEST, V23, P104, DOI 10.1177/104063871102300117; Su C, 2006, INT J PARASITOL, V36, P841, DOI 10.1016/j.ijpara.2006.03.003; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4; Vigil A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011447; Wang JB, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-36; Xiao JC, 2009, MICROBES INFECT, V11, P1011, DOI 10.1016/j.micinf.2009.07.007; ZWEIG MH, 1993, CLIN CHEM, V39, P561	79	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80213	10.1371/journal.pone.0080213	http://dx.doi.org/10.1371/journal.pone.0080213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244652	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900067
J	Ryynanen, J; Carlberg, C				Ryynanen, Jussi; Carlberg, Carsten			Primary 1,25-Dihydroxyvitamin D-3 Response of the Interleukin 8 Gene Cluster in Human Monocyte- and Macrophage-Like Cells	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; FACTOR-KAPPA-B; GENOME-WIDE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; REGULATORY ELEMENTS; CHROMATIN-STRUCTURE; TRANSCRIPTION; EXPRESSION; BINDING; CHEMOKINES	Genome-wide analysis of vitamin D receptor (VDR) binding sites in THP-1 human monocyte-like cells highlighted the interleukin 8 gene, also known as chemokine CXC motif ligand 8 (CXCL8). CXCL8 is a chemotactic cytokine with important functions during acute inflammation as well as in the context of various cancers. The nine genes of the CXCL cluster and the strong VDR binding site close to the CXCL8 gene are insulated from neighboring genes by CCCTC-binding factor (CTCF) binding sites. Only CXCL8, CXCL6 and CXCL1 are expressed in THP-1 cells, but all three are up-regulated primary 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) target genes. Formaldehyde-assisted isolation of regulatory elements sequencing analysis of the whole CXCL cluster demonstrated 1,25(OH)(2)D-3-dependent chromatin opening exclusively for the VDR binding site. In differentiated THP-1 cells the CXCL8 gene showed a 33-fold higher basal expression, but is together with CXCL6 and CXCL1 still a primary 1,25(OH)(2)D-3 target under the control of the same genomic VDR binding site. In summary, both in undifferentiated and differentiated THP-1 cells the genes CXCL8, CXCL6 and CXCL1 are under the primary control of 1,25(OH)(2)D-3 and its receptor VDR. Our observation provides further evidence for the immune-related functions of vitamin D.	[Ryynanen, Jussi; Carlberg, Carsten] Univ Eastern Finland, Sch Med, Inst Biomed, Kuopio, Finland	University of Eastern Finland	Carlberg, C (corresponding author), Univ Eastern Finland, Sch Med, Inst Biomed, Kuopio, Finland.	carsten.carlberg@uef.fi	Carlberg, Carsten/C-9075-2011	Carlberg, Carsten/0000-0003-2633-0684	Academy of Finland; Juselius Foundation	Academy of Finland(Academy of Finland); Juselius Foundation	This work was supported by the Academy of Finland and the Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Carlberg C, 2012, CURR TOP MED CHEM, V12, P528, DOI 10.2174/156802612799436623; Carlberg C, 2012, ANTICANCER RES, V32, P271; Carlberg C, 2010, CHROMOSOMA, V119, P479, DOI 10.1007/s00412-010-0283-8; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Di Rosa M, 2012, CELL IMMUNOL, V280, P36, DOI 10.1016/j.cellimm.2012.10.009; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giri D, 2001, AM J PATHOL, V159, P139, DOI 10.1016/S0002-9440(10)61681-1; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gynther P, 2011, BBA-MOL CELL RES, V1813, P810, DOI 10.1016/j.bbamcr.2011.01.037; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Harant H, 1997, EUR J BIOCHEM, V250, P63, DOI 10.1111/j.1432-1033.1997.00063.x; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Homey B, 2002, NAT REV IMMUNOL, V2, P175, DOI 10.1038/nri748; Ikeuchi T, 2013, INT IMMUNOPHARMACOL, V15, P15, DOI 10.1016/j.intimp.2012.10.027; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Lee BK, 2012, J BIOL CHEM, V287, P30906, DOI 10.1074/jbc.R111.324962; LINDLEY I, 1988, P NATL ACAD SCI USA, V85, P9199, DOI 10.1073/pnas.85.23.9199; Malinen M, 2008, NUCLEIC ACIDS RES, V36, P121, DOI 10.1093/nar/gkm913; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; Maxwell PJ, 2013, EUR UROL, V64, P177, DOI 10.1016/j.eururo.2012.08.032; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; Polly P, 2000, FASEB J, V14, P1455, DOI 10.1096/fj.14.10.1455; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Seuter S, 2013, J STEROID B IN PRESS; Seuter S, 2013, DYNAMICS 1 ALP UNPUB; Seuter S, 2013, J STEROID BIOCHEM, V136, P62, DOI 10.1016/j.jsbmb.2012.11.011; Seuter S, 2013, NUCLEIC ACIDS RES, V41, P110, DOI 10.1093/nar/gks959; Singh S, 2010, FUTURE ONCOL, V6, P111, DOI 10.2217/FON.09.128; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanoirbeek E, 2011, BEST PRACT RES CL EN, V25, P593, DOI 10.1016/j.beem.2011.05.001; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Wolf JS, 2001, CLIN CANCER RES, V7, P1812; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	59	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78170	10.1371/journal.pone.0078170	http://dx.doi.org/10.1371/journal.pone.0078170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24250750	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600077
J	Schureck, MA; Maehigashi, T; Miles, SJ; Marquez, J; Cho, SE; Erdman, R; Dunham, CM				Schureck, Marc A.; Maehigashi, Tatsuya; Miles, Stacey J.; Marquez, Jhomar; Cho, Shein Ei; Erdman, Rachel; Dunham, Christine M.			Structure of the Proteus vulgaris HigB-(HigA)(2)-HigB Toxin-Antitoxin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER GENE SYSTEM; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REPRESSION; MULTIDRUG TOLERANCE; SECONDARY-STRUCTURE; LON PROTEASE; DNA-BINDING; YOEB TOXIN; RNA	Bacterial toxin-antitoxin (TA) systems regulate key cellular processes to promote cell survival during periods of stress. During steady-state cell growth, antitoxins typically interact with their cognate toxins to inhibit activity presumably by preventing substrate recognition. We solved two x-ray crystal structures of the Proteus vulgaris tetrameric HigB-(HigA)(2)-HigB TA complex and found that, unlike most other TA systems, the antitoxin HigA makes minimal interactions with toxin HigB. HigB adopts a RelE family tertiary fold containing a highly conserved concave surface where we predict its active site is located. HigA does not cover the solvent-exposed HigB active site, suggesting that, in general, toxin inhibition is not solely mediated by active site hindrance by its antitoxin. Each HigA monomer contains a helix-turn-helix motif that binds to its own DNA operator to repress transcription during normal cellular growth. This is distinct from antitoxins belonging to other superfamilies that typically only form DNA-binding motifs upon dimerization. We further show that disruption of the HigB-(HigA)(2)-HigB tetramer to a HigBA heterodimer ablates operator binding. Taken together, our biochemical and structural studies elucidate the novel molecular details of the HigBA TA system.	[Schureck, Marc A.; Maehigashi, Tatsuya; Miles, Stacey J.; Marquez, Jhomar; Cho, Shein Ei; Erdman, Rachel; Dunham, Christine M.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA	Emory University	Dunham, CM (corresponding author), Emory Univ, Dept Biochem, Sch Med, 1510 Clifton Rd NE,Ste G223, Atlanta, GA 30322 USA.	christine.m.dunham@emory.edu			National Science Foundation CAREER [MCB0953714]; National Institutes of Health NCRR [RR-15301]; United States Department of Energy [DE-AC02-06CH11357]; Biochemistry, Cellular and Molecular Biology (BCMB) Graduate Training Grant [5T32GM8367]; National Institutes of Health National Research Service [GM108351]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, F31GM108351] Funding Source: NIH RePORTER	National Science Foundation CAREER(National Science Foundation (NSF)); National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy(United States Department of Energy (DOE)); Biochemistry, Cellular and Molecular Biology (BCMB) Graduate Training Grant; National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation CAREER Award MCB0953714 (to C. M. D.). This work is based on research conducted at the Advanced Photon Source on the NE-CAT beamlines, which is supported by National Institutes of Health NCRR Award RR-15301, and at the SER-CAT beamline. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357.; Supported by Biochemistry, Cellular and Molecular Biology (BCMB) Graduate Training Grant 5T32GM8367 and National Institutes of Health National Research Service Award Fellowship GM108351.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Arbing MA, 2010, STRUCTURE, V18, P996, DOI 10.1016/j.str.2010.04.018; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bauerova-Hlinkova V, 2009, FEBS J, V276, P4156, DOI 10.1111/j.1742-4658.2009.07125.x; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Brown BL, 2013, J BIOL CHEM, V288, P1286, DOI 10.1074/jbc.M112.421008; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dienemann C, 2011, J MOL BIOL, V414, P713, DOI 10.1016/j.jmb.2011.10.024; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francuski D, 2009, J MOL BIOL, V393, P898, DOI 10.1016/j.jmb.2009.08.048; Francuski M, 2009, TRANSPL INT, V22, P482, DOI 10.1111/j.1432-2277.2008.00776.x; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Goeders N, 2013, J BACTERIOL, V195, P2541, DOI 10.1128/JB.02266-12; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Heaton BE, 2012, J BIOL CHEM, V287, P12098, DOI 10.1074/jbc.M111.332163; HEINEMANN U, 1983, J BIOMOL STRUCT DYN, V1, P523, DOI 10.1080/07391102.1983.10507459; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hurley JM, 2011, J BIOL CHEM, V286, P14770, DOI 10.1074/jbc.M110.108969; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Luscombe NM, 2000, GENOME BIOL, V1; Mate MJ, 2012, NUCLEIC ACIDS RES, V40, P3245, DOI 10.1093/nar/gkr1167; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2013, STRUCTURE, V21, P627, DOI 10.1016/j.str.2013.02.008; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Schifano JM, 2013, P NATL ACAD SCI USA, V110, P8501, DOI 10.1073/pnas.1222031110; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; TERAWAKI Y, 1967, J BACTERIOL, V94, P687, DOI 10.1128/JB.94.3.687-690.1967; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Tian QB, 2001, PLASMID, V45, P63, DOI 10.1006/plas.2000.1506; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	72	55	60	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1060	1070		10.1074/jbc.M113.512095	http://dx.doi.org/10.1074/jbc.M113.512095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24257752	hybrid, Green Published			2022-12-25	WOS:000330541200038
J	Boku, S; Hisaoka-Nakashima, K; Nakagawa, S; Kato, A; Kajitani, N; Inoue, T; Kusumi, I; Takebayashi, M				Boku, Shuken; Hisaoka-Nakashima, Kazue; Nakagawa, Shin; Kato, Akiko; Kajitani, Naoto; Inoue, Takeshi; Kusumi, Ichiro; Takebayashi, Minoru			Tricyclic Antidepressant Amitriptyline Indirectly Increases the Proliferation of Adult Dentate Gyrus-Derived Neural Precursors: An Involvement of Astrocytes	PLOS ONE			English	Article							STEM-CELL PROLIFERATION; NEUROTROPHIC-FACTOR; HIPPOCAMPAL NEUROGENESIS; GROWTH-FACTOR; CYSTATIN-C; PROTEIN; BRAIN; DEPRESSION; RECEPTOR; KINASE	Antidepressants increase the proliferation of neural precursors in adult dentate gyrus (DG), which is considered to be involved in the therapeutic action of antidepressants. However, the mechanism underlying it remains unclear. By using cultured adult rat DG-derived neural precursors (ADP), we have already shown that antidepressants have no direct effects on ADP. Therefore, antidepressants may increase the proliferation of neural precursors in adult DG via unknown indirect mechanism. We have also shown that amitriptyline (AMI), a tricyclic antidepressant, induces the expressions of GDNF, BDNF, FGF2 and VEGF, common neurogenic factors, in primary cultured astrocytes (PCA). These suggest that AMI-induced factors in astrocytes may increase the proliferation of neural precursors in adult DG. To test this hypothesis, we examined the effects of AMI-induced factors and conditioned medium (CM) from PCA treated with AMI on ADP proliferation. The effects of CM and factors on ADP proliferation were examined with BrdU immunocytochemistry. AMI had no effect on ADP proliferation, but AMI-treated CM increased it. The receptors of GDNF, BDNF and FGF2, but not VEGF, were expressed in ADP. FGF2 significantly increased ADP proliferation, but not BDNF and GDNF. In addition, both of a specific inhibitor of FGF receptors and anti-FGF2 antibody significantly counteracted the increasing effect of CM on ADP proliferation. In addition, FGF2 in brain is mainly derived from astrocytes that are key components of the neurogenic niches in adult DG. These suggest that AMI may increase ADP proliferation indirectly via PCA and that FGF2 may a potential candidate to mediate such an indirect effect of AMI on ADP proliferation via astrocytes.	[Boku, Shuken] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Boku, Shuken; Nakagawa, Shin; Kato, Akiko; Inoue, Takeshi; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Hisaoka-Nakashima, Kazue; Kajitani, Naoto] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pharmacol, Hiroshima, Japan; [Takebayashi, Minoru] NHO Kure Med Ctr, Inst Clin Res, Div Psychiat & Neurosci, Kure, Japan; [Takebayashi, Minoru] Chugoku Canc Ctr, Kure, Japan	Yeshiva University; Albert Einstein College of Medicine; Hokkaido University; Hiroshima University	Boku, S (corresponding author), Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA.	shuboku@gmail.com	Inoue, Takeshi/D-7431-2012; Boku, Shuken/H-2776-2017; Inoue, Takeshi/X-8057-2019	Inoue, Takeshi/0000-0001-5248-1289; Kajitani, Naoto/0000-0001-7245-9206	JSPS KAKENHI [18591269, 22791102, 23591686, 23790297, 24006852]; Grants-in-Aid for Scientific Research [24591673, 12J06852] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was suggested by JSPS KAKENHI Grant Number 18591269, 22791102, 23591686, 23790297 and 24006852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Allaman I, 2011, PSYCHOPHARMACOLOGY, V216, P75, DOI 10.1007/s00213-011-2190-y; Amsterdam JD, 1996, PSYCHIAT CLIN N AM, V19, P371, DOI 10.1016/S0193-953X(05)70293-8; Aronica E, 2001, EUR J NEUROSCI, V14, P1485, DOI 10.1046/j.0953-816x.2001.01779.x; Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Boku S, 2011, PROG NEURO-PSYCHOPH, V35, P111, DOI 10.1016/j.pnpbp.2010.09.019; Boku S, 2009, NEUROPSYCHOPHARMACOL, V34, P805, DOI 10.1038/npp.2008.198; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; ECKENSTEIN F, 1991, ANN NY ACAD SCI, V638, P348, DOI 10.1111/j.1749-6632.1991.tb49045.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; FAWCETT J, 1994, PSYCHIAT ANN, V24, P214, DOI 10.3928/0048-5713-19940501-05; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Iwata M, 2011, HIPPOCAMPUS, V21, P877, DOI 10.1002/hipo.20803; Jarosik J, 2011, RESTOR NEUROL NEUROS, V29, P153, DOI 10.3233/RNN-2011-0588; Kajitani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051197; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Ko HG, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-16; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Liu Q, 2009, EUR NEUROPSYCHOPHARM, V19, P796, DOI 10.1016/j.euroneuro.2009.06.010; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manev H, 2003, J AFFECT DISORDERS, V75, P59, DOI 10.1016/S0165-0327(02)00044-7; Masuda T, 2012, PROG NEURO-PSYCHOPH, V36, P44, DOI 10.1016/j.pnpbp.2011.08.019; Mercier G, 2004, J MOL NEUROSCI, V24, P207, DOI 10.1385/JMN:24:2:207; Nakagawa S, 2002, J NEUROSCI, V22, P3673; NIERENBERG A A, 1990, Journal of Clinical Psychiatry, V51, P39; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; PICKEL VM, 1974, J COMP NEUROL, V155, P15, DOI 10.1002/cne.901550103; Rousell J, 1996, MOL PHARMACOL, V49, P629; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Savona C, 1991, GROWTH FACTORS, V5, DOI 10.3109/08977199109000291; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Steinhoff T, 2001, NEUROBIOL DIS, V8, P647, DOI 10.1006/nbdi.2001.0412; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79371	10.1371/journal.pone.0079371	http://dx.doi.org/10.1371/journal.pone.0079371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260208	Green Published, gold			2022-12-25	WOS:000327308500053
J	Kretschmer, F; Kretschmer, V; Kunze, VP; Kretzberg, J				Kretschmer, Friedrich; Kretschmer, Viola; Kunze, Vincent P.; Kretzberg, Jutta			OMR-Arena: Automated Measurement and Stimulation System to Determine Mouse Visual Thresholds Based on Optomotor Responses	PLOS ONE			English	Article							SPATIAL VISION; EYE-MOVEMENTS; ACUITY; MICE; SENSITIVITY; ZEBRAFISH; PLASTICITY; BEHAVIORS; STRAINS; ADULT	Measurement of the optomotor response is a common way to determine thresholds of the visual system in animals. Particularly in mice, it is frequently used to characterize the visual performance of different genetically modified strains or to test the effect of various drugs on visual performance. Several methods have been developed to facilitate the presentation of stimuli using computer screens or projectors. Common methods are either based on the measurement of eye movement during optokinetic reflex behavior or rely on the measurement of head and/or body-movements during optomotor responses. Eye-movements can easily and objectively be quantified, but their measurement requires invasive fixation of the animals. Head movements can be observed in freely moving animals, but until now depended on the judgment of a human observer who reported the counted tracking movements of the animal during an experiment. In this study we present a novel measurement and stimulation system based on open source building plans and software. This system presents appropriate 3600 stimuli while simultaneously video-tracking the animal's head-movements without fixation. The on-line determined head gaze is used to adjust the stimulus to the head position, as well as to automatically calculate visual acuity. Exemplary, we show that automatically measured visual response curves of mice match the results obtained by a human observer very well. The spatial acuity thresholds yielded by the automatic analysis are also consistent with the human observer approach and with published results. Hence, OMR-arena provides an affordable, convenient and objective way to measure mouse visual performance.	[Kretschmer, Friedrich] NEI, Retinal Circuit Dev & Genet Unit, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Kretschmer, Viola; Kunze, Vincent P.; Kretzberg, Jutta] Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany; [Kretzberg, Jutta] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Kretschmer, F (corresponding author), NEI, Retinal Circuit Dev & Genet Unit, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA.	friedrich.kretschmer@nih.gov		Kunze, Vincent/0000-0002-7869-9793	German research foundation [DFG FOR 701]	German research foundation(German Research Foundation (DFG))	The work was supported by German research foundation, DFG FOR 701. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Anstis S, 1998, VISION RES, V38, P45, DOI 10.1016/S0042-6989(97)00159-4; Ariel M, 1997, VISION RES, V37, P925, DOI 10.1016/S0042-6989(96)00229-5; Balogh SA, 1999, BRAIN RES, V836, P38, DOI 10.1016/S0006-8993(99)01586-3; Balogh SA, 1998, DEV BRAIN RES, V111, P291, DOI 10.1016/S0165-3806(98)00138-2; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Beck JC, 2004, J NEUROPHYSIOL, V92, P3546, DOI 10.1152/jn.00311.2004; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Chang L, 2013, NEURON, V77, P559, DOI 10.1016/j.neuron.2012.12.012; Dedek K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001714; DIERINGER N, 1982, EXP BRAIN RES, V47, P407; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; Gianfranceschi L, 1999, VISION RES, V39, P569, DOI 10.1016/S0042-6989(98)00169-2; Huang YY, 2008, FRONT BIOSCI-LANDMRK, V13, P1899, DOI 10.2741/2810; Huber-Reggi Sabina P, 2013, Methods Mol Biol, V935, P139, DOI 10.1007/978-1-62703-080-9_10; Kretschmer F., 2011, 2011 4th International Congress on Image and Signal Processing (CISP 2011), P441, DOI 10.1109/CISP.2011.6099935; Kretschmer F, 2012, IEEE P 2012 5 INT C; Kretschmer F, 2012, NEUROCOMPUTING, V84, P39, DOI 10.1016/j.neucom.2011.12.026; Lantinga S, 2012, SIMPLE DIRECTMEDIA L; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mueller KP, 2011, JOVE-J VIS EXP, DOI 10.3791/3556; Origlia N, 2012, INVEST OPHTH VIS SCI, V53, P1211, DOI 10.1167/iovs.11-8007; PASTOR AM, 1991, J NEUROPHYSIOL, V66, P2125, DOI 10.1152/jn.1991.66.6.2125; Pinto LH, 2000, MAMM GENOME, V11, P531, DOI 10.1007/s003350010102; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Puk O, 2008, FRONT BIOSCI-LANDMRK, V13, P6269, DOI 10.2741/3153; Roeser T, 2003, J NEUROSCI, V23, P3726; Sakatani T, 2004, NEUROSCI RES, V49, P123, DOI 10.1016/j.neures.2004.02.002; Segal M, 2009, TECHNICAL REPORT; SINEX DG, 1979, VISION RES, V19, P853, DOI 10.1016/0042-6989(79)90018-X; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Tabata H, 2010, J VISION, V10, DOI 10.1167/10.1.13; Thaung C, 2002, NEUROSCI LETT, V325, P21, DOI 10.1016/S0304-3940(02)00223-9; Umino Y, 2012, J NEUROSCI, V32, P14364, DOI 10.1523/JNEUROSCI.1296-12.2012; van Alphen B, 2010, INVEST OPHTH VIS SCI, V51, P623, DOI 10.1167/iovs.09-4072; van Alphen B, 2009, INVEST OPHTH VIS SCI, V50, P2451, DOI 10.1167/iovs.08-2594; Wallace DJ, 2013, NATURE, V498, P65, DOI 10.1038/nature12153; Wang YV, 2011, J NEUROSCI, V31, P7670, DOI 10.1523/JNEUROSCI.0629-11.2011; WIESENFELD Z, 1976, VISION RES, V16, P823, DOI 10.1016/0042-6989(76)90142-5; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x	45	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e78058	10.1371/journal.pone.0078058	http://dx.doi.org/10.1371/journal.pone.0078058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260105	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600005
J	Thaxter, CB; Daunt, F; Gremillet, D; Harris, MP; Benvenuti, S; Watanuki, Y; Hamer, KC; Wanless, S				Thaxter, Chris B.; Daunt, Francis; Gremillet, David; Harris, Mike P.; Benvenuti, Silvano; Watanuki, Yutaka; Hamer, Keith C.; Wanless, Sarah			Modelling the Effects of Prey Size and Distribution on Prey Capture Rates of Two Sympatric Marine Predators	PLOS ONE			English	Article							CHICK-REARING RAZORBILLS; FEEDING STRATEGIES; FORAGING BEHAVIOR; AMMODYTES-MARINUS; DIVING BEHAVIOR; TIME ALLOCATION; URIA-AALGE; SEABIRDS; COMMON; GUILLEMOTS	Understanding how prey capture rates are influenced by feeding ecology and environmental conditions is fundamental to assessing anthropogenic impacts on marine higher predators. We compared how prey capture rates varied in relation to prey size, prey patch distribution and prey density for two species of alcid, common guillemot (Uria aalge) and razorbill (Alca torda) during the chick-rearing period. We developed a Monte Carlo approach parameterised with foraging behaviour from bird-borne data loggers, observations of prey fed to chicks, and adult diet from water-offloading, to construct a bioenergetics model. Our primary goal was to estimate prey capture rates, and a secondary aim was to test responses to a set of biologically plausible environmental scenarios. Estimated prey capture rates were 1.5 +/- 0.8 items per dive (0.8 +/- 0.4 and 1.1 +/- 0.6 items per minute foraging and underwater, respectively) for guillemots and 3.7 +/- 2.4 items per dive (4.9 +/- 3.1 and 7.3 +/- 4.0 items per minute foraging and underwater, respectively) for razorbills. Based on species' ecology, diet and flight costs, we predicted that razorbills would be more sensitive to decreases in 0-group sandeel (Ammodytes marinus) length (prediction 1), but guillemots would be more sensitive to prey patches that were more widely spaced (prediction 2), and lower in prey density (prediction 3). Estimated prey capture rates increased non-linearly as 0-group sandeel length declined, with the slope being steeper in razorbills, supporting prediction 1. When prey patches were more dispersed, estimated daily energy expenditure increased by a factor of 3.0 for guillemots and 2.3 for razorbills, suggesting guillemots were more sensitive to patchier prey, supporting prediction 2. However, both species responded similarly to reduced prey density (guillemot expenditure increased by 1.7; razorbill by 1.6), thus not supporting prediction 3. This bio-energetics approach complements other foraging models in predicting likely impacts of environmental change on marine higher predators dependent on species-specific foraging ecologies.	[Thaxter, Chris B.; Hamer, Keith C.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Thaxter, Chris B.; Daunt, Francis; Harris, Mike P.; Wanless, Sarah] Ctr Ecol & Hydrol, Penuick, Midlothian, Scotland; [Gremillet, David] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Gremillet, David] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Benvenuti, Silvano] Univ Pisa, Dept Biol, Pisa, Italy; [Watanuki, Yutaka] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan	University of Leeds; UK Centre for Ecology & Hydrology (UKCEH); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; National Research Foundation - South Africa; University of Cape Town; University of Pisa; Hokkaido University	Thaxter, CB (corresponding author), The Nunnery, British Trust Ornithol, Thetford, Norfolk, England.	chris.thaxter@bto.org	Daunt, Francis/K-6688-2012; Thaxter, Chris B/J-4787-2017; Gremillet, David/W-1946-2018	Daunt, Francis/0000-0003-4638-3388; Thaxter, Chris B/0000-0003-0341-4199; Gremillet, David/0000-0002-7711-9398	Natural Environmental Research Council (NERC) [NER/S/A/2004/12298]; EU [Q5RS-2000-30864]; Natural England; Scottish Natural Heritage; Countryside Council for Wales; Council for Nature Conservation; Countryside in Northern Ireland; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); Natural England; Scottish Natural Heritage; Countryside Council for Wales; Council for Nature Conservation; Countryside in Northern Ireland; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a Case Studentship (NER/S/A/2004/12298) from the Natural Environmental Research Council (NERC), an EU-funded project (FP5 Project Interactions between the marine environment, predators and prey: implications for sustainable sandeel fisheries' (IMPRESS, Q5RS-2000-30864), and the Joint Nature Conservation Committee (on behalf of Natural England, Scottish Natural Heritage, the Countryside Council for Wales and the Council for Nature Conservation and the Countryside in Northern Ireland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbrook K, 2008, BIOL LETTERS, V4, P630, DOI 10.1098/rsbl.2008.0417; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Benoit-Bird KJ, 2011, MAR ECOL PROG SER, V443, P217, DOI 10.3354/meps09408; Benvenuti S, 2001, IBIS, V143, P402, DOI 10.1111/j.1474-919X.2001.tb04941.x; BIRTFRIESEN VL, 1989, ECOLOGY, V70, P357, DOI 10.2307/1937540; BRYANT DM, 1995, IBIS, V137, P219, DOI 10.1111/j.1474-919X.1995.tb03242.x; Charrassin JB, 2001, P ROY SOC B-BIOL SCI, V268, P151, DOI 10.1098/rspb.2000.1343; CROLL DA, 1993, J COMP PHYSIOL B, V163, P160; Dall'Antonia L, 2001, CONDOR, V103, P469, DOI 10.1650/0010-5422(2001)103[0469:TAAFPO]2.0.CO;2; DAUNT F, 2005, UNDERSTANDING MARINE, P163; Daunt F, 2008, CAN J FISH AQUAT SCI, V65, P362, DOI 10.1139/F07-164; Davoren GK, 1999, ANIM BEHAV, V58, P853, DOI 10.1006/anbe.1999.1209; Doniol-Valcroze T, 2011, BEHAV ECOL, V22, P880, DOI 10.1093/beheco/arr038; DRENT RH, 1980, ARDEA, V68, P225; Enstipp MR, 2007, MAR ECOL PROG SER, V331, P267, DOI 10.3354/meps331267; Enstipp MR, 2006, CONSERV BIOL, V12, P131; Fauchald P, 1999, AM NAT, V153, P603, DOI 10.1086/303203; Frederiksen M, 2011, MAR ECOL PROG SER, V432, P137, DOI 10.3354/meps09177; Gaston A.J., 1998, THE AUKS; Grecian WJ, 2012, BIOL CONSERV, V156, P43, DOI 10.1016/j.biocon.2011.12.010; Gremillet D, 2003, J APPL ECOL, V40, P266, DOI 10.1046/j.1365-2664.2003.00806.x; Halsey LG, 2007, POLAR BIOL, V30, P991, DOI 10.1007/s00300-007-0257-3; Harding AMA, 2009, POLAR BIOL, V32, P785, DOI 10.1007/s00300-009-0581-x; HARRIS MP, 1985, J ZOOL, V207, P441; Hilton GM, 2000, J AVIAN BIOL, V31, P36, DOI 10.1034/j.1600-048X.2000.310106.x; Hilton GM, 2000, EVOL ECOL RES, V2, P207; HISLOP JRG, 1991, J ZOOL, V224, P501, DOI 10.1111/j.1469-7998.1991.tb06039.x; Hunt G.L. Jr, 1990, Studies in Avian Biology, P7; ICES, 2008, 2008ACOM59 ICES CM; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Linnebjerg JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072987; Miramontes O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034317; Paredes R, 2008, CAN J ZOOL, V86, P610, DOI 10.1139/Z08-036; PENNYCUICK CJ, 1987, J EXP BIOL, V128, P335; Pennycuick CJ, 1997, J EXP BIOL, V200, P2355; Piatt J.F., 1990, Studies in Avian Biology, P36; Ponganis PJ, 2000, J EXP BIOL, V203, P3275; R Development Core Team, 2012, R LANG ENV STAT COMP; Regular PM, 2013, ANIM BEHAV, V86, P545, DOI 10.1016/j.anbehav.2013.06.008; SIBLY RM, 1990, ANIM BEHAV, V39, P63, DOI 10.1016/S0003-3472(05)80726-2; Smout S, 2013, J APPL ECOL, V50, P1071, DOI 10.1111/1365-2664.12095; Sonntag Nicole, 2005, Atlantic Seabirds, V7, P1; Stearns S.C., 1992, pi; Stephens D., 2007, FORAGING BEHAV ECOLO; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Thaxter CB, 2010, J EXP BIOL, V213, P1018, DOI 10.1242/jeb.037390; Thaxter CB, 2009, J AVIAN BIOL, V40, P75, DOI 10.1111/j.1600-048X.2008.04507.x; Tremblay Y, 2003, J EXP BIOL, V206, P1929, DOI 10.1242/jeb.00363; Videler JJ., 2005, AVIAN FLIGHT; Wanless S, 2004, MAR ECOL PROG SER, V279, P237, DOI 10.3354/meps279237; WANLESS S, 1993, J ZOOL, V231, P11, DOI 10.1111/j.1469-7998.1993.tb05349.x; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Welcker J, 2010, J ANIM ECOL, V79, P205, DOI 10.1111/j.1365-2656.2009.01626.x; Wilson LJ, 2004, ARDEA, V92, P197; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; WILSON RP, 1992, J EXP BIOL, V167, P267; Xavier JC, 2003, MAR BIOL, V143, P221, DOI 10.1007/s00227-003-1049-0; Ydenberg RC, 1994, ECOSCIENCE, V1, P1; Yen PPW, 2004, ECOL MODEL, V171, P395, DOI 10.1016/j.ecolmodel.2003.07.006	61	23	23	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79915	10.1371/journal.pone.0079915	http://dx.doi.org/10.1371/journal.pone.0079915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260318	Green Published, gold, Green Accepted			2022-12-25	WOS:000327258600051
J	Baptista, MAS; Dave, KD; Frasier, MA; Sherer, TB; Greeley, M; Beck, MJ; Varsho, JS; Parker, GA; Moore, C; Churchill, MJ; Meshul, CK; Fiske, BK				Baptista, Marco A. S.; Dave, Kuldip D.; Frasier, Mark A.; Sherer, Todd B.; Greeley, Melanie; Beck, Melissa J.; Varsho, Julie S.; Parker, George A.; Moore, Cindy; Churchill, Madeline J.; Meshul, Charles K.; Fiske, Brian K.			Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs	PLOS ONE			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; IMPAIRMENT; MUTATIONS; G2019S	The objective of this study was to evaluate the pathology time course of the LRRK2 knockout rat model of Parkinson's disease at 1-, 2-, 4-, 8-, 12-, and 16-months of age. The evaluation consisted of histopathology and ultrastructure examination of selected organs, including the kidneys, lungs, spleen, heart, and liver, as well as hematology, serum, and urine analysis. The LRRK2 knockout rat, starting at 2-months of age, displayed abnormal kidney staining patterns and/or morphologic changes that were associated with higher serum phosphorous, creatinine, cholesterol, and sorbitol dehydrogenase, and lower serum sodium and chloride compared to the LRRK2 wild-type rat. Urinalysis indicated pronounced changes in LRRK2 knockout rats in urine specific gravity, total volume, urine potassium, creatinine, sodium, and chloride that started as early as 1- to 2-months of age. Electron microscopy of 16-month old LRRK2 knockout rats displayed an abnormal kidney, lung, and liver phenotype. In contrast, there were equivocal or no differences in the heart and spleen of LRRK2 wild-type and knockout rats. These findings partially replicate data from a recent study in 4-month old LRRK2 knockout rats [1] and expand the analysis to demonstrate that the renal and possibly lung and liver abnormalities progress with age. The characterization of LRRK2 knockout rats may prove to be extremely valuable in understanding potential safety liabilities of LRRK2 kinase inhibitor therapeutics for treating Parkinson's disease.	[Baptista, Marco A. S.; Dave, Kuldip D.; Frasier, Mark A.; Sherer, Todd B.; Fiske, Brian K.] Michael J Fox Fdn Parkinsons Res, Res Programs, New York, NY USA; [Greeley, Melanie; Beck, Melissa J.; Varsho, Julie S.; Parker, George A.] WIL Res, Ashland, OH USA; [Moore, Cindy; Churchill, Madeline J.; Meshul, Charles K.] Oregon Hlth & Sci Univ, VA Med Ctr Portland, Res Serv, Portland, OR 97201 USA; [Moore, Cindy; Churchill, Madeline J.; Meshul, Charles K.] Oregon Hlth & Sci Univ, Dept Behav Neurosci & Pathol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Baptista, MAS (corresponding author), Michael J Fox Fdn Parkinsons Res, Res Programs, New York, NY USA.	mbaptista@michaeljfox.org	Beck, Melissa/GQA-6895-2022; Fiske, Brian Kenneth/L-9324-2016	Churchill, Madeline/0000-0001-7624-4894; Sherer, Todd/0000-0001-9667-6600	Michael J. Fox Foundation; Department of Veterans Affairs Merit Review Program	Michael J. Fox Foundation; Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs)	The Michael J. Fox Foundation funded this study and had a role in the study design and preparation of the manuscript. CKM has received funding from the Department of Veterans Affairs Merit Review Program (CKM) and this funder also had no influence on the study. However, the funders had no role in the data collection, analysis, and decision to publish.	Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; CORDER CN, 1977, J HISTOCHEM CYTOCHEM, V25, P1, DOI 10.1177/25.1.401844; Dawson TM, 2009, BBA-MOL BASIS DIS, V1792, P585, DOI 10.1016/j.bbadis.2009.06.001; De Rijk EPCT, 2003, TOXICOL PATHOL, V31, P462, DOI 10.1080/01926230390213775; Fraser KB, 2013, HUM MOL GENET, V22, P4988, DOI 10.1093/hmg/ddt346; Hard GC, 2004, TOXICOL PATHOL, V32, P171, DOI 10.1080/01926230490422574; Herzig M.C., 2011, HUM MOL GENET; Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Ishihara L, 2007, MOVEMENT DISORD, V22, P55, DOI 10.1002/mds.21180; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; LOEB WF, CLIN CHEM LAB ANIMAL, P2; LUNA LG, 1968, AFIP METHOD LIPOFUSC; Ness D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066164; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ross OA, 2008, ANN NEUROL, V64, P88, DOI 10.1002/ana.21405; Rudenko IN, 2012, BMC MED, V10, DOI [10.1186/PREACCEPT-3356971966272323, 10.1186/1741-7015-10-20]; Tong YR, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-2; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Walker RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032919; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Westhuyzen J, 2003, NEPHROL DIAL TRANSPL, V18, P543, DOI 10.1093/ndt/18.3.543; Zhang J, 2009, TOXICOL PATHOL, V37, P629, DOI 10.1177/0192623309339605; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	27	117	119	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80705	10.1371/journal.pone.0080705	http://dx.doi.org/10.1371/journal.pone.0080705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244710	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800159
J	Kittl, S; Heckel, G; Korczak, BM; Kuhnert, P				Kittl, Sonja; Heckel, Gerald; Korczak, Bozena M.; Kuhnert, Peter			Source Attribution of Human Campylobacter Isolates by MLST and Fla-Typing and Association of Genotypes with Quinolone Resistance	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; POPULATION-STRUCTURE; ANTIMICROBIAL RESISTANCE; JEJUNI; COLI; DISEASE; STRAIN; MEAT	Campylobacteriosis is the most frequent zoonosis in developed countries and various domestic animals can function as reservoir for the main pathogens Campylobacter jejuni and Campylobacter coli. In the present study we compared population structures of 730 C. jejuni and C. coli from human cases, 610 chicken, 159 dog, 360 pig and 23 cattle isolates collected between 2001 and 2012 in Switzerland. All isolates had been typed with multi locus sequence typing (MLST) and flaB-typing and their genotypic resistance to quinolones was determined. We used complementary approaches by testing for differences between isolates from different hosts with the proportion similarity as well as the fixation index and by attributing the source of the human isolates with Bayesian assignment using the software STRUCTURE. Analyses were done with MLST and flaB data in parallel and both typing methods were tested for associations of genotypes with quinolone resistance. Results obtained with MLST and flaB data corresponded remarkably well, both indicating chickens as the main source for human infection for both Campylobacter species. Based on MLST, 70.9% of the human cases were attributed to chickens, 19.3% to cattle, 8.6% to dogs and 1.2% to pigs. Furthermore we found a host independent association between sequence type (ST) and quinolone resistance. The most notable were ST-45, all isolates of which were susceptible, while for ST-464 all were resistant.	[Kittl, Sonja; Korczak, Bozena M.; Kuhnert, Peter] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Heckel, Gerald] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Heckel, Gerald] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Bern; University of Bern; Swiss Institute of Bioinformatics	Kuhnert, P (corresponding author), Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland.	peter.kuhnert@vetsuisse.unibe.ch	Kuhnert, Peter/O-1651-2014	Kuhnert, Peter/0000-0002-1575-5225; Heckel, Gerald/0000-0002-0162-323X	Swiss Federal Veterinary Office [1.10.08]	Swiss Federal Veterinary Office	This work was supported by Swiss Federal Veterinary Office grant 1.10.08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredson DA, 2007, FEMS MICROBIOL LETT, V277, P123, DOI 10.1111/j.1574-6968.2007.00935.x; Amar C, 2013, VET MICROBI IN PRESS; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1437; [Anonymous], 2011, SCHWEIZ ZOON 2010; Baumgartner A, 2012, CAMPYLOBACTER SWITZE; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Carrillo CD, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00057; Colles FM, 2012, MICROBIOL-SGM, V158, P2695, DOI 10.1099/mic.0.062000-0; Dingle KE, 2008, EMERG INFECT DIS, V14, P1620, DOI 10.3201/eid1410.071109; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676; Egger R, 2012, VET MICROBIOL, V155, P272, DOI 10.1016/j.vetmic.2011.08.012; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garrett N, 2007, J APPL MICROBIOL, V103, P2113, DOI 10.1111/j.1365-2672.2007.03437.x; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Gras LM, 2013, EPIDEMIOL INFECT, V141, P2526, DOI 10.1017/S0950268813000356; Griekspoor P, 2013, MOL ECOL, V22, P1463, DOI 10.1111/mec.12144; Habib I, 2009, APPL ENVIRON MICROB, V75, P4264, DOI 10.1128/AEM.00168-09; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Helms M, 2005, J INFECT DIS, V191, P1050, DOI 10.1086/428453; Horrocks SM, 2009, ANAEROBE, V15, P18, DOI 10.1016/j.anaerobe.2008.09.001; Kittl S, 2011, J APPL MICROBIOL, V110, P513, DOI 10.1111/j.1365-2672.2010.04906.x; Kittl S, 2013, APPL ENVIRON MICROB, V79, P3875, DOI 10.1128/AEM.00493-13; Korczak BM, 2009, J CLIN MICROBIOL, V47, P1996, DOI 10.1128/JCM.00237-09; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Mullner P, 2010, EPIDEMIOL INFECT, V138, P1372, DOI 10.1017/S0950268809991579; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Niederer L, 2012, APPL ENVIRON MICROB, V78, P288, DOI 10.1128/AEM.06194-11; O'Hara JR, 2012, INFECT IMMUN, V80, P1563, DOI 10.1128/IAI.06066-11; Pires SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/fpd.2008.0208; Pritchard JK, 2000, GENETICS, V155, P945; ROSEF O, 1985, APPL ENVIRON MICROB, V49, P1507, DOI 10.1128/AEM.49.6.1507-1510.1985; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Smid JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055029; Sopwith W, 2008, EMERG INFECT DIS, V14, P1769, DOI 10.3201/eid1411.071678; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Wirz SE, 2010, APPL ENVIRON MICROB, V76, P6377, DOI 10.1128/AEM.00813-10; Zhang QJ, 2008, CAMPYLOBACTER, 3RD EDITION, P263	38	91	92	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81796	10.1371/journal.pone.0081796	http://dx.doi.org/10.1371/journal.pone.0081796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244747	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800185
J	Vanderheyden, WM; Vanderheyden, M; Tanenhaus, A; Yin, JC; Shaw, PJ				Vanderheyden, William M.; Gerstner, Jason R.; Tanenhaus, Anne; Yin, Jerry C.; Shaw, Paul J.			ERK Phosphorylation Regulates Sleep and Plasticity in Drosophila	PLOS ONE			English	Article							PROTEIN-KINASE CASCADE; SYNAPTIC PLASTICITY; MUSHROOM BODIES; MEMORY; DEPRIVATION; HOMEOSTASIS; ACTIVATION; WAKING; CONSOLIDATION; EXPRESSION	Given the relationship between sleep and plasticity, we examined the role of Extracellular signal-regulated kinase (ERK) in regulating baseline sleep, and modulating the response to waking experience. Both sleep deprivation and social enrichment increase ERK phosphorylation in wild-type flies. The effects of both sleep deprivation and social enrichment on structural plasticity in the LNvs can be recapitulated by expressing an active version of ERK (UAS-ERKSEM) pan-neuronally in the adult fly using GeneSwitch (Gsw) Gsw-elav-GAL4. Conversely, disrupting ERK reduces sleep and prevents both the behavioral and structural plasticity normally induced by social enrichment. Finally, using transgenic flies carrying a cAMP response Element (CRE)-luciferase reporter we show that activating ERK enhances CRE-Luc activity while disrupting ERK reduces it. These data suggest that ERK phosphorylation is an important mediator in transducing waking experience into sleep.	[Vanderheyden, William M.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Vanderheyden, William M.; Shaw, Paul J.] Washington Univ, Sch Med, Dept Anat, St Louis, MO USA; [Gerstner, Jason R.] Univ Penn, Perelman Sch Med, Ctr Sleep & Circadian Neurobiol, Translat Res Labs, Philadelphia, PA 19104 USA; [Tanenhaus, Anne; Yin, Jerry C.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Tanenhaus, Anne; Yin, Jerry C.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vanderheyden, WM (corresponding author), Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA.	wmvander@med.umich.edu	Gerstner, Jason/J-3778-2013	Gerstner, Jason/0000-0003-3113-6974	National Institutes of Health (NIH) [2 R01 NS051305-06]; NIH Neuroscience Blueprint Core Grant [NS057105]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS076980, R01NS051305] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Neuroscience Blueprint Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded in part by National Institutes of Health (NIH) grant 2 R01 NS051305-06, and NIH Neuroscience Blueprint Core Grant NS057105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; Blum S, 1999, J NEUROSCI, V19, P3535; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Donlea JM, 2009, ADV GENET, V68, P57, DOI 10.1016/S0065-2660(09)68003-2; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Gerstner Jason R, 2011, Commun Integr Biol, V4, P623, DOI 10.4161/cib.4.5.16927; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Giovannini MG, 2006, REV NEUROSCIENCE, V17, P619; Goldin M, 2003, EUR J NEUROSCI, V17, P2529, DOI 10.1046/j.1460-9568.2003.02694.x; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Iijima-Andot K, 2005, P NATL ACAD SCI USA, V102, P10261, DOI 10.1073/pnas.0503937102; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim MJ, 2006, EMBO J, V25, P3056, DOI 10.1038/sj.emboj.7601180; Koh YH, 2002, J NEUROSCI, V22, P2496, DOI 10.1523/JNEUROSCI.22-07-02496.2002; Li XJ, 2009, SLEEP, V32, P1417, DOI 10.1093/sleep/32.11.1417; Lim YM, 1999, GENETICS, V153, P763; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; Morgan TH, 1925, GENETICS DROSOPHILA, P1; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Peng S, 2010, INT J MOL SCI, V11, P222, DOI 10.3390/ijms11010222; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Seugnet L, 2011, SLEEP, V34, P137, DOI 10.1093/sleep/34.2.137; Seugnet L, 2009, SLEEP, V32, P984, DOI 10.1093/sleep/32.8.984; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867; Thiels E, 2001, REV NEUROSCIENCE, V12, P327; Thimgan MS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000466; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009	57	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81554	10.1371/journal.pone.0081554	http://dx.doi.org/10.1371/journal.pone.0081554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244744	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800183
J	de Stoppelaar, SF; Bootsma, HJ; Zomer, A; Roelofs, JJTH; Hermans, PWM; van 't Veer, C; van der Poll, T				de Stoppelaar, Sacha F.; Bootsma, Hester J.; Zomer, Aldert; Roelofs, Joris J. T. H.; Hermans, Peter W. M.; van 't Veer, Cornelis; van der Poll, Tom			Streptococcus pneumoniae Serine Protease HtrA, but Not SFP or PrtA, Is a Major Virulence Factor in Pneumonia	PLOS ONE			English	Article							CONTRIBUTES; COMPETENCE; PROTEINS; PATHWAY; PLAYS	Streptococcus (S.) pneumoniae is a common causative pathogen in pneumonia. Serine protease orthologs expressed by a variety of bacteria have been found of importance for virulence. Previous studies have identified two serine proteases in S. pneumoniae, HtrA (high-temperature requirement A) and PrtA (cell wall-associated serine protease A), that contributed to virulence in models of pneumonia and intraperitoneal infection respectively. We here sought to identify additional S. pneumoniae serine proteases and determine their role in virulence. The S. pneumoniae D39 genome contains five putative serine proteases, of which HtrA, Subtilase Family Protein (SFP) and PrtA were selected for insertional mutagenesis because they are predicted to be secreted and surface exposed. Mutant D39 strains lacking serine proteases were constructed by in-frame insertion deletion mutagenesis. Pneumonia was induced by intranasal infection of mice with wild-type or mutant D39. After high dose infection, only D39 Delta htrA showed reduced virulence, as reflected by strongly reduced bacterial loads, diminished dissemination and decreased lung inflammation. D39 Delta prtA induced significantly less lung inflammation together with smaller infiltrated lung surface, but without influencing bacterial loads. After low dose infection, D39 Delta htrA again showed strongly reduced bacterial loads; notably, pneumococcal burdens were also modestly lower in lungs after infection with D39 Delta sfp. These data confirm the important role for HtrA in S. pneumoniae virulence. PrtA contributes to lung damage in high dose pneumonia; it does not however contribute to bacterial outgrowth in pneumococcal pneumonia. SFP may facilitate S. pneumoniae growth after low dose infection.	[de Stoppelaar, Sacha F.; van 't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [de Stoppelaar, Sacha F.; van 't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, CEMM, NL-1105 AZ Amsterdam, Netherlands; [Bootsma, Hester J.; Zomer, Aldert; Hermans, Peter W. M.] Radboud Univ Nijmegen Med Ctr, Lab Pediat Infect Dis, Nijmegen, Netherlands; [Zomer, Aldert] Radboud Univ Nijmegen Med Ctr, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Roelofs, Joris J. T. H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Stoppelaar, SF (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.f.destoppelaar@amc.uva.nl	Hermans, Peter W.M./H-8042-2014	Zomer, Aldert/0000-0002-0758-5190; Roelofs, Joris/0000-0001-9595-6571	AMC	AMC	This work was supported by an AMC PhD Scholarship to S. F. de Stoppelaar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bethe G, 2001, FEMS MICROBIOL LETT, V205, P99, DOI 10.1016/S0378-1097(01)00453-0; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Bryan JD, 2009, J BACTERIOL, V191, P1847, DOI 10.1128/JB.01124-08; Burghout P, 2007, J BACTERIOL, V189, P6540, DOI 10.1128/JB.00573-07; Cassone M, 2012, J BIOL CHEM, V287, P38449, DOI 10.1074/jbc.M112.391482; COURTNEY HS, 1991, BIOCHEM BIOPH RES CO, V175, P1023, DOI 10.1016/0006-291X(91)91667-2; Dawid S, 2009, J BACTERIOL, V191, P1509, DOI 10.1128/JB.01213-08; Dessing MC, 2008, CELL MICROBIOL, V10, P237, DOI 10.1111/j.1462-5822.2007.01035.x; Dockrell DH, 2012, CHEST, V142, P482, DOI 10.1378/chest.12-0210; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Garau J, 2002, LANCET INFECT DIS, V2, P404, DOI 10.1016/S1473-3099(02)00316-X; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Ibrahim YM, 2004, INFECT IMMUN, V72, P3584, DOI 10.1128/IAI.72.6.3584-3591.2004; Kochan TJ, 2013, J BACTERIOL; Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004; Mirza S, 2011, INFECT IMMUN, V79, P2440, DOI 10.1128/IAI.00489-10; Paterson GK, 2010, RESPIROLOGY, V15, P1057, DOI 10.1111/j.1440-1843.2010.01814.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rijneveld AW, 2006, CRIT CARE MED, V34, P1725, DOI 10.1097/01.CCM.0000218807.20570.C2; Rijneveld AW, 2003, BLOOD, V102, P934, DOI 10.1182/blood-2003-01-0227; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; van den Boogaard FE, 2011, J THROMB HAEMOST, V9, P122, DOI 10.1111/j.1538-7836.2010.04089.x; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	26	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80062	10.1371/journal.pone.0080062	http://dx.doi.org/10.1371/journal.pone.0080062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244609	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600176
J	Mogami, T; Yokota, N; Asai-Sato, M; Yamada, R; Koizume, S; Sakuma, Y; Yoshihara, M; Nakamura, Y; Takano, Y; Hirahara, F; Miyagi, Y; Miyagi, E				Mogami, Tae; Yokota, Naho; Asai-Sato, Mikiko; Yamada, Roppei; Koizume, Shiro; Sakuma, Yuji; Yoshihara, Mitsuyo; Nakamura, Yoshiyasu; Takano, Yasuo; Hirahara, Fumiki; Miyagi, Yohei; Miyagi, Etsuko			Annexin A4 Is Involved in Proliferation, Chemo-Resistance and Migration and Invasion in Ovarian Clear Cell Adenocarcinoma Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR MARKER; CARCINOMA; CANCER; IV; CHEMORESISTANCE; RECEPTOR; IDENTIFICATION; HYALURONAN; ACTIVATION	Ovarian clear cell adenocarcinoma (CCC) is the second most common subtype of ovarian cancer after high-grade serous adenocarcinomas. CCC tends to develop resistance to the standard platinum-based chemotherapy, and has a poor prognosis when diagnosed in advanced stages. The ANXA4 gene, along with its product, a Ca++-binding annexin A4 (ANXA4) protein, has been identified as the CCC signature gene. We reported two subtypes of ANXA4 with different isoelectric points (IEPs) that are upregulated in CCC cell lines. Although several in vitro investigations have shown ANXA4 to be involved in cancer cell proliferation, chemoresistance, and migration, these studies were generally based on its overexpression in cells other than CCC. To elucidate the function of the ANXA4 in CCC cells, we established CCC cell lines whose ANXA4 expressions are stably knocked down. Two parental cells were used: OVTOKO contains almost exclusively an acidic subtype of ANXA4, and OVISE contains predominantly a basic subtype but also a detectable acidic subtype. ANXA4 knockdown (KO) resulted in significant growth retardation and greater sensitivity to carboplatin in OVTOKO cells. ANXA4-KO caused significant loss of migration and invasion capability in OVISE cells, but this effect was not seen in OVTOKO cells. We failed to find the cause of the different IEPs of ANXA4, but confirmed that the two subtypes are found in clinical CCC samples in ratios that vary by patient. Further investigation to clarify the mechanism that produces the subtypes is needed to clarify the function of ANXA4 in CCC, and might allow stratification and improved treatment strategies for patients with CCC.	[Mogami, Tae; Yamada, Roppei; Koizume, Shiro; Sakuma, Yuji; Yoshihara, Mitsuyo; Nakamura, Yoshiyasu; Takano, Yasuo; Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Mol Pathol & Genet Div, Yokohama, Kanagawa 2410815, Japan; [Mogami, Tae; Yokota, Naho; Asai-Sato, Mikiko; Hirahara, Fumiki; Miyagi, Etsuko] Yokohama City Univ, Grad Sch Med, Dept Obstet & Gynecol, Yokohama, Kanagawa 232, Japan	Kanagawa Prefectural Cancer Center; Yokohama City University	Miyagi, Y (corresponding author), Kanagawa Canc Ctr, Res Inst, Mol Pathol & Genet Div, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	miyagi@gancen.asahi.yokohama.jp; emiyagi@med.yokohama-cu.ac.jp	Mogami, Tae/GXZ-7026-2022		Japan Society for the Promotion of Science [22591860, 25462602]; Yokohama Foundation for Advancement of Medical Science; Grants-in-Aid for Scientific Research [23501280, 25462602] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yokohama Foundation for Advancement of Medical Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html): grant number 22591860 to EM and 25462602 to EM, YM and RY; and by a grant from the Yokohama Foundation for Advancement of Medical Science to EM (http://igakuz.sakura.ne.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso P, 2008, J PROTEOME RES, V7, P4247, DOI 10.1021/pr800152u; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Choi CH, 2013, HUM PATHOL, V44, P1017, DOI 10.1016/j.humpath.2012.08.024; Deng SS, 2013, ONCOL LETT, V5, P107, DOI 10.3892/ol.2012.959; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Foley JP, 2012, J BIOL CHEM, V287, P37406, DOI 10.1074/jbc.M112.360982; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gurung A, 2013, HISTOPATHOLOGY, V62, P59, DOI 10.1111/his.12033; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; Han EKH, 2000, BRIT J CANCER, V83, P83; Khau T, 2011, FASEB J, V25, P483, DOI 10.1096/fj.09-154096; Kim A, 2010, EXPERT OPIN THER TAR, V14, P963, DOI 10.1517/14728222.2010.511180; Kim A, 2009, INT J CANCER, V125, P2316, DOI 10.1002/ijc.24587; Krajewska M, 1996, AM J PATHOL, V148, P1567; Lin LL, 2008, PROTEOM CLIN APPL, V2, P619, DOI 10.1002/prca.200780088; Lin LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044615; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Masuishi Y, 2011, FEBS J, V278, P1470, DOI 10.1111/j.1742-4658.2011.08059.x; Miao Y, 2009, INT J GYNECOL CANCER, V19, P1545, DOI 10.1111/IGC.0b013e3181a844c8; Morita A, 2006, PROTEOMICS, V6, P5880, DOI 10.1002/pmic.200500708; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Ortiz-Zapater E, 2007, AM J PATHOL, V170, P1573, DOI 10.2353/ajpath.2007.060850; Sarafian V, 1998, INT J CANCER, V75, P105, DOI 10.1002/(SICI)1097-0215(19980105)75:1<105::AID-IJC16>3.3.CO;2-L; Schwartz DR, 2002, CANCER RES, V62, P4722; Shigetomi H, 2012, CANCER INVEST, V30, P473, DOI 10.3109/07357907.2012.681821; Takano M, 2006, BRIT J CANCER, V94, P1369, DOI 10.1038/sj.bjc.6603116; Toyama A, 2012, CANCER SCI, V103, P747, DOI 10.1111/j.1349-7006.2012.02224.x; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Yanagibashi T, 1997, BRIT J CANCER, V76, P829, DOI 10.1038/bjc.1997.471; Yokota N, 2009, BRIT J CANCER, V101, P2023, DOI 10.1038/sj.bjc.6605406; Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.002; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	33	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80359	10.1371/journal.pone.0080359	http://dx.doi.org/10.1371/journal.pone.0080359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244679	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600205
J	Vignaud, H; Bobo, C; Lascu, I; Sorgjerd, KM; Zako, T; Maeda, M; Salin, B; Lecomte, S; Cullin, C				Vignaud, Helene; Bobo, Claude; Lascu, Ioan; Soergjerd, Karin Margareta; Zako, Tamotsu; Maeda, Mizuo; Salin, Benedicte; Lecomte, Sophie; Cullin, Christophe			A Structure-Toxicity Study of A beta(42) Reveals a New Anti-Parallel Aggregation Pathway	PLOS ONE			English	Article							ANTIPARALLEL BETA-SHEET; ALZHEIMERS-DISEASE; SACCHAROMYCES-CEREVISIAE; PROTEIN OLIGOMERS; COMMON MECHANISM; YEAST MODEL; PEPTIDE; NEURODEGENERATION; FIBRILS; NEUROTOXICITY	Amyloid beta (A beta) peptides produced by APP cleavage are central to the pathology of Alzheimer's disease. Despite widespread interest in this issue, the relationship between the auto-assembly and toxicity of these peptides remains controversial. One intriguing feature stems from their capacity to form anti-parallel beta-sheet oligomeric intermediates that can be converted into a parallel topology to allow the formation of protofibrillar and fibrillar A beta. Here, we present a novel approach to determining the molecular aspects of A beta assembly that is responsible for its in vivo toxicity. We selected A beta mutants with varying intracellular toxicities. In vitro, only toxic A beta (including wild-type A beta(42)) formed urea-resistant oligomers. These oligomers were able to assemble into fibrils that are rich in anti-parallel beta-sheet structures. Our results support the existence of a new pathway that depends on the folding capacity of A beta.	[Vignaud, Helene; Bobo, Claude; Lascu, Ioan; Salin, Benedicte; Cullin, Christophe] Univ Bordeaux Segalen, CNRS UMR 5095, Inst Biochim & Genet Cellulaires, Bordeaux, France; [Soergjerd, Karin Margareta; Zako, Tamotsu; Maeda, Mizuo] Bioengn Lab RIKEN Inst, Wako, Saitama, Japan; [Lecomte, Sophie] Univ Bordeaux 1, CNRS UMR 5248, IPB, Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; RIKEN; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Cullin, C (corresponding author), Univ Bordeaux Segalen, CNRS UMR 5095, Inst Biochim & Genet Cellulaires, Bordeaux, France.	Christophe.Cullin@IBGC.CNRS.Fr	Zako, Tamotsu/C-3004-2012; cullin, christophe/AAM-2179-2020; Maeda, Mizuo/I-3498-2014	cullin, christophe/0000-0003-4110-4677; 	PEPS IDEX; JSPS KAKENHI [24570143]; RIKEN; Grants-in-Aid for Scientific Research [24570143] Funding Source: KAKEN	PEPS IDEX; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the PEPS IDEX 2012 "Analyse structure-toxicite du peptide A beta implique dans l'apparition de la maladie d'Alzheimer" and by JSPS KAKENHI (No. 24570143) and RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT NEUROSCI, V14, P399, DOI 10.1038/nn0411-399; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Baskakov IV, 2009, FEBS LETT, V583, P2618, DOI 10.1016/j.febslet.2009.05.044; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Berthelot K, 2013, BIOCHIMIE, V95, P12, DOI 10.1016/j.biochi.2012.07.011; Berthelot K, 2011, J MOL BIOL, V412, P137, DOI 10.1016/j.jmb.2011.07.009; Berthelot K, 2009, FASEB J, V23, P2254, DOI 10.1096/fj.08-125724; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P627, DOI 10.1002/bip.1976.360150403; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Couthouis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004539; CULLIN C, 1994, YEAST, V10, P105, DOI 10.1002/yea.320100110; D'Angelo F, 2013, DIS MODEL MECH, V6, P206, DOI 10.1242/dmm.010108; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	52	28	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80262	10.1371/journal.pone.0080262	http://dx.doi.org/10.1371/journal.pone.0080262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244667	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600198
J	Wisaksana, R; de Mast, Q; Alisjahbana, B; Jusuf, H; Sudjana, P; Indrati, AR; Sumantri, R; Swinkels, D; van Crevel, R; van der Ven, A				Wisaksana, Rudi; de Mast, Quirijn; Alisjahbana, Bachti; Jusuf, Hadi; Sudjana, Primal; Indrati, Agnes R.; Sumantri, Rachmat; Swinkels, Dorine; van Crevel, Reinout; van der Ven, Andre			Inverse Relationship of Serum Hepcidin Levels with CD4 Cell Counts in HIV-Infected Patients Selected from an Indonesian Prospective Cohort Study	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; IRON HOMEOSTASIS; ANEMIA; TUBERCULOSIS; FERROPORTIN; INDIVIDUALS; EXPRESSION; SURVIVAL; REQUIRES	Background: Distortion of iron homeostasis may contribute to the pathogenesis of human immunodeficiency virus (HIV) infection and tuberculosis (TB). We studied the association of the central iron-regulatory hormone hepcidin with the severity of HIV and the association between hepcidin and other markers of iron homeostasis with development of TB. Methods: Three groups of patients were selected from a prospective cohort of HIV-infected subjects in Bandung, Indonesia. The first group consisted of HIV-infected patients who started TB treatment more than 30 days after cohort enrollment (cases). The second group consisted of HIV-infected patients who were matched for age, gender and CD4 cell count to the cases group (matched controls). The third group consisted of HIV-infected patients with CD4 cell counts above 200 cells/mm(3) (unmatched controls). Iron parameters including hepcidin were compared using samples collected at cohort enrollment, and compared with recently published reference values for serum hepcidin. Results: A total of 127 HIV-infected patients were included, 42 cases together with 42 matched controls and 43 unmatched controls. Patients with advanced HIV infection had elevated serum hepcidin and ferritin levels. Hepcidin levels correlated inversely with CD4 cells and hemoglobin. Cases had significantly higher hepcidin and ferritin concentrations at cohort enrollment compared to matched controls, but these differences were fully accounted for by the cases who started TB treatment between day 31 and 60 after enrollment. Hepcidin levels were not different in those with or without hepatitis C infection. Conclusion: Iron metabolism is distorted in advanced HIV infection with CD4 cell counts correlating inversely with serum hepcidin levels. High serum hepcidin levels and hyperferritinemia were found in patients starting TB treatment shortly after cohort enrollment, suggesting that these parameters have a predictive value for development of manifest TB in HIV-infected patients.	[Wisaksana, Rudi; Alisjahbana, Bachti; Jusuf, Hadi; Sudjana, Primal; Sumantri, Rachmat] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Internal Med, Bandung, Indonesia; [Wisaksana, Rudi; Alisjahbana, Bachti; Indrati, Agnes R.] Padjadjaran State Univ, Fac Med, Hlth Res Unit, Bandung, Indonesia; [de Mast, Quirijn; van Crevel, Reinout; van der Ven, Andre] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Indrati, Agnes R.] Padjadjaran State Univ, Hasan Sadikin Hosp, Clin Pathol Fac Med, Bandung, Indonesia; [Swinkels, Dorine] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Universitas Padjadjaran; Radboud University Nijmegen; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Radboud University Nijmegen	Wisaksana, R (corresponding author), Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Internal Med, Bandung, Indonesia.	rudiw98@gmail.com	van der Ven, A.J.A.M./H-8102-2014; van Crevel, reinout/A-6636-2010; de Mast, Quirijn/H-3427-2015; Swinkels, Dorine W./H-8098-2014	van der Ven, A.J.A.M./0000-0003-1833-3391; van Crevel, reinout/0000-0002-6233-6410; Swinkels, Dorine W./0000-0002-1040-9446; de Mast, Quirijn/0000-0001-6056-157X	European Commisssion [SANTE/2005/105-033]	European Commisssion(European Commission)	This study was supported by the European Commisssion (SANTE/2005/105-033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2012, J INFECT DIS, V205, P1043, DOI 10.1093/infdis/jis026; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; Camaschella C, 2009, HAEMATOL-HEMATOL J, V94, P307, DOI 10.3324/haematol.2008.005405; Chartier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021212; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Dallalio G, 2006, BLOOD, V107, P2702, DOI 10.1182/blood-2005-07-2854; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; de Monye C, 1999, AIDS, V13, P375, DOI 10.1097/00002030-199902250-00010; Drakesmith H, 2005, P NATL ACAD SCI USA, V102, P11017, DOI 10.1073/pnas.0504823102; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Girelli D, 2009, J HEPATOL, V51, P845, DOI 10.1016/j.jhep.2009.06.027; Hearnshaw S, 2006, WORLD J GASTROENTERO, V12, P5866, DOI 10.3748/wjg.v12.i36.5866; Kanda J, 2008, HAEMATOL-HEMATOL J, V93, P1550, DOI 10.3324/haematol.12399; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lundgren JD, 2003, CLIN INFECT DIS, V37, pS297, DOI 10.1086/376909; Masaisa F, 2012, ANN HEMATOL, V91, P911, DOI 10.1007/s00277-011-1400-3; McDermid JM, 2007, JAIDS-J ACQ IMM DEF, V46, P498, DOI 10.1097/QAI.0b013e31815b2d4b; Nekhai S, 2013, FUTURE VIROL, V8, P301, DOI 10.2217/FVL.13.6; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Parwati I, 2003, J CLIN MICROBIOL, V41, P5350, DOI 10.1128/JCM.41.11.5350-5351.2003; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Silva VSS, 2005, J GASTROEN HEPATOL, V20, P243, DOI [10.1111/j.1400-1746.2004.03549.x, 10.1111/j.1440-1746.2004.03549.x]; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Sow FB, 2011, TUBERCULOSIS, V91, P314, DOI 10.1016/j.tube.2011.03.003; Stop TB, 2006, IMPR DIAGN TREATM SM; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Tripathi Prachi B, 2009, Trop Gastroenterol, V30, P35; Visser A, 2011, CLIN INFECT DIS, V52, P273, DOI 10.1093/cid/ciq126; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; Wisaksana R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-213; Xu M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-104	39	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79904	10.1371/journal.pone.0079904	http://dx.doi.org/10.1371/journal.pone.0079904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244576	gold, Green Published, Green Submitted			2022-12-25	WOS:000327221600158
J	ElZarrad, MK; Mukhopadhyay, P; Mohan, N; Hao, EK; Dokmanovic, M; Hirsch, DS; Shen, Y; Pacher, P; Wu, WJ				ElZarrad, M. Khair; Mukhopadhyay, Partha; Mohan, Nishant; Hao, Enkui; Dokmanovic, Milos; Hirsch, Dianne S.; Shen, Yi; Pacher, Pal; Wu, Wen Jin			Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice	PLOS ONE			English	Article							BREAST-CANCER; INDUCED APOPTOSIS; BLOOD-PRESSURE; INDUCED CARDIOTOXICITY; CIRCADIAN VARIATION; HEART-FAILURE; TROPONIN-I; STRESS; MODULATION; RECEPTOR	Treatment with trastuzumab, a humanized monoclonal antibody directed against the extracellular domain of Human Epidermal Growth Factor Receptor 2 (HER2), very successfully improves outcomes for women with HER2-positive breast cancer. However, trastuzumab treatment was recently linked to potentially irreversible serious cardiotoxicity, the mechanisms of which are largely elusive. This study reports that trastuzumab significantly alters the expression of myocardial genes essential for DNA repair, cardiac and mitochondrial functions, which is associated with impaired left ventricular performance in mice coupled with significant ultrastructural alterations in cardiomyocytes revealed by electron microscopy. Furthermore, trastuzumab treatment also promotes oxidative stress and apoptosis in myocardium of mice, and elevates serum levels of cardiac troponin-I (cTnI) and cardiac myosin light chain-1 (cMLC1). The elevated serum levels of cMLC1 in mice treated with trastuzumab highlights the potential that cMLC1 could be a useful biomarker for trastuzumab-induced cardiotoxicity.	[ElZarrad, M. Khair; Mohan, Nishant; Dokmanovic, Milos; Hirsch, Dianne S.; Shen, Yi; Wu, Wen Jin] US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [ElZarrad, M. Khair] NCI, Interagcy Oncol Task Force IOTF Fellowship Progra, NIH, Bethesda, MD 20892 USA; [Mukhopadhyay, Partha; Hao, Enkui; Pacher, Pal] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Wu, WJ (corresponding author), US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	wen.wu@fda.hhs.gov	MUKHOPADHYAY, PARTHA/G-3890-2010; Pacher, Pal/B-6378-2008	MUKHOPADHYAY, PARTHA/0000-0002-1178-1274; Pacher, Pal/0000-0001-7036-8108	Federal Drug Administration-Office of Women's Health Research Science Program Award [750912CDR]; Interagency Oncology Task Force Joint Fellowship Program; United States Food and Drug Administration; National Cancer Institute; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	Federal Drug Administration-Office of Women's Health Research Science Program Award; Interagency Oncology Task Force Joint Fellowship Program; United States Food and Drug Administration; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study is supported by Federal Drug Administration-Office of Women's Health Research Science Program Award to WJW (Project ID: 750912CDR) and the Interagency Oncology Task Force Joint Fellowship Program sponsored by the United States Food and Drug Administration and National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth AS, 2012, STEM CELL TRANSL MED, V1, P289, DOI 10.5966/sctm.2011-0016; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bowles EJA, 2012, JNCI-J NATL CANCER I, V104, P1293, DOI 10.1093/jnci/djs317; Cardinale D, 2010, J CLIN ONCOL, V28, P3910, DOI 10.1200/JCO.2009.27.3615; Chan R, 2002, MOL CELL BIOL, V22, P1073, DOI 10.1128/MCB.22.4.1073-1078.2002; Coon TA, 2012, CELL CYCLE, V11, P721, DOI 10.4161/cc.11.4.19171; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; DeCara JM, 2012, CURR CARDIOL REP, V14, P334, DOI 10.1007/s11886-012-0256-z; Di Cosimo S, 2011, TARGET ONCOL, V6, P189, DOI 10.1007/s11523-011-0203-8; Dschietzig T, 2009, J CARD FAIL, V15, P182, DOI 10.1016/j.cardfail.2009.01.008; Ewer MS, 2005, J CLIN ONCOL, V23, P7820, DOI 10.1200/JCO.2005.13.300; Fallah-Rad N, 2011, J AM COLL CARDIOL, V57, P2263, DOI 10.1016/j.jacc.2010.11.063; Fedele C, 2011, BREAST CANC RES TREA, V133, P511, DOI [10.1007/s10549-011-1783-1789, DOI 10.1007/S10549-011-1783-1789.PUBMED:21947749]; Goto T, 2003, HEART, V89, P1303, DOI 10.1136/heart.89.11.1303; Gramlich M, 2009, J MOL CELL CARDIOL, V47, P352, DOI 10.1016/j.yjmcc.2009.04.014; Grimm M, 2005, CARDIOVASC RES, V65, P211, DOI 10.1016/j.cardiores.2004.09.019; Hansen MS, 2002, AM J CARDIOL, V90, P969, DOI 10.1016/S0002-9149(02)02663-2; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hopcroft LEM, 2010, NUCLEIC ACIDS RES, V38, P6831, DOI 10.1093/nar/gkq550; Huang CQ, 2003, DEVELOPMENT, V130, P6111, DOI 10.1242/dev.00831; Labugger R, 2000, CIRCULATION, V102, P1221, DOI 10.1161/01.CIR.102.11.1221; LEE JHW, 2011, J HYDRO-ENVIRON RES, V5, P1, DOI DOI 10.1016/J.JHER.2011.02.001; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Melanson SEF, 2007, CIRCULATION, V116, pE501, DOI 10.1161/CIRCULATIONAHA.107.722975; Nakayama F, 2008, J RADIAT RES, V49, P491, DOI 10.1269/jrr.08021; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Pacher P, 2005, TRENDS PHARMACOL SCI, V26, P302, DOI 10.1016/j.tips.2005.04.003; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pentassuglia L, 2007, EXP CELL RES, V313, P1588, DOI 10.1016/j.yexcr.2007.02.007; Perez EA, 2004, J CLIN ONCOL, V22, P322, DOI 10.1200/JCO.2004.01.120; Riccio G, 2009, FASEB J, V23, P3171, DOI 10.1096/fj.09-131383; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Ritchie A, 2009, CELL DEATH DIFFER, V16, P838, DOI 10.1038/cdd.2009.13; Ritter Oliver, 2002, Exp Clin Cardiol, V7, P151; Sawaya H, 2012, CIRC-CARDIOVASC IMAG, V5, P596, DOI 10.1161/CIRCIMAGING.112.973321; Sawyer DB, 2002, CIRCULATION, V105, P1551, DOI 10.1161/01.CIR.0000013839.41224.1C; Seidman A, 2002, J CLIN ONCOL, V20, P1215, DOI 10.1200/JCO.20.5.1215; Shanmugam M, 2011, BIOCHEM BIOPH RES CO, V410, P97, DOI 10.1016/j.bbrc.2011.05.113; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stejskal David, 2005, Biomedical Papers (Olomouc), V149, P89; Stow LR, 2012, HYPERTENSION, V59, P1151, DOI 10.1161/HYPERTENSIONAHA.112.190892; Su W, 2012, AM J PHYSIOL-HEART C, V302, pH621, DOI 10.1152/ajpheart.00825.2011; SUTSCH G, 1992, CIRC RES, V70, P1035, DOI 10.1161/01.RES.70.5.1035; Telli ML, 2007, J CLIN ONCOL, V25, P3525, DOI 10.1200/JCO.2007.11.0106; Telli ML, 2011, J NATL COMPR CANC NE, V9, P243, DOI 10.6004/jnccn.2011.0019; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Wang Q, 2010, AM J PHYSIOL-REG I, V299, pR1013, DOI 10.1152/ajpregu.00241.2010; Wang XS, 2010, HUM MOL GENET, V19, P2886, DOI 10.1093/hmg/ddq174; Wu WJ, 2009, ENCY CANC SPRINGER R, DOI [10.1007/978-3-540-47648-1, DOI 10.1007/978-3-540-47648-1]	56	81	84	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79543	10.1371/journal.pone.0079543	http://dx.doi.org/10.1371/journal.pone.0079543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255707	Green Published, gold			2022-12-25	WOS:000327216200073
J	Howel, D; Stamp, E; Chadwick, TJ; Adamson, AJ; White, M				Howel, Denise; Stamp, Elaine; Chadwick, Thomas J.; Adamson, Ashley J.; White, Martin			Are Social Inequalities Widening in Generalised and Abdominal Obesity and Overweight among English Adults?	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; EDUCATIONAL INEQUALITIES; UNITED-STATES; RISK-FACTORS; TRENDS; HEALTH; PREVALENCE; EPIDEMIC; MEN	Background: Obesity is now more common in lower socioeconomic groups in developed nations, but the socio-economic patterning of obesity has changed over time. This study examines the time trends in the socioeconomic patterning of generalised and abdominal obesity and overweight in English adults. Methods: Data were from core annual samples of the Health Survey for England 1993-2008, including 155 661 participants aged 18-75 years. The prevalence of generalised and abdominal obesity and overweight was reported as crude and age-adjusted estimates. Binomial regression was used to model measures of obesity and overweight with age, sex, survey years, and two indicators of socioeconomic position: Registrar General's Social Class (manual and non-manual occupational groups) and relative length of full time education. Trends in socioeconomic patterning were assessed by formal tests for interactions between socioeconomic position measures and survey periods in these models. Results: The prevalence of generalised and abdominal overweight and obesity increased consistently between 1993 and 2008. There were significant differences in the four outcomes between the two socioeconomic position (SEP) groups in men and women, except for generalised and abdominal overweight with social class in men. The prevalence of obesity and overweight across the whole period was higher in subgroups with lower SEP (differences of 0.2% to 9.5%). There was no significant widening of the socioeconomic gradient of most indicators of greater body fat since the early 1990s, except for educational gradient in generalised obesity in men and women (P = 0.001). Conclusions: Substantial social class and education gradients in obesity and overweight are still present in both sexes. However, there is limited evidence that these socioeconomic inequalities have changed since 1993.	[Howel, Denise; Stamp, Elaine; Chadwick, Thomas J.; Adamson, Ashley J.; White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adamson, Ashley J.; White, Martin] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adamson, Ashley J.; White, Martin] UKCRC Ctr Translat Res Publ Hlth, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	White, M (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	martin.white@ncl.ac.uk		Adamson, Ashley/0000-0003-3735-2846; White, Martin/0000-0002-1861-6757	UK Department of Health [0180042]; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute of Health Research (NIHR); ESRC [ES/G007470/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/008, NIHR-RP-02-12-001] Funding Source: researchfish	UK Department of Health; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The research was partly funded by a grant from the UK Department of Health Policy Research Programme to the Public Health Research Consortium (0180042) in its 2005-10 programme. Further details are available at http://phrc.lshtm.ac.uk/). MW and AA are funded in part by the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, Medical Research Council and National Institute of Health Research (NIHR) as director and associate director respectively of Fuse - the Centre for Translational Research in Public Health, which is a UKCRC Public Health Research Centre of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed herein are those of the authors and not necessarily those of the above named funders.	[Anonymous], 2010, MARMOT REV; Bartley M, 2000, J EPIDEMIOL COMMUN H, V54, P806, DOI 10.1136/jech.54.11.806; Brunner E, 1998, BRIT MED J, V316, P308, DOI 10.1136/bmj.316.7127.308a; Butland BJ, 2007, FORESIGHT TACKLING O; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Charafeddine R, 2009, PREV MED, V48, P54, DOI 10.1016/j.ypmed.2008.09.010; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Craig RJM, 2008, HLTH SURVEY ENGLAND; Cross Government Obesity Unit, 2009, HLTH WEIGHT HLTH LIV; Cross Government Obesity Unit, 2008, HLTH WEIGHT HLTH LIV; Czernichow S, 2009, PREV MED, V48, P262, DOI 10.1016/j.ypmed.2008.12.016; de Saint Pol T, 2009, ECON HUM BIOL, V7, P398, DOI 10.1016/j.ehb.2009.06.002; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2005, CHOOS ACT PHYS ACT A; Department of Health, 2004, CHOOS HLTH MAK HLTH; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Faeh D, 2011, OBES REV, V12, P151, DOI 10.1111/j.1467-789X.2010.00793.x; Fone DL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-115; Ford ES, 2011, INT J OBESITY, V35, P736, DOI 10.1038/ijo.2010.186; Galobardes B, 2003, AM J PUBLIC HEALTH, V93, P1302, DOI 10.2105/AJPH.93.8.1302; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Gutierrez-Fisac JL, 2002, J EPIDEMIOL COMMUN H, V56, P457, DOI 10.1136/jech.56.6.457; Himes CL, 2005, GEND ISSUES, V22, P45, DOI 10.1007/s12147-005-0014-2; Hotchkiss JW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000771; Icks A, 2007, EUR J EPIDEMIOL, V22, P685, DOI 10.1007/s10654-007-9170-x; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Jones-Smith JC, 2011, AM J EPIDEMIOL, V173, P667, DOI 10.1093/aje/kwq428; Kark M, 2005, SCAND J PUBLIC HEALT, V33, P472, DOI 10.1080/14034940510032130; Lahti-Koski M, 2000, INT J OBESITY, V24, P1669, DOI 10.1038/sj.ijo.0801437; Lahti-Koski M, 2010, OBES REV, V11, P171, DOI 10.1111/j.1467-789X.2009.00681.x; Lissner L, 2000, INT J OBESITY, V24, P801, DOI 10.1038/sj.ijo.0801237; Lorant V, 2000, J EPIDEMIOL COMMUN H, V54, P637, DOI 10.1136/jech.54.8.637; Marques-Vidal P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-87; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; Office for National Statistics, 2000, STAND OCC CLASS 2000; Office of Population Censuses and Surveys, 1990, STAND OCC CLASS; Pigeyre M, 2012, APPETITE, V58, P703, DOI 10.1016/j.appet.2011.11.031; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Sassi F, 2009, ED OBESITY 4 OECD CO; Singh GK, 2011, J COMMUN HEALTH, V36, P94, DOI 10.1007/s10900-010-9287-9; Singh-Manoux A, 2009, OBES REV, V10, P511, DOI 10.1111/j.1467-789X.2009.00596.x; Statacorp, 2011, STATA REL 12; Sulander TT, 2007, PREV MED, V45, P153, DOI 10.1016/j.ypmed.2007.02.008; White M, 2009, HLTH INEQUALITY SOC; WHO, 2000, OB PREV MAN GLOB EP; Wolff H, 2006, OBESITY, V14, P2080, DOI 10.1038/oby.2006.243; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	53	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79027	10.1371/journal.pone.0079027	http://dx.doi.org/10.1371/journal.pone.0079027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255CG	24250823	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200056
J	Junqueira-Kipnis, AP; de Oliveira, FM; Trentini, MM; Tiwari, S; Chen, B; Resende, DP; Silva, BDS; Chen, M; Tesfa, L; Jacobs, WR; Kipnis, A				Junqueira-Kipnis, Ana Paula; de Oliveira, Fabio Muniz; Trentini, Monalisa Martins; Tiwari, Sangeeta; Chen, Bing; Resende, Danilo Pires; Silva, Bruna D. S.; Chen, Mei; Tesfa, Lydia; Jacobs, William R., Jr.; Kipnis, Andre			Prime-Boost with Mycobacterium smegmatis Recombinant Vaccine Improves Protection in Mice Infected with Mycobacterium tuberculosis	PLOS ONE			English	Article							T-CELL RESPONSES; MEDIATED PROTECTION; LEISHMANIA-MAJOR; T(H)1 CELLS; DIAGNOSIS; ANTIGEN; MACROPHAGES; CORRELATE; IMMUNITY; HSPX	The development of a new vaccine as a substitute for Bacillus Calmette-Guerin or to improve its efficacy is one of the many World Health Organization goals to control tuberculosis. Mycobacterial vectors have been used successfully in the development of vaccines against tuberculosis. To enhance the potential utility of Mycobacterium smegmatis as a vaccine, it was transformed with a recombinant plasmid containing the partial sequences of the genes Ag85c, MPT51, and HspX (CMX) from M. tuberculosis. The newly generated recombinant strain mc(2)-CMX was tested in a murine model of infection. The recombinant vaccine induced specific IgG1 or IgG2a responses to CMX. CD4(+) and CD8(+) T cells from the lungs and spleen responded ex vivo to CMX, producing IFN-gamma, IL17, TNF-alpha, and IL2. The vaccine thus induced a significant immune response in mice. Mice vaccinated with mc(2)-CMX and challenged with M. tuberculosis showed better protection than mice immunized with wild-type M. smegmatis or BCG. To increase the safety and immunogenicity of the CMX antigens, we used a recombinant strain of M. smegmatis, IKE (immune killing evasion), to express CMX. The recombinant vaccine IKE-CMX induced a better protective response than mc(2)-CMX. The data presented here suggest that the expression of CMX antigens improves the immune response and the protection induced in mice when M. smegmatis is used as vaccine against tuberculosis.	[Junqueira-Kipnis, Ana Paula; de Oliveira, Fabio Muniz; Trentini, Monalisa Martins; Resende, Danilo Pires; Silva, Bruna D. S.; Kipnis, Andre] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Tiwari, Sangeeta; Chen, Bing; Chen, Mei; Tesfa, Lydia; Jacobs, William R., Jr.] Albert Einstein Coll Med, New York, NY USA; [Tesfa, Lydia] Albert Einstein Coll Med, Flow Cytometry Core Facil, New York, NY USA	Universidade Federal de Goias; Yeshiva University; Yeshiva University	Junqueira-Kipnis, AP (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.	apkipnis@gmail.com	de Oliveira, Fábio Muniz/AAG-4987-2019; Kipnis, Andre/ABG-5707-2020; Junqueira-Kipnis, Ana Paula/I-5534-2012; Tiwari, Sangeeta/GWV-0350-2022; tiwari, sangeeta/T-5810-2019; Kipnis, Andre/M-7485-2017; Trentini, Monalisa M/P-7092-2017	de Oliveira, Fábio Muniz/0000-0002-4470-8444; Kipnis, Andre/0000-0001-5950-106X; Kipnis, Andre/0000-0001-5950-106X; Trentini, Monalisa M/0000-0002-3207-8967; Resende, Danilo/0000-0002-3329-7352; Jacobs, William/0000-0003-3321-3080	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301976/2011-2, 472906/2011-9, 301198/2009-8, 472909/2011-8]; Fundacao de Amparo a Pesquisa do Estado de Goias: FAPEG-PRONEX; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063537, R01AI097548] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias: FAPEG-PRONEX; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grants numbers: 301976/2011-2, 472906/2011-9, 301198/2009-8, 472909/2011-8); Fundacao de Amparo a Pesquisa do Estado de Goias: FAPEG-PRONEX. APJK was awarded with a Science without borders senior training fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Achkar JM, 2010, CLIN VACCINE IMMUNOL, V17, P384, DOI 10.1128/CVI.00503-09; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; Bohsali A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-237; Bretl DJ, 2012, INFECT IMMUN, V80, P3018, DOI 10.1128/IAI.00520-12; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Almeida CM, 2008, CLIN VACCINE IMMUNOL, V15, P579, DOI 10.1128/CVI.00359-07; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Cheadle EJ, 2005, INFECT IMMUN, V73, P784, DOI 10.1128/IAI.73.2.784-794.2005; Ciuffreda D, 2008, EUR J IMMUNOL, V38, P2665, DOI 10.1002/eji.200838336; Costa AE., 2011, REV PATOL TROP, V40, P23; Cristina M, 2011, BRAZ J INFECT DIS, V15, P617, DOI 10.1590/S1413-86702011000600022; da Silva EB, 2011, VET J, V187, P276, DOI 10.1016/j.tvjl.2009.11.017; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; de Araujo JA, 2008, TUBERCULOSIS, V88, P474, DOI 10.1016/j.tube.2008.06.002; de Sousa EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047781; Silva BDD, 2009, VACCINE, V27, P4402, DOI 10.1016/j.vaccine.2009.05.049; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Geluk A, 2012, VACCINE, V30, P7513, DOI 10.1016/j.vaccine.2012.10.045; dos Reis MCG, 2009, BRAZ J INFECT DIS, V13, P417, DOI 10.1590/S1413-86702009000600006; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kashyap RS, 2013, CLIN NEUROL NEUROSUR, V115, P678, DOI 10.1016/j.clineuro.2012.07.031; Kremer L, 2002, LETT APPL MICROBIOL, V34, P233, DOI 10.1046/j.1472-765x.2002.01091.x; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; LIM EM, 1995, J BACTERIOL, V177, P59, DOI 10.1128/jb.177.1.59-65.1995; Lindenstrom T, 2012, INFECT IMMUN, V80, P3533, DOI 10.1128/IAI.00550-12; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Rabahi MF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-148; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Limongi LCSA, 2011, J BRAS PNEUMOL, V37, P302, DOI 10.1590/S1806-37132011000300005; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Siddiqui KF, 2011, CRIT REV MICROBIOL, V37, P349, DOI 10.3109/1040841X.2011.606425; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Taylor JL, 2012, IMMUNOL CELL BIOL, V90, P945, DOI 10.1038/icb.2012.34; Tenbusch M, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-13; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; WHO, 2012, GLOB TUB REP 2012; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson RA, 2004, J MOL BIOL, V335, P519, DOI 10.1016/j.jmb.2003.11.001; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Yang C, 2009, INT J TUBERC LUNG D, V13, P1360; Yi ZJ, 2007, VACCINE, V25, P638, DOI 10.1016/j.vaccine.2006.08.037; Young SL, 2004, INT J CANCER, V112, P653, DOI 10.1002/ijc.20442; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zhang H, 2010, SCAND J IMMUNOL, V72, P349, DOI 10.1111/j.1365-3083.2010.02448.x	54	24	30	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78639	10.1371/journal.pone.0078639	http://dx.doi.org/10.1371/journal.pone.0078639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250805	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200038
J	Reijnders, CMA; van Essen, HW; van Rens, BTTM; van Beek, JHGM; Ylstra, B; Blankenstein, MA; Lips, P; Bravenboer, N				Reijnders, Christianne M. A.; van Essen, Huib W.; van Rens, Birgitte T. T. M.; van Beek, Johannes H. G. M.; Ylstra, Bauke; Blankenstein, Marinus A.; Lips, Paul; Bravenboer, Nathalie			Increased Expression of Matrix Extracellular Phosphoglycoprotein (MEPE) in Cortical Bone of the Rat Tibia after Mechanical Loading: Identification by Oligonucleotide Microarray	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FALSE DISCOVERY RATE; GENE-EXPRESSION; IN-VIVO; OSTEOGENIC RESPONSE; OSTEOCYTES; STRAIN; PROTEINS; CELLS; COX-2	Skeletal integrity in humans and animals is maintained by daily mechanical loading. It has been widely accepted that osteocytes function as mechanosensors. Many biochemical signaling molecules are involved in the response of osteocytes to mechanical stimulation. The aim of this study was to identify genes involved in the translation of mechanical stimuli into bone formation. The four-point bending model was used to induce a single period of mechanical loading on the right tibia, while the contra lateral left tibia served as control. Six hours after loading, the effects of mechanical loading on gene-expression were determined with microarray analysis. Protein expression of differentially regulated genes was evaluated with immunohistochemistry. Nine genes were found to exhibit a significant differential gene expression in LOAD compared to control. MEPE, Garnl1, V2R2B, and QFG-TN1 olfactory receptor were up-regulated, and creatine kinase (muscle form), fibrinogen-B beta-polypeptide, monoamine oxidase A, troponin-C and kinesin light chain-C were down-regulated. Validation with real-time RT-PCR analysis confirmed the up-regulation of MEPE and the down-regulation of creatine kinase (muscle form) and troponin-C in the loaded tibia. Immunohistochemistry showed that the increase of MEPE protein expression was already detectable six hours after mechanical loading. In conclusion, these genes probably play a role during translation of mechanical stimuli six hours after mechanical loading. The modulation of MEPE expression may indicate a connection between bone mineralization and bone formation after mechanical stimulation.	[Reijnders, Christianne M. A.; van Rens, Birgitte T. T. M.; Lips, Paul] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Endocrine Sect, Amsterdam, Netherlands; [van Essen, Huib W.; Blankenstein, Marinus A.; Bravenboer, Nathalie] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [van Rens, Birgitte T. T. M.] Vrije Univ Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands; [van Beek, Johannes H. G. M.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands; [Ylstra, Bauke] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Ylstra, Bauke] Res Inst MOVE, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Bravenboer, N (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands.	n.bravenboer@vumc.nl	Ylstra, Bauke/D-2906-2012	Ylstra, Bauke/0000-0001-9479-3010; Blankenstein, Marinus/0000-0003-1186-0770	Research Institute MOVE	Research Institute MOVE	This research was funded by the Research Institute MOVE allied to the VU University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir LR, 2007, J HISTOCHEM CYTOCHEM, V55, P1095, DOI 10.1369/jhc.6A7162.2007; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Bakker AD, 2003, BIOCHEM BIOPH RES CO, V305, P677, DOI 10.1016/S0006-291X(03)00831-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bravenboer N, 2001, J ORTHOP RES, V19, P945, DOI 10.1016/S0736-0266(01)00026-2; Buermans HPJ, 2005, PHYSIOL GENOMICS, V21, P314, DOI 10.1152/physiolgenomics.00185.2004; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; David V, 2009, ENDOCRINOLOGY, V150, P4012, DOI 10.1210/en.2009-0216; Davidovitch Z, 1984, CALCIF TISSUE INT S1, V36, pS97; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Forwood MR, 1998, BONE, V23, P307, DOI 10.1016/S8756-3282(98)00090-8; Forwood MR, 1996, J BONE MINER RES, V11, P1688; Forwood MR, 1996, AM J PHYSIOL-ENDOC M, V270, pE419, DOI 10.1152/ajpendo.1996.270.3.E419; Gluhak-Heinrich J, 2007, ARCH ORAL BIOL, V52, P684, DOI 10.1016/j.archoralbio.2006.12.010; Gluhak-Heinrich J, 2005, J BONE MINER RES, V20, pS73; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; GROSS M, 1990, AM J PHYSIOL, V259, pF195, DOI 10.1152/ajprenal.1990.259.2.F195; Hayashibara T, 2004, J BONE MINER RES, V19, P455, DOI 10.1359/JBMR.0301263; Kamata A, 1998, BIOCHEM BIOPH RES CO, V246, P404, DOI 10.1006/bbrc.1998.8632; Kulkarni RN, 2010, CALCIFIED TISSUE INT, V87, P461, DOI 10.1007/s00223-010-9407-7; LANYON LE, 1992, J BONE MINER RES, V7, pS369, DOI 10.1002/jbmr.5650071403; LEAN JM, 1995, AM J PHYSIOL-ENDOC M, V268, pE318, DOI 10.1152/ajpendo.1995.268.2.E318; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; Mason DJ, 1997, BONE, V20, P199, DOI 10.1016/S8756-3282(96)00386-9; Nagel DE, 2004, J CELL BIOCHEM, V93, P1107, DOI 10.1002/jcb.20249; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Petersen DN, 2000, J BIOL CHEM, V275, P36172, DOI 10.1074/jbc.M003622200; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; POINTON JJ, 1979, CLIN SCI, V57, P257, DOI 10.1042/cs0570257; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Reijnders CMA, 2007, CALCIFIED TISSUE INT, V80, P137, DOI 10.1007/s00223-006-0077-4; Reijnders CMA, 2007, J ENDOCRINOL, V192, P131, DOI 10.1677/joe.1.06880; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rowe PSN, 2004, CRIT REV ORAL BIOL M, V15, P264, DOI 10.1177/154411130401500503; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; SKERRY TM, 1989, J BONE MINER RES, V4, P783, DOI 10.1002/jbmr.5650040519; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SMYTH GK, 2005, 55 SESS INT STAT I 5; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Taylor J, 2005, BIOSTATISTICS, V6, P111, DOI 10.1093/biostatistics/kxh021; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; TURNER CH, 1991, BONE, V12, P73, DOI 10.1016/8756-3282(91)90003-2; Wadhwa S, 2002, BIOCHEM BIOPH RES CO, V297, P46, DOI 10.1016/S0006-291X(02)02124-1; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; ZHAO JQ, 1994, MOL CELL BIOL, V14, P8483, DOI 10.1128/MCB.14.12.8483	49	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79672	10.1371/journal.pone.0079672	http://dx.doi.org/10.1371/journal.pone.0079672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255709	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200081
J	Ribeck, N; Saleh, OA				Ribeck, Noah; Saleh, Omar A.			DNA Unwinding by Ring-Shaped T4 Helicase gp41 Is Hindered by Tension on the Occluded Strand	PLOS ONE			English	Article							TERMINATION FACTOR-RHO; HEXAMERIC HELICASE; SINGLE-MOLECULE; REPLICATIVE HELICASE; STERIC EXCLUSION; RNA; BACTERIOPHAGE-T4; MECHANISM; FORCE; STOICHIOMETRY	The replicative helicase for bacteriophage T4 is gp41, which is a ring-shaped hexameric motor protein that achieves unwinding of dsDNA by translocating along one strand of ssDNA while forcing the opposite strand to the outside of the ring. While much study has been dedicated to the mechanism of binding and translocation along the ssDNA strand encircled by ring-shaped helicases, relatively little is known about the nature of the interaction with the opposite, 'occluded' strand. Here, we investigate the interplay between the bacteriophage T4 helicase gp41 and the ss/dsDNA fork by measuring, at the single-molecule level, DNA unwinding events on stretched DNA tethers in multiple geometries. We find that gp41 activity is significantly dependent on the geometry and tension of the occluded strand, suggesting an interaction between gp41 and the occluded strand that stimulates the helicase. However, the geometry dependence of gp41 activity is the opposite of that found previously for the E. coli hexameric helicase DnaB. Namely, tension applied between the occluded strand and dsDNA stem inhibits unwinding activity by gp41, while tension pulling apart the two ssDNA tails does not hinder its activity. This implies a distinct variation in helicase-occluded strand interactions among superfamily IV helicases, and we propose a speculative model for this interaction that is consistent with both the data presented here on gp41 and the data that had been previously reported for DnaB.	[Ribeck, Noah] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Saleh, Omar A.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Saleh, Omar A.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Saleh, OA (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	saleh@engineering.ucsb.edu	Saleh, Omar/B-5014-2008	Saleh, Omar/0000-0002-9197-4024	National Science Foundation [PHY-0748564]; Direct For Mathematical & Physical Scien [0748564] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation under grant number PHY-0748564. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAR DG, 1988, J MOL BIOL, V199, P623, DOI 10.1016/0022-2836(88)90306-3; Betterton MD, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011904; Betterton MD, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.258103; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; Indiani C, 2009, P NATL ACAD SCI USA, V106, P6031, DOI 10.1073/pnas.0901403106; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Jose D, 2012, P NATL ACAD SCI USA, V109, P14428, DOI 10.1073/pnas.1212929109; Jose D, 2012, P NATL ACAD SCI USA, V109, P13596, DOI 10.1073/pnas.1210040109; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Ribeck N, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2981687; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Rouzina I, 2001, BIOPHYS J, V80, P882, DOI 10.1016/S0006-3495(01)76067-5; van Mameren J, 2009, P NATL ACAD SCI USA, V106, P18231, DOI 10.1073/pnas.0904322106; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79237	10.1371/journal.pone.0079237	http://dx.doi.org/10.1371/journal.pone.0079237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250825	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200058
J	Xie, XJ; Gu, WH; Gao, S; Lu, S; Li, J; Pan, GH; Wang, GC; Shen, SD				Xie, Xiujun; Gu, Wenhui; Gao, Shan; Lu, Shan; Li, Jian; Pan, Guanghua; Wang, Guangce; Shen, Songdong			Alternative Electron Transports Participate in the Maintenance of Violaxanthin De-Epoxidase Activity of Ulva sp under Low Irradiance	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; SPINACH-CHLOROPLASTS; XANTHOPHYLL CYCLE; OXIDATIVE STRESS; PHOTOSYSTEM-II; ZEAXANTHIN; ARABIDOPSIS; ASCORBATE; SALICYLALDOXIME; PURIFICATION	The xanthophyll cycle (Xc), which involves violaxanthin de-epoxidase (VDE) and the zeaxanthin epoxidase (ZEP), is one of the most rapid and efficient responses of plant and algae to high irradiance. High light intensity can activate VDE to convert violaxanthin (Vx) to zeaxanthin (Zx) via antheraxanthin (Ax). However, it remains unclear whether VDE remains active under low light or dark conditions when there is no significant accumulation of Ax and Zx, and if so, how the Delta pH required for activation of VDE is built. In this study, we used salicylaldoxime (SA) to inhibit ZEP activity in the intertidal macro-algae Ulva sp. (Ulvales, Chlorophyta) and then characterized VDE under low light and dark conditions with various metabolic inhibitors. With inhibition of ZEP by SA, VDE remained active under low light and dark conditions, as indicated by large accumulations of Ax and Zx at the expense of Vx. When PSII-mediated linear electron transport systems were completely inhibited by SA and DCMU, alternative electron transport systems (i.e., cyclic electron transport and chlororespiration) could maintain VDE activity. Furthermore, accumulations of Ax and Zx decreased significantly when SA, DCMU, or DBMIB together with an inhibitor of chlororespiration (i.e., propyl gallate (PG)) were applied to Ulva sp. This result suggests that chlororespiration not only participates in the build-up of the necessary DpH, but that it also possibly influences VDE activity indirectly by diminishing the oxygen level in the chloroplast.	[Xie, Xiujun; Pan, Guanghua] Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin Key Lab Marine Resources & Chem, Tianjin, Peoples R China; [Gu, Wenhui; Gao, Shan; Wang, Guangce] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Gu, Wenhui; Gao, Shan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Lu, Shan] Nanjing Univ, Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China; [Li, Jian] Catholic Univ Louvain, Earth & Life Inst, B-3000 Louvain, Belgium; [Shen, Songdong] Soochow Univ, Coll Life Sci, Suzhou, Peoples R China	Tianjin University Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing University; Universite Catholique Louvain; Soochow University - China	Wang, GC (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	gcwang@qdio.ac.cn; shensongdong@suda.edu.cn	Shen, Songdong/G-9385-2011; Li, Jian/AFO-3420-2022; Li, Jian/H-4273-2019; Lu, Shan/J-8386-2015	Shen, Songdong/0000-0002-5731-1681; Li, Jian/0000-0001-8170-7654; Lu, Shan/0000-0002-1419-5166; Xie, Xiujun/0000-0002-0672-9199; Gu, Wenhui/0000-0001-9326-001X	National Natural Science Foundation of China [30830015, 40806063, 30970302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30830015, 40806063, and 30970302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson PO, 1996, PHOTOSYNTH RES, V49, P119, DOI 10.1007/BF00117662; Asada K, 2000, PHILOS T ROY SOC B, V355, P1419, DOI 10.1098/rstb.2000.0703; BARR R, 1976, PLANT PHYSIOL, V57, P450, DOI 10.1104/pp.57.3.450; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; BERG SP, 1976, BIOCHIM BIOPHYS ACTA, V440, P483, DOI 10.1016/0005-2728(76)90036-0; BRATT CE, 1995, PHOTOSYNTH RES, V45, P169, DOI 10.1007/BF00032588; BUCH K, 1995, FEBS LETT, V376, P45, DOI 10.1016/0014-5793(95)01243-9; Cleland RE, 1999, FEBS LETT, V457, P348, DOI 10.1016/S0014-5793(99)01067-4; Cournac L, 2000, J BIOL CHEM, V275, P17256, DOI 10.1074/jbc.M908732199; Cournac L, 2000, PHILOS T ROY SOC B, V355, P1447, DOI 10.1098/rstb.2000.0705; Cruz JA, 2001, PLANT PHYSIOL, V127, P1167, DOI 10.1104/pp.127.3.1167; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Fernandez-Marin B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-181; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; GOLBECK JH, 1985, PHOTOSYNTH RES, V6, P371, DOI 10.1007/BF00054110; GOLBECK JH, 1980, ARCH BIOCHEM BIOPHYS, V202, P458, DOI 10.1016/0003-9861(80)90450-6; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Gotz T, 2002, PLANT MOL BIOL, V50, P129, DOI 10.1023/A:1016072218801; GRUSZECKI WI, 1991, BIOCHIM BIOPHYS ACTA, V1060, P310, DOI 10.1016/S0005-2728(05)80322-6; HAGER A, 1966, BER DEUT BOT GES, V79, P94; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Havir EA, 1997, PLANT SCI, V123, P57, DOI 10.1016/S0168-9452(97)04579-2; Holtgrefe S, 2003, PLANT PHYSIOL, V133, P1768, DOI 10.1104/pp.103.026013; Hurry V, 1997, PLANT PHYSIOL, V113, P639, DOI 10.1104/pp.113.2.639; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; KARLISH SJD, 1969, EUR J BIOCHEM, V9, P291, DOI 10.1111/j.1432-1033.1969.tb00608.x; KLECZKOWSKI LA, 1994, ANNU REV PLANT PHYS, V45, P339, DOI 10.1146/annurev.pp.45.060194.002011; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McDonald AE, 2011, BBA-BIOENERGETICS, V1807, P954, DOI 10.1016/j.bbabio.2010.10.024; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Muller-Moule P, 2002, PLANT PHYSIOL, V128, P970, DOI 10.1104/pp.010924; Nixon PJ, 2000, PHILOS T R SOC B, V355, P1541, DOI 10.1098/rstb.2000.0714; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Rizhsky L, 2002, PLANT J, V32, P329, DOI 10.1046/j.1365-313X.2002.01427.x; Rockholm DC, 1996, PLANT PHYSIOL, V110, P697, DOI 10.1104/pp.110.2.697; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Takahashi H, 2006, PLANT CELL PHYSIOL, V47, P1678, DOI 10.1093/pcp/pcl029; TAKEGUCH.CA, 1968, BIOCHIM BIOPHYS ACTA, V153, P459, DOI 10.1016/0005-2728(68)90087-X; Teicher HB, 1998, PLANT PHYSIOL, V117, P525, DOI 10.1104/pp.117.2.525; THAYER SS, 1990, PHOTOSYNTH RES, V23, P331, DOI 10.1007/BF00034864; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Xu CC, 1999, PLANT SCI, V146, P27, DOI 10.1016/S0168-9452(99)00084-9; Yamamoto HY, 1999, ADV PHOTOSYNTH, V8, P293; YAMAMOTO HY, 1972, BIOCHIM BIOPHYS ACTA, V267, P538, DOI 10.1016/0005-2728(72)90182-X	49	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78211	10.1371/journal.pone.0078211	http://dx.doi.org/10.1371/journal.pone.0078211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250793	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200014
J	Takayama, H; Misu, H; Iwama, H; Chikamoto, K; Saito, Y; Murao, K; Teraguchi, A; Lan, F; Kikuchi, A; Saito, R; Tajima, N; Shirasaki, T; Matsugo, S; Miyamoto, K; Kaneko, S; Takamura, T				Takayama, Hiroaki; Misu, Hirofumi; Iwama, Hisakazu; Chikamoto, Keita; Saito, Yoshiro; Murao, Koji; Teraguchi, Atsushi; Lan, Fei; Kikuchi, Akihiro; Saito, Reina; Tajima, Natsumi; Shirasaki, Takayoshi; Matsugo, Seiichi; Miyamoto, Ken-ichi; Kaneko, Shuichi; Takamura, Toshinari			Metformin Suppresses Expression of the Selenoprotein P Gene via an AMP-activated Kinase (AMPK)/FoxO3a Pathway in H4IIEC3 Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Gene Expression; Hepatocyte; Insulin Resistance; Transcription Promoter; FoxO3a; Hepatokine; Metformin; Selenoprotein P	FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE; HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; OXIDATIVE STRESS; FOXO; LIVER; SELENIUM; MOUSE; CELLS	Selenoprotein P (SeP; encoded by SEPP1 in humans) is a liver-derived secretory protein that induces insulin resistance in type 2 diabetes. Suppression of SeP might provide a novel therapeutic approach to treating type 2 diabetes, but few drugs that inhibit SEPP1 expression in hepatocytes have been identified to date. The present findings demonstrate that metformin suppresses SEPP1 expression by activating AMP-activated kinase (AMPK) and subsequently inactivating FoxO3a in H4IIEC3 hepatocytes. Treatment with metformin reduced SEPP1 promoter activity in a concentration- and time-dependent manner; this effect was cancelled by co-administration of an AMPK inhibitor. Metformin also suppressed Sepp1 gene expression in the liver of mice. Computational analysis of transcription factor binding sites conserved among the species resulted in identification of the FoxO-binding site in the metformin-response element of the SEPP1 promoter. A luciferase reporter assay showed that metformin suppresses Forkhead-response element activity, and a ChIP assay revealed that metformin decreases binding of FoxO3a, a direct target of AMPK, to the SEPP1 promoter. Transfection with siRNAs for Foxo3a, but not for Foxo1, cancelled metformin-induced luciferase activity suppression of the metformin-response element of the SEPP1 promoter. The overexpression of FoxO3a stimulated SEPP1 promoter activity and rescued the suppressive effect of metformin. Metformin did not affect FoxO3a expression, but it increased its phosphorylation and decreased its nuclear localization. These data provide a novel mechanism of action for metformin involving improvement of systemic insulin sensitivity through the regulation of SeP production and suggest an additional approach to the development of anti-diabetic drugs.	[Takayama, Hiroaki; Misu, Hirofumi; Chikamoto, Keita; Lan, Fei; Kikuchi, Akihiro; Saito, Reina; Tajima, Natsumi; Shirasaki, Takayoshi; Kaneko, Shuichi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Chikamoto, Keita] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Nat Syst, Kanazawa, Ishikawa 9201192, Japan; [Saito, Yoshiro] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 6100394, Japan; [Murao, Koji] Kagawa Univ, Dept Adv Med, Miki, Kagawa 7610793, Japan; [Teraguchi, Atsushi] Kanazawa Univ, Dept Hosp Pharm, Kanazawa, Ishikawa 9208641, Japan; [Shirasaki, Takayoshi] Kanazawa Univ, Grad Sch Hlth Med, Dept Adv Med Technol, Kanazawa, Ishikawa 9208641, Japan; [Matsugo, Seiichi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Engn, Kanazawa, Ishikawa 9201192, Japan; [Matsugo, Seiichi] Kanazawa Univ, Fac Nat Syst, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Miyamoto, Ken-ichi] Kanazawa Univ, Grad Sch Med Sci, Dept Hosp Pharm, Kanazawa, Ishikawa 9208641, Japan; [Miyamoto, Ken-ichi] Kanazawa Univ, Grad Sch Med Sci, Dept Med Informat, Kanazawa, Ishikawa 9208641, Japan	Kanazawa University; Kagawa University; Kanazawa University; Doshisha University; Kagawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	ttakamura@m-kanazawa.jp	Takayama, Hiroaki/C-4694-2015; Saito, Yoshiro/H-4597-2019	Takayama, Hiroaki/0000-0003-4792-3868; Saito, Yoshiro/0000-0002-0559-5889; Kikuchi, Akihiro/0000-0001-9332-1273	Ministry of Education, Culture, Sports, Science and Technology, Japan; Dainippon Sumitomo Pharma; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24591352] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. M., T. T., and S. K.) and research grants from Dainippon Sumitomo Pharma (to S. K.) and Takeda Science Foundation (to H. M.).	Boyle JG, 2010, DIABETIC MED, V27, P1097, DOI 10.1111/j.1464-5491.2010.03098.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Dreher I, 1997, J BIOL CHEM, V272, P29364, DOI 10.1074/jbc.272.46.29364; Eckers A, 2011, ARCH BIOCHEM BIOPHYS, V516, P138, DOI 10.1016/j.abb.2011.10.006; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Honda M, 2011, GASTROENTEROLOGY, V141, P128, DOI 10.1053/j.gastro.2011.03.051; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; Lutzner N., 2012, PLOS ONE, V7; Magwere T, 1997, FREE RADICAL BIO MED, V22, P321, DOI 10.1016/S0891-5849(96)00285-7; Malin SK, 2012, DIABETES CARE, V35, P131, DOI 10.2337/dc11-0925; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Shargorodsky M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-61; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Singh S, 2012, DIABETES METAB SYND, V6, P207, DOI 10.1016/j.dsx.2012.05.013; Speckmann B, 2009, BIOCHEM BIOPH RES CO, V387, P158, DOI 10.1016/j.bbrc.2009.06.143; Speckmann B, 2008, HEPATOLOGY, V48, P1998, DOI 10.1002/hep.22526; Takebe G, 2002, J BIOL CHEM, V277, P41254, DOI 10.1074/jbc.M202773200; ukaszewicz-Hussain A., 2004, POL J ENVIRON STUD, V13, P303; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	44	57	59	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					335	345		10.1074/jbc.M113.479386	http://dx.doi.org/10.1074/jbc.M113.479386			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257750	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000329370900029
J	Feng, XX; Liu, M; Yan, W; Zhou, ZZ; Xia, YJ; Tu, W; Li, PY; Tian, DA				Feng, Xin-Xia; Liu, Mei; Yan, Wei; Zhou, Zhen-Zhen; Xia, Yu-Jia; Tu, Wei; Li, Pei-Yuan; Tian, De-An			beta 3 Integrin Promotes TGF-beta 1/H2O2/HOCl-Mediated Induction of Metastatic Phenotype of Hepatocellular Carcinoma Cells by Enhancing TGF-beta 1 Signaling	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CBD-HEPII POLYPEPTIDE; BREAST-CANCER; ALPHA-3-BETA-1 INTEGRIN; INVASION; TUMOR; ACTIVATION; EXPRESSION; MIGRATION; HEPATOCARCINOMA	In addition to being an important mediator of migration and invasion of tumor cells, b3 integrin can also enhance TGF-beta 1 signaling. However, it is not known whether beta 3 might influence the induction of metastatic phenotype of tumor cells, especially non-metastatic tumor cells which express low level of beta 3. Here we report that H2O2 and HOCl, the reactive oxygen species produced by neutrophils, could cooperate with TGF-beta 1 to induce metastatic phenotype of non-metastatic hepatocellular carcinoma (HCC) cells. TGF-beta 1/H2O2/HOCl, but not TGF-beta 1 or H2O2/HOCl, induced beta 3 expression by triggering the enhanced activation of p38 MAPK. Intriguingly, beta 3 in turn promoted TGF-beta 1/H2O2/HOCl-mediated induction of metastatic phenotype of HCC cells by enhancing TGF-beta 1 signaling. beta 3 promoted TGF-beta 1/H2O2/HOCl-induced expression of itself via positive feed-back effect on p38 MAPK activation, and also promoted TGF-beta 1/H2O2/HOCl-induced expression of alpha 3 and SNAI2 by enhancing the activation of ERK pathway, thus resulting in higher invasive capacity of HCC cells. By enhancing MAPK activation, beta 3 enabled TGF-beta 1 to augment the promoting effect of H2O2/HOCl on anoikis-resistance of HCC cells. TGF-beta 1/H2O2/HOCl-induced metastatic phenotype was sufficient for HCC cells to extravasate from circulation and form metastatic foci in an experimental metastasis model in nude mice. Inhibiting the function of beta 3 could suppress or abrogate the promoting effects of TGF-beta 1/H2O2/HOCl on invasive capacity, anoikis-resistance, and extravasation of HCC cells. These results suggest that beta 3 could function as a modulator to promote TGF-beta 1/H2O2/HOCl-mediated induction of metastatic phenotype of non-metastatic tumor cells, and that targeting beta 3 might be a potential approach in preventing the induction of metastatic phenotype of non-metastatic tumor cells.	[Feng, Xin-Xia; Liu, Mei; Yan, Wei; Zhou, Zhen-Zhen; Xia, Yu-Jia; Tu, Wei; Li, Pei-Yuan; Tian, De-An] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Gastroenterol, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Tian, DA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Gastroenterol, Tongji Hosp, Wuhan 430074, Peoples R China.	datian@tjh.tjmu.edu.cn			National Science Foundation of China [81070333, 81270507, 81001066]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation of China (No. 81070333 and 81270507 to DAT, No. 81001066 to PYL) (http://isisn.nsfc.gov.cn/egrantweb/main). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aomatsu K, 2011, INVEST OPHTH VIS SCI, V52, P2437, DOI 10.1167/iovs.10-5635; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Fransvea E, 2009, HEPATOLOGY, V49, P839, DOI 10.1002/hep.22731; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Giannelli G, 2002, AM J PATHOL, V161, P183, DOI 10.1016/S0002-9440(10)64170-3; Giannelli G, 2001, LAB INVEST, V81, P613, DOI 10.1038/labinvest.3780270; Gong W, 2008, INT J CANCER, V123, P702, DOI 10.1002/ijc.23553; Gong W, 2008, BIOCHEM BIOPH RES CO, V367, P144, DOI 10.1016/j.bbrc.2007.12.110; Jin ZH, 2012, ANGIOGENESIS, V15, P569, DOI 10.1007/s10456-012-9281-1; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Katabami K, 2005, CLIN EXP METASTAS, V22, P539, DOI 10.1007/s10585-005-5260-x; Lane AE, 2010, BIOCHEM J, V430, P161, DOI 10.1042/BJ20100082; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liu Y, 2007, INT J CANCER, V121, P184, DOI 10.1002/ijc.22644; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Marshall JCA, 2012, JNCI-J NATL CANCER I, V104, P1306, DOI 10.1093/jnci/djs319; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Nejjari M, 1999, INT J CANCER, V83, P518, DOI 10.1002/(SICI)1097-0215(19991112)83:4<518::AID-IJC14>3.3.CO;2-H; Nejjari M, 2002, HEPATOLOGY, V36, P418, DOI 10.1053/jhep.2002.34611; Okoh V, 2011, BBA-REV CANCER, V1815, P115, DOI 10.1016/j.bbcan.2010.10.005; Ozaki I, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00078; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Saito D, 2013, J BIOCHEM, V153, P303, DOI 10.1093/jb/mvs144; Tang NH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-552; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; Vellon L, 2005, ONCOGENE, V24, P3759, DOI 10.1038/sj.onc.1208452; Wang XS, 2011, MED ONCOL, V28, pS413, DOI 10.1007/s12032-010-9728-4; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Yang CQ, 2003, CANCER RES, V63, P8312; Yang T, 2012, WORLD J GASTROENTERO, V18, P2533, DOI 10.3748/wjg.v18.i20.2533; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhou SL, 2012, HEPATOLOGY, V56, P2242, DOI 10.1002/hep.25907	39	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79857	10.1371/journal.pone.0079857	http://dx.doi.org/10.1371/journal.pone.0079857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260309	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500104
J	Harrington, MG; Chiang, JR; Pogoda, JM; Gomez, M; Thomas, K; Marion, SD; Miller, KJ; Siddarth, P; Yi, XY; Zhou, FM; Lee, S; Arakaki, X; Cowan, RP; Tran, T; Charleswell, C; Ross, BD; Fonteh, AN				Harrington, Michael G.; Chiang, Jiarong; Pogoda, Janice M.; Gomez, Megan; Thomas, Kris; Marion, Sarah DeBoard; Miller, Karen J.; Siddarth, Prabha; Yi, Xinyao; Zhou, Feimeng; Lee, Sherri; Arakaki, Xianghong; Cowan, Robert P.; Thao Tran; Charleswell, Cherise; Ross, Brian D.; Fonteh, Alfred N.			Executive Function Changes before Memory in Preclinical Alzheimer's Pathology: A Prospective, Cross-Sectional, Case Control Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; NORMATIVE DATA; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; CLINICAL-TRIALS; OLDER-ADULTS; STROOP COLOR; DISEASE	Background: Early treatment of Alzheimer's disease may reduce its devastating effects. By focusing research on asymptomatic individuals with Alzheimer's disease pathology (the preclinical stage), earlier indicators of disease may be discovered. Decreasing cerebrospinal fluid beta-amyloid(42) is the first indicator of preclinical disorder, but it is not known which pathology causes the first clinical effects. Our hypothesis is that neuropsychological changes within the normal range will help to predict preclinical disease and locate early pathology. Methods and Findings: We recruited adults with probable Alzheimer's disease or asymptomatic cognitively healthy adults, classified after medical and neuropsychological examination. By logistic regression, we derived a cutoff for the cerebrospinal fluid beta amyloid(42)/tau ratios that correctly classified 85% of those with Alzheimer's disease. We separated the asymptomatic group into those with (n = 34; preclinical Alzheimer's disease) and without (n = 36; controls) abnormal beta amyloid42/tau ratios; these subgroups had similar distributions of age, gender, education, medications, apolipoprotein-e genotype, vascular risk factors, and magnetic resonance imaging features of small vessel disease. Multivariable analysis of neuropsychological data revealed that only Stroop Interference (response inhibition) independently predicted preclinical pathology (OR = 0.13, 95% CI = 0.04-0.42). Lack of longitudinal and post-mortem data, older age, and small population size are limitations of this study. Conclusions: Our data suggest that clinical effects from early amyloid pathophysiology precede those from hippocampal intraneuronal neurofibrillary pathology. Altered cerebrospinal fluid beta amyloid(42) with decreased executive performance before memory impairment matches the deposits of extracellular amyloid that appear in the basal isocortex first, and only later involve the hippocampus. We propose that Stroop Interference may be an additional important screen for early pathology and useful to monitor treatment of preclinical Alzheimer's disease; measures of executive and memory functions in a longitudinal design will be necessary to more fully evaluate this approach.	[Harrington, Michael G.; Chiang, Jiarong; Lee, Sherri; Arakaki, Xianghong; Fonteh, Alfred N.] Huntington Med Res Inst, Mol Neurol Program, Pasadena, CA USA; [Pogoda, Janice M.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Gomez, Megan; Thomas, Kris; Marion, Sarah DeBoard] Fuller Grad Sch Psychol, Pasadena, CA USA; [Miller, Karen J.; Siddarth, Prabha] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Yi, Xinyao; Zhou, Feimeng] Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA; [Cowan, Robert P.] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Thao Tran; Charleswell, Cherise; Ross, Brian D.] Huntington Med Res Inst, Magnet Resonance Program, Pasadena, CA USA	Huntington Medical Research Institutes; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California State University System; California State University Los Angeles; Stanford University; Huntington Medical Research Institutes	Harrington, MG (corresponding author), Huntington Med Res Inst, Mol Neurol Program, Pasadena, CA USA.	mghworks@hmri.org		Harrington, Michael/0000-0002-7923-8032; Cowan, Robert/0000-0002-6868-0108	L. K. Whittier Foundation; Huntington Medical Research Institutes; Posthuma and Dunlevy family Foundations; National Institutes of Health [SC1NS070155-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC1NS070155] Funding Source: NIH RePORTER	L. K. Whittier Foundation; Huntington Medical Research Institutes; Posthuma and Dunlevy family Foundations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by The L. K. Whittier Foundation, Huntington Medical Research Institutes, the Posthuma and Dunlevy family Foundations, and National Institutes of Health Grant No. SC1NS070155-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balota DA, 2010, PSYCHOL AGING, V25, P208, DOI 10.1037/a0017474; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; BERG L, 1988, ANN NEUROL, V23, P477, DOI 10.1002/ana.410230509; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Byrne H, 1995, Aust J Adv Nurs, V13, P18; Chao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065175; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Clark LR, 2012, J INT NEUROPSYCH SOC, V18, P118, DOI 10.1017/S1355617711001524; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Delis JH, 2000, CALIFORNIA VERBAL LE; Dewar M, 2012, BRAIN COGNITION, V78, P189, DOI 10.1016/j.bandc.2011.12.005; Duchek JM, 2009, NEUROPSYCHOLOGY, V23, P746, DOI 10.1037/a0016583; Endo K, 2013, J PHYSL SCI; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2011, ARCH NEUROL-CHICAGO, V68, P1137, DOI 10.1001/archneurol.2011.105; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Freitas S, 2011, MONTREAL COGNITIVE A; Gale SD, 2007, J CLIN EXP NEUROPSYC, V29, P561, DOI 10.1080/13803390600864760; Gallagher C, 2007, BRIT J CLIN PSYCHOL, V46, P35, DOI 10.1348/014466506X106047; Galvin JE, 2010, BRAIN, V133, P3290, DOI 10.1093/brain/awq204; Godbolt AK, 2006, NEUROLOGY, V66, P718, DOI 10.1212/01.wnl.0000201237.05869.df; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Hedden T, 2013, NEUROLOGY, V80, P1341, DOI 10.1212/WNL.0b013e31828ab35d; Holtzman D.M., 2012, COLD SPRING HARB PER, V2; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hutchison KA, 2010, PSYCHOL AGING, V25, P545, DOI 10.1037/a0018498; Irwin DJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00006; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jessen F, 2013, ALZHEIMERS DEMENT; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; Kantarci K, 2013, NEUROLOGY, V81, P126, DOI 10.1212/WNL.0b013e31829a3329; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kramer JH, 2002, J NEUROL NEUROSUR PS, V72, P217, DOI 10.1136/jnnp.72.2.217; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; McFarlane J, 2006, BRIT J CLIN PSYCHOL, V45, P453, DOI 10.1348/014466505X71245; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mielke MM, 2012, NEUROLOGY, V79, P1570, DOI 10.1212/WNL.0b013e31826e2696; Mograbi DC, 2012, INT PSYCHOGERIATR, V24, P931, DOI 10.1017/S1041610211002730; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Ono M, 2012, J PHARMACOL SCI, V118, P338, DOI 10.1254/jphs.11R08FM; Parra MA, 2010, BRAIN, V133, P2702, DOI 10.1093/brain/awq148; Petersen R.C., 2013, ANN NEUROL; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pilgrim B M, 1999, Appl Neuropsychol, V6, P243, DOI 10.1207/s15324826an0604_7; Pillai JA, 2013, MED CLIN N AM, V97, P439, DOI 10.1016/j.mcna.2013.01.002; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ross BD, 1997, BIOPHYS CHEM, V68, P161, DOI 10.1016/S0301-4622(97)00032-X; Sambataro F, 2012, EUR J NEUROSCI, V36, P3559, DOI 10.1111/j.1460-9568.2012.08254.x; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Saxton J, 2004, NEUROLOGY, V63, P2341, DOI 10.1212/01.WNL.0000147470.58328.50; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Selkoe D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011460; Seo EH, 2008, INT J GERIATR PSYCH, V23, P1020, DOI 10.1002/gps.2027; Seshadri S, 2011, ALZHEIMERS DEMENT, V7, P35, DOI 10.1016/j.jalz.2010.12.002; Sjogren M, 2001, CLIN CHEM, V47, P1776; Small GW, 2012, ARCH NEUROL-CHICAGO, V69, P215, DOI 10.1001/archneurol.2011.559; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P280, DOI 10.1080/13854040590945229; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vlassenko AG, 2011, ANN NEUROL, V70, P857, DOI 10.1002/ana.22608; Wang L, 2012, ALZ DIS ASSOC DIS, V26, P314, DOI 10.1097/WAD.0b013e31823c0cf4; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Williams MM, 2013, ALZHEIMERS DEMENT, V9, pS39, DOI 10.1016/j.jalz.2012.01.005; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	79	57	57	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79378	10.1371/journal.pone.0079378	http://dx.doi.org/10.1371/journal.pone.0079378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260210	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500055
J	Hvid, H; Blouin, MJ; Birman, E; Damgaard, J; Poulsen, F; Fels, JJ; Fledelius, C; Hansen, BF; Pollak, M				Hvid, Henning; Blouin, Marie-Jose; Birman, Elena; Damgaard, Jesper; Poulsen, Fritz; Fels, Johannes Josef; Fledelius, Christian; Hansen, Bo Falck; Pollak, Michael			Treatment with Insulin Analog X10 and IGF-1 Increases Growth of Colon Cancer Allografts	PLOS ONE			English	Article							INCREASED MITOGENIC POTENCY; GLUCOSE-TOLERANCE TEST; HIGH-ENERGY DIET; IN-VIVO; HYPOPHYSECTOMIZED RATS; ADENOCARCINOMA CELLS; COST-EFFECTIVENESS; DIABETES-MELLITUS; COLORECTAL-CANCER; CARCINOMA GROWTH	Obesity and type 2 diabetes are associated with an increased risk for development of certain forms of cancer, including colon cancer. The publication of highly controversial epidemiological studies in 2009 raised the possibility that use of the insulin analog glargine increases this risk further. However, it is not clear how mitogenic effects of insulin and insulin analogs measured in vitro correlate with tumor growth-promoting effects in vivo. The aim of this study was to examine possible growth-promoting effects of native human insulin, insulin X10 and IGF-1, which are considered positive controls in vitro, in a short-term animal model of an obesity-and diabetes-relevant cancer. We characterized insulin and IGF-1 receptor expression and the response to treatment with insulin, X10 and IGF-1 in the murine colon cancer cell line (MC38 cells) in vitro and in vivo. Furthermore, we examined pharmacokinetics and pharmacodynamics and monitored growth of MC38 cell allografts in mice with diet-induced obesity treated with human insulin, X10 and IGF-1. Treatment with X10 and IGF-1 significantly increased growth of MC38 cell allografts in mice with diet-induced obesity and we can therefore conclude that supra-pharmacological doses of the insulin analog X10, which is super-mitogenic in vitro and increased the incidence of mammary tumors in female rats in a 12-month toxicity study, also increase growth of tumor allografts in a short-term animal model.	[Hvid, Henning; Damgaard, Jesper; Poulsen, Fritz; Fels, Johannes Josef; Fledelius, Christian; Hansen, Bo Falck] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Blouin, Marie-Jose; Birman, Elena; Pollak, Michael] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	Novo Nordisk; Lady Davis Institute; McGill University	Hvid, H (corresponding author), Novo Nordisk AS, Diabet Res Unit, Malov, Denmark.	hhvd@novonordisk.com		Pollak, Michael/0000-0003-3047-0604	Canadian Institute of Health Research [TFF-116128]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was partly supported by a grant (TFF-116128) from the Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Algire C, 2008, ENDOCR-RELAT CANCER, V15, P833, DOI 10.1677/ERC-08-0038; Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bibby BM, 2004, EXPT DESIGN AGR SCI; Blouin MJ, 2010, CANCER LETT, V289, P246, DOI 10.1016/j.canlet.2009.08.021; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chen J, 2011, OBES REV, V12, P1063, DOI 10.1111/j.1467-789X.2011.00917.x; CORBETT TH, 1975, CANCER RES, V35, P2434; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dideriksen LH, 1992, DIABETES S1, V41, p143A; EMEA (European Medicines Evaluation Agency), 2001, CPMPSWP37201 EMEA; FDA, 2005, PHARM TOX REV EV; Ferguson RD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3089; Fierz Y, 2010, DIABETES, V59, P686, DOI 10.2337/db09-1291; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Gammeltoft S, 1999, Expert Opin Investig Drugs, V8, P1431, DOI 10.1517/13543784.8.9.1431; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Hansen BF, 2008, HORM METAB RES, V40, P431, DOI 10.1055/s-2008-1062740; Hansen BF, 2011, DIABETOLOGIA, V54, P2226, DOI 10.1007/s00125-011-2203-8; Hansen BF, 1996, BIOCHEM J, V315, P271; Hansen BF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034274; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; HEUSON JC, 1972, CANCER RES, V32, P233; Hvid H, 2012, ENDOCR-RELAT CANCER, V19, P557, DOI 10.1530/ERC-12-0125; Hvid H, 2011, TOXICOL PATHOL, V39, P623, DOI 10.1177/0192623311406936; Koohestani N, 1998, CARCINOGENESIS, V19, P1679, DOI 10.1093/carcin/19.9.1679; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Lee WM, 2001, CANCER LETT, V162, P155, DOI 10.1016/S0304-3835(00)00635-2; Listov-Saabye N, 2009, J APPL TOXICOL, V29, P470, DOI 10.1002/jat.1428; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nagel Jutta M., 2010, Hormones & Cancer, V1, P320, DOI 10.1007/s12672-010-0020-z; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Oleksiewicz MB, 2011, J APPL TOXICOL, V31, P329, DOI 10.1002/jat.1590; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Poulsen F, 2012, TRENDS IMMUNOLABELLE, P259; Poulsen F, 2007, J BIOMOL SCREEN, V12, P240, DOI 10.1177/1087057106297566; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Stammberger I, 2002, INT J TOXICOL, V21, P171, DOI 10.1080/10915810290096306; Stephens L, 2005, CURR OPIN PHARMACOL, V5, P357, DOI 10.1016/j.coph.2005.03.002; Tennagels N, 2013, DIABETOLOGIA, V56, P1826, DOI 10.1007/s00125-013-2923-z; Tennekes H, 2004, REGUL TOXICOL PHARM, V40, P18, DOI 10.1016/j.yrtph.2004.04.003; Tran TT, 1996, CANCER EPIDEM BIOMAR, V5, P1013; Tran TT, 2006, ENDOCRINOLOGY, V147, P1830, DOI 10.1210/en.2005-1012; Tran TT, 2003, CANCER EPIDEM BIOMAR, V12, P47; Tsoi KKF, 2008, ALIMENT PHARM THER, V28, P353, DOI 10.1111/j.1365-2036.2008.03726.x; Weber RV, 2000, DIGEST DIS SCI, V45, P890, DOI 10.1023/A:1005560621722; ZAPF J, 1986, J CLIN INVEST, V77, P1768, DOI 10.1172/JCI112500	52	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79710	10.1371/journal.pone.0079710	http://dx.doi.org/10.1371/journal.pone.0079710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260289	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500094
J	Jegerlehner, A; Zabel, F; Langer, A; Dietmeier, K; Jennings, GT; Saudan, P; Bachmann, MF				Jegerlehner, Andrea; Zabel, Franziska; Langer, Alice; Dietmeier, Klaus; Jennings, Gary T.; Saudan, Philippe; Bachmann, Martin F.			Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RECEPTOR-BINDING; ANTIBODY-RESPONSE; IMMUNE-RESPONSE; CELL RESPONSES; HEMAGGLUTININ; IMMUNIZATION; VACCINATION; GLYCOPROTEIN; PROTECTION	Although current influenza vaccines are effective in general, there is an urgent need for the development of new technologies to improve vaccine production timelines, capacities and immunogenicity. Herein, we describe the development of an influenza vaccine technology which enables recombinant production of highly efficient influenza vaccines in bacterial expression systems. The globular head domain of influenza hemagglutinin, comprising most of the protein's neutralizing epitopes, was expressed in E. coli and covalently conjugated to bacteriophage-derived virus-like particles produced independently in E. coli. Conjugate influenza vaccines produced this way were used to immunize mice and found to elicit immune sera with high antibody titers specific for the native influenza hemagglutinin protein and high hemagglutination-inhibition titers. Moreover vaccination with these vaccines induced full protection against lethal challenges with homologous and highly drifted influenza strains.	[Jegerlehner, Andrea; Zabel, Franziska; Langer, Alice; Dietmeier, Klaus; Jennings, Gary T.; Saudan, Philippe; Bachmann, Martin F.] Cytos Biotechnol AG, Immunodrugs Dept, Zurich, Switzerland		Saudan, P (corresponding author), Cytos Biotechnol AG, Immunodrugs Dept, Zurich, Switzerland.	philippe.saudan@cytos.com						Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; Belsey MJ, 2006, NAT REV DRUG DISCOV, V5, P183, DOI 10.1038/nrd1988; Bessa J, 2009, J IMMUNOL, V183, P3788, DOI 10.4049/jimmunol.0804004; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; Cox MMJ, 2008, CURR OPIN MOL THER, V10, P56; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; GRAVES PN, 1983, VIROLOGY, V126, P106, DOI 10.1016/0042-6822(83)90465-8; Hagenaars N, 2008, VACCINE; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Jeon SH, 2002, VIRAL IMMUNOL, V15, P165, DOI 10.1089/088282402317340314; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; KREIJTZ JH, 2009, HUM VACCIN, V5; Kundig TM, 2006, J ALLERGY CLIN IMMUN, V117, P1470, DOI 10.1016/j.jaci.2006.01.040; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Saelens X, 1999, EUR J BIOCHEM, V260, P166, DOI 10.1046/j.1432-1327.1999.00150.x; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Storni T, 2002, J IMMUNOL, V168, P2880, DOI 10.4049/jimmunol.168.6.2880; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0	37	39	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e78947	10.1371/journal.pone.0078947	http://dx.doi.org/10.1371/journal.pone.0078947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260136	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500013
J	Murray, BR; Hardstaff, LK; Phillips, ML				Murray, Brad R.; Hardstaff, Lyndle K.; Phillips, Megan L.			Differences in Leaf Flammability, Leaf Traits and Flammability-Trait Relationships between Native and Exotic Plant Species of Dry Sclerophyll Forest	PLOS ONE			English	Article							CLIMATE-CHANGE; SYDNEY REGION; FIRE REGIMES; AUSTRALIA; EVOLUTION; WATER; PHYLOGENETICS; COMPONENTS; CALIFORNIA; VEGETATION	The flammability of plant leaves influences the spread of fire through vegetation. Exotic plants invading native vegetation may increase the spread of bushfires if their leaves are more flammable than native leaves. We compared fresh-leaf and dry-leaf flammability (time to ignition) between 52 native and 27 exotic plant species inhabiting dry sclerophyll forest. We found that mean time to ignition was significantly faster in dry exotic leaves than in dry native leaves. There was no significant native-exotic difference in mean time to ignition for fresh leaves. The significantly higher fresh-leaf water content that was found in exotics, lost in the conversion from a fresh to dry state, suggests that leaf water provides an important buffering effect that leads to equivalent mean time to ignition in fresh exotic and native leaves. Exotic leaves were also significantly wider, longer and broader in area with significantly higher specific leaf area-but not thicker-than native leaves. We examined scaling relationships between leaf flammability and leaf size (leaf width, length, area, specific leaf area and thickness). While exotics occupied the comparatively larger and more flammable end of the leaf size-flammability spectrum in general, leaf flammability was significantly correlated with all measures of leaf size except leaf thickness in both native and exotic species such that larger leaves were faster to ignite. Our findings for increased flammability linked with larger leaf size in exotics demonstrate that exotic plant species have the potential to increase the spread of bushfires in dry sclerophyll forest.	[Murray, Brad R.; Hardstaff, Lyndle K.; Phillips, Megan L.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	University of Technology Sydney	Murray, BR (corresponding author), Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia.	Brad.Murray@uts.edu.au		Murray, Megan/0000-0002-0417-4337; Murray, Brad/0000-0002-4734-5976	University of Technology Sydney	University of Technology Sydney	This work was supported by the University of Technology Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio GA, 2008, INT J WILDLAND FIRE, V17, P274, DOI 10.1071/WF07038; [Anonymous], 1996, IGNITABILITY LEAVES; Baker AC, 2012, FOREST ECOL MANAG, V277, P25, DOI 10.1016/j.foreco.2012.04.009; Beaty RM, 2007, J VEG SCI, V18, P879, DOI 10.1111/j.1654-1103.2007.tb02604.x; Behm AL, 2004, INT J WILDLAND FIRE, V13, P355, DOI 10.1071/WF03075; Bekker MF, 2001, PLANT ECOL, V155, P15, DOI 10.1023/A:1013263212092; Benson Doug, 1994, Cunninghamia, V3, P677; Berry ZC, 2011, WEED RES, V51, P525, DOI 10.1111/j.1365-3180.2011.00869.x; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Bradstock RA., 2002, FLAMMABLE AUSTR FIRE; Bradstock Ross A., 2002, P238; Brennan KEC, 2009, GLOBAL CHANGE BIOL, V15, P2958, DOI 10.1111/j.1365-2486.2009.02011.x; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; CLEMENTS AM, 1983, AUST J ECOL, V8, P307, DOI 10.1111/j.1442-9993.1983.tb01328.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; De Lillis M, 2009, INT J WILDLAND FIRE, V18, P203, DOI 10.1071/WF07075; de Magalhaes RMQ, 2012, J ECOL, V100, P1153, DOI 10.1111/j.1365-2745.2012.01987.x; DICKINSON KJM, 1985, J BIOGEOGR, V12, P121, DOI 10.2307/2844836; Dimitrakopoulos AP, 2001, INT J WILDLAND FIRE, V10, P113, DOI 10.1071/WF01004; Dragovich D, 2002, EARTH SURF PROC LAND, V27, P1309, DOI 10.1002/esp.413; Etlinger MG, 2004, INT J WILDLAND FIRE, V13, P479, DOI 10.1071/WF04039; Fairley, 1989, NATIVE PLANTS SYDNEY; HARDEN GJ, 1990, FLORA NEW S WALES; Hardstaff LK, 2010, THESIS U TECHNOLOGY; Jordan GJ, 2005, AM J BOT, V92, P789, DOI 10.3732/ajb.92.5.789; KARLIC H, 1979, NEW PHYTOL, V83, P379, DOI 10.1111/j.1469-8137.1979.tb07463.x; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keith D.A., 2004, OCEAN SHORES DESERT; KELLMAN M, 1984, BIOTROPICA, V16, P158, DOI 10.2307/2387850; King SA, 2000, AUSTRAL ECOL, V25, P455, DOI 10.1046/j.1442-9993.2000.01085.x; Leigh A, 2012, NEW PHYTOL, V194, P477, DOI 10.1111/j.1469-8137.2012.04058.x; Moriondo M, 2006, CLIM RES, V31, P85, DOI 10.3354/cr031085; MORRISON DA, 1995, AUST J ECOL, V20, P239, DOI 10.1111/j.1442-9993.1995.tb00535.x; Murray Brad R., 2009, International Journal of Ecology, V2009, P1; Nobel PS., 2005, PHYSICOCHEMICAL ENV; Odion DC, 2010, J ECOL, V98, P96, DOI 10.1111/j.1365-2745.2009.01597.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E., 2012, ANAL PHYLOGENETICS E; Pausas JG, 2012, NEW PHYTOL, V193, P18, DOI 10.1111/j.1469-8137.2011.03945.x; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Penman TD, 2007, FOREST ECOL MANAG, V252, P24, DOI 10.1016/j.foreco.2007.06.004; Pickett BM, 2009, INT J WILDLAND FIRE, V18, P865, DOI 10.1071/WF08143; Quinn GP, 2003, EXPT DESIGN DATA ANA; Raison R.J, 2005, REV C N RATIOS VEGET; Ramsay C, 2003, LANDSCAPING BUILDING; Robinson L., 2003, FIELD GUIDE NATIVE P; Rossiter-Rachor NA, 2008, ECOSYSTEMS, V11, P77, DOI 10.1007/s10021-007-9108-x; Scarff FR, 2006, FUNCT ECOL, V20, P745, DOI 10.1111/j.1365-2435.2006.01174.x; Schwilk DW, 2011, J ECOL, V99, P970, DOI 10.1111/j.1365-2745.2011.01828.x; Stevens P. F., 2012, ANGIOSPERM PHYLOGENY; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Whelan R.J.., 1995, ECOLOGY FIRE; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Williams AAJ, 2001, CLIMATIC CHANGE, V49, P171, DOI 10.1023/A:1010706116176; Wiser SK, 2008, ECOLOGY, V89, P380, DOI 10.1890/07-0196.1	60	54	54	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79205	10.1371/journal.pone.0079205	http://dx.doi.org/10.1371/journal.pone.0079205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260169	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500033
J	Serra-Negra, JM; Paiva, SM; Abreu, MH; Flores-Mendoza, CE; Pordeus, IA				Serra-Negra, Junia Maria; Paiva, Saul Martins; Abreu, Mauro Henrique; Flores-Mendoza, Carmen Elvira; Pordeus, Isabela Almeida			Relationship between Tasks Performed, Personality Traits, and Sleep Bruxism in Brazilian School Children - A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							TEMPOROMANDIBULAR DISORDERS; PHYSICAL-ACTIVITY; PREVALENCE; LABOR; NEUROTICISM; CHILDHOOD; SYMPTOMS; WORK	Background: Tasks can be instruments of stress and may affect the health of children. Sleep bruxism is a multifactorial sleep-related movement disorder that affects children and adults. The aim of the present study was to analyze the association between children's tasks, personality traits and sleep bruxism. Methods And Findings: A cross-sectional, population-based study of 652 randomly selected Brazilian schoolchildren (52% of whom were female), aged from 7 to 10 years was conducted in the city of Belo Horizonte, Brazil. A questionnaire based on criteria proposed by the American Academy of Sleep Medicine (AASM) was completed by parents. In addition, the Neuroticism and Responsibility sub-scales of the Big Five Questionnaire for Children (BFQ-C) were administered to the children. Psychological tests were administered and evaluated by psychologists. The Social Vulnerability Index from the city council database was used to determine the social classification of the families. Chi-square and Poisson regression statistical tests were used with a 95% confidence interval. The majority of families were classified as having low social vulnerability (61.3%), whereas, 38.7% were classified as having high social vulnerability. Regarding extracurricular activities, the majority of girls performed household work (56.4%) and some artistic activity (51.3%) while sporting activities were most common among boys (61%). The results of the Poisson regression model indicated that sleep bruxism was most prevalent in children who scored highly in the Neuroticism sub-scale, and who frequently performed household tasks. Conclusion: Children whose personality domain has a high level of Neuroticism and who perform household chores imposed by the family are more vulnerable to sleep bruxism.	[Serra-Negra, Junia Maria; Paiva, Saul Martins; Pordeus, Isabela Almeida] Univ Fed Minas Gerais, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil; [Abreu, Mauro Henrique] Univ Fed Minas Gerais, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil; [Flores-Mendoza, Carmen Elvira] Univ Fed Minas Gerais, Dept Psychol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Serra-Negra, JM (corresponding author), Univ Fed Minas Gerais, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil.	juniaserranegra@hotmail.com	PORDEUS, ISABELA A/B-1570-2013; Flores-Mendoza, Carmen/GXH-1100-2022; Paiva, Saul Martins/H-5757-2012; SERRA-NEGRA, JÚNIA MARIA CHEIB/I-1419-2012; Abreu, Mauro Henrique/G-6502-2012	PORDEUS, ISABELA A/0000-0002-5902-7481; Paiva, Saul Martins/0000-0002-3968-1638; SERRA-NEGRA, JÚNIA MARIA CHEIB/0000-0001-6098-3027; Abreu, Mauro Henrique/0000-0001-8794-5725	National Council for Scientific and Technological Development (CNPq); State of Minas Gerais Research Foundation (FAPEMIG)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by the following Brazilian funding agencies: the National Council for Scientific and Technological Development (CNPq) and the State of Minas Gerais Research Foundation (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2003, J APPL DEV PSYCHOL, V24, P241, DOI 10.1016/S0193-3973(03)00046-7; Barbaranelli C, 2003, PERS INDIV DIFFER, V34, P645, DOI 10.1016/S0191-8869(02)00051-X; Barros AJD, 2003, BMC MED RES METHODOL, P3, DOI DOI 10.1186/1471-2288-3-21; Berridge CW, 2011, J FAM ISSUES, V32, P157, DOI 10.1177/0192513X10380832; Braga LD, 2010, CAD SAUDE PUBLICA, V26, P2306; Breslin G, 2012, J PHYS ACT HEALTH, V9, P394, DOI 10.1123/jpah.9.3.394; Buysse DJ, 2003, SLEEP, V26, P48; Camparis CM, 2006, ORAL SURG ORAL MED O, V101, P190, DOI 10.1016/j.tripleo.2005.01.014; Cederquist AV, 2006, ACTA PAEDIATR, V95, P901, DOI 10.1080/080335250600786753; Cheifetz AT, 2005, J DENT CHILD, V72, P67; Cohen R, 2001, INT J COMP SOCIOL, V42, P353, DOI 10.1163/156851801753290379; Degirmencioglu SM, 2008, CHILD SOC, V22, P191, DOI 10.1111/j.1099-0860.2008.00150.x; Dias DM, 2010, ENG SANIT AMBIENT, V15, P155, DOI 10.1590/S1413-41522010000200008; Emodi-Perlman A, 2012, J ORAL REHABIL, V39, P126, DOI 10.1111/j.1365-2842.2011.02254.x; Gager CT, 2009, J FAM ISSUES, V30, P1459, DOI 10.1177/0192513X09336647; Grist RM, 2012, J BEHAV THER EXP PSY, V43, P801, DOI 10.1016/j.jbtep.2011.11.002; Habib RR, 2006, SEX ROLES, V55, P321, DOI 10.1007/s11199-006-9086-z; Kelly RJ, 2011, J FAM PSYCHOL, V25, P412, DOI 10.1037/a0023789; Lam MHB, 2011, SLEEP MED, V12, P641, DOI 10.1016/j.sleep.2010.11.013; Lavigne GJ, 2007, ARCH ORAL BIOL, V52, P381, DOI 10.1016/j.archoralbio.2006.11.017; Manfredini D, 2013, J ORAL REHABIL, V40, P631, DOI 10.1111/joor.12069; Mansur-Alves Marcela, 2009, Psicol. Estud., V14, P807; Mansur-Alves Marcela, 2010, Estud. psicol. (Campinas), V27, P315, DOI 10.1590/S0103-166X2010000300004; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; MCCRAE RR, 1990, STRESS MEDICINE, V6, P237, DOI 10.1002/smi.2460060309; Ng D. K.-K., 2002, SMJ Singapore Medical Journal, V43, P554; Pai M, 2010, J HEALTH SOC BEHAV, V51, P183, DOI 10.1177/0022146510368933; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; Petit D, 2007, PEDIATRICS, V119, pE1016, DOI 10.1542/peds.2006-2132; Potkin KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042191; Restrepo CC, 2008, J ORAL REHABIL, V35, P585, DOI 10.1111/j.1365-2842.2007.01838.x; Schreiber S, 2009, SLEEP MED, V10, P13, DOI 10.1016/j.sleep.2008.02.003; Serra-Negra JM, 2010, EUR ARCH PAEDIATR DE, V11, P192, DOI 10.1007/BF03262743; Serra-Negra JM, 2012, PEDIATR DENT, V34, P30; Serra-Negra JM, 2009, INT J PAEDIATR DENT, V19, P309, DOI 10.1111/j.1365-263X.2009.00973.x; Sharpe JP, 2011, PERS INDIV DIFFER, V51, P946, DOI 10.1016/j.paid.2011.07.033; Shiner R, 2003, J CHILD PSYCHOL PSYC, V44, P2, DOI 10.1111/1469-7610.00101; Shiner RL, 2012, DEV PSYCHOPATHOL, V24, P507, DOI 10.1017/S0954579412000120; Tanaka H, 2012, BIOPSYCHOSOC MED, V6, P20; van de Glind H, 2008, CHILD SOC, V22, P150, DOI 10.1111/j.1099-0860.2008.00147.x; van de Vijver FJR, 2007, SEX ROLES, V57, P813, DOI 10.1007/s11199-007-9316-z; Vreeke LJ, 2012, CHILD PSYCHIAT HUM D, V43, P884, DOI 10.1007/s10578-012-0302-5	42	31	31	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80075	10.1371/journal.pone.0080075	http://dx.doi.org/10.1371/journal.pone.0080075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244614	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800119
J	Suter, L; Widmer, A				Suter, Leonie; Widmer, Alex			Phenotypic Effects of Salt and Heat Stress over Three Generations in Arabidopsis thaliana	PLOS ONE			English	Article							EMPIRICAL-EVIDENCE; EPIGENETIC MEMORY; SHOCK PROTEINS; ADAPTATION; PLASTICITY; RESPONSES; WORLD; PHOTOSYNTHESIS; DYNAMICS; RUBISCO	Current and predicted environmental change will force many organisms to adapt to novel conditions, especially sessile organisms such as plants. It is therefore important to better understand how plants react to environmental stress and to what extent genotypes differ in such responses. It has been proposed that adaptation to novel conditions could be facilitated by heritable epigenetic changes induced by environmental stress, independent of genetic variation. Here we assessed phenotypic effects of heat and salt stress within and across three generations using four highly inbred Arabidopsis thaliana genotypes (Col, Cvi, Ler and Sha). Salt stress generally decreased fitness, but genotypes were differently affected, suggesting that susceptibility of A. thaliana to salt stress varies among genotypes. Heat stress at an early rosette stage had less detrimental effects but accelerated flowering in three out of four accessions. Additionally, we found three different modes of transgenerational effects on phenotypes, all harboring the potential of being adaptive: heat stress in previous generations induced faster rosette growth in Sha, both under heat and control conditions, resembling a tracking response, while in Cvi, the phenotypic variance of several traits increased, resembling diversified bet-hedging. Salt stress experienced in earlier generations altered plant architecture of Sha under salt but not control conditions, similar to transgenerational phenotypic plasticity. However, transgenerational phenotypic effects depended on the type of stress as well as on genotype, suggesting that such effects may not be a general response leading to adaptation to novel environmental conditions in A. thaliana.	[Suter, Leonie; Widmer, Alex] ETH, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Widmer, A (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	alex.widmer@env.ethz.ch	Widmer, Alex/B-6841-2009; Suter, Leonie/A-3157-2017	Widmer, Alex/0000-0001-8253-5137; Suter, Leonie/0000-0002-6434-1766	Competence Center Environment and Sustainability (CCES) of the ETH-Domain in the framework of the BioChange project	Competence Center Environment and Sustainability (CCES) of the ETH-Domain in the framework of the BioChange project	This work was partially supported by the Competence Center Environment and Sustainability (CCES) of the ETH-Domain in the framework of the BioChange project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; [Anonymous], 2010, R LANG ENV STAT COMP; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Balasubramanian S, 2006, PLANT SIGNAL BEHAV, V1, P227, DOI 10.4161/psb.1.5.3452; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2010, PLANT CELL PHYSIOL, V51, P1066, DOI 10.1093/pcp/pcq048; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Childs DZ, 2010, P ROY SOC B-BIOL SCI, V277, P3055, DOI 10.1098/rspb.2010.0707; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1583, DOI 10.1093/pcp/pcr107; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; DeRose-Wilson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022832; Donohue K, 2005, NEW PHYTOL, V166, P83, DOI 10.1111/j.1469-8137.2005.01357.x; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galpaz N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015198; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hedhly A, 2011, ENVIRON EXP BOT, V74, P9, DOI 10.1016/j.envexpbot.2011.03.016; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kim SG, 2007, PLANTA, V226, P647, DOI 10.1007/s00425-007-0513-3; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Larkindale J, 2005, BIOL SCI SER, P100, DOI 10.1002/9780470988503.ch5; Lauria M, 2011, BBA-GENE REGUL MECH, V1809, P369, DOI 10.1016/j.bbagrm.2011.03.002; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Rainey PB, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S14; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Reboud X, 2004, Plant Adaptation: Molecular Genetics and Ecology, P135; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Saze H, 2008, SEMIN CELL DEV BIOL, V19, P527, DOI 10.1016/j.semcdb.2008.07.017; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060364; Tittel-Elmer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001175; Tonsor SJ, 2008, MOL ECOL, V17, P1614, DOI 10.1111/j.1365-294X.2008.03690.x; Vallejo AJ, 2010, ANN BOT-LONDON, V106, P833, DOI 10.1093/aob/mcq179; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Wender NJ, 2005, AM J BOT, V92, P960, DOI 10.3732/ajb.92.6.960; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; Yi CX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-259; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	53	36	36	6	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80819	10.1371/journal.pone.0080819	http://dx.doi.org/10.1371/journal.pone.0080819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244719	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800166
J	Blanco-Fontao, B; Sandercock, BK; Obeso, JR; McNew, LB; Quevedo, M				Blanco-Fontao, Beatriz; Sandercock, Brett K.; Ramon Obeso, Jose; McNew, Lance B.; Quevedo, Mario			Effects of Sexual Dimorphism and Landscape Composition on the Trophic Behavior of Greater Prairie-Chicken	PLOS ONE			English	Article							COMMUNITY-WIDE MEASURES; ISOTOPE RATIOS PROVIDE; STABLE-ISOTOPES; SIZE DIMORPHISM; BODY-SIZE; NICHE; DIET; FRAGMENTATION; CONSEQUENCES; POPULATION	Partitioning of ecological niche is expected in lekking species that show marked sexual size dimorphism as a consequence of sex-specific ecological constraints. However, niche partitioning is uncertain in species with moderate sexual dimorphism. In addition, the ecological niche of a species may also be affected by landscape composition; particularly, agricultural fragmentation may greatly influence the trophic behavior of herbivores. We studied trophic niche variation in Greater Prairie-Chickens (Tympanuchus cupido), a grouse species that shows moderate sex-dimorphism. Greater Prairie-Chickens are native to tallgrass prairies of North America, although populations persist in less natural mosaics of cropland and native habitats. We used stable isotope analysis of carbon and nitrogen in blood, claws and feathers to assess seasonal differences in trophic niche breadth and individual specialization between male and female Greater Prairie-Chickens, and between birds living in continuous and fragmented landscapes. We found that females showed broader niches and higher individual specialization than males, especially in winter and autumn. However, differences between females and males were smaller in spring when birds converge at leks, suggesting that females and males may exhibit similar feeding behaviors during the lekking period. In addition, we found that birds living in native prairies showed greater annual trophic variability than conspecifics in agricultural mosaic landscapes. Native habitats may provide greater dietary diversity, resulting in greater diversity of feeding strategies.	[Blanco-Fontao, Beatriz; Ramon Obeso, Jose; Quevedo, Mario] UO CSIC PA, Res Unit Biodivers, Asturias, Spain; [Blanco-Fontao, Beatriz; Ramon Obeso, Jose; Quevedo, Mario] Univ Oviedo, Area Ecol, Dpt Biol Organismos & Sistemas, Asturias, Spain; [Sandercock, Brett K.; McNew, Lance B.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Kansas State University	Blanco-Fontao, B (corresponding author), UO CSIC PA, Res Unit Biodivers, Asturias, Spain.	beablancofontao@gmail.com	Sandercock, Brett K/L-1644-2016; Quevedo, Mario/I-2493-2015	Sandercock, Brett K/0000-0002-9240-0268; Quevedo, Mario/0000-0002-6067-3237; Blanco Fontao, Beatriz/0000-0002-5492-2399	PFPU-MEC fellowship; Asturian Environmental Agency [CN-07-174]; Oviedo University [UNOV-08-MB-2]	PFPU-MEC fellowship; Asturian Environmental Agency; Oviedo University	The project was financially supported by a PFPU-MEC fellowship to BBF, grant CN-07-174, from the Asturian Environmental Agency to JRO, and grant UNOV-08-MB-2 from Oviedo University to MQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas F, 2011, OECOLOGIA, V167, P401, DOI 10.1007/s00442-011-1994-0; [Anonymous], 1994, SEXUAL SELECTION; Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Banuelos MJ, 2008, J ORNITHOL, V149, P245, DOI 10.1007/s10336-007-0267-5; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; BJORKLUND M, 1990, J EVOLUTION BIOL, V3, P171, DOI 10.1046/j.1420-9101.1990.3030171.x; Blanco-Fontao B, 2012, J ORNITHOL, V153, P555, DOI 10.1007/s10336-011-0776-0; Blanco-Fontao B, 2010, J ORNITHOL, V151, P269, DOI 10.1007/s10336-009-0452-9; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bulte G, 2008, CAN J ZOOL, V86, P1235, DOI 10.1139/Z08-107; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Catry P, 2005, SEXUAL SEGREGATION V; Chase J.M., 2009, ECOLOGICAL NICHES LI; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Cousins SAO, 2007, LANDSCAPE ECOL, V22, P723, DOI 10.1007/s10980-006-9067-1; Crawley MJ., 2007, R BOOK; de Juana E., 1994, HDB BIRDS WORLD, V2, P376; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; Durell SEALD, 2000, BIOL REV, V75, P503; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gotelli NJ, 2013, ECOSIMR 1 00; Gregory AJ, 2011, STUD AVIAN BIOL, P21; HERKERT JR, 1994, ECOL APPL, V4, P461, DOI 10.2307/1941950; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hoeinghaus DJ, 2008, ECOLOGY, V89, P2353, DOI 10.1890/07-1143.1; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; Jonhson JA, 2011, BIRDS N AM ONLINE; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Laurance WF, 2010, CONSERVATION BIOLOGY FOR ALL, P73; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Madge S., 2002, PHEASANTS PARTRIDGES; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; McNew LB, 2011, STUD AVIAN BIOL, P209; McNew LB, 2012, J WILDLIFE MANAGE, V76, P987, DOI 10.1002/jwmg.369; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; Payne R.B., 1984, ORNITHOLOGICAL MONOG, V33, P1, DOI DOI 10.2307/40166729; Pekar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014603; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; PULLIAM HR, 1992, ECOL APPL, V2, P165, DOI 10.2307/1941773; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robb L.A., 2005, GREATER PRAIRIE CHIC; ROBEL RJ, 1970, J WILDLIFE MANAGE, V34, P286, DOI 10.2307/3799013; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SCHROEDER MA, 1991, J FIELD ORNITHOL, V62, P378; Sedinger JS, 1997, CONDOR, V99, P314, DOI 10.2307/1369937; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Silvy Nova J., 1990, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V44, P374; Storch I., 2007, GROUSE STATUS SURVEY; SUTHERLAND RA, 1993, SOIL SCI SOC AM J, V57, P169, DOI 10.2136/sssaj1993.03615995005700010031x; Sutherland WJ, 2004, TECH ECOL CONSERVAT, P233; Svedarsky W.D., 2022, US GEOLOGICAL SURVEY, P1842; Svedarsky WD, 2000, WILDLIFE BIOL, V6, P277, DOI 10.2981/wlb.2000.027; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Van Gils JA, 2007, ECOLOGY, V88, P2926, DOI 10.1890/06-0904.1; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; VANKESSEL C, 1994, SOIL SCI SOC AM J, V58, P382, DOI 10.2136/sssaj1994.03615995005800020020x; Watson A, 2008, GROUSE; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Zuur Alain F., 2009, P1	74	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79986	10.1371/journal.pone.0079986	http://dx.doi.org/10.1371/journal.pone.0079986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244588	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600166
J	Renard, LM; Bocquet, V; Vidal-Trecan, G; Lair, ML; Blum-Boisgard, C				Renard, Laurence M.; Bocquet, Valery; Vidal-Trecan, Gwenaelle; Lair, Marie-Lise; Blum-Boisgard, Claudine			Adherence to International Follow-Up Guidelines in Type 2 Diabetes: A Longitudinal Cohort Study in Luxembourg	PLOS ONE			English	Article							DISEASE MANAGEMENT PROGRAM; QUALITY-OF-CARE; GENERAL-PRACTICE; EFFICIENCY; MELLITUS; OUTCOMES; IMPACT	Introduction: Type 2 diabetes is associated with severe micro-and macro-vascular complications. Physicians' and patients' adherence to follow-up guidelines permits postponing or reducing these complications. The objectives were to assess the level of adherence to fundamental follow-up guidelines and determine patients' characteristics associated with this level of adherence in the context of Luxembourg, where no guidelines were implemented. Study population: The exhaustive residing population treated for type 2 diabetes in Luxembourg during the 2000-2006 period (N = 21,068). Methods: Seven fundamental criteria were extracted from international guidelines (consultation with the treating physician, HbA1c tests, electrocardiogram, retinal, dental, lipid and renal check-ups). The factors associated with the level of adherence to those criteria were identified using a partial proportional odds model. Results: In 2006, despite 90% of the patients consulted at least 4 times their treating physician, only 0.6% completed all criteria; 55.0% had no HbA1c test (-8.6 points since 2000) and 31.1% had a renal check-up (+21.6 points). The sex (ORmale: 0.87 [95%CI, 0.83-0.92]), the nationality (ORNonEU: 0.64 [0.52-0.78]), the type of antidiabetic treatment (ORoral: 1.48 [1.35-1.63], ORmixed: 1.35 [1.20-1.52]) and the type of treating physician (ORG-ID: 0.47 [0.42-0.53]) were the main factors associated with the level of adherence in 2006 (3 or more criteria). Conclusion: A large percentage of patients were not provided with a systematic annual follow-up between 2000 and 2006. This study highlighted the necessity to promote guidelines in Luxembourg, education for physicians and to launch a national discussion on a disease management program for diabetic patients.	[Renard, Laurence M.; Lair, Marie-Lise] Publ Res Ctr Hlth, Ctr Hlth Studies, Strassen, Luxembourg; [Renard, Laurence M.; Vidal-Trecan, Gwenaelle; Blum-Boisgard, Claudine] Univ Paris 05, EA Epidemiol Assessment & Hlth Policies 4069, Paris, France; [Bocquet, Valery] Publ Res Ctr Hlth, Competence Ctr Methodol & Stat, Strassen, Luxembourg; [Vidal-Trecan, Gwenaelle; Blum-Boisgard, Claudine] Univ Paris 05, Dept Publ Hlth, Fac Med, Paris, France; [Vidal-Trecan, Gwenaelle] Cochin St Vincent de Paul Hosp, AP HP, Risk Management & Qual Unit, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Renard, LM (corresponding author), Publ Res Ctr Hlth, Ctr Hlth Studies, Strassen, Luxembourg.	laurence.renard@crp-sante.lu	Bocquet, Valéry/GWC-0796-2022	bocquet, valery/0000-0002-3089-2877; Vidal-Trecan, Gwenaelle/0000-0002-2010-0207	National Fund for Research, Luxembourg [EXT-BFR07-146]	National Fund for Research, Luxembourg	Laurence M. Renard received a grant from the National Fund for Research, Luxembourg (EXT-BFR07-146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.D. Association, 2003, DIABETES CARE, V26, pS33, DOI DOI 10.2337/DIACARE.26.2007.S33; AFSSAPS HAS, 2007, DIABETES METABOLISM, V32; Allison PD, 2010, HANDBOOK OF SURVEY RESEARCH, 2ND EDITION, P631; [Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS1, DOI 10.2337/dc10-S001; [Anonymous], 2005, DIABETES CARE, V28, pS4; Austin Sam, 2011, WMJ, V110, P132; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Bovier PA, 2007, SWISS MED WKLY, V137, P173; Bruni ML, 2009, HEALTH POLICY, V90, P140, DOI 10.1016/j.healthpol.2008.09.008; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Conseil Scientifique, CONS SCI DOM SANT; de Sante Haute Autorite, 2007, PRIS CHARG VOTR MAL; de Sante Haute Autorite, 2007, GUID AFF LONG DUR DI; Drabik A, 2012, Z EVIDENZ FORTBILD Q, V106, P649, DOI 10.1016/j.zefq.2011.12.007; Flamm M, 2012, WIEN KLIN WOCHENSCHR, V124, P639, DOI 10.1007/s00508-012-0226-x; Flamm M, 2012, EUR J PUBLIC HEALTH, V22, P625, DOI 10.1093/eurpub/ckr147; Flanders WD, 2005, J HEALTH CARE POOR U, V16, P720; German Diabetes Association German Geriatric Society, 2006, EV BAS GUID DIAGN TR; Gravely S, 2012, CAN J CARDIOL, V28, P490, DOI 10.1016/j.cjca.2012.01.004; Gross R, 2003, FAM PRACT, V20, P563, DOI 10.1093/fampra/cmg512; HAS AFSSAPS, 2006, TRAIT MED DIAB TYP 2; Institut national de la statistique et des etudes economiques, 2010, LUX CHIFFR 2010; International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Juul L, 2012, PRIM CARE DIABETES, V6, P221, DOI 10.1016/j.pcd.2012.04.001; Kanavos P, 2012, DIABETES EXPENDITURE; Kirkman MS, 2002, DIABETES CARE, V25, P1946, DOI 10.2337/diacare.25.11.1946; Kramer HU, 2012, AM J MANAG CARE, V18, P362; Levin A, 2008, BLOOD PURIFICAT, V26, P67, DOI 10.1159/000110568; Linder R, 2011, DTSCH ARZTEBL INT, V108, P155, DOI 10.3238/arztebl.2011.0155; Louazel V, 2008, ENJEUX SANTE; Marissal JP, 2005, REV EPIDEMIOL SANTE, V53, P67, DOI 10.1016/S0398-7620(05)84760-1; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.1093/biomet/80.2.267; Oh SW, 2011, INT J QUAL HEALTH C, V23, P413, DOI 10.1093/intqhc/mzr036; Ohman-Strickland PA, 2008, ANN FAM MED, V6, P14, DOI 10.1370/afm.758; Ostermann H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-490; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Ratsep A, 2007, Prim Care Diabetes, V1, P93, DOI 10.1016/j.pcd.2007.03.002; Renard L, BMC MED INFORM DECIS; Renard LM, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-23; Renard LM, 2013, RAPPORT NATL DIABETE; Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927; Robert J., 2009, Bulletin Epidemiologique Hebdomadaire, P455; Rothe U, 2008, DIABETES CARE, V31, P863, DOI 10.2337/dc07-0858; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Scott A, 2009, HEALTH ECON, V18, P1091, DOI 10.1002/hec.1536; Simon D, 2009, DIABETE DEFINITION D, P3; Sloan Frank A, 2004, Rev Diabet Stud, V1, P29, DOI 10.1900/RDS.2004.1.29; Sonnichsen AC, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-86; Sohn C, 2006, VILLES AGGLOMERATION, P1; Stark RG, 2011, DIABETES-METAB RES, V27, P383, DOI 10.1002/dmrr.1186; Steuten LMG, 2007, DIABETIC MED, V24, P1112, DOI 10.1111/j.1464-5491.2007.02202.x; Stone MA, 2010, DIABETES RES CLIN PR, V87, P252, DOI 10.1016/j.diabres.2009.10.020; Tchicaya A, 2011, 201119 CEPS; Wens J, 2007, RECOMMANDATIONS BONN; WHO Collaborating Centre for Drug Statistics Methodology, 2011, ATC DDD IND 2011; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yamashita T, 2011, J BEHAV MED	61	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80162	10.1371/journal.pone.0080162	http://dx.doi.org/10.1371/journal.pone.0080162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244637	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600188
J	Willadt, S; Nenniger, M; Vogt, KE				Willadt, Silvia; Nenniger, Markus; Vogt, Kaspar E.			Hippocampal Feedforward Inhibition Focuses Excitatory Synaptic Signals into Distinct Dendritic Compartments	PLOS ONE			English	Article							PYRAMIDAL NEURONS; BASAL DENDRITES; CORTEX; VOLTAGE; RAT; ORGANIZATION; PROJECTIONS; INTEGRATION; DYNAMICS; CALCIUM	Feedforward inhibition controls the time window for synaptic integration and ensures temporal precision in cortical circuits. There is little information whether feedforward inhibition affects neurons uniformly, or whether it contributes to computational refinement within the dendritic tree. Here we demonstrate that feedforward inhibition crucially shapes the integration of synaptic signals in pyramidal cell dendrites. Using voltage-sensitive dye imaging we studied the transmembrane voltage patterns in CA1 pyramidal neurons after Schaffer collateral stimulation in acute brain slices from mice. We observed a high degree of variability in the excitation-inhibition ratio between different branches of the dendritic tree. Many dendritic segments showed no depolarizing signal at all, especially the basal dendrites that received predominantly inhibitory signals. Application of the GABAA receptor antagonist bicuculline resulted in the spread of depolarizing signals throughout the dendritic tree. Tetanic stimulation of Schaffer collateral inputs induced significant alterations in the patterns of excitation/inhibition, indicating that they are modified by synaptic plasticity. In summary, we show that feedforward inhibition restricts the occurrence of depolarizing signals within the dendritic tree of CA1 pyramidal neurons and thus refines signal integration spatially.	[Willadt, Silvia; Nenniger, Markus; Vogt, Kaspar E.] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Vogt, KE (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	kaspar.vogt@unibas.ch		Vogt, Kaspar/0000-0002-0859-876X	Swiss National Science Foundation [31003A-118352]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding came from the Swiss National Science Foundation Grant # 31003A-118352. www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic S, 1999, J NEUROPHYSIOL, V82, P1615, DOI 10.1152/jn.1999.82.3.1615; Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130, DOI 10.1152/jn.1996.76.1.130; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024; Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y; Derdikman D, 2003, J NEUROSCI, V23, P3100; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tominaga Y, 2009, NEUROSCI RES, V64, P152, DOI 10.1016/j.neures.2009.02.007; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; Zhou D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053508; Zhou WL, 2012, J PHYSIOL-LONDON, V590, P3891, DOI 10.1113/jphysiol.2011.227157	27	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80984	10.1371/journal.pone.0080984	http://dx.doi.org/10.1371/journal.pone.0080984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244727	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600218
J	Zheng, XG; Chen, L; Li, MS; Lou, QJ; Xia, H; Wang, P; Li, TM; Liu, HY; Luo, LJ				Zheng, Xiaoguo; Chen, Liang; Li, Mingshou; Lou, Qiaojun; Xia, Hui; Wang, Pei; Li, Tiemei; Liu, Hongyan; Luo, Lijun			Transgenerational Variations in DNA Methylation Induced by Drought Stress in Two Rice Varieties with Distinguished Difference to Drought Resistance	PLOS ONE			English	Article							SENSITIVE AMPLIFICATION POLYMORPHISM; EPIGENETIC INHERITANCE; CYTOSINE METHYLATION; AGRONOMIC TRAITS; GENE-EXPRESSION; SALT TOLERANCE; GENOME; ARABIDOPSIS; PATTERNS; ADAPTATION	Adverse environmental conditions have large impacts on plant growth and crop production. One of the crucial mechanisms that plants use in variable and stressful natural environments is gene expression modulation through epigenetic modification. In this study, two rice varieties with different drought resistance levels were cultivated under drought stress from tilling stage to seed filling stage for six successive generations. The variations in DNA methylation of the original generation (G0) and the sixth generation (G6) of these two varieties in normal condition (CK) and under drought stress (DT) at seedling stage were assessed by using Methylation Sensitive Amplification Polymorphism (MSAP) method. The results revealed that drought stress had a cumulative effect on the DNA methylation pattern of both varieties, but these two varieties had different responses to drought stress in DNA methylation. The DNA methylation levels of II-32B (sensitive) and Huhan-3 (resistant) were around 39% and 32%, respectively. Genome-wide DNA methylation variations among generations or treatments accounted for around 13.1% of total MSAP loci in II-32B, but was only approximately 1.3% in Huhan-3. In II-32B, 27.6% of total differentially methylated loci (DML) were directly induced by drought stress and 3.2% of total DML stably transmitted their changed DNA methylation status to the next generation. In Huhan-3, the numbers were 48.8% and 29.8%, respectively. Therefore, entrainment had greater effect on Huhan-3 than on II-32B. Sequence analysis revealed that the DML were widely distributed on all 12 rice chromosomes and that it mainly occurred on the gene's promoter and exon region. Some genes with DML respond to environmental stresses. The inheritance of epigenetic variations induced by drought stress may provide a new way to develop drought resistant rice varieties.	[Zheng, Xiaoguo; Luo, Lijun] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Zheng, Xiaoguo; Chen, Liang; Li, Mingshou; Lou, Qiaojun; Xia, Hui; Wang, Pei; Li, Tiemei; Liu, Hongyan; Luo, Lijun] Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China	Huazhong Agricultural University	Luo, LJ (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	lijun@sagc.org.cn	Xia, Hui/L-7129-2019	Xia, Hui/0000-0003-2446-5171	National High-Tech Research and Development Program of China (863 Plan) [2012AA101102]; National Natural Science Foundation of China [31200279]; National Basic Research Program of China (973 Plan) [2012CB114305]; Postdoctoral Science Foundation of Shanghai [12R21421300]; Talented Person Project [2010CI120]	National High-Tech Research and Development Program of China (863 Plan)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Plan)(National Basic Research Program of China); Postdoctoral Science Foundation of Shanghai(China Postdoctoral Science Foundation); Talented Person Project	This research was supported by the National High-Tech Research and Development Program of China (863 Plan) (Grant No. 2012AA101102), National Natural Science Foundation of China (Grant no. 31200279), National Basic Research Program of China (973 Plan) (Grant No. 2012CB114305), the Postdoctoral Science Foundation of Shanghai (No. 12R21421300) and Talented Person Project (2010CI120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2010, NEW PHYTOL, V185, P867, DOI 10.1111/j.1469-8137.2010.03189.x; Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; Akimoto K, 2007, ANN BOT-LONDON, V100, P205, DOI 10.1093/aob/mcm110; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bhardwaj J, 2013, BIOCHEM GENET, V51, P493, DOI 10.1007/s10528-013-9580-2; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Casas-Mollano JA, 2008, P NATL ACAD SCI USA, V105, P6486, DOI 10.1073/pnas.0711310105; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Cui KH, 2008, PHYSIOL PLANTARUM, V132, P53, DOI 10.1111/j.1399-3054.2007.00991.x; DeBolt S, 2010, GENOME BIOL EVOL, V2, P441, DOI 10.1093/gbe/evq033; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Fan Jian-cheng, 2010, Huanjing Kexue, V31, P793; Fu BY, 2007, MOL GENET GENOMICS, V278, P599, DOI 10.1007/s00438-007-0276-3; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hwang SG, 2010, PLANT SCI, V178, P12, DOI 10.1016/j.plantsci.2009.09.014; JABLONKA E, 1989, J THEOR BIOL, V139, P69, DOI 10.1016/S0022-5193(89)80058-X; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Lafitte HR, 2006, FIELD CROP RES, V97, P77, DOI 10.1016/j.fcr.2005.08.017; Lavrov SA, 2003, ZH OBSHCH BIOL, V64, P403; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu CF, 1997, THEOR APPL GENET, V94, P145, DOI 10.1007/s001220050393; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Mastan SG, 2012, GENE, V508, P125, DOI 10.1016/j.gene.2012.07.063; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Migicovsky Z, 2013, BIOCHEM CELL BIOL, V91, P1, DOI 10.1139/bcb-2012-0046; Miura K, 2009, P NATL ACAD SCI USA, V106, P11218, DOI 10.1073/pnas.0901942106; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakaminami K, 2012, BBA-GENE REGUL MECH, V1819, P149, DOI 10.1016/j.bbagrm.2011.07.015; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Ou XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041143; Paszkowski J, 2001, CURR OPIN PLANT BIOL, V4, P123, DOI 10.1016/S1369-5266(00)00147-3; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Rahavi MR, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00091; Sano H, 2010, PLANT SIGNAL BEHAV, V5, P346, DOI 10.4161/psb.5.4.10803; Saze H, 2012, GENES GENET SYST, V87, P145, DOI 10.1266/ggs.87.145; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Shen SL, 2006, SCI CHINA SER C, V49, P97, DOI 10.1007/s11427-006-0097-3; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Smita S, 2013, BIOINFORMATION, V9, P72, DOI 10.6026/97320630009072; Steimer A, 2004, CURR OPIN PLANT BIOL, V7, P11, DOI 10.1016/j.pbi.2003.11.008; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; van Dijk K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-238; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WANG GL, 1994, GENETICS, V136, P1421; Wang HG, 2007, THEOR APPL GENET, V115, P1109, DOI 10.1007/s00122-007-0637-7; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Yadav RS, 2002, THEOR APPL GENET, V104, P67, DOI 10.1007/s001220200008; Yi H, 2004, COLD SPRING HARB SYM, V69, P155, DOI 10.1101/sqb.2004.69.155; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao ZM, 2009, BIOCHEM BIOPH RES CO, V382, P643, DOI 10.1016/j.bbrc.2009.03.076; Zong W, 2013, PLANT MOL BIOL, V81, P175, DOI 10.1007/s11103-012-9990-2	77	60	63	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80253	10.1371/journal.pone.0080253	http://dx.doi.org/10.1371/journal.pone.0080253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244664	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600197
J	Liu, PD; Yang, WJ; Chen, J; Huang, XT; Chen, AT				Liu, Peiduo; Yang, Wenjing; Chen, Jia; Huang, Xiting; Chen, Antao			Alertness Modulates Conflict Adaptation and Feature Integration in an Opposite Way	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; ATTENTIONAL NETWORKS; FLANKER TASK; PHASIC ALERTNESS; REJECTION; BRAIN; INDEPENDENCE; ADJUSTMENTS; PERFORMANCE	Previous studies show that the congruency sequence effect can result from both the conflict adaptation effect (CAE) and feature integration effect which can be observed as the repetition priming effect (RPE) and feature overlap effect (FOE) depending on different experimental conditions. Evidence from neuroimaging studies suggests that a close correlation exists between the neural mechanisms of alertness-related modulations and the congruency sequence effect. However, little is known about whether and how alertness mediates the congruency sequence effect. In Experiment 1, the Attentional Networks Test (ANT) and a modified flanker task were used to evaluate whether the alertness of the attentional functions had a correlation with the CAE and RPE. In Experimental 2, the ANT and another modified flanker task were used to investigate whether alertness of the attentional functions correlate with the CAE and FOE. In Experiment 1, through the correlative analysis, we found a significant positive correlation between alertness and the CAE, and a negative correlation between the alertness and the RPE. Moreover, a significant negative correlation existed between CAE and RPE. In Experiment 2, we found a marginally significant negative correlation between the CAE and the RPE, but the correlation between alertness and FOE, CAE and FOE was not significant. These results suggest that alertness can modulate conflict adaptation and feature integration in an opposite way. Participants at the high alerting level group may tend to use the top-down cognitive processing strategy, whereas participants at the low alerting level group tend to use the bottom-up processing strategy.	[Liu, Peiduo; Yang, Wenjing; Chen, Jia; Huang, Xiting; Chen, Antao] Southwest Univ, Fac Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Chen, Antao] Liaoning Normal Univ, Sch Psychol, Dalian, Liaoning, Peoples R China	Southwest University - China; Liaoning Normal University	Huang, XT (corresponding author), Southwest Univ, Fac Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xthuang@swu.edu.cn; xscat@swu.edu.cn	Liu, Peiduo/A-3502-2014	Liu, Peiduo/0000-0001-8022-1791	National Natural Science Foundation of China [31170980, 81271477]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]; New Century Excellent Talents in University [NCET-11-0698]; Fundamental Research Funds for the Central Universities [SWU1009001]; Key Discipline Fund of National 211 Project [NSKD11006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This work was supported by the National Natural Science Foundation of China (31170980, 81271477), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), the New Century Excellent Talents in University (NCET-11-0698), the Fundamental Research Funds for the Central Universities (SWU1009001), and the Key Discipline Fund of National 211 Project (NSKD11006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2008, J EXP PSYCHOL HUMAN, V34, P958, DOI 10.1037/0096-1523.34.4.958; Akcay C, 2007, PSYCHON B REV, V14, P742, DOI 10.3758/BF03196831; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bish JP, 2005, DEVELOPMENTAL SCI, V8, P36, DOI 10.1111/j.1467-7687.2005.00391.x; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boy F, 2010, P NATL ACAD SCI USA, V107, P11134, DOI 10.1073/pnas.1001925107; Braver T. S., 2007, EXPLAINING MANY VARI, P76; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Callejas A, 2004, BRAIN COGNITION, V54, P225, DOI 10.1016/j.bandc.2004.02.012; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fischer R, 2008, J EXP PSYCHOL LEARN, V34, P712, DOI 10.1037/0278-7393.34.3.712; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; McNeely HE, 2003, J ABNORM PSYCHOL, V112, P679, DOI 10.1037/0021-843X.112.4.679; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Notebaert W, 2006, PSYCHON B REV, V13, P1078, DOI 10.3758/BF03213929; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Tang D., 2013, PLOS ONE, V8; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Verbruggen F, 2006, PSYCHON B REV, V13, P328, DOI 10.3758/BF03193852; Verguts T, 2009, TRENDS COGN SCI, V13, P252, DOI 10.1016/j.tics.2009.02.007; Wendt M, 2007, J COGNITIVE NEUROSCI, V19, P1104, DOI 10.1162/jocn.2007.19.7.1104; Wuhr P, 2005, Q J EXP PSYCHOL-A, V58, P705, DOI 10.1080/02724980443000269; Yanaka HT, 2010, NEUROSCI RES, V68, P51, DOI 10.1016/j.neures.2010.05.005	41	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79146	10.1371/journal.pone.0079146	http://dx.doi.org/10.1371/journal.pone.0079146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255CG	24250824	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200057
J	Osawa, T; Kohyama, K; Mitsuhashi, H				Osawa, Takeshi; Kohyama, Kazunori; Mitsuhashi, Hiromune			Areas of Increasing Agricultural Abandonment Overlap the Distribution of Previously Common, Currently Threatened Plant Species	PLOS ONE			English	Article							LANDSCAPE; BIODIVERSITY; DIVERSITY	Human-driven land-use changes increasingly threaten biodiversity. In agricultural ecosystems, abandonment of former farmlands constitutes a major land-use shift. We examined the relationships between areas in which agriculture has been abandoned and the distribution records of threatened plant species across Japan. We selected 23 plant species that are currently identified as threatened but were previously common in the country as indicators of threatened plant species. The areas of abandoned farmlands within the distribution ranges of the indicator species were significantly larger than the proportion of abandoned farmland area across the whole country. Also, abandoned farmland areas were positively correlated with the occurrence of indicator species. Therefore, sections of agricultural landscape that are increasingly becoming abandoned and the distribution ranges of indicator species overlapped. These results suggest that abandoned farmland areas contain degraded or preferred habitats of threatened plant species. We propose that areas experiencing increased abandonment of farmland can be divided into at least two categories: those that threaten the existence of threatened species and those that provide habitats for these threatened species.	[Osawa, Takeshi; Kohyama, Kazunori] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan; [Mitsuhashi, Hiromune] Museum Nat & Human Activ, Sanda, Hyogo, Japan	National Institute for Agro-Environmental Sciences (NIAES) Japan	Osawa, T (corresponding author), Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan.	arosawa@gmail.com			Japan Society for the Promotion of Science [24710038]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan)	This study was partially supported by a grant-in-aid for young scientists (No. 24710038) from the Japan Society for the Promotion of Science and the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Bolliger J, 2007, LANDSCAPE ECOL, V22, P773, DOI 10.1007/s10980-007-9077-7; Bouma J, 1998, AGR ECOSYST ENVIRON, V67, P103, DOI 10.1016/S0167-8809(97)00109-6; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Farina A, 1997, LANDSCAPE ECOL, V12, P365, DOI 10.1023/A:1007934518160; Fukamachi K, 2001, LANDSCAPE ECOL, V16, P703, DOI 10.1023/A:1014464909698; Fukamachi K, 2005, LANDSCAPE ECOLOGICAL, V1, P191, DOI DOI 10.1007/S11355-005-0019-8; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Hampel F, 2000, SEM STAT EIDG TH; Ikegami Y., 2011, Japanese Journal of Conservation Ecology, V16, P1; Japan Biodiversity Outlook Science Committee, JAP BIOD OUTL REP CO; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Kusumoto Y., 2005, Journal of Rural Planning Association, V24, P7, DOI 10.2750/arp.24.S7; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Maurer BA, 1999, UNTANGLING ECOLOGICA; MEEUS JHA, 1995, LANDSCAPE URBAN PLAN, V31, P57, DOI 10.1016/0169-2046(94)01036-8; Ministry of Agriculture Forestry and Fisheries, 2005, CURR SIT CHALL AGR A; Ministry of Agriculture Forestry and Fisheries, 2008, CENS AGR FOR FISH 20; Ministry of Agriculture Forestry and Fisheries Japan, 2007, CENS AGR FOR FISH; MOCK G, 2000, DOMESTICATING WORLD; Morimoto Y, 2011, LANDSC ECOL ENG, V7, P163, DOI 10.1007/s11355-010-0120-5; Ohkuro T., 2001, Journal of Rural Planning Association, V20, P211, DOI 10.2750/arp.20.20-suppl_211; Osawa T, 2011, ECOL INFORM, V6, P270, DOI 10.1016/j.ecoinf.2011.05.003; Osawa T, 2011, AQUAT CONSERV, V21, P358, DOI 10.1002/aqc.1194; Ostermann OP, 1998, J APPL ECOL, V35, P968, DOI 10.1111/j.1365-2664.1998.tb00016.x; Parody JM, 2001, GLOBAL ECOL BIOGEOGR, V10, P305, DOI 10.1046/j.1466-822X.2001.00233.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Selmi S, 2003, BIOL CONSERV, V110, P285, DOI 10.1016/S0006-3207(02)00231-8; Shimoda Michiko, 2003, Japanese Journal of Ecology (Otsu), V53, P197; Smith FA, 2008, PROG PHYS GEOG, V32, P115, DOI 10.1177/0309133308094425; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tokuoka Y, 2011, PLANT ECOL, V212, P923, DOI 10.1007/s11258-010-9868-9; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Uematsu Y, 2010, AGR ECOSYST ENVIRON, V135, P304, DOI 10.1016/j.agee.2009.10.010; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Yahara T, 2002, BIOL CONSERVATION RE; Yahara T., 2003, RED DATA PLANTS; Yamada S, 2002, J JAPANESE I LANDSCA, V65, P290; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	40	36	37	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79978	10.1371/journal.pone.0079978	http://dx.doi.org/10.1371/journal.pone.0079978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260328	Green Submitted, gold, Green Published			2022-12-25	WOS:000327216200097
J	Chen, XH; Xu, ZJ; Zhang, LN; Liu, HC; Liu, X; Lou, M; Zhu, LJ; Huang, BD; Yang, CG; Zhu, WL; Shao, JM				Chen, Xinhuan; Xu, Zhijian; Zhang, Lingna; Liu, Hongchuan; Liu, Xia; Lou, Meng; Zhu, Lijun; Huang, Bingding; Yang, Cai-Guang; Zhu, Weiliang; Shao, Jimin			The Conserved Lys-95 Charged Residue Cluster Is Critical for the Homodimerization and Enzyme Activity of Human Ribonucleotide Reductase Small Subunit M2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; ESCHERICHIA-COLI; IN-VITRO; PROTEIN R2; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; ALLOSTERIC REGULATION; MOLECULAR-MECHANICS; ELECTRON-TRANSFER; DNA-REPLICATION	Ribonucleotide reductase (RR) catalyzes the reduction of ribonucleotides to deoxyribonucleotides for DNA synthesis. Human RR small subunit M2 exists in a homodimer form. However, the importance of the dimer form to the enzyme and the related mechanism remain unclear. In this study, we tried to identify the interfacial residues that may mediate the assembly of M2 homodimer by computational alanine scanning based on the x-ray crystal structure. Co-immunoprecipitation, size exclusion chromatography, and RR activity assays showed that the K95E mutation in M2 resulted in dimer disassembly and enzyme activity inhibition. In comparison, the charge-exchanging double mutation of K95E and E98K recovered the dimerization and activity. Structural comparisons suggested that a conserved cluster of charged residues, including Lys-95, Glu-98, Glu-105, and Glu-174, at the interface may function as an ionic lock for M2 homodimer. Although the measurements of the radical and iron contents showed that the monomer (the K95E mutant) was capable of generating the diiron and tyrosyl radical cofactor, co-immunoprecipitation and competitive enzyme inhibition assays indicated that the disassembly of M2 dimer reduced its interaction with the large subunit M1. In addition, the immunofluorescent and fusion protein-fluorescent imaging analyses showed that the dissociation of M2 dimer altered its subcellular localization. Finally, the transfection of the wild-type M2 but not the K95E mutant rescued the G(1)/S phase cell cycle arrest and cell growth inhibition caused by the siRNA knockdown of M2. Thus, the conserved Lys-95 charged residue cluster is critical for human RR M2 homodimerization, which is indispensable to constitute an active holoenzyme and function in cells.	[Chen, Xinhuan; Zhang, Lingna; Liu, Xia; Lou, Meng; Zhu, Lijun; Shao, Jimin] Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Zhijian; Liu, Hongchuan; Yang, Cai-Guang; Zhu, Weiliang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Huang, Bingding] German Canc Res Ctr, Genom & Prote Core Facil, D-69120 Heidelberg, Germany	Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Helmholtz Association; German Cancer Research Center (DKFZ)	Zhu, WL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	wlzhu@mail.shcnc.ac.cn; shaojimin@zju.edu.cn	Xu, Zhijian/Q-9834-2016	Xu, Zhijian/0000-0002-3063-8473	National Natural Science Foundation of China [81372138, 30873094, 81090421]; 863 National High Technology Research and Development Program of China [2012AA020206, 2012AA01A305]; Ministry of Education of China [J20100041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 81372138, 30873094, and 81090421; 863 National High Technology Research and Development Program of China Grants 2012AA020206 and 2012AA01A305; and Ministry of Education of China Grant J20100041.	Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DOBELN UV, 1976, J BIOL CHEM, V251, P3616; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ekberg M, 1996, J BIOL CHEM, V271, P20655, DOI 10.1074/jbc.271.34.20655; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; ENGSTROM Y, 1984, EMBO J, V3, P863, DOI 10.1002/j.1460-2075.1984.tb01897.x; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; Kauppi B, 1996, J MOL BIOL, V262, P706, DOI 10.1006/jmbi.1996.0546; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lee YD, 2006, GENE DEV, V20, P334, DOI 10.1101/gad.1380506; Liu XY, 2005, BIOCHEM PHARMACOL, V70, P1288, DOI 10.1016/j.bcp.2005.08.005; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Narvaez AJ, 2006, J BIOL CHEM, V281, P26022, DOI 10.1074/jbc.M604598200; Nocentini G, 1996, CRIT REV ONCOL HEMAT, V22, P89, DOI 10.1016/1040-8428(95)00187-5; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Qi HY, 2012, J BIOL CHEM, V287, P12622, DOI 10.1074/jbc.M111.313429; Reddy G P, 1993, Crit Rev Eukaryot Gene Expr, V3, P255; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scott CP, 2001, BIOCHEMISTRY-US, V40, P1651, DOI 10.1021/bi002335z; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shao JM, 2005, BIOCHEM PHARMACOL, V69, P627, DOI 10.1016/j.bcp.2004.11.016; Shao JM, 2004, CANCER RES, V64, P1, DOI 10.1158/0008-5472.CAN-03-3048; SJOBERG BM, 1987, J BIOL CHEM, V262, P9736; Strand KR, 2004, J BIOL CHEM, V279, P46794, DOI 10.1074/jbc.M407346200; Strand KR, 2002, J BIOL CHEM, V277, P34229, DOI 10.1074/jbc.M203358200; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; THELANDER M, 1985, J BIOL CHEM, V260, P2737; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Wu XR, 2008, MOL CELL BIOL, V28, P7156, DOI 10.1128/MCB.01388-08; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Xue LJ, 2003, CANCER RES, V63, P980; Zhang Y, 2013, J BIOL CHEM, V288, P13951, DOI 10.1074/jbc.M113.467001; Zhou BS, 1998, BIOCHEM PHARMACOL, V55, P1657, DOI 10.1016/S0006-2952(98)00042-2; Zhu LJ, 2009, BIOCHEM PHARMACOL, V78, P1178, DOI 10.1016/j.bcp.2009.06.103	58	5	5	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					909	920		10.1074/jbc.M113.524546	http://dx.doi.org/10.1074/jbc.M113.524546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24253041	hybrid, Green Published			2022-12-25	WOS:000330541200026
J	Kishikawa, J; Nakanishi, A; Furuike, S; Tamakoshi, M; Yokoyama, K				Kishikawa, Jun-ichi; Nakanishi, Atsuko; Furuike, Shou; Tamakoshi, Masatada; Yokoyama, Ken			Molecular Basis of ADP Inhibition of Vacuolar (V)-type ATPase/Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP Synthase; F1F0 ATPase; Membrane Proteins; Molecular Motors; Vacuolar ATPase; ADP Inhibition	PROKARYOTIC V-ATPASE; THERMUS-THERMOPHILUS; ENTEROCOCCUS-HIRAE; H+-ATPASE/SYNTHASE; CRYSTAL-STRUCTURE; NA+-ATPASE; ROTATION; F-1-ATPASE; V-1-ATPASE; HYDROLYSIS	Reduction of ATP hydrolysis activity of vacuolar-type ATPase/synthase (V0V1) as a result of ADP inhibition occurs as part of the normal mechanism of V0V1 of Thermus thermophilus but not V0V1 of Enterococcus hirae or eukaryotes. To investigate the molecular basis for this difference, domain-swapped chimeric V-1 consisting of both T. thermophilus and E. hirae enzymes were generated, and their function was analyzed. The data showed that the interaction between the nucleotide binding and C-terminal domains of the catalytic A subunit from E. hirae V-1 is central to increasing binding affinity of the chimeric V-1 for phosphate, resulting in reduction of the ADP inhibition. These findings together with a comparison of the crystal structures of T. thermophilus V-1 with E. hirae V-1 strongly suggest that the A subunit adopts a conformation in T. thermophilus V-1 different from that in E. hirae V-1. This key difference results in ADP inhibition of T. thermophilus V-1 by abolishing the binding affinity for phosphate during ATP hydrolysis.	[Kishikawa, Jun-ichi; Nakanishi, Atsuko; Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan; [Furuike, Shou] Osaka Med Coll, Dept Phys, Osaka 5698686, Japan; [Tamakoshi, Masatada] Tokyo Univ Pharm & Life Sci, Dept Appl Life Sci, Hachioji, Tokyo 1920392, Japan	Kyoto Sangyo University; Osaka Medical College; Tokyo University of Pharmacy & Life Sciences	Yokoyama, K (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	yokoken@cc.kyoto-su.ac.jp	Yokoyama, Ken/AAJ-3582-2020	Yokoyama, Ken/0000-0002-6813-1096; Kishikawa, Jun-ichi/0000-0003-3913-7330	National Institutes of Health from NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Bernadette Byrne for critical reading of the manuscript and Dr. Takeshi Murata for the gift of pCemtp18. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41-GM103311 from the NIGMS).	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Kettner C, 2003, FEBS LETT, V535, P119, DOI 10.1016/S0014-5793(02)03886-3; Kishikawa J, 2012, J BIOL CHEM, V287, P24597, DOI 10.1074/jbc.M112.367813; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Tamakoshi M, 1997, J BACTERIOL, V179, P4811, DOI 10.1128/jb.179.15.4811-4814.1997; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504	26	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					403	412		10.1074/jbc.M113.523498	http://dx.doi.org/10.1074/jbc.M113.523498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24247239	Green Published, hybrid			2022-12-25	WOS:000329370900035
J	Bies, J; Sramko, M; Wolff, L				Bies, Juraj; Sramko, Marek; Wolff, Linda			Stress-induced Phosphorylation of Thr(486) in c-Myb by p38 Mitogen-activated Protein Kinases Attenuates Conjugation of SUMO-2/3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; p38 MAPK; Phosphorylation; Protein Degradation; Protein Stability; Stress; Sumoylation; Transcription; Myb	NEGATIVE REGULATORY DOMAIN; INDUCED TRANSCRIPTION ACTIVATION; T-CELL DEVELOPMENT; V-MYB; LEUKEMIA; PROLIFERATION; DEGRADATION; GENE; DIFFERENTIATION; INTEGRATION	c-Myb plays an essential role in regulation of properly balanced hematopoiesis through transcriptional regulation of genes directly controlling cellular processes such as proliferation, differentiation, and apoptosis. The transcriptional activity and protein levels of c-Myb are strictly controlled through post-translational modifications such as phosphorylation, acetylation, ubiquitination, and SUMOylation. Conjugation of small ubiquitin-like modifier (SUMO) proteins has been shown to suppress the transcriptional activity of c-Myb. SUMO-1 modifies c-Myb under physiological conditions, whereas SUMO-2/3 conjugation was reported in cells under stress. Because stress also activates several cellular protein kinases, we investigated whether phosphorylation of c-Myb changes in stressed cells and whether a mutual interplay exists between phosphorylation and SUMOylation of c-Myb. Here we show that several types of environmental stress induce a rapid change in c-Myb phosphorylation. Interestingly, the phosphorylation of Thr(486), located in close proximity to SUMOylation site Lys(499) of c-Myb, is detected preferentially in nonSUMOylated protein and has a negative effect on stress-induced SUMOylation of c-Myb. Stress-activated p38 MAPKs phosphorylate Thr(486) in c-Myb, attenuate its SUMOylation, and increase its proteolytic turnover. Stressed cells expressing a phosphorylation-deficient T486A mutant demonstrate decreased expression of c-Myb target genes Bcl-2 and Bcl-xL and accelerated apoptosis because of increased SUMOylation of the mutant protein. These results suggest that phosphorylation-dependent modulation of c-Myb SUMOylation may be important for proper response of cells to stress. In summary, we have identified a novel regulatory interplay between phosphorylation and SUMOylation of c-Myb that regulates its activity in stressed cells.	[Bies, Juraj; Sramko, Marek; Wolff, Linda] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bies, J (corresponding author), NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bldg 37-4124,37 Convent Dr,MSC 4263, Bethesda, MD 20892 USA.	biesj@mail.nih.gov			Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health	Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health	This work was supported, in whole or in part, by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health.	Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; AZIZ N, 1995, P NATL ACAD SCI USA, V92, P6429, DOI 10.1073/pnas.92.14.6429; BARLETTA C, 1987, SCIENCE, V235, P1064, DOI 10.1126/science.3469751; Belloni E, 2011, LEUKEMIA, V25, P733, DOI 10.1038/leu.2010.317; Bies J, 2000, ONCOGENE, V19, P2846, DOI 10.1038/sj.onc.1203613; Bies J, 1999, J VIROL, V73, P2038, DOI 10.1128/JVI.73.3.2038-2044.1999; Bies J, 2001, BLOOD CELL MOL DIS, V27, P422, DOI 10.1006/bcmd.2001.0400; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bies J, 1997, ONCOGENE, V14, P203, DOI 10.1038/sj.onc.1200828; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; CALABRETTA B, 1991, P NATL ACAD SCI USA, V88, P2351, DOI 10.1073/pnas.88.6.2351; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Corradini F, 2005, J BIOL CHEM, V280, P30254, DOI 10.1074/jbc.M504703200; Dahle O, 2003, EUR J BIOCHEM, V270, P1338, DOI 10.1046/j.1432-1033.2003.03504.x; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Frampton J, 1996, GENE DEV, V10, P2720, DOI 10.1101/gad.10.21.2720; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Kitagawa K, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-27; Koller R, 1996, VIROLOGY, V224, P224, DOI 10.1006/viro.1996.0524; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lieu YK, 2009, P NATL ACAD SCI USA, V106, P21689, DOI 10.1073/pnas.0907623106; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; Lipsick JS, 1999, ONCOGENE, V18, P3047, DOI 10.1038/sj.onc.1202745; Miglarese MR, 1996, J BIOL CHEM, V271, P22697, DOI 10.1074/jbc.271.37.22697; Molvaersmyr AK, 2010, NUCLEIC ACIDS RES, V38, P4970, DOI 10.1093/nar/gkq245; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Murati A, 2009, LEUKEMIA, V23, P85, DOI 10.1038/leu.2008.257; O'Neil J, 2007, J EXP MED, V204, P3059, DOI 10.1084/jem.20071637; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Ouyang J, 2009, EPIGENETICS-US, V4, P440, DOI 10.4161/epi.4.7.9807; Pani E, 2008, BLOOD CELL MOL DIS, V40, P388, DOI 10.1016/j.bcmd.2007.09.010; Pearson R, 2000, EMBO J, V19, P6112, DOI 10.1093/emboj/19.22.6112; PELICCI PG, 1984, SCIENCE, V224, P1117, DOI 10.1126/science.6585957; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Sramko M, 2006, J BIOL CHEM, V281, P40065, DOI 10.1074/jbc.M609404200; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; Taylor D, 1996, GENE DEV, V10, P2732, DOI 10.1101/gad.10.21.2732; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Tomita A, 1998, LEUKEMIA, V12, P1422, DOI 10.1038/sj.leu.2401113; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Wolff L, 1996, CRIT REV ONCOGENESIS, V7, P245, DOI 10.1615/CritRevOncog.v7.i3-4.60; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597; Yuan J, 2010, J IMMUNOL, V184, P2793, DOI 10.4049/jimmunol.0902846; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang JF, 2012, J VIROL, V86, P10524, DOI 10.1128/JVI.01077-12; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483; Zhou Y, 2011, FRONT BIOSCI-LANDMRK, V16, P1109, DOI 10.2741/3738	54	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36983	36993		10.1074/jbc.M113.500264	http://dx.doi.org/10.1074/jbc.M113.500264			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24257756	hybrid, Green Published			2022-12-25	WOS:000329189700020
J	Yamashita, O; Yoshimura, K; Nagasawa, A; Ueda, K; Morikage, N; Ikeda, Y; Hamano, K				Yamashita, Osamu; Yoshimura, Koichi; Nagasawa, Ayako; Ueda, Koshiro; Morikage, Noriyasu; Ikeda, Yasuhiro; Hamano, Kimikazu			Periostin Links Mechanical Strain to Inflammation in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CYCLIC STRAIN; MATRIX-METALLOPROTEINASE-9; PROLIFERATION; INHIBITION; EXPRESSION; MANAGEMENT; MARKER; REPAIR; FORCE	Aims: Abdominal aortic aneurysms (AAAs) are characterized by chronic inflammation, which contributes to the pathological remodeling of the extracellular matrix. Although mechanical stress has been suggested to promote inflammation in AAA, the molecular mechanism remains uncertain. Periostin is a matricellular protein known to respond to mechanical strain. The aim of this study was to elucidate the role of periostin in mechanotransduction in the pathogenesis of AAA. Methods and Results: We found significant increases in periostin protein levels in the walls of human AAA specimens. Tissue localization of periostin was associated with inflammatory cell infiltration and destruction of elastic fibers. We examined whether mechanical strain could stimulate periostin expression in cultured rat vascular smooth muscle cells. Cells subjected to 20% uniaxial cyclic strains showed significant increases in periostin protein expression, focal adhesion kinase (FAK) activation, and secretions of monocyte chemoattractant protein-1 (MCP-1) and the active form of matrix metalloproteinase (MMP)-2. These changes were largely abolished by a periostin-neutralizing antibody and by the FAK inhibitor, PF573228. Interestingly, inhibition of either periostin or FAK caused suppression of the other, indicating a positive feedback loop. In human AAA tissues in ex vivo culture, MCP-1 secretion was dramatically suppressed by PF573228. Moreover, in vivo, periaortic application of recombinant periostin in mice led to FAK activation and MCP-1 upregulation in the aortic walls, which resulted in marked cellular infiltration. Conclusion: Our findings indicated that periostin plays an important role in mechanotransduction that maintains inflammation via FAK activation in AAA.	[Yamashita, Osamu; Yoshimura, Koichi; Nagasawa, Ayako; Ueda, Koshiro; Morikage, Noriyasu; Hamano, Kimikazu] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan; [Yoshimura, Koichi] Yamaguchi Prefectural Univ, Grad Sch Hlth & Welf, Yamaguchi, Japan; [Ikeda, Yasuhiro] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Ube, Yamaguchi 755, Japan	Yamaguchi University; Yamaguchi University	Yoshimura, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan.	yoshimko@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 24390302, 22659232]; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [24390302] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 24390302 and 22659232 to KY), the Takeda Science Foundation (to KY), and the Uehara Memorial Foundation (to KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2003, AM J PHYSIOL-HEART C, V284, pH1778, DOI 10.1152/ajpheart.00494.2002; Cattaruzza M, 2000, FASEB J, V14, P991, DOI 10.1096/fasebj.14.7.991; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Chapman GB, 2000, AM J PHYSIOL-HEART C, V278, pH748, DOI 10.1152/ajpheart.2000.278.3.H748; Cummins PM, 2007, AM J PHYSIOL-HEART C, V292, pH28, DOI 10.1152/ajpheart.00304.2006; DOBRIN PB, 1978, PHYSIOL REV, V58, P397, DOI 10.1152/physrev.1978.58.2.397; Ellozy SH, 2006, J VASC SURG, V43, P2, DOI 10.1016/j.jvs.2005.09.039; Feng YJ, 1999, CIRC RES, V85, P1118; Goergen CJ, 2010, J MAGN RESON IMAGING, V32, P847, DOI 10.1002/jmri.22331; Golledge J, 2007, EUR J VASC ENDOVASC, V34, P267, DOI 10.1016/j.ejvs.2007.03.006; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Hellenthal FAMVI, 2012, EUR J VASC ENDOVASC, V43, P171, DOI 10.1016/j.ejvs.2011.10.014; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Kimura T, 2011, PATHOL INT, V61, P559, DOI 10.1111/j.1440-1827.2011.02699.x; Kona Soujanya, 2009, Open Biomed Eng J, V3, P28, DOI 10.2174/1874120700903010028; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo J., 2007, Bulletin of the Yamaguchi Medical School, V54, P47; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Kwon ST, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003134; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Ma DD, 2009, IN VITRO CELL DEV-AN, V45, P467, DOI 10.1007/s11626-009-9214-5; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Nagasawa A, 2013, J SURG RES, V183, P472, DOI 10.1016/j.jss.2012.12.012; Nguyen KT, 2001, HYPERTENSION, V38, P1038, DOI 10.1161/hy1101.092840; Qi YX, 2010, J CELL BIOCHEM, V109, P906, DOI 10.1002/jcb.22465; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Sangiorgi G, 2001, CIRCULATION, V104, pI288; Sasaki H, 2001, CANCER-AM CANCER SOC, V92, P843, DOI 10.1002/1097-0142(20010815)92:4<843::AID-CNCR1391>3.0.CO;2-P; Sein TT, 2000, ONCOGENE, V19, P5539, DOI 10.1038/sj.onc.1203932; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Tedesco MM, 2010, VASCULAR SURG, P117; Thompson Robert W, 2002, Curr Probl Surg, V39, P110, DOI 10.1067/msg.2002.121421; van Keulen JW, 2009, EUR J VASC ENDOVASC, V38, P586, DOI 10.1016/j.ejvs.2009.06.018; Walton LJ, 1999, CIRCULATION, V100, P48, DOI 10.1161/01.CIR.100.1.48; Wen W, 2010, J DENT RES, V89, P1439, DOI 10.1177/0022034510378684; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Yates CM, 2011, J VASC SURG, V54, P497, DOI 10.1016/j.jvs.2011.02.061; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Yoshimura K, 2008, AORTIC ANEURYSMS NEW; Yoshimura K, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/648167	45	48	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79753	10.1371/journal.pone.0079753	http://dx.doi.org/10.1371/journal.pone.0079753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260297	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900045
J	Pan, Y; Zhang, XH; Wang, Y; Cai, L; Ren, LQ; Tang, LG; Wang, JY; Zhao, YJ; Wang, YG; Liu, Q; Li, XK; Liang, G				Pan, Yong; Zhang, Xiuhua; Wang, Yi; Cai, Lu; Ren, Luqing; Tang, Longguang; Wang, Jingying; Zhao, Yunjie; Wang, Yonggang; Liu, Quan; Li, Xiaokun; Liang, Guang			Targeting JNK by a New Curcumin Analog to Inhibit NF-kappa B-Mediated Expression of Cell Adhesion Molecules Attenuates Renal Macrophage Infiltration and Injury in Diabetic Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; ICAM-1 EXPRESSION; MYCOPHENOLATE-MOFETIL; MONOCYTE ADHESION; MESANGIAL CELLS; C-JUN; NEPHROPATHY; PATHWAYS	Macrophage infiltration contributes to the pathogenesis of diabetic renal injury. However, the regulatory mechanisms between macrophage infiltration and epithelial cell activation are still unclear. Our previous study found that C66, a novel curcumin analog, was able to inhibit inflammatory cytokine expression in vitro and in vivo. This study further elucidated whether C66 can prevent glucose-induced renal epithelial activation and inflammatory macrophage infiltration by a MAPK/ NF-kappa B medicated mechanism. Our data show that pretreatment with C66 not only significantly reduced high glucose (HG)induced over-expressions of VCAM-1, ICAM-1 and MCP-1, but also remarkably inhibited NF-kB activation, MAPKs phosphorylation, and subsequently macrophage adhesion in renal epithelial NRK-52E cells. Furthermore, we find that MAPKs, especially JNK, play important roles in HG-induced NF-kB activation, which regulates the over-expression of adhesion molecules in HG-stimulated NRK-52E cells. A molecular docking predicted that C66 may target JNK2, which leads to its anti-inflammatory actions. In vivo, administration of C66 or JNK special inhibitor SP600125 at 5 mg/kg markedly decreased diabetes-induced renal adhesion molecule expression, NF-kB activation, inflammatory cell infiltration, and pathological indexes in the kidneys of diabetic mice. These findings provide a perspective on the renoprotective effects of C66 in diabetes, and outline a novel therapeutic strategy of JNK inhibition for the treatment of diabetic nephropathy.	[Pan, Yong; Wang, Yi; Ren, Luqing; Tang, Longguang; Wang, Jingying; Zhao, Yunjie; Li, Xiaokun; Liang, Guang] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou, Zhejiang, Peoples R China; [Pan, Yong; Cai, Lu; Li, Xiaokun] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiuhua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pharm, Wenzhou, Zhejiang, Peoples R China; [Cai, Lu; Wang, Yonggang; Liu, Quan] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA; [Wang, Yonggang; Liu, Quan] Jilin Univ, Hosp 1, Dept Cardiol, Changchun 130023, Jilin, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; University of Louisville; Jilin University	Liang, G (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou, Zhejiang, Peoples R China.	wzmcliangguang@163.com	Cai, Lu/AAG-9920-2019; Tang, Longguang/AAU-9594-2021	tang, Longguang/0000-0002-9517-1325	National "863'' key project [2011AA 02A 113]; Natural Science Funding of China [81261120560, 81072683, 81302821, 81173140, 81200572]; High-level Innovative Talent Funding of Zhejiang Department of Health; Zhejiang provincial Natural Science Funding [LQ13H310002]; Wenzhou Medical College; Zhejiang Key Group in Scientific Innovation [2010R50042]	National "863'' key project; Natural Science Funding of China; High-level Innovative Talent Funding of Zhejiang Department of Health; Zhejiang provincial Natural Science Funding; Wenzhou Medical College; Zhejiang Key Group in Scientific Innovation	This study was supported by the National "863'' key project [Grant 2011AA 02A 113]; Natural Science Funding of China [Grants 81261120560, 81072683, 81302821, 81173140, and 81200572]; High-level Innovative Talent Funding of Zhejiang Department of Health [to GL], Zhejiang provincial Natural Science Funding [Grants LQ13H310002], a start-up fund for the Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical College [to LC], and Zhejiang Key Group in Scientific Innovation (2010R50042 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; De Borst MH, 2007, J PATHOL, V213, P219, DOI 10.1002/path.2228; Duzgun SA, 2000, J CELL BIOCHEM, V76, P567, DOI 10.1002/(SICI)1097-4644(20000315)76:4<567::AID-JCB5>3.0.CO;2-W; FURUTA T, 1993, AM J KIDNEY DIS, V21, P480, DOI 10.1016/S0272-6386(12)80393-3; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Kang MJ, 1999, KIDNEY INT, V55, P2203, DOI 10.1046/j.1523-1755.1999.00488.x; Kikuchi Y, 2005, NEPHROL DIAL TRANSPL, V20, P1573, DOI 10.1093/ndt/gfh888; Kiyici S, 2006, ARCH MED RES, V37, P998, DOI 10.1016/j.arcmed.2006.06.002; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Ku KT, 2008, J AGR FOOD CHEM, V56, P8911, DOI 10.1021/jf8019369; Lakshmanan AP, 2012, MOL CELL ENDOCRINOL, V348, P104, DOI 10.1016/j.mce.2011.07.041; Lee FTH, 2004, J AM SOC NEPHROL, V15, P2139, DOI 10.1097/01.ASN.0000135055.61833.A8; Li JJ, 2009, AM J PHYSIOL-RENAL, V297, pF200, DOI 10.1152/ajprenal.90649.2008; Liang G, 2009, J CELL MOL MED, V13, P3370, DOI 10.1111/j.1582-4934.2009.00711.x; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Mamputu JC, 2004, J LEUKOCYTE BIOL, V75, P1062, DOI 10.1189/jlb.0603265; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Pan Y, 2012, BRIT J PHARMACOL, V166, P1169, DOI 10.1111/j.1476-5381.2012.01854.x; Park CW, 2000, DIABETOLOGIA, V43, P1544, DOI 10.1007/s001250051567; Sakai N, 2005, AM J KIDNEY DIS, V45, P54, DOI 10.1053/j.ajkd.2004.08.039; Sampson MJ, 2002, ARTERIOSCL THROM VAS, V22, P1187, DOI 10.1161/01.ATV.0000021759.08060.63; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Sugimoto H, 1997, DIABETES, V46, P2075, DOI 10.2337/diabetes.46.12.2075; Tesch GH, 2010, SEMIN NEPHROL, V30, P290, DOI 10.1016/j.semnephrol.2010.03.007; Tomita N, 2000, J AM SOC NEPHROL, V11, P1244, DOI 10.1681/ASN.V1171244; Utimura R, 2003, KIDNEY INT, V63, P209, DOI 10.1046/j.1523-1755.2003.00736.x; Wang YP, 2000, KIDNEY INT, V57, P2011, DOI 10.1046/j.1523-1755.2000.00051.x; Watanabe M, 2009, AM J NEPHROL, V30, P1, DOI 10.1159/000195722; Watanabe N, 2011, ACTA MED OKAYAMA, V65, P247; Wittmann S, 2009, TRANSPLANTATION, V87, P1290, DOI 10.1097/TP.0b013e3181a192bd; Wong CK, 2008, J CLIN IMMUNOL, V28, P36, DOI 10.1007/s10875-007-9137-4; Wu YG, 2006, INFLAMM RES, V55, P192, DOI 10.1007/s00011-006-0070-4; Yang Y, 2007, AM J NEPHROL, V27, P495, DOI 10.1159/000106782; Yeh JL, 2011, INT J IMMUNOPATH PH, V24, P345, DOI 10.1177/039463201102400208; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898	38	87	97	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79084	10.1371/journal.pone.0079084	http://dx.doi.org/10.1371/journal.pone.0079084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260158	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500024
J	Steffensmeier, AM; Tare, M; Puli, OR; Modi, R; Nainaparampil, J; Kango-Singh, M; Singh, A				Steffensmeier, Andrew M.; Tare, Meghana; Puli, Oorvashi Roy; Modi, Rohan; Nainaparampil, Jaison; Kango-Singh, Madhuri; Singh, Amit			Novel Neuroprotective Function of Apical-Basal Polarity Gene Crumbs in Amyloid Beta 42 (A beta 42) Mediated Neurodegeneration	PLOS ONE			English	Article							EPITHELIAL-CELL POLARITY; TRANSMEMBRANE PROTEIN CRUMBS; ZONULA ADHERENS FORMATION; DROSOPHILA-MELANOGASTER; ALZHEIMERS-DISEASE; RETINAL DEGENERATION; PRECURSOR PROTEIN; EYE DEVELOPMENT; COMPLEX; APOPTOSIS	Alzheimer's disease (AD, OMIM: 104300), a progressive neurodegenerative disorder with no cure to date, is caused by the generation of amyloid-beta-42 (A beta 42) aggregates that trigger neuronal cell death by unknown mechanism(s). We have developed a transgenic Drosophila eye model where misexpression of human A beta 42 results in AD-like neuropathology in the neural retina. We have identified an apical-basal polarity gene crumbs (crb) as a genetic modifier of A beta 42-mediated-neuropathology. Misexpression of A beta 42 caused upregulation of Crb expression, whereas downregulation of Crb either by RNAi or null allele approach rescued the Ab42-mediated-neurodegeneration. Co-expression of full length Crb with A beta 42 increased severity of A beta 42-mediated-neurodegeneration, due to three fold induction of cell death in comparison to the wild type. Higher Crb levels affect axonal targeting from the retina to the brain. The structure function analysis identified intracellular domain of Crb to be required for A beta 42-mediated-neurodegeneration. We demonstrate a novel neuroprotective role of Crb in Ab42-mediated-neurodegeneration.	[Steffensmeier, Andrew M.; Modi, Rohan; Nainaparampil, Jaison; Kango-Singh, Madhuri; Singh, Amit] Univ Dayton, Premed Program, Dayton, OH 45469 USA; [Tare, Meghana; Puli, Oorvashi Roy; Kango-Singh, Madhuri; Singh, Amit] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Kango-Singh, Madhuri; Singh, Amit] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton, Dayton, OH 45469 USA	University of Dayton; University of Dayton; University of Dayton	Kango-Singh, M (corresponding author), Univ Dayton, Premed Program, Dayton, OH 45469 USA.	mkangosingh1@udayton.edu; asingh1@udayton.edu	Puli, Oorvashi G./N-7671-2017	Puli, Oorvashi G./0000-0003-0358-7428	National Institutes of Health (NIH) [1R15 HD064557-01]; University of Dayton; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD064557] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Dayton; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding from National Institutes of Health (NIH) grant (1R15 HD064557-01), University of Dayton, Start-up Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bachmann A, 2008, EUR J CELL BIOL, V87, P123, DOI 10.1016/j.ejcb.2007.11.002; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Brachmann CB, 2003, TRENDS GENET, V19, P91, DOI 10.1016/S0168-9525(02)00041-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Campbell K, 2009, J CELL SCI, V122, P2604, DOI 10.1242/jcs.047183; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Cowan CM, 2010, BIOCHEM SOC T, V38, P988, DOI 10.1042/BST0380988; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Iijima K, 2008, J ALZHEIMERS DIS, V15, P523; Iijima-Ando K, 2010, BRAIN STRUCT FUNCT, V214, P245, DOI 10.1007/s00429-009-0234-4; Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Johnson K, 2002, CURR BIOL, V12, P1675, DOI 10.1016/S0960-9822(02)01180-6; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; League GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021218; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Mehlen P, 2005, J NEUROBIOL, V64, P357, DOI 10.1002/neu.20167; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; O'Brien RJ, 2010, ANN REV NEUROSCI; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Richard M, 2009, EUR J CELL BIOL, V88, P765, DOI 10.1016/j.ejcb.2009.07.006; Richardson ECN, 2010, DEVELOPMENT, V137, P641, DOI 10.1242/dev.041913; RINCONLIMAS DE, 2012, CURR PHARM DES; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Singh A, 2002, DEVELOPMENT, V129, P4271; Singh A, 2006, DEVELOPMENT, V133, P4771, DOI 10.1242/dev.02686; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Tare M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024361; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	52	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e78717	10.1371/journal.pone.0078717	http://dx.doi.org/10.1371/journal.pone.0078717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260128	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500009
J	Zahedi, K; Barone, S; Xu, J; Soleimani, M				Zahedi, Kamyar; Barone, Sharon; Xu, Jie; Soleimani, Manoocher			Potentiation of the Effect of Thiazide Derivatives by Carbonic Anhydrase Inhibitors: Molecular Mechanisms and Potential Clinical Implications	PLOS ONE			English	Article							DISTAL CONVOLUTED TUBULE; NA-CL COTRANSPORTER; RENAL PHYSIOLOGY; PROXIMAL TUBULE; SLC26A4 PENDRIN; COLLECTING DUCT; TRANSPORT; DIURETICS; HYPERTENSION; REABSORPTION	Background: Carbonic anhydrase inhibitors (CAI) are mild diuretics, hence not widely used in fluid overloaded states. They are however the treatment of choice for certain non-kidney conditions. Thiazides, specific inhibitors of Na-Cl cotransport (NCC), are mild agents and the most widely used diuretics in the world for control of mild hypertension. Hypothesis: In addition to inhibiting the salt reabsorption in the proximal tubule, CAIs down-regulate pendrin, therefore leaving NCC as the major salt absorbing transporter in the distal nephron, and hence allowing for massive diuresis by the inhibitors of NCC in the setting of increased delivery of salt from the proximal tubule. Experimental Protocols and Results: Daily treatment of rats with acetazolamide (ACTZ), a known CAI, for 10 days caused mild diuresis whereas daily treatment with hydrochlorothiazide (HCTZ) for 4 days caused hardly any diuresis. However, treatment of rats that were pretreated with ACTZ for 6 days with a combination of ACTZ plus HCTZ for 4 additional days increased the urine output by greater than 2 fold (p<0.001, n = 5) compared to ACTZ-treated animals. Sodium excretion increased by 80% in the ACTZ plus HCTZ group and animals developed significant volume depletion, metabolic alkalosis and pre-renal failure. Molecular studies demonstrated similar to 75% reduction in pendrin expression by ACTZ. The increased urine output in ACTZ/HCTZ treated rats was associated with a significant reduction in urine osmolality and reduced membrane localization of AQP-2 (aquaporin2). Conclusions: These results indicate that ACTZ down-regulates pendrin expression and leaves NCC as the major salt absorbing transporter in the distal nephron in the setting of increased delivery of salt from the proximal tubule. Despite being considered mild agents individually, we propose that the combination of ACTZ and HCTZ is a powerful diuretic regimen.	[Soleimani, Manoocher] Univ Cincinnati, Vet Affairs Med Ctr, Res Serv, Ctr Genet Transport, Cincinnati, OH 45221 USA; Univ Cincinnati, Dept Med, Res Serv, Vet Affairs Med Ctr, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center	Soleimani, M (corresponding author), Univ Cincinnati, Vet Affairs Med Ctr, Res Serv, Ctr Genet Transport, Cincinnati, OH 45221 USA.	Manoocher.Soleimani@uc.edu	soleimani, m/U-6889-2017; Zahedi, Kamyar/AAQ-3428-2021	soleimani, m/0000-0002-3446-8870; 	Department of Veterans Affairs; Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati, an NIH [R56DK62809]; DCI; US Renal Care; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062809] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati, an NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DCI; US Renal Care; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by a Merit Review award from the Department of Veterans Affairs, funds from the Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati, an NIH award (R56DK62809) and by grants from DCI and US Renal Care (to M. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper SL, 2010, J NEPHROL, V23, pS57; Amlal H, 2010, AM J PHYSIOL-CELL PH, V299, pC33, DOI 10.1152/ajpcell.00033.2010; Aronson PS, 2002, CELL BIOCHEM BIOPHYS, V36, P147, DOI 10.1385/CBB:36:2-3:147; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; Baum M, 2008, PEDIATR NEPHROL, V23, P185, DOI 10.1007/s00467-007-0569-0; Bernstein PL, 2011, SEMIN NEPHROL, V31, P475, DOI 10.1016/j.semnephrol.2011.09.002; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; deJong M, 1996, J NUCL MED, V37, P1388; Ecelbarger CA, 1996, AM J PHYSL 2, V271, pL619; Eladari D, 2011, CURR OPIN NEPHROL HY, V20, P506, DOI 10.1097/MNH.0b013e3283486c4a; Ellison DH, 2003, J AM SOC NEPHROL, V14, P538, DOI 10.1681/ASN.V142538; Friedman DI, 2004, J NEURO-OPHTHALMOL, V24, P138, DOI 10.1097/00041327-200406000-00009; Greenberg A, 2000, AM J MED SCI, V319, P10, DOI 10.1097/00000441-200001000-00002; Grieff M, 2011, SEMIN NEPHROL, V31, P535, DOI 10.1016/j.semnephrol.2011.09.008; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; HORISBERGER JD, 1992, HYPERTENSION, V19, P221, DOI 10.1161/01.HYP.19.3.221; Jang HR, 2009, J KOREAN MED SCI, V24, pS161, DOI 10.3346/jkms.2009.24.S1.S161; Ko B, 2009, CURR OPIN NEPHROL HY, V18, P421, DOI 10.1097/MNH.0b013e32832f2fcb; Leaf DE, 2007, J APPL PHYSIOL, V102, P1313, DOI 10.1152/japplphysiol.01572.2005; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; Messerli FH, 2011, AM J MED, V124, P896, DOI 10.1016/j.amjmed.2011.05.009; MORSING P, 1991, AM J PHYSIOL, V261, pF137, DOI 10.1152/ajprenal.1991.261.1.F137; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; Purkerson JM, 2007, KIDNEY INT, V71, P103, DOI 10.1038/sj.ki.5002020; Reyes AJ, 1999, CARDIOVASC DRUG THER, V13, P371, DOI 10.1023/A:1007835821228; Rice WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032843; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Schwartz GJ, 2002, J NEPHROL, V15, pS61; Sindic A, 2007, CURR OPIN NEPHROL HY, V16, P484; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Soleimani M, 2012, P NATL ACAD SCI USA, V109, P13368, DOI 10.1073/pnas.1202671109; Sun XM, 2008, CELL PHYSIOL BIOCHEM, V21, P95, DOI 10.1159/000113751; Toris CB, 2010, CURR MOL MED, V10, P824; Uchida S, 2010, PFLUG ARCH EUR J PHY, V460, P695, DOI 10.1007/s00424-010-0848-7; Vallet M, 2006, J AM SOC NEPHROL, V17, P2153, DOI 10.1681/ASN.2005101054; Wall SM, 2004, HYPERTENSION, V44, P982, DOI 10.1161/01.HYP.0000145863.96091.89; Wall SM, 2008, CURR OPIN NEPHROL HY, V17, P18, DOI 10.1097/MNH.0b013e3282f29086; Xu J, 2009, J BIOL CHEM, V284, P29470, DOI 10.1074/jbc.M109.044396; Zahedi K, CELL PHYSL IN PRESS; Zalyapin EA, 2008, KIDNEY INT, V74, P1557, DOI 10.1038/ki.2008.412	42	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79327	10.1371/journal.pone.0079327	http://dx.doi.org/10.1371/journal.pone.0079327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260196	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500044
J	Seo, JB; Gowda, GAN; Koh, DS				Seo, Jong Bae; Gowda, G. A. Nagana; Koh, Duk-Su			Apoptotic Damage of Pancreatic Ductal Epithelia by Alcohol and Its Rescue by an Antioxidant	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; ETHANOL-INDUCED APOPTOSIS; CELL-DEATH; IN-VIVO; ACINAR-CELLS; ACTIVATION; SECRETION; NECROSIS; PERMEABILITY; METABOLISM	Alcohol abuse is a major cause of pancreatitis. However alcohol toxicity has not been fully elucidated in the pancreas and little is known about the effect of alcohol on pancreatic ducts. We report the molecular mechanisms of ethanol-induced damage of pancreatic duct epithelial cells (PDEC). Ethanol treatment for 1, 4, and 24 h resulted in cell death in a dose-dependent manner. The ethanol-induced cell damage was mainly apoptosis due to generation of reactive oxygen species (ROS), depolarization of mitochondrial membrane potential (MMP), and activation of caspase-3 enzyme. The antioxidant N-acetylcysteine (NAC) attenuated these cellular responses and reduced cell death significantly, suggesting a critical role for ROS. Acetaldehyde, a metabolic product of alcohol dehydrogenase, induced significant cell death, depolarization of MMP, and caspase-3 activation as ethanol and this damage was also averted by NAC. Reverse transcription-polymerase chain reaction revealed the expression of several subtypes of alcohol dehydrogenase and acetaldehyde dehydrogenase. Nuclear magnetic resonance spectroscopy data confirmed the accumulation of acetaldehyde in ethanol-treated cells, suggesting that acetaldehyde formation can contribute to alcohol toxicity in PDEC. Finally, ethanol increased the leakage of PDEC monolayer which was again attenuated by NAC. In conclusion, ethanol induces apoptosis of PDEC and thereby may contribute to the development of alcohol-induced pancreatitis.	[Seo, Jong Bae; Koh, Duk-Su] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Gowda, G. A. Nagana] Univ Washington, Northwest Metabol Res Ctr, Seattle, WA 98195 USA; [Koh, Duk-Su] POSTECH, Dept Phys, Pohang, Kyungbuk, South Korea	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pohang University of Science & Technology (POSTECH)	Koh, DS (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	koh@uw.edu			National Institutes of Health [R01-DK080840]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health grant (R01-DK080840 to DSK) (http://www2.niddk.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanvermez R, 2005, ADV THER, V22, P548, DOI 10.1007/BF02849949; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; CABALLERIA J, 1991, DIGEST DIS SCI, V36, P1673, DOI 10.1007/BF01296608; CHEN CL, 2011, PLOS ONE, V24, DOI DOI 10.1371/J0URNAL.P0NE.0019111.PUBMED:21556371; Chiang CP, 2009, ALCOHOL CLIN EXP RES, V33, P1059, DOI 10.1111/j.1530-0277.2009.00927.x; Chinopoulos C, 1999, J NEUROCHEM, V73, P220, DOI 10.1046/j.1471-4159.1999.0730220.x; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Cullen JJ, 2003, PANCREAS, V26, P23, DOI 10.1097/00006676-200301000-00005; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Delhaye M, 2008, WORLD J GASTROENTERO, V14, P1027, DOI 10.3748/wjg.14.1027; Dembele K, 2009, CELL BIOL TOXICOL, V25, P141, DOI 10.1007/s10565-008-9067-9; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gong GH, 2010, EUR J PHARMACOL, V628, P27, DOI 10.1016/j.ejphar.2009.11.028; Gorelick FS, 2003, PANCREAS, V27, P305, DOI 10.1097/00006676-200311000-00006; Gout J, 2013, JOVE-J VIS EXP, DOI 10.3791/50514; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P106, DOI 10.1053/gast.2002.30302; Hamada H, 2005, AM J PHYSIOL-CELL PH, V288, pC1431, DOI 10.1152/ajpcell.00373.2004; HARVEY MH, 1989, BRIT J SURG, V76, P859, DOI 10.1002/bjs.1800760832; Henzel K, 2004, BBA-MOL CELL RES, V1644, P37, DOI 10.1016/j.bbamcr.2003.10.017; Higuchi H, 1996, ALCOHOL CLIN EXP RES, V20, pA340, DOI 10.1111/j.1530-0277.1996.tb01804.x; Iaquinto G, 1998, DIGEST DIS SCI, V43, P816, DOI 10.1023/A:1018878400935; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jayalakshmi K, 2005, BRAIN RES, V1046, P97, DOI 10.1016/j.brainres.2005.03.054; Jones AW, 2009, FORENSIC SCI INT, V188, P40, DOI 10.1016/j.forsciint.2009.03.010; Jung JY, 2007, NEUROSCI LETT, V411, P222, DOI 10.1016/j.neulet.2006.09.089; KEUNG WM, 1993, P NATL ACAD SCI USA, V90, P1247, DOI 10.1073/pnas.90.4.1247; Nguyen KH, 2012, ALCOHOL, V46, P89, DOI 10.1016/j.alcohol.2011.04.001; Koh DS, 2000, J GEN PHYSIOL, V116, P507, DOI 10.1085/jgp.116.4.507; KOKO V, 1995, HISTOL HISTOPATHOL, V10, P325; Kouzoukas DE, 2013, J NEUROCHEM, V124, P323, DOI 10.1111/jnc.12076; LaRusch J, 2011, CURR OPIN GASTROEN, V27, P467, DOI 10.1097/MOG.0b013e328349e2f8; Lee JH, 2010, FEBS J, V277, P488, DOI 10.1111/j.1742-4658.2009.07505.x; LINDBLAD B, 1976, JAMA-J AM MED ASSOC, V236, P1600, DOI 10.1001/jama.236.14.1600; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; MAJCHROWICZ E, 1971, J PHARMACOL EXP THER, V179, P293; Mustonen H, 2007, AM J PHYSIOL-GASTR L, V292, pG1614, DOI 10.1152/ajpgi.00273.2006; Nepal S, 2012, BIOCHEM PHARMACOL, V84, P974, DOI 10.1016/j.bcp.2012.07.019; Niebergall-Roth E, 1998, ALCOHOL CLIN EXP RES, V22, P1570, DOI 10.1097/00000374-199810000-00029; Niemela Onni, 2007, Novartis Found Symp, V285, P183; Oda D, 1996, AM J PATHOL, V148, P977; Olney JW, 2002, NEUROBIOL DIS, V9, P205, DOI 10.1006/nbdi.2001.0475; Plante MK, 2013, PROSTATE CANCER P D, V16, P16, DOI 10.1038/pcan.2012.37; Ramachandran V, 2003, J NEUROSCI RES, V74, P577, DOI 10.1002/jnr.10767; Rotoli BM, 2004, J MOL HISTOL, V35, P355; Schmid-Schonbein GW, 2005, MICROCIRCULATION, V12, P71, DOI 10.1080/10739680590896009; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Shalbueva N, 2013, GASTROENTEROLOGY, V144, P437, DOI 10.1053/j.gastro.2012.10.037; Sheth DS, 2009, BRAIN RES, V1285, P14, DOI 10.1016/j.brainres.2009.06.029; Steward MC, 2009, CURR OPIN GASTROEN, V25, P447, DOI 10.1097/MOG.0b013e32832e06ce; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TOWELL JF, 1983, CLIN PHARMACOL THER, V33, P517, DOI 10.1038/clpt.1983.70; TUOI DTH, 2011, ALCOHOL CLIN EXP RES, V35, P408, DOI DOI 10.1111/J.1530-0277.2010.01358.X.PUBMED:21143242; Werner J, 1997, GASTROENTEROLOGY, V113, P286, DOI 10.1016/S0016-5085(97)70106-9; Wilson JS, 2003, PANCREAS, V27, P311, DOI 10.1097/00006676-200311000-00007; Wu H, 2008, ALCOHOL ALCOHOLISM, V43, P1, DOI 10.1093/alcalc/agm044; Xie X, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-63; Xue T, 2012, TOXICOL APPL PHARM, V261, P280, DOI 10.1016/j.taap.2012.04.010; Yamamoto A, 2003, J PHYSIOL-LONDON, V551, P917, DOI 10.1113/jphysiol.2003.048827; Yao P, 2007, J HEPATOL, V47, P253, DOI 10.1016/j.jhep.2007.02.008; Young C, 2003, CELL DEATH DIFFER, V10, P1148, DOI 10.1038/sj.cdd.4401277; Yuan HT, 2013, NEUROCHEM INT, V63, P146, DOI 10.1016/j.neuint.2013.05.011; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245	65	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81893	10.1371/journal.pone.0081893	http://dx.doi.org/10.1371/journal.pone.0081893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244749	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800187
J	Aoki, H; Mogi, C; Hisada, T; Nakakura, T; Kamide, Y; Ichimonji, I; Tomura, H; Tobo, M; Sato, K; Tsurumaki, H; Dobashi, K; Mori, T; Harada, A; Yamada, M; Mori, M; Ishizuka, T; Okajima, F				Aoki, Haruka; Mogi, Chihiro; Hisada, Takeshi; Nakakura, Takashi; Kamide, Yosuke; Ichimonji, Isao; Tomura, Hideaki; Tobo, Masayuki; Sato, Koichi; Tsurumaki, Hiroaki; Dobashi, Kunio; Mori, Tetsuya; Harada, Akihiro; Yamada, Masanobu; Mori, Masatomo; Ishizuka, Tamotsu; Okajima, Fumikazu			Proton-Sensing Ovarian Cancer G Protein-Coupled Receptor 1 on Dendritic Cells Is Required for Airway Responses in a Murine Asthma Model	PLOS ONE			English	Article							EXTRACELLULAR ACIDIFICATION; SMOOTH-MUSCLE; ACIDIC PH; INFLAMMATION; OGR1; HYPERRESPONSIVENESS; RESPONSIVENESS; INHIBITION; EXPRESSION; TDAG8	Ovarian cancer G protein-coupled receptor 1 (OGR1) stimulation by extracellular protons causes the activation of G proteins and subsequent cellular functions. However, the physiological and pathophysiological roles of OGR1 in airway responses remain largely unknown. In the present study, we show that OGR1-deficient mice are resistant to the cardinal features of asthma, including airway eosinophilia, airway hyperresponsiveness (AHR), and goblet cell metaplasia, in association with a remarkable inhibition of Th2 cytokine and IgE production, in an ovalbumin (OVA)-induced asthma model. Intratracheal transfer to wild-type mice of OVA-primed bone marrow-derived dendritic cells (DCs) from OGR1-deficient mice developed lower AHR and eosinophilia after OVA inhalation compared with the transfer of those from wild-type mice. Migration of OVA-pulsed DCs to peribronchial lymph nodes was also inhibited by OGR1 deficiency in the adoption experiments. The presence of functional OGR1 in DCs was confirmed by the expression of OGR1 mRNA and the OGR1-sensitive Ca2+ response. OVA-induced expression of CCR7, a mature DC chemokine receptor, and migration response to CCR7 ligands in an in vitro Transwell assay were attenuated by OGR1 deficiency. We conclude that OGR1 on DCs is critical for migration to draining lymph nodes, which, in turn, stimulates Th2 phenotype change and subsequent induction of airway inflammation and AHR.	[Aoki, Haruka; Mogi, Chihiro; Nakakura, Takashi; Ichimonji, Isao; Tomura, Hideaki; Tobo, Masayuki; Sato, Koichi; Tsurumaki, Hiroaki; Okajima, Fumikazu] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma 371, Japan; [Aoki, Haruka; Hisada, Takeshi; Kamide, Yosuke; Tsurumaki, Hiroaki; Yamada, Masanobu; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan; [Dobashi, Kunio] Gunma Univ, Sch Hlth Sci, Maebashi, Gunma 371, Japan; [Mori, Tetsuya] Takasaki Univ Hlth & Welf, Fac Pharm, Lab Allergy & Immunol, Takasaki, Gunma, Japan; [Harada, Akihiro] Osaka Univ, Grad Sch Med, Dept Cell Biol, Osaka, Japan; [Ishizuka, Tamotsu] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 910, Japan	Gunma University; Gunma University; Gunma University; Osaka University; University of Fukui	Ishizuka, T (corresponding author), Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 910, Japan.	tamotsui@u-fukui.ac.jp; okajima@gunma-u.ac.jp	Tsurumaki, Hiroaki/HDL-6889-2022	Nakakura, Takashi/0000-0003-1898-563X; Tsurumaki, Hiroaki/0000-0003-0837-9329; Sato, Koichi/0000-0001-7694-4014	Japan Society for the Promotion of Science (JSPS); Institute for Molecular and Cellular Regulation, Gunma University [12023]; Grants-in-Aid for Scientific Research [23591456] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Molecular and Cellular Regulation, Gunma University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Grant-in-Aid for Scientific Research (B) (to FO), Grant-in-Aid for Challenging Exploratory Research (to FO), Grant-in-Aid for Scientific Research (C) (to TI and CM), and Grant-in-Aid for Young Scientists (B) (to HA) from the Japan Society for the Promotion of Science (JSPS). This work was also supported in part by the joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (12023) (to TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2004, J APPL PHYSIOL, V97, P286, DOI 10.1152/japplphysiol.00821.2003; Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Ichimonji I, 2010, AM J PHYSIOL-LUNG C, V299, pL567, DOI 10.1152/ajplung.00415.2009; Kodric M, 2007, AM J RESP CRIT CARE, V175, P905, DOI 10.1164/rccm.200607-940OC; Kottyan LC, 2009, BLOOD, V114, P2774, DOI 10.1182/blood-2009-05-220681; Koya T, 2006, AM J RESP CELL MOL, V35, P147, DOI 10.1165/rcmb.2005-0394OC; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Liu CY, 2013, RESP PHYSIOL NEUROBI, V185, P265, DOI 10.1016/j.resp.2012.10.003; Liu JP, 2010, AM J PHYSIOL-HEART C, V299, pH731, DOI 10.1152/ajpheart.00977.2009; Liu JP, 2010, PHARMACOL RES, V61, P499, DOI 10.1016/j.phrs.2010.02.013; Lomask M, 2006, EXP TOXICOL PATHOL, V57, P13, DOI 10.1016/j.etp.2006.02.014; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Matsuzaki S, 2011, BIOCHEM BIOPH RES CO, V413, P499, DOI 10.1016/j.bbrc.2011.08.087; Miyahara N, 2008, J IMMUNOL, V181, P1170, DOI 10.4049/jimmunol.181.2.1170; Mogi C, 2005, J PHARMACOL SCI, V99, P160, DOI 10.1254/jphs.FP0050599; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Murata N, 2009, CELL IMMUNOL, V259, P21, DOI 10.1016/j.cellimm.2009.05.008; Nakakura T, 2012, ENDOCRINOLOGY, V153, P4171, DOI 10.1210/en.2012-1164; Okajima F, 2013, CELL SIGNAL; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Ricciardolo FLM, 2004, J ALLERGY CLIN IMMUN, V113, P610, DOI 10.1016/j.jaci.2003.12.034; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Takeda K, 1997, J EXP MED, V186, P449, DOI 10.1084/jem.186.3.449; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Tomura H, 2008, J BONE MINER RES, V23, P1129, DOI 10.1359/JBMR.080236; Tsuchiya K, 2012, AM J PHYSIOL-LUNG C, V303, pL54, DOI 10.1152/ajplung.00208.2011; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	36	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79985	10.1371/journal.pone.0079985	http://dx.doi.org/10.1371/journal.pone.0079985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244587	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600165
J	Pinelli, M; Acquaviva, F; Barbetti, F; Caredda, E; Cocozza, S; Delvecchio, M; Mozzillo, E; Pirozzi, D; Prisco, F; Rabbone, I; Sacchetti, L; Tinto, N; Toni, S; Zucchini, S; Iafusco, D				Pinelli, Michele; Acquaviva, Fabio; Barbetti, Fabrizio; Caredda, Elisabetta; Cocozza, Sergio; Delvecchio, Maurizio; Mozzillo, Enza; Pirozzi, Daniele; Prisco, Francesco; Rabbone, Ivana; Sacchetti, Lucia; Tinto, Nadia; Toni, Sonia; Zucchini, Stefano; Iafusco, Dario		ISPED	Identification of Candidate Children for Maturity-Onset Diabetes of the Young Type 2 (MODY2) Gene Testing: A Seven-Item Clinical Flowchart (7-iF)	PLOS ONE			English	Article							PRACTICE GUIDELINES; GLUCOKINASE GENE; MUTATIONS; DIAGNOSIS; MELLITUS	MODY2 is the most prevalent monogenic form of diabetes in Italy with an estimated prevalence of about 0.5-1.5%. MODY2 is potentially indistinguishable from other forms of diabetes, however, its identification impacts on patients' quality of life and healthcare resources. Unfortunately, DNA direct sequencing as diagnostic test is not readily accessible and expensive. In addition current guidelines, aiming to establish when the test should be performed, proved a poor detection rate. Aim of this study is to propose a reliable and easy-to-use tool to identify candidate patients for MODY2 genetic testing. We designed and validated a diagnostic flowchart in the attempt to improve the detection rate and to increase the number of properly requested tests. The flowchart, called 7-iF, consists of 7 binary "yes or no" questions and its unequivocal output is an indication for whether testing or not. We tested the 7-iF to estimate its clinical utility in comparison to the clinical suspicion alone. The 7-iF, in a prospective 2-year study (921 diabetic children) showed a precision of about the 76%. Using retrospective data, the 7-iF showed a precision in identifying MODY2 patients of about 80% compared to the 40% of the clinical suspicion. On the other hand, despite a relatively high number of missing MODY2 patients, the 7-iF would not suggest the test for 90% of the non-MODY2 patients, demonstrating that a wide application of this method might 1) help less experienced clinicians in suspecting MODY2 patients and 2) reducing the number of unnecessary tests. With the 7-iF, a clinician can feel confident of identifying a potential case of MODY2 and suggest the molecular test without fear of wasting time and money. A Qaly-type analysis estimated an increase in the patients' quality of life and savings for the health care system of about 9 million euros per year.	[Pinelli, Michele; Acquaviva, Fabio; Cocozza, Sergio; Pirozzi, Daniele; Sacchetti, Lucia; Tinto, Nadia] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Barbetti, Fabrizio] Bambino Gesu Pediat Hosp, Inst Sci, Lab Mendelian Diabet, Lab Mol Endocrinol & Metab, Rome, Italy; [Caredda, Elisabetta; Prisco, Francesco; Iafusco, Dario] Univ Naples 2, Dept Pediat, Naples, Italy; [Delvecchio, Maurizio] IRCCS Casa Sollievo Sofferenza, Pediat Unit, San Giovanni Rotondo, FG, Italy; [Mozzillo, Enza] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Pirozzi, Daniele; Sacchetti, Lucia; Tinto, Nadia] CEINGE Adv Biotechnol SC RL, Naples, Italy; [Rabbone, Ivana] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Toni, Sonia] Meyer Children Hosp, Pediat Diabetol Unit, Florence, Italy; [Zucchini, Stefano] Univ Bologna, Dept Pediat, Bologna, Italy	University of Naples Federico II; IRCCS Bambino Gesu; Universita della Campania Vanvitelli; IRCCS Casa Sollievo Della Sofferenza; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Turin; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Bologna	Iafusco, D (corresponding author), Univ Naples 2, Dept Pediat, Naples, Italy.	dario.iafusco@unina2.it	Galderisi, Alfonso/G-3259-2018; Acquaviva, Fabio/N-6402-2016; Rabbone, Ivana/AAC-4250-2020; Barbetti, Fabrizio/AAK-9106-2021; Barbetti, Fabrizio/I-7351-2018; Picariello, Stefania/AAC-5357-2022; Pinelli, Michele/A-1584-2010; Delvecchio, Maurizio/K-8762-2012; Cocozza, Sergio/F-6488-2010; Comberiati, Pasquale/P-6904-2018; Zuccotti, Gianvincenzo/H-8572-2017	Galderisi, Alfonso/0000-0001-8885-3056; Acquaviva, Fabio/0000-0001-9192-1232; Barbetti, Fabrizio/0000-0003-4687-980X; Barbetti, Fabrizio/0000-0003-4687-980X; Pinelli, Michele/0000-0002-5927-1185; Delvecchio, Maurizio/0000-0002-1528-0012; Comberiati, Pasquale/0000-0001-5209-9733; CALCATERRA, VALERIA/0000-0002-2137-5974; Valerio, Giuliana/0000-0001-5063-4333; Salzano, Giuseppina/0000-0003-2180-4510; cardella, francesca/0000-0001-7219-392X; cherubini, valentino/0000-0002-7664-1475; Zuccotti, Gianvincenzo/0000-0002-2795-9874; Calcaterra, Valeria/0000-0003-3862-7872; CAPPA, MARCO/0000-0001-5647-7519; Rabbone, Ivana/0000-0003-4173-146X; MOZZILLO, ENZA/0000-0002-8437-8494; Zanfardino, Angela/0000-0003-0641-1321; Picariello, Stefania/0000-0001-5013-1138; Piccini, Barbara/0000-0002-2684-8638; Iafusco, Dario/0000-0002-9398-3856				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BYRNE MM, 1994, J CLIN INVEST, V93, P1120, DOI 10.1172/JCI117064; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Gill Carey OJ, 2007, DIABETIC MED, V24, P1; Hameed S, 2011, PEDIATR DIABETES, V12, P142, DOI 10.1111/j.1399-5448.2010.00681.x; Iafusco D, 2011, DIABETOLOGIA, V54, P1583, DOI 10.1007/s00125-011-2113-9; Incani M, 2010, DIABETIC MED, V27, P1332, DOI 10.1111/j.1464-5491.2010.03095.x; Italian Barometer Diabetes Observatory, 2012, BAR REP 2012 FACTS F; LEDERMANN HM, 1995, DIABETOLOGIA, V38, P1482, DOI 10.1007/BF00400611; Lorini R, 2009, DIABETES CARE, V32, P1864, DOI 10.2337/dc08-2018; Massa O, 2001, DIABETOLOGIA, V44, P898; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Naylor R, 2011, CLIN ENDOCRINOL, V75, P422, DOI 10.1111/j.1365-2265.2011.04049.x; Russo L, 2011, DIABETOLOGIA, V54, P1693, DOI 10.1007/s00125-011-2094-8; Salina A, 2012, DIABETES RES CLIN PR, V95, pE29, DOI 10.1016/j.diabres.2011.10.031; Schober E, 2009, DIABETIC MED, V26, P466, DOI 10.1111/j.1464-5491.2009.02720.x; Shields BM, 2012, DIABETOLOGIA, V55, P1265, DOI 10.1007/s00125-011-2418-8; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Stride A, 2002, DIABETOLOGIA, V45, P427, DOI 10.1007/s00125-001-0770-9; Tinto N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001870; VELHO G, 1992, LANCET, V340, P444, DOI 10.1016/0140-6736(92)91768-4; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974	22	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79933	10.1371/journal.pone.0079933	http://dx.doi.org/10.1371/journal.pone.0079933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244580	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600161
J	Cheng, H; Furnham, A				Cheng, Helen; Furnham, Adrian			Personality Traits, Education, Physical Exercise, and Childhood Neurological Function as Independent Predictors of Adult Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; BRITISH BIRTH COHORT; LIFE; WEIGHT; HEALTH; FAMILY	Objective: To investigate whether personality traits, education, physical exercise, parental socio-economic conditions, and childhood neurological function are independently associated with obesity in 50 year old adults in a longitudinal birth cohort study. Method: The sample consisted of 5,921 participants born in Great Britain in 1958 and followed up at 7, 11, 33, 42, and 50 years with data on body mass index measured at 42 and 50 years. Results: There was an increase of adult obesity from 14.2% at age 42 to 23.6% at 50 years. Cohort members who were reported by teachers on overall clumsiness as "certainly applied" at age 7 were more likely to become obese at age 50. In addition, educational qualifications, traits Conscientiousness and Extraversion, psychological distress, and physical exercise were all significantly associated with adult obesity. The associations remained to be significant after controlling for birth weight and gestation, maternal and paternal BMI, childhood BMI, childhood intelligence and behavioural adjustment, as well as diet. Conclusion: Neurological function in childhood, education, trait Conscientiousness, and exercise were all significantly and independently associated with adult obesity, each explained unique individual variability.	[Cheng, Helen; Furnham, Adrian] UCL, Dept Psychol, London, England; [Furnham, Adrian] BI Norwegian Business Sch, Oslo, Norway	University of London; University College London; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Dept Psychol, London, England.	a.furnham@ucl.ac.uk	Furnham, Adrian/ABB-2072-2020					Butler N.R., 1963, PERINATAL MORTALITY; Chandola T, 2006, INT J OBESITY, V30, P1422, DOI 10.1038/sj.ijo.0803279; Chapman BP, 2009, HEALTH PSYCHOL, V28, P419, DOI 10.1037/a0015212; Dallman MF, 2005, BRAIN BEHAV IMMUN, V19, P275, DOI 10.1016/j.bbi.2004.11.004; Deckelbaum RJ, 2001, OBES RES, V9, p239S, DOI 10.1038/oby.2001.125; Duckworth AL, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00356; Ferri E., 2003, CHANGING BRITAIN CHA; Furnham A, 2011, ENCY BODY IMAGE ATTR; Furnham A., 2008, PERSONALITY INTELLIG; Goldberg L. R., 1999, PERSONALITY PSYCHOL, V7, P7; Johnson JG, 2006, INT J EAT DISORDER, V39, P184, DOI 10.1002/eat.20223; Judge TA, 2011, J APPL PSYCHOL, V96, P95, DOI 10.1037/a0020860; Kanazawa S, 2006, OBESITY SILVER SPRIN, V21, P434; Kern ML, 2008, HEALTH PSYCHOL, V27, P505, DOI 10.1037/0278-6133.27.5.505; Laitinen J, 2001, AM J CLIN NUTR, V74, P287; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Leete R, 1977, POPULATION TRENDS, V8, P1; Ljungvall A, 2012, SOC SCI MED, V75, P109, DOI 10.1016/j.socscimed.2012.03.003; Marmot M, 2003, SOLID FACTS; MARSH C, 1986, KEY VARIABLES SOCIAL; MILLER TR, 1991, J PERS ASSESS, V57, P415, DOI 10.1207/s15327752jpa5703_3; Osika W, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a699; Parsons TJ, 2001, BRIT MED J, V323, P1331, DOI 10.1136/bmj.323.7325.1331; Plewis I, 2004, NATL CHILD DEV STUDY; Power C, 2003, INT J OBESITY, V27, P1081, DOI 10.1038/sj.ijo.0802323; Power C, 1997, AM J CLIN NUTR, V66, P1094, DOI 10.1093/ajcn/66.5.1094; Roberts BW, 2005, REV GEN PSYCHOL, V9, P156, DOI 10.1037/1089-2680.9.2.156; Rutter M., 1970, ED HLTH BEHAV; Stott GH, 1987, SOCIAL ADJUSTMENT CH; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Sund ER, 2010, SOC SCI MED, V70, P1194, DOI 10.1016/j.socscimed.2010.01.007; Sutin AR, 2011, J PERS SOC PSYCHOL, V101, P579, DOI 10.1037/a0024286; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0; Wellman NS, 2002, ASIA PAC J CLIN NUTR, V11, pS705, DOI 10.1046/j.1440-6047.11.s8.6.x; WHO. World Health Organization, 1995, TECHNICAL REPORT SER, V854; Zinbarg RE, 2008, J PERS, V76, P1649, DOI 10.1111/j.1467-6494.2008.00534.x	36	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79586	10.1371/journal.pone.0079586	http://dx.doi.org/10.1371/journal.pone.0079586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255CG	24250828	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200077
J	Feldman, MR				Feldman, Michael R.			Re-Examination of Globally Flat Space-Time	PLOS ONE			English	Article							SOLAR-SYSTEM; GRAVITATIONAL ORIGIN; GENERAL-RELATIVITY; EMISSION-LINE; DARK-MATTER; BLACK-HOLE; PIONEER; PLANETARY; CONSTANT; GALAXIES	In the following, we offer a novel approach to modeling the observed effects currently attributed to the theoretical concepts of "dark energy," "dark matter," and "dark flow." Instead of assuming the existence of these theoretical concepts, we take an alternative route and choose to redefine what we consider to be inertial motion as well as what constitutes an inertial frame of reference in flat space-time. We adopt none of the features of our current cosmological models except for the requirement that special and general relativity be local approximations within our revised definition of inertial systems. Implicit in our ideas is the assumption that at "large enough" scales one can treat objects within these inertial systems as point-particles having an insignificant effect on the curvature of space-time. We then proceed under the assumption that time and space are fundamentally intertwined such that time-and spatial-translational invariance are not inherent symmetries of flat space-time (i.e., observable clock rates depend upon both relative velocity and spatial position within these inertial systems) and take the geodesics of this theory in the radial Rindler chart as the proper characterization of inertial motion. With this commitment, we are able to model solely with inertial motion the observed effects expected to be the result of "dark energy," "dark matter," and "dark flow." In addition, we examine the potential observable implications of our theory in a gravitational system located within a confined region of an inertial reference frame, subsequently interpreting the Pioneer anomaly as support for our redefinition of inertial motion. As well, we extend our analysis into quantum mechanics by quantizing for a real scalar field and find a possible explanation for the asymmetry between matter and antimatter within the framework of these redefined inertial systems.				mrf44@cornell.edu		Feldman, Michael/0000-0003-1567-9725				Abramowitz M., 1972, HDB MATH FUNCTIONS F; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321569; ALPHER RA, 1948, PHYS REV, V73, P803, DOI 10.1103/PhysRev.73.803; Anderson JD, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.082004; Anderson JD, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.091102; Anderson JD, 2007, NEW ASTRON, V12, P383, DOI 10.1016/j.newast.2006.11.004; [Anonymous], 1729, MATH PRINCIPLES NATU; Arfken G. B., 2012, MATH METHODS PHYS CO; Basu D, 1998, ASTROPHYS SPACE SCI, V259, P415, DOI 10.1023/A:1001713023880; Basu D, 2011, CAN J PHYS, V89, P985, DOI 10.1139/P11-091; Basu D, 2001, PHYS SCRIPTA, V63, P425, DOI 10.1238/Physica.Regular.063a00425; Bertolami O, 2010, SPACE SCI REV, V151, P75, DOI 10.1007/s11214-009-9589-3; Bertolami O, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.103001; BROWN BA, 1988, ANNU REV NUCL PART S, V38, P29; Carloni S, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.124024; Clowes RG, 2013, MON NOT R ASTRON SOC, V429, P2910, DOI 10.1093/mnras/sts497; Cox TJ, 2008, MON NOT R ASTRON SOC, V386, P461, DOI 10.1111/j.1365-2966.2008.13048.x; CULETU H, 1994, GEN RELAT GRAVIT, V26, P283, DOI 10.1007/BF02108008; Culetu H, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/23/235021; Dirac PAM, 1928, P R SOC LOND A-CONTA, V117, P610, DOI 10.1098/rspa.1928.0023; DUNSTER TM, 1990, SIAM J MATH ANAL, V21, P995, DOI 10.1137/0521055; Einstein A, 1905, ANN PHYS-BERLIN, V18, P639; Einstein A, 1916, ANN PHYS-BERLIN, V49, P769; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Eisenhauer F, 2003, ASTROPHYS J, V597, pL121, DOI 10.1086/380188; Fienga A, 2011, CELEST MECH DYN ASTR, V111, P363, DOI 10.1007/s10569-011-9377-8; FIENGA A, 2010, IAU SYMP P SERIES, V5, P159, DOI DOI 10.1017/S1743921309990330; Fixsen DJ, 2009, ASTROPHYS J, V707, P916, DOI 10.1088/0004-637X/707/2/916; Francisco F, 2012, PHYS LETT B, V711, P337, DOI 10.1016/j.physletb.2012.04.034; Friedman A, 1922, Z PHYS, V10, P377, DOI 10.1007/BF01332580; Friedmann A, 1924, Z PHYS, V21, P326, DOI 10.1007/BF01328280; FULLING SA, 1973, PHYS REV D, V7, P2850, DOI 10.1103/PhysRevD.7.2850; GAMOW G, 1946, PHYS REV, V70, P572, DOI 10.1103/PhysRev.70.572.2; Ghez AM, 2003, ASTROPHYS J, V586, pL127, DOI 10.1086/374804; Goldstein H., 2001, CLASSICAL MECH; Grumiller D, 2011, INT J MOD PHYS D, V20, P2761, DOI 10.1142/S0218271811020585; Grumiller D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.211303; GUTH AH, 1981, PHYS REV D, V23, P347, DOI 10.1103/PhysRevD.23.347; Hawking S. W., 1973, LARGE SCALE STRUCTUR; HINTON K, 1983, PHYS LETT B, V120, P88, DOI 10.1016/0370-2693(83)90629-9; Hubble E, 1929, P NATL ACAD SCI USA, V15, P168, DOI 10.1073/pnas.15.3.168; Iorio L, 2006, NEW ASTRON, V11, P600, DOI 10.1016/j.newast.2006.04.001; Iorio L, 2013, MON NOT R ASTRON SOC, V429, P915, DOI 10.1093/mnras/sts396; Iorio L, 2012, MOD PHYS LETT A, V27, DOI 10.1142/S021773231250071X; Iorio L, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/3/68; Iorio L, 2011, MON NOT R ASTRON SOC, V415, P1266, DOI 10.1111/j.1365-2966.2011.18777.x; Iorio L, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/05/019; Iorio Lorenzo, 2009, Scholarly Research Exchange Physics, DOI 10.3814/2009/807695; Iorio L, 2010, MON NOT R ASTRON SOC, V405, P2615, DOI 10.1111/j.1365-2966.2010.16637.x; Iorio L, 2010, OPEN ASTRON J, V3, P1, DOI DOI 10.2174/1874381101003010001; Iorio L, 2008, ADV ASTRON, V2008, DOI 10.1155/2008/268647; Iorio L, 2007, FOUND PHYS, V37, P897, DOI 10.1007/s10701-007-9132-x; Iorio L, 2011, ASTROPHYS SPACE SCI, V331, P351, DOI 10.1007/s10509-010-0489-5; Iorio L, 2009, INT J MOD PHYS D, V18, P947, DOI 10.1142/S0218271809014856; Iorio L, 2009, ASTRON J, V137, P3615, DOI 10.1088/0004-6256/137/3/3615; Kashlinsky A, 2008, ASTROPHYS J LETT, V686, pL49, DOI 10.1086/592947; Kopeikin SM, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.064004; Lemaitre G, 1931, NATURE, V127, P706, DOI 10.1038/127706b0; Lemaitre G., 1927, ANN SOC SCI BRUX, VA47, P49; Massey R, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/8/086901; Mayer M. G., 1955, ELEMENTARY THEORY NU; Meier DL, 2001, SCIENCE, V291, P84, DOI 10.1126/science.291.5501.84; Minkowski H, 1915, ANN PHYS-BERLIN, V47, P927; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Page GL, 2009, ASTROPHYS J, V697, P1226, DOI 10.1088/0004-637X/697/2/1226; Page GL, 2006, ASTROPHYS J, V642, P606, DOI 10.1086/500796; Passian A, 2009, J MATH ANAL APPL, V360, P380, DOI 10.1016/j.jmaa.2009.06.067; Peebles PJE, 2003, REV MOD PHYS, V75, P559, DOI 10.1103/RevModPhys.75.559; PENZIAS AA, 1965, ASTROPHYS J, V142, P419, DOI 10.1086/148307; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Pitjev NP, 2013, ASTRON LETT+, V39, P141, DOI 10.1134/S1063773713020060; Pitjeva EV, 2012, SOLAR SYST RES+, V46, P78, DOI 10.1134/S0038094612010054; Pitjeva EV, 2010, IAU SYMP P SERIES, P170, DOI 10.1017/S1743921309990342; Riess AG, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/119; Rievers B, 2010, SPACE SCI REV, V151, P123, DOI 10.1007/s11214-009-9594-6; Rievers B, 2010, ACTA ASTRONAUT, V66, P467, DOI 10.1016/j.actaastro.2009.06.009; Rievers B, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113032; RINDLER W, 1966, AM J PHYS, V34, P1174, DOI 10.1119/1.1972547; RUBIN VC, 1980, ASTROPHYS J, V238, P471, DOI 10.1086/158003; Sakurai J. J., 2010, MODERN QUANTUM MECH; Schwarkschid K, 1916, SITZBER K PREUSS AKA, P189; Standish EM, 2008, AIP CONF PROC, V977, P254, DOI 10.1063/1.2902789; Tangen K, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.042005; Titchmarsh E.C, 1962, EIGENFUNCTIONS EXPAN, Vsecond; TRIMBLE V, 1987, ANNU REV ASTRON ASTR, V25, P425, DOI 10.1146/annurev.aa.25.090187.002233; Turyshev SG, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.241101; Turyshev SG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.081103; UNRUH WG, 1976, PHYS REV D, V14, P870, DOI 10.1103/PhysRevD.14.870; UNRUH WG, 1984, PHYS REV D, V29, P1047, DOI 10.1103/PhysRevD.29.1047; Van den Bergh S, 2000, PUBL ASTRON SOC PAC, V112, P529, DOI 10.1086/316548; van den Bergh S, 1999, ASTRON ASTROPHYS REV, V9, P273, DOI 10.1007/s001590050019; Wald RM., 1994, QUANTUM FIELD THEORY; Wald RM, 1984, GEN RELAT GRAVIT, DOI 10.7208/chicago/9780226870373.001.0001; Wallin JF, 2007, ASTROPHYS J, V666, P1296, DOI 10.1086/520528; Watkins R, 2009, MON NOT R ASTRON SOC, V392, P743, DOI 10.1111/j.1365-2966.2008.14089.x; Watson G., 1922, TREATISE THEORY BESS; Webb JK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.191101; Will CM, 2006, LIVING REV RELATIV, V9, DOI 10.12942/lrr-2006-3; Williams J.G., 2003, 13 INT WORKSH LAS RA, P75; Williams JG, 2001, J GEOPHYS RES-PLANET, V106, P27933, DOI 10.1029/2000JE001396; WITTEN E, 1982, NUCL PHYS B, V195, P481, DOI 10.1016/0550-3213(82)90007-4; Yaqoob T, 1999, ASTROPHYS J, V525, pL9, DOI 10.1086/312327; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	116	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78114	10.1371/journal.pone.0078114	http://dx.doi.org/10.1371/journal.pone.0078114			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250790	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200011
J	Kassahn, KS; Holmes, O; Nones, K; Patch, AM; Miller, DK; Christ, AN; Harliwong, I; Bruxner, TJ; Xu, QY; Anderson, M; Wood, S; Leonard, C; Taylor, D; Newell, F; Song, S; Idrisoglu, S; Nourse, C; Nourbakhsh, E; Manning, S; Wani, S; Steptoe, A; Pajic, M; Cowley, MJ; Pinese, M; Chang, DK; Gill, AJ; Johns, AL; Wu, JM; Wilson, PJ; Fink, L; Biankin, AV; Waddell, N; Grimmond, SM; Pearson, JV				Kassahn, Karin S.; Holmes, Oliver; Nones, Katia; Patch, Ann-Marie; Miller, David K.; Christ, Angelika N.; Harliwong, Ivon; Bruxner, Timothy J.; Xu, Qinying; Anderson, Matthew; Wood, Scott; Leonard, Conrad; Taylor, Darrin; Newell, Felicity; Song, Sarah; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Steptoe, Anita; Pajic, Marina; Cowley, Mark J.; Pinese, Mark; Chang, David K.; Gill, Anthony J.; Johns, Amber L.; Wu, Jianmin; Wilson, Peter J.; Fink, Lynn; Biankin, Andrew V.; Waddell, Nicola; Grimmond, Sean M.; Pearson, John V.			Somatic Point Mutation Calling in Low Cellularity Tumors	PLOS ONE			English	Article							CANCER GENOME; FORMAT	Somatic mutation calling from next-generation sequencing data remains a challenge due to the difficulties of distinguishing true somatic events from artifacts arising from PCR, sequencing errors or mis-mapping. Tumor cellularity or purity, sub-clonality and copy number changes also confound the identification of true somatic events against a background of germline variants. We have developed a heuristic strategy and software (http://www.qcmg.org/bioinformatics/qsnp/) for somatic mutation calling in samples with low tumor content and we show the superior sensitivity and precision of our approach using a previously sequenced cell line, a series of tumor/normal admixtures, and 3,253 putative somatic SNVs verified on an orthogonal platform.	[Kassahn, Karin S.; Holmes, Oliver; Nones, Katia; Patch, Ann-Marie; Miller, David K.; Christ, Angelika N.; Harliwong, Ivon; Bruxner, Timothy J.; Xu, Qinying; Anderson, Matthew; Wood, Scott; Leonard, Conrad; Taylor, Darrin; Newell, Felicity; Song, Sarah; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Steptoe, Anita; Wilson, Peter J.; Fink, Lynn; Waddell, Nicola; Grimmond, Sean M.; Pearson, John V.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld, Australia; [Pajic, Marina; Cowley, Mark J.; Pinese, Mark; Chang, David K.; Gill, Anthony J.; Johns, Amber L.; Wu, Jianmin; Biankin, Andrew V.] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia; [Pajic, Marina; Cowley, Mark J.; Pinese, Mark; Chang, David K.; Gill, Anthony J.; Johns, Amber L.; Wu, Jianmin; Biankin, Andrew V.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Chang, David K.; Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW, Australia; [Chang, David K.; Biankin, Andrew V.] Univ New S Wales, South Western Sydney Clin Sch, Liverpool, NSW, Australia; [Gill, Anthony J.] Univ Sydney, Sydney, NSW 2006, Australia	University of Queensland; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney	Grimmond, SM (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld, Australia.	s.grimmond@imb.uq.edu.au; j.pearson@imb.uq.edu.au	Grimmond, Sean/K-3246-2019; Cowley, Mark/K-8731-2019; Pearson, John V/F-2249-2011; Patch, Ann-Marie/C-4201-2018; Nones, Katia/AAX-6453-2021; Grimmond, Sean M/J-5304-2016; Fink, Lynn/C-2031-2008; Gill, Anthony J./M-5015-2019; Pearson, John/AAT-4211-2020; Newell, Felicity/AAN-1253-2020; Waddell, Nicola/H-4929-2015; Gill, Anthony/D-4215-2015; Leonard, Conrad/AAD-2587-2020	Grimmond, Sean/0000-0002-8102-7998; Cowley, Mark/0000-0002-9519-5714; Pearson, John V/0000-0003-0904-4598; Patch, Ann-Marie/0000-0001-6121-4019; Nones, Katia/0000-0003-1925-5196; Grimmond, Sean M/0000-0002-8102-7998; Fink, Lynn/0000-0003-2912-6048; Waddell, Nicola/0000-0002-3950-2476; Gill, Anthony/0000-0002-9447-1967; Leonard, Conrad/0000-0002-4131-2065; Biankin, Andrew/0000-0002-0362-5597; Chang, David/0000-0002-4821-3078; Pajic, Marina/0000-0002-3871-3829; Pinese, Mark/0000-0001-5078-6687; Christ, Angelika/0000-0002-8680-2367; Kassahn, Karin/0000-0002-1662-3355; Bruxner, Timothy/0000-0002-8088-316X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Biankin A, 2012, NATURE; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Thorvaldsdottir H., 2012, BRIEFINGS BIOINFORMA	19	51	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e74380	10.1371/journal.pone.0074380	http://dx.doi.org/10.1371/journal.pone.0074380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250782	Green Published, Green Accepted, gold			2022-12-25	WOS:000327216200003
J	Kilbourne, BM; Hoffman, LC				Kilbourne, Brandon M.; Hoffman, Louwrens C.			Scale Effects between Body Size and Limb Design in Quadrupedal Mammals	PLOS ONE			English	Article							NATURAL PENDULAR PERIOD; ELASTIC ENERGY-STORAGE; TERRESTRIAL MAMMALS; MASS-DISTRIBUTION; STRIDE FREQUENCY; PHYLOGENETIC SIGNAL; LOCOMOTOR FUNCTION; RUNNING SPEED; EXTERNAL WORK; LONG BONES	Recently the metabolic cost of swinging the limbs has been found to be much greater than previously thought, raising the possibility that limb rotational inertia influences the energetics of locomotion. Larger mammals have a lower mass-specific cost of transport than smaller mammals. The scaling of the mass-specific cost of transport is partly explained by decreasing stride frequency with increasing body size; however, it is unknown if limb rotational inertia also influences the mass-specific cost of transport. Limb length and inertial properties - limb mass, center of mass (COM) position, moment of inertia, radius of gyration, and natural frequency - were measured in 44 species of terrestrial mammals, spanning eight taxonomic orders. Limb length increases disproportionately with body mass via positive allometry (length alpha body mass(0.40)); the positive allometry of limb length may help explain the scaling of the metabolic cost of transport. When scaled against body mass, forelimb inertial properties, apart from mass, scale with positive allometry. Fore- and hindlimb mass scale according to geometric similarity (limb mass alpha body mass(1.0)), as do the remaining hindlimb inertial properties. The positive allometry of limb length is largely the result of absolute differences in limb inertial properties between mammalian subgroups. Though likely detrimental to locomotor costs in large mammals, scale effects in limb inertial properties appear to be concomitant with scale effects in sensorimotor control and locomotor ability in terrestrial mammals. Across mammals, the forelimb's potential for angular acceleration scales according to geometric similarity, whereas the hindlimb's potential for angular acceleration scales with positive allometry.	[Kilbourne, Brandon M.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Kilbourne, Brandon M.] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; [Hoffman, Louwrens C.] Univ Stellenbosch, Dept Anim Sci, ZA-7600 Stellenbosch, Western Cape Pr, South Africa	University of Chicago; Field Museum of Natural History (Chicago); Stellenbosch University	Kilbourne, BM (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	brandon.kilbourne@uni-jena.de	Hoffman, Louwrens C/U-8467-2018; Kilbourne, Brandon/AAQ-5047-2020	Hoffman, Louwrens C/0000-0003-2736-1933; Kilbourne, Brandon/0000-0002-5940-0821	Field Museum of Natural History Council on Africa; University of Chicago Hinds Fund; American Society of Mammalogists; Sigma Xi; Society for Integrative & Comparative Biology; National Science Foundation [2006041573]	Field Museum of Natural History Council on Africa; University of Chicago Hinds Fund; American Society of Mammalogists; Sigma Xi; Society for Integrative & Comparative Biology; National Science Foundation(National Science Foundation (NSF))	Data collection, and associated costs in travel, consumables, and equipment, was supported by the Field Museum of Natural History Council on Africa (http://fieldmuseum.org/support/auxiliary-groups/africacouncil), the University of Chicago Hinds Fund (http://evbio.uchicago.edu/docs/CEB_Research_Funds_App_2012-13.pdf), and grants-in-aid of research from the American Society of Mammalogists (http://mammalsociety.org), Sigma Xi (http://www.sigmaxi.org), and the Society for Integrative & Comparative Biology (http://sicb.org). During this study, B. M. K. was supported by a Predoctoral Fellowship (NSF GRFP ID #: 2006041573) from the National Science Foundation (http://www.nsfgrfp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1981, J ZOOL, V194, P539, DOI 10.1111/j.1469-7998.1981.tb04600.x; ALEXANDER RM, 1985, J ZOOL, V207, P467, DOI 10.1111/j.1469-7998.1985.tb04944.x; BENNETT MB, 1989, J ZOOL, V219, P221, DOI 10.1111/j.1469-7998.1989.tb02578.x; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; Bertram JEA, 2009, J R SOC INTERFACE, V6, P549, DOI 10.1098/rsif.2008.0328; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; BIEWENER AA, 1983, J EXP BIOL, V105, P147; BIEWENER AA, 1989, BIOSCIENCE, V39, P776, DOI 10.2307/1311183; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Boettiger C, 2012, EVOLUTION, V66, P2240, DOI 10.1111/j.1558-5646.2011.01574.x; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Carrier DR, 2008, J EXP BIOL, V211, P150, DOI 10.1242/jeb.010678; Carrier DR, 2006, J EXP BIOL, V209, P2224, DOI 10.1242/jeb.02236; Christiansen P, 2002, J MORPHOL, V251, P195, DOI 10.1002/jmor.1083; Christiansen P, 1999, J MORPHOL, V239, P167, DOI 10.1002/(SICI)1097-4687(199902)239:2<167::AID-JMOR5>3.0.CO;2-8; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; Courtine G, 2005, J NEUROPHYSIOL, V93, P3127, DOI 10.1152/jn.01073.2004; Deban SM, 2012, J EXP BIOL, V215, P287, DOI 10.1242/jeb.063230; Doke J, 2005, J EXP BIOL, V208, P439, DOI 10.1242/jeb.01408; Dutto DJ, 2006, J EXP BIOL, V209, P3990, DOI 10.1242/jeb.02471; Dutto DJ, 2004, J EXP BIOL, V207, P3507, DOI 10.1242/jeb.01171; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GARLAND T, 1983, J ZOOL, V199, P157, DOI 10.1111/j.1469-7998.1983.tb02087.x; Gillis GB, 2005, J EXP BIOL, V208, P4599, DOI 10.1242/jeb.01940; Gillis GB, 2001, J EXP BIOL, V204, P2717; GOSLOW GE, 1973, J MORPHOL, V141, P1, DOI 10.1002/jmor.1051410102; Gregersen CS, 1998, J EXP BIOL, V201, P3197; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; HEGLUND NC, 1988, J EXP BIOL, V138, P301; HEGLUND NC, 1982, J EXP BIOL, V97, P57; Hildebrand M., 1985, P38; HILDEBRAND M, 1984, J MAMMAL, V65, P718, DOI 10.2307/1380866; HILDEBRAND M, 1985, J MORPHOL, V184, P23, DOI 10.1002/jmor.1051840103; HILDEBRAND M, 1980, AM ZOOL, V20, P255; Hill A. V., 1950, Science Progress London, V38, P209; Howell AB, 1944, SPEED ANIMALS THEIR; Hoyt DF, 2000, J EXP BIOL, V203, P221; Hutchinson JR, 2006, J EXP BIOL, V209, P3812, DOI 10.1242/jeb.02443; Janis CM, 2002, J VERTEBR PALEONTOL, V22, P110, DOI 10.1671/0272-4634(2002)022[0110:LEICRA]2.0.CO;2; Kilbourne BM, 2011, THESIS U CHICAGO; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Lee DV, 2011, J R SOC INTERFACE, V8, P1480, DOI 10.1098/rsif.2011.0019; Lee DV, 2004, J EXP BIOL, V207, P1715, DOI 10.1242/jeb.00947; Legendre P., 2008, LMODEL2 MODEL 2 REGR; Lichtwark GA, 2009, J EXP BIOL, V212, P2454, DOI 10.1242/jeb.027995; MADDISON WP, 2006, MESQUITE MODULAR SYS; Maes LD, 2008, J EXP BIOL, V211, P138, DOI 10.1242/jeb.008243; Marsh RL, 2004, SCIENCE, V303, P80, DOI 10.1126/science.1090704; MCMAHON TA, 1975, J APPL PHYSIOL, V39, P619, DOI 10.1152/jappl.1975.39.4.619; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; MERKENS HW, 1993, EQUINE VET J, V25, P134, DOI 10.1111/j.2042-3306.1993.tb02923.x; Michilsens F, 2009, J ZOOL, V279, P236, DOI 10.1111/j.1469-7998.2009.00611.x; More HL, 2010, P ROY SOC B-BIOL SCI, V277, P3563, DOI 10.1098/rspb.2010.0898; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Myers MJ, 1997, J MORPHOL, V234, P183; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Norberg RA, 2010, J EXP BIOL, V213, P2873, DOI 10.1242/jeb.044180; Nudds RL, 2007, J AVIAN BIOL, V38, P515, DOI 10.1111/j.0908-8857.2007.03913.x; Nyakatura JA, 2008, AM J PHYS ANTHROPOL, V135, P13, DOI 10.1002/ajpa.20699; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pfau T, 2011, J ZOOL, V283, P193, DOI 10.1111/j.1469-7998.2010.00763.x; POLLOCK CM, 1994, AM J PHYSIOL, V266, pR1022, DOI 10.1152/ajpregu.1994.266.3.R1022; Pontzer H, 2007, J EXP BIOL, V210, P1752, DOI 10.1242/jeb.002246; Pontzer H, 2007, J EXP BIOL, V210, P484, DOI 10.1242/jeb.02662; PRIDMORE PA, 1992, J MORPHOL, V211, P137, DOI 10.1002/jmor.1052110203; R Development Core Team, 2012, R LANG ENV STAT COMP; Raichlen DA, 2004, J HUM EVOL, V46, P719, DOI 10.1016/j.jhevol.2004.04.002; RAYNER JMV, 1985, J ZOOL, V206, P415; Reilly SM, 2007, ZOOLOGY, V110, P271, DOI 10.1016/j.zool.2007.01.003; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; RICKER WE, 1973, J FISH RES BOARD CAN, V30, P409, DOI 10.1139/f73-072; Robilliard JJ, 2007, J EXP BIOL, V210, P187, DOI 10.1242/jeb.02611; Rocha-Barbosa O, 2005, J ZOOL, V266, P293, DOI 10.1017/S0952836905006928; Rollinson J, 1981, S ZOOL SOC LOND, V48, P377; RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; STEUDEL K, 1990, J EXP BIOL, V154, P287; STEUDEL K, 1990, J EXP BIOL, V154, P273; STRANG KT, 1990, J ZOOL, V221, P343, DOI 10.1111/j.1469-7998.1990.tb04006.x; TAYLOR CR, 1974, AM J PHYSIOL, V227, P848, DOI 10.1152/ajplegacy.1974.227.4.848; Taylor CR, 1982, J EXP BIOL, V79, P1; Van der Sluijs L, 2010, J ZOOL, V282, P291, DOI 10.1111/j.1469-7998.2010.00739.x; Walter RM, 2011, J EXP BIOL, V214, P1763, DOI 10.1242/jeb.054791; Walter RM, 2009, J EXP BIOL, V212, P1930, DOI 10.1242/jeb.023762; Warner SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054784; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; WEBB S D, 1972, Forma et Functio, V5, P99; Wickler SJ, 2004, EQUINE VET J, V36, P772, DOI 10.2746/0425164044848046	94	36	37	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78392	10.1371/journal.pone.0078392	http://dx.doi.org/10.1371/journal.pone.0078392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260117	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200025
J	Li, CL; Jiang, ZG; Fang, HX; Li, CW				Li, Chunlin; Jiang, Zhigang; Fang, Hongxia; Li, Chunwang			A Spatially Explicit Model of Functional Connectivity for the Endangered Przewalski's Gazelle (Procapra przewalskii) in a Patchy Landscape	PLOS ONE			English	Article							QINGHAI; CONSERVATION; HIGHWAY; DISPERSAL; CORRIDORS; MOVEMENT; INDEXES; LAKE	Background: Habitat fragmentation, associated with human population expansion, impedes dispersal, reduces gene flow and aggravates inbreeding in species on the brink of extinction. Both scientific and conservation communities increasingly realize that maintaining and restoring landscape connectivity is of vital importance in biodiversity conservation. Prior to any conservation initiatives, it is helpful to present conservation practitioners with a spatially explicit model of functional connectivity for the target species or landscape. Methodology/Principal Findings: Using Przewalski's gazelle (Procapra przewalskii) as a model of endangered ungulate species in highly fragmented landscape, we present a model providing spatially explicit information to inform the long-term preservation of well-connected metapopulations. We employed a Geographic Information System (GIS) and expert-literature method to create a habitat suitability map, to identify potential habitats and to delineate a functional connectivity network (least-cost movement corridors and paths) for the gazelle. Results indicated that there were limited suitable habitats for the gazelle, mainly found to the north and northwest of the Qinghai Lake where four of five potential habitat patches were identified. Fifteen pairs of least-cost corridors and paths were mapped connecting eleven extant populations and two neighboring potential patches. The least-cost paths ranged from 0.2 km to 26.8 km in length (averaging 12.4 km) and were all longer than corresponding Euclidean distances. Conclusions/Significance: The model outputs were validated and supported by the latest findings in landscape genetics of the species, and may provide impetus for connectivity conservation programs. Dispersal barriers were examined and appropriate mitigation strategies were suggested. This study provides conservation practitioners with thorough and visualized information to reserve the landscape connectivity for Przewalski's gazelle. In a general sense, we proposed a heuristic framework for species with similar biological and ecological characteristics.	[Li, Chunlin] Anhui Univ, Sch Resources & Environm Engn, Hefei, Anhui, Peoples R China; [Jiang, Zhigang; Fang, Hongxia; Li, Chunwang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	Anhui University; Chinese Academy of Sciences; Institute of Zoology, CAS	Jiang, ZG (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014	Jiang, Zhigang/0000-0003-2154-8588	Key Program of Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Sciences Foundation of China [31070469, 31070348, 31372175]; Natural Sciences Foundation of Education Department of Anhui Province [06061749]; Doctor Scientific Research Starting Foundation [33190222]; young teacher foundation of Anhui University of China [12333010296]	Key Program of Knowledge Innovation Program of Chinese Academy of Sciences; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Education Department of Anhui Province; Doctor Scientific Research Starting Foundation; young teacher foundation of Anhui University of China	This study was supported by the Key Program of Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Sciences Foundation of China (No. 31070469, 31070348, 31372175), the Natural Sciences Foundation of Education Department of Anhui Province (No. 06061749), the Doctor Scientific Research Starting Foundation (No. 33190222), and young teacher foundation (No. 12333010296) of Anhui University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Beier P., 2007, CONCEPTUAL STEPS DES; Beier P., 2007, CONCEPTUAL STEPS DES; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Brooks CP, 2003, OIKOS, V102, P433; Cain AT, 2003, BIOL CONSERV, V114, P189, DOI 10.1016/S0006-3207(03)00023-5; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Chien NQ, 2011, COMPUT GEOSCI-UK, V37, P38, DOI 10.1016/j.cageo.2010.03.006; Clevenger A.P., 2009, HDB DESIGN EVALUATIO; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Clevenger AP, 2005, BIOL CONSERV, V121, P453, DOI 10.1016/j.biocon.2004.04.025; Crooks K. R., 2006, CONNECTIVITY CONSERV; Doswald N, 2007, WILDLIFE BIOL, V13, P430, DOI 10.2981/0909-6396(2007)13[430:TEGFAH]2.0.CO;2; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Graves TA, 2007, LANDSCAPE ECOL, V22, P765, DOI 10.1007/s10980-007-9082-x; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Hu J, 2010, J ZOOL, V282, P54, DOI 10.1111/j.1469-7998.2010.00715.x; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022873; Hu JH, 2010, EUR J WILDLIFE RES, V56, P551, DOI 10.1007/s10344-009-0346-4; IUCN SSCAntelope Specialist Group, 2008, IUCN RED LIST THREAT; Jiang ZG, 2000, ORYX, V34, P129, DOI 10.1046/j.1365-3008.2000.00108.x; Jiang Zhi-Gang, 2004, Acta Zoologica Sinica, V50, P706; Jiang Zhi-Gang, 2003, Chinese Journal of Zoology, V38, P129; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; Lei RH, 2003, ANIM CONSERV, V6, P361, DOI 10.1017/S1367943003003433; Li CL, 2012, ORYX, V46, P145, DOI 10.1017/S0030605310001134; Li CW, 2009, WILDLIFE RES, V36, P379, DOI 10.1071/WR08117; Liu Y, 2004, INT J REMOTE SENS, V25, P4177, DOI 10.1080/01431160410001680419; Mallon D.P., 2001, ANTELOPES 4, P231; Mallon DP, 2009, J APPL ECOL, V46, P516, DOI 10.1111/j.1365-2664.2009.01654.x; Merriam G, 1984, P 1 INT SEM METH LAN, P5, DOI DOI 10.1038/NATURE14324; Oberlies NH, 2009, PHYTOCHEM LETT, V2, P1, DOI 10.1016/j.phytol.2008.10.006; Pe'er G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022355; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; SAATY RW, 1987, MATH MODELLING, V9, P161, DOI 10.1016/0270-0255(87)90473-8; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Turghan M, 2010, THESIS CHINESE ACAD; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Vogt P, 2009, ECOL INDIC, V9, P64, DOI 10.1016/j.ecolind.2008.01.011; Xia L, 2007, ORYX, V41, P352, DOI 10.1017/S0030605307000116; Yang J, 2011, CONSERV GENET, V12, P1457, DOI 10.1007/s10592-011-0244-7; Yang Ji, 2011, PLoS One, V6, pe20144, DOI 10.1371/journal.pone.0020144; You ZQ, 2013, CHINESE SCI BULL, V58, P2262, DOI 10.1007/s11434-013-5844-9; You ZQ, 2011, CURR ZOOL, V57, P701, DOI 10.1093/czoolo/57.6.701	51	5	5	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80065	10.1371/journal.pone.0080065	http://dx.doi.org/10.1371/journal.pone.0080065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250829	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200099
J	Lee, HC; Choi, HJ; Park, TS; Lee, SI; Kim, YM; Rengaraj, D; Nagai, H; Sheng, GJ; Lim, JM; Han, JY				Lee, Hyung Chul; Choi, Hee Jung; Park, Tae Sub; Lee, Sang In; Kim, Young Min; Rengaraj, Deivendran; Nagai, Hiroki; Sheng, Guojun; Lim, Jeong Mook; Han, Jae Yong			Cleavage Events and Sperm Dynamics in Chick Intrauterine Embryos	PLOS ONE			English	Article							EMERGING ASYMMETRY; MOUSE EMBRYO; HENS EGG; FERTILIZATION; PATTERN	This study was undertaken to elucidate detailed event of early embryogenesis in chicken embryos using a noninvasive egg retrieval technique before oviposition. White Leghorn intrauterine eggs were retrieved from 95 cyclic hens aged up to 54-56 weeks and morphogenetic observation was made under both bright field and fluorescent image in a time course manner. Differing from mammals, asymmetric cleavage to yield preblastodermal cells was observed throughout early embryogenesis. The first two divisions occurred synchronously and four polarized preblastodermal cells resulted after cruciform cleavage. Then, asynchronous cleavage continued in a radial manner and overall cell size in the initial cleavage region was smaller than that in the distal area. Numerous sperms were visible, regardless of zygotic nuclei formation. Condensed sperm heads were present mainly in the perivitelline space and cytoplasm, and rarely in the yolk region, while decondensed sperm heads were only visible in the yolk. In conclusion, apparent differences in sperm dynamics and early cleavage events compared with mammalian embryos were detected in chick embryo development, which demonstrated polarized cleavage with penetrating supernumerary sperm into multiple regions.	[Lee, Hyung Chul; Choi, Hee Jung; Park, Tae Sub; Lee, Sang In; Kim, Young Min; Rengaraj, Deivendran; Lim, Jeong Mook; Han, Jae Yong] Seoul Natl Univ, WCU Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Hyung Chul; Choi, Hee Jung; Park, Tae Sub; Lee, Sang In; Kim, Young Min; Rengaraj, Deivendran; Lim, Jeong Mook; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Nagai, Hiroki; Sheng, Guojun] RIKEN Ctr Dev Biol, Lab Early Embryogenesis, Chuo Ku, Kobe, Hyogo, Japan	Seoul National University (SNU); Seoul National University (SNU); RIKEN	Han, JY (corresponding author), Seoul Natl Univ, WCU Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea.	jaehan@snu.ac.kr	Sheng, Guojun/I-4900-2015; Nagai, Hiroki/GXZ-7815-2022; Sheng, Guojun/G-4116-2014; Rengaraj, Deivendran/C-5593-2015	Rengaraj, Deivendran/0000-0001-9274-9921	Next-Generation BioGreen 21 Program, Rural Development Administration [PJ008142]; World Class University Program through the National Research Foundation [R31-10056]; Ministry of Education, Science and Technology, Korea	Next-Generation BioGreen 21 Program, Rural Development Administration; World Class University Program through the National Research Foundation; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (PJ008142), Rural Development Administration, and by the World Class University Program (R31-10056) through the National Research Foundation, funded by the Ministry of Education, Science and Technology, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakst MR, 1997, POULTRY SCI, V76, P83, DOI 10.1093/ps/76.1.83; BELLAIRS R, 1978, J EMBRYOL EXP MORPH, V43, P55; BIRKHEAD TR, 1994, J REPROD FERTIL, V101, P353, DOI 10.1530/jrf.0.1010353; BRAMWELL RK, 1995, POULTRY SCI, V74, P1875, DOI 10.3382/ps.0741875; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Olsen MW, 1942, J MORPHOL, V70, P513, DOI 10.1002/jmor.1050700307; Pannett CA, 1924, LANCET, V1, P381; Park HJ, 2006, MOL REPROD DEV, V73, P452, DOI 10.1002/mrd.20441; Patterson JT, 1910, J MORPHOL, V21, P101; PERRY MM, 1987, J ANAT, V150, P99; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Snook RR, 2011, REPRODUCTION, V142, P779, DOI 10.1530/REP-11-0255; Wishart GJ, 1997, ANIM REPROD SCI, V48, P81, DOI 10.1016/S0378-4320(97)00042-0; Zernicka-Goetz M, 2005, MECH DEVELOP, V122, pS17; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	16	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80631	10.1371/journal.pone.0080631	http://dx.doi.org/10.1371/journal.pone.0080631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244702	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900084
J	Bomberger, JM; Ely, KH; Bangia, N; Ye, SY; Green, KA; Green, WR; Enelow, RI; Stanton, BA				Bomberger, Jennifer M.; Ely, Kenneth H.; Bangia, Naveen; Ye, Siying; Green, Kathy A.; Green, William R.; Enelow, Richard I.; Stanton, Bruce A.			Pseudomonas aeruginosa Cif Protein Enhances the Ubiquitination and Proteasomal Degradation of the Transporter Associated with Antigen Processing (TAP) and Reduces Major Histocompatibility Complex (MHC) Class I Antigen Presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Antigen Processing; Deubiquitination; Pseudomonas aeruginosa; Ubiquitination; TAP; Airway Epithelial Cell; Viral-Bacterial Co-infection	TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; PEPTIDE-LOADING COMPLEX; T-LYMPHOCYTE EPITOPE; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; DEUBIQUITINATING ENZYMES; HALF-LIFE; VIRUS; TAPASIN	Cif (PA2934), a bacterial virulence factor secreted in outer membrane vesicles by Pseudomonas aeruginosa, increases the ubiquitination and lysosomal degradation of some, but not all, plasma membrane ATP-binding cassette transporters (ABC), including the cystic fibrosis transmembrane conductance regulator and P-glycoprotein. The goal of this study was to determine whether Cif enhances the ubiquitination and degradation of the transporter associated with antigen processing (TAP1 and TAP2), members of the ABC transporter family that play an essential role in antigen presentation and intracellular pathogen clearance. Cif selectively increased the amount of ubiquitinated TAP1 and increased its degradation in the proteasome of human airway epithelial cells. This effect of Cif was mediated by reducing USP10 deubiquitinating activity, resulting in increased polyubiquitination and proteasomal degradation of TAP1. The reduction in TAP1 abundance decreased peptide antigen translocation into the endoplasmic reticulum, an effect that resulted in reduced antigen available to MHC class I molecules for presentation at the plasma membrane of airway epithelial cells and recognition by CD8(+) T cells. Cif is the first bacterial factor identified that inhibits TAP function and MHC class I antigen presentation.	[Bomberger, Jennifer M.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Ely, Kenneth H.; Ye, Siying; Green, Kathy A.; Green, William R.; Enelow, Richard I.; Stanton, Bruce A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Bangia, Naveen] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; Roswell Park Cancer Institute	Bomberger, JM (corresponding author), Univ Pittsburgh, 450 Technol Dr,416 Bridgeside Point 2, Pittsburgh, PA 15219 USA.	jbomb@pitt.edu	Ye, Siying/H-3156-2013	Ye, Siying/0000-0002-0882-1642; Bangia, Naveen/0000-0003-0631-2323	National Institutes of Health [R00HL098342, P30DK072506, 5T32DK007301, 2R01HL074175, R01-DK/HL45881]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175, R00HL098342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007301, P30DK072506, R01DK045881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R00HL098342 and P30DK072506 (to J. M. B.) and 5T32DK007301, 2R01HL074175, and R01-DK/HL45881 (to B. A. S).	Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bebok Z, 1998, AM J PHYSIOL-CELL PH, V275, pC599, DOI 10.1152/ajpcell.1998.275.2.C599; Beismann-Driemeyer S, 2004, ANGEW CHEM INT EDIT, V43, P4014, DOI 10.1002/anie.200300642; Belicha-Villanueva A, 2008, IMMUNOLOGY, V124, P112, DOI 10.1111/j.1365-2567.2007.02746.x; Bennett EM, 1999, J IMMUNOL, V162, P5049; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Deng YP, 1998, J IMMUNOL, V161, P1677; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hoiby N, 1998, Nord Med, V113, P328; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Iannello A, 2006, J LEUKOCYTE BIOL, V79, P16, DOI 10.1189/jlb.0705397; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; Keusekotten K, 2006, J BIOL CHEM, V281, P17545, DOI 10.1074/jbc.M602360200; Kim V, 1997, VIROLOGY, V236, P221, DOI 10.1006/viro.1997.8747; Kim V, 1998, VIRAL IMMUNOL, V11, P197, DOI 10.1089/vim.1998.11.197; Kim V, 2000, J VIROL, V74, P3924, DOI 10.1128/JVI.74.8.3924-3928.2000; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; Koppers-Lalic D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000080; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Messaoudi I, 1999, J IMMUNOL, V163, P3286; Panter MS, 2012, J BIOL CHEM, V287, P31172, DOI 10.1074/jbc.M112.387704; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Petersen JL, 2003, J IMMUNOL, V171, P4473, DOI 10.4049/jimmunol.171.9.4473; Raghuraman G, 2002, J BIOL CHEM, V277, P41786, DOI 10.1074/jbc.M207128200; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Seliger B, 2001, CANCER RES, V61, P8647; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; van Ewijk BE, 2008, PEDIATRICS, V122, P1171, DOI 10.1542/peds.2007-3139; Verweij MC, 2008, J IMMUNOL, V181, P4894, DOI 10.4049/jimmunol.181.7.4894; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Wat Dennis, 2003, Paediatr Respir Rev, V4, P172, DOI 10.1016/S1526-0542(03)00059-9; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Wilkinson TMA, 2006, AM J RESP CRIT CARE, V173, P871, DOI 10.1164/rccm.200509-1489OC; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; Ye S, 2008, AM J PHYSIOL-CELL PH, V295, pC807, DOI 10.1152/ajpcell.00234.2008; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287; Zeidler R, 1997, BLOOD, V90, P2390; Zhang LW, 2001, J VIROL, V75, P341, DOI 10.1128/JVI.75.1.341-350.2001; Zhu KC, 1999, ONCOGENE, V18, P7740, DOI 10.1038/sj.onc.1203235	65	38	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					152	162		10.1074/jbc.M113.459271	http://dx.doi.org/10.1074/jbc.M113.459271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24247241	Green Published, hybrid			2022-12-25	WOS:000329370900014
J	Saha, S; Kundu, B; Kirkham, J; Wood, D; Kundu, SC; Yang, XBB				Saha, Sushmita; Kundu, Banani; Kirkham, Jennifer; Wood, David; Kundu, Subhas C.; Yang, Xuebin B.			Osteochondral Tissue Engineering In Vivo: A Comparative Study Using Layered Silk Fibroin Scaffolds from Mulberry and Nonmulberry Silkworms	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CURRENT STRATEGIES; BIOMATERIALS; REPAIR; ARCHITECTURE	The ability to treat osteochondral defects is a major clinical need. Existing polymer systems cannot address the simultaneous requirements of regenerating bone and cartilage tissues together. The challenge still lies on how to improve the integration of newly formed tissue with the surrounding tissues and the cartilage-bone interface. This study investigated the potential use of different silk fibroin scaffolds: mulberry (Bombyx mori) and non-mulberry (Antheraea mylitta) for osteochondral regeneration in vitro and in vivo. After 4 to 8 weeks of in vitro culture in chondro-or osteo-inductive media, non-mulberry constructs pre-seeded with human bone marrow stromal cells exhibited prominent areas of the neo tissue containing chondrocyte-like cells, whereas mulberry constructs pre-seeded with human bone marrow stromal cells formed bone-like nodules. In vivo investigation demonstrated neo-osteochondral tissue formed on cell-free multi-layer silk scaffolds absorbed with transforming growth factor beta 3 or recombinant human bone morphogenetic protein-2. Good biointegration was observed between native and neo-tissue within the osteochondrol defect in patellar grooves of Wistar rats. The in vivo neo-matrix formed comprised of a mixture of collagen and glycosaminoglycans except in mulberry silk without growth factors, where a predominantly collagenous matrix was observed. Immunohistochemical assay showed stronger staining of type I and type II collagen in the constructs of mulberry and non-mulberry scaffolds with growth factors. The study opens up a new avenue of using inter-species silk fibroin blended or multi-layered scaffolds of a combination of mulberry and non-mulberry origin for the regeneration of osteochondral defects.	[Saha, Sushmita; Wood, David; Yang, Xuebin B.] Univ Leeds, Sch Dent, Biomat & Tissue Engn Grp, Leeds, W Yorkshire, England; [Kundu, Banani; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India; [Kirkham, Jennifer] Univ Leeds, Sch Dent, Biomineralisat Grp, Leeds, W Yorkshire, England	University of Leeds; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Leeds	Kundu, SC (corresponding author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.	undu@hijli.iitkgp.ernet.in; x.b.yang@leeds.ac.uk	Kundu, Subhas C/AAC-1317-2020; Kundu, Banani/O-9320-2016	Kundu, Subhas C/0000-0002-7170-2291; Kundu, Banani/0000-0003-1251-700X; Saha, Sushmita/0000-0002-5791-8635	NIHR; LMBRU; WELMEC, a Centre of Excellence in Medical Engineering; Welcome Trust; EPSRC [WT 088908/Z/09/Z]; Department of Biotechnology; Department of Science and Technology; Council of Scientific and Industrial Research Government of India	NIHR(National Institute for Health Research (NIHR)); LMBRU; WELMEC, a Centre of Excellence in Medical Engineering; Welcome Trust(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded in part by NIHR LMBRU and WELMEC, a Centre of Excellence in Medical Engineering, Welcome Trust and EPSRC (grant number WT 088908/Z/09/Z), the Department of Biotechnology, Department of Science and Technology, Council of Scientific and Industrial Research (for Senior Fellowship to BK), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1; Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen S, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/6/065003; Fan HB, 2010, J BIOMED MATER RES A, V95A, P982, DOI 10.1002/jbm.a.32899; Haleem AM, 2010, OPER TECH ORTHOP, V20, P76, DOI 10.1053/j.oto.2009.10.004; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; Hensley CP, 2011, INT J SPORTS PHYS TH, V6, P10; Horner EA, 2010, TISSUE ENG PART B-RE, V16, P263, DOI 10.1089/ten.TEB.2009.0224; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Husing B, 2003, HUMAN TISSUE ENG PRO; Hwang YS, 2010, TISSUE ENG PT A, V16, P3033, DOI [10.1089/ten.tea.2010.0045, 10.1089/ten.TEA.2010.0045]; Im G, 2012, CELL TRANSPLANTATION; Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lopiz-Morales Y, 2010, EUR CELLS MATER, V20, P367; Maes M, 2007, MED RADIOL DIAGN IMA, P235, DOI 10.1007/978-3-540-68483-1_10; Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113; Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]; Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109; Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008; Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019; Melton JTK, 2010, EXPERT REV MED DEVIC, V7, P333, DOI 10.1586/ERD.10.15; Nukavarapu SP, 2013, BIOTECHNOL ADV, V31, P706, DOI 10.1016/j.biotechadv.2012.11.004; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Partridge K, 2002, BIOCHEM BIOPH RES CO, V292, P144, DOI 10.1006/bbrc.2002.6623; Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036; Riccio M, 2012, TISSUE ENG PT A, V18, P1006, DOI [10.1089/ten.tea.2011.0542, 10.1089/ten.TEA.2011.0542]; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Rodrigues MT, 2011, CURR OPIN BIOTECH, V22, P726, DOI 10.1016/j.copbio.2011.04.006; Saha S, 2010, BIOCHEM BIOPH RES CO, V401, P333, DOI 10.1016/j.bbrc.2010.09.042; Shanmugasundaram S, 2011, TISSUE ENG PT A, V17, P831, DOI [10.1089/ten.tea.2010.0409, 10.1089/ten.TEA.2010.0409]; Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539; Stenhamre H, 2011, J TISSUE ENG REGEN M, V5, P578, DOI 10.1002/term.350; Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87; TACCHETTI C, 1992, EXP CELL RES, V200, P26, DOI 10.1016/S0014-4827(05)80067-9; Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169; Velema J, 2006, ADV BIOCHEM ENG BIOT, V102, P187, DOI 10.1007/10_013; Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x; Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017; Yang HS, 2011, TISSUE ENG PT A, V17, P2153, DOI [10.1089/ten.tea.2010.0702, 10.1089/ten.TEA.2010.0702]	44	50	52	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80004	10.1371/journal.pone.0080004	http://dx.doi.org/10.1371/journal.pone.0080004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260335	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900056
J	Banerjee, D; Leong, WB; Arora, T; Nolen, M; Punamiya, V; Grunstein, R; Taheri, S				Banerjee, Dev; Leong, Wen Bun; Arora, Teresa; Nolen, Melissa; Punamiya, Vikas; Grunstein, Ron; Taheri, Shahrad			The Potential Association between Obstructive Sleep Apnea and Diabetic Retinopathy in Severe Obesity-The Role of Hypoxemia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PREVALENCE; WEIGHT; COMPLICATIONS; ENGLAND; HYPOXIA; WALES	Background: Obstructive sleep apnea (OSA) is common in obese patients with type 2 diabetes mellitus (DM) and may contribute to diabetic microvascular complications. Methods: To investigate the association between OSA, hypoxemia during sleep, and diabetic retinal complications in severe obesity. This was a prospective observational study of 93 obese patients mean (SD) age: 52(10) years; mean (SD) body mass index (BMI): 47.3(8.3) kg/m(2)) with DM undergoing retinal screening and respiratory monitoring during sleep. OSA was defined as apnea-hypopnea index (AHI) of >= 15 events/hour, resulting in two groups (OSA+ vs. OSA-). Results: Forty-six patients were OSA+: median (95% CI) AHI=37(23-74)/hour and 47 were OSA-ve (AHI=7(4-11)/hour). Both groups were similar for ethnicity, BMI, cardiovascular co-morbidities, diabetes duration, HbA(1 alpha), and insulin treatment (p>0.05). The OSA+ group was significantly more hypoxemic. There was no significant difference between OSA+ and OSA- groups for the presence of retinopathy (39% vs. 38%). More OSA+ subjects had maculopathy (22% vs. 13%), but this did not reach statistical significance. Logistic regression analyses showed that AHI was not significantly associated with the presence of retinopathy or maculopathy (p>0.05). Whilst minimum oxygen saturation was not significantly associated with retinopathy, it was an independent predictor for the presence of maculopathy OR=0.79 (95% CI: 0.65-0.95; p>0.05), after adjustment. Conclusions: The presence of OSA, as determined by AHI, was not associated with diabetic retinal complications. In contrast, severity of hypoxemia during sleep (minimum oxygen saturations) may be an important factor. The importance of hypoxia in the development of retinal complications in patients with OSA remains unclear and further studies assessing the pathogenesis of hypoxemia in patients with OSA and diabetic retinal disease are warranted.	[Banerjee, Dev; Nolen, Melissa; Punamiya, Vikas] Heart England NHS Fdn Trust, Birmingham Heartlands Hosp, Acad Dept Sleep & Ventilat, Birmingham, W Midlands, England; [Banerjee, Dev] Univ Sydney, St Vincents Hosp, Sydney, NSW 2006, Australia; [Banerjee, Dev] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Leong, Wen Bun; Arora, Teresa; Taheri, Shahrad] Univ Birmingham, Birmingham & Black Country NIHR CLAHRC, Birmingham, W Midlands, England; [Leong, Wen Bun; Arora, Teresa; Taheri, Shahrad] Heart England NHS Fdn Trust, Specialist Weight Management Serv, Birmingham, W Midlands, England; [Grunstein, Ron] Univ Sydney, NHMRC Ctr Integrated Res & Understanding Sleep CI, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Grunstein, Ron] St Alfreds Hosp, Sydney, NSW, Australia	Heart of England NHS Foundation Trust; University of Birmingham; St Vincents Hospital Sydney; University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Birmingham; Heart of England NHS Foundation Trust; University of Sydney; Woolcock Institute of Medical Research	Banerjee, D (corresponding author), Heart England NHS Fdn Trust, Birmingham Heartlands Hosp, Acad Dept Sleep & Ventilat, Birmingham, W Midlands, England.	dbanerjee@stvincents.com.au	Taheri, Shahrad/O-9721-2016	Taheri, Shahrad/0000-0001-8314-1500; Arora, Teresa/0000-0001-8360-7358	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme; children's charity Action Medical Research	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme(National Institute for Health Research (NIHR)); children's charity Action Medical Research	Dr Taheri is funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The views expressed in this publication are not necessarily those of the NIHR, the Department of Health, National Health Service South Birmingham, University of Birmingham or the CLAHRC BBC Theme 8 Management/Steering Group. Dr Arora is funded by the children's charity Action Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 2006, DIFF AUD SERV EV RES; Bunce C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-58; Chatziralli Irini P, 2010, BMC Res Notes, V3, P153, DOI 10.1186/1756-0500-3-153; Drager LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012065; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Harding S, 2003, DIABETIC MED, V20, P965, DOI 10.1111/j.1464-5491.2003.01077.x; Iber C., 2007, AASM MANUAL SCORING; Imadojemu VA, 2002, AM J RESP CRIT CARE, V165, P61, DOI 10.1164/ajrccm.165.1.2009062; Kosseifi S, 2010, MIL MED, V175, P913, DOI 10.7205/MILMED-D-10-00131; Lopez PP, 2008, AM SURGEON, V74, P834; Mason RH, 2012, RETINA-J RET VIT DIS, V32, P1791, DOI 10.1097/IAE.0b013e318259568b; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Phillips SA, 2004, AM J PHYSIOL-HEART C, V286, pH388, DOI 10.1152/ajpheart.00683.2003; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; Schulz R, 2002, AM J RESP CRIT CARE, V165, P67, DOI 10.1164/ajrccm.165.1.2101062; Shankar A, 2013, ATHEROSCLEROSIS, V226, P124, DOI 10.1016/j.atherosclerosis.2012.10.046; Shiba T, 2010, AM J OPHTHALMOL, V149, P959, DOI 10.1016/j.ajo.2010.01.006; Shiba T, 2009, AM J OPHTHALMOL, V147, P1017, DOI 10.1016/j.ajo.2008.12.027; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Taheri S, 2004, Minerva Med, V95, P203; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Wang X, 2013, RESPIROLOGY, V18, P140, DOI 10.1111/j.1440-1843.2012.02267.x; West SD, 2010, DIABETIC MED, V27, P423, DOI 10.1111/j.1464-5491.2010.02962.x; Yamauchi M, 2005, CHEST, V127, P1674, DOI 10.1378/chest.127.5.1674; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	30	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79521	10.1371/journal.pone.0079521	http://dx.doi.org/10.1371/journal.pone.0079521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260240	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500071
J	Garcia, JE; Dyer, AG; Greentree, AD; Spring, G; Wilksch, PA				Garcia, Jair E.; Dyer, Adrian G.; Greentree, Andrew D.; Spring, Gale; Wilksch, Philip A.			Linearisation of RGB Camera Responses for Quantitative Image Analysis of Visible and UV Photography: A Comparison of Two Techniques	PLOS ONE			English	Article							SPECTRAL REFLECTANCES; DIGITAL PHOTOGRAPHY; RECOVERY; OBJECTS	Linear camera responses are required for recovering the total amount of incident irradiance, quantitative image analysis, spectral reconstruction from camera responses and characterisation of spectral sensitivity curves. Two commercially-available digital cameras equipped with Bayer filter arrays and sensitive to visible and near-UV radiation were characterised using biexponential and Bezier curves. Both methods successfully fitted the entire characteristic curve of the tested devices, allowing for an accurate recovery of linear camera responses, particularly those corresponding to the middle of the exposure range. Nevertheless the two methods differ in the nature of the required input parameters and the uncertainty associated with the recovered linear camera responses obtained at the extreme ends of the exposure range. Here we demonstrate the use of both methods for retrieving information about scene irradiance, describing and quantifying the uncertainty involved in the estimation of linear camera responses.	[Garcia, Jair E.; Greentree, Andrew D.; Spring, Gale; Wilksch, Philip A.] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Garcia, Jair E.; Dyer, Adrian G.] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Garcia, JE (corresponding author), RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia.	jirgarci@gmail.com	Greentree, Andrew D/A-8503-2008; Wilksch, Philip/I-3888-2019	Greentree, Andrew D/0000-0002-3505-9163; Wilksch, Philip/0000-0003-1552-0263; Garcia, Jair/0000-0001-8456-4759	Colfuturo (Colombia) [200818772]; Australian Research Council [DP0878968, DP0987989, DP0880466]	Colfuturo (Colombia); Australian Research Council(Australian Research Council)	Jair E. Garcia was partially supported by Colfuturo 200818772 (Colombia). A. G. D. was supported by Australian Research Council DP0878968/DP0987989. A. D. G. acknowledges the Australian Research Council for financial support (Project No DP0880466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E., 2011, MANUAL PHOTOGRAPHY, P263; Alsam A, 2007, J OPT SOC AM A, V24, P2505, DOI 10.1364/JOSAA.24.002505; Alsam A, 2007, J OPT SOC AM A, V24, P11, DOI 10.1364/JOSAA.24.000011; [Anonymous], 2002, APPL PHOTOGRAPHIC OP, DOI 10.4324/9780080499253; Barnard K, 2002, COLOR RES APPL, V27, P152, DOI 10.1002/col.10050; Berube Y, 1999, COLOR CAMERA CHARACT; Cassey P, 2012, BIOL J LINN SOC, V106, P657, DOI 10.1111/j.1095-8312.2012.01877.x; Cheung T. L. V., 2003, Final Program and Proceedings of the Digital Photography Conference 2003, P366; Dyer AG, 2004, J FORENSIC SCI, V49, P1056; Garcia JE, 2014, J FORENSIC SCI, V59, P117, DOI 10.1111/1556-4029.12274; Garcia JE, 2013, J EXP BIOL, V216, P4290, DOI 10.1242/jeb.094045; Hansford D., 2002, HDB COMPUTER AIDED G, P75, DOI [10.1016/B978-044451104-1/50005-8, DOI 10.1016/B978-044451104-1/50005-8]; Heikkinen V, 2008, J OPT SOC AM A, V25, P2444, DOI 10.1364/JOSAA.25.002444; Holst GC., 2007, CMOS CCD SENSORS CAM; ISO, 2009, 14594 ISO; Jenkin R., 2011, MANUAL PHOTOGRAPHY, P155; KAWAI S, 1995, IEEE T ELECTRON DEV, V42, P652, DOI 10.1109/16.372069; Khan M, 2009, CUBIC BEZIER LEAST S; L'Ecuyer P, 2012, HDB COMPUTATIONAL ST, V2, P35, DOI 10.1007/978-3-642-21551-3_3; Zamora LL, 2012, J R SOC INTERFACE, V9, P1892, DOI 10.1098/rsif.2011.0809; Zamora LL, 2011, ANAL LETT, V44, P1674, DOI 10.1080/00032719.2010.520394; Lee H.-C., 2005, INTRO COLOR IMAGING; Martinez-Verdu F, 2003, J IMAGING SCI TECHN, V47, P279; Morovic P, 2006, J OPT SOC AM A, V23, P1814, DOI 10.1364/JOSAA.23.001814; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimano N, 2007, J OPT SOC AM A, V24, P3211, DOI 10.1364/JOSAA.24.003211; Shimano N, 2010, J OPT SOC AM A, V27, P251, DOI 10.1364/JOSAA.27.000251; Shrestha M, 2013, NEW PHYTOL, V198, P301, DOI 10.1111/nph.12135; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Westland S, 2004, COMPUTATIONAL COLOR; Williams A. Robin, 1993, Journal of Biological Photography, V61, P115; Wright FD, 2010, FORENSIC SCI INT, V201, P59, DOI 10.1016/j.forsciint.2010.03.013; Young MJ, 2011, J ANIM ECOL, V80, P183, DOI 10.1111/j.1365-2656.2010.01759.x; Zhang XD, 2008, J OPT SOC AM A, V25, P371, DOI 10.1364/JOSAA.25.000371	36	36	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79534	10.1371/journal.pone.0079534	http://dx.doi.org/10.1371/journal.pone.0079534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260244	Green Published, gold			2022-12-25	WOS:000327308500072
J	Ma, ZQ; Zhang, WW; Wang, L; Zhu, MJ; Wang, HX; Feng, WH; Ng, TB				Ma, Zengqiang; Zhang, Weiwei; Wang, Li; Zhu, Mengjuan; Wang, Hexiang; Feng, Wen-hai; Ng, Tzi Bun			A Novel Compound from the Mushroom Cryptoporus volvatus Inhibits Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) In Vitro	PLOS ONE			English	Article							AGARICUS-BRASILIENSIS; POLYSACCHARIDE; REPLICATION; CHINA; EXPRESSION; EMERGENCE; ACIDS	Porcine reproductive and respiratory syndrome (PRRS), caused by PRRS virus (PRRSV), is a serious contagious disease in the swine industry. At present, there are no effective control strategies against PRRSV. Thus, there is an urgent need for new treatment regimens that have efficacious antiviral activity to compensate for vaccines. The anti-infective effect of Cryptoporus volvatus has previously been demonstrated in Tradational Chinese Medicine. In this report, we expected to identify a new anti-PRRSV agent in the aqueous extract of C. volvatus, by employing a combination of modern chromatographic purification techniques and indirect immunofluorescence assay (IFA). Our results showed that C. volvatus extracts from every separation step differed in their inhibitory potency on PRRSV. One anti-PRRSV component designated as CM-H-L-5 was isolated from water-soluble fraction of C. volvatus. The inhibition induced by CM-H-L-5 occurred in a dose-dependent manner. CM-H-L-5 appeared to be a low-molecular-weight polyol fragment with amide groups and carboxylic acid groups. Collectively, our findings imply that CM-H-L-5 from the aqueous extract of C. volvatus has the potential to be used for anti-PRRSV therapy.	[Ma, Zengqiang; Zhang, Weiwei; Wang, Li; Zhu, Mengjuan; Wang, Hexiang; Feng, Wen-hai] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Ma, Zengqiang; Zhang, Weiwei; Wang, Li; Zhu, Mengjuan; Wang, Hexiang; Feng, Wen-hai] China Agr Univ, Dept Microbiol, Beijing 100094, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	China Agricultural University; China Agricultural University; Chinese University of Hong Kong	Wang, HX (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	hxwang@cau.edu.cn; whfeng@cau.edu.cn; b021770@mailserv.cuhk.edu.hk			National Grants of China [2010CB732202]	National Grants of China	This work was financially supported by National Grants of China (2010CB732202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKAWA Y, 1992, PHYTOCHEMISTRY, V31, P579, DOI 10.1016/0031-9422(92)90042-O; Cabrera GM, 2002, PHYTOCHEMISTRY, V61, P189, DOI 10.1016/S0031-9422(02)00221-2; De Francesco R, 2005, NATURE, V436, P953, DOI 10.1038/nature04080; Faccin LC, 2007, LETT APPL MICROBIOL, V45, P24, DOI 10.1111/j.1472-765X.2007.02153.x; Gao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063767; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Han X, 2009, ANTIVIR RES, V82, P59, DOI 10.1016/j.antiviral.2009.01.009; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Horrigan BJ, 2006, EXPLORE-NY, V2, P153, DOI 10.1016/j.explore.2005.12.011; Jansen BJM, 2004, NAT PROD REP, V21, P449, DOI 10.1039/b311170a; Jiang Y, 2011, PHYTOMEDICINE, V18, P189, DOI 10.1016/j.phymed.2010.04.010; Jin Sai-hong, 2003, Zhongguo Zhongyao Zazhi, V28, P650; Karuppannan AK, 2012, ANTIVIR RES, V94, P188, DOI 10.1016/j.antiviral.2012.03.008; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; KRAH DL, 1991, BIOLOGICALS, V19, P223, DOI 10.1016/1045-1056(91)90039-M; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mothana RAA, 2003, FITOTERAPIA, V74, P177, DOI 10.1016/S0367-326X(02)00305-2; NARISAWA T, 1992, JPN J CANCER RES, V83, P830, DOI 10.1111/j.1349-7006.1992.tb01987.x; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Ni JQ, 2012, J VET DIAGN INVEST, V24, P349, DOI 10.1177/1040638711434111; Patel D, 2008, ANTIVIR RES, V77, P95, DOI 10.1016/j.antiviral.2007.09.002; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Rowland RRR, 2001, ARCH VIROL, V146, P539, DOI 10.1007/s007050170161; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; SRINIVAS RV, 1993, ANTIMICROB AGENTS CH, V37, P2247, DOI 10.1128/AAC.37.10.2247; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Wang CR, 2013, MOLECULES, V18, P1775, DOI 10.3390/molecules18021775; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Wu ZY, 1990, XIN HUA COMPENDIUM M; Xie QM, 2006, J ETHNOPHARMACOL, V107, P424, DOI 10.1016/j.jep.2006.03.040; Xu J.T., 1997, CHINESE MED MYCOLOGY; Yamamoto KA, 2013, INT J BIOL MACROMOL, V52, P9, DOI 10.1016/j.ijbiomac.2012.09.029; Yao HY, 2011, J ETHNOPHARMACOL, V137, P1267, DOI 10.1016/j.jep.2011.07.058; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x; Zjawiony JK, 2004, J NAT PROD, V67, P300, DOI 10.1021/np030372w	39	6	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79333	10.1371/journal.pone.0079333	http://dx.doi.org/10.1371/journal.pone.0079333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260198	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500045
J	Peng, CM; Ma, JL; Gao, X; Tian, P; Li, WZ; Zhang, L				Peng, Chaoming; Ma, Junli; Gao, Xue; Tian, Peng; Li, Wenzhang; Zhang, Lei			High Glucose Induced Oxidative Stress and Apoptosis in Cardiac Microvascular Endothelial Cells Are Regulated by FoxO3a	PLOS ONE			English	Article							INDUCTION; PROTEINS; PATHWAY; FAMILY; CANCER; INJURY; SERUM; BIM	Aim: Cardiac microvascular endothelial cells (CMECs) dysfunction contributes to cardiovascular complications in diabetes, whereas, the underlying mechanism is not fully clarified. FoxO transcription factors are involved in apoptosis and reactive oxygen species (ROS) production. Therefore, the present study was designed to elucidate the potential role of FoxO3a on the CMECs injury induced by high glucose. Materials and Methods: CMECs were isolated from hearts of adult rats and cultured in normal or high glucose medium for 6 h, 12 h and 24 h respectively. To down-regulate FoxO3a expression, CMECs were transfected with FoxO3a siRNA. ROS accumulation and apoptosis in CMECs were assessed by dihydroethidine (DHE) staining and TUNEL assay respectively. Moreover, the expressions of Akt, FoxO3a, Bim and BclxL in CMECs were assessed by Western blotting assay. Results: ROS accumulation in CMECs was significantly increased after high glucose incubation for 6 to 24 h. Meanwhile, high glucose also increased apoptosis in CMECs, correlated with decreased the phosphorylation expressions of Akt and FoxO3a. Moreover, high glucose incubation increased the expression of Bim, whereas increased anti-apoptotic protein BclxL. Furthermore, siRNA target FoxO3a silencing enhanced the ROS accumulation, whereas suppressed apoptosis in CMECs. FoxO3a silencing also abolished the disturbance of Bcl-2 proteins induced by high glucose in CMECs. Conclusion: Our data provide evidence that high glucose induced FoxO3a activation which suppressed ROS accumulation, and in parallel, resulted in apoptosis of CMECs.	[Peng, Chaoming; Tian, Peng; Li, Wenzhang; Zhang, Lei] Chengdu Med Coll, Affiliated Hosp 1, Dept Gen Internal Med, Chengdu, Peoples R China; [Ma, Junli] PLA, Mil Hosp 3, Dept Nephrol, Baoji, Peoples R China; [Gao, Xue] Mil Gen Hosp Beijing PLA, Dept Ultrasonog, Beijing, Peoples R China	Chengdu Medical College	Zhang, L (corresponding author), Chengdu Med Coll, Affiliated Hosp 1, Dept Gen Internal Med, Chengdu, Peoples R China.	zhangl_pengcm@126.com						Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Avogaro A, 2006, NUTR METAB CARDIOVAS, V16, pS39, DOI 10.1016/j.numecd.2005.10.015; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chen SL, 2003, AM J PHYSIOL-CELL PH, V284, pC263, DOI 10.1152/ajpcell.00192.2002; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Folli F, 2011, CURR DIABETES REV, V7, P313, DOI 10.2174/157339911797415585; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Goyeneche AA, 2006, REPRODUCTION, V131, P103, DOI 10.1530/rep.1.00751; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Hao M, 2011, EUR J PHARMACOL, V654, P320, DOI 10.1016/j.ejphar.2010.12.030; Hendrickx J, 2004, PHYSIOL GENOMICS, V19, P198, DOI 10.1152/physiolgenomics.00143.2004; Huang XQ, 2012, J CELL BIOCHEM, V113, P857, DOI 10.1002/jcb.23415; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Li JM, 2001, J MOL CELL CARDIOL, V33, P1119, DOI 10.1006/jmcc.2001.1372; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Luan RH, 2009, CARDIOVASC RES, V83, P294, DOI 10.1093/cvr/cvp085; Luo H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.3; Mazzone T, 2010, CIRCULATION, V122, P2201, DOI 10.1161/CIRCULATIONAHA.109.913350; Millar TM, 2007, FREE RADICAL BIO MED, V42, P1165, DOI 10.1016/j.freeradbiomed.2007.01.015; Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514; Naudi A, 2012, EXP DIABETES RES, DOI 10.1155/2012/696215; Patlak Margie, 2002, FASEB Journal, V16, P1853, DOI 10.1096/fj.02-0974bkt; Powell-Coffman JA, 2010, NATURE, V465, P554, DOI 10.1038/465554a; Rao KS, 2009, INDIAN J BIOCHEM BIO, V46, P9; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Samarin J, 2010, J BIOL CHEM, V285, P4328, DOI 10.1074/jbc.M109.049650; Scarabelli T, 2001, CIRCULATION, V104, P253, DOI 10.1161/01.CIR.104.3.253; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Spinetti G, 2013, CIRC RES, V112, P510, DOI 10.1161/CIRCRESAHA.112.300598; Spinetti G, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300418; Sun DD, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-4; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Voulgari C, 2010, VASC HEALTH RISK MAN, V6, P883, DOI 10.2147/VHRM.S11681; Wang D, 2013, DIABETES; Wei W, 2009, HEMOGLOBIN, V33, P370, DOI 10.3109/03630260903212175; Zhang Z, 2011, INFLAMM RES, V60, P37, DOI 10.1007/s00011-010-0232-2	40	44	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79739	10.1371/journal.pone.0079739	http://dx.doi.org/10.1371/journal.pone.0079739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260294	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500095
J	Wade, CL; Krumenacher, P; Kitto, KF; Peterson, CD; Wilcox, GL; Fairbanks, CA				Wade, Carrie L.; Krumenacher, Perry; Kitto, Kelley F.; Peterson, Cristina D.; Wilcox, George L.; Fairbanks, Carolyn A.			Effect of Chronic Pain on Fentanyl Self-Administration in Mice	PLOS ONE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; SIGNAL-REGULATED KINASE; SPINAL NERVE LIGATION; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; NUCLEUS-ACCUMBENS; ANIMAL-MODEL; MORPHINE; RATS; VINCRISTINE	The development of opioid addiction in subjects with established chronic pain is an area that is poorly understood. It is critically important to clearly understand the neurobiology associated with propensity toward conversion to addiction under conditions of chronic pain. To pose the question whether the presence of chronic pain influences motivation to self-administer opioids for reward, we applied a combination of rodent models of chronic mechanical hyperalgesia and opioid self-administration. We studied fentanyl self-administration in mice under three conditions that induce chronic mechanical hyperalgesia: inflammation, peripheral nerve injury, and repeated chemotherapeutic injections. Responding for fentanyl was compared among these conditions and their respective standard controls (naive condition, vehicle injection or sham surgery). Acquisition of fentanyl self-administration behavior was reduced or absent in all three conditions of chronic hyperalgesia relative to control mice with normal sensory thresholds. To control for potential impairment in ability to learn the lever-pressing behavior or perform the associated motor tasks, all three groups were evaluated for acquisition of food-maintained responding. In contrast to the opioid, chronic hyperalgesia did not interfere with the reinforcing effect of food. These studies indicate that the establishment of chronic hyperalgesia is associated with reduced or ablated motivation to seek opioid reward in mice.	[Wade, Carrie L.; Wilcox, George L.; Fairbanks, Carolyn A.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Krumenacher, Perry; Kitto, Kelley F.; Wilcox, George L.; Fairbanks, Carolyn A.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Peterson, Cristina D.; Fairbanks, Carolyn A.] Univ Minnesota, Dept Pharmaceut, Minneapolis, MN 55455 USA; [Wade, Carrie L.; Krumenacher, Perry; Kitto, Kelley F.; Peterson, Cristina D.; Wilcox, George L.; Fairbanks, Carolyn A.] Univ Minnesota, Ctr Pain Res, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Fairbanks, CA (corresponding author), Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	carfair@umn.edu		Fairbanks, Carolyn/0000-0003-4252-8586; Wilcox, George/0000-0002-6411-0423; Peterson, Cristina/0000-0001-7132-5310	NIH/NIDA [F31DA021054];  [R21 DA23545 NIH/NIDA]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA021054, R21DA023545] Funding Source: NIH RePORTER	NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for the project was provided to C. A. Fairbanks by R21 DA23545 NIH/NIDA; C. L. Wade was supported by F31DA021054, NIH/NIDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aley KO, 1996, NEUROSCIENCE, V73, P259, DOI 10.1016/0306-4522(96)00020-6; Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Authier N, 2003, NEUROTOXICOLOGY, V24, P797, DOI 10.1016/S0161-813X(03)00043-3; Bailey JA, 2010, PAIN MED, V11, P1803, DOI 10.1111/j.1526-4637.2010.00982.x; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Ballantyne JC, 2007, PAIN, V129, P235, DOI 10.1016/j.pain.2007.03.028; Barrueto F, 2004, VET HUM TOXICOL, V46, P30; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P352, DOI 10.1007/BF02244932; Berhow MT, 1996, J NEUROSCI, V16, P4707; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Betourne A, 2008, NEUROSCIENCE, V157, P12, DOI 10.1016/j.neuroscience.2008.08.045; Colpaert FC, 2001, PAIN, V91, P33, DOI 10.1016/S0304-3959(00)00413-9; Ewan EE, 2011, ANESTHESIOLOGY, V115, P1271, DOI 10.1097/ALN.0b013e3182330448; Ewan EE, 2011, ANESTHESIOLOGY, V114, P624, DOI 10.1097/ALN.0b013e31820a4edb; Fairbanks CA, 2000, ANESTHESIOLOGY, V93, P765, DOI 10.1097/00000542-200009000-00026; Gutierrez T, 2011, PAIN, V152, P1976, DOI 10.1016/j.pain.2011.03.038; Institute of Medicine (IOM), 2011, REL PAIN AM BLUEPR T; Kiguchi N, 2008, EUR J PHARMACOL, V592, P87, DOI 10.1016/j.ejphar.2008.07.008; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Koob GF, 2008, PHILOS T R SOC B, V363, P3113, DOI 10.1098/rstb.2008.0094; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lynch JJ, 2005, EUR J PHARMACOL, V509, P43, DOI 10.1016/j.ejphar.2004.12.034; LYNESS WH, 1989, LIFE SCI, V45, P2217, DOI 10.1016/0024-3205(89)90062-3; Martin TJ, 2008, EXP CLIN PSYCHOPHARM, V16, P357, DOI 10.1037/a0013597; Martin TJ, 2006, PAIN, V125, P257, DOI 10.1016/j.pain.2006.05.027; Martin TJ, 2007, ANESTHESIOLOGY, V106, P312, DOI 10.1097/00000542-200702000-00020; Narita M, 2006, NEUROPSYCHOPHARMACOL, V31, P739, DOI 10.1038/sj.npp.1300858; Niikura K, 2008, NEUROSCI LETT, V435, P257, DOI 10.1016/j.neulet.2008.02.059; Nunez-Olarte JM, 2011, J PAIN SYMPTOM MANAG, V42, pE6, DOI 10.1016/j.jpainsymman.2011.07.006; Ozaki S, 2004, J NEUROCHEM, V88, P1389, DOI 10.1046/j.1471-4159.2003.02272.x; Passik SD, 2011, J PAIN SYMPTOM MANAG, V41, P116, DOI 10.1016/j.jpainsymman.2010.03.012; Rahn EJ, 2007, BRIT J PHARMACOL, V152, P765, DOI 10.1038/sj.bjp.0707333; SHAHAM Y, 1993, PHARMACOL BIOCHEM BE, V46, P315, DOI 10.1016/0091-3057(93)90359-2; TZSCHENTKE TM, 1995, NEUROSCI LETT, V193, P37, DOI 10.1016/0304-3940(95)11662-G; Urban MO, 1999, P NATL ACAD SCI USA, V96, P7687, DOI 10.1073/pnas.96.14.7687; Wade CL, 2008, EUR J PHARMACOL, V587, P135, DOI 10.1016/j.ejphar.2008.04.007; Woodall KL, 2008, J FORENSIC SCI, V53, P222, DOI 10.1111/j.1556-4029.2007.00597.x; Woolf CJ, 2004, ANN INTERN MED, V140, P441, DOI 10.7326/0003-4819-140-8-200404200-00010; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; Zhu CZ, 2004, EUR J PHARMACOL, V506, P107, DOI 10.1016/j.ejphar.2004.11.005; Zieglgansberger W, 2005, CNS SPECTRUMS, V10, P298, DOI 10.1017/S1092852900022628	42	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79239	10.1371/journal.pone.0079239	http://dx.doi.org/10.1371/journal.pone.0079239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260176	Green Submitted, gold, Green Published			2022-12-25	WOS:000327258600023
J	Zhu, J; Wang, J; Shi, Z; Franklin, JL; Deane, NG; Coffey, RJ; Beauchamp, RD; Zhang, B				Zhu, Jing; Wang, Jing; Shi, Zhiao; Franklin, Jeffrey L.; Deane, Natasha G.; Coffey, Robert J.; Beauchamp, R. Daniel; Zhang, Bing			Deciphering Genomic Alterations in Colorectal Cancer through Transcriptional Subtype-Based Network Analysis	PLOS ONE			English	Article							HUMAN COLON-CANCER; GENE-EXPRESSION; HUMAN BREAST; CARCINOMA; IDENTIFICATION; BEVACIZUMAB; PATHWAYS; MODELS; CLASSIFICATION; TRANSITIONS	Both transcriptional subtype and signaling network analyses have proved useful in cancer genomics research. However, these two approaches are usually applied in isolation in existing studies. We reason that deciphering genomic alterations based on cancer transcriptional subtypes may help reveal subtype-specific driver networks and provide insights for the development of personalized therapeutic strategies. In this study, we defined transcriptional subtypes for colorectal cancer (CRC) and identified driver networks/pathways for each subtype. Applying consensus clustering to a patient cohort with 1173 samples identified three transcriptional subtypes, which were validated in an independent cohort with 485 samples. The three subtypes were characterized by different transcriptional programs related to normal adult colon, early colon embryonic development, and epithelial mesenchymal transition, respectively. They also showed statistically different clinical outcomes. For each subtype, we mapped somatic mutation and copy number variation data onto an integrated signaling network and identified subtype-specific driver networks using a random walk-based strategy. We found that genomic alterations in the Wnt signaling pathway were common among all three subtypes; however, unique combinations of pathway alterations including Wnt, VEGF and Notch drove distinct molecular and clinical phenotypes in different CRC subtypes. Our results provide a coherent and integrated picture of human CRC that links genomic alterations to molecular and clinical consequences, and which provides insights for the development of personalized therapeutic strategies for different CRC subtypes.	[Zhu, Jing; Wang, Jing; Zhang, Bing] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Shi, Zhiao] Vanderbilt Univ, Adv Comp Ctr Res & Educ, Nashville, TN 37235 USA; [Shi, Zhiao] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA; [Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA; [Franklin, Jeffrey L.; Coffey, Robert J.; Beauchamp, R. Daniel] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Deane, Natasha G.; Beauchamp, R. Daniel] Vanderbilt Univ, Dept Surg, Nashville, TN 37235 USA; [Deane, Natasha G.] Vanderbilt Univ, Dept Radiol, Nashville, TN 37235 USA; [Deane, Natasha G.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Beauchamp, R. Daniel; Zhang, Bing] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zhang, B (corresponding author), Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA.	bing.zhang@vanderbilt.edu		Beauchamp, Robert Daniel/0000-0002-8446-4114	United States Public Health Service [GM088822, CA126479, CA159988, CA095103, CA069457, DK052334, CA068485]; NATIONAL CANCER INSTITUTE [R01CA069457, P50CA095103, U24CA126479, R01CA046413, P30CA068485, U24CA159988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052334, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088822] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from United States Public Health Service grants GM088822, CA126479, CA159988, CA095103, CA069457, DK052334, and CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; Ardekani GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047054; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; De Gramont A, 2011, J CLIN ONCOL S4, V29; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ellis L M, 2000, Oncologist, V5 Suppl 1, P11; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Meyerhardt JA, 2012, J CLIN ONCOL, V30, P608, DOI 10.1200/JCO.2011.38.9650; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Park YK, 2005, GENESIS, V41, P1, DOI 10.1002/gene.20088; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Roth AD, 2012, JNCI-J NATL CANCER I, V104, P1635, DOI 10.1093/jnci/djs427; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041292; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wanami LS, 2008, EXP CELL RES, V314, P2448, DOI 10.1016/j.yexcr.2008.05.004; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2011, MOL BIOSYST, V7, P2118, DOI 10.1039/c1mb05014a	51	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79282	10.1371/journal.pone.0079282	http://dx.doi.org/10.1371/journal.pone.0079282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260186	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600027
J	Arnoldini, M; Heck, T; Blanco-Fernandez, A; Hammes, F				Arnoldini, Markus; Heck, Tobias; Blanco-Fernandez, Alfonso; Hammes, Frederik			Monitoring of Dynamic Microbiological Processes Using Real-Time Flow Cytometry	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIA; VIABILITY; PRODUCT; GROWTH	We describe a straightforward approach to continuously monitor a variety of highly dynamic microbiological processes in millisecond resolution with flow cytometry, using standard bench-top instrumentation. Four main experimental examples are provided, namely: (1) green fluorescent protein expression by antibiotic-stressed Escherichia coli, (2) fluorescent labeling of heat-induced membrane damage in an autochthonous freshwater bacterial community, (3) the initial growth response of late stationary E. coli cells inoculated into fresh growth media, and (4) oxidative disinfection of a mixed culture of auto-fluorescent microorganisms. These examples demonstrate the broad applicability of the method to diverse biological experiments, showing that it allows the collection of detailed, time-resolved information on complex processes.	[Arnoldini, Markus; Hammes, Frederik] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Microbiol, Dubendorf, Switzerland; [Arnoldini, Markus] ETH, Dept Environm Syst Sci, Zurich, Switzerland; [Heck, Tobias] Empa Swiss Fed Labs Mat Sci & Technol, Lab Biomat, St Gallen, Switzerland; [Blanco-Fernandez, Alfonso] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Flow Cytometry Core Facil, Dublin 2, Ireland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); University College Dublin	Hammes, F (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Microbiol, Dubendorf, Switzerland.	frederik.hammes@eawag.ch		Blanco, Alfonso/0000-0003-0439-0838	SNF [31003A_130735]	SNF	Markus Arnoldini was supported by SNF grant 31003A_130735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berney M, 2006, APPL ENVIRON MICROB, V72, P2586, DOI 10.1128/AEM.72.4.2586-2593.2006; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Broger T, 2011, J BIOTECHNOL, V154, P240, DOI 10.1016/j.jbiotec.2011.05.003; Cooper S., 1991, BACTERIAL GROWTH DIV; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; GUDAS LJ, 1977, P NATL ACAD SCI USA, V74, P5280, DOI 10.1073/pnas.74.12.5280; Hammes F, 2006, WATER RES, V40, P2275, DOI 10.1016/j.watres.2006.04.029; Hammes F, 2012, CYTOM PART A, V81A, P508, DOI 10.1002/cyto.a.22048; Hammes F, 2011, ADV BIOCHEM ENG BIOT, V124, P123, DOI 10.1007/10_2010_95; JUAN G, 1994, CYTOMETRY, V15, P335, DOI 10.1002/cyto.990150409; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Lage OM, 2001, CYTOMETRY, V44, P226, DOI 10.1002/1097-0320(20010701)44:3<226::AID-CYTO1115>3.0.CO;2-9; Lequerica JL, 2006, J PHYSIOL BIOCHEM, V62, P253, DOI 10.1007/BF03165754; MARTIN JC, 1980, SCIENCE, V207, P199, DOI 10.1126/science.6153131; Monteiro MD, 1999, CYTOMETRY, V35, P302; Nolan JP, 1998, NAT BIOTECHNOL, V16, P633, DOI 10.1038/nbt0798-633; Olofsson SK, 2006, J ANTIMICROB CHEMOTH, V57, P1116, DOI 10.1093/jac/dkl135; PIDDOCK LJV, 1990, ANTIMICROB AGENTS CH, V34, P2331, DOI 10.1128/AAC.34.12.2331; PREMAZZI G, 1989, WATER RES, V23, P431, DOI 10.1016/0043-1354(89)90134-6; PREST EI, 2013, WATER RES, P83559; Ramseier MK, 2011, WATER RES, V45, P1490, DOI 10.1016/j.watres.2010.11.016; Rohacova J, 2009, CHEMMEDCHEM, V4, P466, DOI 10.1002/cmdc.200800383; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; SHAPIRO HM, 1983, CYTOMETRY, V3, P227, DOI 10.1002/cyto.990030402; Shi L, 2007, CYTOM PART A, V71A, P592, DOI 10.1002/cyto.a.20402; Silander OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002443; SKARSTAD K, 1983, J BACTERIOL, V154, P656, DOI 10.1128/JB.154.2.656-662.1983; Vila-Costa M, 2012, ENVIRON MICROBIOL, V14, P1390, DOI 10.1111/j.1462-2920.2012.02720.x; Vines A, 2010, CYTOM PART A, V77A, P1091, DOI 10.1002/cyto.a.20974; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	34	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80117	10.1371/journal.pone.0080117	http://dx.doi.org/10.1371/journal.pone.0080117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244624	Green Published, gold			2022-12-25	WOS:000327143800124
J	Sanghavi, P; Laxani, S; Li, X; Bullock, SL; Gonsalvez, GB				Sanghavi, Paulomi; Laxani, Shobha; Li, Xuan; Bullock, Simon L.; Gonsalvez, Graydon B.			Dynein Associates with oskar mRNPs and Is Required For Their Efficient Net Plus-End Localization in Drosophila Oocytes	PLOS ONE			English	Article							MESSENGER-RNA LOCALIZATION; DORSAL-VENTRAL AXIS; POSTERIOR LOCALIZATION; CYTOPLASMIC DYNEIN; INTRACELLULAR-TRANSPORT; TRANSLATIONAL REGULATION; ANTERIOR-POSTERIOR; MICROTUBULE MOTOR; CELL-FORMATION; HEAVY-CHAIN	In order for eukaryotic cells to function properly, they must establish polarity. The Drosophila oocyte uses mRNA localization to establish polarity and hence provides a genetically tractable model in which to study this process. The spatial restriction of oskar mRNA and its subsequent protein product is necessary for embryonic patterning. The localization of oskar mRNA requires microtubules and microtubule-based motor proteins. Null mutants in Kinesin heavy chain (Khc), the motor subunit of the plus end-directed Kinesin-1, result in oskar mRNA delocalization. Although the majority of oskar particles are non-motile in khc nulls, a small fraction of particles display active motility. Thus, a motor other than Kinesin-1 could conceivably also participate in oskar mRNA localization. Here we show that Dynein heavy chain (Dhc), the motor subunit of the minus end-directed Dynein complex, extensively co-localizes with Khc and oskar mRNA. In addition, immunoprecipitation of the Dynein complex specifically co-precipitated oskar mRNA and Khc. Lastly, germline-specific depletion of Dhc resulted in oskar mRNA and Khc delocalization. Our results therefore suggest that efficient posterior localization of oskar mRNA requires the concerted activities of both Dynein and Kinesin-1.	[Sanghavi, Paulomi; Laxani, Shobha; Gonsalvez, Graydon B.] Georgia Regents Univ, Augusta, GA 30904 USA; [Li, Xuan; Bullock, Simon L.] MRC, Mol Biol Lab, Div Cell Biol, Cambridge CB2 2QH, England	University System of Georgia; Augusta University; MRC Laboratory Molecular Biology	Gonsalvez, GB (corresponding author), Georgia Regents Univ, Augusta, GA 30904 USA.	ggonsalvez@gru.edu		Bullock, Simon/0000-0001-9491-4548; Sanyal, Subhabrata/0000-0003-2590-2732	American Society [123887-RSG-13-006-01-CCG]; National Institutes of Health [1R01GM100088-01A1]; MRC [U105178790]; Lister Institute Research Prize; MRC [MC_U105178790] Funding Source: UKRI; Medical Research Council [MC_U105178790] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100088] Funding Source: NIH RePORTER	American Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute Research Prize; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Graydon B. Gonsalvez was supported by grants from the American Society (123887-RSG-13-006-01-CCG) and the National Institutes of Health (1R01GM100088-01A1). Simon Bullock was supported by MRC core funding (U105178790) and a Lister Institute Research Prize. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Bullock SL, 2011, BIOCHEM SOC T, V39, P1161, DOI 10.1042/BST0391161; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gonsalvez Graydon B, 2012, F1000 Biol Rep, V4, P16, DOI 10.3410/B4-16; Gonsalvez GB, 2010, DEVELOPMENT, V137, P2341, DOI 10.1242/dev.042721; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Jolly AL, 2011, BIOCHEM SOC T, V39, P1126, DOI 10.1042/BST0391126; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; LI MG, 1994, J CELL BIOL, V126, P1475, DOI 10.1083/jcb.126.6.1475; Li X, 2010, EMBO J, V29, P992, DOI 10.1038/emboj.2009.410; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Liu Z, 1999, DEVELOPMENT, V126, P4477; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; McGrail M, 1997, DEVELOPMENT, V124, P2409; Melkonian KA, 2007, J BIOL CHEM, V282, P19355, DOI 10.1074/jbc.M700003200; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Sanghavi P, 2012, DEV BIOL, V367, P66, DOI 10.1016/j.ydbio.2012.04.024; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; SMITH JL, 1992, CELL, V70, P849, DOI 10.1016/0092-8674(92)90318-7; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Wilhelm JE, 2005, BIOL CELL, V97, P235, DOI 10.1042/BC20040097; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Zhao TT, 2012, SCIENCE, V336, P999, DOI 10.1126/science.1219147; Zimyanin V, 2007, CURR BIOL, V17, P353, DOI 10.1016/j.cub.2006.12.044; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	55	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80605	10.1371/journal.pone.0080605	http://dx.doi.org/10.1371/journal.pone.0080605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244700	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600212
J	Souza, TML; Resende, PC; Fintelman-Rodrigues, N; Gregianini, TS; Ikuta, N; Fernandes, SB; Cury, ALF; Rosa, MDD; Siqueira, MM				Souza, Thiago Moreno L.; Resende, Paola C.; Fintelman-Rodrigues, Natalia; Gregianini, Tatiana Schaffer; Ikuta, Nilo; Fernandes, Sandra Bianchini; Furtado Cury, Ana Luisa; Debur Rosa, Maria do Carmo; Siqueira, Marilda M.			Detection of Oseltamivir-Resistant Pandemic Influenza A(H1N1)pdm2009 in Brazil: Can Community Transmission Be Ruled Out?	PLOS ONE			English	Article							DRUG-RESISTANCE; VIRUS	Although surveillance efforts that monitor the emergence of drug-resistant strains of influenza are critical, systematic analysis is overlooked in most developing countries. We report on the occurrence of strains of pandemic influenza A(H1N1)pdm09 with resistance and decreased susceptibility to oseltamivir (OST) in Brazil in 2009, 2011 and 2012. We found 7 mutant viruses, 2 with the mutation S247N and other 5 with the mutation H275Y. Most of these viruses were from samples concentrated in the southern region of Brazil. Some of these resistant viruses were detected prior to the initiation of OST treatment, suggesting that community transmission of mutant viruses may exist. Moreover, we show that one of these OST-resistant (H275Y) strains of A(H1N1) pdm09 was discovered in the tri-border region between Brazil, Argentina and Paraguay, highlighting that this strain could also be found in other Latin American countries. Our findings reinforce the importance of enhanced antiviral resistance surveillance in Brazil and in other Latin American countries to confirm or rule out the community transmission of OST-resistant strains of A(H1N1)pdm09.	[Souza, Thiago Moreno L.; Resende, Paola C.; Fintelman-Rodrigues, Natalia; Siqueira, Marilda M.] Inst Oswaldo Cruz Fiocruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil; [Gregianini, Tatiana Schaffer] Fundacao Estadual Prod & Pesquisa Saude Secao Vir, Lab Cent Saude Publ Estado Rio de Grande do Sul, Porto Alegre, RS, Brazil; [Fernandes, Sandra Bianchini] Lab Cent Saude Publ Estado Santa Catarina, Florianopolis, SC, Brazil; [Furtado Cury, Ana Luisa] Inst Octavio Magalhaes Fundacao Ezequiel Dias, Lab Cent Saude Publ Estado Minas Gerais, Belo Horizonte, MG, Brazil; [Debur Rosa, Maria do Carmo] Lab Cent Saude Publ Estado Parana, Curitiba, Parana, Brazil; [Ikuta, Nilo] Univ Luterana Brasil, Porto Alegre, RS, Brazil	Fundacao Oswaldo Cruz; Universidade Luterana do Brasil	Souza, TML (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil.	tmoreno@ioc.fiocruz.br	Resende, Paola Cristina/P-5002-2015; Souza, Thiago Moreno L./G-2900-2012	Resende, Paola Cristina/0000-0002-2884-3662; Souza, Thiago Moreno L./0000-0003-2212-3899; Ikuta, Nilo/0000-0002-5598-5340	Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit; SVS; CNPq; FAPERJ; IOC/Fiocruz	Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit; SVS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); IOC/Fiocruz	The work was supported by Instituto Oswaldo Cruz/Fiocruz (www.ioc.fiocruz.br) and Brazilian Ministry of Health/Decit and SVS (http://dtr2001.saude.gov.br/sctie/decit/index.htm). MMS was supported in part by individual research grants from CNPq (www.cnpq.br). MMS and TLMS used, in part, individual research grants from FAPERJ (www.faperj.br) and CNPq. Thanks are also due to IOC/Fiocruz for providing PCR and NFR fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Barrero PR, 2011, J VIROL, V85, P1058, DOI 10.1128/JVI.00936-10; Deyde VM, 2010, ANTIMICROB AGENTS CH, V54, P1102, DOI 10.1128/AAC.01417-09; Fry AM, 2012, J INFECT DIS, V206, P145, DOI 10.1093/infdis/jis338; Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Hurt AC, 2011, EUROSURVEILLANCE, V16, P2; *MIN SAUD, 2009, PROT MAN CLIN VIG EP; Ministerio da Saude, 2012, INF TECN CAMP NAC VA; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Roseira AM, 2006, FOZ IGUACU CIDADE RE, P171; Seibert CW, 2012, J VIROL, V86, P5386, DOI 10.1128/JVI.00151-12; Souza TML, 2011, DIAGN MICR INFEC DIS, V71, P98, DOI 10.1016/j.diagmicrobio.2011.05.006; Souza TML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014158; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; WHO, 2012, LAB METH TEST ANT SU; WHO Global Influenza Network, 2011, AN LAB DIAGN VIR SUR, P153; World Health Organization, 2009, CDC PROT REALT RTPCR	18	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80081	10.1371/journal.pone.0080081	http://dx.doi.org/10.1371/journal.pone.0080081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244615	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600178
J	Baker, JG; Proudman, RGW; Hill, SJ				Baker, Jillian G.; Proudman, Richard G. W.; Hill, Stephen J.			Impact of Polymorphic Variants on the Molecular Pharmacology of the Two-Agonist Conformations of the Human beta 1-Adrenoceptor	PLOS ONE			English	Article							ADRENERGIC-RECEPTOR POLYMORPHISMS; INTRINSIC SYMPATHOMIMETIC ACTIVITY; HUMAN BETA(1)-ADRENERGIC RECEPTOR; HEART-FAILURE PATIENTS; BETA-ADRENOCEPTORS; DILATED CARDIOMYOPATHY; ATRIAL-FIBRILLATION; GENE POLYMORPHISMS; PROVIDE EVIDENCE; AFFINITY STATES	beta-blockers are widely used to improve symptoms and prolong life in heart disease primarily by inhibiting the actions of endogenous catecholamines at the beta 1-adrenoceptor. There are two common naturally occurring polymorphisms within the human beta 1-adrenoceptor sequence: Ser or Gly at position 49 in the N-terminus and Gly or Arg at position 389 in the C-terminus and some clinical studies have suggested that expression of certain variants may be associated with disease and affect response to treatment with beta-blockers. The beta 1-adrenoceptor also exists in two agonist conformations - a high affinity catecholamine conformation and a low affinity secondary agonist conformation. Receptor- effector coupling and intracellular signalling from the different conformations may be affected by the polymorphic variants. Here, we examine in detail the molecular pharmacology of the beta 1-adrenoceptor polymorphic variants with respect to ligand affinity, efficacy, activation of the different agonist conformations and signal transduction and determine whether the polymorphic variants do indeed affect this secondary conformation. Stable cell lines expressing the wildtype and polymorphic variants were constructed and receptor pharmacology examined using whole cell binding and intracellular secondary messenger techniques. There was no difference in affinity for agonists and antagonists at the human wildtype beta 1-adrenoceptor (Ser49/Gly389) and the polymorphic variants Gly49/Gly389 and Ser49/Arg389. Furthermore, the polymorphic variant receptors both have two active agonist conformations with pharmacological properties similar to the wildtype receptor. Although the polymorphism at position 389 is thought to occur in an intracellular domain important for Gs-coupling, the two agonist conformations of the polymorphic variants stimulate intracellular signalling pathways, including Gs-cAMP intracellular signalling, in a manner very similar to that of the wildtype receptor.	[Baker, Jillian G.; Proudman, Richard G. W.; Hill, Stephen J.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, Notts, England	University of Nottingham	Baker, JG (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, Notts, England.	jillian.baker@nottingham.ac.uk	Hill, Stephen J/M-6243-2018; Hill, Stephen/N-6753-2013	Hill, Stephen J/0000-0002-4424-239X; Hill, Stephen/0000-0002-4424-239X; baker, jillian/0000-0003-2371-8202	Wellcome Trust Clinician Scientist Fellowship [073377/Z/03/Z]; BBSRC [BB/CS077853/1]	Wellcome Trust Clinician Scientist Fellowship(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Clinician Scientist Fellowship awarded to JGB (grant number 073377/Z/03/Z) and BBSRC grant BB/CS077853/1. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleong RG, 2013, CIRC-ARRHYTHMIA ELEC, V6, P137, DOI 10.1161/CIRCEP.111.969618; Arch JRS, 2004, BRIT J PHARMACOL, V143, P517, DOI 10.1038/sj.bjp.0705991; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Baker JG, 2003, MOL PHARMACOL, V63, P1312, DOI 10.1124/mol.63.6.1312; Baker JG, 2005, J PHARMACOL EXP THER, V313, P1163, DOI 10.1124/jpet.104.082875; Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Baker JG, 2007, J PHARMACOL EXP THER, V320, P218, DOI 10.1124/jpet.106.113589; Biolo A, 2008, AM J CARDIOL, V102, P726, DOI 10.1016/j.amjcard.2008.04.070; Borjesson M, 2000, EUR HEART J, V21, P1853, DOI 10.1053/euhj.1999.1994; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Brodde OE, 2008, PHARMACOL THERAPEUT, V117, P1, DOI 10.1016/j.pharmthera.2007.07.002; Cresci S, 2009, J AM COLL CARDIOL, V54, P432, DOI 10.1016/j.jacc.2009.05.009; Davis Heather M, 2011, Curr Cardiol Rep, V13, P175, DOI 10.1007/s11886-011-0181-6; de Groote P, 2005, EUR J HEART FAIL, V7, P966, DOI 10.1016/j.ejheart.2004.10.006; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Granneman JG, 2001, AM J PHYSIOL-ENDOC M, V280, pE199, DOI 10.1152/ajpendo.2001.280.2.E199; HEITZ A, 1983, BRIT J PHARMACOL, V80, P711, DOI 10.1111/j.1476-5381.1983.tb10062.x; Huntgeburth M, 2011, CLIN RES CARDIOL, V100, P641, DOI 10.1007/s00392-011-0288-1; IREDALE PA, 1993, BRIT J PHARMACOL, V110, P1305, DOI 10.1111/j.1476-5381.1993.tb13960.x; JASPER JR, 1990, MOL PHARMACOL, V37, P44; JASPER JR, 1988, FASEB J, V2, P2891, DOI 10.1096/fasebj.2.13.2901994; Johnson JA, 2011, CLIN PHARMACOL THER, V89, P366, DOI 10.1038/clpt.2010.315; Johnson JA, 2003, CLIN PHARMACOL THER, V74, P44, DOI 10.1016/S0009-9236(03)00068-7; Joseph SS, 2004, BRIT J PHARMACOL, V142, P51, DOI 10.1038/sj.bjp.0705753; Joseph SS, 2003, N-S ARCH PHARMACOL, V368, P496, DOI 10.1007/s00210-003-0835-z; Karlsson J, 2004, CLIN CARDIOL, V27, P347, DOI 10.1002/clc.4960270610; Kaumann AJ, 2008, PHARMACOL THERAPEUT, V118, P303, DOI 10.1016/j.pharmthera.2008.03.009; Konkar AA, 2000, J PHARMACOL EXP THER, V294, P923; Levin MC, 2002, J BIOL CHEM, V277, P30429, DOI 10.1074/jbc.M200681200; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Liu J, 2003, CLIN PHARMACOL THER, V74, P372, DOI 10.1016/S0009-9236(03)00224-8; Liu WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037659; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnusson Y, 2005, CLIN PHARMACOL THER, V78, P221, DOI 10.1016/j.clpt.2005.06.004; Maqbool A, 1999, LANCET, V353, P897, DOI 10.1016/S0140-6736(99)00549-8; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; McLean RC, 2012, AM J CARDIOL, V110, P1001, DOI 10.1016/j.amjcard.2012.05.029; Megson AC, 2001, MOL PHARMACOL, V59, P1012, DOI 10.1124/mol.59.5.1012; Metra M, 2010, CARDIOVASC DRUG THER, V24, P49, DOI 10.1007/s10557-010-6220-5; Molenaar P, 2007, CLIN EXP PHARMACOL P, V34, P1020, DOI 10.1111/j.1440-1681.2007.04730.x; Molenaar P, 2003, BRIT J PHARMACOL, V140, P1, DOI 10.1038/sj.bjp.0705420; Nicoulina S, 2010, GENET TEST MOL BIOMA, V14, P249, DOI 10.1089/gtmb.2009.0100; O'Shaughnessy KM, 2000, CLIN SCI, V99, P233, DOI 10.1042/CS20000030; Parvez B, 2012, J AM COLL CARDIOL, V59, P49, DOI 10.1016/j.jacc.2011.08.061; Perez JM, 2003, NAT MED, V9, P1300, DOI 10.1038/nm930; Petersen M, 2012, CLIN EXP PHARMACOL P, V39, P779, DOI 10.1111/j.1440-1681.2012.05736.x; Petersen M, 2011, BRIT J CLIN PHARMACO, V71, P556, DOI 10.1111/j.1365-2125.2010.03868.x; Rathz DA, 2002, J CARDIOVASC PHARM, V39, P155, DOI 10.1097/00005344-200202000-00001; Rau T, 2012, CLIN PHARMACOL THER, V92, P21, DOI 10.1038/clpt.2012.18; Shin J, 2007, PHARMACOTHERAPY, V27, P874, DOI 10.1592/phco.27.6.874; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Sofowora GG, 2003, CLIN PHARMACOL THER, V73, P366, DOI 10.1016/S0009-9236(02)17734-4; STEPHENSON RP, 1956, BRIT J PHARMACOL, V11, P5109; Terra Steven G, 2005, Pharmacogenet Genomics, V15, P227, DOI 10.1097/01213011-200504000-00006; Tesson F, 1999, J MOL CELL CARDIOL, V31, P1025, DOI 10.1006/jmcc.1999.0947; WALTER M, 1984, N-S ARCH PHARMACOL, V327, P159, DOI 10.1007/BF00500912	59	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e77582	10.1371/journal.pone.0077582	http://dx.doi.org/10.1371/journal.pone.0077582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250787	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200008
J	Rajan, K; Bialek, W				Rajan, Kanaka; Bialek, William			Maximally Informative "Stimulus Energies" in the Analysis of Neural Responses to Natural Signals	PLOS ONE			English	Article							RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; NERVE; MODELS; CELLS	The concept of feature selectivity in sensory signal processing can be formalized as dimensionality reduction: in a stimulus space of very high dimensions, neurons respond only to variations within some smaller, relevant subspace. But if neural responses exhibit invariances, then the relevant subspace typically cannot be reached by a Euclidean projection of the original stimulus. We argue that, in several cases, we can make progress by appealing to the simplest nonlinear construction, identifying the relevant variables as quadratic forms, or "stimulus energies." Natural examples include non-phase-locked cells in the auditory system, complex cells in the visual cortex, and motion-sensitive neurons in the visual system. Generalizing the idea of maximally informative dimensions, we show that one can search for kernels of the relevant quadratic forms by maximizing the mutual information between the stimulus energy and the arrival times of action potentials. Simple implementations of this idea successfully recover the underlying properties of model neurons even when the number of parameters in the kernel is comparable to the number of action potentials and stimuli are completely natural. We explore several generalizations that allow us to incorporate plausible structure into the kernel and thereby restrict the number of parameters. We hope that this approach will add significantly to the set of tools available for the analysis of neural responses to complex, naturalistic stimuli.	[Rajan, Kanaka] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Rajan, K (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	krajan@princeton.edu		Rajan, Kanaka/0000-0003-2749-2917	Human Frontiers Science Program; Swartz Foundation; NSF [PHY{0957573}, CCF{0939370}]; WM Keck Foundation; Direct For Mathematical & Physical Scien [0957573] Funding Source: National Science Foundation	Human Frontiers Science Program(Human Frontier Science Program); Swartz Foundation; NSF(National Science Foundation (NSF)); WM Keck Foundation(W.M. Keck Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by the Human Frontiers Science Program, by the Swartz Foundation, by NSF Grants PHY{0957573 and CCF{0939370, and by the WM Keck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2002, NAT NEUROSCI, V5, P391, DOI 10.1038/nn0502-391; ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Arcas BAY, 2003, NEURAL COMPUT, V15, P1789, DOI 10.1162/08997660360675044; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Barlow Horace, 1995, P415; Bialek W., 2005, ARXIVORGQBIO0505003; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Bussgang J.J, 1952, 216 MIT RES LAB EL; Christianson GB, 2008, J NEUROSCI, V28, P446, DOI 10.1523/JNEUROSCI.1775-07.2007; Cover TM, 1991, ELEMENTS INFORM THEO; de Ruyter van Steveninck RR, 1988, P ROY SOC LOND B BIO, V234, P379; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DeWeese MR, 1999, NETWORK-COMP NEURAL, V10, P325, DOI 10.1088/0954-898X/10/4/303; Dimitrov AG, 2006, J COMPUT NEUROSCI, V20, P265, DOI 10.1007/s10827-006-6357-1; Dimitrov AG, 2009, J COMPUT NEUROSCI, V27, P309, DOI 10.1007/s10827-009-0144-8; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002249; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001111; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Gollisch T, 2006, NETWORK-COMP NEURAL, V17, P103, DOI 10.1080/09548980600569670; Gross CG, 2002, NEUROSCIENTIST, V8, P512, DOI 10.1177/107385802237175; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Javel E, 1988, AUDITORY FUNCTION NE, P515; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Marmarelis PZ, 1978, ANAL PHYSL SYSTEMS W; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Park I, 2011, ADV NEURAL INFORM PR, V25, P2357; Pillow JW, 2006, J VISION, V6, P414, DOI 10.1167/6.4.9; Rajan K, 2013, NEURAL COMPUT, V25, P1661, DOI 10.1162/NECO_a_00463; Recio-Spinoso A, 2005, J NEUROPHYSIOL, V93, P3615, DOI 10.1152/jn.00882.2004; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Rust NC, 2004, NEUROCOMPUTING; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Tkacik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020409; VICTOR JD, 1988, J PHYSIOL-LONDON, V405, P289, DOI 10.1113/jphysiol.1988.sp017334; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Victor JD, 2005, NAT NEUROSCI, V8, P1651, DOI 10.1038/nn1607; WICK GC, 1950, PHYS REV, V80, P268, DOI 10.1103/PhysRev.80.268	46	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e71959	10.1371/journal.pone.0071959	http://dx.doi.org/10.1371/journal.pone.0071959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250780	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200001
J	Xu, JC; Duan, XM; Wu, H; Zhou, Q				Xu, Jiancheng; Duan, Xiumei; Wu, Hui; Zhou, Qi			Surveillance and Correlation of Antimicrobial Usage and Resistance of Pseudomonas aeruginosa: A Hospital Population-Based Study	PLOS ONE			English	Article							RISK-FACTORS; ACQUISITION; COLONIZATION; EPIDEMIOLOGY; PREVALENCE; MORTALITY; SPREAD; BURN	This retrospective study evaluated trends and association between resistance of Pseudomonas aeruginosa isolated from patients with hospital-acquired infections (HAIs) and hospital antimicrobial usage from 2003 through 2011 in a tertiary care hospital in northeast China. HAI was defined as occurrence of infection after hospital admission, without evidence that infection was present or incubating (<= 48 h) on admission. In vitro susceptibilities were determined by disk diffusion test and susceptibility profiles were determined using zone diameter interpretive criteria, as recommended by Clinical and Laboratory Standards Institute (CLSI). Data on usage of various antimicrobial agents, expressed as defined daily dose (DDD) per 1,000 patients-days developed by WHO Anatomical Therapeutical Chemical (ATC)/DDD index 2011, were collected from hospital pharmacy computer database. Most of 747 strains of P. aeruginosa were collected from respiratory samples (201 isolates, 26.9%), blood (179, 24.0%), secretions and pus (145, 19.4%) over the years. Time series analysis demonstrated a significant increase in resistance rates of P. aeruginosa to ticarcillin/clavulanic acid, piperacillin/tazobactam, cefoperazone/sulbactam, piperacillin, imipenem, meropenem, ceftazidime, cefepime, ciprofloxacin, and levofloxacin except aminoglycosides over time in the hospital (P<0.001). The rates of carbapenem-resistant P. aeruginosa (CRPA) isolated from patients with HAIs were 14.3%, 17.1%, 21.1%, 24.6%, 37.0%, 48.8%, 56.4%, 51.2%, and 54.1% over time. A significant increase in usage of anti-pseudomonal carbapenems (P<0.001) was seen. ARIMA models demonstrated that anti-pseudomonal carbapenems usage was strongly correlated with the prevalence of imipenem and meropenem-resistant P. aeruginosa (P<0.001). Increasing of quarterly CRPA was strongly correlated at one time lag with quarterly use of anti-pseudomonal carbapenems (P<0.001). Our data demonstrated positive correlation between anti-pseudomonal antimicrobial usage and P. aeruginosa resistance to several classes of antibiotics, but not all antimicrobial agents in the hospital.	[Xu, Jiancheng] Jilin Univ, Hosp 1, Dept Lab Med, Changchun 130023, Peoples R China; [Duan, Xiumei] Jilin Univ, Hosp 1, Dept Pathol, Changchun 130023, Peoples R China; [Wu, Hui; Zhou, Qi] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Wu, H (corresponding author), Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China.	wuhui97@126.com; qiqi0522@yeah.net		Wu, Hui/0000-0002-7649-4575; Zhou, Qi/0000-0002-5084-8697; xu, jiancheng/0000-0001-8796-271X				Arda B, 2007, J INFECTION, V55, P41, DOI 10.1016/j.jinf.2007.02.014; Cabot G, 2011, ANTIMICROB AGENTS CH, V55, P1906, DOI 10.1128/AAC.01645-10; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; Cattaneo C, 2012, ANN HEMATOL, V91, P1299, DOI 10.1007/s00277-012-1424-3; Cavalcanti FLD, 2012, MEM I OSWALDO CRUZ, V107, P420, DOI 10.1590/S0074-02762012000300019; Deplano A, 2005, J CLIN MICROBIOL, V43, P1198, DOI 10.1128/JCM.43.3.1198-1204.2005; Goldstein EJC, 2009, ANTIMICROB AGENTS CH, V53, P5122, DOI 10.1128/AAC.00064-09; Hsu LY, 2010, ANTIMICROB AGENTS CH, V54, P1173, DOI 10.1128/AAC.01076-09; Baumgart AMK, 2010, BRAZ J INFECT DIS, V14, P433, DOI 10.1590/S1413-86702010000500002; Lipovy B, 2010, Acta Chir Plast, V52, P39; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; Martinez J, 2009, INTENS CARE MED, V35, P439, DOI 10.1007/s00134-008-1326-y; Morata L, 2012, ANTIMICROB AGENTS CH, V56, P4833, DOI 10.1128/AAC.00750-12; Nagao M, 2011, J HOSP INFECT, V79, P49, DOI 10.1016/j.jhin.2011.04.018; Nouer SA, 2005, ANTIMICROB AGENTS CH, V49, P3663, DOI 10.1128/AAC.49.9.3663-3667.2005; Ozkurt Z, 2005, BURNS, V31, P870, DOI 10.1016/j.burns.2005.04.015; Rossolini GM, 2005, CLIN MICROBIOL INFEC, V11, P17, DOI 10.1111/j.1469-0691.2005.01161.x; Scheffer MC, 2010, BRAZ J INFECT DIS, V14, P508, DOI 10.1590/S1413-86702010000500014; Shanthi J, 2013, BURNS, V39, P643, DOI 10.1016/j.burns.2012.08.012; Shigemi A, 2009, INT J ANTIMICROB AG, V34, P589, DOI 10.1016/j.ijantimicag.2009.07.017; Slain D, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/416426; Slama TG, 2008, CRIT CARE, V12, DOI 10.1186/cc6820; Su CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037788; Tacconelli E, 2004, J ANTIMICROB CHEMOTH, V53, P474, DOI 10.1093/jac/dkh107; Tacconelli E, 2009, ANTIMICROB AGENTS CH, V53, P4264, DOI 10.1128/AAC.00431-09; Williams VR, 2009, AM J INFECT CONTROL, V37, P106, DOI 10.1016/j.ajic.2008.05.007; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001	30	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78604	10.1371/journal.pone.0078604	http://dx.doi.org/10.1371/journal.pone.0078604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250801	gold, Green Submitted, Green Published			2022-12-25	WOS:000327216200034
J	Babelova, A; Jansen, F; Sander, K; Lohn, M; Schafer, L; Fork, C; Ruetten, H; Plettenburg, O; Stark, H; Daniel, C; Amann, K; Pavenstadt, H; Jung, O; Brandes, RP				Babelova, Andrea; Jansen, Felix; Sander, Kerstin; Loehn, Matthias; Schaefer, Liliana; Fork, Christian; Ruetten, Hartmut; Plettenburg, Oliver; Stark, Holger; Daniel, Christoph; Amann, Kerstin; Pavenstaedt, Hermann; Jung, Oliver; Brandes, Ralf P.			Activation of Rac-1 and RhoA Contributes to Podocyte Injury in Chronic Kidney Disease	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; KINASE INHIBITION; ANGIOTENSIN-II; IN-VITRO; MECHANICAL STRAIN; ACE-INHIBITORS; DEFICIENT MICE; RENAL-DISEASE; TGF-BETA; APOPTOSIS	Rho-family GTPases like RhoA and Rac-1 are potent regulators of cellular signaling that control gene expression, migration and inflammation. Activation of Rho-GTPases has been linked to podocyte dysfunction, a feature of chronic kidney diseases (CKD). We investigated the effect of Rac-1 and Rho kinase (ROCK) inhibition on progressive renal failure in mice and studied the underlying mechanisms in podocytes. SV129 mice were subjected to 5/6-nephrectomy which resulted in arterial hypertension and albuminuria. Subgroups of animals were treated with the Rac-1 inhibitor EHT1846, the ROCK inhibitor SAR407899 and the ACE inhibitor Ramipril. Only Ramipril reduced hypertension. In contrast, all inhibitors markedly attenuated albumin excretion as well as glomerular and tubulo-interstitial damage. The combination of SAR407899 and Ramipril was more effective in preventing albuminuria than Ramipril alone. To study the involved mechanisms, podocytes were cultured from SV129 mice and exposed to static stretch in the Flexcell device. This activated RhoA and Rac-1 and led via TGF beta to apoptosis and a switch of the cells into a more mesenchymal phenotype, as evident from loss of WT-1 and nephrin and induction of alpha-SMA and fibronectin expression. Rac-1 and ROCK inhibition as well as blockade of TGF beta dramatically attenuated all these responses. This suggests that Rac-1 and RhoA are mediators of podocyte dysfunction in CKD. Inhibition of Rho-GTPases may be a novel approach for the treatment of CKD.	[Babelova, Andrea; Jansen, Felix; Schaefer, Liliana; Fork, Christian; Jung, Oliver; Brandes, Ralf P.] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Sander, Kerstin; Stark, Holger] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60054 Frankfurt, Germany; [Loehn, Matthias; Ruetten, Hartmut; Plettenburg, Oliver] Sanofi Deutschland GmbH, Frankfurt, Germany; [Daniel, Christoph; Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; [Pavenstaedt, Hermann] Univ Hosp Munster, Dept Internal Med D, Munster, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Sanofi-Aventis; University of Erlangen Nuremberg; University of Munster	Brandes, RP (corresponding author), Goethe Univ Frankfurt, D-60054 Frankfurt, Germany.	brandes@zphys1.uni-frankfurt.de	Stark, Holger/A-4235-2009; Daniel, Christoph/AAK-2136-2021; Plettenburg, Oliver/AAY-8083-2020; Brandes, Ralf P/L-3058-2017; Babelova, Andrea/E-7768-2018	Stark, Holger/0000-0003-3336-1710; Brandes, Ralf P/0000-0002-8035-0048; Babelova, Andrea/0000-0001-9548-6602; Daniel, Christoph/0000-0002-6803-4755; Schaefer, Liliana/0000-0002-3318-3005	Goethe University; Sanofi-Aventis	Goethe University; Sanofi-Aventis(Sanofi-Aventis)	This work was supported by the Goethe University and Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann B, 2003, DIABETES CARE, V26, P2421, DOI 10.2337/diacare.26.8.2421; Anderson RJ, 2000, KIDNEY INT, V58, P1996; Binker MG, 2008, EXP PHYSIOL, V93, P1091, DOI 10.1113/expphysiol.2008.043141; BRENNER BM, 1985, AM J PHYSIOL, V249, pF324, DOI 10.1152/ajprenal.1985.249.3.F324; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Dessapt C, 2009, NEPHROL DIAL TRANSPL, V24, P2645, DOI 10.1093/ndt/gfp204; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Giehl K, 2008, AM J PHYSIOL-RENAL, V294, pF407, DOI 10.1152/ajprenal.00093.2007; Giunti S, 2010, AM J PHYSIOL-RENAL, V299, pF528, DOI 10.1152/ajprenal.00127.2010; Haas CS, 2003, J AM SOC NEPHROL, V14, P2288, DOI 10.1097/01.ASN.0000082999.46030.FE; HOSTETTER TH, 1982, AM J MED, V72, P375, DOI 10.1016/0002-9343(82)90490-9; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Jung O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011979; Kanda T, 2003, KIDNEY INT, V64, P2009, DOI 10.1046/j.1523-1755.2003.00300.x; Kawarazaki W, 2012, J AM SOC NEPHROL, V23, P997, DOI 10.1681/ASN.2011070734; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Komers R, 2011, KIDNEY INT, V79, P432, DOI 10.1038/ki.2010.428; Komers R, 2011, CURR OPIN NEPHROL HY, V20, P77, DOI 10.1097/MNH.0b013e32834131f8; KRETZLER M, 1994, VIRCHOWS ARCH, V425, P181; KRIZ W, 1994, KIDNEY INT, V45, pS64; Kshirsagar AV, 2000, AM J KIDNEY DIS, V35, P695, DOI 10.1016/S0272-6386(00)70018-7; Leblond B, 2004, PCT/IB2004/000926, Patent No. 2004000926; Lee HS, 2012, CELL TISSUE RES, V347, P129, DOI 10.1007/s00441-011-1169-7; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Liu YZ, 2012, BIOL RES NURS; Lohn M, 2009, HYPERTENSION, V54, P676, DOI 10.1161/HYPERTENSIONAHA.109.134353; Lv Z, 2012, INT J BIOCHEM CELL B, V45, P255; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Meyer-Schwesinger C, 2009, AM J PHYSIOL-RENAL, V296, pF1088, DOI 10.1152/ajprenal.90746.2008; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Peng FF, 2008, DIABETES, V57, P1683, DOI 10.2337/db07-1149; Petermann AT, 2005, KIDNEY INT, V67, P157, DOI 10.1111/j.1523-1755.2005.00066.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riser BL, 2000, CURR OPIN NEPHROL HY, V9, P43, DOI 10.1097/00041552-200001000-00008; Sawada N, 2010, CURR OPIN PHARMACOL, V10, P116, DOI 10.1016/j.coph.2009.11.004; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Thamilselvan V, 2012, UROL RES, V40, P415, DOI 10.1007/s00240-011-0405-7; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Turner JM, 2012, KIDNEY INT, V81, P351, DOI 10.1038/ki.2011.380; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293; Wu JH, 2012, CELL MOL NEUROBIOL, V32, P1187, DOI 10.1007/s10571-012-9845-z; Yao HY, 2011, BBA-GEN SUBJECTS, V1810, P666, DOI 10.1016/j.bbagen.2011.03.020; Zhang QG, 2009, BRAIN RES, V1265, P138, DOI 10.1016/j.brainres.2009.01.033	54	59	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80328	10.1371/journal.pone.0080328	http://dx.doi.org/10.1371/journal.pone.0080328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244677	Green Submitted, Green Published, gold			2022-12-25	WOS:000327162900077
J	Wegener, JW; Loga, F; Stegner, D; Nieswandt, B; Hofmann, F				Wegener, Joerg W.; Loga, Florian; Stegner, David; Nieswandt, Bernhard; Hofmann, Franz			Phospholipase D1 is involved in alpha(1)-adrenergic contraction of murine vascular smooth muscle	FASEB JOURNAL			English	Article						blood pressure; intracellular signaling; Ca(V)1; 2 Ca2+ channel; U46619	PROTEIN-KINASE-C; RECEPTOR STIMULATION; ALPHA; ACTIVATION; RELAXATION; CHANNELS; ARTERIES; SUBSET; CELLS	(1)-Adrenergic stimulation increases blood vessel tone in mammals. This process involves a number of intracellular signaling pathways that include signaling via phospholipase C, diacylglycerol (DAG), and protein kinase C. So far, it is not certain whether signaling via phospholipase D (PLD) and PLD-derived DAG is involved in this process. We asked whether PLD participates in the (1)-adrenergic-mediated signaling in vascular smooth muscle. (1)-Adrenergic-induced contraction was assessed by myography of isolated aortic rings and by pressure recordings using the hindlimb perfusion model in mice. The effects of the PLD inhibitor 1-butanol (IC50 0.15 vol%) and the inactive congener 2-butanol were comparatively studied. Inhibition of PLD by 1-butanol reduced specifically the (1)-adrenergic-induced contraction and the (1)-adrenergic-induced pressure increase by 10 and 40% of the maximum, respectively. 1-Butanol did not influence the aortic contractions induced by high extracellular potassium, by the thromboxane analog U46619, or by a phorbol ester. The effects of 1-butanol were absent in mice that lack PLD1 (Pld1(-/-) mice) or that selectively lack the Ca(V)1.2 channel in smooth muscle (sm-Ca(V)1.2(-/-) mice) but still present in the heterozygous control mice. (1)-Adrenergic contraction of vascular smooth muscle involves activation of PLD1, which controls a portion of the (1)-adrenergic-induced Ca(V)1.2 channel activity.Wegener, J. W., Loga, F., Stegner, D., Nieswandt, B., Hofmann, F. Phospholipase D1 is involved in (1)-adrenergic contraction of murine vascular smooth muscle.	[Wegener, Joerg W.; Loga, Florian; Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany; [Stegner, David; Nieswandt, Bernhard] Univ Wurzburg, Lehrstuhl Expt Biomed, Univ Klinikum Wurzburg, D-97070 Wurzburg, Germany; [Stegner, David; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Zentrum, Deutsch Forsch Gemeinschaft DFG Forsch Zentrum Ex, D-97070 Wurzburg, Germany	Technical University of Munich; University of Wurzburg; University of Wurzburg	Wegener, JW (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, Biedersteiner Str 29, D-80802 Munich, Germany.	joerg.wegener@mytum.de	Stegner, David/AAA-4948-2019	Stegner, David/0000-0003-1059-9865; Wegener, Jorg/0000-0002-8129-1537	Deutsche Forschungsgemeinschaft [For 923, WE2650/4-1, Ni556/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Theodora Kernel for excellent technical assistance. This study was supported by the Deutsche Forschungsgemeinschaft (For 923, WE2650/4-1 to J.W.W. and Ni556/8-1 to B.N.).	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Balboa MA, 1998, MOL PHARMACOL, V53, P221, DOI 10.1124/mol.53.2.221; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; Becker KP, 2004, J BIOL CHEM, V279, P28251, DOI 10.1074/jbc.M400770200; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Docherty JR, 2010, CELL MOL LIFE SCI, V67, P405, DOI 10.1007/s00018-009-0174-4; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; FISH RD, 1988, CIRC RES, V62, P1049, DOI 10.1161/01.RES.62.5.1049; Hu TH, 2005, BIOCHEM BIOPH RES CO, V327, P1047, DOI 10.1016/j.bbrc.2004.12.117; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Huster M, 2010, FASEB J, V24, P2651, DOI 10.1096/fj.09-149856; Keef KD, 2001, AM J PHYSIOL-CELL PH, V281, pC1743; Klein J, 2005, J NEUROCHEM, V94, P1473, DOI 10.1111/j.1471-4159.2005.03315.x; Kurz T, 1999, CARDIOVASC RES, V42, P48, DOI 10.1016/S0008-6363(98)00298-3; Loga F, 2013, CARDIOVASC RES, V100, P280, DOI 10.1093/cvr/cvt176; Meng W, 1998, AM J PHYSIOL-HEART C, V274, pH411, DOI 10.1152/ajpheart.1998.274.2.H411; Mier K, 2002, CARDIOVASC RES, V54, P133, DOI 10.1016/S0008-6363(01)00566-1; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Mueed I, 2005, BRIT J PHARMACOL, V146, P972, DOI 10.1038/sj.bjp.0706398; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Muthalif MM, 2000, J PHARMACOL EXP THER, V293, P268; NELSON MT, 1988, NATURE, V336, P382, DOI 10.1038/336382a0; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Sang RL, 2007, CHEM BIOL DRUG DES, V69, P240, DOI 10.1111/j.1747-0285.2007.00502.x; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Taves J, 2008, ARCH BIOCHEM BIOPHYS, V477, P60, DOI 10.1016/j.abb.2008.05.007; Vorland M, 2008, PLATELETS, V19, P582, DOI 10.1080/09537100802454992; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wier WG, 2004, REV PHYSIOL BIOCH P, V150, P91, DOI 10.1007/s10254-003-0019-8; Yamamoto Y, 2001, EUR J PHARMACOL, V424, P131, DOI 10.1016/S0014-2999(01)01134-7	31	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1044	1048		10.1096/fj.13-237925	http://dx.doi.org/10.1096/fj.13-237925			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24253251				2022-12-25	WOS:000335324800002
J	Ruisanchez, E; Dancs, P; Kerek, M; Nemeth, T; Farago, B; Balogh, A; Patil, R; Jennings, BL; Liliom, K; Malik, KU; Smrcka, AV; Tigyi, G; Benyo, Z				Ruisanchez, Eva; Dancs, Peter; Kerek, Margit; Nemeth, Tamas; Farago, Bernadett; Balogh, Andrea; Patil, Renukadevi; Jennings, Brett L.; Liliom, Karoly; Malik, Kafait U.; Smrcka, Alan V.; Tigyi, Gabor; Benyo, Zoltan			Lysophosphatidic acid induces vasodilation mediated by LPA(1) receptors, phospholipase C, and endothelial nitric oxide synthase	FASEB JOURNAL			English	Article						LPA; vasorelaxation; endothelium; eNOS; phospholipase C	CRUDE SOYBEAN LECITHIN; SPHINGOSINE 1-PHOSPHATE; GENE-EXPRESSION; SIGNALING PATHWAYS; CA2+ INFLUX; CELL DEATH; IN-VITRO; ACTIVATION; EPSILON; AUTOTAXIN	Lysophosphatidic acid (LPA) has been implicated as a mediator of several cardiovascular functions, but its potential involvement in the control of vascular tone is obscure. Here, we show that both LPA (18:1) and VPC31143 (a synthetic agonist of LPA(1-3) receptors) relax intact mouse thoracic aorta with similar E-max values (53.9 and 51.9% of phenylephrine-induced precontraction), although the EC50 of LPA- and VPC31143-induced vasorelaxations were different (400 vs. 15 nM, respectively). Mechanical removal of the endothelium or genetic deletion of endothelial nitric oxide synthase (eNOS) not only diminished vasorelaxation by LPA or VPC31143 but converted it to vasoconstriction. Freshly isolated mouse aortic endothelial cells expressed LPA(1), LPA(2), LPA(4) and LPA(5) transcripts. The LPA(1,3) antagonist Ki16425, the LPA(1) antagonist AM095, and the genetic deletion of LPA(1), but not that of LPA(2), abolished LPA-induced vasorelaxation. Inhibition of the phosphoinositide 3 kinase-protein kinase B/Akt pathway by wortmannin or MK-2206 failed to influence the effect of LPA. However, pharmacological inhibition of phospholipase C (PLC) by U73122 or edelfosine, but not genetic deletion of PLC epsilon, abolished LPA-induced vasorelaxation and indicated that a PLC enzyme, other than PLC epsilon, mediates the response. In summary, the present study identifies LPA as an endothelium-dependent vasodilator substance acting via LPA(1), PLC, and eNOS.Ruisanchez, E., Dancs, P., Kerek, M., Nemeth, T., Farago, B., Balogh, A., Patil, R., Jennings, B. L., Liliom, K., Malik, K. U., Smrcka, A. V., Tigyi, G., Benyo, Z. Lysophosphatidic acid induces vasodilation mediated by LPA(1) receptors, phospholipase C, and endothelial nitric oxide synthase.	[Ruisanchez, Eva; Dancs, Peter; Kerek, Margit; Nemeth, Tamas; Farago, Bernadett; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1446 Budapest, Hungary; [Balogh, Andrea; Patil, Renukadevi; Tigyi, Gabor] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN USA; [Jennings, Brett L.; Malik, Kafait U.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN USA; [Liliom, Karoly] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Smrcka, Alan V.] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY USA	Semmelweis University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Rochester	Benyo, Z (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, POB 448, H-1446 Budapest, Hungary.	gtigyi@uthsc.edu; benyo.zoltan@med.semmelweis-univ.hu	Liliom, Karoly/A-6563-2011	Liliom, Karoly/0000-0002-7177-6872; Benyo, Zoltan/0000-0001-6015-0359	Hungarian National Innovation Office [OMFB-00770/2009]; Hungarian Scientific Research Fund [OTKA K-101775]; U.S. National Institutes of Health/National Cancer Institute [NCI CA-092160]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	Hungarian National Innovation Office; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); U.S. National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Andras Kiss (2nd Department of Pathology, Semmelweis University, Budapest, Hungary) for providing anticlaudin-5 antibody as well as to Bernadett Balazs, Ibolya Balog, Laszlo Hricisak, Eva Kormoci, Peter Mukli, Gergely Balazs Szabo and Judit Tolgyesi for expert secretarial and technical assistance. This study was supported by grants from the Hungarian National Innovation Office (OMFB-00770/2009), the Hungarian Scientific Research Fund (OTKA K-101775) and the U.S. National Institutes of Health/National Cancer Institute (NCI CA-092160) to Z.B. and to G. T., respectively.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Alexander JS, 1998, AM J PHYSIOL-HEART C, V274, pH115, DOI 10.1152/ajpheart.1998.274.1.H115; Amerongen GPV, 2000, ARTERIOSCL THROM VAS, V20, pE127, DOI 10.1161/01.ATV.20.12.e127; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Brault S, 2007, AM J PHYSIOL-REG I, V292, pR1174, DOI 10.1152/ajpregu.00619.2006; Caner H, 2000, ACTA NEUROCHIR, V142, P455, DOI 10.1007/s007010050457; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Chen CG, 2012, ATHEROSCLEROSIS, V222, P74, DOI 10.1016/j.atherosclerosis.2012.02.010; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Garrido JM, 2012, ANN VASC SURG, V26, P549, DOI 10.1016/j.avsg.2012.01.005; Gupte R, 2011, CHEMMEDCHEM, V6, P922, DOI 10.1002/cmdc.201000425; Gustin C, 2008, ARTERIOSCL THROM VAS, V28, P491, DOI 10.1161/ATVBAHA.107.158642; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Heise CE, 2001, MOL PHARMACOL, V60, P1173, DOI 10.1124/mol.60.6.1173; Horvath B, 2005, J CARDIOVASC PHARM, V45, P225, DOI 10.1097/01.fjc.0000154377.90069.b9; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kim EK, 2008, EXP MOL MED, V40, P445, DOI 10.3858/emm.2008.40.4.445; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lee Yu-We, 2006, Taiwania, V51, P11; LIAW L, 1993, ARTERIOSCLER THROMB, V13, P985, DOI 10.1161/01.ATV.13.7.985; McQuarrie E. B., 1960, U. S. Patent, Patent No. 2931818; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Minnear FL, 2001, AM J PHYSIOL-LUNG C, V281, pL1337, DOI 10.1152/ajplung.2001.281.6.L1337; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Neidlinger NA, 2006, J BIOL CHEM, V281, P775, DOI 10.1074/jbc.M505790200; Niioka T., 2013, J CARDIOVASC PHARM, DOI 10.1097/FJC.0000000000000013; Ohata H, 2001, CIRC RES, V88, P925, DOI 10.1161/hh0901.090300; Ohata H, 2011, EXP PHYSIOL, V96, P468, DOI 10.1113/expphysiol.2011.056416; Palmetshofer A, 1999, THROMB HAEMOSTASIS, V82, P1532; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Panetti TS, 2002, BBA-MOL CELL BIOL L, V1582, P190, DOI 10.1016/S1388-1981(02)00155-5; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Rizza C, 1999, LAB INVEST, V79, P1227; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Sandow SL, 2009, AM J PHYSIOL-HEART C, V297, pH1, DOI 10.1152/ajpheart.00042.2009; Sarker MH, 2010, MICROCIRCULATION, V17, P39, DOI 10.1111/j.1549-8719.2010.00001.x; Schober A, 2012, BRIT J PHARMACOL, V167, P465, DOI 10.1111/j.1476-5381.2012.02021.x; Schulze C, 1997, J NEUROCHEM, V68, P991; SCHUMACHER KA, 1979, THROMB HAEMOSTASIS, V42, P631; Shibata K, 2011, J CARDIOVASC PHARM, V57, P604, DOI 10.1097/FJC.0b013e3182144174; Shimizu Hideki, 2005, Brain Tumor Pathol, V22, P59, DOI 10.1007/s10014-005-0190-5; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; Swaney JS, 2011, J PHARMACOL EXP THER, V336, P693, DOI 10.1124/jpet.110.175901; TIGYI G, 1995, AM J PHYSIOL-HEART C, V268, pH2048, DOI 10.1152/ajpheart.1995.268.5.H2048; Tigyi G, 2010, BRIT J PHARMACOL, V161, P241, DOI 10.1111/j.1476-5381.2010.00815.x; TOKUMURA A, 1978, LIPIDS, V13, P468, DOI 10.1007/BF02533615; TOKUMURA A, 1995, RES COMMUN MOL PATH, V90, P96; TOKUMURA A, 1978, AGR BIOL CHEM TOKYO, V42, P515, DOI 10.1080/00021369.1978.10863013; TOKUMURA A, 1978, LIPIDS, V13, P572, DOI 10.1007/BF02533598; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Xiang SY, 2013, BBA-MOL CELL BIOL L, V1831, P213, DOI 10.1016/j.bbalip.2012.09.004; Yakubu MA, 1997, AM J PHYSIOL-REG I, V273, pR703, DOI 10.1152/ajpregu.1997.273.2.R703; Yanagida K, 2013, BBA-MOL CELL BIOL L, V1831, P33, DOI 10.1016/j.bbalip.2012.08.003; Yin F, 2005, INVEST OPHTH VIS SCI, V46, P1927, DOI 10.1167/iovs.04-1256; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	73	18	18	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					880	890		10.1096/fj.13-234997	http://dx.doi.org/10.1096/fj.13-234997			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24249637	Green Published			2022-12-25	WOS:000331072200033
J	Pandey, MS; Weigel, PH				Pandey, Madhu S.; Weigel, Paul H.			Hyaluronic Acid Receptor for Endocytosis (HARE)-mediated Endocytosis of Hyaluronan, Heparin, Dermatan Sulfate, and Acetylated Low Density Lipoprotein (AcLDL), but Not Chondroitin Sulfate Types A, C, D, or E, Activates NF-kappa B-regulated Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Extracellular Matrix; Ligand-binding Protein; NF-B Transcription Factor; Scavenger Receptor; Luciferase; Stabilin-2	HEPATIC SINUSOIDAL ENDOTHELIUM; SCAVENGER RECEPTOR; RAT; STABILIN-2; PROTEIN; CLEARANCE; BINDING; IDENTIFICATION; CELLS; HARE	Background: HARE mediates systemic clearance of 14 ECM- or stress-derived ligands. Hyaluronan uptake activates NF-B. Results: Heparin, dermatan sulfate, and acetylated LDL also activated NF-B; chondroitin sulfates types A, C, D, and E did not. Conclusion: A subset of HARE ligands activates signaling and gene expression. Significance: HARE may be a systemic tissue-stress sensor that responds to abnormal ECM turnover and damage. The hyaluronan (HA) receptor for endocytosis (HARE; Stab2) clears 14 systemic ligands, including HA and heparin. Here, we used NF-B promoter-driven luciferase reporter assays to test HARE-mediated intracellular signaling during the uptake of eight ligands, whose binding sites in the HARE ectodomain were mapped by competition studies (Harris, E. N., and Weigel, P. H. (2008) Glycobiology 18, 638-648). Unique intermediate size Select-HA(TM), heparin, dermatan sulfate, and acetylated LDL stimulated dose-dependent HARE-mediated NF-B activation of luciferase expression, with half-maximal values of 10-25 nm. In contrast, chondroitin sulfate types A, C, D, and E did not stimulate NF-B activation. Moreover, degradation of endogenous IkB- (an NF-B inhibitor) was stimulated only by the signaling ligands. The stimulatory activities of pairwise combinations of the four signaling ligands were additive. The four nonstimulatory chondroitin sulfate types, which compete for HA binding, also effectively blocked HA-stimulated signaling. Clathrin siRNA decreased clathrin expression by approximate to 50% and completely eliminated NF-B-mediated signaling by all four ligands, indicating that activation of signaling complexes occurs after endocytosis. These results indicate that HARE not only binds and clears extracellular matrix degradation products (e.g. released normally or during infection, injury, tumorigenesis, or other stress situations) but that a subset of ligands also serves as signaling indicator ligands. HARE may be part of a systemic tissue-stress sensor feedback system that responds to abnormal tissue turnover or damage as a danger signal; the signaling indicator ligands would reflect the homeostatic status, whether normal or pathological, of tissue cells and biomatrix components.	[Pandey, Madhu S.; Weigel, Paul H.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA.	paul-weigel@ouhsc.edu			National Institutes of Health from NIGMS [GM69961]; Oklahoma Center for the Advancement of Science and Technology from the State of Oklahoma [HR10-074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069961] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oklahoma Center for the Advancement of Science and Technology from the State of Oklahoma; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69961 from NIGMS. This work was also supported by Oklahoma Center for the Advancement of Science and Technology Grant HR10-074 from the State of Oklahoma.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Baggenstoss BA, 2006, ANAL BIOCHEM, V352, P243, DOI 10.1016/j.ab.2006.01.019; Coller SP, 2001, J LEUKOCYTE BIOL, V70, P142; ERIKSSON S, 1983, EXP CELL RES, V144, P223, DOI 10.1016/0014-4827(83)90458-5; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; FUKUDA S, 1986, VIRCHOWS ARCH B, V52, P1, DOI 10.1007/BF02889945; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017; Harris E. N., 2009, HEPATIC ENDOCYTOSIS, P210; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2009, AM J PHYSIOL-GASTR L, V296, pG1191, DOI 10.1152/ajpgi.90717.2008; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Hupalowska A, 2012, TRAFFIC, V13, P9, DOI 10.1111/j.1600-0854.2011.01249.x; Jung MY, 2007, J LEUKOCYTE BIOL, V82, P1156, DOI 10.1189/jlb.0107052; Kim S, 2012, MOL CELL BIOL, V32, P2698, DOI 10.1128/MCB.06743-11; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; Laurent T.C., 1991, DEGRADATION BIOACTIV, P249; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEBEL L, 1994, EUR J CLIN INVEST, V24, P621, DOI 10.1111/j.1365-2362.1994.tb01114.x; Lee SJ, 2011, BLOOD, V117, P5215, DOI 10.1182/blood-2010-10-313239; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; Matsunaga T, 2003, BIOCHEM BIOPH RES CO, V303, P313, DOI 10.1016/S0006-291X(03)00308-5; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; OKA JA, 1988, J CELL BIOCHEM, V36, P169, DOI 10.1002/jcb.240360208; Pandey MS, 2008, J BIOL CHEM, V283, P21453, DOI 10.1074/jbc.M800886200; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Park SY, 2008, J BIOL CHEM, V283, P10593, DOI 10.1074/jbc.M709105200; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Qian H, 2009, BIOCHEM BIOPH RES CO, V390, P883, DOI 10.1016/j.bbrc.2009.10.068; RAJA RH, 1984, ANAL BIOCHEM, V139, P168, DOI 10.1016/0003-2697(84)90402-0; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; SMEDSROD B, 1988, CELL TISSUE RES, V253, P39; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Weigel P. H., 2012, STRUCTURE FUNCTION B, P293; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; YannarielloBrown J, 1997, GLYCOBIOLOGY, V7, P15, DOI 10.1093/glycob/7.1.15; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029; Zhou B, 2002, MOL BIOL CELL, V13, P2853, DOI 10.1091/mbc.02-03-0048; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	53	30	31	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1756	1767		10.1074/jbc.M113.510339	http://dx.doi.org/10.1074/jbc.M113.510339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24247245	hybrid, Green Published			2022-12-25	WOS:000332401700046
J	Emily, M; Talvas, A; Delamarche, C				Emily, Mathieu; Talvas, Anthony; Delamarche, Christian			MetAmyl: A METa-Predictor for AMYLoid Proteins	PLOS ONE			English	Article							FRAME-SHIFT MUTATION; FIBRIL-FORMING SEGMENTS; ALPHA-CHAIN GENE; SEQUENCE DETERMINANTS; HEREDITARY-AMYLOIDOSIS; AGGREGATION-PRONE; RENAL AMYLOIDOSIS; HOT-SPOTS; A-BETA; FIBRINOGEN	The aggregation of proteins or peptides in amyloid fibrils is associated with a number of clinical disorders, including Alzheimer's, Huntington's and prion diseases, medullary thyroid cancer, renal and cardiac amyloidosis. Despite extensive studies, the molecular mechanisms underlying the initiation of fibril formation remain largely unknown. Several lines of evidence revealed that short amino-acid segments (hot spots), located in amyloid precursor proteins act as seeds for fibril elongation. Therefore, hot spots are potential targets for diagnostic/therapeutic applications, and a current challenge in bioinformatics is the development of methods to accurately predict hot spots from protein sequences. In this paper, we combined existing methods into a meta-predictor for hot spots prediction, called MetAmyl for METapredictor for AMYLoid proteins. MetAmyl is based on a logistic regression model that aims at weighting predictions from a set of popular algorithms, statistically selected as being the most informative and complementary predictors. We evaluated the performances of MetAmyl through a large scale comparative study based on three independent datasets and thus demonstrated its ability to differentiate between amyloidogenic and non-amyloidogenic polypeptides. Compared to 9 other methods, MetAmyl provides significant improvement in prediction on studied datasets. We further show that MetAmyl is efficient to highlight the effect of point mutations involved in human amyloidosis, so we suggest this program should be a useful complementary tool for the diagnosis of these diseases.	[Emily, Mathieu] Agrocampus Ouest, Dept Appl Math, Rennes, France; [Emily, Mathieu; Talvas, Anthony] Inst Rech Math Rennes, CNRS, UMR6625, Rennes, France; [Emily, Mathieu] Univ Rennes 2, F-35043 Rennes, France; [Talvas, Anthony; Delamarche, Christian] Univ Rennes 1, IGDR, CNRS, UMR6290, Rennes, France	Institut Agro; Agrocampus Ouest; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite Rennes 2; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Emily, M (corresponding author), Agrocampus Ouest, Dept Appl Math, Rennes, France.	mathieu.emily@agrocampus-ouest.fr	DELAMARCHE, Christian/A-2138-2010	DELAMARCHE, Christian/0000-0002-8963-0062	Rennes Metropole; CNRS; Region Bretagne	Rennes Metropole(Region Bretagne); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Bretagne(Region Bretagne)	This work has been supported by Rennes Metropole, the Region Bretagne and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asl LH, 1997, BLOOD, V90, P4799; Bellesia G, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216103; Belli M, 2011, EMBO REP, V12, P657, DOI 10.1038/embor.2011.116; BENSON MD, 1993, NAT GENET, V3, P252, DOI 10.1038/ng0393-252; Bryan AW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000333; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; David MPC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-79; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; de Groot NS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-18; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dobson CM, 2004, METHODS, V34, P4, DOI 10.1016/j.ymeth.2004.03.002; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Fandrich M, 2009, PRION, V3, P89; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gillmore JD, 2009, J AM SOC NEPHROL, V20, P444, DOI 10.1681/ASN.2008060614; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hamodrakas SJ, 2011, FEBS J, V278, P2428, DOI 10.1111/j.1742-4658.2011.08164.x; Hanss M, 2001, ANN NY ACAD SCI, V936, P89; Hastie T, 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Kang HG, 2005, KIDNEY INT, V68, P1994, DOI 10.1111/j.1523-1755.2005.00653.x; Kim C, 2009, NUCLEIC ACIDS RES, V37, pW469, DOI 10.1093/nar/gkp351; Liaw C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053235; Marshall KE, 2009, OPEN BIOL J, V2, P185, DOI DOI 10.2174/1874196700902020185; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Meng SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038903; MILLER AJ, 1984, J ROY STAT SOC A STA, V147, P389, DOI 10.2307/2981576; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Morris TA, 2009, BLOOD, V114, P1929, DOI 10.1182/blood-2009-03-208264; Mosesson MW, 1996, J CLIN INVEST, V97, P2342, DOI 10.1172/JCI118677; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Mousson C, 2006, AM J TRANSPLANT, V6, P632, DOI 10.1111/j.1600-6143.2005.01199.x; Neerman-Arbez M, 2010, J COAGULATION DISORD, V2, P1; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; O'Donnell CW, 2011, BIOINFORMATICS, V27, pI34, DOI 10.1093/bioinformatics/btr238; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pawlicki S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-273; R Core Team, 2021, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roland BP, 2013, BIOPOLYMERS; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Salvatella X, 2013, PROG MOL BIOL TRANSL, V117, P73, DOI 10.1016/B978-0-12-386931-9.00004-0; Serpell LC, 2007, AMYLOID, V14, P199, DOI 10.1080/13506120701461111; Stangou AJ, 2010, BLOOD, V115, P2998, DOI 10.1182/blood-2009-06-223792; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Teng PK, 2006, PROTEIN ENG DESIGN S, V16, P260; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Uemichi T, 1996, BLOOD, V87, P4197, DOI 10.1182/blood.V87.10.4197.bloodjournal87104197; Uemichi T, 1998, AMYLOID, V5, P188, DOI 10.3109/13506129809003844; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Wang X, 2008, J MOL BIOL, V380, P570, DOI 10.1016/j.jmb.2008.05.019; Wolberg AS, 2010, THROMB RES, V125, pS35, DOI 10.1016/j.thromres.2010.01.033; Youden WJ, 1988, CANCER, V3, P32; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325; Zibaee S, 2007, PROTEIN SCI, V16, P906, DOI 10.1110/ps.062624507	71	63	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79722	10.1371/journal.pone.0079722	http://dx.doi.org/10.1371/journal.pone.0079722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260292	Green Published, gold			2022-12-25	WOS:000327311900043
J	Pietruszka, M				Pietruszka, Mariusz			Pressure-Induced Cell Wall Instability and Growth Oscillations in Pollen Tubes	PLOS ONE			English	Article							TISSUE STRESSES; TIP-GROWTH; MODEL; EXPANSION; VISUALIZATION; EXOCYTOSIS; MECHANICS; DYNAMICS; CALCIUM; FLOW	In the seed plants, the pollen tube is a cellular extension that serves as a conduit through which male gametes are transported to complete fertilization of the egg cell. It consists of a single elongated cell which exhibits characteristic oscillations in growth rate until it finally bursts, completing its function. The mechanism behind the periodic character of the growth has not been fully understood. In this paper we show that the mechanism of pressure-induced symmetry frustration occurring in the wall at the transition-perimeter between the cylindrical and approximately hemispherical parts of the growing pollen tube, together with the addition of cell wall material, is sufficient to release and sustain mechanical self-oscillations and cell extension. At the transition zone, where symmetry frustration occurs and one cannot distinguish either of the involved symmetries, a kind of 'superposition state' appears where either single or both symmetry(ies) can be realized by the system. We anticipate that testifiable predictions made by the model (f proportional to root P) may deliver, after calibration, a new tool to estimate turgor pressure P from oscillation frequency f of the periodically growing cell. Since the mechanical principles apply to all turgor regulated walled cells including those of plant, fungal and bacterial origin, the relevance of this work is not limited to the case of the pollen tube.	Silesian Univ, Fac Biol & Environm Protect, Katowice, Poland	University of Silesia in Katowice	Pietruszka, M (corresponding author), Silesian Univ, Fac Biol & Environm Protect, Katowice, Poland.	mariusz.pietruszka@us.edu.pl		Pietruszka, Mariusz/0000-0001-5852-9095				Aouar L, 2010, SEX PLANT REPROD, V23, P15, DOI 10.1007/s00497-009-0110-7; Azuah RT, 2009, J RES NATL INST STAN, V114, P341, DOI 10.6028/jres.114.025; Bartnicki-Garcia S, 2000, BIOPHYS J, V79, P2382, DOI 10.1016/S0006-3495(00)76483-6; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Benkert R, 1997, PROTOPLASMA, V198, P1, DOI 10.1007/BF01282125; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Calder GM, 1997, BIOCHEM BIOPH RES CO, V234, P690, DOI 10.1006/bbrc.1997.6514; Campas O, 2009, CURR BIOL, V19, P2102, DOI 10.1016/j.cub.2009.10.075; Chavarria-Krauser A, 2011, J THEOR BIOL, V285, P10, DOI 10.1016/j.jtbi.2011.06.008; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Dumais J, 2004, PLANT PHYSIOL, V136, P3266, DOI 10.1104/pp.104.043752; Dumais J, 2006, INT J DEV BIOL, V50, P209, DOI 10.1387/ijdb.052066jd; Eggen E, 2011, J THEOR BIOL, V283, P113, DOI 10.1016/j.jtbi.2011.05.034; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Geitmann A, 1998, J PLANT PHYSIOL, V152, P439, DOI 10.1016/S0176-1617(98)80261-7; Geitmann A, 2004, SEX PLANT REPROD, V17, P9, DOI 10.1007/s00497-004-0210-3; Geitmann A, 2009, SEX PLANT REPROD, V23, P6371; Geitmann A, 2006, PLANT CELL MONOGR, V3, P177, DOI 10.1007/7089_049; Geitmann A, 2010, CURR OPIN PLANT BIOL, V13, P693, DOI 10.1016/j.pbi.2010.09.017; Geitmann A, 2009, PLANT SIGNAL BEHAV, V4, P136, DOI 10.4161/psb.4.2.7633; Geitmann A, 2009, TRENDS PLANT SCI, V14, P467, DOI 10.1016/j.tplants.2009.07.006; Haduch-Sendecka A, 2013, INT C BIOPH STUD 18; HEJNOWICZ Z, 1984, ACTA SOC BOT POL, V53, P29; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Hill AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036585; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Kroeger J, 2011, MECH RE COMM, DOI [10.1016/j.mechrecomm.2011.11.005, DOI 10.1016/J.MECHREC0MM.2011.11.005]; Kroeger J, 2011, PLANT SIGNAL BEHAV, V6, P1828, DOI 10.4161/psb.6.11.17324; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; Kroeger JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018549; Kroeger JH, 2009, BIOPHYS J, V97, P1822, DOI 10.1016/j.bpj.2009.07.038; KUTSCHERA U, 1989, PHYSIOL PLANTARUM, V77, P157, DOI 10.1111/j.1399-3054.1989.tb05992.x; Kutschera U, 2000, R BRAS FISIOL, V146, P126; Landau L. D., 1986, COURSE THEORETICAL P, V7; Lewicka S, 2009, ACTA SOC BOT POL, V78, P19; Lubliner J., 2006, PLASTICITY THEORY; McKenna ST, 2009, PLANT CELL, V21, P3026, DOI 10.1105/tpc.109.069260; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; Pietruszka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048087; Pietruszka M, 2012, J THEOR BIOL, V315, P119, DOI 10.1016/j.jtbi.2012.09.016; PLYUSHCH TA, 1995, PROTOPLASMA, V187, P13, DOI 10.1007/BF01280228; Proseus TE, 2006, J EXP BOT, V57, P3231, DOI 10.1093/jxb/erl087; Rojas ER, 2011, BIOPHYS J, V101, P1844, DOI 10.1016/j.bpj.2011.08.016; Rounds CM, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr019; Schopfer P, 2006, AM J BOT, V93, P1415, DOI 10.3732/ajb.93.10.1415; TOULOUSE G, 1977, COMMUN PHYS, V2, P115; Vogler H, 2013, PLANT J, V73, P617, DOI 10.1111/tpj.12061; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Wei CF, 2007, PLANT PHYSIOL, V145, P763, DOI 10.1104/pp.107.101964; WEISSMAN MB, 1988, REV MOD PHYS, V60, P537, DOI 10.1103/RevModPhys.60.537; Winship LJ, 2011, TRENDS PLANT SCI, V16, P353, DOI 10.1016/j.tplants.2011.03.010; Winship LJ, 2010, TRENDS PLANT SCI, V15, P363, DOI 10.1016/j.tplants.2010.04.005; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; Zonia L, 2011, TRENDS PLANT SCI, V7, P1; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007; Zonia L, 2007, TRENDS PLANT SCI, V12, P90, DOI 10.1016/j.tplants.2007.01.006; Zonia L, 2010, J EXP BOT, V61, P1939, DOI 10.1093/jxb/erq073; Zonia L, 2009, TRENDS PLANT SCI, V14, P318, DOI 10.1016/j.tplants.2009.03.008	60	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e75803	10.1371/journal.pone.0075803	http://dx.doi.org/10.1371/journal.pone.0075803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260097	gold, Green Submitted, Green Published			2022-12-25	WOS:000327311900001
J	Schwendinger, MG; O'Rourke, M; Traweger, A; Savidis-Dacho, H; Pilz, A; Portsmouth, D; Livey, I; Barrett, PN; Crowe, BA				Schwendinger, Michael G.; O'Rourke, Maria; Traweger, Andreas; Savidis-Dacho, Helga; Pilz, Andreas; Portsmouth, Daniel; Livey, Ian; Barrett, P. Noel; Crowe, Brian A.			Evaluation of OspA Vaccination-Induced Serological Correlates of Protection against Lyme Borreliosis in a Mouse Model	PLOS ONE			English	Article							SURFACE PROTEIN-A; DISEASE VACCINE; ANTIBODY-RESPONSES; FLOW-CYTOMETRY; CLINICAL-TRIAL; BURGDORFERI; IMMUNOGENICITY; MICE; INFECTION; IMMUNITY	Background: For clinical development of a novel multivalent OspA vaccine against Lyme borreliosis, serological assays are required which can be used to establish immune correlates of protection against infection with Borrelia. Methods: Four assays (an OspA IgG ELISA, a competitive inhibition (CI) ELISA, a Borrelia surface-binding (SB) assay and a Borrelia killing assay) were used to evaluate the correlation between immune responses induced by rOspA 1/2 (a chimeric immunogen containing protective epitopes from OspA serotypes 1 and 2), and protective immunity against infection by B. burgdorferi s. s. (OspA-1) and B. afzelii (OspA-2). Mice were immunized with OspA 1/2 doses ranging from 0.3 ng to 100 ng, to induce a range of OspA antibody titers, and exposed to needle challenge with B. burgdorferi s. s. or tick challenge with B. afzelii. Receiver operator characteristics (ROC) curves were constructed for each assay, and the area under the curve (AUC), sensitivity, specificity and Youden Index were calculated. Potential cutoff antibody titers which could be used as correlates of vaccine-induced protection were derived from the maximum Youden Index. Results: Immunization with OspA-1/2 provided dose-dependent protection against infection with B. burgdorferi s. s. and B. afzelii. Antibody responses detected by all four assays were highly significantly correlated with protection from infection by either B. burgdorferi s. s. (p < 0.0001 to 0.0062) or B. afzelii (p < 0.0001). ROC analyses of the diagnostic effectiveness of each assay showed the AUC to range between 0.95 and 0.79, demonstrating that all assays distinguish well between infected and non-infected animals. Based on sensitivity, specificity and AUC, the OspA IgG ELISA and SB assays best discriminated between infected and non-infected animals. Conclusions: All four assays differentiate well between Borrelia-infected and non-infected animals. The relatively simple, high throughput IgG ELISA would be suitable to establish immune correlates of protection for the novel OspA vaccine in clinical trials.	[Schwendinger, Michael G.; O'Rourke, Maria; Traweger, Andreas; Savidis-Dacho, Helga; Pilz, Andreas; Portsmouth, Daniel; Livey, Ian; Barrett, P. Noel; Crowe, Brian A.] Baxter BioSci, Vaccine R&D, Orth Donau, Australia		Crowe, BA (corresponding author), Baxter BioSci, Vaccine R&D, Orth Donau, Australia.	brian_crowe@baxter.com	Traweger, Andreas/M-1460-2015	Traweger, Andreas/0000-0002-0220-4766; Pilz, Andreas/0000-0002-6394-3845	Baxter	Baxter	This study was funded by Baxter. Baxter employees were reponsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adams Deborah A, 2013, MMWR Morb Mortal Wkly Rep, V60, P1; AYDINTUG MK, 1994, INFECT IMMUN, V62, P4929, DOI 10.1128/IAI.62.11.4929-4937.1994; Battisti JM, 2008, INFECT IMMUN, V76, P5228, DOI 10.1128/IAI.00410-08; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Creson JR, 1996, CLIN DIAGN LAB IMMUN, V3, P184, DOI 10.1128/CDLI.3.2.184-190.1996; Crippa M, 2002, VECTOR-BORNE ZOONOT, V2, P3, DOI 10.1089/153036602760260724; Feder HM, 1999, J PEDIATR-US, V135, P575, DOI 10.1016/S0022-3476(99)70055-7; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gern L, 1997, VACCINE, V15, P1551, DOI 10.1016/S0264-410X(97)00066-2; Golde WT, 1997, INFECT IMMUN, V65, P882, DOI 10.1128/IAI.65.3.882-889.1997; GOLDE WT, 1995, VACCINE, V13, P435, DOI 10.1016/0264-410X(94)00027-K; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001; JOHNSON BJB, 1995, VACCINE, V13, P1086, DOI 10.1016/0264-410X(95)00035-Y; Kurtenbach K, 1997, VACCINE, V15, P1670, DOI 10.1016/S0264-410X(97)00086-8; LEBET N, 1994, EXP APPL ACAROL, V18, P177, DOI 10.1007/BF02353685; LEUBAGARCIA S, 1994, ZBL BAKT-INT J MED M, V280, P468; Lindgren E, 2006, LYME BORRELIIOSIS EU; LIU YF, 1994, CLIN DIAGN LAB IMMUN, V1, P145, DOI 10.1128/CDLI.1.2.145-149.1994; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; LOVRICH SD, 1995, INFECT IMMUN, V63, P2113, DOI 10.1128/IAI.63.6.2113-2119.1995; Luke CJ, 2000, J INFECT DIS, V181, P1062, DOI 10.1086/315359; O'Rourke M, 2013, NY TIMES BK REV, P8; Pal U, 2001, J IMMUNOL, V166, P7398, DOI 10.4049/jimmunol.166.12.7398; Plotkin SA, 2011, CLIN INFECT DIS, V52, pS271, DOI 10.1093/cid/ciq119; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Poland GA, 2011, CLIN INFECT DIS, V52, pS253, DOI 10.1093/cid/ciq116; PROBERT WS, 1994, INFECT IMMUN, V62, P1920, DOI 10.1128/IAI.62.5.1920-1926.1994; Sadziene A, 1995, Wien Med Wochenschr, V145, P162; SADZIENE A, 1993, J INFECT DIS, V167, P165, DOI 10.1093/infdis/167.1.165; Schoen RT, 2003, CLIN THER, V25, P210, DOI 10.1016/S0149-2918(03)90027-0; Schoen RT, 2000, CLIN THER, V22, P315, DOI 10.1016/S0149-2918(00)80035-1; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; Sikand VK, 2001, PEDIATRICS, V108, P123, DOI 10.1542/peds.108.1.123; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Steere AC, 2012, LYME DIS VACCINES, P1122; Steere AC, 2011, CLIN INFECT DIS, V52, pS259, DOI 10.1093/cid/ciq117; Wressnigg N, 2013, LANCET INFECT DIS	40	7	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79022	10.1371/journal.pone.0079022	http://dx.doi.org/10.1371/journal.pone.0079022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260146	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500019
J	Shetty, SA; Marathe, NP; Lanjekar, V; Ranade, D; Shouche, YS				Shetty, Sudarshan Anand; Marathe, Nachiket Prakash; Lanjekar, Vikram; Ranade, Dilip; Shouche, Yogesh S.			Comparative Genome Analysis of Megasphaera sp Reveals Niche Specialization and Its Potential Role in the Human Gut	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ANTIBIOTIC-RESISTANCE; BILE RESISTANCE; UTILIZING BACTERIA; EFFLUX PUMP; MICROBIOTA; METABOLISM; ELSDENII; PROTEIN; GLUTATHIONE	With increasing number of novel bacteria being isolated from the human gut ecosystem, there is a greater need to study their role in the gut ecosystem and their effect on the host health. In the present study, we carried out in silico genome-wide analysis of two novel Megasphaera sp. isolates NM10 (DSM25563) and BL7 (DSM25562), isolated from feces of two healthy individuals and validated the key features by in vitro studies. The analysis revealed the general metabolic potential, adaptive features and the potential effects of these isolates on the host. The comparative genome analysis of the two human gut isolates NM10 and BL7 with ruminal isolate Megasphaera elsdenii (DSM20460) highlighted the differential adaptive features for their survival in human gut. The key findings include features like bile resistance, presence of various sensory and regulatory systems, stress response systems, membrane transporters and resistance to antibiotics. Comparison of the "glycobiome" based on the genomes of the ruminal isolate with the human gut isolates NM10 and BL revealed the presence of diverse and unique sets of Carbohydrate-Active enzymes (CAZymes) amongst these isolates, with a higher collection of CAZymes in the human gut isolates. This could be attributed to the difference in host diet and thereby the environment, consequently suggesting host specific adaptation in these isolates. In silico analysis of metabolic potential predicted the ability of these isolates to produce important metabolites like short chain fatty acids (butyrate, acetate, formate, and caproate), vitamins and essential amino acids, which was further validated by in vitro experiments. The ability of these isolates to produce important metabolites advocates for a potential healthy influence on the host. Further in vivo studies including transcriptomic and proteomic analysis will be required for better understanding the role and impact of these Megasphaera sp. isolates NM10 and BL7 on the human host.	[Shetty, Sudarshan Anand; Marathe, Nachiket Prakash; Shouche, Yogesh S.] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Lanjekar, Vikram; Ranade, Dilip] Agharkar Res Inst, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Department of Science & Technology (India); Agharkar Research Institute (ARI)	Shouche, YS (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	yogesh@nccs.res.in	Marathe, Nachiket/AAJ-3565-2021; Shetty, Sudarshan A/N-6785-2014	Marathe, Nachiket/0000-0003-2955-3402; Shetty, Sudarshan A/0000-0001-7280-9915	Department of Biotechnology (DBT), Government of India; Microbial Culture Collection Project; Council of Scientific and Industrial Research (CSIR), New Delhi	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Microbial Culture Collection Project; Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The work was funded by the Department of Biotechnology (DBT), Government of India; Microbial Culture Collection Project. Nachiket Marathe is grateful to Council of Scientific and Industrial Research (CSIR), New Delhi, for fellowship. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikman PC, 2011, J DAIRY SCI, V94, P2840, DOI 10.3168/jds.2010-3783; Alexander RP, 2007, P NATL ACAD SCI USA, V104, P2885, DOI 10.1073/pnas.0609359104; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Bitoun JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044766; Blake DP, 2003, J APPL MICROBIOL, V95, P428, DOI 10.1046/j.1365-2672.2003.01988.x; Booijink CCGM, 2010, APPL ENVIRON MICROB, V76, P5533, DOI 10.1128/AEM.00502-10; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465; Chiquette J, 2009, ADV DAIRY TECHNOL, V21, P143; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; Dighe AS, 1998, INT J SYST BACTERIOL, V48, P783, DOI 10.1099/00207713-48-3-783; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; GIBSON GR, 1993, GUT, V34, P437, DOI 10.1136/gut.34.4.437; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hijova E, 2007, BRATISL MED J, V108, P354; Holdeman LV, 1997, ANAEROBE LAB MANUAL, P1; Huang CB, 2011, ARCH ORAL BIOL, V56, P650, DOI 10.1016/j.archoralbio.2011.01.011; Jousimies-Somer H., 2002, WADSWORTH KTL ANAERO; Juvonen R, 2006, INT J SYST EVOL MICR, V56, P695, DOI 10.1099/ijs.0.63699-0; Kaneko T, 1997, J CLIN MICROBIOL, V35, P3181, DOI 10.1128/JCM.35.12.3181-3185.1997; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Kenealy WR, 1995, APPL MICROBIOL BIOT, V44, P507, DOI [10.1007/s002530050590, 10.1007/BF00169952]; Klieve AV, 2003, J APPL MICROBIOL, V95, P621, DOI 10.1046/j.1365-2672.2003.02024.x; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Li Y, 2003, APPL ENVIRON MICROB, V69, P5739, DOI 10.1128/AEM.69.10.5739-5745.2003; Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005; Lin J, 2006, J ANTIMICROB CHEMOTH, V58, P966, DOI 10.1093/jac/dkl374; Liong MT, 2005, J DAIRY SCI, V88, P55, DOI 10.3168/jds.S0022-0302(05)72662-X; Lumppio HL, 2001, J BACTERIOL, V183, P101, DOI 10.1128/JB.183.1.101-108.2001; Madhu AN, 2010, BIOTECHNOL LETT, V32, P503, DOI 10.1007/s10529-009-0176-1; Marathe N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-222; Marchandin H, 2003, INT J SYST EVOL MICR, V53, P547, DOI 10.1099/ijs.0.02378-0; MAROUNEK M, 1989, APPL ENVIRON MICROB, V55, P1570, DOI 10.1128/AEM.55.6.1570-1573.1989; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Marx H, 2011, J BACTERIOL, V193, P5578, DOI 10.1128/JB.05861-11; Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698; MURATA K, 1980, J GEN MICROBIOL, V120, P545; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Padmanabhan R, 2013, STAND GENOMIC SCI, V8, P525, DOI 10.4056/sigs.4077819; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pereira DIA, 2003, APPL ENVIRON MICROB, V69, P4743, DOI 10.1128/AEM.69.8.4743-4752.2003; Prouty AM, 2004, MICROBIOL-SGM, V150, P775, DOI 10.1099/mic.0.26769-0; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quesada-Chanto A, 1998, WORLD J MICROB BIOT, V14, P843, DOI 10.1023/A:1008868907251; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; ROGOSA M, 1971, International Journal of Systematic Bacteriology, V21, P187; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sambrook J, 2000, MOL CLONING LAB MANU, V1; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Shetty SA, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-24; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; Sun G, 2011, J EVOLUTION BIOL, V24, P587, DOI 10.1111/j.1420-9101.2010.02192.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tsukahara T, 2006, ANIM SCI J, V77, P454, DOI 10.1111/j.1740-0929.2006.00372.x; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Van Immerseel F, 2004, APPL ENVIRON MICROB, V70, P3582, DOI 10.1128/AEM.70.6.3582-3587.2004; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Verneuil N, 2005, MICROBIOL-SGM, V151, P3997, DOI 10.1099/mic.0.28325-0; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Zhang Q, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r40	80	81	83	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79353	10.1371/journal.pone.0079353	http://dx.doi.org/10.1371/journal.pone.0079353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260205	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500050
J	Wurmser, F; Mary-Huard, T; Daudin, JJ; Joly, D; Montchamp-Moreau, C				Wurmser, Francois; Mary-Huard, Tristan; Daudin, Jean-Jacques; Joly, Dominique; Montchamp-Moreau, Catherine			Variation of Gene Expression Associated with Colonisation of an Anthropized Environment: Comparison between African and European Populations of Drosophila simulans	PLOS ONE			English	Article							INSECTICIDE-RESISTANCE; RNA-SEQ; DIFFERENTIAL EXPRESSION; GLUTATHIONE TRANSFERASES; HISTORICAL BIOGEOGRAPHY; NATURAL-POPULATIONS; MELANOGASTER; EVOLUTION; TRANSCRIPTOMICS; POLYMORPHISM	The comparison of transcriptome profiles among populations is a powerful tool for investigating the role of gene expression change in adaptation to new environments. In this study, we use massively parallel sequencing of 3' cDNAs obtained from large samples of adult males, to compare a population of Drosophila simulans from a natural reserve within its ancestral range (eastern Africa) with a derived population collected in the strongly anthropized Rhone valley (France). The goal was to scan for adaptation linked to the invasion of new environments by the species. Among 15,090 genes retained for the analysis, 794 were found to be differentially expressed between the two populations. We observed an increase in expression of reproduction-related genes in eastern Africa, and an even stronger increase in expression of Cytochrome P450, Glutathione transferase and Glucuronosyl transferase genes in the derived population. These three gene families are involved in detoxification processes, which suggests that pesticides are a major environmental pressure for the species in this area. The survey of the Cyp6g1 upstream region revealed the insertion of a transposable element, Juan, in the regulatory sequence that is almost fixed in the Rhone Valley, but barely present in Mayotte. This shows that Cyp6g1 has undergone parallel evolution in derived populations of D. simulans as previously shown for D. melanogaster. The increasing amount of data produced by comparative population genomics and transcriptomics should permit the identification of additional genes associated with functional divergence among those differentially expressed.	[Wurmser, Francois; Joly, Dominique; Montchamp-Moreau, Catherine] CNRS UPR9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France; [Wurmser, Francois; Joly, Dominique; Montchamp-Moreau, Catherine] Univ Paris Sud, Orsay, France; [Mary-Huard, Tristan; Daudin, Jean-Jacques] INRA UMR 518 MIA, Paris, France; [Mary-Huard, Tristan; Daudin, Jean-Jacques] AgroParisTech, UMR MIA 518, Paris, France; [Mary-Huard, Tristan] Univ Paris Sud, CNRS, INRA, UMR Genet Vegetale, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; INRAE; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Wurmser, F (corresponding author), CNRS UPR9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France.	francois.wurmser@legs.cnrs-gif.fr		Wurmser, Francois/0000-0003-0353-1379; Montchamp-Moreau, Catherine/0000-0002-5044-9709	ANR project Adaptanthrop; French National Centre for Scientific Research (CNRS) Institute of Ecology and Environment (INEE)	ANR project Adaptanthrop(French National Research Agency (ANR)); French National Centre for Scientific Research (CNRS) Institute of Ecology and Environment (INEE)	This study was funded by ANR project Adaptanthrop. FW was funded by French National Centre for Scientific Research (CNRS) Institute of Ecology and Environment (INEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreev D, 1999, J MOL EVOL, V48, P615, DOI 10.1007/PL00006504; Baudry E, 2006, GENETICS, V173, P759, DOI 10.1534/genetics.105.046250; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; CAPY P, 1993, GENET SEL EVOL, V25, P517, DOI 10.1051/gse:19930602; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; CHOUDHARY M, 1987, GENETICS, V117, P697; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dean MD, 2004, MOL PHYLOGENET EVOL, V32, P998, DOI 10.1016/j.ympev.2004.03.013; Dworkin I, 2009, GENETICS, V181, P721, DOI 10.1534/genetics.108.093419; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Evans TG, 2011, MOL ECOL, V20, P4472, DOI 10.1111/j.1365-294X.2011.05276.x; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; FFRENCHCONSTANT RH, 1994, INSECT BIOCHEM MOLEC, V24, P335, DOI 10.1016/0965-1748(94)90026-4; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Haerty W, 2006, MOL BIOL EVOL, V23, P1707, DOI 10.1093/molbev/msl033; Hamblin MT, 1999, GENETICS, V153, P305; Herndon LA, 1997, J INSECT PHYSIOL, V43, P1117, DOI 10.1016/S0022-1910(97)00062-0; HEY J, 1993, MOL BIOL EVOL, V10, P804; Huang FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-563; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Irvin SD, 1998, GENETICS, V150, P777; Khaitovich P, 2005, GENETICS, V170, P929, DOI 10.1534/genetics.104.037135; Kliman RM, 2000, GENETICS, V156, P1913; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Kopp A, 2006, MOL PHYLOGENET EVOL, V38, P355, DOI 10.1016/j.ympev.2005.06.006; LACHAISE D, 1988, EVOL BIOL, V22, P159; Lachaise D, 2004, EVOLUTION OF POPULATION BIOLOGY, P315, DOI 10.1017/CBO9780511542619.019; LaFlamme BA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002435; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Luque T, 2002, INSECT BIOCHEM MOLEC, V32, P1597, DOI 10.1016/S0965-1748(02)00080-2; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCart C, 2008, PEST MANAG SCI, V64, P639, DOI 10.1002/ps.1567; McDermott SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002442; McKechnie SW, 2010, MOL ECOL, V19, P775, DOI 10.1111/j.1365-294X.2009.04509.x; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Mueller JL, 2008, GENETICS, V178, P1605, DOI 10.1534/genetics.107.083766; Mueller JL, 2005, GENETICS, V171, P131, DOI 10.1534/genetics.105.043844; Muller L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-81; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Paaby AB, 2010, MOL ECOL, V19, P760, DOI 10.1111/j.1365-294X.2009.04508.x; Palmieri N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006323; Pavey SA, 2010, ANN NY ACAD SCI, V1206, P110, DOI 10.1111/j.1749-6632.2010.05765.x; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Salzman J, 2011, STAT SCI, V26, P62, DOI 10.1214/10-STS343; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Schofl G, 2006, MOL ECOL, V15, P3895, DOI 10.1111/j.1365-294X.2006.03065.x; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Tymchuk WV, 2010, MOL ECOL, V19, P1842, DOI 10.1111/j.1365-294X.2010.04596.x; Veuille M, 2004, GENETICA, V120, P61, DOI 10.1023/B:GENE.0000017630.69020.32; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Wong A, 2012, MOL BIOL EVOL, V29, P229, DOI 10.1093/molbev/msr197; Wu Dong-Dong, 2011, Genome Biol Evol, V3, P396, DOI 10.1093/gbe/evr034; Wurmser F, 2011, GENETICA, V139, P465, DOI 10.1007/s10709-011-9566-0; Zhang R, 2013, MOL ECOL, V22, P1400, DOI 10.1111/mec.12113; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323	71	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79750	10.1371/journal.pone.0079750	http://dx.doi.org/10.1371/journal.pone.0079750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260296	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500097
J	Xiong, WX; Zhou, GX; Wang, B; Xue, ZG; Wang, L; Sun, HC; Ge, SJ				Xiong, Wan-Xia; Zhou, Guo-Xia; Wang, Bei; Xue, Zhang-Gang; Wang, Lu; Sun, Hui-Chuan; Ge, Sheng-Jin			Impaired Spatial Learning and Memory after Sevoflurane-Nitrous Oxide Anesthesia in Aged Rats Is Associated with Down-Regulated cAMP/CREB Signaling	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; ISOFLURANE INDUCES APOPTOSIS; LONG-TERM POTENTIATION; CAMP RESPONSE; ADULT NEUROGENESIS; WATER-MAZE; PHOSPHODIESTERASE INHIBITOR; COGNITIVE DYSFUNCTION; CASPASE ACTIVATION; CELL-SURVIVAL	Neurocognitive deficits arising from anesthetic exposure have recently been debated, while studies have shown that the phosphorylation of cyclic AMP response element-binding protein (CREB) in the hippocampus is critical for long-term memory. To better understand the neural effects of inhalational anesthetics, we studied the behavioral and biochemical changes in aged rats that were exposed to sevoflurane (Sev) and nitrous oxide (N2O) for 4 h. Eighteen-month-old rats were randomly assigned to receive 1.3% sevoflurane and 50% nitrous oxide/50% oxygen or 50% oxygen for 4 h. Spatial learning and memory were tested with the Morris water maze 48 h after exposure, and the results showed that sevoflurane-nitrous oxide exposure induced a significant deficit in spatial learning acquisition and memory retention. Experiments revealed that the cAMP and pCREB levels in the dorsal hippocampus were decreased in rats with anesthetic exposure in comparison with control rats 48 h after anesthesia as well as 15 min after the probe trial, but there were no significant differences in CREB expression. Besides these, the current study also found the DG neurogenesis significantly decreased as well as neuronal loss and neuronal apoptosis increased in the hippocampus of rats exposed to Sev+N2O. The current study demonstrated that down-regulation of cAMP/CREB signaling, decrease of CREB-dependent neurogenesis and neuronal survival in the hippocampus contributed to the neurotoxicity and cognitive dysfunction induced by general anesthesia with sevoflurane-nitrous oxide.	[Xiong, Wan-Xia; Wang, Bei; Xue, Zhang-Gang; Ge, Sheng-Jin] Fudan Univ, Dept Anesthesia, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Xiong, Wan-Xia; Wang, Bei; Xue, Zhang-Gang; Ge, Sheng-Jin] Fudan Univ, Shanghai Med Coll, Dept Anesthesiol, Shanghai 200433, Peoples R China; [Zhou, Guo-Xia] Fudan Univ, Shanghai Peoples Hosp 5, Dept Anesthesia, Shanghai 200433, Peoples R China; [Wang, Lu; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; [Wang, Lu; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Ge, SJ (corresponding author), Fudan Univ, Dept Anesthesia, Zhongshan Hosp, Shanghai 200433, Peoples R China.	ge.shengjin@fudan.edu.cn		Sun, Hui-Chuan/0000-0003-3761-7058	Shanghai Natural Science Fund [10ZR1406500]	Shanghai Natural Science Fund	This project was supported by Shanghai Natural Science Fund (10ZR1406500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alkire MT, 2005, ANESTHESIOLOGY, V102, P754, DOI 10.1097/00000542-200504000-00010; Alkire MT, 2005, ANESTHESIOLOGY, V103, P1167, DOI 10.1097/00000542-200512010-00010; Alkire MT, 2004, ANESTHESIOLOGY, V101, P417, DOI 10.1097/00000542-200408000-00023; Ao H, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-15; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brightwell JJ, 2007, LEARN MEMORY, V14, P195, DOI 10.1101/lm.395407; Callaway JK, 2012, ANESTHESIOLOGY, V117, P1091, DOI 10.1097/ALN.0b013e31826cb228; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Culley DJ, 2007, ANESTH ANALG, V105, P83, DOI 10.1213/01.ANE.0000266491.53318.20; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Curlik DM, 2013, NEUROPHARMACOLOGY, V64, P506, DOI 10.1016/j.neuropharm.2012.07.027; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Dworkin S, 2009, STEM CELLS, V27, P1347, DOI 10.1002/stem.56; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Le Freche H, 2012, ANESTHESIOLOGY, V116, P779, DOI 10.1097/ALN.0b013e31824be8c7; Li YF, 2009, NEUROPSYCHOPHARMACOL, V34, P2404, DOI 10.1038/npp.2009.66; Liu XS, 2010, NEUROBIOL LEARN MEM, V94, P461, DOI 10.1016/j.nlm.2010.08.011; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mellon RD, 2007, ANESTH ANALG, V104, P509, DOI 10.1213/01.ane.0000255729.96438.b0; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mrak RE, 1997, J NEUROPATH EXP NEUR, V56, P1269, DOI 10.1097/00005072-199712000-00001; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Rammes G, 2009, NEUROPHARMACOLOGY, V56, P626, DOI 10.1016/j.neuropharm.2008.11.002; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Romano A, 1996, BEHAV BRAIN RES, V75, P119, DOI 10.1016/0166-4328(96)00179-9; Rosenegger D, 2008, NEUROBIOL LEARN MEM, V90, P544, DOI 10.1016/j.nlm.2008.06.005; Sall JW, 2009, ANESTHESIOLOGY, V110, P826, DOI 10.1097/ALN.0b013e31819b62e2; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; SCHNEIDER HH, 1984, BIOCHEM PHARMACOL, V33, P1690, DOI 10.1016/0006-2952(84)90295-8; Segal M, 1998, NEURAL PLAST, V6, P1, DOI 10.1155/NP.1998.1; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Wiklund A, 2009, NEUROREPORT, V20, P1419, DOI 10.1097/WNR.0b013e328330cd2b; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Yamashima T, 2012, PROG LIPID RES, V51, P221, DOI 10.1016/j.plipres.2012.02.001; Zhang B, 2008, J BIOL CHEM, V283, P11866, DOI 10.1074/jbc.M800199200; Zhou GX, 2013, DEMENT GER COGN D EX, V3, P39, DOI 10.1159/000348349	65	44	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79408	10.1371/journal.pone.0079408	http://dx.doi.org/10.1371/journal.pone.0079408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260214	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600032
J	Fuchs, JC; Zinnamon, FA; Taylor, RR; Ivins, S; Scambler, PJ; Forge, A; Tucker, AS; Linden, JF				Fuchs, Jennifer C.; Zinnamon, Fhatarah A.; Taylor, Ruth R.; Ivins, Sarah; Scambler, Peter J.; Forge, Andrew; Tucker, Abigail S.; Linden, Jennifer F.			Hearing Loss in a Mouse Model of 22q11.2 Deletion Syndrome	PLOS ONE			English	Article							OTITIS-MEDIA; VELOCARDIOFACIAL SYNDROME; RISK-FACTORS; BOX GENE; MICE; DIGEORGE; TBX1; REGION; MANIFESTATIONS; CHILDREN	22q11.2 Deletion Syndrome (22q11DS) arises from an interstitial chromosomal microdeletion encompassing at least 30 genes. This disorder is one of the most significant known cytogenetic risk factors for schizophrenia, and can also cause heart abnormalities, cognitive deficits, hearing difficulties, and a variety of other medical problems. The Df1/+ hemizygous knockout mouse, a model for human 22q11DS, recapitulates many of the deficits observed in the human syndrome including heart defects, impaired memory, and abnormal auditory sensorimotor gating. Here we show that Df1/+ mice, like human 22q11DS patients, have substantial rates of hearing loss arising from chronic middle ear infection. Auditory brainstem response (ABR) measurements revealed significant elevation of click-response thresholds in 48% of Df1/+ mice, often in only one ear. Anatomical and histological analysis of the middle ear demonstrated no gross structural abnormalities, but frequent signs of otitis media (OM, chronic inflammation of the middle ear), including excessive effusion and thickened mucosa. In mice for which both in vivo ABR thresholds and post mortem middle-ear histology were obtained, the severity of signs of OM correlated directly with the level of hearing impairment. These results suggest that abnormal auditory sensorimotor gating previously reported in mouse models of 22q11DS could arise from abnormalities in auditory processing. Furthermore, the findings indicate that Df1/+ mice are an excellent model for increased risk of OM in human 22q11DS patients. Given the frequently monaural nature of OM in Df1/+ mice, these animals could also be a powerful tool for investigating the interplay between genetic and environmental causes of OM.	[Fuchs, Jennifer C.; Tucker, Abigail S.] Kings Coll London, Craniofacial Dev & Stem Cell Biol, London, England; [Zinnamon, Fhatarah A.; Taylor, Ruth R.; Forge, Andrew; Linden, Jennifer F.] UCL, Ear Inst, London, England; [Ivins, Sarah; Scambler, Peter J.] UCL, Inst Child Hlth, London, England; [Linden, Jennifer F.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; King's College London; University of London; University College London; University of London; University College London; University of London; University College London	Linden, JF (corresponding author), UCL, Ear Inst, London, England.	j.linden@ucl.ac.uk	Tucker, Abigail S/K-1788-2016; Scambler, Peter/AAZ-6026-2020	Tucker, Abigail S/0000-0001-8871-6094; Scambler, Peter/0000-0002-1487-4628; Linden, Jennifer/0000-0003-2210-1374; Forge, Andrew/0000-0002-0995-0219	Gatsby Charitable Foundation; Wellcome Trust; UCL MSc Neuroscience programme; Medical Research Council; British Heart Foundation; Action on Hearing Loss; Deafness Research UK; MRC [G1001232] Funding Source: UKRI; British Heart Foundation [RG/10/13/28570] Funding Source: researchfish; Medical Research Council [G1001232] Funding Source: researchfish; RNID [S24] Funding Source: researchfish	Gatsby Charitable Foundation; Wellcome Trust(Wellcome Trust); UCL MSc Neuroscience programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Action on Hearing Loss; Deafness Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID	Work by JFL and FAZ was supported by the Gatsby Charitable Foundation, the Wellcome Trust, Deafness Research UK, and the UCL MSc Neuroscience programme. AST, RRT, and AF are funded by the Medical Research Council and JCF is funded by Action on Hearing Loss. PJS and SI are supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWNING GG, 2010, CLIN OTOLARYNGOL, V35, P490, DOI DOI 10.1111/J.1749-4486.2010.02230.X.PUBMED:20927726; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Digilio MC, 1999, BRIT J AUDIOL, V33, P329, DOI 10.3109/03005369909090116; Dyce O, 2002, ARCH OTOLARYNGOL, V128, P1408, DOI 10.1001/archotol.128.12.1408; Epstein J A, 2001, Trends Genet, V17, pS13, DOI 10.1016/S0168-9525(01)02450-7; Ford LC, 2000, LARYNGOSCOPE, V110, P362, DOI 10.1097/00005537-200003000-00006; Galili N, 1997, GENOME RES, V7, P17, DOI 10.1101/gr.7.1.17; Gerdes M, 1999, AM J MED GENET, V85, P127, DOI 10.1002/(SICI)1096-8628(19990716)85:2<127::AID-AJMG6>3.0.CO;2-F; Hardisty-Hughes RE, 2006, HUM MOL GENET, V15, P3273, DOI 10.1093/hmg/ddl403; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; LANNIGAN FJ, 1993, J LARYNGOL OTOL, V107, P12, DOI 10.1017/S0022215100122005; Lazaridis E, 2008, J CLIN INVEST, V118, P471, DOI [10.1172/JCI33716, 10.1172/JC133716]; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Lindsay EA, 1998, MOL MED TODAY, V4, P350, DOI 10.1016/S1357-4310(98)01302-1; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Parham K, 1997, HEARING RES, V112, P216, DOI 10.1016/S0378-5955(97)00124-X; Paylor R, 2001, HUM MOL GENET, V10, P2645, DOI 10.1093/hmg/10.23.2645; Paylor R, 2006, BIOL PSYCHIAT, V59, P1172, DOI 10.1016/j.biopsych.2006.01.018; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Reyes MRT, 1999, INT J PEDIATR OTORHI, V47, P227, DOI 10.1016/S0165-5876(98)00180-3; Richter CA, 2010, HUM MOL GENET, V19, P1551, DOI 10.1093/hmg/ddq028; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Scambler PJ, 2010, PEDIATR CARDIOL, V31, P378, DOI 10.1007/s00246-009-9613-0; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Sobin C, 2005, AM J PSYCHIAT, V162, P1090, DOI 10.1176/appi.ajp.162.6.1090; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Sutherland HF, 1998, GENOMICS, V52, P37, DOI 10.1006/geno.1998.5414; Taddei I, 2001, P NATL ACAD SCI USA, V98, P11428, DOI 10.1073/pnas.201127298; Thompson H, 2013, SCIENCE, V339, P1453, DOI 10.1126/science.1232862; Uhari M, 1996, CLIN INFECT DIS, V22, P1079, DOI 10.1093/clinids/22.6.1079; Vitelli F, 2002, COLD SPRING HARB SYM, V67, P327, DOI 10.1101/sqb.2002.67.327; Vitelli F, 2003, HUM MOL GENET, V12, P2041, DOI 10.1093/hmg/ddg216; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	37	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80104	10.1371/journal.pone.0080104	http://dx.doi.org/10.1371/journal.pone.0080104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244619	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800122
J	Read, M; Andrews, PS; Timmis, J; Williams, RA; Greaves, RB; Sheng, H; Coles, M; Kumar, V				Read, Mark; Andrews, Paul S.; Timmis, Jon; Williams, Richard A.; Greaves, Richard B.; Sheng, Huiming; Coles, Mark; Kumar, Vipin			Determining Disease Intervention Strategies Using Spatially Resolved Simulations	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; T-CELLS; MEDIATED SUPPRESSION; MICE; INVOLVEMENT; REVERSAL; THERAPY; EAE	Predicting efficacy and optimal drug delivery strategies for small molecule and biological therapeutics is challenging due to the complex interactions between diverse cell types in different tissues that determine disease outcome. Here we present a new methodology to simulate inflammatory disease manifestation and test potential intervention strategies in silico using agent-based computational models. Simulations created using this methodology have explicit spatial and temporal representations, and capture the heterogeneous and stochastic cellular behaviours that lead to emergence of pathology or disease resolution. To demonstrate this methodology we have simulated the prototypic murine T cell-mediated autoimmune disease experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. In the simulation immune cell dynamics, neuronal damage and tissue specific pathology emerge, closely resembling behaviour found in the murine model. Using the calibrated simulation we have analysed how changes in the timing and efficacy of T cell receptor signalling inhibition leads to either disease exacerbation or resolution. The technology described is a powerful new method to understand cellular behaviours in complex inflammatory disease, permits rational design of drug interventional strategies and has provided new insights into the role of TCR signalling in autoimmune disease progression.	[Read, Mark; Timmis, Jon] Univ York, Dept Elect, York YO10 5DD, N Yorkshire, England; [Andrews, Paul S.; Timmis, Jon; Williams, Richard A.] Univ York, Dept Comp Sci, York YO10 5DD, N Yorkshire, England; [Greaves, Richard B.; Coles, Mark] Univ York, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Greaves, Richard B.; Coles, Mark] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Greaves, Richard B.; Coles, Mark] Univ York, HYMS, York YO10 5DD, N Yorkshire, England; [Sheng, Huiming; Kumar, Vipin] Torrey Pines Inst Mol Studies, San Diego, CA USA	University of York - UK; University of York - UK; University of York - UK; University of York - UK; University of York - UK; Torrey Pines Institute for Molecular Studies, California	Read, M (corresponding author), Univ York, Dept Elect, York YO10 5DD, N Yorkshire, England.	mark.read@york.ac.uk	Williams, Richard/AAI-9331-2020; Williams, Richard A/I-7883-2014; sheng, huiming/GQZ-8569-2022	Williams, Richard/0000-0001-6333-9448; Williams, Richard A/0000-0001-6333-9448; sheng, huiming/0000-0001-9382-3687; Timmis, Jonathan Ian/0000-0003-1055-0471; Read, Mark/0000-0002-1481-4780	EC CoCoRo Project [GA 270382]; Royal Society; Engineering and Physical Sciences Research Council [EP/I005943/1, EP/E053505/1]; Wellcome Trust; Centre for Chronic Diseases and Disorders; National Institutes of Health (NIH), United States of America; Multiple Sclerosis National Research Institute (MSNRI), United States of America (NIH); Medical Research Council [G0601156] Funding Source: researchfish; EPSRC [EP/I005943/1, EP/E053505/1] Funding Source: UKRI; MRC [G0601156] Funding Source: UKRI	EC CoCoRo Project; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust); Centre for Chronic Diseases and Disorders; National Institutes of Health (NIH), United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Sclerosis National Research Institute (MSNRI), United States of America (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MR and JT are supported by the EC CoCoRo Project, GA 270382 (http://www.ec.europa.eu). JT is also financially supported by the Royal Society (http://www.royalsociety.org). PSA is funded by Engineering and Physical Sciences Research Council grant numbers EP/I005943/1, EP/E053505/1 and EP/I005943/1 (http://www.epsrc.ac.uk). MC is supported by the Wellcome Trust-funded Centre for Chronic Diseases and Disorders (http://www.wellcome.ac.uk/). VK is supported by grants from the National Institutes of Health (NIH), United States of America and the Multiple Sclerosis National Research Institute (MSNRI), United States of America (NIH: http://www.nih.gov, MSNRI: http://www.ms-research.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002916; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; Beeston T, 2010, J NEUROIMMUNOL, V229, P91, DOI 10.1016/j.jneuroim.2010.07.007; BENNUN A, 1980, NATURE, V288, P389, DOI 10.1038/288389a0; Bown J, 2012, CURR DRUG TARGETS, V13, P1560, DOI 10.2174/138945012803530071; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Fowler M., 2004, UML DISTILLED, VThird; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Greaves RB, 2013, BIOSYSTEMS, V112, P107, DOI 10.1016/j.biosystems.2013.03.007; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Kohm AP, 2005, J IMMUNOL, V174, P4525, DOI 10.4049/jimmunol.174.8.4525; Kumar V, 1996, J EXP MED, V184, P1609, DOI 10.1084/jem.184.5.1609; Kumar V, 2004, J CLIN INVEST, V114, P1222, DOI 10.1172/JCI200423166; KUMAR V, 1993, J EXP MED, V178, P909, DOI 10.1084/jem.178.3.909; Kumar V, 2001, IMMUNOL REV, V182, P113, DOI 10.1034/j.1600-065X.2001.1820109.x; LINDSEY JW, 1995, CELL IMMUNOL, V162, P235, DOI 10.1006/cimm.1995.1074; Luke S, 2005, SIMUL-T SOC MOD SIM, V81, P517, DOI 10.1177/0037549705058073; Madakamutil LT, 2003, J IMMUNOL, V170, P2985, DOI 10.4049/jimmunol.170.6.2985; Menezes JS, 2007, J CLIN INVEST, V117, P2176, DOI 10.1172/JCI28277; Read M, 2012, MATH COMP MODEL DYN, V18, P67, DOI 10.1080/13873954.2011.601419; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Smith TRF, 2008, TRENDS IMMUNOL, V29, P337, DOI 10.1016/j.it.2008.04.002; Smith TRF, 2010, EUR J IMMUNOL, V40, P1906, DOI 10.1002/eji.200939608; Tang X, 2006, J IMMUNOL, V177, P7645, DOI 10.4049/jimmunol.177.11.7645; Tran GT, 2001, INT IMMUNOL, V13, P1109, DOI 10.1093/intimm/13.9.1109; Vargha A, 2000, J EDUC BEHAV STAT, V25, P101, DOI 10.3102/10769986025002101; Williams RA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S9	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80506	10.1371/journal.pone.0080506	http://dx.doi.org/10.1371/journal.pone.0080506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244694	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000327143800150
J	Garcia-Heras, MS; Cortes-Avizanda, A; Donazar, JA				Garcia-Heras, Marie-Sophie; Cortes-Avizanda, Ainara; Donazar, Jose-Antonio			Who Are We Feeding? Asymmetric Individual Use of Surplus Food Resources in an Insular Population of the Endangered Egyptian Vulture Neophron percnopterus	PLOS ONE			English	Article							BEHAVIORAL SYNDROMES; BREEDING SUCCESS; BODY CONDITION; BIRDS; SUPPLEMENTATION; CONSERVATION; PRODUCTIVITY; HABITAT; SIZE; SELECTION	Supplementary feeding stations, or "vulture restaurants", are common conservation management tools. While a number of studies have investigated the consequences of surplus food on the population dynamics of scavengers, relatively little is known about the effects of such practices at the individual level. Within the long-term monitored breeding population of Canarian Egyptian vultures (Neophron percnopterus majorensis) we investigated individual bird's patterns of use of a supplementary feeding station at Fuerteventura (Canary Islands), over the course of breeding (2001, 2002; 2004-2011) and non-breeding seasons (2000-2010). Our results show that during the breeding season the individual use of the supplementary feeding station was inversely related to the distance to the breeding territory, which suggests the existence of central-place foraging constraints. In addition, larger birds of poor body-condition and individuals that ultimately failed to fledge young were detected more frequently at the feeding station. During the non-breeding season, and because most breeding birds abandoned the breeding territories, the overall abundance of Egyptian vultures at the feeding station grew. Moreover, the only variable increasing the probability of presence of individuals was poor body condition so that birds with lower wing residual visited the feeding station more frequently. Supplementary feeding may benefit individuals who would otherwise have been subject to selective pressures. From our results it follows that this conservation strategy must be used with caution because it can have consequences on an individual level and thus potentially affect the viability of endangered populations.	[Garcia-Heras, Marie-Sophie; Cortes-Avizanda, Ainara; Donazar, Jose-Antonio] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Garcia-Heras, Marie-Sophie] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Cortes-Avizanda, Ainara] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Theoret Ecol & Biodivers Change Grp, Lisbon, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); National Research Foundation - South Africa; University of Cape Town; Universidade de Lisboa	Garcia-Heras, MS (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	ms.garciaheras@gmail.com	CORTES-AVIZANDA, AINARA/O-3248-2019; Cortés-Avizanda, Ainara/C-6634-2013	CORTES-AVIZANDA, AINARA/0000-0002-9674-6434; Cortés-Avizanda, Ainara/0000-0002-9674-6434; Donazar, Jose Antonio/0000-0002-9433-9755	Ministerio de Ciencia e Innovacion [CGL2009-12753-C02-02, CGL2012-40013-C02-01]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by the, Ministerio de Ciencia e Innovacion Project CGL2009-12753-C02-02 and CGL2012-40013-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agudo R, 2010, THESIS U COMPLUTENSE; [Anonymous], 2006, SAS MIXED MODELS; Benitez JR, 2009, MUNIBE S29, P276; BirdLife International, 2008, IUCN RED LIST THREAT; Blanco G, 2006, ARDEOLA, V53, P341; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Carrete M, 2005, BIOL CONSERV, V126, P582, DOI 10.1016/j.biocon.2005.06.031; Carrete M, 2007, BIOL CONSERV, V136, P143, DOI 10.1016/j.biocon.2006.11.025; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Chamberlain DE, 1999, J AVIAN BIOL, V30, P427, DOI 10.2307/3677015; Cortes-Avizanda A, 2009, ANIM CONSERV, V12, P85, DOI 10.1111/j.1469-1795.2008.00231.x; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; Cortes-Avizanda A, 2009, BASIC APPL ECOL, V10, P265, DOI 10.1016/j.baae.2008.03.009; COULSON JC, 1968, NATURE, V217, P478, DOI 10.1038/217478a0; Crawley M.J., 1993, GLIM ECOLOGISTS; Deygout C, 2010, BEHAV ECOL, V21, P1131, DOI 10.1093/beheco/arq120; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; donAZar J. a., 2004, LIBRO ROJO AVES ESPA, P129; Donazar JA, 2005, J BIOGEOGR, V32, P1701, DOI 10.1111/j.1365-2699.2005.01294.x; Donazar JA, 2002, BIOL CONSERV, V107, P89, DOI 10.1016/S0006-3207(02)00049-6; Donazar JA, 2002, J RAPTOR RES, V36, P17; DONAZAR JA, 1993, J APPL ECOL, V30, P504, DOI 10.2307/2404190; DONAZAR JA, 1990, ARDEA, V78, P387; Donazar JA, 1993, BIOL CONSERVACION RY, P256; Donazar JA, 2010, EUR J WILDLIFE RES, V56, P613, DOI 10.1007/s10344-009-0358-0; Gangoso L, 2005, J RAPTOR RES, V39, P186; Gangoso L, 2006, THESIS U SEVILLA; Gangoso L, 2009, ENVIRON POLLUT, V157, P569, DOI 10.1016/j.envpol.2008.09.015; Grande JM, 2009, MUNIBE S29, P254; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; HOUSTON AI, 1985, THEOR POPUL BIOL, V28, P233, DOI 10.1016/0040-5809(85)90029-2; Jovani R, 2001, ANIM BEHAV, V62, P723, DOI 10.1006/anbe.2001.1814; Koenig R, 2006, SCIENCE, V312, P1591, DOI 10.1126/science.312.5780.1591; Lopez-Bao JV, 2010, ANIM CONSERV, V13, P35, DOI 10.1111/j.1469-1795.2009.00300.x; Margalida A, 2013, PLOS ONE; Margalida A, 2008, IBIS, V150, P242, DOI 10.1111/j.1474-919X.2007.00768.x; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2012, IBIS, V154, P184, DOI 10.1111/j.1474-919X.2011.01189.x; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Marzluff JM, 1997, CONDOR, V99, P567, DOI 10.2307/1370470; McCullagh P, 1989, GEN LINEAR MODELS; MENDELSOHN JM, 1989, OSTRICH, V60, P35, DOI 10.1080/00306525.1989.9634503; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Newton I., 1991, Oxford Ornithology Series, P3; NEWTON I, 1992, BIOL REV, V67, P129, DOI 10.1111/j.1469-185X.1992.tb01017.x; Newton I., 1998, POPULATION LIMITATIO; Newton I., 1979, POPULATION ECOLOGY R; Orians G.H., 1979, P155; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peterson C, 2007, J WILDLIFE MANAGE, V71, P1440, DOI 10.2193/2006-202; Piper Steven E., 2006, P41; Putman RJ, 2004, MAMMAL REV, V34, P285, DOI 10.1111/j.1365-2907.2004.00044.x; Renison D, 2002, BEHAV ECOL, V13, P462, DOI 10.1093/beheco/13.4.462; Reynolds SJ, 2004, IBIS, V146, P601, DOI 10.1111/j.1474-919x.2004.00298.x; RICHARDSON PRK, 1986, J ZOOL, V210, P23; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Whitfield DP, 2009, IBIS, V151, P255, DOI 10.1111/j.1474-919X.2009.00924.x; Winkler DW, 1996, ECOLOGY, V77, P922, DOI 10.2307/2265512; Zajac T, 2008, J AVIAN BIOL, V39, P206, DOI 10.1111/j.0908-8857.2008.04183.x; Zajac T, 2011, BEHAV ECOL SOCIOBIOL, V65, P2305, DOI 10.1007/s00265-011-1241-z	69	30	30	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80523	10.1371/journal.pone.0080523	http://dx.doi.org/10.1371/journal.pone.0080523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244695	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600210
J	Owais, A; Faruque, AG; Das, SK; Ahmed, S; Rahman, S; Stein, AD				Owais, Aatekah; Faruque, Abu Syed Golam; Das, Sumon K.; Ahmed, Shahnawaz; Rahman, Shahed; Stein, Aryeh D.			Maternal and Antenatal Risk Factors for Stillbirths and Neonatal Mortality in Rural Bangladesh: A Case-Control Study	PLOS ONE			English	Article							CONFOUNDER-SELECTION; HEALTH; DEATHS; CARE; EPIDEMIOLOGY; PREVENTION; PREDICTORS; SURVIVAL; SEPSIS; SEX	Objective: To identify maternal and antenatal factors associated with stillbirths and neonatal deaths in rural Bangladesh. Study Design: A prospective cohort study is being conducted to evaluate a maternal and child nutrition program in rural Bangladesh. Cases were all stillbirths and neonatal deaths that occurred in the cohort between March 7, 2011 and December 30, 2011. Verbal autopsies were used to determine cause of death. For each case, four controls were randomly selected from cohort members alive at age 3-months. Multivariable logistic regression was used to identify factors associated with these deaths. Results: Overall, 112 adverse pregnancy outcomes (44 stillbirths, 19/1,000 births; 68 neonatal deaths, 29/1,000 live births) were reported. Of the stillbirths 25 (56.8%) were fresh. The main causes of neonatal death were birth asphyxia (35%), sepsis (28%) and preterm birth (19%). History of bleeding during pregnancy was the strongest risk factor for stillbirths (adjusted odds ratio 22.4 [95% confidence interval 2.5, 197.5]) and neonatal deaths (adjusted odds ratio 19.6 [95% confidence interval 2.1, 178.8]). Adequate maternal nutrition was associated with decreased risk of neonatal death (adjusted odds ratio 0.4 [95% confidence interval 0.2, 0.8]). Conclusions: Identifying high-risk pregnancies during gestation and ensuring adequate antenatal and obstetric care needs to be a priority for any community-based maternal and child health program in similar settings.	[Owais, Aatekah] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Owais, Aatekah] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA; [Faruque, Abu Syed Golam; Das, Sumon K.; Ahmed, Shahnawaz] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Rahman, Shahed] CARE Bangladesh, Dhaka, Bangladesh; [Stein, Aryeh D.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; International Centre for Diarrhoeal Disease Research (ICDDR); Emory University	Stein, AD (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	aryeh.stein@emory.edu	Das, Sumon Kumar/T-6384-2019; Das, Sumon Kumar/AAD-1551-2019	Stein, Aryeh/0000-0003-1138-6458; Ahmed, Shahnawaz/0000-0001-8339-4137; Owais, Aatekah/0000-0002-9148-843X				Adetola AO, 2011, PEDIATR NEONATOL, V52, P243, DOI 10.1016/j.pedneo.2011.06.001; ANKER M, 1999, STANDARD VERBAL AUTO; [Anonymous], 2011, STAT WORLDS CHILDR 2; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Bapat U, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-39; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Budtz-Jorgensen E, 2007, ANN EPIDEMIOL, V17, P27, DOI 10.1016/j.annepidem.2006.05.007; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Diallo AH, 2011, J PERINATOL, V31, P656, DOI 10.1038/jp.2011.6; Fretts R, 2010, CLIN OBSTET GYNECOL, V53, P588, DOI 10.1097/GRF.0b013e3181eb63fc; GOLDENBERG RL, 1993, OBSTET GYNECOL, V81, P444; Hirst JE, 2010, INT J GYNECOL OBSTET, V110, P109, DOI 10.1016/j.ijgo.2010.03.028; Hodgins S, 2010, J PERINATOL, V30, P388, DOI 10.1038/jp.2009.181; Kayode GA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-10; Khatun F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-84; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LeVine RA, 2009, J DEV BEHAV PEDIATR, V30, P340, DOI 10.1097/DBP.0b013e3181b0eeff; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McClure EM, 2011, ACTA OBSTET GYN SCAN, V90, P1379, DOI 10.1111/j.1600-0412.2011.01275.x; MCMILLEN MM, 1979, SCIENCE, V204, P89, DOI 10.1126/science.571144; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; National Institute of Population Research and Training (NIPORT) and ICF. 2019, BANGL DEM HLTH SURV; Onwuanaku Caroline A, 2011, BMC Res Notes, V4, P562, DOI 10.1186/1756-0500-4-562; Owais A, 2011, J PERINATOL, V31, P586, DOI 10.1038/jp.2010.191; Reddy UM, 2007, OBSTET GYNECOL, V110, P1151, DOI 10.1097/01.AOG.0000287616.71602.d0; Ronsmans C, 2008, PAEDIATR PERINAT EP, V22, P269, DOI 10.1111/j.1365-3016.2008.00939.x; Rubayet S, 2012, HEALTH POLICY PLANN, V27, P40, DOI 10.1093/heapol/czs044; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; Ulizzi L, 2002, HUM BIOL, V74, P879, DOI 10.1353/hub.2003.0012; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070549; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Weber MW, 2003, PEDIATR INFECT DIS J, V22, P711, DOI 10.1097/01.inf.0000078163.80807.88; World Health Organization, 2006, INT STAT CLASS DIS R	39	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80164	10.1371/journal.pone.0080164	http://dx.doi.org/10.1371/journal.pone.0080164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244638	Green Submitted, gold, Green Published			2022-12-25	WOS:000327162900065
J	Smith, LK; Tandon, A; Shah, RR; Mav, D; Scoltock, AB; Cidlowski, JA				Smith, Lindsay K.; Tandon, Arpit; Shah, Ruchir R.; Mav, Deepak; Scoltock, Alyson B.; Cidlowski, John A.			Deep Sequencing Identification of Novel Glucocorticoid-Responsive miRNAs in Apoptotic Primary Lymphocytes	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; BH3-ONLY PROTEIN BIM; LEUKEMIA CELLS; LYMPHOBLASTIC-LEUKEMIA; MESSENGER-RNA; HUMAN GENOME; MICRORNAS; EXPRESSION; RESISTANCE; REVEALS	Apoptosis of lymphocytes governs the response of the immune system to environmental stress and toxic insult. Signaling through the ubiquitously expressed glucocorticoid receptor, stress-induced glucocorticoid hormones induce apoptosis via mechanisms requiring altered gene expression. Several reports have detailed the changes in gene expression mediating glucocorticoid-induced apoptosis of lymphocytes. However, few studies have examined the role of non-coding miRNAs in this essential physiological process. Previously, using hybridization-based gene expression analysis and deep sequencing of small RNAs, we described the prevalent post-transcriptional repression of annotated miRNAs during glucocorticoid-induced apoptosis of lymphocytes. Here, we describe the development of a customized bioinformatics pipeline that facilitates the deep sequencing-mediated discovery of novel glucocorticoid-responsive miRNAs in apoptotic primary lymphocytes. This analysis identifies the potential presence of over 200 novel glucocorticoid-responsive miRNAs. We have validated the expression of two novel glucocorticoid-responsive miRNAs using small RNA-specific qPCR. Furthermore, through the use of Ingenuity Pathways Analysis (IPA) we determined that the putative targets of these novel validated miRNAs are predicted to regulate cell death processes. These findings identify two and predict the presence of additional novel glucocorticoid-responsive miRNAs in the rat transcriptome, suggesting a potential role for both annotated and novel miRNAs in glucocorticoid-induced apoptosis of lymphocytes.	[Smith, Lindsay K.; Scoltock, Alyson B.; Cidlowski, John A.] NIEHS, Mol Endocrinol Grp, Lab Signal Transduct, NIH,Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Tandon, Arpit; Shah, Ruchir R.; Mav, Deepak] SRA Int, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); SRA International	Cidlowski, JA (corresponding author), NIEHS, Mol Endocrinol Grp, Lab Signal Transduct, NIH,Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	tandon, arpit/ABI-4342-2020; Cidlowski, John A/G-2548-2019; tandon, arpit/AAS-8013-2020	Cidlowski, John A/0000-0003-1420-0516; 	NIH, National Institute of Environmental Health Sciences	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambady S, 2012, GENESIS, V50, P286, DOI 10.1002/dvg.22010; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Cifone MG, 1999, BLOOD, V93, P2282, DOI 10.1182/blood.V93.7.2282.407a23_2282_2296; Clokie SJH, 2012, J BIOL CHEM, V287, P25312, DOI 10.1074/jbc.M112.356733; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Davis TE, 2013, ARTHRITIS RHEUM-US, V65, P1882, DOI 10.1002/art.37966; Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao ZH, 2012, GENE, V505, P167, DOI 10.1016/j.gene.2012.03.072; Gebelin V, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-18; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Harada M, 2012, LEUKEMIA LYMPHOMA, V53, P2041, DOI 10.3109/10428194.2012.678004; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Iglesias-Serret D, 2007, LEUKEMIA, V21, P281, DOI 10.1038/sj.leu.2404483; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Keller A, 2011, MOL BIOSYST, V7, P3187, DOI 10.1039/c1mb05353a; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kotani A, 2010, CELL CYCLE, V9, P1037, DOI 10.4161/cc.9.6.11011; Kotani A, 2009, BLOOD, V114, P4169, DOI 10.1182/blood-2008-12-191619; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Mann CL, 2000, ENDOCRINOLOGY, V141, P528, DOI 10.1210/en.141.2.528; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ryu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016403; Sionov Ronit Vogt, 2013, ISRN Hematol, V2013, P348212, DOI 10.1155/2013/348212; Smith LK, 2010, J BIOL CHEM, V285, P36698, DOI 10.1074/jbc.M110.162123; Smith LK, 2010, PROG BRAIN RES, V182, P1, DOI 10.1016/S0079-6123(10)82001-1; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian S, 2010, J CELL PHYSIOL, V223, P289, DOI 10.1002/jcp.22066; Tandon M, 2012, ORAL DIS, V18, P127, DOI 10.1111/j.1601-0825.2011.01849.x; Tessel Michael A., 2011, Hormones & Cancer, V2, P182, DOI 10.1007/s12672-011-0072-8; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Yang AP, 2012, LEUKEMIA LYMPHOMA, V53, P2465, DOI 10.3109/10428194.2012.693178; Yao YX, 2012, J GEN VIROL, V93, P1530, DOI 10.1099/vir.0.040634-0; Zhu JY, 2010, J VIROL, V84, P10266, DOI 10.1128/JVI.01119-10	66	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78316	10.1371/journal.pone.0078316	http://dx.doi.org/10.1371/journal.pone.0078316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24250753	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300048
J	Holm, T; Brogger-Jensen, MR; Johnson, L; Kessel, L				Holm, Thomas; Brogger-Jensen, Martin Rocho; Johnson, Leif; Kessel, Line			Glutathione Preservation during Storage of Rat Lenses in Optisol-GS and Castor Oil	PLOS ONE			English	Article							OXIDATIVE STRESS; INDUCED CATARACT; TRANSPORTER; METABOLISM; PROTEINS; ENZYMES	Background: Glutathione concentration in the lens decreases in aging and cataractous lenses, providing a marker for tissue condition. Experimental procedures requiring unfrozen lenses from donor banks rely on transportation in storage medium, affecting lens homeostasis and alterations in glutathione levels. The aim of the study was to examine the effects of Optisol-GS and castor oil on lens condition, determined from their ability to maintain glutathione concentrations. Methodology/Principal Findings: Rat lenses were stored in the two types of storage media at varying time intervals up to 3 days. Glutathione concentration was afterwards determined in an enzymatic detection assay, specific for both reduced and oxidized forms. Lenses removed immediately after death exhibited a glutathione concentration of 4.70 +/- 0.29 mM. In vitro stored lenses in Optisol-GS lost glutathione quickly, ending with a concentration of 0.60 +/-.34 mM after 3 days while castor oil stored lenses exhibited a slower decline and ended at 3 times the concentration. A group of lenses were additionally stored under post mortem conditions within the host for 6 hours before its removal. Total glutathione after 6 hours was similar to that of lenses removed immediately after death, but with altered GSH and GSSG concentrations. Subsequent storage of these lenses in media showed changes similar to those in the first series of experiments, albeit to a lesser degree. Conclusions/Significance: It was determined that storage in Optisol-GS resulted in a higher loss of glutathione than lenses stored in castor oil. Storage for more than 12 hours reduced glutathione to half its original concentration, and was considered unusable after 24 hours.	[Holm, Thomas; Brogger-Jensen, Martin Rocho; Johnson, Leif; Kessel, Line] Univ Copenhagen, Glostrup Hosp, Dept Ophtalmol, Copenhagen, Denmark	University of Copenhagen	Holm, T (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Ophtalmol, Copenhagen, Denmark.	holm03@gmail.com		Kessel, Line/0000-0002-9375-1510	Danish Medical Research Council; The Foundation of June 15; Manufacturer Einar Willumsens memorial scholarship; merchant Chr. Andersen and wife Ingeborg Andersen Scholarship	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Foundation of June 15; Manufacturer Einar Willumsens memorial scholarship; merchant Chr. Andersen and wife Ingeborg Andersen Scholarship	Funding statement: The study was funded by the Danish Medical Research Council (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-frieforskningsrad/radet/dff-sundhed-og-sygdom), The Foundation of June 15 http://www.15junifonden.dk/content/dk/om_15_ juni_fonden), Manufacturer Einar Willumsens memorial scholarship and merchant Chr. Andersen and wife Ingeborg Andersen Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER GW, 1979, EXP EYE RES, V29, P663; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; BETTELHEIM FA, 1983, BIOPHYS J, V41, P29, DOI 10.1016/S0006-3495(83)84402-6; De Donatis GM, 2010, MOL VIS, V16, P1025; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; FERNANDEZCHECA JC, 1993, J BIOL CHEM, V268, P2324; Fujii J, 2011, J CLIN BIOCHEM NUTR, V49, P70, DOI 10.3164/jcbn.10-138SR; GARADI R, 1987, OPHTHALMIC RES, V19, P141, DOI 10.1159/000265486; GIBLIN FJ, 1978, EXP EYE RES, V26, P507, DOI 10.1016/0014-4835(78)90060-X; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; HOCKWIN O, 1985, GRAEF ARCH CLIN EXP, V222, P142, DOI 10.1007/BF02173539; KANNAN R, 1995, INVEST OPHTH VIS SCI, V36, P1785; Kannan R, 1996, INVEST OPHTH VIS SCI, V37, P2269; Liang JJN, 2000, BIOCHEM BIOPH RES CO, V275, P354, DOI 10.1006/bbrc.2000.3306; LOU MF, 1992, EXP EYE RES, V55, P889, DOI 10.1016/0014-4835(92)90015-K; McNulty R, 2004, J PHYSIOL-LONDON, V559, P883, DOI 10.1113/jphysiol.2004.068619; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; MOSTAFAPOUR MK, 1982, CURR EYE RES, V1, P517, DOI 10.3109/02713688208996359; Qin CA, 1996, CURR EYE RES, V15, P719, DOI 10.3109/02713689609003454; RAO GN, 1983, OPHTHALMIC RES, V15, P173, DOI 10.1159/000265254; RATHBUN WB, 1991, EXP EYE RES, V53, P205, DOI 10.1016/0014-4835(91)90075-P; RATHBUN WB, 1983, EXP EYE RES, V36, P845, DOI 10.1016/0014-4835(83)90038-6; REDDY D. V. N., 1966, INVEST OPHTHALMOL, V5, P594; REDDY VN, 1990, EXP EYE RES, V50, P771, DOI 10.1016/0014-4835(90)90127-G; REDDY VN, 1973, EXP EYE RES, V16, P105, DOI 10.1016/0014-4835(73)90305-9	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79620	10.1371/journal.pone.0079620	http://dx.doi.org/10.1371/journal.pone.0079620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260265	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900036
J	Wheeler, RJ; Gluenz, E; Gull, K				Wheeler, Richard John; Gluenz, Eva; Gull, Keith			The Limits on Trypanosomatid Morphological Diversity	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RIBOSOMAL-RNA GENES; RED-BLOOD-CELLS; DOMESTIC-ANIMALS; LIFE-CYCLE; N-SP; BIOCHEMICAL-CHARACTERIZATION; REPETITIVE PROTEIN; MOLECULAR CHARACTERIZATION; MEGATRYPANUM THEILERI	Cell shape is one, often overlooked, way in which protozoan parasites have adapted to a variety of host and vector environments and directional transmissions between these environments. Consequently, different parasite life cycle stages have characteristic morphologies. Trypanosomatid parasites are an excellent example of this in which large morphological variations between species and life cycle stage occur, despite sharing well-conserved cytoskeletal and membranous structures. Here, using previously published reports in the literature of the morphology of 248 isolates of trypanosomatid species from different hosts, we perform a meta-analysis of the occurrence and limits on morphological diversity of different classes of trypanosomatid morphology (trypomastigote, promastigote, etc.) in the vertebrate bloodstream and invertebrate gut environments. We identified several limits on cell body length, cell body width and flagellum length diversity which can be interpreted as biomechanical limits on the capacity of the cell to attain particular dimensions. These limits differed for morphologies with and without a laterally attached flagellum which we suggest represent two morphological superclasses, the 'juxtaform' and 'liberform' superclasses. Further limits were identified consistent with a selective pressure from the mechanical properties of the vertebrate bloodstream environment; trypanosomatid size showed limits relative to host erythrocyte dimensions. This is the first comprehensive analysis of the limits of morphological diversity in any protozoan parasite, revealing the morphogenetic constraints and extrinsic selection pressures associated with the full diversity of trypanosomatid morphology.	[Wheeler, Richard John; Gluenz, Eva; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Wheeler, RJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	richard.wheeler@path.ox.ac.uk	Wheeler, Richard/S-9413-2019	Wheeler, Richard/0000-0002-4270-8360; gull, keith/0000-0001-6954-9569; Gluenz, Eva/0000-0003-4346-8896	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	EG is a Royal Society University Research Fellow. Work in KG's laboratory is funded by The Wellcome Trust. This work was initiated whilst RJW was funded by a Wellcome Trust 4-year PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2008, J CELL SCI, V121, P3704, DOI 10.1242/jcs.035626; Ambit A, 2011, EUKARYOT CELL, V10, P1429, DOI 10.1128/EC.05118-11; ANGELOPOULOS E, 1970, J PROTOZOOL, V17, P39, DOI 10.1111/j.1550-7408.1970.tb05157.x; [Anonymous], 1952, STAND VAL BLOOD BEIN; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Austen JM, 2009, PARASITOLOGY, V136, P783, DOI 10.1017/S0031182009005927; Baines A, 2008, PROTIST, V159, P115, DOI 10.1016/j.protis.2007.09.001; BAKER JR, 1956, PARASITOLOGY, V46, P335, DOI 10.1017/S0031182000026548; BARTA J R, 1984, Journal of Wildlife Diseases, V20, P180; Bartsch P., 1937, Auk, V1987, P516; BATES PA, 1994, PARASITOLOGY, V108, P1, DOI 10.1017/S0031182000078458; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; BEARD CB, 1989, J PARASITOL, V75, P658, DOI 10.2307/3283045; Beattie P, 1997, PARASITOLOGY, V115, P47, DOI 10.1017/S0031182097001042; BECKER ELERY R., 1927, JOUR PARASITOL, V14, P85, DOI 10.2307/3271719; Benga G, 2000, COMP HAEMATOL INT, V10, P1, DOI 10.1007/s005800070020; Bengs F, 2005, MOL MICROBIOL, V55, P1606, DOI 10.1111/j.1365-2958.2005.04498.x; BENNETT GF, 1994, MEM I OSWALDO CRUZ, V89, P531, DOI 10.1590/S0074-02761994000400007; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Borghesan T.C., 2012, PROTIST; BROOKER BE, 1971, PROTOPLASMA, V73, P191, DOI 10.1007/BF01275594; BROOKS AS, 1978, T AM MICROSC SOC, V97, P287, DOI 10.2307/3225982; Bruce D, 1911, P R SOC LOND B-CONTA, V84, P181, DOI 10.1098/rspb.1911.0063; Bruce D, 1911, P R SOC LOND B-CONTA, V83, P176, DOI 10.1098/rspb.1911.0001; Bruce D, 1911, P R SOC LOND B-CONTA, V83, P180, DOI 10.1098/rspb.1911.0002; Bruce D, 1910, P R SOC LOND B-CONTA, V83, P15, DOI 10.1098/rspb.1910.0063; Bruce D, 1910, P R SOC LOND B-CONTA, V83, P1, DOI 10.1098/rspb.1910.0062; Bruce D, 1910, P R SOC LOND B-CONTA, V82, P468, DOI 10.1098/rspb.1910.0040; Bruce D, 1912, P R SOC LOND B-CONTA, V85, P477, DOI 10.1098/rspb.1912.0074; Bruce D, 1909, P R SOC LOND B-CONTA, V81, P14, DOI 10.1098/rspb.1909.0002; Channon HA, 1927, J PATHOL BACTERIOL, V30, P253, DOI 10.1002/path.1700300203; Cleland J. B., 1912, Emu Melbourne, V11; Collingridge PW, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-117; COLLINS GH, 1986, J WILDLIFE DIS, V22, P19, DOI 10.7589/0090-3558-22.1.19; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; CONROY D. A., 1966, PROG FISH CULT, V28, P46, DOI 10.1577/1548-8640(1966)28[46:EMOSAF]2.0.CO;2; CROSS GAM, 1990, ANNU REV IMMUNOL, V8, P83, DOI 10.1146/annurev.iy.08.040190.000503; DAGGETT PM, 1972, J PARASITOL, V58, P946, DOI 10.2307/3286591; Dean SD, 2007, CELL HOST MICROBE, V2, P279, DOI 10.1016/j.chom.2007.10.006; DEANE M P, 1969, Revista do Instituto de Medicina Tropical de Sao Paulo, V11, P34; DEJESUS AR, 1993, J CELL SCI, V106, P1023; DESA MFG, 1980, J PROTOZOOL, V27, P253; DRBOHLAV JAROSLAV J., 1926, JOUR PARASITOL, V12, P183, DOI 10.2307/3270969; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ELWASILA M, 1988, PARASITOL RES, V74, P591, DOI 10.1007/BF00531640; Emmons WF, 1927, J PHYSIOL-LONDON, V64, P215, DOI 10.1113/jphysiol.1927.sp002431; ENGEL JC, 1988, J PROTOZOOL, V35, P513, DOI 10.1111/j.1550-7408.1988.tb04140.x; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Erdmann M, 2006, MOL BIOL CELL, V17, P2035, DOI 10.1091/mbc.E05-10-0976; Fantham H. B., 1942, PARASITOLOGY, V34, P199, DOI 10.1017/S0031182000016176; Fantham HB, 1912, P R SOC LOND B-CONTA, V84, P505, DOI 10.1098/rspb.1912.0009; Farr H, 2009, CELL MOTIL CYTOSKEL, V66, P24, DOI 10.1002/cm.20322; Fernandes MC, 2011, J EXP MED, V208, P909, DOI 10.1084/jem.20102518; Flegontov P, 2013, CURR BIOL, V23, P1787, DOI 10.1016/j.cub.2013.07.045; Frevert U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043913; Galetovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027634; Gentry PA, 2004, VET J, V168, P238, DOI 10.1016/j.tvjl.2003.09.013; GIBBS AJ, 1959, PARASITOLOGY, V49, P411, DOI 10.1017/S0031182000026949; GIBBS AJ, 1947, T ROY SOC TROP MED H, V40, P495, DOI 10.1016/0035-9203(47)90012-6; GIBBS AJ, 1951, PARASITOLOGY, V41, P128, DOI 10.1017/S003118200001667X; Gibson WC, 2005, PARASITOLOGY, V130, P405, DOI 10.1017/S0031182004006778; GILLIES C, 1963, J PROTOZOOL, V10, P467, DOI 10.1111/j.1550-7408.1963.tb01707.x; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goldenberg S, 2011, ADV PARASIT, V75, P285, DOI 10.1016/B978-0-12-385863-4.00013-7; Goniakowska L., 1970, Bull. Acad. pol. Sci. (Ser. Sci. biol.), V18, P793; Green HP, 2003, J BIOL CHEM, V278, P422, DOI 10.1074/jbc.M207215200; Gregory TR, 2000, GENOME, V43, P895, DOI 10.1139/gen-43-5-895; Gregory TR, 2005, ERYTHR CELL SIZ DAT; Gull K, 2003, CURR OPIN MICROBIOL, V6, P365, DOI 10.1016/S1369-5274(03)00092-4; Gull K, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, P453; Gulliver G, 1875, P ZOOL SOC LOND, V1875, P474; Gupta D. K., 2012, Proceedings of the Zoological Society (Calcutta), V65, P22, DOI 10.1007/s12595-012-0024-5; Hamilton PB, 2004, INT J PARASITOL, V34, P1393, DOI 10.1016/j.ijpara.2004.08.011; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Hanna W, 1903, Q J MICROSC SCI, V47, P433; HANSON WL, 1961, J PROTOZOOL, V8, P200, DOI 10.1111/j.1550-7408.1961.tb01204.x; HARTMAN F. A., 1963, AUK, V80, P467; HARTMAN FA, 1964, BIOL BULL, V126, P83, DOI 10.2307/1539418; Hawkey CM, 1975, COMP MAMMALIAN HAEMA; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Heddergott N, 2011, P KIN MOL CELL BIOL; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Hoare C.A., 1972, P1; Hoare C. A., 1923, Parasitology Cambridge, V15, P365, DOI 10.1017/S0031182000014888; HOARE CA, 1966, NATURE, V212, P1385, DOI 10.1038/2121385a0; HOARE CA, 1964, J PROTOZOOL, V11, P200, DOI 10.1111/j.1550-7408.1964.tb01741.x; HYAMS JS, 1982, J CELL SCI, V55, P199; IVANOV KP, 1981, MICROVASC RES, V22, P143, DOI 10.1016/0026-2862(81)90084-4; Jackson AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002121; Jakes KA, 2001, PARASITOLOGY, V123, P483, DOI 10.1017/S0031182001008721; JANKEVICIUS JV, 1989, J PROTOZOOL, V36, P265, DOI 10.1111/j.1550-7408.1989.tb05361.x; Jastrzebski M, 1894, WIAD PARAZYT, V30, P172; JOHN MC, 1992, VET PARASITOL, V43, P143, DOI 10.1016/0304-4017(92)90057-G; JONES SRM, 1993, J PARASITOL, V79, P542, DOI 10.2307/3283380; JONES SRM, 1994, J PARASITOL, V80, P521, DOI 10.2307/3283186; Karbowiak G, 2004, ACTA PROTOZOOL, V43, P173; Karbowiak G, 2009, BIOLOGIA, V64, P1219, DOI 10.2478/s11756-009-0195-3; Karlsbakk E, 2006, SYST PARASITOL, V65, P175, DOI 10.1007/s11230-006-9049-3; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Kendell AI, 1906, J INFECT DIS, V3, P228, DOI 10.1093/infdis/3.2.228; KILLICKKENDRICK R, 1974, PROC R SOC SER B-BIO, V187, P409, DOI 10.1098/rspb.1974.0085; KILLICKKENDRICK R, 1988, PARASITOL RES, V74, P586, DOI 10.1007/BF00531639; KINGSTON N, 1981, Journal of Wildlife Diseases, V17, P539; KINGSTON N, 1975, J PARASITOL, V61, P17, DOI 10.2307/3279099; Kisch B., 1951, Experimental Medicine and Surgery, V9, P125; Kisch B., 1949, Experimental Medicine and Surgery, V7, P318; Kisch B., 1949, Experimental Medicine and Surgery, V7, P118; Kollien AH, 1998, ACTA TROP, V70, P127, DOI 10.1016/S0001-706X(97)00117-4; Kollien AH, 2003, PARASITOL RES, V89, P430, DOI 10.1007/s00436-002-0790-5; KURAMOTO M, 1981, COMP BIOCHEM PHYS A, V69, P771; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; LAIRD MARSHALL, 1959, CANADIAN JOUR ZOOL, V37, P749, DOI 10.1139/z59-075; LANGRIDGE DF, 1967, J PROTOZOOL, V14, P485, DOI 10.1111/j.1550-7408.1967.tb02033.x; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; LAUGE G, 1977, J MORPHOL, V154, P291, DOI 10.1002/jmor.1051540207; LEHMANN DL, 1954, J PARASITOL, V40, P656, DOI 10.2307/3273704; LETCH CA, 1980, PARASITOLOGY, V80, P163, DOI 10.1017/S0031182000000627; LETCH CA, 1979, PARASITOLOGY, V79, P107, DOI 10.1017/S0031182000052008; Lewis JH, 1996, COMP HEMOSTASIS VERT; LLOYD LI., 1924, Bulletin of Entomological Research, V14, P265; Lukes J, 1997, J MOL EVOL, V44, P521, DOI 10.1007/PL00006176; MACKERRAS M. JOSEPHINE, 1959, AUSTRALIAN JOUR ZOOL, V7, P105, DOI 10.1071/ZO9590105; Mackinnon Doris L., 1909, Parasitology Cambridge, V2; Mackinnon Doris L., 1911, Parasitology Cambridge, V4; Malassez M, 1872, COMPTES REND SEANCES, V75, P1528; MALONE LA, 1985, NEW ZEAL J ZOOL, V12, P155, DOI 10.1080/03014223.1985.10428274; Malysheva M N, 2006, Tsitologiia, V48, P723; MANAIA AD, 1981, J PROTOZOOL, V28, P124, DOI 10.1111/j.1550-7408.1981.tb02817.x; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; MCGHEE RB, 1969, J PROTOZOOL, V16, P514, DOI 10.1111/j.1550-7408.1969.tb02310.x; MCGHEE RB, 1964, J PROTOZOOL, V11, P555, DOI 10.1111/j.1550-7408.1964.tb01798.x; Minchin EA, 1915, Q J MICROSC SCI, V60, P463; MIYATA A, 1994, RAFFLES B ZOOL, V42, P539; Mo Xiu-ling, 2008, Redai Yixue Zazhi, V8, P621; MOLYNEUX DH, 1969, PARASITOLOGY, V59, P55, DOI 10.1017/S0031182000069821; MONNICKENDAM MA, 1973, COMP BIOCHEM PHYSIOL, V44, P871, DOI 10.1016/0300-9629(73)90150-3; Morgan GW, 2002, TRENDS PARASITOL, V18, P540, DOI 10.1016/S1471-4922(02)02392-9; Morgan GW, 2002, TRENDS PARASITOL, V18, P491, DOI 10.1016/S1471-4922(02)02391-7; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; MOTTA MCM, 1991, CAN J ZOOL, V69, P571, DOI 10.1139/z91-086; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; NANDI NC, 1994, MEM I OSWALDO CRUZ, V89, P145, DOI 10.1590/S0074-02761994000200005; NIGRELLI R. F., 1929, TRANS AMER MICROSC SOC, V48, P366, DOI 10.2307/3222056; Noguchi H, 1926, J EXP MED, V44, P307, DOI 10.1084/jem.44.3.307; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Patton W. S., 1908, Archiv fuer Protistenkunde, V12; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Podlipaev S.A., 1990, Trudy Zoologicheskogo Instituta, V217, P1; Podlipaev SA, 2004, J EUKARYOT MICROBIOL, V51, P283, DOI 10.1111/j.1550-7408.2004.tb00568.x; Ponder E., 1948, HEMOLYSIS RELATED PH; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; QADRI SS, 1962, PARASITOLOGY, V52, P221, DOI 10.1017/S0031182000024185; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; RINDISBACHER L, 1993, MOL BIOCHEM PARASIT, V58, P83, DOI 10.1016/0166-6851(93)90093-D; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Rodrigues AC, 2006, PARASITOLOGY, V132, P215, DOI 10.1017/S0031182005008929; Rodrigues AC, 2003, VET PARASITOL, V116, P185, DOI 10.1016/S0304-4017(03)00236-X; ROGERS WE, 1971, J PROTOZOOL, V18, P645, DOI 10.1111/j.1550-7408.1971.tb03390.x; ROITMAN I, 1977, J PROTOZOOL, V24, P553, DOI 10.1111/j.1550-7408.1977.tb01013.x; Romeiro A, 2000, J EUKARYOT MICROBIOL, V47, P208, DOI 10.1111/j.1550-7408.2000.tb00040.x; ROUF MA, 1969, COPEIA, P682; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato H, 2007, PARASITOL RES, V101, P453, DOI 10.1007/s00436-007-0504-0; SAUNDERS DC, 1959, J PARASITOL, V45, P623, DOI 10.2307/3274813; SAUNDERS DC, 1966, COPEIA, P348, DOI 10.2307/1441146; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; Sehgal RNM, 2006, J PARASITOL, V92, P1336, DOI 10.1645/GE-927R.1; Sharma R, 2008, PROTIST, V159, P137, DOI 10.1016/j.protis.2007.07.004; SHAW JJ, 1972, ANN TROP MED PARASIT, V66, P25, DOI 10.1080/00034983.1972.11686794; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMIRNOFF WA, 1970, J INVERTEBR PATHOL, V16, P187, DOI 10.1016/0022-2011(70)90059-5; Smith HM, 1925, BIOL BULL-US, V48, P347, DOI 10.2307/1536602; Snyder GK, 1999, AM ZOOL, V39, P189; Stevens J, 1999, MEM I OSWALDO CRUZ, V94, P225, DOI 10.1590/S0074-02761999000200019; Sun SY, 2013, J CELL SCI, V126, P520, DOI 10.1242/jcs.113621; SZARSKI H, 1966, B ACAD POL SCI BIOL, V14, P433; Tamarit A, 2011, VET PARASITOL, V177, P152, DOI 10.1016/j.vetpar.2010.11.044; Teixeira MMG, 2011, PROTIST, V162, P503, DOI 10.1016/j.protis.2011.01.001; TETLEY L, 1985, J CELL SCI, V74, P1; THEVENAZ P, 1980, ACTA TROP, V37, P163; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264; Tyzzer EE, 1919, J MED RES, V40, P129; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; Valkiunas G, 2011, J PARASITOL, V97, P924, DOI 10.1645/GE-2796.1; Vaughan S, 2008, BIOCHEM SOC T, V36, P421, DOI 10.1042/BST0360421; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; VERNBERG F. JOHN, 1955, HERPETOLOGICA, V11, P129; VICKERMAN K, 1969, J PROTOZOOL, V16, P54, DOI 10.1111/j.1550-7408.1969.tb02233.x; VICKERMAN K, 1973, J PROTOZOOL, V20, P394, DOI 10.1111/j.1550-7408.1973.tb00909.x; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; VICKERMAN K, 1969, J CELL SCI, V5, P163; VICKERMAN K, 1960, PARASITOLOGY, V50, P351, DOI 10.1017/S0031182000025452; VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8; Wakid MH, 2004, EXP PARASITOL, V106, P173, DOI 10.1016/j.exppara.2004.03.001; Wallace F. G., 1943, JOUR PARASITOL, V29, P196, DOI 10.2307/3273098; WALLACE FG, 1962, J PROTOZOOL, V9, P53, DOI 10.1111/j.1550-7408.1962.tb02580.x; WALLACE FG, 1960, J PROTOZOOL, V7, P390, DOI 10.1111/j.1550-7408.1960.tb05986.x; WALLACE FG, 1964, J PROTOZOOL, V11, P502, DOI 10.1111/j.1550-7408.1964.tb01788.x; WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4; WALLACE FG, 1965, J PROTOZOOL, V12, P390, DOI 10.1111/j.1550-7408.1965.tb03230.x; WEINMAN D, 1984, J PROTOZOOL, V31, P429, DOI 10.1111/j.1550-7408.1984.tb02990.x; Weisse S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037296; Wenyon CM, 1926, PROTOZOOLOGY MANUAL; WERNER JK, 1993, J PARASITOL, V79, P356, DOI 10.2307/3283570; WERNER JK, 1976, J PARASITOL, V62, P20, DOI 10.2307/3279035; Wheeler RJ, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-1; Wheeler RJ, 2011, MOL MICROBIOL, V79, P647, DOI 10.1111/j.1365-2958.2010.07479.x; Wiese M, 2003, EUKARYOT CELL, V2, P769, DOI 10.1128/EC.2.4.769-777.2003; Wilson V.C.L.C., 1979, P241; Wintrobe M.M., 1934, FOLIA HAEMATOL, V51, P32, DOI DOI 10.1111/J.1365-2141.1991.TB08590.X; WOO PTK, 1984, J PARASITOL, V70, P788, DOI 10.2307/3281762; Woods K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052846; WOODWARD R, 1994, MOL BIOCHEM PARASIT, V67, P31, DOI 10.1016/0166-6851(94)90093-0; Yakimoff W. L., 1918, Parasitology Cambridge, V11, DOI 10.1017/S003118200000408X; Yeld EM, 2006, J MAR BIOL ASSOC UK, V86, P829, DOI 10.1017/S0025315406013750; YOSHIDA N, 1978, J PROTOZOOL, V25, P421, DOI 10.1111/j.1550-7408.1978.tb04161.x; Yurchenko VY, 2006, PARASITOLOGY, V133, P537, DOI 10.1017/S0031182006000746; Zhang LM, 1997, PARASITE, V4, P299, DOI 10.1051/parasite/1997044299; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660; Ziccardi M, 1998, MEM I OSWALDO CRUZ, V93, P45, DOI 10.1590/S0074-02761998000100010; Zidkova L, 2010, INT J SYST EVOL MICR, V60, P2236, DOI 10.1099/ijs.0.014555-0	237	41	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79581	10.1371/journal.pone.0079581	http://dx.doi.org/10.1371/journal.pone.0079581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260255	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327311900031
J	Chandramouli, A; Hatsell, SJ; Pinderhughes, A; Koetz, L; Cowin, P				Chandramouli, Anupama; Hatsell, Sarah J.; Pinderhughes, Alicia; Koetz, Lisa; Cowin, Pamela			Gli Activity Is Critical at Multiple Stages of Embryonic Mammary and Nipple Development	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; HEDGEHOG SIGNALING PATHWAY; HAIR FOLLICLE DEVELOPMENT; SONIC-HEDGEHOG; GLAND DEVELOPMENT; LIMB DEVELOPMENT; BREAST-CANCER; TRANSCRIPTION FACTOR; CUBITUS-INTERRUPTUS; DORSOVENTRAL AXIS	Gli3 is a transcriptional regulator of Hedgehog (Hh) signaling that functions as a repressor (Gli3(R)) or activator (Gli3(A)) depending upon cellular context. Previously, we have shown that Gli3(R) is required for the formation of mammary placodes #3 and #5. Here, we report that this early loss of Gli3 results in abnormal patterning of two critical regulators: Bmp4 and Tbx3, within the presumptive mammary rudiment (MR) #3 zone. We also show that Gli3 loss leads to failure to maintain mammary mesenchyme specification and loss of epithelial Wnt signaling, which impairs the later development of remaining MRs: MR#2 showed profound evagination and ectopic hairs formed within the presumptive areola; MR#4 showed mild invagination defects and males showed inappropriate retention of mammary buds in Gli3(xt/xt) mice. Importantly, mice genetically manipulated to misactivate Hh signaling displayed the same phenotypic spectrum demonstrating that the repressor function of Gli3(R) is essential during multiple stages of mammary development. In contrast, positive Hh signaling occurs during nipple development in a mesenchymal cuff around the lactiferous duct and in muscle cells of the nipple sphincter. Collectively, these data show that repression of Hh signaling by Gli3(R) is critical for early placodal patterning and later mammary mesenchyme specification whereas positive Hh signaling occurs during nipple development.	[Chandramouli, Anupama; Hatsell, Sarah J.; Pinderhughes, Alicia; Koetz, Lisa; Cowin, Pamela] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Chandramouli, Anupama; Hatsell, Sarah J.; Cowin, Pamela] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA	New York University; New York University	Cowin, P (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	cowinp01@nyumc.org		Cowin, Pamela/0000-0002-1827-1154; Hatsell, Sarah/0000-0003-1103-6087	DOD BCRP IDEA Awards [BC093088, BC074763]; DOD BCRP Fellowship [BC112418]; Susan G. Komen Foundation [BCTR0504557];  [NIH-F31CA130137]; NATIONAL CANCER INSTITUTE [F31CA130137] Funding Source: NIH RePORTER	DOD BCRP IDEA Awards; DOD BCRP Fellowship; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DOD BCRP IDEA Awards BC093088 (PC), BC074763 (SH/PC), DOD BCRP Fellowship BC112418 (AC), Susan G. Komen Foundation BCTR0504557 (PC), NIH-F31CA130137 (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalkhani A, 2002, MECH DEVELOP, V115, P63, DOI 10.1016/S0925-4773(02)00092-8; Aubele M, 2002, ANAL CELL PATHOL, V24, P77, DOI 10.1155/2002/820269; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Behesti H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-62; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Bok J, 2007, DEVELOPMENT, V134, P1713, DOI 10.1242/dev.000760; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Cho KW, 2006, P NATL ACAD SCI USA, V103, P16788, DOI 10.1073/pnas.0604645103; Cho KW, 2012, DEV BIOL, V365, P259, DOI 10.1016/j.ydbio.2012.02.020; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Chuong CM, 2000, CELL MOL LIFE SCI, V57, P1672, DOI 10.1007/PL00000650; Cobourne MT, 2004, DEVELOPMENT, V131, P2875, DOI 10.1242/dev.01163; Cowin P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003251; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Dunbar ME, 1998, DEV BIOL, V203, P75, DOI 10.1006/dbio.1998.9029; Dunbar ME, 1999, DEVELOPMENT, V126, P3485; Dunbar ME, 1999, J MAMMARY GLAND BIOL, V4, P21, DOI 10.1023/A:1018700502518; Eblaghie MC, 2004, J ANAT, V205, P1, DOI 10.1111/j.0021-8782.2004.00309.x; Eriksson KS, 2009, BRAIN RES, V1302, P233, DOI 10.1016/j.brainres.2009.08.101; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Foley J, 2001, DEVELOPMENT, V128, P513; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Hatsell S, 2007, J MAMMARY GLAND BIOL, V12, P163, DOI 10.1007/s10911-007-9048-2; Hatsell SJ, 2006, DEVELOPMENT, V133, P3661, DOI 10.1242/dev.02542; Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306; Hens JR, 2007, DEVELOPMENT, V134, P1221, DOI 10.1242/dev.000182; HEUBERGER B, 1982, P NATL ACAD SCI-BIOL, V79, P2957, DOI 10.1073/pnas.79.9.2957; Hill P, 2009, DEV BIOL, V328, P506, DOI 10.1016/j.ydbio.2009.02.017; Hiremath M, 2012, DEVELOPMENT, V139, P4239, DOI 10.1242/dev.080671; Howard B, 2005, GENE DEV, V19, P2078, DOI 10.1101/gad.338505; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson ET, 2008, DEV DYNAM, V237, P2053, DOI 10.1002/dvdy.21612; Kawai S, 2001, BONE, V29, P54, DOI 10.1016/S8756-3282(01)00470-7; Kobayashi T, 2005, DEV DYNAM, V233, P794, DOI 10.1002/dvdy.20406; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KRATOCHWIL K, 1976, P NATL ACAD SCI USA, V73, P4041, DOI 10.1073/pnas.73.11.4041; KRATOCHWIL K, 1977, DEV BIOL, V61, P358, DOI 10.1016/0012-1606(77)90305-0; KRATOCHWIL K, 1971, J EMBRYOL EXP MORPH, V25, P141; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026242; Lee YS, 1997, MOL CARCINOGEN, V18, P44, DOI 10.1002/(SICI)1098-2744(199701)18:1<44::AID-MC6>3.0.CO;2-R; Li YN, 2004, DEV BIOL, V270, P214, DOI 10.1016/j.ydbio.2004.03.009; Liu J, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-65; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Mayer JA, 2008, AM J PATHOL, V173, P1339, DOI 10.2353/ajpath.2008.070920; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Michno K, 2003, DEV BIOL, V264, P153, DOI 10.1016/S0012-1606(03)00401-9; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/ng0298-104; Park HL, 2000, DEVELOPMENT, V127, P1593; Pu YB, 2004, DEV BIOL, V273, P257, DOI 10.1016/j.ydbio.2004.06.002; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Rowley M, 2004, J MAMMARY GLAND BIOL, V9, P109, DOI 10.1023/B:JOMG.0000037156.64331.3f; Sasaki H, 1999, DEVELOPMENT, V126, P3915; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394; Veltmaat JM, 2004, DEV DYNAM, V229, P349, DOI 10.1002/dvdy.10441; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Widelitz RB, 2007, SEMIN CELL DEV BIOL, V18, P255, DOI 10.1016/j.semcdb.2007.02.005; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; WYSOLMERSKI JJ, 1994, P NATL ACAD SCI USA, V91, P1133, DOI 10.1073/pnas.91.3.1133; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yarosh W, 2008, CANCER RES, V68, P693, DOI 10.1158/0008-5472.CAN-07-5012; Yu J, 2002, DEVELOPMENT, V129, P5301	91	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79845	10.1371/journal.pone.0079845	http://dx.doi.org/10.1371/journal.pone.0079845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260306	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500101
J	Johansson, H; Dhaygude, K; Lindstrom, S; Helantera, H; Sundstrom, L; Trontti, K				Johansson, Helena; Dhaygude, Kishor; Lindstrom, Stafva; Helantera, Heikki; Sundstrom, Liselotte; Trontti, Kalevi			A Metatranscriptomic Approach to the Identification of Microbiota Associated with the Ant Formica exsecta	PLOS ONE			English	Article							IMPORTED FIRE ANT; THELOHANIA-SOLENOPSAE MICROSPORIDIA; STRAND RNA VIRUS; WOLBACHIA INFECTION; PARALYSIS VIRUS; DRAFT GENOME; HYMENOPTERA; SEQUENCE; DIVERSITY; INVICTA	Social insects live in cooperative colonies, often in high densities and with closely related individuals, and interact using social contact behaviours. Compared to solitary insects, social insects have evolved multi-level immunity that includes immune responses common to holometabolous insects, and social immunity, which is exclusive to social taxa. This suggests that social insects may be subject to high pathogen pressure, yet relatively little is known about the range of symbiotic and pathogenic microbial communities that associate with social insects. In this study we examined transcriptome data generated from the ant Formica exsecta for sequences identifying as microbes (or other organisms potentially of non-ant origin). Sequences showing homology to two viruses and several other potentially or obligate intracellular organisms, such as Wolbachia, Arsenophonus, Entomoplasmatales and Microsporidia, were present in the transcriptome data. These homologous sequence matches correspond to genera/species that have previously been associated with a variety of insects, including social insects. There were also sequences with identity to several other microbes such as common moulds and soil bacteria. We conclude that this sequence data provides a starting point for a deeper understanding of the biological interactions between a species of ant and the micro- and macrobiotic communities that it potentially encounters.	[Johansson, Helena; Dhaygude, Kishor; Lindstrom, Stafva; Helantera, Heikki; Sundstrom, Liselotte; Trontti, Kalevi] Univ Helsinki, Ctr Excellence Biol Interact, Dept Biosci, Helsinki, Finland	University of Helsinki	Johansson, H (corresponding author), Univ Helsinki, Ctr Excellence Biol Interact, Dept Biosci, Helsinki, Finland.	helena.z.johansson@helsinki.fi	Helanterä, Heikki/C-7568-2011; Johansson, Helena/H-6042-2012; Sundstrom, Liselotte/G-5080-2010; Lindstrom, Stafva/GQZ-6278-2022	Helanterä, Heikki/0000-0002-6468-5956; Sundstrom, Liselotte/0000-0002-6176-8940; Trontti, Kalevi/0000-0002-3797-8163; Lindstrom, Stafva/0000-0002-2863-940X; Dhaygude, Kishor/0000-0003-4499-6180	Academy of Finland [140990, 135970, 134561]; Centre of Excellence in Biological Interactions [251337]	Academy of Finland(Academy of Finland); Centre of Excellence in Biological Interactions	This work received funding from Academy of Finland (http://www.aka.fi/eng) grant numbers 140990 and 135970 to Heikki Helantera, 134561 to Kalevi Trontti, and Centre of Excellence in Biological Interactions grant number 251337 to Liselotte Sundstrom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GE, 2013, J NEW YORK ENTOMOL S, V82, P125; Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Ba AS, 1996, MYCOL RES, V100, P740, DOI 10.1016/S0953-7562(96)80208-5; Badouin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068200; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Briano JA, 2002, ENVIRON ENTOMOL, V31, P887, DOI 10.1603/0046-225X-31.5.887; Celle O, 2008, VIRUS RES, V133, P280, DOI 10.1016/j.virusres.2007.12.011; Christian P., 2005, VIRUS TAXONOMY, P783; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cotter SC, 2010, ECOL LETT, V13, P1114, DOI 10.1111/j.1461-0248.2010.01500.x; Cotter SC, 2010, BEHAV ECOL, V21, P663, DOI 10.1093/beheco/arq070; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; CZECHOWSKI W, 2002, ANTS HYMENOPTERA FOR; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Darby AC, 2010, INSECT MOL BIOL, V19, P75, DOI 10.1111/j.1365-2583.2009.00950.x; de Miranda JR, 2004, J GEN VIROL, V85, P2263, DOI 10.1099/vir.0.79990-0; Douwes P, 2012, HYMENOPTERA FORMICID; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; EICKWORT GC, 1990, ANNU REV ENTOMOL, V35, P469, DOI 10.1146/annurev.en.35.010190.002345; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Funaro CF, 2011, APPL ENVIRON MICROB, V77, P346, DOI 10.1128/AEM.01896-10; Fuxa JR, 2005, J INVERTEBR PATHOL, V88, P79, DOI 10.1016/j.jip.2004.10.001; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haag-Liautard C, 2009, J EVOLUTION BIOL, V22, P134, DOI 10.1111/j.1420-9101.2008.01635.x; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; JOUVENAZ DP, 1986, J PROTOZOOL, V33, P457, DOI 10.1111/j.1550-7408.1986.tb05641.x; Keller L, 2001, HEREDITY, V87, P227, DOI 10.1046/j.1365-2540.2001.00918.x; Kidd SE, 2003, MED MYCOL, V41, P171, DOI 10.1080/714858208; KNELL JD, 1977, J INVERTEBR PATHOL, V29, P192, DOI 10.1016/0022-2011(77)90193-8; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehtinen Tapiola P, 1987, ENTOMOLOGISK TIDSKRI, V108, P13; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; MARTINI A, 1992, BIODIVERS CONSERV, V1, P324, DOI 10.1007/BF00693768; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; OI DH, 1993, FLA ENTOMOL, V76, P63, DOI 10.2307/3496014; Oi DH, 2005, J INVERTEBR PATHOL, V88, P108, DOI 10.1016/j.jip.2004.11.006; Oi DH, 2002, J ECON ENTOMOL, V95, P558, DOI 10.1603/0022-0493-95.3.558; PAMILO P, 1991, INSECT SOC, V38, P111, DOI 10.1007/BF01240961; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pisarski B., 1982, Memorabilia Zoologica, V38, P31; Pisarski B, 1982, MEMORABILIA ZOOLOGIC, V38, P38; Reber A, 2012, INSECT SOC, V59, P231, DOI 10.1007/s00040-011-0209-3; Reuter M, 2003, MOL BIOL EVOL, V20, P748, DOI 10.1093/molbev/msg082; Ribeiro Myriam M.R., 2012, Psyche (Cambridge), V2012, P1; Russell JA, 2012, MYRMECOL NEWS, V16, P7; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Schluns H, 2008, P 4 EUR M INT UN STU, P65; Schluns H, 2009, MYRMECOL NEWS, V12, P237; Schmid-Hempel P., 1998, Parasites in social insects.; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Seifert Bernhard, 2000, Zoosystema, V22, P517; Simola DF, 2013, GENOME RES, V23, P1235, DOI 10.1101/gr.155408.113; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Slavikova E, 2003, J BASIC MICROB, V43, P430, DOI 10.1002/jobm.200310277; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stevens L, 2001, ANNU REV ECOL SYST, V32, P519, DOI 10.1146/annurev.ecolsys.32.081501.114132; Stoll S, 2007, BIOL J LINN SOC, V90, P399, DOI 10.1111/j.1095-8312.2006.00730.x; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Troemel ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001243; Valles SM, 2004, VIROLOGY, V328, P151, DOI 10.1016/j.virol.2004.07.016; Valles SM, 2008, J INVERTEBR PATHOL, V99, P74, DOI 10.1016/j.jip.2008.01.004; Valles SM, 2007, VIROLOGY, V365, P457, DOI 10.1016/j.virol.2007.03.043; Valles SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031828; Valles SM, 2009, VIROLOGY, V388, P354, DOI 10.1016/j.virol.2009.03.028; Van der Geest LPS, 2000, EXP APPL ACAROL, V24, P497, DOI 10.1023/A:1026518418163; van Oers MM, 2010, INSECT VIROLOGY, P231; Vanninen I, 1996, MYCOL RES, V100, P93, DOI 10.1016/S0953-7562(96)80106-7; Viljakainen L, 2008, EVOLUTIONARY GENETIC; Viljakainen L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-55; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Werner P., 1979, ECOLOGIE INSECTES SO, P115; Williams DF, 1999, J ECON ENTOMOL, V92, P7; Wittekindt NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013432; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Wurm Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-5; Yang CC, 2010, BIOL INVASIONS, V12, P3307, DOI 10.1007/s10530-010-9724-9; Zientz E, 2005, ARCH MICROBIOL, V184, P199, DOI 10.1007/s00203-005-0041-0	95	43	45	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79777	10.1371/journal.pone.0079777	http://dx.doi.org/10.1371/journal.pone.0079777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260298	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500098
J	Traister, A; Walsh, M; Aafaqi, S; Lu, ML; Dai, XJ; Henkleman, MR; Momen, A; Zhou, YQ; Husain, M; Arab, S; Piran, S; Hannigan, G; Coles, JG				Traister, Alexandra; Walsh, Mark; Aafaqi, Shabana; Lu, Mingliang; Dai, Xiaojing; Henkleman, Mark R.; Momen, Abdul; Zhou, Yu-Quing; Husain, Mansoor; Arab, Sara; Piran, Sara; Hannigan, Gregory; Coles, John G.			Mutation in Integrin-Linked Kinase (ILKR211A) and Heat-Shock Protein 70 Comprise a Broadly Cardioprotective Complex	PLOS ONE			English	Article							CARDIAC DYSFUNCTION; EXPRESSION; MICE; PHOSPHORYLATION; CONTRACTILITY; HEART	Rationale: Integrin-linked kinase (ILK) has been proposed as a novel molecular target that has translational potential in diverse cardiac diseases, since its upregulation promotes a broadly cardioprotective phenotype. However, ILK has been implicated as both a cardioprotective and oncogenic target, which imposes therapeutic constraints that are generally relevant to the translational potential of many kinases. Objective: To study the cardioprotective properties of the activation-resistant, non-oncogenic, mutation of ILK (ILKR211A) against experimental MI in vivo and Doxorubicin induced apoptosis in vitro and it's relationships to stress induced heat shock proteins. Methods/Results: The transgenic mouse heart over-expressing a point mutation in the ILK pleckstrin homology (PH) domain (Tg(R211A)) exhibits a highly cardioprotective phenotype based on LAD-ligation-induced MI reduction in vivo, and on protection against doxorubicin (DOX)-induced cardiomyocyte apoptosis when overexpressed in human induced pluripotent stem cell (iPS)-derived cardiomyocytes in vitro. Intriguingly, the degree of cardioprotection seen with the ILKR211A mutation exceeded that with the ILKS343D mutation. Microarray and immunoprecipitation analyses revealed upregulation of expression levels and specific binding of ILKWT, ILKS343D and ILKR211A to both constitutively active heat-shock protein 70 (Hsc70) and inducible Hsp70 in response to MI, and to acute ILK overexpression in iPSC-cardiomyocytes. ILK-mediated cardioprotection was shown to depend upon Hsp70 ATPase activity. Conclusions: These findings indicate that wild type ILK and the non-oncogenic ILKR211A mutation comprise a cardioprotective module with Hsp/c70. These results advance a novel target discovery theme in which kinase mutations can be safely engineered to enhance cardioprotective effects.	[Traister, Alexandra; Walsh, Mark; Aafaqi, Shabana; Lu, Mingliang; Dai, Xiaojing; Arab, Sara; Piran, Sara; Coles, John G.] Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada; [Hannigan, Gregory] Monash Inst Med Res, Cell Adhes Signaling Lab, Melbourne, Vic, Australia; [Henkleman, Mark R.; Zhou, Yu-Quing] Toronto Ctr Phenogen, Mouse Imaging Facil, Toronto, ON, Canada; [Momen, Abdul; Husain, Mansoor] Univ Hlth Network, Div Cellular & Mol Biol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Coles, JG (corresponding author), Hosp Sick Children, Div Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.coles@sickkids.ca		Husain, Mansoor/0000-0002-3740-6739	GL2-Ministry of Research and Innovations Ministry of Health Ontario, Cardiovascular biomarker discovery and validation [GL2-01-012]	GL2-Ministry of Research and Innovations Ministry of Health Ontario, Cardiovascular biomarker discovery and validation	This work was supported by GL2-Ministry of Research and Innovations Ministry of Health Ontario, Cardiovascular biomarker discovery and validation Grant # GL2-01-012 (http://www.ontario.ca/ministry-research-innovation).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud ER, 2007, INT J ONCOL, V30, P113; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; CAGLIO S, 1993, ELECTROPHORESIS, V14, P554, DOI 10.1002/elps.1150140184; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Diaz RJ, 2010, CARDIOVASC RES, V87, P545, DOI 10.1093/cvr/cvq084; Durbin AD, 2009, J CLIN INVEST, V119, P1558, DOI 10.1172/JCI37958; Durbin AD, 2010, CELL CYCLE, V9, P1951, DOI 10.4161/cc.9.10.11554; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Gu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031279; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; Herranz B, 2012, CIRC RES, V110, P439, DOI 10.1161/CIRCRESAHA.111.253948; Jasmin JF, 2011, AM J PHYSIOL-HEART C, V300, pH1274, DOI 10.1152/ajpheart.01173.2010; Kattman SJ, 2011, J CARDIOVASC TRANSL, V4, P66, DOI 10.1007/s12265-010-9235-1; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu J, 2006, AM J PHYSIOL-CELL PH, V290, pC583, DOI 10.1152/ajpcell.00145.2005; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Marechal X, 2011, CLIN SCI, V121, P405, DOI 10.1042/CS20110069; Peng W, 2010, CIRC RES, V106, P102, DOI 10.1161/CIRCRESAHA.109.210914; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Radovanac K, 2013, EMBO J, V32, P1409, DOI 10.1038/emboj.2013.90; Sheng R, 2012, AUTOPHAGY, V8, P310, DOI 10.4161/auto.18673; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Sussman M, 2007, TRENDS CARDIOVAS MED, V17, P235, DOI 10.1016/j.tcm.2007.08.003; Vaduganathan M, 2013, NAT REV CARDIOL, V10, P85, DOI 10.1038/nrcardio.2012.181; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250; Xie J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024115; Yamabi H, 2006, J THORAC CARDIOV SUR, V132, P1272, DOI 10.1016/j.jtcvs.2006.08.028; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou YQ, 2005, AM J PHYSIOL-HEART C, V289, pH992, DOI 10.1152/ajpheart.00027.2005; Zhou YQ, 2004, PHYSIOL GENOMICS, V18, P232, DOI 10.1152/physiolgenomics.00026.2004	37	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e77331	10.1371/journal.pone.0077331	http://dx.doi.org/10.1371/journal.pone.0077331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260102	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500005
J	Ribeiz, SRI; Duran, F; Oliveira, MC; Bezerra, D; Castro, CC; Steffens, DC; Busatto, G; Bottino, CMC				Ribeiz, Salma R. I.; Duran, Fabio; Oliveira, Melaine C.; Bezerra, Diana; Castro, Claudio Campi; Steffens, David C.; Busatto Filho, Geraldo; Bottino, Cassio M. C.			Structural Brain Changes as Biomarkers and Outcome Predictors in Patients with Late-Life Depression: A CrossSectional and Prospective Study	PLOS ONE			English	Article							GRAY-MATTER CHANGES; HUMAN ORBITOFRONTAL CORTEX; VOXEL-BASED MORPHOMETRY; ANTERIOR CINGULATE; CORTICAL THICKNESS; HIPPOCAMPAL VOLUME; SAO-PAULO; SCALE; MRI; REGISTRATION	The relationship between structural changes in grey matter and treatment response in patients with late-life depression remains an intriguing area of research. This magnetic resonance imaging (MRI) study compares the baseline grey matter volume of elderly people with and without major depression (according to the DSM-IV-TR criteria) and assesses its association with antidepressant treatment response. Brain MRI scans were processed using statistical parametric mapping and voxel-based morphometry. The sample consisted of 30 patients with depression and 22 healthy controls. We found a significant volumetric reduction in the orbitofrontal cortex bilaterally in patients in comparison with controls. According to their remission status after antidepressant treatment, patients were classified as remitted or not remitted. Compared with controls, remitted patients showed a volumetric reduction in the orbitofrontal cortex bilaterally and in another cluster in the right middle temporal pole. Non-remitted patients showed an even greater volumetric reduction in the orbitofrontal cortex bilaterally compared with controls. To investigate predictive factors of remission after antidepressant treatment, we used a logistic regression. Both baseline Mini Mental State Examination score and baseline left superior lateral orbitofrontal cortex volume (standardized to the total grey matter volume) were associated with remission status. Our findings support the use of regional brain atrophy as a potential biomarker for depression. In addition, baseline cognitive impairment and regional grey matter abnormalities predict antidepressant response in patients with late-life depression.	[Ribeiz, Salma R. I.; Bezerra, Diana; Bottino, Cassio M. C.] Univ Sao Paulo, Sch Med, Inst Psychiat, Old Age Res Grp PROTER, Sao Paulo, Brazil; [Duran, Fabio; Busatto Filho, Geraldo] Univ Sao Paulo, Inst Psychiat, Lab Psychiat Neuroimaging LIM 21, Sao Paulo, Brazil; [Duran, Fabio; Busatto Filho, Geraldo] Univ Sao Paulo, Dept Psychiat, Lab Psychiat Neuroimaging LIM 21, Sao Paulo, Brazil; [Oliveira, Melaine C.] Univ Sao Paulo, Inst Math & Stat IME, Sao Paulo, Brazil; [Castro, Claudio Campi] Univ Sao Paulo, Sch Med, Heart Inst InCor, Dept Diagnost Imaging, Sao Paulo, Brazil; [Steffens, David C.] Univ Connecticut, Sch Med, Dept Psychiat, Farmington, CT USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Connecticut	Ribeiz, SRI (corresponding author), Univ Sao Paulo, Sch Med, Inst Psychiat, Old Age Res Grp PROTER, Sao Paulo, Brazil.	salma.ribeiz@usp.br	Busatto, Geraldo F/D-4431-2009; Duran, Fabio L S/I-5704-2012; DE CASTRO, CLAUDIO CAMPI/AAN-5220-2020; Souza-Duran, Fabio Luis/L-1371-2013; Ribeiz, Salma/D-1794-2014	Busatto, Geraldo F/0000-0003-4749-4602; Duran, Fabio L S/0000-0003-2494-7250; Souza-Duran, Fabio Luis/0000-0002-7603-6152; Ribeiz, Salma/0000-0002-2214-4318	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/09586-9]; "National Counsel of Technological and Scientific Development" (CNPq-Researcher Level 2); United States National Institute of Mental Health [K24 MH 070027]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "National Counsel of Technological and Scientific Development" (CNPq-Researcher Level 2); United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) no. 04/09586-9. Dr. Salma R. I. Ribeiz is supported by a research fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Dr. C~ssio M. C. Bottino is a researcher of the "National Counsel of Technological and Scientific Development" (CNPq-Researcher Level 2). Dr. David Steffens is supported by United States National Institute of Mental Health grant K24 MH 070027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, INT J GERIATR PSYCH, V23, P347, DOI 10.1002/gps.1939; Alexopoulos GS, 2002, AM J GERIAT PSYCHIAT, V10, P687, DOI 10.1176/appi.ajgp.10.6.687; *AM PSYCH ASS E, 2000, DIAGN STAT MAN MENT; Andreescu C, 2008, NEUROPSYCHOPHARMACOL, V33, P2566, DOI 10.1038/sj.npp.1301655; Arnone D, 2012, EUR NEUROPSYCHOPHARM, V22, P1, DOI 10.1016/j.euroneuro.2011.05.003; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Avila R, 2011, NEUROBIOL AGING, V32, P1857, DOI 10.1016/j.neurobiolaging.2009.11.004; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Ballmaier M, 2004, BIOL PSYCHIAT, V55, P382, DOI 10.1016/j.biopsych.2003.09.004; Barcelos-Ferreira R, 2009, AM J GERIAT PSYCHIAT, V17, P582, DOI 10.1097/JGP.0b013e3181a76ddc; Bottino CMC, 2008, DEMENT GERIATR COGN, V26, P291, DOI 10.1159/000161053; Bottino CMC, 2012, CURR PSYCHIAT REP, V14, P289, DOI 10.1007/s11920-012-0281-z; BOTTINO CMC, 2001, JORNAL OFICIAL ACAD, P20; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; COFFEY CE, 1993, ARCH GEN PSYCHIAT, V50, P7; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; CRAIGHEAD WES, 2007, GUIDE TREATMENTS WOR, P271; Disabato BM, 2012, CURR PSYCHIAT REP, V14, P273, DOI 10.1007/s11920-012-0279-6; Egger K, 2008, PSYCHIAT RES-NEUROIM, V164, P237, DOI 10.1016/j.pscychresns.2007.12.018; Folquitto JC, 2007, REV BRAS PSIQUIATR, V29, P350, DOI 10.1590/S1516-44462006005000037; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frodl T, 2008, J PSYCHIATR NEUROSCI, V33, P423; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; Gunning FM, 2009, INT J GERIATR PSYCH, V24, P829, DOI 10.1002/gps.2290; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hsieh MH, 2002, INT J GERIATR PSYCH, V17, P519, DOI 10.1002/gps.611; Janssen J, 2007, INT J GERIATR PSYCH, V22, P468, DOI 10.1002/gps.1790; Koolschijn PCMP, 2010, EUR NEUROPSYCHOPHARM, V20, P398, DOI 10.1016/j.euroneuro.2010.02.010; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lai TJ, 2000, BIOL PSYCHIAT, V48, P971, DOI 10.1016/S0006-3223(00)01042-8; Lavretsky H, 2007, AM J GERIAT PSYCHIAT, V15, P386, DOI 10.1097/JGP.0b013e3180325a16; Lehfeld H, 1997, ALZ DIS ASSOC DIS, V11, pS39; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Masi G, 2011, CNS DRUGS, V25, P913, DOI 10.2165/11595900-000000000-00000; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; NEMEROFF CB, 2007, GUIDE TREATMENTS WOR, P271; OBrien JT, 1997, INT J GERIATR PSYCH, V12, P211, DOI 10.1002/(SICI)1099-1166(199702)12:2<211::AID-GPS558>3.0.CO;2-K; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; RIBEIZ SR, 2012, INT J GERIATR PSYCHI; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Sexton CE, 2012, AM J GERIATR PSYCHIA; Sexton CE, 2012, ARCH GEN PSYCHIAT, V69, P680, DOI 10.1001/archgenpsychiatry.2011.1862; Sheline YI, 2012, AM J PSYCHIAT, V169, P1185, DOI 10.1176/appi.ajp.2012.12010122; SNAITH RP, 1986, BRIT J PSYCHIAT, V148, P599, DOI 10.1192/bjp.148.5.599; Steffens David C, 2002, Psychopharmacol Bull, V36, P58; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor WD, 2007, PSYCHOL MED, V37, P1763, DOI 10.1017/S0033291707000128; Yuan YG, 2008, BIOL PSYCHIAT, V64, P541, DOI 10.1016/j.biopsych.2008.04.032; Zhao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001837	58	25	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80049	10.1371/journal.pone.0080049	http://dx.doi.org/10.1371/journal.pone.0080049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244606	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800113
J	Sawler, J; Reisch, B; Aradhya, MK; Prins, B; Zhong, GY; Schwaninger, H; Simon, C; Buckler, E; Myles, S				Sawler, Jason; Reisch, Bruce; Aradhya, Mallikarjuna K.; Prins, Bernard; Zhong, Gan-Yuan; Schwaninger, Heidi; Simon, Charles; Buckler, Edward; Myles, Sean			Genomics Assisted Ancestry Deconvolution in Grape	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-STRUCTURE	The genus Vitis (the grapevine) is a group of highly diverse, diploid woody perennial vines consisting of approximately 60 species from across the northern hemisphere. It is the world's most valuable horticultural crop with similar to 8 million hectares planted, most of which is processed into wine. To gain insights into the use of wild Vitis species during the past century of interspecific grape breeding and to provide a foundation for marker-assisted breeding programmes, we present a principal components analysis (PCA) based ancestry estimation method to calculate admixture proportions of hybrid grapes in the United States Department of Agriculture grape germplasm collection using genome-wide polymorphism data. We find that grape breeders have backcrossed to both the domesticated V. vinifera and wild Vitis species and that reasonably accurate genome-wide ancestry estimation can be performed on interspecific Vitis hybrids using a panel of fewer than 50 ancestry informative markers (AIMs). We compare measures of ancestry informativeness used in selecting SNP panels for two-way admixture estimation, and verify the accuracy of our method on simulated populations of admixed offspring. Our method of ancestry deconvolution provides a first step towards selection at the seed or seedling stage for desirable admixture profiles, which will facilitate marker-assisted breeding that aims to introgress traits from wild Vitis species while retaining the desirable characteristics of elite V. vinifera cultivars.	[Sawler, Jason; Myles, Sean] Dalhousie Univ, Fac Agr, Dept Plant & Anim Sci, Truro, NS, Canada; [Reisch, Bruce] Cornell Univ, Dept Hort, Ithaca, NY USA; [Aradhya, Mallikarjuna K.; Prins, Bernard] Univ Calif Davis, ARS, USDA, Davis, CA 95616 USA; [Zhong, Gan-Yuan] Cornell Univ, USDA, ARS, Grape Genet Res Unit,New York State Agr Exp Stn, Geneva, NY USA; [Zhong, Gan-Yuan; Schwaninger, Heidi; Simon, Charles] Cornell Univ, USDA, ARS, Plant Genet Resources Unit,New York State Agr Exp, Geneva, NY USA; [Buckler, Edward] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Buckler, Edward] ARS, USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	Dalhousie University; Cornell University; United States Department of Agriculture (USDA); University of California System; University of California Davis; Cornell University; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA)	Myles, S (corresponding author), Dalhousie Univ, Fac Agr, Dept Plant & Anim Sci, Truro, NS, Canada.	sean.myles@dal.ca	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; Myles, Sean/0000-0001-9754-5987; Aradhya, Mallikarjuna/0000-0002-2118-7885	Canada Research Chairs program; National Sciences and Engineering Research Council of Canada	Canada Research Chairs program(Canada Research Chairs); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This article was written, in part, thanks to funding from the Canada Research Chairs program and the National Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Di Gaspero G, 2010, AUST J GRAPE WINE R, V16, P122, DOI 10.1111/j.1755-0238.2009.00072.x; Ding LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-622; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Ma JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040115; McGovern PE, 2003, ANCIENT WINE SEARCH; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Myles S, 2013, TRENDS GENET, V29, P190, DOI 10.1016/j.tig.2013.01.006; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2022, R LANG ENV STAT COMP; Reisch BI, 2012, HANDB PLANT BREED, V8, P225, DOI 10.1007/978-1-4419-0763-9_7; Robinson J., 2012, WINE GRAPES COMPLETE; USDA, 2013, ARS NAT GEN RES PROG; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	25	25	26	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80791	10.1371/journal.pone.0080791	http://dx.doi.org/10.1371/journal.pone.0080791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244717	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600217
J	Zhu, ZD; Fan, YY; Feng, GY; Huang, RW; Wang, SP				Zhu, Zude; Fan, Yuanyuan; Feng, Gangyi; Huang, Ruiwang; Wang, Suiping			Large Scale Brain Functional Networks Support Sentence Comprehension: Evidence from Both Explicit and Implicit Language Tasks	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; SMALL-WORLD; NEURAL-NETWORK; ANTERIOR; CONNECTIVITY; SPEECH; FMRI; CORTEX; ORGANIZATION; INTEGRATION	Previous studies have indicated that sentences are comprehended via widespread brain regions in the fronto-temporoparietal network in explicit language tasks (e.g., semantic congruency judgment tasks), and through restricted temporal or frontal regions in implicit language tasks (e.g., font size judgment tasks). This discrepancy has raised questions regarding a common network for sentence comprehension that acts regardless of tasks effect and whether different tasks modulate network properties. To this end, we constructed brain functional networks based on 27 subjects' fMRI data that was collected while performing explicit and implicit language tasks. We found that network properties and network hubs corresponding to the implicit language tasks were similar to those associated with the explicit language task. We also found common hubs in occipital, temporal and frontal regions in both tasks. Compared with the implicit language task, the explicit language task resulted in greater global efficiency and increased integrated betweenness centrality of the left interior frontal gyrus, which is a key region related to sentence comprehension. These results suggest that brain functional networks support both explicit and implicit sentence comprehension; in addition, these two types of language tasks may modulate the properties of brain functional networks.	[Huang, Ruiwang] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Huang, RW (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	ruiwang.huang@gmail.com; suiping@scnu.edu.cn		Wang, Suiping/0000-0001-8726-169X; Feng, Gangyi/0000-0003-2239-5296	Natural Science Foundation of China [31100811, 31271086, 81071149, 81271548]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Key Laboratory of Mental Health and Cognitive Science; South China Normal University; Scientific Research Foundation for Returned Overseas Chinese Scholar; State Education Ministry	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Key Laboratory of Mental Health and Cognitive Science; South China Normal University; Scientific Research Foundation for Returned Overseas Chinese Scholar(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry	This work was supported by grants from the Natural Science Foundation of China (Grant numbers: 31100811, 31271086, 81071149, and 81271548), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2012), Guangdong Key Laboratory of Mental Health and Cognitive Science, South China Normal University, and Scientific Research Foundation for Returned Overseas Chinese Scholar (RH), State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Braze D, 2011, CORTEX, V47, P416, DOI 10.1016/j.cortex.2009.11.005; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caplan D, 2008, CORTEX, V44, P257, DOI 10.1016/j.cortex.2006.06.005; Cheung H, 2012, INT J PSYCHOPHYSIOL, V83, P357, DOI 10.1016/j.ijpsycho.2011.12.002; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Cooke A, 2006, BRAIN LANG, V96, P14, DOI 10.1016/j.bandl.2005.07.072; Crinion J, 2005, BRAIN, V128, P2858, DOI 10.1093/brain/awh659; Crinion JT, 2003, BRAIN, V126, P1193, DOI 10.1093/brain/awg104; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Diaz MT, 2011, NEUROPSYCHOLOGIA, V49, P320, DOI 10.1016/j.neuropsychologia.2010.12.004; Faria AV, 2012, NEUROIMAGE, V61, P613, DOI 10.1016/j.neuroimage.2012.03.078; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friederici AD, 2009, NEUROREPORT, V20, P563, DOI 10.1097/WNR.0b013e3283297dee; Gold BT, 2006, J NEUROSCI, V26, P6523, DOI 10.1523/JNEUROSCI.0808-06.2006; Gold BT, 2010, NEUROBIOL AGING, V31, P512, DOI 10.1016/j.neurobiolaging.2008.04.005; Green JJ, 2011, J NEUROSCI, V31, P3560, DOI 10.1523/JNEUROSCI.5758-10.2011; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P., 2009, COGNITIVE NEUROSCIEN, V4th, P819, DOI [10.1002/int.4550070108, DOI 10.1002/INT.4550070108]; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Huang J, 2012, BRAIN RES, V1440, P56, DOI 10.1016/j.brainres.2011.11.060; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Jin H, 2009, INT J PSYCHOPHYSIOL, V71, P142, DOI 10.1016/j.ijpsycho.2008.08.009; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Liu Y, 1990, MODERN FREQUENCY DIC; Neubert FX, 2010, P NATL ACAD SCI USA, V107, P13240, DOI 10.1073/pnas.1000674107; Newman SD, 2009, HUM BRAIN MAPP, V30, P2499, DOI 10.1002/hbm.20684; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Rodd JM, 2012, CEREB CORTEX, V22, P1761, DOI 10.1093/cercor/bhr252; Rodd JM, 2005, CEREB CORTEX, V15, P1261, DOI 10.1093/cercor/bhi009; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ruff I, 2008, BRAIN LANG, V105, P41, DOI 10.1016/j.bandl.2008.01.003; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Snijders TM, 2010, NEUROIMAGE, V52, P1633, DOI 10.1016/j.neuroimage.2010.05.035; Spitsyna G, 2006, J NEUROSCI, V26, P7328, DOI 10.1523/JNEUROSCI.0559-06.2006; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vuong LC, 2011, BRAIN LANG, V116, P22, DOI 10.1016/j.bandl.2010.09.012; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Warren JE, 2009, BRAIN, V132, P3428, DOI 10.1093/brain/awp270; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitney C, 2012, J COGNITIVE NEUROSCI, V24, P133, DOI 10.1162/jocn_a_00123; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Ye Z, 2014, HUM BRAIN MAPP, V35, P367, DOI 10.1002/hbm.22182; Ye Z, 2009, NEUROSCI BIOBEHAV R, V33, P1168, DOI 10.1016/j.neubiorev.2009.03.003; Zempleni MZ, 2007, NEUROIMAGE, V34, P1270, DOI 10.1016/j.neuroimage.2006.09.048; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhu ZD, 2013, NEUROIMAGE, V76, P325, DOI 10.1016/j.neuroimage.2013.02.060; Zhu ZD, 2012, NEUROIMAGE, V60, P2230, DOI 10.1016/j.neuroimage.2012.02.036; [朱祖德 ZHU ZuDe], 2011, [心理科学进展, Advances in Psychological Science], V19, P1147; Zhu ZD, 2009, NEUROIMAGE, V47, P756, DOI 10.1016/j.neuroimage.2009.04.086	74	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80214	10.1371/journal.pone.0080214	http://dx.doi.org/10.1371/journal.pone.0080214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244653	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600193
J	Poeschl, Y; Delker, C; Trenner, J; Ullrich, KK; Quint, M; Grosse, I				Poeschl, Yvonne; Delker, Carolin; Trenner, Jana; Ullrich, Kristian Karsten; Quint, Marcel; Grosse, Ivo			Optimized Probe Masking for Comparative Transcriptomics of Closely Related Species	PLOS ONE			English	Article							DENSITY OLIGONUCLEOTIDE ARRAYS; GENE-EXPRESSION; DNA MICROARRAYS; QUALITY-CONTROL; ARABIDOPSIS; NORMALIZATION; SELECTION; SEQUENCE; LEVEL; TOOL	Microarrays are commonly applied to study the transcriptome of specific species. However, many available microarrays are restricted to model organisms, and the design of custom microarrays for other species is often not feasible. Hence, transcriptomics approaches of non-model organisms as well as comparative transcriptomics studies among two or more species often make use of cost-intensive RNAseq studies or, alternatively, by hybridizing transcripts of a query species to a microarray of a closely related species. When analyzing these cross-species microarray expression data, differences in the transcriptome of the query species can cause problems, such as the following: (i) lower hybridization accuracy of probes due to mismatches or deletions, (ii) probes binding multiple transcripts of different genes, and (iii) probes binding transcripts of non-orthologous genes. So far, methods for (i) exist, but these neglect (ii) and (iii). Here, we propose an approach for comparative transcriptomics addressing problems (i) to (iii), which retains only transcript-specific probes binding transcripts of orthologous genes. We apply this approach to an Arabidopsis lyrata expression data set measured on a microarray designed for Arabidopsis thaliana, and compare it to two alternative approaches, a sequence-based approach and a genomic DNA hybridization-based approach. We investigate the number of retained probe sets, and we validate the resulting expression responses by qRT-PCR. We find that the proposed approach combines the benefit of sequence-based stringency and accuracy while allowing the expression analysis of much more genes than the alternative sequence-based approach. As an added benefit, the proposed approach requires probes to detect transcripts of orthologous genes only, which provides a superior base for biological interpretation of the measured expression responses.	[Poeschl, Yvonne; Grosse, Ivo] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Saale, Germany; [Delker, Carolin; Trenner, Jana; Ullrich, Kristian Karsten; Quint, Marcel] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany; [Grosse, Ivo] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzenbiochemie	Poeschl, Y (corresponding author), Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Saale, Germany.	poeschl@informatik.uni-halle.de	Ullrich, Kristian/AAP-6724-2021; quint, marcel/J-8483-2012	Ullrich, Kristian/0000-0003-4308-9626; Quint, Marcel/0000-0003-2935-4083	Leibniz Association; "Exzellenzinitiative fur Biowissenschaften" by State of Sachsen-Anhalt	Leibniz Association; "Exzellenzinitiative fur Biowissenschaften" by State of Sachsen-Anhalt	CD, JT, KKU, and MQ were supported by the Leibniz Association and the "Exzellenzinitiative fur Biowissenschaften" by State of Sachsen-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Bar-Or C, 2007, TRENDS GENET, V23, P200, DOI 10.1016/j.tig.2007.02.003; Broadley MR, 2008, NEW PHYTOL, V180, P587, DOI 10.1111/j.1469-8137.2008.02640.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dannemann M, 2009, BIOINFORMATICS, V25, P2772, DOI 10.1093/bioinformatics/btp492; Delker C, 2008, PLANTA, V227, P929, DOI 10.1007/s00425-008-0710-8; Fujimoto R, 2011, PLANT MOL BIOL, V77, P419, DOI 10.1007/s11103-011-9820-y; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Graham NS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-344; Hammond JP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-10; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; IRIZARRY RA, 2006, MAKECDFENV CDF ENV M; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Naiser T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-509; Orlov Yuriy L., 2007, In Silico Biology, V7, P241; R Development Core Team, 2010, R LANG ENV STAT COMP; Redman JC, 2004, PLANT J, V38, P545, DOI 10.1111/j.1365-313X.2004.02061.x; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605	24	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78497	10.1371/journal.pone.0078497	http://dx.doi.org/10.1371/journal.pone.0078497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260119	Green Published, gold			2022-12-25	WOS:000327216200028
J	Sahu, A; Dalal, K; Naglot, S; Aggarwal, P; Krishna, CM				Sahu, Aditi; Dalal, Krishna; Naglot, Sarla; Aggarwal, Parveen; Krishna, C. Murali			Serum Based Diagnosis of Asthma Using Raman Spectroscopy: An Early Phase Pilot Study	PLOS ONE			English	Article							HUMAN CORONARY ATHEROSCLEROSIS; BLOOD-PLASMA; INFRARED-SPECTROSCOPY; BREAST-CANCER; SPECTRA; SAMPLES; IDENTIFICATION; MECHANISMS; TESTS; KEY	The currently prescribed tests for asthma diagnosis require compulsory patient compliance, and are usually not sensitive to mild asthma. Development of an objective test using minimally invasive samples for diagnosing and monitoring of the response of asthma may help better management of the disease. Raman spectroscopy (RS) has previously shown potential in several biomedical applications, including pharmacology and forensics. In this study, we have explored the feasibility of detecting asthma and determining treatment response in asthma patients, through RS of serum. Serum samples from 44 asthma subjects of different grades (mild, moderate, treated severe and untreated severe) and from 15 reference subjects were subjected to Raman spectroscopic analysis and YKL-40 measurements. The force expiratory volume in 1 second (FEV1) values were used as gold standard and the serum YKL-40 levels were used as an additional parameter for diagnosing the different grades of asthma. For spectral acquisition, serum was placed on a calcium fluoride (CaF2) window and spectra were recorded using Raman microprobe. Mean and difference spectra comparisons indicated significant differences between asthma and reference spectra. Differences like changes in protein structure, increase in DNA specific bands and increased glycosaminoglycans-like features were more prominent with increase in asthma severity. Multivariate tools using Principal-component-analysis (PCA) and Principal-component based-linear-discriminant analysis (PC-LDA) followed by Leave-one-out-cross-validation (LOOCV), were employed for data analyses. PCA and PC-LDA results indicate separation of all asthma groups from the reference group, with minor overlap (19.4%) between reference and mild groups. No overlap was observed between the treated severe and untreated severe groups, indicating that patient response to treatment could be determined. Overall promising results were obtained, and a large scale validation study on random subjects is warranted before the routine clinical usage of this technique.	[Sahu, Aditi; Krishna, C. Murali] ACTREC, Chilakapati Lab, KS 04, Kharghar, Navi Mumbai, India; [Dalal, Krishna; Naglot, Sarla] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Aggarwal, Parveen] All India Inst Med Sci, Dept Emergency Med, New Delhi, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Krishna, CM (corresponding author), ACTREC, Chilakapati Lab, KS 04, Kharghar, Navi Mumbai, India.	mchilakapati@actrec.gov.in	Sahu, Aditi/AAA-3877-2019	C, Murali Krishna/0000-0002-4974-8533; Sahu, Aditi/0000-0003-0004-3839	Department of Biotechnology, Government of India [BT/PRI11282/MED/32/83/2008]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The Raman spectrometer employed in the study was procured from DBT project BT/PRI11282/MED/32/83/2008, entitled "Development of in vivo laser Raman spectroscopy methods for diagnosis of oral precancerous and cancerous conditions", Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSSJ, 2010, VIB SPECTROSC, V53, P181, DOI 10.1016/j.vibspec.2010.01.019; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Backhaus J, 2010, VIB SPECTROSC, V52, P173, DOI 10.1016/j.vibspec.2010.01.013; Barrios RJ, 2006, ARCH PATHOL LAB MED, V130, P447; Bloemen K, 2007, IMMUNOL LETT, V113, P6, DOI 10.1016/j.imlet.2007.07.010; Boyd S, 2011, FORENSIC SCI INT, V208, P124, DOI 10.1016/j.forsciint.2010.11.012; Burns DH, 2009, J ALZHEIMERS DIS, V17, P391, DOI 10.3233/JAD-2009-1053; Buschman HP, 2001, CARDIOVASC PATHOL, V10, P69, DOI 10.1016/S1054-8807(01)00064-3; Buschman HP, 2001, CARDIOVASC PATHOL, V10, P59, DOI 10.1016/S1054-8807(01)00063-1; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Enejder AMK, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1920212; Enejder AMK, 2002, OPT LETT, V27, P2004, DOI 10.1364/OL.27.002004; ENRIGHT PL, 1994, AM J RESP CRIT CARE, V149, pS9, DOI 10.1164/ajrccm/149.2_Pt_2.S9; Erahimovitch V, 2006, VIB SPECTROSC, V40, P40, DOI 10.1016/j.vibspec.2005.06.004; Gajjar K, 2013, ANALYST, V138, P3917, DOI 10.1039/c3an36654e; Ghanate AD, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548303; Gonchukov S, 2012, LASER PHYS LETT, V9, P73, DOI 10.1002/lapl.201110095; Gonzalez-Solis JL, 2010, AIP CONF PROC, V1226, P91, DOI 10.1063/1.3453792; Good DM, 2007, J PROTEOME RES, V6, P4549, DOI 10.1021/pr070529w; Haka AS, 2002, CANCER RES, V62, P5375; Harris AT, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-34; Harvey TJ, 2009, ANALYST, V134, P1083, DOI 10.1039/b903249e; Hunter CJ, 2002, CHEST, V121, P1051, DOI 10.1378/chest.121.4.1051; *IN GLOB ASTHM, 1995, NIH PUBL; Kalaivani R, 2008, PHOTOMED LASER SURG, V26, P251, DOI 10.1089/pho.2007.2162; Koljenovic S, 2002, LAB INVEST, V82, P1265, DOI 10.1097/01.LAB.0000032545.96931.B8; Li XZ, 2011, PROC SPIE, V8087, DOI 10.1117/12.889320; LI XZ, 2001, P SOC PHOTO-OPT INS, V2, P124, DOI DOI 10.1117/12.447127; Madhuri S, 2003, PHOTOCHEM PHOTOBIOL, V78, P197, DOI 10.1562/0031-8655(2003)078<0197:NFSOBP>2.0.CO;2; Montuschi P, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00131; Montuschi P, 2011, DRUG DISCOV TODAY, V16, P1084, DOI 10.1016/j.drudis.2011.09.005; Nahavandi M, 2009, HEMATOLOGY, V14, P46, DOI 10.1179/102453309X385133; *NIH, 1997, NIH PUBL; Nijssen A, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2750287; Papakonstantinou E, 2012, AM J RESP CELL MOL, V47, P759, DOI 10.1165/rcmb.2012-0101OC; Pappas D, 2000, TALANTA, V51, P131, DOI 10.1016/S0039-9140(99)00254-4; PARKER FS, 1983, APPL INFRARED RAMAN, P550; Pichardo-Molina JL, 2007, LASER MED SCI, V22, P229, DOI 10.1007/s10103-006-0432-8; Priftis KN, 2006, PEDIAT ALLERG IMM-UK, V17, P194, DOI 10.1111/j.1399-3038.2006.00387.x; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Schmitt M, 2006, J RAMAN SPECTROSC, V37, P20, DOI 10.1002/jrs.1486; Shifren Adrian, 2012, J Allergy (Cairo), V2012, P316049, DOI 10.1155/2012/316049; Shim MG, 2000, PHOTOCHEM PHOTOBIOL, V72, P146, DOI 10.1562/0031-8655(2000)072<0146:IVNIRS>2.0.CO;2; Sikirzhytski V, 2010, SENSORS-BASEL, V10, P2869, DOI 10.3390/s100402869; Specjalski K, 2011, J ASTHMA, V48, P767, DOI 10.3109/02770903.2011.611955; Tang H, 2010, EUR RESPIR J, V35, P757, DOI 10.1183/09031936.00034409; Venkatesan N, 2012, AM J RESP CELL MOL, V46, P96, DOI 10.1165/rcmb.2011-0014OC; Virkler K, 2008, FORENSIC SCI INT, V181, pE1, DOI 10.1016/j.forsciint.2008.08.004; Virkler K, 2009, FORENSIC SCI INT, V188, P1, DOI 10.1016/j.forsciint.2009.02.013; Wedzicha JA, 2003, THORAX, V58, P1, DOI 10.1136/thorax.58.1.1; World Health Organization, 2008, GLOB BURD DIS; World Health Organization, 2007, GLOBAL SURVEILLANCE, P155; Yuen C, 2010, BIOSENS BIOELECTRON, V26, P580, DOI 10.1016/j.bios.2010.07.030	54	53	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78921	10.1371/journal.pone.0078921	http://dx.doi.org/10.1371/journal.pone.0078921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250817	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200050
J	Andre, J; Kerry, L; Qi, X; Hawkins, E; Drizyte, K; Ginger, ML; McKean, PG				Andre, Jane; Kerry, Louise; Qi, Xin; Hawkins, Erica; Drizyte, Kristina; Ginger, Michael L.; McKean, Paul G.			An Alternative Model for the Role of RP2 Protein in Flagellum Assembly in the African Trypanosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centriole; Cilia; Protein Targeting; Trypanosoma Brucei; Tubulin; GTPase-activating Protein; Axoneme	TRANSITION ZONE; BASAL BODY; INTRAFLAGELLAR TRANSPORT; FUNCTIONAL GENOMICS; PROTEOMIC ANALYSIS; ATTACHMENT ZONE; ALPHA-TUBULIN; MEMBRANE; BRUCEI; CILIA	The tubulin cofactor C domain-containing protein TbRP2 is a basal body (centriolar) protein essential for axoneme formation in the flagellate protist Trypanosoma brucei, the causal agent of African sleeping sickness. Here, we show how TbRP2 is targeted and tethered at mature basal bodies and provide novel insight into TbRP2 function. Regarding targeting, understanding how several hundred proteins combine to build a microtubule axoneme is a fundamental challenge in eukaryotic cell biology. We show that basal body localization of TbRP2 is mediated by twinned, N-terminal TOF (TON1, OFD1, and FOP) and LisH motifs, motifs that otherwise facilitate localization of only a few conserved proteins at microtubule-organizing centers in animals, plants, and flagellate protists. Regarding TbRP2 function, there is a debate as to whether the flagellar assembly function of specialized, centriolar tubulin cofactor C domain-containing proteins is processing tubulin, the major component of axonemes, or general vesicular trafficking in a flagellum assembly context. Here we report that TbRP2 is required for the recruitment of T. brucei orthologs of MKS1 and MKS6, proteins that, in animal cells, are part of a complex that assembles at the base of the flagellum to regulate protein composition and cilium function. We also identify that TbRP2 is detected by YL1/2, an antibody classically used to detect -tubulin. Together, these data suggest a general processing role for TbRP2 in trypanosome flagellum assembly and challenge the notion that TbRP2 functions solely in assessing tubulin quality prior to tubulin incorporation into the elongating axoneme.	[Andre, Jane; Kerry, Louise; Qi, Xin; Hawkins, Erica; Drizyte, Kristina; Ginger, Michael L.; McKean, Paul G.] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England	Lancaster University	Ginger, ML (corresponding author), Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England.	m.ginger@lancaster.ac.uk; p.mckean@lancaster.ac.uk		Hawkins, Erica/0000-0002-9839-6212; McKean, Paul Gerard/0000-0002-0445-0741; Drizyte-Miller, Kristina/0000-0001-7049-2934; Ginger, Michael/0000-0002-9643-8482; Harmer, Jane/0000-0003-1247-4468	Biological and Biotechnological Sciences Research Council of the UK [BBG0210581, BBF0109311]; Royal Society Research Fellowship; BBSRC [BB/G021058/1, BB/F010931/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G021058/1, BB/F010931/1] Funding Source: researchfish	Biological and Biotechnological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Research Fellowship(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biological and Biotechnological Sciences Research Council of the UK Grants BBG0210581 and BBF0109311 (to P. G. M. and M. L. G.) and a Royal Society Research Fellowship (to M. L. G.).	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Aubusson-Fleury A, 2012, J CELL SCI, V125, P4395, DOI 10.1242/jcs.108639; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Azimzadeh J, 2008, PLANT CELL, V20, P2146, DOI 10.1105/tpc.107.056812; Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Briggs LJ, 2004, CURR BIOL, V14, pR611, DOI 10.1016/j.cub.2004.07.041; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Davidge JA, 2006, J CELL SCI, V119, P3935, DOI 10.1242/jcs.03203; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Hurd TW, 2011, J CELL SCI, V124, P718, DOI 10.1242/jcs.070839; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lee J. K., 2013, PLOS ONE, V8; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lukes J, 2009, P NATL ACAD SCI USA, V106, P9963, DOI 10.1073/pnas.0901004106; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; Mori R, 2013, MOL BIOL CELL, V24, P1713, DOI 10.1091/mbc.E12-11-0792; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; Rovini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065694; Schwarz N, 2012, HUM MOL GENET, V21, P863, DOI 10.1093/hmg/ddr520; Sedjai F, 2010, J CELL SCI, V123, P2391, DOI 10.1242/jcs.065045; SHERWIN T, 1987, J CELL BIOL, V104, P439, DOI 10.1083/jcb.104.3.439; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Tran KD, 2013, J BIOL CHEM, V288, P22721, DOI 10.1074/jbc.M113.483461; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Wang WJ, 2013, NAT CELL BIOL, V15, P591, DOI 10.1038/ncb2739; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; WEHLAND J, 1984, EMBO J, V3, P1295, DOI 10.1002/j.1460-2075.1984.tb01965.x; WOODS A, 1989, J CELL SCI, V93, P491; WOODWARD R, 1995, PARASITOLOGY, V111, P77, DOI 10.1017/S0031182000064623; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111	54	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					464	475		10.1074/jbc.M113.509521	http://dx.doi.org/10.1074/jbc.M113.509521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257747	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000329370900040
J	Kook, S; Zhan, XZ; Kaoud, TS; Dalby, KN; Gurevich, VV; Gurevich, EV				Kook, Seunghyi; Zhan, Xuanzhi; Kaoud, Tamer S.; Dalby, Kevin N.; Gurevich, Vsevolod V.; Gurevich, Eugenia V.			Arrestin-3 Binds c-Jun N-terminal Kinase 1 (JNK1) and JNK2 and Facilitates the Activation of These Ubiquitous JNK Isoforms in Cells via Scaffolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Jun N-terminal Kinase (JNK); MAP Kinases (MAPKs); Protein Phosphorylation; Scaffold Proteins; Signal Transduction	PROTEIN-COUPLED RECEPTORS; MAP-KINASE; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; BETA-ARRESTINS; INOSITOL HEXAKISPHOSPHATE; NONVISUAL ARRESTINS; CORTICAL-NEURONS; PATHWAY; DEATH	Non-visual arrestins scaffold mitogen-activated protein kinase (MAPK) cascades. The c-Jun N-terminal kinases (JNKs) are members of MAPK family. Arrestin-3 has been shown to enhance the activation of JNK3, which is expressed mainly in neurons, heart, and testes, in contrast to ubiquitous JNK1 and JNK2. Although all JNKs are activated by MKK4 and MKK7, both of which bind arrestin-3, the ability of arrestin-3 to facilitate the activation of JNK1 and JNK2 has never been reported. Using purified proteins we found that arrestin-3 directly binds JNK11 and JNK22, interacting with the latter comparably to JNK32. Phosphorylation of purified JNK11 and JNK22 by MKK4 or MKK7 is increased by arrestin-3. Endogenous arrestin-3 interacted with endogenous JNK1/2 in different cell types. Arrestin-3 also enhanced phosphorylation of endogenous JNK1/2 in intact cells upon expression of upstream kinases ASK1, MKK4, or MKK7. We observed a biphasic effect of arrestin-3 concentrations on phosphorylation of JNK11 and JNK22 both in vitro and in vivo. Thus, arrestin-3 acts as a scaffold, facilitating JNK11 and JNK22 phosphorylation by MKK4 and MKK7 via bringing JNKs and their activators together. The data suggest that arrestin-3 modulates the activity of ubiquitous JNK1 and JNK2 in non-neuronal cells, impacting the signaling pathway that regulates their proliferation and survival.	[Kook, Seunghyi; Zhan, Xuanzhi; Gurevich, Vsevolod V.; Gurevich, Eugenia V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Kaoud, Tamer S.] Menia Univ, Fac Pharm, Al Minya 61519, Egypt; [Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Div Med Chem, Austin, TX 78712 USA	Vanderbilt University; Egyptian Knowledge Bank (EKB); Minia University; University of Texas System; University of Texas Austin	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu; Eugenia.gurevich@vanderbilt.edu	Zhan, Xuanzhi/N-4644-2013; Gurevich, Vsevolod/A-3236-2008; Dalby, Kevin N/A-1905-2013; Kaoud, Tamer S/C-3618-2019	Gurevich, Vsevolod/0000-0002-3950-5351; Dalby, Kevin N/0000-0001-9272-5129; Kaoud, Tamer S/0000-0003-1298-8725	National Institutes of Health [NS065868, DA030103, GM077561, GM081756, EY011500, GM059802]; Welch Foundation [F-1390]; Cancer Prevention Research Institute of Texas (CPRIT); NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM081756, R01GM059802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention Research Institute of Texas (CPRIT); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS065868 and DA030103 (to E. V. G.), GM077561, GM081756, and EY011500 (to V. V. G.), and GM059802 (to K. N. D.). This work was also supported by the Welch Foundation (F-1390) (to K. N. D.).; Supported by a postdoctoral trainee fellowship from Cancer Prevention Research Institute of Texas (CPRIT).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; DONOSO LA, 1990, CURR EYE RES, V9, P343, DOI 10.3109/02713689008999622; Engstrom W, 2010, CELL PROLIFERAT, V43, P56, DOI 10.1111/j.1365-2184.2009.00654.x; Fogarty MP, 2003, BIOCHEM J, V371, P789, DOI 10.1042/BJ20021660; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Hanson SM, 2008, BIOCHEMISTRY-US, V47, P1070, DOI 10.1021/bi7021359; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Johnson GL, 2011, ACS CHEM BIOL, V6, P18, DOI 10.1021/cb100384z; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaoud TS, 2012, ACS CHEM BIOL, V7, P1873, DOI 10.1021/cb300261e; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Levchenko A., 2004, Systems Biology, V1, P139, DOI 10.1049/sb:20045014; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Madsen JA, 2011, PROTEOMICS, V11, P1329, DOI 10.1002/pmic.201000565; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pullikuth A, 2005, MOL CELL BIOL, V25, P5119, DOI 10.1128/MCB.25.12.5119-5133.2005; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; WACKER WB, 1977, J IMMUNOL, V119, P1949; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Willoughby EA, 2003, J BIOL CHEM, V278, P10731, DOI 10.1074/jbc.M207324200; Yan CL, 2011, J PHYS CHEM B, V115, P1491, DOI 10.1021/jp1073522; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; Zhan XZ, 2013, J BIOL CHEM, V288, P28535, DOI 10.1074/jbc.M113.508085; Zhan XZ, 2011, BIOCHEMISTRY-US, V50, P10520, DOI 10.1021/bi201506g	70	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37332	37342		10.1074/jbc.M113.510412	http://dx.doi.org/10.1074/jbc.M113.510412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24257757	hybrid, Green Published			2022-12-25	WOS:000329189700049
J	Coleman, AW				Coleman, Annette W.			Analysis of Mammalian rDNA Internal Transcribed Spacers	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNAS; SECONDARY STRUCTURE; SEQUENCE; ITS2; MOUSE; PHYLOGENY; EVOLUTION; REGIONS; ROOT	Nuclear rDNA Internal Transcribed Spacers, ITS1 and ITS2, are widely used for eukaryote phylogenetic studies from the ordinal level to the species level, and there is even a database for ITS2 sequences. However, ITS regions have been ignored in mammalian phylogenetic studies, and only a few rodent and ape sequences are represented in GenBank. The reasons for this dearth, and the remedies, are described here. We have recovered these sequences, mostly > 1 kb in length, for 36 mammalian species. Sequence alignment and transcript folding comparisons reveal the rRNA transcript secondary structure. Mammalian ITS regions, though quite long, still fold into the recognizable secondary structure of other eukaryotes. The ITS2 in particular bears the four standard helix loops, and loops II and III have the hallmark characters universal to eukaryotes. Both sequence and insertions/deletions of transcript secondary structure helices observed here support the four superorder taxonomy of Placentalia. On the family level, major unique indels, neatly excising entire helices, will be useful when additional species are represented, resulting in significant further understanding of the details of mammalian evolutionary history. Furthermore, the identification of a highly conserved element of ITS1 common to warm-blooded vertebrates may aid in deciphering the complex mechanism of RNA transcript processing. This is the last major group of terrestrial vertebrates for which rRNA ITS secondary structure has been resolved.	Brown Univ, Div Biol & Med, Providence, RI 02912 USA	Brown University	Coleman, AW (corresponding author), Brown Univ, Div Biol & Med, Providence, RI 02912 USA.	Annette_Coleman@brown.edu						Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P225, DOI 10.1016/S1055-7903(03)00118-0; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; BEDFORD JM, 1977, ANAT RECORD, V188, P477, DOI 10.1002/ar.1091880407; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Delsuc F, 2002, MOL BIOL EVOL, V19, P1656, DOI 10.1093/oxfordjournals.molbev.a003989; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; GONZALEZ IL, 1990, J MOL BIOL, V212, P27, DOI 10.1016/0022-2836(90)90302-3; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Kupriyanova N, 2012, GENE, V508, P85, DOI 10.1016/j.gene.2012.07.024; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; MERRY DE, 1983, CYTOGENET CELL GENET, V35, P244, DOI 10.1159/000131875; MICHOT B, 1982, FEBS LETT, V140, P193, DOI 10.1016/0014-5793(82)80892-2; Michot B, 1999, NUCLEIC ACIDS RES, V27, P2271, DOI 10.1093/nar/27.11.2271; MICHOT B, 1983, NUCLEIC ACIDS RES, V11, P3375, DOI 10.1093/nar/11.10.3375; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Peculis BA, 1998, RNA, V4, P1610, DOI 10.1017/S1355838298981420; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; TANTRAVAHI R, 1976, CHROMOSOMA, V56, P15, DOI 10.1007/BF00293725; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; [No title captured]	29	9	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79122	10.1371/journal.pone.0079122	http://dx.doi.org/10.1371/journal.pone.0079122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260162	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900014
J	Garcia-Munoz, E; Rato, C; Jorge, F; Carretero, MA				Garcia-Munoz, Enrique; Rato, Catarina; Jorge, Fatima; Carretero, Miguel A.			Lateralization in Escape Behaviour at Different Hierarchical Levels in a Gecko: Tarentola angustimentalis from Eastern Canary Islands	PLOS ONE			English	Article							DIRECTIONAL ASYMMETRY; MORPHOLOGY; ADVANTAGES; PREDATION; HINDLIMBS; RESPONSES; SELECTION; EVOLUTION; BRAIN	At the individual level, to be behaviourally lateralized avoids costly duplication of neural circuitry and decreases possible contradictory order from the two brain hemispheres. However, being prey behaviour lateralized at higher hierarchical levels could generate different negative implications, especially if predators are able to make predictions after multiple encounters. These conflicting pressures, namely between the advantages for individuals and the disadvantages for populations could be concealed if higher-level lateralization would arise from the combination of lateralized behaviours of individuals which are mutually dependent. Here, we investigated the lateralization patterns in the escape behaviour of the gecko Tarentola angustimentalis undergoing a predatory attack simulation in a "T'' maze experiment. Results showed that gecko populations displayed different degrees of lateralization, with an overall dominance of right-biased individuals. This trend is similar to that observed in the Podarcis wall lizards, which share predators with Tarentola. In addition, different morphological parameters plausible to affect refuge selection were explored in order to link directional asymmetries at morphological level with lateralization during refuge selection.	[Garcia-Munoz, Enrique] Univ Aveiro, Ctr Estudios Ambiente Mar, CESAM, P-3800 Aveiro, Portugal; [Garcia-Munoz, Enrique; Rato, Catarina; Jorge, Fatima; Carretero, Miguel A.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Garcia-Munoz, Enrique] Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Jaen, Spain	Universidade de Aveiro; Universidade do Porto; Universidad de Jaen	Garcia-Munoz, E (corresponding author), Univ Aveiro, Ctr Estudios Ambiente Mar, CESAM, Campus Univ Santiago, P-3800 Aveiro, Portugal.	engamu@gmail.com	Carretero, Miguel A/A-1472-2013; Rato, Catarina CS/F-5784-2012	Carretero, Miguel A/0000-0002-2335-7198; Rato, Catarina CS/0000-0002-8292-2433; Garcia-Munoz, Enrique/0000-0002-4831-8822	Fundacxao para a Ciencia e a Tecnologia (FCT, Portugal); FCT [SFRH/BPD/72806/2010];  [PTDC/BIA-BEC/101256/2008]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BEC/101256/2008] Funding Source: FCT	Fundacxao para a Ciencia e a Tecnologia (FCT, Portugal); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ; Fundação para a Ciência e a Tecnologia	Fieldwork was carried out with the support of the project PTDC/BIA-BEC/101256/2008 funded by Fundacxao para a Ciencia e a Tecnologia (FCT, Portugal). E. G.- M. was supported by postdoc grant from FCT (SFRH/BPD/72806/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonati B, 2010, BEHAV BRAIN RES, V207, P1, DOI 10.1016/j.bbr.2009.09.002; Brown C, 2004, P ROY SOC B-BIOL SCI, V271, pS455, DOI 10.1098/rsbl.2004.0222; Brown C, 2007, ANIM BEHAV, V74, P231, DOI 10.1016/j.anbehav.2006.08.014; Carretero MA, RELATIONSHIPS UNPUB; Gamble T, 2008, J BIOGEOGR, V35, P88, DOI 10.1111/j.1365-2699.2007.01770.x; Gamble T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035982, 10.1371/journal.pone.0039429]; Garcia-Marquez M, 2003, MEMORIA FINAL AHE VI, P1; Garcia-Munoz E, 2012, BEHAV ECOL, V23, P955, DOI 10.1093/beheco/ars058; Graham JH, 1998, BIOL J LINN SOC, V64, P1, DOI 10.1111/j.1095-8312.1998.tb01530.x; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Levy J, 1977, Ann N Y Acad Sci, V299, P264, DOI 10.1111/j.1749-6632.1977.tb41913.x; Lippolis G, 2005, LATERALITY, V10, P457, DOI 10.1080/13576500442000210; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; Martin J, 2010, ETHOLOGY, V116, P1226, DOI 10.1111/j.1439-0310.2010.01836.x; Martinez-Silvestre Albert, 2012, Boletin de la Asociacion Herpetologica Espanola, V23, P25; Mateo JA, 2002, ATLAS LIBRO ROJO ANF, P180; McMillan DM, 2010, J HERPETOL, V44, P272, DOI 10.1670/08-196.1; MEDEL RG, 1988, OIKOS, V53, P321, DOI 10.2307/3565531; MUSHINSKY HR, 1993, COPEIA, P660; Novosolov M, 2013, GLOBAL ECOL BIOGEOGR, V22, P184, DOI 10.1111/j.1466-8238.2012.00791.x; PIANKA ER, 1970, ECOLOGY, V51, P703, DOI 10.2307/1934053; Prosser C, 2006, J HERPETOL, V40, P151, DOI 10.1670/38-05A.1; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Salvador A, 2007, ENCICLOPEDIA VIRTUAL; SCHOENER TW, 1979, ECOLOGY, V60, P1110, DOI 10.2307/1936958; Seligmann H, 2000, BIOL J LINN SOC, V69, P461, DOI 10.1111/j.1095-8312.2000.tb01219.x; Seligmann H, 2002, LATERALITY, V7, P277, DOI 10.1080/13576500244000067; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; TURNER FB, 1982, COPEIA, P835; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; Vasconcelos R, 2012, J ARID ENVIRON, V81, P18, DOI 10.1016/j.jaridenv.2012.01.013; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703	33	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e78329	10.1371/journal.pone.0078329	http://dx.doi.org/10.1371/journal.pone.0078329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260110	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900007
J	Johnson, MP; White, M; Wilson, A; Wurzberg, L; Schwabe, E; Folch, H; Allcock, AL				Johnson, Mark P.; White, Martin; Wilson, Annette; Wuerzberg, Laura; Schwabe, Enrico; Folch, Helka; Allcock, A. Louise			A Vertical Wall Dominated by Acesta excavata and Neopycnodonte zibrowii, Part of an Undersampled Group of Deep-Sea Habitats	PLOS ONE			English	Article							OCEAN MARGIN EXCHANGE; INTERNAL WAVES; BENTHIC FAUNA; CORAL-REEFS; PROPAGATION; BISCAY; SLOPE; ATLANTIC; CANYON; BAY	We describe a novel biotope at 633 to 762 m depth on a vertical wall in the Whittard Canyon, an extensive canyon system reaching from the shelf to the deep sea on Ireland's continental margin. We explored this wall with an ROV and compiled a photomosaic of the habitat. The assemblage contributing to the biotope was dominated by large limid bivalves, Acesta excavata (mean shell height 10.4 cm), and deep-sea oysters, Neopycnodonte zibrowii, at high densities, particularly at overhangs. Mean density of N. zibrowii increased with depth, with densities of the most closely packed areas of A. excavata also increasing with depth. Other taxa associated with the assemblage included the solitary coral Desmophyllum dianthus, cerianthid anemones, comatulid crinoids, the trochid gastropod Margarites sp., the portunid crab Bathynectes longispina and small fish of the family Bythitidae. The scleractinian coral Madrepora oculata, the pencil urchin Cidaris cidaris and a species of Epizoanthus were also common. Prominent but less abundant species included the flytrap anemone Actinoscyphia saginata, the carrier crab Paramola cuvieri, and the fishes Lepidion eques and Conger conger. Observations of the hydrography of the canyon system identified that the upper 500 m was dominated by Eastern North Atlantic Water, with Mediterranean Outflow Water beneath it. The permanent thermocline is found between 600 and 1000 m depth, i.e., in the depth range of the vertical wall and the dense assemblage of filter feeders. Beam attenuation indicated nepheloid layers present in the canyon system with the greatest amounts of suspended material at the ROV dive site between 500 and 750 m. A cross-canyon CTD transect indicated the presence of internal waves between these depths. We hypothesise that internal waves concentrate suspended sediment at high concentrations at the foot of the vertical wall, possibly explaining the large size and high density of filter-feeding molluscs.	[Johnson, Mark P.; White, Martin; Wilson, Annette; Allcock, A. Louise] Natl Univ Ireland Galway, Ryan Inst, Galway, Ireland; [Johnson, Mark P.; White, Martin; Wilson, Annette; Allcock, A. Louise] Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland; [Wuerzberg, Laura] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Wuerzberg, Laura] Univ Hamburg, Zool Museum, Hamburg, Germany; [Schwabe, Enrico] Bavarian State Collect Zool, Munich, Germany; [Folch, Helka] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Hamburg; University of Hamburg; Queens University Belfast	Allcock, AL (corresponding author), Natl Univ Ireland Galway, Ryan Inst, Galway, Ireland.	louise.allcock@gmail.com	Johnson, Mark P/B-5017-2009; Johnson, Mark/W-4226-2019; Allcock, Louise/A-7359-2012	Johnson, Mark P/0000-0002-5078-1410; Johnson, Mark/0000-0002-5078-1410; Allcock, Louise/0000-0002-4806-0040; white, martin/0000-0003-3271-1221	Beaufort Marine Biodiscovery Research Award under the Sea Change Strategy; German Science Foundation (DFG) [SCHR667/9-1]; Hardiman Scholarship; Strategy for Science Technology and Innovation	Beaufort Marine Biodiscovery Research Award under the Sea Change Strategy; German Science Foundation (DFG)(German Research Foundation (DFG)); Hardiman Scholarship; Strategy for Science Technology and Innovation	This research survey was carried out under the Sea Change strategy with the support of the Marine Institute and the Marine Research Sub-programme of the National Development Plan 2007-2013. HF was funded by the Beaufort Marine Biodiscovery Research Award under the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013). LW and ES were supported by a grant from the German Science Foundation (DFG; SCHR667/9-1). AW is supported by a Hardiman Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Correa ML, 2005, ERLANGEN EARTH C SER, P173, DOI 10.1007/3-540-27673-4_9; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Duineveld G, 2001, OCEANOL ACTA, V24, P69, DOI 10.1016/S0399-1784(00)01129-4; GAGE JD, 1986, P ROY SOC EDINB B, V88, P159, DOI 10.1017/S026972700000453X; Gardner WD, 1989, J GEOPHYS RES, V94, P185; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Holt JT, 1997, DEEP-SEA RES PT I, V44, P2087, DOI 10.1016/S0967-0637(97)00091-5; HOTCHKISS FS, 1982, DEEP-SEA RES, V29, P415, DOI 10.1016/0198-0149(82)90068-1; Howell KL, 2010, J MAR BIOL ASSOC UK, V90, P33, DOI 10.1017/S0025315409991299; Huvenne VAI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028755; Jarnegren J, 2006, J EXP MAR BIOL ECOL, V334, P122, DOI 10.1016/j.jembe.2006.01.014; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Menot L., 2010, LIFE WORLDS OCEANS D; PINGREE RD, 1989, PROG OCEANOGR, V23, P303, DOI 10.1016/0079-6611(89)90003-7; PINGREE RD, 1986, NATURE, V321, P154, DOI 10.1038/321154a0; PINGREE RD, 1989, DEEP-SEA RES, V36, P735, DOI 10.1016/0198-0149(89)90148-9; Pingree RD, 1999, CONT SHELF RES, V19, P929, DOI 10.1016/S0278-4343(98)00116-2; R Development Core Team, 2010, R LANG ENV STAT COMP; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; REID GS, 1990, MAR GEOL, V92, P69, DOI 10.1016/0025-3227(90)90027-H; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Sacchetti F, 2012, MAR GEOL, V291, P113, DOI 10.1016/j.margeo.2011.11.011; Soffker M, 2011, DEEP-SEA RES PT I, V58, P818, DOI 10.1016/j.dsr.2011.06.002; Stephens J., 1921, FISHERIES BRANCH SCI, V2, P1; Van Rooij D, 2010, DEEP-SEA RES PT I, V57, P1561, DOI 10.1016/j.dsr.2010.09.002; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; White M, 2010, EARTH PLANET SC LETT, V296, P395, DOI 10.1016/j.epsl.2010.05.025; Wollast R, 2001, DEEP-SEA RES PT II, V48, P2971, DOI 10.1016/S0967-0645(01)00029-7	29	31	31	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79917	10.1371/journal.pone.0079917	http://dx.doi.org/10.1371/journal.pone.0079917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260319	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500107
J	Li, AY; Stevens, CM; Liang, B; Rayani, K; Little, S; Davis, J; Tibbits, GF				Li, Alison Y.; Stevens, Charles M.; Liang, Bo; Rayani, Kaveh; Little, Sean; Davis, Jonathan; Tibbits, Glen F.			Familial Hypertrophic Cardiomyopathy Related Cardiac Troponin C L29Q Mutation Alters Length-Dependent Activation and Functional Effects of Phosphomimetic Troponin I	PLOS ONE			English	Article							MYOFILAMENT CALCIUM SENSITIVITY; CA2+ SENSITIVITY; OSMOTIC COMPRESSION; SARCOMERE-LENGTH; N-TERMINUS; PHOSPHORYLATION; BINDING; KINETICS; EXCHANGE; DESENSITIZATION	The Ca2+ binding properties of the FHC-associated cardiac troponin C (cTnC) mutation L29Q were examined in isolated cTnC, troponin complexes, reconstituted thin filament preparations, and skinned cardiomyocytes. While higher Ca2+ binding affinity was apparent for the L29Q mutant in isolated cTnC, this phenomenon was not observed in the cTn complex. At the level of the thin filament in the presence of phosphomimetic TnI, L29Q cTnC further reduced the Ca2+ affinity by 27% in the steady-state measurement and increased the Ca2+ dissociation rate by 20% in the kinetic studies. Molecular dynamics simulations suggest that L29Q destabilizes the conformation of cNTnC in the presence of phosphomimetic cTnI and potentially modulates the Ca2+ sensitivity due to the changes of the opening/closing equilibrium of cNTnC. In the skinned cardiomyocyte preparation, L29Q cTnC increased Ca2+ sensitivity in a highly sarcomere length (SL)-dependent manner. The well-established reduction of Ca2+ sensitivity by phosphomimetic cTnI was diminished by 68% in the presence of the mutation and it also depressed the SL-dependent increase in myofilament Ca2+ sensitivity. This might result from its modified interaction with cTnI which altered the feedback effects of cross-bridges on the L29Q cTnC-cTnI-Tm complex. This study demonstrates that the L29Q mutation alters the contractility and the functional effects of the phosphomimetic cTnI in both thin filament and single skinned cardiomyocytes and importantly that this effect is highly sarcomere length dependent.	[Li, Alison Y.; Stevens, Charles M.; Liang, Bo; Rayani, Kaveh; Tibbits, Glen F.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Tibbits, Glen F.] Cardiovasc Sci Child & Family Res Inst, Vancouver, BC, Canada; [Little, Sean; Davis, Jonathan] Ohio State Univ, Columbia, OH USA	Simon Fraser University; Child & Family Research Institute; University System of Ohio; Ohio State University	Tibbits, GF (corresponding author), Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada.	tibbits@sfu.ca		liang, binhua/0000-0002-1108-6407; Tibbits, Glen/0000-0002-2586-3115; Stevens, Charles/0000-0002-7341-5253	Heart and Stroke Foundation of British Columbia; Yukon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091986] Funding Source: NIH RePORTER	Heart and Stroke Foundation of British Columbia; Yukon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The experiments in this study were conducted with the generous support of a grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon (www.heartandstroke.bc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; Chandra M, 1999, BIOCHEM BIOPH RES CO, V263, P219, DOI 10.1006/bbrc.1999.1341; CHURCOTT CS, 1994, AM J PHYSIOL, V267, pR62, DOI 10.1152/ajpregu.1994.267.1.R62; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dewar L, 2012, CARDIOMYOPATHIES BAS, P277; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dong WJ, 1996, J BIOL CHEM, V271, P688, DOI 10.1074/jbc.271.2.688; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103; Farman GP, 2006, AM J PHYSIOL-HEART C, V291, pH1847, DOI 10.1152/ajpheart.01237.2005; Farman GP, 2011, AM J PHYSIOL-HEART C, V300, pH2155, DOI 10.1152/ajpheart.01221.2010; Farman GP, 2010, BIOPHYS J, V99, P2978, DOI 10.1016/j.bpj.2010.09.003; Fuchs F, 2001, NEWS PHYSIOL SCI, V16, P5; Fuchs F, 1996, J MOL CELL CARDIOL, V28, P1375, DOI 10.1006/jmcc.1996.0129; Gillis TE, 2005, PHYSIOL GENOMICS, V22, P1, DOI 10.1152/physiolgenomics.00007.2005; Gillis TE, 2007, PHYSIOL GENOMICS, V32, P16, DOI 10.1152/physiolgenomics.00197.2007; Gollapudi SK, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/824068; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Harada K, 2004, JPN J PHYSIOL, V54, P307, DOI 10.2170/jjphysiol.54.307; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Huke SS, 2013, CIRC RES; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Konhilas JP, 2002, CIRC RES, V90, P59, DOI 10.1161/hh0102.102269; Korte FS, 2012, AM J PHYSIOL-HEART C, V303, pH863, DOI 10.1152/ajpheart.00395.2012; Kruger M, 2003, J CHROMATOGR B, V786, P287, DOI 10.1016/S1570-0232(02)00763-8; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038259; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Martyn DA, 2001, BIOPHYS J, V80, P2798, DOI 10.1016/S0006-3495(01)76247-9; Matsuba D, 2009, J GEN PHYSIOL, V133, P571, DOI 10.1085/jgp.200910206; MCDONALD KS, 1995, CIRC RES, V77, P199, DOI 10.1161/01.RES.77.1.199; Neulen A, 2007, CARDIOVASC RES, V74, P124, DOI 10.1016/j.cardiores.2007.01.019; Neulen A, 2009, BASIC RES CARDIOL, V104, P751, DOI 10.1007/s00395-009-0038-y; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pena JR, 2004, CARDIOVASC RES, V61, P756, DOI 10.1016/j.cardiores.2003.12.019; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; Rao VS, 2013, J PHYSIOL-LONDON, V591, P475, DOI 10.1113/jphysiol.2012.241604; ROBERTSON S, 1984, METHOD PHARMACOL, V5, P63, DOI DOI 10.1007/978-1-4684-4778-1_6; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Solaro RJ, 2007, BIOPHYS J, V93, P4095, DOI 10.1529/biophysj.107.117200; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; Yap Kyoko L, 2002, Methods Mol Biol, V173, P317; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773	62	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79363	10.1371/journal.pone.0079363	http://dx.doi.org/10.1371/journal.pone.0079363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260207	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500052
J	Ham, DS; Shin, J; Kim, JW; Park, HS; Cho, JH; Yoon, KH				Ham, Dong-Sik; Shin, Juyoung; Kim, Ji-Won; Park, Heon-Seok; Cho, Jae-Hyoung; Yoon, Kun-Ho			Generation of Functional Insulin-Producing Cells from Neonatal Porcine Liver-Derived Cells by PDX1/VP16, BETA2/NeuroD and MafA	PLOS ONE			English	Article							IN-VITRO; ISLET TRANSPLANTATION; GENE-EXPRESSION; STEM-CELLS; BETA-CELLS; NUDE-MICE; DIFFERENTIATION; NEUROD; PANCREAS; TRANSDIFFERENTIATION	Surrogate beta-cells derived from stem cells are needed to cure type 1 diabetes, and neonatal liver cells may be an attractive alternative to stem cells for the generation of beta-cells. In this study, we attempted to generate insulin-producing cells from neonatal porcine liver-derived cells using adenoviruses carrying three genes: pancreatic and duodenal homeobox factor1 (PDX1)/VP16, BETA2/NeuroD and v-maf musculo aponeurotic fibrosarcoma oncogene homolog A (MafA), which are all known to play critical roles in pancreatic development. Isolated neonatal porcine liver-derived cells were sequentially transduced with triple adenoviruses and grown in induction medium containing a high concentration of glucose, epidermal growth factors, nicotinamide and a low concentration of serum following the induction of aggregation for further maturation. We noted that the cells displayed a number of molecular characteristics of pancreatic beta-cells, including expressing several transcription factors necessary for beta-cell development and function. In addition, these cells synthesized and physiologically secreted insulin. Transplanting these differentiated cells into streptozotocin-induced immunodeficient diabetic mice led to the reversal of hyperglycemia, and more than 18% of the cells in the grafts expressed insulin at 6 weeks after transplantation. These data suggested that neonatal porcine liver-derived cells can be differentiated into functional insulin-producing cells under the culture conditions presented in this report and indicated that neonatal porcine liver-derived cells (NPLCs) might be useful as a potential source of cells for beta-cell replacement therapy in efforts to cure type I diabetes.	[Ham, Dong-Sik; Shin, Juyoung; Kim, Ji-Won; Park, Heon-Seok; Cho, Jae-Hyoung; Yoon, Kun-Ho] Catholic Univ Korea, Dept Endocrinol & Metab, Coll Med, Seoul, South Korea; [Ham, Dong-Sik; Shin, Juyoung; Kim, Ji-Won; Park, Heon-Seok; Yoon, Kun-Ho] Seoul St Marys Hosp Convergent Res Consortium Imm, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Yoon, KH (corresponding author), Catholic Univ Korea, Dept Endocrinol & Metab, Coll Med, Seoul, South Korea.	yoonk@catholic.ac.kr	Ham, Dong-sik/A-9340-2015	Ham, Dong-sik/0000-0003-4563-7083	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Project No. A092258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Criscimanna A, 2012, CELL TRANSPLANT, V21, P73, DOI 10.3727/096368911X580635; Edlund H, 2001, DIABETES, V50, pS5, DOI 10.2337/diabetes.50.2007.S5; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Ham DS, 2011, TISSUE ENG REGEN MED, V8, P564; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Jin CX, 2008, J CELL BIOCHEM, V104, P224, DOI 10.1002/jcb.21617; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Kaneto H, 2009, CURR MED CHEM, V16, P3144, DOI 10.2174/092986709788802980; Ko SH, 2004, DIABETES RES CLIN PR, V66, pS97, DOI 10.1016/j.diabres.2003.12.010; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Michalopoulos GK, 2003, GENE EXPRESSION, V11, P55, DOI 10.3727/000000003108748964; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Otsuka M, 2003, J GASTROENTEROL, V38, P89; Paty BW, 2002, DIABETES, V51, P3428, DOI 10.2337/diabetes.51.12.3428; Pennesi ME, 2003, J NEUROSCI, V23, P453; Racanicchi L, 2007, TISSUE ENG, V13, P2923, DOI 10.1089/ten.2007.0098; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Song KH, 2004, BIOCHEM BIOPH RES CO, V316, P1094, DOI 10.1016/j.bbrc.2004.02.153; 유영혜, 2007, Diabetes and Metabolism Journal, V31, P51; Tang DQ, 2006, LAB INVEST, V86, P829, DOI 10.1038/labinvest.3700434; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038; Vizzardelli C, 2002, XENOTRANSPLANTATION, V9, P14, DOI 10.1034/j.1399-3089.2002.0o128.x; Wang HS, 2011, CELL TRANSPLANT, V20, P455, DOI 10.3727/096368910X522270; Yang LJ, 2006, AUTOIMMUN REV, V5, P409, DOI 10.1016/j.autrev.2005.10.009; Yatoh S, 2007, DIABETES-METAB RES, V23, P239, DOI 10.1002/dmrr.678; Yoon KH, 1999, CELL TRANSPLANT, V8, P673, DOI 10.1177/096368979900800613; You YH, 2011, DIABETES METAB J, V35, P119, DOI 10.4093/dmj.2011.35.2.119; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3	38	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79076	10.1371/journal.pone.0079076	http://dx.doi.org/10.1371/journal.pone.0079076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260156	gold, Green Submitted, Green Published			2022-12-25	WOS:000327258600018
J	Shiratake, T; Sato, A; Minoda, A; Tsuzuki, M; Sato, N				Shiratake, Takuma; Sato, Atsushi; Minoda, Ayumi; Tsuzuki, Mikio; Sato, Norihiro			Air-Drying of Cells, the Novel Conditions for Stimulated Synthesis of Triacylglycerol in a Green Alga, Chlorella kessleri	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; WALL; ACCUMULATION; DESICCATION; PLANT; DEGRADATION; FEEDSTOCKS; MICROALGAE; BIOFUELS; STARCH	Triacylglycerol is used for the production of commodities including food oils and biodiesel fuel. Microalgae can accumulate triacylglycerol under adverse environmental conditions such as nitrogen-starvation. This study explored the possibility of air-drying of green algal cells as a novel and simple protocol for enhancement of their triacylglycerol content. Chlorella kessleri cells were fixed on the surface of a glass fibre filter and then subjected to air-drying with light illumination. The dry cell weight, on a filter, increased by 2.7-fold in 96 h, the corresponding chlorophyll content ranging from 1.0 to 1.3-fold the initial one. Concomitantly, the triacylglycerol content remarkably increased to 70.3 mole% of fatty acids and 15.9% (w/w), relative to total fatty acids and dry cell weight, respectively, like in cells starved of nitrogen. Reduction of the stress of air-drying by placing the glass filter on a filter paper soaked in H2O lowered the fatty acid content of triacylglycerol to 26.4 mole% as to total fatty acids. Moreover, replacement of the H2O with culture medium further decreased the fatty acid content of triacylglycerol to 12.2 mole%. It thus seemed that severe dehydration is required for full induction of triacylglycerol synthesis, and that nutritional depletion as well as dehydration are crucial environmental factors. Meanwhile, air-drying of Chlamydomonas reinhardtii cells increased the triacylglycerol content to only 37.9 mole% of fatty acids and 4.8% (w/w), relative to total fatty acids and dry cell weight, respectively, and a marked decrease in the chlorophyll content, on a filter, of 33%. Air-drying thus has an impact on triacylglycerol synthesis in C. reinhardtii also, however, the effect is considerably limited, owing probably to instability of the photosynthetic machinery. This air-drying protocol could be useful for the development of a system for industrial production of triacylglycerol with appropriate selection of the algal species.	[Shiratake, Takuma; Sato, Atsushi; Minoda, Ayumi; Tsuzuki, Mikio; Sato, Norihiro] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan; [Sato, Atsushi; Tsuzuki, Mikio; Sato, Norihiro] CREST, JST, Chiyoda Ku, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST)	Sato, N (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	nsato@ls.toyaku.ac.jp	Minoda, Ayumi/GQB-3657-2022	Minoda, Ayumi/0000-0003-1968-7984	JST, CREST	JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was financially supported by JST, CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard B, 2001, PHYTOCHEMISTRY, V57, P459, DOI 10.1016/S0031-9422(01)00071-1; Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kamisaka Y, 2006, BIOSCI BIOTECH BIOCH, V70, P646, DOI 10.1271/bbb.70.646; Karsten U, 2012, MICROB ECOL, V63, P51, DOI 10.1007/s00248-011-9924-6; Kawamitsu Y, 2000, PLANT CELL PHYSIOL, V41, P344, DOI 10.1093/pcp/41.3.344; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Li Y, 2008, BIOTECHNOL PROGR, V24, P815, DOI 10.1021/bp070371k; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Mizuno Y, 2013, BIORESOURCE TECHNOL, V129, P150, DOI 10.1016/j.biortech.2012.11.030; MORISON MO, 1985, PHYCOLOGIA, V24, P129, DOI 10.2216/i0031-8884-24-2-129.1; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Papanikolaou S., 2012, FERMENT TECHNOL, V1, P1, DOI [10.4172/2167-7972.1000e103, DOI 10.4172/2167-7972.1000E103]; Quettier AL, 2009, PLANT PHYSIOL BIOCH, V47, P485, DOI 10.1016/j.plaphy.2008.12.005; SATO N, 1995, EUR J BIOCHEM, V234, P16, DOI 10.1111/j.1432-1033.1995.016_c.x; Sato N, 2003, BBA-MOL CELL BIOL L, V1633, P27, DOI 10.1016/S1388-1981(03)00069-6; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Sivakumar G, 2012, BIORESOURCE TECHNOL, V107, P1, DOI 10.1016/j.biortech.2011.12.091; SUEN Y, 1987, J PHYCOL, V23, P289, DOI 10.1111/j.1529-8817.1987.tb04137.x; Sugimoto K, 2010, NEW PHYTOL, V185, P676, DOI 10.1111/j.1469-8137.2009.03115.x; Takahashi H, 2001, PLANT PHYSIOL, V127, P665, DOI 10.1104/pp.127.2.665; TAKEDA H, 1991, J PHYCOL, V27, P224, DOI 10.1111/j.0022-3646.1991.00224.x; Vicre M, 2004, PHYSIOL PLANTARUM, V120, P229, DOI 10.1111/j.0031-9317.2004.0234.x; Xu ZZ, 2010, PLANT SIGNAL BEHAV, V5, P649, DOI 10.4161/psb.5.6.11398	28	22	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79630	10.1371/journal.pone.0079630	http://dx.doi.org/10.1371/journal.pone.0079630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260270	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600041
J	Siu, IM; Ruzevick, J; Zhao, Q; Connis, N; Jiao, YC; Bettegowda, C; Xia, XW; Burger, PC; Hann, CL; Gallia, GL				Siu, I-Mei; Ruzevick, Jacob; Zhao, Qi; Connis, Nick; Jiao, Yuchen; Bettegowda, Chetan; Xia, Xuewei; Burger, Peter C.; Hann, Christine L.; Gallia, Gary L.			Erlotinib Inhibits Growth of a Patient-Derived Chordoma Xenograft	PLOS ONE			English	Article							FACTOR RECEPTOR; PHASE-II; TYROSINE KINASES; LUNG-CANCER; C-MET; HYBRIDIZATION; MUTATIONS	Chordomas are rare primary bone tumors that occur along the neuraxis. Primary treatment is surgery, often followed by radiotherapy. Treatment options for patients with recurrence are limited and, notably, there are no FDA approved therapeutic agents. Development of therapeutic options has been limited by the paucity of preclinical model systems. We have established and previously reported the initial characterization of the first patient-derived chordoma xenograft model. In this study, we further characterize this model and demonstrate that it continues to resemble the original patient tumor histologically and immunohistochemically, maintains nuclear expression of brachyury, and is highly concordant with the original patient tumor by whole genome genotyping. Pathway analysis of this xenograft demonstrates activation of epidermal growth factor receptor (EGFR). In vitro studies demonstrate that two small molecule inhibitors of EGFR, erlotinib and gefitinib, inhibit proliferation of the chordoma cell line U-CH 1. We further demonstrate that erlotinib significantly inhibits chordoma growth in vivo. Evaluation of tumors post-treatment reveals that erlotinib reduces phosphorylation of EGFR. This is the first demonstration of antitumor activity in a patient-derived chordoma xenograft model and these findings support further evaluation of EGFR inhibitors in this disease.	[Siu, I-Mei; Zhao, Qi; Bettegowda, Chetan; Xia, Xuewei; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Ruzevick, Jacob] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Zhao, Qi] Johns Hopkins Univ, Sch Med, Ludwig Collaborat Lab, Baltimore, MD USA; [Connis, Nick; Hann, Christine L.; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Jiao, Yuchen; Bettegowda, Chetan] Johns Hopkins Univ, Sch Med, Ludwig Ctr Canc Genet, Baltimore, MD USA; [Xia, Xuewei] Gulin Med Coll, Affiliated Hosp, Dept Neurosurg, Guilin, Peoples R China; [Burger, Peter C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gallia, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	ggallia1@jhmi.edu		Connis, Nick/0000-0001-5725-0674	Chordoma Foundation	Chordoma Foundation	This work was supported in part by the Chordoma Foundation (GLG) as well as by Dr. and Mrs. Irving J. Sherman (GLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chugh R, 2005, J CLIN ONCOL, V23, P3597, DOI 10.1200/JCO.2005.02.170; Dewaele B, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-4; Fasig JH, 2008, NEUROPATH APPL NEURO, V34, P95, DOI 10.1111/j.1365-2990.2007.00873.x; Hof H, 2006, ONKOLOGIE, V29, P572, DOI 10.1159/000096283; Launay SG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-423; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Linden O, 2009, ACTA ONCOL, V48, P158, DOI 10.1080/02841860802266672; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Ptaszynski K, 2009, POL J PATHOL, V60, P81; Schaefer G, 2007, CANCER RES, V67, P1228, DOI 10.1158/0008-5472.CAN-06-3493; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Shalaby A, 2011, J PATHOL, V223, P336, DOI 10.1002/path.2818; Singhal N, 2009, ANTI-CANCER DRUG, V20, P953, DOI 10.1097/CAD.0b013e328330c7f0; Siu IM, 2012, J NEUROSURG, V116, P801, DOI 10.3171/2011.12.JNS111123; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stacchiotti S, 2013, ANN ONCOL, V24, P1931, DOI 10.1093/annonc/mdt117; Stacchiotti S, 2012, J CLIN ONCOL, V30, P914, DOI 10.1200/JCO.2011.35.3656; Stacchiotti S, 2011, CURR ONCOL REP, V13, P323, DOI 10.1007/s11912-011-0176-x; Tamborini E, 2010, NEURO-ONCOLOGY, V12, P776, DOI 10.1093/neuonc/noq003; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Walter BA, 2011, J NEURO-ONCOL, V101, P199, DOI 10.1007/s11060-010-0250-5; Weinberger PM, 2005, ARCH OTOLARYNGOL, V131, P707, DOI 10.1001/archotol.131.8.707	27	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e78895	10.1371/journal.pone.0078895	http://dx.doi.org/10.1371/journal.pone.0078895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260133	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600008
J	Aberg, E; Holst, S; Neagu, A; Ogren, SO; Lavebratt, C				Aberg, Elin; Holst, Sarah; Neagu, Alexandru; Ogren, Sven Ove; Lavebratt, Catharina			Prenatal Exposure to Carbamazepine Reduces Hippocampal and Cortical Neuronal Cell Population in New-Born and Young Mice without Detectable Effects on Learning And Memory	PLOS ONE			English	Article							UNBIASED STEREOLOGICAL ESTIMATION; MAJOR CONGENITAL-MALFORMATIONS; DRUGS IN-UTERO; ANTIEPILEPTIC DRUGS; CHILDREN BORN; ANTICONVULSANT DRUGS; DEVELOPING BRAIN; WATER-MAZE; EPILEPSY; PREGNANCY	Pregnant women with epilepsy have to balance maternal and fetal risks associated with uncontrolled seizures against the potential teratogenic effects from antiepileptic drugs (AEDs). Carbamazepine (CBZ) is among the four most commonly used AEDs for treatment of pregnant epileptic women. We previously reported that new-born children had a decreased head circumference after in utero CBZ exposure. This study investigates how prenatal exposure of CBZ influences the number of neurons in new-born and young mouse hippocampus, amygdala and cortex cerebri. Clinical studies describe inconclusive results on if prenatal CBZ treatment influences cognition. Here we investigate this issue in mice using two well characterized cognitive tasks, the passive avoidance test and the Morris water maze test. Prenatal exposure of CBZ reduced the number of neurons (NeuN-immunoreactive cells) in the new-born mouse hippocampus with 50% compared to non-exposed mice. A reduction of neurons (20%) in hippocampus was still observed when the animals were 5 weeks old. These mice also displayed a 25% reduction of neurons in cortex cerebri. Prenatal CBZ treatment did not significantly impair learning and memory measured in the passive avoidance test and in the Morris water maze. However, these mice displayed a higher degree of thigmotaxic behaviour than the control mice. The body weight of prenatally CBZ exposed five-week old mice were lower compared to control mice not exposed to CBZ (p = 0.001). In conclusion, prenatal exposure to CBZ reduces the number of neurons dramatically in areas important for cognition such as hippocampus and cortex, without severe impairments on learning and memory. These results are in line with some clinical studies, reporting that CBZ has minor negative effects on cognition. The challenge for future studies are to segment out what possible effects a reduction of neurons could have on different types of cognition, like intellectual ability and social interaction.	[Aberg, Elin; Neagu, Alexandru; Lavebratt, Catharina] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden; [Aberg, Elin; Neagu, Alexandru; Lavebratt, Catharina] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Holst, Sarah; Ogren, Sven Ove] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Aberg, E (corresponding author), Karolinska Inst, AstraZeneca Translat Sci Ctr, Stockholm, Sweden.	elin.aberg@astrazeneca.com		Ogren, Sven Ove/0000-0003-2573-5276; Lavebratt, Catharina/0000-0003-4987-2718	Swedish Medical Research Council, Ahlen Foundation; Fredrik and Ingrid Thuring's Foundation	Swedish Medical Research Council, Ahlen Foundation; Fredrik and Ingrid Thuring's Foundation	This work was supported by the Swedish Medical Research Council, Ahlen Foundation and Fredrik and Ingrid Thuring's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; Adab N, 2001, J NEUROL NEUROSUR PS, V70, P15, DOI 10.1136/jnnp.70.1.15; Adab N, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858]; Almgren M, 2009, SEIZURE-EUR J EPILEP, V18, P672, DOI 10.1016/j.seizure.2009.09.002; Baarendse PJJ, 2008, HIPPOCAMPUS, V18, P11, DOI 10.1002/hipo.20356; Banach R, 2010, DRUG SAFETY, V33, P73, DOI 10.2165/11317640-000000000-00000; BAYER SA, 1974, J COMP NEUROL, V158, P55, DOI 10.1002/cne.901580105; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Bromley RL, 2009, CURR OPIN NEUROL, V22, P162, DOI 10.1097/WCO.0b013e3283292401; CharriautMarlangue C, 1996, TRENDS NEUROSCI, V19, P109, DOI 10.1016/S0166-2236(96)80039-7; Chen J, 2009, J NEUROSCI RES, V87, P2898, DOI 10.1002/jnr.22125; Crawford P, 1999, SEIZURE-EUR J EPILEP, V8, P201, DOI 10.1053/seiz.1999.0295; Crepel V, 2003, J CELL MOL MED, V7, P401, DOI 10.1111/j.1582-4934.2003.tb00242.x; Cummings C, 2011, ARCH DIS CHILD, V96, P643, DOI 10.1136/adc.2009.176990; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dean JCS, 2002, J MED GENET, V39, P251, DOI 10.1136/jmg.39.4.251; Dessens A, 1998, ACTA NEUROBIOL EXP, V58, P221; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Eriksson K, 2005, EPILEPSY RES, V65, P189, DOI 10.1016/j.eplepsyres.2005.06.001; Eriksson TM, 2008, NEUROPHARMACOLOGY, V54, P1041, DOI 10.1016/j.neuropharm.2008.02.007; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gaily E, 2004, NEUROLOGY, V62, P28, DOI 10.1212/WNL.62.1.28; Galbally M, 2010, AUST NZ J PSYCHIAT, V44, P967, DOI 10.3109/00048674.2010.506637; Gentile S, 2011, CURR OPIN PSYCHIATR, V24, P34, DOI 10.1097/YCO.0b013e3283413451; Gentile S, 2010, DEPRESS ANXIETY, V27, P675, DOI 10.1002/da.20706; Harden CL, 2009, EPILEPSIA, V50, P1237, DOI 10.1111/j.1528-1167.2009.02129.x; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; JONES KL, 1989, NEW ENGL J MED, V320, P1661, DOI 10.1056/NEJM198906223202505; Kaneko S, 1999, EPILEPSY RES, V33, P145, DOI 10.1016/S0920-1211(98)00084-9; Kaplan PW, 2007, EPILEPSY BEHAV, V11, P283, DOI 10.1016/j.yebeh.2007.08.012; Kim J, 2007, J PHARMACOL EXP THER, V323, P165, DOI 10.1124/jpet.107.126250; Lavebratt C, 2006, NEUROBIOL DIS, V24, P374, DOI 10.1016/j.nbd.2006.07.018; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; Lepicard EM, 2000, PHARMACOL BIOCHEM BE, V67, P739, DOI 10.1016/S0091-3057(00)00419-6; Madjid N, 2006, J PHARMACOL EXP THER, V316, P581, DOI 10.1124/jpet.105.092262; Martin JMP, 2008, MUTAT RES-FUND MOL M, V637, P124, DOI 10.1016/j.mrfmmm.2007.07.014; Meador KJ, 2008, NEUROLOGY, V71, P1109, DOI 10.1212/01.wnl.0000316199.92256.af; Meador KJ, 2007, EPILEPSY BEHAV, V11, P292, DOI 10.1016/j.yebeh.2007.08.009; Meador Kimford J, 2009, Epilepsy Behav, V15, P339, DOI 10.1016/j.yebeh.2009.04.026; Meador KJ, 2009, NEW ENGL J MED, V360, P1597, DOI 10.1056/NEJMoa0803531; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrow JI, 2009, J NEUROL NEUROSUR PS, V80, P506, DOI 10.1136/jnnp.2008.156109; Ohl F, 2001, J PSYCHIAT RES, V35, P147, DOI 10.1016/S0022-3956(01)00017-6; Olafsson E, 1998, EPILEPSIA, V39, P887, DOI 10.1111/j.1528-1157.1998.tb01186.x; Ornoy A, 1996, ARCH DIS CHILD, V75, P517, DOI 10.1136/adc.75.6.517; Paxinos G., 2007, ATLAS DEV MOUSE BRAI; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Pennell PB, 2008, EPILEPSIA, V49, P43, DOI 10.1111/j.1528-1167.2008.01926.x; Pennell PB, 2004, NEUROL CLIN, V22, P799, DOI 10.1016/j.ncl.2004.07.004; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; REINISCH JM, 1995, JAMA-J AM MED ASSOC, V274, P1518, DOI 10.1001/jama.274.19.1518; Samren EB, 1999, ANN NEUROL, V46, P739; Samren EB, 1997, EPILEPSIA, V38, P981, DOI 10.1111/j.1528-1157.1997.tb01480.x; SCOLNIK D, 1994, JAMA-J AM MED ASSOC, V271, P767, DOI 10.1001/jama.271.10.767; Stiedl O, 2000, J NEUROSCI, V20, P8515, DOI 10.1523/JNEUROSCI.20-22-08515.2000; Sulzbacher S, 1999, CLIN PEDIATR, V38, P387, DOI 10.1177/000992289903800702; Thomas SV, 2008, EPILEPSY BEHAV, V13, P229, DOI 10.1016/j.yebeh.2008.01.010; Titze K, 2008, DEV MED CHILD NEUROL, V50, P117, DOI 10.1111/j.1469-8749.2007.02020.x; Vinten J, 2005, NEUROLOGY, V64, P949, DOI 10.1212/01.WNL.0000154514.82948.69; Vinten J, 2009, EPILEPSY BEHAV, V14, P197, DOI 10.1016/j.yebeh.2008.10.011; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	65	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80497	10.1371/journal.pone.0080497	http://dx.doi.org/10.1371/journal.pone.0080497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244693	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800149
J	Compte, N; Boudjeltia, KZ; Vanhaeverbeek, M; De Breucker, S; Pepersack, T; Tassignon, J; Trelcat, A; Goriely, S				Compte, Nathalie; Boudjeltia, Karim Zouaoui; Vanhaeverbeek, Michel; De Breucker, Sandra; Pepersack, Thierry; Tassignon, Joel; Trelcat, Anne; Goriely, Stanislas			Increased Basal and Alum-Induced Interleukin-6 Levels in Geriatric Patients Are Associated with Cardiovascular Morbidity	PLOS ONE			English	Article							AGE-RELATED INCREASES; NECROSIS-FACTOR-ALPHA; ILLNESS RATING-SCALE; C-REACTIVE PROTEIN; INFLAMMATORY MARKERS; CYTOMEGALOVIRUS-INFECTION; ALZHEIMERS-DISEASE; FUNCTIONAL IMPAIRMENT; MONOCYTE SUBSETS; CHRONIC STRESS	Background/Aim of the study: Low-grade systemic inflammation was suggested to participate to the decline of physiological functions and increased vulnerability encountered in older patients. Geriatric syndromes encompass various features such as functional dependence, polymorbidity, depression and malnutrition. There is a strong prevalence of cardiovascular diseases and related risk factors and chronic cytomegalovirus infections in the geriatric population. As these underlying conditions were proposed to influence the inflammatory state, the aim of this study was to assess their potential contribution to the association of geriatric syndromes with inflammatory parameters. Methodology: We recruited 100 subjects in the general population or hospitalized for chronic medical conditions (age, 23-96 years). We collected information on clinical status (medical history, ongoing comorbidities, treatments and geriatric scales), biological parameters (hematological tests, cytomegalovirus serology) and cytokines production (basal and alum-induced interleukin (IL)-1 beta and IL-6 levels). Using stepwise backward multivariate analyses, we defined which set of clinical and biological variables could be predictive for increased inflammatory markers. Principal Findings: We confirmed the age-associated increase of circulating IL-6 levels. In contrast to geriatric scales, we found history of cardiovascular diseases to be strongly associated for this parameter as for high IL-6 production upon ex vivo stimulation with alum. Conclusions: Association between low-grade inflammation and geriatric conditions could be linked to underlying cardiovascular diseases.	[Compte, Nathalie; Goriely, Stanislas] Univ Libre Bruxelles, IMI, Charleroi, Belgium; [Boudjeltia, Karim Zouaoui; Vanhaeverbeek, Michel] Univ Libre Bruxelles, Hop A Vesale, Expt Med Lab Unit 222, Montignies le Tilleul, Belgium; [De Breucker, Sandra; Pepersack, Thierry] Free Univ Brussels, Hop Erasme, Serv Geriatrie, B-1070 Brussels, Belgium; [Tassignon, Joel; Trelcat, Anne] ImmuneHlth, Charleroi, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Goriely, S (corresponding author), Univ Libre Bruxelles, IMI, Charleroi, Belgium.	stgoriel@ulb.ac.be	De Breucker, Sandra/AAZ-1759-2020	De Breucker, Sandra/0000-0003-4598-0295; compte, nathalie/0000-0002-1175-4153; Goriely, Stanislas/0000-0002-7005-6195; Pepersack, Thierry/0000-0001-6197-582X	government of the Walloon Region; GlaxoSmithKline Biologicals; Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium); Interuniversity Attraction Pole of the Belgian Federal Science Policy; FRS-FNRS; Fonds Erasme	government of the Walloon Region; GlaxoSmithKline Biologicals(GlaxoSmithKline); Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole of the Belgian Federal Science Policy(Belgian Federal Science Policy Office); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme	The Institute for Medical Immunology is sponsored by the government of the Walloon Region and GlaxoSmithKline Biologicals. This study was supported by the Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium) and an Interuniversity Attraction Pole of the Belgian Federal Science Policy. NC was supported by the FRS-FNRS and Fonds Erasme. SG is a research associate of the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Bauer ME, 2009, ANN NY ACAD SCI, V1153, P139, DOI 10.1111/j.1749-6632.2008.03966.x; Baune BT, 2012, PSYCHONEUROENDOCRINO, V37, P1521, DOI 10.1016/j.psyneuen.2012.02.006; Bautmans I, 2005, AGING CLIN EXP RES, V17, P217; Bautmans I, 2011, J NUTR HEALTH AGING, V15, P731, DOI 10.1007/s12603-010-0317-1; Bautmans I, 2008, J AM GERIATR SOC, V56, P389, DOI 10.1111/j.1532-5415.2007.01571.x; Bautmans Ivan, 2007, BMC Geriatr, V7, P5, DOI 10.1186/1471-2318-7-5; Baylis D, 2012, AGE DORDR; Blain H, 2012, EXP GERONTOL, V47, P143, DOI 10.1016/j.exger.2011.11.008; Blankenberg S, 2001, CIRCULATION, V103, P2915, DOI 10.1161/01.CIR.103.24.2915; Bonotis K, 2008, J NEUROIMMUNOL, V193, P183, DOI 10.1016/j.jneuroim.2007.10.020; Bruunsgaard H, 2003, CLIN EXP IMMUNOL, V132, P24, DOI 10.1046/j.1365-2249.2003.02137.x; Buurman BM, 2011, J CLIN EPIDEMIOL, V64, P619, DOI 10.1016/j.jclinepi.2010.07.005; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Chan G, 2009, VIRUS RES, V144, P329, DOI 10.1016/j.virusres.2009.04.026; Chang SS, 2012, ARCH GERONTOL GERIAT, V54, P9, DOI 10.1016/j.archger.2011.05.020; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; de Gonzalo-Calvo D, 2012, CYTOKINE, V58, P193, DOI 10.1016/j.cyto.2012.01.005; Dik MG, 2005, NEUROLOGY, V64, P1371, DOI 10.1212/01.WNL.0000158281.08946.68; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsey RJ, 2003, MECH AGEING DEV, V124, P487, DOI 10.1016/S0047-6374(03)00025-3; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Gouin JP, 2008, NEUROIMMUNOMODULAT, V15, P251, DOI 10.1159/000156468; GRAVENSTEIN S, 1994, J AM GERIATR SOC, V42, P245, DOI 10.1111/j.1532-5415.1994.tb01746.x; Guigoz Y, 1996, NUTR REV, V54, pS59; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Hristov M, 2011, THROMB HAEMOSTASIS, V106, P757, DOI 10.1160/TH11-07-0500; Hristov M, 2010, THROMB HAEMOSTASIS, V104, P412, DOI 10.1160/TH10-01-0069; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Licastro F, 2000, J NEUROIMMUNOL, V103, P97, DOI 10.1016/S0165-5728(99)00226-X; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Mathei C, 2011, J AM GERIATR SOC, V59, P2201, DOI 10.1111/j.1532-5415.2011.03719.x; McCusker J, 1998, ACAD EMERG MED, V5, P883, DOI 10.1111/j.1553-2712.1998.tb02818.x; Merino A, 2011, J IMMUNOL, V186, P1809, DOI 10.4049/jimmunol.1001866; Miles EA, 2008, ATHEROSCLEROSIS, V196, P298, DOI 10.1016/j.atherosclerosis.2006.11.002; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Nagaratnam N, 2007, ARCH GERONTOL GERIAT, V44, P29, DOI 10.1016/j.archger.2006.02.002; Nakajima T, 2010, J PERIODONTAL RES, V45, P116, DOI 10.1111/j.1600-0765.2009.01209.x; Niu WQ, 2012, INT J CARDIOL, V157, P243, DOI 10.1016/j.ijcard.2011.12.098; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Pawelec G, 2011, VIRUS RES, V157, P175, DOI 10.1016/j.virusres.2010.09.010; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Puts MTE, 2005, CLIN ENDOCRINOL, V63, P403, DOI 10.1111/j.1365-2265.2005.02355.x; Ravaglia G, 2007, NEUROBIOL AGING, V28, P1810, DOI 10.1016/j.neurobiolaging.2006.08.012; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Schmaltz HN, 2005, J AM GERIATR SOC, V53, P747, DOI 10.1111/j.1532-5415.2005.53250.x; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Uslu S, 2012, NEUROCHEM RES, V37, P1554, DOI 10.1007/s11064-012-0750-0; van den Biggelaar AHJ, 2004, EXP GERONTOL, V39, P1407, DOI 10.1016/j.exger.2004.06.009; Vellas B, 2006, J NUTR HEALTH AGING, V10, P456; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; Wright Clinton B, 2006, J Stroke Cerebrovasc Dis, V15, P34, DOI 10.1016/j.jstrokecerebrovasdis.2005.08.009; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Zheng GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034839; Zuliani G, 2007, J PSYCHIATR RES, V41, P686, DOI 10.1016/j.jpsychires.2006.02.008; Zuliani G, 2007, INT J GERIATR PSYCH, V22, P305, DOI 10.1002/gps.1674	68	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81911	10.1371/journal.pone.0081911	http://dx.doi.org/10.1371/journal.pone.0081911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244750	gold, Green Published, Green Submitted			2022-12-25	WOS:000327143800188
J	Gao, HL; Li, C; Nabeka, H; Shimokawa, T; Kobayashi, N; Saito, S; Wang, ZY; Cao, YM; Matsuda, S				Gao, Hui-ling; Li, Cheng; Nabeka, Hiroaki; Shimokawa, Tetsuya; Kobayashi, Naoto; Saito, Shouichiro; Wang, Zhan-You; Cao, Ya-ming; Matsuda, Seiji			Decrease in Prosaposin in the Dystrophic mdx Mouse Brain	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; FACIAL-NERVE TRANSECTION; MESSENGER-RNA; IN-VIVO; MOLECULAR-MECHANISMS; MUSCLE REGENERATION; NEUROTROPHIC FACTOR; ACTIVATOR PROTEIN; GENE-EXPRESSION; 18-MER PEPTIDE	Background: Duchenne muscular dystrophy caused by a mutation in the X-linked dystrophin gene induces metabolic and structural disorders in the brain. A lack of dystrophin in brain structures is involved in impaired cognitive function. Prosaposin (PS), a neurotrophic factor, is abundant in the choroid plexus and various brain regions. We investigated whether PS serves as a link between dystrophin loss and gross and/or ultrastructural brain abnormalities. Methodology/Principal Findings: The distribution of PS in the brains of juvenile and adult mdx mice was investigated by immunochemistry, Western blotting, and in situ hybridization. Immunochemistry revealed lower levels of PS in the cytoplasm of neurons of the cerebral cortex, hippocampus, cerebellum, and choroid plexus in mdx mice. Western blotting confirmed that PS levels were lower in these brain regions in both juveniles and adults. Even with low PS production in the choroids plexus, there was no significant PS decrease in cerebrospinal fluid (CSF). In situ hybridization revealed that the primary form of PS mRNA in both normal and mdx mice was Pro+ 9, a secretory-type PS, and the hybridization signals for Pro+ 9 in the above-mentioned brain regions were weaker in mdx mice than in normal mice. We also investigated mitogen-activated protein kinase signalling. Stronger activation of ERK1/2 was observed in mdx mice, ERK1/2 activity was positively correlated with PS activity, and exogenous PS18 stimulated both p-ERK1/2 and PS in SH-SY5Y cells. Conclusions/Significance: Low levels of PS and its receptors suggest the participation of PS in some pathological changes in the brains of mdx mice.	[Gao, Hui-ling; Li, Cheng; Nabeka, Hiroaki; Shimokawa, Tetsuya; Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Kobayashi, Naoto] Ehime Univ, Grad Sch Med, Med Educ Ctr, Toon, Ehime, Japan; [Saito, Shouichiro] Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Yanagi, Gifu, Japan; [Gao, Hui-ling; Wang, Zhan-You] Northeastern Univ, Coll Life & Hlth Sci, Shenyang, Peoples R China; [Li, Cheng; Cao, Ya-ming] China Med Univ, Dept Immunol, Shenyang, Peoples R China	Ehime University; Ehime University; Gifu University; Northeastern University - China; China Medical University	Nabeka, H (corresponding author), Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan.	nabeka@m.ehime-u.ac.jp		Wang, Zhan-You/0000-0003-0807-9916	Ministry of Education, Culture, Sports, Science and Technology of Japan [22591637, 19659380, 22591979]; Ehime University [021000]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ehime University	This study was supported in part by Grants to SM (22591637, 19659380) and NK (22591979) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and to CL (021000) from Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; Anderson JL, 2002, BRAIN, V125, P4, DOI 10.1093/brain/awf012; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BILLARD C, 1992, NEUROMUSCULAR DISORD, V2, P371, DOI 10.1016/S0960-8966(06)80008-8; BRESOLIN N, 1994, NEUROMUSCULAR DISORD, V4, P359, DOI 10.1016/0960-8966(94)90072-8; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Chen J, 2008, NEUROSCI RES, V60, P82, DOI 10.1016/j.neures.2007.09.010; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cohen T, 2005, MOL CELL BIOL, V25, P2431, DOI 10.1128/MCB.25.6.2431-2440.2005; Cohen T, 2004, MOL BRAIN RES, V129, P8, DOI 10.1016/j.molbrainres.2004.06.027; COLLARD MW, 1988, BIOCHEMISTRY-US, V27, P4557, DOI 10.1021/bi00412a050; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; GORECKI D, 1991, NEUROREPORT, V2, P773, DOI 10.1097/00001756-199112000-00011; HINENO T, 1991, BIOCHEM BIOPH RES CO, V176, P668, DOI 10.1016/S0006-291X(05)80236-0; Hinton VJ, 2001, J INT NEUROPSYCH SOC, V7, P45, DOI 10.1017/S1355617701711058; Hiraiwa M, 1997, P NATL ACAD SCI USA, V94, P4778, DOI 10.1073/pnas.94.9.4778; Hiraiwa M, 2003, J NEUROTRAUM, V20, P755, DOI 10.1089/089771503767869980; HIRAIWA M, 1993, J BIOCHEM-TOKYO, V114, P901, DOI 10.1093/oxfordjournals.jbchem.a124274; Hiraiwa M, 1997, BIOCHEM BIOPH RES CO, V240, P415, DOI 10.1006/bbrc.1997.7673; Hnia K, 2007, AM J PATHOL, V170, P633, DOI 10.2353/ajpath.2007.060344; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOLTSCHMIDT H, 1991, J BIOL CHEM, V266, P7556; Hosoda Y, 2007, CELL TISSUE RES, V330, P197, DOI 10.1007/s00441-007-0464-9; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KONDOH K, 1993, J COMP NEUROL, V334, P590, DOI 10.1002/cne.903340407; KONDOH K, 1991, BIOCHEM BIOPH RES CO, V181, P286, DOI 10.1016/S0006-291X(05)81415-9; Kotani Y, 1996, J NEUROCHEM, V66, P2197; Kotani Y, 1996, J NEUROCHEM, V66, P2019; KREDA SM, 1994, DEV NEUROSCI-BASEL, V16, P90, DOI 10.1159/000112093; LAMONTAGNE S, 1994, J BIOL CHEM, V269, P20528; Li C, 2013, HISTOL HISTOPATHOL, V28, P875, DOI 10.14670/HH-28.875; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; LIDOV HGW, 1993, NEUROSCIENCE, V54, P167, DOI 10.1016/0306-4522(93)90392-S; Lidov HGW, 1996, BRAIN PATHOL, V6, P63, DOI 10.1111/j.1750-3639.1996.tb00783.x; Liu L., 2008, J VIS EXP; LOVE DR, 1993, NEUROMUSCULAR DISORD, V3, P5, DOI 10.1016/0960-8966(93)90037-K; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Misasi R, 2001, FASEB J, V15, P467, DOI 10.1096/fj.00-0217com; Morita F, 2001, J CEREBR BLOOD F MET, V21, P1295, DOI 10.1097/00004647-200111000-00005; Morris MA, 2001, FASEB J, V15, pA1026, DOI 10.1096/fj.00-0603fje; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nico B, 2004, NEUROSCIENCE, V125, P921, DOI 10.1016/j.neuroscience.2004.02.008; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; OBRIEN JS, 1995, FASEB J, V9, P681, DOI 10.1096/fasebj.9.8.7768361; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Qi XY, 1996, J BIOL CHEM, V271, P6874, DOI 10.1074/jbc.271.12.6874; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192; SANO A, 1994, BIOCHEM BIOPH RES CO, V204, P994, DOI 10.1006/bbrc.1994.2558; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; Sikora J, 2007, ACTA NEUROPATHOL, V113, P163, DOI 10.1007/s00401-006-0148-7; Subramaniam S, 2006, NEUROSCIENCE, V138, P1055, DOI 10.1016/j.neuroscience.2005.12.013; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; SUN Y, 1994, AM J PATHOL, V145, P1390; Terashita T, 2007, NEUROSCI RES, V57, P372, DOI 10.1016/j.neures.2006.11.006; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Tsuboi K, 1998, DEV BRAIN RES, V110, P249, DOI 10.1016/S0165-3806(98)00109-6; Turk R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-98; Unuma K, 2005, NEUROSCI RES, V52, P220, DOI 10.1016/j.neures.2005.03.009; Wicksell RK, 2004, DEV MED CHILD NEUROL, V46, P154, DOI 10.1017/S0012162204000283; Zhao Q, 1997, MOL REPROD DEV, V48, P1, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;1::AID-MRD1&gt;3.0.CO;2-N	69	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80032	10.1371/journal.pone.0080032	http://dx.doi.org/10.1371/journal.pone.0080032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244600	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800109
J	Rekker, K; Saare, M; Roost, AM; Salumets, A; Peters, M				Rekker, Kadri; Saare, Merli; Roost, Anne Mari; Salumets, Andres; Peters, Maire			Circulating microRNA Profile throughout the Menstrual Cycle	PLOS ONE			English	Article							CANCER-DETECTION; MESSENGER-RNAS; EXPRESSION; ENDOMETRIOSIS; BIOMARKER; MECHANISM; DISEASES; MARKERS; WOMEN; SERUM	Normal physiological variables, such as age and gender, contribute to alterations in circulating microRNA (miRNA) expression levels. The changes in the female body during the menstrual cycle can also be reflected in plasma miRNA expression levels. Therefore, this study aimed to determine the plasma miRNA profile of healthy women during the menstrual cycle and to assess which circulating miRNAs are derived from blood cells. The plasma miRNA expression profiles in nine healthy women were determined by quantitative real time PCR using Exiqon Human Panel I assays from four time-points of the menstrual cycle. This platform was also used for studying miRNAs from pooled whole blood RNA samples at the same four time-points. Our results indicated that circulating miRNA expression levels in healthy women were not significantly altered by the processes occurring during the menstrual cycle. No significant differences in plasma miRNA expression levels were observed between the menstrual cycle time-points, but the number of detected miRNAs showed considerable variation among the studied individuals. miRNA analysis from whole blood samples revealed that majority of miRNAs in plasma are derived from blood cells. The most abundant miRNA in plasma and blood was hsa-miR-451a, but a number of miRNAs were only detected in one or the other sample type. In conclusion, our data suggest that the changes in the female body during the menstrual cycle do not affect the expression of circulating miRNAs at measurable levels.	[Rekker, Kadri; Saare, Merli; Roost, Anne Mari; Salumets, Andres; Peters, Maire] Competence Ctr Reprod Med & Biol, Tartu, Estonia; [Rekker, Kadri; Saare, Merli; Salumets, Andres; Peters, Maire] Univ Tartu, Dept Obstet & Gynecol, EE-50090 Tartu, Estonia; [Saare, Merli; Salumets, Andres] Univ Tartu, Inst Biomed & Translat Med, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu	Rekker, K (corresponding author), Competence Ctr Reprod Med & Biol, Tartu, Estonia.	kadri.vaidla@gmail.com	Peters, Maire/J-2310-2015; Saare, Merli/J-2559-2015; Salumets, Andres/J-2278-2015	Peters, Maire/0000-0003-2063-242X; Salumets, Andres/0000-0002-1251-8160	Estonian Ministry of Education and Research [SF0180044s09]; European Regional Development Fund through the Estonian Centre of Excellence in Genomics; Enterprise Estonia [EU30020, Eurostars EU41564 NOTED]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund through the Estonian Centre of Excellence in Genomics; Enterprise Estonia	This research was funded by grant SF0180044s09 from the Estonian Ministry of Education and Research, by the European Regional Development Fund through the Estonian Centre of Excellence in Genomics, by Enterprise Estonia, grant no EU30020 and Eurostars EU41564 NOTED project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Altmae S, 2013, REPROD SCI, V20, P308, DOI 10.1177/1933719112453507; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Hanke Merle, 2010, Urol Oncol, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jia SZ, 2013, HUM REPROD, V28, P322, DOI 10.1093/humrep/des413; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; Kim DJ, 2012, J MOL DIAGN, V14, P71, DOI 10.1016/j.jmoldx.2011.09.002; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Petracco R, 2011, J CLIN ENDOCR METAB, V96, pE1925, DOI 10.1210/jc.2011-1231; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ratner ES, 2010, GYNECOL ONCOL, V118, P251, DOI 10.1016/j.ygyno.2010.05.010; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Sha AG, 2011, FERTIL STERIL, V96, P150, DOI 10.1016/j.fertnstert.2011.04.072; Sredni Simone T., 2011, Frontiers in Genetics, V2, P49, DOI 10.3389/fgene.2011.00049; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang WT, 2013, J CLIN ENDOCR METAB, V98, P281, DOI 10.1210/jc.2012-2415; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Wu XW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-42; Zahm AM, 2011, J PEDIATR GASTR NUTR, V53, P26, DOI 10.1097/MPG.0b013e31822200cc; Zhao Z, 2012, CLIN CHEM, V58, P896, DOI 10.1373/clinchem.2011.179283	36	37	40	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81166	10.1371/journal.pone.0081166	http://dx.doi.org/10.1371/journal.pone.0081166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244734	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800177
J	Sorte, CJB; Etter, RJ; Spackman, R; Boyle, EE; Hannigan, RE				Sorte, Cascade J. B.; Etter, Ron J.; Spackman, Robert; Boyle, Elizabeth E.; Hannigan, Robyn E.			Elemental Fingerprinting of Mussel Shells to Predict Population Sources and Redistribution Potential in the Gulf of Maine	PLOS ONE			English	Article							MYTILUS-EDULIS L.; LARVAL DISPERSAL; GEOCHEMICAL SIGNATURES; CLIMATE-CHANGE; BLUE MUSSEL; CONNECTIVITY; BIOGEOGRAPHY; PATTERNS; VARIABILITY; CIRCULATION	As the climate warms, species that cannot tolerate changing conditions will only persist if they undergo range shifts. Redistribution ability may be particularly variable for benthic marine species that disperse as pelagic larvae in ocean currents. The blue mussel, Mytilus edulis, has recently experienced a warming-related range contraction in the southeastern USA and may face limitations to northward range shifts within the Gulf of Maine where dominant coastal currents flow southward. Thus, blue mussels might be especially vulnerable to warming, and understanding dispersal patterns is crucial given the species' relatively long planktonic larval period (>1 month). To determine whether trace elemental "fingerprints'' incorporated in mussel shells could be used to identify population sources (i.e. collection locations), we assessed the geographic variation in shell chemistry of blue mussels collected from seven populations between Cape Cod, Massachusetts and northern Maine. Across this similar to 500 km of coastline, we were able to successfully predict population sources for over two-thirds of juvenile individuals, with almost 80% of juveniles classified within one site of their collection location and 97% correctly classified to region. These results indicate that significant differences in elemental signatures of mussel shells exist between open-coast sites separated by similar to 50 km throughout the Gulf of Maine. Our findings suggest that elemental "fingerprinting'' is a promising approach for predicting redistribution potential of the blue mussel, an ecologically and economically important species in the region.	[Sorte, Cascade J. B.; Hannigan, Robyn E.] Univ Massachusetts, Sch Environm, Boston, MA 02125 USA; [Etter, Ron J.; Boyle, Elizabeth E.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Spackman, Robert] Univ Great Falls, Great Falls, MT USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; University of Great Falls	Sorte, CJB (corresponding author), Univ Massachusetts, Sch Environm, Harbor Campusn, Boston, MA 02125 USA.	cjsorte@ucdavis.edu	Hannigan, Robyn/AAG-3626-2019; Hannigan, Robyn/F-8628-2010	Hannigan, Robyn/0000-0003-4782-1124; Hannigan, Robyn/0000-0003-4782-1124	Department of Energy [DOE-ER64982]; Massachusetts Institute of Technology (MIT) [2013-R/RC-132]; Direct For Biological Sciences [0959666] Funding Source: National Science Foundation	Department of Energy(United States Department of Energy (DOE)); Massachusetts Institute of Technology (MIT); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by the Department of Energy (DOE-ER64982) and Massachusetts Institute of Technology (MIT) Sea Grant (2013-R/RC-132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, LIMNOL OCEANOGR, V42, P1009, DOI 10.4319/lo.1997.42.5_part_2.1009; [Anonymous], 2004, ELAN DRC 2; Becker BJ, 2005, LIMNOL OCEANOGR, V50, P48, DOI 10.4319/lo.2005.50.1.0048; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Bradbury IR, 2011, MAR ECOL PROG SER, V433, P195, DOI 10.3354/meps09178; Broadaway BJ, 2012, J SHELLFISH RES, V31, P671, DOI 10.2983/035.031.0310; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Byers JE, 2006, MAR ECOL PROG SER, V313, P27, DOI 10.3354/meps313027; Carson HS, 2013, MAR ECOL PROG SER, V473, P133, DOI 10.3354/meps10078; Carson HS, 2011, ECOLOGY, V92, P1972, DOI 10.1890/11-0488.1; Cathey AM, 2012, MAR ECOL PROG SER, V465, P155, DOI 10.3354/meps09895; Chase ME, 2001, MAR POLLUT BULL, V42, P491; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fodrie FJ, 2011, J SEA RES, V65, P141, DOI 10.1016/j.seares.2010.09.001; Hayhurst S, 2009, J MOLLUS STUD, V75, P215, DOI 10.1093/mollus/eyp019; HERSHEY AE, 1993, ECOLOGY, V74, P2315, DOI 10.2307/1939584; Jones SJ, 2010, J BIOGEOGR, V37, P2243, DOI 10.1111/j.1365-2699.2010.02386.x; Jones SJ, 2009, BIOL BULL-US, V217, P73, DOI 10.1086/BBLv217n1p73; Leis JM, 2011, OCEANOGR MAR BIOL, V49, P193; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lopez-Duarte PC, 2012, INTEGR COMP BIOL, V52, P511, DOI 10.1093/icb/ics104; Lutscher Frithjof, 2010, Theoretical Ecology, V3, P271, DOI 10.1007/s12080-009-0068-y; Lynch DR, 1996, CONT SHELF RES, V16, P875, DOI 10.1016/0278-4343(95)00028-3; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; Miller SH, 2013, MAR ECOL PROG SER, V474, P179, DOI 10.3354/meps10119; National Oceanic and Atmospheric Association, 2013, NOAA FISH LAND; Osher LJ, 2006, ESTUAR COAST SHELF S, V70, P169, DOI 10.1016/j.ecss.2006.06.009; Pachepsky E, 2005, THEOR POPUL BIOL, V67, P61, DOI 10.1016/j.tpb.2004.09.001; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Palumbi SR, 2003, FRONT ECOL ENVIRON, V1, P73, DOI 10.2307/3868033; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pettigrew NR, 2005, DEEP-SEA RES PT II, V52, P2369, DOI 10.1016/j.dsr2.2005.06.033; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Pringle JM, 2006, DEEP-SEA RES PT II, V53, P2457, DOI 10.1016/j.dsr2.2006.08.015; Pringle JM, 2011, P NATL ACAD SCI USA, V108, P15288, DOI 10.1073/pnas.1100473108; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; SEED R, 1969, OECOLOGIA, V3, P277, DOI 10.1007/BF00390380; Sorte CJB, 2013, OIKOS, V122, P161, DOI 10.1111/j.1600-0706.2012.00066.x; Sorte CJB, 2011, J EXP MAR BIOL ECOL, V400, P209, DOI 10.1016/j.jembe.2011.02.009; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Strasser CA, 2008, J EXP MAR BIOL ECOL, V355, P153, DOI 10.1016/j.jembe.2007.12.022; Suchanek TH, 1987, NW ENV J, V8, P150; Sukhotin AA, 2002, MAR ECOL PROG SER, V226, P223, DOI 10.3354/meps226223; Tam JC, 2011, J BIOGEOGR, V38, P1536, DOI 10.1111/j.1365-2699.2011.02498.x; Thorrold SR, 2007, OCEANOGRAPHY, V20, P80, DOI 10.5670/oceanog.2007.31; Thorrold SR, 2002, B MAR SCI, V70, P291	51	29	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80868	10.1371/journal.pone.0080868	http://dx.doi.org/10.1371/journal.pone.0080868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244724	Green Submitted, gold, Green Published			2022-12-25	WOS:000327143800171
J	Zhou, H; Cheng, FY; Wang, R; Zhong, Y; He, CY				Zhou, Hua; Cheng, Fang-Yun; Wang, Rong; Zhong, Yuan; He, Chaoying			Transcriptome Comparison Reveals Key Candidate Genes Responsible for the Unusual Reblooming Trait in Tree Peonies	PLOS ONE			English	Article							FLOWERING-LOCUS-T; RNA-SEQ; MOLECULAR-MECHANISM; GIBBERELLIN; TIME; ARABIDOPSIS; TOOL; VERNALIZATION; ANNOTATION; TRANSITION	Tree peonies are important ornamental plants worldwide, but growing them can be frustrating due to their short and concentrated flowering period. Certain cultivars exhibit a reblooming trait that provides a valuable alternative for extending the flowering period. However, the genetic control of reblooming in tree peonies is not well understood. In this study, we compared the molecular properties and morphology of reblooming and non-reblooming tree peonies during the floral initiation and developmental processes. Using transcriptome sequencing technology, we generated 59,275 and 63,962 unigenes with a mean size of 698 bp and 699 bp from the two types of tree peonies, respectively, and identified eight differentially expressed genes that are involved in the floral pathways of Arabidopsis thaliana. These differentially regulated genes were verified through a detailed analysis of their expression pattern during the floral process by real time RT-PCR. From this combined analysis, we identified four genes, PsFT, PsVIN3, PsCO and PsGA20OX, which likely play important roles in the regulation of the reblooming process in tree peonies. These data constitute a valuable resource for the discovery of genes involved in flowering time and insights into the molecular mechanism of flowering to further accelerate the breeding of tree peonies and other perennial woody plants.	[Zhou, Hua; Cheng, Fang-Yun; Wang, Rong; Zhong, Yuan] Beijing Forestry Univ, Landscape Architecture Coll, Natl Flower Engn Res Ctr, Beijing, Peoples R China; [Zhou, Hua] Jiangxi Acad Sci, Inst Biol & Resources, Nanchang, Peoples R China; [He, Chaoying] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Cheng, FY (corresponding author), Beijing Forestry Univ, Landscape Architecture Coll, Natl Flower Engn Res Ctr, Beijing, Peoples R China.	chengfy8@263.net; chaoying@ibcas.ac.cn			National High Technology Research and Development Program of China (863 Program) [2011AA100207]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2011AA100207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani MC, 2004, THEOR APPL GENET, V109, P571, DOI 10.1007/s00122-004-1654-4; Amasino R, 2004, PLANT CELL, V16, P2553, DOI 10.1105/tpc.104.161070; Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barzilay A, 2002, HORTSCIENCE, V37, P300, DOI 10.21273/HORTSCI.37.2.300; Battey NH, 1998, GENETICS AND ENVIRONMENTAL MANIPULATION OF HORTICULTURAL CROPS, P111; Benjamini Y, 2001, ANN STAT, V29, P1165; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Cheng F. Y., 2007, INT J PLANT BREEDING, V1, P89, DOI [10.3923/ijpbg.2007.89.94, DOI 10.3923/IJPBG.2007.89.94, DOI 10.3923/ijpbg.2007.89.94]; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dennis ES, 2006, DEV CELL, V11, P1, DOI 10.1016/j.devcel.2006.06.007; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Foucher F, 2008, GENOME, V51, P827, DOI 10.1139/G08-067; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Hartweck LM, 2006, PLANT CELL, V18, P278, DOI 10.1105/tpc.105.039958; HEMPEL FD, 1995, PLANT J, V8, P725, DOI 10.1046/j.1365-313X.1995.08050725.x; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Homolka A, 2010, AM J BOT, V97, pE42, DOI 10.3732/ajb.1000127; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Hyun TK, 2012, PLANT MOL BIOL, V79, P413, DOI 10.1007/s11103-012-9919-9; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Jiang Zhuo, 2007, Acta Horticulturae Sinica, V34, P683; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Jones HG, 1987, TREES-STRUCT FUNCT, V1, P135; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li JJ, 2011, TREE PEONY CHINESE; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060181; LORD EM, 1987, BOT GAZ, V148, P17, DOI 10.1086/337623; MCDANIEL CN, 1992, DEV BIOL, V153, P59, DOI 10.1016/0012-1606(92)90091-T; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Mornya PMP, 2011, HORTIC SCI, V38, P104, DOI 10.17221/11/2011-HORTSCI; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouhu K, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-122; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Pineiro M, 1998, PLANT PHYSIOL, V117, P1, DOI 10.1104/pp.117.1.1; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Ren XiaoLin, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P895; Roberts AV, 1999, J PLANT GROWTH REGUL, V18, P113, DOI 10.1007/PL00007058; Rogers A., 1995, PEONIES; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; SEMENIUK, 1971, J HERED, V62, P203; Shu QY, 2009, PHYSIOL PLANTARUM, V135, P436, DOI 10.1111/j.1399-3054.2009.01206.x; Shu QY, 2012, GENE, V493, P113, DOI 10.1016/j.gene.2011.11.008; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sonsteby A, 2007, J HORTIC SCI BIOTECH, V82, P266, DOI 10.1080/14620316.2007.11512228; Srinivasan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040715; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Suh SS, 2003, PLANT CELL PHYSIOL, V44, P836, DOI 10.1093/pcp/pcg109; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Trainin T, 2013, TREE GENET GENOMES, V9, P753, DOI 10.1007/s11295-012-0590-8; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wang L., 1986, Acta Horticulturae Sinica, V13, P203; Wang LY., 1998, CHINESE TREE PEONY; Wang YanJie, 2012, Journal of Agricultural Biotechnology, V20, P521; Wang Z.Z., 1987, J SHANDONG AGR U, V3, P9; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkie JD, 2008, J EXP BOT, V59, P3215, DOI 10.1093/jxb/ern188; Wister JC, 1962, PEONIES; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang JJ, 2012, PLANT CELL REP, V31, P299, DOI 10.1007/s00299-011-1164-1; Zhang XX, 2005, STUDIES FORCING CULT; Zheng GuoSheng, 2009, Scientia Silvae Sinicae, V45, P48	83	22	26	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79996	10.1371/journal.pone.0079996	http://dx.doi.org/10.1371/journal.pone.0079996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244590	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800107
J	Yao, HW; Sundar, IK; Gorbunova, V; Rahman, I				Yao, Hongwei; Sundar, Isaac K.; Gorbunova, Vera; Rahman, Irfan			P21-PARP-1 Pathway Is Involved in Cigarette Smoke-Induced Lung DNA Damage and Cellular Senescence	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; INFLAMMATORY CYTOKINE SECRETION; OBSTRUCTIVE PULMONARY-DISEASE; ALVEOLAR EPITHELIAL-CELLS; DOUBLE-STRAND BREAKS; POLY(ADP-RIBOSE) POLYMERASE-1; HOMOLOGOUS RECOMBINATION; OXIDATIVE STRESS; IN-VIVO; NUCLEAR ANTIGEN	Persistent DNA damage triggers cellular senescence, which may play an important role in the pathogenesis of cigarette smoke (CS)-induced lung diseases. Both p21(CDKN1A) (p21) and poly(ADP-ribose) polymerase-1 (PARP-1) are involved in DNA damage and repair. However, the role of p21-PARP-1 axis in regulating CS-induced lung DNA damage and cellular senescence remains unknown. We hypothesized that CS causes DNA damage and cellular senescence through a p21-PARP-1 axis. To test this hypothesis, we determined the levels of gamma H2AX (a marker for DNA double-strand breaks) as well as non-homologous end joining proteins (Ku70 and Ku80) in lungs of mice exposed to CS. We found that the level of gamma H2AX was increased, whereas the level of Ku70 was reduced in lungs of CS-exposed mice. Furthermore, p21 deletion reduced the level of gamma H2AX, but augmented the levels of Ku70, Ku80, and PAR in lungs by CS. Administration of PARP-1 inhibitor 3-aminobenzamide increased CS-induced DNA damage, but lowered the levels of Ku70 and Ku80, in lungs of p21 knockout mice. Moreover, 3-aminobenzamide increased senescence-associated beta-galactosidase activity, but decreased the expression of proliferating cell nuclear antigen in mouse lungs in response to CS. Interestingly, 3-aminobenzamide treatment had no effect on neutrophil influx into bronchoalveolar lavage fluid by CS. These results demonstrate that the p21-PARP-1 pathway is involved in CS-induced DNA damage and cellular senescence.	[Yao, Hongwei; Sundar, Isaac K.; Rahman, Irfan] Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Gorbunova, Vera] Univ Rochester, Med Ctr, Dept Biol, Rochester, NY 14642 USA	University of Rochester	Yao, HW (corresponding author), Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA.	Hongwei_Yao@urmc.rochester.edu; irfan_rahman@urmc.rochester.edu	Sundar, Isaac K/F-8764-2012; Yao, Hongwei/G-6444-2010	Sundar, Isaac K/0000-0001-6742-3460; Gorbunova, Vera/0000-0001-8979-0333	National Institutes of Health (NIH) [1R01HL092842, 2R01HL085613, 1R01HL097751]; American Lung Association [RG-266456-N]; NIEHS Environmental Health Science Center [P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613, R01HL092842, R01HL097751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027237] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NIEHS Environmental Health Science Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health (NIH) 1R01HL092842, 2R01HL085613, 1R01HL097751 (to IR), American Lung Association RG-266456-N (to HY), and NIEHS Environmental Health Science Center grant P30-ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-21; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Caito S, 2010, BIOCHEM BIOPH RES CO, V392, P264, DOI 10.1016/j.bbrc.2009.12.161; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Caramori G, 2011, THORAX, V66, P521, DOI 10.1136/thx.2010.156448; Cazzalini O, 2010, DNA REPAIR, V9, P627, DOI 10.1016/j.dnarep.2010.02.011; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Ceylan E, 2006, RESP MED, V100, P1270, DOI 10.1016/j.rmed.2005.10.011; Claybon A, 2010, NUCLEIC ACIDS RES, V38, P7538, DOI 10.1093/nar/gkq624; Cooper MP, 1999, MOL BIOL CELL, V10, P2119, DOI 10.1091/mbc.10.7.2119; Couto CAM, 2011, J CELL BIOL, V194, P367, DOI 10.1083/jcb.201012132; de Souza AR, 2011, J BIOL CHEM, V286, P43214, DOI 10.1074/jbc.M111.258764; Deslee G, 2009, CHEST, V135, P965, DOI 10.1378/chest.08-2257; Dolan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055190; Efimova EV, 2010, CANCER RES, V70, P6277, DOI 10.1158/0008-5472.CAN-09-4224; Genovese T, 2005, J PHARMACOL EXP THER, V313, P529, DOI 10.1124/jpet.104.080705; Hageman GJ, 2003, FREE RADICAL BIO MED, V35, P140, DOI 10.1016/S0891-5849(03)00237-5; Herbig U, 2003, AGING CELL, V2, P295, DOI 10.1046/j.1474-9728.2003.00067.x; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Hwang JW, 2010, ARCH BIOCHEM BIOPHYS, V500, P203, DOI 10.1016/j.abb.2010.05.013; Jakob B, 2002, INT J RADIAT BIOL, V78, P75, DOI 10.1080/09553000110090007; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Kamp DW, 2001, J INVEST MED, V49, P68, DOI 10.2310/6650.2001.34092; Koike M, 2011, BIOCHEM BIOPH RES CO, V412, P39, DOI 10.1016/j.bbrc.2011.07.032; Kovacs K, 2012, FREE RADICAL BIO MED, V53, P1680, DOI 10.1016/j.freeradbiomed.2012.08.579; Lapucci A, 2011, MOL PHARMACOL, V79, P932, DOI 10.1124/mol.110.070110; Lee JY, 2009, BIOCHEM BIOPH RES CO, V390, P1361, DOI 10.1016/j.bbrc.2009.10.160; Liaudet L, 2002, AM J RESP CRIT CARE, V165, P372, DOI 10.1164/ajrccm.165.3.2106050; Liu XD, 2005, AM J RESP CELL MOL, V33, P121, DOI 10.1165/rcmb.2003-0341OC; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Marwick JA, 2002, ANN NY ACAD SCI, V973, P278, DOI 10.1111/j.1749-6632.2002.tb04649.x; Mauro M, 2012, NUCLEIC ACIDS RES, V40, P8348, DOI 10.1093/nar/gks612; Neofytou E, 2012, INT J MOL SCI, V13, P16853, DOI 10.3390/ijms131216853; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Oit-Wiscombe I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070333; Pagano A, 2007, AM J PHYSIOL-LUNG C, V293, pL619, DOI 10.1152/ajplung.00037.2007; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pastukh VM, 2011, INT J CHRONIC OBSTR, V6, P209, DOI 10.2147/COPD.S15922; Perucca P, 2006, J CELL SCI, V119, P1517, DOI 10.1242/jcs.02868; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P8869, DOI 10.1021/bi00027a039; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Robu M, 2013, P NATL ACAD SCI USA, V110, P1658, DOI 10.1073/pnas.1209507110; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shi Y, 2012, AM J RESP CRIT CARE, V186, P412, DOI 10.1164/rccm.201111-2023OC; Stivala LA, 2001, ONCOGENE, V20, P563, DOI 10.1038/sj.onc.1204132; te Poele RH, 2002, CANCER RES, V62, P1876; Tomita K, 2002, AM J RESP CRIT CARE, V166, P724, DOI 10.1164/rccm.2104010; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Yao HW, 2008, AM J RESP CELL MOL, V39, P7, DOI 10.1165/rcmb.2007-0342OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2012, AM J PHYSIOL-LUNG C, V303, pL557, DOI 10.1152/ajplung.00175.2012; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022	64	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80007	10.1371/journal.pone.0080007	http://dx.doi.org/10.1371/journal.pone.0080007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244594	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600171
J	Aktary, Z; Pasdar, M				Aktary, Zackie; Pasdar, Manijeh			Plakoglobin Represses SATB1 Expression and Decreases In Vitro Proliferation, Migration and Invasion	PLOS ONE			English	Article							MAJOR BREAKPOINT REGION; METASTASIS SUPPRESSOR FUNCTION; REGULATES GENE-EXPRESSION; CHROMATIN ORGANIZER SATB1; SQUAMOUS-CELL CARCINOMA; BINDING-PROTEIN 1; BETA-CATENIN; C-MYC; CANCER CELLS; TUMOR PROGRESSION	Plakoglobin (gamma-catenin) is a homolog of beta-catenin with dual adhesive and signaling functions. Plakoglobin participates in cell-cell adhesion as a component of the adherens junction and desmosomes whereas its signaling function is mediated by its interactions with various intracellular protein partners. To determine the role of plakoglobin during tumorigenesis and metastasis, we expressed plakoglobin in the human tongue squamous cell carcinoma (SCC9) cells and compared the mRNA profiles of parental SCC9 cells and their plakoglobin-expressing transfectants (SCC9-PG). We observed that the mRNA levels of SATB1, the oncogenic chromatin remodeling factor, were decreased approximately 3-fold in SCC9-PG cells compared to parental SCC9 cells. Here, we showed that plakoglobin decreased levels of SATB1 mRNA and protein in SCC9-PG cells and that plakoglobin and p53 associated with the SATB1 promoter. Plakoglobin expression also resulted in decreased SATB1 promoter activity. These results were confirmed following plakoglobin expression in the very low plakoglobin expressing and invasive mammary carcinoma cell line MDA-MB-231 cells (MDA-231-PG). In addition, knockdown of endogenous plakoglobin in the non-invasive mammary carcinoma MCF-7 cells (MCF-7-shPG) resulted in increased SATB1 mRNA and protein. Plakoglobin expression also resulted in increased mRNA and protein levels of the metastasis suppressor Nm23-H1, a SATB1 target gene. Furthermore, the levels of various SATB1 target genes involved in tumorigenesis and metastasis were altered in MCF-7-shPG cells relative to parental MCF-7 cells. Finally, plakoglobin expression resulted in decreased in vitro proliferation, migration and invasion in different carcinoma cell lines. Together with the results of our previous studies, the data suggests that plakoglobin suppresses tumorigenesis and metastasis through the regulation of genes involved in these processes.	[Pasdar, Manijeh] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Aktary, Zackie; Pasdar, Manijeh] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Pasdar, M (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	mpasdar@ualberta.ca		Aktary, Zackie/0000-0002-7238-3245	Canadian Breast Cancer Foundation-Prairies/NWT Chapter; Killam Trusts Izaak Walton Killam Memorial Graduate Scholarship; University of Alberta Dissertation Fellowship	Canadian Breast Cancer Foundation-Prairies/NWT Chapter; Killam Trusts Izaak Walton Killam Memorial Graduate Scholarship; University of Alberta Dissertation Fellowship	This work is supported by the Canadian Breast Cancer Foundation-Prairies/NWT Chapter (MP) and by the Killam Trusts Izaak Walton Killam Memorial Graduate Scholarship and the University of Alberta Dissertation Fellowship (ZA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktary Z, 2010, ONCOGENE, V29, P2118, DOI 10.1038/onc.2009.495; Aktary Zackie, 2012, Int J Cell Biol, V2012, P189521, DOI 10.1155/2012/189521; Aktary Z, 2013, J CELL SCI, V126, P3031, DOI 10.1242/jcs.120642; Alvarez JD, 2000, GENE DEV, V14, P521; Ayabe Takanori, 2004, Ann Thorac Cardiovasc Surg, V10, P152; Bago R, 2009, MOL CARCINOGEN, V48, P779, DOI 10.1002/mc.20536; Bailey CK, 2012, J BIOL CHEM, V287, P19472, DOI 10.1074/jbc.M112.345728; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Burute M, 2012, IMMUNOL CELL BIOL, V90, P852, DOI 10.1038/icb.2012.28; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Cervoni L, 2006, J CELL BIOCHEM, V98, P421, DOI 10.1002/jcb.20808; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Chen SL, 2003, MOL CARCINOGEN, V36, P204, DOI 10.1002/mc.10110; Choudhuri T, 2010, CANCER BIOL THER, V9, P1065, DOI 10.4161/cbt.9.12.11995; Chu SH, 2012, MOL MED REP; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; Franzen CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042132; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Holen I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3201; Huang B, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-8; Jarrett SG, 2012, CANCER RES, V72, P133, DOI 10.1158/0008-5472.CAN-11-1795; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jung S, 2006, ANTICANCER RES, V26, P249; Kar A, 2012, NUCLEIC ACIDS RES, V40, P2554, DOI 10.1093/nar/gkr1109; Khan MH, 2001, AM J PATHOL, V158, P1785, DOI 10.1016/S0002-9440(10)64134-X; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Kowalczyk AP, 2013, PROG MOL BIOL TRANSL, V116, P95, DOI 10.1016/B978-0-12-394311-8.00005-4; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kumar PP, 2005, MOL CELL BIOL, V25, P1620, DOI 10.1128/MCB.25.5.1620-1633.2005; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lam L, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.4; Lam L, 2009, BREAST CANCER RES TR, V118, P605, DOI 10.1007/s10549-008-0231-y; Lee HY, 1999, CANCER LETT, V145, P93, DOI 10.1016/S0304-3835(99)00236-0; Li LJ, 2007, MOL CARCINOGEN, V46, P824, DOI 10.1002/mc.20310; Li Lei, 2010, Chinese Medical Sciences Journal, V25, P199, DOI 10.1016/S1001-9294(11)60002-3; Li Q, 2007, ONCOGENE, V26, P6194, DOI 10.1038/sj.onc.1210438; Li QQ, 2010, CANCER SCI, V101, P80, DOI 10.1111/j.1349-7006.2009.01372.x; Ma C, 2007, ONCOGENE, V26, P2649, DOI 10.1038/sj.onc.1210069; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Marino N, 2012, CANCER METAST REV, V31, P593, DOI 10.1007/s10555-012-9374-8; McDermott WG, 2008, CLIN EXP METASTAS, V25, P131, DOI 10.1007/s10585-007-9128-0; Miravet S, 2002, J BIOL CHEM, V277, P1884, DOI 10.1074/jbc.M110248200; Nakanishi K, 2006, ARCH PATHOL LAB MED, V130, P1330; Nelson WJ, 2013, PROG MOL BIOL TRANSL, V116, P3, DOI 10.1016/B978-0-12-394311-8.00001-7; Nodin B, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-24; Notani D, 2011, J BIOSCIENCES, V36, P461, DOI 10.1007/s12038-011-9091-4; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Novak M, 2011, N-S ARCH PHARMACOL, V384, P433, DOI 10.1007/s00210-011-0621-2; Parker HR, 1998, CELL MOTIL CYTOSKEL, V40, P87, DOI 10.1002/(SICI)1097-0169(1998)40:1<87::AID-CM8>3.0.CO;2-C; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Postel EH, 2003, J BIOENERG BIOMEMBR, V35, P31, DOI 10.1023/A:1023485505621; Purbey PK, 2009, MOL CELL BIOL, V29, P1321, DOI 10.1128/MCB.00822-08; Qu SM, 2008, CLIN CANCER RES, V14, P4787, DOI 10.1158/1078-0432.CCR-08-0083; Rahman-Roblick R, 2007, P NATL ACAD SCI USA, V104, P5401, DOI 10.1073/pnas.0700794104; Ramakrishnan M, 2000, MOL CELL BIOL, V20, P868, DOI 10.1128/MCB.20.3.868-877.2000; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; Saito M, 2012, J CELL SCI, V125, P2547, DOI 10.1242/jcs.066654; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Suzuki E, 2004, INT J CANCER, V108, P207, DOI 10.1002/ijc.11546; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Thakur RK, 2011, N-S ARCH PHARMACOL, V384, P397, DOI 10.1007/s00210-011-0631-0; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Todorovic V, 2010, J CELL SCI, V123, P3576, DOI 10.1242/jcs.070391; Tokonzaba E, 2013, J INVEST DERMATOL; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; Wagner PD, 1997, P NATL ACAD SCI USA, V94, P9000, DOI 10.1073/pnas.94.17.9000; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Xiang JD, 2012, ONCOL LETT, V3, P865, DOI 10.3892/ol.2012.571; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yim JH, 2013, BIOCH BIOPHYS RES CO; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001; Zhang JJ, 2006, GENE, V379, P127, DOI 10.1016/j.gene.2006.05.002; Zhang QB, 2011, INT J CANCER, V128, P40, DOI 10.1002/ijc.25307; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777; Zhurinsky J, 2000, J CELL SCI, V113, P3127; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	95	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78388	10.1371/journal.pone.0078388	http://dx.doi.org/10.1371/journal.pone.0078388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260116	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200024
J	Cabrera-Guzman, E; Crossland, MR; Gonzalez-Bernal, E; Shine, R				Cabrera-Guzman, Elisa; Crossland, Michael R.; Gonzalez-Bernal, Edna; Shine, Richard			The Interacting Effects of Ungulate Hoofprints and Predatory Native Ants on Metamorph Cane Toads in Tropical Australia	PLOS ONE			English	Article							BUFO-MARINUS; INVASION FRONT; SITE SELECTION; ABUNDANCE; ECOSYSTEM; SUCCESS; IMPACT; FROGS; DESICCATION; PREFERENCES	Many invasive species exploit the disturbed habitats created by human activities. Understanding the effects of habitat disturbance on invasion success, and how disturbance interacts with other factors (such as biotic resistance to the invaders from the native fauna) may suggest new ways to reduce invader viability. In tropical Australia, commercial livestock production can facilitate invasion by the cane toad (Rhinella marina), because hoofprints left by cattle and horses around waterbody margins provide distinctive (cool, moist) microhabitats; nevertheless the same microhabitat can inhibit the success of cane toads by increasing the risks of predation or drowning. Metamorph cane toads actively select hoofprints as retreat-sites to escape dangerous thermal and hydric conditions in the surrounding landscape. However, hoofprint geometry is important: in hoofprints with steep sides the young toads are more likely to be attacked by predatory ants (Iridomyrmex reburrus) and are more likely to drown following heavy rain. Thus, anthropogenic changes to the landscape interact with predation by native taxa to affect the ability of cane toads in this vulnerable life-history stage to thrive in the harsh abiotic conditions of tropical Australia.	[Cabrera-Guzman, Elisa; Crossland, Michael R.; Gonzalez-Bernal, Edna; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia	University of Sydney	Cabrera-Guzman, E (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	elicabguz@hotmail.com	Crossland, Michael R/G-1091-2012; González-Bernal, Edna/AAH-9372-2021	Crossland, Michael R/0000-0001-9967-7158; Gonzalez-Bernal, Edna/0000-0001-7817-4156	Australian Research Council; Australian Government; National Council on Science and Technology of Mexico (CONACyT); University of Sydney	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR); National Council on Science and Technology of Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Sydney(University of Sydney)	The work was funded by the Australian Research Council, the Australian Government, the National Council on Science and Technology of Mexico (CONACyT), and the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AN, 1994, OECOLOGIA, V98, P15, DOI 10.1007/BF00326085; Andersen AN, 2000, ANTS NO AUSTR GUIDE; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Australian Government, 2009, AUSTR NAT RES ATL LA; Australian State of the Environment Committee, 2006, IND REP COMM MIN ENV; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; BRAITHWAITE RW, 1984, AUST J ECOL, V9, P309, DOI 10.1111/j.1442-9993.1984.tb01369.x; Brown GP, 2011, FUNCT ECOL, V25, P1339, DOI 10.1111/j.1365-2435.2011.01888.x; Cabrera-Guzman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070121; Calaby J, 2005, MARSUPIALS AUSTR, V3; Child T, 2008, AUSTRAL ECOL, V33, P630, DOI 10.1111/j.1442-9993.2007.01829.x; Child T, 2008, J EXP ZOOL PART A, V309A, P215, DOI 10.1002/jez.450; Child T, 2009, J TROP ECOL, V25, P193, DOI 10.1017/S0266467408005695; Choi MB, 2012, J ASIA-PAC ENTOMOL, V15, P473, DOI 10.1016/j.aspen.2011.11.004; Clerke R. B., 1992, Australian Zoologist, V28, P64; COHEN MP, 1993, WILDLIFE RES, V20, P1; D'Amore A, 2010, BIOL INVASIONS, V12, P145, DOI 10.1007/s10530-009-9438-z; Dorfman EJ, 2001, EMU, V101, P145, DOI 10.1071/MU00008; Dutta P, 2010, ECOHEALTH, V7, P498, DOI 10.1007/s10393-010-0337-7; Federle W, 2004, ARTHROPOD STRUCT DEV, V33, P67, DOI 10.1016/j.asd.2003.11.001; Florance D, 2011, P ROY SOC B-BIOL SCI, V278, P2900, DOI 10.1098/rspb.2011.0032; FREELAND WJ, 1991, WILDLIFE RES, V18, P431, DOI 10.1071/WR9910431; FRIEND GR, 1984, AUST WILDLIFE RES, V11, P311; FRIEND GR, 1990, J TROP ECOL, V6, P131, DOI 10.1017/S0266467400004235; Gonzalez-Bernal E, 2013, AUSTRAL ECOL, V38, P891, DOI 10.1111/aec.12028; Gonzalez-Bernal E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049351; Hagman M, 2006, AUSTRAL ECOL, V31, P551, DOI 10.1111/j.1442-9993.2006.01627.x; Henery ML, 2010, J ECOL, V98, P800, DOI 10.1111/j.1365-2745.2010.01672.x; Hiltbrunner D, 2012, GEODERMA, V170, P369, DOI 10.1016/j.geoderma.2011.11.026; Isselin-Nondedeu F, 2007, ECOL ENG, V30, P278, DOI 10.1016/j.ecoleng.2007.01.013; Isselin-Nondedeu F, 2006, ECOL ENG, V27, P193, DOI 10.1016/j.ecoleng.2006.02.006; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kohler A, 2011, HERPETOL J, V21, P17; KRAKAUER T, 1970, COMP BIOCHEM PHYSIOL, V33, P15, DOI 10.1016/0010-406X(70)90479-2; Kutt AS, 2012, ANIM CONSERV, V15, P416, DOI 10.1111/j.1469-1795.2012.00530.x; LEVER C., 2001, CANE TOAD HIST ECOLO; Lopez-Vaamonde C, 2010, ALIEN TERRESTRIAL AR, V4, P45; MCIVER JD, 1991, INSECT SOC, V38, P129, DOI 10.1007/BF01240963; MEEK CL, 1977, ENVIRON ENTOMOL, V6, P161, DOI 10.1093/ee/6.1.161; MOFFETT MW, 1988, NATL GEOGR RES, V4, P386; Newbery Brock, 2005, Queensland Naturalist, V43, P8; Pares-Casanova PM, 2012, J ANIM SCI ADV, V2, P374; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Pichancourt JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032323; Pizzatto L, 2008, BEHAV ECOL SOCIOBIOL, V63, P123, DOI 10.1007/s00265-008-0642-0; Pizzatto L, 2008, BEHAV ECOL, V19, P990, DOI 10.1093/beheco/arn060; Pyke Graham H., 2001, Australian Zoologist, V31, P563; Rodder D, 2009, TROP ZOOL, V22, P205; Saetre GP, 2012, J EVOLUTION BIOL, V25, P788, DOI 10.1111/j.1420-9101.2012.02470.x; SAS, 2002, JMP 5 0 1; Schwarzkopf L, 1996, FUNCT ECOL, V10, P193, DOI 10.2307/2389843; Seebacher F, 1999, J HERPETOL, V33, P208, DOI 10.2307/1565716; Seebacher F, 2002, J HERPETOL, V36, P69, DOI 10.1670/0022-1511(2002)036[0069:SMDBTA]2.0.CO;2; Semeniuk M, 2007, WILDLIFE RES, V34, P59, DOI 10.1071/WR06112; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; SSEMAKULA J, 1983, AFR J ECOL, V21, P325, DOI 10.1111/j.1365-2028.1983.tb00332.x; TAYLOR JA, 1985, AUST J ECOL, V10, P281, DOI 10.1111/j.1442-9993.1985.tb00890.x; Tingley R, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025979, DOI 10.1371/J0URNAL.P0NE.0025979]; Toledo LF, 2007, J ZOOL, V271, P170, DOI 10.1111/j.1469-7998.2006.00195.x; Triggs B., 2004, TRACKS SCATS OTHER T; Tyler Michael J., 2007, Applied Herpetology, V4, P1, DOI 10.1163/157075407779766741; Voros J, 2008, AUSTRAL ECOL, V33, P623, DOI 10.1111/j.1442-9993.2007.01828.x; Ward-Fear G, 2010, BIOL J LINN SOC, V99, P738, DOI 10.1111/j.1095-8312.2010.01395.x; Ward-Fear G, 2010, J APPL ECOL, V47, P273, DOI 10.1111/j.1365-2664.2010.01773.x; Ward-Fear G, 2009, FUNCT ECOL, V23, P559, DOI 10.1111/j.1365-2435.2009.01556.x; Waterhouse D. F., 1974, Scientific American, V230, P100; Witt ABR, 2011, BIOL INVASIONS, V13, P125, DOI 10.1007/s10530-010-9795-7; Wojtusiak J, 1995, TROP ZOOL, V8, P309, DOI 10.1080/03946975.1995.10539287	70	6	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79496	10.1371/journal.pone.0079496	http://dx.doi.org/10.1371/journal.pone.0079496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255703	Green Published, gold			2022-12-25	WOS:000327216200068
J	Ding, ZJ; Bergman, A; Rutemark, C; Ouchida, R; Ohno, H; Wang, JY; Heyman, B				Ding, Zhoujie; Bergman, Anna; Rutemark, Christian; Ouchida, Rika; Ohno, Hiroshi; Wang, Ji-Yang; Heyman, Birgitta			Complement-Activating IgM Enhances the Humoral but Not the T Cell Immune Response in Mice	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; ANTIBODY-RESPONSES; B-CELLS; IN-VIVO; MEDIATED ENHANCEMENT; RECEPTOR TYPE-2; FC-RECEPTOR; ANTIGEN; INDUCTION; EXPRESSION	IgM antibodies specific for a certain antigen can enhance antibody responses when administered together with this antigen, a process believed to require complement activation by IgM. However, recent data show that a knock-in mouse strain, C mu 13, which only produces IgM unable to activate complement, has normal antibody responses. Moreover, the recently discovered murine IgM Fc receptor (Fc mu R or TOSO/FAIM3) was shown to affect antibody responses. This prompted the re-investigation of whether complement activation by specific IgM is indeed required for enhancement of antibody responses and whether the mutation in C mu 13 IgM also caused impaired binding to Fc mu R. The results show that IgM from C mu 13 and wildtype mice bound equally well to the murine Fc mu R. In spite of this, specific C mu 13 IgM administered together with sheep red blood cells or keyhole limpet hemocyanine was a very poor enhancer of the antibody and germinal center responses as compared with wildtype IgM. Within seconds after immunization, wildtype IgM induced deposition of C3 on sheep red blood cells in the blood. IgM which efficiently enhanced the T-dependent humoral immune response had no effect on activation of specific CD4+ T cells as measured by cell numbers, cell division, blast transformation, or expression of the activation markers LFA-1 and CD44 in vivo. These observations confirm the importance of complement for the ability of specific IgM to enhance antibody responses and suggest that there is a divergence between the regulation of T-and B-cell responses by IgM.	[Ding, Zhoujie; Bergman, Anna; Rutemark, Christian; Heyman, Birgitta] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Ouchida, Rika] RIKEN, Res Ctr Allergy & Immunol, Lab Immune Divers, Yokohama, Kanagawa, Japan; [Ohno, Hiroshi] RIKEN, Lab Intestinal Ecosyst, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Wang, Ji-Yang] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo, Japan; [Wang, Ji-Yang] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200433, Peoples R China; [Wang, Ji-Yang] Fudan Univ, Biotherapy Res Ctr, Shanghai 200433, Peoples R China	Uppsala University; RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU); Fudan University; Fudan University	Heyman, B (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	birgitta.heyman@imbim.uu.se	Ohno, Hiroshi/L-7899-2014	Ohno, Hiroshi/0000-0001-8776-9661; Ding, Zhoujie/0000-0001-8765-8814; Heyman, Birgitta/0000-0003-0869-0483	Swedish Research Council [K2012-57X-07492-25-6]; Hans von Kantzow's Foundation; King Gustaf V:s 80 Years Foundation; Ollie and Elof Ericsson's Foundation; Agnes and Mac Rudberg's Foundation; Japan Society for the Promotion of Science [25460604]; Grants-in-Aid for Scientific Research [25460604] Funding Source: KAKEN	Swedish Research Council(Swedish Research CouncilEuropean Commission); Hans von Kantzow's Foundation; King Gustaf V:s 80 Years Foundation; Ollie and Elof Ericsson's Foundation; Agnes and Mac Rudberg's Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Swedish Research Council, grant K2012-57X-07492-25-6, http://www.vr.se/; Hans von Kantzow's Foundation (no number or web page); King Gustaf V:s 80 Years Foundation, no grant number, http://ams.orbelon.com/gv80/, Ollie and Elof Ericsson's Foundation (no number or web page); and Agnes and Mac Rudberg's Foundation, no grant number, http://www.uu.se/; to BH, ZD, CR and BH, and by Grant-in-Aid 25460604 from the Japan Society for the Promotion of Science, http://www.jsps.go.jp/english/ to JYW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Applequist SE, 2000, J IMMUNOL, V165, P2398, DOI 10.4049/jimmunol.165.5.2398; Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Bowman J M, 1988, Transfus Med Rev, V2, P129, DOI 10.1016/S0887-7963(88)70039-5; Carlsson F, 2009, SCAND J IMMUNOL, V70, P77, DOI 10.1111/j.1365-3083.2009.02274.x; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; CARTER RH, 1988, J IMMUNOL, V141, P457; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; CLARKE C A, 1963, Br Med J, V1, P979; COLLISSON EW, 1983, CELL IMMUNOL, V79, P44, DOI 10.1016/0008-8749(83)90049-7; COULIE PG, 1985, EUR J IMMUNOL, V15, P793, DOI 10.1002/eji.1830150810; Cutler AJ, 1998, J EXP MED, V187, P1789, DOI 10.1084/jem.187.11.1789; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P12708, DOI 10.1073/pnas.96.22.12708; de Stahl TD, 2003, J EXP MED, V197, P1183, DOI 10.1084/jem.20022232; DENNERT G, 1971, J IMMUNOL, V106, P951; Donius LR, 2013, J IMMUNOL, V191, P434, DOI 10.4049/jimmunol.1203176; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Fang YF, 1998, J IMMUNOL, V160, P5273; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Fischer MB, 1996, J IMMUNOL, V157, P549; Getahun A, 2005, J IMMUNOL, V175, P1473, DOI 10.4049/jimmunol.175.3.1473; Good A., 1980, SELECTED METHODS CEL, P343; GUSTAVSSON S, 1995, J IMMUNOL, V154, P6524; Guttormsen HK, 2009, CLIN IMMUNOL, V130, P264, DOI 10.1016/j.clim.2008.09.012; Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; HENRY C, 1968, J EXP MED, V128, P133, DOI 10.1084/jem.128.1.133; HEYMAN B, 1988, J EXP MED, V167, P1999, DOI 10.1084/jem.167.6.1999; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; HEYMAN B, 1982, J EXP MED, V155, P994, DOI 10.1084/jem.155.4.994; Hjelm F, 2005, SCAND J IMMUNOL, V62, P453, DOI 10.1111/j.1365-3083.2005.01684.x; Honjo K, 2012, P NATL ACAD SCI USA, V109, P15882, DOI 10.1073/pnas.1206567109; KINOSHITA T, 1990, INT IMMUNOL, V2, P651, DOI 10.1093/intimm/2.7.651; KURTZ CB, 1990, J IMMUNOL, V144, P3581; Link A, 2012, J IMMUNOL, V188, P3724, DOI 10.4049/jimmunol.1103312; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Mollnes TE, 2002, BLOOD, V100, P1869; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2012, P NATL ACAD SCI USA, V109, pE2699, DOI 10.1073/pnas.1210706109; PAPAMICHAIL M, 1975, SCAND J IMMUNOL, V4, P343, DOI 10.1111/j.1365-3083.1975.tb02635.x; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Rutemark C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041968; Rutemark C, 2011, P NATL ACAD SCI USA, V108, pE934, DOI 10.1073/pnas.1109831108; THORNTON BP, 1994, J IMMUNOL, V152, P1727; Wolniak KL, 2004, CRIT REV IMMUNOL, V24, P39, DOI 10.1615/CritRevImmunol.v24.20; Youd ME, 2002, EUR J IMMUNOL, V32, P2328, DOI 10.1002/1521-4141(200208)32:8<2328::AID-IMMU2328>3.0.CO;2-T	49	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e81299	10.1371/journal.pone.0081299	http://dx.doi.org/10.1371/journal.pone.0081299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250831	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200119
J	Genies, C; Maitre, A; Lefebvre, E; Jullien, A; Chopard-Lallier, M; Douki, T				Genies, Camille; Maitre, Anne; Lefebvre, Emmanuel; Jullien, Amandine; Chopard-Lallier, Marianne; Douki, Thierry			The Extreme Variety of Genotoxic Response to Benzo[a]pyrene in Three Different Human Cell Lines from Three Different Organs	PLOS ONE			English	Article							POLYCYCLIC-AROMATIC-HYDROCARBONS; DNA-ADDUCT FORMATION; PRIMARY HUMAN HEPATOCYTES; REGION DIOL EPOXIDES; CYTOCHROMES P450 1A1; IN-VITRO; METABOLIC-ACTIVATION; MESSENGER-RNA; HEPG2 CELLS; RAT-LIVER	Polycyclic aromatic hydrocarbons (PAHs) are associated with occupational exposure and urban atmospheric pollution. Determination of the genotoxic properties of these compounds is thus of outmost importance. For this purpose a variety of cellular models have been widely used. Reliable results can however only be obtained with models reflecting the specific sensitivity of different organs towards PAHs. In this work, we compared the response to benzo[a] pyrene in cell lines from human lungs (A549) and bladder (T24); two important target organs for PAHs-induced cancer. Human hepatocytes (HepG2) were used as a reference, although liver is not a concern for PAHs carcinogenesis. Adducts arising from the ultimate diolepoxide metabolite of B[a] P, BPDE, were found to be produced in a dose-dependent manner in HepG2. BPDE DNA adducts were not detected in T24 and in A549 their formation was found to be most efficient at the lowest concentration studied (0.2 mu M). These results are probably explained by differences in induction and activity of phase I metabolization enzymes, as well as by proteins eliminating the B[a] P epoxide in A549. In addition to BPDE adducts, oxidative DNA damage, namely strand breaks and oxidized purines were measured and found to be produced only in minute amounts in all three cell lines. In summary, our results emphasize the large differences in the response of cells originating from different organs. Our data also point out the importance of carefully selecting the doses used in in vitro toxicological experiments. The example of A549 shows that working at high doses may lead to an underestimation of the risk. Finally, the choice of method for evaluating genotoxicity appears to be of crucial importance. The comet assay does not seem to be the best method for a compound like B[a] P which induces stable adducts causing limited oxidative damage.	[Genies, Camille; Jullien, Amandine; Chopard-Lallier, Marianne; Douki, Thierry] Univ Grenoble 1, CEA, Inst Nanosci & Cryogenie, Lab Les Acides Nucl,SCIB, Grenoble, France; [Genies, Camille; Maitre, Anne; Lefebvre, Emmanuel] Univ Grenoble 1, CHU Grenoble, Equipe EPSP Environm & Predict Sante Populat, Lab TIMC,UMR CNRS 5525,UFR Med, La Tronche, France; [Genies, Camille] Agence Environm & Maitrise Energie 20, Angers, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Douki, T (corresponding author), Univ Grenoble 1, CEA, Inst Nanosci & Cryogenie, Lab Les Acides Nucl,SCIB, Grenoble, France.	thierry.douki@cea.fr	Thierry, Douki/H-2108-2018	Thierry, Douki/0000-0002-5022-071X	French Environment and Energy Management Agency (ADEME); CEA; La Region Rhone-Alpes	French Environment and Energy Management Agency (ADEME); CEA(French Atomic Energy Commission); La Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by the French Environment and Energy Management Agency (ADEME) and CEA. Funding for this project was also provided by a grant from "La Region Rhone-Alpes". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin Z, 2012, CHEM RES TOXICOL, V25, P113, DOI 10.1021/tx200272v; Ahnstrom G, 1981, DNA REPAIR LAB MANUA, P403; Baird WM, 2005, ENVIRON MOL MUTAGEN, V45, P106, DOI 10.1002/em.20095; BALLS M, 1994, LAB ANIM, V28, P193, DOI 10.1258/002367794780681714; Billet S, 2008, CANCER LETT, V270, P144, DOI 10.1016/j.canlet.2008.04.044; Binkova B, 2004, MUTAT RES-FUND MOL M, V547, P109, DOI 10.1016/j.mrfmmm.2003.12.006; Bonetta S, 2009, CHEMOSPHERE, V77, P1030, DOI 10.1016/j.chemosphere.2009.07.076; Bosetti C, 2007, ANN ONCOL, V18, P431, DOI 10.1093/annonc/mdl172; Brauers A, 2000, CANCER DETECT PREV, V24, P356; Briede JJ, 2004, FREE RADICAL RES, V38, P995, DOI 10.1080/10715760400000976; Burstyn I, 2007, OCCUP ENVIRON MED, V64, P520, DOI 10.1136/oem.2006.029801; Castorena-Torres F, 2008, TOXICOL IN VITRO, V22, P411, DOI 10.1016/j.tiv.2007.10.009; Conney AH, 2001, ADV EXP MED BIOL, V500, P697; DANIEL FB, 1983, CANCER RES, V43, P4723; Danielsen PH, 2011, CHEM RES TOXICOL, V24, P168, DOI 10.1021/tx100407m; Dreij K, 2002, CHEM RES TOXICOL, V15, P825, DOI 10.1021/tx025519i; Forestier A, 2012, INT J MOL SCI, V13, P14766, DOI 10.3390/ijms131114766; Gelhaus SL, 2011, CHEM RES TOXICOL, V24, P89, DOI 10.1021/tx100297z; GOODHEAD DT, 1989, INT J RADIAT BIOL, V56, P623, DOI 10.1080/09553008914551841; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harrigan JA, 2004, TOXICOL SCI, V77, P307, DOI 10.1093/toxsci/kfh030; Harrigan JA, 2006, TOXICOL IN VITRO, V20, P426, DOI 10.1016/j.tiv.2005.08.015; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P521; IARC, 2010, SOM NONH POL AR HYDR; Iwanari M, 2002, ARCH TOXICOL, V76, P287, DOI 10.1007/s00204-002-0340-z; Jernstrom B, 1996, CARCINOGENESIS, V17, P1491, DOI 10.1093/carcin/17.7.1491; Kafferlein HU, 2012, ARCH TOXICOL, V86, P1317, DOI 10.1007/s00204-012-0882-7; Lekas P, 2000, ARCH BIOCHEM BIOPHYS, V384, P311, DOI 10.1006/abbi.2000.2115; LORENZEN A, 1993, ANAL BIOCHEM, V214, P346, DOI 10.1006/abio.1993.1504; Mangal D, 2009, CHEM RES TOXICOL, V22, P788, DOI 10.1021/tx800343c; Marie C, 2008, J APPL TOXICOL, V28, P579, DOI 10.1002/jat.1306; Marie C, 2009, ENVIRON MOL MUTAGEN, V50, P88, DOI 10.1002/em.20439; Mastrangelo G, 1996, ENVIRON HEALTH PERSP, V104, P1166, DOI 10.2307/3432909; McFadyen MCE, 2003, BIOCHEM PHARMACOL, V65, P1663, DOI 10.1016/S0006-2952(03)00111-4; MOORE BP, 1982, CANCER RES, V42, P642; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Park JH, 2009, J BIOL CHEM, V284, P29725, DOI 10.1074/jbc.M109.042143; PELTONEN K, 1995, J OCCUP ENVIRON MED, V37, P52, DOI 10.1097/00043764-199501000-00008; Petry T, 1996, CHEMOSPHERE, V32, P639, DOI 10.1016/0045-6535(95)00348-7; Plottner S, 2009, ARCH TOXICOL, V83, P131, DOI 10.1007/s00204-008-0329-3; Plottner S, 2008, J TOXICOL ENV HEAL A, V71, P969, DOI 10.1080/15287390801989184; Pouget JP, 2000, CHEM RES TOXICOL, V13, P541, DOI 10.1021/tx000020e; Pushparajah DS, 2008, MUTAGENESIS, V23, P299, DOI 10.1093/mutage/gen012; Pushparajah DS, 2008, TOXICOL IN VITRO, V22, P128, DOI 10.1016/j.tiv.2007.08.014; Quinn AM, 2008, CHEM RES TOXICOL, V21, P1086, DOI 10.1021/tx700345v; Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010; Schiltz M, 1999, CARCINOGENESIS, V20, P2279, DOI 10.1093/carcin/20.12.2279; Sevastyanova O, 2007, MUTAT RES-FUND MOL M, V620, P123, DOI 10.1016/j.mrfmmm.2007.03.002; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Shimada T, 2001, DRUG METAB DISPOS, V29, P1176; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Siddens LK, 2012, TOXICOL APPL PHARM, V264, P377, DOI 10.1016/j.taap.2012.08.014; Singh R, 2007, MUTAT RES-FUND MOL M, V620, P83, DOI 10.1016/j.mrfmmm.2007.02.025; Sundberg K, 2002, CHEM RES TOXICOL, V15, P170, DOI 10.1021/tx015546t; Sundberg K, 1998, FEBS LETT, V438, P206, DOI 10.1016/S0014-5793(98)01291-5; Tarantini A, 2009, MUTAT RES-FUND MOL M, V671, P67, DOI 10.1016/j.mrfmmm.2009.08.014; Tobiszewski M, 2012, ENVIRON POLLUT, V162, P110, DOI 10.1016/j.envpol.2011.10.025; TREMBLAY C, 1995, AM J IND MED, V27, P335, DOI 10.1002/ajim.4700270303; Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017; Urani C, 1998, CHEMOSPHERE, V37, P2785, DOI 10.1016/S0045-6535(98)00321-X; Verma N, 2012, ARCH TOXICOL, V86, P1861, DOI 10.1007/s00204-012-0899-y; Westerink WMA, 2007, TOXICOL IN VITRO, V21, P1581, DOI 10.1016/j.tiv.2007.05.014; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Wilkening S, 2003, J BIOCHEM MOL TOXIC, V17, P207, DOI 10.1002/jbt.10085; Wolf A, 2005, TOXICOLOGY, V207, P255, DOI 10.1016/j.tox.2004.09.006; Wu SJ, 2003, ANAL BIOCHEM, V312, P162, DOI 10.1016/S0003-2697(02)00444-X; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006	67	52	52	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78356	10.1371/journal.pone.0078356	http://dx.doi.org/10.1371/journal.pone.0078356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260113	gold, Green Published, Green Submitted			2022-12-25	WOS:000327216200021
J	Manteniotis, S; Lehmann, R; Flegel, C; Vogel, F; Hofreuter, A; Schreiner, BSP; Altmuller, J; Becker, C; Schobel, N; Hatt, H; Gisselmann, G				Manteniotis, Stavros; Lehmann, Ramona; Flegel, Caroline; Vogel, Felix; Hofreuter, Adrian; Schreiner, Benjamin S. P.; Altmueller, Janine; Becker, Christian; Schoebel, Nicole; Hatt, Hanns; Gisselmann, Guenter			Comprehensive RNA-Seq Expression Analysis of Sensory Ganglia with a Focus on Ion Channels and GPCRs in Trigeminal Ganglia	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DORSAL-ROOT GANGLION; ACTIVATED CHLORIDE CHANNEL; GATED CALCIUM-CHANNELS; POTENTIAL THERAPEUTIC TARGET; OF-FUNCTION MUTATIONS; SENSITIVE K+ CHANNEL; SODIUM-CHANNEL; POTASSIUM CHANNEL; MICE LACKING	The specific functions of sensory systems depend on the tissue-specific expression of genes that code for molecular sensor proteins that are necessary for stimulus detection and membrane signaling. Using the Next Generation Sequencing technique (RNA-Seq), we analyzed the complete transcriptome of the trigeminal ganglia (TG) and dorsal root ganglia (DRG) of adult mice. Focusing on genes with an expression level higher than 1 FPKM (fragments per kilobase of transcript per million mapped reads), we detected the expression of 12984 genes in the TG and 13195 in the DRG. To analyze the specific gene expression patterns of the peripheral neuronal tissues, we compared their gene expression profiles with that of the liver, brain, olfactory epithelium, and skeletal muscle. The transcriptome data of the TG and DRG were scanned for virtually all known G-protein-coupled receptors (GPCRs) as well as for ion channels. The expression profile was ranked with regard to the level and specificity for the TG. In total, we detected 106 non-olfactory GPCRs and 33 ion channels that had not been previously described as expressed in the TG. To validate the RNA-Seq data, in situ hybridization experiments were performed for several of the newly detected transcripts. To identify differences in expression profiles between the sensory ganglia, the RNA-Seq data of the TG and DRG were compared. Among the differentially expressed genes (> 1 FPKM), 65 and 117 were expressed at least 10-fold higher in the TG and DRG, respectively. Our transcriptome analysis allows a comprehensive overview of all ion channels and G protein-coupled receptors that are expressed in trigeminal ganglia and provides additional approaches for the investigation of trigeminal sensing as well as for the physiological and pathophysiological mechanisms of pain.	[Manteniotis, Stavros; Lehmann, Ramona; Flegel, Caroline; Vogel, Felix; Hofreuter, Adrian; Schreiner, Benjamin S. P.; Schoebel, Nicole; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Lehmann, Ramona] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Schoebel, Nicole] Ruhr Univ Bochum, Dept Anim Physiol, Bochum, Germany	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); University of Cologne; Ruhr University Bochum	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany.	Guenter.Gisselmann@rub.de		Altmuller, Janine/0000-0003-4372-1521; Vogel, Felix Christian Eduard/0000-0003-4067-2074	DFG-Sonderforschungsbereich [SFB874]; Heinrich und Alma Vogelsang Stiftung	DFG-Sonderforschungsbereich(German Research Foundation (DFG)); Heinrich und Alma Vogelsang Stiftung	This project was founded by the DFG-Sonderforschungsbereich SFB874 "Integration and Representation of Sensory Processes". Caroline Flegel was funded by the Heinrich und Alma Vogelsang Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	ABBADIE C, 1994, NEUROSCIENCE, V59, P457, DOI 10.1016/0306-4522(94)90609-2; Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Ahrens J, 2009, PHARMACOLOGY, V83, P217, DOI 10.1159/000201556; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Albe-Fessard D, 1973, SOMATOSENSORY SYSTEM; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; AMARA SG, 1985, SCIENCE, V229, P1094, DOI 10.1126/science.2994212; Ambalavanar R, 2009, J DENT RES, V88, P201, DOI 10.1177/0022034508330176; Andratsch M, 2009, J NEUROSCI, V29, P13473, DOI 10.1523/JNEUROSCI.1822-09.2009; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Ashcroft F. M., 2000, ION CHANNELS DIS CHA; Bartnik M, 2012, AM J MED GENET B, V159B, P760, DOI 10.1002/ajmg.b.32081; BASTOS LFS, 2013, NEUROSCI LETT; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Begenisich T, 1998, METHOD ENZYMOL, V293, P383; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Blankenship ML, 2013, NEUROSCIENCE, V231, P305, DOI 10.1016/j.neuroscience.2012.11.053; Bocksteins E, 2009, AM J PHYSIOL-CELL PH, V296, pC1271, DOI 10.1152/ajpcell.00088.2009; Boda E, 2012, J MOL NEUROSCI, V46, P606, DOI 10.1007/s12031-011-9648-6; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Bouchelet I, 1996, MOL PHARMACOL, V50, P219; Bradshaw HB, 2009, PROSTAG OTH LIPID M, V89, P131, DOI 10.1016/j.prostaglandins.2009.04.006; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Cao YQ, 2006, PAIN, V126, P5, DOI 10.1016/j.pain.2006.10.019; Carrasquillo Y, 2012, J PHYSIOL-LONDON, V590, P3877, DOI 10.1113/jphysiol.2012.229013; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CATT KJ, 1984, J CARDIOVASC PHARM, V6, pS575, DOI 10.1097/00005344-198406004-00004; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chang YC, 1996, J NEUROSCI, V16, P5415; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; Chen CD, 2007, PROTEOMICS, V7, P155, DOI 10.1002/pmic.200600663; Chen G, 2000, MOL PHARMACOL, V57, P125; Chen RS, 2007, CELL BIOCHEM BIOPHYS, V47, P178, DOI 10.1007/s12013-007-0002-0; Cheng KT, 2003, HISTOCHEM CELL BIOL, V120, P475, DOI 10.1007/s00418-003-0596-2; Chiesa A, 2012, EUR ARCH PSY CLIN N, V262, P305, DOI 10.1007/s00406-011-0270-y; Chiou LC, 2010, CURR PHARM DESIGN, V16, P3089, DOI 10.2174/138161210793292483; Cho HJ, 2009, NEUROSCIENCE, V162, P453, DOI 10.1016/j.neuroscience.2009.04.063; Cho HJ, 2009, CELL TISSUE RES, V338, P171, DOI 10.1007/s00441-009-0869-8; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; CODY FWJ, 1972, J PHYSIOL-LONDON, V226, P249, DOI 10.1113/jphysiol.1972.sp009983; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Comings DE, 2003, MOL PSYCHIATR, V8, P10, DOI 10.1038/sj.mp.4001095; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Cooper EC, 2011, SEMIN CELL DEV BIOL, V22, P185, DOI 10.1016/j.semcdb.2010.10.001; Cosi C, 2011, NEUROPHARMACOLOGY, V60, P1227, DOI 10.1016/j.neuropharm.2010.11.014; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cutrer FM, 1996, HEADACHE, V36, P579, DOI 10.1046/j.1526-4610.1996.3610579.x; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Damasio A, 2005, NATURE, V435, P571, DOI 10.1038/435571a; DARIANSMITH J, 1973, HDB SENSORY PHYSL; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Delisle BP, 2005, MOL PHARMACOL, V68, P233, DOI 10.1124/mol.105.012914; Demir R, 2009, PHARMACOLOGY, V83, P270, DOI 10.1159/000209291; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Ding YQ, 1996, J COMP NEUROL, V364, P290; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dinh QT, 2003, NEUROPEPTIDES, V37, P245, DOI 10.1016/S0143-4179(03)00065-9; DIRKSEN R, 1990, PHARM WEEKBLAD, V12, P41, DOI 10.1007/BF01970144; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Doutheil J, 1999, PHARMACOL TOXICOL, V85, P85, DOI 10.1111/j.1600-0773.1999.tb00071.x; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Dunn IC, 2013, AM J PHYSIOL-ENDOC M, V304, pE909, DOI 10.1152/ajpendo.00580.2012; Dupen A, 2007, PAIN MANAG NURS, V8, P113, DOI 10.1016/j.pmn.2007.02.004; Durham PL, 2013, HEADACHE, V53, P67, DOI 10.1111/j.1526-4610.2012.02262.x; Eisenberg Elon, 2005, Expert Rev Neurother, V5, P729, DOI 10.1586/14737175.5.6.729; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Friedli M, 2003, GENE, V320, P31, DOI 10.1016/S0378-1119(03)00830-8; Galer BS, 1995, NEUROLOGY, V45, pS17, DOI 10.1212/WNL.45.12_Suppl_9.S17; Gao Yun, 2009, Ai Zheng, V28, P104; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Gebremedhin D, 1999, AM J PHYSIOL-HEART C, V276, pH2085, DOI 10.1152/ajpheart.1999.276.6.H2085; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gerevich Zoltan, 2004, Purinergic Signal, V1, P3, DOI 10.1007/s11302-004-4740-9; Gerhold KA, 2009, ANN NY ACAD SCI, V1170, P184, DOI 10.1111/j.1749-6632.2009.03895.x; Goadsby PJ, 2007, TRENDS MOL MED, V13, P39, DOI 10.1016/j.molmed.2006.11.005; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Godinez-Chaparro B, 2011, PAIN, V152, P687, DOI 10.1016/j.pain.2010.12.020; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gondim DV, 2012, CAN J PHYSIOL PHARM, V90, P1479, DOI 10.1139/y2012-130; Green BG, 2004, J NEUROBIOL, V61, P13, DOI 10.1002/neu.20081; GREEN BG, 1985, PHYSIOL BEHAV, V35, P427, DOI 10.1016/0031-9384(85)90319-1; Griswold DE, 1999, MOL PHARMACOL, V56, P807; Guan YY, 2006, TRENDS PHARMACOL SCI, V27, P290, DOI 10.1016/j.tips.2006.04.008; Guler AD, 2002, J NEUROSCI, V22, P6408; Haeseler G, 2002, EUR J ANAESTH, V19, P571, DOI 10.1017/S0265021502000923; Haitina T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-24; Hao JZ, 2013, NEURON, V77, P899, DOI 10.1016/j.neuron.2012.12.035; Hargreaves RJ, 1999, CAN J NEUROL SCI, V26, pS12, DOI 10.1017/S0317167100000147; Hatch RJ, 2013, EUR J PAIN, V17, P972, DOI 10.1002/j.1532-2149.2012.00261.x; Hayasaki H, 2006, EUR J NEUROSCI, V23, P745, DOI 10.1111/j.1460-9568.2006.04602.x; Haywood SA, 1999, ENDOCRINOLOGY, V140, P3255, DOI 10.1210/en.140.7.3255; He HQ, 2010, BIOCHEM J, V431, P289, DOI 10.1042/BJ20100517; Heide J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045624; Heidenreich M, 2012, NAT NEUROSCI, V15, P138, DOI 10.1038/nn.2985; Heilstedt HA, 2001, EPILEPSIA, V42, P1103, DOI 10.1046/j.1528-1157.2001.08801.x; Heron A, 2001, MECH DEVELOP, V105, P167, DOI 10.1016/S0925-4773(01)00389-6; Hicks GA, 1998, J PHYSIOL-LONDON, V508, P721, DOI 10.1111/j.1469-7793.1998.721bp.x; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffman AF, 2003, EUR J NEUROSCI, V18, P524, DOI 10.1046/j.1460-9568.2003.02773.x; Holden JE, 2005, NEUROSCIENCE, V135, P1255, DOI 10.1016/j.neuroscience.2005.07.023; Horne K, 2009, INFLAMM RES, V58, P431, DOI 10.1007/s00011-009-0023-9; Hu WP, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-35; Hu WP, 2005, ACTA PHARMACOL SIN, V26, P428, DOI 10.1111/j.1745-7254.2005.00074.x; Ichikawa H, 2003, BRAIN RES, V974, P222, DOI 10.1016/S0006-8993(03)02583-6; Isbrandt D, 2000, GENOMICS, V64, P144, DOI 10.1006/geno.2000.6117; Ito G, 2013, EUR J PAIN, V17, P185, DOI 10.1002/j.1532-2149.2012.00174.x; Jarvis MF, 2003, EXPERT OPIN THER TAR, V7, P513, DOI 10.1517/14728222.7.4.513; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Judget SIV, 2009, EXPERT OPIN THER PAT, V19, P433, DOI 10.1517/13543770902765151; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Kaneko H, 2001, AM J PHYSIOL-CELL PH, V280, pC1387, DOI 10.1152/ajpcell.2001.280.6.C1387; Kashiba H, 2001, Nihon Yakurigaku Zasshi, V118, P43; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Ke CB, 2012, NEUROSCIENCE, V227, P80, DOI 10.1016/j.neuroscience.2012.09.046; Keydar I, 2013, HUM MUTAT, V34, P32, DOI 10.1002/humu.22212; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kim DS, 2002, MOL BRAIN RES, V105, P146, DOI 10.1016/S0169-328X(02)00388-1; Kim MJ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-16; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; Kinali M, 2004, NEUROMUSCULAR DISORD, V14, P689, DOI 10.1016/j.nmd.2004.06.007; Kingwell K, 2012, NAT REV NEUROL, V8, P589, DOI [10.1038/nrneurol.2012.229, 10.1038/nrneurol.2012.128, 10.1038/nrneurol.2012.218, 10.1038/nrneurol.2012.55, 10.1038/nrneurol.2012.84]; KNAPP HR, 1990, NEW ENGL J MED, V323, P1745, DOI 10.1056/NEJM199012203232506; Ko MC, 1999, PSYCHOPHARMACOLOGY, V143, P322, DOI 10.1007/s002130050955; Kondo D, 2006, EUR J PHARMACOL, V541, P44, DOI 10.1016/j.ejphar.2006.05.010; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Kreienkamp HJ, 2000, J BIOL CHEM, V275, P32387, DOI 10.1074/jbc.C000490200; Krusz JC, 2000, HEADACHE, V40, P224, DOI 10.1046/j.1526-4610.2000.00032.x; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kupchak BR, 2009, BIOCHEMISTRY-US, V48, P5504, DOI 10.1021/bi9006258; Kuroda H, 2012, NEUROREPORT, V23, P752, DOI 10.1097/WNR.0b013e3283568a29; Kurtenbach S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-234; La JH, 2006, NEUROSCI LETT, V406, P244, DOI 10.1016/j.neulet.2006.07.039; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lai J, 2003, CURR OPIN NEUROBIOL, V13, P291, DOI 10.1016/S0959-4388(03)00074-6; Lam David K, 2005, Pain Res Manag, V10, P145; Langeslag M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-102; Lazarov NE, 2007, BRAIN RES REV, V56, P362, DOI 10.1016/j.brainresrev.2007.08.009; Lazarov NE, 2006, NEUROSCI LETT, V404, P67, DOI 10.1016/j.neulet.2006.05.050; Lee H, 2007, NEUROGENETICS, V8, P195, DOI 10.1007/s10048-007-0091-3; Lee Y, 2005, MOL CELLS, V20, P315; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Lemons LL, 2011, NEUROPEPTIDES, V45, P377, DOI 10.1016/j.npep.2011.08.002; LEWIS SS, 2013, BRAIN BEHAV IMMUN; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Jun, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P535; Li L, 2012, J BIOL CHEM, V287, P6002, DOI 10.1074/jbc.M111.310110; LIU L, 1994, P NATL ACAD SCI USA, V91, P738, DOI 10.1073/pnas.91.2.738; Liu L, 1998, BRAIN RES, V809, P238, DOI 10.1016/S0006-8993(98)00862-2; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lundstrom K, 2005, IDRUGS, V8, P909; Lynch JW, 2006, CURR OPIN INVEST DR, V7, P48; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Magnusson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029060; Maheshwari HG, 1998, J CLIN ENDOCR METAB, V83, P4065, DOI 10.1210/jc.83.11.4065; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; MCCARSON KE, 1994, J NEUROSCI, V14, P712; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McMahon SB, 2006, CELL, V124, P1123, DOI 10.1016/j.cell.2006.03.006; Meadows LS, 2002, J NEUROSCI, V22, P10699; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Meng H, 2009, DEV DYNAM, V238, P487, DOI 10.1002/dvdy.21852; Mistry T, 2006, BIOCHEM BIOPH RES CO, V348, P832, DOI 10.1016/j.bbrc.2006.07.139; MIYAWAKI A, 1994, EMBO J, V13, P5835, DOI 10.1002/j.1460-2075.1994.tb06927.x; Mizushima T, 2006, NEUROSCIENCE, V140, P1337, DOI 10.1016/j.neuroscience.2006.03.024; Mongan LC, 2005, NEUROSCIENCE, V131, P161, DOI 10.1016/j.neuroscience.2004.09.062; Monheim L M, 1961, J Am Dent Soc Anesthesiol, V8, P199; Moreno-Dominguez A, 2009, J PHYSIOL-LONDON, V587, P625, DOI 10.1113/jphysiol.2008.165217; Moro S, 2005, TRENDS PHARMACOL SCI, V26, P44, DOI 10.1016/j.tips.2004.11.006; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu J, 1999, J PHARMACOL EXP THER, V291, P893; Munns C, 2007, CELL CALCIUM, V41, P331, DOI 10.1016/j.ceca.2006.07.008; Murphy GG, 2004, CURR BIOL, V14, P1907, DOI 10.1016/j.cub.2004.10.021; Murray KC, 2011, J NEUROPHYSIOL, V106, P925, DOI 10.1152/jn.01011.2010; Nakae K, 2005, J PHARMACOL EXP THER, V315, P1136, DOI 10.1124/jpet.105.091967; Nakasaki T, 1999, PROSTAG OTH LIPID M, V58, P29, DOI 10.1016/S0090-6980(99)00021-0; Negri L, 2006, J NEUROSCI, V26, P6716, DOI 10.1523/JNEUROSCI.5403-05.2006; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Nilius Bernd, 2004, Novartis Found Symp, V258, P140; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; North RA, 1997, CURR OPIN NEUROBIOL, V7, P346, DOI 10.1016/S0959-4388(97)80062-1; Nyholt DR, 2008, HUM MOL GENET, V17, P3318, DOI 10.1093/hmg/ddn227; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Padilla F, 2007, MOL CELL NEUROSCI, V35, P138, DOI 10.1016/j.mcn.2007.02.008; Palecek J, 2004, PAIN, V111, P151, DOI 10.1016/j.pain.2004.06.012; Palikhe NS, 2011, CLIN EXP ALLERGY, V41, P179, DOI 10.1111/j.1365-2222.2010.03642.x; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Patel KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020559; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pertwee RG, 2000, EXPERT OPIN INV DRUG, V9, P1553, DOI 10.1517/13543784.9.7.1553; Pieraut S, 2011, J NEUROSCI, V31, P13516, DOI 10.1523/JNEUROSCI.3382-11.2011; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pifferi S, 2012, EXP PHYSIOL, V97, P193, DOI 10.1113/expphysiol.2011.058230; Pifferi S, 2009, J PHYSIOL-LONDON, V587, P4265, DOI 10.1113/jphysiol.2009.176131; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Price TJ, 2005, NEUROSCI LETT, V389, P94, DOI 10.1016/j.neulet.2005.07.029; Price TJ, 2003, NEUROSCIENCE, V120, P155, DOI 10.1016/S0306-4522(03)00333-6; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Ralevic V, 1998, PHARMACOL REV, V50, P413; Raouf R, 2010, J CLIN INVEST, V120, P3745, DOI 10.1172/JCI43158; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Rasmussen MS, 2006, OBESITY, V14, P28, DOI 10.1038/oby.2006.5; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Read MA, 1999, J HYPERTENS, V17, P389, DOI 10.1097/00004872-199917030-00012; REBECK GW, 1994, P NATL ACAD SCI USA, V91, P3666, DOI 10.1073/pnas.91.9.3666; Reilly CA, 2003, TOXICOL SCI, V73, P170, DOI 10.1093/toxsci/kfg044; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rothermel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026158; Roza C, 2008, PAIN, V138, P537, DOI 10.1016/j.pain.2008.01.031; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Sabharwal R K, 1990, J Assoc Physicians India, V38, P227; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Santos ARS, 1997, NEUROPEPTIDES, V31, P381, DOI 10.1016/S0143-4179(97)90075-5; Scammell TE, 2011, ANNU REV PHARMACOL, V51, P243, DOI 10.1146/annurev-pharmtox-010510-100528; Schizas N, 2010, SCAND J MED SCI SPOR, V20, P208, DOI 10.1111/j.1600-0838.2009.00913.x; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Shi B, 2012, J HUAZHONG U SCI-MED, V32, P265, DOI 10.1007/s11596-012-0047-1; Shiao MS, 2012, GENOME BIOL EVOL, V4, P703, DOI 10.1093/gbe/evs039; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Singer K, 2013, MOL NEUROBIOL, V47, P186, DOI 10.1007/s12035-012-8343-0; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; So I, 2005, INT J IMPOT RES, V17, P475, DOI 10.1038/sj.ijir.3901356; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Spehr J, 2004, EUR J NEUROSCI, V19, P2497, DOI 10.1111/j.0953-816X.2004.03329.x; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Srikiatkhachorn A, 1996, CEPHALALGIA, V16, P419, DOI 10.1046/j.1468-2982.1996.1606419.x; Staaf S, 2009, PAIN, V144, P187, DOI 10.1016/j.pain.2009.04.013; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Strickland IT, 2008, EUR J PAIN, V12, P564, DOI 10.1016/j.ejpain.2007.09.001; Sung KW, 2000, J NEUROSCI, V20, P7531; Supornsilpchai W, 2006, HEADACHE, V46, P34, DOI 10.1111/j.1526-4610.2006.00310.x; Supornsilpchai W, 2010, HEADACHE, V50, P185, DOI 10.1111/j.1526-4610.2009.01591.x; Swayne LA, 2008, PFLUG ARCH EUR J PHY, V456, P459, DOI 10.1007/s00424-007-0390-4; Takeda M, 2006, NEUROSCIENCE, V138, P621, DOI 10.1016/j.neuroscience.2005.11.024; Takeda M, 2008, PAIN, V139, P594, DOI 10.1016/j.pain.2008.06.015; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; Tang ZX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3179; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430; Terron JA, 2001, NEUROSCI LETT, V302, P9, DOI 10.1016/S0304-3940(01)01617-2; TESTI R, 1992, J IMMUNOL, V148, P2867; Thun J, 2009, BRAIN RES, V1269, P11, DOI 10.1016/j.brainres.2009.02.044; Tilney F, 1930, Bull N Y Acad Med, V6, P69; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tsantoulas C, 2012, J NEUROSCI, V32, P17502, DOI 10.1523/JNEUROSCI.3561-12.2012; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vanderhaeghen P, 1997, BIOCHEM BIOPH RES CO, V237, P283, DOI 10.1006/bbrc.1997.7043; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524; Verkman AS, 2000, EXP PHYSIOL, V85, p233S, DOI 10.1111/j.1469-445X.2000.tb00028.x; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wang W, 2011, ANAT REC, V294, P1406, DOI 10.1002/ar.21437; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watkins Gareth, 2005, Int Semin Surg Oncol, V2, P23, DOI 10.1186/1477-7800-2-23; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Willis WD, 2006, PROG NEUROBIOL, V78, P189, DOI 10.1016/j.pneurobio.2006.02.007; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Wonnacott S, 2006, J MOL NEUROSCI, V30, P137, DOI 10.1385/JMN:30:1:137; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Xu GY, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-68; Xu JZ, 2001, AM J MED GENET, V105, P669, DOI 10.1002/ajmg.1549; Xu W, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-49; YAMADA Y, 1995, GENOMICS, V27, P312, DOI 10.1006/geno.1995.1048; Yamamoto Y, 2009, NEUROSCI LETT, V454, P129, DOI 10.1016/j.neulet.2009.02.069; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yan JA, 2008, PHYSIOL RES, V57, P797, DOI 10.33549/physiolres.931574; Yan J, 2011, PAIN, V152, P106, DOI 10.1016/j.pain.2010.09.036; Yoo BC, 2001, ELECTROPHORESIS, V22, P172, DOI 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zhang YH, 2002, J PHYSIOL-LONDON, V544, P385, DOI 10.1113/jphysiol.2002.024265; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; ZHOU X, 2013, J BIOL CHEM; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003; Zufall F, 2012, ARCH NEUROL-CHICAGO, V69, P1119, DOI 10.1001/archneurol.2012.21; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	330	82	82	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79523	10.1371/journal.pone.0079523	http://dx.doi.org/10.1371/journal.pone.0079523			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260241	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200069
J	Rellstab, C; Zoller, S; Tedder, A; Gugerli, F; Fischer, MC				Rellstab, Christian; Zoller, Stefan; Tedder, Andrew; Gugerli, Felix; Fischer, Martin C.			Validation of SNP Allele Frequencies Determined by Pooled Next-Generation Sequencing in Natural Populations of a Non-Model Plant Species	PLOS ONE			English	Article							ADAPTATION; DIFFERENTIATION; VARIANTS; MARKERS	Sequencing of pooled samples (Pool-Seq) using next-generation sequencing technologies has become increasingly popular, because it represents a rapid and cost-effective method to determine allele frequencies for single nucleotide polymorphisms (SNPs) in population pools. Validation of allele frequencies determined by Pool-Seq has been attempted using an individual genotyping approach, but these studies tend to use samples from existing model organism databases or DNA stores, and do not validate a realistic setup for sampling natural populations. Here we used pyrosequencing to validate allele frequencies determined by Pool-Seq in three natural populations of Arabidopsis halleri (Brassicaceae). The allele frequency estimates of the pooled population samples (consisting of 20 individual plant DNA samples) were determined after mapping Illumina reads to (i) the publicly available, high-quality reference genome of a closely related species (Arabidopsis thaliana) and (ii) our own de novo draft genome assembly of A. halleri. We then pyrosequenced nine selected SNPs using the same individuals from each population, resulting in a total of 540 samples. Our results show a highly significant and accurate relationship between pooled and individually determined allele frequencies, irrespective of the reference genome used. Allele frequencies differed on average by less than 4%. There was no tendency that either the Pool-Seq or the individual-based approach resulted in higher or lower estimates of allele frequencies. Moreover, the rather high coverage in the mapping to the two reference genomes, ranging from 55 to 284x, had no significant effect on the accuracy of the Pool-Seq. A resampling analysis showed that only very low coverage values (below 10-20x) would substantially reduce the precision of the method. We therefore conclude that a pooled re-sequencing approach is well suited for analyses of genetic variation in natural populations.	[Rellstab, Christian; Gugerli, Felix] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Zoller, Stefan] Swiss Fed Inst Technol, Genet Divers Ctr, Zurich, Switzerland; [Tedder, Andrew] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Tedder, Andrew] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Fischer, Martin C.] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fischer, MC (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	martin.fischer@env.ethz.ch	Gugerli, Felix/U-7195-2019; Fischer, Martin C/D-4326-2012; Fischer, Martin C./AAE-7287-2019; Tedder, Andrew/B-3830-2015; Rellstab, Christian/D-6460-2012; Tedder, Andrew/H-6678-2019; Gugerli, Felix/C-9369-2009	Gugerli, Felix/0000-0003-3878-1845; Fischer, Martin C/0000-0002-1888-1809; Fischer, Martin C./0000-0002-1888-1809; Rellstab, Christian/0000-0002-0221-5975; Tedder, Andrew/0000-0002-7378-4673; Gugerli, Felix/0000-0003-3878-1845	Swiss National Science Foundation [CRSI33_127155]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (project CRSI33_127155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Al-Shehbaz Ihsan A, 2002, Arabidopsis Book, V1, pe0001, DOI 10.1199/tab.0001; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Boitard S, 2012, MOL BIOL EVOL, V29, P2177, DOI 10.1093/molbev/mss090; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Fabian DK, 2012, MOL ECOL, V21, P4748, DOI 10.1111/j.1365-294X.2012.05731.x; Feder AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048588; Fischer MC, 2013, MOL ECOL, DOI [10.1111/mec.12521, DOI 10.1111/MEC.12521.PUBMED:24102711]; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Futschik A, 2010, GENETICS, V186, P207, DOI 10.1534/genetics.110.114397; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; Gruber JD, 2002, HUM GENET, V110, P395, DOI 10.1007/s00439-002-0722-6; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Ingman M, 2009, EUR J HUM GENET, V17, P383, DOI 10.1038/ejhg.2008.182; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kessner D, 2013, MOL BIOL EVOL, V30, P1145, DOI 10.1093/molbev/mst016; Kofler R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002487; Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margraf Rebecca L, 2011, J Biomol Tech, V22, P74; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer CL, 2010, NEW PHYTOL, V185, P130, DOI 10.1111/j.1469-8137.2009.03062.x; Niranjan TS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r93; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Pauwels M, 2006, J EVOLUTION BIOL, V19, P1838, DOI 10.1111/j.1420-9101.2006.01178.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rellstab C, 2011, INFECT GENET EVOL, V11, P1276, DOI 10.1016/j.meegid.2011.04.018; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Shimizu KK, 2011, ANN BOT-LONDON, V108, P777, DOI 10.1093/aob/mcr180; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Zavodna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061471; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041901	44	64	64	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80422	10.1371/journal.pone.0080422	http://dx.doi.org/10.1371/journal.pone.0080422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244686	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900080
J	Shaukat, S; Angez, M; Alam, MM; Sharif, S; Khurshid, A; Mahmood, T; Zaidi, SSZ				Shaukat, Shahzad; Angez, Mehar; Alam, Muhammad Masroor; Sharif, Salmaan; Khurshid, Adnan; Mahmood, Tariq; Zaidi, Syed Sohail Zahoor			Characterization of a Novel Enterovirus Serotype and an Enterovirus EV-B93 Isolated from Acute Flaccid Paralysis Patients	PLOS ONE			English	Article							NILE-VIRUS-INFECTION; POLIO ERADICATION; CHILDREN; IDENTIFICATION; EPIDEMIOLOGY; PAKISTAN; INDIA; PCR	Non-polio enteroviruses (NPEVs) are among the most common viruses infecting humans worldwide. Most of these infections are asymptomatic but few can lead to systemic and neurological disorders like Acute Flaccid Paralysis (AFP). Acute Flaccid Paralysis is a clinical syndrome and NPEVs have been isolated frequently from the patients suffering from AFP but little is known about their causal relationship. The objective of this study was to identify and characterize the NPEV serotypes recovered from 184 stool samples collected from AFP patients in Federally Administered Tribal Areas (FATA) in north-west of Pakistan. Overall, 44 (95.6 %) isolates were successfully typed through microneutralization assay as a member of enterovirus B species including echovirus (E)-2, E-3, E-4, E-6, E-7, E-11, E-13, E-14, E-21 and E-29 while two isolates (PAK NIH SP6545B and PAK NIH SP1202B) remained untypeable. The VP1 and capsid regions analysis characterized these viruses as EV-B93 and EV-B106. Phylogenetic analysis confirmed that PAK NIH isolates had high genetic diversity and represent distinct genotypes circulating in the country. Our findings highlight the role of NPEVs in AFP cases to be thoroughly investigated especially in high disease risk areas, with limited surveillance activities and health resources.	[Shaukat, Shahzad; Angez, Mehar; Alam, Muhammad Masroor; Sharif, Salmaan; Khurshid, Adnan; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan; [Shaukat, Shahzad] Quaid I Azam Univ, Fac Biol Sci, Dept Biotechnol, Islamabad, Pakistan; [Mahmood, Tariq] Quaid I Azam Univ, Fac Biol Sci, Dept Plant Sci, Islamabad, Pakistan	Quaid I Azam University; Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	sohailz@live.com	Zaidi, Syed Sohail Zahoor/F-7432-2015; Mahmood, Tariq/O-8742-2019; Shaukat, Shahzad/HHZ-1088-2022; Angez, Mehar/J-3792-2015	Mahmood, Tariq/0000-0001-9083-1702; 				Abbasian F, 2012, J GASTROEN HEPATOL, V1, P44; Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0; Chen CY, 2001, AM J NEURORADIOL, V22, P200; Dhole TN, 2009, J PAEDIATR CHILD H, V45, P409, DOI 10.1111/j.1440-1754.2009.01529.x; Dietz V, 1995, B WORLD HEALTH ORGAN, V73, P597; FIGUEROA JP, 1989, J MED VIROL, V29, P315, DOI 10.1002/jmv.1890290418; Francis PT, 2008, INDIAN PEDIATR, V45, P422; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Junttila N, 2007, J MED VIROL, V79, P393, DOI 10.1002/jmv.20825; Kapoor A, 2004, INDIAN J MED RES, V119, P149; Kapoor Amit, 2001, Indian Journal of Pediatrics, V68, P927, DOI 10.1007/BF02722583; Kilpatrick DR, 2009, J CLIN MICROBIOL, V47, P1939, DOI 10.1128/JCM.00702-09; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Laxmivandana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061650; Li J, 2003, ANN NEUROL, V53, P703, DOI 10.1002/ana.10575; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Liu Kun, 2012, Zhonghua Yi Xue Za Zhi, V92, P1742; Mark A, 2001, ENTEROVIRUSES POLIOV, P839; Mascola L., 2008, Morbidity and Mortality Weekly Report, V57, P553; Melnick J.L., 1996, FIELDS VIROLOGY, Vthird, P655; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Persu Ana, 2009, Roum Arch Microbiol Immunol, V68, P20; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Saeed M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-6; Santti J, 2000, J GEN VIROL, V81, P1361, DOI 10.1099/0022-1317-81-5-1361; Saskia L, 2013, EMERG INFECT DIS, V19; Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129; Shaukat S, 2012, VIRUS RES, V170, P164, DOI 10.1016/j.virusres.2012.09.010; Tan le V, 2013, MBIO, V4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torno M, 2007, NEUROLOGY, V68, pE5, DOI 10.1212/01.wnl.0000253223.07720.bb; World Health Organization, 2004, WHOIVB0410; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P69	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80040	10.1371/journal.pone.0080040	http://dx.doi.org/10.1371/journal.pone.0080040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244603	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900060
J	Berkyurek, AC; Suetake, I; Arita, K; Takeshita, K; Nakagawa, A; Shirakawa, M; Tajima, S				Berkyurek, Ahmet Can; Suetake, Isao; Arita, Kyohei; Takeshita, Kohei; Nakagawa, Atsushi; Shirakawa, Masahiro; Tajima, Shoji			The DNA Methyltransferase Dnmt1 Directly Interacts with the SET and RING Finger-associated (SRA) Domain of the Multifunctional Protein Uhrf1 to Facilitate Accession of the Catalytic Center to Hemi-methylated DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; DNA Methyltransferase; Epigenetics; Gene Regulation; Gene Silencing	CYTOSINE-5 METHYLTRANSFERASES; MAINTENANCE; REPLICATION; SEQUENCE; BINDS; RECOGNITION; COMPLEX; SITES	Dnmt1 is responsible for the maintenance DNA methylation during replication to propagate methylation patterns to the next generation. The replication foci targeting sequence (RFTS), which plugs the catalytic pocket, is necessary for recruitment of Dnmt1 to the replication site. In the present study we found that the DNA methylation activity of Dnmt1 was DNA length-dependent and scarcely methylated 12-bp short hemi-methylated DNA. Contrarily, the RFTS-deleted Dnmt1 and Dnmt1 mutants that destroyed the hydrogen bonds between the RFTS and catalytic domain showed significant DNA methylation activity even toward 12-bp hemi-methylated DNA. The DNA methylation activity of the RFTS-deleted Dnmt1 toward 12-bp hemi-methylated DNA was strongly inhibited on the addition of RFTS, but to a lesser extent by Dnmt1 harboring the mutations that impair the hydrogen bond formation. The SRA domain of Uhrf1, which is a prerequisite factor for maintenance methylation and selectively binds to hemi-methylated DNA, stimulated the DNA methylation activity of Dnmt1. The SRA to Dnmt1 concentration ratio was the determinant for the maximum stimulation. In addition, a mutant SRA, which had lost the DNA binding activity but was able to bind to Dnmt1, stimulated the DNA methylation activity of Dnmt1. The results indicate that the DNA methylation activity of Dnmt1 was stimulated on the direct interaction of the SRA and Dnmt1. The SRA facilitated acceptance of the 12-bp fluorocytosine-containing DNA by the catalytic center. We propose that the SRA removes the RFTS plug from the catalytic pocket to facilitate DNA acceptance by the catalytic center.	[Berkyurek, Ahmet Can; Suetake, Isao; Takeshita, Kohei; Nakagawa, Atsushi; Tajima, Shoji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Arita, Kyohei] Yokohama City Univ, Grad Sch Nanobiosci, Div Macromol Crystallog, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Suetake, Isao; Shirakawa, Masahiro] Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan	Osaka University; Yokohama City University; Kyoto University; Japan Science & Technology Agency (JST)	Tajima, S (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tajima@protein.osaka-u.ac.jp	Nakagawa, Atsushi/D-4329-2009; Suetake, Isao/D-4326-2009; Arita, Kyohei/AAJ-6402-2020; Nakagawa, Atsushi/M-5731-2019; Suetake, Isao/G-3144-2013	Nakagawa, Atsushi/0000-0002-1700-7861; Suetake, Isao/0000-0002-1246-8474; Arita, Kyohei/0000-0002-9762-8405; Nakagawa, Atsushi/0000-0002-1700-7861; 	Japan Society for the Promotion of Science; CREST by Japan Science and Technology Agency; Japanese Government; Grants-in-Aid for Scientific Research [24116515, 24651214, 24570153, 24113711] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST by Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japanese Government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research B (to S. T.) and scientific research C (to I. S.) from the Japan Society for the Promotion of Science, and CREST by Japan Science and Technology Agency (to M. S. and I. S.).; Supported by a Japanese Government scholarship program.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Brank AS, 2002, PROTEIN EXPRES PURIF, V25, P31, DOI 10.1006/prep.2001.1606; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Pradhan S, 2002, EMBO J, V21, P779, DOI 10.1093/emboj/21.4.779; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Suetake I, 2006, J BIOCHEM, V140, P763, DOI 10.1093/jb/mvj210; Sugiyama Y, 2010, BIOCHEM J, V427, P489, DOI 10.1042/BJ20091856; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200	23	80	84	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					379	386		10.1074/jbc.M113.523209	http://dx.doi.org/10.1074/jbc.M113.523209			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24253042	Green Published, hybrid			2022-12-25	WOS:000329370900033
J	Borowsky, R; Cohen, D				Borowsky, Richard; Cohen, Dana			Genomic Consequences of Ecological Speciation in Astyanax Cavefish	PLOS ONE			English	Article							BLIND CAVEFISH; EVOLUTION; CONVERGENCE; SURFACE; SPERM; FISH	The cave environment is consistently radically different than the surface environment because it lacks light, and animals adapting to cave life are subject to strong selective forces much different than those experienced by their ancestors who evolved in the presence of light. As such, their divergence from surface ancestors and eventual speciation is likely to be driven by the shift in ecology. We report here that hybrids between cave and surface Astyanax mexicanus fishes produce offspring with allelic frequencies that differ significantly from Mendelian expectations both for transmission ratios and for independent assortment of unlinked markers. Comparison of allelic content of DNA from fin clips and sperm pools show that the transmission ratio distortion likely occurs during spermatogenesis. Departures from expectations of independent assortment are essentially epistatic phenomena generating linkage disequilibrium. A novel analysis of the epistatic interactions reveals an apparent network of interactions among genes known or suspected to be involved in cave adaptation, implying that the epistasis arose as a "by product'' of the divergence due to cave adaptation.	[Borowsky, Richard; Cohen, Dana] NYU, Dept Biol, New York, NY 10003 USA	New York University	Borowsky, R (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.	rborowsky@nyu.edu			NSF [IOS - 0821939]	NSF(National Science Foundation (NSF))	This work was funded by NSF grant IOS - 0821939 (http://nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Borowsky R, 2002, J HERED, V93, P19, DOI 10.1093/jhered/93.1.19; Borowsky R, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P115, DOI 10.1201/EBK1578086702-c5; Bradic M, 2013, MOL BIOL EVOL; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; COHEN J, 1973, HEREDITY, V31, P408, DOI 10.1038/hdy.1973.96; Culver DC, 1982, CAVE LIFE EVOLUTION, Vviii; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Duboue ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030868; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; Ezawa K, 2013, GENETICS, V194, P709, DOI 10.1534/genetics.113.152066; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Hooven TA, 2004, INT J DEV BIOL, V48, P731, DOI 10.1387/ijdb.041874th; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Ornelas-Garcia CP, 2008, BMC EVOL BIOL, V8, P340, DOI DOI 10.1186/1471-2148-8-340; Pottin K, 2011, DEVELOPMENT, V138, P2467, DOI 10.1242/dev.054106; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Strecker U, 2004, MOL PHYLOGENET EVOL, V33, P469, DOI 10.1016/j.ympev.2004.07.001; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108	27	17	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79903	10.1371/journal.pone.0079903	http://dx.doi.org/10.1371/journal.pone.0079903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260315	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900050
J	DeWoody, J; Viger, M; Lakatos, F; Tuba, K; Taylor, G; Smulders, MJM				DeWoody, Jennifer; Viger, Maud; Lakatos, Ferenc; Tuba, Katalin; Taylor, Gail; Smulders, Marinus J. M.			Insight into the Genetic Components of Community Genetics: QTL Mapping of Insect Association in a Fast-Growing Forest Tree	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ANALYSIS; X POPULUS-DELTOIDES; PLANT HYBRID ZONES; GLUTAMATE-RECEPTOR; ARTHROPOD COMMUNITY; MOLECULAR-GENETICS; SHORT-ROTATION; SEGREGATION DISTORTION; TRANSCRIPTION FACTORS	Identifying genetic sequences underlying insect associations on forest trees will improve the understanding of community genetics on a broad scale. We tested for genomic regions associated with insects in hybrid poplar using quantitative trait loci (QTL) analyses conducted on data from a common garden experiment. The F-2 offspring of a hybrid poplar (Populus trichocarpa x P. deltoides) cross were assessed for seven categories of insect leaf damage at two time points, June and August. Positive and negative correlations were detected among damage categories and between sampling times. For example, sap suckers on leaves in June were positively correlated with sap suckers on leaves (P < 0.001) but negatively correlated with skeletonizer damage (P < 0.01) in August. The seven forms of leaf damage were used as a proxy for seven functional groups of insect species. Significant variation in insect association occurred among the hybrid offspring, including transgressive segregation of susceptibility to damage. NMDS analyses revealed significant variation and modest broad-sense heritability in insect community structure among genets. QTL analyses identified 14 genomic regions across 9 linkage groups that correlated with insect association. We used three genomics tools to test for putative mechanisms underlying the QTL. First, shikimate-phenylpropanoid pathway genes co-located to 9 of the 13 QTL tested, consistent with the role of phenolic glycosides as defensive compounds. Second, two insect association QTL corresponded to genomic hotspots for leaf trait QTL as identified in previous studies, indicating that, in addition to biochemical attributes, leaf morphology may influence insect preference. Third, network analyses identified categories of gene models over-represented in QTL for certain damage types, providing direction for future functional studies. These results provide insight into the genetic components involved in insect community structure in a fast-growing forest tree.	[DeWoody, Jennifer; Viger, Maud; Taylor, Gail] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Lakatos, Ferenc; Tuba, Katalin] Univ West Hungary, Inst Silviculture & Forest Protect, Sopron, Hungary; [Smulders, Marinus J. M.] Wageningen UR Plant Breeding, Plant Res Int, Wageningen, Netherlands	University of Southampton; Wageningen University & Research	Taylor, G (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	G.Taylor@soton.ac.uk	Lakatos, Ferenc/AAO-4232-2021; Smulders, M.J.M./B-3654-2009; Lakatos, Ferenc/K-7981-2019; DeWoody, James Andrew/C-4909-2008	Lakatos, Ferenc/0000-0001-6718-6178; Smulders, M.J.M./0000-0002-8549-6046; DeWoody, James Andrew/0000-0002-7315-5631; Taylor, Gail/0000-0001-8470-6390	European Commission 6th Framework Programme for Research Network of Excellence EVOLTREE [016322]; NERC funds [GR9/04077]; Overseas Research Student Award Scheme; Netherlands' Ministry of Economic Affairs [KB-01-007-001, KB-14-004-030]	European Commission 6th Framework Programme for Research Network of Excellence EVOLTREE; NERC funds; Overseas Research Student Award Scheme; Netherlands' Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was funded by the European Commission 6th Framework Programme for Research Network of Excellence EVOLTREE (project number 016322), by NERC funds to GT (GR9/04077), an Overseas Research Student Award Scheme (to JD), and the Netherlands' Ministry of Economic Affairs (KB-01-007-001, KB-14-004-030). This study does not necessarily reflect the Commission's views and in no way anticipates the Commission's future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bangert RK, 2006, MOL ECOL, V15, P1379, DOI 10.1111/j.1365-294X.2005.02749.x; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x; BRADSHAW HD, 1995, GENETICS, V139, P963; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P551, DOI 10.1007/BF00222447; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P167, DOI 10.1007/BF00225137; Bradshaw HD, 2000, J PLANT GROWTH REGUL, V19, P306, DOI 10.1007/s003440000030; Brosche M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r101; Brunner AM, 2004, TRENDS PLANT SCI, V9, P49, DOI 10.1016/j.tplants.2003.11.006; Burse A, 2009, PHYTOCHEMISTRY, V70, P1899, DOI 10.1016/j.phytochem.2009.08.002; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Cervera MT, 2001, GENETICS, V158, P787; CEULEMANS R, 1992, CAN J FOREST RES, V22, P1937, DOI 10.1139/x92-253; Cho D, 2009, PLANT J, V58, P437, DOI 10.1111/j.1365-313X.2009.03789.x; CHURCHILL GA, 1994, GENETICS, V138, P963; Coyle DR, 2006, BIOMASS BIOENERG, V30, P759, DOI 10.1016/j.biombioe.2005.07.019; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dietrich P, 2010, PLANT BIOLOGY, V12, P80, DOI 10.1111/j.1438-8677.2010.00362.x; Donaldson JR, 2008, AGR FOREST ENTOMOL, V10, P399, DOI 10.1111/j.1461-9563.2008.00392.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; ECKENWALDER JE, 1984, CAN J BOT, V62, P325, DOI 10.1139/b84-051; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Ferris R, 2002, TREE PHYSIOL, V22, P633, DOI 10.1093/treephys/22.9.633; FLOATE KD, 1995, CAN J BOT, V73, P1, DOI 10.1139/b95-001; FLOATE KD, 1993, ECOLOGY, V74, P2056, DOI 10.2307/1940851; Fluch S, 2008, PLANTA, V228, P757, DOI 10.1007/s00425-008-0777-2; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Freeman JS, 2008, NEW PHYTOL, V178, P846, DOI 10.1111/j.1469-8137.2008.02417.x; Gardner SDL, 2005, FUNCT PLANT BIOL, V32, P221, DOI 10.1071/FP04131; Glynn C, 2004, ENTOMOL EXP APPL, V113, P1, DOI 10.1111/j.0013-8703.2004.00199.x; Groover AT, 2006, PLANT MOL BIOL, V61, P917, DOI 10.1007/s11103-006-0059-y; Gugerli F, 2013, MOL ECOL, V22, P3198, DOI 10.1111/mec.12300; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Kang JM, 2004, PLANT CELL PHYSIOL, V45, P1380, DOI 10.1093/pcp/pch159; Kang S, 2006, MOL CELLS, V21, P418; Keith AR, 2010, ECOLOGY, V91, P3398, DOI 10.1890/09-1236.1; Kelleher CT, 2007, PLANT J, V50, P1063, DOI 10.1111/j.1365-313X.2007.03112.x; Klaper R, 2001, J HERED, V92, P421, DOI 10.1093/jhered/92.5.421; Knott SA, 1997, THEOR APPL GENET, V94, P810, DOI 10.1007/s001220050482; Kohler A, 2003, FEBS LETT, V542, P37, DOI 10.1016/S0014-5793(03)00334-X; Kudoh G, 2003, PLANT ECOLOGY, V169; Li J, 2006, PLANT CELL, V18, P340, DOI 10.1105/tpc.105.037713; LINDROTH RL, 1988, ECOLOGY, V69, P814, DOI 10.2307/1941031; Major IT, 2006, NEW PHYTOL, V172, P617, DOI 10.1111/j.1469-8137.2006.01877.x; Marron N, 2010, TREE GENET GENOMES, V6, P533, DOI 10.1007/s11295-010-0270-5; Philippe RN, 2007, CAN J BOT, V85, P1111, DOI 10.1139/B07-109; Rae AM, 2006, PLANT CELL ENVIRON, V29, P1730, DOI 10.1111/j.1365-3040.2006.01545.x; Rae AM, 2004, CAN J FOREST RES, V34, P1488, DOI 10.1139/X04-033; Rae AM, 2008, TREE GENET GENOMES, V4, P97, DOI 10.1007/s11295-007-0091-3; Rae AM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-23; Ridge CR, 1986, TREE PHYSIOL, V1, P209, DOI 10.1093/treephys/1.2.209; Rodriguez-Acosta M, 2006, GENETIC BASIS DROUGH; Ronnberg-Wastljung AC, 2006, ENTOMOL EXP APPL, V118, P163, DOI 10.1111/j.1570-7458.2006.00371.x; Rowntree JK, 2011, PHILOS T R SOC B, V366, P1322, DOI 10.1098/rstb.2010.0357; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Schweitzer JA, 2008, ECOSYSTEMS, V11, P1005, DOI 10.1007/s10021-008-9173-9; Schweitzer JA, 2008, ECOLOGY, V89, P773, DOI 10.1890/07-0337.1; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Seaton G, 2006, P 8 WORLD C GEN APPL; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Street NR, 2006, PLANT J, V48, P321, DOI 10.1111/j.1365-313X.2006.02864.x; Taylor G, 2002, ANN BOT-LONDON, V90, P681, DOI 10.1093/aob/mcf255; Tomescu R, 2007, ANN FOREST SCI, V64, P99, DOI 10.1051/forest:2006093; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tschaplinski TJ, 2006, TREE PHYSIOL, V26, P595, DOI 10.1093/treephys/26.5.595; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Vatsa P, 2011, BIOCHIMIE, V93, P2095, DOI 10.1016/j.biochi.2011.04.006; Walch-Liu P, 2006, PLANT CELL PHYSIOL, V47, P1045, DOI 10.1093/pcp/pcj075; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; WHITHAM TG, 1994, OECOLOGIA, V97, P481, DOI 10.1007/BF00325886; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wimp GM, 2007, MOL ECOL, V16, P5057, DOI 10.1111/j.1365-294X.2007.03544.x; Wimp GM, 2004, ECOL LETT, V7, P776, DOI 10.1111/j.1461-0248.2004.00635.x; Wu R, 1998, THEOR APPL GENET, V97, P1110, DOI 10.1007/s001220050998; Xu SZ, 2003, GENETICS, V165, P2259; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yin TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014021; Yukawa J, 2000, POPUL ECOL, V42, P105, DOI 10.1007/PL00011989; Zhu QH, 2007, BIOINFORMATICS, V23, P1307, DOI 10.1093/bioinformatics/btm113; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087	85	13	13	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79925	10.1371/journal.pone.0079925	http://dx.doi.org/10.1371/journal.pone.0079925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260320	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000327311900051
J	Zhu, YH; Xu, Q; Lin, HL; Yue, DH; Song, LZ; Wang, CY; Tian, HY; Wu, XX; Xu, AQ; Li, XJ				Zhu, Yuhui; Xu, Qing; Lin, Hualiang; Yue, Dahai; Song, Lizhi; Wang, Changyin; Tian, Huaiyu; Wu, Xiaoxu; Xu, Aiqiang; Li, Xiujun			Spatiotemporal Analysis of Infant Measles Using Population Attributable Risk in Shandong Province, 1999-2008	PLOS ONE			English	Article							TIME; REEMERGENCE; CLUSTERS; VACCINE	Background: Reduction of measles incidence and mortality has been encouraging in China. However, it remains an important public health concern among infants. This study aimed to examine the space-time distribution pattern of infant measles occurrence for the period of 1999-2008 in Shandong, China. Methods and Findings: Measles cases among infants aged younger than 1 year were obtained from the national infectious diseases reporting information system. A spatiotemporal analysis using population attributable risk percent (PAR%) was used to distinguish between multiple geographic clusters of potential interest. The analysis detected 29 statistically significant space-time clusters with the most likely cluster in Zaozhuang City from 2006 to 2008. Of the 28 secondary clusters, 22 were found in 2008. The map of PAR%, relative risk (RR) and space-time cluster analysis indicated that the clusters were generally unchanged, and were found south-west and north-west of Shandong. The Lanshan District in Linyi had the highest PAR%, while highest RR was in the Yicheng District in Zaozhuang. Conclusion: There were significant space-time clusters of infant measles in Shandong over the study period. PAR% is an effective way to analyze multiple clusters from their application like RR. Interrupting measles circulation and maintaining routine coverage over 95% may be the only effective strategy to achieve measles elimination.	[Zhu, Yuhui; Li, Xiujun] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Xu, Qing; Song, Lizhi; Wang, Changyin; Xu, Aiqiang] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Lin, Hualiang] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Yue, Dahai] Peking Univ, China Ctr Hlth Dev Studies, Beijing 100871, Peoples R China; [Tian, Huaiyu] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China; [Tian, Huaiyu; Wu, Xiaoxu] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China	Shandong University; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Peking University; Tsinghua University; Beijing Normal University	Xu, AQ (corresponding author), Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China.	aqxuepi@163.com; xjli@sdu.edu.cn	Tian, Huaiyu/G-1934-2016	Tian, Huaiyu/0000-0002-4466-0858; Zhu, Yuhui/0000-0001-9926-250X	Shandong Provincial Natural Science Fund [ZR2010HM126]; National Basic Research Program of China [2012CB955500-955502]; National Research Program of the Ministry of Science and Technology, China [2012AA12A407, 2013AA122003]	Shandong Provincial Natural Science Fund(Natural Science Foundation of Shandong Province); National Basic Research Program of China(National Basic Research Program of China); National Research Program of the Ministry of Science and Technology, China	This study was supported by the following grants: Shandong Provincial Natural Science Fund (ZR2010HM126), National Basic Research Program of China (973 Program, 2012CB955500-955502), National Research Program of the Ministry of Science and Technology, China (2012AA12A407 & 2013AA122003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis E, 2009, J INFECTION, V59, P252, DOI 10.1016/j.jinf.2009.07.005; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P29; Banu S, 2012, TROP MED INT HEALTH, V17, P1086, DOI 10.1111/j.1365-3156.2012.03038.x; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Bozzola E, 2011, PEDIATR INFECT DIS J, V30, P271, DOI 10.1097/INF.0b013e31820676e8; Changyin W, 2007, CHIN VACCINES IMMUN, V13, P112; du Chatelet IP, 2010, EUROSURVEILLANCE, V15, P2; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Fitzpatrick G, 2012, EURO SURVEILL, V17; Gomez-Barroso D, 2012, EPIDEMIOL INFECT, V140, P407, DOI 10.1017/S0950268811000811; Klinge J, 2000, VACCINE, V18, P3134, DOI 10.1016/S0264-410X(00)00096-7; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2011, SATSCAN US GUID VERS; Leuridan E, 2007, VACCINE, V25, P6296, DOI 10.1016/j.vaccine.2007.06.020; Leuridan E, 2010, BMJ, P340; Li X, 2012, PUBLIC HEALTH, V126, P1017, DOI 10.1016/j.puhe.2012.07.011; Loha E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047354; Ma C, 2011, J INFECT DIS, V204, pS447, DOI 10.1093/infdis/jir103; Machaira M, 2012, PEDIATR INFECT DIS J, V31, P756, DOI 10.1097/INF.0b013e31825ad11b; Poland GA, 2012, VACCINE, V30, P103, DOI 10.1016/j.vaccine.2011.11.085; Qu JW, 2011, CHIN J VAC IMMUN, V17, P152; Rubin DB, 2008, INT J BIOSTAT, V6, P1; Song L, 2007, CHIN J VACCINE IMMUN, V13, P373; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Sugerman DE, 2010, PEDIATRICS, V125, P747, DOI 10.1542/peds.2009-1653; Wand H, 2009, ADDICTION, V104, P2049, DOI 10.1111/j.1360-0443.2009.02704.x; Watson J C, 1998, MMWR Recomm Rep, V47, P1; World Health Organization, 2003, WHO REC STAND SURV S; Wu ChengYin, 2009, Chinese Preventive Medicine, V10, P1008; Xu Q, 2008, PREV MED TRIBUNAL, V14, P684; Yiannakoulias N, 2009, HEALTH PLACE, V15, P1142, DOI 10.1016/j.healthplace.2009.07.001; Zuokui X, 2001, CLIN PREV MED, V2, P127	33	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79334	10.1371/journal.pone.0079334	http://dx.doi.org/10.1371/journal.pone.0079334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260199	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900020
J	Rezai, X; Kieffer, BL; Roux, MJ; Massotte, D				Rezai, Xavier; Kieffer, Brigitte L.; Roux, Michel J.; Massotte, Dominique			Delta Opioid Receptors Regulate Temporoammonic-Activated Feedforward Inhibition to the Mouse CA1 Hippocampus	PLOS ONE			English	Article							RAT HIPPOCAMPUS; IN-VIVO; PYRAMIDAL NEURONS; CORTICAL INPUT; AREA CA1; MORPHINE; MEMORY; CELLS; MICE; INTERNEURONS	The opioid system influences learning and memory processes. However, neural mechanisms underlying the modulation of hippocampal activity by opioid receptors remain largely unknown. Here, we compared how mu and delta receptors operate within the mouse CA1 network, and used knock-in mice expressing functional delta opioid receptors fused to the green fluorescent protein (DOR-eGFP) to determine how delta opioid receptor-expressing interneurons integrate within the hippocampal circuitry. Through whole cell patch-clamp recording of CA1 pyramidal neurons from wild-type and DOR-eGFP mice, we found that mu and delta receptors both modulate spontaneous GABAergic inhibition received by these cells. Interestingly, mu but not delta receptor activation decreased the feed-forward inhibitory input evoked by Schaffer collateral stimulation. However, mu and delta agonists modulated GABAergic feed-forward inhibition when evoked upon stimulation of the temporoammonic pathway. In addition, anterograde tracing using biotinylated dextran amine injected into the entorhinal cortex of DOR-eGFP mice suggests the existence of synaptic contacts between temporoammonic afferents and delta receptor-expressing interneurons processes in CA1. Altogether, our data demonstrate a distinct modulatory role of the hippocampal network activity by mu and delta opioid receptors, and show for the first time that delta receptor-expressing interneurons in the CA1 are recruited by the temporoammonic pathway rather than the Schaffer collateral.	[Rezai, Xavier; Kieffer, Brigitte L.; Roux, Michel J.; Massotte, Dominique] IGBMC, Dept Neurogenet & Translat Med, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Roux, MJ (corresponding author), IGBMC, Dept Neurogenet & Translat Med, Illkirch Graffenstaden, France.	mjroux@igbmc.fr; massotte@igbmc.fr	Roux, Michel J/A-3213-2009	Roux, Michel J/0000-0002-5812-5215; massotte, dominique/0000-0002-8758-1009	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite de Strasbourg; Agence Nationale pour la Recherche (IMOP); National Institutes of Health [NIDA DA-05010]; Stefan and Shirley Hatos Center for Neuropharmacology; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg; Agence Nationale pour la Recherche (IMOP)(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stefan and Shirley Hatos Center for Neuropharmacology; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank their funding sources including the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite de Strasbourg, The Agence Nationale pour la Recherche (IMOP), the National Institutes of Health (NIDA DA-05010) and the Stefan and Shirley Hatos Center for Neuropharmacology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Ciccocioppo R, 2002, NEUROPSYCHOPHARMACOL, V27, P391, DOI 10.1016/S0893-133X(02)00302-0; Commons KG, 1997, J COMP NEUROL, V381, P373; Drake CT, 2007, PROG BRAIN RES, V163, P245, DOI 10.1016/S0079-6123(07)63015-5; Drake CT, 2002, HIPPOCAMPUS, V12, P119, DOI 10.1002/hipo.1107; Dugue GP, 2005, J NEUROSCI, V25, P6490, DOI 10.1523/JNEUROSCI.1500-05.2005; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; Erbs E, 2012, NEUROSCIENCE, V221, P203, DOI 10.1016/j.neuroscience.2012.06.023; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Ito HT, 2011, HIPPOCAMPUS; Jafari-Sabet M, 2009, BEHAV BRAIN RES, V202, P5, DOI 10.1016/j.bbr.2009.03.010; Kieffer BL, 2009, NEUROPHARMACOLOGY, V56, P205, DOI 10.1016/j.neuropharm.2008.07.033; Kiss J, 1996, HIPPOCAMPUS, V6, P239, DOI 10.1002/(SICI)1098-1063(1996)6:3<239::AID-HIPO3>3.0.CO;2-I; Le Merrer J, 2011, BIOL PSYCHIAT, V69, P700, DOI 10.1016/j.biopsych.2010.10.021; Lecoq I, 2004, J PHARMACOL EXP THER, V310, P666, DOI 10.1124/jpet.103.063958; LUPICA CR, 1992, BRAIN RES, V593, P226, DOI 10.1016/0006-8993(92)91312-3; LUPICA CR, 1995, J NEUROSCI, V15, P737; Marinelli PW, 2009, EUR J NEUROSCI, V30, P671, DOI 10.1111/j.1460-9568.2009.06851.x; McQuiston AR, 2008, NEUROSCIENCE, V151, P209, DOI 10.1016/j.neuroscience.2007.09.077; McQuiston AR, 2011, NEUROPHARMACOLOGY, V60, P472, DOI 10.1016/j.neuropharm.2010.10.029; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Olmstead MC, 1997, BEHAV NEUROSCI, V111, P1324, DOI 10.1037/0735-7044.111.6.1324; Pradhan AAA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005425; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Rezai X, 2012, CELL MOL NEUROBIOL, V32, P509, DOI 10.1007/s10571-011-9791-1; Robles Y, 2003, NEUROBIOL LEARN MEM, V80, P80, DOI 10.1016/S1074-7427(03)00025-X; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shippenberg TS, 2009, BIOL PSYCHIAT, V65, P169, DOI 10.1016/j.biopsych.2008.09.009; Stumm RK, 2004, J COMP NEUROL, V469, P107, DOI 10.1002/cne.10997; Zhu F, 2011, PHYSIOL BEHAV, V104, P754, DOI 10.1016/j.physbeh.2011.07.014; ZIEGLGANSBERGER W, 1979, SCIENCE, V205, P415, DOI 10.1126/science.451610	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79081	10.1371/journal.pone.0079081	http://dx.doi.org/10.1371/journal.pone.0079081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260157	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600019
J	Wu, Q; Sun, X; Chi, R; Xu, L; Li, X; Feng, J; Chen, HY				Wu, Qi; Sun, Xin; Chi, Ruo; Xu, Long; Li, Xue; Feng, Jing; Chen, Huaiyong			ROR gamma t Modulates Macrophage Recruitment during a Hydrocarbon Oil-Induced Inflammation	PLOS ONE			English	Article							IMMUNE-COMPLEX GLOMERULONEPHRITIS; PRISTANE-INDUCED ARTHRITIS; BALB/C MICE; INTRAPERITONEAL INJECTION; GRANULOMA RESPONSES; MURINE MODEL; INDUCTION; CELLS; PLASMACYTOMA; AUTOANTIBODIES	Hydrocarbon oils are often utilized as adjuvants in vaccines. In response to naturally occurring hydrocarbon oils, inflammation is initiated and persists with the continuous recruitment of immune cells such as macrophages and neutrophils. However, the mechanism underlying the chronic inflammation in response to hydrocarbon oils is not fully defined. In this study, we revealed an essential role of retinoid-related orphan receptor gamma t (ROR gamma t) in sustaining the recruitment of macrophages following pristane treatment. ROR gamma t absence resulted in the incompetent formation of mesenteric oil granulomas which may associate to a reduction in the migration of macrophages into the mesentery during pristane-induced inflammation. This is at least partially dependent on the expression of the monocyte chemoattractant protein-1 (MCP-1) in the mesentery and the decrease in the macrophage reservoir in the spleen. However, the absence of ROR gamma t had no impact on the recruitment of neutrophils to the mesentery after pristane treatment. Our data uncovered an important role of ROR gamma t in the recruitment of macrophages during hydrocarbon oil-induced chronic inflammation.	[Wu, Qi; Sun, Xin; Chi, Ruo; Xu, Long; Li, Xue; Chen, Huaiyong] Tianjin Haihe Hosp, Tianjin Inst Resp Dis, Tianjin, Peoples R China; [Feng, Jing] Tianjin Med Univ, Gen Hosp, Resp Dept, Tianjin, Peoples R China	Tianjin Medical University	Feng, J (corresponding author), Tianjin Med Univ, Gen Hosp, Resp Dept, Tianjin, Peoples R China.	zyyhxkfj@126.com; huaiyong.chen@foxmail.com	Chen, Huaiyong/G-3822-2014		National Natural Science Foundation of China [81270144, 30800507, 81170071]; Natural Science Foundation of Tianjin City [13JCYBJC22400, 13JCYBJC40000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin City(Natural Science Foundation of Tianjin)	This study was supported by grants from the National Natural Science Foundation of China (81270144, 30800507, 81170071) and by grants from the Natural Science Foundation of Tianjin City (13JCYBJC22400, 13JCYBJC40000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PN, 1969, NATURE, V222, P994, DOI 10.1038/222994a0; Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386; Avcu F, 2005, EUR J HAEMATOL, V74, P496, DOI 10.1111/j.1600-0609.2005.00427.x; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; CANCRO M, 1976, J EXP MED, V144, P1554, DOI 10.1084/jem.144.6.1554; Chen HY, 2010, INT J EXP PATHOL, V91, P472, DOI 10.1111/j.1365-2613.2010.00732.x; Chen HY, 2010, INT J EXP PATHOL, V91, P460, DOI 10.1111/j.1365-2613.2010.00725.x; Chowdhary VR, 2007, RHEUMATOLOGY, V46, P1405, DOI 10.1093/rheumatology/kem117; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; EHRICH WE, 1945, J EXP MED, V82, P343, DOI 10.1084/jem.82.5.343; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; HOPKINS SJ, 1984, RHEUMATOL INT, V5, P21, DOI 10.1007/BF00541361; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Lee PY, 2011, J IMMUNOL, V186, P1747, DOI 10.4049/jimmunol.1001328; Lee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328; Nacionales DC, 2006, AM J PATHOL, V168, P1227, DOI 10.2353/ajpath.2006.050125; Patten C, 2004, ARTHRITIS RHEUM-US, V50, P3334, DOI 10.1002/art.20507; POTTER M, 1964, J NATL CANCER I, V33, P497; POTTER M, 1973, J NATL CANCER I, V51, P875, DOI 10.1093/jnci/51.3.875; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Satoh M, 1996, J IMMUNOL, V157, P3200; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; SPICKARD A, 1994, ARCH INTERN MED, V154, P686, DOI 10.1001/archinte.154.6.686; Summers SA, 2010, J AUTOIMMUN, V35, P291, DOI 10.1016/j.jaut.2010.05.004; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; WILNER BI, 1963, J IMMUNOL, V91, P210; Zhang N, 2003, J IMMUNOL, V171, P1667, DOI 10.4049/jimmunol.171.4.1667	32	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79497	10.1371/journal.pone.0079497	http://dx.doi.org/10.1371/journal.pone.0079497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260235	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600037
J	Benede, S; Lopez-Fandino, R; Reche, M; Molina, E; Lopez-Exposito, I				Benede, Sara; Lopez-Fandino, Rosina; Reche, Marta; Molina, Elena; Lopez-Exposito, Ivan			Influence of the Carbohydrate Moieties on the Immunoreactivity and Digestibility of the Egg Allergen Ovomucoid	PLOS ONE			English	Article							IGE-BINDING; PROTEIN GLYCOSYLATION; MAJOR ALLERGEN; 3RD DOMAIN; EPITOPES; ANTIBODY; POLLEN	Background: Ovomucoid (OM) has two carbohydrate chains on each of the first and second domains and one in the third. The contribution of the covalently bound carbohydrate chains to the overall OM allergenicity is controversial. Another aspect directly related with the immunological properties of OM that has not been studied in depth is the importance of the carbohydrate chains on its digestibility. Objective: The aim of the study was to assess the involvement of the carbohydrate moieties of OM in its digestibility and allergenic properties. Methods: IgE-binding and basophil activation by glycosylated and enzymatically deglycosylated OM (dOM) were compared using blood from egg-allergic patients. The peptides obtained after digestion using a physiologically relevant model were identified by RP-HPLC-MS/MS and the IgE-binding of the resulting fragments was evaluated by DOT-Blot. Results: No structural changes were observed after deglycosylation of OM. 80% of the patients showed lower IgE binding to dOM as compared with OM and, in some patients, IgE reactivity could not be inhibited by pre-incubation with dOM. A subtle reduction in the percentage of activated basophils was observed when incubated with dOM as compared to OM. Following simulated digestion, dOM was more extensively degraded than OM, particularly during the gastric phase and both, OM and dOM, yielded, after the duodenal phase, immunoreactive fragments that were totally or partially coincident with previously described epitopes. Conclusion: & Clinical Relevance: this work demonstrated an enhanced IgE reactivity towards carbohydrate containing OM in some egg-allergic patients that could be attributed to cross-sensitization or sensitization to the glycosylated components. The carbohydrate chains contributed to an increased resistance to proteolysis, and thus, to its allergenic potency. Evaluation of the products of digestion of OM and dOM revealed the presence of high-frequency IgE-binding epitopes that could remain linked by disulphide bonds.	[Benede, Sara; Lopez-Fandino, Rosina; Molina, Elena; Lopez-Exposito, Ivan] Univ Autonoma Madrid, CSIC, Inst Invest Ciencias Alimentac, Dept Bioactividad & Anal Alimentos, Madrid, Spain; [Reche, Marta] Hosp Infanta Sofia, Serv Alergia, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL)	Lopez-Exposito, I (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Ciencias Alimentac, Dept Bioactividad & Anal Alimentos, Madrid, Spain.	ivan.lopez@csic.es	Benedé, Sara/H-6147-2013; Molina, Elena/H-4055-2012; López-Fandiño, Rosina/H-4132-2012; Reche, Marta/ABF-8972-2021; López-Expósito, Iván/M-1150-2014	Benedé, Sara/0000-0002-9288-9438; Molina, Elena/0000-0001-7918-7768; López-Fandiño, Rosina/0000-0002-6979-9258; López-Expósito, Iván/0000-0003-3011-3527	Ministerio de Economia y Competitividad (Spain) [AGL2011-24740]; Consejo Superior de Investigaciones Cientificas	Ministerio de Economia y Competitividad (Spain); Consejo Superior de Investigaciones Cientificas	This work was funded by the Ministerio de Economia y Competitividad (Spain) project AGL2011-24740. SB and IL-E acknowledge the financial support of Consejo Superior de Investigaciones Cientificas through Junta para la Ampliacion de Estudios Pre and Doc grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; BATANERO E, 1994, MOL IMMUNOL, V31, P31, DOI 10.1016/0161-5890(94)90135-X; Benhamou AH, 2010, ALLERGY, V65, P283, DOI 10.1111/j.1398-9995.2009.02251.x; Besler M, 1997, FOOD AGR IMMUNOL, V9, P277, DOI 10.1080/09540109709354958; Blank S, 2012, CLIN EXP ALLERGY, V42, P976, DOI 10.1111/j.1365-2222.2012.03966.x; Breiteneder H, 2005, J ALLERGY CLIN IMMUN, V115, P14, DOI 10.1016/j.jaci.2004.10.022; Chiang WC, 2012, J ALLERGY CLIN IMMUN, V130, P1361, DOI 10.1016/j.jaci.2012.08.048; Cooke SK, 1997, J IMMUNOL, V159, P2026; Hasan SA, 2013, ALLERGY ASTHMA PROC, V34, P26, DOI 10.2500/aap.2013.34.3621; Holen E, 2001, CLIN EXP ALLERGY, V31, P952, DOI 10.1046/j.1365-2222.2001.01102.x; Jaervinen KM, 2007, ALLERGY, V62, P758, DOI 10.1111/j.1398-9995.2007.01332.x; Jimenez-Saiz R, 2013, FOOD HYDROCOLLOID, V30, P597, DOI 10.1016/j.foodhyd.2012.07.014; Jimenez-Saiz R, 2011, J AGR FOOD CHEM, V59, P10044, DOI 10.1021/jf2014638; Kovacs-Nolan J, 2000, J AGR FOOD CHEM, V48, P6261, DOI 10.1021/jf000358e; Martinez-Botas J, 2013, INT ARCH ALLERGY IMM, V161, P11, DOI 10.1159/000343040; Martos G, 2011, J ALLERGY CLIN IMMUN, V127, P990, DOI 10.1016/j.jaci.2011.01.057; Martos G, 2010, J AGR FOOD CHEM, V58, P5640, DOI 10.1021/jf904538w; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; MATSUDA T, 1985, BIOCHEM BIOPH RES CO, V129, P505, DOI 10.1016/0006-291X(85)90180-9; Mine Y, 2002, BIOCHEM BIOPH RES CO, V292, P1070, DOI 10.1006/bbrc.2002.6725; Mine Y, 2008, J AGR FOOD CHEM, V56, P4874, DOI 10.1021/jf8001153; Moreno FJ, 2005, FEBS J, V272, P341, DOI 10.1111/j.1742-4658.2004.04472.x; Moverare R, 2000, IMMUNOL LETT, V73, P51, DOI 10.1016/S0165-2478(00)00199-1; Ongay S, 2012, J SEP SCI, V35, P2341, DOI 10.1002/jssc.201200434; PELLEGRINI A, 1992, J APPL BACTERIOL, V72, P180, DOI 10.1111/j.1365-2672.1992.tb01821.x; Ruiter B, 2012, SEMIN IMMUNOPATHOL, V34, P617, DOI 10.1007/s00281-012-0334-8; Rupa P, 2007, CLIN EXP ALLERGY, V37, P918, DOI 10.1111/j.1365-2222.2007.02720.x; Takagi K, 2005, INT ARCH ALLERGY IMM, V136, P23, DOI 10.1159/000082581; Vickery BP, 2012, CURR OPIN ALLERGY CL, V12, P278, DOI 10.1097/ACI.0b013e3283535bae; WATANABE K, 1981, BIOCHIM BIOPHYS ACTA, V667, P242, DOI 10.1016/0005-2795(81)90189-6; Yamada K, 2000, ALLERGY, V55, P565, DOI 10.1034/j.1398-9995.2000.00430.x; Yousif AN, 2002, ANAL BIOCHEM, V311, P93, DOI 10.1016/S0003-2697(02)00385-8; Zhang JW, 1998, BIOCHEM BIOPH RES CO, V253, P124, DOI 10.1006/bbrc.1998.9761	33	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80810	10.1371/journal.pone.0080810	http://dx.doi.org/10.1371/journal.pone.0080810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244718	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800164
J	Gerbaba, TK; Gedamu, L				Gerbaba, Teklu Kuru; Gedamu, Lashitew			Cathepsin B Gene Disruption Induced Leishmania donovani Proteome Remodeling Implies Cathepsin B Role in Secretome Regulation	PLOS ONE			English	Article							PROTEINASE-DEFICIENT MUTANTS; TRYPANOSOMA-BRUCEI; CYSTEINE PROTEASES; CYTOSOLIC TRYPAREDOXIN; PATHOGEN LEISHMANIA; DRUG-RESISTANCE; CELL-DEATH; EXPRESSION; VIRULENCE; MEXICANA	Leishmania cysteine proteases are potential vaccine candidates and drug targets. To study the role of cathepsin B cysteine protease, we have generated and characterized cathepsin B null mutant L. donovani parasites. L. donovani cathepsin B null mutants grow normally in culture, but they show significantly attenuated virulence inside macrophages. Quantitative proteome profiling of wild type and null mutant parasites indicates cathepsin B disruption induced remodeling of L. donovani proteome. We identified 83 modulated proteins, of which 65 are decreased and 18 are increased in the null mutant parasites, and 66% (55/83) of the modulated proteins are L. donovani secreted proteins. Proteins involved in oxidation-reduction (trypanothione reductase, peroxidoxins, tryparedoxin, cytochromes) and translation (ribosomal proteins) are among those decreased in the null mutant parasites, and most of these proteins belong to the same complex network of proteins. Our results imply virulence role of cathepsin B via regulation of Leishmania secreted proteins.	[Gerbaba, Teklu Kuru; Gedamu, Lashitew] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Gedamu, L (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	lgedamu@ucalgary.ca		Gerbaba, Teklu/0000-0002-0319-2824	University of Calgary, Canada; Natural Sciences and Engineering Council of Canada (NSERC) [12034]	University of Calgary, Canada; Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant provided to LG (University of Calgary, Canada) by the Natural Sciences and Engineering Council of Canada (NSERC; Grant No. 12034). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; Alexander J, 1998, J IMMUNOL, V161, P6794; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Bart G, 1997, MOL BIOCHEM PARASIT, V88, P53, DOI 10.1016/S0166-6851(97)00072-8; BRUN R, 1979, ACTA TROP, V36, P387; Chan VJ, 1999, BIOCHEM J, V340, P113, DOI 10.1042/0264-6021:3400113; Chong PK, 2006, J PROTEOME RES, V5, P1232, DOI 10.1021/pr060018u; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; Daifalla NS, 2011, EXP PARASITOL, V129, P292, DOI 10.1016/j.exppara.2011.07.001; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; El-Fadili AK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.51; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Ghosh M, 2003, MOL CELL BIOCHEM, V253, P199, DOI 10.1023/A:1026047429604; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Hassani K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018724; Iyer JP, 2008, MOL MICROBIOL, V68, P372, DOI 10.1111/j.1365-2958.2008.06154.x; Jayanarayan KG, 2002, J CLIN PHARM THER, V27, P313, DOI 10.1046/j.1365-2710.2002.00431.x; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; Mertins P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014423; Mundodi V, 2002, GENE, V282, P257, DOI 10.1016/S0378-1119(01)00851-4; Omara-Opyene AL, 1997, MOL BIOCHEM PARASIT, V90, P247, DOI 10.1016/S0166-6851(97)00158-8; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Park J, 2010, FUNCT PLANT BIOL, V37, P1, DOI 10.1071/FP09074; Probst P, 2001, J IMMUNOL, V166, P498, DOI 10.4049/jimmunol.166.1.498; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; ROBERTSON CD, 1993, MOL BIOCHEM PARASIT, V62, P271, DOI 10.1016/0166-6851(93)90116-F; Romao S, 2009, INT J PARASITOL, V39, P703, DOI 10.1016/j.ijpara.2008.11.009; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santarem N, 2013, J PROTEOMICS; Selzer PM, 1997, EXP PARASITOL, V87, P212, DOI 10.1006/expr.1997.4220; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00026; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Trinh Hung V, 2013, Int J Proteomics, V2013, P581862, DOI 10.1155/2013/581862; Zhang WW, 1997, P NATL ACAD SCI USA, V94, P8807, DOI 10.1073/pnas.94.16.8807; Zhu Y, 2011, CELL RES	51	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79951	10.1371/journal.pone.0079951	http://dx.doi.org/10.1371/journal.pone.0079951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244582	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800105
J	Lewis, JJ; Fielding, KL; Grant, AD; Chihota, VN; Popane, F; Luttig, M; Muller, D; Coetzee, L; Churchyard, GJ				Lewis, James J.; Fielding, Katherine L.; Grant, Alison D.; Chihota, Violet N.; Popane, Flora; Luttig, Mariette; Muller, Dorothy; Coetzee, Leonie; Churchyard, Gavin J.			Eligibility for Isoniazid Preventive Therapy in South African Gold Mines	PLOS ONE			English	Article							TUBERCULOSIS; EXPERIENCE; DISEASE; ADULTS; IMPACT	Setting: The "Thibela TB" cluster randomised trial of community-wide isoniazid preventive therapy (IPT) to reduce tuberculosis incidence in the South African gold mines. Objectives: To determine the proportion of participants eligible for IPT and the reasons and risk factors for ineligibility, to inform the scale-up of IPT. Design: Cross-sectional survey of participants in intervention clusters (mine shafts) consenting to tuberculosis screening and assessment for eligibility to start IPT. Results: Among 27,126 consenting participants, 94.7% were male, the median age was 41 years, 12.2% reported previous tuberculosis, 0.6% reported ever taking IPT and 2.5% reported currently taking antiretroviral therapy. There were 24,430 (90.1%) assessed as eligible to start IPT, of whom 23,659 started IPT. The most common reasons for ineligibility were having suspected tuberculosis that was subsequently confirmed by a positive smear and/or culture (n=705), excessive alcohol consumption (n=427) and being on tuberculosis treatment at time of initial screen (n=241). Ineligibility was associated with factors including older age, female gender, prior history of tuberculosis and being in "HIV care". However, at least 78% were eligible for IPT in all of these sub-groups. Conclusions: The vast majority of participants in this community-wide intervention were eligible for IPT.	[Lewis, James J.; Fielding, Katherine L.; Grant, Alison D.; Churchyard, Gavin J.] London Sch Hyg & Trop Med, London WC1, England; [Lewis, James J.; Chihota, Violet N.; Popane, Flora; Luttig, Mariette; Muller, Dorothy; Coetzee, Leonie; Churchyard, Gavin J.] Aurum Inst Hlth Res, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine	Lewis, JJ (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	james.lewis@lshtm.ac.uk	Chihota, Violet/DWH-9372-2022; Lewis, James/F-6333-2013	Lewis, James/0000-0002-8603-2761; Churchyard, Gavin/0000-0002-4269-3699; Chihota, Violet/0000-0003-1444-9266	Consortium to Respond Effectively to the AIDS TB Epidemic (CREATE), United States; Bill and Melinda Gates foundation; South African Mine Health and Safety Council; Foundation for Innovative New Diagnostics, Switzerland; National Institutes of Health/National Institutes of Allergy and Infectious Diseases [AI077486]; UK Department of Health; NIH Fogarty, ICORTA TB/AIDS [5U2RTW007370, 5U2RTW007373]; Biostatistics core of CREATE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077486] Funding Source: NIH RePORTER; Medical Research Council [MR/K007467/1, MR/K012126/1] Funding Source: researchfish; National Institute for Health Research [PHCS/03/01] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	Consortium to Respond Effectively to the AIDS TB Epidemic (CREATE), United States; Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); South African Mine Health and Safety Council; Foundation for Innovative New Diagnostics, Switzerland; National Institutes of Health/National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UK Department of Health; NIH Fogarty, ICORTA TB/AIDS; Biostatistics core of CREATE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge funding from: the Consortium to Respond Effectively to the AIDS TB Epidemic (CREATE), United States, who received funding from the Bill and Melinda Gates foundation (www.gatesfoundation.org); the South African Mine Health and Safety Council; the Foundation for Innovative New Diagnostics, Switzerland (www.finddiagnostics.org); National Institutes of Health/National Institutes of Allergy and Infectious Diseases (www.niaid.nih.gov) award #AI077486. Alison Grant was supported by a Public Health Career Scientist award from the UK Department of Health (www.dh.gov.uk). Violet Chihota was supported by NIH Fogarty (www.fic.nih.gov) ICORTA TB/AIDS (Grant 5U2RTW007370 and 5U2RTW007373). Katherine Fielding was partially funded and James Lewis fully funded by the Biostatistics core of CREATE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUID INT TUB CAS FIN; Churchyard GJ, 2010, AIDS, V24, pS19, DOI 10.1097/01.aids.0000391018.72542.46; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; Fielding KL, 2011, CONTEMP CLIN TRIALS, V32, P382, DOI 10.1016/j.cct.2010.12.008; Grant AD, 2010, AIDS, V24, pS29, DOI 10.1097/01.aids.0000391019.10661.66; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; LEWIS JJ, 2008, 39 WORLD C LUNG HLTH; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Mosimaneotsile B, 2010, JAIDS-J ACQ IMM DEF, V54, P71, DOI 10.1097/QAI.0b013e3181c3cbf0; Mugisha B, 2006, INT J TUBERC LUNG D, V10, P761; *SOUTH AFR DEP HLT, 2010, GUID TUB PREV THER H; South African Department of Health, 2013, S AFR ANT TREATM GUI; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Swaminathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047400; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	17	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81376	10.1371/journal.pone.0081376	http://dx.doi.org/10.1371/journal.pone.0081376			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244741	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000327143800181
J	Silva, CC; Mendonca, C; Mouta, S; Silva, R; Campos, JC; Santos, J				Silva, Carlos Cesar; Mendonca, Catarina; Mouta, Sandra; Silva, Rosa; Campos, Jose Creissac; Santos, Jorge			Depth Cues and Perceived Audiovisual Synchrony of Biological Motion	PLOS ONE			English	Article							PERCEPTION; INTEGRATION; DISTANCE	Background: Due to their different propagation times, visual and auditory signals from external events arrive at the human sensory receptors with a disparate delay. This delay consistently varies with distance, but, despite such variability, most events are perceived as synchronic. There is, however, contradictory data and claims regarding the existence of compensatory mechanisms for distance in simultaneity judgments. Principal Findings: In this paper we have used familiar audiovisual events - a visual walker and footstep sounds and manipulated the number of depth cues. In a simultaneity judgment task we presented a large range of stimulus onset asynchronies corresponding to distances of up to 35 meters. We found an effect of distance over the simultaneity estimates, with greater distances requiring larger stimulus onset asynchronies, and vision always leading. This effect was stronger when both visual and auditory cues were present but was interestingly not found when depth cues were impoverished. Significance: These findings reveal that there should be an internal mechanism to compensate for audiovisual delays, which critically depends on the depth information available.	[Silva, Carlos Cesar] Univ Minho, Dept Informat, Braga, Portugal; [Mendonca, Catarina] Carl Ossietzky Univ, Sch Med & Hlth Sci, Dept Psychol, Oldenburg, Lower Saxony, Germany; [Mouta, Sandra] Univ Barcelona, Dept Psicol Basica, Barcelona, Catalonia, Spain; [Mouta, Sandra] INESC, Inst Engn Sistemas & Comp, Porto, Portugal; [Silva, Rosa; Santos, Jorge] Univ Minho, Sch Psychol, Dept Basic Psychol, Braga, Portugal; [Campos, Jose Creissac] Univ Minho, Sch Engn, Dept Informat, Braga, Portugal; [Campos, Jose Creissac] INESC TEC, HASLab, Porto, Portugal; [Santos, Jorge] Univ Minho, Ctr Algoritmi, Braga, Portugal; [Santos, Jorge] Ctr Comp Graf, Braga, Portugal	Universidade do Minho; Carl von Ossietzky Universitat Oldenburg; University of Barcelona; INESC TEC; Universidade do Porto; Universidade do Minho; Universidade do Minho; INESC TEC; Universidade do Minho	Silva, CC (corresponding author), Univ Minho, Dept Informat, Braga, Portugal.	carlos.cl.silva@gmail.com	Mouta, Sandra/H-8112-2013; Campos, José Creissac/B-2506-2008; Silva, Carlos/K-8821-2014; Mendonça, Catarina/L-8877-2013	Mouta, Sandra/0000-0002-0119-2329; Campos, José Creissac/0000-0001-9163-580X; Silva, Carlos/0000-0003-1973-2343; Mendonça, Catarina/0000-0002-4333-898X; Loureiro Silva, Carlos Cesar/0000-0002-4886-9405; Silva, Rosa Mariana/0000-0002-9902-6205; Santos, Jorge/0000-0001-5881-8567	Portuguese Foundation for Science and Technology [PTDC/EEA-ELC/112137/2009, SFRH/BPD/63393/2009]; FEDER grants through the Operational Competitiveness Program -COMPETE; national grants through FCT -Portuguese Foundation for Science and Technology [FCOMP-01-0124-FEDER-022674, PEst-C/CTM/U10264/2011, FCOMP-01-0124-FEDER-037281, PEst-C/EEI/LA0014/2013, FCOMP-01-0124-FEDER-015095]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER grants through the Operational Competitiveness Program -COMPETE; national grants through FCT -Portuguese Foundation for Science and Technology	This research was financed by the Portuguese Foundation for Science and Technology [PTDC/EEA-ELC/112137/2009; SFRH/BPD/63393/2009]. This work was financed by FEDER grants through the Operational Competitiveness Program -COMPETE and by national grants through FCT -Portuguese Foundation for Science and Technology, with the following projects: FCOMP-01-0124-FEDER-022674 and PEst-C/CTM/U10264/2011; FCOMP-01-0124-FEDER-037281 and PEst-C/EEI/LA0014/2013; and FCOMP-01-0124-FEDER-015095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2005, P NATL ACAD SCI USA, V102, P2244, DOI 10.1073/pnas.0407034102; Arnold DH, 2005, VISION RES, V45, P1275, DOI 10.1016/j.visres.2004.11.014; Arrighi R, 2006, J VISION, V6, P260, DOI 10.1167/6.3.6; BEGAULT DR, 2000, SOUND VIRTUAL REALIT, pD3; Bronkhorst AW, 1999, NATURE, V397, P517, DOI 10.1038/17374; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; ENGEL GR, 1971, NATURE, V234, P308, DOI 10.1038/234308a0; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Harris L., 2010, SPACE TIME PERCEPTIO, P232, DOI DOI 10.1017/CB09780511750540.015; Heron J, 2007, J VISION, V7, DOI 10.1167/7.13.5; Keetels M, 2005, EXP BRAIN RES, V167, P635, DOI 10.1007/s00221-005-0067-1; KING AJ, 1985, EXP BRAIN RES, V60, P492; Kopinska A, 2004, PERCEPTION, V33, P1049, DOI 10.1068/p5169; LENNIE P, 1981, VISION RES, V21, P815, DOI 10.1016/0042-6989(81)90180-2; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Lewkowicz DJ, 1996, J EXP PSYCHOL HUMAN, V22, P1094, DOI 10.1037/0096-1523.22.5.1094; Love SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054798; Marcell ME, 2000, J CLIN EXP NEUROPSYC, V22, P830, DOI 10.1076/jcen.22.6.830.949; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; PETRINI K, 2010, J VIS, V10, P14, DOI DOI 10.1167/10.5.2.PUBMED:20616143; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Virsu V, 2008, EXP BRAIN RES, V186, P525, DOI 10.1007/s00221-007-1254-z; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80096	10.1371/journal.pone.0080096	http://dx.doi.org/10.1371/journal.pone.0080096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244617	Green Submitted, gold, Green Published			2022-12-25	WOS:000327143800121
J	Silva-Sousa, R; Casacuberta, E				Silva-Sousa, Rute; Casacuberta, Elena			The JIL-1 Kinase Affects Telomere Expression in the Different Telomere Domains of Drosophila	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; DISTINCT CHROMATIN DOMAINS; HETEROCHROMATIN; ORGANIZATION; ELONGATION; BALANCE; HP1	In Drosophila, the non-LTR retrotransposons HeT-A, TART and TAHRE build a head-to-tail array of repetitions that constitute the telomere domain by targeted transposition at the end of the chromosome whenever needed. As a consequence, Drosophila telomeres have the peculiarity to harbor the genes in charge of telomere elongation. Understanding telomere expression is important in Drosophila since telomere homeostasis depends in part on the expression of this genomic compartment. We have recently shown that the essential kinase JIL-1 is the first positive regulator of the telomere retrotransposons. JIL-1 mediates chromatin changes at the promoter of the HeT-A retrotransposon that are necessary to obtain wild type levels of expression of these telomere transposons. With the present study, we show how JIL-1 is also needed for the expression of a reporter gene embedded in the telomere domain. Our analysis, using different reporter lines from the telomere and subtelomere domains of different chromosomes, indicates that JIL-1 likely acts protecting the telomere domain from the spreading of repressive chromatin from the adjacent subtelomere domain. Moreover, the analysis of the 4R telomere suggests a slightly different chromatin structure at this telomere. In summary, our results strongly suggest that the action of JIL-1 depends on which telomere domain, which chromosome and which promoter is embedded in the telomere chromatin.	[Silva-Sousa, Rute; Casacuberta, Elena] IBE CSIC UPF, Inst Evolutionary Biol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE)	Silva-Sousa, R (corresponding author), IBE CSIC UPF, Inst Evolutionary Biol, Barcelona, Spain.	elena.casacuberta@ibe.upf-csic.es		Casacuberta, Elena/0000-0002-8203-8357	Spanish Ministry of Science and Innovation [BFU2009-08318/BMC]; PhD Fellowship Fundacao para a Ciencia e Tecnologia, Portugal [SFRH / BD / 36291 / 2007]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PhD Fellowship Fundacao para a Ciencia e Tecnologia, Portugal	This work was supported by a grant from the Spanish Ministry of Science and Innovation BFU2009-08318/BMC to EC and a PhD Fellowship Fundacao para a Ciencia e Tecnologia, Portugal SFRH / BD / 36291 / 2007 to RSS. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva EN, 2005, J CELL SCI, V118, P5465, DOI 10.1242/jcs.02654; Antao JM, 2012, MOL CELL BIOL, V32, P2170, DOI 10.1128/MCB.00010-12; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; Boivin A, 2003, GENETICS, V164, P195; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Frydrychova RC, 2008, CYTOGENET GENOME RES, V122, P356, DOI 10.1159/000167823; Frydrychova RC, 2008, GENETICS, V180, P121, DOI 10.1534/genetics.108.090647; George JA, 2006, GENOME RES, V16, P1231, DOI 10.1101/gr.5348806; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Perrini B, 2004, MOL CELL, V15, P467, DOI 10.1016/j.molcel.2004.06.036; Regnard C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001327; Riddle NC, 2008, GENETICS, V178, P1177, DOI 10.1534/genetics.107.081828; Savitsky M, 2002, MOL CELL BIOL, V22, P3204, DOI 10.1128/MCB.22.9.3204-3218.2002; Silva-Sousa R, 2012, GENOME DYNAM, V7, P46, DOI 10.1159/000337127; Silva-Sousa R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003153; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang C, 2011, J CELL SCI, V124, P4309, DOI 10.1242/jcs.092585; Wang C, 2011, GENETICS, V188, P745, DOI 10.1534/genetics.111.129353; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhang WG, 2003, GENETICS, V165, P1341	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81543	10.1371/journal.pone.0081543	http://dx.doi.org/10.1371/journal.pone.0081543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244743	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800182
J	Peer, N; Steyn, K; Lombard, C; Gwebushe, N; Levitt, N				Peer, Nasheeta; Steyn, Krisela; Lombard, Carl; Gwebushe, Nomonde; Levitt, Naomi			A High Burden of Hypertension in the Urban Black Population of Cape Town: The Cardiovascular Risk in Black South Africans (CRIBSA) Study	PLOS ONE			English	Article							BLOOD-PRESSURE; HEART-DISEASE; PHYSICAL INACTIVITY; PREVALENCE; ASSOCIATION; COHERENCE; COMMUNITY; AWARENESS; SENSE	Objective: To determine the prevalence, associations and management of hypertension in the 25-74-year-old urban black population of Cape Town and examine the change between 1990 and 2008/09 in 25-64-year-olds. Methods: In 2008/09, a representative cross-sectional sample, stratified for age and sex, was randomly selected from the same townships sampled in 1990. Cardiovascular disease risk factors were determined by administered questionnaires, clinical measurements and fasting biochemical analyses. Logistic regression models evaluated the associations with hypertension. Results: There were 1099 participants, 392 men and 707 women (response rate 86%) in 2008/09. Age-standardised hypertension prevalence was 38.9% (95% confidence interval (CI): 35.6-42.3) with similar rates in men and women. Among 25-64-year-olds, hypertension prevalence was significantly higher in 2008/09 (35.6%, 95% CI: 32.3-39.0) than in 1990 (21.6%, 95% CI: 18.6-24.9). In 2008/09, hypertension odds increased with older age, family history of hypertension, higher body mass index, problematic alcohol intake, physical inactivity and urbanisation. Among hypertensive participants, significantly more women than men were detected (69.5% vs. 32.7%), treated (55.7% vs. 21.9%) and controlled (32.4% vs. 10.4%) in 2008/09. There were minimal changes from 1990 except for improved control in 25-64-year-old women (1990: 14.1% vs. 2008/09: 31.5%). Conclusions: The high and rising hypertension burden in this population, its association with modifiable risk factors and the sub-optimal care provided highlight the urgent need to prioritise hypertension management. Innovative solutions with efficient and cost-effective healthcare delivery as well as population-based strategies are required.	[Peer, Nasheeta] MRC, Chron Dis Lifestyle Unit, Durban, South Africa; [Steyn, Krisela; Levitt, Naomi] Univ Cape Town, Dept Med, Chron Dis Initiat Africa, ZA-7925 Cape Town, South Africa; [Lombard, Carl; Gwebushe, Nomonde] MRC, Biostat Unit, Cape Town, South Africa; [Levitt, Naomi] Univ Cape Town, Dept Med, Div Endocrinol & Diabet, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Peer, N (corresponding author), MRC, Chron Dis Lifestyle Unit, Durban, South Africa.	nasheeta.peer@mrc.ac.za		Peer, Nasheeta/0000-0003-2131-8344; Gwebushe, Nomonde/0000-0003-4315-3798; Levitt, Naomi/0000-0001-6480-8066; Lombard, Carl/0000-0002-2136-6533	Servier Laboratories (South Africa); Medical Research Council of South Africa; Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; Brigham Women's Hospital; Harvard University	Servier Laboratories (South Africa); Medical Research Council of South Africa(South African Medical Research Council); Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; Brigham Women's Hospital; Harvard University	This work was supported by an unrestricted grant from Servier Laboratories (South Africa); the Medical Research Council of South Africa; the Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; and Brigham Women's Hospital and Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2008, ETHNIC DIS, V18, P505; Agardh EE, 2003, DIABETES CARE, V26, P719, DOI 10.2337/diacare.26.3.719; Ahmad OB., 2001, AGE STANDARDIZATION; Akinboboye O, 2003, J HUM HYPERTENS, V17, P381, DOI 10.1038/sj.jhh.1001562; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2000, S AFR MED J, V90, P176; [Anonymous], 2002, SAS 9 3 TS LEV 1M0 W; Berger GMB, 2000, S AFR MED J, V90, P164; Bonita R, 2002, SURVEILLANCE RISK FA; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Charlton KE, 2005, NUTRITION, V21, P39, DOI 10.1016/j.nut.2004.09.007; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Danon-Hersch N, 2007, EPIDEMIOLOGY, V18, P493, DOI 10.1097/EDE.0b013e318063eebf; Department of Health, 2011, NCD SUMM 2011; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fezeu L, 2010, J EPIDEMIOL COMMUN H, V64, P360, DOI 10.1136/jech.2008.086355; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gavin JR, 1997, DIABETES CARE, V20, P1183; Golbidi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/349710; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Joubert J, 2007, SAMJ S AFR MED J, V97, P683; Joubert J, 2007, SAMJ S AFR MED J, V97, P725; Kruger HS, 2002, NUTRITION, V18, P422, DOI 10.1016/S0899-9007(01)00751-1; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; MOLLENTZE WF, 1995, S AFR MED J, V85, P90; Norman R, 2007, SAMJ S AFR MED J, V97, P692; Opie LH, 2006, LANCET, V368, P449, DOI 10.1016/S0140-6736(06)69149-6; Peden M, 2000, S AFR MED J, V90, P251; Peer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043336; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Puoane T, 2005, S AFR J CLIN NUTR, V18, P6; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Schutte AE, 2003, J HUM HYPERTENS, V17, P339, DOI 10.1038/sj.jhh.1001553; StataCorp, 2019, STATA STAT SOFTWARE; Steyn K, 1996, E AFR MED J, V73, P758; van Rooyen JM, 2000, J HUM HYPERTENS, V14, P779, DOI 10.1038/sj.jhh.1001098; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization (WHO) Department of Non-communicable Diseases, 2002, GLOB PHYS ACT QUEST	45	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78567	10.1371/journal.pone.0078567	http://dx.doi.org/10.1371/journal.pone.0078567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255CG	24250798	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200031
J	Yoon, SM; Lim, YS; Park, MJ; Kim, SY; Cho, B; Shim, JH; Kim, KM; Lee, HC; Chung, YH; Lee, YS; Lee, SG; Lee, YS; Park, JH; Kim, JH				Yoon, Sang Min; Lim, Young-Suk; Park, Mee Jin; Kim, So Yeon; Cho, Byungchul; Shim, Ju Hyun; Kim, Kang Mo; Lee, Han Chu; Chung, Young-Hwa; Lee, Yung Sang; Lee, Sung Gyu; Lee, Yu Sun; Park, Jin-hong; Kim, Jong Hoon			Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma	PLOS ONE			English	Article							PHASE-I; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; SALVAGE TREATMENT; MILAN CRITERIA; RADIOTHERAPY; TRIAL; HEPATECTOMY	Background: Even with early stage hepatocellular carcinoma (HCC), patients are often ineligible for surgical resection, transplantation, or local ablation due to advanced cirrhosis, donor shortage, or difficult location. Stereotactic body radiation therapy (SBRT) has been established as a standard treatment option for patients with stage I lung cancer, who are not eligible for surgery, and may be a promising alternative treatment for patients with small HCC who are not eligible for curative treatment. Materials and Methods: A registry database of 93 patients who were treated with SBRT for HCC between 2007 and 2009 was analyzed. A dose of 10-20 Gy per fraction was given over 3-4 consecutive days, resulting in a total dose of 30-60 Gy. The tumor response was determined using dynamic computed tomography or magnetic resonance imaging, which was performed 3 months after completion of SBRT. Results: The median follow-up period was 25.6 months. Median size of tumors was 2 cm (range: 1-6 cm). Overall patients' survival rates at 1 and 3 years were 86.0% and 53.8%, respectively. Complete and partial tumor response were achieved in 15.5% and 45.7% of patients, respectively. Local recurrence-free survival rate was 92.1% at 3 years. Most local failures were found in patients with HCCs > 3 cm, and local control rate at 3 years was 76.3% in patients with HCC > 3 cm, 93.3% in patients with tumors between 2.1-3 cm, and 100% in patients with tumors <= 2 cm, respectively. Out-of-field intrahepatic recurrence-free survival rates at 1 and 3 years were 51.9% and 32.4%, respectively. Grade >= 3 hepatic toxicity was observed in 6 (6.5%). Conclusions: SBRT was effective in local control of small HCC. SBRT may be a promising alternative treatment for patients with small HCC which is unsuitable for other curative therapy.	[Yoon, Sang Min; Cho, Byungchul; Lee, Yu Sun; Park, Jin-hong; Kim, Jong Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Lim, Young-Suk; Shim, Ju Hyun; Kim, Kang Mo; Lee, Han Chu; Chung, Young-Hwa; Lee, Yung Sang] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Park, Mee Jin; Kim, So Yeon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Lee, Sung Gyu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, JH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea.	jhkim2@amc.seoul.kr		Shim, Ju Hyun/0000-0002-7336-1371; Park, Jin-hong/0000-0002-1088-0174				Andolino DL, 2011, INT J RADIAT ONCOL, V81, pE447, DOI 10.1016/j.ijrobp.2011.04.011; Bae SH, 2012, INT J RADIAT ONCOL, V82, pE603, DOI 10.1016/j.ijrobp.2011.09.053; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cardenes HR, 2010, CLIN TRANSL ONCOL, V12, P218, DOI 10.1007/s12094-010-0492-x; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Feng K, 2012, J HEPATOL, V57, P794, DOI 10.1016/j.jhep.2012.05.007; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Huang WY, 2012, INT J RADIAT ONCOL, V84, P355, DOI 10.1016/j.ijrobp.2011.11.058; Ishii H, 2008, HEPATO-GASTROENTEROL, V55, P621; Krishnan S, 2008, ANN SURG ONCOL, V15, P1015, DOI 10.1245/s10434-007-9729-5; Kwon JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-475; Lau WY, 2007, ANN SURG ONCOL, V14, P3301, DOI 10.1245/s10434-007-9549-7; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Livraghi T, 2001, Eur J Ultrasound, V13, P159, DOI 10.1016/S0929-8266(01)00128-8; Romero AM, 2006, ACTA ONCOL, V45, P831, DOI 10.1080/02841860600897934; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Pawlik TM, 2005, LIVER TRANSPLANT, V11, P1086, DOI 10.1002/lt.20472; Sala M, 2004, HEPATOLOGY, V40, P1352, DOI 10.1002/hep.20465; Schefter TE, 2005, INT J RADIAT ONCOL, V62, P1371, DOI 10.1016/j.ijrobp.2005.01.002; Seo YS, 2010, J SURG ONCOL, V102, P209, DOI 10.1002/jso.21593; Taguchi H, 2007, INT J RADIAT ONCOL, V69, P376, DOI 10.1016/j.ijrobp.2007.03.042; Tse RV, 2008, J CLIN ONCOL, V26, P657, DOI 10.1200/JCO.2007.14.3529; Yang W, 2006, AM J ROENTGENOL, V186, pS275, DOI 10.2214/AJR.04.1573	25	112	123	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79854	10.1371/journal.pone.0079854	http://dx.doi.org/10.1371/journal.pone.0079854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24255719	gold, Green Submitted, Green Published			2022-12-25	WOS:000327216200092
J	Yu, L; Xie, S; Xiao, JX; Wang, ZX; Zhang, XD				Yu, Lei; Xie, Sheng; Xiao, Jiangxi; Wang, Zhaoxia; Zhang, Xiaodong			Quantitative Measurement of Cerebral Oxygen Extraction Fraction Using MRI in Patients with MELAS	PLOS ONE			English	Article							STROKE-LIKE EPISODES; MITOCHONDRIAL MYOPATHY; LACTIC-ACIDOSIS; BLOOD-FLOW; ENCEPHALOPATHY; METABOLISM; PERFUSION; DIFFUSION; MUTATION; VOLUME	Objective: To quantify the cerebral OEF at different phases of stroke-like episodes in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) by using MRI. Methods: We recruited 32 patients with MELAS confirmed by gene analysis. Conventional MRI scanning, as well as functional MRI including arterial spin labeling and oxygen extraction fraction imaging, was undertaken to obtain the pathological and metabolic information of the brains at different stages of stroke-like episodes in patients. A total of 16 MRI examinations at the acute and subacute phase and 19 examinations at the interictal phase were performed. In addition, 24 healthy volunteers were recruited for control subjects. Six regions of interest were placed in the anterior, middle, and posterior parts of the bilateral hemispheres to measure the OEF of the brain or the lesions. Results: OEF was reduced significantly in brains of patients at both the acute and subacute phase (0.266 +/- 0.026) and at the interictal phase (0.295 +/- 0.009), compared with normal controls (0.316 +/- 0.025). In the brains at the acute and subacute phase of the episode, 13 ROIs were prescribed on the stroke-like lesions, which showed decreased OEF compared with the contralateral spared brain regions. Increased blood flow was revealed in the stroke-like lesions at the acute and subacute phase, which was confined to the lesions. Conclusion: MRI can quantitatively show changes in OEF at different phases of stroke-like episodes. The utilization of oxygen in the brain seems to be reduced more severely after the onset of episodes in MELAS, especially for those brain tissues involved in the episodes.	[Yu, Lei; Xiao, Jiangxi; Zhang, Xiaodong] Peking Univ, Hosp 1, Dept Radiol, Beijing 100871, Peoples R China; [Xie, Sheng] China Japan Friendship Hosp, Dept Radiol, Beijing, Peoples R China; [Wang, Zhaoxia] Peking Univ, Hosp 1, Dept Neurol, Beijing 100871, Peoples R China	Peking University; China-Japan Friendship Hospital; Peking University	Xie, S (corresponding author), China Japan Friendship Hosp, Dept Radiol, Beijing, Peoples R China.	xs_mri@126.com; Xiao_jiangxi@163.com			National Natural Science Foundation of China [30870864, 81201154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the National Natural Science Foundation of China [No. 30870864 to Zhaoxia Wang and No. 81201154 to Xie Sheng]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An H, 2003, MAGN RESON MED, V50, P708, DOI 10.1002/mrm.10576; Davidson MM, 2009, MITOCHONDRION, V9, P463, DOI 10.1016/j.mito.2009.08.006; Feddersen B, 2003, NEUROLOGY, V61, P1149, DOI 10.1212/01.WNL.0000092497.53706.1B; Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; He X, 2007, MAGN RESON MED, V57, P115, DOI 10.1002/mrm.21108; Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544; Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040; Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011; Katayama Y, 2009, MITOCHONDRION, V9, P306, DOI 10.1016/j.mito.2009.04.002; Kavec M, 2004, NEUROIMAGE, V22, P258, DOI 10.1016/j.neuroimage.2004.01.009; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15; Lindroos MM, 2009, BRAIN, V132, P3274, DOI 10.1093/brain/awp259; Nariai R, 2001, J NEUROIMAGING, V11, P325, DOI 10.1111/j.1552-6569.2001.tb00057.x; OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Takahashi S, 1998, J NEUROL SCI, V158, P58, DOI 10.1016/S0022-510X(98)00105-1; Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003; Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118; Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6; Wang ZX, 2012, J NEUROL SCI, V323, P173, DOI 10.1016/j.jns.2012.09.011; Xie S, 2011, AM J NEURORADIOL, V32, P1504, DOI 10.3174/ajnr.A2523; Yeh HL, 2013, BRAIN DEV-JPN, V35, P158, DOI 10.1016/j.braindev.2012.03.017	24	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79859	10.1371/journal.pone.0079859	http://dx.doi.org/10.1371/journal.pone.0079859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260310	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200093
J	Rius, B; Titos, E; Moran-Salvador, E; Lopez-Vicario, C; Garcia-Alonso, V; Gonzalez-Periz, A; Arroyo, V; Claria, J				Rius, Bibiana; Titos, Esther; Moran-Salvador, Eva; Lopez-Vicario, Cristina; Garcia-Alonso, Veronica; Gonzalez-Periz, Ana; Arroyo, Vicente; Claria, Joan			Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis	FASEB JOURNAL			English	Article						inflammation; anti-inflammatory mediators; macrophages; NAFLD; weight loss	FATTY LIVER-DISEASE; LIPID MEDIATORS; WEIGHT-LOSS; METABOLIC SYNDROME; INFLAMMATION; OMEGA-3-FATTY-ACIDS; MECHANISMS; MICRORNAS; THERAPY; PROMOTE	Insulin resistance and nonalcoholic steatohepatitis (NASH), characterized by hepatic steatosis combined with inflammation, are major sequelae of obesity. Currently, lifestyle modification (i.e., weight loss) is the first-line therapy for NASH. However, weight loss resolves steatosis but not inflammation. In this study, we tested the ability of resolvin D1 (RvD1), an anti-inflammatory and proresolving molecule, to promote the resolution initiated by calorie restriction in obese mice with NASH. Calorie restriction reduced adipose and liver weight (-56 and -13%, respectively; P<0.001), serum leptin and resistin levels, hepatic steatosis, and insulin resistance. In addition to these, mice receiving RvD1 during the dietary intervention showed increased adiponectin expression at both the mRNA and protein levels and reduced liver macrophage infiltration (-15%, P<0.01). Moreover, RvD1 skewed macrophages from an M1- to an M2-like anti-inflammatory phenotype, induced a specific hepatic miRNA signature (i.e., miR-219-5p and miR-199a-5p), and reduced inflammatory adipokine mRNA and protein expression and macrophage innate immune response. In precision-cut liver slices (PCLSs), which override the influence of circulating factors, RvD1 attenuated hypoxia-induced mRNA and protein expression of COX-2, IL-1, IL-6, and CCR7. Of note, RvD1 anti-inflammatory actions were absent in macrophage-depleted PCLSs. In summary, RvD1 acts as a facilitator of the hepatic resolution process by reducing the inflammatory component of obesity-induced NASH.Rius, B., Titos, E., Moran-Salvador, E., Lopez-Vicario, C., Garcia-Alonso, V., Gonzalez-Periz, A., Arroyo, V., Claria, J. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis.	[Rius, Bibiana; Titos, Esther; Moran-Salvador, Eva; Lopez-Vicario, Cristina; Garcia-Alonso, Veronica; Gonzalez-Periz, Ana; Claria, Joan] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Esther Koplowitz Ctr, Dept Biochem & Mol Genet, E-08036 Barcelona, Spain; [Arroyo, Vicente] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Esther Koplowitz Ctr, Liver Unit, Barcelona 08036, Spain; [Titos, Esther; Gonzalez-Periz, Ana; Arroyo, Vicente; Claria, Joan] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Claria, Joan] Univ Barcelona, Dept Physiol Sci 1, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona	Claria, J (corresponding author), Hosp Clin Barcelona, Dept Biochem & Mol Genet, Villarroel 170, E-08036 Barcelona, Spain.	jclaria@clinic.ub.es	Arroyo, Vicente/F-9189-2015; Titos, Esther/AAA-5394-2019; Claria, Joan/M-7772-2019	Arroyo, Vicente/0000-0002-2728-1848; Titos, Esther/0000-0002-2543-2243; Lopez-Vicario, Cristina/0000-0002-6609-8501; Claria, Joan/0000-0003-4333-7749	Ministerio de Economia y Competitividad [SAF 12/32789]; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion (MICINN) [AP2007-02004, BES-2010-034193]; CIBERehd; IDIBAPS	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERehd; IDIBAPS	The authors thank the Bioinformatics Unit of the Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) for technical help. This work was supported by Ministerio de Economia y Competitividad (SAF 12/32789). Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by the Instituto de Salud Carlos III. The authors' laboratory is a Consolidated Research Group recognized by the Generalitat de Catalunya (2009SGR1484). This study was conducted at the Esther Koplowitz Center (Barcelona, Spain) and was supported by Ministerio de Ciencia e Innovacion (MICINN) grants AP2007-02004 (to E. M-S.) and BES-2010-034193 (to V. G.-A). E. T. and A. G.-P. had contracts with CIBERehd. C. L.-V. was supported by IDIBAPS.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Capristo E, 2005, Eur Rev Med Pharmacol Sci, V9, P265; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Huang MA, 2005, AM J GASTROENTEROL, V100, P1072, DOI 10.1111/j.1572-0241.2005.41334.x; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Klassen LW, 2008, BIOCHEM PHARMACOL, V76, P426, DOI 10.1016/j.bcp.2008.05.012; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lopez-Vicario C., 2013, GUT, DOI 10.1136/gutjnl-2012-303179; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Masterton GS, 2010, ALIMENT PHARM THER, V31, P679, DOI 10.1111/j.1365-2036.2010.04230.x; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Rius B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00257; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sackmann-Sala L, 2012, OBESITY, V20, P101, DOI 10.1038/oby.2011.235; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Schnitger AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027435; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Szabo G, 2012, J HEPATOL, V57, P462, DOI 10.1016/j.jhep.2012.01.030; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Xydakis AM, 2004, J CLIN ENDOCR METAB, V89, P2697, DOI 10.1210/jc.2003-031826; Zelber-Sagi S, 2012, J HEPATOL, V56, P1145, DOI 10.1016/j.jhep.2011.12.011; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	42	69	71	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					836	848		10.1096/fj.13-235614	http://dx.doi.org/10.1096/fj.13-235614			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24249635				2022-12-25	WOS:000331072200029
J	Wang, W; Mutka, AL; Zmrzljak, UP; Rozman, D; Tanila, H; Gylling, H; Remes, AM; Huttunen, HJ; Ikonen, E				Wang, Wei; Mutka, Aino-Liisa; Zmrzljak, Ursula Prosenc; Rozman, Damjana; Tanila, Heikki; Gylling, Helena; Remes, Anne M.; Huttunen, Henri J.; Ikonen, Elina			Amyloid precursor protein alpha- and beta-cleaved ectodomains exert opposing control of cholesterol homeostasis via SREBP2	FASEB JOURNAL			English	Article						LDL uptake; APP processing	ALZHEIMERS-DISEASE; SURROGATE MARKERS; SITE-1 PROTEASE; LIPID RAFTS; APP; METABOLISM; TRANSPORT; ABSORPTION; PRESENILIN; SECRETASE	Amyloid precursor protein (APP) is ubiquitously expressed. Studies in neuronal cells have implicated APP or its fragments as negative regulators of cholesterol metabolism. In the current study, APP acted, via its -cleavage, as a positive regulator of sterol regulatory element-binding protein-2 (SREBP2) signaling in human astrocytic cells (U251MG), hepatic cells (HepG2), and primary fibroblasts, leading to an approximate 30% increase in SRE-dependent gene expression and, consequently, enhanced cholesterol biosynthesis and LDL receptor levels. This effect was mediated via the secretory ectodomain APPs. The -cleaved ectodomain, in turn, repressed SRE-dependent gene expression by up to approximate to 30%. This resulted in decreased cholesterol synthesis and LDL receptor content, establishing a physiological feedback loop in cholesterol-loaded cells, where APP undergoes preferential -cleavage. Patients with familial Alzheimer's disease had decreased circulating lathosterol, reflecting hepatic cholesterol synthesis, and their fibroblasts had reduced LDL receptor content, which was alleviated by decreasing -cleavage. These results show that APP regulates cholesterol metabolism in cells relevant for whole-body cholesterol balance and reveal that APP - and -cleavages produce opposing paracrine regulators of SREBP2 signaling.Wang, W., Mutka, A.-L., Zmrzljak, U. P., Tanila, D. R. H., Gylling, H., Remes, A. M., Huttunen, H. J., Ikonen, E. Amyloid precursor protein - and -cleaved ectodomains exert opposing control of cholesterol homeostasis via SREBP2.	[Wang, Wei; Mutka, Aino-Liisa; Ikonen, Elina] Univ Helsinki, Inst Biomed, FI-00014 Helsinki, Finland; [Gylling, Helena] Univ Helsinki, Dept Med, Div Internal Med, FI-00014 Helsinki, Finland; [Huttunen, Henri J.] Univ Helsinki, Ctr Neurosci, FI-00014 Helsinki, Finland; [Wang, Wei; Ikonen, Elina] Minerva Fdn, Inst Med Res, Helsinki, Finland; [Zmrzljak, Ursula Prosenc; Rozman, Damjana] Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Genom & Biochips, Ljubljana, Slovenia; [Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland; [Remes, Anne M.] Univ Eastern Finland, Inst Clin Med, Dept Neurol, Kuopio, Finland; [Remes, Anne M.] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Ljubljana; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Ikonen, E (corresponding author), Univ Helsinki, Inst Biomed, Haartmaninkatu 8, FI-00014 Helsinki, Finland.	elina.ikonen@helsinki.fi		Ikonen, Elina/0000-0001-8382-1135; Huttunen, Henri/0000-0002-9867-4438; Rozman, Damjana/0000-0002-6501-2163; Prosenc Zmrzljak, Ursula/0000-0002-9034-790X	Academy of Finland [123743, 131313, 131489, 126889, 218066, 218081]; Sigrid Juselius Foundation; Jenny and Antti Wihuri Foundation; Maire Taponen Foundation; Finnish Medical Foundation; Biocentrum Helsinki; Slovenian Research Agency [J1-9438, P1-0104]; Slovenian Research Agency	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jenny and Antti Wihuri Foundation; Maire Taponen Foundation; Finnish Medical Foundation; Biocentrum Helsinki; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors thank Petra Makinen and Mikko Hiltunen (Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland and Kuopio University Hospital, Finland) for help with APP Western blot analyses and ELISA; Anna Uro, Pipsa Kaipainen, and Hennariikka Koivisto for technical assistance; Dennis Selkoe (Harvard Medical School Center for Neurological Diseases, Brigham and Women's Hospital, Boston, MA, USA), Frederic Checler (Institut de Pharmacologie Moleculaire et Cellularie, Centre National de la Recherche Scientifique, Valbonne, France), and Timothy Levine (University College London, London, UK) for the plasmids; and Pentti Tienari for discussions and comments on the manuscript. This study was financially supported by the Academy of Finland (grants 123743, 131313, 131489, 126889, 218066, and 218081), the Sigrid Juselius Foundation, the Jenny and Antti Wihuri Foundation, the Maire Taponen Foundation, the Finnish Medical Foundation, Biocentrum Helsinki, and Slovenian Research Agency grants J1-9438 and P1-0104. U.P.Z. was funded as young researcher by the Slovenian Research Agency. H.J.H. is an employee and share-holder of Hermo Pharma, Ltd. (Helsinki, Finland).	Basi G, 2003, J BIOL CHEM, V278, P31512, DOI 10.1074/jbc.M300169200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burns M, 2003, J NEUROSCI, V23, P5645; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Feng XR, 2006, GENE, V371, P68, DOI 10.1016/j.gene.2005.11.006; Fink M, 2005, ENDOCRINOLOGY, V146, P5321, DOI 10.1210/en.2005-0781; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gong JS, 2002, J NEUROSCI RES, V70, P438, DOI 10.1002/jnr.10347; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Kolsch H., 1801, BIOCHIM BIOPHYS ACTA, V1801, P945; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marquer C, 2011, FASEB J, V25, P1295, DOI 10.1096/fj.10-168633; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Miettinen TA, 2011, NUTR METAB CARDIOVAS, V21, P765, DOI 10.1016/j.numecd.2011.05.005; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Mohamed A, 2012, J NEUROSCI, V32, P6490, DOI 10.1523/JNEUROSCI.0630-12.2012; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rosen C, 2012, NEUROMOL MED, V14, P65, DOI 10.1007/s12017-012-8171-4; Rovelet-Lecrux A, 2007, J NEUROL NEUROSUR PS, V78, P1158, DOI 10.1136/jnnp.2006.113514; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Simonen P, 2008, ATHEROSCLEROSIS, V197, P883, DOI 10.1016/j.atherosclerosis.2007.08.003; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; van der Wulp MYM, 2013, MOL CELL ENDOCRINOL, V368, P1, DOI 10.1016/j.mce.2012.06.007; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Xiong HQ, 2008, NEUROBIOL DIS, V29, P422, DOI 10.1016/j.nbd.2007.10.005; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	55	16	16	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					849	860		10.1096/fj.13-239301	http://dx.doi.org/10.1096/fj.13-239301			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24249638				2022-12-25	WOS:000331072200030
J	Lee, MJ; Gravelat, FN; Cerone, RP; Baptista, SD; Campoli, PV; Choe, SI; Kravtsov, I; Vinogradov, E; Creuzenet, C; Liu, H; Berghuis, AM; Latge, JP; Filler, SG; Fontaine, T; Sheppard, DC				Lee, Mark J.; Gravelat, Fabrice N.; Cerone, Robert P.; Baptista, Stefanie D.; Campoli, Paolo V.; Choe, Se-In; Kravtsov, Ilia; Vinogradov, Evgeny; Creuzenet, Carole; Liu, Hong; Berghuis, Albert M.; Latge, Jean-Paul; Filler, Scott G.; Fontaine, Thierry; Sheppard, Donald C.			Overlapping and Distinct Roles of Aspergillus fumigatus UDP-glucose 4-Epimerases in Galactose Metabolism and the Synthesis of Galactose-containing Cell Wall Polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Cell Wall; Galactose Metabolism; Glycobiology; Mycology; Polysaccharide	N-ACETYLGLUCOSAMINE; PSEUDOMONAS-AERUGINOSA; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; C4 EPIMERASE; BIOSYNTHESIS; GALACTOFURANOSE; IDENTIFICATION; EXPRESSION; DATABASE	Background:Aspergillus fumigatus produces two galactose-containing exopolysaccharides, galactomannan and galactosaminogalactan. Results: Galactosaminogalactan synthesis requires the UDP-glucose 4-epimerases, Uge5 and Uge3, whereas galactomannan synthesis requires Uge5 alone. Conclusion: Epimerases in A. fumigatus play both distinct and overlapping roles in exopolysaccharide synthesis. Significance: Uncovering the biosynthetic pathways of galactosaminogalactan will be crucial in developing therapeutics targeting this exopolysaccharide. The cell wall of Aspergillus fumigatus contains two galactose-containing polysaccharides, galactomannan and galactosaminogalactan, whose biosynthetic pathways are not well understood. The A. fumigatus genome contains three genes encoding putative UDP-glucose 4-epimerases, uge3, uge4, and uge5. We undertook this study to elucidate the function of these epimerases. We found that uge4 is minimally expressed and is not required for the synthesis of galactose-containing exopolysaccharides or galactose metabolism. Uge5 is the dominant UDP-glucose 4-epimerase in A. fumigatus and is essential for normal growth in galactose-based medium. Uge5 is required for synthesis of the galactofuranose (Galf) component of galactomannan and contributes galactose to the synthesis of galactosaminogalactan. Uge3 can mediate production of both UDP-galactose and UDP-N-acetylgalactosamine (GalNAc) and is required for the production of galactosaminogalactan but not galactomannan. In the absence of Uge5, Uge3 activity is sufficient for growth on galactose and the synthesis of galactosaminogalactan containing lower levels of galactose but not the synthesis of Galf. A double deletion of uge5 and uge3 blocked growth on galactose and synthesis of both Galf and galactosaminogalactan. This study is the first survey of glucose epimerases in A. fumigatus and contributes to our understanding of the role of these enzymes in metabolism and cell wall synthesis.	[Lee, Mark J.; Gravelat, Fabrice N.; Cerone, Robert P.; Baptista, Stefanie D.; Campoli, Paolo V.; Choe, Se-In; Kravtsov, Ilia; Sheppard, Donald C.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Vinogradov, Evgeny] CNR, Ottawa, ON K1A 0R6, Canada; [Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Liu, Hong; Filler, Scott G.] Harbor UCLA Med Ctr, Los Angeles Biomed Med Inst, Div Infect Dis, Torrance, CA 90502 USA; [Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada; [Latge, Jean-Paul; Fontaine, Thierry] Inst Pasteur, Aspergillus Unit, F-75724 Paris, France	McGill University; National Research Council Canada; Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; McGill University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sheppard, DC (corresponding author), McGill Univ, Dept Microbiol & Immunol, 3775 Rue Univ, Montreal, PQ H3A 2B4, Canada.	don.sheppard@mcgill.ca	Berghuis, Albert M/A-6495-2008; Fontaine, Thierry/F-8227-2011; Fontaine, thierry/Q-2201-2018; Sheppard, Donald/B-4637-2008	Fontaine, thierry/0000-0002-8184-789X; Sheppard, Donald/0000-0001-8877-880X; Berghuis, Albert/0000-0002-2663-025X; Gravelat, Fabrice/0000-0003-2416-9380	National Institutes of Health [R01AI073829]; Canadian Institutes of Health Research; Research Institute of the McGill University Health Center; Fonds de Recherche du Quebec-Sante; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Center; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI073829. This work was also supported by operating funds from the Canadian Institutes of Health Research.; Supported by a studentship from the Research Institute of the McGill University Health Center.; Supported by a Chercheur-Boursier award from the Fonds de Recherche du Quebec-Sante. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, McGill University, 3775 Rue University, Montreal, Quebec H3A 2B4, Canada. Tel.: 514-398-1759; Fax: 514-398-7052; E-mail: don.sheppard@mcgill.ca.	Afroz S, 2011, FUNGAL GENET BIOL, V48, P896, DOI 10.1016/j.fgb.2011.06.001; Al Abdallah Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049959; Alam MK, 2013, BOTANY, V91, P467, DOI 10.1139/cjb-2012-0270; Alam MK, 2012, FUNGAL GENET BIOL, V49, P1033, DOI 10.1016/j.fgb.2012.08.010; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Campoli P., 2013, J INFECT DIS, DOI 10.1093/infdis/jit358; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Choe SI, 2012, APPL ENVIRON MICROB, V78, P3855, DOI 10.1128/AEM.07771-11; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Demendi M, 2005, BIOCHEM J, V389, P173, DOI 10.1042/BJ20050263; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; El-Ganiny AM, 2010, FUNGAL GENET BIOL, V47, P629, DOI 10.1016/j.fgb.2010.03.002; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Garcia-Vidal C, 2008, CLIN INFECT DIS, V47, P1041, DOI 10.1086/591969; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gravelat FN, 2008, INFECT IMMUN, V76, P3632, DOI 10.1128/IAI.01483-07; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Gravelat Fabrice N, 2012, Methods Mol Biol, V845, P119, DOI 10.1007/978-1-61779-539-8_8; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Gu XG, 2011, MICROBIOL-SGM, V157, P260, DOI 10.1099/mic.0.040758-0; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; Hartmann T, 2010, APPL ENVIRON MICROB, V76, P6313, DOI 10.1128/AEM.00882-10; Henry C, 2012, EUKARYOT CELL, V11, P26, DOI 10.1128/EC.05270-11; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Johnson AE, 1998, BIOCHEMISTRY-US, V37, P5746, DOI 10.1021/bi972984j; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Luong ML, 2010, DIAGN MICR INFEC DIS, V68, P132, DOI 10.1016/j.diagmicrobio.2010.03.017; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; McCallum M, 2011, BIOCHEM J, V439, P235, DOI 10.1042/BJ20110890; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Mellado E, 2003, FUNGAL GENET BIOL, V38, P98, DOI 10.1016/S1087-1845(02)00516-9; Mikusova K, 2006, J BACTERIOL, V188, P6592, DOI 10.1128/JB.00489-06; Oppenheimer M, 2010, ARCH BIOCHEM BIOPHYS, V502, P31, DOI 10.1016/j.abb.2010.06.035; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Paul BC, 2011, EUKARYOT CELL, V10, P646, DOI 10.1128/EC.00304-10; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Shaw MP, 2003, MOL BIOCHEM PARASIT, V126, P173, DOI 10.1016/S0166-6851(02)00243-8; Slepak T, 2005, MOL GENET METAB, V86, P360, DOI 10.1016/j.ymgme.2005.08.002; Stoco PH, 2012, EXP PARASITOL, V130, P246, DOI 10.1016/j.exppara.2011.12.005; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STYNEN D, 1992, INFECT IMMUN, V60, P2237, DOI 10.1128/IAI.60.6.2237-2245.1992; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Timson DJ., 2007, DYN BIOCH PROCE BIOT, V1, P63, DOI DOI 10.1046/j.1365-8711.2003.06497.x; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wing C, 2006, ORG BIOMOL CHEM, V4, P3945, DOI 10.1039/b609455d	65	70	72	4	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1243	1256		10.1074/jbc.M113.522516	http://dx.doi.org/10.1074/jbc.M113.522516			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24257745	hybrid, Green Published			2022-12-25	WOS:000332401700005
J	Hurlburt, BK; Offermann, LR; McBride, JK; Majorek, KA; Maleki, SJ; Chruszcz, M				Hurlburt, Barry K.; Offermann, Lesa R.; McBride, Jane K.; Majorek, Karolina A.; Maleki, Soheila J.; Chruszcz, Maksymilian			Structure and Function of the Peanut Panallergen Ara h 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergen; Antigen; Crystal Structure; Flavonoids; Fluorescence; Peanut	BET V 1; BIRCH POLLEN ALLERGEN; PATHOGENESIS-RELATED PROTEINS; X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; MAJOR ALLERGEN; RIBONUCLEASE-ACTIVITY; FOOD ALLERGENS; NUCLEIC-ACIDS	The incidence of peanut allergy continues to rise in the United States and Europe. Whereas exposure to the major allergens Ara h 1, 2, 3, and 6 can cause fatal anaphylaxis, exposure to the minor allergens usually does not. Ara h 8 is a minor allergen. Importantly, it is the minor food allergens that are thought to be responsible for oral allergy syndrome (OAS), in which sensitization to airborne allergens causes a Type 2 allergic reaction to ingested foods. Furthermore, it is believed that similar protein structure rather than a similar linear sequence is the cause of OAS. Bet v 1 from birch pollen is a common sensitizing agent, and OAS results when patients consume certain fruits, vegetables, tree nuts, and peanuts. Here, we report the three-dimensional structure of Ara h 8, a Bet v 1 homolog. The overall fold is very similar to that of Bet v 1, Api g 1 (celery), Gly m 4 (soy), and Pru av 1 (cherry). Ara h 8 binds the isoflavones quercetin and apigenin as well as resveratrol avidly.	[Hurlburt, Barry K.; McBride, Jane K.; Maleki, Soheila J.] ARS, So Reg Res Ctr, USDA, New Orleans, LA 70124 USA; [Offermann, Lesa R.; Chruszcz, Maksymilian] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Majorek, Karolina A.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	United States Department of Agriculture (USDA); University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Virginia	Hurlburt, BK (corresponding author), ARS, So Reg Res Ctr, USDA, New Orleans, LA 70124 USA.	barry.hurlburt@ars.usda.gov; chruszcz@mailbox.sc.edu	Chruszcz, Maksymilian/E-6407-2011	Chruszcz, Maksymilian/0000-0001-7521-5485	United States Department of Agriculture, Agricultural Research Service; University of South Carolina	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); University of South Carolina	This work was supported by the United States Department of Agriculture, Agricultural Research Service, and internal funds from the University of South Carolina.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asarnoj A, 2010, ALLERGY, V65, P213, DOI 10.1111/j.1398-9995.2009.02138.x; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; Berkner H, 2009, BIOSCIENCE REP, V29, P183, DOI 10.1042/BSR20080117; Biesiadka J, 2002, J MOL BIOL, V319, P1223, DOI 10.1016/S0022-2836(02)00385-6; Bufe A, 1996, PLANTA, V199, P413, DOI 10.1007/BF00195733; Casanal A, 2013, ACTA CRYSTALLOGR F, V69, P510, DOI 10.1107/S1744309113006945; Chruszcz M, 2013, MOL IMMUNOL, V56, P794, DOI 10.1016/j.molimm.2013.07.004; D'Avino R, 2011, ALLERGY, V66, P870, DOI 10.1111/j.1398-9995.2011.02555.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Fernandes H, 2009, FEBS J, V276, P1596, DOI 10.1111/j.1742-4658.2009.06892.x; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; GOLDBERG ME, 1990, FEBS LETT, V263, P51, DOI 10.1016/0014-5793(90)80703-L; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Koistinen KM, 2005, PHYTOCHEMISTRY, V66, P2524, DOI 10.1016/j.phytochem.2005.09.007; Koistinen KM, 2002, PLANT CELL ENVIRON, V25, P707, DOI 10.1046/j.1365-3040.2002.00858.x; Kondo Yasuto, 2009, Allergology International, V58, P485, DOI 10.2332/allergolint.09-RAI-0136; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008; Mittag D, 2005, CLIN EXP ALLERGY, V35, P1049, DOI 10.1111/j.1365-2222.2005.02309.x; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Mittag D, 2004, J ALLERGY CLIN IMMUN, V113, P148, DOI 10.1016/j.jaci.2003.09.030; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Mogensen JE, 2007, BIOCHEMISTRY-US, V46, P3356, DOI 10.1021/bi062058h; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; Osmark P, 1998, PLANT MOL BIOL, V38, P1243, DOI 10.1023/A:1006060224012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pasternak O, 2005, ACTA CRYSTALLOGR D, V61, P99, DOI 10.1107/S0907444904028173; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Riecken S, 2008, BIOL CHEM, V389, P415, DOI 10.1515/BC.2008.038; Samanta A., 2011, CARBON, V100, P12; Schirmer T, 2005, J MOL BIOL, V351, P1101, DOI 10.1016/j.jmb.2005.06.054; Schweimer K, 1999, APPL MAGN RESON, V17, P449, DOI 10.1007/BF03162177; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Swoboda I, 1996, PHYSIOL PLANTARUM, V96, P433, DOI 10.1111/j.1399-3054.1996.tb00455.x; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vereda A, 2011, J ALLERGY CLIN IMMUN, V127, P603, DOI 10.1016/j.jaci.2010.09.010; Watari H, 1997, P NATL ACAD SCI USA, V94, P8462, DOI 10.1073/pnas.94.16.8462; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419	58	32	34	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36890	36901		10.1074/jbc.M113.517797	http://dx.doi.org/10.1074/jbc.M113.517797			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24253038	Green Published, hybrid			2022-12-25	WOS:000329189700012
J	Peng, XL; Lin, P; Zhang, TS; Wang, J				Peng, Xiaolong; Lin, Pan; Zhang, Tongsheng; Wang, Jue			Extreme Learning Machine-Based Classification of ADHD Using Brain Structural MRI Data	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFAULT-MODE NETWORK; CORTICAL THICKNESS; PATTERN-RECOGNITION; ALZHEIMERS-DISEASE; FEATURE-SELECTION; CHILDREN; DIAGNOSIS; ABNORMALITIES	Background: Effective and accurate diagnosis of attention-deficit/ hyperactivity disorder (ADHD) is currently of significant interest. ADHD has been associated with multiple cortical features from structural MRI data. However, most existing learning algorithms for ADHD identification contain obvious defects, such as time-consuming training, parameters selection, etc. The aims of this study were as follows: (1) Propose an ADHD classification model using the extreme learning machine (ELM) algorithm for automatic, efficient and objective clinical ADHD diagnosis. (2) Assess the computational efficiency and the effect of sample size on both ELM and support vector machine (SVM) methods and analyze which brain segments are involved in ADHD. Methods: High-resolution three-dimensional MR images were acquired from 55 ADHD subjects and 55 healthy controls. Multiple brain measures (cortical thickness, etc.) were calculated using a fully automated procedure in the FreeSurfer software package. In total, 340 cortical features were automatically extracted from 68 brain segments with 5 basic cortical features. F-score and SFS methods were adopted to select the optimal features for ADHD classification. Both ELM and SVM were evaluated for classification accuracy using leave-one-out cross-validation. Results: We achieved ADHD prediction accuracies of 90.18% for ELM using eleven combined features, 84.73% for SVM-Linear and 86.55% for SVM-RBF. Our results show that ELM has better computational efficiency and is more robust as sample size changes than is SVM for ADHD classification. The most pronounced differences between ADHD and healthy subjects were observed in the frontal lobe, temporal lobe, occipital lobe and insular. Conclusion: Our ELM-based algorithm for ADHD diagnosis performs considerably better than the traditional SVM algorithm. This result suggests that ELM may be used for the clinical diagnosis of ADHD and the investigation of different brain diseases.	[Peng, Xiaolong; Lin, Pan; Wang, Jue] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Biomed Engn, Minist Educ,Key Lab Biomed Informat Engn, Xian 710049, Peoples R China; [Peng, Xiaolong; Lin, Pan; Wang, Jue] Xi An Jiao Tong Univ, Natl Engn Res Ctr Hlth Care & Med Devices, Xian 710049, Peoples R China; [Zhang, Tongsheng] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; University of New Mexico	Lin, P (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Biomed Engn, Minist Educ,Key Lab Biomed Informat Engn, Xian 710049, Peoples R China.	linpan@mail.xjtu.edu.cn; juewang1@126.com	Hassan, Randa/AAW-3624-2021; Wang, Jue/GVU-0480-2022	Peng, Xiaolong/0000-0002-4488-9628	National Natural Science Foundation [81071150]; Ministry of Education of China [20120201120071]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation (number 81071150) (http://www.nsfc.gov.cn); Fundamental Research Funds for the Central Universities of China and by Doctoral Fund of Ministry of Education of China (20120201120071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adleman NE, 2012, J CHILD PSYCHOL PSYC, V53, P1149, DOI 10.1111/j.1469-7610.2012.02568.x; Barakat N, 2012, AM J NEURORADIOL, V33, P1127, DOI 10.3174/ajnr.A2924; Berger I, 2011, ISR MED ASSOC J, V13, P571; Blakemore F, 2005, LEARNING BRAIN; Brown JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024124; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Chang CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00066; Chen L, 2005, PATTERN RECOGN, V38, P799, DOI 10.1016/j.patcog.2004.11.003; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Oliveira PPD, 2010, J ALZHEIMERS DIS, V19, P1263, DOI 10.3233/JAD-2010-1322; Ding L, 2013, HUM BRAIN MAPP, V34, P775, DOI 10.1002/hbm.21473; Dukart J, 2013, PSYCHIAT RES-NEUROIM, V212, P230, DOI 10.1016/j.pscychresns.2012.04.007; Elder TE, 2010, J HEALTH ECON, V29, P641, DOI 10.1016/j.jhealeco.2010.06.003; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Grant JA, 2013, BIOL PSYCHOL, V92, P275, DOI 10.1016/j.biopsycho.2012.09.007; Haller S, 2012, AM J NEURORADIOL, V33, P2123, DOI 10.3174/ajnr.A3126; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Heinrich H, 1999, IEEE T BIO-MED ENG, V46, P867, DOI 10.1109/10.771199; Hyatt CJ, 2012, BIOL PSYCHIAT, V72, P207, DOI 10.1016/j.biopsych.2011.11.017; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Li X, 2013, HUMAN BRAIN MAPPING; Lin P, 2011, CEREB CORTEX, V21, P821, DOI 10.1093/cercor/bhq151; Lorberboym M, 2004, J CHILD NEUROL, V19, P91, DOI 10.1177/08830738040190020201; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Missonnier P, 2013, NEUROSCIENCE, V241, P135, DOI 10.1016/j.neuroscience.2013.03.011; O'Dwyer L., 2012, PLOS ONE, V7; Polanczyk G, 2008, CHILD ADOL PSYCH CL, V17, P245, DOI 10.1016/j.chc.2007.11.006; Poustchi-Amin M, 2001, RADIOGRAPHICS, V21, P767, DOI 10.1148/radiographics.21.3.g01ma23767; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; Rader R, 2009, AM FAM PHYSICIAN, V79, P657; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAUDYS SJ, 1991, IEEE T PATTERN ANAL, V13, P252, DOI 10.1109/34.75512; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Sahiner B, 2000, MED PHYS, V27, P1509, DOI 10.1118/1.599017; Sato JR, 2013, NEUROIMAGE, V77, P44, DOI 10.1016/j.neuroimage.2013.03.035; Sato JR, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00068; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Simon Viktoria, 2007, Psychiatr Hung, V22, P4; Smith K, 2007, COGNITIVE PSYCHOL MI; Solmaz B, 2012, MED IMAGING 2012 IMA; Su LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036147; Swanson CJ, 2006, NEUROPHARMACOLOGY, V50, P755, DOI 10.1016/j.neuropharm.2005.11.022; Toplak ME, 2006, J NEUROSCI METH, V151, P15, DOI 10.1016/j.jneumeth.2005.09.018; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Wigal SB, 2009, CNS DRUGS, V23, P21, DOI 10.2165/00023210-200923000-00004; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Wilson TW, 2013, HUM BRAIN MAPP, V34, P566, DOI 10.1002/hbm.21459; Wolosin SM, 2009, HUM BRAIN MAPP, V30, P175, DOI 10.1002/hbm.20496; Wu W, 2012, CIRC SYST SIGNAL PR, V31, P669, DOI 10.1007/s00034-011-9337-2; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	54	1036	1056	13	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79476	10.1371/journal.pone.0079476	http://dx.doi.org/10.1371/journal.pone.0079476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LO	24260229	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900026
J	Chachami, G; Kalousi, A; Papatheodorou, L; Lyberopoulou, A; Nasikas, V; Tanimoto, K; Simos, G; Malizos, KN; Georgatsou, E				Chachami, Georgia; Kalousi, Alkmini; Papatheodorou, Loukia; Lyberopoulou, Aggeliki; Nasikas, Vasileios; Tanimoto, Keiji; Simos, George; Malizos, Konstantinos N.; Georgatsou, Eleni			An Association Study between Hypoxia Inducible Factor-1alpha (HIF-1 alpha) Polymorphisms and Osteonecrosis	PLOS ONE			English	Article							FEMORAL-HEAD; FACTOR-1-ALPHA POLYMORPHISMS; KOREAN POPULATION; NATURAL-HISTORY; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; GENE; DISEASE; CANCER; BONE; IDENTIFICATION	Bone hypoxia resulting from impaired blood flow is the final pathway for the development of osteonecrosis (ON). The aim of this study was to evaluate if HIF-1 alpha, the major transcription factor triggered by hypoxia, is genetically implicated in susceptibility to ON. For this we analyzed frequencies of three known HIF-1 alpha polymorphisms: one in exon 2 (C111A) and two in exon 12 (C1772T and G1790A) and their association with ON in a Greek population. Genotype analysis was performed using PCR-RFLP and rare alleles were further confirmed with sequencing. We found that genotype and allele frequency of C1772T and G1790A SNP of HIF-1 alpha (SNPs found in our cohort) were not significantly different in ON patients compared to control patients. Furthermore these SNPs could not be associated with the different subgroups of ON. At the protein level we observed that the corresponding mutations (P582S and A588T, respectively) are not significant for protein function since the activity, expression and localization of the mutant proteins is practically indistinguishable from wt in HEK293 and Saos-2 cells. These results suggest that these missense mutations in the HIF-1 alpha gene are not important for the risk of developing ON.	[Chachami, Georgia; Kalousi, Alkmini; Lyberopoulou, Aggeliki; Nasikas, Vasileios; Simos, George; Georgatsou, Eleni] Univ Thessaly, Sch Hlth Sci, Fac Med, Biochem Lab, Biopolis, Larissa, Greece; [Chachami, Georgia; Kalousi, Alkmini; Lyberopoulou, Aggeliki; Simos, George; Malizos, Konstantinos N.; Georgatsou, Eleni] Inst Biomed Res & Technol BIOMED CERETETH, Larisa, Greece; [Papatheodorou, Loukia; Malizos, Konstantinos N.] Univ Thessaly, Sch Hlth Sci, Fac Med, Dept Orthopaed Surg, Biopolis, Larissa, Greece; [Tanimoto, Keiji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Translat Canc Res, Hiroshima, Japan	University of Thessaly; University of Thessaly; Hiroshima University	Georgatsou, E (corresponding author), Univ Thessaly, Sch Hlth Sci, Fac Med, Biochem Lab, Biopolis, Larissa, Greece.	egeorgat@med.uth.gr	Keiji, Tanimoto/U-1839-2019; Simos, George/AAH-2596-2021	Keiji, Tanimoto/0000-0003-4912-4197; Simos, George/0000-0001-5453-3185; Chachami, Georgia/0000-0002-4771-4196	Hellenic Association of Orthopaedic Surgery and Trauma; Musculoskeletal Research Unit of BIOMED/CERETETH	Hellenic Association of Orthopaedic Surgery and Trauma; Musculoskeletal Research Unit of BIOMED/CERETETH	The study was partially funded by a grant from the Hellenic Association of Orthopaedic Surgery and Trauma (http://www.eexot.gr/en/?about = 1) and by the Musculoskeletal Research Unit of BIOMED/CERETETH (http://biomed.cereteth.gr/el/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Childs SG, 2005, ORTHOP NURS, V24, P295; Clifford SC, 2001, ONCOGENE, V20, P5067, DOI 10.1038/sj.onc.1204602; Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190; Goswami SK, 2010, CURR CARDIOL REV, V6, P265, DOI 10.2174/157340310793566136; Hadjigeorgiou G, 2008, SKELETAL RADIOL, V37, P1, DOI 10.1007/s00256-007-0395-2; Hebert C, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-3; Hlatky MA, 2007, AM HEART J, V154, P1035, DOI 10.1016/j.ahj.2007.07.042; Hong JM, 2007, OSTEOARTHR CARTILAGE, V15, P688, DOI 10.1016/j.joca.2006.12.007; Kim HKW, 2009, BONE, V45, P280, DOI 10.1016/j.bone.2009.03.665; Kim TH, 2008, OSTEOARTHR CARTILAGE, V16, P287, DOI 10.1016/j.joca.2007.06.017; Komatsu DE, 2004, BONE, V34, P680, DOI 10.1016/j.bone.2003.12.024; Konac E, 2007, CANCER DETECT PREV, V31, P102, DOI 10.1016/j.cdp.2007.01.001; Koo KH, 2002, CLIN RHEUMATOL, V21, P299, DOI 10.1007/s100670200078; Lafforgue P, 2006, JOINT BONE SPINE, V73, P500, DOI 10.1016/j.jbspin.2006.01.025; Lee YJ, 2012, J ORTHOP RES, V30, P21, DOI 10.1002/jor.21492; Li WZ, 2009, J ORTHOP RES, V27, P694, DOI 10.1002/jor.20802; Liu B, 2012, GENET TEST MOL BIOMA, V16, P739, DOI 10.1089/gtmb.2011.0384; Lyberopoulou A, 2007, CELL PHYSIOL BIOCHEM, V20, P995, DOI 10.1159/000110460; Maes C, 2012, NAT REV RHEUMATOL, V8, P358, DOI 10.1038/nrrheum.2012.36; Malizos KN, 2007, EUR J RADIOL, V63, P16, DOI 10.1016/j.ejrad.2007.03.019; MATSUO K, 1988, CLIN ORTHOP RELAT R, P115; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Nagy G, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-79; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Putra AC, 2011, RESPIROLOGY, V16, P796, DOI 10.1111/j.1440-1843.2011.01972.x; Resar JR, 2005, CHEST, V128, P787, DOI 10.1378/chest.128.2.787; Rey S, 2011, BLOOD, V117, P4988, DOI 10.1182/blood-2010-11-321190; Saito T, 2010, OSTEOARTHR CARTILAGE, V18, P1552, DOI 10.1016/j.joca.2010.10.006; Schipani E, 2001, GENE DEV, V15, P2865; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132; Yamada N, 2005, J CLIN ENDOCR METAB, V90, P5841, DOI 10.1210/jc.2005-0991	36	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79647	10.1371/journal.pone.0079647	http://dx.doi.org/10.1371/journal.pone.0079647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260273	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500084
J	Ducarouge, B; Pelissier-Rota, M; Laine, M; Cristina, N; Vachez, Y; Scoazec, JY; Bonaz, B; Jacquier-Sarlin, M				Ducarouge, Benjamin; Pelissier-Rota, Marjolaine; Laine, Michele; Cristina, Nadine; Vachez, Yvan; Scoazec, Jean-Yves; Bonaz, Bruno; Jacquier-Sarlin, Muriel			CRF2 Signaling Is a Novel Regulator of Cellular Adhesion and Migration in Colorectal Cancer Cells	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; E-CADHERIN EXPRESSION; ERK ACTIVATION; UROCORTIN; CATENIN; COLON; KAISO; PHOSPHORYLATION; P120(CTN); DISEASE	Stress has been proposed to be a tumor promoting factor through the secretion of specific neuromediators, such as Urocortin2 and 3 (Ucn2/3), however its role in colorectal cancer (CRC) remains elusive. We observed that Ucn2/3 and their receptor the Corticotropin Releasing Factor receptor 2 (CRF2) were up-regulated in high grade and poorly differentiated CRC. This suggests a role for CRF2 in the loss of cellular organization and tumor progression. Using HT-29 and SW620 cells, two CRC cell lines differing in their abilities to perform cell-cell contacts, we found that CRF2 signals through Src/ERK pathway to induce the alteration of cell-cell junctions and the shuttle of p120ctn and Kaiso in the nucleus. In HT-29 cells, this signaling pathway also leads to the remodeling of cell adhesion by i) the phosphorylation of Focal Adhesion Kinase and ii) a modification of actin cytoskeleton and focal adhesion complexes. These events stimulate cell migration and invasion. In conclusion, our findings indicate that CRF2 signaling controls cellular organization and may promote metastatic potential of human CRC cells through an epithelial-mesenchymal transition like process. This contributes to the comprehension of the tumor-promoting effects of stress molecules and designates Ucn2/3-CRF2 tandem as a target to prevent CRC progression and aggressiveness.	[Ducarouge, Benjamin; Pelissier-Rota, Marjolaine; Laine, Michele; Cristina, Nadine; Bonaz, Bruno; Jacquier-Sarlin, Muriel] INSERM, U836, Equipe Stress & Interact Neurodigest, Grenoble, France; [Ducarouge, Benjamin; Pelissier-Rota, Marjolaine; Laine, Michele; Cristina, Nadine; Vachez, Yvan; Bonaz, Bruno; Jacquier-Sarlin, Muriel] Univ Grenoble 1, Grenoble Inst Neurosci, Grenoble, France; [Scoazec, Jean-Yves] Hop Edouard Herriot, Lyon, France; [Bonaz, Bruno] Ctr Hosp Univ Grenoble, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Lyon; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Jacquier-Sarlin, M (corresponding author), INSERM, U836, Equipe Stress & Interact Neurodigest, Grenoble, France.	muriel.jacquier-sarlin@ujf-grenoble.fr	Jacquier-Sarlin, Muriel/ABF-4923-2021	Jacquier-Sarlin, Muriel/0000-0001-8501-7511	Association pour la Recherche sur le Cancer; Ligue Nationale contre le Cancer; Association Francois Aupetit; GEFLUC; ESPOIR Isere Cancer	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association Francois Aupetit; GEFLUC; ESPOIR Isere Cancer	This work was supported by the Association pour la Recherche sur le Cancer (www.arc-cancer.net), Ligue Nationale contre le Cancer (www.ligue-cancer.net), Association Francois Aupetit (www.afa.asso.fr), GEFLUC (www.gefluc.org) and ESPOIR Isere Cancer (www.espoir-isere-cancer.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2011, EUR J PHARMACOL, V650, P145, DOI 10.1016/j.ejphar.2010.10.014; Androulidaki A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-30; Arcuri F, 2002, PROSTATE, V52, P167, DOI 10.1002/pros.10094; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Chartier NT, 2006, J CELL SCI, V119, P31, DOI 10.1242/jcs.02698; Chartier NT, 2011, EXP CELL RES; CHEN FM, 1986, BRAIN RES, V381, P49; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Ducarouge B, 2012, TRENDS CELL MOL BIOL; Grace CRR, 2007, J AM CHEM SOC, V129, P16102, DOI 10.1021/ja0760933; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Kaprara A, 2010, NEUROPEPTIDES, V44, P355, DOI 10.1016/j.npep.2010.06.005; Karayiannakis AJ, 1998, J PATHOL, V185, P413; Kiank C, 2010, BRAIN BEHAV IMMUN, V24, P41, DOI 10.1016/j.bbi.2009.08.006; Larauche M, 2009, J PHYSIOL PHARMACOL, V60, P33; Li LH, 2010, INT J ONCOL, V37, P951, DOI 10.3892/ijo_00000746; Li W, 2005, J CLIN ENDOCR METAB, V90, P6569, DOI 10.1210/jc.2005-1445; Miceli F, 2009, MOL CELL ENDOCRINOL, V305, P6, DOI 10.1016/j.mce.2009.02.013; Minas V, 2007, BRIT J CANCER, V97, P637, DOI 10.1038/sj.bjc.6603918; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Muramatsu Y, 2000, PEPTIDES, V21, P1799, DOI 10.1016/S0196-9781(00)00335-1; Noe V, 2001, J CELL SCI, V114, P111; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Shahani S, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-56; Soubry A, 2005, CANCER RES, V65, P2224, DOI 10.1158/0008-5472.CAN-04-2020; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tsanou E, 2008, ANTICANCER RES, V28, P3815; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Van Kolen K, 2010, NEUROPHARMACOLOGY, V58, P135, DOI 10.1016/j.neuropharm.2009.06.022; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; VANAKEN J, 1993, PATHOL RES PRACT, V189, P975; von Wichert G, 2008, EUR J CELL BIOL, V87, P1, DOI 10.1016/j.ejcb.2007.07.008; Wang JJ, 2007, BIOCHEM BIOPH RES CO, V362, P785, DOI 10.1016/j.bbrc.2007.08.014; WAYNER EA, 1993, J CELL BIOL, V121, P1141, DOI 10.1083/jcb.121.5.1141; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; Yuan ZK, 2010, MOL CELL ENDOCRINOL, V325, P1, DOI 10.1016/j.mce.2010.04.013; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437	49	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79335	10.1371/journal.pone.0079335	http://dx.doi.org/10.1371/journal.pone.0079335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260200	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500046
J	Eberhardt, HU; Buhlmann, D; Hortschansky, P; Chen, Q; Bohm, S; Kemper, MJ; Wallich, R; Hartmann, A; Hallstrom, T; Zipfel, PF; Skerka, C				Eberhardt, Hannes U.; Buhlmann, Denise; Hortschansky, Peter; Chen, Qian; Boehm, Sascha; Kemper, Markus J.; Wallich, Reinhard; Hartmann, Andrea; Hallstroem, Teresia; Zipfel, Peter F.; Skerka, Christine			Human Factor H-Related Protein 2 (CFHR2) Regulates Complement Activation	PLOS ONE			English	Article							ALTERNATIVE PATHWAY; MUTATION; GENES; RISK	Mutations and deletions within the human CFHR gene cluster on chromosome 1 are associated with diseases, such as dense deposit disease, CFHR nephropathy or age-related macular degeneration. Resulting mutant CFHR proteins can affect complement regulation. Here we identify human CFHR2 as a novel alternative pathway complement regulator that inhibits the C3 alternative pathway convertase and terminal pathway assembly. CFHR2 is composed of four short consensus repeat domains (SCRs). Two CFHR2 molecules form a dimer through their N-terminal SCRs, and each of the two C-terminal ends can bind C3b. C3b bound CFHR2 still allows C3 convertase formation but the CFHR2 bound convertases do not cleave the substrate C3. Interestingly CFHR2 hardly competes off factor H from C3b. Thus CFHR2 likely acts in concert with factor H, as CFHR2 inhibits convertases while simultaneously allowing factor H assisted degradation by factor I.	[Eberhardt, Hannes U.; Buhlmann, Denise; Chen, Qian; Boehm, Sascha; Hartmann, Andrea; Hallstroem, Teresia; Zipfel, Peter F.; Skerka, Christine] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Hortschansky, Peter] Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, Jena, Germany; [Kemper, Markus J.] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Friedrich Schiller University of Jena	Skerka, C (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany.	christine.skerka@hki-jena.de			Deutsche Forschungsgemeinschaft (DFG) [Sk 46, Zi 432]; International Leibniz Research School (ILRS); Jena school of Microbial Communication (JSMC), Jena, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); International Leibniz Research School (ILRS); Jena school of Microbial Communication (JSMC), Jena, Germany	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, Sk 46, Zi 432), Germany. HUE, DB and QC are doctoral researchers at the International Leibniz Research School (ILRS), part of the Jena school of Microbial Communication (JSMC), Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Jorge EG, 2013, P NATL ACAD SCI USA, V110, P4685, DOI 10.1073/pnas.1219260110; Diaz-Guillen MA, 1999, IMMUNOGENETICS, V49, P549, DOI 10.1007/s002510050534; Eberhardt HU, 2009, MED 2 EUR C IMM; Eyler SJ, 2013, PEDIAT NEPH IN PRESS; Francis NJ, 2012, BLOOD, V119, P591, DOI 10.1182/blood-2011-03-339903; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; Hebecker M, 2012, J BIOL CHEM, V287, P19528, DOI 10.1074/jbc.M112.364471; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hourcade DE, 1999, IMMUNOPHARMACOLOGY, V42, P167, DOI 10.1016/S0162-3109(99)00005-3; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kubista KE, 2011, MOL VIS, V17, P2080; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; de Cordoba SR, 2012, IMMUNOBIOLOGY, V217, P1034, DOI 10.1016/j.imbio.2012.07.021; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Sethi S, 2011, CLIN J AM SOC NEPHRO, V6, P1009, DOI 10.2215/CJN.07110810; SKERKA C, 1992, J IMMUNOL, V148, P3313; Skerka C, 2013, MOL IMMUNOL, V56, P170, DOI 10.1016/j.molimm.2013.06.001; Tortajada A, 2013, J CLIN INVEST, V123, P2434, DOI 10.1172/JCI68280; Venables JP, 2006, PLOS MED, V3, P1957, DOI 10.1371/journal.pmed.0030431; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Zhang H, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-51; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	25	50	52	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e78617	10.1371/journal.pone.0078617	http://dx.doi.org/10.1371/journal.pone.0078617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260121	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500007
J	Lopez-Quintero, SV; Cancel, LM; Pierides, A; Antonetti, D; Spray, DC; Tarbell, JM				Lopez-Quintero, Sandra V.; Cancel, Limary M.; Pierides, Alexis; Antonetti, David; Spray, David C.; Tarbell, John M.			High Glucose Attenuates Shear-Induced Changes in Endothelial Hydraulic Conductivity by Degrading the Glycocalyx	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HEPARAN-SULFATE PROTEOGLYCAN; FROG MESENTERIC CAPILLARIES; DIABETES-MELLITUS; CELL MONOLAYERS; STRESS; PERMEABILITY; DYSFUNCTION; ATHEROSCLEROSIS; TETRAHYDROBIOPTERIN	Diabetes mellitus is a risk factor for cardiovascular disease; however, the mechanisms through which diabetes impairs homeostasis of the vasculature have not been completely elucidated. The endothelium interacts with circulating blood through the surface glycocalyx layer, which serves as a mechanosensor/transducer of fluid shear forces leading to biomolecular responses. Atherosclerosis localizes typically in regions of low or disturbed shear stress, but in diabetics, the distribution is more diffuse, suggesting that there is a fundamental difference in the way cells sense shear forces. In the present study, we examined the effect of hyperglycemia on mechanotranduction in bovine aortic endothelial cells (BAEC). After six days in high glucose media, we observed a decrease in heparan sulfate content coincident with a significant attenuation of the shear-induced hydraulic conductivity response, lower activation of eNOS after exposure to shear, and reduced cell alignment with shear stress. These studies are consistent with a diabetes-induced change to the glycocalyx altering endothelial response to shear stress that could affect the distribution of atherosclerotic plaques.	[Lopez-Quintero, Sandra V.; Cancel, Limary M.; Pierides, Alexis; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [Antonetti, David] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Lopez-Quintero, Sandra V.; Spray, David C.] Yeshiva Univ, Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine	Tarbell, JM (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu		Spray, David/0000-0001-8368-5073; antonetti, david/0000-0003-1130-6577	NIH [HL094889, HL057093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge support from NIH Grants HL094889 and HL057093. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RH, 1990, J PHYSIOL-LONDON, V428, P1; ADAMSON RH, 1993, J PHYSIOL-LONDON, V466, P303; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Bollineni JS, 1997, CURR EYE RES, V16, P127, DOI 10.1076/ceyr.16.2.127.5089; Brower JB, 2010, CYTOSKELETON, V67, P135, DOI 10.1002/cm.20430; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; Cancel LM, 2011, AM J PHYSIOL-HEART C, V300, pH769, DOI 10.1152/ajpheart.00445.2010; Celie JWAM, 2007, AM J PATHOL, V170, P1865, DOI 10.2353/ajpath.2007.070061; Chang YS, 2000, ARTERIOSCL THROM VAS, V20, P35, DOI 10.1161/01.ATV.20.1.35; Danese C, 2006, Clin Ter, V157, P9; DeMaio L, 2004, AM J PHYSIOL-HEART C, V286, pH731, DOI 10.1152/ajpheart.00427.2003; Ding H, 2010, PFLUG ARCH EUR J PHY, V459, P977, DOI 10.1007/s00424-010-0807-3; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Ebong EE, 2013, EXPT BIOL; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Giantsos KM, 2009, BIOMATERIALS, V30, P5885, DOI 10.1016/j.biomaterials.2009.06.048; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; HOLLMANN J, 1989, ARTERIOSCLEROSIS, V9, P154, DOI 10.1161/01.ATV.9.2.154; Kim MH, 2005, AM J PHYSIOL-HEART C, V289, pH2126, DOI 10.1152/ajpheart.01270.2004; Lakshminarayanan S, 2000, CURR EYE RES, V21, P944, DOI 10.1076/ceyr.21.6.944.6985; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lopez-Quintero SV, 2009, AM J PHYSIOL-HEART C, V296, pH1451, DOI 10.1152/ajpheart.00894.2008; McMackin CJ, 2005, METHOD ENZYMOL, V396, P541, DOI 10.1016/S0076-6879(05)96046-1; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mine S, 2006, ENDOCR J, V53, P761, DOI 10.1507/endocrj.K05-119; MORRISON P, 1989, EXP CELL RES, V184, P304, DOI 10.1016/0014-4827(89)90330-3; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; PIRART J, 1977, DIABETES METAB, V3, P245; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Reyes-Soffer G, 2010, METABOLISM; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; SHIMOKAWA H, 1995, GERONTOLOGY, V41, P28; SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535, DOI 10.1152/ajpheart.1995.268.2.H535; Soro-Paavonen A, 2010, J HYPERTENS, V28, P780, DOI 10.1097/HJH.0b013e328335043e; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; van Haaren PMA, 2003, AM J PHYSIOL-HEART C, V285, pH2848, DOI 10.1152/ajpheart.00117.2003; Vogl-Willis CA, 2004, BBA-GEN SUBJECTS, V1672, P36, DOI 10.1016/j.bbagen.2004.02.005; Wang F, 2010, CARDIOVASC RES, V87, P127, DOI 10.1093/cvr/cvq051; Wang Jian Yong, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P301; WASTY F, 1993, DIABETOLOGIA, V36, P316, DOI 10.1007/BF00400234; Weinbaum S, 2003, P NATL ACAD SCI USA, V100, P7988, DOI 10.1073/pnas.1332808100; Williams DA, 1999, MICROVASC RES, V57, P107, DOI 10.1006/mvre.1998.2128; Williams DA, 2003, MICROVASC RES, V66, P147, DOI 10.1016/S0026-2862(03)00038-4; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Zuurbier CJ, 2005, J APPL PHYSIOL, V99, P1471, DOI 10.1152/japplphysiol.00436.2005	51	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e78954	10.1371/journal.pone.0078954	http://dx.doi.org/10.1371/journal.pone.0078954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260138	Green Published, gold			2022-12-25	WOS:000327308500015
J	Shiobara, T; Usui, T; Han, J; Isoda, H; Nagumo, Y				Shiobara, Tomoko; Usui, Takeo; Han, Junkyu; Isoda, Hiroko; Nagumo, Yoko			The Reversible Increase in Tight Junction Permeability Induced by Capsaicin Is Mediated via Cofilin-Actin Cytoskeletal Dynamics and Decreased Level of Occludin	PLOS ONE			English	Article							EPITHELIAL-CELLS; CYTOCHALASIN-D; PROTEIN; EXPRESSION; BARRIER; ZO-1; KINASE; MODULATION; ADHESION; DELIVERY	Previous results demonstrated that capsaicin induces the reversible tight junctions (TJ) opening via cofilin activation. The present study investigated the mechanisms underlying the reversible TJ opening and compared the effect to the irreversible opening induced by actin inhibitors. Capsaicin treatment induced the F-actin alteration unique to capsaicin compared to actin-interacting agents such as latrunculin A, which opens TJ irreversibly. Along with TJ opening, capsaicin decreased the level of F-actin at bicellular junctions but increased it at tricellular junctions accompanied with its concentration on the apical side of the lateral membrane. No change in TJ protein localization was observed upon exposure to capsaicin, but the amount of occludin was decreased significantly. In addition, cosedimentation analyses suggested a decrease in the interactions forming TJ, thereby weakening TJ tightness. Introduction of cofilin, LIMK and occludin into the cell monolayers confirmed their contribution to the transepithelial electrical resistance decrease. Finally, exposure of monolayers to capsaicin augmented the paracellular passage of both charged and uncharged compounds, as well as of insulin, indicating that capsaicin can be employed to modulate epithelial permeability. Our results demonstrate that capsaicin induces TJ opening through a unique mechanism, and suggest that it is a new type of paracellular permeability enhancer.	[Shiobara, Tomoko; Usui, Takeo; Han, Junkyu; Isoda, Hiroko; Nagumo, Yoko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Nagumo, Y (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	nagumo.yoko.fn@u.tsukuba.ac.jp		Isoda, Hiroko/0000-0002-1399-9541; Usui, Takeo/0000-0003-2377-7499	JSPS KAKENHI Grant [21710219, 24658107]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 21710219 and 24658107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; BENTZEL CJ, 1980, AM J PHYSIOL, V239, pC75, DOI 10.1152/ajpcell.1980.239.3.C75; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Fukasawa H, 2009, J AM SOC NEPHROL, V20, P1491, DOI 10.1681/ASN.2008101117; Han JK, 2005, CYTOTECHNOLOGY, V47, P89, DOI 10.1007/s10616-005-3756-5; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Huang Y, 2010, CELL MOL BIOENG, V3, P415, DOI 10.1007/s12195-010-0138-7; Humen MA, 2011, CELL MICROBIOL, V13, P1683, DOI 10.1111/j.1462-5822.2011.01647.x; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Lee E, 1998, CELL MOTIL CYTOSKEL, V39, P122, DOI 10.1002/(SICI)1097-0169(1998)39:2<122::AID-CM3>3.0.CO;2-8; Liu LB, 2008, J NEUROSCI RES, V86, P1153, DOI 10.1002/jnr.21558; Ma TY, 2000, AM J PHYSIOL-GASTR L, V279, pG875, DOI 10.1152/ajpgi.2000.279.5.G875; MADARA JL, 1986, J CELL BIOL, V102, P2125, DOI 10.1083/jcb.102.6.2125; Maher S, 2009, ADV DRUG DELIVER REV, V61, P1427, DOI 10.1016/j.addr.2009.09.006; Nagumo Y, 2007, BIOCHEM BIOPH RES CO, V355, P520, DOI 10.1016/j.bbrc.2007.02.002; Nagumo Y, 2008, BIOCHEM BIOPH RES CO, V377, P921, DOI 10.1016/j.bbrc.2008.10.071; Nava P, 2004, J CELL SCI, V117, P5509, DOI 10.1242/jcs.01425; Noth R, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-109; Peignon G, 2006, J BIOL CHEM, V281, P3560, DOI 10.1074/jbc.M506360200; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Rosenthal R, 2012, BIOMATERIALS, V33, P2791, DOI 10.1016/j.biomaterials.2011.12.034; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Salama NN, 2006, ADV DRUG DELIVER REV, V58, P15, DOI 10.1016/j.addr.2006.01.003; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Sonaje K, 2010, ADV FUNCT MATER, V20, P3695, DOI 10.1002/adfm.201001014; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; STEVENSON BR, 1994, J CELL SCI, V107, P367; Tirumalasetty PP, 2006, J PHARM PHARM SCI, V9, P32; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 2000, SEMIN CELL DEV BIOL, V11, P301, DOI 10.1006/scdb.2000.0180; Vogelmann R, 2005, MOL BIOL CELL, V16, P701, DOI 10.1091/mbc.E04-09-0827; Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004	40	43	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79954	10.1371/journal.pone.0079954	http://dx.doi.org/10.1371/journal.pone.0079954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260326	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500110
J	Zhou, WM; Lin, F; Teng, LF; Li, H; Hou, JY; Tong, R; Zheng, CH; Lou, YL; Tan, WJ				Zhou, Weimin; Lin, Feng; Teng, Lingfang; Li, Hua; Hou, Jianyi; Tong, Rui; Zheng, Changhua; Lou, Yongliang; Tan, Wenjie			Prevalence of Herpes and Respiratory Viruses in Induced Sputum among Hospitalized Children with Non Typical Bacterial Community-Acquired Pneumonia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CRITICALLY-ILL PATIENTS; EPSTEIN-BARR-VIRUS; VIRAL-INFECTIONS; HUMAN BOCAVIRUS; CORONAVIRUS INFECTIONS; ETIOLOGY; CYTOMEGALOVIRUS; EPIDEMIOLOGY; RHINOVIRUS	Objective: Few comprehensive studies have searched for viruses in infants and young children with community-acquired pneumonia (CAP) in China. The aim of this study was to investigate the roles of human herpes viruses (HHVs) and other respiratory viruses in CAP not caused by typical bacterial infection and to determine their prevalence and clinical significance. Methods: Induced sputum (IS) samples were collected from 354 hospitalised patients (infants, n = 205; children, n = 149) with respiratory illness (CAP or non-CAP) admitted to Wenling Hospital of China. We tested for HHVs and respiratory viruses using PCR-based assays. The epidemiological profiles were also analysed. Results: High rate of virus detection (more than 98%) and co-infection (more than 80%) were found among IS samples from 354 hospitalised infants and children with respiratory illness in this study. Of 273 CAP samples tested, CMV (91.6%), HHV-6 (50.9%), RSV (37.4%), EBV (35.5%), HBoV (28.2%), HHV-7 (18.3%) and rhinovirus (17.2%) were the most commonly detected viruses. Of 81 non-CAP samples tested, CMV (63%), RSV (49.4%), HHV-6 (42%), EBV (24.7%), HHV-7 (13.6%) and HBoV (8.6%) were the dominant viruses detected. The prevalence of several viral agents (rhinovirus, bocavirus, adenovirus and CMV) among IS samples of CAP were significantly higher than that of non-CAP control group. We also found the prevalence of RSV coinfection with HHVs was also higher among CAP group than that of non-CAP control. Conclusions: With sensitive molecular detection techniques and IS samples, high rates of viral identification were achieved in infants and young children with respiratory illness in a rural area of China. The clinical significance of rhinovirus, bocavirus, adenovirus and HHV (especially CMV) infections should receive greater attention in future treatment and prevention studies of CAP in infants and children.	[Zhou, Weimin; Tan, Wenjie] China CDC, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China; [Zhou, Weimin; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Lin, Feng; Teng, Lingfang; Li, Hua; Hou, Jianyi; Zheng, Changhua] Wenzhou Med Coll, Wenling Affiliated Hosp, Wenling, Zhejiang, Peoples R China; [Tong, Rui; Lou, Yongliang; Tan, Wenjie] Wenzhou Med Coll, Inst Med Virol, Wenzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Wenzhou Medical University; Wenzhou Medical University	Tan, WJ (corresponding author), China CDC, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China.	tanwj28@163.com			State Megaproject for Infectious Disease Research of China [2011ZX10004-001, 2013ZX10004601]; National 863 Project of China [2007AA02Z464]	State Megaproject for Infectious Disease Research of China; National 863 Project of China	This work was supported by grants from the State Megaproject for Infectious Disease Research of China (2011ZX10004-001, 2013ZX10004601) and National 863 Project of China (2007AA02Z464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abughali N, 2002, PEDIATR PULM, V33, P395, DOI 10.1002/ppul.10075; Marcos MA, 2006, ANTIVIR THER, V11, P351; Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Brittain-Long R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-44; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; Coisel Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051340; Costa C, 2010, TRANSPL P, V42, P1270, DOI 10.1016/j.transproceed.2010.03.086; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gambarino S, 2009, MINERVA MED, V100, P349; Greenberg SB, 2011, SEMIN RESP CRIT CARE, V32, P433, DOI 10.1055/s-0031-1283283; Grilli E, 2012, J CLIN VIROL, V55, P356, DOI 10.1016/j.jcv.2012.08.010; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hamano-Hasegawa Keiko, 2008, Journal of Infection and Chemotherapy, V14, P424, DOI 10.1007/s10156-008-0648-6; Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Lahti E, 2009, THORAX, V64, P252, DOI 10.1136/thx.2008.099051; Levy JA, 1997, LANCET, V349, P558, DOI 10.1016/S0140-6736(97)80119-5; Limaye AP, 2010, REV MED VIROL, V20, P372, DOI 10.1002/rmv.664; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Lu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038638; Mackay IM, 2003, J CLIN MICROBIOL, V41, P100, DOI 10.1128/JCM.41.1.100-105.2003; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Nascimento-Carvalho CM, 2008, PEDIATR INFECT DIS J, V27, P939, DOI 10.1097/INF.0b013e3181723751; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Principi N, 2010, EMERG INFECT DIS, V16, P183, DOI 10.3201/eid1602.090469; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Solidoro P, 2008, TRANSPL P, V40, P2013, DOI 10.1016/j.transproceed.2008.05.028; Tanaka T, 2009, BIOMED RES-TOKYO, V30, P279, DOI 10.2220/biomedres.30.279; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174	41	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79477	10.1371/journal.pone.0079477	http://dx.doi.org/10.1371/journal.pone.0079477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260230	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500064
J	Kondo, M; Yamaoka, K; Sonomoto, K; Fukuyo, S; Oshita, K; Okada, Y; Tanaka, Y				Kondo, Masahiro; Yamaoka, Kunihiro; Sonomoto, Koshiro; Fukuyo, Shunsuke; Oshita, Koichi; Okada, Yosuke; Tanaka, Yoshiya			IL-17 Inhibits Chondrogenic Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; ARTICULAR-CARTILAGE; JOINT DESTRUCTION; PROGENITOR CELLS; GENE-EXPRESSION; UP-REGULATION; FACTOR SOX9; INTERLEUKIN-1-BETA; CHONDROCYTE	Objective: Mesenchymal stem cells (MSCs) can differentiate into cells of mesenchymal lineages, such as osteoblasts and chondrocytes. Here we investigated the effects of IL-17, a key cytokine in chronic inflammation, on chondrogenic differentiation of human MSCs. Methods: Human bone marrow MSCs were pellet cultured in chondrogenic induction medium containing TGF-beta 3. Chondrogenic differentiation was detected by cartilage matrix accumulation and chondrogenic marker gene expression. Results: Over-expression of cartilage matrix and chondrogenic marker genes was noted in chondrogenic cultures, but was inhibited by IL-17 in a dose-dependent manner. Expression and phosphorylation of SOX9, the master transcription factor for chondrogenesis, were induced within 2 days and phosphorylated SOX9 was stably maintained until day 21. IL-17 did not alter total SOX9 expression, but significantly suppressed SOX9 phosphorylation in a dose-dependent manner. At day 7, IL-17 also suppressed the activity of cAMP-dependent protein kinase A (PKA), which is known to phosphorylate SOX9. H89, a selective PKA inhibitor, also suppressed SOX9 phosphorylation, expression of chondrogenic markers and cartilage matrix, and also decreased chondrogenesis. Conclusions: IL-17 inhibited chondrogenesis of human MSCs through the suppression of PKA activity and SOX9 phosphorylation. These results suggest that chondrogenic differentiation of MSCs can be inhibited by a mechanism triggered by IL-17 under chronic inflammation.	[Kondo, Masahiro; Yamaoka, Kunihiro; Sonomoto, Koshiro; Fukuyo, Shunsuke; Okada, Yosuke; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Dept Internal Med 1, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan; [Kondo, Masahiro; Oshita, Koichi] Mitsubishi Tanabe Pharma Corp, Pharmacol Res Labs 1, Div Res, Aoba Ku, Yokohama, Kanagawa, Japan	University of Occupational & Environmental Health - Japan; Mitsubishi Tanabe Pharma Corporation	Tanaka, Y (corresponding author), Univ Occupat & Environm Hlth, Dept Internal Med 1, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan.	tanaka@med.uoeh-u.ac.jp	Okada, Yosuke/AAT-3173-2020		Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; University of Occupational and Environmental Health, Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Occupational and Environmental Health, Japan(University of Occupational & Environmental Health - Japan)	Supported in part by a Research Grant-In-Aid for Scientific Research by the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the University of Occupational and Environmental Health, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Bauge C, 2008, ARTHRITIS RHEUM, V58, P221, DOI 10.1002/art.23154; Bauge C, 2007, ARTHRITIS RHEUM, V56, P3020, DOI 10.1002/art.22840; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chabaud M, 2000, CYTOKINE, V12, P1092, DOI 10.1006/cyto.2000.0681; Chabaud M, 2001, ARTHRITIS RES, V3, P168, DOI 10.1186/ar294; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Clark CA, 2005, BIOCHEM BIOPH RES CO, V328, P764, DOI 10.1016/j.bbrc.2004.11.074; Djouad F, 2006, REGEN MED, V1, P529, DOI 10.2217/17460751.1.4.529; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Ham O, 2012, BIOMATERIALS, V33, P4500, DOI 10.1016/j.biomaterials.2012.03.025; Haudenschild DR, 2010, ARTHRITIS RHEUM-US, V62, P191, DOI 10.1002/art.25051; Heldens GTH, 2012, TISSUE ENG PT A, V18, P45, DOI [10.1089/ten.tea.2011.0083, 10.1089/ten.TEA.2011.0083]; Hitchon CA, 2004, J RHEUMATOL, V31, P2336; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Jorgensen Christian, 2011, Regen Med, V6, P44, DOI 10.2217/rme.11.80; Kawakami Y, 2006, CURR OPIN CELL BIOL, V18, P723, DOI 10.1016/j.ceb.2006.10.007; Kayakabe M, 2006, CYTOTHERAPY, V8, P343, DOI 10.1080/14653240600845070; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; KOSHER RA, 1986, DEV BIOL, V118, P112, DOI 10.1016/0012-1606(86)90078-3; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Li TF, 2005, FRONT BIOSCI-LANDMRK, V10, P681, DOI 10.2741/1563; Li X, 2010, BIOCHEM BIOPH RES CO, V397, P131, DOI 10.1016/j.bbrc.2010.05.111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Luyten FP, 2004, CURR OPIN RHEUMATOL, V16, P599, DOI 10.1097/01.bor.0000130284.64686.63; MALEMUD CJ, 1986, J CELL PHYSIOL, V129, P51, DOI 10.1002/jcp.1041290108; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pretzel D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3320; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Roman-Blas JA, 2007, OSTEOARTHR CARTILAGE, V15, P1367, DOI 10.1016/j.joca.2007.04.011; Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006; Sitcheran R, 2003, GENE DEV, V17, P2368, DOI 10.1101/gad.1114503; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	49	44	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79463	10.1371/journal.pone.0079463	http://dx.doi.org/10.1371/journal.pone.0079463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260226	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600035
J	Braesch-Andersen, S; Paulie, S; Smedman, C; Mia, S; Kumagai-Braesch, M				Braesch-Andersen, Sten; Paulie, Staffan; Smedman, Christian; Mia, Sohel; Kumagai-Braesch, Makiko			ApoE Production in Human Monocytes and Its Regulation by Inflammatory Cytokines	PLOS ONE			English	Article							HUMAN APOLIPOPROTEIN-E; E-DEFICIENT MICE; IN-VIVO; APOPROTEIN-E; E SECRETION; REDUCES ATHEROSCLEROSIS; TRANSPORT PROTEIN; IMMUNE-RESPONSES; GENE-EXPRESSION; E SUPPRESSES	The apoE production by tissue macrophages is crucial for the prevention of atherosclerosis and the aim of this study was to further elucidate how this apolipoprotein is regulated by cytokines present during inflammation. Here we studied apoE production in peripheral blood mononuclear cells (PBMC) and analysis was made with a newly developed apoE ELISpot assay. In PBMC, apoE secretion was restricted to monocytes with classical (CD14(++) CD16(-)) and intermediate (CD14(+) CD16(+)) monocytes being the main producers. As earlier described for macrophages, production was strongly upregulated by TGF-beta and downregulated by bacterial lipopolysaccharide (LPS) and the inflammatory cytokines IFN-gamma, TNF-alpha and IL-1 beta. We could here show that a similar down-regulatory effect was also observed with the type I interferon, IFN-alpha, while IL-6, often regarded as one of the more prominent inflammatory cytokines, did not affect TGF-beta-induced apoE production. The TNF-alpha inhibitor Enbrel could partly block the down-regulatory effect of IFN-gamma, IFN-alpha and IL-1 beta, indicating that inhibition of apoE by these cytokines may be dependent on or synergize with TNF-alpha. Other cytokines tested, IL-2, IL-4, IL-12, IL-13, IL-17A and IL23, had no inhibitory effect on apoE production. In contrast to the effect on monocytes, apoE production by primary hepatocytes and the hepatoma cell line HepG2 was more or less unaffected by treatment with cytokines or LPS.	[Braesch-Andersen, Sten; Paulie, Staffan] Mabtech, Nacka Strand, Sweden; [Smedman, Christian] Karolinska Univ Hosp, Karolinska Inst, Infect Dis Unit L8 01, Mabtech, Stockholm, Sweden; [Smedman, Christian] Karolinska Univ Hosp, Karolinska Inst, Infect Dis Unit L8 01, Ctr Mol Med, Stockholm, Sweden; [Mia, Sohel] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med, Stockholm, Sweden; [Kumagai-Braesch, Makiko] Karolinska Inst, Mabtech, Stockholm, Sweden; [Kumagai-Braesch, Makiko] Karolinska Inst, Div Transplantat Surg, CLINTEC, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Braesch-Andersen, S (corresponding author), Mabtech, Nacka Strand, Sweden.	sten@mabtech.com		Kumagai-Braesch, Makiko/0000-0001-6011-0744				Aleong R, 2008, CURR ALZHEIMER RES, V5, P33; Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; AVILA EM, 1982, J BIOL CHEM, V257, P5900; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; BRAND K, 1993, J CLIN INVEST, V91, P2031, DOI 10.1172/JCI116425; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; DUAN HW, 1995, J CLIN INVEST, V96, P915, DOI 10.1172/JCI118139; Fazio S, 2002, J LIPID RES, V43, P1602, DOI 10.1194/jlr.M200108-JLR200; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Frostegard J, 2005, ARTERIOSCL THROM VAS, V25, P1776, DOI 10.1161/01.ATV.0000174800.78362.ec; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; HANSSON GK, 1993, BRIT HEART J, V69, pS38; Hayashi C, 2010, J INNATE IMMUN, V2, P334, DOI 10.1159/000314686; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; KELLY ME, 1994, CELL IMMUNOL, V159, P124, DOI 10.1006/cimm.1994.1302; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Laskowitz DT, 2000, J LIPID RES, V41, P613; Madan M, 2008, ATHEROSCLEROSIS, V197, P504, DOI 10.1016/j.atherosclerosis.2007.02.023; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Pedersen BK, 2004, P NUTR SOC, V63, P263, DOI 10.1079/PNS2004338; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; RALL SC, 1982, J BIOL CHEM, V257, P4171; Roselaar SE, 1998, J LIPID RES, V39, P1740; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Smedman C, 2012, SCAND J IMMUNOL, V75, P249, DOI 10.1111/j.1365-3083.2011.02641.x; Song H, 1998, CYTOKINE, V10, P275, DOI 10.1006/cyto.1997.0291; Taleb S, 2010, CURR OPIN PHARMACOL, V10, P197, DOI 10.1016/j.coph.2010.02.003; UTERMANN G, 1975, H-S Z PHYSIOL CHEM, V356, P1113, DOI 10.1515/bchm2.1975.356.2.1113; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; WEISGRABER KH, 1978, J BIOL CHEM, V253, P6281; WEISGRABER KH, 1991, J BIOL CHEM, V266, P12029; WERB Z, 1986, CIBA F SYMP, V118, P155, DOI 10.1002/9780470720998.ch11; WERB Z, 1983, J BIOL CHEM, V258, P642; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; ZANNIS VI, 1986, J BIOL CHEM, V261, P3415; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; Zhou Y, 1999, BRAIN RES BULL, V49, P173, DOI 10.1016/S0361-9230(99)00052-0; Zhu YH, 1998, P NATL ACAD SCI USA, V95, P7585, DOI 10.1073/pnas.95.13.7585; ZUCKERMAN SH, 1992, ATHEROSCLEROSIS, V96, P203, DOI 10.1016/0021-9150(92)90066-P; ZUCKERMAN SH, 1994, J LEUKOCYTE BIOL, V55, P743, DOI 10.1002/jlb.55.6.743	47	30	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79908	10.1371/journal.pone.0079908	http://dx.doi.org/10.1371/journal.pone.0079908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244577	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800104
J	den Hartog, CR; Beckley, JT; Smothers, TC; Lench, DH; Holseberg, ZL; Fedarovich, H; Gilstrap, MJ; Homanics, GE; Woodward, JJ				den Hartog, Carolina R.; Beckley, Jacob T.; Smothers, Thetford C.; Lench, Daniel H.; Holseberg, Zack L.; Fedarovich, Hleb; Gilstrap, Meghin J.; Homanics, Gregg E.; Woodward, John J.			Alterations in Ethanol-Induced Behaviors and Consumption in Knock-In Mice Expressing Ethanol-Resistant NMDA Receptors	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; VENTRAL TEGMENTAL AREA; PROTEIN-TYROSINE-PHOSPHATASE; MESOLIMBIC DOPAMINE SYSTEM; MEDIAL PREFRONTAL CORTEX; ABUSED INHALANT TOLUENE; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; NR1 SUBUNIT	Ethanol's action on the brain likely reflects altered function of key ion channels such as glutamatergic N-methyl-D-aspartate receptors (NMDARs). In this study, we determined how expression of a mutant GluN1 subunit (F639A) that reduces ethanol inhibition of NMDARs affects ethanol-induced behaviors in mice. Mice homozygous for the F639A allele died prematurely while heterozygous knock-in mice grew and bred normally. Ethanol (44 mM; similar to 0.2 g/dl) significantly inhibited NMD-Amediated EPSCs in wild-type mice but had little effect on responses in knock-in mice. Knock-in mice had normal expression of GluN1 and GluN2B protein across different brain regions and a small reduction in levels of GluN2A in medial prefrontal cortex. Ethanol (0.75-2.0 g/kg; IP) increased locomotor activity in wild-type mice but had no effect on knock-in mice while MK-801 enhanced activity to the same extent in both groups. Ethanol (2.0 g/kg) reduced rotarod performance equally in both groups but knock-in mice recovered faster following a higher dose (2.5 g/kg). In the elevated zero maze, knock-in mice had a blunted anxiolytic response to ethanol (1.25 g/kg) as compared to wild-type animals. No differences were noted between wild-type and knock-in mice for ethanol-induced loss of righting reflex, sleep time, hypothermia or ethanol metabolism. Knock-in mice consumed less ethanol than wild-type mice during daily limited-access sessions but drank more in an intermittent 24 h access paradigm with no change in taste reactivity or conditioned taste aversion. Overall, these data support the hypothesis that NMDA receptors are important in regulating a specific constellation of effects following exposure to ethanol.	[den Hartog, Carolina R.; Beckley, Jacob T.; Smothers, Thetford C.; Lench, Daniel H.; Holseberg, Zack L.; Fedarovich, Hleb; Gilstrap, Meghin J.; Woodward, John J.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Woodward, JJ (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	woodward@musc.edu		Beckley, Jacob/0000-0003-2950-6462; Homanics, Gregg/0000-0003-3641-8153	MUSC Neurosciences Institute; National Institutes of Health [R37AA10422, R37AA009986]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009986, R37AA010422] Funding Source: NIH RePORTER	MUSC Neurosciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by an MUSC Neurosciences Institute International Fellowship (CRD) and National Institutes of Health grants R37AA10422 (GEH) and R37AA009986 (JJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders DL, 2000, J BIOL CHEM, V275, P15019, DOI 10.1074/jbc.275.20.15019; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Badanich KA, 2011, GENES BRAIN BEHAV, V10, P805, DOI 10.1111/j.1601-183X.2011.00720.x; Bale AS, 2005, NEUROSCIENCE, V130, P197, DOI 10.1016/j.neuroscience.2004.08.040; Beckley JT, 2013, J NEUROSCI, V33, P804, DOI 10.1523/JNEUROSCI.3729-12.2013; Beckley JT, 2011, NEUROPSYCHOPHARMACOL, V36, P1531, DOI 10.1038/npp.2011.38; Borghese CM, 2006, J PHARMACOL EXP THER, V319, P208, DOI 10.1124/jpet.106.104406; Boyce-Rustay JM, 2006, PSYCHOPHARMACOLOGY, V187, P455, DOI 10.1007/s00213-006-0448-6; Boyce-Rustay JM, 2005, SYNAPSE, V56, P222, DOI 10.1002/syn.20143; Brodie MS, 1999, ALCOHOL CLIN EXP RES, V23, P1848, DOI 10.1111/j.1530-0277.1999.tb04082.x; BRODIE MS, 1990, BRAIN RES, V508, P65, DOI 10.1016/0006-8993(90)91118-Z; Camp MC, 2011, ADDICT BIOL, V16, P428, DOI 10.1111/j.1369-1600.2010.00282.x; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; CUNNINGHAM CL, 1993, BEHAV NEUROSCI, V107, P468, DOI 10.1037/0735-7044.107.3.468; Davis CM, 2010, ANN NY ACAD SCI, V1187, P247, DOI 10.1111/j.1749-6632.2009.05147.x; DeBrouse L, 2013, ALCOHOL CLIN EXP RES, V37, P223, DOI 10.1111/j.1530-0277.2012.01922.x; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; GONZALES RA, 1990, J PHARMACOL EXP THER, V253, P1138; GOTHERT M, 1989, N-S ARCH PHARMACOL, V340, P516; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; Jentsch JD, 1998, PSYCHOPHARMACOLOGY, V138, P89, DOI 10.1007/s002130050649; Kavalaii ET, 2012, AM J PSYCHIAT, V169, P1150, DOI 10.1176/appi.ajp.2012.12040531; Kretschmer BD, 1999, J NEUROCHEM, V73, P839, DOI 10.1046/j.1471-4159.1999.0730839.x; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Krystal JH, 2003, ANN NY ACAD SCI, V1003, P176, DOI 10.1196/annals.1300.010; Krystal JH, 1998, ARCH GEN PSYCHIAT, V55, P354, DOI 10.1001/archpsyc.55.4.354; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lockridge A, 2012, ALCOHOL, DOI [10.1016/j.alcohol.2011.11.004, DOI 10.1016/J.ALC0H0L.2011.11.004]; Lovinger DM, 2013, CURR TOP BEHAV NEURO, V13, P31, DOI 10.1007/7854_2011_143; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; MASOOD K, 1994, MOL PHARMACOL, V45, P324; Mathe JM, 1999, NEUROPHARMACOLOGY, V38, P121, DOI 10.1016/S0028-3908(98)00163-4; Mirshahi T, 1998, J NEUROCHEM, V71, P1095; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Morikawa H, 2010, INT REV NEUROBIOL, V91, P235, DOI 10.1016/S0074-7742(10)91008-8; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ogata J, 2006, J PHARMACOL EXP THER, V318, P434, DOI 10.1124/jpet.106.101691; Palachick B, 2008, ALCOHOL CLIN EXP RES, V32, P1479, DOI 10.1111/j.1530-0277.2008.00715.x; Pava MJ, 2012, PSYCHOPHARMACOLOGY, V219, P137, DOI 10.1007/s00213-011-2387-0; Peoples RW, 2000, NEUROPHARMACOLOGY, V39, P1681, DOI 10.1016/S0028-3908(00)00067-8; Petrakis IL, 2004, AM J PSYCHIAT, V161, P1776, DOI 10.1176/appi.ajp.161.10.1776; RABE CS, 1990, MOL PHARMACOL, V38, P753; Ren H, 2003, J BIOL CHEM, V278, P48815, DOI 10.1074/jbc.M302097200; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Single FN, 2000, J NEUROSCI, V20, P2558; Smothers CT, 2006, ALCOHOL CLIN EXP RES, V30, P523, DOI 10.1111/j.1530-0277.2006.00058.x; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Wang J, 2007, J NEUROSCI, V27, P3593, DOI 10.1523/JNEUROSCI.4749-06.2007; Wills TA, 2012, P NATL ACAD SCI USA, V109, pE278, DOI 10.1073/pnas.1113820109; Woodward JJ, 1999, NEUROCHEM INT, V35, P107, DOI 10.1016/S0197-0186(99)00052-2; Wright JM, 1996, BRAIN RES, V738, P249, DOI 10.1016/S0006-8993(96)00780-9; Wu PH, 2011, MOL PHARMACOL, V80, P529, DOI 10.1124/mol.110.068643; Xu MF, 2012, J PHARMACOL EXP THER, V340, P218, DOI 10.1124/jpet.111.187179; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006	63	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80541	10.1371/journal.pone.0080541	http://dx.doi.org/10.1371/journal.pone.0080541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244696	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000327143800151
J	Gupta, M; Brand, M				Gupta, Mansi; Brand, Michael			Identification and Expression Analysis of Zebrafish Glypicans during Embryonic Development	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CELL POLARITY; MORPHOGEN; GENE; RESPONSES; PROTEIN; GPC3; FGF8	Heparan sulfate Proteoglycans (HSPG) are ubiquitous molecules with indispensable functions in various biological processes. Glypicans are a family of HSPG's, characterized by a Gpi-anchor which directs them to the cell surface and/or extracellular matrix where they regulate growth factor signaling during development and disease. We report the identification and expression pattern of glypican genes from zebrafish. The zebrafish genome contains 10 glypican homologs, as opposed to six in mammals, which are highly conserved and are phylogenetically related to the mammalian genes. Some of the fish glypicans like Gpc1a, Gpc3, Gpc4, Gpc6a and Gpc6b show conserved synteny with their mammalian cognate genes. Many glypicans are expressed during the gastrulation stage, but their expression becomes more tissue specific and defined during somitogenesis stages, particularly in the developing central nervous system. Existence of multiple glypican orthologs in fish with diverse expression pattern suggests highly specialized and/or redundant function of these genes during embryonic development.	[Gupta, Mansi; Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, DFG Ctr Regenerat Therapies Dresden, Cluster Excellence CRTD, D-01062 Dresden, Saxony, Germany	German Research Foundation (DFG); Technische Universitat Dresden	Brand, M (corresponding author), Tech Univ Dresden, Ctr Biotechnol, DFG Ctr Regenerat Therapies Dresden, Cluster Excellence CRTD, D-01062 Dresden, Saxony, Germany.	michael.brand@crt-dresden.de	Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512	Deutsche Forschungsgemeinschaft [SFB 655 A3]; European Union (ZF Health); Center for Regenerative Therapies Dresden (CRTD)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (ZF Health)(European Commission); Center for Regenerative Therapies Dresden (CRTD)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 655 A3), European Union (ZF Health) and by a seed grant of the Center for Regenerative Therapies Dresden (CRTD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida Y, 1995, J LEUKOCYTE BIOL, V58, P675, DOI 10.1002/jlb.58.6.675; Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Bassuk AG, 2013, HUM MOL GENET, V22, P1097, DOI 10.1093/hmg/dds515; Bokel C, 2013, CURR OPIN GENET DEV, V23, P415, DOI 10.1016/j.gde.2013.03.002; Brand Michael, 2002, P7; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; CUI S, 2013, GASTROENTEROLOGY; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; Filmus J, 2001, J CLIN INVEST, V108, P497, DOI 10.1172/JCI13712; FILMUS J, 2013, FEBS J; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Flowers GP, 2012, DEVELOPMENT, V139, P2416, DOI 10.1242/dev.063206; Fukushima M, 1995, AM J KIDNEY DIS, V26, P952, DOI 10.1016/0272-6386(95)90061-6; Galli A, 2003, DEVELOPMENT, V130, P4919, DOI 10.1242/dev.00706; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Iglesias BV, 2008, HISTOL HISTOPATHOL, V23, P1333, DOI 10.14670/HH-23.1333; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KITAGAWA H, 1995, SPINE, V20, P2233, DOI 10.1097/00007632-199510001-00010; KOBAYASHI H, 1995, PHYS REV B, V52, P5781, DOI 10.1103/PhysRevB.52.5781; LeClair EE, 2009, DEV DYNAM, V238, P2550, DOI 10.1002/dvdy.22086; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.3.CO;2-8; Luxardi G, 2007, BIOCHEM BIOPH RES CO, V352, P55, DOI 10.1016/j.bbrc.2006.10.185; NAKAMURA H, 1995, NEUROSCI LETT, V199, P155, DOI 10.1016/0304-3940(95)12031-X; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Reifers F, 1998, DEVELOPMENT, V125, P2381; Saunders S, 1997, DEV BIOL, V190, P78, DOI 10.1006/dbio.1997.8690; Svensson G, 2012, J BIOL CHEM, V287, P14040, DOI 10.1074/jbc.M111.322487; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	35	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80824	10.1371/journal.pone.0080824	http://dx.doi.org/10.1371/journal.pone.0080824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244720	Green Published, gold, Green Submitted			2022-12-25	WOS:000327143800167
J	Hu, LY; Liu, CJ; Lu, T; Hu, TM; Tsai, CF; Hu, YW; Shen, CC; Chang, YS; Chen, MH; Teng, CJ; Chiang, HL; Yeh, CM; Su, VYF; Wang, WS; Chen, PM; Chen, TJ; Su, TP				Hu, Li-Yu; Liu, Chia-Jen; Lu, Ti; Hu, Tsung-Ming; Tsai, Chia-Fen; Hu, Yu-Wen; Shen, Cheng-Che; Chang, Yu-Sheng; Chen, Mu-Hong; Teng, Chung-Jen; Chiang, Huey-Ling; Yeh, Chiu-Mei; Su, Vincent Yi-Fong; Wang, Wei-Shu; Chen, Pan-Ming; Chen, Tzeng-Ji; Su, Tung-Ping			Delayed Onset Urticaria in Depressive Patients with Bupropion Prescription: A Nationwide Population-Based Study	PLOS ONE			English	Article							GENERALIZED ACUTE URTICARIA; SMOKING-CESSATION; SERUM; ASSOCIATION; ALPHA	Background: Bupropion, which is widely used in patients with depressive disorder, may cause allergic reactions. However, the real prevalence of these side effects may be overlooked and underreported due to the delayed onset phenomenon. Objective: This study aimed to estimate the real incidence of bupropion-induced urticaria and clarify the delayed onset phenomenon. Methods: We conducted a nationwide cohort study between 2000 and 2009 using Taiwan's National Health Insurance Dataset. Among 65,988 patients with depressive disorders, we identified new users of bupropion with depressive disorders (bupropion cohort, n = 2,839) and matched them at a ratio of 1: 4 regarding age and sex (non-bupropion matched cohort, n = 11,356). The risk of urticaria was compared between the two cohorts. Results: The risk of urticaria occurrence was higher in bupropion users than in matched controls within 4 weeks of starting the medication (risk ratio 1.81; 95% confidence interval 1.28-2.54; p = 0.001). The occurrence of urticaria in the bupropion cohort were more frequent on Days 15-28 than Day 1-14 (p = 0.002). Cox proportional hazards model showed that a history of urticaria was an independent risk factor for developing bupropion-induced urticaria. Conclusions: Of the antidepressants, bupropion may pose a higher risk of drug-induced urticaria, and this condition might be ignored due to the delayed onset phenomenon. Depressive patients with a history of urticaria are at higher risk of the adverse drug reaction. This study emphasizes the need for increased clinical awareness of this adverse outcome to bupropion use.	[Hu, Li-Yu; Lu, Ti] Kaohsiung Vet Gen Vet Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Hu, Li-Yu; Hu, Tsung-Ming] Yuli Vet Hosp, Dept Psychiat, Yuli, Taiwan; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Hu, Li-Yu; Liu, Chia-Jen; Hu, Yu-Wen; Chang, Yu-Sheng] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Liu, Chia-Jen; Wang, Wei-Shu] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan; [Tsai, Chia-Fen; Chen, Mu-Hong; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan; [Chang, Yu-Sheng] Shuang Ho Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, New Taipei City, Taiwan; [Chang, Yu-Sheng] Taipei Med Univ, New Taipei City, Taiwan; [Teng, Chung-Jen] Far Eastern Mem Hosp, Div Hematol & Oncol, Dept Med, New Taipei City, Taiwan; [Chiang, Huey-Ling] Far Eastern Mem Hosp, Dept Psychiat, New Taipei City, Taiwan; [Chiang, Huey-Ling] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Su, Vincent Yi-Fong] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chen, Pan-Ming] Taipei Vet Gen Hosp, Dept Psychiat, Su Ao & Yuanshan Branch, Taipei, Taiwan; [Hu, Li-Yu; Tsai, Chia-Fen; Shen, Cheng-Che; Teng, Chung-Jen; Wang, Wei-Shu; Chen, Tzeng-Ji; Su, Tung-Ping] Natl Yang Ming Univ, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taichung Veterans General Hospital; Taipei Medical University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Su, TP (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	tomsu0402@gmail.com	Chen, TJ/AAH-8430-2021; Chen, MuHong/ACJ-6131-2022	Chen, MuHong/0000-0001-6516-1073; CHIANG, HUEY-LING/0000-0002-2979-6108; Hu, Yu-Wen/0000-0002-7983-415X	Taipei Veterans General Hospital [V102D-001-1, V102D-001-2]; Yuli Veterans Hospital [VHYL-102-08]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Yuli Veterans Hospital	This study was supported by grants from Taipei Veterans General Hospital (V102D-001-1 and V102D-001-2) and Yuli Veterans Hospital (VHYL-102-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson E, 2001, MED J AUSTRALIA, V174, P650, DOI 10.5694/j.1326-5377.2001.tb143479.x; Beyens MN, 2008, DRUG SAFETY, V31, P1017, DOI 10.2165/00002018-200831110-00006; Bhella R, 2010, Acute Med, V9, P70; Boshier A, 2003, EUR J CLIN PHARMACOL, V59, P767, DOI 10.1007/s00228-003-0693-0; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Chiaverini C, 2003, ANN DERMATOL VENER, V130, P208; Crain Dominique, 2010, Hosp Pract (1995), V38, P53; Dadic-Hero E, 2011, PSYCHIAT DANUB, V23, P120; Fava Maurizio, 2005, Prim Care Companion J Clin Psychiatry, V7, P106; Fays S, 2003, BRIT J DERMATOL, V148, P177, DOI 10.1046/j.1365-2133.2003.50768.x; Hack S, 2004, J CHILD ADOL PSYCHOP, V14, P478, DOI 10.1089/cap.2004.14.478; Huang KL, 2009, PSYCHIAT CLIN NEUROS, V63, P401, DOI 10.1111/j.1440-1819.2009.01974.x; Kast RE, 2005, LEUKEMIA RES, V29, P1459, DOI 10.1016/j.leukres.2005.05.006; Lin CE, 2010, GEN HOSP PSYCHIAT, V32, pe341; Lineberry MTW, 2001, MAYO CLIN PROC, V76, P664; Loo WJ, 2003, BRIT J DERMATOL, V149, P660, DOI 10.1046/j.1365-2133.2003.05509.x; McCollom RA, 2000, ANN PHARMACOTHER, V34, P471, DOI 10.1345/aph.19297; Milionis HJ, 2000, POSTGRAD MED J, V76, P361, DOI 10.1136/pmj.76.896.361; Ornetti P, 2004, JOINT BONE SPINE, V71, P583, DOI 10.1016/j.jbspin.2003.10.004; Peloso PM, 1999, JAMA-J AM MED ASSOC, V282, P1817, DOI 10.1001/jama.282.19.1817; ROGER D, 1995, DERMATOLOGY, V191, P164, DOI 10.1159/000246539; Sheng LX, 2012, NICOTINE TOB RES; Staubach P, 2011, ACTA DERM-VENEREOL, V91, P557, DOI 10.2340/00015555-1109; Stockli Simone Schwarzenbach, 2007, J Dtsch Dermatol Ges, V5, P303, DOI 10.1111/j.1610-0387.2007.06270.x; Surovik J, 2010, J DRUGS DERMATOL, V9, P1010; Tackett AE, 2008, AM J HEALTH-SYST PH, V65, P1627, DOI 10.2146/ajhp070575; Tripathi A, 1999, ANN ALLERG ASTHMA IM, V83, P165, DOI 10.1016/S1081-1206(10)62630-0; Tsuboi I, 2012, EXP BIOL MED, V237, P1289, DOI 10.1258/ebm.2012.012158; van der Meer RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006102.pub2; Welsh John Patrick, 2006, J Drugs Dermatol, V5, P1012; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	33	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80064	10.1371/journal.pone.0080064	http://dx.doi.org/10.1371/journal.pone.0080064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244611	Green Submitted, Green Published, gold			2022-12-25	WOS:000327143800117
J	Nacher, M; Basurko, C; Adenis, A; Gaubert-Marechal, E; Mosnier, E; Edouard, S; Vantilcke, V; Sivapregassam, S; Tressieres, B; Cabie, A; Couppie, P				Nacher, Mathieu; Basurko, Celia; Adenis, Antoine; Gaubert-Marechal, Emilie; Mosnier, Emilie; Edouard, Sophie; Vantilcke, Vincent; Sivapregassam, Sindou; Tressieres, Benoit; Cabie, Andre; Couppie, Pierre			Predictive Factors of Herpes Zoster HIV-Infected Patients: Another Adverse Effect of Crack Cocaine	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; RISK-FACTORS; AIDS; COHORT; PROGRESSION; VARICELLA; DISEASE; ERA	A retrospective cohort study was conducted on 1541 HIV-infected patients to determine variables associated with the incidence of herpes zoster. A single failure Cox model showed that herpes zoster incidence increased following the first 6 months of antiretroviral treatment adjusted hazard ratio (AHR)=5 (95%CI=2.6-9.2), P<0.001; in the >60 years age group AHR=2 (95%CI=1-4), P=0.04; in patients in the top CD8 quartile AHR=2.1 (95%CI=1.3-3.6), P<0.001; and in patients previously reported to use crack cocaine AHR=5.9, (95%CI=1.4-25), P=0.02. Herpes zoster incidence increased in patients with CD4 counts<500 per mm(3) and gradually declined since 1992-1996, with AHR=0.3 (95%CI=0.2-0.5), P<0.001 for the 1997-2002 period and AHR=0.24 (95%CI=0.14-0.4), P<0.001 for the 2002-2008 period. Contrary to what has been described elsewhere, there was no specific effect of protease inhibitors on herpes zoster incidence. The present study is the first to suggest that crack cocaine is associated with an increased incidence of herpes zoster. The neurological or immunological effects of crack are discussed.	[Nacher, Mathieu; Basurko, Celia; Adenis, Antoine; Sivapregassam, Sindou] Ctr Hosp Cayenne, Ctr Invest Clin Epidemiol Clin Antilles Guyane IN, DGOS CIE 802, Cayenne, French Guiana; [Nacher, Mathieu] Univ Antilles Guyane, EA 3593, Cayenne, French Guiana; [Nacher, Mathieu] COREVIH Guyane, Cayenne, French Guiana; [Nacher, Mathieu; Gaubert-Marechal, Emilie] Ctr Hosp Cayenne, Cayenne, French Guiana; [Mosnier, Emilie; Couppie, Pierre] Ctr Hosp Cayenne, Serv Dermatol Venereol, Cayenne, French Guiana; [Vantilcke, Vincent] Ctr Hosp Franck Ouest Guyanais, Med Serv, St Laurent Du Maroni, French Guiana; [Tressieres, Benoit] Ctr Hosp Univ Martinique, Ctr Invest Clin Epidemiol Clin Antilles Guyane IN, DGOS CIE 802, Fort De France, Martinique, France; [Cabie, Andre] Ctr Hosp Univ Martinique, Serv Malad Infect & Trop, Fort De France, Martinique, France	CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Martinique	Nacher, M (corresponding author), Ctr Hosp Cayenne, Ctr Invest Clin Epidemiol Clin Antilles Guyane IN, DGOS CIE 802, Cayenne, French Guiana.	mathieu.nacher@ch-cayenne.fr	nacher, mathieu/AAH-4796-2021; Basurko, Célia/AAM-8297-2021; TRESSIERES, Benoit/ABH-1085-2020; MOSNIER, Emilie/GXV-4053-2022	nacher, mathieu/0000-0001-9397-3204; MOSNIER, Emilie/0000-0002-6004-3323; Couppie, Pierre/0000-0002-4213-2867; Cabie, Andre/0000-0003-0117-3061; adenis, antoine/0000-0003-4000-4981				Aldeen T, 1998, AIDS, V12, P1719; Alliegro MB, 1996, CLIN INFECT DIS, V23, P990, DOI 10.1093/clinids/23.5.990; Blank LJ, J ACQ IMMUN DEF SYND, V61, P203, DOI [10.1097/QAI.0b013e318266cd3c, DOI 10.1097/QAI.0B013E318266CD3C.PUBMED:22766968]; BUCHBINDER SP, 1992, J INFECT DIS, V166, P1153, DOI 10.1093/infdis/166.5.1153; Cabral GA, 2006, J NEUROIMMUNE PHARM, V1, P280, DOI 10.1007/s11481-006-9023-5; Carr A, 1996, J ACQ IMMUN DEF SYND, V13, P320, DOI 10.1097/00042560-199612010-00004; CAUDA R, 1987, J IMMUNOL, V138, P1229; Domingo P, 2001, AM J MED, V110, P605, DOI 10.1016/S0002-9343(01)00703-3; Engels EA, 1999, J INFECT DIS, V180, P1784, DOI 10.1086/315146; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V40, P169, DOI 10.1097/01.qai.0000178408.62675.b0; GLESBY MJ, 1993, J INFECT DIS, V168, P1264, DOI 10.1093/infdis/168.5.1264; MAHALINGAM R, 1990, NEW ENGL J MED, V323, P627, DOI 10.1056/NEJM199009063231002; Martinez E, 1998, CLIN INFECT DIS, V27, P1510, DOI 10.1086/515019; Moanna A, 2013, CLIN INFECT DIS, V57, P122, DOI 10.1093/cid/cit165; Molton J, 2010, J INFECTION, V61, P73, DOI 10.1016/j.jinf.2010.04.004; Murdoch DM, 2008, AIDS, V22, P1689, DOI 10.1097/QAD.0b013e328308de33; Nacher M, 2009, AIDS, V23, P2223, DOI 10.1097/QAD.0b013e32833147c2; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; ROGUES AM, 1993, J INFECT DIS, V168, P245, DOI 10.1093/infdis/168.1.245; VEENSTRA J, 1995, AIDS, V9, P1153, DOI 10.1097/00002030-199510000-00006; Wood SM, 2008, PEDIATRICS, V121, pE150, DOI 10.1542/peds.2007-0564	21	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80187	10.1371/journal.pone.0080187	http://dx.doi.org/10.1371/journal.pone.0080187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244647	gold, Green Published			2022-12-25	WOS:000327221600190
J	Oneyama, C; Kito, Y; Asai, R; Ikeda, J; Yoshida, T; Okuzaki, D; Kokuda, R; Kakumoto, K; Takayama, K; Inoue, S; Morii, E; Okada, M				Oneyama, Chitose; Kito, Yoriko; Asai, Rei; Ikeda, Jun-ichiro; Yoshida, Takuya; Okuzaki, Daisuke; Kokuda, Rie; Kakumoto, Kyoko; Takayama, Ken-ichi; Inoue, Satoshi; Morii, Eiichi; Okada, Masato			MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression	PLOS ONE			English	Article							MTOR COMPLEX 2; C-SRC; AKT PHOSPHORYLATION; DOWN-REGULATION; MICRORNA; GROWTH; CANCER; RAPTOR; TRANSFORMATION; PATHWAY	mTOR complex 2 (mTORC2) signaling is upregulated in multiple types of human cancer, but the molecular mechanisms underlying its activation and regulation remain elusive. Here, we show that microRNA-mediated upregulation of Rictor, an mTORC2-specific component, contributes to tumor progression. Rictor is upregulated via the repression of the miR-424/503 cluster in human prostate and colon cancer cell lines that harbor c-Src upregulation and in Src-transformed cells. The tumorigenicity and invasive activity of these cells were suppressed by re-expression of miR-424/503. Rictor upregulation promotes formation of mTORC2 and induces activation of mTORC2, resulting in promotion of tumor growth and invasion. Furthermore, downregulation of miR-424/503 is associated with Rictor upregulation in colon cancer tissues. These findings suggest that the miR-424/503-Rictor pathway plays a crucial role in tumor progression.	[Oneyama, Chitose; Kito, Yoriko; Asai, Rei; Kokuda, Rie; Kakumoto, Kyoko; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan; [Ikeda, Jun-ichiro; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan; [Yoshida, Takuya] Osaka Univ, Grad Sch Pharmaceut Sci, Biophys Chem Lab, Suita, Osaka, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 565, Japan; [Takayama, Ken-ichi; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo, Japan; [Takayama, Ken-ichi; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Takayama, Ken-ichi; Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Saitama, Japan	Osaka University; Osaka University; Osaka University; Osaka University; University of Tokyo; University of Tokyo; Saitama Medical University	Oneyama, C (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan.	coneyama@biken.osaka-u.ac.jp	Takayama, Kenichi/AAK-9238-2020; Okuzaki, Daisuke/AAN-5641-2020	Okuzaki, Daisuke/0000-0002-4552-783X; Yoshida, Takuya/0000-0002-3491-9344	Ministry of Education, Culture, Sports, Science and Technology of Japan; Exciting Leading-Edge Research Project at Osaka University; Grants-in-Aid for Scientific Research [25670678] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Exciting Leading-Edge Research Project at Osaka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for P-DIRECT from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by The Exciting Leading-Edge Research Project at Osaka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lowy DR, 2012, NAT MED, V18, P28, DOI [10.1038/nm0112-28, 10.1038/nm.3040]; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; OKADA M, 1991, J BIOL CHEM, V266, P24249; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Penuel E, 1999, MOL BIOL CELL, V10, P1693, DOI 10.1091/mbc.10.6.1693; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; Yagi R, 2007, EMBO J, V26, P1234, DOI 10.1038/sj.emboj.7601595; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	59	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80300	10.1371/journal.pone.0080300	http://dx.doi.org/10.1371/journal.pone.0080300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244675	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600202
J	Pamphlett, R; Rikard-Bell, A				Pamphlett, Roger; Rikard-Bell, Anna			Different Occupations Associated with Amyotrophic Lateral Sclerosis: Is Diesel Exhaust the Link?	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; ENGINE EXHAUST; RISK-FACTORS; ALS; EXPOSURE; MORTALITY; PARTICLES; MUTATIONS; SMOKING	The cause of sporadic amyotrophic lateral sclerosis (SALS) remains unknown. We attempted to find out if occupational exposure to toxicants plays a part in the pathogenesis of this disease. In an Australia-wide case-control study we compared the lifetime occupations of 611 SALS and 775 control individuals. Occupations were coded using country-specific as well as international classifications. The risk of SALS for each occupation was calculated with odds ratios using logistic regression. In addition, the literature was searched for possible toxicant links between our findings and previously-reported occupational associations with SALS. Male occupations in our study that required lower skills and tasks tended to have increased risks of SALS, and conversely, those occupations that required higher skills and tasks had decreased risks of SALS. Of all the occupations, only truck drivers, where exposure to diesel exhaust is common, maintained an increased risk of SALS throughout all occupational groups. Another large case-control study has also found truck drivers to be at risk of SALS, and almost two-thirds of occupations, as well as military duties, that have previously been associated with SALS have potential exposure to diesel exhaust. In conclusion, two of the largest case-control studies of SALS have now found that truck drivers have an increased risk of SALS. Since exposure to diesel exhaust is common in truck drivers, as well as in other occupations that have been linked to SALS, exposure to this toxicant may underlie some of the occupations that are associated with SALS.	[Pamphlett, Roger; Rikard-Bell, Anna] Univ Sydney, Dept Pathol, Sydney Med Sch, Stacey Motor Neuron Dis Lab, Sydney, NSW 2006, Australia	University of Sydney	Pamphlett, R (corresponding author), Univ Sydney, Dept Pathol, Sydney Med Sch, Stacey Motor Neuron Dis Lab, Sydney, NSW 2006, Australia.	roger.pamphlett@sydney.edu.au			Aimee Stacey Memorial Bequest; Burnett Bequest; Australian National Health and Medical Research Council [402783]	Aimee Stacey Memorial Bequest; Burnett Bequest; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Supported by the Aimee Stacey Memorial Bequest and the Burnett Bequest. Questionnaire data were obtained from the Australian Motor Neuron Disease DNA Bank, which is supported by an Australian National Health and Medical Research Council Enabling Grant #402783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulos Y, 2013, WORK, V46, P113, DOI 10.3233/WOR-121553; Armon C, 2009, NEUROLOGY, V73, P1693, DOI 10.1212/WNL.0b013e3181c1df48; Belzil VV, 2012, J NEUROL NEUROSUR PS, V83, P1133, DOI 10.1136/jnnp-2012-303127; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; CARPENTER S, 1968, NEUROLOGY, V18, P841, DOI 10.1212/WNL.18.9.841; CHIO A, 1991, NEUROEPIDEMIOLOGY, V10, P174, DOI 10.1159/000110267; Davis ME, 2007, J OCCUP ENVIRON HYG, V4, P848, DOI 10.1080/15459620701643347; Donoghue AM, 2004, OCCUP MED-OXFORD, V54, P283, DOI 10.1093/occmed/kqh072; DURHAM HD, 1995, CLIN EXP PHARMACOL P, V22, P366, DOI 10.1111/j.1440-1681.1995.tb02019.x; Fang F, 2009, ENVIRON HEALTH PERSP, V117, P1387, DOI 10.1289/ehp.0900580; Genc S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/782462; Gerlofs-Nijland ME, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-12; Govoni V, 2012, J NEUROL, V259, P1623, DOI 10.1007/s00415-011-6390-5; GUNNARSSON LG, 1991, ACTA NEUROL SCAND, V83, P394, DOI 10.1111/j.1600-0404.1991.tb03970.x; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; HARGREAVES RJ, 1988, NEUROPATH APPL NEURO, V14, P443, DOI 10.1111/j.1365-2990.1988.tb01336.x; Hauser RM, 1997, SOCIOL METHODOL, V27, P177, DOI 10.1111/1467-9531.271028; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; KURTZKE JF, 1980, NEUROLOGY, V30, P453, DOI 10.1212/WNL.30.5.453; Levesque S, 2011, ENVIRON HEALTH PERSP, V119, P1149, DOI 10.1289/ehp.1002986; Lewne M, 2006, INT ARCH OCC ENV HEA, V79, P220, DOI 10.1007/s00420-005-0047-6; Lloyd AC, 2001, J AIR WASTE MANAGE, V51, P809, DOI 10.1080/10473289.2001.10464315; McGuire V, 1997, AM J EPIDEMIOL, V145, P1076, DOI 10.1093/oxfordjournals.aje.a009070; O'Reilly EJ, 2013, AMYOTROPH LAT SCL FR, V14, P205, DOI 10.3109/21678421.2012.735240; Pamphlett R, 1996, J NEUROL SCI, V135, P63, DOI 10.1016/0022-510X(95)00258-4; Pamphlett R, 2012, EUR J NEUROL, V19, P1343, DOI 10.1111/j.1468-1331.2012.03769.x; Pamphlett R, 2002, J OCCUP ENVIRON MED, V44, P987, DOI 10.1097/00043764-200211000-00001; Pamphlett R, 2013, ACTA NEUROPATHOL COM, V1, P14, DOI [10.1186/2051-5960-1-14, DOI 10.1186/2051-5960-1-14]; Papadimitriou D, 2010, NEUROBIOL DIS, V37, P493, DOI 10.1016/j.nbd.2009.10.005; Park RM, 2005, AM J IND MED, V48, P63, DOI 10.1002/ajim.20178; Peters S, 2013, INT J CANCER, V132, P2975, DOI 10.1002/ijc.27972; Pinkerton LE, 2013, AMYOTROPH LA SCL FR, V14, P353, DOI 10.3109/21678421.2013.778284; Pratt SL, 1999, APPL OCCUP ENV HYG, V12, P1032; Pronk A, 2009, J EXPO SCI ENV EPID, V19, P443, DOI 10.1038/jes.2009.21; Ris C, 2007, INHAL TOXICOL, V19, P229, DOI 10.1080/08958370701497960; Ritchie GD, 2001, J TOXICOL ENV HEAL B, V4, P223, DOI 10.1080/109374001301419728; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Savitz DA, 1998, ARCH ENVIRON HEALTH, V53, P71, DOI 10.1080/00039899809605691; Schulte PA, 1996, AM J PUBLIC HEALTH, V86, P1281, DOI 10.2105/AJPH.86.9.1281; Scott KM, 2010, AMYOTROPH LATERAL SC, V11, P435, DOI 10.3109/17482961003754552; Smith Thomas J, 2012, Res Rep Health Eff Inst, P5; Spencer PS, 2002, INT J HYG ENVIR HEAL, V205, P131, DOI 10.1078/1438-4639-00138; Strickland D, 1996, ARCH NEUROL-CHICAGO, V53, P730, DOI 10.1001/archneur.1996.00550080044011; Sutedja NA, 2007, NEUROLOGY, V69, P1508, DOI 10.1212/01.wnl.0000277463.87361.8c; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P295, DOI 10.3109/17482960802430799; Ulhoa MA, 2011, CHRONOBIOL INT, V28, P810, DOI 10.3109/07420528.2011.613136; Vanacore N, 2010, AMYOTROPH LATERAL SC, V11, P430, DOI 10.3109/17482961003605796; Vucic S, 2008, CLIN NEUROPHYSIOL, V119, P1088, DOI 10.1016/j.clinph.2008.01.011; Weisskopf MG, 2009, J NEUROL NEUROSUR PS, V80, P558, DOI 10.1136/jnnp.2008.156976; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; Yin HZ, 2012, EXP NEUROL, V238, P93, DOI 10.1016/j.expneurol.2012.08.004	55	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80993	10.1371/journal.pone.0080993	http://dx.doi.org/10.1371/journal.pone.0080993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244728	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600219
J	Smith, SA; Ray, D; Cook, KB; Mallory, MJ; Hughes, TR; Lynch, KW				Smith, Sarah A.; Ray, Debashish; Cook, Kate B.; Mallory, Michael J.; Hughes, Timothy R.; Lynch, Kristen W.			Paralogs hnRNP L and hnRNP LL Exhibit Overlapping but Distinct RNA Binding Constraints	PLOS ONE			English	Article							RIBONUCLEOPROTEIN; REGULATORS; PROTEINS; PTBP2; GENE	HnRNP (heterogeneous nuclear ribonucleoprotein) proteins are a large family of RNA-binding proteins that regulate numerous aspects of RNA processing. Interestingly, several paralogous pairs of hnRNPs exist that exhibit similar RNA-binding specificity to one another, yet have non-redundant functional targets in vivo. In this study we systematically investigate the possibility that the paralogs hnRNP L and hnRNP LL have distinct RNA binding determinants that may underlie their lack of functional redundancy. Using a combination of RNAcompete and native gel analysis we find that while both hnRNP L and hnRNP LL preferentially bind sequences that contain repeated CA dinucleotides, these proteins differ in their requirement for the spacing of the CAs. Specifically, hnRNP LL has a more stringent requirement for a two nucleotide space between CA repeats than does hnRNP L, resulting in hnRNP L binding more promiscuously than does hnRNP LL. Importantly, this differential requirement for the spacing of CA dinucleotides explains the previously observed differences in the sensitivity of hnRNP L and LL to mutations within the CD45 gene. We suggest that overlapping but divergent RNA-binding preferences, as we show here for hnRNP L and hnRNP LL, may be commonplace among other hnRNP paralogs.	[Smith, Sarah A.; Mallory, Michael J.; Lynch, Kristen W.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ray, Debashish; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Cook, Kate B.; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University of Toronto	Lynch, KW (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA.	klync@mail.med.upenn.edu			National Institutes of Health (NIH) [1R01GM084034, 1R01HG00570]; Canadian Institutes of Health Research [MOP-49451, MOP-125894]; National Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067719, R01GM084034] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH)(1R01GM084034 to KWL and 1R01HG00570 to TRH and QDM); Canadian Institutes of Health Research (MOP-49451 to TRH and MOP-125894 to QDM and TRH); National Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship (KBC). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Heyd F, 2010, MOL CELL, V40, P126, DOI 10.1016/j.molcel.2010.09.013; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Martinez-Contreras R, 2007, HNRNP PROTEINS SPLIC; Motta-Mena LB, 2011, J BIOL CHEM, V286, P20043, DOI 10.1074/jbc.M111.218727; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Perez I, 1997, RNA, V3, P764; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026	16	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80701	10.1371/journal.pone.0080701	http://dx.doi.org/10.1371/journal.pone.0080701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244709	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600214
J	Homem, CCF; Reichardt, I; Berger, C; Lendl, T; Knoblich, JA				Homem, Catarina C. F.; Reichardt, Ilka; Berger, Christian; Lendl, Thomas; Knoblich, Juergen A.			Long-Term Live Cell Imaging and Automated 4D Analysis of Drosophila Neuroblast Lineages	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; SELF-RENEWAL; LARVAL NEUROBLASTS; DIVISION; CULTURE; CYCLE; PROLIFERATION; PROTEIN; DIFFERENTIATION	The developing Drosophila brain is a well-studied model system for neurogenesis and stem cell biology. In the Drosophila central brain, around 200 neural stem cells called neuroblasts undergo repeated rounds of asymmetric cell division. These divisions typically generate a larger self-renewing neuroblast and a smaller ganglion mother cell that undergoes one terminal division to create two differentiating neurons. Although single mitotic divisions of neuroblasts can easily be imaged in real time, the lack of long term imaging procedures has limited the use of neuroblast live imaging for lineage analysis. Here we describe a method that allows live imaging of cultured Drosophila neuroblasts over multiple cell cycles for up to 24 hours. We describe a 4D image analysis protocol that can be used to extract cell cycle times and growth rates from the resulting movies in an automated manner. We use it to perform lineage analysis in type II neuroblasts where clonal analysis has indicated the presence of a transit-amplifying population that potentiates the number of neurons. Indeed, our experiments verify type II lineages and provide quantitative parameters for all cell types in those lineages. As defects in type II neuroblast lineages can result in brain tumor formation, our lineage analysis method will allow more detailed and quantitative analysis of tumorigenesis and asymmetric cell division in the Drosophila brain.	[Homem, Catarina C. F.; Reichardt, Ilka; Berger, Christian; Lendl, Thomas; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Lendl, Thomas] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Lendl, Thomas] Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Homem, Catarina/0000-0003-4243-0298	Austrian Academy of Sciences; Austrian Science Fund (FWF) [I_552-B19, Z_153_B09]; European Research Council (ERC); Austrian Science Fund (FWF) [Z 153, I 1281, I 552] Funding Source: researchfish	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Work in J.A.K.'s lab is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF, grants I_552-B19 and Z_153_B09), and an advanced grant of the European Research Council (ERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Ceron J, 2006, EUR J CELL BIOL, V85, P567, DOI 10.1016/j.ejcb.2006.02.006; Datta S, 1999, BRAIN RES, V818, P77, DOI 10.1016/S0006-8993(98)01292-X; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Feiguin F, 1998, CURR TOP DEV BIOL, V36, P279; FURST A, 1985, DEV BIOL, V112, P467, DOI 10.1016/0012-1606(85)90419-1; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Goodman Corey S., 1993, P1131; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Luer K, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-30; LUER K, 1992, DEVELOPMENT, V116, P377; Moraru MM, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-14; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; San-Juan BP, 2011, DEV BIOL, V352, P70, DOI 10.1016/j.ydbio.2011.01.019; Savoian MS, 2002, J CELL SCI, V115, P3061; SEECOF RL, 1973, CELL DIFFER DEV, V2, P143, DOI 10.1016/0045-6039(73)90014-6; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; WU CF, 1983, J NEUROSCI, V3, P1888; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	39	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79588	10.1371/journal.pone.0079588	http://dx.doi.org/10.1371/journal.pone.0079588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260257	Green Submitted, Green Published, gold			2022-12-25	WOS:000327216200078
J	Bottcher, C; Fernandez-Klett, F; Gladow, N; Rolfes, S; Priller, J				Boettcher, Chotima; Fernandez-Klett, Francisco; Gladow, Nadine; Rolfes, Simone; Priller, Josef			Targeting Myeloid Cells to the Brain Using Non-Myeloablative Conditioning	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MARROW-DERIVED CELLS; BONE-MARROW; MOUSE MODEL; RAT MODEL; MICROGLIA; CONTRIBUTE; MONOCYTES; GENE; MICE	Bone marrow-derived cells (BMDCs) are able to colonize the central nervous system (CNS) at sites of damage. This ability makes BMDCs an ideal cellular vehicle for transferring therapeutic genes/molecules to the CNS. However, conditioning is required for bone marrow-derived myeloid cells to engraft in the brain, which so far has been achieved by total body irradiation (TBI) and by chemotherapy (e. g. busulfan treatment). Unfortunately, both regimens massively disturb the host's hematopoietic compartment. Here, we established a conditioning protocol to target myeloid cells to sites of brain damage in mice using non-myeloablative focal head irradiation (HI). This treatment was associated with comparatively low inflammatory responses in the CNS despite cranial radiation doses which are identical to TBI, as revealed by gene expression analysis of cytokines/chemokines such as CCL2, CXCL10, TNF-alpha and CCL5. HI prior to bone marrow transplantation resulted in much lower levels of blood chimerism defined as the percentage of donor-derived cells in peripheral blood (< 5%) compared with TBI (> 95%) or busulfan treatment (>50%). Nevertheless, HI effectively recruited myeloid cells to the area of motoneuron degeneration in the brainstem within 7 days after facial nerve axotomy. In contrast, no donor-derived cells were detected in the lesioned facial nucleus of busulfan-treated animals up to 2 weeks after transplantation. Our findings suggest that myeloid cells can be targeted to sites of brain damage even in the presence of very low levels of peripheral blood chimerism. We established a novel non-myeloablative conditioning protocol with minimal disturbance of the host's hematopoietic system for targeting BMDCs specifically to areas of pathology in the brain.	[Boettcher, Chotima; Fernandez-Klett, Francisco; Gladow, Nadine; Rolfes, Simone; Priller, Josef] Charite, Dept Neuropsychiat, D-13353 Berlin, Germany; [Boettcher, Chotima; Fernandez-Klett, Francisco; Gladow, Nadine; Rolfes, Simone; Priller, Josef] Charite, Lab Mol Psychiat, D-13353 Berlin, Germany; [Priller, Josef] Cluster Excellence NeuroCure, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Priller, J (corresponding author), Charite, Dept Neuropsychiat, D-13353 Berlin, Germany.	josef.priller@charite.de	Priller, Josef/ABW-3835-2022	Priller, Josef/0000-0001-7596-0979; Bottcher, Chotima/0000-0002-6226-586X	Deutsche Forschungsgemeinschaft [FOR 1336, TRR43]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grants FOR 1336 and TRR43. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; CLIFT RA, 1990, BLOOD, V76, P1867; CLIFT RA, 1991, BLOOD, V77, P1660; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Flugel A, 2001, J CEREBR BLOOD F MET, V21, P69; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HOOGERBRUGGE PM, 1988, SCIENCE, V239, P1035, DOI 10.1126/science.3278379; Keshet GI, 2007, J COMP NEUROL, V504, P690, DOI 10.1002/cne.21483; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lampron A, 2012, CELL TRANSPLANT, V21, P1149, DOI 10.3727/096368911X593154; Lewis CAB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060661; Makar TK, 2008, J NEUROIMMUNOL, V196, P67, DOI 10.1016/j.jneuroim.2008.02.014; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; van Vliet EA, 2012, EPILEPSIA, V53, P1254, DOI 10.1111/j.1528-1167.2012.03513.x; Wilkinson FL, 2013, MOL THER, V21, P868, DOI 10.1038/mt.2013.29; Wong JYC, 2006, BIOL BLOOD MARROW TR, V12, P306, DOI 10.1016/j.bbmt.2005.10.026; Ye M, 2007, BRAIN RES, V1142, P206, DOI 10.1016/j.brainres.2006.12.061; Zhang SZ, 2008, CELL MOL NEUROBIOL, V28, P529, DOI 10.1007/s10571-007-9191-8	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80260	10.1371/journal.pone.0080260	http://dx.doi.org/10.1371/journal.pone.0080260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244666	Green Submitted, gold, Green Published			2022-12-25	WOS:000327162900074
J	Mortier, V; Dauwe, K; Vancoillie, L; Staelens, D; Van Wanzeele, F; Vogelaers, D; Vandekerckhove, L; Chalmet, K; Verhofstede, C				Mortier, Virginie; Dauwe, Kenny; Vancoillie, Leen; Staelens, Delfien; Van Wanzeele, Filip; Vogelaers, Dirk; Vandekerckhove, Linos; Chalmet, Kristen; Verhofstede, Chris			Frequency and Predictors of HIV-1 Co-receptor Switch in Treatment Naive Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; INFECTED PATIENTS; INTERACTIVE TREE; PROGNOSTIC VALUE; TROPISM; DISEASE; PROGRESSION; POPULATION; USAGE	Background: Determination of HIV-1 co-receptor use is a necessity before initiation of a CCR5 antagonist but the longevity of a CCR5-use prediction remains unknown. Methods: Genotypic co-receptor tropism determination was performed in 225 newly diagnosed individuals consulting an AIDS Reference Centre. Samples were collected at diagnosis and at initiation of antiretroviral therapy or just before closure of the study for patients who did not initiate therapy. For individuals with a discordant tropism prediction on the two longitudinal samples, analysis of intermediate samples and single genome sequencing of proviral DNA was performed to confirm the tropism switch. Deep sequencing was done to identify minor CXCR4 or CCR5-using populations in the initial sample. Results: Overall, tropism switches were rare (7.6%). Only a geno2pheno false positive rate of <50% at baseline was retained as predictive for a subsequent switch from CCR5-use only to predicted CXCR4-use. Minor CXCR4-using virus populations were detected in the first sample of 9 of the 14 R5-to-X4 switchers but the subsequent outgrowth of these minor populations was documented in only 3. Conclusions: With the current guidelines for treatment initiation at CD4(+) T cell counts of <500 cells/mm(3), co-receptor switch between diagnosis and starting antiretroviral therapy is rare. Patients with R5 viruses and a geno2pheno FPR of <50% are more prone to subsequent co-receptor switch than patients with an FPR of >50% and will need repeat tropism testing if initiation of maraviroc is considered and previous testing dates from more than a year before.	[Mortier, Virginie; Dauwe, Kenny; Vancoillie, Leen; Staelens, Delfien; Chalmet, Kristen; Verhofstede, Chris] Univ Ghent, Dept Clin Chem Microbiol & Immunol, Aids Reference Lab, B-9000 Ghent, Belgium; [Van Wanzeele, Filip; Vogelaers, Dirk; Vandekerckhove, Linos] Ghent Univ Hosp, Aids Reference Ctr, Dept Gen Internal Med & Infect Dis, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital	Verhofstede, C (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, Aids Reference Lab, B-9000 Ghent, Belgium.	Chris.Verhofstede@UGent.be	Vandekerckhove, Linos/J-6420-2013	Vandekerckhove, Linos/0000-0002-8600-1631	Belgian Ministry of Social Affairs within the Health Insurance System; Research Foundation - Flanders (FWO) [1.8.020.09.N.00]	Belgian Ministry of Social Affairs within the Health Insurance System; Research Foundation - Flanders (FWO)(FWO)	The Aids Reference Laboratory of Ghent receives support from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. Linos Vandekerckhove is supported by the Research Foundation - Flanders (FWO) (Grant n: 1.8.020.09.N.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BOZZETTE SA, 1993, J INFECT DIS, V168, P1374, DOI 10.1093/infdis/168.6.1374; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Dybowski JN, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-41; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; FENYO EM, 1989, AIDS, V3, pS5, DOI 10.1097/00002030-198901001-00002; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hunt PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Koot M, 1999, J INFECT DIS, V179, P254, DOI 10.1086/314539; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Mild M, 2010, INFECT GENET EVOL, V10, P356, DOI 10.1016/j.meegid.2009.05.003; Mulinge M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060566; Pastore C, 2004, J VIROL, V78, P7565, DOI 10.1128/JVI.78.14.7565-7574.2004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poveda E, 2010, AIDS REV, V12, P135; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Shepherd JC, 2008, J INFECT DIS, V198, P1104, DOI 10.1086/591623; Sing T, 2007, ANTIVIR THER, V12, P1097; Soulie C, 2007, AIDS, V21, P2243, DOI 10.1097/QAD.0b013e3282f0e3d0; Svicher V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053603; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Verhofstede C, 2011, HIV MED, V12, P544, DOI 10.1111/j.1468-1293.2011.00922.x; Waters LJ, 2011, CLIN INFECT DIS, V52, P671, DOI 10.1093/cid/ciq198; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80259	10.1371/journal.pone.0080259	http://dx.doi.org/10.1371/journal.pone.0080259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244665	Green Published, Green Submitted, gold			2022-12-25	WOS:000327162900073
J	Liu, RT; Zhu, F; Song, NP; Yang, XG; Chai, YQ				Liu, Rentao; Zhu, Fan; Song, Naiping; Yang, Xinguo; Chai, Yongqing			Seasonal Distribution and Diversity of Ground Arthropods in Microhabitats Following a Shrub Plantation Age Sequence in Desertified Steppe	PLOS ONE			English	Article							HORQIN SANDY LAND; MACRO-FAUNAL COMMUNITY; SEMIARID ENVIRONMENT; RETAMA SPHAEROCARPA; ANIMAL MOVEMENT; SOIL; BEETLES; HABITAT; FACILITATION; VEGETATION	In desertified regions, shrub-dominated patches are important microhabitats for ground arthropod assemblages. As shrub age increases, soil, vegetation and microbiological properties can change remarkably and spontaneously across seasons. However, relatively few studies have analyzed how ground arthropods respond to the microhabitats created by shrubs of different plantation ages across seasons. Using 6, 15, 24 and 36 year-old plantations of re-vegetated shrubs (Caragana koushinskii) in the desert steppe of northwestern China as a model system, we sampled ground arthropod communities using a pitfall trapping method in the microhabitats under shrubs and in the open areas between shrubs, during the spring, summer and autumn. The total ground arthropod assemblage was dominated by Carabidae, Melolonthidae, Curculionidae, Tenebrionidae and Formicidae that were affected by plantation age, seasonal changes, or the interaction between these factors, with the later two groups also influenced by microhabitat. Overall, a facilitative effect was observed, with more arthropods and a greater diversity found under shrubs as compared to open areas, but this was markedly affected by seasonal changes. There was a high degree of similarity in arthropod assemblages and diversity between microhabitats in summer and autumn. Shrub plantation age significantly influenced the distribution of the most abundant groups, and also the diversity indices of the ground arthropods. However, there was not an overall positive relationship between shrub age and arthropod abundance, richness or diversity index. The influence of plantation age on arthropod communities was also affected by seasonal changes. From spring through summer to autumn, community indices of ground arthropods tended to decline, and a high degree of similarity in these indices (with fluctuation) was observed among different ages of shrub plantation in autumn. Altogether the recovery of arthropod communities was markedly affected by seasonal variability, and they demonstrated distinctive communal fingerprints in different microhabitats for each plantation age stage.	[Liu, Rentao; Zhu, Fan; Song, Naiping; Yang, Xinguo; Chai, Yongqing] Ningxia Univ, Minist Educ, Key Lab Restorat & Reconstruct Degraded Ecosyst N, Yinchuan, Peoples R China	Ningxia University	Liu, RT (corresponding author), Ningxia Univ, Minist Educ, Key Lab Restorat & Reconstruct Degraded Ecosyst N, Yinchuan, Peoples R China.	nxuliu2012@126.com	Liu, Rentao/C-7848-2013	Liu, Rentao/0000-0001-6537-1986	National Natural Science Foundation of China [41101050]; 16 National Science and Technology Support Program [2011BAC07B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 16 National Science and Technology Support Program	This project was supported by the National Natural Science Foundation of China (number 41101050) and 16 National Science and Technology Support Program (2011BAC07B03). The funders had no role in study design, data 17 collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, INSECT CLASSIFICATIO; [Anonymous], 2001, PICTORIAL KEYS SOIL; Basset Y, 2008, INSECT CONSERV DIVER, V1, P55, DOI 10.1111/j.1752-4598.2007.00011.x; Bhojvaid PP, 1998, FOREST ECOL MANAG, V106, P181, DOI 10.1016/S0378-1127(97)00310-1; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Cao CY, 2008, APPL SOIL ECOL, V40, P78, DOI 10.1016/j.apsoil.2008.03.008; Coleman D.C., 2004, FUNDAMENTALS SOIL EC; CRIST TO, 1992, FUNCT ECOL, V6, P536, DOI 10.2307/2390050; de Bruyn LAL, 1999, AGR ECOSYST ENVIRON, V74, P425, DOI 10.1016/S0167-8809(99)00047-X; deBruyn LAL, 1997, ECOL ECON, V23, P167, DOI 10.1016/S0921-8009(97)00052-9; Decaens T, 1998, APPL SOIL ECOL, V9, P361, DOI 10.1016/S0929-1393(98)00090-0; Doblas-Miranda E, 2007, SOIL BIOL BIOCHEM, V39, P1916, DOI 10.1016/j.soilbio.2007.02.009; Doblas-Miranda E, 2009, APPL SOIL ECOL, V41, P329, DOI 10.1016/j.apsoil.2008.12.008; Holmquist JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054109; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; Lavelle P, 1997, ADV ECOL RES, V27, P93, DOI 10.1016/S0065-2504(08)60007-0; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEIGH EG, 1965, P NATL ACAD SCI USA, V53, P777, DOI 10.1073/pnas.53.4.777; Leps J, 2003, MULTIVARIATE ANAL EC, P43; Li J, 2007, J ARID ENVIRON, V71, P350, DOI 10.1016/j.jaridenv.2007.03.015; Li SG, 2002, J ARID ENVIRON, V52, P101, DOI 10.1006/jare.2001.0983; Lindberg N., 2003, THESIS SWEDISH U AGR; Lindsey PA, 2001, J ARID ENVIRON, V48, P551, DOI 10.1006/jare.2000.0764; Liu JL, 2012, BIODIVERS CONSERV, V21, P2601, DOI 10.1007/s10531-012-0320-4; Liu Ren-tao, 2012, Yingyong Shengtai Xuebao, V23, P2955; Liu RT, 2013, ARID LAND RES MANAG, V27, P377, DOI 10.1080/15324982.2013.787470; Liu Ren-tao, 2013, Yingyong Shengtai Xuebao, V24, P211; [刘任涛 Liu Rentao], 2014, [生态学报, Acta Ecologica Sinica], V34, P500; [刘任涛 Liu Rentao], 2013, [水土保持研究, Research of Soil and Water Conservation], V20, P19; Liu RT, 2011, EUR J SOIL BIOL, V47, P316, DOI 10.1016/j.ejsobi.2011.07.006; Liu RT, 2009, EUR J SOIL BIOL, V45, P417, DOI 10.1016/j.ejsobi.2009.06.006; Magurran AE, 1988, ECOLOGICAL DIVERSITY, P415; Mazia CN, 2006, J ARID ENVIRON, V67, P177, DOI 10.1016/j.jaridenv.2006.02.006; McIntyre NE, 1999, ECOLOGY, V80, P2261, DOI 10.1890/0012-9658(1999)080[2261:HDHPSA]2.0.CO;2; Moro MJ, 1997, FUNCT ECOL, V11, P425, DOI 10.1046/j.1365-2435.1997.00106.x; Norlon R, 1994, MITES ECOLOGICAL EVO, P99; PARMENTER RR, 1989, J ARID ENVIRON, V17, P57, DOI 10.1016/S0140-1963(18)30924-8; Patrick Ruth, 1997, P15; Peterson AC, 2001, PEDOBIOLOGIA, V45, P509, DOI 10.1078/0031-4056-00103; Pugnaire FI, 2000, ANN BOT-LONDON, V86, P807, DOI 10.1006/anbo.2000.1240; Pugnaire FI, 1996, OIKOS, V76, P455, DOI 10.2307/3546339; Punttila P, 1996, OIKOS, V75, P291, DOI 10.2307/3546252; Sackmann P, 2009, J ARID ENVIRON, V73, P1095, DOI 10.1016/j.jaridenv.2009.05.007; Sanders NJ, 2007, J BIOGEOGR, V34, P1632, DOI 10.1111/j.1365-2699.2007.01714.x; Schulze ED, 1994, BIODIVERSITY ECOSYST, P524; [沈彦 Shen Yan], 2008, [西北林学院学报, Journal of Northwest Forestry College], V23, P70; Siemann E, 1998, ECOLOGY, V79, P2057, DOI 10.1890/0012-9658(1998)079[2057:ETOEOP]2.0.CO;2; Silveira JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012877; Stapp P, 1997, AM MIDL NAT, V137, P298, DOI 10.2307/2426849; STEWART AJA, 2000, ECOLOGICAL CONSEQUEN, P1; Su YZ, 2003, ECOL ENG, V20, P223, DOI 10.1016/S0925-8574(03)00042-9; Titus JH, 2002, J ARID ENVIRON, V52, P269, DOI 10.1006/jare.2002.1010; Vele A, 2009, EUR J SOIL BIOL, V45, P301, DOI 10.1016/j.ejsobi.2009.03.002; Wang T., 2000, J DESERT RES, V20, P103; Whitford WG, 2000, INVERTEBRATES AS WEB-MASTERS IN ECOSYSTEMS, P25, DOI 10.1079/9780851993942.0025; Xu DM, 2012, POL J ECOL, V60, P251; Zhao HL, 2007, ECOL ENG, V31, P1, DOI 10.1016/j.ecoleng.2007.04.010; Zhao HL, 2013, CATENA, V105, P69, DOI 10.1016/j.catena.2013.01.009; Ziesche TM, 2008, FOREST ECOL MANAG, V255, P738, DOI 10.1016/j.foreco.2007.09.060; Zuo Zhong, 2006, Pratacultural Science, V23, P17	60	29	40	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77962	10.1371/journal.pone.0077962	http://dx.doi.org/10.1371/journal.pone.0077962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24250746	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600055
J	Roy, A; Ganesh, G; Sippola, H; Bolin, S; Sawesi, O; Dagalv, A; Schlenner, SM; Feyerabend, T; Rodewald, HR; Kjellen, L; Hellman, L; Abrink, M				Roy, Ananya; Ganesh, Goutham; Sippola, Helena; Bolin, Sara; Sawesi, Osama; Dagalv, Anders; Schlenner, Susan M.; Feyerabend, Thorsten; Rodewald, Hans-Reimer; Kjellen, Lena; Hellman, Lars; Abrink, Magnus			Mast Cell Chymase Degrades the Alarmins Heat Shock Protein 70, Biglycan, HMGB1, and Interleukin-33 (IL-33) and Limits Danger-induced Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Innate Immunity; Mast Cell; Serine Protease; Tumor Necrosis Factor (TNF); Virulence Factors; Biglycan; High Mobility Group Box Protein 1; Hsp70; IL-33	PRO-MATRIX METALLOPROTEASE-2; IL-1-LIKE CYTOKINE IL-33; HEAT-SHOCK PROTEINS; TOLL-LIKE; TRICHINELLA-SPIRALIS; CARBOXYPEPTIDASE-A; DELAYED EXPULSION; DENDRITIC CELLS; DYING CELLS; NO DAMPS	During infection and tissue damage, virulence factors and alarmins are pro-inflammatory and induce activation of various immune cells including macrophages and mast cells (MCs). Activated MCs instantly release preformed inflammatory mediators, including several proteases. The chymase mouse mast cell protease (MCPT)-4 is thought to be pro-inflammatory, whereas human chymase also degrades pro-inflammatory cytokines, suggesting that chymase instead limits inflammation. Here we explored the contribution of MCPT4 and human chymase to the control of danger-induced inflammation. We found that protein extracts from wild type (WT), carboxypeptidase A3-, and MCPT6-deficient mice and MCs and recombinant human chymase efficiently degrade the Trichinella spiralis virulence factor heat shock protein 70 (Hsp70) as well as endogenous Hsp70. MC-(W-sash)-, serglycin-, NDST2-, and MCPT4-deficient extracts lacked this capacity, indicating that chymase is responsible for the degradation. Chymase, but not MC tryptase, also degraded other alarmins, i.e. biglycan, HMGB1, and IL-33, a degradation that was efficiently blocked by the chymase inhibitor chymostatin. IL-7, IL-22, GM-CSF, and CCL2 were resistant to chymase degradation. MCPT4-deficient conditions ex vivo and in vivo showed no reduction in added Hsp70 and only minor reduction of IL-33. Peritoneal challenge with Hsp70 resulted in increased neutrophil recruitment and TNF- levels in the MCPT4-deficient mice, whereas IL-6 and CCL2 levels were similar to the levels found in WT mice. The rapid and MC chymase-specific degradation of virulence factors and alarmins may depend on the presence of accessible extended recognition cleavage sites in target substrates and suggests a protective and regulatory role of MC chymase during danger-induced inflammation.	[Roy, Ananya; Ganesh, Goutham; Sippola, Helena; Bolin, Sara; Sawesi, Osama; Dagalv, Anders; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Bolin, Sara] Uppsala Univ, Dept Immunol Genet & Pathol, S-75123 Uppsala, Sweden; [Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, S-75123 Uppsala, Sweden; [Schlenner, Susan M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Feyerabend, Thorsten; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Abrink, Magnus] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Immunol Sect, S-75123 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Swedish University of Agricultural Sciences	Abrink, M (corresponding author), Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Immunol Sect, BMC, Box 588, S-75123 Uppsala, Sweden.	Magnus.Abrink@slu.se	Åbrink, Magnus/AAK-8346-2020; Schlenner, Susan/P-7905-2017	Schlenner, Susan/0000-0002-8553-3388; Abrink, Magnus/0000-0002-1335-3927	Swedish Research Council; FORMAS	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas)	This research was supported by the Swedish Research Council and FORMAS (to M. A.)	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Akahoshi M, 2011, J CLIN INVEST, V121, P4180, DOI 10.1172/JCI46139; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Broere F, 2011, NAT REV IMMUNOL, V11, P565, DOI 10.1038/nri2873-c1; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Fischer N, 2010, EUR J IMMUNOL, V40, P986, DOI 10.1002/eji.200939738; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gophna U, 2003, INT J MED MICROBIOL, V292, P453, DOI 10.1078/1438-4221-00230; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; HA TY, 1983, INFECT IMMUN, V41, P445, DOI 10.1128/IAI.41.1.445-447.1983; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Komai-Koma M, 2012, ALLERGY, V67, P1118, DOI 10.1111/j.1398-9995.2012.02859.x; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; LATHIGRA RB, 1991, CURR TOP MICROBIOL, V167, P125; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; Lundequist A, 2004, J BIOL CHEM, V279, P32339, DOI 10.1074/jbc.M405576200; Lundequist A, 2006, BIOL CHEM, V387, P1513, DOI 10.1515/BC.2006.189; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Malaviya R, 1998, J MOL MED, V76, P617, DOI 10.1007/s001090050259; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Theriault JR, 2005, FEBS LETT, V579, P1951, DOI 10.1016/j.febslet.2005.02.046; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; van Eden W, 2012, CELL STRESS CHAPERON, V17, P281, DOI 10.1007/s12192-011-0311-5; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yera H, 2003, CLIN DIAGN LAB IMMUN, V10, P793, DOI 10.1128/CDLI.10.5.793-796.2003; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	65	92	92	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					237	250		10.1074/jbc.M112.435156	http://dx.doi.org/10.1074/jbc.M112.435156			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257755	Green Published, hybrid			2022-12-25	WOS:000329370900021
J	Berlin, JC; Kirk, EC; Rowe, TB				Berlin, Jeri C.; Kirk, E. Christopher; Rowe, Timothy B.			Functional Implications of Ubiquitous Semicircular Canal Non-Orthogonality in Mammals	PLOS ONE			English	Article							AFFERENT SENSITIVITY; PLANAR RELATIONSHIPS; ORIENTATION; BIOMECHANICS; MORPHOLOGY; MOVEMENTS; LABYRINTH; EVOLUTION; GEOMETRY; MOTION	The 'canonical model' of semicircular canal orientation in mammals assumes that 1) the three ipsilateral canals of an inner ear exist in orthogonal planes (i.e., orthogonality), 2) corresponding left and right canal pairs have equivalent angles (i.e., angle symmetry), and 3) contralateral synergistic canals occupy parallel planes (i.e., coplanarity). However, descriptions of vestibular anatomy that quantify semicircular canal orientation in single species often diverge substantially from this model. Data for primates further suggest that semicircular canal orthogonality varies predictably with the angular head velocities encountered in locomotion. These observations raise the possibility that orthogonality, symmetry, and coplanarity are misleading descriptors of semicircular canal orientation in mammals, and that deviations from these norms could have significant functional consequences. Here we critically assess the canonical model of semicircular canal orientation using high-resolution X-ray computed tomography scans of 39 mammal species. We find that substantial deviations from orthogonality, angle symmetry, and coplanarity are the rule for the mammals in our comparative sample. Furthermore, the degree to which the semicircular canals of a given species deviate from orthogonality is negatively correlated with estimated vestibular sensitivity. We conclude that the available comparative morphometric data do not support the canonical model and that its overemphasis as a heuristic generalization obscures a large amount of functionally relevant variation in semicircular canal orientation between species.	[Berlin, Jeri C.; Kirk, E. Christopher; Rowe, Timothy B.] Univ Texas Austin, Vertebrate Paleontol Lab, Austin, TX 78712 USA; [Kirk, E. Christopher] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Rowe, Timothy B.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Berlin, JC (corresponding author), Univ Texas Austin, Vertebrate Paleontol Lab, Austin, TX 78712 USA.	JeriCR55@aol.com		Kirk, Chris/0000-0001-9439-3041	 [NSFIIS-0208675];  [EAR-0948842]	; 	Funding for this research was provided by grants NSFIIS-0208675 (http://www.nsf.gov/cise/iis/hcc_pgm.jsp), and EAR-0948842 (http://www.nsf.gov/awards/award_visualization.jsp?org=EAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur A. M. R., 1999, GRANTS ATLAS ANATOMY, V10th; Billet G, 2012, P ROY SOC B-BIOL SCI, V279, P3932, DOI 10.1098/rspb.2012.1212; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLANKS RHI, 1989, BRAIN RES, V487, P278, DOI 10.1016/0006-8993(89)90832-9; BLANKS RHI, 1975, ACTA OTO-LARYNGOL, V80, P185, DOI 10.3109/00016487509121318; Calabrese DR, 2006, JARO-J ASSOC RES OTO, V7, P151, DOI 10.1007/s10162-006-0031-1; Carlson WD, 2003, GEOL SOC SPEC PUBL, V215, P7, DOI 10.1144/GSL.SP.2003.215.01.02; Clarke AH, 2005, J VESTIBUL RES-EQUIL, V15, P65; Cox PG, 2008, J ANAT, V213, P583, DOI 10.1111/j.1469-7580.2008.00983.x; CURTHOYS IS, 1975, ACTA OTO-LARYNGOL, V80, P197, DOI 10.3109/00016487509121319; David R, 2010, CR PALEVOL, V9, P397, DOI 10.1016/j.crpv.2010.07.012; Ekdale EG, 2009, THESIS U TEXAS AUSTI; EZURE K, 1984, NEUROSCIENCE, V12, P85, DOI 10.1016/0306-4522(84)90140-4; Fisher N., 1995, STAT ANAL CIRCULAR D; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GRAF W, 1988, ANN NY ACAD SCI, V545, P154; Gray H., 1918, ANATOMY HUMAN BODY, V20th; Gulya AJ., 2007, GULYA SCHUKNECHTS AN; Haines DE, 2013, FUNDAMENTAL NEUROSCI, V4th; Highstein SM, 2005, J NEUROPHYSIOL, V93, P2359, DOI 10.1152/jn.00533.2004; Hullar TE, 2006, ANAT REC PART A, V288A, P466, DOI 10.1002/ar.a.20304; Ifediba MA, 2007, ANN BIOMED ENG, V35, P1247, DOI 10.1007/s10439-007-9277-y; JONES GM, 1963, PROC R SOC SER B-BIO, V157, P403, DOI 10.1098/rspb.1963.0019; Kaas JH, 2009, EVOLUTIONARY NEUROSC; Lessard C, 2009, BASIC FEEDBACK CONTR; Malinzak MD, 2010, THESIS DUKE U DURHAM; Malinzak M, 2011, AM J PHYS ANTHROPOL, V144, P204; Malinzak MD, 2012, P NATL ACAD SCI USA, V109, P17914, DOI 10.1073/pnas.1206139109; Marugan-Lobon J, 2013, PEERJ, V1, DOI 10.7717/peerj.124; MAZZA D, 1984, ACTA OTO-LARYNGOL, V98, P472, DOI 10.3109/00016488409107588; OMAN CM, 1987, ACTA OTO-LARYNGOL, V103, P1, DOI 10.3109/00016488709134691; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pinheiro J., 2011, NLME LINEAR NONLINEA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabbitt RD, 1999, BIOL CYBERN, V80, P417, DOI 10.1007/s004220050536; Rabbitt RD, 2004, SPR HDB AUD, P153; Rodgers J, 2011, COMP MORPHOLOGY META; Romer A.S., 1962, VERTEBRATE BODY; Romer AS., 1986, VERTEBRATE BODY; Rowe T, 1997, GEOTIMES, V42, P23; Ryan TM, 2012, P ROY SOC B-BIOL SCI, V279, P3467, DOI 10.1098/rspb.2012.0939; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Silcox MT, 2009, J HUM EVOL, V56, P315, DOI 10.1016/j.jhevol.2008.10.007; Spoor F, 2003, COUR FOR SEKENBG, V243, P93; SPOOR F, 1995, J ANAT, V186, P271; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; TENKATE JH, 1970, J EXP BIOL, V53, P501; Venes D., 2005, TABERS CYCLOPEDIC ME; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Yang AZ, 2007, J NEUROPHYSIOL, V98, P3197, DOI 10.1152/jn.00798.2007	53	61	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79585	10.1371/journal.pone.0079585	http://dx.doi.org/10.1371/journal.pone.0079585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260256	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900032
J	Makiyama, Y; Ooto, S; Hangai, M; Takayama, K; Uji, A; Oishi, A; Ogino, K; Nakagawa, S; Yoshimura, N				Makiyama, Yukiko; Ooto, Sotaro; Hangai, Masanori; Takayama, Kohei; Uji, Akihito; Oishi, Akio; Ogino, Ken; Nakagawa, Satoko; Yoshimura, Nagahisa			Macular Cone Abnormalities in Retinitis Pigmentosa with Preserved Central Vision Using Adaptive Optics Scanning Laser Ophthalmoscopy	PLOS ONE			English	Article							VISUAL-FIELD SENSITIVITY; COHERENCE TOMOGRAPHY; OCT; THICKNESS; EDEMA; LAYER; ELECTRORETINOGRAM; BOUNDARIES; MUTATIONS; RECEPTOR	Purpose: To assess macular photoreceptor abnormalities in eyes with retinitis pigmentosa (RP) with preserved central vision using adaptive optics scanning laser ophthalmoscopy (AO-SLO). Methods: Fourteen eyes of 14 patients with RP (best-corrected visual acuity 20/20 or better) and 12 eyes of 12 volunteers underwent a full ophthalmologic examination, fundus autofluorescence, spectral- domain optical coherence tomography (SD-OCT), and imaging with a prototype AO-SLO system. Cone density and spatial organization of the cone mosaic were assessed using AO-SLO images. Results: In 3 eyes with RP and preserved central vision, cones formed a mostly regular mosaic pattern with small patchy dark areas, and in 10 eyes, the cone mosaic patterns were less regular, and large dark regions with missing cones were apparent. Only one eye with RP demonstrated a normal, regular cone mosaic pattern. In eyes with RP, cone density was significantly lower at 0.5 mm and 1.0 mm from the center of the fovea compared to normal eyes (P < 0.001 and 0.021, respectively). At 0.5 mm and 1.0 mm from the center of the fovea, a decreased number of cones had 6 neighbors in eyes with RP (P = 0.002 for both). Greater decrease in cone density was related to disruption of the photoreceptor inner segment (IS) ellipsoid band on SD-OCT images (P = 0.044); however, dark regions were seen on AO-SLO even in areas of continuous IS ellipsoid on SD-OCT. Decreased cone density correlated thinner outer nuclear layer (P = 0.029) and thinner inner segment and outer segment thickness (P = 0.011) on SD-OCT. Conclusions: Cone density is decreased and the regularity of the cone mosaic spatial arrangement is disrupted in eyes with RP, even when visual acuity and foveal sensitivity are good. AO-SLO imaging is a sensitive quantitative tool for detecting photoreceptor abnormalities in eyes with RP.	[Makiyama, Yukiko; Ooto, Sotaro; Hangai, Masanori; Takayama, Kohei; Uji, Akihito; Oishi, Akio; Ogino, Ken; Nakagawa, Satoko; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kyoto University	Ooto, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	ohoto@kuhp.kyoto-u.ac.jp	Oishi, Akio/AAE-9996-2020	Oishi, Akio/0000-0002-0977-9458	Innovative Techno-Hub for Integrated Medical Bio-imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Canon Inc	Innovative Techno-Hub for Integrated Medical Bio-imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Canon Inc	Supported, in part, by the Innovative Techno-Hub for Integrated Medical Bio-imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and Canon Inc. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2005, INVEST OPHTH VIS SCI, V46, P1540, DOI 10.1167/iovs.04-0968; Baraas RC, 2007, J OPT SOC AM A, V24, P1438, DOI 10.1364/JOSAA.24.001438; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Chen YM, 2011, INVEST OPHTH VIS SCI, V52, P3281, DOI 10.1167/iovs.10-6538; Choi SS, 2008, J NEURO-OPHTHALMOL, V28, P120, DOI 10.1097/WNO.0b013e318175c6f5; Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05-0997; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Curcio CA, 2000, INVEST OPHTH VIS SCI, V41, P2015; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1864, DOI 10.1364/BOE.2.001864; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Grover S, 1997, OPHTHALMOLOGY, V104, P460, DOI 10.1016/S0161-6420(97)30291-7; Hagiwara A, 2011, ACTA OPHTHALMOL, V89, pE122, DOI 10.1111/j.1755-3768.2010.01866.x; Hamada S, 2000, OPHTHALMIC SURG LAS, V31, P253; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hirakawa H, 1999, AM J OPHTHALMOL, V128, P185, DOI 10.1016/S0002-9394(99)00100-2; Hirose F, 2011, PROC SPIE, V7885, DOI 10.1117/12.873671; Hood DC, 2011, BIOMED OPT EXPRESS, V2, P1106, DOI 10.1364/BOE.2.001106; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P101, DOI 10.1167/iovs.10-5799; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Jacobson SG, 2008, HUM MOL GENET, V17, P2405, DOI 10.1093/hmg/ddn140; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P1886, DOI 10.1167/iovs.08-3122; Kitaguchi Y, 2008, OPHTHALMOLOGY, V115, P1771, DOI 10.1016/j.ophtha.2008.03.026; Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Marmor MF, 2008, ARCH OPHTHALMOL-CHIC, V126, P907, DOI 10.1001/archopht.126.7.907; Ogino K, 2013, INVEST OPHTH VIS SCI, V54, P3771, DOI 10.1167/iovs.12-11494; Oishi A, 2009, EYE, V23, P1411, DOI 10.1038/eye.2008.266; Ooto S, 2013, AM J OPHTHALMOL, V155, P1045, DOI 10.1016/j.ajo.2013.01.006; Ooto S, 2012, AM J OPHTHALMOL, V154, P174, DOI 10.1016/j.ajo.2012.01.031; Ooto S, 2011, ARCH OPHTHALMOL-CHIC, V129, P1633, DOI 10.1001/archophthalmol.2011.345; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P5541, DOI 10.1167/iovs.11-7251; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Ooto S, 2010, OPHTHALMOLOGY, V117, P1800, DOI 10.1016/j.ophtha.2010.01.042; Pallikaris A, 2003, INVEST OPHTH VIS SCI, V44, P4580, DOI 10.1167/iovs.03-0094; Rangaswamy NV, 2010, INVEST OPHTH VIS SCI, V51, P4213, DOI 10.1167/iovs.09-4945; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Roorda A, 2002, J VISION, V2, P404, DOI 10.1167/2.5.4; Rumen F, 2001, J FR OPHTALMOL, V24, P854; Sandberg MA, 2005, INVEST OPHTH VIS SCI, V46, P3349, DOI 10.1167/iovs.04-1383; Schatz P, 2003, ACTA OPHTHALMOL SCAN, V81, P500, DOI 10.1034/j.1600-0420.2003.00134.x; Sugita T, 2008, INVEST OPHTH VIS SCI, V49, P3551, DOI 10.1167/iovs.08-1954; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Uji A, 2012, INVEST OPHTH VIS SCI, V53, P171, DOI 10.1167/iovs.11-8192; Wen Y, 2012, INVEST OPHTH VIS SCI, V53, P833, DOI 10.1167/iovs.11-8410; Wolfing JI, 2006, OPHTHALMOLOGY, V113, P1014, DOI 10.1016/j.ophtha.2006.01.056; Yokota S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063786; Yoon MK, 2009, INVEST OPHTH VIS SCI, V50, P1838, DOI 10.1167/iovs.08-2029	52	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79447	10.1371/journal.pone.0079447	http://dx.doi.org/10.1371/journal.pone.0079447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260224	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900024
J	Abubakar, A; Van Baar, A; Fischer, R; Bomu, G; Gona, JK; Newton, CR				Abubakar, Amina; Van Baar, Anneloes; Fischer, Ronald; Bomu, Grace; Gona, Joseph K.; Newton, Charles R.			Socio-Cultural Determinants of Health-Seeking Behaviour on the Kenyan Coast: A Qualitative Study	PLOS ONE			English	Article							EPILEPSY TREATMENT; CHILDHOOD ILLNESSES; TRADITIONAL HEALERS; CARE-SEEKING; MALARIA; COMMUNITY; NUTRITION; CHILDREN	Background: Severe childhood illnesses present a major public health challenge for Africa, which is aggravated by a suboptimal response to the child's health problems with reference to the health-seeking behaviour of the parents or guardians. We examined the health-seeking behaviour of parents at the Kenyan coast because understanding impediments to optimal health-seeking behaviour could greatly contribute to reducing the impact of severe illness on children's growth and development. Methods and Results: Health-seeking behaviour, and the factors influencing this behaviour, were examined in two traditional communities. We held in-depth interviews with 53 mothers, fathers and caregivers from two rural clinics at the Kenyan Coast. Biomedical medicine (from health facilities and purchased over the counter) was found to be the most popular first point of treatment. However, traditional healing still plays a salient role in the health care within these two communities. Traditional healers were consulted for various reasons: a) attribution of causation of ill-health to supernatural sources, b) chronic illness (inability of modern medicine to cure the problem) and c) as prevention against possible ill-health. In developing an explanatory model of decision-making, we observed that this was a complex process involving consultation at various levels, with elders, but also between both parents, depending on the perceived nature and chronicity of the illness. However, it was reported that fathers were the ultimate decision makers in relation to decisions concerning where the child would be taken for treatment. Conclusions: Health systems need to see traditional healing as a complementary system in order to ensure adequate access to health care. Importantly, fathers also need to be addressed in intervention and education programs.	[Abubakar, Amina; Van Baar, Anneloes] Univ Utrecht, Utrecht, Netherlands; [Abubakar, Amina; Bomu, Grace; Gona, Joseph K.; Newton, Charles R.] KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya; [Abubakar, Amina] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Fischer, Ronald] Victoria Univ Wellington, Wellington, New Zealand; [Newton, Charles R.] Univ Oxford, Oxford, England	Utrecht University; Tilburg University; Victoria University Wellington; University of Oxford	Abubakar, A (corresponding author), Univ Utrecht, Utrecht, Netherlands.	A.AbubakarAli@uvt.nl	Newton, Charles/V-7872-2019; Newton, Charles RJC/B-7578-2014; van Baar, Anneloes/L-8236-2013; Fischer, Ronald/G-6447-2017; Abubakar, Amina/F-1479-2017	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; van Baar, Anneloes/0000-0002-3498-9019; Fischer, Ronald/0000-0002-3055-3955; Abubakar, Amina/0000-0002-3686-7904	Utrecht University	Utrecht University	The study was funded by an internal grant by Utrecht University to Amina Abubakar and Anneloes Van Baar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 2011, RURAL REMOTE HEALTH, V11; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Carter JA, 2012, EPILEPSY BEHAV, V25, P614, DOI 10.1016/j.yebeh.2012.07.009; Chibwana AI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-219; Dillip A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-113; Feyisetan B J, 1997, Health Transit Rev, V7, P221; Goodman CA, 2006, HEALTH POLICY PLANN, V21, P275, DOI 10.1093/heapol/czl011; Government of Kenya, 2009, MSAMBW DISTR DEV PLA; Government of Kenya, 2001, POV ER STRAT PAP KIL; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Kendall-Taylor NH, 2009, RURAL REMOTE HEALTH, V9; Kendall-Taylor N, 2008, EPILEPSIA, V49, P1638, DOI 10.1111/j.1528-1167.2008.01580_1.x; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Ministry of Planning and National Development, 2005, KIL DISTR STRAT PLAN; Muthaura CN, 2007, J ETHNOPHARMACOL, V114, P377, DOI 10.1016/j.jep.2007.08.033; Mwangome M, 2010, J HEALTH POPUL NUTR, V28, P167; Mwenesi H, 1995, SOCIAL SCI MED, V40; Oberlander L, 2000, B WORLD HEALTH ORGAN, V78, P1352; Ogunjuyigbe P. O., 2004, DEM RES, V11, P43, DOI DOI 10.4054/DEMRES.2004.11.2; Sabuni LP, 2007, QUAL HEALTH RES, V17, P1280, DOI 10.1177/1049732307307864; Silverman D., 2010, DOING QUALITATIVE RE, V3; Solarsh G, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P125; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Tinuade O, 2010, J PAEDIATR CHILD H, V46, P238, DOI 10.1111/j.1440-1754.2009.01677.x; Winkler AS, 2010, EPILEPSY BEHAV, V19, P596, DOI 10.1016/j.yebeh.2010.09.023; World Health Organization, 2002, WHO TRAD MED STRAT 2; World Health Organization, 2007, MILL DEV GOALS REP 2; Wreford J, 2005, SOC DYNAMICS, V31, P55, DOI 10.1080/02533950508628708	30	52	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e71998	10.1371/journal.pone.0071998	http://dx.doi.org/10.1371/journal.pone.0071998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260094	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000327308500002
J	Zollner, FG; Schock-Kusch, D; Backer, S; Neudecker, S; Gretz, N; Schad, LR				Zoellner, Frank G.; Schock-Kusch, Daniel; Baecker, Sandra; Neudecker, Sabine; Gretz, Norbert; Schad, Lothar R.			Simultaneous Measurement of Kidney Function by Dynamic Contrast Enhanced MRI and FITC-Sinistrin Clearance in Rats at 3 Tesla: Initial Results	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; DCE-MRI; TRANSCUTANEOUS MEASUREMENT; HEALTHY-VOLUNTEERS; SERUM CREATININE; DISEASE; SEGMENTATION; PERFUSION; GFR	Glomerular filtration rate (GFR) is an essential parameter of kidney function which can be measured by dynamic contrast enhanced magnetic resonance imaging (MRI-GFR) and transcutaneous approaches based on fluorescent tracer molecules (optical-GFR). In an initial study comparing both techniques in separate measurements on the same animal, the correlation of the obtained GFR was poor. The goal of this study was to investigate if a simultaneous measurement was feasible and if thereby, the discrepancies in MRI-GFR and optical-GFR could be reduced. For the experiments healthy and unilateral nephrectomised (UNX) Sprague Dawley (SD) rats were used. The miniaturized fluorescent sensor was fixed on the depilated back of an anesthetized rat. A bolus of 5 mg/100 g b.w. of FITC-sinistrin was intravenously injected. For dynamic contrast enhanced perfusion imaging (DCE-MRI) a 3D time-resolved angiography with stochastic trajectories (TWIST) sequence was used. By means of a one compartment model the excretion half-life (t1/2) of FITC-sinistrin was calculated and converted into GFR. GFR from DCE-MRI was calculated by fitting pixel-wise a two compartment renal filtration model. Mean cortical GFR and GFR by FITC-sinistrin were compared by Bland-Altman plots and pair-wise t-test. Results show that a simultaneous GFR measurement using both techniques is feasible. Mean optical-GFR was 4.34 +/- 2.22 ml/min (healthy SD rats) and 2.34 +/- 0.90 ml/min (UNX rats) whereas MRI-GFR was 2.10 +/- 0.64 ml/min (SD rats) and 1.17 +/- 0.38 ml/min (UNX rats). Differences between healthy and UNX rats were significant (p<0.05) and almost equal percentage difference (46.1% and 44.3%) in mean GFR were assessed with both techniques. Overall mean optical-GFR values were approximately twice as high compared to MRI-GFR values. However, compared to a previous study, our results showed a higher agreement. In conclusion, the possibility to use the transcutaneous method in MRI may have a huge impact in improving and validating MRI methods for GFR assessment in animal models.	[Zoellner, Frank G.; Schad, Lothar R.] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany; [Schock-Kusch, Daniel; Baecker, Sandra; Neudecker, Sabine; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Zollner, FG (corresponding author), Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany.	frank.zoellner@medma.uni-heidelberg.de	Zöllner, Frank G/A-2725-2012; Neudecker, Sabine/E-4771-2011	Zöllner, Frank G/0000-0003-3405-1394; 				Baumann D, 2000, MAGN RESON IMAGING, V18, P587, DOI 10.1016/S0730-725X(00)00134-X; Cheng HLM, 2008, J MAGN RESON IMAGING, V28, P736, DOI 10.1002/jmri.21489; COLSON P, 1992, ANESTH ANALG, V74, P481; Cowley Jr AW, 2013, HYPERTENSIO IN PRESS, DOI [10.1161/HYPERTENSIONAHA.1113.01194, DOI 10.1161/HYPERTENSI0NAHA.1113.01194]; Cutajar M, 2010, EUR J RADIOL, V74, pE155, DOI 10.1016/j.ejrad.2009.05.041; DOOLAN PD, 1962, AM J MED, V32, P65, DOI 10.1016/0002-9343(62)90183-3; Elwood CM, 1967, BRIT J RADIOL, V40, P778; FINNEY JS, 1990, MAGN RESON IMAGING, V8, P713, DOI 10.1016/0730-725X(90)90006-N; Fischer PA, 2000, KIDNEY INT, V58, P1336, DOI 10.1046/j.1523-1755.2000.00290.x; Fleck C, 1999, PHYSIOL RES, V48, P267; Fusellier M, 2007, AM J VET RES, V68, P807, DOI 10.2460/ajvr.68.8.807; GASPARI F, 1992, KIDNEY INT, V41, P1081, DOI 10.1038/ki.1992.164; Grenier N, 2011, SEMIN NUCL MED, V41, P45, DOI 10.1053/j.semnuclmed.2010.09.001; Jaber BL, 2005, AM J MED, V118, P1323, DOI 10.1016/j.amjmed.2005.02.032; Jones RA, 2011, J MAGN RESON IMAGING, V33, P1270, DOI 10.1002/jmri.22335; Kittelson JA, 1917, ANAT REC, V13, P385, DOI 10.1002/ar.1090130607; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li S, 2012, COMPUT MED IMAG GRAP, V36, P108, DOI 10.1016/j.compmedimag.2011.06.005; Lietzmann F, 2012, J MAGN RESON IMAGING, V35, P868, DOI 10.1002/jmri.23509; Mendichovszky I, 2008, J MAGN RESON IMAGING, V27, P925, DOI 10.1002/jmri.21313; Michaely HJ, 2007, ABDOM IMAGING, V32, P758, DOI 10.1007/s00261-006-9150-8; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Peters AM, 2004, EUR J NUCL MED MOL I, V31, P137, DOI 10.1007/s00259-003-1341-8; Poreddy AR, 2012, BIOORGAN MED CHEM, V20, P2490, DOI 10.1016/j.bmc.2012.03.015; Rahn KH, 1999, J HYPERTENS, V17, P309, DOI 10.1097/00004872-199917030-00002; Rajagopalan R, 2011, J MED CHEM, V54, P5048, DOI 10.1021/jm200257k; Reuter S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005296; Rieg T, 2004, N-S ARCH PHARMACOL, V370, P320, DOI 10.1007/s00210-004-0982-x; Rusinek H, 2007, MAGN RESON MED, V57, P1159, DOI 10.1002/mrm.21240; Sadick M, 2011, NEPHROL DIAL TRANSPL, V26, P3101, DOI 10.1093/ndt/gfr148; Schock-Kusch D, 2012, KIDNEY INT, V82, P314, DOI 10.1038/ki.2012.117; Schock-Kusch D, 2011, KIDNEY INT, V79, P1254, DOI 10.1038/ki.2011.31; Schock-Kusch D, 2009, NEPHROL DIAL TRANSPL, V24, P2997, DOI 10.1093/ndt/gfp225; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Song T, 2009, MAGN RESON MED, V61, P1242, DOI 10.1002/mrm.21901; Sourbron SP, 2008, INVEST RADIOL, V43, P40, DOI 10.1097/RLI.0b013e31815597c5; Tillmann HC, 2006, KIDNEY INT, V69, P60, DOI 10.1038/sj.ki.5000006; Winter JD, 2011, J MAGN RESON IMAGING, V34, P608, DOI 10.1002/jmri.22660; Wojtczyk H, 2011, Z MED PHYS, V21, P135, DOI 10.1016/j.zemedi.2010.12.001; Yankeelov TE, 2007, MAGN RESON MED, V57, P353, DOI 10.1002/mrm.21131; Zimmer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053849; Zollner FG, 2013, J DIGIT IMAGING, V26, P344, DOI 10.1007/s10278-012-9510-6; Zollner FG, 2012, AM J ROENTGENOL, V199, P1060, DOI 10.2214/AJR.12.8657; Zollner FG, 2009, COMPUT MED IMAG GRAP, V33, P171, DOI 10.1016/j.compmedimag.2008.11.004	46	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79992	10.1371/journal.pone.0079992	http://dx.doi.org/10.1371/journal.pone.0079992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260332	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500113
J	Liu, J; Ruan, B; You, N; Huang, QK; Liu, WH; Dang, Z; Xu, WH; Zhou, T; Ji, R; Cao, Y; Li, X; Wang, DS; Tao, KS; Dou, KF				Liu, Jie; Ruan, Bai; You, Nan; Huang, Qike; Liu, Weihui; Dang, Zheng; Xu, Weihua; Zhou, Ti; Ji, Ru; Cao, Yang; Li, Xia; Wang, Desheng; Tao, Kaishan; Dou, Kefeng			Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the beta-catenin Pathway in Hepatic Oval Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; SELF-RENEWAL; STEM/PROGENITOR CELLS; PROGENITOR CELLS; IN-VIVO; ZEB2	Hepatocellular carcinoma (HCC) can be derived from malignant transformed adult hepatic progenitor cells. However, the regulatory factors and molecular mechanisms underlying the process are not well defined. Our previous microRNA (miRNA) microarray analysis revealed a significant decrease of miR-200a level in F344 rat HCC side population (SP) fraction cells versus their normal counterparts. In the present study, we further investigated the effect of miR-200a on hepatic oval cell (HOC) phenotypes. We first confirmed downregulated miR-200a levels in rat hepatoma cells compared with WB-F344 cells. Next, by lentivirus-mediated loss-of-function studies, we showed that stable knockdown of miR-200a confers a mesenchymal phenotype to WB-F344 cells, including an elongated cell morphology, enhanced cell migration ability and expression of epithelial mesenchymal transition (EMT)-representative markers. Concomitantly, several cancer stem cell (CSC)-like traits appeared in these cells, which exhibit enhanced spheroid-forming capacity, express putative hepatic CSC markers and display superior resistance to chemotherapeutic drugs in vitro. Furthermore, bioinformatics analysis, luciferase assays and western blot analysis identified beta-catenin (CTNNB1) as a direct and functional target of miR-200a. Knockdown of miR-200a partially activated Wnt/beta-catenin signaling, and silencing of beta-catenin functionally attenuated anti-miR-200a effects in vitro in WB-F344 cells. At length, in vivo xenograft assay demonstrated the acquisition of tumorigenicity of WB-F344 cells after miR-200a siliencing. Collectively, our findings indicate that miR-200a may function as an important regulatory factor in neoplastic transition of HOCs by targeting the beta-catenin pathway.	[Liu, Jie; Ruan, Bai; You, Nan; Huang, Qike; Liu, Weihui; Dang, Zheng; Xu, Weihua; Zhou, Ti; Ji, Ru; Cao, Yang; Li, Xia; Wang, Desheng; Tao, Kaishan; Dou, Kefeng] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China; [You, Nan] Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Liu, Weihui] Gen Hosp Chengdu Army Reg, PLA Ctr Gen Surg, Chengdu, Peoples R China	Air Force Military Medical University; Army Medical University	Tao, KS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China.	kaistao@163.com; gdwkgwx@fmmu.edu.cn	Xu, Weihua/GYJ-6124-2022; Hwang, Kirkland/O-1855-2016; Liu, Jie/ADI-6901-2022	Hwang, Kirkland/0000-0001-8534-5443; 	National Natural Science Foundation of China [81170419, 81272648, 81302168]; Major Program of the National Natural Science Foundation of China [81030010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Grants No. 81170419, 81272648, 81302168) and the Major Program of the National Natural Science Foundation of China (Grants No. 81030010/H0318). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453; Anand M, 2011, HAEMATOL-HEMATOL J, V96, P253, DOI 10.3324/haematol.2010.027086; Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chau WK, 2012, ONCOGENE, DOI 10.1038/onc.2012.290; Cheng C, 2012, MOL PHARM; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gastro.2007.06.016; Chiba T, 2010, HEPATOLOGY, V52, P1111, DOI 10.1002/hep.23793; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hung CS, 2012, ANN SURG ONCOL; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Itoh T, 2009, FEBS LETT, V583, P777, DOI 10.1016/j.febslet.2009.01.022; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li CH, 2011, CANCER LETT, V311, P1, DOI 10.1016/j.canlet.2011.05.035; Li XF, 2010, CANCER SCI, V101, P1099, DOI 10.1111/j.1349-7006.2010.01513.x; Liu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023311; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mao J, 2013, INT J BIOCHEM CELL B, V45, P1064, DOI 10.1016/j.biocel.2013.02.022; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Oishi N, 2011, INT J BIOL SCI, V7, P517, DOI 10.7150/ijbs.7.517; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rogers HA, 2012, BRIT J CANCER, V107, P1144, DOI 10.1038/bjc.2012.377; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Soltanian S, 2011, TUMOR BIOL, V32, P425, DOI 10.1007/s13277-011-0155-8; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson MD, 2010, AM J PATHOL, V177, P1812, DOI 10.2353/ajpath.2010.100173; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; Wu QH, 2011, GYNECOL ONCOL, V122, P149, DOI 10.1016/j.ygyno.2011.03.026; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yuan JH, 2011, HEPATOLOGY, V54, P2025, DOI 10.1002/hep.24606; Zhang N, 2010, ONCOL REP, V23, P827, DOI 10.3892/or_00000704; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	57	15	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79409	10.1371/journal.pone.0079409	http://dx.doi.org/10.1371/journal.pone.0079409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260215	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600033
J	Ma, J; Stiller, J; Berkman, PJ; Wei, YM; Rogers, J; Feuillet, C; Dolezel, J; Mayer, KF; Eversole, K; Zheng, YL; Liu, CJ				Ma, Jian; Stiller, Jiri; Berkman, Paul J.; Wei, Yuming; Rogers, Jan; Feuillet, Catherine; Dolezel, Jaroslav; Mayer, Klaus F.; Eversole, Kellye; Zheng, You-Liang; Liu, Chunji			Sequence-Based Analysis of Translocations and Inversions in Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CHROMOSOMAL TRANSLOCATIONS; HOMOEOLOGOUS GROUP-4; GENOME; REARRANGEMENTS; EVOLUTION; RECOMBINATION	Structural changes of chromosomes are a primary mechanism of genome rearrangement over the course of evolution and detailed knowledge of such changes in a given species and its close relatives should increase the efficiency and precision of chromosome engineering in crop improvement. We have identified sequences bordering each of the main translocation and inversion breakpoints on chromosomes 4A, 5A and 7B of the modern bread wheat genome. The locations of these breakpoints allow, for the first time, a detailed description of the evolutionary origins of these chromosomes at the gene level. Results from this study also demonstrate that, although the strategy of exploiting sorted chromosome arms has dramatically simplified the efforts of wheat genome sequencing, simultaneous analysis of sequences from homoeologous and non-homoeologous chromosomes is essential in understanding the origins of DNA sequences in polyploid species.	[Ma, Jian; Stiller, Jiri; Berkman, Paul J.; Liu, Chunji] Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Brisbane, Qld, Australia; [Ma, Jian; Wei, Yuming; Zheng, You-Liang] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China; [Rogers, Jan] Genome Anal Ctr, Norwich, Norfolk, England; [Rogers, Jan] Int Wheat Genome Sequencing Consortium, Norwich, Norfolk, England; [Feuillet, Catherine] Univ Blaise Pascal, INRA, Domaine Crouelle, Genet Divers & Ecophysiol Cereals, Clermont Ferrand, France; [Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic; [Mayer, Klaus F.] Helmholtz Ctr Munich, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Eversole, Kellye] Int Wheat Genome Sequencing Consortium, Bethesda, MD USA; [Liu, Chunji] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Sichuan Agricultural University; The Genome Analysis Centre (TGAC); Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Western Australia	Liu, CJ (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Brisbane, Qld, Australia.	chunji.liu@csiro.au	Stiller, Jiri/E-1564-2012; Ma, Jian/M-3639-2019; Dolezel, Jaroslav/B-7716-2008; Mayer, Klaus FX/M-7941-2015; Ma, Jian/G-4596-2014; Berkman, Paul/G-8678-2011; Eversole, Kellye/AAN-6141-2020; Liu, Chunji/B-5243-2009	Ma, Jian/0000-0001-6265-7911; Dolezel, Jaroslav/0000-0002-6263-0492; Mayer, Klaus FX/0000-0001-6484-1077; Ma, Jian/0000-0001-6265-7911; Berkman, Paul/0000-0002-6523-4356; Eversole, Kellye/0000-0002-8784-4913; 	Commonwealth Scientific and Industrial Research Organisation Plant Industry; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish	Commonwealth Scientific and Industrial Research Organisation Plant Industry; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work reported in this paper is funded by Commonwealth Scientific and Industrial Research Organisation Plant Industry. The funders played a role in deciding to publish this paper. However, they had no role in study design, data collection and analysis, or preparation of the manuscript.	Berkman PJ, 2012, THEOR APPL GENET, V124, P423, DOI 10.1007/s00122-011-1717-2; Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brown JD, 2010, ANNU REV GENOM HUM G, V11, P291, DOI 10.1146/annurev-genom-082509-141554; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Colson I, 2004, EMBO REP, V5, P392, DOI 10.1038/sj.embor.7400123; DEVOS KM, 1995, THEOR APPL GENET, V91, P282, DOI 10.1007/BF00220890; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Hao WL, 2009, GENETICS, V182, P1365, DOI 10.1534/genetics.109.104216; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; KING IP, 1994, GENOME, V37, P882, DOI 10.1139/g94-125; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LIU CJ, 1992, THEOR APPL GENET, V83, P305, DOI 10.1007/BF00224276; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MCKIM KS, 1988, GENETICS, V120, P987; MICKELSONYOUNG L, 1995, THEOR APPL GENET, V90, P1007, DOI 10.1007/BF00222914; Miftahudin, 2004, GENETICS, V168, P651, DOI 10.1534/genetics.104.034827; Morrow JD, 2012, GENOME BIOL EVOL, V4, P1256, DOI 10.1093/gbe/evs099; NARANJO T, 1987, GENOME, V29, P873, DOI 10.1139/g87-149; NELSON JC, 1995, GENETICS, V141, P721; Rowley JD, 2004, LANDMARKS MED GENETI, V243, P104; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Sankoff D, 2003, P NATL ACAD SCI USA, V100, P11188, DOI 10.1073/pnas.2035002100; Sherizen D, 2005, GENETICS, V169, P767, DOI 10.1534/genetics.104.035824; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747	26	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e79329	10.1371/journal.pone.0079329	http://dx.doi.org/10.1371/journal.pone.0079329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260197	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600031
J	Johnson, JR; Kashyap, S; Rankin, K; Barclay, JW				Johnson, James R.; Kashyap, Sudhanva; Rankin, Kim; Barclay, Jeff W.			Rab-3 and unc-18 Interactions in Alcohol Sensitivity Are Distinct from Synaptic Transmission	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NEUROTRANSMITTER RELEASE; BEHAVIORAL-RESPONSES; VESICLE DOCKING; MUNC18-1; ETHANOL; EXOCYTOSIS; SYNTAXIN; PROTEINS; PROMOTES	The molecular mechanisms underlying sensitivity to alcohol are incompletely understood. Recent research has highlighted the involvement of two presynaptic proteins, Munc18 and Rab3. We have previously characterised biochemically a number of specific Munc18 point mutations including an E466K mutation that augments a direct Rab3 interaction. Here the phenotypes of this and other Munc18 mutations were assessed in alcohol sensitivity and exocytosis using Caenorhabditis elegans. We found that expressing the orthologous E466K mutation (unc-18 E465K) enhanced alcohol sensitivity. This enhancement in sensitivity was surprisingly independent of rab-3. In contrast unc-18 R39C, which decreases syntaxin binding, enhanced sensitivity to alcohol in a manner requiring rab-3. Finally, overexpression of R39C could suppress partially the reduction in neurotransmitter release in rab-3 mutant worms, whereas wild-type or E465K mutants showed no rescue. These data indicate that the epistatic interactions between unc-18 and rab-3 in modulating sensitivity to alcohol are distinct from interactions affecting neurotransmitter release.	[Johnson, James R.; Kashyap, Sudhanva; Rankin, Kim; Barclay, Jeff W.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Barclay, JW (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Physiol Lab, Liverpool L69 3BX, Merseyside, England.	barclayj@liverpool.ac.uk	Johnson, James R/D-9721-2014	Johnson, James R/0000-0002-8849-0993; Barclay, Jeff W/0000-0003-4320-2094; Kashyap, Sudhanva/0000-0003-3988-1055	Wellcome Trust; National Institutes of Health National Center for Research Resources	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the Wellcome Trust (to JWB). Strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Agrawal A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.54; Barclay JW, 2008, BIOPHYS J, V94, P1084, DOI 10.1529/biophysj.107.111203; Barclay JW, 2012, CELL CALCIUM, V52, P289, DOI 10.1016/j.ceca.2012.03.005; Barclay JW, 2010, BIOCHEM SOC T, V38, P172, DOI 10.1042/BST0380172; Ben Hamida S, 2012, J NEUROSCI, V32, P15849, DOI 10.1523/JNEUROSCI.2846-12.2012; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Chen X, 2007, GENES BRAIN BEHAV, V6, P689, DOI 10.1111/j.1601-183X.2006.00296.x; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; Dillon J, 2013, FASEB J, V27, P4266, DOI 10.1096/fj.11-189340; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Edwards MR, 2012, J NEUROSCI, V32, P7042, DOI 10.1523/JNEUROSCI.4029-11.2012; Fehr C, 2005, ALCOHOL CLIN EXP RES, V29, P708, DOI 10.1097/01.ALC.0000164366.18376.EF; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Gracheva Elena O, 2010, Front Synaptic Neurosci, V2, P141, DOI 10.3389/fnsyn.2010.00141; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Graham ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017999; Graham ME, 2009, MOL BIOL CELL, V20, P43, DOI 10.1091/mbc.E08-07-0689; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; Howard RJ, 2011, ALCOHOL CLIN EXP RES, V35, P1561, DOI 10.1111/j.1530-0277.2011.01502.x; Huang CC, 2011, TRAFFIC, V12, P1356, DOI 10.1111/j.1600-0854.2011.01237.x; Johnson JR, 2009, BIOCHEM J, V418, P73, DOI 10.1042/BJ20081956; Jorgacevski J, 2011, J NEUROSCI, V31, P9055, DOI 10.1523/JNEUROSCI.0185-11.2011; Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x; Koehnke MD, 2008, BIOCHEM PHARMACOL, V75, P160, DOI 10.1016/j.bcp.2007.06.021; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; Mitchell PH, 2007, PHARMACOGENOMICS J, V7, P411, DOI 10.1038/sj.tpj.6500440; Nonet ML, 1997, J NEUROSCI, V17, P8061; Parry CD, 2011, ADDICTION, V106, P1718, DOI 10.1111/j.1360-0443.2011.03605.x; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Speca DJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001057; van Swinderen B, 1999, P NATL ACAD SCI USA, V96, P2479, DOI 10.1073/pnas.96.5.2479; van Weering JRT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000616; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; YCDPRL P, 2012, J NEUROSCI, V32, P17706, DOI DOI 10.1523/JNEUR0SCI.1944-12.2012.PUBMED:23223291	49	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e81117	10.1371/journal.pone.0081117	http://dx.doi.org/10.1371/journal.pone.0081117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244732	Green Published, Green Submitted, gold			2022-12-25	WOS:000327143800176
J	Laquitaine, S; Piron, C; Abellanas, D; Loewenstein, Y; Boraud, T				Laquitaine, Steeve; Piron, Camille; Abellanas, David; Loewenstein, Yonatan; Boraud, Thomas			Complex Population Response of Dorsal Putamen Neurons Predicts the Ability to Learn	PLOS ONE			English	Article							STRIATAL NEURONS; BASAL GANGLIA; CAUDATE-NUCLEUS; FIRING PATTERNS; HOT HAND; DOPAMINE; REWARD; REINFORCEMENT; PRIMATES; VALUES	Day-to-day variability in performance is a common experience. We investigated its neural correlate by studying learning behavior of monkeys in a two-alternative forced choice task, the two-armed bandit task. We found substantial session-to-session variability in the monkeys' learning behavior. Recording the activity of single dorsal putamen neurons we uncovered a dual function of this structure. It has been previously shown that a population of neurons in the DLP exhibits firing activity sensitive to the reward value of chosen actions. Here, we identify putative medium spiny neurons in the dorsal putamen that are cue-selective and whose activity builds up with learning. Remarkably we show that session-to-session changes in the size of this population and in the intensity with which this population encodes cue-selectivity is correlated with session-to-session changes in the ability to learn the task. Moreover, at the population level, dorsal putamen activity in the very beginning of the session is correlated with the performance at the end of the session, thus predicting whether the monkey will have a "good" or "bad" learning day. These results provide important insights on the neural basis of inter-temporal performance variability.	[Laquitaine, Steeve; Piron, Camille; Abellanas, David; Boraud, Thomas] Univ Bordeaux, UMR 5293, Bordeaux, France; [Laquitaine, Steeve; Piron, Camille; Abellanas, David; Boraud, Thomas] CNRS, UMR 5293, Bordeaux, France; [Loewenstein, Yonatan] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Edmond & Lily Safra Ctr Brain Sci, Dept Neurobiol, Jerusalem, Israel; [Loewenstein, Yonatan] Hebrew Univ Jerusalem, Ctr Study Rat, Jerusalem, Israel; [Boraud, Thomas] CHU Bordeaux, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Hebrew University of Jerusalem; Hebrew University of Jerusalem; CHU Bordeaux	Boraud, T (corresponding author), Univ Bordeaux, UMR 5293, Bordeaux, France.	tboraud@u-bordeaux2.fr		Laquitaine, Steeve/0000-0002-9647-3149	Franco-Israeli Neuroscience Lab; HUJI; University of Bordeaux; University Paris VI-Descartes; Ministry of Science, Culture Sport, Israel; Ministry of Research, France; Programme Interdisciplinaire NeuroInformatique; France-Parkinson foundation; Israel Science Foundation [868/08]	Franco-Israeli Neuroscience Lab; HUJI; University of Bordeaux; University Paris VI-Descartes; Ministry of Science, Culture Sport, Israel; Ministry of Research, France(Ministry of Research, France); Programme Interdisciplinaire NeuroInformatique; France-Parkinson foundation; Israel Science Foundation(Israel Science Foundation)	This study was partly supported by the Franco-Israeli Neuroscience Lab administered by the CNRS, the HUJI, the University of Bordeaux and the University Paris VI-Descartes; a grant from the Ministry of Science, Culture & Sport, Israel, and the Ministry of Research, France and by the Programme Interdisciplinaire NeuroInformatique administered by the CNRS. S. L. was supported by a France-Parkinson foundation grant. Y.L. was supported by the Israel Science Foundation (grant No. 868/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMALRIC M, 1987, J NEUROSCI, V7, P2129; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; Ballard C, 2001, INT J GERIATR PSYCH, V16, P494, DOI 10.1002/gps.368; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; Bar-Eli M, 2006, PSYCHOL SPORT EXERC, V7, P525, DOI 10.1016/j.psychsport.2006.03.001; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Boraud T, 2001, BRAIN, V124, P546, DOI 10.1093/brain/124.3.546; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Clark L, 2010, PHILOS T R SOC B, V365, P319, DOI 10.1098/rstb.2009.0147; Clarke D, 2004, J GAMBL STUD, V20, P319, DOI 10.1007/s10899-004-4578-7; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Escandon A, 2010, NEUROLOGY, V74, P210, DOI 10.1212/WNL.0b013e3181ca017d; Frank MJ, 2010, NAT NEUROSCI, V13, P649, DOI 10.1038/nn0510-649a; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; GRAF V, 1964, J EXP ANAL BEHAV, V7, P151, DOI 10.1901/jeab.1964.7-151; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; Ishii S, 2002, NEURAL NETWORKS, V15, P665, DOI 10.1016/S0893-6080(02)00056-4; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Mahon S, 2000, J PHYSIOL-LONDON, V527, P345, DOI 10.1111/j.1469-7793.2000.t01-1-00345.x; Mahon S, 2003, J PHYSIOL-PARIS, V97, P557, DOI 10.1016/j.jphysparis.2004.01.013; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; MEYER DR, 1960, J COMP PHYSIOL PSYCH, V53, P173, DOI 10.1037/h0045852; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Nambu A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00026; Neiman T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1580; Orfanidis S. J., 1995, INTRO SIGNAL PROCESS; Pasquereau B, 2007, J NEUROSCI, V27, P1176, DOI 10.1523/JNEUROSCI.3745-06.2007; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Samejima K, 2007, ANN NY ACAD SCI, V1104, P213, DOI 10.1196/annals.1390.024; Sandstrom MI, 2003, SYNAPSE, V47, P91, DOI 10.1002/syn.10142; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; SELEMON LD, 1985, J NEUROSCI, V5, P776; Shanks DR, 2002, J BEHAV DECIS MAKING, V15, P233, DOI 10.1002/bdm.413; Sharott A, 2009, J NEUROSCI, V29, P4571, DOI 10.1523/JNEUROSCI.5097-08.2009; Shteingart H, 2013, J EXP PSYCHOL GEN, V142, P476, DOI 10.1037/a0029550; Takada M, 2001, EUR J NEUROSCI, V14, P1633, DOI 10.1046/j.0953-816x.2001.01789.x; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; TVERSKY A, 1966, J EXP PSYCHOL, V71, P680, DOI 10.1037/h0023123; Vo LTK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016093; West RF, 2003, MEM COGNITION, V31, P243, DOI 10.3758/BF03194383; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; WILSON WA, 1959, J EXP PSYCHOL, V58, P174, DOI 10.1037/h0043061; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	54	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80683	10.1371/journal.pone.0080683	http://dx.doi.org/10.1371/journal.pone.0080683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244706	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800157
J	Peng, H; Luo, PL; Li, YQ; Wang, C; Liu, X; Ye, ZC; Li, CM; Lou, TQ				Peng, Hui; Luo, Pengli; Li, Yuanqing; Wang, Cheng; Liu, Xun; Ye, Zengchun; Li, Canming; Lou, Tanqi			Simvastatin Alleviates Hyperpermeability of Glomerular Endothelial Cells in Early-Stage Diabetic Nephropathy by Inhibition of RhoA/ROCK1	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; MATRIX METALLOPROTEINASES; BARRIER DYSFUNCTION; EPITHELIAL BARRIER; GROWTH-FACTOR; RECEPTOR 1; PERMEABILITY; ACTIVATION; PHOSPHORYLATION; OCCLUDIN	Background: Endothelial dysfunction is an early sign of diabetic cardiovascular disease and may contribute to progressive diabetic nephropathy (DN). There is increasing evidence that dysfunction of the endothelial tight junction is a crucial step in the development of endothelial hyperpermeability, but it is unknown whether this occurs in glomerular endothelial cells (GEnCs) during the progression of DN. We examined tight junction dysfunction of GEnCs during early-stage DN and the potential underlying mechanisms. We also examined the effect of simvastatin (3-Hydroxy-3-methylglutaryl CoA reductase inhibitor) on dysfunction of the tight junctions of cultured GEnCs and in db/db mice with early-stage DN. Methods: We assessed the expression of occludin and ZO-1, two major components of the tight junction complex, in cultured rat GEnCs treated with high glucose and in 12 week-old db/db mice with early-stage DN. We also investigated activation of RhoA/ROCK1 signaling, GEnC permeability, and renal function of the mice. Results: High glucose suppresses occludin expression and disrupts occludin/ZO-1 translocation in GEnCs. These changes were associated with increased permeability to albumin and activation of RhoA/ROCK1 signaling. Occludin and ZO-1 dysregulation also occurred in the glomeruli of mice with early-stage DN, and these abnormalities were accompanied by albuminuria and activation of RhoA/ROCK1 in isolated glomeruli. Simvastatin prevented high glucose or hyperglycemia-induced dysregulation of occludin and ZO-1 by inhibition of RhoA/ROCK1 signaling in cultured GEnCs and in db/db mice with early-stage DN. Conclusion: Our results indicate that activation of RhoA/ROCK1 by high glucose disrupts the expression and translocation of occludin/ZO-1 and that simvastatin alleviates occludin/ZO-1 dysregulation and albuminuria by suppressing RhoA/ROCK1 signaling during early-stage DN. These results suggest a potential therapeutic strategy for preventing the onset of albuminuria in early-stage DN.	[Peng, Hui; Luo, Pengli; Li, Yuanqing; Wang, Cheng; Liu, Xun; Ye, Zengchun; Li, Canming; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lou, TQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	lou.tq@163.com	wang, cheng/A-4225-2017		"National Natural Science Funds of China'' [30800408, 30771011, 81170678]; "Fundamental Research Funds for the Central Universities''	"National Natural Science Funds of China''(National Natural Science Foundation of China (NSFC)); "Fundamental Research Funds for the Central Universities''(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the "National Natural Science Funds of China'' (No. 30800408, No. 30771011 and No. 81170678) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the "Fundamental Research Funds for the Central Universities'' (http://jkw.mof.gov.cn/zhengwuxinxi/zhengcefabu/201106/t20110620_563835.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Badiola N, 2009, NEUROBIOL DIS, V35, P438, DOI 10.1016/j.nbd.2009.06.005; Bhattacharjee PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052152; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Colhoun HM, 2009, AM J KIDNEY DIS, V54, P810, DOI 10.1053/j.ajkd.2009.03.022; Colhoun HM, 2005, DIABETOLOGIA, V48, P2482, DOI 10.1007/s00125-005-0029-y; Collins R, 2004, LANCET, V363, P757; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fried LF, 2001, J DIABETES COMPLICAT, V15, P113, DOI 10.1016/S1056-8727(01)00140-4; Fukasawa H, 2009, J AM SOC NEPHROL, V20, P1491, DOI 10.1681/ASN.2008101117; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; HEILIG CW, 1995, J CLIN INVEST, V96, P1802, DOI 10.1172/JCI118226; Hirose A, 2010, FEBS LETT, V584, P61, DOI 10.1016/j.febslet.2009.11.082; Ho JE, 2003, STROKE, V34, P2812, DOI 10.1161/01.STR.0000102901.41780.5C; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Liu E, 2007, J AM SOC NEPHROL, V18, P2094, DOI 10.1681/ASN.2006010075; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Mangialardi G, 2013, ARTERIOSCL THROM VAS, V33, P555, DOI 10.1161/ATVBAHA.112.300424; Martini S, 2009, J AM SOC NEPHROL, V20, P1420, DOI 10.1681/ASN.2009050514; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Peng H, 2010, ACTA DIABETOL, V47, pS57, DOI 10.1007/s00592-009-0121-8; Pieper GM, 1997, CARDIOVASC RES, V34, P169, DOI 10.1016/S0008-6363(97)00007-2; Remuzzi G, 2006, J AM SOC NEPHROL, V17, pS90, DOI 10.1681/ASN.2005121324; Rincon-Choles H, 2006, DIABETES, V55, P894, DOI 10.2337/diabetes.55.04.06.db05-0355; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2012, ANN NY ACAD SCI, V1258, P9, DOI 10.1111/j.1749-6632.2012.06613.x; Spoerri PE, 2006, MOL VIS, V12, P32; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Street CA, 2011, ANTICANCER RES, V31, P3645; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tejada T, 2008, KIDNEY INT, V73, P1385, DOI 10.1038/ki.2008.109; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Wang JP, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-7; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Wu JH, 2012, CELL MOL NEUROBIOL, V32, P1187, DOI 10.1007/s10571-012-9845-z; Xie H, 2012, J MOL NEUROSCI, V46, P666, DOI 10.1007/s12031-011-9564-9; Xu JR, 2012, J BIOMOL STRUCT DYN, V30, P30, DOI 10.1080/07391102.2012.674188; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831; Zebda N, 2013, J BIOL CHEM, V288, P18290, DOI 10.1074/jbc.M112.432757; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; Zoja C, 2010, AM J PHYSIOL-RENAL, V299, pF1203, DOI 10.1152/ajprenal.00045.2010	60	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80009	10.1371/journal.pone.0080009	http://dx.doi.org/10.1371/journal.pone.0080009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244596	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800108
J	Lee, J; Rha, E; Yeom, SJ; Lee, DH; Choi, ES; Lee, SG				Lee, Jeongmin; Rha, Eugene; Yeom, Soo-Jin; Lee, Dae-Hee; Choi, Eui-Sung; Lee, Seung-Goo			Generating In Vivo Cloning Vectors for Parallel Cloning of Large Gene Clusters by Homologous Recombination	PLOS ONE			English	Article							PCR; EXPRESSION; GENOME	A robust method for the in vivo cloning of large gene clusters was developed based on homologous recombination (HR), requiring only the transformation of PCR products into Escherichia coli cells harboring a receiver plasmid. Positive clones were selected by an acquired antibiotic resistance, which was activated by the recruitment of a short ribosome-binding site plus start codon sequence from the PCR products to the upstream position of a silent antibiotic resistance gene in receiver plasmids. This selection was highly stringent and thus the cloning efficiency of the GFPuv gene (size: 0.7 kb) was comparable to that of the conventional restriction-ligation method, reaching up to 4.3 x 10(4) positive clones per mu g of DNA. When we attempted parallel cloning of GFPuv fusion genes (size: 2.0 kb) and carotenoid biosynthesis pathway clusters (sizes: 4 kb, 6 kb, and 10 kb), the cloning efficiency was similarly high regardless of the DNA size, demonstrating that this would be useful for the cloning of large DNA sequences carrying multiple open reading frames. However, restriction analyses of the obtained plasmids showed that the selected cells may contain significant amounts of receiver plasmids without the inserts. To minimize the amount of empty plasmid in the positive selections, the sacB gene encoding a levansucrase was introduced as a counter selection marker in receiver plasmid as it converts sucrose to a toxic levan in the E. coli cells. Consequently, this method yielded completely homogeneous plasmids containing the inserts via the direct transformation of PCR products into E. coli cells.	[Lee, Jeongmin; Rha, Eugene; Yeom, Soo-Jin; Lee, Dae-Hee; Choi, Eui-Sung; Lee, Seung-Goo] KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea; [Lee, Seung-Goo] Univ Sci & Technol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, SG (corresponding author), KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea.	sglee@kribb.re.kr	Yeom, Soojin/AAE-3558-2022; Lee, Seung-Goo/AAR-9823-2021; Lee, Seung-Goo/AAS-1613-2021; LEE, DAE-HEE/O-5243-2018	Lee, Seung-Goo/0000-0003-4539-9812; LEE, DAE-HEE/0000-0002-0423-9057; Yeom, Soo-Jin/0000-0001-7307-237X	Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031944]; Korea Research Council of Fundamental Science and Technology Grant [Seed-10-3]; Next-Generation Biogreen 21 Program [PJ009524]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Intelligent Synthetic Biology Center of Global Frontier Project; Korea Research Council of Fundamental Science and Technology Grant; Next-Generation Biogreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This research was supported by grants from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031944), the Korea Research Council of Fundamental Science and Technology Grant (Seed-10-3), the Next-Generation Biogreen 21 Program (PJ009524), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieniossek C, 2009, NAT METHODS, V6, P447, DOI [10.1038/NMETH.1326, 10.1038/nmeth.1326]; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Das A, 2007, APPL MICROBIOL BIOT, V77, P505, DOI 10.1007/s00253-007-1206-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dutton G, 2005, SCIENTIST, V19, P32; Ha JS, 2007, APPL ENVIRON MICROB, V73, P7408, DOI 10.1128/AEM.01080-07; Keasling JD, 1999, TRENDS BIOTECHNOL, V17, P452, DOI 10.1016/S0167-7799(99)01376-1; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; McArthur GH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/459760; Muyrers Joep P P, 2004, Methods Mol Biol, V256, P107; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Spiliotis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035407; Tao LA, 2006, METAB ENG, V8, P523, DOI 10.1016/j.ymben.2006.06.001; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556; Visser H, 2003, FEMS YEAST RES, V4, P221, DOI 10.1016/s1567-1356(03)00158-2; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yoon SH, 2006, BIOTECHNOL BIOENG, V94, P1025, DOI 10.1002/bit.20912; Yosef I, 2004, APPL ENVIRON MICROB, V70, P7156, DOI 10.1128/AEM.70.12.7156-7160.2004; Young E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/130781; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	27	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79979	10.1371/journal.pone.0079979	http://dx.doi.org/10.1371/journal.pone.0079979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244585	Green Submitted, gold, Green Published			2022-12-25	WOS:000327221600163
J	Mutoh, R; Nishimura, A; Yasui, S; Onai, K; Ishiura, M				Mutoh, Risa; Nishimura, Atsuhito; Yasui, So; Onai, Kiyoshi; Ishiura, Masahiro			The ATP-Mediated Regulation of KaiB-KaiC Interaction in the Cyanobacterial Circadian Clock	PLOS ONE			English	Article							N-TERMINAL DOMAIN; PROTEIN KAIB; SYNECHOCOCCUS-ELONGATUS; CRYSTAL-STRUCTURE; PHOSPHORYLATION; COMPLEX; RHYTHM; ROLES; RING; OSCILLATION	The cyanobacterial circadian clock oscillator is composed of three clock proteins-KaiA, KaiB, and KaiC, and interactions among the three Kai proteins generate clock oscillation in vitro. However, the regulation of these interactions remains to be solved. Here, we demonstrated that ATP regulates formation of the KaiB-KaiC complex. In the absence of ATP, KaiC was monomeric (KaiC(1mer)) and formed a complex with KaiB. The addition of ATP plus Mg2+ (Mg-ATP), but not that of ATP only, to the KaiB-KaiC(1mer) complex induced the hexamerization of KaiC and the concomitant release of KaiB from the KaiB-KaiC(1mer) complex, indicating that Mg-ATP and KaiB compete each other for KaiC. In the presence of ATP and Mg2+ (Mg-ATP), KaiC became a homohexameric ATPase (KaiC(6mer)) with bound Mg-ATP and formed a complex with KaiB, but KaiC hexamerized by unhydrolyzable substrates such as ATP and Mg-ATP analogs, did not. A KaiC N-terminal domain protein, but not its C-terminal one, formed a complex with KaiB, indicating that KaiC associates with KaiB via its N-terminal domain. A mutant KaiC(6mer) lacking N-terminal ATPase activity did not form a complex with KaiB whereas a mutant lacking C-terminal ATPase activity did. Thus, the N-terminal domain of KaiC is responsible for formation of the KaiB-KaiC complex, and the hydrolysis of the ATP bound to N-terminal ATPase motifs on KaiC(6mer) is required for formation of the KaiB-KaiC(6mer) complex. KaiC(6mer) that had been hexamerized with ADP plus aluminum fluoride, which are considered to mimic ADP-Pi state, formed a complex with KaiB, suggesting that KaiB is able to associate with KaiC(6mer) with bound ADP-Pi.	[Mutoh, Risa; Nishimura, Atsuhito; Yasui, So; Onai, Kiyoshi; Ishiura, Masahiro] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 46401, Japan; [Nishimura, Atsuhito; Yasui, So; Ishiura, Masahiro] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Ishiura, M (corresponding author), Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 46401, Japan.	ishiura@gene.nagoya-u.ac.jp	Mutoh, Risa/L-6494-2017	Mutoh, Risa/0000-0003-0069-8931; Onai, Kiyoshi/0000-0001-9062-2548	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science Society; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Society; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to MI and RM and the Sasakawa Scientific Research Grant from the Japan Science Society to AN. RM was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Chang YG, 2012, P NATL ACAD SCI USA, V109, P16847, DOI 10.1073/pnas.1211508109; Chang YG, 2011, P NATL ACAD SCI USA, V108, P14431, DOI 10.1073/pnas.1104221108; Egli M, 2012, BIOCHEMISTRY-US, V51, P1547, DOI 10.1021/bi201525n; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; Garces RG, 2004, EMBO J, V23, P1688, DOI 10.1038/sj.emboj.7600190; GROBBELAAR N, 1986, FEMS MICROBIOL LETT, V37, P173, DOI 10.1111/j.1574-6968.1986.tb01788.x; Hayashi F, 2004, J BIOL CHEM, V279, P52331, DOI 10.1074/jbc.M406604200; Hayashi F, 2004, BIOCHEM BIOPH RES CO, V316, P195, DOI 10.1016/j.bbrc.2004.02.034; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwase R, 2005, J BIOL CHEM, V280, P43141, DOI 10.1074/jbc.M503360200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; LUNARDI J, 1988, P NATL ACAD SCI USA, V85, P8958, DOI 10.1073/pnas.85.23.8958; MILNER P, 1990, P ROY SOC B-BIOL SCI, V241, P245, DOI 10.1098/rspb.1990.0092; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Murakami R, 2008, GENES CELLS, V13, P387, DOI 10.1111/j.1365-2443.2008.01174.x; Murakami R, 2012, J BIOL CHEM, V287, P29506, DOI 10.1074/jbc.M112.349092; Mutoh R, 2011, APPL MAGN RESON, V40, P525, DOI 10.1007/s00723-011-0228-2; Mutoh R, 2010, GENES CELLS, V15, P269, DOI 10.1111/j.1365-2443.2009.01377.x; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Nishiwaki T, 2012, J BIOL CHEM, V287, P18030, DOI 10.1074/jbc.M112.350660; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023697; Phong C, 2013, P NATL ACAD SCI USA, V110, P1124, DOI 10.1073/pnas.1212113110; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Uzumaki T, 2004, NAT STRUCT MOL BIOL, V104, P16377; Valencia J, 2012, GENES CELLS, V17, P398, DOI 10.1111/j.1365-2443.2012.01597.x; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024	43	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80200	10.1371/journal.pone.0080200	http://dx.doi.org/10.1371/journal.pone.0080200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244649	Green Published, Green Submitted, gold			2022-12-25	WOS:000327221600191
J	Beck, B; Bertini, C; Scarpazza, C; Ladavas, E				Beck, Brianna; Bertini, Caterina; Scarpazza, Cristina; Ladavas, Elisabetta			Observed Touch on a Non-Human Face Is Not Remapped onto the Human Observer's Own Face	PLOS ONE			English	Article							FACIAL EXPRESSIONS; SOMATOSENSORY ACTIVATIONS; TACTILE PERCEPTION; RECOGNITION; EMOTION; AMYGDALA; CORTICES; DAMAGE	Visual remapping of touch (VRT) is a phenomenon in which seeing a human face being touched enhances detection of tactile stimuli on the observer's own face, especially when the observed face expresses fear. This study tested whether VRT would occur when seeing touch on monkey faces and whether it would be similarly modulated by facial expressions. Human participants detected near-threshold tactile stimulation on their own cheeks while watching fearful, happy, and neutral human or monkey faces being concurrently touched or merely approached by fingers. We predicted minimal VRT for neutral and happy monkey faces but greater VRT for fearful monkey faces. The results with human faces replicated previous findings, demonstrating stronger VRT for fearful expressions than for happy or neutral expressions. However, there was no VRT (i.e. no difference between accuracy in touch and no-touch trials) for any of the monkey faces, regardless of facial expression, suggesting that touch on a non-human face is not remapped onto the somatosensory system of the human observer.	[Beck, Brianna; Bertini, Caterina; Scarpazza, Cristina; Ladavas, Elisabetta] Univ Bologna, Ctr & Ric Neurosci Cognit CNC, Cesena, Italy; [Beck, Brianna; Bertini, Caterina; Scarpazza, Cristina; Ladavas, Elisabetta] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna; University of Bologna	Ladavas, E (corresponding author), Univ Bologna, Ctr & Ric Neurosci Cognit CNC, Cesena, Italy.	elisabetta.ladavas@unibo.it	Scarpazza, Cristina/AAA-2306-2022	Scarpazza, Cristina/0000-0002-4126-426X; Beck, Brianna/0000-0002-6784-6583; LADAVAS, ELISABETTA/0000-0001-8930-725X	Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN)	Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was supported by grants from the Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN) to EL (http://prin.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1996, J NEUROSCI, V16, P7678; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Bloom T, 2013, BEHAV PROCE IN PRESS, DOI [10.1016/j.be-proc.2013.02.010, DOI 10.1016/J.BE-PR0C.2013.02.010]; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Cardini F, 2012, EMOTION, V12, P980, DOI 10.1037/a0027351; Cardini F, 2011, J COGNITIVE NEUROSCI, V23, P503, DOI 10.1162/jocn.2010.21484; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; Ekman P., 1976, PICTURES FACIAL AFFE; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Kanazawa S, 1996, PRIMATES, V37, P25, DOI 10.1007/BF02382917; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Kujala MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039145; Ladavas E, 1998, J COGNITIVE NEUROSCI, V10, P581, DOI 10.1162/089892998562988; Neiworth JJ, 2007, ANIM COGN, V10, P125, DOI 10.1007/s10071-006-0045-4; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; Pourtois G, 2004, EUR J NEUROSCI, V20, P3507, DOI 10.1111/j.1460-9568.2004.03794.x; Racca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036076; Ro T, 2004, J COGNITIVE NEUROSCI, V16, P24, DOI 10.1162/089892904322755520; Schaefer M, 2005, NEUROREPORT, V16, P1101, DOI 10.1097/00001756-200507130-00014; Schaefer M, 2009, HUM BRAIN MAPP, V30, P2722, DOI 10.1002/hbm.20701; Scott LS, 2006, INFANCY, V10, P171, DOI 10.1207/s15327078in1002_4; Scott LS, 2005, COGN AFFECT BEHAV NE, V5, P405, DOI 10.3758/CABN.5.4.405; Serino A, 2008, PSYCHOL SCI, V19, P434, DOI 10.1111/j.1467-9280.2008.02105.x; Serino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004930; Sprengelmeyer R, 1999, P ROY SOC B-BIOL SCI, V266, P2451, DOI 10.1098/rspb.1999.0945; Wan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051775; Zhu Q, 2013, NEUROIMAGE, V66, P402, DOI 10.1016/j.neuroimage.2012.10.083	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e73681	10.1371/journal.pone.0073681	http://dx.doi.org/10.1371/journal.pone.0073681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255CG	24250781	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327216200002
J	Smith, MD; Gu, Y; Querol-Audi, J; Vogan, JM; Nitido, A; Cate, JHD				Smith, M. Duane; Gu, Yu; Querol-Audi, Jordi; Vogan, Jacob M.; Nitido, Adam; Cate, Jamie H. D.			Human-Like Eukaryotic Translation Initiation Factor 3 from Neurospora crassa	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; FACTOR EIF3; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; NEW-GENERATION; H-SUBUNIT; COMPLEX; YEAST; REVEALS	Eukaryotic translation initiation factor 3 (eIF3) is a key regulator of translation initiation, but its in vivo assembly and molecular functions remain unclear. Here we show that eIF3 from Neurospora crassa is structurally and compositionally similar to human eIF3. N. crassa eIF3 forms a stable 12-subunit complex linked genetically and biochemically to the 13th subunit, eIF3j, which in humans modulates mRNA start codon selection. Based on N. crassa genetic analysis, most subunits in eIF3 are essential. Subunits that can be deleted (e, h, k and l) map to the right side of the eIF3 complex, suggesting that they may coordinately regulate eIF3 function. Consistent with this model, subunits eIF3k and eIF3l are incorporated into the eIF3 complex as a pair, and their insertion depends on the presence of subunit eIF3h, a key regulator of vertebrate development. Comparisons to other eIF3 complexes suggest that eIF3 assembles around an eIF3a and eIF3c dimer, which may explain the coordinated regulation of human eIF3 levels. Taken together, these results show that Neurospora crassa eIF3 provides a tractable system for probing the structure and function of human-like eIF3 in the context of living cells.	[Smith, M. Duane; Gu, Yu; Querol-Audi, Jordi; Vogan, Jacob M.; Nitido, Adam; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcate@lbl.gov	Querol-Audí, Jordi/AAJ-9259-2021; gu, yu/GSD-4507-2022	Querol-Audi, Jordi/0000-0003-2892-7599; Nitido, Adam/0000-0001-5679-838X	NIH [R56-AI095687, R01-GM65050, P50-GM102706]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232, P50GM102706, R01GM065050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the NIH (grants R56-AI095687, R01-GM65050, and P50-GM102706 to JHDC; and from the Howard Hughes Medical Institute for JQA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; ATWOOD KC, 1953, P NATL ACAD SCI USA, V39, P1027, DOI 10.1073/pnas.39.10.1027; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Choudhuri A, 2013, P NATL ACAD SCI USA, V110, P9818, DOI 10.1073/pnas.1302934110; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DESAI C, 1989, GENETICS, V121, P703; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; George N., 2003, FUNGAL GENET NEWSL, V50, P17; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hershey JWB, 2010, BRAZ J MED BIOL RES, V43, P920, DOI 10.1590/S0100-879X2010001000002; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Kim BH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r60; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee DW, 2004, GENETICS, V167, P131, DOI 10.1534/genetics.167.1.131; Lopez-Lastra M, 2005, BIOL RES, V38, P121, DOI 10.4067/S0716-97602005000200003; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Masutani M, 2013, PROTEIN EXPRES PURIF, V87, P5, DOI 10.1016/j.pep.2012.10.001; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Ray A, 2008, YEAST, V25, P809, DOI 10.1002/yea.1635; Roy B, 2010, RNA, V16, P748, DOI 10.1261/rna.2056010; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Verlhac MH, 1997, EMBO J, V16, P6812, DOI 10.1093/emboj/16.22.6812; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	47	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e78715	10.1371/journal.pone.0078715	http://dx.doi.org/10.1371/journal.pone.0078715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24250809	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200042
J	Bergiers, I; Bridoux, L; Nguyen, N; Twizere, JC; Rezsohazy, R				Bergiers, Isabelle; Bridoux, Laure; Nguyen, Nathan; Twizere, Jean-Claude; Rezsohazy, Rene			The Homeodomain Transcription Factor Hoxa2 Interacts with and Promotes the Proteasomal Degradation of the E3 Ubiquitin Protein Ligase RCHY1	PLOS ONE			English	Article							DNA-POLYMERASE ETA; HOMEOTIC TRANSFORMATION; GENES; PIRH2; EXPRESSION; CELLS; HINDBRAIN; MOUSE; NETWORK; ROLES	Hox proteins are conserved homeodomain transcription factors known to be crucial regulators of animal development. As transcription factors, the functions and modes of action (co-factors, target genes) of Hox proteins have been very well studied in a multitude of animal models. However, a handful of reports established that Hox proteins may display molecular activities distinct from gene transcription regulation. Here, we reveal that Hoxa2 interacts with 20S proteasome subunits and RCHY1 (also known as PIRH2), an E3 ubiquitin ligase that targets p53 for degradation. We further show that Hoxa2 promotes proteasome-dependent degradation of RCHY1 in an ubiquitin-independent manner. Correlatively, Hoxa2 alters the RCHY1-mediated ubiquitination of p53 and promotes p53 stabilization. Together, our data establish that Hoxa2 can regulate the proteasomal degradation of RCHY1 and stabilization of p53.	[Bergiers, Isabelle; Bridoux, Laure; Nguyen, Nathan; Rezsohazy, Rene] Catholic Univ Louvain, Inst Life Sci, Mol & Cellular Anim Embryol Grp, B-1348 Louvain, Belgium; [Twizere, Jean-Claude] Univ Liege, GIGA R, Lab Signaling & Prot Interact, Liege, Belgium	Universite Catholique Louvain; University of Liege	Rezsohazy, R (corresponding author), Catholic Univ Louvain, Inst Life Sci, Mol & Cellular Anim Embryol Grp, B-1348 Louvain, Belgium.	rene.rezsohazy@uclouvain.be	Twizere, Jean-Claude/AAG-3706-2019; Nguyen, Nathan/AAV-9430-2021	TWIZERE, Jean-Claude/0000-0002-8683-705X; Bergiers, Isabelle/0000-0001-9622-7960; Nguyen, Nathan/0000-0001-6969-3894	Fonds de la Recherche Scientifique Medicale (FRSM) from Belgian National Fund for Scientific Research (FRS-FNRS) [3.4.536.06 F]; FRS-FNRS	Fonds de la Recherche Scientifique Medicale (FRSM) from Belgian National Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Fonds de la Recherche Scientifique Medicale (FRSM grant #3.4.536.06 F) from the Belgian National Fund for Scientific Research (FRS-FNRS). IB and LB hold a FRIA fellowship from the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Beitel LK, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290041; Bertrand N, 2011, DEV BIOL, V353, P266, DOI 10.1016/j.ydbio.2011.02.029; Bobola N, 2003, DEVELOPMENT, V130, P3403, DOI 10.1242/dev.00554; Brison N, 2012, EUR J MED GENET, V55, P1, DOI 10.1016/j.ejmg.2011.06.003; Cardoso WV, 1996, DEV DYNAM, V207, P47, DOI 10.1002/(SICI)1097-0177(199609)207:1<47::AID-AJA6>3.0.CO;2-W; Chambers D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-6; Chatelin L, 1996, MECH DEVELOP, V55, P111, DOI 10.1016/0925-4773(95)00478-5; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen MZ, 2005, J VIROL, V79, P11824, DOI 10.1128/JVI.79.18.11824-11836.2005; Cillo C, 2011, INT J CANCER, V129, P2577, DOI 10.1002/ijc.25941; Donaldson IJ, 2012, NUCLEIC ACIDS RES, V40, P3990, DOI 10.1093/nar/gkr1240; Donaldson IJ, 2012, NUCL ACIDS RES; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Duan SS, 2007, EMBO J, V26, P3062, DOI 10.1038/sj.emboj.7601749; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; Fernandez CC, 2009, J CELL BIOCHEM, V106, P427, DOI 10.1002/jcb.22023; Ferretti E, 2005, MOL CELL BIOL, V25, P8541, DOI 10.1128/MCB.25.19.8541-8552.2005; Gabellini D, 2003, EMBO J, V22, P3715, DOI 10.1093/emboj/cdg340; Gavalas A, 1997, DEVELOPMENT, V124, P3693; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Grier DG, 2009, NEONATOLOGY, V96, P50, DOI 10.1159/000201739; Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Jung YS, 2011, MOL CELL BIOL, V31, P3997, DOI 10.1128/MCB.05808-11; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Kirilenko P, 2011, MOL CELL BIOL, V31, P1301, DOI 10.1128/MCB.00705-10; Kutejova E, 2005, DEVELOPMENT, V132, P469, DOI 10.1242/dev.01536; Lambert B, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-29; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lampe X, 2008, NUCLEIC ACIDS RES, V36, P3214, DOI 10.1093/nar/gkn148; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Logan IR, 2004, J BIOL CHEM, V279, P11696, DOI 10.1074/jbc.M312712200; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Massip L, 2007, DIFFERENTIATION, V75, P256, DOI 10.1111/j.1432-0436.2006.00132.x; Matis C, 2007, DEV DYNAM, V236, P2675, DOI 10.1002/dvdy.21266; McGonigle GJ, 2008, FRONT BIOSCI, V13, P4297, DOI 10.2741/3006; Miguez A, 2012, J NEUROSCI, V32, P17172, DOI 10.1523/JNEUROSCI.0885-12.2012; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Narita Y, 2009, CURR TOP DEV BIOL, V88, P139, DOI 10.1016/S0070-2153(09)88005-8; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P21529, DOI 10.1073/pnas.1011054107; Oury F, 2006, SCIENCE, V313, P1408, DOI 10.1126/science.1130042; Pachkowski BF, 2011, MUTAT RES-REV MUTAT, V728, P35, DOI 10.1016/j.mrrev.2011.05.003; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5472.CAN-06-4283; Salsi V, 2009, MOL CELL BIOL, V29, P5775, DOI 10.1128/MCB.00509-09; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tavella S, 2010, DIFFERENTIATION, V79, P194, DOI 10.1016/j.diff.2009.11.004; Topisirovic I, 2005, MOL CELL BIOL, V25, P1100, DOI 10.1128/MCB.25.3.1100-1112.2005; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Wang M, 2011, CELL MOL NEUROBIOL, V31, P875, DOI 10.1007/s10571-011-9685-2; Wellik DM, 2011, PEDIATR NEPHROL, V26, P1559, DOI 10.1007/s00467-011-1902-1; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Williams TM, 2005, DEV BIOL, V279, P462, DOI 10.1016/j.ydbio.2004.12.015; Yang X, 2008, DEV BIOL, V314, P171, DOI 10.1016/j.ydbio.2007.11.032; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zheng G, 2007, BIOCHEM BIOPH RES CO, V364, P344, DOI 10.1016/j.bbrc.2007.10.003; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	76	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80387	10.1371/journal.pone.0080387	http://dx.doi.org/10.1371/journal.pone.0080387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244684	Green Published, gold, Green Submitted			2022-12-25	WOS:000327162900079
J	Dile, YT; Berndtsson, R; Setegn, SG				Dile, Yihun Taddele; Berndtsson, Ronny; Setegn, Shimelis G.			Hydrological Response to Climate Change for Gilgel Abay River, in the Lake Tana Basin - Upper Blue Nile Basin of Ethiopia	PLOS ONE			English	Article							WATER-RESOURCES; CHANGE IMPACTS; GLOBAL CHANGE; UNCERTAINTY; CATCHMENT; AFRICA; 20TH-CENTURY; CALIFORNIA; EMISSIONS; SCALE	Climate change is likely to have severe effects on water availability in Ethiopia. The aim of the present study was to assess the impact of climate change on the Gilgel Abay River, Upper Blue Nile Basin. The Statistical Downscaling Tool (SDSM) was used to downscale the HadCM3 (Hadley centre Climate Model 3) Global Circulation Model (GCM) scenario data into finer scale resolution. The Soil and Water Assessment Tool (SWAT) was set up, calibrated, and validated. SDSM downscaled climate outputs were used as an input to the SWAT model. The climate projection analysis was done by dividing the period 2010-2100 into three time windows with each 30 years of data. The period 1990-2001 was taken as the baseline period against which comparison was made. Results showed that annual mean precipitation may decrease in the first 30-year period but increase in the following two 30-year periods. The decrease in mean monthly precipitation may be as much as about -30% during 2010-2040 but the increase may be more than +30% in 2070-2100. The impact of climate change may cause a decrease in mean monthly flow volume between -40% to -50% during 2010-2040 but may increase by more than the double during 2070-2100. Climate change appears to have negligible effect on low flow conditions of the river. Seasonal mean flow volume, however, may increase by more than the double and +30% to +40% for the Belg (small rainy season) and Kiremit (main rainy season) periods, respectively. Overall, it appears that climate change will result in an annual increase in flow volume for the Gilgel Abay River. The increase in flow is likely to have considerable importance for local small scale irrigation activities. Moreover, it will help harnessing a significant amount of water for ongoing dam projects in the Gilgel Abay River Basin.	[Dile, Yihun Taddele] Stockholm Environm Inst, Stockholm, Sweden; [Dile, Yihun Taddele] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Berndtsson, Ronny] Lund Univ, Ctr Middle Eastern Studies, Lund, Sweden; [Berndtsson, Ronny] Lund Univ, Dept Water Resources Engn, Lund, Sweden; [Setegn, Shimelis G.] Florida Int Univ, Dept Earth & Environm, Miami, FL 33199 USA	Stockholm Environment Institute; Stockholm University; Lund University; Lund University; State University System of Florida; Florida International University	Dile, YT (corresponding author), Stockholm Environm Inst, Stockholm, Sweden.	yihun.dile@sei-international.org	Berndtsson, Ronny/C-7449-2015	Berndtsson, Ronny/0000-0003-1473-0138; Setegn, Shimelis/0000-0002-7603-9505	Swedish Institute (SI); MECW project at Center for Middle Eastern Studies, Lund University; Swedish Council for the Environment, Agricultural Sciences and Spatial Planning (Formas)	Swedish Institute (SI); MECW project at Center for Middle Eastern Studies, Lund University; Swedish Council for the Environment, Agricultural Sciences and Spatial Planning (Formas)	The authors are thankful for the Swedish Institute (SI) and the MECW project at Center for Middle Eastern Studies, Lund University, which provided financial support for the first and the second author, respectively. The first author was sponsored by Swedish Council for the Environment, Agricultural Sciences and Spatial Planning (Formas) while writing this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo KS, 2009, HYDROL PROCESS, V23, P3661, DOI 10.1002/hyp.7363; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Ashton PJ, 2002, AMBIO, V31, P236, DOI 10.1639/0044-7447(2002)031[0236:ACOASW]2.0.CO;2; Bader D.C., 2008, CLIMATE MODELS ASSES; Bank World, 2006, COUNTR WAT RES ASS S; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Betrie GD, 2011, HYDROL EARTH SYST SC, V15, P807, DOI 10.5194/hess-15-807-2011; Beyene T, 2010, CLIMATIC CHANGE, V100, P433, DOI 10.1007/s10584-009-9693-0; Canada E, 2009, HADCM3 PREDICTORS A2; Carter T. R., 1999, GUIDELINES USE SCENA; Central Statistical Agency, 2007, CENTRAL STAT AGENCY; Conway D, 1996, INT J WATER RESOUR D, V12, P261, DOI [10.1080/07900629650169, DOI 10.1080/07900629650169]; Conway D, 2011, GLOBAL ENVIRON CHANG, V21, P227, DOI 10.1016/j.gloenvcha.2010.07.013; Cook KH, 2006, J CLIMATE, V19, P3681, DOI 10.1175/JCLI3814.1; Deressa TT, 2009, GLOBAL ENVIRON CHANG, V19, P248, DOI 10.1016/j.gloenvcha.2009.01.002; Easton ZM, 2010, HYDROL EARTH SYST SC, V14, P1827, DOI 10.5194/hess-14-1827-2010; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Giannini A, 2008, CLIMATIC CHANGE, V90, P359, DOI [10.1007/s10584-008-9396-y, 10.1007/s10584-008-9396-v]; Gibson CC, 2000, ECOL ECON, V32, P217, DOI 10.1016/S0921-8009(99)00092-0; GLEICK P H, 1991, Environmental Professional, V13, P66; Hailemarian K, 1999, CLIM RES, V12, P91, DOI 10.3354/cr012091; Hawkins E, 2011, CLIM DYNAM, V37, P407, DOI 10.1007/s00382-010-0810-6; Held IM, 2006, P NATL ACAD SCI USA, V103, P1152, DOI 10.1073/pnas.0510844103; Hoerling M, 2006, J CLIMATE, V19, P3989, DOI 10.1175/JCLI3842.1; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; IFAD, 2009, FED DEM REP ETH COUN; Kim U, 2008, J AM WATER RESOUR AS, V44, P1231, DOI 10.1111/j.1752-1688.2008.00220.x; Kim U, 2009, J AM WATER RESOUR AS, V45, P1361, DOI 10.1111/j.1752-1688.2009.00369.x; LEAVESLEY GH, 1994, CLIMATIC CHANGE, V28, P159, DOI 10.1007/BF01094105; Legesse D, 2003, J HYDROL, V275, P67, DOI 10.1016/S0022-1694(03)00019-2; Lines GS, 2006, BUILDING CLIMATE CHA; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; Maurer EP, 2007, CLIMATIC CHANGE, V82, P309, DOI 10.1007/s10584-006-9180-9; Maurer EP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021462; Mearns LO, 2003, GUIDELINE USE CLIMAT, P38; Mohamed YA, 2005, HYDROL EARTH SYST SC, V9, P263, DOI 10.5194/hess-9-263-2005; MoWR, 1998, BAY RIV BAS INT DEV, P140; MoWR, 2009, SPAT HYDR DAT; Muller C, 2011, P NATL ACAD SCI USA, V108, P4313, DOI 10.1073/pnas.1015078108; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; Neitsch S.L., 2005, SOIL WATER ASSESSMEN; NMSA, 2009, METR DAT; NRCS, 2004, HYDR NAT ENG HDB 630, P79; Parry M. L., 2007, CONTRIBUTION WORKING, P976; Refsgaard JC, 1997, J HYDROL, V198, P69, DOI 10.1016/S0022-1694(96)03329-X; Santhi C, 2001, J AM WATER RESOUR AS, V37, P1169, DOI 10.1111/j.1752-1688.2001.tb03630.x; Setegn SG, 2010, HYDROL PROCESS, V24, P357, DOI 10.1002/hyp.7457; Setegn SG, 2009, HYDROL PROCESS, V23, P3738, DOI 10.1002/hyp.7476; Setegne SG, 2011, WATER RESOUR RES, V47, P13; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SRTM, 2009, SRTM DAT SEL OPT; Tarekegne D, 2006, ASSESSING IMPACT CLI; Taye MT, 2011, HYDROL EARTH SYST SC, V15, P209, DOI 10.5194/hess-15-209-2011; van Griensven A, 2006, J HYDROL, V324, P10, DOI 10.1016/j.jhydrol.2005.09.008; van Lieshout M, 2004, GLOBAL ENVIRON CHANG, V14, P87, DOI 10.1016/j.gloenvcha.2003.10.009; Vorosmarty CJ, 2005, AMBIO, V34, P230, DOI 10.1639/0044-7447(2005)034[0230:GIOEWS]2.0.CO;2; Wilbanks TJ, 1999, CLIMATIC CHANGE, V43, P601, DOI 10.1023/A:1005418924748; Wilby RL, 1999, J HYDROL, V225, P67, DOI 10.1016/S0022-1694(99)00136-5; Wilby RL, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004065; Wilby RL, 2007, USER MANUAL LEICS; Winchell M, 2009, ARCSWAT 2 3 4; Xu CY, 1999, WATER RESOUR MANAG, V13, P369, DOI 10.1023/A:1008190900459	63	95	95	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79296	10.1371/journal.pone.0079296	http://dx.doi.org/10.1371/journal.pone.0079296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24250755	Green Submitted, gold, Green Published			2022-12-25	WOS:000326152300091
J	Dharmarajan, K; Strait, KM; Lagu, T; Lindenauer, PK; Tinetti, ME; Lynn, J; Li, SX; Krumholz, HM				Dharmarajan, Kumar; Strait, Kelly M.; Lagu, Tara; Lindenauer, Peter K.; Tinetti, Mary E.; Lynn, Joanne; Li, Shu-Xia; Krumholz, Harlan M.			Acute Decompensated Heart Failure Is Routinely Treated as a Cardiopulmonary Syndrome	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COMMUNITY-ACQUIRED PNEUMONIA; ACUTE RESPIRATORY-FAILURE; CLINICAL CHARACTERISTICS; ACUTE EXACERBATIONS; OLDER PATIENTS; TASK-FORCE; DIAGNOSIS; RISK; ASSOCIATION	Background: Heart failure as recognized and treated in typical practice may represent a complex condition that defies discrete categorizations. To illuminate this complexity, we examined treatment strategies for patients hospitalized and treated for decompensated heart failure. We focused on the receipt of medications appropriate for other acute conditions associated with shortness of breath including acute asthma, pneumonia, and exacerbated chronic obstructive pulmonary disease. Methods and Results: Using Premier Perspective (R), we studied adults hospitalized with a principal discharge diagnosis of heart failure and evidence of acute heart failure treatment from 2009-2010 at 370 US hospitals. We determined treatment with acute respiratory therapies during the initial 2 days of hospitalization and daily during hospital days 3-5. We also calculated adjusted odds of in-hospital death, admission to the intensive care unit, and late intubation (intubation after hospital day 2). Among 164,494 heart failure hospitalizations, 53% received acute respiratory therapies during the first 2 hospital days: 37% received short-acting inhaled bronchodilators, 33% received antibiotics, and 10% received high-dose corticosteroids. Of these 87,319 hospitalizations, over 60% continued receiving respiratory therapies after hospital day 2. Respiratory treatment was more frequent among the 60,690 hospitalizations with chronic lung disease. Treatment with acute respiratory therapy during the first 2 hospital days was associated with higher adjusted odds of all adverse outcomes. Conclusions: Acute respiratory therapy is administered to more than half of patients hospitalized with and treated for decompensated heart failure. Heart failure is therefore regularly treated as a broader cardiopulmonary syndrome rather than as a singular cardiac condition.	[Dharmarajan, Kumar] Columbia Univ, Div Cardiol, Med Ctr, New York, NY 10027 USA; [Dharmarajan, Kumar; Strait, Kelly M.; Li, Shu-Xia; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Lagu, Tara; Lindenauer, Peter K.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA USA; [Lagu, Tara; Lindenauer, Peter K.] Baystate Med Ctr, Div Gen Internal Med & Geriatr, Springfield, MA USA; [Lagu, Tara; Lindenauer, Peter K.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Tinetti, Mary E.] Yale Univ, Sch Med, Dept Med, Program Aging, New Haven, CT 06510 USA; [Tinetti, Mary E.] Yale Univ, Sch Publ Hlth, Sect Chron Dis Epidemiol, New Haven, CT USA; [Lynn, Joanne] Altarum Inst, Washington, DC USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA	Columbia University; Yale University; Baystate Medical Center; Baystate Medical Center; Tufts University; Yale University; Yale University; Yale University; Yale University; Yale University	Dharmarajan, K (corresponding author), Columbia Univ, Div Cardiol, Med Ctr, New York, NY 10027 USA.	kumar.dharmarajan@yale.edu	, Harlan/AAI-2875-2020; Lagu, Tara/GPT-5173-2022		Patrick and Catherine Weldon Donaghue Medical Research Foundation in West Hartford, Connecticut [DF10-301]; National Center for Advancing Translational Sciences in Bethesda, Maryland [UL1 RR024139-06S1]; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute in Bethesda, Maryland [U01 HL105270-03]; National Heart, Lung, and Blood Institute [T32 HL007854]; Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A. Hartford Foundation; American Federation for Aging Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270, T32HL007854] Funding Source: NIH RePORTER	Patrick and Catherine Weldon Donaghue Medical Research Foundation in West Hartford, Connecticut; National Center for Advancing Translational Sciences in Bethesda, Maryland; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute in Bethesda, Maryland; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A. Hartford Foundation; American Federation for Aging Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by grant DF10-301 from the Patrick and Catherine Weldon Donaghue Medical Research Foundation in West Hartford, Connecticut; grant UL1 RR024139-06S1 from the National Center for Advancing Translational Sciences in Bethesda, Maryland; and grant U01 HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute in Bethesda, Maryland. Dr. Dharmarajan is supported by grant T32 HL007854 from the National Heart, Lung, and Blood Institute; he is also supported as a Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A. Hartford Foundation and the American Federation for Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2010, HURSTS HEART, P748; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Au DH, 2000, AM J RESP CRIT CARE, V161, P827, DOI 10.1164/ajrccm.161.3.9904006; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Centers for Medicare and Medicaid Services, 2007, US DEP HLTH HUM SERV; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Christiansen CF, 2009, ARCH INTERN MED, V169, P1677, DOI 10.1001/archinternmed.2009.297; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Delerme S, 2008, AGE AGEING, V37, P251, DOI 10.1093/ageing/afn060; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Felker GM, 2001, AM HEART J, V142, P393, DOI 10.1067/mhj.2001.117606; Fonarow GC, 2007, AM HEART J, V153, P1021, DOI [10.1016/j.ahj.2007.03.012, 10.1016/j.ahj.2007.07.043]; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Havranek EP, 2002, AM HEART J, V143, P412, DOI 10.1067/mhj.2002.120773; Hawkins NM, 2011, J AM COLL CARDIOL, V57, P2127, DOI 10.1016/j.jacc.2011.02.020; Hawkins NM, 2009, EUR J HEART FAIL, V11, P130, DOI 10.1093/eurjhf/hfn013; Hines LE, 2011, AM J GERIATR PHARMAC, V9, P364, DOI 10.1016/j.amjopharm.2011.10.004; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Lichtman JH, 2006, AM J MED, V119, P843, DOI 10.1016/j.amjmed.2006.03.040; Lindenauer PK, 2010, JAMA-J AM MED ASSOC, V303, P2359, DOI 10.1001/jama.2010.796; Liu C, 2007, CAN J CARDIOL, V23, P865, DOI 10.1016/S0828-282X(07)70840-1; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mann LD, 2011, HARRISONS PRINCIPLES, P1901; McMurray JJ, 2012, GOLDMANS CECIL MED, P303; Mentz RJ, 2012, J CARD FAIL, V18, P515, DOI 10.1016/j.cardfail.2012.04.010; Mentz RJ, 2012, EUR J HEART FAIL, V14, P395, DOI 10.1093/eurjhf/hfs009; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; National Quality Forum, 2008, NAT VOL CONS STAND H; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Ray P, 2006, CRIT CARE, V10, DOI 10.1186/cc4926; Rosamond WD, 2012, CIRC-HEART FAIL, V5, P152, DOI 10.1161/CIRCHEARTFAILURE.111.963199; Rothberg MB, 2010, JAMA-J AM MED ASSOC, V303, P2035, DOI 10.1001/jama.2010.672; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; SLUTSKY R, 1981, AM HEART J, V101, P556, DOI 10.1016/0002-8703(81)90221-0; Teerlink JR, 2008, BRAUNWALDS HEART DIS, P583; UREN NG, 1993, EUR HEART J, V14, P744, DOI 10.1093/eurheartj/14.6.744; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Witte KKA, 2004, J CARD FAIL, V10, P149, DOI 10.1016/j.cardfail.2003.08.007; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	51	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78222	10.1371/journal.pone.0078222	http://dx.doi.org/10.1371/journal.pone.0078222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24250751	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600084
J	Cunningham, SJ; Kruger, AC; Nxumalo, MP; Hockey, PAR				Cunningham, Susan J.; Kruger, Andries C.; Nxumalo, Mthobisi P.; Hockey, Philip A. R.			Identifying Biologically Meaningful Hot-Weather Events Using Threshold Temperatures That Affect Life-History	PLOS ONE			English	Article							CLIMATE-CHANGE; MORTALITY; EXTREMES; FITNESS; RANGE; BIRDS	Increases in the frequency, duration and intensity of heat waves are frequently evoked in climate change predictions. However, there is no universal definition of a heat wave. Recent, intense hot weather events have caused mass mortalities of birds, bats and even humans, making the definition and prediction of heat wave events that have the potential to impact populations of different species an urgent priority. One possible technique for defining biologically meaningful heat waves is to use threshold temperatures (T-thresh) above which known fitness costs are incurred by species of interest. We set out to test the utility of this technique using T-thresh values that, when exceeded, affect aspects of the fitness of two focal southern African bird species: the southern pied babbler Turdiodes bicolor (T-thresh = 35.5 degrees C) and the common fiscal Lanius collaris (T-thresh = 33 degrees C). We used these T-thresh values to analyse trends in the frequency, duration and intensity of heat waves of magnitude relevant to the focal species, as well as the annual number of hot days (maximum air temperature > T-thresh), in north-western South Africa between 1961 and 2010. Using this technique, we were able to show that, while all heat wave indices increased during the study period, most rapid increases for both species were in the annual number of hot days and in the maximum intensity (and therefore intensity variance) of biologically meaningful heat waves. Importantly, we also showed that warming trends were not uniform across the study area and that geographical patterns in warming allowed both areas of high risk and potential climate refugia to be identified. We discuss the implications of the trends we found for our focal species, and the utility of the T-thresh technique as a conservation tool.	[Cunningham, Susan J.; Hockey, Philip A. R.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Kruger, Andries C.; Nxumalo, Mthobisi P.] South African Weather Serv, Climate Serv, Pretoria, South Africa	National Research Foundation - South Africa; University of Cape Town; South African Weather Service (SAWS)	Cunningham, SJ (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa.	susie.j.c@gmail.com	Iwaniuk, Andrew/H-7255-2019; Cunningham, Susan/AAR-3915-2020; Castro, Isabel C/B-4447-2011; Castro, Isabel/L-7653-2019	Iwaniuk, Andrew/0000-0001-9273-3655; Cunningham, Susan/0000-0001-9934-2585; Castro, Isabel C/0000-0002-3335-2024; Castro, Isabel/0000-0002-3335-2024; Parsons, Stuart/0000-0003-1025-5616	DST/NRF Centre of Excellence grant	DST/NRF Centre of Excellence grant(Department of Science & Technology (India))	The work was supported by DST/NRF Centre of Excellence grant to PARH and SJC. www.fitzpatrick.uct.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoon I., 2011, S AFRICAN RISK VULNE; Angert AL, 2011, INTEGR COMP BIOL, V51, P733, DOI 10.1093/icb/icr048; Angilletta MJ, 2011, INTEGR COMP BIOL, V51, P653, DOI 10.1093/icb/icr091; Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Calder W.A., 1974, AVIAN BIOL, V4, P259; Cunningham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074613; Dean W. R. J., 2005, ROBERTS BIRDS SO AFR, P811; Donald PF, 2012, J ORNITHOL, V153, P1031, DOI 10.1007/s10336-012-0832-4; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; FINLAYSON H. H., 1932, SO AUSTRALIAN ORNITHOL, V11, P158; Harrison J. A., 1997, ATLAS SO AFRICAN BIR, VII; Herremans M, 1997, ATLAS SO AFRICAN BIR, V2, P128; Immelmann K., 1973, P121; Jiguet F, 2010, GLOBAL CHANGE BIOL, V16, P497, DOI 10.1111/j.1365-2486.2009.01963.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Klein Tank A.M.G., 2009, 72 WCDMP, P49; Kruger AC, 2013, INT J CLIMATOL, V33, P661, DOI 10.1002/joc.3455; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; McKechnie AE, 2012, EMU, V112, pI, DOI 10.1071/MUv112n2_ED; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Moise AF, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009250; Moses MR, 2012, OECOLOGIA, V168, P257, DOI 10.1007/s00442-011-2073-2; New M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006289; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Towie N, 2009, 1000 BIRDS DIE SWELT; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Whitman S, 1997, AM J PUBLIC HEALTH, V87, P1515, DOI 10.2105/AJPH.87.9.1515; Wolf BO, 1996, J EXP BIOL, V199, P451; [No title captured]	35	73	75	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82492	10.1371/journal.pone.0082492	http://dx.doi.org/10.1371/journal.pone.0082492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24244601	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300156
J	Muller, L; Goncalves, GL; Cordeiro-Estrela, P; Marinho, JR; Althoff, SL; Testoni, AF; Gonzalez, EM; Freitas, TRO				Mueller, Livia; Goncalves, Gislene L.; Cordeiro-Estrela, Pedro; Marinho, Jorge R.; Althoff, Sergio L.; Testoni, Andre F.; Gonzalez, Enrique M.; Freitas, Thales R. O.			DNA Barcoding of Sigmodontine Rodents: Identifying Wildlife Reservoirs of Zoonoses	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; TRYPANOSOMA-CRUZI; SPECIES DELIMITATION; DELTAMYS-KEMPI; HANTAVIRUS; GENUS; TRANSMISSION; CRICETIDAE; MAMMALS; AREAS	Species identification through DNA barcoding is a tool to be added to taxonomic procedures, once it has been validated. Applying barcoding techniques in public health would aid in the identification and correct delimitation of the distribution of rodents from the subfamily Sigmodontinae. These rodents are reservoirs of etiological agents of zoonoses including arenaviruses, hantaviruses, Chagas disease and leishmaniasis. In this study we compared distance-based and probabilistic phylogenetic inference methods to evaluate the performance of cytochrome c oxidase subunit I (COI) in sigmodontine identification. A total of 130 sequences from 21 field-trapped species (13 genera), mainly from southern Brazil, were generated and analyzed, together with 58 GenBank sequences (24 species; 10 genera). Preliminary analysis revealed a 9.5% rate of misidentifications in the field, mainly of juveniles, which were reclassified after examination of external morphological characters and chromosome numbers. Distance and model-based methods of tree reconstruction retrieved similar topologies and monophyly for most species. Kernel density estimation of the distance distribution showed a clear barcoding gap with overlapping of intraspecific and interspecific densities < 1% and 21 species with mean intraspecific distance < 2%. Five species that are reservoirs of hantaviruses could be identified through DNA barcodes. Additionally, we provide information for the description of a putative new species, as well as the first COI sequence of the recently described genus Drymoreomys. The data also indicated an expansion of the distribution of Calomys tener. We emphasize that DNA barcoding should be used in combination with other taxonomic and systematic procedures in an integrative framework and based on properly identified museum collections, to improve identification procedures, especially in epidemiological surveillance and ecological assessments.	[Mueller, Livia; Goncalves, Gislene L.; Cordeiro-Estrela, Pedro; Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Dept Genet, Lab Citogenet & Evolucao, Porto Alegre, RS, Brazil; [Mueller, Livia; Goncalves, Gislene L.; Cordeiro-Estrela, Pedro; Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Cordeiro-Estrela, Pedro] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, Brazil; [Cordeiro-Estrela, Pedro] Univ Fed Paraiba, Dept Sistemat & Ecol, Lab Mamiferos, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Marinho, Jorge R.] Univ Reg Integrada Alto Uruguai & Missoes, Erechim, RS, Brazil; [Althoff, Sergio L.; Testoni, Andre F.] Fundacao Univ Reg Blumenau, Blumenau, SC, Brazil; [Gonzalez, Enrique M.] Museo Nacl Hist Nat, Montevideo, Uruguay	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz; Universidade Federal da Paraiba; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Regional de Blumenau (FURB)	Cordeiro-Estrela, P (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Lab Citogenet & Evolucao, Porto Alegre, RS, Brazil.	pedroestrela@yahoo.com	Goncalves, Gislene Lopes/D-3567-2013; Köstler, Herbert/B-2089-2010; Cordeiro-Estrela, Pedro/A-2913-2015; Freitas, Thales Renato Ochotorena de/G-1160-2012; Marinho, Jorge/AAC-1097-2019; Althoff, Sérgio Luiz/AAE-5820-2020; Nichols, Thomas E./N-9902-2017	Goncalves, Gislene Lopes/0000-0002-1459-4888; Köstler, Herbert/0000-0001-6207-9226; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Nichols, Thomas E./0000-0002-4516-5103; Althoff, Sergio Luiz/0000-0002-0877-5156; Testoni, Andre Filipe/0000-0002-4680-0092; Cordeiro-Estrela, Pedro/0000-0003-3383-571X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES-CNPq-PROTAX; PDJ CNPq FIOCRUZ [500091/2010-2]; CNPq [141604/2007-7]; BrBOL: Brazilian Barcoding of Life under project Tetrapoda	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-CNPq-PROTAX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PDJ CNPq FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BrBOL: Brazilian Barcoding of Life under project Tetrapoda	This research was financially supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). PCE was funded by CAPES-CNPq-PROTAX and by PDJ CNPq FIOCRUZ 500091/2010-2. G. L. Goncalves received CNPq fellowship (141604/2007-7). This study was supported by BrBOL: Brazilian Barcoding of Life under project Tetrapoda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrellos R, 2012, ZOOTAXA, P1; Almeida FC, 2007, MOL PHYLOGENET EVOL, V42, P449, DOI 10.1016/j.ympev.2006.07.005; Badzinski C, 2012, CHECK LIST, V8, P264, DOI DOI 10.15560/8.2.264; Bonvicino CR, 2010, ZOOTAXA, P19, DOI 10.11646/zootaxa.2336.1.2; Bonvicino CR, 2008, GUIA ROEDORES BRASIL; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Castro E.C., 1991, Cytobios, V68, P153; Chu YK, 2006, AM J TROP MED HYG, V75, P1127, DOI 10.4269/ajtmh.2006.75.1127; Chu YK, 2009, EMERG INFECT DIS, V15, P1977, DOI 10.3201/eid1512.090338; D'Elia G, 2003, CLADISTICS, V19, P307, DOI 10.1016/S0748-3007(03)00071-9; de Oliveira JA, 2002, ACTA THERIOL, V47, P307, DOI 10.1007/BF03194149; de Oliveira RC, 2012, MEM I OSWALDO CRUZ, V107, P424, DOI 10.1590/S0074-02762012000300020; DEFRONZA TMLG, 1981, CARYOLOGIA, V34, P457, DOI 10.1080/00087114.1981.10796914; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Donalisio MR, 2011, ACTA TROP, V119, P125, DOI 10.1016/j.actatropica.2011.04.019; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; Firth C, 2012, J VIROL, V86, P13756, DOI 10.1128/JVI.02341-12; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goncalves Pablo Rodrigues, 2007, MISCELLANEOUS PUBLICATIONS MUSEUM OF ZOOLOGY UNIVERSITY OF MICHIGAN, P1; Goncalves PR, 2005, MAMM BIOL, V70, P46, DOI 10.1078/1616-5047-00175; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haag T, 2007, J MAMMAL, V88, P769, DOI 10.1644/05-MAMM-A-319R1.1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herrera HM, 2011, T ROY SOC TROP MED H, V105, P380, DOI 10.1016/j.trstmh.2011.04.008; Ittig REG, 2004, HEREDITY, V93, P535, DOI 10.1038/sj.hdy.6800546; Jayat J. Pablo, 2010, Zootaxa, V2409, P1; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; KIMURA M, 1980, P NATL ACAD SCI-BIOL, V77, P522, DOI 10.1073/pnas.77.1.522; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nicolas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036586; Nylander J.A.A., 2004, MRAIC PL; Oliveira RC, 2011, VECTOR-BORNE ZOONOT, V3, P301; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Percequillo AR, 2011, ZOOL J LINN SOC-LOND, V161, P357, DOI 10.1111/j.1096-3642.2010.00643.x; Percequillo AR, 2008, AM MUS NOVIT, P1, DOI 10.1206/495.1; Percequillo AR, 2005, J MAMMAL, V86, P873, DOI 10.1644/1545-1542(2005)86[873:ANSONI]2.0.CO;2; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porcasi Ximena, 2005, Mastozool. neotrop., V12, P199; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANG ENV STAT COMP; Raboni SM, 2012, AM J TROP MED HYG, V87, P371, DOI 10.4269/ajtmh.2012.11-0762; Raboni SM, 2009, J GEN VIROL, V90, P2166, DOI 10.1099/vir.0.011585-0; Rambaut A., 2006, FIGTREE TREE FIGURE; Rivera PC, 2007, ZOOL SCR, V36, P231, DOI 10.1111/j.1463-6409.2007.00273.x; Rocha FL, 2013, PARASITOLOGY, V140, P160, DOI 10.1017/S0031182012001539; Rocha Rita G., 2011, Zootaxa, V2789, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Salazar-Bravo J, 2002, INFECT GENET EVOL, V1, P191, DOI 10.1016/S1567-1348(02)00026-6; Sambrook J., 1989, MOL CLONING LAB MANU; SBALQUEIRO IJ, 1984, CYTOGENET CELL GENET, V38, P50, DOI 10.1159/000132029; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith Margaret F., 1999, Journal of Mammalian Evolution, V6, P89, DOI 10.1023/A:1020668004578; Stahls G, 2008, MOL PHYLOGENET EVOL, V46, P82, DOI 10.1016/j.ympev.2007.09.009; Steiner-Souza F, 2008, ZOOTAXA, P28, DOI 10.11646/zootaxa.1824.1.3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; da Rosa EST, 2012, EMERG INFECT DIS, V18, P982, DOI 10.3201/eid1806.110948; Ventura K, 2011, CYTOGENET GENOME RES, V135, P126, DOI 10.1159/000331584; Weksler M, 2003, MOL PHYLOGENET EVOL, V29, P331, DOI 10.1016/S1055-7903(03)00132-5; Weksler M., 2005, ARQUIVOS MUSEU NACL, V63, P113; Weksler M, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3537[1:TNGOOR]2.0.CO;2; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619	73	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80282	10.1371/journal.pone.0080282	http://dx.doi.org/10.1371/journal.pone.0080282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24040262	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600200
J	Xu, JY; Xue, CC; Xue, D; Zhao, JM; Gai, JY; Guo, N; Xing, H				Xu, Jinyan; Xue, Chenchen; Xue, Dong; Zhao, Jinming; Gai, Junyi; Guo, Na; Xing, Han			Overexpression of GmHsp90s, a Heat Shock Protein 90 (Hsp90) Gene Family Cloning from Soybean, Decrease Damage of Abiotic Stresses in Arabidopsis thaliana	PLOS ONE			English	Article							PROLINE ACCUMULATION; MOLECULAR CHAPERONES; LIPID-PEROXIDATION; EXPRESSION; SEQUENCE; PLANTS; HOMEOSTASIS; PROTECTION; GENOMICS; ENCODES	Hsp90 is one of the most conserved and abundant molecular chaperones and is an essential component of the protective stress response; however, its roles in abiotic stress responses in soybean (Glycine max) remain obscure. Here, 12 GmHsp90 genes from soybean were identified and found to be expressed and to function differentially under abiotic stresses. The 12 GmHsp90 genes were isolated and named GmHsp90A1-GmHsp90A6, GmHsp90B1, GmHsp90B2, GmHsp90C1.1, GmHsp90C1.2, GmHsp90C2.1 and GmHsp90C2.2 based on their characteristics and high homology to other Hsp90s according to a new nomenclature system. Quantitative real-time PCR expression data revealed that all the genes exhibited higher transcript levels in leaves and could be strongly induced under heat, osmotic and salt stress but not cold stress. Overexpression of five typical genes (GmHsp90A2, GmHsp90A4, GmHsp90B1, GmHsp90C1.1 and GmHsp90C2.1) in Arabidopsis thaliana provided useful evidences that GmHsp90 genes can decrease damage of abiotic stresses. In addition, an abnormal accumulation of proline was detected in some transgenic Arabidopsis plants suggested overexpressing GmHsp90s may affect the synthesis and response system of proline. Our work represents a systematic determination of soybean genes encoding Hsp90s, and provides useful evidence that GmHsp90 genes function differently in response to abiotic stresses and may affect the synthesis and response system of proline.	[Xu, Jinyan; Xue, Chenchen; Xue, Dong; Zhao, Jinming; Gai, Junyi; Guo, Na; Xing, Han] Nanjing Agr Univ, Minist Agr,Natl Ctr Soybean Improvement, Key Lab Biol & Genet & Breeding Soybean, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Guo, N (corresponding author), Nanjing Agr Univ, Minist Agr,Natl Ctr Soybean Improvement, Key Lab Biol & Genet & Breeding Soybean, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	guona@njau.edu.cn; hanx@njau.edu.cn		Xue, Chenchen/0000-0002-9703-2986	National Basic Research Program of China (973 program) [2009CB118400]; Modern Agro-industry Technology Research System of China [CARS-004-PS10]; National Core Soybean Genetic Engineering Project [2011ZX08004-002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 program)(National Basic Research Program of China); Modern Agro-industry Technology Research System of China; National Core Soybean Genetic Engineering Project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The work was supported by the National Basic Research Program of China (973 program: 2009CB118400), Modern Agro-industry Technology Research System of China (CARS-004-PS10), National Core Soybean Genetic Engineering Project (2011ZX08004-002) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIGUE R, 1994, EMBO J, V13, P6099, DOI 10.1002/j.1460-2075.1994.tb06956.x; Banilas G, 2012, AUST J GRAPE WINE R, V18, P29, DOI 10.1111/j.1755-0238.2011.00166.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Cao DS, 2003, PLANT J, V33, P107, DOI 10.1046/j.1365-313X.2003.016011.x; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FELSHEIM RF, 1992, PLANT PHYSIOL, V100, P1764, DOI 10.1104/pp.100.4.1764; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Fu DQ, 2009, MOL PLANT MICROBE IN, V22, P86, DOI 10.1094/MPMI-22-1-0086; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hossain M, 2003, CURR MICROBIOL, V46, P70, DOI 10.1007/s00284-002-3831-5; Hossain Z, 2012, J PROTEOME RES, V11, P37, DOI 10.1021/pr200863r; Kornbrot D, 2000, BRIT J MATH STAT PSY, V53, P335; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu DL, 2009, CURR MICROBIOL, V58, P129, DOI 10.1007/s00284-008-9288-4; Liu DL, 2006, PLANT PHYSIOL BIOCH, V44, P380, DOI 10.1016/j.plaphy.2006.06.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARRS KA, 1993, DEV GENET, V14, P27, DOI 10.1002/dvg.1020140105; Michaels G S, 1998, Pac Symp Biocomput, P42; Milioni D, 1997, PLANT MOL BIOL, V35, P955, DOI 10.1023/A:1005874521528; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neckers L, 2007, CHEM BIOL, V14, P1204, DOI 10.1016/j.chembiol.2007.11.002; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; NORUSIS MJ, 1990, SPSS ADV STAT USERS; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Parvanova D, 2004, PLANT PHYSIOL BIOCH, V42, P57, DOI 10.1016/j.plaphy.2003.10.007; Picard D, 1990, REDUCED LEVELS HSP90; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prassinos C, 2008, PLANT MOL BIOL, V67, P323, DOI 10.1007/s11103-008-9322-8; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Priti K, 1995, PLANT PHYSIOL, V107, P9; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Reddy RK, 1998, PLANT SCI, V131, P131, DOI 10.1016/S0168-9452(97)00254-9; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHMEDES A, 1989, J AM OIL CHEM SOC, V66, P813, DOI 10.1007/BF02653674; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz G, 1996, PLANT MOL BIOL, V30, P479, DOI 10.1007/BF00049326; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Song HM, 2012, BIOL PLANTARUM, V56, P197, DOI 10.1007/s10535-012-0042-1; Song HM, 2010, J PLANT PHYSIOL, V167, P1172, DOI 10.1016/j.jplph.2010.03.016; Song HM, 2009, PLANTA, V229, P955, DOI 10.1007/s00425-008-0886-y; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; WALTHERLARSEN H, 1993, PLANT MOL BIOL, V21, P1097, DOI 10.1007/BF00023606; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wilkins MR, 1999, METH MOL B, V112, P531; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Ye SF, 2012, CHINESE SCI BULL, V57, P336, DOI 10.1007/s11434-011-4863-7; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	65	52	66	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69810	10.1371/journal.pone.0069810	http://dx.doi.org/10.1371/journal.pone.0069810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936107	gold, Green Published, Green Submitted			2022-12-25	WOS:000322433300068
J	Cunningham, SJ; Corfield, JR; Iwaniuk, AN; Castro, I; Alley, MR; Birkhead, TR; Parsons, S				Cunningham, Susan J.; Corfield, Jeremy R.; Iwaniuk, Andrew N.; Castro, Isabel; Alley, Maurice R.; Birkhead, Tim R.; Parsons, Stuart			The Anatomy of the bill Tip of Kiwi and Associated Somatosensory Regions of the Brain: Comparisons with Shorebirds	PLOS ONE			English	Article							ANAS-PLATYRHYNCHOS L; OYSTERCATCHERS HAEMATOPUS-OSTRALEGUS; NUCLEUS BASALIS PROSENCEPHALI; PIGEON COLUMBA-LIVIA; TRIGEMINAL SYSTEM; FORAGING BEHAVIOR; PREY-DETECTION; FRONTAL TELENCEPHALON; SENSORY PROJECTIONS; PRIMARY AFFERENTS	Three families of probe-foraging birds, Scolopacidae (sandpipers and snipes), Apterygidae (kiwi), and Threskiornithidae (ibises, including spoonbills) have independently evolved long, narrow bills containing clusters of vibration-sensitive mechanoreceptors (Herbst corpuscles) within pits in the bill-tip. These 'bill-tip organs' allow birds to detect buried or submerged prey via substrate-borne vibrations and/or interstitial pressure gradients. Shorebirds, kiwi and ibises are only distantly related, with the phylogenetic divide between kiwi and the other two taxa being particularly deep. We compared the bill-tip structure and associated somatosensory regions in the brains of kiwi and shorebirds to understand the degree of convergence of these systems between the two taxa. For comparison, we also included data from other taxa including waterfowl (Anatidae) and parrots (Psittaculidae and Cacatuidae), non-apterygid ratites, and other probe-foraging and non probe-foraging birds including non-scolopacid shorebirds (Charadriidae, Haematopodidae, Recurvirostridae and Sternidae). We show that the bill-tip organ structure was broadly similar between the Apterygidae and Scolopacidae, however some inter-specific variation was found in the number, shape and orientation of sensory pits between the two groups. Kiwi, scolopacid shorebirds, waterfowl and parrots all shared hypertrophy or near-hypertrophy of the principal sensory trigeminal nucleus. Hypertrophy of the nucleus basorostralis, however, occurred only in waterfowl, kiwi, three of the scolopacid species examined and a species of oystercatcher (Charadriiformes: Haematopodidae). Hypertrophy of the principal sensory trigeminal nucleus in kiwi, Scolopacidae, and other tactile specialists appears to have co-evolved alongside bill-tip specializations, whereas hypertrophy of nucleus basorostralis may be influenced to a greater extent by other sensory inputs. We suggest that similarities between kiwi and scolopacid bill-tip organs and associated somatosensory brain regions are likely a result of similar ecological selective pressures, with inter-specific variations reflecting finer-scale niche differentiation.	[Cunningham, Susan J.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Cunningham, Susan J.; Castro, Isabel] Massey Univ, Inst Nat Resources, Palmerston North, New Zealand; [Corfield, Jeremy R.; Iwaniuk, Andrew N.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Alley, Maurice R.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Birkhead, Tim R.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Corfield, Jeremy R.; Parsons, Stuart] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	National Research Foundation - South Africa; University of Cape Town; Massey University; University of Lethbridge; Massey University; University of Sheffield; University of Auckland	Corfield, JR (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	jr.corfield@gmail.com	Iwaniuk, Andrew/H-7255-2019; Cunningham, Susan/AAR-3915-2020; Castro, Isabel C/B-4447-2011; Castro, Isabel/L-7653-2019	Iwaniuk, Andrew/0000-0001-9273-3655; Cunningham, Susan/0000-0001-9934-2585; Castro, Isabel C/0000-0002-3335-2024; Castro, Isabel/0000-0002-3335-2024; Parsons, Stuart/0000-0003-1025-5616	NSERC Discovery Grant [372237]; Tertiary Education Commission New Zealand grant;  [380284-2009]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tertiary Education Commission New Zealand grant; 	Funding for this study was provided in part by an NSERC Discovery Grant (372237) and Accelerator Supplement (380284-2009) to ANI and in part through a Tertiary Education Commission New Zealand grant to SJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS JJA, 1984, NEUROSCIENCE, V13, P781, DOI 10.1016/0306-4522(84)90096-4; ARENDS JJA, 1986, BRAIN RES, V398, P375, DOI 10.1016/0006-8993(86)91499-X; Bancroft J.D., 1996, THEORY PRACTICE HIST, VVolume 6; BANG BG, 1968, AUK, V85, P55; Barbosa A, 1999, AUK, V116, P712; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; BERKHOUDT H, 1981, J COMP NEUROL, V196, P407, DOI 10.1002/cne.901960305; BERKHOUDT H, 1980, NETH J ZOOL, V30, P1; BOATES JS, 1992, CAN J ZOOL, V70, P2398, DOI 10.1139/z92-321; BOATES JS, 1989, CAN J ZOOL, V67, P2225, DOI 10.1139/z89-314; BOIRE D, 1989, COMP QUANTITATIVE EN; BOLZE G, 1968, Zoologischer Anzeiger, V181, P313; Corfield J, 2008, AUK, V125, P326, DOI 10.1525/auk.2008.06234; Corfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023771; Corfield JR, 2008, BRAIN BEHAV EVOLUT, V71, P87, DOI 10.1159/000111456; Corfield JR, 2012, BRAIN BEHAV EVOLUT, V80, P181, DOI 10.1159/000339828; Corfield JR, 2012, JARO-J ASSOC RES OTO, V13, P629, DOI 10.1007/s10162-012-0341-4; Craigie EH, 1940, J COMP NEUROL, V73, P179, DOI 10.1002/cne.900730202; Craigie EH, 1930, J COMP NEUROL, V49, P223, DOI 10.1002/cne.900490202; Cramp S., 1983, BIRDS W PALEARCTIC, V3, P444; Cunningham S, 2007, J ANAT, V211, P493, DOI 10.1111/j.1469-7580.2007.00786.x; Cunningham SJ, 2011, J MORPHOL, V272, P118, DOI 10.1002/jmor.10908; Cunningham SJ, 2010, J AVIAN BIOL, V41, P350, DOI 10.1111/j.1600-048X.2010.05138.x; Cunningham SJ, 2010, AUK, V127, P308, DOI 10.1525/auk.2009.09117; Cunningham SJ, 2009, ANIM BEHAV, V78, P899, DOI 10.1016/j.anbehav.2009.07.015; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; DELIUS JD, 1979, EXP NEUROL, V63, P594, DOI 10.1016/0014-4886(79)90174-2; Demery ZP, 2011, P ROY SOC B-BIOL SCI, V278, P3687, DOI 10.1098/rspb.2011.0374; DUBBELDAM JL, 1978, J COMP NEUROL, V180, P661, DOI 10.1002/cne.901800402; DUBBELDAM JL, 1980, J COMP NEUROL, V191, P557, DOI 10.1002/cne.901910404; DUBBELDAM JL, 1990, NETH J ZOOL, V40, P241; Dubbeldam JL, 1998, ARCH PHYSIOL BIOCHEM, V106, P338, DOI 10.1076/apab.106.5.338.4367; DUBBELDAM JL, 1981, J COMP NEUROL, V196, P391, DOI 10.1002/cne.901960304; Elner RW, 2005, MAR BIOL, V146, P1223, DOI 10.1007/s00227-004-1521-5; Eo SH, 2009, ZOOL SCR, V38, P465, DOI 10.1111/j.1463-6409.2008.00382.x; FUNKE K, 1989, EXP BRAIN RES, V76, P603, DOI 10.1007/BF00248917; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GERRITSEN AFC, 1986, NETH J ZOOL, V36, P530, DOI 10.1163/002829686X00216; Gill F, 2013, IOC WORLD BIRD LIST; Gooders J, 1982, COLLINS BRIT BIRDS; Gottschaldt K.-M., 1985, P375; GOTTSCHALDT KM, 1974, CELL TISSUE RES, V153, P477; Goujon D, 1869, J ANAT PHYSL, V6, P449; Gutierrez-Ibanez C, 2011, BRAIN BEHAV EVOLUT, V78, P286, DOI 10.1159/000330359; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HALL WS, 1993, BRAIN BEHAV EVOLUT, V41, P97, DOI 10.1159/000113827; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Heather B., 2005, FIELD GUIDE BIRDS NZ; IGGO A, 1974, P153; Iwaniuk AN, 2006, BEHAV BRAIN RES, V167, P305, DOI 10.1016/j.bbr.2005.09.015; Jerison HJ., 1973, EVOLUTION BRAIN INTE; KEPPIE DM, 1994, BIRDS N AM NUMBER 10; Kubke MF, 2004, BRAIN BEHAV EVOLUT, V63, P169, DOI 10.1159/000076242; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Maddison WP, 2011, MESQUITE MODULAR SYS; MAEKAWA M, 1987, HEARING RES, V27, P231, DOI 10.1016/0378-5955(87)90004-9; MARTIN GR, 1994, J COMP PHYSIOL A, V174, P787; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Martin GR, 2009, P ROY SOC B-BIOL SCI, V276, P437, DOI 10.1098/rspb.2008.1110; Midford P. E., 2010, PDAP PDTREE PACKAGE; MOURITSEN KN, 1994, J AVIAN BIOL, V25, P55, DOI 10.2307/3677294; Nebel S, 2005, ECOL RES, V20, P503, DOI 10.1007/s11284-005-0061-x; Nisbet I.C, 2002, COMMON TERN STERNA H; PETTIGREW JD, 1985, BRAIN BEHAV EVOLUT, V26, P185, DOI 10.1159/000118775; Piersma T, 1998, P ROY SOC B-BIOL SCI, V265, P1377, DOI 10.1098/rspb.1998.0445; Piersma T, 1996, HDB BIRDS WORLD, V3, P444; Piersma T, 2011, IBIS, V153, P659, DOI 10.1111/j.1474-919X.2011.01170.x; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; RASBAND WS, 1997, MAGEJ; SANTOS ESA, 2010, SO LAPWING VANELLUS; SCHALL U, 1986, CELL TISSUE RES, V245, P539; STINGELI.W, 1965, BIBL ANAT, P1; Swennen Cornelis, 2004, Ornithological Science, V3, P119, DOI 10.2326/osj.3.119; Thomas GH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-28; Tuckwell J, 1997, CAN J ZOOL, V75, P170, DOI 10.1139/z97-024; Ward BJ, 2012, BIOL LETTERS, V8, P657, DOI 10.1098/rsbl.2011.1180; Wild JM, 2008, J COMP NEUROL, V509, P156, DOI 10.1002/cne.21731; Wild JM, 1996, J COMP NEUROL, V368, P136, DOI 10.1002/(SICI)1096-9861(19960422)368:1<136::AID-CNE9>3.0.CO;2-4; Wild JM, 1997, BRAIN RES, V759, P122, DOI 10.1016/S0006-8993(97)00253-9; Wild JM, 1996, J COMP NEUROL, V365, P306, DOI 10.1002/(SICI)1096-9861(19960205)365:2<306::AID-CNE8>3.0.CO;2-9; WILD JM, 1987, BRAIN RES, V412, P205; WILD JM, 1985, J COMP NEUROL, V234, P441, DOI 10.1002/cne.902340404; Wild JM, 2001, BRAIN BEHAV EVOLUT, V57, P39, DOI 10.1159/000047225; WILD JM, 1981, J COMP NEUROL, V203, P351, DOI 10.1002/cne.902030304; Wild JM, 1997, BRAIN RES, V755, P137, DOI 10.1016/S0006-8993(97)00026-7; WITKOVSKY P, 1973, J COMP NEUROL, V147, P119, DOI 10.1002/cne.901470106; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Zweers G.A, 1977, Contributions vert. Evol., V3, P1; Zweers GA, 1997, NETH J ZOOL, V47, P161, DOI 10.1163/156854297X00166	92	73	75	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80036	10.1371/journal.pone.0080036	http://dx.doi.org/10.1371/journal.pone.0080036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244601	Green Published, Green Accepted, gold			2022-12-25	WOS:000327143800110
J	Zeller, M; Muller, A; Gutberlet, M; Nichols, T; Hahn, D; Kostler, H; Bartsch, AJ				Zeller, Mario; Mueller, Alexander; Gutberlet, Marcel; Nichols, Thomas; Hahn, Dietbert; Koestler, Herbert; Bartsch, Andreas J.			Boosting BOLD fMRI by K-Space Density Weighted Echo Planar Imaging	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; TO-NOISE RATIO; PHYSIOLOGICAL NOISE; GEOMETRIC DISTORTION; BLOOD OXYGENATION; SIGNAL CHANGES; TIME-SERIES; HUMAN BRAIN; RESONANCE; ROBUST	Functional magnetic resonance imaging (fMRI) has become a powerful and influential method to non-invasively study neuronal brain activity. For this purpose, the blood oxygenation level-dependent (BOLD) effect is most widely used. T-2* weighted echo planar imaging (EPI) is BOLD sensitive and the prevailing fMRI acquisition technique. Here, we present an alternative to its standard Cartesian recordings, i.e. k-space density weighted EPI, which is expected to increase the signal-to-noise ratio in fMRI data. Based on in vitro and in vivo pilot measurements, we show that fMRI by k-space density weighted EPI is feasible and that this new acquisition technique in fact boosted spatial and temporal SNR as well as the detection of local fMRI activations. Spatial resolution, spatial response function and echo time were identical for density weighted and conventional Cartesian EPI. The signal-to-noise ratio gain of density weighting can improve activation detection and has the potential to further increase the sensitivity of fMRI investigations.	[Zeller, Mario; Mueller, Alexander; Hahn, Dietbert; Koestler, Herbert] Univ Wurzburg, Dept Radiol, Univ Clin, D-97070 Wurzburg, Germany; [Gutberlet, Marcel] Hannover Med Sch, Dept Radiol, Hannover, Germany; [Nichols, Thomas] Univ Warwick, Dept Stat, Warwick, England; [Nichols, Thomas; Bartsch, Andreas J.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford OX3 9DU, England; [Koestler, Herbert] Univ Wurzburg, Comprehens Heart Failure Ctr, Bavaria, Germany; [Bartsch, Andreas J.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany	University of Wurzburg; Hannover Medical School; University of Warwick; University of Oxford; University of Wurzburg; Ruprecht Karls University Heidelberg	Zeller, M (corresponding author), Univ Wurzburg, Dept Radiol, Univ Clin, D-97070 Wurzburg, Germany.	zeller@roentgen.uni-wuerzburg.de	Goncalves, Gislene Lopes/D-3567-2013; Köstler, Herbert/B-2089-2010; Cordeiro-Estrela, Pedro/A-2913-2015; Freitas, Thales Renato Ochotorena de/G-1160-2012; Marinho, Jorge/AAC-1097-2019; Althoff, Sérgio Luiz/AAE-5820-2020; Nichols, Thomas E./N-9902-2017	Goncalves, Gislene Lopes/0000-0002-1459-4888; Köstler, Herbert/0000-0001-6207-9226; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Nichols, Thomas E./0000-0002-4516-5103; Althoff, Sergio Luiz/0000-0002-0877-5156; Testoni, Andre Filipe/0000-0002-4680-0092; Cordeiro-Estrela, Pedro/0000-0003-3383-571X	Deutsche Forschungsgemeinschaft (dfg.de) [DFG KO 2938/3-1]; German Research Foundation (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft (dfg.de); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by grant sponsor Deutsche Forschungsgemeinschaft (dfg.de), Grant number: DFG KO 2938/3-1. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Bartsch AJ, 2006, J MAGN RESON IMAGING, V23, P921, DOI 10.1002/jmri.20579; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Clare S, 2001, MAGNET RESON MED, V45, P930, DOI 10.1002/mrm.1124; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Duong TQ, 2003, MAGN RESON MED, V49, P1019, DOI 10.1002/mrm.10472; Feinberg DA, 2002, MAGN RESON MED, V48, P1, DOI 10.1002/mrm.10227; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fujita N, 2001, MAGN RESON MED, V46, P723, DOI 10.1002/mrm.1251; Geier OM, 2007, MAGN RESON MATER PHY, V20, P19, DOI 10.1007/s10334-006-0065-8; Greiser A, 2003, MAGN RESON MED, V50, P1266, DOI 10.1002/mrm.10647; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Gutberlet M, 2010, MAGN RESON IMAGING, V28, P341, DOI 10.1016/j.mri.2009.11.007; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kasper L, 2011, P INT SOC MAG RES ME, V19, P1634; Kriegeskorte N, 2010, J CEREBR BLOOD F MET, V30, P1551, DOI 10.1038/jcbfm.2010.86; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Man LC, 1997, MAGNET RESON MED, V37, P785, DOI 10.1002/mrm.1910370523; MARECI TH, 1984, J MAGN RESON, V57, P157, DOI 10.1016/0022-2364(84)90249-X; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; PARKER DL, 1987, MED PHYS, V14, P640, DOI 10.1118/1.596032; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Schmithorst VJ, 2001, IEEE T MED IMAGING, V20, P535, DOI 10.1109/42.929619; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Triantafyllou C, 2006, NEUROIMAGE, V32, P551, DOI 10.1016/j.neuroimage.2006.04.182; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Wu GH, 2005, MAGN RESON MED, V53, P1046, DOI 10.1002/mrm.20451; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zeller M, 2012, P ESMRMB 29 ANN M, P510; Zeller M, 2014, MAGN RESON MED, V71, P1117, DOI 10.1002/mrm.24737; Zeller M, 2013, J MAGN RESON IMAGING, V37, P965, DOI 10.1002/jmri.23872; Zellhuber M, 2012, PROCEEDINGS OF THE ASME TURBO EXPO 2012, VOL 2, PTS A AND B, P243	53	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74501	10.1371/journal.pone.0074501	http://dx.doi.org/10.1371/journal.pone.0074501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040262	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600096
J	Chen, L; Wang, T; Liu, L; Shen, YC; Wan, C; Wen, FQ				Chen, Lei; Wang, Tao; Liu, Lian; Shen, Yongchun; Wan, Chun; Wen, Fuqiang			Matrix Metalloproteinase-9-1562C/T Promoter Polymorphism Confers Risk for COPD: A Meta-Analysis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENETIC-POLYMORPHISM; MATRIX-METALLOPROTEINASE-9; POPULATION; EMPHYSEMA; ASSOCIATION	Background: The role of matrix metalloproteinase (MMP) gene polymorphisms in the development of chronic obstructive pulmonary disease (COPD) has been reported with inconsistent results. This meta-analysis was performed to assess the association of MMP-1 -1607G/GG and MMP-9 -1562C/T promoter polymorphisms with COPD susceptibility. Methods: Published case-control studies from Pubmed and China National Knowledge Infrastructure (CNKI) databases were retrieved. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. Results: A total of fourteen case-control studies were included in this meta-analysis. Pooled effect size showed an association of MMP-9 -1562 C/T with the risk of COPD (dominant model: TT+CT vs CC; OR: 1.46; 95% CI: 1.02-2.08; p = 0.04). However, no correlation with COPD was revealed in MMP-1 -1607G/GG polymorphism. When stratified by ethnicity, results indicated MMP-1 -1607G/GG (recessive model: G/G vs G/GG+GG/GG; OR: 1.20; 95% CI: 1.01-1.44; p = 0.04) and MMP-9 -1562 C/T (dominant model; OR: 1.66; 95% CI: 1.01-2.71; p = 0.04) were correlated with COPD susceptibility among Caucasians and Asians respectively. According to source of controls, signifiant association of MMP-9 -1562 C/T (additive model: T vs C; OR: 1.71, 95% CI: 1.42-2.07; p<0.00001, and dominant model; OR: 1.92; 95% CI: 1.34-2.76; p = 0.0004) with COPD susceptibility was revealed in the subgroup with smoker-based controls. However, in the aforementioned risk estimates, only the association of MMP-9 -1562 C/T (additive and dominant models) with the risk of COPD in the subgroup with smoker-based controls persisted significantly after Bonferroni correction for multiple testing. Moreover, after excluding the studies without Hardy-Weinberg equilibrium and/or with small sample size, the pooled results were robust and no publication bias was found in this study. Conclusion: This meta-analysis suggests, when using healthy smokers as controls, MMP-9 -1562 C/T, but not MMP-1 -1607 G/GG polymorphism is associated with the risk of COPD.	[Chen, Lei; Wang, Tao; Liu, Lian; Shen, Yongchun; Wan, Chun; Wen, Fuqiang] Sichuan Univ, West China Hosp, West China Sch Med, Div Pulm Dis,State Key Lab Biotherapy China, Chengdu 610064, Sichuan, Peoples R China; [Chen, Lei; Wang, Tao; Liu, Lian; Shen, Yongchun; Wan, Chun; Wen, Fuqiang] Sichuan Univ, West China Hosp, West China Sch Med, Dept Resp Med, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Wen, FQ (corresponding author), Sichuan Univ, West China Hosp, West China Sch Med, Div Pulm Dis,State Key Lab Biotherapy China, Chengdu 610064, Sichuan, Peoples R China.	wenfuqiang.scu@gmail.com	; YANG, Jun/E-6680-2011	Chen, Guangjie/0000-0001-8035-6565; YANG, Jun/0000-0002-7920-2777; Liu, Lemian/0000-0002-8977-6969	National Natural Science Foundation of China [31000513, 31171103, 81200031, 81230001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by grants 31000513, 31171103, 81200031, and 81230001 from the National Natural Science Foundation of China. The funders (grants 31000513, 31171103, 81200031, and 81230001 from the National Natural Science Foundation of China) have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Cai J., 2010, SHAN DONG YI YAO, V50, P76; Cheng SL, 2009, BIOCHEM GENET, V47, P591, DOI 10.1007/s10528-009-9252-4; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Han W., 2006, ZHONG HUA JIE HE HE, V29, P277; Haq I, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-7; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hua DM, 2010, INT J RESPI, V30, P1157; Ito I, 2005, AM J RESP CRIT CARE, V172, P1378, DOI 10.1164/rccm.200506-953OC; Korytina GF, 2008, RUSS J GENET+, V44, P202, DOI 10.1134/S1022795408020130; Lee SY, 2010, RESPIRATION, V80, P133, DOI 10.1159/000284926; Minematsu N, 2001, BIOCHEM BIOPH RES CO, V289, P116, DOI 10.1006/bbrc.2001.5936; Rutter JL, 1998, CANCER RES, V58, P5321; Sampsonas F, 2007, POSTGRAD MED J, V83, P244, DOI 10.1136/pgmj.2006.052100; Schirmer H, 2009, GENET MOL RES, V8, P1028, DOI 10.4238/vol8-3gmr596; Soler Artigas M, 2012, THORAX, V67, P271, DOI 10.1136/thoraxjnl-2011-200724; Sun P., 2005, CHIN J RESP CRIT CAR, V4, P342; Tesfaigzi Yohannes, 2006, Int J Chron Obstruct Pulmon Dis, V1, P267, DOI 10.2147/copd.2006.1.3.267; Todd JL, 2011, AM J RESP CRIT CARE, V184, P873, DOI 10.1164/rccm.201106-0971PP; Zhang BP, 1999, CIRCULATION, V99, P1788, DOI 10.1161/01.CIR.99.14.1788; Zhang Rong-bao, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P907; Zhou M, 2004, CHINESE MED J-PEKING, V117, P1481	23	40	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60523	10.1371/journal.pone.0060523	http://dx.doi.org/10.1371/journal.pone.0060523			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555986	gold, Green Published, Green Submitted			2022-12-25	WOS:000317262200123
J	Lin, YL; Tsai, YJ; Liu, YF; Cheng, YC; Hung, CM; Lee, YJ; Pan, HC; Li, C				Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Cheng, Yi-Chuan; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan			The Critical Role of Protein Arginine Methyltransferase prmt8 in Zebrafish Embryonic and Neural Development Is Non-Redundant with Its Paralogue prmt1	PLOS ONE			English	Article							METHYLATION; PROTEIN-ARGININE-METHYLTRANSFERASE-8; IDENTIFICATION; BINDING; FAMILY; DOMAIN; GENES; BRAIN; REST	Protein arginine methyltransferase (PRMT) 1 is the most conserved and widely distributed PRMT in eukaryotes. PRMT8 is a vertebrate-restricted paralogue of PRMT1 with an extra N-terminal sequence and brain-specific expression. We use zebrafish (Danio rerio) as a vertebrate model to study PRMT8 function and putative redundancy with PRMT1. The transcripts of zebrafish prmt8 were specifically expressed in adult zebrafish brain and ubiquitously expressed from zygotic to early segmentation stage before the neuronal development. Whole-mount in situ hybridization revealed ubiquitous prmt8 expression pattern during early embryonic stages, similar to that of prmt1. Knockdown of prmt8 with antisense morpholino oligonucleotide phenocopied prmt1-knockdown, with convergence/extension defects at gastrulation. Other abnormalities observed later include short body axis, curled tails, small and malformed brain and eyes. Catalytically inactive prmt8 failed to complement the morphants, indicating the importance of methyltransferase activity. Full-length prmt8 but not prmt1 cRNA can rescue the phenotypic changes. Nevertheless, cRNA encoding Prmt1 fused with the N-terminus of Prmt8 can rescue the prmt8 morphants. In contrast, N-terminus-deleted but not full-length prmt8 cRNA can rescue the prmt1 morphants as efficiently as prmt1 cRNA. Abnormal brain morphologies illustrated with brain markers and loss of fluorescent neurons in a transgenic fish upon prmt8 knockdown confirm the critical roles of prmt8 in neural development. In summery, our study is the first report showing the expression and function of prmt8 in early zebrafish embryogenesis. Our results indicate that prmt8 may play important roles non-overlapping with prmt1 in embryonic and neural development depending on its specific N-terminus.	[Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fang; Pan, Huichin; Li, Chuan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Yi-Chuan] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung University	Li, C (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan.	cli@csmu.edu.tw	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196	National Science Council [95-2320-B-040-042, 96-2320-B-040-022-MY2, 98-2320-B-040-011-MY3]; Chung Shan Medical University [CSMU 94-OM-A-023, 97-OM-A-136, 98OM-A-060]	National Science Council(Ministry of Science and Technology, Taiwan); Chung Shan Medical University	The project was supported by 95-2320-B-040-042, 96-2320-B-040-022-MY2 and 98-2320-B-040-011-MY3 from National Science Council and CSMU 94-OM-A-023, 97-OM-A-136 and 98OM-A-060 from Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Batut J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025427; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Gates KP, 2010, DEV BIOL, V340, P293, DOI 10.1016/j.ydbio.2010.01.029; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lin CH, 2002, J PROTEIN CHEM, V21, P447, DOI 10.1023/A:1021394903025; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Tsai YJ, 2011, FEBS J, V278, P905, DOI 10.1111/j.1742-4658.2011.08006.x; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	29	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e55221	10.1371/journal.pone.0055221	http://dx.doi.org/10.1371/journal.pone.0055221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	24244618	gold, Green Submitted, Green Published			2022-12-25	WOS:000316252500001
J	Liu, Y; Zhang, AQ; Cao, L; Xia, HT; Ma, JJ				Liu, Yong; Zhang, An-Qiang; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie			Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; TARGETED USE; HEMODIALYSIS; BACTEREMIA; CITRATE; HEPARIN; SEPSIS; CANCER; TAUROLOCK(R)	Background: Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of CRBSIs remains controversial. In this meta-analysis, we aim to assess the efficacy of TLS for preventing CRBSIs. Methods: We conducted a systematic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Eligible studies included randomized controlled trials that reported on the effects of TLS for preventing CRBSIs. The primary outcome in these studies was catheter-related bloodstream infections, with microbial distribution of CRBSI and catheter-associated thrombosis as secondary outcomes. Data were combined using random-effects models owing to significant clinical heterogeneity. Results: Six randomized controlled trials (RCTs) conducted from 2004 through 2013 involving 431 patients and 86,078 catheter-days were included in the review. TLS were significantly associated with a lower incidence of CRBSIs when compared to heparin lock solutions (Risk Ratio [RR], 0.34; 95% Confidence Interval [CI], 0.21-0.55). Use of TLS significantly decreased the incidence of CRBSIs from gram-negative (G-) bacteria (P = 0.004; RR, 0.27; CI, 0.11-0.65), and was associated with a non-significant decrease in gram-positive (G+) bacterial infections (P = 0.07; RR, 0.41; CI, 0.15-1.09). No significant association was observed with TLS and catheter-associated thrombosis (RR, 1.99; CI, 0.75-5.28). Conclusions: The use of TLS reduced the incidence of CRBSIs without obvious adverse effects or bacterial resistance. However, the susceptibility of G+ and G- bacteria to taurolidine and the risk for catheter-associated thrombosis of TLS are indeterminate due to limited data. The results should be treated with caution due to the limited sample sizes and methodological deficiencies of included studies. Therefore, additional well-designed and adequately powered RCTs are needed to confirm these findings.	[Liu, Yong; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie] Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China; [Zhang, An-Qiang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Liu, Y (corresponding author), Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China.	616756156@qq.com	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196				Akyuz C, 2010, PEDIATR BLOOD CANCER, V55, P949; Al-Amin A, 2012, BRIT J SURG, V99, P158; Allon M, 2003, CLIN INFECT DIS, V36, P1539, DOI 10.1086/375234; Betjes MGH, 2004, NEPHROL DIAL TRANSPL, V19, P1546, DOI 10.1093/ndt/gfh014; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Bradshaw JH, 2008, J PEDIATR GASTR NUTR, V47, P179, DOI 10.1097/MPG.0b013e318162c428; Branger B, 2008, ARTIF ORGANS, V32, P918, DOI 10.1111/j.1525-1594.2008.00684.x; Braumann C, 2005, J SURG RES, V129, P129, DOI 10.1016/j.jss.2005.03.012; Chu HP, 2012, J PEDIATR GASTR NUTR, V55, P403, DOI 10.1097/MPG.0b013e31825bb0ae; Dumichen MJ, 2012, J HOSP INFECT, V80, P304, DOI 10.1016/j.jhin.2012.01.003; Filiopoulos V, 2011, AM J NEPHROL, V33, P260, DOI 10.1159/000324685; Geron R, 2006, HAREFUAH, V145, P943; Geron Ronit, 2006, Harefuah, V145, P881; GORMAN SP, 1987, J APPL BACTERIOL, V62, P315, DOI 10.1111/j.1365-2672.1987.tb04926.x; Haag GM, 2011, J VASC ACCESS, V12, P244, DOI 10.5301/JVA.2011.6265; Handrup MM, 2012, APMIS, V120, P794, DOI 10.1111/j.1600-0463.2012.02910.x; Handrup MM, 2013, PEDIAT BLOOD CANC; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill SM, 2011, J PEDIAT GASTROEN S1, V52, pE64; Jonkers C., 2012, CLIN NUTR S, V7, P203; Jurewitsch B, 2005, CLIN NUTR, V24, P462, DOI 10.1016/j.clnu.2005.02.001; Jurewitsch B, 1998, JPEN-PARENTER ENTER, V22, P242, DOI 10.1177/0148607198022004242; Labriola L, 2008, NEPHROL DIAL TRANSPL, V23, P1666, DOI 10.1093/ndt/gfm847; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Moher David, 2009, BMJ, V339, pb2535, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Novikov A, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-40; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Horo JC, 2011, AM J NEPHROL, V34, P415, DOI 10.1159/000331262; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; Olthof ED, 2012, CLIN NUTR; Olthof ED, 2012, CLIN NUTR S7, V7, P149; Rafferty GP, 2010, GUT, V59, pA35, DOI 10.1136/gut.2009.208991f; Rommes JH, 2001, CURR ANAESTH CRIT CA, V12, P25; Schiavone PA, 2010, PRACT GASTROENTEROL, V34, P22; Schiffer CA, 2013, J CLIN ONCOL; Shah CB, 2002, ANTIMICROB AGENTS CH, V46, P1674, DOI 10.1128/AAC.46.6.1674-1679.2002; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-102; Solomon LR, 2012, SEMIN DIALYSIS, V25, P233, DOI 10.1111/j.1525-139X.2011.00951.x; Solomon LR, 2010, AM J KIDNEY DIS, V55, P1060, DOI 10.1053/j.ajkd.2009.11.025; Sweet S, 2009, AM J KIDNEY DIS, V53, pA74; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Taylor C, 2008, J REN CARE, V34, P116, DOI 10.1111/j.1755-6686.2008.00027.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Torres-Viera C, 2000, ANTIMICROB AGENTS CH, V44, P1720, DOI 10.1128/AAC.44.6.1720-1724.2000; Toure A, 2012, CLIN NUTR, V31, P567, DOI 10.1016/j.clnu.2012.01.001; van de Wetering MD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003295.pub2; Vernon MA, 2006, SCOT MED J, V51, P54; Weber M, 2009, ZBL CHIR, V134, P350, DOI 10.1055/s-0028-1098929; Yahav D, 2008, CLIN INFECT DIS, V47, P83, DOI 10.1086/588667; Zwiech R, 2013, AM J THER	53	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79417	10.1371/journal.pone.0079417	http://dx.doi.org/10.1371/journal.pone.0079417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24244618	Green Published, Green Submitted, gold			2022-12-25	WOS:000327539800007
J	Liu, Y; Lai, NW; Gao, K; Chen, FJ; Yuan, LX; Mi, GH				Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua			Ammonium Inhibits Primary Root Growth by Reducing the Length of Meristem and Elongation Zone and Decreasing Elemental Expansion Rate in the Root Apex in Arabidopsis thaliana	PLOS ONE			English	Article							AUXIN TRANSPORT; GRAVITROPISM; STRESS; EFFLUX; NH4+; ORGANIZATION; SENSITIVITY; MUTATIONS; TOXICITY; NITROGEN	The inhibitory effect of ammonium on primary root growth has been well documented; however the underlying physiological and molecular mechanisms are still controversial. To avoid ammonium toxicity to shoot growth, we used a vertical two-layer split plate system, in which the upper layer contained nitrate and the lower layer contained ammonium. In this way, nitrogen status was maintained and only the apical part of the root system was exposed to ammonium. Using a kinematic approach, we show here that 1 mM ammonium reduces primary root growth, decreasing both elemental expansion and cell production. Ammonium inhibits the length of elongation zone and the maximum elemental expansion rate. Ammonium also decreases the apparent length of the meristem as well as the number of dividing cells without affecting cell division rate. Moreover, ammonium reduces the number of root cap cells but appears to affect neither the status of root stem cell niche nor the distal auxin maximum at the quiescent center. Ammonium also inhibits root gravitropism and concomitantly down-regulates the expression of two pivotal auxin transporters, AUX1 and PIN2. Insofar as ammonium inhibits root growth rate in AUX1 and PIN2 loss-of-function mutants almost as strongly as in wild type, we conclude that ammonium inhibits root growth and gravitropism by largely distinct pathways.	[Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China	China Agricultural University	Mi, GH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	miguohua@cau.edu.cn	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196	NSFC [30771289, 31121062]	NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC (No.30771289), the innovative group grant of NSFC (No.31121062) [http://isisn.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, SOIL SOLUTION CHEM A; Baskin TI, 2013, WIRES DEV BIOL, V2, P65, DOI 10.1002/wdev.94; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; CAO YW, 1993, PLANT PHYSIOL, V102, P983, DOI 10.1104/pp.102.3.983; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Gazzarrini S, 1999, PLANT CELL, V11, P937, DOI 10.1105/tpc.11.5.937; Geisler M, 2002, PLANT PHYSIOL, V130, P1747, DOI 10.1104/pp.011197; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Kudoyarova GR, 1997, PLANT GROWTH REGUL, V23, P207, DOI 10.1023/A:1005990725068; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Ma Z, 2003, PLANT PHYSIOL, V131, P1381, DOI 10.1104/pp.012161; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MORRIS AK, 1992, B MATH BIOL, V54, P1069, DOI 10.1007/BF02460667; Mosier AR, 2004, AGR NITROGEN CYCLE A; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rogato A, 2010, PLANT PHYSIOL, V154, P784, DOI 10.1104/pp.110.160309; ROMAN G, 1995, GENETICS, V139, P1393; SHARP RE, 1988, PLANT PHYSIOL, V87, P50, DOI 10.1104/pp.87.1.50; SILK WK, 1992, INT J PLANT SCI, V153, pS49, DOI 10.1086/297063; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Walch-Liu P, 2000, J EXP BOT, V51, P227, DOI 10.1093/jexbot/51.343.227; West G, 2004, PLANT PHYSIOL, V135, P1050, DOI 10.1104/pp.104.040022; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zou N, 2012, J EXP BOT, V63, P3777, DOI 10.1093/jxb/ers068	44	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61031	10.1371/journal.pone.0061031	http://dx.doi.org/10.1371/journal.pone.0061031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	24244618	gold, Green Published, Green Submitted			2022-12-25	WOS:000317898000091
J	Liu, YX; van den Berg, A; Veenstra, R; Rutgers, B; Nolte, I; van Imhoff, G; Visser, L; Diepstra, A				Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Nolte, Ilja; van Imhoff, Gustaaf; Visser, Lydia; Diepstra, Arjan			PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV plus Hodgkin Lymphoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; ARCHITECTURE; RESPONSES; CHROMATIN	Tumor cells of classical Hodgkin lymphoma (cHL) are characterized by a general loss of B cell phenotype, whereas antigen presenting properties are commonly retained. HLA class I is expressed in most EBV+ cHL cases, with an even enhanced expression in a proportion of the cases. Promyelocytic leukemia protein (PML) and special AT-rich region binding protein 1 (SATB1) are two global chromatin organizing proteins that have been shown to regulate HLA class I expression in Jurkat cells. We analyzed HLA class I, number of PML nuclear bodies (NBs) and SATB1 expression in tumor cells of 54 EBV+ cHL cases and used 27 EBV- cHL cases as controls. There was a significant difference in presence of HLA class I staining between EBV+ and EBV2 cases (p < 0.0001). We observed normal HLA class I expression in 35% of the EBV+ and in 19% of the EBV- cases. A stronger than normal HLA class I expression was observed in approximately 40% of EBV+ cHL and not in EBV- cHL cases. 36 EBV+ cHL cases contained less than 10 PML-NBs per tumor cell, whereas 16 cases contained more than 10 PMLNBs. The number of PML-NBs was positively correlated to the level of HLA class I expression (p < 0.01). The percentage of SATB1 positive cells varied between 0% to 100% in tumor cells and was inversely correlated with the level of HLA class I expression, but only between normal and strong expression (p < 0.05). Multivariable analysis indicated that the number of PML-NBs and the percentage of SATB1+ tumor cells are independent factors affecting HLA class I expression in EBV+ cHL. In conclusion, both PML and SATB1 are correlated to HLA class I expression levels in EBV+ cHL.	[Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Visser, Lydia; Diepstra, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Nolte, Ilja] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Imhoff, Gustaaf] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.diepstra@umcg.nl	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF) [RUG 2009-4313]	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	This work was supported by grants from Abel Tasman Talent Program (ATTP), University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang SK, 2002, MOL CELLS, V14, P130; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; DELABIE J, 1995, LEUKEMIA LYMPHOMA, V18, P35, DOI 10.3109/10428199509064920; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Jarrett RF, 2002, ANN ONCOL, V13, P23, DOI 10.1093/annonc/13.S1.23; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kuppers R, 2006, TRENDS IMMUNOL, V27, P203, DOI 10.1016/j.it.2006.03.001; Lallemand-Breitenbach V, COLD SPRING HARB PER, V2; Lee SP, 1997, J IMMUNOL, V158, P3325; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Shiels C, 2001, J CELL SCI, V114, P3705; Sides MD, 2011, VIROLOGY, V416, P86, DOI 10.1016/j.virol.2011.04.005; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Stein H, 2008, WHO CLASSIFICATION T, V2, P321; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Zuo J, 2008, J VIROL, V82, P2385, DOI 10.1128/JVI.01946-07; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	29	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72930	10.1371/journal.pone.0072930	http://dx.doi.org/10.1371/journal.pone.0072930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24244618	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600043
